Citrus Sinensis ID: 000706
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1342 | 2.2.26 [Sep-21-2011] | |||||||
| Q2QAV0 | 1322 | Serine/threonine-protein | yes | no | 0.977 | 0.992 | 0.650 | 0.0 | |
| Q9NRP7 | 1315 | Serine/threonine-protein | yes | no | 0.186 | 0.190 | 0.665 | 1e-105 | |
| Q5RAJ5 | 1315 | Serine/threonine-protein | yes | no | 0.187 | 0.191 | 0.661 | 1e-104 | |
| Q69ZM6 | 1316 | Serine/threonine-protein | yes | no | 0.187 | 0.191 | 0.661 | 1e-103 | |
| Q55FT4 | 2247 | Probable serine/threonine | yes | no | 0.189 | 0.113 | 0.523 | 7e-78 | |
| P23647 | 805 | Serine/threonine-protein | yes | no | 0.187 | 0.313 | 0.519 | 2e-71 | |
| E9PTG8 | 967 | Serine/threonine-protein | no | no | 0.254 | 0.352 | 0.344 | 2e-42 | |
| F1NBT0 | 969 | Serine/threonine-protein | no | no | 0.186 | 0.257 | 0.393 | 3e-42 | |
| Q7SY52 | 974 | Serine/threonine-protein | no | no | 0.184 | 0.254 | 0.400 | 4e-42 | |
| Q9P7J8 | 569 | Serine/threonine-protein | yes | no | 0.192 | 0.453 | 0.342 | 1e-41 |
| >sp|Q2QAV0|TIO_ARATH Serine/threonine-protein kinase TIO OS=Arabidopsis thaliana GN=TIO PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1696 bits (4393), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 875/1345 (65%), Positives = 1065/1345 (79%), Gaps = 33/1345 (2%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
MGVE+YHVIELVGEGSFG+VYKGRRKYTGQTVAMKFIMK GK++KDIH+LRQEIEILRKL
Sbjct: 1 MGVEDYHVIELVGEGSFGRVYKGRRKYTGQTVAMKFIMKQGKTDKDIHSLRQEIEILRKL 60
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
KH+NIIEMLDSFE+ +EFCVVTEFAQGELFEILEDDKCLPEEQVQ+IAKQLV+AL YLHS
Sbjct: 61 KHENIIEMLDSFENAREFCVVTEFAQGELFEILEDDKCLPEEQVQAIAKQLVKALDYLHS 120
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS NTVVLRSIKGTPLYMAPELV+EQPY+
Sbjct: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSTNTVVLRSIKGTPLYMAPELVKEQPYD 180
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
T DLWSLGVILYEL+VGQPPFYTNSVYALIRHIVKDPVKYPDEMS F+SFLKGLLNK
Sbjct: 181 RTVDLWSLGVILYELYVGQPPFYTNSVYALIRHIVKDPVKYPDEMSTYFESFLKGLLNKE 240
Query: 241 PQNRLTWSALLEHPFVKETSDELNAWELRATSVEARGCNATWTAEGNAIQSSSGKSNSPA 300
P +RLTW AL EHPFVKET +E+ A E+ V+ + A W +GN Q + K +S
Sbjct: 241 PHSRLTWPALREHPFVKETQEEVEAREIHTAVVDNK---AAWMLKGNGGQQRNEKCDSVT 297
Query: 301 VSANNTSPSLHTDVELNSSNTSQSNSSPCEAFPGFSSPNNVKPSGSQALNRLENNSRTVK 360
+ + ++ DV+ + + + NS P E F GF + +K SG+ L++LEN SRTVK
Sbjct: 298 LVEDMSATKGLADVQSDMKSAVKVNSPPTEDFVGFPTQEEIKSSGNPTLDKLENTSRTVK 357
Query: 361 GALSICQDNEALALILLPLKKWSQGSQNTCRDQDVLNSNQSLRILSNLVAASAIQSNGLL 420
GA I ++++AL L+LL L+++S+ S ++ RD+DV S QSLRI+SNLVA AI S GL+
Sbjct: 358 GAQVIGENDKALDLVLLSLERFSK-SPDSKRDKDVACSVQSLRIISNLVATRAIVSVGLI 416
Query: 421 DEIISELLDFSSVVVSLKASELNDLLAKSFLIIKMLIDN-SGSCIASSYFTNWVAVVEIF 479
++I LLDF+ +V +K+ E N+++ KS + K L+ + G+ I SSY +W VVEIF
Sbjct: 417 EKITCALLDFTDALVGMKSPEFNNIIPKSLSVTKNLVGHVEGNNIHSSYIRHWTKVVEIF 476
Query: 480 SKVVSCNEDASGRVLYEATACITVMLSRVAQNLKASSSAPGPDANSTPRVNETLKRILDH 539
+VV E+ +GR++YEA +CIT MLSRVAQ+LK+S+ PD+ S K+IL+H
Sbjct: 477 IQVVRWEEEGTGRIIYEACSCITTMLSRVAQDLKSST----PDSVS--------KQILEH 524
Query: 540 AKTSGLVDHLCCCLATSGSNLNSGSSNMLRAACETCKAIFSLVDVLEIHFSMENAYLFPL 599
A S +VDHLC CLA+SGS+L SGSS ML AACE C+AI+ L+D E F ++ + PL
Sbjct: 525 ANMSRIVDHLCLCLASSGSSLTSGSSQMLAAACEACRAIWILIDTSETFFKNDDVNILPL 584
Query: 600 NAFWSHSLLRLDIRDHERGSLVGPESARIIDALTRAFLRSKAVQLAINHCLHQRAEATLS 659
+A + L + DI + E GP S +++D +TRA+LRSK VQ+A+ HCLHQR EA L
Sbjct: 585 DAL-QNRLSQHDIGNSEW----GPLSEKLVDTVTRAYLRSKHVQVAVGHCLHQRVEAPLV 639
Query: 660 AVIQLLSRCCLRSGIIPSILCGFPSSLPVTTVVSGGEDGTAVLEIFSILSLCASSNKDSQ 719
+ IQLLSRCCL +GI+PS+LCG PSSLP+TTVVSGGEDGT + EIFSILS S+KD Q
Sbjct: 640 SAIQLLSRCCLHNGILPSMLCGLPSSLPITTVVSGGEDGTVISEIFSILSYATLSSKDQQ 699
Query: 720 VGETSNVKGKLSNPCALALHSCLFLAIVAQCLKSTLRNSALFMLTTTPKKQLSRLKILAH 779
GE N +G+L+N L HSCL LA VAQCLK T RNS L MLTT+PKK RL +A+
Sbjct: 700 TGEKDNFEGRLNN---LVFHSCLMLATVAQCLKLTGRNSVLLMLTTSPKKHQHRLSAIAN 756
Query: 780 YFSSDDRIKTYFQLHSASAMLAFASILSLESGATVESSIYEIAVPLIPPTATLCDLLKIT 839
+ +SDD+I+ Q HSASAMLA ASIL+LE G++ SS+ E+ V LIP LC L+
Sbjct: 757 HIASDDKIEASLQNHSASAMLALASILALEKGSSAGSSVSELVVSLIPRATKLCYHLRPM 816
Query: 840 SGNADQMGPISQSNSFSYWHGLKDGCVGLLESRLKCGGPLAVQQMIASNIPMLLIDLLA- 898
N ++ IS S +++ WHGL DGC+GLLESRLK GGPLAVQQ+IAS P+LLI+LLA
Sbjct: 817 PSNEGEV--ISHSANYAKWHGLLDGCIGLLESRLKWGGPLAVQQLIASGTPLLLINLLAG 874
Query: 899 --NTHSSQQIGSTRDQMMLSPAGVVSTISSIYHCLSGGVLMFRQVLLKNEYMKLICNLLS 956
+ S + I T +++ LSP GVV TISSI HCLSGG FRQVL+K E MKLI LLS
Sbjct: 875 KLSNASPEDIKKTSNRIGLSPIGVVWTISSICHCLSGGT-TFRQVLVKIETMKLITCLLS 933
Query: 957 DVHLKLVKGWGGPGGGKDGIRDIINAVIDLLAFPFVAVQNAPGLPSATASVNSGFILNMG 1016
D H+KLVK WGGPGGGKDG+R+ IN +IDLLAFPFVA+Q+ PG SATASVNSGFILN+G
Sbjct: 934 DAHIKLVKSWGGPGGGKDGVRETINVIIDLLAFPFVALQSQPGSLSATASVNSGFILNIG 993
Query: 1017 SAGGKVCMEDRDMAKAIEEDMGKYIKILMEVGVPGIILRCLEHMELKNLGRPIAFLAKMI 1076
S G +VCMEDRD+ KAIEEDM KYI +L+EVGVP +ILRCL+H+ELK+L RP+AFLAKM+
Sbjct: 994 SPGVRVCMEDRDLLKAIEEDMDKYIIVLLEVGVPSLILRCLDHLELKDLVRPVAFLAKMV 1053
Query: 1077 GQRSLAVQLVGKGLLDPNRVRRLLD-SSTREVTLDVLMIVSDLARMDKWFYEYINGASML 1135
G+ LAV LV KGLLDPNR+++LL+ SS REV LD+LMI+SDL+RMDK FY+YI AS+L
Sbjct: 1054 GRPRLAVDLVSKGLLDPNRMKKLLNQSSPREVILDILMIISDLSRMDKAFYKYIGEASVL 1113
Query: 1136 EFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFA 1195
+ LK++LTH DPN+RAKACSALGNMCRH+ YFYS+LA+++IIGLLIDRCADPDKRT+KFA
Sbjct: 1114 QPLKEYLTHVDPNIRAKACSALGNMCRHNGYFYSALAEHQIIGLLIDRCADPDKRTQKFA 1173
Query: 1196 CFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIV 1255
CF+IGNAAYHND LYEELRRSI LAN+L + EEDKTKANAAGALSNL+RNS+KLCEDIV
Sbjct: 1174 CFAIGNAAYHNDTLYEELRRSITQLANVLTTAEEDKTKANAAGALSNLVRNSNKLCEDIV 1233
Query: 1256 SKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCA-HTPCRQFLQSSELF 1314
SKGA+Q L++LVADCS LALNPS+K+ +ESPLKIALFSLAKMC+ H CRQF++SSELF
Sbjct: 1234 SKGALQTLLRLVADCSTLALNPSKKETASESPLKIALFSLAKMCSNHQICRQFVKSSELF 1293
Query: 1315 PVIARLRQSPESTIANYASVIISKV 1339
PVIARL+QSPE+ IA+YASVI++KV
Sbjct: 1294 PVIARLKQSPEANIAHYASVIVAKV 1318
|
Plays a role in conventional modes of cytokinesis in meristems and during male gametogenesis but also acts in nonconventional modes of cytokinesis (cellularization) during female gametogenesis. Constitutes a signaling module in association with Kinesin-12 members that is required to support phragmoplast expansion and cell-plate growth in plant cells. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9NRP7|STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 382 bits (982), Expect = e-105, Method: Compositional matrix adjust.
Identities = 169/254 (66%), Positives = 214/254 (84%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
+E YHV+E++GEGSFG+VYKGRRKY+ Q VA+KFI K G+SEK++ NL++EIEI+R L+H
Sbjct: 1 MEKYHVLEMIGEGSFGRVYKGRRKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLRH 60
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+ MLDSFE+ +E VVT++A+GELF+ILEDD LPE+QVQ+IA QLV AL+YLHS+R
Sbjct: 61 PNIVHMLDSFETDKEVVVVTDYAEGELFQILEDDGKLPEDQVQAIAAQLVSALYYLHSHR 120
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHT 182
I+HRDMKPQNIL+ G +KLCDFGFARAMS NT+VL SIKGTPLYM+PELV E+PY+HT
Sbjct: 121 ILHRDMKPQNILLAKGGGIKLCDFGFARAMSTNTMVLTSIKGTPLYMSPELVEERPYDHT 180
Query: 183 ADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQ 242
ADLWS+G ILYEL VG PPFY S++ L+ I+KDPV++P +SP FK+FL+GLL K P+
Sbjct: 181 ADLWSVGCILYELAVGTPPFYATSIFQLVSLILKDPVRWPSTISPCFKNFLQGLLTKDPR 240
Query: 243 NRLTWSALLEHPFV 256
RL+W LL HPF+
Sbjct: 241 QRLSWPDLLYHPFI 254
|
Serine/threonine protein kinase which plays an important role in the sonic hedgehog (Shh) pathway by regulating the activity of GLI transcription factors. Controls the activity of the transcriptional regulators GLI1, GLI2 and GLI3 by opposing the effect of SUFU and promoting their nuclear localization. GLI2 requires an additional function of STK36 to become transcriptionally active, but the enzyme does not need to possess an active kinase catalytic site for this to occur. Required for postnatal development, possibly by regulating the homeostasis of cerebral spinal fluid or ciliary function. Essential for construction of the central pair apparatus of motile cilia. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5RAJ5|STK36_PONAB Serine/threonine-protein kinase 36 OS=Pongo abelii GN=STK36 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 380 bits (977), Expect = e-104, Method: Compositional matrix adjust.
Identities = 168/254 (66%), Positives = 213/254 (83%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
+E YHV+E++GEGSFG+VYKGRRKY+ Q VA+KFI K G+SEK++ NL++EIEI+R L+H
Sbjct: 1 MEKYHVLEMIGEGSFGRVYKGRRKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLRH 60
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+ MLDSFE+ +E VVT++A+GEL +ILEDD LPE+QVQ+IA QLV AL+YLHS+R
Sbjct: 61 PNIVHMLDSFETDKEVVVVTDYAEGELLQILEDDGKLPEDQVQAIAAQLVSALYYLHSHR 120
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHT 182
I+HRDMKPQNIL+ G +KLCDFGFARAMS NT+VL SIKGTPLYM+PELV E+PY+HT
Sbjct: 121 ILHRDMKPQNILLAKGGGIKLCDFGFARAMSTNTMVLTSIKGTPLYMSPELVEERPYDHT 180
Query: 183 ADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQ 242
ADLWS+G ILYEL VG PPFY S++ L+ I+KDPV++P +SP FK+FL+GLL K P+
Sbjct: 181 ADLWSVGCILYELAVGTPPFYATSIFQLVSLILKDPVRWPSTISPCFKNFLQGLLTKDPR 240
Query: 243 NRLTWSALLEHPFV 256
RL+W LL HPF+
Sbjct: 241 QRLSWPDLLYHPFI 254
|
Serine/threonine protein kinase which plays an important role in the sonic hedgehog (Shh) pathway by regulating the activity of GLI transcription factors. Controls the activity of the transcriptional regulators GLI1, GLI2 and GLI3 by opposing the effect of SUFU and promoting their nuclear localization. GLI2 requires an additional function of STK36 to become transcriptionally active, but the enzyme does not need to possess an active kinase catalytic site for this to occur. Required for postnatal development, possibly by regulating the homeostasis of cerebral spinal fluid or ciliary function. Essential for construction of the central pair apparatus of motile cilia. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q69ZM6|STK36_MOUSE Serine/threonine-protein kinase 36 OS=Mus musculus GN=Stk36 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 378 bits (971), Expect = e-103, Method: Compositional matrix adjust.
Identities = 168/254 (66%), Positives = 213/254 (83%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
+E YHV+E++GEGSFG+VYKGR+KY+ Q VA+KFI K G+SEK++ NL++EIEI+R L H
Sbjct: 1 MEKYHVLEMIGEGSFGRVYKGRKKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLWH 60
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+ MLDSFE+ +E VVT++A+GELF+ILEDD LPE+QVQ+IA QLV AL+YLHS+R
Sbjct: 61 PNIVHMLDSFETDKEVVVVTDYAEGELFQILEDDGKLPEDQVQAIAAQLVSALYYLHSHR 120
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHT 182
I+HRDMKPQNIL+ G +KLCDFGFARAMS NT+VL SIKGTPLYM+PELV E+PY+HT
Sbjct: 121 ILHRDMKPQNILLAKGGGIKLCDFGFARAMSTNTMVLTSIKGTPLYMSPELVEERPYDHT 180
Query: 183 ADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQ 242
ADLWS+G ILYEL VG PPFYT S++ L+ I+KDPV++P +S FK+FL+GLL K P+
Sbjct: 181 ADLWSVGCILYELAVGTPPFYTTSIFQLVSLILKDPVRWPSTISSCFKNFLQGLLTKDPR 240
Query: 243 NRLTWSALLEHPFV 256
RL+W LL HPF+
Sbjct: 241 QRLSWPDLLHHPFI 254
|
Serine/threonine protein kinase which plays an important role in the sonic hedgehog (Shh) pathway by regulating the activity of GLI transcription factors. Controls the activity of the transcriptional regulators GLI1, GLI2 and GLI3 by opposing the effect of SUFU and promoting their nuclear localization. GLI2 requires an additional function of STK36 to become transcriptionally active, but the enzyme does not need to possess an active kinase catalytic site for this to occur. Required for postnatal development, possibly by regulating the homeostasis of cerebral spinal fluid or ciliary function. Essential for construction of the central pair apparatus of motile cilia. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55FT4|TSUA_DICDI Probable serine/threonine-protein kinase tsuA OS=Dictyostelium discoideum GN=tsuA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 293 bits (750), Expect = 7e-78, Method: Compositional matrix adjust.
Identities = 134/256 (52%), Positives = 191/256 (74%), Gaps = 2/256 (0%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
++Y +I +GEGSFGKVYK R+K+TGQ VA K I K GK+E+DI +LRQEI+IL+ L H
Sbjct: 3 DDYKLIGQIGEGSFGKVYKYRKKFTGQLVACKVISKKGKNEEDILSLRQEIDILKNLSHP 62
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRI 123
NII+ + FE+ EF +VTE+A G+L +I+ ++K L + +QSI QLV AL+YLH ++
Sbjct: 63 NIIQFISCFENKNEFTLVTEYADGDLSQIISEEKTLSVDLIQSICYQLVIALNYLHYKKV 122
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTA 183
IHRD+KPQNILI +G +K+CDFGFA+ +S+N+++L S+KGTPLY+APE+++EQPY++ A
Sbjct: 123 IHRDIKPQNILITSGGQIKVCDFGFAKTISSNSILLTSLKGTPLYLAPEIIQEQPYDYKA 182
Query: 184 DLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMS--PNFKSFLKGLLNKVP 241
DLWSLG+ILY++ VG PPF NS+ L+ ++ ++ P E++ P+ S + LL K P
Sbjct: 183 DLWSLGIILYQILVGSPPFSANSLADLVHMTLESNIEIPKELNKYPDLVSLFRQLLCKNP 242
Query: 242 QNRLTWSALLEHPFVK 257
R+ W LL HPFVK
Sbjct: 243 DKRIGWPDLLYHPFVK 258
|
Plays a role in chemotaxis and seems to be involved in polarization. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P23647|FUSED_DROME Serine/threonine-protein kinase fused OS=Drosophila melanogaster GN=fu PE=1 SV=2 | Back alignment and function description |
|---|
Score = 271 bits (694), Expect = 2e-71, Method: Compositional matrix adjust.
Identities = 131/252 (51%), Positives = 174/252 (69%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
Y V LVG+GSFG VYK RK + VA+K I K G++ K++ NLR+E +I +LKH ++
Sbjct: 4 YAVSSLVGQGSFGCVYKATRKDDSKVVAIKVISKRGRATKELKNLRRECDIQARLKHPHV 63
Query: 66 IEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIH 125
IEM++SFES + VVTEFA +L L + + EE + + LV AL+YLHSNRI+H
Sbjct: 64 IEMIESFESKTDLFVVTEFALMDLHRYLSYNGAMGEEPARRVTGHLVSALYYLHSNRILH 123
Query: 126 RDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADL 185
RD+KPQN+L+ KLCDFG AR M+ T VL SIKGTPLYMAPEL+ EQPY+H AD+
Sbjct: 124 RDLKPQNVLLDKNMHAKLCDFGLARNMTLGTHVLTSIKGTPLYMAPELLAEQPYDHHADM 183
Query: 186 WSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRL 245
WSLG I YE GQPPF +S+ L++ I + VK+P ++ +SFL+GLL K P R+
Sbjct: 184 WSLGCIAYESMAGQPPFCASSILHLVKMIKHEDVKWPSTLTSECRSFLQGLLEKDPGLRI 243
Query: 246 TWSALLEHPFVK 257
+W+ LL HPFV+
Sbjct: 244 SWTQLLCHPFVE 255
|
Probable serine/threonine-protein kinase; maternally required for correct patterning in the posterior part of each embryonic metamere. May be involved in control of cell division during metamorphosis and ovarian development. May interact with costal-2. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|E9PTG8|STK10_RAT Serine/threonine-protein kinase 10 OS=Rattus norvegicus GN=Stk10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 176 bits (445), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 127/369 (34%), Positives = 200/369 (54%), Gaps = 28/369 (7%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
+ ++ +G+G+FGKVYK + K TG A K I KSE+++ + EIEIL H I
Sbjct: 36 WEILGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVEIEILATCDHPYI 93
Query: 66 IEMLDSFESPQEFCVVTEFAQGELFE--ILEDDKCLPEEQVQSIAKQLVRALHYLHSNRI 123
+++L ++ + ++ EF G + +LE D+ L E Q+Q + +Q++ AL++LH RI
Sbjct: 94 VKLLGAYYYDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHGKRI 153
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR-SIKGTPLYMAPELV-----REQ 177
IHRD+K N+L+ ++L DFG + A + T+ R S GTP +MAPE+V ++
Sbjct: 154 IHRDLKAGNVLMTLEGDIRLADFGVS-AKNLKTLQKRDSFIGTPYWMAPEVVLCETMKDA 212
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKDP--VKYPDEMSPNFKSFLK 234
PY++ AD+WSLG+ L E+ +PP + N + L++ DP + P + S F+ FLK
Sbjct: 213 PYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSTEFRDFLK 272
Query: 235 GLLNKVPQNRLTWSALLEHPFVKETSD-----ELNAWELRATSVEARGCNATWTAEGNAI 289
L+K P+ R + + LL+HPFV + EL A E +A +E +E +A+
Sbjct: 273 IALDKNPETRPSAAQLLQHPFVSTVTSNKALRELVA-EAKAEVMEEIEDGKEDGSEKDAV 331
Query: 290 QSSSGKSN-SPAVSANNTSPSLHTDVELNSSNT----SQSN---SSPCEAFPGFSSPNNV 341
+ N + SAN T PSL++D L S+T SQ + PC G SP N
Sbjct: 332 SAVPPPVNHTQDSSANGTQPSLNSDKLLQDSSTPLPPSQPQEPVNGPCNQPSGDGSPQNT 391
Query: 342 KPSGSQALN 350
P+ + N
Sbjct: 392 SPADEVSKN 400
|
Serine/threonine-protein kinase involved in regulation of lymphocyte migration. Phosphorylates MSN, and possibly PLK1. Involved in regulation of lymphocyte migration by mediating phosphorylation of ERM proteins such as MSN. Acts as a negative regulator of MAP3K1/MEKK1. May also act as a cell cycle regulator by acting as a polo kinase kinase: mediates phosphorylation of PLK1 in vitro; however such data require additional evidences in vivo. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|F1NBT0|STK10_CHICK Serine/threonine-protein kinase 10 OS=Gallus gallus GN=STK10 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 175 bits (443), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 104/264 (39%), Positives = 158/264 (59%), Gaps = 14/264 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E + V+ +G+G+FGKVYK + K TG A K I K+E ++ + EIEIL H
Sbjct: 34 EVWEVVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKNEDELEDYMVEIEILATCDHP 91
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGELFE--ILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
+I+++L +F + ++ EF G + +LE D+ L E Q+Q I +Q++ ALHYLHS
Sbjct: 92 HIVKLLGAFYWEGKLWIMIEFCPGGAVDATMLELDRGLTEPQIQVICRQMLEALHYLHSK 151
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR-SIKGTPLYMAPELV-----R 175
+IIHRD+K N+L+ +KL DFG + A + T+ R S GTP +MAPE+V +
Sbjct: 152 KIIHRDLKAGNVLLTQDGDIKLADFGVS-AKNVKTLQKRDSFIGTPYWMAPEVVMCETMK 210
Query: 176 EQPYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKDP--VKYPDEMSPNFKSF 232
+ PY++ AD+WSLG+ L E+ +PP + N + L++ DP + P + S F+ F
Sbjct: 211 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLSCPSKWSLEFRDF 270
Query: 233 LKGLLNKVPQNRLTWSALLEHPFV 256
LK L+K P+ R + + LLEHPFV
Sbjct: 271 LKTALDKNPETRPSAAQLLEHPFV 294
|
May act as a polo kinase kinase by mediating phosphorylation of PLK1. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7SY52|STK10_DANRE Serine/threonine-protein kinase 10 OS=Danio rerio GN=stk10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (441), Expect = 4e-42, Method: Compositional matrix adjust.
Identities = 105/262 (40%), Positives = 158/262 (60%), Gaps = 14/262 (5%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
+ +I +G+G+FGKVYK + K TG A K I KSE+++ + EI+IL HQ I
Sbjct: 37 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVI--ETKSEEELEDYMVEIDILASCNHQYI 94
Query: 66 IEMLDSFESPQEFCVVTEFAQGELFE--ILEDDKCLPEEQVQSIAKQLVRALHYLHSNRI 123
+++LD+F + ++ EF G + +LE D+ L E Q++ I KQ++ AL YLHS +I
Sbjct: 95 VKLLDAFFFDNKLSIMIEFCPGGAVDAIMLELDRGLQEPQIRVICKQMLEALQYLHSMKI 154
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR-SIKGTPLYMAPELV-----REQ 177
IHRD+K NIL+ +KL DFG + A + T+ R S GTP +MAPE+V ++
Sbjct: 155 IHRDLKAGNILLTLDGDIKLADFGVS-AKNTKTLQRRDSFIGTPYWMAPEVVMCETMKDA 213
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKDP--VKYPDEMSPNFKSFLK 234
PY++ AD+WSLG+ L EL +PP + N + L++ +P + P + S +F FLK
Sbjct: 214 PYDYKADIWSLGITLIELAQIEPPHHELNPMRVLLKIAKSEPPGLDQPSKWSMDFNDFLK 273
Query: 235 GLLNKVPQNRLTWSALLEHPFV 256
L++ P+ R T + LLEHPFV
Sbjct: 274 KALDRHPETRPTAAQLLEHPFV 295
|
May act as a polo kinase kinase by mediating phosphorylation of plk1. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9P7J8|GAD8_SCHPO Serine/threonine-protein kinase gad8 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=gad8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 172 bits (437), Expect = 1e-41, Method: Compositional matrix adjust.
Identities = 90/263 (34%), Positives = 148/263 (56%), Gaps = 5/263 (1%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEILRK 59
+ ++ + ++++VG+GSFGKV + R++ T + A+K + K H S ++ + E +L +
Sbjct: 225 LTIDAFELLKVVGKGSFGKVMQVRKRDTSRIYALKTMKKAHIVSRSEVDHTLAERTVLAQ 284
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
+ + I+ + SF+SP + +V F G ELF L+ + C + + +L+ AL L
Sbjct: 285 VNNPFIVPLKFSFQSPGKLYLVLAFVNGGELFHHLQREGCFDTYRAKFYIAELLVALECL 344
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQP 178
H +I+RD+KP+NIL+ + LCDFG + A T + GTP Y+APEL+
Sbjct: 345 HEFNVIYRDLKPENILLDYTGHIALCDFGLCKLNMAKTDRTNTFCGTPEYLAPELLLGHG 404
Query: 179 YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLN 238
Y D W+LGV+LYE+ G PPFY ++ + R I++DP+++PD + K L GLL
Sbjct: 405 YTKVVDWWTLGVLLYEMITGLPPFYDENINEMYRKILQDPLRFPDNIDEKAKDLLSGLLT 464
Query: 239 KVPQNRLTWSALLE---HPFVKE 258
+ P+ RL E HPF +
Sbjct: 465 RAPEKRLGSGGAQEIKNHPFFDD 487
|
Involved in a signaling module for sexual development and cell growth under stressed conditions. Required for G1 arrest under nitrogen starvation and for growth at high temperature and osmolarity. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1342 | ||||||
| 356533261 | 1332 | PREDICTED: probable serine/threonine-pro | 0.988 | 0.996 | 0.696 | 0.0 | |
| 255557967 | 1279 | ATP binding protein, putative [Ricinus c | 0.942 | 0.989 | 0.725 | 0.0 | |
| 359489909 | 1292 | PREDICTED: uncharacterized protein LOC10 | 0.951 | 0.988 | 0.715 | 0.0 | |
| 356577508 | 1363 | PREDICTED: uncharacterized protein LOC10 | 0.989 | 0.974 | 0.674 | 0.0 | |
| 449451811 | 1284 | PREDICTED: serine/threonine-protein kina | 0.948 | 0.991 | 0.679 | 0.0 | |
| 297847360 | 1325 | hypothetical protein ARALYDRAFT_474153 [ | 0.978 | 0.990 | 0.662 | 0.0 | |
| 72004127 | 1322 | fused [Arabidopsis thaliana] | 0.977 | 0.992 | 0.651 | 0.0 | |
| 145324891 | 1322 | Protein kinase family protein with ARM r | 0.977 | 0.992 | 0.650 | 0.0 | |
| 242059887 | 1331 | hypothetical protein SORBIDRAFT_03g04564 | 0.979 | 0.987 | 0.561 | 0.0 | |
| 357115976 | 1334 | PREDICTED: uncharacterized protein LOC10 | 0.983 | 0.989 | 0.563 | 0.0 |
| >gi|356533261|ref|XP_003535184.1| PREDICTED: probable serine/threonine-protein kinase tsuA-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1914 bits (4957), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 937/1345 (69%), Positives = 1114/1345 (82%), Gaps = 18/1345 (1%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
MGVENYHVIELVGEGSFGKVYKGRRK+TGQTVAMKFIMKHGK+EKDIHNLRQEIEILRKL
Sbjct: 1 MGVENYHVIELVGEGSFGKVYKGRRKHTGQTVAMKFIMKHGKTEKDIHNLRQEIEILRKL 60
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
KH NII+MLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQ+IAKQLV+ALHYLHS
Sbjct: 61 KHGNIIQMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQAIAKQLVKALHYLHS 120
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
NRIIHRDMKPQNILIGAGS+VKLCDFGFARAMS NTVVLRSIKGTPLYMAPELVREQPYN
Sbjct: 121 NRIIHRDMKPQNILIGAGSIVKLCDFGFARAMSTNTVVLRSIKGTPLYMAPELVREQPYN 180
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
HT DLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPD MSPNFKSFLKGLLNK
Sbjct: 181 HTVDLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDCMSPNFKSFLKGLLNKA 240
Query: 241 PQNRLTWSALLEHPFVKETSDELNAWELRATSVEARGCNATWTAEGNAIQSSSGKSNSPA 300
P++RLTW LLEHPFVKE+SDEL A ELR + + EG IQ+ + + + +
Sbjct: 241 PESRLTWPTLLEHPFVKESSDELEARELREINGSHMHSDEARVVEGKTIQTPTTEEHIAS 300
Query: 301 VSANNTSPSLHTDVELNSSNTSQSNSSPCEAFPGFSSPNNVKPSGSQALNRLENNSRTVK 360
+ L + ++LNS N ++N+S + GFS+ NV SG Q LNRLENNS TV
Sbjct: 301 L--------LQSAIQLNSPNLDRANTSVLDESLGFSN-QNVGESGCQRLNRLENNSCTVS 351
Query: 361 GALSICQDNEALALILLPLKKWSQGSQNTCRDQDVLNSNQSLRILSNLVAASAIQSNGLL 420
GA I QDNEAL ILLPLKKWS+GSQN C DQDV SNQSLRILSNLVAA A S+GL+
Sbjct: 352 GAKLIGQDNEALKHILLPLKKWSKGSQNICSDQDVPESNQSLRILSNLVAAGAFSSSGLI 411
Query: 421 DEIISELLDFSSVVVSLKASELNDLLAKSFLIIKMLIDNSGSCIASSYFTNWVAVVEIFS 480
DE+I ELL F+ V+++K+SE+ D++AK F I K+L+DN GS +SSY ++WV VEI+S
Sbjct: 412 DELIKELLVFTESVIAMKSSEVTDMMAKGFSITKILLDNGGSFTSSSYVSHWVEFVEIYS 471
Query: 481 KVVSCNEDASGRVLYEATACITVMLSRVAQNLKASSSAPGPDANSTPRVNETLKRILDHA 540
+VV+ N DASGRVLYE++ACITVMLSRVAQ L++S P + ++NET RIL+H+
Sbjct: 472 QVVTSNNDASGRVLYESSACITVMLSRVAQVLRSS-----PKISGQEKLNETAYRILEHS 526
Query: 541 KTSGLVDHLCCCLATSGSNLNSGSSNMLRAACETCKAIFSLVDVLEIHFSMENAYLFPLN 600
KT+GLVDHLC CLATSGS+L +GSSNMLRAA E CKA++SL++ L+I F ++A LFP+N
Sbjct: 527 KTTGLVDHLCLCLATSGSSLITGSSNMLRAASEACKAVWSLINALDILFMKKSAILFPIN 586
Query: 601 AFWSHSLLRLDIRDHERGSLVGPESARIIDALTRAFLRSKAVQLAINHCLHQRAEATLSA 660
A SHSL R+++ HE+ L +S +++DA+TRAFLRSK V +A+ +C HQ E+ ++
Sbjct: 587 ALRSHSLHRMEVVHHEQDLLHKADSTKVVDAMTRAFLRSKTVLVAVYYCFHQGLESAMNC 646
Query: 661 VIQLLSRCCLRSGIIPSILCGFPSSLPVTTVVSGGEDGTAVLEIFSILSLCASS-NKDSQ 719
+QLLSRCCL +GI+P++LCG PSSLPVTTVVSGG DGT V E+F++LSLC+SS NKD+Q
Sbjct: 647 GLQLLSRCCLHNGIVPALLCGLPSSLPVTTVVSGGGDGTIVSEVFTVLSLCSSSVNKDTQ 706
Query: 720 VGETSNVKGKLSNPCALALHSCLFLAIVAQCLKSTLRNSALFMLTTTPKKQLSRLKILAH 779
E SN K KL+NP AL HSCL +A++AQCLKS+ RNSA+FMLTT+PKKQ +RL +LAH
Sbjct: 707 SVEPSNAKCKLTNPSALVRHSCLLVAVIAQCLKSSGRNSAIFMLTTSPKKQFARLSVLAH 766
Query: 780 YFSSDDRIKTYFQLHSASAMLAFASILSLESGATVESSIYEIAVPLIPPTATLCDLLKIT 839
SSDD+IK + SASAMLA ASILSLESGA VES I EIA+PLIP T+TL D LK +
Sbjct: 767 QISSDDKIKASIEPQSASAMLALASILSLESGALVESPISEIAMPLIPRTSTLSDHLKFS 826
Query: 840 SGNADQMGPISQSNSFSYWHGLKDGCVGLLESRLKCGGPLAVQQMIASNIPMLLIDLLAN 899
S N +++ P + S FSYW G++DG VGLL+SRLK GGPLAVQQ+ AS P+LL+ LL N
Sbjct: 827 SSNVNELDPCNISGKFSYWQGVRDGFVGLLDSRLKWGGPLAVQQLCASGTPLLLMGLLGN 886
Query: 900 T--HSSQQIGSTRDQMMLSPAGVVSTISSIYHCLSGGVLMFRQVLLKNEYMKLICNLLSD 957
++S D++ LSP GVV TISS+ HCLSGG L +RQ+L++NE++KL NL+ D
Sbjct: 887 DVLNASHGNDHVNDRVGLSPIGVVWTISSLCHCLSGGALTYRQILIRNEHIKLFSNLICD 946
Query: 958 VHLKLVKGWGGPGGGKDGIRDIINAVIDLLAFPFVAVQNAPGLPSATASVNSGFILNMGS 1017
VH+KLVK W GPGGG+ G+RD+IN VIDLLAFPFVA+QNAPGLPSATASV+SGF+LN+GS
Sbjct: 947 VHMKLVKCWIGPGGGRAGVRDLINGVIDLLAFPFVALQNAPGLPSATASVSSGFLLNIGS 1006
Query: 1018 AGGKVCMEDRDMAKAIEEDMGKYIKILMEVGVPGIILRCLEHMELKNLGRPIAFLAKMIG 1077
G +VCMED+ + KAIEEDMGKYIKIL+EVGVPGIILRCL+HM+L +LGRP+AF+AKM+
Sbjct: 1007 PGQRVCMEDKGIVKAIEEDMGKYIKILVEVGVPGIILRCLDHMDLNDLGRPVAFMAKMVC 1066
Query: 1078 QRSLAVQLVGKGLLDPNRVRRLLDS-STREVTLDVLMIVSDLARMDKWFYEYINGASMLE 1136
R LA+QLV KGLLDPN +R+L D + +EV LD LMI+SDLARMDK FYEYI GAS+LE
Sbjct: 1067 HRPLAIQLVSKGLLDPNSMRKLFDCLAPKEVKLDALMIISDLARMDKGFYEYIKGASILE 1126
Query: 1137 FLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFAC 1196
FLKDFL+HEDPN+RAKACSALGNMCRHS+YFYSSLA+++I+G+LI+RC+DPDKRTRKFAC
Sbjct: 1127 FLKDFLSHEDPNMRAKACSALGNMCRHSAYFYSSLARHQIVGILIERCSDPDKRTRKFAC 1186
Query: 1197 FSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVS 1256
F+IGNAAYHND+LYEELRRSIP LAN+L EEDKTKANAAGALSNL+RNS KLCEDIV
Sbjct: 1187 FAIGNAAYHNDLLYEELRRSIPQLANLLQMAEEDKTKANAAGALSNLVRNSDKLCEDIVC 1246
Query: 1257 KGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQFLQSSELFPV 1316
KGA+Q+L+KL++DC+V ALNPSR D+ NESPLKIALFSLAKMCAH CR F++SS LFPV
Sbjct: 1247 KGAVQSLLKLISDCAVSALNPSRNDSGNESPLKIALFSLAKMCAHPLCRHFIRSSPLFPV 1306
Query: 1317 IARLRQSPESTIANYASVIISKVGD 1341
I RL+QSPES+IA YAS IISKV +
Sbjct: 1307 IGRLQQSPESSIAKYASAIISKVAE 1331
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255557967|ref|XP_002520012.1| ATP binding protein, putative [Ricinus communis] gi|223540776|gb|EEF42336.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1908 bits (4943), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 983/1354 (72%), Positives = 1107/1354 (81%), Gaps = 89/1354 (6%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
MGVENYHVIELVGEGSFGKVYKGRRK+TGQTVAMKFIMKHGKSEKDI NLRQEIEILRKL
Sbjct: 1 MGVENYHVIELVGEGSFGKVYKGRRKFTGQTVAMKFIMKHGKSEKDIQNLRQEIEILRKL 60
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
KH+NIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQ+IAKQLVRALHYLHS
Sbjct: 61 KHENIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQAIAKQLVRALHYLHS 120
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS NTVVLRSIKGTPLYMAPELVREQPYN
Sbjct: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSTNTVVLRSIKGTPLYMAPELVREQPYN 180
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPD+MSPNFKSFLKGLLNKV
Sbjct: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDDMSPNFKSFLKGLLNKV 240
Query: 241 PQNRLTWSALLEHPFVKETSDELNAWELRATSVEARGCNATWTAEGNAIQSSS------- 293
PQNRLTW ALLEHPF+KET DEL A E+RA + ARGC+A W E N IQ+S+
Sbjct: 241 PQNRLTWPALLEHPFIKETLDELEAREMRAATAAARGCDAAWRGEANVIQASNGLAVSSP 300
Query: 294 -GKSNSPAVSANNTSPSLHTDVELNSSNTSQSNSSPCEAFPGFSSPNNVKPSGSQALNRL 352
G+SN A N +P LH D +LNS T+ NSSP F GF+SP +VK SGSQAL+RL
Sbjct: 301 DGRSNPVAALDNCNTPKLHGDSKLNSPITATGNSSPNNEFVGFASPTDVKQSGSQALDRL 360
Query: 353 ENNSRTVKGALSICQDNEALALILLPLKKWSQGSQNTCRDQDVLNSNQSLRILSNLVAAS 412
ENNSRTVKGA I QDNEALAL+LLPL++WS+ S ++CRDQDV SNQ+LRI SNL AA
Sbjct: 361 ENNSRTVKGAQIIGQDNEALALLLLPLQRWSKESPHSCRDQDVSTSNQALRIFSNLAAAG 420
Query: 413 AIQSNGLLDEIISELLDFSSVVVSLKASELNDLLAKSFLIIKMLIDNSGSCIASSYFTNW 472
AIQS+GLLD+I+S LLDF++ ++ LK+SELN+L+AKSF I+K+L+DN G + +SYFT+W
Sbjct: 421 AIQSSGLLDDILSGLLDFTATLICLKSSELNELIAKSFAIMKLLLDNKGGGVGASYFTHW 480
Query: 473 VAVVEIFSKVVSCNEDASGRVLYEATACITVMLSRVAQNLKASSSAPGPDANSTPRVNET 532
VA++EIF++VV CNED SGRVLYEA+ACITV+LS +AQ LKA++ G +
Sbjct: 481 VALIEIFAQVVGCNEDNSGRVLYEASACITVVLSTIAQGLKATALTSGSE---------- 530
Query: 533 LKRILDHAKTSGLVDHLCCCLATSGSNLNSGSSNMLRAACETCKAIFSLVDVLEIHFSME 592
+ILDHAKT GLV+HLC CLATSGS+L SGSSNMLRAACE CKAI+SL+D +E F
Sbjct: 531 --KILDHAKTCGLVEHLCLCLATSGSSLISGSSNMLRAACEACKAIWSLIDAVETLFMNA 588
Query: 593 NAYLFPLNAFWSHSLLRLDIRDHERGSLVGPESARIIDALTRAFLRSKAVQLAINHCLHQ 652
AYLFPLNA SHSL RLDIRD ERGSL+G +SARIIDA+TRAFL+SKAVQ+AI +CLHQ
Sbjct: 589 TAYLFPLNALRSHSLTRLDIRDQERGSLIGTDSARIIDAVTRAFLKSKAVQVAIYYCLHQ 648
Query: 653 RAEATLSAVIQLLSRCCLRSGIIPSILCGFPSSLPVTTVVSGGEDGTAVLEIFSILSLCA 712
R EA LSA IQLLSRCCL + I+P +LCG PSSLPVTTVVSGG DGT V EIFS+LSLCA
Sbjct: 649 RLEAALSASIQLLSRCCLHNAIVPGVLCGLPSSLPVTTVVSGGGDGTIVSEIFSVLSLCA 708
Query: 713 -SSNKDSQVGETSNVKGKLSNPCALALHSCLFLAIVAQCLKSTLRNSALFMLTTTPKKQL 771
SSNKD Q+GET+N K KL NP AL LHSCL LA VAQCLKST RNSALFMLTT+PKKQL
Sbjct: 709 SSSNKDHQMGETNNFKSKLVNPSALILHSCLTLATVAQCLKSTGRNSALFMLTTSPKKQL 768
Query: 772 SRLKILAHYFSSDDRIKTYFQLHSASAMLAFASILSLESGATVESSIYEIAVPLIPPTAT 831
SRL +LAH FS DDR K Q H ASAMLA ASILSLESGA+VESSI EIAVPLIP T T
Sbjct: 769 SRLSVLAHQFSHDDRTKNSLQPHCASAMLALASILSLESGASVESSISEIAVPLIPRTGT 828
Query: 832 LCDLLKITSGNADQMGPISQSNSFSYWHGLKDGCVGLLESRLKCGGPLAVQQMIASNIPM 891
+C+ LKI++GN ++MGP + SYWHGL+DGCVGLLESRLK GGPLAVQQ+ AS IP+
Sbjct: 829 ICEHLKISTGNENEMGPNNADGILSYWHGLRDGCVGLLESRLKWGGPLAVQQLCASGIPL 888
Query: 892 LLIDLLANTH---SSQQIGSTRDQMMLSPAGVVSTISSIYHCLSGGVLMFRQVLLKNEYM 948
LI+LL+N++ S Q + S +D++ LSP GVV TISSI HCL GG + RQ+L ++E+M
Sbjct: 889 FLIELLSNSYLTASPQGMDSIKDRIGLSPLGVVWTISSICHCLPGGTSICRQILFRSEHM 948
Query: 949 KLICNLLSDVHLKLVKGWGGPGGGKDGIRDIINAVIDLLAFPFVAVQNAPGLPSATASVN 1008
KLI L+SDVHLKLVK WGGPGGGKDG+RD+IN V G+P
Sbjct: 949 KLISELISDVHLKLVKHWGGPGGGKDGVRDLINTV---------------GVP------- 986
Query: 1009 SGFILNMGSAGGKVCMEDRDMAKAIEEDMGKYIKILMEVGVPGIILRCLEHMELKNLGRP 1068
G IL C+E HMEL++LGRP
Sbjct: 987 -GVILR--------CLE---------------------------------HMELRDLGRP 1004
Query: 1069 IAFLAKMIGQRSLAVQLVGKGLLDPNRVRRLLD-SSTREVTLDVLMIVSDLARMDKWFYE 1127
+AFLAKM+G R LAVQLVG+GLLDPNRVRRLLD SS REV LD LMIVSDLARMDK FY+
Sbjct: 1005 VAFLAKMVGHRPLAVQLVGRGLLDPNRVRRLLDTSSPREVVLDSLMIVSDLARMDKGFYD 1064
Query: 1128 YINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADP 1187
+INGASMLE LK+FL HEDPN+RAKACSA+GNMCRHSSYFY SLA++ IIGLLIDRCADP
Sbjct: 1065 HINGASMLESLKNFLVHEDPNIRAKACSAVGNMCRHSSYFYGSLARHHIIGLLIDRCADP 1124
Query: 1188 DKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNS 1247
DKRTRKFACF+IGNAAYHNDVLYEEL+RSIP LA +L+S EEDKTKANAAGALSNL+RNS
Sbjct: 1125 DKRTRKFACFAIGNAAYHNDVLYEELKRSIPQLAKLLLSSEEDKTKANAAGALSNLVRNS 1184
Query: 1248 SKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQF 1307
+KLCEDIVS+GAMQAL+KLVADCS +ALNPSRKDAVNESP+KIALFSLAKMCAH PCR F
Sbjct: 1185 NKLCEDIVSRGAMQALLKLVADCSAVALNPSRKDAVNESPIKIALFSLAKMCAHAPCRLF 1244
Query: 1308 LQSSELFPVIARLRQSPESTIANYASVIISKVGD 1341
L++SELFPVI RLRQSPESTIANYASVIISKV +
Sbjct: 1245 LRTSELFPVIGRLRQSPESTIANYASVIISKVAE 1278
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359489909|ref|XP_002274752.2| PREDICTED: uncharacterized protein LOC100257868 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1900 bits (4921), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 969/1355 (71%), Positives = 1103/1355 (81%), Gaps = 78/1355 (5%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
MGVENYHVIELVGEGSFGKVYKGRRK+TGQTVAMKFI+KHGKSEKDI NLRQEIEILRKL
Sbjct: 1 MGVENYHVIELVGEGSFGKVYKGRRKFTGQTVAMKFILKHGKSEKDIQNLRQEIEILRKL 60
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
KH+NIIEMLDSFE+PQEFCVVTEFAQGELFEILEDDKCLPEEQVQ+IAKQLVRALHYLHS
Sbjct: 61 KHENIIEMLDSFETPQEFCVVTEFAQGELFEILEDDKCLPEEQVQAIAKQLVRALHYLHS 120
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
NRIIHRDMKPQNILIGAGS+VKLCDFGFARAMS NTVVLRSIKGTPLYMAPELVREQPYN
Sbjct: 121 NRIIHRDMKPQNILIGAGSIVKLCDFGFARAMSTNTVVLRSIKGTPLYMAPELVREQPYN 180
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
HTADLWSLGVILYELFVGQPPFYTNSVYALIRHI+KDPVKYPD MS NF+SFLKGLLNKV
Sbjct: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIIKDPVKYPDNMSANFRSFLKGLLNKV 240
Query: 241 PQNRLTWSALLEHPFVKETSDELNAWELRATSVEARGCNATWTAEGNAIQSSSG------ 294
PQNRLTW ALLEHPFV+ETSDEL A E+RA + ARGC+A W EGN IQ+S+G
Sbjct: 241 PQNRLTWPALLEHPFVQETSDELEAREMRAATAAARGCDAAWRGEGNIIQASTGSTVPSP 300
Query: 295 --KSNSPAVSANNTSPSLHTDVELNSSNTSQSNSSPCEAFPGFSSPNNVKPSGSQALNRL 352
+S+SPA +N + + + + S N++ NSSP E FPGF SPN+V SG Q L++L
Sbjct: 301 ENRSHSPAAFESNNASKIQSGAQSCSPNSATVNSSPHEEFPGFGSPNDVNQSGCQTLDKL 360
Query: 353 ENNSRTVKGALSICQDNEALALILLPLKKWSQGSQNTCRDQDVLNSNQSLRILSNLVAAS 412
ENNSRTVKGA I QDNEALA ILLPLKKWS+ SQN+ RDQD+ +S+QSL+ILSNLVAA
Sbjct: 361 ENNSRTVKGAKIIGQDNEALAFILLPLKKWSKESQNSGRDQDMFSSSQSLKILSNLVAAG 420
Query: 413 AIQSNGLLDEIISELLDFSSVVVSLKASELNDLLAKSFLIIKMLIDNSGSCIASSYFTNW 472
AI S+GLLDEII E+L F++ V++K++E NDL+AKSF IIKML+DNSGS I SSYF +W
Sbjct: 421 AIHSSGLLDEIIFEVLGFTAAAVNVKSAEANDLIAKSFSIIKMLVDNSGSGIGSSYFRHW 480
Query: 473 VAVVEIFSKVVSCNEDASGRVLYEATACITVMLSRVAQNLKASSSAPGPDANSTP-RVNE 531
V+ VEIFS+VV CNEDASGR+LYE ACI MLS VAQ LKA + PDA S+P RVNE
Sbjct: 481 VSSVEIFSQVVGCNEDASGRILYECNACIATMLSHVAQGLKACAPTLVPDAASSPSRVNE 540
Query: 532 TLKRILDHAKTSGLVDHLCCCLATSGSNLNSGSSNMLRAACETCKAIFSLVDVLEIHFSM 591
L RILDHAKTSGLVDHLC CL +G +L SGSS++LRAACE C+AI+SL+D LEI F
Sbjct: 541 ILNRILDHAKTSGLVDHLCLCLENAGLSLLSGSSHLLRAACEACRAIWSLIDALEILFVK 600
Query: 592 ENAYLFPLNAFWSHSLLRLDIRDHERGSLVGPESARIIDALTRAFLRSKAVQLAINHCLH 651
EN Y FPLN WSHS L++D R+ +RGSLVG ESA+I+D +TRAFLRSK +Q+AI +CLH
Sbjct: 601 ENVYSFPLNTLWSHSSLQIDNREQDRGSLVGIESAKIVDVVTRAFLRSKDIQVAIYYCLH 660
Query: 652 QRAEATLSAVIQLLSRCCLRSGIIPSILCGFPSSLPVTTVVSGGEDGTAVLEIFSILSLC 711
QR EA LSA IQL+ RCCL SGI+PS+LCG SSLPVTT+VSGG DGT + EIFSILS C
Sbjct: 661 QRLEAPLSAGIQLMLRCCLHSGIVPSVLCGLRSSLPVTTIVSGGGDGTILSEIFSILSFC 720
Query: 712 AS-SNKDSQVGETSNVKGKLSNPCALALHSCLFLAIVAQCLKSTLRNSALFMLTTTPKKQ 770
AS SNKD+Q GET+N+KGK++NPC L LHSCL +A VAQCLKS+ RNSALFMLTT KKQ
Sbjct: 721 ASCSNKDAQTGETNNLKGKITNPCGLVLHSCLIIATVAQCLKSSGRNSALFMLTTNSKKQ 780
Query: 771 LSRLKILAHYFSSDDRIKTYFQLHSASAMLAFASILSLESGATVESSIYEIAVPLIPPTA 830
SRL +LAH+FSSD+R+KT Q H ASAMLA ASILSLE+G ++ESSI EIAVPLIP TA
Sbjct: 781 SSRLSLLAHHFSSDERMKTSLQPHCASAMLALASILSLETGVSIESSISEIAVPLIPRTA 840
Query: 831 TLCDLLKITSGNADQMGPISQSNSFSYWHGLKDGCVGLLESRLKCGGPLAVQQMIASNIP 890
TLC+ LKI SG+ +++G + SYWHGL+DGCVGLLESRLK GG LAVQQ+ AS IP
Sbjct: 841 TLCNHLKIISGDENELGSTIPNGMLSYWHGLRDGCVGLLESRLKWGGALAVQQLCASGIP 900
Query: 891 MLLIDLLANTHSS---QQIGSTRDQMMLSPAGVVSTISSIYHCLSGGVLMFRQVLLKNEY 947
LLI+LL N HS Q I ST D++ LS GVV T+SSI HCLSGG L FRQ L++NE+
Sbjct: 901 QLLINLLYNNHSKACPQGIDSTIDRVGLSSVGVVWTVSSICHCLSGGALTFRQTLVRNEH 960
Query: 948 MKLICNLLSDVHLKLVKGWGGPGGGKDGIRDIINAVIDLLAFPFVAVQNAPGLPSATASV 1007
+KLI L+SDVHLKLV+ WGGPGGGKDG+RD+INAV G+P
Sbjct: 961 IKLISCLISDVHLKLVRVWGGPGGGKDGVRDVINAV---------------GVP------ 999
Query: 1008 NSGFILNMGSAGGKVCMEDRDMAKAIEEDMGKYIKILMEVGVPGIILRCLEHMELKNLGR 1067
G IL C+E +MELK++GR
Sbjct: 1000 --GIILR--------CLE---------------------------------YMELKDMGR 1016
Query: 1068 PIAFLAKMIGQRSLAVQLVGKGLLDPNRVRRLLDSST-REVTLDVLMIVSDLARMDKWFY 1126
P+AFLAKM R LAVQLVGKGLLDP +RRLLD S REVTLDVLMI+SDLARMDK FY
Sbjct: 1017 PVAFLAKMASHRLLAVQLVGKGLLDPKGMRRLLDCSCPREVTLDVLMIISDLARMDKAFY 1076
Query: 1127 EYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCAD 1186
EYINGA +LEFL++FLTHEDPNVRAKACSA+GNMCRHSSYFY SLA++ II LLIDRCAD
Sbjct: 1077 EYINGACILEFLREFLTHEDPNVRAKACSAIGNMCRHSSYFYGSLARHHIISLLIDRCAD 1136
Query: 1187 PDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRN 1246
PDKRTRKFACF+IGNAAYHND LYEEL+RSIP LAN+L+S EEDKTKANAAGALSNLIRN
Sbjct: 1137 PDKRTRKFACFAIGNAAYHNDNLYEELKRSIPQLANLLLSAEEDKTKANAAGALSNLIRN 1196
Query: 1247 SSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQ 1306
S+KLCEDIVSKGA+QAL+KLVADCS +ALNP+RKDA+NESPLKIALFSLAKM +H PCRQ
Sbjct: 1197 SNKLCEDIVSKGALQALLKLVADCSAVALNPTRKDAINESPLKIALFSLAKMSSHQPCRQ 1256
Query: 1307 FLQSSELFPVIARLRQSPESTIANYASVIISKVGD 1341
F++SSELFPVI RLRQSPESTIANYAS+II+KV +
Sbjct: 1257 FIRSSELFPVIGRLRQSPESTIANYASLIINKVSE 1291
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356577508|ref|XP_003556866.1| PREDICTED: uncharacterized protein LOC100813995 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1849 bits (4790), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 928/1375 (67%), Positives = 1107/1375 (80%), Gaps = 47/1375 (3%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
MGVENYHVIELVGEGSFGKVYKGRRK+TGQTVAMKFIMKHGK+EKDIHNLRQEIEILRKL
Sbjct: 1 MGVENYHVIELVGEGSFGKVYKGRRKHTGQTVAMKFIMKHGKTEKDIHNLRQEIEILRKL 60
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
KH NII+MLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQ+IAKQLV+ALHYLHS
Sbjct: 61 KHGNIIQMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQAIAKQLVKALHYLHS 120
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS NTVVLRSIKGTPLYMAPELVREQPYN
Sbjct: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSTNTVVLRSIKGTPLYMAPELVREQPYN 180
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
HT DLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPD MSPNFKSFLKGLLNK
Sbjct: 181 HTVDLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDRMSPNFKSFLKGLLNKA 240
Query: 241 PQNRLTWSALLEHPFVKETSDELNAWELRATSVEARGCNATWTAEGNAIQSSSGKSNSPA 300
P++RLTW ALLEHPFVKE+ DEL A ELR + +A EG IQ+ +
Sbjct: 241 PESRLTWPALLEHPFVKESYDELEARELREINGSHMHSDAARVVEGKTIQTL-----TTG 295
Query: 301 VSANNTSPSLHTDVELNSSNTSQSNSSPCEAFPGFSSPNNVKPSGS-------------- 346
+ A+ SP + V+LNS ++NSS + P FS+ NV SG+
Sbjct: 296 MEAHIASPP-QSAVQLNSPILDRANSSVLDESPVFSN-QNVGESGNSLGLAYIQINPCNI 353
Query: 347 ---QALNRLENNSRTVKGALSICQDNEALALILLPLKKWSQGSQNTCR--DQDVLNSNQS 401
Q L+RLENNSRTV A I QDNEAL ILLPLKKWS+GSQN CR D +VL S
Sbjct: 354 LCCQRLDRLENNSRTVNSAKLIGQDNEALGHILLPLKKWSKGSQNICRLLDCNVLGSYLV 413
Query: 402 LRILSNLVAASAIQS------NGLLDE-----IISELLDFSSVVVSLKASELNDLLAKSF 450
L L ++ I+S L E ++ LL F+ V+++K+SE+ DL+AKSF
Sbjct: 414 LAALCYVIYV-FIRSLLCSCFGFFLQEVTFSVVLFYLLVFTGSVIAMKSSEVTDLMAKSF 472
Query: 451 LIIKMLIDNSGSCIASSYFTNWVAVVEIFSKVVSCNEDASGRVLYEATACITVMLSRVAQ 510
I K+L+DN GSC +SSY ++WV VEI+S+VV+ N DASGRVLYE++ACITVMLSRVAQ
Sbjct: 473 SITKILLDNGGSCTSSSYLSHWVEFVEIYSQVVTSNNDASGRVLYESSACITVMLSRVAQ 532
Query: 511 NLKASSSAPGPDANSTPRVNETLKRILDHAKTSGLVDHLCCCLATSGSNLNSGSSNMLRA 570
L++S P + ++NET RIL+HAKT+GLVD+LC CLATSGS+L +GSSNMLRA
Sbjct: 533 VLRSS-----PKISGQEKLNETANRILEHAKTTGLVDNLCLCLATSGSSLITGSSNMLRA 587
Query: 571 ACETCKAIFSLVDVLEIHFSMENAYLFPLNAFWSHSLLRLDIRDHERGSLVGPESARIID 630
A E C+A++ L++ L+I F ++A LFP+NA SHSL R+++ HE+ L +S +++D
Sbjct: 588 ASEACRAVWCLINALDILFMKKSAILFPINALQSHSLHRMEVVHHEQDLLDKADSTKVVD 647
Query: 631 ALTRAFLRSKAVQLAINHCLHQRAEATLSAVIQLLSRCCLRSGIIPSILCGFPSSLPVTT 690
A+TRAFLRSKAV +A+ +C HQ+ E+ ++ +QLLSRCCL + I+P++LCG PSSLPVTT
Sbjct: 648 AMTRAFLRSKAVLVAVYYCFHQQLESAMNCGLQLLSRCCLHNRIVPALLCGLPSSLPVTT 707
Query: 691 VVSGGEDGTAVLEIFSILSLCAS-SNKDSQVGETSNVKGKLSNPCALALHSCLFLAIVAQ 749
VVSGG DGT V E+F++LSLC+S +NKD+Q E SN K KL+NP AL HSCL +A++AQ
Sbjct: 708 VVSGGGDGTIVSEVFTVLSLCSSPANKDTQSVEPSNAKCKLTNPSALVRHSCLLVAVIAQ 767
Query: 750 CLKSTLRNSALFMLTTTPKKQLSRLKILAHYFSSDDRIKTYFQLHSASAMLAFASILSLE 809
CLKS+ RNSA+FMLTT+PKKQL+RL + AH SSDD+IK + SASAMLA ASILSLE
Sbjct: 768 CLKSSGRNSAIFMLTTSPKKQLARLSVFAHQISSDDKIKASIEPQSASAMLALASILSLE 827
Query: 810 SGATVESSIYEIAVPLIPPTATLCDLLKITSGNADQMGPISQSNSFSYWHGLKDGCVGLL 869
SGA VES I EIA+PLIP T+ L D LK +SGN ++ P + S SYW G++DGCVGLL
Sbjct: 828 SGALVESPISEIALPLIPRTSKLSDHLKFSSGNVNESDPCNISGKLSYWQGVRDGCVGLL 887
Query: 870 ESRLKCGGPLAVQQMIASNIPMLLIDLLANT--HSSQQIGSTRDQMMLSPAGVVSTISSI 927
+SRLK GGPLAVQQ+ AS P+LL+ LL N ++S D++ LSP GVV TISS+
Sbjct: 888 DSRLKWGGPLAVQQLCASGTPLLLMGLLGNDVLNASHGNDHVNDRVGLSPIGVVWTISSL 947
Query: 928 YHCLSGGVLMFRQVLLKNEYMKLICNLLSDVHLKLVKGWGGPGGGKDGIRDIINAVIDLL 987
HCLSGG L +RQ+L++NE++KL NL+ DVH+ LVK W GPGGG+ G+RD+INAVIDLL
Sbjct: 948 CHCLSGGALTYRQILIRNEHIKLFSNLICDVHINLVKCWIGPGGGRAGVRDLINAVIDLL 1007
Query: 988 AFPFVAVQNAPGLPSATASVNSGFILNMGSAGGKVCMEDRDMAKAIEEDMGKYIKILMEV 1047
AFPFVA+QNAPGLPSATASV+SGF+LN+GS G +VCMED+ + KAIEED+GKYIKIL+EV
Sbjct: 1008 AFPFVALQNAPGLPSATASVSSGFLLNIGSPGQRVCMEDKGIVKAIEEDIGKYIKILVEV 1067
Query: 1048 GVPGIILRCLEHMELKNLGRPIAFLAKMIGQRSLAVQLVGKGLLDPNRVRRLLD-SSTRE 1106
GVPGIILRCL+HM+L +LGRP+AFLAKM+ R LA+QLV KGLLDPN++R+L D S+ +E
Sbjct: 1068 GVPGIILRCLDHMDLNDLGRPVAFLAKMVCHRPLAIQLVSKGLLDPNKMRKLFDCSAPKE 1127
Query: 1107 VTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSY 1166
VTLD LMI+SDLARMDK FYEYI GAS+LEFLKDFL HEDPN+RAKACSALGNMCRHS+Y
Sbjct: 1128 VTLDALMIISDLARMDKGFYEYIKGASVLEFLKDFLLHEDPNMRAKACSALGNMCRHSAY 1187
Query: 1167 FYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILIS 1226
FYSSLA+++I+G+LI+RC+DPDKRTRKFACF+IGNAAYHND+LYEELR+SIP LAN+L
Sbjct: 1188 FYSSLARHQIVGILIERCSDPDKRTRKFACFAIGNAAYHNDLLYEELRKSIPQLANLLQM 1247
Query: 1227 DEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNES 1286
EEDKTKANAAGALSNL+RNS KLCEDIVS GA+Q+L+KL++DC+V ALNPSR D+ NES
Sbjct: 1248 AEEDKTKANAAGALSNLVRNSDKLCEDIVSNGAVQSLLKLISDCAVSALNPSRNDSGNES 1307
Query: 1287 PLKIALFSLAKMCAHTPCRQFLQSSELFPVIARLRQSPESTIANYASVIISKVGD 1341
PLKIALFSLAKMCAH CRQF++SS LFPVI RL+QSPES+IA YAS IISKV +
Sbjct: 1308 PLKIALFSLAKMCAHPLCRQFIRSSPLFPVIGRLQQSPESSIAKYASAIISKVAE 1362
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449451811|ref|XP_004143654.1| PREDICTED: serine/threonine-protein kinase TIO-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1774 bits (4594), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 920/1353 (67%), Positives = 1071/1353 (79%), Gaps = 80/1353 (5%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
MGVENYHVIELVGEGSFGKVYKGRRK TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL
Sbjct: 1 MGVENYHVIELVGEGSFGKVYKGRRKNTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
KH+NIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQ+IAKQLVRALHYLHS
Sbjct: 61 KHENIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQAIAKQLVRALHYLHS 120
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
NR IHRDMKPQNILIGAGSVVKLCDFGFARAMS NTVVLRSIKGTPLYMAPELVREQPYN
Sbjct: 121 NRFIHRDMKPQNILIGAGSVVKLCDFGFARAMSTNTVVLRSIKGTPLYMAPELVREQPYN 180
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP+ MS +FKSFL+GLLNKV
Sbjct: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPENMSSSFKSFLRGLLNKV 240
Query: 241 PQNRLTWSALLEHPFVKETSDELNAWELRATSVEARGCNATWTAEGNA-----IQSSSGK 295
PQNRLTW ALLEHPFVKETSDEL EL ATSV RGC+ TW EGNA + S+ GK
Sbjct: 241 PQNRLTWPALLEHPFVKETSDELEMKELNATSVATRGCSPTWRGEGNANLASNVSSAGGK 300
Query: 296 SNSPAVSANNTSPSLHTDVELNSSNTSQSNSSPCEAFPGFSSPNNVKPSGSQALNRLENN 355
++PA + S + + + NS N+ N+S E FPGF+SPN+VK SG Q L++ E+N
Sbjct: 301 IDAPASFQDKISVNT-PNAQHNSPNSILGNNSHPEEFPGFASPNDVKHSGCQTLDKFEDN 359
Query: 356 SRTVKGALSICQDNEALALILLPLKKWSQGSQNTCRDQDVLNSNQSLRILSNLVAASAIQ 415
SRTVKGA I QD EAL IL L++WS+ SQN+CR+Q +L+S+QSLRILSNL AA AIQ
Sbjct: 360 SRTVKGAQVISQDTEALTHILGQLQRWSEMSQNSCREQIILSSSQSLRILSNLAAAGAIQ 419
Query: 416 SNGLLDEIISELLDFSSVVVSLKASELNDLLAKSFLIIKMLIDNSGSCIASSYFTNWVAV 475
G DE+ ELL F+ V+++LK+ E+NDL+ KSF I++ L+ SG + S F +WV +
Sbjct: 420 CTGRFDEVTHELLVFTRVIINLKSIEVNDLIIKSFSIVRTLVSKSGGVMGSLSFRHWVTL 479
Query: 476 VEIFSKVVSCNEDASGRVLYEATACITVMLSRVAQNLKASSSAPGPDANSTPRVNETLKR 535
EIFS+V+ + D SG V+ E+TAC+ V+LS+VAQ LKAS+S GP+ P NE L++
Sbjct: 480 AEIFSQVICSSGDLSGDVVCESTACVAVLLSKVAQGLKASNSGSGPEVVCAP--NEILRK 537
Query: 536 ILDHAKTSGLVDHLCCCLATSGSNLNSGSSNMLRAACETCKAIFSLVDVLEIHFSMENAY 595
ILDHAKTSGLVDHLC CLATSG++L SGSS +LRAACE C+A++SL++ EI F EN Y
Sbjct: 538 ILDHAKTSGLVDHLCLCLATSGASLISGSSILLRAACEACRALWSLIESFEILFVKENTY 597
Query: 596 LFPLNAFWSHSLLRLDIRDHERGSLVGPESARIIDALTRAFLRSKAVQLAINHCLHQRAE 655
LFPLNAF SHSLLRLDIRDHE+GSL G +S +++DA+TRAFL+S A+Q++I +CLHQR E
Sbjct: 598 LFPLNAFRSHSLLRLDIRDHEKGSLQGSDSTKVVDAVTRAFLKSNAIQVSIYYCLHQRHE 657
Query: 656 ATLSAVIQLLSRCCLRSGIIPSILCGFPSSLPVTTVVSGGEDGTAVLEIFSILSLCASS- 714
A LS+ IQ+L RCCL +GI+P +LCG PSSLPVTTVVSGG DGT V E F++LSLC S
Sbjct: 658 AALSSCIQILLRCCLHNGIVPGVLCGLPSSLPVTTVVSGGGDGTIVAEAFNVLSLCISVL 717
Query: 715 NKDSQVGETSNVKGKLSNPCALALHSCLFLAIVAQCLKSTLRNSALFMLTTTPKKQLSRL 774
NKDSQ G+ SN+K KL NP +L +HSCL LA VAQCLKS RNSALFMLTT+PK+QLSRL
Sbjct: 718 NKDSQTGDMSNMKCKLVNPSSLVMHSCLLLATVAQCLKSMGRNSALFMLTTSPKRQLSRL 777
Query: 775 KILAHYFSSDDRIKTYFQLHSASAMLAFASILSLESGATVESSIYEIAVPLIPPTATLCD 834
+LAH FSSDD+I+ H AS MLA ASILSLE GA+VESS+ EI++PLIP TATLCD
Sbjct: 778 TVLAHSFSSDDKIRNAVLPHCASGMLALASILSLEIGASVESSVSEISIPLIPRTATLCD 837
Query: 835 LLKITS-GNADQMGPISQSNSF-SYWHGLKDGCVGLLESRLKCGGPLAVQQMIASNIPML 892
LKI+S GN D G ++ F S+WHG DGCVGLLE+RL+ GGPLAVQQ+ ASNIP L
Sbjct: 838 YLKISSLGNND--GHTNEFGQFLSHWHGCMDGCVGLLEARLRWGGPLAVQQLCASNIPHL 895
Query: 893 LIDLLANTHSSQQIGS--TRDQMMLSPAGVVSTISSIYHCLSGGVLMFRQVLLKNEYMKL 950
L+++LA SS Q G DQ+ LSP G+V T+SSI HCL GG L FRQ+L++N+ +KL
Sbjct: 896 LVNMLAKNGSSAQQGMDIKNDQVGLSPIGLVWTVSSISHCLLGGSLTFRQILIRNDNVKL 955
Query: 951 ICNLLSDVHLKLVKGWGGPGGGKDGIRDIINAVIDLLAFPFVAVQNAPGLPSATASVNSG 1010
+ +L+SD HLKLVKGWGGPGGGK G++D+IN V G+P G
Sbjct: 956 MSDLISDAHLKLVKGWGGPGGGKSGVKDVINVV---------------GVP--------G 992
Query: 1011 FILNMGSAGGKVCMEDRDMAKAIEEDMGKYIKILMEVGVPGIILRCLEHMELKNLGRPIA 1070
++ C+E + +D+G RP+A
Sbjct: 993 IVIR--------CLEHSEF-----KDIG----------------------------RPVA 1011
Query: 1071 FLAKMIGQRSLAVQLVGKGLLDPNRVRRLLDSS-TREVTLDVLMIVSDLARMDKWFYEYI 1129
FLAKMI R LAVQLVGKGLLD NR+RRLLD+S ++E+ LD+LMI+SDLARMDK FYEYI
Sbjct: 1012 FLAKMISHRPLAVQLVGKGLLDANRMRRLLDTSNSKEILLDILMIISDLARMDKAFYEYI 1071
Query: 1130 NGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDK 1189
NGAS+LEFLK+FL HEDPN+RAKACSALGNMCRHSSYFY SLA+ II LLIDRC+D DK
Sbjct: 1072 NGASILEFLKEFLAHEDPNIRAKACSALGNMCRHSSYFYGSLARYGIINLLIDRCSDADK 1131
Query: 1190 RTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSK 1249
RTRKFACF+IGNAAYH+D LY ELRRSIP LAN+L+S EEDKTKANAAGALSNL+RNS+
Sbjct: 1132 RTRKFACFAIGNAAYHDDTLYGELRRSIPQLANLLVSSEEDKTKANAAGALSNLVRNSNM 1191
Query: 1250 LCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQFLQ 1309
LCEDIVS+GAMQAL+KLVADCS +ALNPSRKDA NESPLKIALFSLAKMCAHTPCRQFL
Sbjct: 1192 LCEDIVSRGAMQALLKLVADCSAVALNPSRKDAANESPLKIALFSLAKMCAHTPCRQFLL 1251
Query: 1310 SSELFPVIARLRQSPESTIANYASVIISKVGDT 1342
SS+LFPVI +LRQSPES IA YASVI+ KV +T
Sbjct: 1252 SSKLFPVIGQLRQSPESIIAKYASVIVRKVAET 1284
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297847360|ref|XP_002891561.1| hypothetical protein ARALYDRAFT_474153 [Arabidopsis lyrata subsp. lyrata] gi|297337403|gb|EFH67820.1| hypothetical protein ARALYDRAFT_474153 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1744 bits (4518), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 893/1347 (66%), Positives = 1079/1347 (80%), Gaps = 34/1347 (2%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
MGVE+YHVIELVGEGSFG+VYKGRRKYTGQTVAMKFIMK GKS+KDIH+LRQEIEILRKL
Sbjct: 1 MGVEDYHVIELVGEGSFGRVYKGRRKYTGQTVAMKFIMKQGKSDKDIHSLRQEIEILRKL 60
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
KH+NIIEMLDSFE+ +EFCVVTEFAQGELFEILEDDKCLPEEQVQ+IAKQLV+ALHYLHS
Sbjct: 61 KHENIIEMLDSFENAREFCVVTEFAQGELFEILEDDKCLPEEQVQAIAKQLVKALHYLHS 120
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS NTVVLRSIKGTPLYMAPELVRE+PYN
Sbjct: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSTNTVVLRSIKGTPLYMAPELVREKPYN 180
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
T DLWSLGVILYEL+VGQPPFYTNSVYALI+HIVKDPVKYPDEMSP FKSFLKGLLNK
Sbjct: 181 RTVDLWSLGVILYELYVGQPPFYTNSVYALIQHIVKDPVKYPDEMSPYFKSFLKGLLNKE 240
Query: 241 PQNRLTWSALLEHPFVKETSDELNAWELRATSVEARGCNATWTAEGNAIQSSSGKSNSPA 300
PQNRLTW ALLEHPFVKE+ +E+ A E++ + V+ + A W +GN Q + K +S
Sbjct: 241 PQNRLTWPALLEHPFVKESQEEVEAREIQTSVVDHK---AAWMLKGNGGQQRNEKCDSVT 297
Query: 301 VSANNTSPSLHTDVELNSSNTSQSNSSPCEAFPGFSSPNNVKPSGSQALNRLENNSRTVK 360
+ N ++ + DV+ + + NS P E F GF + +K SG+ L++LEN SRTVK
Sbjct: 298 LVENMSATKVLADVQSDMKSAVNVNSPPHEDFLGFPTQEEIKSSGNATLDKLENTSRTVK 357
Query: 361 GALSICQDNEALALILLPLKKWSQGSQNTCRDQDVLNSNQSLRILSNLVAASAIQSNGLL 420
GA I +D++AL L+LL L+++S+ S ++ RD+DV S QSLRI+SNLVA AI S GL+
Sbjct: 358 GAQVIGEDDKALDLVLLSLERFSK-SPDSKRDKDVACSVQSLRIISNLVAVRAIVSVGLI 416
Query: 421 DEIISELLDFSSVVVSLKASELNDLLAKSFLIIKMLIDN-SGSCIASSYFTNWVAVVEIF 479
++I LLDF+ +V +K+SE N ++ KS + K L+ + G+ I SSY +W VVEIF
Sbjct: 417 EKITCALLDFTDALVGMKSSEFNKIIPKSLSVTKNLVGHIEGNSIHSSYIRHWAKVVEIF 476
Query: 480 SKVVSCNEDASGRVLYEATACITVMLSRVAQNLKASSSAPGPDANSTPRVNETLKRILDH 539
+VV E+ +GR++YEA +CIT MLSRVA++LK+S+ PD+ S K+IL+H
Sbjct: 477 VQVVGWKEEGTGRIIYEACSCITTMLSRVAEDLKSST----PDSVS--------KQILEH 524
Query: 540 AKTSGLVDHLCCCLATSGSNLNSGSSNMLRAACETCKAIFSLVDVLEIHFSMENAYLFPL 599
A S LVDHLC CLA+SGS+L SG+S ML AACE C+AI+ L+D E F +N + PL
Sbjct: 525 ANMSRLVDHLCLCLASSGSSLTSGTSQMLAAACEACRAIWILIDTSETFFKNDNVNILPL 584
Query: 600 NAFWSHSLLRLDIRDHERG-SLVGPESARIIDALTRAFLRSKAVQLAINHCLHQRAEATL 658
+A L+ + HE+G S GP S +++D +TR +LRSK VQ+AI HCLHQR EA L
Sbjct: 585 DA------LQNRLSQHEKGNSEWGPLSEKLVDTVTRTYLRSKHVQVAIGHCLHQRVEAPL 638
Query: 659 SAVIQLLSRCCLRSGIIPSILCGFPSSLPVTTVVSGGEDGTAVLEIFSILSLCASSNKDS 718
+ IQLLSRCCL +GI+PS+LCG PSSLP+TTVVSGGEDGT + E+FSILS S+KD
Sbjct: 639 VSAIQLLSRCCLHNGIMPSMLCGLPSSLPITTVVSGGEDGTVISELFSILSYATLSSKDQ 698
Query: 719 QVGETSNVKGKLSNPCALALHSCLFLAIVAQCLKSTLRNSALFMLTTTPKKQLSRLKILA 778
Q E +N +G+L+N L HSCL LA VAQCLK T RNSAL MLTT+P+K L RL +A
Sbjct: 699 QTREKNNFEGRLNN---LVFHSCLLLATVAQCLKLTGRNSALLMLTTSPRKHLHRLTAIA 755
Query: 779 HYFSSDDRIKTYFQLHSASAMLAFASILSLESGATVESSIYEIAVPLIPPTATLCDLLKI 838
++ +SDD+I+ Q HSASAMLA ASILSLE G++ ESS+ EIAVPLIP LC L+
Sbjct: 756 NHIASDDKIEASLQNHSASAMLALASILSLEKGSSAESSVSEIAVPLIPRATKLCYHLRP 815
Query: 839 TSGNADQMGPISQSNSFSYWHGLKDGCVGLLESRLKCGGPLAVQQMIASNIPMLLIDLLA 898
+ ++ IS S +F+ WHGL DGC+GLLESRLK GGPL VQQ+IAS P+LLI+LLA
Sbjct: 816 MPSHEGEV--ISHSANFTKWHGLLDGCIGLLESRLKWGGPLTVQQLIASGAPLLLINLLA 873
Query: 899 ---NTHSSQQIGSTRDQMMLSPAGVVSTISSIYHCLSGGVLMFRQVLLKNEYMKLICNLL 955
+ S I T +++ LSP GV+ T+SSI HCLSGG L FRQVL+K E MKLI LL
Sbjct: 874 GKLSNASPDDIKKTPNRIGLSPVGVIWTVSSICHCLSGGTLTFRQVLVKIENMKLITCLL 933
Query: 956 SDVHLKLVKGWGGPGGGKDGIRDIINAVIDLLAFPFVAVQNAPGLPSATASVNSGFILNM 1015
SD H+KLVK WGGPGGGKDG+R+ IN +IDLLAFPFVA+Q+ PG SATASVNSGFILNM
Sbjct: 934 SDAHIKLVKNWGGPGGGKDGVRETINVIIDLLAFPFVALQSQPGSLSATASVNSGFILNM 993
Query: 1016 GSAGGKVCMEDRDMAKAIEEDMGKYIKILMEVGVPGIILRCLEHMELKNLGRPIAFLAKM 1075
GS G +VCMEDRD+ KAIEEDM KYIK+L+EVGVP +ILRCLEH+E+K+L RP+AFLAKM
Sbjct: 994 GSPGVRVCMEDRDLLKAIEEDMDKYIKVLLEVGVPSLILRCLEHLEIKDLVRPVAFLAKM 1053
Query: 1076 IGQRSLAVQLVGKGLLDPNRVRRLLD-SSTREVTLDVLMIVSDLARMDKWFYEYINGASM 1134
+G+ LAV+LV KGLLDPNR+++LL+ SS REV LD+LMI+SDL+RMDK FY+YI AS+
Sbjct: 1054 VGRPRLAVELVSKGLLDPNRMKKLLNQSSPREVILDILMIISDLSRMDKAFYKYIGEASV 1113
Query: 1135 LEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKF 1194
L+ LK+FLTH DPN+RAKACSALGNMCRH+ YFYSSLA+++IIGLLIDRCADPDKRT+KF
Sbjct: 1114 LQPLKEFLTHVDPNIRAKACSALGNMCRHNGYFYSSLAEHQIIGLLIDRCADPDKRTQKF 1173
Query: 1195 ACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDI 1254
ACF+IGNAAYHND LYEELRRSI LAN+L + EEDKTKANAAGALSNL+RNS+KLCEDI
Sbjct: 1174 ACFAIGNAAYHNDTLYEELRRSITQLANVLTTAEEDKTKANAAGALSNLVRNSNKLCEDI 1233
Query: 1255 VSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCA-HTPCRQFLQSSEL 1313
VSKGA+Q L++LVADCS LALNPS+K+ V+ESPLKIALFSLAKMC+ H CRQF++SSEL
Sbjct: 1234 VSKGALQTLLRLVADCSTLALNPSKKETVSESPLKIALFSLAKMCSNHQICRQFVKSSEL 1293
Query: 1314 FPVIARLRQSPESTIANYASVIISKVG 1340
FPVIARL+QSPE+ IA+YASVI++KVG
Sbjct: 1294 FPVIARLKQSPEANIAHYASVIVAKVG 1320
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|72004127|gb|AAZ66047.1| fused [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1697 bits (4395), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 876/1345 (65%), Positives = 1065/1345 (79%), Gaps = 33/1345 (2%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
MGVE+YHVIELVGEGSFG+VYKGRRKYTGQTVAMKFIMK GK++KDIH+LRQEIEILRKL
Sbjct: 1 MGVEDYHVIELVGEGSFGRVYKGRRKYTGQTVAMKFIMKQGKTDKDIHSLRQEIEILRKL 60
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
KH+NIIEMLDSFE+ +EFCVVTEFAQGELFEILEDDKCLPEEQVQ+IAKQLV+AL YLHS
Sbjct: 61 KHENIIEMLDSFENAREFCVVTEFAQGELFEILEDDKCLPEEQVQAIAKQLVKALDYLHS 120
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS NTVVLRSIKGTPLYMAPELV+EQPY+
Sbjct: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSTNTVVLRSIKGTPLYMAPELVKEQPYD 180
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
T DLWSLGVILYEL+VGQPPFYTNSVYALIRHIVKDPVKYPDEMS FKSFLKGLLNK
Sbjct: 181 RTVDLWSLGVILYELYVGQPPFYTNSVYALIRHIVKDPVKYPDEMSTYFKSFLKGLLNKE 240
Query: 241 PQNRLTWSALLEHPFVKETSDELNAWELRATSVEARGCNATWTAEGNAIQSSSGKSNSPA 300
P +RLTW AL EHPFVKET +E+ A E+ V+ + A W +GN Q + K +S
Sbjct: 241 PHSRLTWPALREHPFVKETQEEVEAREIHTAVVDNK---AAWMLKGNGGQQRNEKCDSVT 297
Query: 301 VSANNTSPSLHTDVELNSSNTSQSNSSPCEAFPGFSSPNNVKPSGSQALNRLENNSRTVK 360
+ + ++ DV+ + + + NS P E F GF + +K SG+ L++LEN SRTVK
Sbjct: 298 LVEDMSATKGLADVQSDMKSAVKVNSPPTEDFVGFPTQEEIKSSGNPTLDKLENTSRTVK 357
Query: 361 GALSICQDNEALALILLPLKKWSQGSQNTCRDQDVLNSNQSLRILSNLVAASAIQSNGLL 420
GA I ++++AL L+LL L+++S+ S ++ RD+DV S QSLRI+SNLVA AI S GL+
Sbjct: 358 GAQVIGENDKALDLVLLSLERFSK-SPDSKRDKDVACSVQSLRIISNLVATRAIVSVGLI 416
Query: 421 DEIISELLDFSSVVVSLKASELNDLLAKSFLIIKMLIDN-SGSCIASSYFTNWVAVVEIF 479
++I LLDF+ +V +K+ E N+++ KS + K L+ + G+ I SSY +W VVEIF
Sbjct: 417 EKITCALLDFTDALVGMKSPEFNNIIPKSLSVTKNLVGHVEGNNIHSSYIRHWTKVVEIF 476
Query: 480 SKVVSCNEDASGRVLYEATACITVMLSRVAQNLKASSSAPGPDANSTPRVNETLKRILDH 539
+VV E+ +GR++YEA +CIT MLSRVAQ+LK+S+ PD+ S K+IL+H
Sbjct: 477 IQVVRWEEEGTGRIIYEACSCITTMLSRVAQDLKSST----PDSVS--------KQILEH 524
Query: 540 AKTSGLVDHLCCCLATSGSNLNSGSSNMLRAACETCKAIFSLVDVLEIHFSMENAYLFPL 599
A S +VDHLC CLA+SGS+L SGSS ML AACE C+AI+ L+D E F ++ + PL
Sbjct: 525 ANMSRIVDHLCLCLASSGSSLTSGSSQMLAAACEACRAIWILIDTSETFFKNDDVNILPL 584
Query: 600 NAFWSHSLLRLDIRDHERGSLVGPESARIIDALTRAFLRSKAVQLAINHCLHQRAEATLS 659
+A + L + DI + E GP S +++D +TRA+LRSK VQ+A+ HCLHQR EA L
Sbjct: 585 DAL-QNRLSQHDIGNSEW----GPLSEKLVDTVTRAYLRSKHVQVAVGHCLHQRVEAPLV 639
Query: 660 AVIQLLSRCCLRSGIIPSILCGFPSSLPVTTVVSGGEDGTAVLEIFSILSLCASSNKDSQ 719
+ IQLLSRCCL +GI+PS+LCG PSSLP+TTVVSGGEDGT + EIFSILS S+KD Q
Sbjct: 640 SAIQLLSRCCLHNGILPSMLCGLPSSLPITTVVSGGEDGTVISEIFSILSYATLSSKDQQ 699
Query: 720 VGETSNVKGKLSNPCALALHSCLFLAIVAQCLKSTLRNSALFMLTTTPKKQLSRLKILAH 779
GE N +G+L+N L HSCL LA VAQCLK T RNS L MLTT+PKK RL +A+
Sbjct: 700 TGEKDNFEGRLNN---LVFHSCLMLATVAQCLKLTGRNSVLLMLTTSPKKHQHRLSAIAN 756
Query: 780 YFSSDDRIKTYFQLHSASAMLAFASILSLESGATVESSIYEIAVPLIPPTATLCDLLKIT 839
+ +SDD+I+ Q HSASAMLA ASIL+LE G++ SS+ E+ V LIP LC L+
Sbjct: 757 HIASDDKIEASLQNHSASAMLALASILALEKGSSAGSSVSELVVSLIPRATKLCYHLRPM 816
Query: 840 SGNADQMGPISQSNSFSYWHGLKDGCVGLLESRLKCGGPLAVQQMIASNIPMLLIDLLA- 898
N ++ IS S +++ WHGL DGC+GLLESRLK GGPLAVQQ+IAS P+LLI+LLA
Sbjct: 817 PSNEGEV--ISHSANYAKWHGLLDGCIGLLESRLKWGGPLAVQQLIASGTPLLLINLLAG 874
Query: 899 --NTHSSQQIGSTRDQMMLSPAGVVSTISSIYHCLSGGVLMFRQVLLKNEYMKLICNLLS 956
+ S + I T +++ LSP GVV TISSI HCLSGG FRQVL+K E MKLI LLS
Sbjct: 875 KLSNASPEDIKKTSNRIGLSPIGVVWTISSICHCLSGGT-TFRQVLVKIETMKLITCLLS 933
Query: 957 DVHLKLVKGWGGPGGGKDGIRDIINAVIDLLAFPFVAVQNAPGLPSATASVNSGFILNMG 1016
D H+KLVK WGGPGGGKDG+R+ IN +IDLLAFPFVA+Q+ PG SATASVNSGFILN+G
Sbjct: 934 DAHIKLVKSWGGPGGGKDGVRETINVIIDLLAFPFVALQSQPGSLSATASVNSGFILNIG 993
Query: 1017 SAGGKVCMEDRDMAKAIEEDMGKYIKILMEVGVPGIILRCLEHMELKNLGRPIAFLAKMI 1076
S G +VCMEDRD+ KAIEEDM KYI +L+EVGVP +ILRCL+H+ELK+L RP+AFLAKM+
Sbjct: 994 SPGVRVCMEDRDLLKAIEEDMDKYIIVLLEVGVPSLILRCLDHLELKDLVRPVAFLAKMV 1053
Query: 1077 GQRSLAVQLVGKGLLDPNRVRRLLD-SSTREVTLDVLMIVSDLARMDKWFYEYINGASML 1135
G+ LAV LV KGLLDPNR+++LL+ SS REV LD+LMI+SDL+RMDK FY+YI AS+L
Sbjct: 1054 GRPRLAVDLVSKGLLDPNRMKKLLNQSSPREVILDILMIISDLSRMDKAFYKYIGEASVL 1113
Query: 1136 EFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFA 1195
+ LK++LTH DPN+RAKACSALGNMCRH+ YFYS+LA+++IIGLLIDRCADPDKRT+KFA
Sbjct: 1114 QPLKEYLTHVDPNIRAKACSALGNMCRHNGYFYSALAEHQIIGLLIDRCADPDKRTQKFA 1173
Query: 1196 CFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIV 1255
CF+IGNAAYHND LYEELRRSI LAN+L + EEDKTKANAAGALSNL+RNS+KLCEDIV
Sbjct: 1174 CFAIGNAAYHNDTLYEELRRSITQLANVLTTAEEDKTKANAAGALSNLVRNSNKLCEDIV 1233
Query: 1256 SKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCA-HTPCRQFLQSSELF 1314
SKGA+Q L++LVADCS LALNPS+K+ +ESPLKIALFSLAKMC+ H CRQF++SSELF
Sbjct: 1234 SKGALQTLLRLVADCSTLALNPSKKETASESPLKIALFSLAKMCSNHQICRQFVKSSELF 1293
Query: 1315 PVIARLRQSPESTIANYASVIISKV 1339
PVIARL+QSPE+ IA+YASVI++KV
Sbjct: 1294 PVIARLKQSPEANIAHYASVIVAKV 1318
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145324891|ref|NP_001077692.1| Protein kinase family protein with ARM repeat domain [Arabidopsis thaliana] gi|122232594|sp|Q2QAV0.1|TIO_ARATH RecName: Full=Serine/threonine-protein kinase TIO; AltName: Full=Fused homolog; Short=AtFUSED; AltName: Full=Protein TWO-IN-ONE; Short=AtTIO gi|72004129|gb|AAZ66048.1| fused [Arabidopsis thaliana] gi|332194406|gb|AEE32527.1| Protein kinase family protein with ARM repeat domain [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1696 bits (4393), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 875/1345 (65%), Positives = 1065/1345 (79%), Gaps = 33/1345 (2%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
MGVE+YHVIELVGEGSFG+VYKGRRKYTGQTVAMKFIMK GK++KDIH+LRQEIEILRKL
Sbjct: 1 MGVEDYHVIELVGEGSFGRVYKGRRKYTGQTVAMKFIMKQGKTDKDIHSLRQEIEILRKL 60
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
KH+NIIEMLDSFE+ +EFCVVTEFAQGELFEILEDDKCLPEEQVQ+IAKQLV+AL YLHS
Sbjct: 61 KHENIIEMLDSFENAREFCVVTEFAQGELFEILEDDKCLPEEQVQAIAKQLVKALDYLHS 120
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS NTVVLRSIKGTPLYMAPELV+EQPY+
Sbjct: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSTNTVVLRSIKGTPLYMAPELVKEQPYD 180
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
T DLWSLGVILYEL+VGQPPFYTNSVYALIRHIVKDPVKYPDEMS F+SFLKGLLNK
Sbjct: 181 RTVDLWSLGVILYELYVGQPPFYTNSVYALIRHIVKDPVKYPDEMSTYFESFLKGLLNKE 240
Query: 241 PQNRLTWSALLEHPFVKETSDELNAWELRATSVEARGCNATWTAEGNAIQSSSGKSNSPA 300
P +RLTW AL EHPFVKET +E+ A E+ V+ + A W +GN Q + K +S
Sbjct: 241 PHSRLTWPALREHPFVKETQEEVEAREIHTAVVDNK---AAWMLKGNGGQQRNEKCDSVT 297
Query: 301 VSANNTSPSLHTDVELNSSNTSQSNSSPCEAFPGFSSPNNVKPSGSQALNRLENNSRTVK 360
+ + ++ DV+ + + + NS P E F GF + +K SG+ L++LEN SRTVK
Sbjct: 298 LVEDMSATKGLADVQSDMKSAVKVNSPPTEDFVGFPTQEEIKSSGNPTLDKLENTSRTVK 357
Query: 361 GALSICQDNEALALILLPLKKWSQGSQNTCRDQDVLNSNQSLRILSNLVAASAIQSNGLL 420
GA I ++++AL L+LL L+++S+ S ++ RD+DV S QSLRI+SNLVA AI S GL+
Sbjct: 358 GAQVIGENDKALDLVLLSLERFSK-SPDSKRDKDVACSVQSLRIISNLVATRAIVSVGLI 416
Query: 421 DEIISELLDFSSVVVSLKASELNDLLAKSFLIIKMLIDN-SGSCIASSYFTNWVAVVEIF 479
++I LLDF+ +V +K+ E N+++ KS + K L+ + G+ I SSY +W VVEIF
Sbjct: 417 EKITCALLDFTDALVGMKSPEFNNIIPKSLSVTKNLVGHVEGNNIHSSYIRHWTKVVEIF 476
Query: 480 SKVVSCNEDASGRVLYEATACITVMLSRVAQNLKASSSAPGPDANSTPRVNETLKRILDH 539
+VV E+ +GR++YEA +CIT MLSRVAQ+LK+S+ PD+ S K+IL+H
Sbjct: 477 IQVVRWEEEGTGRIIYEACSCITTMLSRVAQDLKSST----PDSVS--------KQILEH 524
Query: 540 AKTSGLVDHLCCCLATSGSNLNSGSSNMLRAACETCKAIFSLVDVLEIHFSMENAYLFPL 599
A S +VDHLC CLA+SGS+L SGSS ML AACE C+AI+ L+D E F ++ + PL
Sbjct: 525 ANMSRIVDHLCLCLASSGSSLTSGSSQMLAAACEACRAIWILIDTSETFFKNDDVNILPL 584
Query: 600 NAFWSHSLLRLDIRDHERGSLVGPESARIIDALTRAFLRSKAVQLAINHCLHQRAEATLS 659
+A + L + DI + E GP S +++D +TRA+LRSK VQ+A+ HCLHQR EA L
Sbjct: 585 DAL-QNRLSQHDIGNSEW----GPLSEKLVDTVTRAYLRSKHVQVAVGHCLHQRVEAPLV 639
Query: 660 AVIQLLSRCCLRSGIIPSILCGFPSSLPVTTVVSGGEDGTAVLEIFSILSLCASSNKDSQ 719
+ IQLLSRCCL +GI+PS+LCG PSSLP+TTVVSGGEDGT + EIFSILS S+KD Q
Sbjct: 640 SAIQLLSRCCLHNGILPSMLCGLPSSLPITTVVSGGEDGTVISEIFSILSYATLSSKDQQ 699
Query: 720 VGETSNVKGKLSNPCALALHSCLFLAIVAQCLKSTLRNSALFMLTTTPKKQLSRLKILAH 779
GE N +G+L+N L HSCL LA VAQCLK T RNS L MLTT+PKK RL +A+
Sbjct: 700 TGEKDNFEGRLNN---LVFHSCLMLATVAQCLKLTGRNSVLLMLTTSPKKHQHRLSAIAN 756
Query: 780 YFSSDDRIKTYFQLHSASAMLAFASILSLESGATVESSIYEIAVPLIPPTATLCDLLKIT 839
+ +SDD+I+ Q HSASAMLA ASIL+LE G++ SS+ E+ V LIP LC L+
Sbjct: 757 HIASDDKIEASLQNHSASAMLALASILALEKGSSAGSSVSELVVSLIPRATKLCYHLRPM 816
Query: 840 SGNADQMGPISQSNSFSYWHGLKDGCVGLLESRLKCGGPLAVQQMIASNIPMLLIDLLA- 898
N ++ IS S +++ WHGL DGC+GLLESRLK GGPLAVQQ+IAS P+LLI+LLA
Sbjct: 817 PSNEGEV--ISHSANYAKWHGLLDGCIGLLESRLKWGGPLAVQQLIASGTPLLLINLLAG 874
Query: 899 --NTHSSQQIGSTRDQMMLSPAGVVSTISSIYHCLSGGVLMFRQVLLKNEYMKLICNLLS 956
+ S + I T +++ LSP GVV TISSI HCLSGG FRQVL+K E MKLI LLS
Sbjct: 875 KLSNASPEDIKKTSNRIGLSPIGVVWTISSICHCLSGGT-TFRQVLVKIETMKLITCLLS 933
Query: 957 DVHLKLVKGWGGPGGGKDGIRDIINAVIDLLAFPFVAVQNAPGLPSATASVNSGFILNMG 1016
D H+KLVK WGGPGGGKDG+R+ IN +IDLLAFPFVA+Q+ PG SATASVNSGFILN+G
Sbjct: 934 DAHIKLVKSWGGPGGGKDGVRETINVIIDLLAFPFVALQSQPGSLSATASVNSGFILNIG 993
Query: 1017 SAGGKVCMEDRDMAKAIEEDMGKYIKILMEVGVPGIILRCLEHMELKNLGRPIAFLAKMI 1076
S G +VCMEDRD+ KAIEEDM KYI +L+EVGVP +ILRCL+H+ELK+L RP+AFLAKM+
Sbjct: 994 SPGVRVCMEDRDLLKAIEEDMDKYIIVLLEVGVPSLILRCLDHLELKDLVRPVAFLAKMV 1053
Query: 1077 GQRSLAVQLVGKGLLDPNRVRRLLD-SSTREVTLDVLMIVSDLARMDKWFYEYINGASML 1135
G+ LAV LV KGLLDPNR+++LL+ SS REV LD+LMI+SDL+RMDK FY+YI AS+L
Sbjct: 1054 GRPRLAVDLVSKGLLDPNRMKKLLNQSSPREVILDILMIISDLSRMDKAFYKYIGEASVL 1113
Query: 1136 EFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFA 1195
+ LK++LTH DPN+RAKACSALGNMCRH+ YFYS+LA+++IIGLLIDRCADPDKRT+KFA
Sbjct: 1114 QPLKEYLTHVDPNIRAKACSALGNMCRHNGYFYSALAEHQIIGLLIDRCADPDKRTQKFA 1173
Query: 1196 CFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIV 1255
CF+IGNAAYHND LYEELRRSI LAN+L + EEDKTKANAAGALSNL+RNS+KLCEDIV
Sbjct: 1174 CFAIGNAAYHNDTLYEELRRSITQLANVLTTAEEDKTKANAAGALSNLVRNSNKLCEDIV 1233
Query: 1256 SKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCA-HTPCRQFLQSSELF 1314
SKGA+Q L++LVADCS LALNPS+K+ +ESPLKIALFSLAKMC+ H CRQF++SSELF
Sbjct: 1234 SKGALQTLLRLVADCSTLALNPSKKETASESPLKIALFSLAKMCSNHQICRQFVKSSELF 1293
Query: 1315 PVIARLRQSPESTIANYASVIISKV 1339
PVIARL+QSPE+ IA+YASVI++KV
Sbjct: 1294 PVIARLKQSPEANIAHYASVIVAKV 1318
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|242059887|ref|XP_002459089.1| hypothetical protein SORBIDRAFT_03g045640 [Sorghum bicolor] gi|241931064|gb|EES04209.1| hypothetical protein SORBIDRAFT_03g045640 [Sorghum bicolor] | Back alignment and taxonomy information |
|---|
Score = 1462 bits (3786), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 759/1352 (56%), Positives = 987/1352 (73%), Gaps = 37/1352 (2%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
MG+E+YHVI+LVGEGSFGKVYKGRRKYT QTVAMKFI+KHGK++KDIHNLRQEIEILRKL
Sbjct: 1 MGIEDYHVIDLVGEGSFGKVYKGRRKYTRQTVAMKFILKHGKTDKDIHNLRQEIEILRKL 60
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
KH+NIIEM+D+FE+PQEFCVVTEFAQGELFE+LEDDKCLPEEQVQ+IAKQLV+AL+YLHS
Sbjct: 61 KHENIIEMIDAFETPQEFCVVTEFAQGELFEVLEDDKCLPEEQVQAIAKQLVKALYYLHS 120
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
NRIIHRDMKPQNILIG GS+VKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN
Sbjct: 121 NRIIHRDMKPQNILIGKGSIVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPD MS NFKSFLKGLLNKV
Sbjct: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDNMSANFKSFLKGLLNKV 240
Query: 241 PQNRLTWSALLEHPFVKETSDELNAWELRATSVEARGCNATWTAEGNAIQSSSGKSNSPA 300
PQ+RLTW ALLEHPFVK+ S +A E R EARG T E +S SPA
Sbjct: 241 PQSRLTWPALLEHPFVKDDSMG-SAAESRPAPFEARGSEGTRKTEET---QTSRNQPSPA 296
Query: 301 VSANNTSPSLHTDVELNSSNTSQSNSSPCEAF------PGFSSPNNVKPSGSQALNRLEN 354
+ T+ + + D + + ++ P +A P + P + PS AL++LE
Sbjct: 297 APQSRTTAT-NRDNDSDKPKANRKLDGPMQATQDRHGSPTGAVPESCSPSECTALDKLEK 355
Query: 355 NSRTVKGALSICQDNEALALILLPLKKWSQGSQNTCRDQDVLNSNQSLRILSNLVAASAI 414
S+TV+GA SI +DNEAL+ +L P+K W + + R+ ++ +NQSLRI+ NL+ A +
Sbjct: 356 ASQTVEGANSIVEDNEALSTVLSPIKIWLTNTPSPPRELNIDGANQSLRIIKNLIDAGSC 415
Query: 415 QSNGLLDEIISELLDFSSVVVSLKASELNDLLAKSFLIIKMLIDNSGSCIASSYFTNWVA 474
QS +D IS LL+F+++++ K S L+ K I + L+D + I SY +W++
Sbjct: 416 QSYAAID--ISLLLEFTNLIIKTKLSNAYGLVVKCLAIARKLLDTNDEVILKSYDRHWLS 473
Query: 475 VVEIFSKVVSCNEDASGRVLYEATACITVMLSRVAQNLKASSSAPGPDANSTPRVNETLK 534
+ E++S+++ D SGR+ E+TAC+ +MLSRV LKAS S+ P V E+L
Sbjct: 474 LYELYSQILVSTVDPSGRISRESTACLALMLSRVISGLKASMSSEDPKP-----VEESLL 528
Query: 535 RILDHAKTSGLVDHLCCCLATSGSNLNSGSSNMLRAACETCKAIFSLVDVLEIHFSMENA 594
+I+DHA+TS L++ LC CL SGS+ SGS+NM+ AACE CKAI+ L ++I +
Sbjct: 529 KIIDHARTSQLLELLCECLIASGSDTISGSTNMVPAACEACKAIWYLAHAVDIMSIGAHH 588
Query: 595 YLFPLNAFWS--HSLLRLDIRDHERGSLVGPESARIIDALTRAFLRSKAVQLAINHCLHQ 652
+ FPL W HS+ E+GS+ S +I+ ++FL S+ +Q+A+ HCLH
Sbjct: 589 FSFPLANSWRQIHSM-------QEQGSMADSNSTNLINIFVKSFLASRPMQVAVYHCLHN 641
Query: 653 RAEATLSAVIQLLSRCCLRSGIIPSILCGFPSSLPVTTVVSGGEDGTAVLEIFSILSLCA 712
E+ + A +QL+SR CL++ +I+C +S V G DGT V ++FS+LSLC
Sbjct: 642 GLESAIHACLQLISRACLQNVSFCAIMCRPWNSPSDVDAVEYGGDGTIVSDMFSLLSLCG 701
Query: 713 SS-NKDSQVGETSNVKGKLSNPCALALHSCLFLAIVAQCLKSTLRNSALFMLTTTPKKQL 771
S NK+S+ + SN K KLSNP AL +H CL LA +A CLKS +SA +LT++ KKQ
Sbjct: 702 SYLNKESK--QNSNQKCKLSNPHALVVHCCLALATIAACLKSEGESSASVILTSSQKKQR 759
Query: 772 SRLKILAHYFSSDDRIKTYFQLHSASAMLAFASILSLESGATVESSIYEIAVPLIPPTAT 831
SRL +LAH S DD +K+ Q H ASAMLA +SI+SLE+G SS+ E A+ L P AT
Sbjct: 760 SRLSVLAHLSSVDDTVKSCLQPHCASAMLALSSIVSLENGGQTRSSLCETALALFPRMAT 819
Query: 832 LCDLLKITSGNADQMGPISQSNSFSYWHGLKDGCVGLLESRLKCGGPLAVQQMIASNIPM 891
L LLK+ + + + + + GL+DG +GLLE+RLK GGPLA++Q + IP
Sbjct: 820 LHTLLKLWLSDGSEALCRYNAGLLNLF-GLRDGSIGLLETRLKWGGPLAIEQACSVGIPQ 878
Query: 892 LLIDLLANTHS---SQQIGSTRDQMMLSPAGVVSTISSIYHCLSGGVLMFRQVLLKNEYM 948
LLI LL + S S S+ ++ LSP GVV T+S++ CL GGV FR++L + E +
Sbjct: 879 LLIRLLTDGFSKEISDGKDSSTNRSGLSPLGVVWTLSALSQCLPGGV--FREILYRREQL 936
Query: 949 KLICNLLSDVHLKLVKGWGGPGGGKDGIRDIINAVIDLLAFPFVAVQNAPGLPSATASVN 1008
KL+ +LLSD HLK + W G GGGK G+R++IN+V+D+LAFPFVAVQ++P +PSA+AS+N
Sbjct: 937 KLLTDLLSDTHLKALAAWTGLGGGKRGVRELINSVVDILAFPFVAVQSSPNMPSASASIN 996
Query: 1009 SGFILNMGSAGGKVCMEDRDMAKAIEEDMGKYIKILMEVGVPGIILRCLEHMELKNLGRP 1068
SGF+LN+ S GG++ E+++M K IE++M +YI++L+EVG+PG +LRCL+++++++LGRP
Sbjct: 997 SGFLLNVASPGGRIGTENKEMLKTIEQNMPQYIQVLLEVGIPGCMLRCLDYVDMEDLGRP 1056
Query: 1069 IAFLAKMIGQRSLAVQLVGKGLLDPNRVRRLLDSS-TREVTLDVLMIVSDLARMDKWFYE 1127
+A +AKM G R LA+QL +GLLDP+RV LL+ +E LD LMI+SDLARM K FY
Sbjct: 1057 LAIVAKMAGYRPLALQLHKEGLLDPSRVAALLEGPIAKETLLDFLMIISDLARMSKDFYV 1116
Query: 1128 YINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADP 1187
I+ A ++ FLK+FL++ DP++RAKACSA+GNMCRHSSYFY LA N++I L++DRC+DP
Sbjct: 1117 PIDKAGLVGFLKNFLSNGDPDIRAKACSAIGNMCRHSSYFYGPLAANKVIQLVVDRCSDP 1176
Query: 1188 DKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNS 1247
DKRTRKFACF++GNAAYHND+LYEELRRSIP L +L+ EEDKTK NAAGALSNL+RNS
Sbjct: 1177 DKRTRKFACFAVGNAAYHNDMLYEELRRSIPQLTTLLLGPEEDKTKGNAAGALSNLVRNS 1236
Query: 1248 SKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQF 1307
KLCEDIVS+GA+QAL+K+V S +AL+PSR+DA+ ESPL+I LF+L KMC H CR F
Sbjct: 1237 DKLCEDIVSQGAIQALLKMVGSYSTVALSPSRRDALTESPLRIVLFALRKMCDHAICRNF 1296
Query: 1308 LQSSELFPVIARLRQSPESTIANYASVIISKV 1339
L+SSEL PVI LRQSP+STI+ YAS I ++V
Sbjct: 1297 LRSSELLPVIVHLRQSPDSTISEYASAIATRV 1328
|
Source: Sorghum bicolor Species: Sorghum bicolor Genus: Sorghum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357115976|ref|XP_003559761.1| PREDICTED: uncharacterized protein LOC100843914 [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 1456 bits (3768), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 759/1348 (56%), Positives = 981/1348 (72%), Gaps = 28/1348 (2%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
MGV++YHV+ELVGEGSFGKVYKGRRKY+ QTVAMKFI+KHGK++KDIHNLRQEIEILRKL
Sbjct: 1 MGVDDYHVVELVGEGSFGKVYKGRRKYSRQTVAMKFILKHGKTDKDIHNLRQEIEILRKL 60
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
KH+NIIEM+D+FE+PQEFCVVTEFAQGELFE+LEDDKCLPEEQVQ+IAKQLV+AL+YLHS
Sbjct: 61 KHENIIEMIDAFETPQEFCVVTEFAQGELFEVLEDDKCLPEEQVQAIAKQLVKALYYLHS 120
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
NRIIHRDMKPQNILIG GS+VKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN
Sbjct: 121 NRIIHRDMKPQNILIGKGSIVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPD MS NFKSFLKGLLNK+
Sbjct: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDNMSANFKSFLKGLLNKL 240
Query: 241 PQNRLTWSALLEHPFVKETSDELNAWELRATSVEARGCNATWTAEGNAIQSSSGKSNSPA 300
PQNRLTW ALLEHPFVK+ S E A + ++T E + A A+ IQ++ + +
Sbjct: 241 PQNRLTWPALLEHPFVKDDSVEFLA-DTQSTPFEVKKSEAPRKAD--EIQTTKNQPCATE 297
Query: 301 VSANNTSPSLHTDVELNSSNTSQSNSSPCEAFPGFSSPNNVK--PSGSQALNRLENNSRT 358
+ NT + D + N E G SSP + PS AL++LE S+T
Sbjct: 298 PPSRNTVNNGENDYDKQKGNKKGGPMPATEGHHG-SSPAAISDTPSECTALDKLEKTSQT 356
Query: 359 VKGALSICQDNEALALILLPLKKWSQGSQNTCRDQDVLNSNQSLRILSNLVAASAIQSNG 418
GA SI D EAL+ +L P+K W R+ ++ +NQSLRI+ NL+ A + S
Sbjct: 357 ASGASSIIADREALSTVLSPIKIWLSNPSTPPRELNIDGANQSLRIVKNLIEAGSYHSCA 416
Query: 419 LLDEIISELLDFSSVVVSLKASELNDLLAKSFLIIKMLIDNSGSCIASSYFTNWVAVVEI 478
+D+II L+F+S+++ K SE L+ K I + L+D S + + SSY +W ++ ++
Sbjct: 417 AIDDIICIFLEFTSLIIKTKLSEAYSLVVKCLAIARKLLDTSEALVLSSYGRHWSSLYDL 476
Query: 479 FSKVVSCNEDASGRVLYEATACITVMLSRVAQNLKASSSAPGPDANSTPRVNETLKRILD 538
+S+++ D SGR+ E+TAC+ +MLSRV LK S S+ GP+ V E+L I+D
Sbjct: 477 YSQILVSTVDPSGRISRESTACLALMLSRVISVLKTSISSEGPNP-----VEESLANIID 531
Query: 539 HAKTSGLVDHLCCCLATSGSNLNSGSSNMLRAACETCKAIFSLVDVLEIHFSMENAYLFP 598
HA+ S L++ LC CL SGS++ SGS+NM+ AACE CKAI+ L ++I N + FP
Sbjct: 532 HARKSQLLELLCECLIASGSDIISGSTNMVPAACEACKAIWYLAHAVDIVSLGANHFSFP 591
Query: 599 LNAFWSHSLLRLDIRDHERGSLVGPESARIIDALTRAFLRSKAVQLAINHCLHQRAEATL 658
L + W + D + E+ SL S +I+ ++FL S+ +Q+A+ HCLH E+ +
Sbjct: 592 LASSWRKGHSKSDGKMQEQDSLPDSNSTSLINIFVKSFLASRQMQVAVYHCLHNGLESAI 651
Query: 659 SAVIQLLSRCCLRSGIIPSILCG-FPSSLPVTTVVSGGEDGTAVLEIFSILSLCASS-NK 716
A +QL+SR CL + +I+C SSL V V GG DGT V ++FS+LSLC S NK
Sbjct: 652 HASLQLISRACLLNPSFCAIVCTPLNSSLDVNEVEYGG-DGTIVSDMFSLLSLCGSYLNK 710
Query: 717 DSQVGETSNVKGKLSNPCALALHSCLFLAIVAQCLKSTLRNSALFMLTTTPKKQLSRLKI 776
+S+ SN K KLSNP AL +H CL LA +A CLKS ++SA +LT++ KKQ SRL +
Sbjct: 711 ESK---QSNQKCKLSNPHALVVHCCLALATIAACLKSEGKSSASIILTSSHKKQRSRLSV 767
Query: 777 LAHYFSSDDRIKTYFQLHSASAMLAFASILSLESGATVESSIYEIAVPLIPPTATLCDLL 836
LAH S DD +K+ Q H ASA LA ++I+SLE+G SS+ E A+ L P AT+ LL
Sbjct: 768 LAHLSSVDDTVKSCLQPHCASATLALSTIISLENGGQTRSSLCETALALFPRMATVHTLL 827
Query: 837 KITSGNADQMGPISQSNS-FSYWHGLKDGCVGLLESRLKCGGPLAVQQMIASNIPMLLID 895
K+ + + + + N+ GL+DG +GLLE+RLK GGPLA++Q + IP LL+
Sbjct: 828 KLWLSDGSE--ELCRYNAGLLNLFGLRDGSIGLLETRLKWGGPLAIEQACSVGIPQLLVR 885
Query: 896 LLANTH----SSQQIGSTRDQMMLSPAGVVSTISSIYHCLSGGVLMFRQVLLKNEYMKLI 951
LL + S + GST + LSP GV T+S++ CL GGV FR++L K E++KL+
Sbjct: 886 LLTDGFLRDPSDGKEGSTH-RSGLSPLGVAWTLSALSQCLPGGV--FREILYKGEHVKLL 942
Query: 952 CNLLSDVHLKLVKGWGGPGGGKDGIRDIINAVIDLLAFPFVAVQNAPGLPSATASVNSGF 1011
++LSD+HLK + W G GGGK G+R++IN+V+D+LAFPFVAVQ++P +PS +AS+NSGF
Sbjct: 943 TDMLSDMHLKALVAWTGLGGGKRGVRELINSVVDILAFPFVAVQSSPNMPSTSASINSGF 1002
Query: 1012 ILNMGSAGGKVCMEDRDMAKAIEEDMGKYIKILMEVGVPGIILRCLEHMELKNLGRPIAF 1071
+LN+GS GG++ E+++M K IE M +YI+IL+EVGVPG ILRCL+++ +++L RP+A
Sbjct: 1003 LLNIGSPGGRIGTENKEMLKTIEHSMPQYIQILLEVGVPGCILRCLDYVNMEDLARPLAI 1062
Query: 1072 LAKMIGQRSLAVQLVGKGLLDPNRVRRLLDSS-TREVTLDVLMIVSDLARMDKWFYEYIN 1130
+AKM+G R LA+QL+ +GLL+P RV +LL S +E LD LMIVSDLARM K FYE I+
Sbjct: 1063 VAKMVGYRPLALQLLREGLLNPRRVAKLLKGSLAKETLLDFLMIVSDLARMSKDFYEPID 1122
Query: 1131 GASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKR 1190
A M+EFLK+FL+ EDP++RAKACSA+GNMCRHS YFYS A N++I L+++RC+DPDKR
Sbjct: 1123 KAGMVEFLKNFLSDEDPDIRAKACSAIGNMCRHSPYFYSPFAANKVIELVVERCSDPDKR 1182
Query: 1191 TRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKL 1250
TRKFACF++GNAAYHND+LYEELR SIP L +L++ EEDKTK NAAGALSNL+RNS L
Sbjct: 1183 TRKFACFAVGNAAYHNDMLYEELRGSIPQLTKLLLAPEEDKTKGNAAGALSNLVRNSDIL 1242
Query: 1251 CEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQFLQS 1310
CEDIVS+GAMQAL+K+V+ S +AL+PSRKDA+ ESPL+I LF+L KMC HT CR FL+S
Sbjct: 1243 CEDIVSQGAMQALLKMVSSFSTVALSPSRKDALTESPLRIVLFALRKMCDHTVCRLFLRS 1302
Query: 1311 SELFPVIARLRQSPESTIANYASVIISK 1338
SEL P+I LRQSP+ TI+ YAS I SK
Sbjct: 1303 SELLPIIVHLRQSPDQTISEYASAIASK 1330
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1342 | ||||||
| TAIR|locus:2011927 | 1322 | FU "FUSED" [Arabidopsis thalia | 0.598 | 0.607 | 0.629 | 0.0 | |
| UNIPROTKB|E1BWJ1 | 1328 | E1BWJ1 "Uncharacterized protei | 0.189 | 0.191 | 0.677 | 3.3e-116 | |
| UNIPROTKB|E1BWJ2 | 1331 | E1BWJ2 "Uncharacterized protei | 0.189 | 0.190 | 0.677 | 3.8e-116 | |
| UNIPROTKB|D4A8P3 | 1188 | Stk36 "Protein Stk36" [Rattus | 0.189 | 0.213 | 0.661 | 3.2e-111 | |
| UNIPROTKB|E1B793 | 1317 | STK36 "Uncharacterized protein | 0.189 | 0.192 | 0.669 | 3.5e-107 | |
| UNIPROTKB|E2RCC2 | 1314 | STK36 "Uncharacterized protein | 0.189 | 0.193 | 0.673 | 2.5e-106 | |
| UNIPROTKB|J9JHL2 | 1319 | STK36 "Uncharacterized protein | 0.189 | 0.192 | 0.673 | 3.4e-106 | |
| MGI|MGI:1920831 | 1316 | Stk36 "serine/threonine kinase | 0.189 | 0.193 | 0.661 | 2.7e-105 | |
| UNIPROTKB|A8MU99 | 1294 | STK36 "Serine/threonine-protei | 0.189 | 0.196 | 0.665 | 3.5e-104 | |
| UNIPROTKB|Q9NRP7 | 1315 | STK36 "Serine/threonine-protei | 0.189 | 0.193 | 0.665 | 1.2e-103 |
| TAIR|locus:2011927 FU "FUSED" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2543 (900.2 bits), Expect = 0., Sum P(2) = 0.
Identities = 517/821 (62%), Positives = 634/821 (77%)
Query: 524 NSTPRVNETLKRILDHAKTSGLVDHLCCCLATXXXXXXXXXXXMLRAACETCKAIFSLVD 583
+STP + K+IL+HA S +VDHLC CLA+ ML AACE C+AI+ L+D
Sbjct: 511 SSTP--DSVSKQILEHANMSRIVDHLCLCLASSGSSLTSGSSQMLAAACEACRAIWILID 568
Query: 584 VLEIHFSMENAYLFPLNAFWSHSLLRLDIRDHERGSLVGPESARIIDALTRAFLRSKAVQ 643
E F ++ + PL+A + L + DI + E G P S +++D +TRA+LRSK VQ
Sbjct: 569 TSETFFKNDDVNILPLDAL-QNRLSQHDIGNSEWG----PLSEKLVDTVTRAYLRSKHVQ 623
Query: 644 LAINHCLHQRAEATLSAVIQLLSRCCLRSGIIPSILCGFPSSLPVTTVVSGGEDGTAVLE 703
+A+ HCLHQR EA L + IQLLSRCCL +GI+PS+LCG PSSLP+TTVVSGGEDGT + E
Sbjct: 624 VAVGHCLHQRVEAPLVSAIQLLSRCCLHNGILPSMLCGLPSSLPITTVVSGGEDGTVISE 683
Query: 704 IFSILSLCASSNKDSQVGETSNVKGKLSNPCALALHSCLFLAIVAQCLKSTLRNSALFML 763
IFSILS S+KD Q GE N +G+L+N L HSCL LA VAQCLK T RNS L ML
Sbjct: 684 IFSILSYATLSSKDQQTGEKDNFEGRLNN---LVFHSCLMLATVAQCLKLTGRNSVLLML 740
Query: 764 TTTPKKQLSRLKILAHYFSSDDRIKTYFQLHSASAMLAFASILSLESGATVESSIYEIAV 823
TT+PKK RL +A++ +SDD+I+ Q HSASAMLA ASIL+LE G++ SS+ E+ V
Sbjct: 741 TTSPKKHQHRLSAIANHIASDDKIEASLQNHSASAMLALASILALEKGSSAGSSVSELVV 800
Query: 824 PLIPPTATLCDLLKITSGNADQMGPISQSNSFSYWHGLKDGCVGLLESRLKCGGPLAVQQ 883
LIP LC L+ N ++ IS S +++ WHGL DGC+GLLESRLK GGPLAVQQ
Sbjct: 801 SLIPRATKLCYHLRPMPSNEGEV--ISHSANYAKWHGLLDGCIGLLESRLKWGGPLAVQQ 858
Query: 884 MIASNIPMLLIDLLA---NTHSSQQIGSTRDQMMLSPAGVVSTISSIYHCLSGGVLMFRQ 940
+IAS P+LLI+LLA + S + I T +++ LSP GVV TISSI HCLSGG FRQ
Sbjct: 859 LIASGTPLLLINLLAGKLSNASPEDIKKTSNRIGLSPIGVVWTISSICHCLSGGTT-FRQ 917
Query: 941 VLLKNEYMKLICNLLSDVHLKLVKXXXXXXXXXXXIRDIINAVIDLLAFPFVAVQNAPGL 1000
VL+K E MKLI LLSD H+KLVK +R+ IN +IDLLAFPFVA+Q+ PG
Sbjct: 918 VLVKIETMKLITCLLSDAHIKLVKSWGGPGGGKDGVRETINVIIDLLAFPFVALQSQPGS 977
Query: 1001 PSATASVNSGFILNMGSAGGKVCMEDRDMAKAIEEDMGKYIKILMEVGVPGIILRCLEHM 1060
SATASVNSGFILN+GS G +VCMEDRD+ KAIEEDM KYI +L+EVGVP +ILRCL+H+
Sbjct: 978 LSATASVNSGFILNIGSPGVRVCMEDRDLLKAIEEDMDKYIIVLLEVGVPSLILRCLDHL 1037
Query: 1061 ELKNLGRPIAFLAKMIGQRSLAVQLVGKGLLDPNRVRRLLD-SSTREVTLDVLMIVSDLA 1119
ELK+L RP+AFLAKM+G+ LAV LV KGLLDPNR+++LL+ SS REV LD+LMI+SDL+
Sbjct: 1038 ELKDLVRPVAFLAKMVGRPRLAVDLVSKGLLDPNRMKKLLNQSSPREVILDILMIISDLS 1097
Query: 1120 RMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGL 1179
RMDK FY+YI AS+L+ LK++LTH DPN+RAKACSALGNMCRH+ YFYS+LA+++IIGL
Sbjct: 1098 RMDKAFYKYIGEASVLQPLKEYLTHVDPNIRAKACSALGNMCRHNGYFYSALAEHQIIGL 1157
Query: 1180 LIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGA 1239
LIDRCADPDKRT+KFACF+IGNAAYHND LYEELRRSI LAN+L + EEDKTKANAAGA
Sbjct: 1158 LIDRCADPDKRTQKFACFAIGNAAYHNDTLYEELRRSITQLANVLTTAEEDKTKANAAGA 1217
Query: 1240 LSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMC 1299
LSNL+RNS+KLCEDIVSKGA+Q L++LVADCS LALNPS+K+ +ESPLKIALFSLAKMC
Sbjct: 1218 LSNLVRNSNKLCEDIVSKGALQTLLRLVADCSTLALNPSKKETASESPLKIALFSLAKMC 1277
Query: 1300 A-HTPCRQFLQSSELFPVIARLRQSPESTIANYASVIISKV 1339
+ H CRQF++SSELFPVIARL+QSPE+ IA+YASVI++KV
Sbjct: 1278 SNHQICRQFVKSSELFPVIARLKQSPEANIAHYASVIVAKV 1318
|
|
| UNIPROTKB|E1BWJ1 E1BWJ1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 931 (332.8 bits), Expect = 3.3e-116, Sum P(3) = 3.3e-116
Identities = 172/254 (67%), Positives = 216/254 (85%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
+E YHV+E++GEGSFG+VYKGRR+ + Q VA+KFI K G+SEK++ NL++EIEI+R L H
Sbjct: 1 MERYHVLEVIGEGSFGRVYKGRRRCSAQVVALKFIPKVGRSEKELKNLQREIEIMRGLHH 60
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NII+MLDSFE+ +E +VT++A+GELF+ILEDD LPE+QVQ+IA QLV AL+YLHS+R
Sbjct: 61 PNIIQMLDSFETDKEVVMVTDYAEGELFQILEDDGSLPEDQVQTIAAQLVSALYYLHSHR 120
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHT 182
I+HRDMKPQNIL+G V+KLCDFGFARAMS +T+VL SIKGTPLYM+PELV E+PY+HT
Sbjct: 121 ILHRDMKPQNILLGKDGVIKLCDFGFARAMSIHTMVLTSIKGTPLYMSPELVEERPYDHT 180
Query: 183 ADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQ 242
ADLWS+G ILYELF+G PPFYT+S++ L+ IVKDPVK+P +SP FKSFL+GLL K P
Sbjct: 181 ADLWSVGCILYELFMGTPPFYTSSIFQLVSLIVKDPVKWPKAISPAFKSFLQGLLMKDPH 240
Query: 243 NRLTWSALLEHPFV 256
RL+W LL HPFV
Sbjct: 241 QRLSWPELLSHPFV 254
|
|
| UNIPROTKB|E1BWJ2 E1BWJ2 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 931 (332.8 bits), Expect = 3.8e-116, Sum P(3) = 3.8e-116
Identities = 172/254 (67%), Positives = 216/254 (85%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
+E YHV+E++GEGSFG+VYKGRR+ + Q VA+KFI K G+SEK++ NL++EIEI+R L H
Sbjct: 1 MERYHVLEVIGEGSFGRVYKGRRRCSAQVVALKFIPKVGRSEKELKNLQREIEIMRGLHH 60
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NII+MLDSFE+ +E +VT++A+GELF+ILEDD LPE+QVQ+IA QLV AL+YLHS+R
Sbjct: 61 PNIIQMLDSFETDKEVVMVTDYAEGELFQILEDDGSLPEDQVQTIAAQLVSALYYLHSHR 120
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHT 182
I+HRDMKPQNIL+G V+KLCDFGFARAMS +T+VL SIKGTPLYM+PELV E+PY+HT
Sbjct: 121 ILHRDMKPQNILLGKDGVIKLCDFGFARAMSIHTMVLTSIKGTPLYMSPELVEERPYDHT 180
Query: 183 ADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQ 242
ADLWS+G ILYELF+G PPFYT+S++ L+ IVKDPVK+P +SP FKSFL+GLL K P
Sbjct: 181 ADLWSVGCILYELFMGTPPFYTSSIFQLVSLIVKDPVKWPKAISPAFKSFLQGLLMKDPH 240
Query: 243 NRLTWSALLEHPFV 256
RL+W LL HPFV
Sbjct: 241 QRLSWPELLSHPFV 254
|
|
| UNIPROTKB|D4A8P3 Stk36 "Protein Stk36" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 916 (327.5 bits), Expect = 3.2e-111, Sum P(4) = 3.2e-111
Identities = 168/254 (66%), Positives = 213/254 (83%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
+E YHV+E++GEGSFG+VYKGR+KY+ Q VA+KFI K G+SEK++ NL++EIEI+R L H
Sbjct: 1 MEKYHVLEMIGEGSFGRVYKGRKKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLWH 60
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+ MLDSFE+ +E VVT++A+GELF+ILEDD LPEEQVQ+IA QLV AL+YLHS+R
Sbjct: 61 PNIVHMLDSFETDKEVVVVTDYAEGELFQILEDDGKLPEEQVQAIAAQLVSALYYLHSHR 120
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHT 182
I+HRDMKPQNIL+ G +KLCDFGFARAMS NT+VL SIKGTPLYM+PELV E+PY+HT
Sbjct: 121 ILHRDMKPQNILLAKGGGIKLCDFGFARAMSTNTMVLTSIKGTPLYMSPELVEERPYDHT 180
Query: 183 ADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQ 242
ADLWS+G ILYEL VG PPFYT S++ L+ I+KDPV++P ++ FK+FL+GLL K P+
Sbjct: 181 ADLWSVGCILYELAVGTPPFYTTSIFQLVSLILKDPVRWPSTITSCFKNFLQGLLTKDPR 240
Query: 243 NRLTWSALLEHPFV 256
RL+W LL HPF+
Sbjct: 241 QRLSWPDLLHHPFI 254
|
|
| UNIPROTKB|E1B793 STK36 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 931 (332.8 bits), Expect = 3.5e-107, Sum P(3) = 3.5e-107
Identities = 170/254 (66%), Positives = 215/254 (84%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
+E YHV+E++GEGSFG+VYKGRRKY+ Q VA+KFI K G+SEK++ NL++EIEI+R L+H
Sbjct: 1 MEKYHVLEMIGEGSFGRVYKGRRKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLRH 60
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+ MLDSFE+ +E VVT++A+GELF+ILEDD LPE+QVQ+IA QLV AL+YLHS+R
Sbjct: 61 PNIVHMLDSFETDKEVVVVTDYAEGELFQILEDDGKLPEDQVQAIAAQLVSALYYLHSHR 120
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHT 182
I+HRDMKPQNIL+ G +KLCDFGFARAMS NT+VL SIKGTPLYM+PELV E+PY+HT
Sbjct: 121 ILHRDMKPQNILLAKGGGIKLCDFGFARAMSTNTMVLTSIKGTPLYMSPELVEERPYDHT 180
Query: 183 ADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQ 242
ADLWS+G ILYEL VG PPFYT S++ L+ I+KDPV++P +SP FK+FL+GLL K P+
Sbjct: 181 ADLWSVGCILYELAVGTPPFYTTSIFQLVSLILKDPVRWPPTISPCFKNFLQGLLTKDPR 240
Query: 243 NRLTWSALLEHPFV 256
RL+W LL HPF+
Sbjct: 241 QRLSWPDLLHHPFI 254
|
|
| UNIPROTKB|E2RCC2 STK36 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 934 (333.8 bits), Expect = 2.5e-106, Sum P(3) = 2.5e-106
Identities = 171/254 (67%), Positives = 215/254 (84%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
+E YHV+E++GEGSFG+VYKGRRKY+ Q VA+KFI K G+SEK++ NL++EIEI+R L+H
Sbjct: 1 MEKYHVLEMIGEGSFGRVYKGRRKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLRH 60
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+ MLDSFE+ +E VVT++A+GELF+ILEDD LPE+QVQ+IA QLV AL+YLHS+R
Sbjct: 61 PNIVHMLDSFETDKEVVVVTDYAEGELFQILEDDGKLPEDQVQAIAAQLVSALYYLHSHR 120
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHT 182
I+HRDMKPQNIL+ G +KLCDFGFARAMS NT+VL SIKGTPLYM+PELV E+PY+HT
Sbjct: 121 ILHRDMKPQNILLAKGGGIKLCDFGFARAMSTNTMVLTSIKGTPLYMSPELVEERPYDHT 180
Query: 183 ADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQ 242
ADLWS+G ILYEL VG PPFYT S++ L+ I+KDPV++P +SP FKSFL+GLL K P+
Sbjct: 181 ADLWSVGCILYELAVGTPPFYTTSIFQLVSLILKDPVRWPTTISPCFKSFLQGLLTKDPR 240
Query: 243 NRLTWSALLEHPFV 256
RL+W LL HPF+
Sbjct: 241 QRLSWPDLLHHPFI 254
|
|
| UNIPROTKB|J9JHL2 STK36 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 934 (333.8 bits), Expect = 3.4e-106, Sum P(3) = 3.4e-106
Identities = 171/254 (67%), Positives = 215/254 (84%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
+E YHV+E++GEGSFG+VYKGRRKY+ Q VA+KFI K G+SEK++ NL++EIEI+R L+H
Sbjct: 1 MEKYHVLEMIGEGSFGRVYKGRRKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLRH 60
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+ MLDSFE+ +E VVT++A+GELF+ILEDD LPE+QVQ+IA QLV AL+YLHS+R
Sbjct: 61 PNIVHMLDSFETDKEVVVVTDYAEGELFQILEDDGKLPEDQVQAIAAQLVSALYYLHSHR 120
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHT 182
I+HRDMKPQNIL+ G +KLCDFGFARAMS NT+VL SIKGTPLYM+PELV E+PY+HT
Sbjct: 121 ILHRDMKPQNILLAKGGGIKLCDFGFARAMSTNTMVLTSIKGTPLYMSPELVEERPYDHT 180
Query: 183 ADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQ 242
ADLWS+G ILYEL VG PPFYT S++ L+ I+KDPV++P +SP FKSFL+GLL K P+
Sbjct: 181 ADLWSVGCILYELAVGTPPFYTTSIFQLVSLILKDPVRWPTTISPCFKSFLQGLLTKDPR 240
Query: 243 NRLTWSALLEHPFV 256
RL+W LL HPF+
Sbjct: 241 QRLSWPDLLHHPFI 254
|
|
| MGI|MGI:1920831 Stk36 "serine/threonine kinase 36" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 916 (327.5 bits), Expect = 2.7e-105, Sum P(4) = 2.7e-105
Identities = 168/254 (66%), Positives = 213/254 (83%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
+E YHV+E++GEGSFG+VYKGR+KY+ Q VA+KFI K G+SEK++ NL++EIEI+R L H
Sbjct: 1 MEKYHVLEMIGEGSFGRVYKGRKKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLWH 60
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+ MLDSFE+ +E VVT++A+GELF+ILEDD LPE+QVQ+IA QLV AL+YLHS+R
Sbjct: 61 PNIVHMLDSFETDKEVVVVTDYAEGELFQILEDDGKLPEDQVQAIAAQLVSALYYLHSHR 120
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHT 182
I+HRDMKPQNIL+ G +KLCDFGFARAMS NT+VL SIKGTPLYM+PELV E+PY+HT
Sbjct: 121 ILHRDMKPQNILLAKGGGIKLCDFGFARAMSTNTMVLTSIKGTPLYMSPELVEERPYDHT 180
Query: 183 ADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQ 242
ADLWS+G ILYEL VG PPFYT S++ L+ I+KDPV++P +S FK+FL+GLL K P+
Sbjct: 181 ADLWSVGCILYELAVGTPPFYTTSIFQLVSLILKDPVRWPSTISSCFKNFLQGLLTKDPR 240
Query: 243 NRLTWSALLEHPFV 256
RL+W LL HPF+
Sbjct: 241 QRLSWPDLLHHPFI 254
|
|
| UNIPROTKB|A8MU99 STK36 "Serine/threonine-protein kinase 36" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 925 (330.7 bits), Expect = 3.5e-104, Sum P(3) = 3.5e-104
Identities = 169/254 (66%), Positives = 214/254 (84%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
+E YHV+E++GEGSFG+VYKGRRKY+ Q VA+KFI K G+SEK++ NL++EIEI+R L+H
Sbjct: 1 MEKYHVLEMIGEGSFGRVYKGRRKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLRH 60
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+ MLDSFE+ +E VVT++A+GELF+ILEDD LPE+QVQ+IA QLV AL+YLHS+R
Sbjct: 61 PNIVHMLDSFETDKEVVVVTDYAEGELFQILEDDGKLPEDQVQAIAAQLVSALYYLHSHR 120
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHT 182
I+HRDMKPQNIL+ G +KLCDFGFARAMS NT+VL SIKGTPLYM+PELV E+PY+HT
Sbjct: 121 ILHRDMKPQNILLAKGGGIKLCDFGFARAMSTNTMVLTSIKGTPLYMSPELVEERPYDHT 180
Query: 183 ADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQ 242
ADLWS+G ILYEL VG PPFY S++ L+ I+KDPV++P +SP FK+FL+GLL K P+
Sbjct: 181 ADLWSVGCILYELAVGTPPFYATSIFQLVSLILKDPVRWPSTISPCFKNFLQGLLTKDPR 240
Query: 243 NRLTWSALLEHPFV 256
RL+W LL HPF+
Sbjct: 241 QRLSWPDLLYHPFI 254
|
|
| UNIPROTKB|Q9NRP7 STK36 "Serine/threonine-protein kinase 36" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 925 (330.7 bits), Expect = 1.2e-103, Sum P(3) = 1.2e-103
Identities = 169/254 (66%), Positives = 214/254 (84%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
+E YHV+E++GEGSFG+VYKGRRKY+ Q VA+KFI K G+SEK++ NL++EIEI+R L+H
Sbjct: 1 MEKYHVLEMIGEGSFGRVYKGRRKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLRH 60
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+ MLDSFE+ +E VVT++A+GELF+ILEDD LPE+QVQ+IA QLV AL+YLHS+R
Sbjct: 61 PNIVHMLDSFETDKEVVVVTDYAEGELFQILEDDGKLPEDQVQAIAAQLVSALYYLHSHR 120
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHT 182
I+HRDMKPQNIL+ G +KLCDFGFARAMS NT+VL SIKGTPLYM+PELV E+PY+HT
Sbjct: 121 ILHRDMKPQNILLAKGGGIKLCDFGFARAMSTNTMVLTSIKGTPLYMSPELVEERPYDHT 180
Query: 183 ADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQ 242
ADLWS+G ILYEL VG PPFY S++ L+ I+KDPV++P +SP FK+FL+GLL K P+
Sbjct: 181 ADLWSVGCILYELAVGTPPFYATSIFQLVSLILKDPVRWPSTISPCFKNFLQGLLTKDPR 240
Query: 243 NRLTWSALLEHPFV 256
RL+W LL HPF+
Sbjct: 241 QRLSWPDLLYHPFI 254
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q2QAV0 | TIO_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6505 | 0.9776 | 0.9924 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00014064001 | SubName- Full=Chromosome chr16 scaffold_10, whole genome shotgun sequence; (1350 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | GSVIVG00031645001 | SubName- Full=Chromosome chr5 scaffold_58, whole genome shotgun sequence; (1295 aa) | • | • | • | 0.417 | |||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1342 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-99 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-92 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-82 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-73 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-73 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-71 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-69 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-67 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-67 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-62 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-60 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-60 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-60 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-59 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-59 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-58 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-57 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-57 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-57 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-54 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-54 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-54 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-54 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-54 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-53 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-53 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-52 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-51 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-51 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-50 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-50 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-49 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-49 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-49 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-49 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-49 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-48 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-48 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-48 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-47 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-47 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-46 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-46 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-46 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-46 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-46 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-45 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-45 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-45 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-45 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-44 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-44 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-44 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-44 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-44 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-43 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-43 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-43 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-43 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-43 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-43 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-43 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-43 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-42 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-42 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-42 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-42 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-42 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-42 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-42 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-42 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-42 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-41 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-41 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-41 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-41 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-41 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-41 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-41 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-41 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-40 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-40 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-40 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-40 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-40 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-40 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-39 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-39 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-39 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-39 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-39 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-39 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-39 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-39 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-38 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-38 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-38 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-38 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-38 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-38 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-38 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-37 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-37 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-37 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-36 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-36 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-36 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-36 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-36 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-36 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-36 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-36 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-36 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-36 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-35 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-35 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-35 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-35 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-35 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-35 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-35 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-35 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-35 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-35 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-35 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-35 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-35 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-34 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-34 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-34 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-34 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-34 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-34 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-34 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-34 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-34 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-34 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-34 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-33 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-33 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-33 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-33 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-33 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-33 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-33 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-32 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-32 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-32 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-32 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-32 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-31 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-31 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-31 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-31 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-31 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-31 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-31 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-31 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-30 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-30 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-30 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-30 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-30 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-30 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-29 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-29 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-29 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-29 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-29 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-29 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-29 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-29 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-29 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-28 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-28 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-28 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-28 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-28 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-27 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-27 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-27 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-27 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-27 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-27 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-27 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-27 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-26 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-26 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-26 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-26 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-26 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-25 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-25 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-25 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-25 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-25 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-25 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-25 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-25 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-24 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-24 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-24 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-24 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-24 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-24 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-23 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-23 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-22 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-21 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-21 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-21 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-20 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-20 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-20 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-18 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-18 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-18 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-17 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-17 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-17 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-16 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-16 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-15 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-15 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-14 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-14 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-12 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-12 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-11 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-11 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-10 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-10 | |
| cd00020 | 120 | cd00020, ARM, Armadillo/beta-catenin-like repeats | 2e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-09 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| pfam13646 | 88 | pfam13646, HEAT_2, HEAT repeats | 7e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-06 | |
| cd00020 | 120 | cd00020, ARM, Armadillo/beta-catenin-like repeats | 2e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-05 | |
| cd00020 | 120 | cd00020, ARM, Armadillo/beta-catenin-like repeats | 2e-04 | |
| COG5064 | 526 | COG5064, SRP1, Karyopherin (importin) alpha [Intra | 0.001 | |
| COG1413 | 335 | COG1413, COG1413, FOG: HEAT repeat [Energy product | 0.002 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.002 | |
| pfam13513 | 55 | pfam13513, HEAT_EZ, HEAT-like repeat | 0.003 | |
| PRK10345 | 210 | PRK10345, PRK10345, hypothetical protein; Provisio | 0.003 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.004 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.004 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.004 | |
| PLN00181 | 793 | PLN00181, PLN00181, protein SPA1-RELATED; Provisio | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 317 bits (814), Expect = 2e-99
Identities = 111/256 (43%), Positives = 155/256 (60%), Gaps = 7/256 (2%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
Y ++E +GEGSFGKVY R K TG+ VA+K I K K +KD + +EI+IL+KLKH NI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKK-KIKKDRERILREIKILKKLKHPNI 59
Query: 66 IEMLDSFESPQEFCVVTEFA-QGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRII 124
+ + D FE + +V E+ G+LF++L+ L E++ + +Q++ AL YLHS I+
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIV 119
Query: 125 HRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTAD 184
HRD+KP+NIL+ VKL DFG AR + L + GTP YMAPE++ + Y D
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFVGTPEYMAPEVLLGKGYGKAVD 178
Query: 185 LWSLGVILYELFVGQPPFYT-NSVYALIRHIVKDPVKYPDEM---SPNFKSFLKGLLNKV 240
+WSLGVILYEL G+PPF + + L + I K +P SP K ++ LL K
Sbjct: 179 IWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKD 238
Query: 241 PQNRLTWSALLEHPFV 256
P+ RLT L+HPF
Sbjct: 239 PEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 296 bits (761), Expect = 7e-92
Identities = 107/260 (41%), Positives = 152/260 (58%), Gaps = 9/260 (3%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
Y ++ +G GSFG VYK + K TG+ VA+K + K + K R+EI ILR+L H NI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 66 IEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRII 124
+ ++D+FE +V E+ + G+LF+ L L E++ + IA Q++R L YLHSN II
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 125 HRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVRE-QPYNHTA 183
HRD+KP+NIL+ VVK+ DFG A+ + ++ L + GTP YMAPE++ Y
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKV 180
Query: 184 DLWSLGVILYELFVGQPPFY---TNSVYALIRHIVKDPVKYP----DEMSPNFKSFLKGL 236
D+WSLGVILYEL G+PPF LIR I+ P+++ S K +K
Sbjct: 181 DVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKC 240
Query: 237 LNKVPQNRLTWSALLEHPFV 256
LNK P R T +L+HP+
Sbjct: 241 LNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 268 bits (688), Expect = 7e-82
Identities = 100/258 (38%), Positives = 157/258 (60%), Gaps = 6/258 (2%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
Y +I+ +G+GSFGKVY RRK G+ +K I SEK+ + E++IL+KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 65 IIEMLDSFESPQEFCVVTEFA-QGELFEILEDDKC----LPEEQVQSIAKQLVRALHYLH 119
II+ +SFE + C+V E+A G+L + ++ K PEEQ+ QL AL YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
S +I+HRD+KPQNI + + +VKL DFG ++ +S+ + +++ GTP Y++PEL + +PY
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPY 180
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK-DPVKYPDEMSPNFKSFLKGLLN 238
N+ +D+WSLG +LYEL + PF ++ L I+K P + S ++ + LL
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQ 240
Query: 239 KVPQNRLTWSALLEHPFV 256
K P+ R + + +L+ PF+
Sbjct: 241 KDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 244 bits (625), Expect = 2e-73
Identities = 96/249 (38%), Positives = 147/249 (59%), Gaps = 5/249 (2%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEILRKLKHQNIIEMLD 70
+G+GSFGKV R+K TG+ AMK + K K++ + E IL ++ H I+++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 71 SFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMK 129
+F++ ++ +V E+A GELF L + EE+ + A ++V AL YLHS II+RD+K
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 130 PQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLG 189
P+NIL+ A +KL DFG A+ +S+ + GTP Y+APE++ + Y D WSLG
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLG 180
Query: 190 VILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTW-- 247
V+LYE+ G+PPFY + I+KDP+++P+ +SP + + GLL K P RL
Sbjct: 181 VLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240
Query: 248 -SALLEHPF 255
+ HPF
Sbjct: 241 AEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 244 bits (624), Expect = 4e-73
Identities = 94/260 (36%), Positives = 145/260 (55%), Gaps = 8/260 (3%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
+ EL+G GSFG VY K TG+ +A+K + G SE+++ L +EI IL L+H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 65 IIEMLDSFESPQE--FCVVTEFA-QGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
I+ S ++ + E+ G L +L+ LPE ++ +Q++ L YLHSN
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAM--SANTVVLRSIKGTPLYMAPELVREQPY 179
I+HRD+K NIL+ + VVKL DFG A+ + S++GTP +MAPE++R + Y
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 180 NHTADLWSLGVILYELFVGQPPFY-TNSVYALIRHI--VKDPVKYPDEMSPNFKSFLKGL 236
AD+WSLG + E+ G+PP+ + A + I +P + P+ +S K FL+
Sbjct: 181 GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKC 240
Query: 237 LNKVPQNRLTWSALLEHPFV 256
L + P+ R T LL+HPF+
Sbjct: 241 LRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 236 bits (604), Expect = 5e-71
Identities = 92/247 (37%), Positives = 141/247 (57%), Gaps = 36/247 (14%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDS 71
+GEG FG VY R K TG+ VA+K I+K S + L +EIEIL+KL H NI+++
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIK-IIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 72 FESPQEFCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMK 129
FE +V E+ + G L ++L++ + L E+++ I Q++ L YLHSN IIHRD+K
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119
Query: 130 PQNILIGAGS-VVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQP-YNHTADLWS 187
P+NIL+ + + VKL DFG ++ ++++ +L++I GTP YMAPE++ + Y+ +D+WS
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 188 LGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTW 247
LGVILYEL P K ++ +L K P+ R +
Sbjct: 180 LGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPSA 208
Query: 248 SALLEHP 254
+LEH
Sbjct: 209 KEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 3e-69
Identities = 101/255 (39%), Positives = 155/255 (60%), Gaps = 8/255 (3%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
+ ++E +G+G FG+VYK R K TG+ VA+K ++K +S++ + EI+IL+K KH NI
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIK-VIKL-ESKEKKEKIINEIQILKKCKHPNI 59
Query: 66 IEMLDSFESPQEFCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRI 123
++ S+ E +V EF G L ++L+ ++ L E Q+ + K+L++ L YLHSN I
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI 119
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTA 183
IHRD+K NIL+ + VKL DFG + +S +T ++ GTP +MAPE++ +PY++ A
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 184 DLWSLGVILYELFVGQPPFY-TNSVYALIRHIVKDPVKYPD--EMSPNFKSFLKGLLNKV 240
D+WSLG+ EL G+PP+ + AL + P + + S FK FLK L K
Sbjct: 179 DIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKN 238
Query: 241 PQNRLTWSALLEHPF 255
P+ R T LL+HPF
Sbjct: 239 PEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 227 bits (582), Expect = 1e-67
Identities = 98/255 (38%), Positives = 145/255 (56%), Gaps = 4/255 (1%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
NY + +L+G G+FG VYKG TG VA+K I E+ + ++ QEI++L+ LKH N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 65 IIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRI 123
I++ + S E+ ++ E+A+ G L +I++ PE V Q+++ L YLH +
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTA 183
IHRD+K NIL VVKL DFG A ++ + S+ GTP +MAPE++ + +
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTAS 180
Query: 184 DLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKDPVKY-PDEMSPNFKSFLKGLLNKVP 241
D+WSLG + EL G PP+Y N + AL R IV+D P+ +SP K FL K P
Sbjct: 181 DIWSLGCTVIELLTGNPPYYDLNPMAALFR-IVQDDHPPLPEGISPELKDFLMQCFQKDP 239
Query: 242 QNRLTWSALLEHPFV 256
R T LL+HP++
Sbjct: 240 NLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 227 bits (580), Expect = 8e-67
Identities = 94/259 (36%), Positives = 146/259 (56%), Gaps = 8/259 (3%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E Y +E +GEG+ G+VYK + TG+ VA+K M+ K ++ + EI I++ KH
Sbjct: 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIK-KMRLRK--QNKELIINEILIMKDCKHP 75
Query: 64 NIIEMLDSFESPQEFCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSN 121
NI++ DS+ E VV E+ G L +I+ + E Q+ + +++++ L YLHS
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNH 181
+IHRD+K NIL+ VKL DFGFA ++ S+ GTP +MAPE+++ + Y
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP 195
Query: 182 TADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PVKYPDEMSPNFKSFLKGLLN 238
D+WSLG++ E+ G+PP+ + I P+K P++ SP FK FL L
Sbjct: 196 KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV 255
Query: 239 KVPQNRLTWSALLEHPFVK 257
K P+ R + LL+HPF+K
Sbjct: 256 KDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 211 bits (540), Expect = 9e-62
Identities = 87/256 (33%), Positives = 142/256 (55%), Gaps = 10/256 (3%)
Query: 13 GEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDI-HNLRQEIEILRKLKHQNIIEMLDS 71
G+GS G VYK R K TG+ A+K I H +++ L +E++ LR + +++ +
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 72 FESPQEFCVVTEFA-QGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR-IIHRDMK 129
F E +V E+ G L ++L+ +PE + IA+Q+++ L YLH+ R IIHRD+K
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIK 127
Query: 130 PQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLG 189
P N+LI + VK+ DFG ++ + + GT YM+PE ++ + Y++ AD+WSLG
Sbjct: 128 PSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLG 187
Query: 190 VILYELFVGQPPFY---TNSVYALIRHIVKDPVKYPDE--MSPNFKSFLKGLLNKVPQNR 244
+ L E +G+ PF S + L++ I P SP F+ F+ L K P+ R
Sbjct: 188 LTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKR 247
Query: 245 LTWSALLEHPFVKETS 260
+ + LL+HPF+K+
Sbjct: 248 PSAAELLQHPFIKKAD 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 1e-60
Identities = 88/283 (31%), Positives = 144/283 (50%), Gaps = 35/283 (12%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMK-----FIMKHGKSEKDIHNLRQEIEILR 58
+++ +++GEGSF V + K T + A+K ++K K K + E E+L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK-VKYVKI---EKEVLT 56
Query: 59 KLK-HQNIIEMLDSFESPQEFCVVTEFA-QGELFEILEDDKCLPEEQVQSIAKQLVRALH 116
+L H II++ +F+ + V E+A GEL + + L E+ + A +++ AL
Sbjct: 57 RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL----------------- 159
YLHS IIHRD+KP+NIL+ +K+ DFG A+ + N+
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 160 ---RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK 216
S GT Y++PEL+ E+P ++DLW+LG I+Y++ G+PPF ++ Y + I+K
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK 236
Query: 217 DPVKYPDEMSPNFKSFLKGLLNKVPQNRLT----WSALLEHPF 255
+P P+ K ++ LL PQ+RL + L HPF
Sbjct: 237 LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 2e-60
Identities = 95/263 (36%), Positives = 152/263 (57%), Gaps = 19/263 (7%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E + ++E +GEGS+G VYK K TGQ VA+K + E+D+ + +EI IL++
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV----PVEEDLQEIIKEISILKQCDSP 58
Query: 64 NIIEMLDSFESPQEFCVVTEF-AQGELFEILE-DDKCLPEEQVQSIAKQLVRALHYLHSN 121
I++ S+ + +V E+ G + +I++ +K L EE++ +I Q ++ L YLHSN
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMS-----ANTVVLRSIKGTPLYMAPELVRE 176
+ IHRD+K NIL+ KL DFG + ++ NTV+ GTP +MAPE+++E
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-----GTPFWMAPEVIQE 173
Query: 177 QPYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKDP--VKYPDEMSPNFKSFL 233
YN+ AD+WSLG+ E+ G+PP+ + + A+ K P + P++ SP F F+
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV 233
Query: 234 KGLLNKVPQNRLTWSALLEHPFV 256
K L K P+ R + LL+HPF+
Sbjct: 234 KKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 208 bits (531), Expect = 4e-60
Identities = 83/249 (33%), Positives = 138/249 (55%), Gaps = 15/249 (6%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQ------EIEIL 57
+++ I+ +G GSFG+V R K +G+ A+K I+ K I L+Q E IL
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALK-ILSKAK----IVKLKQVEHVLNEKRIL 55
Query: 58 RKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALH 116
+ ++H ++ + SF+ +V E+ GELF L PE + A Q+V AL
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE 115
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVRE 176
YLHS I++RD+KP+N+L+ + +K+ DFGFA+ + T ++ GTP Y+APE++
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT---YTLCGTPEYLAPEIILS 172
Query: 177 QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGL 236
+ Y D W+LG+++YE+ G PPF+ ++ + I++ V++P SP+ K ++ L
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNL 232
Query: 237 LNKVPQNRL 245
L RL
Sbjct: 233 LQVDLTKRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 206 bits (525), Expect = 2e-59
Identities = 102/289 (35%), Positives = 154/289 (53%), Gaps = 39/289 (13%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHN--LRQEIEILRKLK 61
Y V+ +VGEG++G V K R K TG+ VA+K K + ++D+ LR E+++LR+L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIK-KFKESEDDEDVKKTALR-EVKVLRQLR 58
Query: 62 HQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKC-LPEEQVQSIAKQLVRALHYLHS 120
H+NI+ + ++F +V E+ + L E+LE LP + V+S QL++A+ Y HS
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN-TVVLRSIKGTPLYMAPE-LVREQP 178
+ IIHRD+KP+NIL+ V+KLCDFGFARA+ A L T Y APE LV +
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 179 YNHTADLWSLGVILYELFVGQP--P-------------------------FYTNSVYALI 211
Y D+W++G I+ EL G+P P F +N +A +
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238
Query: 212 RHI---VKDPV--KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPF 255
+ + +YP ++S FLK L P+ RLT LL+HP+
Sbjct: 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 3e-59
Identities = 98/290 (33%), Positives = 145/290 (50%), Gaps = 49/290 (16%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD---IHNLRQEIEILRKLKH 62
Y +E +GEG++G VYK R K TG+ VA+K I +E++ LR EI +L++LKH
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALR-EISLLKELKH 57
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSN 121
NI+++LD + ++ +V E+ +L + L+ L ++SI QL+R L Y HS+
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARA----MSANT--VVLRSIKGTPLYMAPE-LV 174
RI+HRD+KPQNILI V+KL DFG ARA + T VV T Y APE L+
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV------TLWYRAPEILL 171
Query: 175 REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK-----DPVKYPD-----E 224
+ Y+ D+WS+G I E+ G+P F +S + I + +P +
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231
Query: 225 MSPNFKSFLKGLLNKV-------------------PQNRLTWSALLEHPF 255
P F F L KV P R++ L+HP+
Sbjct: 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 1e-58
Identities = 86/259 (33%), Positives = 143/259 (55%), Gaps = 15/259 (5%)
Query: 15 GSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD-IHNLRQEIEILRKLKHQNIIEMLDSFE 73
G++G+V+ ++K TG A+K I K K+ + + E +IL + + ++++ SF+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 74 SPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQN 132
+ +V E+ G+L +LE+ L E+ + ++V AL YLHSN IIHRD+KP N
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123
Query: 133 ILIGAGSVVKLCDFGFARA--------MSANTVVLRSIKGTPLYMAPELVREQPYNHTAD 184
ILI + +KL DFG ++ ++ + + I GTP Y+APE++ Q ++ T D
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVD 183
Query: 185 LWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPD--EMSPNFKSFLKGLLNKVPQ 242
WSLG ILYE VG PPF+ + + ++I+ +++P+ E+S + LL P+
Sbjct: 184 WWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPE 243
Query: 243 NRLTWSALLE---HPFVKE 258
RL ++ E HPF K
Sbjct: 244 KRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 1e-57
Identities = 86/259 (33%), Positives = 138/259 (53%), Gaps = 13/259 (5%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFI-MKHGKSEKDIHNLRQEIEILRKLKHQN 64
+ ++E +G+GSFG+VYK K T Q VA+K I ++ +E +I +++QEI+ L + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPY 60
Query: 65 IIEMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRI 123
I + SF + ++ E+ G ++L+ K L E + I ++++ L YLH
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHEEGK 119
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTA 183
IHRD+K NIL+ VKL DFG + +++ + GTP +MAPE++++ Y+ A
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKA 179
Query: 184 DLWSLGVILYELFVGQPPFYTNSVY----ALIRHIVKDPVKYPDEM-SPNFKSFLKGLLN 238
D+WSLG+ EL G+PP S L +P S FK F+ LN
Sbjct: 180 DIWSLGITAIELAKGEPP---LSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLN 236
Query: 239 KVPQNRLTWSALLEHPFVK 257
K P+ R + LL+H F+K
Sbjct: 237 KDPKERPSAKELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 1e-57
Identities = 89/269 (33%), Positives = 136/269 (50%), Gaps = 23/269 (8%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
Y V+E +G+GSFG V K RRK G+ + K I +EK+ L E+ ILR+LKH NI
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 66 IEMLDSFESPQ--------EFCVVTEFAQGELFEIL----EDDKCLPEEQVQSIAKQLVR 113
+ D E+C G+L +++ ++ K + EE + I QL+
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYC-----EGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 114 ALHYLH-----SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLY 168
AL+ H N ++HRD+KP NI + A + VKL DFG A+ + ++ ++ GTP Y
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYY 176
Query: 169 MAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV-KYPDEMSP 227
M+PE + Y+ +D+WSLG ++YEL PPF + L I + + P S
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236
Query: 228 NFKSFLKGLLNKVPQNRLTWSALLEHPFV 256
+K +LN P R + LL+ P +
Sbjct: 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 2e-57
Identities = 88/254 (34%), Positives = 130/254 (51%), Gaps = 8/254 (3%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMK---FIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
EL+G GSFG VY+G G A+K ++ + L QEI +L KL+H NI+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 67 EMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIH 125
+ L + + E G L ++L+ PE ++ +Q++ L YLH +H
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125
Query: 126 RDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQ-PYNHTAD 184
RD+K NIL+ VVKL DFG A+ + +S KG+P +MAPE++ +Q Y AD
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVVEF-SFAKSFKGSPYWMAPEVIAQQGGYGLAAD 184
Query: 185 LWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV--KYPDEMSPNFKSFLKGLLNKVPQ 242
+WSLG + E+ G+PP+ A + I + PD +S K F+ L + P
Sbjct: 185 IWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPS 244
Query: 243 NRLTWSALLEHPFV 256
R T + LLEHPFV
Sbjct: 245 LRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 2e-54
Identities = 88/256 (34%), Positives = 138/256 (53%), Gaps = 8/256 (3%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
++ ++ +G+GSFG V+K RK + AMK I + ++ E +L KL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 65 IIEMLDSFESPQEFCVVTEFAQ-GELFEIL--EDDKCLPEEQVQSIAKQLVRALHYLHSN 121
II +SF + +V E+A+ G+L ++L + + LPE+QV Q++ L +LHS
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNH 181
+I+HRD+K N+ + A VK+ D G A+ +S NT +I GTP Y++PEL ++PYN
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 182 TADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK---DPVKYPDEMSPNFKSFLKGLLN 238
+D+W+LGV+LYE G+ PF N+ ALI I++ PV S + L
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV--SQMYSQQLAQLIDQCLT 238
Query: 239 KVPQNRLTWSALLEHP 254
K + R LL +P
Sbjct: 239 KDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 191 bits (486), Expect = 2e-54
Identities = 94/265 (35%), Positives = 143/265 (53%), Gaps = 20/265 (7%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMK----FIMKHGKSEKDIHNLRQEIEILR 58
+ N+ + + +G+G F VYK G+ VA+K F M K+ +D +EI++L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDC---LKEIDLLK 57
Query: 59 KLKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEIL----EDDKCLPEEQVQSIAKQLVR 113
+L H N+I+ L SF E +V E A G+L ++ + + +PE + QL
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 114 ALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPEL 173
AL ++HS RI+HRD+KP N+ I A VVKL D G R S+ T S+ GTP YM+PE
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 174 VREQPYNHTADLWSLGVILYELFVGQPPFYTN--SVYALIRHIVKDPVKYP----DEMSP 227
+ E YN +D+WSLG +LYE+ Q PFY + ++Y+L + I K YP D S
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK--CDYPPLPADHYSE 235
Query: 228 NFKSFLKGLLNKVPQNRLTWSALLE 252
+ + +N P+ R S +L+
Sbjct: 236 ELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 3e-54
Identities = 78/241 (32%), Positives = 129/241 (53%), Gaps = 9/241 (3%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIH-NLRQEIEILRKLKHQNIIEMLD 70
+G G FG+V + K +T A+K + K E ++ E EIL + H I+++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 71 SFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMK 129
+F+ + ++ E+ G EL+ IL D E + +V A YLH+ II+RD+K
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 130 PQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLG 189
P+N+L+ + VKL DFGFA+ + + + GTP Y+APE++ + Y+ + D WSLG
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLK-SGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLG 179
Query: 190 VILYELFVGQPPFYTNSV---YALIRHIVK--DPVKYPDEMSPNFKSFLKGLLNKVPQNR 244
++LYEL G+PPF + I+K +++P+ + K +K LL + P+ R
Sbjct: 180 ILLYELLTGRPPF-GEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238
Query: 245 L 245
L
Sbjct: 239 L 239
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 4e-54
Identities = 99/269 (36%), Positives = 164/269 (60%), Gaps = 14/269 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ + +I +G+G+FGKVYK + K TG A K I +SE+++ + EI+IL + KH
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHP 62
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGELFE--ILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
NI+ + +++ + ++ EF G + +LE ++ L E Q++ + +Q++ AL++LHS+
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR-SIKGTPLYMAPELV-----R 175
++IHRD+K NIL+ VKL DFG + A + +T+ R + GTP +MAPE+V +
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVS-AKNKSTLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 176 EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK-DPVKY--PDEMSPNFKSF 232
+ PY++ AD+WSLG+ L EL +PP + + ++ I+K +P P + S +F F
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDF 241
Query: 233 LKGLLNKVPQNRLTWSALLEHPFVKETSD 261
LK L K P +R T + LL+HPFV + SD
Sbjct: 242 LKSCLVKDPDDRPTAAELLKHPFVSDQSD 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 9e-54
Identities = 106/278 (38%), Positives = 161/278 (57%), Gaps = 14/278 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E + +I +G+G+FGKVYK + K TG A K I KSE+++ + EIEIL H
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYMVEIEILATCNHP 69
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGELFE--ILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
I+++L +F + ++ EF G + +LE D+ L E Q+Q I +Q++ AL YLHS
Sbjct: 70 YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM 129
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR-SIKGTPLYMAPELV-----R 175
+IIHRD+K N+L+ +KL DFG + A + T+ R S GTP +MAPE+V +
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVS-AKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 176 EQPYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKDP--VKYPDEMSPNFKSF 232
+ PY++ AD+WSLG+ L E+ +PP + N + L++ +P + P + S F+ F
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF 248
Query: 233 LKGLLNKVPQNRLTWSALLEHPFVKETSDELNAWELRA 270
LK L+K P+ R + + LLEHPFV + EL A
Sbjct: 249 LKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRELVA 286
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 191 bits (485), Expect = 3e-53
Identities = 108/382 (28%), Positives = 176/382 (46%), Gaps = 43/382 (11%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNL-RQEIEILRKLKHQ 63
+Y ++ +GEGSFG+VY R + + VA+K + K +S+ +EI+IL L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 64 -NIIEMLDSFESPQEFCVVTEFAQG----ELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
NI+++ D F+ +V E+ G +L + + L E + I Q++ AL YL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 119 HSNRIIHRDMKPQNILIGA-GSVVKLCDFGFARAM------SANTVVLRSIKGTPLYMAP 171
HS IIHRD+KP+NIL+ G VVKL DFG A+ + S+ + + GTP YMAP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 172 ELVR---EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK------------ 216
E++ + ++D+WSLG+ LYEL G PPF + +K
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 217 -DPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDELNAWELRATSVEA 275
P+ +S LK LL K P+NRL+ S+ L H + + +
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPD-- 295
Query: 276 RGCNATWTAEGNAIQSSSGKSNSPAVSANNTSPSLHTDVELNSSNTSQSNSSPCEAFPGF 335
+ ++ S S +S+ N+ +D++L+ SN S+ + +
Sbjct: 296 ---------DSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPH 346
Query: 336 SSPNNVKPSGSQALNRLENNSR 357
+S + + + S + L S
Sbjct: 347 NSSSLLLSTASSKRSSLPKISA 368
|
Length = 384 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 6e-53
Identities = 92/265 (34%), Positives = 137/265 (51%), Gaps = 28/265 (10%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII----- 66
+G G+FGKVY TG+ +A+K I K I + E+++L LKH N++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 67 ----EMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
E + F E+C + G L E+LE + L E ++ QL+ L YLHS+
Sbjct: 68 EVHREKVYIF---MEYC-----SGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR----SIKGTPLYMAPELVREQP 178
I+HRD+KP NI + V+KL DFG A + NT + S+ GTP YMAPE++
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 179 YNH---TADLWSLGVILYELFVGQPPFYT-NSVYALIRHI-VKDPVKYPD--EMSPNFKS 231
AD+WSLG ++ E+ G+ P+ ++ + ++ H+ PD ++SP K
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239
Query: 232 FLKGLLNKVPQNRLTWSALLEHPFV 256
FL L P+ R T S LL+HPFV
Sbjct: 240 FLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 8e-52
Identities = 89/256 (34%), Positives = 143/256 (55%), Gaps = 11/256 (4%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKF--IMKHGKSEKDIHNLRQEIEILRKLKHQNIIEML 69
+GEGS G V K TG+ VA+K + K + E L E+ I+R +H NI+EM
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL----LFNEVVIMRDYQHPNIVEMY 82
Query: 70 DSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDM 128
S+ E VV EF +G L +I+ + + EEQ+ ++ +++AL +LH+ +IHRD+
Sbjct: 83 SSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLAVLKALSFLHAQGVIHRDI 141
Query: 129 KPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSL 188
K +IL+ + VKL DFGF +S +S+ GTP +MAPE++ PY D+WSL
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSL 201
Query: 189 GVILYELFVGQPPFYTNSVYALIRHIVKDP---VKYPDEMSPNFKSFLKGLLNKVPQNRL 245
G+++ E+ G+PP++ ++ I + +K ++SP +SFL +L + P R
Sbjct: 202 GIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRA 261
Query: 246 TWSALLEHPFVKETSD 261
T + LL HPF+ +
Sbjct: 262 TAAELLNHPFLAKAGP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 1e-51
Identities = 88/258 (34%), Positives = 134/258 (51%), Gaps = 8/258 (3%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD-IHNLRQEIEILRKLKHQ 63
++ ++ ++G+G+FGKV +++ T + AMK++ K EK + N+ E IL++L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 64 NIIEMLDSFESPQE-FCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
++ + SF+ + + VV G+L L EEQV+ ++V AL YLHS
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHT 182
IIHRD+KP NIL+ V + DF A ++ +T + S GTP YMAPE++ Q Y+
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCRQGYSVA 179
Query: 183 ADLWSLGVILYELFVGQPPFY--TNSVYALIRHI-VKDPVKYPDEMSPNFKSFLKGLLNK 239
D WSLGV YE G+ P+ + ++ IR V YP S + LL +
Sbjct: 180 VDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLER 239
Query: 240 VPQNRL--TWSALLEHPF 255
PQ RL L HP+
Sbjct: 240 DPQKRLGDNLKDLKNHPY 257
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 5e-51
Identities = 104/270 (38%), Positives = 157/270 (58%), Gaps = 14/270 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E + +I +G+G+FGKVYK + K TG A K I KSE+++ + EI+IL H
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI--DTKSEEELEDYMVEIDILASCDHP 62
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGELFE--ILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
NI+++LD+F ++ EF G + +LE ++ L E Q++ + KQ + AL+YLH N
Sbjct: 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN 122
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR-SIKGTPLYMAPELV-----R 175
+IIHRD+K NIL +KL DFG + A + T+ R S GTP +MAPE+V +
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVS-AKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 176 EQPYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKDP--VKYPDEMSPNFKSF 232
++PY++ AD+WSLG+ L E+ +PP + N + L++ +P + P S FK F
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241
Query: 233 LKGLLNKVPQNRLTWSALLEHPFVKETSDE 262
LK L K R T + LL+HPFV S++
Sbjct: 242 LKKCLEKNVDARWTTTQLLQHPFVTVNSNK 271
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 5e-50
Identities = 102/281 (36%), Positives = 154/281 (54%), Gaps = 43/281 (15%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQN 64
+ ++E++GEG++GKVYK R K TGQ VA+K IM + E++ +++E ILRK H N
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEE--EIKEEYNILRKYSNHPN 64
Query: 65 IIEMLDSF--ESPQ----------EFC---VVTEFAQGELFEILEDDKCLPEEQVQSIAK 109
I +F ++P E C VT+ +G + + K L EE + I +
Sbjct: 65 IATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKG----LRKKGKRLKEEWIAYILR 120
Query: 110 QLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA-----NTVVLRSIKG 164
+ +R L YLH N++IHRD+K QNIL+ + VKL DFG + + + NT + G
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-----G 175
Query: 165 TPLYMAPELV--REQP---YNHTADLWSLGVILYELFVGQPPFY-TNSVYALIRHIVKDP 218
TP +MAPE++ EQP Y+ +D+WSLG+ EL G+PP + + AL + I ++P
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK-IPRNP 234
Query: 219 ---VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256
+K P+ S F F+ L K + R LLEHPF+
Sbjct: 235 PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 179 bits (454), Expect = 5e-50
Identities = 90/252 (35%), Positives = 150/252 (59%), Gaps = 5/252 (1%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDS 71
+GEGS G V R K++G+ VA+K + + +++ L E+ I+R +HQN++EM S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRDYQHQNVVEMYKS 86
Query: 72 FESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQ 131
+ +E V+ EF QG + L EEQ+ ++ + +++AL YLHS +IHRD+K
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSD 146
Query: 132 NILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVI 191
+IL+ VKL DFGF +S + +S+ GTP +MAPE++ PY D+WSLG++
Sbjct: 147 SILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIM 206
Query: 192 LYELFVGQPPFYTNSVYALIRHIVKDP---VKYPDEMSPNFKSFLKGLLNKVPQNRLTWS 248
+ E+ G+PP++++S ++ + P +K ++SP + FL+ +L + PQ R T
Sbjct: 207 VIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQ 266
Query: 249 ALLEHPFVKETS 260
LL+HPF+ +T
Sbjct: 267 ELLDHPFLLQTG 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 1e-49
Identities = 88/286 (30%), Positives = 140/286 (48%), Gaps = 40/286 (13%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIH---NLRQEIEILRKLKH 62
Y + +GEG++G VYK R K TG+ VA+K I + E + LR EI++L++L H
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKL--RFESEGIPKTALR-EIKLLKELNH 57
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSN 121
NII++LD F + +V EF +L+++++D + LPE ++S QL++ L + HS+
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE-LVREQPYN 180
I+HRD+KP+N+LI V+KL DFG AR+ + T Y APE L+ ++ Y+
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 181 HTADLWSLGVILYELFVGQPPF----YTNSVYALIRHIVKDPVK--------YPDEMSPN 228
D+WS+G I EL +P F + ++ I + P +
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF-KIFRTLGTPDPEVWPKFTSLARNYKFS 236
Query: 229 FKSF-------------------LKGLLNKVPQNRLTWSALLEHPF 255
F L +L+ P R+T L HP+
Sbjct: 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 1e-49
Identities = 88/274 (32%), Positives = 137/274 (50%), Gaps = 23/274 (8%)
Query: 11 LVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEIL----RKL----KH 62
++G+GSFGKV K T + A+K ++K KD+ ++E R L KH
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVK-VLK-----KDVILQDDDVECTMTEKRVLALAGKH 55
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGE--LFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
+ ++ F++ V E+ G +F I + E + + A ++V L +LH
Sbjct: 56 PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR-FDEPRARFYAAEIVLGLQFLHE 114
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
II+RD+K N+L+ + +K+ DFG + V + GTP Y+APE++ QPY
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
D W+LGV+LYE+ GQ PF + L + I++D V+YP +S KS LK L K
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKN 234
Query: 241 PQNRLTWS-----ALLEHPFVKETS-DELNAWEL 268
P+ RL + HPF +E D+L E+
Sbjct: 235 PEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEI 268
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 2e-49
Identities = 86/260 (33%), Positives = 146/260 (56%), Gaps = 12/260 (4%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
++ V++ +G+GS+G VYK +R Q A+K + S+K+ + EI IL + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 65 IIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKC----LPEEQVQSIAKQLVRALHYLH 119
II ++F + C+V E+A G+L + + K +PE+++ I QL+R L LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
+I+HRD+K NIL+ A +VK+ D G ++ + N + ++ GTP YMAPE+ + +PY
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPY 178
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK---DPVKYPDEMSPNFKSFLKGL 236
++ +D+WSLG +LYE+ PPF S+ L + + P+ P S + ++F++ +
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI--PPIYSQDLQNFIRSM 236
Query: 237 LNKVPQNRLTWSALLEHPFV 256
L P+ R +L P V
Sbjct: 237 LQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 6e-49
Identities = 88/265 (33%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E+Y +I+ +G G++G VYK R TG+ VA+K ++K + D ++QEI +L++ +H
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIK-VIKLEPGD-DFEIIQQEISMLKECRHP 60
Query: 64 NIIEMLDSFESPQEFCVVTEFAQG----ELFEILEDDKCLPEEQVQSIAKQLVRALHYLH 119
NI+ S+ + +V E+ G +++++ L E Q+ + ++ ++ L YLH
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP--LSELQIAYVCRETLKGLAYLH 118
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR-SIKGTPLYMAPELV---R 175
IHRD+K NIL+ VKL DFG + A T+ R S GTP +MAPE+ R
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVS-AQLTATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 176 EQPYNHTADLWSLGVILYELFVGQPPFY----TNSVYALIRHIVKDP-VKYPDEMSPNFK 230
+ Y+ D+W+LG+ EL QPP + +++ + + P +K ++ SP F
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237
Query: 231 SFLKGLLNKVPQNRLTWSALLEHPF 255
F+K L K P+ R T + LL+HPF
Sbjct: 238 DFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 9e-49
Identities = 94/291 (32%), Positives = 134/291 (46%), Gaps = 41/291 (14%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFI----MKHGKSEKDIHNLRQEIEILRKL 60
Y + +GEG++ VYK R K TG+ VA+K I K K + LR EI++L++L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQEL 59
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLP--EEQVQSIAKQLVRALHYL 118
KH NII +LD F +V EF + +L E + DK + ++S +R L YL
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFMETDL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELV---R 175
HSN I+HRD+KP N+LI + V+KL DFG AR+ + + T Y APEL+ R
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGAR 178
Query: 176 EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHI-----------------VKDP 218
Y D+WS+G I EL + P +S + I + D
Sbjct: 179 H--YGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY 236
Query: 219 VKYPDEMSPNFKS-----------FLKGLLNKVPQNRLTWSALLEHPFVKE 258
V++ K L+ LL P R+T LEHP+
Sbjct: 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 4e-48
Identities = 81/218 (37%), Positives = 115/218 (52%), Gaps = 37/218 (16%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMK-FIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
Y I +GEG++G+VYK R K TG+ VA+K M++ K I +R EI++L+KL+H N
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPN 59
Query: 65 IIEMLDSFESPQEFCVVTEFAQGELFEILE----------DDKCLP--EEQVQSIAKQLV 112
I+ + +VT +G ++ + E D + E Q++ KQL+
Sbjct: 60 IVRLK---------EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLL 110
Query: 113 RALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA-------NTVVLRSIKGT 165
L YLHSN I+HRD+K NILI V+KL DFG AR + N V+ T
Sbjct: 111 EGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI------T 164
Query: 166 PLYMAPE-LVREQPYNHTADLWSLGVILYELFVGQPPF 202
Y PE L+ Y D+WS+G IL ELF+G+P F
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 5e-48
Identities = 83/261 (31%), Positives = 145/261 (55%), Gaps = 7/261 (2%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH--- 62
Y +EL+G G++G VY+G+ TG+ VA+K I+ + D+ ++++E+ +L +L+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALK-IINLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI + S+ ++ E+A+G L + E+ + I ++++ AL Y+H
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVG 121
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVRE-QPYNH 181
+IHRD+K NIL+ VKLCDFG A ++ N+ + GTP +MAPE++ E + Y+
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDT 181
Query: 182 TADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-PVKYPD-EMSPNFKSFLKGLLNK 239
AD+WSLG+ +YE+ G PP+ + + I K P + D S + F+ L++
Sbjct: 182 KADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDE 241
Query: 240 VPQNRLTWSALLEHPFVKETS 260
P+ RL+ LL+ ++K S
Sbjct: 242 EPKERLSAEELLKSKWIKAHS 262
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 9e-48
Identities = 88/254 (34%), Positives = 141/254 (55%), Gaps = 5/254 (1%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEILRKLKHQNIIEMLD 70
+G+GSFGKV + R++ T + A+K I K H S ++ + E +L ++ I+ +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 71 SFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMK 129
SF+SP++ +V F G ELF L+ + + + +L+ AL LH +I+RD+K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 130 PQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLG 189
P+NIL+ + LCDFG + + + GTP Y+APEL+ Y D W+LG
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLG 180
Query: 190 VILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSA 249
V+LYE+ G PPFY +V + R I+++P+++PD + K L GLL++ P RL ++
Sbjct: 181 VLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNG 240
Query: 250 LLE---HPFVKETS 260
E HPF + S
Sbjct: 241 AQEIKNHPFFSQLS 254
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 3e-47
Identities = 95/289 (32%), Positives = 147/289 (50%), Gaps = 41/289 (14%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLR---QEIEILRKL 60
E Y + LVGEGS+G V K + K TGQ VA+K K +SE D + +EI +L++L
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIK---KFLESEDDKMVKKIAMREIRMLKQL 57
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLH 119
+H+N++ +++ F + +V EF + + LE L E +V+ Q++R + + H
Sbjct: 58 RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPEL-VREQP 178
S+ IIHRD+KP+NIL+ VVKLCDFGFAR ++A V T Y APEL V +
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 179 YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIV---------------KDPV---- 219
Y D+W++G ++ E+ G+P F +S + HI+ K+P+
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 220 -------------KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPF 255
++P ++S K L P +R + S LL H F
Sbjct: 238 RLPEVKEIEPLEKRFP-KLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 8e-47
Identities = 74/201 (36%), Positives = 116/201 (57%), Gaps = 3/201 (1%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
Y ++ +GEG+ G V+K + + TG+TVA+K + + +EI+ L+ +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 65 IIEMLDSFESPQEFCVVTEFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRI 123
++++LD F F +V E+ +L E+L D ++ LPE QV+S + L++ + Y+H+N I
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGI 120
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK-GTPLYMAPELVREQP-YNH 181
+HRD+KP N+LI A V+K+ DFG AR S L S + T Y APEL+ Y+
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180
Query: 182 TADLWSLGVILYELFVGQPPF 202
DLW++G I EL G P F
Sbjct: 181 GVDLWAVGCIFAELLNGSPLF 201
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 1e-46
Identities = 91/256 (35%), Positives = 148/256 (57%), Gaps = 7/256 (2%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
Y E +G+G+ G VY TGQ VA+K + + +K++ + EI ++R+ KH NI
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKHPNI 78
Query: 66 IEMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRII 124
+ LDS+ E VV E+ A G L +++ + C+ E Q+ ++ ++ ++AL +LHSN++I
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVI 137
Query: 125 HRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTAD 184
HRD+K NIL+G VKL DFGF ++ ++ GTP +MAPE+V + Y D
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 185 LWSLGVILYELFVGQPPFYT-NSVYA--LIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVP 241
+WSLG++ E+ G+PP+ N + A LI ++ P+++S F+ FL L
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 257
Query: 242 QNRLTWSALLEHPFVK 257
+ R + LL+HPF+K
Sbjct: 258 EKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 1e-46
Identities = 99/340 (29%), Positives = 169/340 (49%), Gaps = 36/340 (10%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHG--KSEKDIHNLRQEIEILRKLKHQNIIEML 69
+G+GSFGKV + K G+ A+K + K K ++ H + + +L+ +KH ++ +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 70 DSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDM 128
SF++ + V ++ G ELF L+ ++ PE + + A ++ AL YLHS II+RD+
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 129 KPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSL 188
KP+NIL+ + V L DFG + ++ + GTP Y+APE++R+QPY+ T D W L
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCL 182
Query: 189 GVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRL--- 245
G +LYE+ G PPFY+ + +I+ P++ +S + + L+GLL K RL
Sbjct: 183 GAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAK 242
Query: 246 -TWSALLEHPFVKETS-DELNAWELR-------ATSVEARGCNATWTAEGNAIQSSSGKS 296
+ + H F + D+L ++ + ++ + + +T E + +S GKS
Sbjct: 243 DDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEE--PVPNSVGKS 300
Query: 297 NSPAVSANNTSPSLHTDVELNSSNTSQSNSSPCEAFPGFS 336
+ S S +AF GFS
Sbjct: 301 PDSVL-------------------VSASVKEADDAFLGFS 321
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 4e-46
Identities = 97/294 (32%), Positives = 147/294 (50%), Gaps = 45/294 (15%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE----KDIHNLRQEIEILRK 59
+++ VI+++G G+FG+V+ R K TGQ AMK +++ KS+ I ++R E +IL
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMK-VLR--KSDMIKRNQIAHVRAERDILAD 57
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
I+++ SF+ + +V E+ G +L +L PEE + +LV AL +
Sbjct: 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN----------------------- 155
H IHRD+KP NILI A +KL DFG + M+
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 156 ------TVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYA 209
V S GTP Y+APE++R PY D WSLGVILYE+ G PPFY++++
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237
Query: 210 LIRHIV--KDPVKYP--DEMSPNFKSFLKGLLNKVPQNRLTWSA--LLEHPFVK 257
I+ K+ +++P +SP + LL P++RL S + HPF K
Sbjct: 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLCD-PEDRLG-SFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 5e-46
Identities = 87/263 (33%), Positives = 138/263 (52%), Gaps = 18/263 (6%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
Y I +VG G+FG V+ RRK + V +K I ++ + + E ++L+ L H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 65 IIEMLDSFESPQEFCVVTEFAQGELFEILEDDKC---LPEEQVQSIAKQLVRALHYLHSN 121
IIE ++F + +V E+A G +C L E+ + Q++ ALH++H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 122 RIIHRDMKPQNILIGA-GSVVKLCDFGFARAMS----ANTVVLRSIKGTPLYMAPELVRE 176
I+HRD+K QNIL+ VVK+ DFG ++ +S A TVV GTP Y++PEL
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV-----GTPCYISPELCEG 175
Query: 177 QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK---DPVKYPDEMSPNFKSFL 233
+PYN +D+W+LG +LYEL + F ++ AL+ I+ P+ D SP+ + +
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS--DRYSPDLRQLI 233
Query: 234 KGLLNKVPQNRLTWSALLEHPFV 256
+LN P R S ++ P
Sbjct: 234 LSMLNLDPSKRPQLSQIMAQPIC 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 9e-46
Identities = 97/296 (32%), Positives = 150/296 (50%), Gaps = 56/296 (18%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDI--HNLRQEIEILRKLK-- 61
Y + +GEG++G VYK R TG+ VA+K + SE+ I LR EI +L++L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPL-SEEGIPLSTLR-EIALLKQLESF 58
Query: 62 -HQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDD------KC----LPEEQVQSIAKQ 110
H NI+ +LD P+ E +FE ++ D KC LP E ++ + +Q
Sbjct: 59 EHPNIVRLLDVCHGPR---TDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 111 LVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFAR----AMSANTVVLRSIKGTP 166
L+R + +LHS+RI+HRD+KPQNIL+ + VK+ DFG AR M+ +VV+ T
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV-----TL 170
Query: 167 LYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS-------VYALI-------- 211
Y APE++ + Y D+WS+G I ELF +P F S ++ +I
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230
Query: 212 -RHIVKDPVKYPDEMSPNFKSFLKG-------LLNKV----PQNRLTWSALLEHPF 255
R++ +P +FKSF+ LL K+ P R++ L+HP+
Sbjct: 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-45
Identities = 89/258 (34%), Positives = 147/258 (56%), Gaps = 11/258 (4%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD--IHNLRQEIEILRKLKHQN--IIE 67
+G+G+FG+VY+ R+K T + AMK + K K H + + ++R L ++ I+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 68 MLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHR 126
+ SF++ + +VT++ + GELF L+ + E++ + +LV AL +LH I++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 127 DMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE-LVREQPYNHTADL 185
D+KP+NIL+ A + LCDFG ++A + + GT Y+APE L+ E+ Y D
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180
Query: 186 WSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP-DEMSPNFKSFLKGLLNKVPQNR 244
WSLGV+++E+ G PFY + R+I V++P + +S + F+KGLLN+ PQ+R
Sbjct: 181 WSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240
Query: 245 LTWSA----LLEHPFVKE 258
L L EHPF +
Sbjct: 241 LGAHRDAVELKEHPFFAD 258
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-45
Identities = 98/290 (33%), Positives = 146/290 (50%), Gaps = 43/290 (14%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD--IHN--LRQEIEILRK 59
E Y + +GEGS+G V+K R + TGQ VA+K K +SE D I LR EI +L++
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIK---KFVESEDDPVIKKIALR-EIRMLKQ 56
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDD-KCLPEEQVQSIAKQLVRALHYL 118
LKH N++ +++ F ++ +V E+ + LE + + +PE ++ I Q ++A+++
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPEL-VREQ 177
H + IHRD+KP+NILI +KLCDFGFAR ++ T Y APEL V +
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 178 PYNHTADLWSLGVILYELFVGQP--P-------------------------FYTNSVYAL 210
Y D+W++G + EL GQP P F TN +
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236
Query: 211 IRHIVKDPV-----KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPF 255
+ + K+P+ SP SFLKG L P RL+ LLEHP+
Sbjct: 237 LSIPEPETREPLESKFPNISSPAL-SFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 4e-45
Identities = 75/258 (29%), Positives = 131/258 (50%), Gaps = 13/258 (5%)
Query: 7 HVIELVGEGSFGKVYKGRRK----YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
+ + +GEG+FG+VYKG K T VA+K +K G SE++ +E I++KL H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVK-TLKEGASEEEREEFLEEASIMKKLSH 60
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHS 120
NI+ +L + +VTE+ G+L + L + L + + +A Q+ + + YL S
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL---YMAPELVREQ 177
+HRD+ +N L+ VVK+ DFG +R + R G L +MAPE +++
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIY-EDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 178 PYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKG 235
+ +D+WS GV+L+E+F +G+ P+ S ++ + + P+ +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYELMLQ 239
Query: 236 LLNKVPQNRLTWSALLEH 253
P++R T+S L+E
Sbjct: 240 CWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 4e-45
Identities = 81/238 (34%), Positives = 135/238 (56%), Gaps = 2/238 (0%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD-IHNLRQEIEILRKLKHQNIIEM 68
+L+G+G+FGKV R K TG+ AMK + K KD + + E +L+ +H + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 69 LDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRD 127
+F++ C V E+A G ELF L ++ EE+ + ++V AL YLHS +++RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 128 MKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWS 187
+K +N+++ +K+ DFG + ++ +++ GTP Y+APE++ + Y D W
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 180
Query: 188 LGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRL 245
LGV++YE+ G+ PFY L I+ + +++P +SP KS L GLL K P+ RL
Sbjct: 181 LGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 5e-45
Identities = 83/238 (34%), Positives = 129/238 (54%), Gaps = 5/238 (2%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE-KDIHNLRQEIEILRKLKHQNIIEM 68
E +G GSFG+V + K TG+ A+K + K + K + ++ QE IL +L H I+ M
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 69 LDSFESPQEFCVVTEFA-QGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRD 127
+ SF+ + EF GELF L P + + +LV A YLHS II+RD
Sbjct: 84 MCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRD 143
Query: 128 MKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWS 187
+KP+N+L+ VK+ DFGFA+ + T L GTP Y+APE+++ + + D W+
Sbjct: 144 LKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL---CGTPEYLAPEVIQSKGHGKAVDWWT 200
Query: 188 LGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRL 245
+GV+LYE G PPF+ ++ + + I+ +K+P+ + +KGLL RL
Sbjct: 201 MGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 88/297 (29%), Positives = 141/297 (47%), Gaps = 62/297 (20%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-HQN 64
Y VI+ +G+G+FG VY R K TG+ VA+K + K S ++ NLR E++ LRKL H N
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-EVKSLRKLNEHPN 59
Query: 65 IIEMLDSFESPQEFCVVTEFAQGELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNR 122
I+++ + F E V E+ +G L+++++D K E ++SI Q+++ L ++H +
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK------GTPLYMAPE-LVR 175
HRD+KP+N+L+ VVK+ DFG AR + RS T Y APE L+R
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAREI-------RSRPPYTDYVSTRWYRAPEILLR 172
Query: 176 EQPYNHTADLWSLGVILYELFVGQPPF--------------------------------- 202
Y+ D+W+LG I+ EL+ +P F
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232
Query: 203 ----YTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPF 255
+ + ++ + SP +K +L P+ R T S L+HP+
Sbjct: 233 LGFRFPQFAPTSLHQLIPNA-------SPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 3e-44
Identities = 73/263 (27%), Positives = 130/263 (49%), Gaps = 22/263 (8%)
Query: 10 ELVGEGSFGKVYKGRRK---YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
+ +GEG+FG+VYKG+ K VA+K +K SE++ + +E +++KL H N++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVK-TLKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 67 EMLDSFESPQEFCVVTEFA-QGEL---------FEILEDDKCLPEEQVQSIAKQLVRALH 116
+L + +V E+ G+L + L + + S A Q+ + +
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL---YMAPEL 173
YL S + +HRD+ +N L+G VVK+ DFG +R + + R G L +MAPE
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY-DDDYYRKKTGGKLPIRWMAPES 178
Query: 174 VREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD--PVKYPDEMSPNFK 230
+++ + +D+WS GV+L+E+F G P+ S ++ ++ K K P+
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPK-PEYCPDELY 237
Query: 231 SFLKGLLNKVPQNRLTWSALLEH 253
+ P++R T+S L+E
Sbjct: 238 ELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 3e-44
Identities = 79/258 (30%), Positives = 132/258 (51%), Gaps = 20/258 (7%)
Query: 9 IELVGEGSFGKVYKGR----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
+ +GEG+FG+VYKG+ VA+K +K SE+ I +E I+RKL H N
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVK-TLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 65 IIEMLDSFESPQEFCVVTEFA-QGELFEILEDDKC-LPEEQVQSIAKQLVRALHYLHSNR 122
++++L + +V E+ G+L L ++ L + S A Q+ R + YL S
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN 122
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL---YMAPELVREQPY 179
IHRD+ +N L+G VVK+ DFG +R + + R +G L +MAPE ++E +
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYRK-RGGKLPIRWMAPESLKEGKF 180
Query: 180 NHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKDPVKY----PDEMSPNFKSFLK 234
+D+WS GV+L+E+F +G+ P+ S ++ ++ Y P P +
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG---YRLPQPPNCPPELYDLML 237
Query: 235 GLLNKVPQNRLTWSALLE 252
+ P++R T+S L+E
Sbjct: 238 QCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 3e-44
Identities = 89/310 (28%), Positives = 137/310 (44%), Gaps = 66/310 (21%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK------HGKSEKDIHNLRQEIEILRK 59
Y +++ +G G++G V K TG+ VA+K I K LR EI++LR
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAK-----RILR-EIKLLRH 55
Query: 60 LKHQNIIEMLDSFESPQ-----EFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRA 114
L+H+NII +LD P + +VTE + +L ++++ + L ++ +Q Q++R
Sbjct: 56 LRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRG 115
Query: 115 LHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT---------VVLRSIKGT 165
L YLHS +IHRD+KP NIL+ + +K+CDFG AR + + VV R
Sbjct: 116 LKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR----- 170
Query: 166 PLYMAPELVREQP-YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIV--------- 215
Y APEL+ Y D+WS+G I EL +P F + IV
Sbjct: 171 -WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE 229
Query: 216 -------------------KDPVK----YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252
K +P SP L+ +L P+ R+T L
Sbjct: 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFP-GASPEAIDLLEKMLVFDPKKRITADEALA 288
Query: 253 HPFVKETSDE 262
HP++ + D
Sbjct: 289 HPYLAQLHDP 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 6e-44
Identities = 92/260 (35%), Positives = 147/260 (56%), Gaps = 11/260 (4%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMK----HGKSEKDIHNLRQEIEILRKLKHQNI 65
+++G+GSFGKV +RK G+ A+K + K + K +K H + + +L+ +KH +
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQK--HIMAERNVLLKNVKHPFL 58
Query: 66 IEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRII 124
+ + SF++ ++ V +F G ELF L+ ++ PE + + A ++ AL YLHS I+
Sbjct: 59 VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 125 HRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTAD 184
+RD+KP+NIL+ + V L DFG + A + + GTP Y+APE++R+QPY++T D
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVD 178
Query: 185 LWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNR 244
W LG +LYE+ G PPFY V + +I+ P+ S S L+ LL K Q R
Sbjct: 179 WWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRR 238
Query: 245 L----TWSALLEHPFVKETS 260
L + + EHPF + S
Sbjct: 239 LGAKEDFLEIQEHPFFESLS 258
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 7e-44
Identities = 80/257 (31%), Positives = 130/257 (50%), Gaps = 17/257 (6%)
Query: 9 IELVGEGSFGKVYKGR----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
+ +GEG+FG+VYKG VA+K +K SE+ I +E I+RKL H N
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVK-TLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 65 IIEMLDSFESPQEFCVVTEFA-QGELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSN 121
I+++L + +V E+ G+L + L K L + S A Q+ R + YL S
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-YMAPELVREQPYN 180
IHRD+ +N L+G VVK+ DFG +R + + P+ +MAPE ++E +
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFT 182
Query: 181 HTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKDPVKY----PDEMSPNFKSFLKG 235
+D+WS GV+L+E+F +G+ P+ S ++ ++ K Y P P +
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK---GYRLPKPPNCPPELYKLMLQ 239
Query: 236 LLNKVPQNRLTWSALLE 252
+ P++R T+S L+E
Sbjct: 240 CWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 7e-44
Identities = 78/257 (30%), Positives = 144/257 (56%), Gaps = 8/257 (3%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
Y ++ +GEGSFGK + K G+ +K I S K+ R+E+ +L +KH NI
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 66 IEMLDSFESPQEFCVVTEFAQG-ELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNR 122
++ +SFE +V ++ +G +L++ + + PE+Q+ Q+ AL ++H +
Sbjct: 62 VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHT 182
I+HRD+K QNI + +KL DFG AR +++ + R+ GTP Y++PE+ +PYN+
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNK 181
Query: 183 ADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PVKYPDEMSPNFKSFLKGLLNK 239
+D+W+LG +LYE+ + F ++ L+ I++ PV S + ++ + L +
Sbjct: 182 SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV--SSHYSYDLRNLVSQLFKR 239
Query: 240 VPQNRLTWSALLEHPFV 256
P++R + +++LE F+
Sbjct: 240 NPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 162 bits (410), Expect = 9e-44
Identities = 82/239 (34%), Positives = 133/239 (55%), Gaps = 4/239 (1%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD--IHNLRQEIEILRKLKHQNIIE 67
+L+G+G+FGKV R K +G+ AMK + K KD H L E +L+ +H +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTL-TESRVLKNTRHPFLTS 59
Query: 68 MLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHR 126
+ SF++ C V E+ G ELF L ++ E++ + ++V AL YLHS +I++R
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 127 DMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLW 186
D+K +N+++ +K+ DFG + + +++ GTP Y+APE++ + Y D W
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179
Query: 187 SLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRL 245
LGV++YE+ G+ PFY L I+ + +K+P +S + KS L GLL K P RL
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 1e-43
Identities = 82/240 (34%), Positives = 135/240 (56%), Gaps = 5/240 (2%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD--IHNLRQEIEILRKLKHQNIIE 67
+L+G+G+FGKV + K TG+ AMK + K KD H L E +L+ +H +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSRHPFLTA 59
Query: 68 MLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR-IIH 125
+ SF++ C V E+A G ELF L ++ E++ + ++V AL YLHS + +++
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 126 RDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADL 185
RD+K +N+++ +K+ DFG + + +++ GTP Y+APE++ + Y D
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 179
Query: 186 WSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRL 245
W LGV++YE+ G+ PFY L I+ + +++P +SP KS L GLL K P+ RL
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 78/267 (29%), Positives = 134/267 (50%), Gaps = 16/267 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
++Y +IE++G G+ VY + VA+K + K + + LR+E++ + + H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIK-RIDLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 64 NIIEMLDSFESPQEFCVVTEF-AQGELFEILE---DDKCLPEEQVQSIAKQLVRALHYLH 119
N+++ SF E +V + + G L +I++ L E + ++ K++++ L YLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV----VLRSIKGTPLYMAPELVR 175
SN IHRD+K NIL+G VK+ DFG + +++ V ++ GTP +MAPE++
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 176 EQP-YNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKDPVKYPDE-----MSPN 228
+ Y+ AD+WS G+ EL G P+ + L+ + DP S +
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS 239
Query: 229 FKSFLKGLLNKVPQNRLTWSALLEHPF 255
F+ + L K P R T LL+H F
Sbjct: 240 FRKMISLCLQKDPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 2e-43
Identities = 90/253 (35%), Positives = 138/253 (54%), Gaps = 13/253 (5%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLD 70
+G GSFG VY R T + VA+K + GK S + ++ +E+ L++L+H N IE
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 71 SFESPQEFCVVTEFAQGELFEILE-DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMK 129
+ +V E+ G +ILE K L E ++ +I ++ L YLHS+ IHRD+K
Sbjct: 83 CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIK 142
Query: 130 PQNILIGAGSVVKLCDFGFARAMS-ANTVVLRSIKGTPLYMAPELV---REQPYNHTADL 185
NIL+ VKL DFG A +S AN+ V GTP +MAPE++ E Y+ D+
Sbjct: 143 AGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 186 WSLGVILYELFVGQPPFYTNSVYALIRHIVKD--PVKYPDEMSPNFKSFLKGLLNKVPQN 243
WSLG+ EL +PP + + + + HI ++ P ++ S F++F+ L K+PQ+
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQD 257
Query: 244 RLTWSALLEHPFV 256
R + LL+H FV
Sbjct: 258 RPSSEELLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 85/260 (32%), Positives = 148/260 (56%), Gaps = 11/260 (4%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
Y +I+ +GEGSFGK+Y + K + +K I K+ ++E+ +L K+KH N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 65 IIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSN 121
I+ SF+ +V E+ G +L + + + E+Q+ S Q+ L ++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 122 RIIHRDMKPQNILIGA-GSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
+I+HRD+K QNI + G V KL DFG AR ++ + + + GTP Y++PE+ + +PYN
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYN 180
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
+ D+WSLG +LYEL + PF N+++ L+ I + Y +SPNF L+ L++++
Sbjct: 181 NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ---GYFAPISPNFSRDLRSLISQL 237
Query: 241 ----PQNRLTWSALLEHPFV 256
P++R + +++L+ PF+
Sbjct: 238 FKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 4e-43
Identities = 80/257 (31%), Positives = 128/257 (49%), Gaps = 8/257 (3%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
+Y I ++G+G+FG+ RR V K + SEK+ + EI IL L+H N
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 65 IIEMLDSFESPQEFCVVTEFAQG-ELFEIL--EDDKCLPEEQVQSIAKQLVRALHYLHSN 121
II + F + E+A G L++ + + + EE V Q+V A+ Y+H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNH 181
I+HRD+K NI + ++KL DFG ++ + + + ++ GTP YM+PEL + YN
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNF 180
Query: 182 TADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK---DPVKYPDEMSPNFKSFLKGLLN 238
+D+W+LG +LYEL + F + L+ IV+ PV S S + LL
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV--VSVYSSELISLVHSLLQ 238
Query: 239 KVPQNRLTWSALLEHPF 255
+ P+ R T +L+ P
Sbjct: 239 QDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 5e-43
Identities = 86/254 (33%), Positives = 140/254 (55%), Gaps = 9/254 (3%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD--IHNLRQEIEILRKLKHQNIIE 67
+L+G+G+FGKV R K TG+ AMK + K KD H L E +L+ +H +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTL-TESRVLQNTRHPFLTA 59
Query: 68 MLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHR 126
+ SF++ C V E+A G ELF L ++ E++ + ++V AL YLHS +++R
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 127 DMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLW 186
D+K +N+++ +K+ DFG + ++ +++ GTP Y+APE++ + Y D W
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179
Query: 187 SLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLT 246
LGV++YE+ G+ PFY L I+ + +++P +SP KS L GLL K P+ RL
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239
Query: 247 WSA-----LLEHPF 255
++EH F
Sbjct: 240 GGPEDAKEIMEHRF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 6e-43
Identities = 77/261 (29%), Positives = 139/261 (53%), Gaps = 9/261 (3%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMK---FIMKHGKSEKDIHNLRQEIEILRKLK 61
N+ +L+G+G+FG+VY TG+ +A+K F +++K+++ L EI++L+ L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 62 HQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
H+ I++ + + E+ G + + L+ L E + +Q++ + YLHS
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA---NTVVLRSIKGTPLYMAPELVREQ 177
N I+HRD+K NIL + VKL DFG ++ + + ++S+ GTP +M+PE++ +
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKY--PDEMSPNFKSFLKG 235
Y AD+WS+G + E+ +PP+ A I I P P +SP+ ++FL+
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRR 242
Query: 236 LLNKVPQNRLTWSALLEHPFV 256
+ + R + LL H FV
Sbjct: 243 TFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 7e-43
Identities = 85/257 (33%), Positives = 146/257 (56%), Gaps = 5/257 (1%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ Y E +G+G+ G V+ TGQ VA+K I + +K++ + EI ++++LK+
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNP 76
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRI 123
NI+ LDSF E VV E+ G + + C+ E Q+ ++ ++ ++AL +LH+N++
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQV 136
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTA 183
IHRD+K N+L+G VKL DFGF ++ ++ GTP +MAPE+V + Y
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 184 DLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PVKYPDEMSPNFKSFLKGLLNKV 240
D+WSLG++ E+ G+PP+ + + I + ++ P+++SP F+ FL L
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMD 256
Query: 241 PQNRLTWSALLEHPFVK 257
+ R + LL+HPF+K
Sbjct: 257 VEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 87/258 (33%), Positives = 137/258 (53%), Gaps = 19/258 (7%)
Query: 13 GEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSF 72
G G+ G V K + TG+ +A+K I + +E++IL K I+ +F
Sbjct: 10 GAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI-QKQILRELDILHKCNSPYIVGFYGAF 68
Query: 73 ESPQEFCVVTEFAQ-GELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLHSNR-IIHRDMK 129
+ + + E+ G L +IL E +PE + IA +++ L YLH IIHRD+K
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVK 128
Query: 130 PQNILIGAGSVVKLCDFGFARAMS---ANTVVLRSIKGTPLYMAPELVREQPYNHTADLW 186
P NIL+ + +KLCDFG + + A T V GT YMAPE ++ Y+ +D+W
Sbjct: 129 PSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQGNDYSVKSDIW 183
Query: 187 SLGVILYELFVGQPPF-----YTNSVYALIRHIVK-DPVKYP-DEMSPNFKSFLKGLLNK 239
SLG+ L EL G+ P+ + ++ L+++IV P + P + SP+F+ F+ L K
Sbjct: 184 SLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIK 243
Query: 240 VPQNRLTWSALLEHPFVK 257
P+ R ++ LLEHPF+K
Sbjct: 244 DPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 86/255 (33%), Positives = 137/255 (53%), Gaps = 20/255 (7%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMK----FIMKHGKSEKDIHNLRQEIEILRKL 60
N+ + + +G G F +VY+ + VA+K F M K+ +D +EI++L++L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDC---VKEIDLLKQL 59
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEIL----EDDKCLPEEQVQSIAKQLVRAL 115
H N+I+ LDSF E +V E A G+L +++ + + +PE V QL A+
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 116 HYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVR 175
++HS R++HRD+KP N+ I A VVKL D G R S+ T S+ GTP YM+PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 176 EQPYNHTADLWSLGVILYELFVGQPPFYTN--SVYALIRHIVKDPVKYP----DEMSPNF 229
E YN +D+WSLG +LYE+ Q PFY + ++++L + I + YP + S
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI--EQCDYPPLPTEHYSEKL 237
Query: 230 KSFLKGLLNKVPQNR 244
+ + + P R
Sbjct: 238 RELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 2e-42
Identities = 83/239 (34%), Positives = 137/239 (57%), Gaps = 3/239 (1%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG--KSEKDIHNLRQEIEILRKLKHQNIIE 67
+++G+GSFGKV +RK G A+K + K K ++ H + + +L+ LKH ++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 68 MLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHR 126
+ SF++ ++ V ++ G ELF L+ ++C E + + A ++ A+ YLHS II+R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 127 DMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLW 186
D+KP+NIL+ + V L DFG + + GTP Y+APE++R++PY+ T D W
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWW 180
Query: 187 SLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRL 245
LG +LYE+ G PPFY+ V + +I+ P++ P + L GLL+K + RL
Sbjct: 181 CLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 157 bits (397), Expect = 2e-42
Identities = 86/248 (34%), Positives = 140/248 (56%), Gaps = 5/248 (2%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDS 71
+GEGS G V K +G+ VA+K + + +++ L E+ I+R +H+N++EM +S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNS 85
Query: 72 FESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQ 131
+ E VV EF +G + + EEQ+ ++ +++AL LH+ +IHRD+K
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSD 145
Query: 132 NILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVI 191
+IL+ VKL DFGF +S +S+ GTP +MAPEL+ PY D+WSLG++
Sbjct: 146 SILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIM 205
Query: 192 LYELFVGQPPFYTN---SVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWS 248
+ E+ G+PP++ +IR + +K ++SP+ K FL LL + P R T +
Sbjct: 206 VIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAA 265
Query: 249 ALLEHPFV 256
LL+HPF+
Sbjct: 266 ELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 2e-42
Identities = 86/235 (36%), Positives = 133/235 (56%), Gaps = 20/235 (8%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQT-VAMKFIMKH------GKSEKD--IHNLRQEIE 55
Y V+E +G G+FG VYK R+K GQ +A+K I H K E+D I ++ E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 56 ILRK-LKHQNIIEMLDSFESPQEFCVVTEFAQG----ELFEILEDDK-CLPEEQVQSIAK 109
I+++ L+H NI+ +F +V + +G E F L++ K EE++ +I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 110 QLVRALHYLH-SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLY 168
Q+V AL YLH RI+HRD+ P NI++G V + DFG A+ + L S+ GT LY
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK-LTSVVGTILY 179
Query: 169 MAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK---DPVK 220
PE+V+ +PY AD+W+ G ILY++ QPPFY+ ++ +L IV+ +P+
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP 234
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 4e-42
Identities = 85/249 (34%), Positives = 140/249 (56%), Gaps = 5/249 (2%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDS 71
+GEGS G V K+TG+ VA+K + + +++ L E+ I+R H+N+++M +S
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL--LFNEVVIMRDYHHENVVDMYNS 87
Query: 72 FESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQ 131
+ E VV EF +G + + EEQ+ ++ ++RAL YLH+ +IHRD+K
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSD 147
Query: 132 NILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVI 191
+IL+ + +KL DFGF +S +S+ GTP +MAPE++ PY D+WSLG++
Sbjct: 148 SILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIM 207
Query: 192 LYELFVGQPPFYTNSVYALIRHI---VKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWS 248
+ E+ G+PP++ +R I + VK ++S + FL +L + P R T
Sbjct: 208 VIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQ 267
Query: 249 ALLEHPFVK 257
LL+HPF+K
Sbjct: 268 ELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 6e-42
Identities = 84/251 (33%), Positives = 137/251 (54%), Gaps = 5/251 (1%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
Y+V+ +VGEGSFG+ + + Q AMK I + KS + + R+E +L K+KH N
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI-RLPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 65 IIEMLDSFESPQEFCVVTEFAQ-GELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSN 121
I+ +SFE+ +V E+ G+L + ++ K PE+ + Q+ + ++H
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNH 181
R++HRD+K +NI + VKL DFG AR +++ + GTP Y+ PE+ PYN+
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNN 179
Query: 182 TADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVK-YPDEMSPNFKSFLKGLLNKV 240
+D+WSLG ILYEL + PF NS LI + + K P S +S +K + +
Sbjct: 180 KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRN 239
Query: 241 PQNRLTWSALL 251
P++R + + +L
Sbjct: 240 PRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 6e-42
Identities = 85/275 (30%), Positives = 142/275 (51%), Gaps = 23/275 (8%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD-IHNLRQEIEILRKLKH 62
E++ I+L+ G++G VY R K T Q AMK I K ++ I + E +IL ++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
++ M SFE+ + C+V E+ +G + +L++ LP + + + V AL YLH+
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARA--MSANTVVL-------------RSIKGTP 166
I+HRD+KP N+LI + +KL DFG ++ MS T + + + GTP
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180
Query: 167 LYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE-- 224
Y+APE++ Q Y D W++G+ILYE VG PF+ ++ L ++ D +++P+
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE 240
Query: 225 -MSPNFKSFLKGLLNKVPQNRLTWSALLE---HPF 255
+ + + + LL + P RL E H F
Sbjct: 241 ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 7e-42
Identities = 85/257 (33%), Positives = 142/257 (55%), Gaps = 5/257 (1%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ Y E +G+G+ G VY TGQ VA+K + + +K++ + EI ++R+ K+
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNP 76
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRI 123
NI+ LDS+ E VV E+ G + + C+ E Q+ ++ ++ ++AL +LHSN++
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQV 136
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTA 183
IHRD+K NIL+G VKL DFGF ++ ++ GTP +MAPE+V + Y
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 184 DLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PVKYPDEMSPNFKSFLKGLLNKV 240
D+WSLG++ E+ G+PP+ + + I + ++ P+ +S F+ FL L
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMD 256
Query: 241 PQNRLTWSALLEHPFVK 257
R + LL+HPF+K
Sbjct: 257 VDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 2e-41
Identities = 95/306 (31%), Positives = 139/306 (45%), Gaps = 57/306 (18%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD---IHNLRQEIEILRKL 60
+Y ++ +GEG+FG+VYK R+ TG+ VA+K I+ H +EKD I LR EI+IL+KL
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMH--NEKDGFPITALR-EIKILKKL 64
Query: 61 KHQNIIEMLD--------SFESPQEFCVVTEFAQGELFEILEDDKC-LPEEQVQSIAKQL 111
KH N++ ++D S +VT + +L +LE+ L E Q++ QL
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124
Query: 112 VRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARA--------MSANTVVLRSIK 163
+ ++YLH N I+HRD+K NILI ++K+ DFG AR R
Sbjct: 125 LEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184
Query: 164 G---TPLYMAPELV-REQPYNHTADLWSLGVILYELFVGQPPFYTNS-------VYALI- 211
T Y PEL+ E+ Y D+W +G + E+F +P S ++ L
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244
Query: 212 ---------------RHIVKDPVKYPDEMSPNFK-------SFLKGLLNKVPQNRLTWSA 249
V YP + F L LL+ P RLT S
Sbjct: 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASD 304
Query: 250 LLEHPF 255
LEHP+
Sbjct: 305 ALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 2e-41
Identities = 88/258 (34%), Positives = 144/258 (55%), Gaps = 8/258 (3%)
Query: 9 IELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEM 68
+E +G+GSFG+VYKG T + VA+K I+ ++E +I +++QEI +L + I
Sbjct: 9 LERIGKGSFGEVYKGIDNRTKEVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYITRY 67
Query: 69 LDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRD 127
S+ + ++ E+ G ++L+ L E + +I +++++ L YLHS R IHRD
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLLKPGP-LEETYIATILREILKGLDYLHSERKIHRD 126
Query: 128 MKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWS 187
+K N+L+ VKL DFG A ++ + + GTP +MAPE++++ Y+ AD+WS
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWS 186
Query: 188 LGVILYELFVGQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLNKVPQNRLT 246
LG+ EL G+PP ++ I K+ P + S FK F++ LNK P+ R T
Sbjct: 187 LGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPT 246
Query: 247 WSALLEHPFV----KETS 260
LL+H F+ K+TS
Sbjct: 247 AKELLKHKFITRYTKKTS 264
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 78/199 (39%), Positives = 122/199 (61%), Gaps = 2/199 (1%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
+ V+ +VGEG++G V K R K T + VA+K ++E+ +E+++LR LK +NI
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 66 IEMLDSFESPQEFCVVTEFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRII 124
+E+ ++F + +V E+ + + E+LE+ +P E+V+S QL++A+H+ H N I+
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIV 122
Query: 125 HRDMKPQNILIGAGSVVKLCDFGFARAMS-ANTVVLRSIKGTPLYMAPELVREQPYNHTA 183
HRD+KP+N+LI V+KLCDFGFAR +S + T Y +PEL+ PY
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAV 182
Query: 184 DLWSLGVILYELFVGQPPF 202
D+WS+G IL EL GQP F
Sbjct: 183 DMWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 3e-41
Identities = 76/240 (31%), Positives = 131/240 (54%), Gaps = 13/240 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-----HGKSEKDIHNLRQEIEILR 58
++ I+ VG G+FG+V+ R + + A+K +M K E+ +HN E +L+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALK-VMAIPEVIRLKQEQHVHN---EKRVLK 56
Query: 59 KLKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
++ H II + + + ++ E+ G ELF L + A ++V AL Y
Sbjct: 57 EVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEY 116
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQ 177
LHS I++RD+KP+NIL+ +KL DFGFA+ + T L GTP Y+APE+++ +
Sbjct: 117 LHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL---CGTPEYLAPEVIQSK 173
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLL 237
+N D W+LG+++YE+ VG PPF+ ++ + + I+ +++P + K +K LL
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLL 233
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 4e-41
Identities = 83/257 (32%), Positives = 144/257 (56%), Gaps = 5/257 (1%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ Y E +G+G+ G VY TGQ VA++ + + +K++ + EI ++R+ K+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNP 77
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRI 123
NI+ LDS+ E VV E+ G + + C+ E Q+ ++ ++ ++AL +LHSN++
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTA 183
IHRD+K NIL+G VKL DFGF ++ ++ GTP +MAPE+V + Y
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 184 DLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PVKYPDEMSPNFKSFLKGLLNKV 240
D+WSLG++ E+ G+PP+ + + I + ++ P+++S F+ FL L+
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257
Query: 241 PQNRLTWSALLEHPFVK 257
+ R + LL+H F+K
Sbjct: 258 VEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 4e-41
Identities = 87/263 (33%), Positives = 143/263 (54%), Gaps = 8/263 (3%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E + +E +G+GSFG+V+KG T Q VA+K I+ ++E +I +++QEI +L +
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 64 NIIEMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
+ + S+ + ++ E+ G ++L E Q+ ++ K++++ L YLHS +
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSEK 121
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHT 182
IHRD+K N+L+ VKL DFG A ++ + + GTP +MAPE++++ Y+
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 183 ADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV-KYPDEMSPNFKSFLKGLLNKVP 241
AD+WSLG+ EL G+PP ++ I K+ E S FK F+ LNK P
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDP 241
Query: 242 QNRLTWSALLEHPFV----KETS 260
R T LL+H F+ K+TS
Sbjct: 242 SFRPTAKELLKHKFIVKNAKKTS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 7e-41
Identities = 88/255 (34%), Positives = 136/255 (53%), Gaps = 20/255 (7%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMK----FIMKHGKSEKDIHNLRQEIEILRKL 60
N+ + + +G G F +VY+ G VA+K F + K+ D +EI++L++L
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADC---IKEIDLLKQL 59
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEIL----EDDKCLPEEQVQSIAKQLVRAL 115
H N+I+ SF E +V E A G+L ++ + + +PE+ V QL AL
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 116 HYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVR 175
++HS R++HRD+KP N+ I A VVKL D G R S+ T S+ GTP YM+PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 176 EQPYNHTADLWSLGVILYELFVGQPPFYTN--SVYALIRHIVKDPVKYP----DEMSPNF 229
E YN +D+WSLG +LYE+ Q PFY + ++Y+L + I + YP D S
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--EQCDYPPLPSDHYSEEL 237
Query: 230 KSFLKGLLNKVPQNR 244
+ + +N P+ R
Sbjct: 238 RQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 9e-41
Identities = 86/281 (30%), Positives = 143/281 (50%), Gaps = 25/281 (8%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEK--DIHNLRQEIEILRKLKHQ 63
+ ++ VG+G +G+V+ ++K TG+ VA+K MK K ++ ++ E +IL K +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALK-RMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGELFE-ILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
++++L +F+ + + E+ G F +L + L E+ + ++ A+ LH
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL-RSIKGTPLYMAPELVREQPYNH 181
IHRD+KP+N LI A +KL DFG +S V S+ G+P YMAPE++R + Y+
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFG----LSKGIVTYANSVVGSPDYMAPEVLRGKGYDF 177
Query: 182 TADLWSLGVILYELFVGQPPF---YTNSVYALIRHIVKDPVKYPDEMSPNFK------SF 232
T D WSLG +LYE G PPF N + +++ K+ ++ P P F
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW-KETLQRPVYDDPRFNLSDEAWDL 236
Query: 233 LKGLLNKVPQNRL-TWSALLEHPFVKETSDELNAWELRATS 272
+ L+N P R + + HPF K E++ ELR
Sbjct: 237 ITKLIND-PSRRFGSLEDIKNHPFFK----EVDWNELRELK 272
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 1e-40
Identities = 87/260 (33%), Positives = 131/260 (50%), Gaps = 12/260 (4%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILR-KLKHQNIIE 67
+++G+GSFGKV K T + A+K + K + D+ E IL KH +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 68 MLDSFESPQEFCVVTEFAQGE--LFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIH 125
+ F++ V E+ G +F+I K E + + A ++ AL +LH + +I+
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRHGVIY 119
Query: 126 RDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADL 185
RD+K NIL+ A KL DFG + N V + GTP Y+APE+++E Y + D
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179
Query: 186 WSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRL 245
W+LGV++YE+ GQPPF ++ L I+ D V YP +S S LK + K P RL
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRL 239
Query: 246 -------TWSALLEHPFVKE 258
A+ +HPF KE
Sbjct: 240 GCVASQGGEDAIKQHPFFKE 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 84/262 (32%), Positives = 136/262 (51%), Gaps = 20/262 (7%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFI----MKHGKSEKDIHNLRQEIEILRKLKHQNIIE 67
+G+G FG+V + K TG+ A K + +K K E+ N E +IL K+ + I+
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALN---EKKILEKVSSRFIVS 57
Query: 68 MLDSFESPQEFC-VVTEFAQGEL-FEILE-DDKCLPEEQVQSIAKQLVRALHYLHSNRII 124
+ +FE+ + C V+T G+L + I + PE + A Q++ L +LH RI+
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIV 117
Query: 125 HRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTAD 184
+RD+KP+N+L+ V++ D G A + + GTP YMAPE+++ + Y+ + D
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA-GTPGYMAPEVLQGEVYDFSVD 176
Query: 185 LWSLGVILYELFVGQPPF--YTNSV--YALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
++LG LYE+ G+ PF V L R ++ V+YPD+ SP K + LL K
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236
Query: 241 PQNRL-----TWSALLEHPFVK 257
P+ RL + + EHP K
Sbjct: 237 PEKRLGCRGGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 80/264 (30%), Positives = 132/264 (50%), Gaps = 15/264 (5%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKHQNIIEMLD 70
+G+G FG+V + + TG+ A K + K K K E IL K+ + I+ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 71 SFESPQEFCVVTEFAQG-----ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIH 125
+F++ + C+V G ++ + E++ PE + Q++ L +LH RII+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 126 RDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADL 185
RD+KP+N+L+ V++ D G A + + GTP +MAPEL++ + Y+ + D
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDY 180
Query: 186 WSLGVILYELFVGQPPFYTNSVYA----LIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVP 241
++LGV LYE+ + PF L + I+ D V YPD+ SP KSF + LL K P
Sbjct: 181 FALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP 240
Query: 242 QNRL-----TWSALLEHPFVKETS 260
+ RL L HP ++ +
Sbjct: 241 EKRLGFRDGNCDGLRTHPLFRDLN 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 4e-40
Identities = 79/256 (30%), Positives = 140/256 (54%), Gaps = 5/256 (1%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
Y + +VG+GS+G+V R + G+ +K + S ++ QE ++L +LKH NI
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 66 IEMLDSFESPQ-EFCVVTEFAQG-ELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSN 121
+ +S+E +V F +G +L+ L++ K LPE QV Q+ AL YLH
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNH 181
I+HRD+K QN+ + +++K+ D G AR + + ++ GTP YM+PEL +PYN+
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNY 181
Query: 182 TADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV-KYPDEMSPNFKSFLKGLLNKV 240
+D+W+LG +YE+ + F + +L+ I++ + P + SP + +L+K
Sbjct: 182 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKR 241
Query: 241 PQNRLTWSALLEHPFV 256
P+ R + ++L P++
Sbjct: 242 PEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 4e-40
Identities = 86/262 (32%), Positives = 141/262 (53%), Gaps = 13/262 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E++ +I+ +G G++G VYK R TG+ A+K I + + ++QEI +++ KH
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV--VQQEIIMMKDCKHS 66
Query: 64 NIIEMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+ S+ + + EF G L +I L E Q+ ++++ ++ L+YLHS
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELV---REQPY 179
+HRD+K NIL+ VKL DFG + ++A +S GTP +MAPE+ R+ Y
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186
Query: 180 NHTADLWSLGVILYELFVGQPPFY----TNSVYALIRHIVKDPVKYPDEM--SPNFKSFL 233
N D+W++G+ EL QPP + +++ + + + P K D+M S +F F+
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP-KLKDKMKWSNSFHHFV 245
Query: 234 KGLLNKVPQNRLTWSALLEHPF 255
K L K P+ R T LL+HPF
Sbjct: 246 KMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 5e-40
Identities = 78/239 (32%), Positives = 137/239 (57%), Gaps = 3/239 (1%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG--KSEKDIHNLRQEIEILRKLKHQNIIE 67
+++G+GSFGKV R K + A+K + K K +++ H + + +L+ +KH ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 68 MLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHR 126
+ SF++ + V ++ G ELF L+ ++C E + + A ++ AL YLHS I++R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 127 DMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLW 186
D+KP+NIL+ + + L DFG + + + GTP Y+APE++ +QPY+ T D W
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWW 180
Query: 187 SLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRL 245
LG +LYE+ G PPFY+ + + +I+ P++ ++ + + L+GLL K RL
Sbjct: 181 CLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 1e-39
Identities = 87/263 (33%), Positives = 145/263 (55%), Gaps = 8/263 (3%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E + +E +G+GSFG+V+KG T + VA+K I+ ++E +I +++QEI +L +
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 64 NIIEMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
+ + S+ + ++ E+ G ++LE L E Q+ +I +++++ L YLHS +
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEK 121
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHT 182
IHRD+K N+L+ VKL DFG A ++ + + GTP +MAPE++++ Y+
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 183 ADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK-DPVKYPDEMSPNFKSFLKGLLNKVP 241
AD+WSLG+ EL G+PP ++ I K +P S K F++ LNK P
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 241
Query: 242 QNRLTWSALLEHPFV----KETS 260
R T LL+H F+ K+TS
Sbjct: 242 SFRPTAKELLKHKFIVRFAKKTS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 79/262 (30%), Positives = 139/262 (53%), Gaps = 17/262 (6%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK----SEKDIHNLRQEIEILRKLKHQNI 65
E++G+G++G VY G GQ +A+K + +EK+ L++E+++L+ LKH NI
Sbjct: 6 EVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 66 IEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRII 124
++ L + + EF G + IL LPE KQ++ + YLH+N ++
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 125 HRDMKPQNILIGAGSVVKLCDFGFARAMS------ANTVVLRSIKGTPLYMAPELVREQP 178
HRD+K N+++ ++KL DFG AR ++ ++ +L+S+ GTP +MAPE++ E
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184
Query: 179 YNHTADLWSLGVILYELFVGQPPFYT----NSVYALIRHIVKDPVKYPDEMSPNFKSFLK 234
Y +D+WS+G ++E+ G+PP + +++ + H P + PD S F+
Sbjct: 185 YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP-RLPDSFSAAAIDFVT 243
Query: 235 GLLNKVPQNRLTWSALLEHPFV 256
L + R + LL H F+
Sbjct: 244 SCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 4e-39
Identities = 89/271 (32%), Positives = 136/271 (50%), Gaps = 28/271 (10%)
Query: 9 IELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIH-NLRQEIEILRKLKHQNIIE 67
+ +GEG+ G V K R K TG A+K I D+ + +E+EI + K I++
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITT--DPNPDLQKQILRELEINKSCKSPYIVK 63
Query: 68 MLDSFESPQE--FCVVTEFAQGE-----LFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
+F + E+ +G ++ + + E+ + IA+ +++ L YLHS
Sbjct: 64 YYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV--VLRSIKGTPLYMAPELVREQP 178
+IIHRD+KP NIL+ VKLCDFG +S V + + GT YMAPE ++ +P
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFG----VSGELVNSLAGTFTGTSFYMAPERIQGKP 179
Query: 179 YNHTADLWSLGVILYELFVGQPPFYTNSVYA-----LIRHIVKDPV-KYPDEM------S 226
Y+ T+D+WSLG+ L E+ + PF L+ +IV P + DE S
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWS 239
Query: 227 PNFKSFLKGLLNKVPQNRLTWSALLEHPFVK 257
FK F+K L K P R T +LEHP++K
Sbjct: 240 EEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 75/256 (29%), Positives = 126/256 (49%), Gaps = 14/256 (5%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQ-NIIEML 69
+ +G+FG VY +++ TG A+K + K ++ + N++ E I+ + ++
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 70 DSFESPQEFCVVTE-FAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDM 128
SF+S +V E G+ +++ LPE+ + ++V + LH IIHRD+
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 129 KPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSL 188
KP+N+LI +KL DFG +R N + GTP Y+APE + + +D WSL
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSRNGLEN----KKFVGTPDYLAPETILGVGDDKMSDWWSL 179
Query: 189 GVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE----MSPNFKSFLKGLLNKVPQNR 244
G +++E G PPF+ + A+ +I+ + +P+E SP + LL P R
Sbjct: 180 GCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239
Query: 245 LTWSALLE---HPFVK 257
L + E HPF K
Sbjct: 240 LGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 5e-39
Identities = 86/298 (28%), Positives = 138/298 (46%), Gaps = 48/298 (16%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLR--QEIEILRKLKHQ 63
Y + VG G++G+V TG+ VA+K + + +S IH R +E+ +L+ + H+
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA--IHAKRTYRELRLLKHMDHE 74
Query: 64 NIIEMLDSF------ESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
N+I +LD F E Q+ +VT +L I++ K L ++ +Q + Q++R L Y
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK-LSDDHIQFLVYQILRGLKY 133
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE-LVRE 176
+HS IIHRD+KP NI + +K+ DFG AR + T Y APE ++
Sbjct: 134 IHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNW 190
Query: 177 QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE------------ 224
YN T D+WS+G I+ EL G+ F + ++ I+ + V PDE
Sbjct: 191 MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIM-NLVGTPDEELLQKISSESAR 249
Query: 225 --------------------MSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDE 262
+P L+ +L P R+T + L HP++ E D
Sbjct: 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 6e-39
Identities = 85/272 (31%), Positives = 147/272 (54%), Gaps = 12/272 (4%)
Query: 9 IELVGEGSFGKVYKGRR---KYTGQTVAMKFIMKHG--KSEKDIHNLRQEIEILRKLKHQ 63
++++G+G +GKV++ R+ TG+ AMK + K +++KD + + E IL +KH
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 64 NIIEMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
I++++ +F++ + ++ E+ + GELF LE + E+ ++ AL +LH
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHT 182
II+RD+KP+NIL+ A VKL DFG + V + GT YMAPE++ +
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKA 180
Query: 183 ADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQ 242
D WSLG ++Y++ G PPF + I I+K + P ++P + LK LL + P
Sbjct: 181 VDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPS 240
Query: 243 NRL-----TWSALLEHPFVKETS-DELNAWEL 268
+RL + + HPF + + D+L A ++
Sbjct: 241 SRLGAGPGDAAEVQSHPFFRHVNWDDLLARKV 272
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 6e-39
Identities = 91/284 (32%), Positives = 139/284 (48%), Gaps = 33/284 (11%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
+Y IE +GEG++G VYKGR K TGQ VAMK I + E +EI +L++L+H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 65 IIEMLDSFESPQEFCVVTEFAQGEL---FEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
I+ + D ++ EF +L + L + + E V+S Q+++ + + HS
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE-LVREQPYN 180
R++HRD+KPQN+LI V+KL DFG ARA V T Y APE L+ Y+
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYS 180
Query: 181 HTADLWSLGVILYELFVGQPPFYTNS-VYALIR--HIVKDPVK---------------YP 222
D+WS+G I E+ +P F+ +S + L R I+ P + +P
Sbjct: 181 TPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFP 240
Query: 223 DEMSPNFKSFLKG-------LLNKV----PQNRLTWSALLEHPF 255
+ +S +K LL K+ P R++ L HP+
Sbjct: 241 KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 7e-39
Identities = 85/291 (29%), Positives = 141/291 (48%), Gaps = 39/291 (13%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD-IHNLRQEIEILRKLKHQN 64
+ I+L+G+G G+V+ R K TG+ A+K + K +++ + + E EIL L H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 65 IIEMLDSFESPQEFCVVTEFAQG-ELFEILE--DDKCLPEEQVQSIAKQLVRALHYLHSN 121
+ + SF++ C+V ++ G ELF +L+ KCL EE + A +++ AL YLH
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL 122
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFA------------------RAMSANTVVL---- 159
I++RD+KP+NIL+ + L DF + R S N++
Sbjct: 123 GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 160 -------RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIR 212
S GT Y+APE++ + D W+LG++LYE+ G PF ++
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFS 242
Query: 213 HIVKDPVKYPDE--MSPNFKSFLKGLLNKVPQNRL-TWSALLE---HPFVK 257
+I+K V +P +S + + ++ LL K P RL + E HPF +
Sbjct: 243 NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 89/288 (30%), Positives = 137/288 (47%), Gaps = 44/288 (15%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
Y +E +GEG++G VYK R K TG+ VA+K I + E +EI +L++L H NI
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 66 IEMLDSFESPQEFCVVTEFAQGELFEILEDDKC----LPEEQVQSIAKQLVRALHYLHSN 121
+ +LD S + +V EF +L + + D L ++S QL++ + Y HS+
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDLDLKKYM--DSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG---TPLYMAPELVREQP 178
R++HRD+KPQN+LI +KL DFG ARA V +R+ T Y APE++
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFG---VPVRTYTHEVVTLWYRAPEILLGSR 175
Query: 179 YNHTA-DLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMS-------PNFK 230
T D+WS+G I E+ +P F +S + I + + PDE P++K
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFR-TLGTPDEDVWPGVTSLPDYK 234
Query: 231 S-----------------------FLKGLLNKVPQNRLTWSALLEHPF 255
L +L P R++ A L+HP+
Sbjct: 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 90/272 (33%), Positives = 141/272 (51%), Gaps = 13/272 (4%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLD 70
+G GSFG VY R + VA+K + GK S + ++ +E+ L+KL+H N I+
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 71 SFESPQEFCVVTEFAQGELFEILE-DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMK 129
+ +V E+ G ++LE K L E ++ ++ ++ L YLHS+ +IHRD+K
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 142
Query: 130 PQNILIGAGSVVKLCDFGFARAMS-ANTVVLRSIKGTPLYMAPELV---REQPYNHTADL 185
NIL+ +VKL DFG A M+ AN V GTP +MAPE++ E Y+ D+
Sbjct: 143 AGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 186 WSLGVILYELFVGQPPFYTNSVYALIRHIVKD--PVKYPDEMSPNFKSFLKGLLNKVPQN 243
WSLG+ EL +PP + + + + HI ++ P S F++F+ L K+PQ+
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257
Query: 244 RLTWSALLEHPFVKETSDELNAWELRATSVEA 275
R T LL+H FV +L + +A
Sbjct: 258 RPTSEVLLKHRFVLRERPPTVIMDLIQRTKDA 289
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 90/268 (33%), Positives = 148/268 (55%), Gaps = 20/268 (7%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH-QN 64
+ ++ELVG G++G+VYKGR TGQ A+K + G E++I +QEI +L+K H +N
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEI---KQEINMLKKYSHHRN 64
Query: 65 IIEMLDSF--ESP----QEFCVVTEF-AQGELFEILEDDK--CLPEEQVQSIAKQLVRAL 115
I +F ++P + +V EF G + +++++ K L EE + I ++++R L
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124
Query: 116 HYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVR 175
+LH +++IHRD+K QN+L+ + VKL DFG + + + GTP +MAPE++
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184
Query: 176 --EQP---YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKY--PDEMSPN 228
E P Y+ +DLWSLG+ E+ G PP + I ++P + S
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKK 244
Query: 229 FKSFLKGLLNKVPQNRLTWSALLEHPFV 256
F+SF++ L K R T L++HPF+
Sbjct: 245 FQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-38
Identities = 88/254 (34%), Positives = 138/254 (54%), Gaps = 13/254 (5%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLD 70
+G GSFG VY +T + VA+K + GK + + ++ +E++ L++LKH N IE
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 71 SFESPQEFCVVTEFAQGELFEILE-DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMK 129
+ +V E+ G ++LE K L E ++ +I ++ L YLHS+ +IHRD+K
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148
Query: 130 PQNILIGAGSVVKLCDFGFARAMS-ANTVVLRSIKGTPLYMAPELV---REQPYNHTADL 185
NIL+ VKL DFG A S AN+ V GTP +MAPE++ E Y+ D+
Sbjct: 149 AGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDV 203
Query: 186 WSLGVILYELFVGQPPFYTNSVYALIRHIVKD--PVKYPDEMSPNFKSFLKGLLNKVPQN 243
WSLG+ EL +PP + + + + HI ++ P +E + +F+ F+ L K+PQ
Sbjct: 204 WSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQE 263
Query: 244 RLTWSALLEHPFVK 257
R + LL H FV+
Sbjct: 264 RPASAELLRHDFVR 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 144 bits (363), Expect = 4e-38
Identities = 86/262 (32%), Positives = 140/262 (53%), Gaps = 13/262 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFI-MKHGKSEKDIHNLRQEIEILRKLKH 62
+Y +I+ VG G++G VYK R +TG+ A+K I ++ G D ++QEI ++++ KH
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKH 65
Query: 63 QNIIEMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
NI+ S+ S ++ + E+ G L +I L E Q+ + ++ ++ L YLHS
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELV---REQP 178
+HRD+K NIL+ VKL DFG A ++A +S GTP +MAPE+ +
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 179 YNHTADLWSLGVILYELFVGQPPFY----TNSVYALIRHIVKDP-VKYPDEMSPNFKSFL 233
YN D+W++G+ EL QPP + +++ + + + P +K + S F +F+
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFV 245
Query: 234 KGLLNKVPQNRLTWSALLEHPF 255
K L K P+ R T LL H F
Sbjct: 246 KISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 5e-38
Identities = 91/253 (35%), Positives = 139/253 (54%), Gaps = 13/253 (5%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLD 70
+G GSFG VY R T + VA+K + GK S + ++ +E++ L+++KH N IE
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 71 SFESPQEFCVVTEFAQGELFEILE-DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMK 129
+ +V E+ G ++LE K L E ++ +I ++ L YLHS+ +IHRD+K
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 152
Query: 130 PQNILIGAGSVVKLCDFGFARAMS-ANTVVLRSIKGTPLYMAPELV---REQPYNHTADL 185
NIL+ VKL DFG A S AN+ V GTP +MAPE++ E Y+ D+
Sbjct: 153 AGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDV 207
Query: 186 WSLGVILYELFVGQPPFYTNSVYALIRHIVKD--PVKYPDEMSPNFKSFLKGLLNKVPQN 243
WSLG+ EL +PP + + + + HI ++ P +E S F++F+ L K+PQ+
Sbjct: 208 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQD 267
Query: 244 RLTWSALLEHPFV 256
R T LL+H FV
Sbjct: 268 RPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 9e-38
Identities = 96/307 (31%), Positives = 146/307 (47%), Gaps = 54/307 (17%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-H 62
Y +++ +G+G++G V+K + T + VA+K I ++ D +EI L++L H
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 63 QNIIEMLDSF--ESPQEFCVVTEFAQGELF-----EILEDDKCLPEEQVQSIAKQLVRAL 115
NI+++L+ E+ ++ +V E+ + +L ILED + I QL++AL
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV------HKRYIMYQLLKAL 120
Query: 116 HYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV-----VLRSIKGTPLYMA 170
Y+HS +IHRD+KP NIL+ + VKL DFG AR++S VL T Y A
Sbjct: 121 KYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180
Query: 171 PE-LVREQPYNHTADLWSLGVILYELFVGQPPF-------------------------YT 204
PE L+ Y D+WS+G IL E+ +G+P F
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240
Query: 205 NSVYA--LIRHIVKDPVKYPDEMSPNFKS----FLKGLLNKVPQNRLTWSALLEHPFVKE 258
S +A ++ + P K DE+ P LK LL P RLT LEHP+V +
Sbjct: 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300
Query: 259 ---TSDE 262
SDE
Sbjct: 301 FHNPSDE 307
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-37
Identities = 80/241 (33%), Positives = 131/241 (54%), Gaps = 4/241 (1%)
Query: 9 IELVGEGSFGKVY---KGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
++++G+GSFGKV+ K GQ AMK + K +D + E +IL ++ H I
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 66 IEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRII 124
+++ +F++ + ++ +F +G +LF L + EE V+ +L AL +LHS II
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 125 HRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTAD 184
+RD+KP+NIL+ +KL DFG ++ + S GT YMAPE+V + + +AD
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSAD 180
Query: 185 LWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNR 244
WS GV+++E+ G PF + I+K + P +SP +S L+ L + P NR
Sbjct: 181 WWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANR 240
Query: 245 L 245
L
Sbjct: 241 L 241
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-37
Identities = 86/259 (33%), Positives = 134/259 (51%), Gaps = 17/259 (6%)
Query: 9 IELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHN-LRQEIEILRKLKHQNIIE 67
+ +G G+ G VYK + TG+ A+K I +G E + + +EIEILR + H N+++
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVI--YGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 68 MLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRD 127
D F+ E V+ EF G LE E+ + +A+Q++ + YLH I+HRD
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGG---SLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRD 193
Query: 128 MKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTA---- 183
+KP N+LI + VK+ DFG +R ++ S GT YM+PE + NH A
Sbjct: 194 IKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTD-LNHGAYDGY 252
Query: 184 --DLWSLGVILYELFVGQPPFYTNSV---YALIRHI-VKDPVKYPDEMSPNFKSFLKGLL 237
D+WSLGV + E ++G+ PF +L+ I + P + P S F+ F+ L
Sbjct: 253 AGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCL 312
Query: 238 NKVPQNRLTWSALLEHPFV 256
+ P R + LL+HPF+
Sbjct: 313 QREPAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 78/261 (29%), Positives = 137/261 (52%), Gaps = 15/261 (5%)
Query: 11 LVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD-------IHNLRQEIEILRKLKHQ 63
L+G GSFG VY G +G+ +A+K + S + L +EI +L++L+H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 64 NIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI++ L S + E+ G + +L + E V++ +Q+++ L+YLH+
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR------SIKGTPLYMAPELVRE 176
IIHRD+K NIL+ +K+ DFG ++ + AN++ + S++G+ +MAPE+V++
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ 186
Query: 177 QPYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKDPVKYPDEMSPNFKSFLKG 235
Y AD+WSLG ++ E+ G+ PF + A+ + + P +S FL+
Sbjct: 187 TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEK 246
Query: 236 LLNKVPQNRLTWSALLEHPFV 256
R T + LL+HPF+
Sbjct: 247 TFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 1e-36
Identities = 87/271 (32%), Positives = 150/271 (55%), Gaps = 26/271 (9%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH-QN 64
+ ++E+VG G++G+VYKGR TGQ A+K + E++I + EI +L+K H +N
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEI---KLEINMLKKYSHHRN 74
Query: 65 IIEMLDSF--ESP----QEFCVVTEF-AQGELFEILEDDK--CLPEEQVQSIAKQLVRAL 115
I +F +SP + +V EF G + +++++ K L E+ + I ++++R L
Sbjct: 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL 134
Query: 116 HYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELV- 174
+LH++++IHRD+K QN+L+ + VKL DFG + + + GTP +MAPE++
Sbjct: 135 AHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194
Query: 175 -REQP---YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEM----- 225
E P Y++ +D+WSLG+ E+ G PP + I ++P P ++
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---PPKLKSKKW 251
Query: 226 SPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256
S F F++G L K +R + LL+HPF+
Sbjct: 252 SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 80/256 (31%), Positives = 130/256 (50%), Gaps = 12/256 (4%)
Query: 11 LVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLD 70
++G+G++G VY R T +A+K I + + + + L +EI + LKH+NI++ L
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPE--RDSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 71 SFESPQEFCVVTEFAQGELFEILEDDKCLP----EEQVQSIAKQLVRALHYLHSNRIIHR 126
S F + E G L K P E+ + KQ++ L YLH N+I+HR
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 127 DMKPQNILIGAGS-VVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQP--YNHTA 183
D+K N+L+ S VVK+ DFG ++ ++ + GT YMAPE++ + P Y A
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPA 192
Query: 184 DLWSLGVILYELFVGQPPFYT--NSVYALIR-HIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
D+WSLG + E+ G+PPF A+ + + K + P+ +S K+F+
Sbjct: 193 DIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPD 252
Query: 241 PQNRLTWSALLEHPFV 256
P R + LL+ PF+
Sbjct: 253 PDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 91/284 (32%), Positives = 139/284 (48%), Gaps = 37/284 (13%)
Query: 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK 61
+ + + +G G+ G+VYK R K TG +A+K + + G E+ N R IL L
Sbjct: 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE---NKR----ILMDLD 65
Query: 62 HQNIIEMLDSFESP---QEF-CVVTEFAQGELFEILED--DKCL-------PEEQVQSIA 108
+L S + P + + +T+ E++ DK L PE+ + +
Sbjct: 66 -----VVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMT 120
Query: 109 KQLVRALHYLHSNR-IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL 167
+V+ALHYL +IHRD+KP NIL+ A VKLCDFG + + + RS G
Sbjct: 121 VAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGCAA 179
Query: 168 YMAPELVREQP----YNHTADLWSLGVILYELFVGQPPFYTNSV--YALIRHIVKDPVKY 221
YMAPE + Y+ AD+WSLG+ L EL GQ P+ L + + ++P
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239
Query: 222 PDEM--SPNFKSFLKGLLNKVPQNRLTWSALLEHPFVK--ETSD 261
P SP+F SF+ L K + R + LL+HPF++ ET++
Sbjct: 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 93/291 (31%), Positives = 138/291 (47%), Gaps = 48/291 (16%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
N+ +E +GEG++G VYK R K TG+ VA+K I ++E +EI +L++L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 65 IIEMLDSFESPQEFCVVTEFAQGELFEILEDDKC----LPEEQVQSIAKQLVRALHYLHS 120
I+++LD + + +V EF +L + + D +P ++S QL++ L + HS
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG---TPLYMAPELVREQ 177
+R++HRD+KPQN+LI +KL DFG ARA V +R+ T Y APE++
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYTHEVVTLWYRAPEILLGC 175
Query: 178 PYNHTA-DLWSLGVILYE------LFVG--------------------------QPPFYT 204
Y TA D+WSLG I E LF G P Y
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235
Query: 205 NSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPF 255
S R V DE + + L +L+ P R++ A L HPF
Sbjct: 236 PSFPKWARQDFSKVVPPLDE---DGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 85/266 (31%), Positives = 132/266 (49%), Gaps = 12/266 (4%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKHQN--II 66
++G+GSFGKV R K +G+ A+K + K + D+ E IL L + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRIL-SLARNHPFLT 59
Query: 67 EMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIH 125
++ F++P V EF G +L ++ + E + + A ++ AL +LH II+
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 126 RDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADL 185
RD+K N+L+ KL DFG + N + GTP Y+APE+++E Y + D
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179
Query: 186 WSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRL 245
W++GV+LYE+ G PF + L I+ D V YP +S + LK + K P RL
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRL 239
Query: 246 TW------SALLEHPFVKETS-DELN 264
A+L HPF KE ++LN
Sbjct: 240 GSLTLGGEEAILRHPFFKELDWEKLN 265
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 4e-36
Identities = 79/265 (29%), Positives = 132/265 (49%), Gaps = 18/265 (6%)
Query: 11 LVGEGSFGKVYKGRRKYTGQTVAMKFIMKH-GKSEKDIHNLRQEIEILRKLKHQNIIEML 69
++G GS+ KV K T + AMK I K ++DI ++ E + + + L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 70 DS-FESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRD 127
S F++ V EF G +L ++ + LPEE + + ++ AL++LH II+RD
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRD 121
Query: 128 MKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWS 187
+K N+L+ A +KL D+G + + GTP Y+APE++R + Y + D W+
Sbjct: 122 LKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 181
Query: 188 LGVILYELFVGQPPF---------YTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLN 238
LGV+++E+ G+ PF N+ L + I++ ++ P +S S LKG LN
Sbjct: 182 LGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLN 241
Query: 239 KVPQNRL------TWSALLEHPFVK 257
K P+ RL + + HPF +
Sbjct: 242 KDPKERLGCHPQTGFRDIKSHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 5e-36
Identities = 88/302 (29%), Positives = 134/302 (44%), Gaps = 58/302 (19%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFI-MKHGKSEKDIHNLRQEIEILRKLK 61
V + + +GEG++G VY+ R +G+ VA+K + M + + I +LR EI +L L+
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLR 64
Query: 62 HQNIIEMLD-----SFESPQEFCVVTEFAQGELFEILEDDKC-LPEEQVQSIAKQLVRAL 115
H NI+E+ + +S +V E+ + +L +L++ E QV+ + QL+R L
Sbjct: 65 HPNIVELKEVVVGKHLDS---IFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGL 121
Query: 116 HYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARA-------MSANTVVLRSIKGTPLY 168
YLH N IIHRD+K N+L+ +K+ DFG AR M+ V L Y
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTL-------WY 174
Query: 169 MAPELV-REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE--- 224
APEL+ Y D+W++G IL EL +P S + I+ + P+E
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII-QLLGTPNESIW 233
Query: 225 --MS--PNFKSF------------------------LKGLLNKVPQNRLTWSALLEHPFV 256
S P F L LL P+ R T LE +
Sbjct: 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293
Query: 257 KE 258
KE
Sbjct: 294 KE 295
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 6e-36
Identities = 87/293 (29%), Positives = 140/293 (47%), Gaps = 52/293 (17%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
Y +E +GEG++G V+K + + T + VA+K + E + +EI +L++LKH+N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 65 IIEMLDSFESPQEFCVVTEFAQGELFEILEDDKC---LPEEQVQSIAKQLVRALHYLHSN 121
I+ + D S ++ +V E+ +L + D C + E V+S QL++ L + HS+
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYF--DSCNGDIDPEIVKSFMFQLLKGLAFCHSH 118
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAM-------SANTVVLRSIKGTPLYMAPE-L 173
++HRD+KPQN+LI +KL DFG ARA SA V L Y P+ L
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTL-------WYRPPDVL 171
Query: 174 VREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKDPVKYPDEMS------ 226
+ Y+ + D+WS G I EL G+P F N V ++ I + + P E S
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR-LLGTPTEESWPGVSK 230
Query: 227 -PNFKSF-----------------------LKGLLNKVPQNRLTWSALLEHPF 255
P++K + L+ LL P R++ L+HP+
Sbjct: 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 83/260 (31%), Positives = 139/260 (53%), Gaps = 10/260 (3%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE---KDIHNLRQEIEILRKLKH 62
Y + + +G+GSFG VY + K +K + + E + QE ++L KL H
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQG-----ELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
I++ SF FC++TE+ +G +L E+ K L E QV QL+ +HY
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQ 177
+H RI+HRD+K +NI + +++K+ DFG +R + + + + GTP YM+PE ++ Q
Sbjct: 122 MHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV-KYPDEMSPNFKSFLKGL 236
Y+ +D+WSLG ILYE+ F + +++ IV+ P P+ S S ++ +
Sbjct: 181 GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSM 240
Query: 237 LNKVPQNRLTWSALLEHPFV 256
LNK P R + + +L +PF+
Sbjct: 241 LNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 9e-36
Identities = 82/268 (30%), Positives = 134/268 (50%), Gaps = 25/268 (9%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMK-------FIMKHGKSEKDI-HNLRQEIEILRKLK 61
EL+G+G++G+VY TG+ +A+K +H +KD+ LR EIE L+ L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 62 HQNIIEMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
H NI++ L + + + E+ G + L E+ V+ +Q++ L YLHS
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN---TVVLRSIKGTPLYMAPELV--R 175
I+HRD+K N+L+ A + K+ DFG ++ S + S++G+ +MAPE++
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKK-SDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 176 EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD----PVKYPDEMSPNFKS 231
Q Y+ D+WSLG ++ E+F G+ P+ A + + P+ P ++S N
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI--PPDVSMNLSP 243
Query: 232 ----FLKGLLNKVPQNRLTWSALLEHPF 255
FL P NR T LL+HPF
Sbjct: 244 VALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-35
Identities = 79/241 (32%), Positives = 125/241 (51%), Gaps = 6/241 (2%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTG-QTVAMKFIMKHGK-SEKDIHNLRQEIEILR 58
M E+++ I +G GSFG+V K VA+K K +K + ++ E +IL
Sbjct: 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILN 86
Query: 59 KLKHQNIIEMLDSFESPQEFCVVTEFA-QGELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
+ H + + SF+ +V EF GE F L +K P + A Q+V Y
Sbjct: 87 YINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEY 146
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQ 177
L S I++RD+KP+N+L+ +K+ DFGFA+ + T L GTP Y+APE++
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTL---CGTPEYIAPEILLNV 203
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLL 237
+ AD W+LG+ +YE+ VG PPFY N + + I++ + +P + N K +K LL
Sbjct: 204 GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLL 263
Query: 238 N 238
+
Sbjct: 264 S 264
|
Length = 340 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 89/274 (32%), Positives = 141/274 (51%), Gaps = 36/274 (13%)
Query: 8 VIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQ---EIEILRKLKHQN 64
V++ +G+G++G VYK + TG T+AMK I + E D Q E++IL K
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEI----RLELDESKFNQIIMELDILHKAVSPY 60
Query: 65 IIEMLDSF--ESPQEFCVVTEFAQGELFEILEDDKC----LPEEQVQSIAKQLVRALHYL 118
I++ +F E C+ E+ + L +PE+ ++ I +V+ L +L
Sbjct: 61 IVDFYGAFFIEGAVYMCM--EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 119 -HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL----YMAPEL 173
+ IIHRD+KP N+L+ VKLCDFG +S N V S+ T + YMAPE
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFG----VSGNLV--ASLAKTNIGCQSYMAPER 172
Query: 174 VR-EQP-----YNHTADLWSLGVILYELFVGQ---PPFYTNSVYALIRHIVK-DPVKYPD 223
++ P Y +D+WSLG+ + E+ +G+ PP +++A + IV DP P
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPS 232
Query: 224 EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVK 257
S + + F+ LNK+P R T++ LLEHP++
Sbjct: 233 GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-35
Identities = 88/302 (29%), Positives = 145/302 (48%), Gaps = 50/302 (16%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD--IHNLRQEIEILRKLK 61
+++ I+++G G+FG+V ++K TG AMK + K EK+ H +R E +IL +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAH-VRAERDILAEAD 59
Query: 62 HQNIIEMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
+ ++++ SF+ ++ E+ G++ +L EE+ + + + A+ +H
Sbjct: 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK 119
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFG------------FAR-----AMSANTVVLR--- 160
IHRD+KP N+L+ A +KL DFG F R S +
Sbjct: 120 LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM 179
Query: 161 ------------------SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPF 202
S GTP Y+APE+ + YN D WSLGVI+YE+ VG PPF
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239
Query: 203 YTNSVYALIRHIV--KDPVKYPDEM--SPNFKSFLKGLLNKVPQNRLTWSALLE---HPF 255
+++ R I+ K+ +++PDE+ SP K +K L + + RL + + E HPF
Sbjct: 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCE-AERRLGNNGVNEIKSHPF 298
Query: 256 VK 257
K
Sbjct: 299 FK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 78/220 (35%), Positives = 117/220 (53%), Gaps = 28/220 (12%)
Query: 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFI-MKHGKSEKDIHNLRQEIEILRKL 60
V Y + +G+G+FG+V+K R K T Q VA+K + M++ K I LR EI+IL+ L
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLL 68
Query: 61 KHQNI---IEMLDSFESPQ-----EFCVVTEFAQGELFEILEDDKC-LPEEQVQSIAKQL 111
KH+N+ IE+ + +P F +V EF + +L +L + +++ + K L
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKML 128
Query: 112 VRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA----------NTVVLRS 161
+ L+Y+H N+I+HRDMK NILI ++KL DFG ARA S N VV
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV--- 185
Query: 162 IKGTPLYMAPE-LVREQPYNHTADLWSLGVILYELFVGQP 200
T Y PE L+ E+ Y D+W G I+ E++ P
Sbjct: 186 ---TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 2e-35
Identities = 84/294 (28%), Positives = 135/294 (45%), Gaps = 46/294 (15%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD---IHNLRQEIEILRK 59
V+ Y + + EG++G VY+ R K TG+ VA+K + EK+ I +LR EI IL K
Sbjct: 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKME--KEKEGFPITSLR-EINILLK 60
Query: 60 LKHQNII---EMLDSFESPQEFCVVTEFAQGELFEILED-DKCLPEEQVQSIAKQLVRAL 115
L+H NI+ E++ + + +V E+ + +L ++E + + +V+ + QL+ +
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIY-MVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGV 119
Query: 116 HYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVR 175
+LH N I+HRD+K N+L+ ++K+CDFG AR + + T Y APEL+
Sbjct: 120 AHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLL 179
Query: 176 EQP-YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMS-PNFKSF- 232
Y+ D+WS+G I EL +P F S + I K + P E P F
Sbjct: 180 GAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKL-LGTPTEKIWPGFSELP 238
Query: 233 -------------------------------LKGLLNKVPQNRLTWSALLEHPF 255
L LL P R++ L+HP+
Sbjct: 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 79/260 (30%), Positives = 134/260 (51%), Gaps = 15/260 (5%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFI--MKHGKSEKD--IHNLRQEIEILRKLKHQNI 65
+ +G G+F Y+ R TG +A+K + +++ SE++ + LR+EI ++ +L H +I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 66 IEMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRII 124
I ML + F + E+ A G + +L E + + +QL+R L YLH N+II
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125
Query: 125 HRDMKPQNILIGA-GSVVKLCDFGFARAMSANTVVLRSIKG----TPLYMAPELVREQPY 179
HRD+K N+LI + G +++ DFG A ++A +G T +MAPE++R + Y
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY 185
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSV---YALIRHIVK--DPVKYPDEMSPNFKSFLK 234
+ D+WS+G ++ E+ +PP+ ALI I P+ +SP +
Sbjct: 186 GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTL 245
Query: 235 GLLNKVPQNRLTWSALLEHP 254
L P++R LL+HP
Sbjct: 246 RCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 85/290 (29%), Positives = 144/290 (49%), Gaps = 25/290 (8%)
Query: 5 NYHVIELVGEGSFGKVY---KGRRKYTGQTVAMKF-----IMKHGKSEKDIHNLRQEIEI 56
N+ ++ ++G G++GKV+ K G+ AMK I++ K+ + RQ +E
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 57 LRKLKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRAL 115
+R+ ++ + +F++ + ++ ++ G ELF L + E +V+ ++V AL
Sbjct: 61 VRRCPF--LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLAL 118
Query: 116 HYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV-LRSIKGTPLYMAPELV 174
+LH II+RD+K +NIL+ + V L DFG ++ A S GT YMAPE++
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178
Query: 175 REQP--YNHTADLWSLGVILYELFVGQPPFYT----NSVYALIRHIVKDPVKYPDEMSPN 228
R ++ D WSLGV+ +EL G PF NS + R I+K +P MS
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE 238
Query: 229 FKSFLKGLLNKVPQNRLTW---SALLEHPFVKETSDELNAWELRATSVEA 275
+ F++ LL K P+ RL + HPF + ++ +L A + A
Sbjct: 239 ARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ----GIDWDDLAAKRIPA 284
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 82/262 (31%), Positives = 127/262 (48%), Gaps = 10/262 (3%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQ 63
+++ + ++G+GSFGKV RK T + A+K + K + D+ E +L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 64 NIIEMLDS-FESPQEFCVVTEFAQGE--LFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
+ L S F++ V E+ G ++ I + K E A ++ L +LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK-FKEPHAVFYAAEIAIGLFFLHS 119
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
II+RD+K N+++ A +K+ DFG + R+ GTP Y+APE++ QPY
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYG 179
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
+ D W+ GV+LYE+ GQPPF L + I++ V YP +S S KGLL K
Sbjct: 180 KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKH 239
Query: 241 PQNRLTWSA-----LLEHPFVK 257
P RL + EH F +
Sbjct: 240 PAKRLGCGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 4e-35
Identities = 89/285 (31%), Positives = 144/285 (50%), Gaps = 16/285 (5%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEK-DIHNLRQEIEILRK 59
M E++ VI+++G G+FG+V R K + Q AMK + K ++ D +E +I+
Sbjct: 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH 99
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLH 119
+ I+++ +F+ + +V E+ G L + +PE+ + ++V AL +H
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIH 159
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK-GTPLYMAPELVREQ- 177
S IHRD+KP N+L+ +KL DFG M AN +V GTP Y++PE+++ Q
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 178 ---PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIV--KDPVKYPD--EMSPNFK 230
Y D WS+GV LYE+ VG PFY +S+ I+ K+ + +PD E+S K
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAK 279
Query: 231 SFLKGLLNKVPQNRLTWSALLE---HPFVKETSDELNAWELRATS 272
+ L RL + + E HPF K +D+ +R T
Sbjct: 280 DLICAFLTDREV-RLGRNGVDEIKSHPFFK--NDQWTFDNIRETV 321
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 6e-35
Identities = 78/262 (29%), Positives = 128/262 (48%), Gaps = 11/262 (4%)
Query: 9 IELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD-IHNLRQE---IEILRKLKHQN 64
+ ++G G FGKV K TG+ A+K + K +D + +L E E +H
Sbjct: 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 65 IIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRI 123
++ + F++ C V E+A G +L + D E + A +V L YLH N+I
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDV-FSEPRAVFYAACVVLGLQYLHENKI 122
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTA 183
++RD+K N+L+ VK+ DFG + + GTP ++APE++ E Y
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAV 182
Query: 184 DLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQN 243
D W LGV++YE+ VG+ PF + + IV D V+YP +S S ++ LL + P+
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPER 242
Query: 244 RLTWSA-----LLEHPFVKETS 260
RL + + PF ++ +
Sbjct: 243 RLGSGEKDAEDVKKQPFFRDIN 264
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 6e-35
Identities = 79/263 (30%), Positives = 137/263 (52%), Gaps = 12/263 (4%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMK---FIMKHGKSEKDIHNLRQEIEILRKLK 61
N+ + +L+G+G+FG+VY TG+ +A+K F + ++ K+++ L EI++L+ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 62 HQNIIEMLDSFESPQE--FCVVTEFA-QGELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
H+ I++ P E + E G + + L+ L E + +Q++ + YL
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA---NTVVLRSIKGTPLYMAPELVR 175
HSN I+HRD+K NIL + VKL DFG ++ + + ++S+ GTP +M+PE++
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 176 EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV--KYPDEMSPNFKSFL 233
+ Y AD+WS+G + E+ +PP+ A I I P P +S + + FL
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242
Query: 234 KGLLNKVPQNRLTWSALLEHPFV 256
K + + R + LL H FV
Sbjct: 243 KRIFVEAKL-RPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 6e-35
Identities = 91/300 (30%), Positives = 139/300 (46%), Gaps = 45/300 (15%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFI-MKHGKSEKDIHNLRQEIEILRK 59
V+ + +I +GEG++G+VYK R K TG+ VA+K + + + K I +R EI+ILR+
Sbjct: 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQ 62
Query: 60 LKHQNIIEMLDSFESPQE----------FCVVTEFAQGELFEILEDDKC-LPEEQVQSIA 108
L H+NI+ + + Q+ F +V E+ +L +LE E+ ++S
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 109 KQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL- 167
KQL+ L+Y H +HRD+K NIL+ +KL DFG AR ++ + K L
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182
Query: 168 YMAPELVR-EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK-----DPVKY 221
Y PEL+ E+ Y D+WS G IL ELF +P F N A + I + P +
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242
Query: 222 PDEMS-PNFKSF------------------------LKGLLNKVPQNRLTWSALLEHPFV 256
PD + P F + L +L P R T L P++
Sbjct: 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 9e-35
Identities = 91/291 (31%), Positives = 137/291 (47%), Gaps = 37/291 (12%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
Y ++ VG G+FG V R + TGQ VA+K IMK + +E+++L+ L+H+
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 64 NIIEMLDSFESPQE-FCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NII + D F SP E VTE +L +L + L ++ +Q Q++R L Y+HS
Sbjct: 70 NIISLSDIFISPLEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG 128
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVRE-QPYNH 181
++HRD+KP NILI +K+CDFG AR S T Y APE++ Q Y+
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS---TRYYRAPEIMLTWQKYDV 185
Query: 182 TADLWSLGVILYELFVGQPPF----YTNSVYAL--------------------IRHIVKD 217
D+WS G I E+ G+P F + N + +R +
Sbjct: 186 EVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSL 245
Query: 218 PVKYPDEMSPNFK-------SFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261
P + P S FK L+ +L PQ R++ + L HP++ D
Sbjct: 246 PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-34
Identities = 83/269 (30%), Positives = 137/269 (50%), Gaps = 15/269 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKH 62
+++ V LVG G FG+V R K TG AMK + K +++ + +E +IL
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQG-ELFEILED-DKCLPEEQVQSIAKQLVRALHYLHS 120
I ++ +F+ +V E+ G +L +L + E+ Q +LV A+H +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN-TVVLRSIKGTPLYMAPELVR---- 175
+HRD+KP+N+LI +KL DFG A ++AN V + GTP Y+APE++
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180
Query: 176 --EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIV--KDPVKYPDE--MSPNF 229
+ Y D WSLGVI YE+ G+ PF+ + +I+ + +K+P++ +S +F
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240
Query: 230 KSFLKGLLNKVPQNRLTWSALLEHPFVKE 258
++ LL + RL + L HPF +
Sbjct: 241 LDLIQSLLCG-QKERLGYEGLCCHPFFSK 268
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 89/292 (30%), Positives = 145/292 (49%), Gaps = 50/292 (17%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLR-QEIEILRKLKHQ 63
N+ +E +GEG++ VYKGR + TG+ VA+K I H +E+ + +EI ++++LKH+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEI--HLDAEEGTPSTAIREISLMKELKHE 58
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGEL---FEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
NI+ + D + + +V E+ +L + L V+S QL++ + + H
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS------ANTVVLRSIKGTPLYMAPE-L 173
NR++HRD+KPQN+LI +KL DFG ARA +N VV T Y AP+ L
Sbjct: 119 NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV------TLWYRAPDVL 172
Query: 174 VREQPYNHTADLWSLGVILYELFVGQPPFY-TNSVYALIR--HIVKDP--------VKYP 222
+ + Y+ + D+WS+G I+ E+ G+P F TN+ L++ I+ P + P
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232
Query: 223 DEMSPNFK-------------------SFLKGLLNKVPQNRLTWSALLEHPF 255
E P F L LL P+ R++ L+HP+
Sbjct: 233 -EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-34
Identities = 93/308 (30%), Positives = 145/308 (47%), Gaps = 47/308 (15%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
Y + +GEG++G V K TG VA+K I LR EI+ILR+ KH+
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHE 63
Query: 64 NIIEMLD-----SFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
NII +LD SFES + +V E + +L+++++ L + +Q Q++R L Y+
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH-LSNDHIQYFLYQILRGLKYI 122
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFAR---AMSANTVVLRSIKGTPLYMAPE-LV 174
HS ++HRD+KP N+L+ +K+CDFG AR +T L T Y APE ++
Sbjct: 123 HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIML 182
Query: 175 REQPYNHTADLWSLGVILYELFVGQPPF----YTNSVYALIRHIVKDPVK---------- 220
+ Y D+WS+G IL E+ +P F Y + + LI ++ P +
Sbjct: 183 NSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL-NLILGVLGTPSQEDLNCIISLR 241
Query: 221 ----------YP----DEMSPNFKS----FLKGLLNKVPQNRLTWSALLEHPFVKE---T 259
P +++ PN L +L P R+T L HP++++
Sbjct: 242 ARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301
Query: 260 SDELNAWE 267
SDE A E
Sbjct: 302 SDEPVAEE 309
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 2e-34
Identities = 84/266 (31%), Positives = 140/266 (52%), Gaps = 16/266 (6%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMK---FIMKHGKSEKDIHNLRQEIEILRKL 60
N+ + +L+G G+FG+VY TG+ +A+K F ++ K+++ L EI++L+ L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 61 KHQNIIEMLDSFESPQE--FCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
+H I++ P+E + E+ G + + L+ L E + +Q+++ + Y
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFAR-----AMSANTVVLRSIKGTPLYMAPE 172
LHSN I+HRD+K NIL + VKL DFG ++ MS + +S+ GTP +M+PE
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI--KSVTGTPYWMSPE 179
Query: 173 LVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVK--YPDEMSPNFK 230
++ + Y AD+WS+ + E+ +PP+ A I I P K PD +S +
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACR 239
Query: 231 SFLKGLLNKVPQNRLTWSALLEHPFV 256
FLK + + + R T LL HPFV
Sbjct: 240 DFLKQIFVE-EKRRPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 88/284 (30%), Positives = 142/284 (50%), Gaps = 37/284 (13%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-HQN 64
Y ++ +GEG+F +V K + + TG+ A+K + KH KS + ++NLR EI+ LR+L H N
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPN 59
Query: 65 IIEMLDSFESPQEFCV--VTEFAQGELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHSN 121
I+ +++ + + V E L+E+++ K LPE++V+S QL+++L ++H N
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE-LVREQPYN 180
I HRD+KP+NILI ++KL DFG R + + I T Y APE L+ + Y
Sbjct: 120 GIFHRDIKPENILI-KDDILKLADFGSCRGIYSKPPYTEYI-STRWYRAPECLLTDGYYG 177
Query: 181 HTADLWSLGVILYELFVGQPPFY-TNSV--YALIRHIVKDPV---------------KYP 222
D+W++G + +E+ P F TN + A I ++ P +P
Sbjct: 178 PKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237
Query: 223 DE-----------MSPNFKSFLKGLLNKVPQNRLTWSALLEHPF 255
+ S LK LL P R+T L HP+
Sbjct: 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-34
Identities = 73/222 (32%), Positives = 120/222 (54%), Gaps = 32/222 (14%)
Query: 6 YHVIELVGEGSFGKVYKGRRK--YTGQTVAMKFIMKHGKSEKDIH------NLRQEIEIL 57
Y + +G G++G+VYK +RK G+ A+K K +K+ + R EI +L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF----KGDKEQYTGISQSACR-EIALL 56
Query: 58 RKLKHQNIIEMLDSFESPQEFCV--VTEFAQGELFEILEDD-----KCLPEEQVQSIAKQ 110
R+LKH+N++ +++ F + V + ++A+ +L++I++ +P V+S+ Q
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 111 LVRALHYLHSNRIIHRDMKPQNILI-GAGS---VVKLCDFGFARAMSANTVVLRSIKG-- 164
++ +HYLHSN ++HRD+KP NIL+ G G VVK+ D G AR +A L +
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 165 -TPLYMAPELV---REQPYNHTADLWSLGVILYELFVGQPPF 202
T Y APEL+ R Y D+W++G I EL +P F
Sbjct: 177 VTIWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 84/261 (32%), Positives = 131/261 (50%), Gaps = 15/261 (5%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEML 69
E++G G+ G VYK T + +A+K I E + E+EIL K II
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ-KQIMSELEILYKCDSPYIIGFY 65
Query: 70 DSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMK 129
+F + TEF G ++ + +PE + IA +V+ L YL S +I+HRD+K
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVK 122
Query: 130 PQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLG 189
P N+L+ VKLCDFG + + N++ ++ GT YMAPE + + Y +D+WSLG
Sbjct: 123 PSNMLVNTRGQVKLCDFGVSTQL-VNSIA-KTYVGTNAYMAPERISGEQYGIHSDVWSLG 180
Query: 190 VILYELFVGQ---PPFYTNSVY----ALIRHIV-KDPVKYPD-EMSPNFKSFLKGLLNKV 240
+ EL +G+ P N L++ IV +DP P + S F F+ + K
Sbjct: 181 ISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQ 240
Query: 241 PQNRLTWSALLEHPFVKETSD 261
P+ R L++HPF+ + +D
Sbjct: 241 PKERPAPENLMDHPFIVQYND 261
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 89/286 (31%), Positives = 153/286 (53%), Gaps = 20/286 (6%)
Query: 5 NYHVIELVGEGSFGKVYKGRR---KYTGQTVAMKFIMKHG--KSEKDIHNLRQEIEILRK 59
N+ +++++G G++GKV+ R+ +G+ AMK + K + K + R E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 60 LKHQNIIEMLD-SFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
++ + L +F++ + ++ ++ G ELF L + E++VQ + ++V AL +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV-LRSIKGTPLYMAPELVR- 175
LH II+RD+K +NIL+ + V L DFG ++ + V S GT YMAP++VR
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180
Query: 176 -EQPYNHTADLWSLGVILYELFVGQPPFYT----NSVYALIRHIVKDPVKYPDEMSPNFK 230
+ ++ D WS+GV++YEL G PF NS + R I+K YP EMS K
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240
Query: 231 SFLKGLLNKVPQNRL-----TWSALLEHPFVKETS-DELNAWELRA 270
++ LL K P+ RL + +HPF ++ + D+L A ++ A
Sbjct: 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPA 286
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 7e-34
Identities = 83/299 (27%), Positives = 131/299 (43%), Gaps = 48/299 (16%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQ---EIEILRKL 60
Y IE +G G++G V +G+ VA+K K + ++ E++ILR
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIK---KIPHAFDVPTLAKRTLRELKILRHF 61
Query: 61 KHQNIIEMLDSFESPQE----FCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALH 116
KH NII + D P VV + + +L I+ D+ L EE ++ QL+R L
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLK 121
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK----GTPLYMAPE 172
Y+HS +IHRD+KP N+L+ +++ DFG AR +S++ + T Y APE
Sbjct: 122 YIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 173 LVREQP-YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIV---------------- 215
L+ P Y D+WS+G I E+ + F + ++ I+
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241
Query: 216 ------------KDPVK----YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258
K PV +P SP L +L P+ R+T L+HPF+ +
Sbjct: 242 DRVRKYIQNLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 7e-34
Identities = 78/245 (31%), Positives = 124/245 (50%), Gaps = 5/245 (2%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQ 63
+++ + ++G+GSFGKV RK T + A+K + K + D+ E +L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 64 NIIEMLDS-FESPQEFCVVTEFAQGE--LFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
+ L S F++ V E+ G ++ I + K E Q A ++ L +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLHR 119
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
II+RD+K N+++ + +K+ DFG + + V R+ GTP Y+APE++ QPY
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYG 179
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
+ D W+ GV+LYE+ GQPPF L + I++ V YP +S S KGL+ K
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKH 239
Query: 241 PQNRL 245
P RL
Sbjct: 240 PSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 8e-34
Identities = 73/258 (28%), Positives = 127/258 (49%), Gaps = 16/258 (6%)
Query: 11 LVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIE---ILRKL-----KH 62
++G+GSFGKV K T + A+K + +KD+ ++E + R++ +H
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKAL------KKDVVLEDDDVECTMVERRVLALAWEH 55
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
+ + +F++ + V E+ G +L ++ E + + A +++ L +LH
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK 115
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNH 181
II+RD+K N+L+ +K+ DFG + + GTP Y+APE+++ Q YN
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175
Query: 182 TADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVP 241
+ D WS GV+LYE+ +GQ PF+ L I+ D +P +S K L L + P
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDP 235
Query: 242 QNRLTWSA-LLEHPFVKE 258
RL + +HPF +
Sbjct: 236 TKRLGVDGDIRQHPFFRG 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 1e-33
Identities = 82/290 (28%), Positives = 138/290 (47%), Gaps = 39/290 (13%)
Query: 4 ENYHVIELVGEGSFGKVYKGRR-KYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK- 61
+ Y + +GEG++GKV+K R K G+ VA+K + E + +E+ +LR L+
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 62 --HQNIIEMLD-----SFESPQEFCVVTEFAQGELFEILED--DKCLPEEQVQSIAKQLV 112
H N++ + D + + +V E +L L+ + +P E ++ + QL+
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 113 RALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE 172
R L +LHS+R++HRD+KPQNIL+ + +KL DFG AR S + L S+ T Y APE
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPE 179
Query: 173 LVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHI-----VKDPVKYPDEMS- 226
++ + Y DLWS+G I E+F +P F +S + I + +P +++
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239
Query: 227 -----------------PNF----KSFLKGLLNKVPQNRLTWSALLEHPF 255
+ K L L P R++ + L HP+
Sbjct: 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 73/209 (34%), Positives = 111/209 (53%), Gaps = 14/209 (6%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
Y + E++G+GS+G V +TG+ VA+K I + D + +EI++LR L+H +I
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 66 IE----MLDSFESPQEF---CVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
+E ML S +EF VV E + +L ++++ + L E Q QL+RAL Y+
Sbjct: 62 VEIKHIMLPP--SRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM---SANTVVLRSIKGTPLYMAPELVR 175
H+ + HRD+KP+NIL A +K+CDFG AR + + T Y APEL
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179
Query: 176 E--QPYNHTADLWSLGVILYELFVGQPPF 202
Y D+WS+G I E+ G+P F
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 89/283 (31%), Positives = 131/283 (46%), Gaps = 56/283 (19%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIE-ILRKLKHQNIIEM 68
+G G+FG V K K +G +A+K I + EK+ L +++ ++R I++
Sbjct: 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 69 LDSFESPQEFCVVTEFAQG------ELFEILED----------DKCLPEEQVQSIAKQLV 112
+ F +G EL +I D +PEE + IA V
Sbjct: 69 YGAL-----------FREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATV 117
Query: 113 RALHYLHSN-RIIHRDMKPQNILIGAGSVVKLCDFG--------FARAMSANTVVLRSIK 163
+AL+YL +IIHRD+KP NIL+ +KLCDFG A+ A
Sbjct: 118 KALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA--------- 168
Query: 164 GTPLYMAPELV---REQPYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVK-DP 218
G YMAPE + Y+ +D+WSLG+ LYE+ G+ P+ NSV+ + +VK DP
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDP 228
Query: 219 VK----YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVK 257
E SP+F +F+ L K R + LLEHPF+K
Sbjct: 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 5e-33
Identities = 85/273 (31%), Positives = 146/273 (53%), Gaps = 22/273 (8%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ Y + ++G G+ G V +R G+ A+K + G SE D + + E+ L
Sbjct: 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFF 91
Query: 64 NIIEMLDSF--------ESPQEFCVVTEFAQ-GELFEILED----DKCLPEEQVQSIAKQ 110
+I++ + F E+ +V ++A G+L + ++ ++ E + + Q
Sbjct: 92 SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151
Query: 111 LVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV---VLRSIKGTPL 167
++ A+H++HS +IHRD+K NIL+ + +VKL DFGF++ M A TV V R+ GTP
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK-MYAATVSDDVGRTFCGTPY 210
Query: 168 YMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK---DPVKYPDE 224
Y+APE+ R +PY+ AD++SLGV+LYEL + PF ++ ++ + DP+ P
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL--PPS 268
Query: 225 MSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVK 257
+SP + + LL+ P+ R + S LL P K
Sbjct: 269 ISPEMQEIVTALLSSDPKRRPSSSKLLNMPICK 301
|
Length = 496 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 7e-33
Identities = 86/293 (29%), Positives = 146/293 (49%), Gaps = 35/293 (11%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
++ Y +E +GEG++G VYK R + T +T+A+K I + E +EI +L++++H
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQ--VQSIAKQLVRALHYLHS 120
NI+ + D S + +V E+ +L + ++ + +++ Q++R + Y HS
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120
Query: 121 NRIIHRDMKPQNILIG-AGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE-LVREQP 178
+R++HRD+KPQN+LI + +KL DFG ARA T Y APE L+ +
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRH 180
Query: 179 YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMS-------PNFKS 231
Y+ D+WS+G I E+ +P F +S + I + + P+E + P++KS
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFR-ILGTPNEETWPGVTSLPDYKS 239
Query: 232 -FLK------------------GLLNKV----PQNRLTWSALLEHPFVKETSD 261
F K LL+K+ P R+T A LEH + K+ D
Sbjct: 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292
|
Length = 294 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 7e-33
Identities = 91/282 (32%), Positives = 144/282 (51%), Gaps = 40/282 (14%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIE----ILRK 59
+ + +IE +G+G++GKVYK K G A+K + I ++ +EIE IL+
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-------DPISDVDEEIEAEYNILQS 74
Query: 60 L-KHQNIIEMLDSFESPQ-----------EFC---VVTEFAQGELFEILEDDKCLPEEQV 104
L H N+++ F E C VTE +G +L + L E +
Sbjct: 75 LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG----LLICGQRLDEAMI 130
Query: 105 QSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG 164
I + L +LH+NRIIHRD+K NIL+ VKL DFG + +++ + + G
Sbjct: 131 SYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 190
Query: 165 TPLYMAPELVR-EQPYNHT----ADLWSLGVILYELFVGQPP-FYTNSVYALIRHIVKDP 218
TP +MAPE++ EQ Y+++ D+WSLG+ EL G PP F + V L + I ++P
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK-IPRNP 249
Query: 219 ---VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVK 257
+ +P++ +F F+ L K + R + + LLEHPF+K
Sbjct: 250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 8e-33
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQ-------------EIEILR 58
+GEG++GKV K TG+ VA+K +K + D+ RQ E++I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIK-KVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 59 KLKHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
++KH+NI+ ++D + +V + +L ++++ L E QV+ I Q++ L+ L
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVL 135
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG-------------- 164
H +HRD+ P NI I + + K+ DFG AR K
Sbjct: 136 HKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVV 195
Query: 165 TPLYMAPELVR-EQPYNHTADLWSLGVILYELFVGQPPF 202
T Y APEL+ + Y+ D+WS+G I EL G+P F
Sbjct: 196 TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234
|
Length = 335 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 2e-32
Identities = 86/288 (29%), Positives = 142/288 (49%), Gaps = 40/288 (13%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFI-MKHGKSEKDIHNLRQEIEILRKLK--- 61
Y + +G G++G VYK R ++G VA+K + ++ + + +R E+ +L++L+
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFD 60
Query: 62 HQNIIEMLD---SFESPQEFCV--VTEFAQGELFEILED--DKCLPEEQVQSIAKQLVRA 114
H NI+ ++D + + +E V V E +L L+ LP E ++ + +Q +R
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 115 LHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELV 174
L +LH+N I+HRD+KP+NIL+ +G VKL DFG AR S + L + T Y APE++
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ-MALTPVVVTLWYRAPEVL 179
Query: 175 REQPYNHTADLWSLGVILYELFVGQPPFYTNS-------VYALIRHIVKD---------- 217
+ Y D+WS+G I E+F +P F NS ++ LI +D
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239
Query: 218 ---------PV-KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPF 255
PV E+ + L +L P R++ L+HPF
Sbjct: 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 76/245 (31%), Positives = 127/245 (51%), Gaps = 10/245 (4%)
Query: 11 LVGEGSFGKVYKGRRKYTGQTVAMKFIMKH-GKSEKDIHNLRQEIEILRKLKHQNIIEML 69
++G GS+ KV R K Q AMK + K ++DI ++ E + + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 70 DS-FESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRD 127
S F++ +V E+ G +L ++ + LPEE + A ++ AL++LH II+RD
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 128 MKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWS 187
+K N+L+ A +KL D+G + + GTP Y+APE++R + Y + D W+
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWA 181
Query: 188 LGVILYELFVGQPPF-------YTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
LGV+++E+ G+ PF N+ L + I++ P++ P +S LKG LNK
Sbjct: 182 LGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKD 241
Query: 241 PQNRL 245
P+ RL
Sbjct: 242 PKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 75/244 (30%), Positives = 122/244 (50%), Gaps = 3/244 (1%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQ 63
+++ + ++G+GSFGKV RK T + A+K + K + D+ E +L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 64 NIIEMLDS-FESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
+ L S F++ V E+ G +L ++ E A ++ L +LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNH 181
II+RD+K N+++ + +K+ DFG + + V ++ GTP Y+APE++ QPY
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180
Query: 182 TADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVP 241
+ D W+ GV+LYE+ GQ PF L + I++ V YP MS + KGL+ K P
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 240
Query: 242 QNRL 245
RL
Sbjct: 241 GKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 86/284 (30%), Positives = 135/284 (47%), Gaps = 55/284 (19%)
Query: 8 VIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIE 67
VIE +G G++G V K R TG +A+K I S++ L +++I +
Sbjct: 5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVD----- 58
Query: 68 MLDSFESPQEFCVVTEFAQGELF---------------------EILEDDKCLPEEQVQS 106
C T G LF ++ + +PE+ +
Sbjct: 59 -----------CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK 107
Query: 107 IAKQLVRALHYLHSN-RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV--VLRSIK 163
IA +V+AL YLHS +IHRD+KP N+LI VKLCDFG +S V V ++I
Sbjct: 108 IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFG----ISGYLVDSVAKTID 163
Query: 164 -GTPLYMAPELV----REQPYNHTADLWSLGVILYELFVGQPPFYTN--SVYALIRHIVK 216
G YMAPE + ++ Y+ +D+WSLG+ + EL G+ P Y + + + ++ +V+
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP-YDSWKTPFQQLKQVVE 222
Query: 217 DPV-KYPDE-MSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258
+P + P E SP F+ F+ L K + R + LL+HPF +
Sbjct: 223 EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 78/259 (30%), Positives = 134/259 (51%), Gaps = 12/259 (4%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMK---FIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
+L+G+G+FG+VY TG+ +A K F + ++ K++ L EI++L+ L+H+ I+
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 67 EMLDSFESPQE--FCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRI 123
+ E + E+ G + + L+ L E + +Q++ + YLHSN I
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSA---NTVVLRSIKGTPLYMAPELVREQPYN 180
+HRD+K NIL + VKL DFG ++ + + +RS+ GTP +M+PE++ + Y
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYG 187
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV--KYPDEMSPNFKSFLKGLLN 238
AD+WSLG + E+ +PP+ A I I P + P +S + + FL +
Sbjct: 188 RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFV 247
Query: 239 KVPQNRLTWSALLEHPFVK 257
+ R + LL HPF +
Sbjct: 248 EARH-RPSAEELLRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 85/285 (29%), Positives = 139/285 (48%), Gaps = 28/285 (9%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E+ I +G G+ G V K + TG +A K + KS LR E++I+ + +
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR-ELQIMHECRSP 63
Query: 64 NIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS-N 121
I+ +F + C+ EF G L I + +P E + IA +V L YL++ +
Sbjct: 64 YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAM---SANTVVLRSIKGTPLYMAPELVREQP 178
RI+HRD+KP NIL+ + +KLCDFG + + A+T V GT YM+PE ++
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGK 178
Query: 179 YNHTADLWSLGVILYELFVGQPPFYTN-----------SVYALIRHIVKDPV-KYP-DEM 225
Y +D+WSLG+ + EL +G+ PF + + L++ IV++P + P +
Sbjct: 179 YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF 238
Query: 226 SPNFKSFLKGLLNKVPQNRLTWSALLEHPFV----KETSDELNAW 266
+ + F+ L K P R T L P + ++ +L AW
Sbjct: 239 PEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDLQAW 283
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 1e-31
Identities = 73/265 (27%), Positives = 135/265 (50%), Gaps = 27/265 (10%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFI-MKHGKS-EKDIHNLRQEIEILRKL 60
V+ +I+ G FGKV + K T + K I K+ + E +H L +
Sbjct: 19 VKKLKLID----GKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMK-------- 66
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLH 119
+ N I++ S + + ++ ++ + G+LF++L+ + L E +V+ I +QLV AL+ LH
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 120 SNRIIHRDMKPQNILI-GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQP 178
+ IIH D+K +N+L A + LCD+G + + + GT Y +PE ++
Sbjct: 127 KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC----YDGTLDYFSPEKIKGHN 182
Query: 179 YNHTADLWSLGVILYELFVGQPPFYTN-----SVYALIRHIVKDPVKYPDEMSPNFKSFL 233
Y+ + D W++GV+ YEL G+ PF + + +L++ K + +S N F+
Sbjct: 183 YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKN-VSKNANDFV 241
Query: 234 KGLLNKVPQNRL-TWSALLEHPFVK 257
+ +L RL ++ +++HPF+K
Sbjct: 242 QSMLKYNINYRLTNYNEIIKHPFLK 266
|
Length = 267 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 79/213 (37%), Positives = 115/213 (53%), Gaps = 25/213 (11%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFI-MKH--GKSEKDIHNLRQEIEILRK 59
+E Y ++ +GEGS+ VYKGR K TGQ VA+K I ++H G I +E +L+
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI----REASLLKD 59
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKC---LPEEQVQSIAKQLVRALH 116
LKH NI+ + D + + +V E+ +L + + D C L V+ QL+R L
Sbjct: 60 LKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYM--DDCGGGLSMHNVRLFLFQLLRGLA 117
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS------ANTVVLRSIKGTPLYMA 170
Y H R++HRD+KPQN+LI +KL DFG ARA S +N VV T Y
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV------TLWYRP 171
Query: 171 PE-LVREQPYNHTADLWSLGVILYELFVGQPPF 202
P+ L+ Y+ + D+W +G I YE+ G+P F
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-31
Identities = 86/285 (30%), Positives = 144/285 (50%), Gaps = 16/285 (5%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEK-DIHNLRQEIEILRK 59
M E+Y V++++G G+FG+V R K T + AMK + K ++ D +E +I+
Sbjct: 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLH 119
++++ +F+ + +V E+ G L + +PE+ + ++V AL +H
Sbjct: 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH 159
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV-LRSIKGTPLYMAPELVREQP 178
S IHRD+KP N+L+ +KL DFG M+ +V + GTP Y++PE+++ Q
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 179 ----YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIV--KDPVKYPD--EMSPNFK 230
Y D WS+GV LYE+ VG PFY +S+ I+ K+ + +PD ++S K
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 279
Query: 231 SFLKGLLN--KVPQNRLTWSALLEHPFVKETSDELNAWE-LRATS 272
+ + L +V R + H F K ++ AWE LR T
Sbjct: 280 NLICAFLTDREVRLGRNGVEEIKRHLFFK---NDQWAWETLRDTV 321
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 5e-31
Identities = 83/293 (28%), Positives = 137/293 (46%), Gaps = 33/293 (11%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
+E Y ++ +GEG++ VYKGR K T VA+K I + +R E+ +L+ LKH
Sbjct: 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKH 63
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSN 121
NI+ + D + + +V E+ +L + L+D + V+ QL+R L+Y H
Sbjct: 64 ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR 123
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE-LVREQPYN 180
+++HRD+KPQN+LI +KL DFG ARA S T + T Y P+ L+ Y+
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK-----------------------D 217
D+W +G I YE+ G+P F ++V + I +
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243
Query: 218 PVKYPDEM---SPNFKSFLKGLLNKVPQ----NRLTWSALLEHPFVKETSDEL 263
P D + +P S LL+K+ Q R++ ++HP+ + +
Sbjct: 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERI 296
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 5e-31
Identities = 76/265 (28%), Positives = 134/265 (50%), Gaps = 18/265 (6%)
Query: 11 LVGEGSFGKVYKGRRKYTGQTVAMKFIMKH-GKSEKDIHNLRQEIEILRKL-KHQNIIEM 68
++G GS+ KV R K T + AMK + K ++DI ++ E + + H ++ +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 69 LDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRD 127
F++ V E+ G +L ++ + LPEE + + ++ AL+YLH II+RD
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 121
Query: 128 MKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWS 187
+K N+L+ + +KL D+G + + GTP Y+APE++R + Y + D W+
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 181
Query: 188 LGVILYELFVGQPPF---------YTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLN 238
LGV+++E+ G+ PF N+ L + I++ ++ P +S S LK LN
Sbjct: 182 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLN 241
Query: 239 KVPQNRL------TWSALLEHPFVK 257
K P+ RL ++ + HPF +
Sbjct: 242 KDPKERLGCHPQTGFADIQGHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 6e-31
Identities = 78/262 (29%), Positives = 132/262 (50%), Gaps = 20/262 (7%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIE---ILRKL-----K 61
+++G+GSFGKV+ K T Q A+K + +KD+ + ++E + +++ +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKAL------KKDVVLMDDDVECTMVEKRVLSLAWE 54
Query: 62 HQNIIEMLDSFESPQEFCVVTEFAQGE--LFEILEDDKC-LPEEQVQSIAKQLVRALHYL 118
H + + +F++ + V E+ G +F I K LP A +++ L +L
Sbjct: 55 HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFL 112
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQP 178
HS I++RD+K NIL+ +K+ DFG + + GTP Y+APE++ Q
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK 172
Query: 179 YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLN 238
YN + D WS GV+LYE+ +GQ PF+ + L + I D YP ++ K L L
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFV 232
Query: 239 KVPQNRLTWSA-LLEHPFVKET 259
+ P+ RL + +HPF +E
Sbjct: 233 REPERRLGVKGDIRQHPFFREI 254
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 9e-31
Identities = 84/256 (32%), Positives = 132/256 (51%), Gaps = 19/256 (7%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
+E Y ++ +GEG++ V+KGR K T VA+K I + +R E+ +L+ LKH
Sbjct: 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKH 62
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKC---LPEEQVQSIAKQLVRALHYLH 119
NI+ + D + + +V E+ +L + L D C + V+ QL+R L Y H
Sbjct: 63 ANIVTLHDIIHTERCLTLVFEYLDSDLKQYL--DNCGNLMSMHNVKIFMFQLLRGLSYCH 120
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE-LVREQP 178
+I+HRD+KPQN+LI +KL DFG ARA S T + T Y P+ L+
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 179 YNHTADLWSLGVILYELFVGQPPFYTNSV---YALIRHIVKDPVK--YPDEMS-PNFKSF 232
Y+ D+W +G ILYE+ G+P F ++V LI ++ P + +P S F+S+
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240
Query: 233 L------KGLLNKVPQ 242
L + L+N P+
Sbjct: 241 LFPQYRAQPLINHAPR 256
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-30
Identities = 77/263 (29%), Positives = 129/263 (49%), Gaps = 20/263 (7%)
Query: 11 LVGEGSFGKVYKGRRKYTGQTVAMKFI----MKHGKSEKDIHNLRQEIEILRKLKHQNII 66
++G+G FG+V + + TG+ A K + +K K E N +Q IL K+ + ++
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ---ILEKVNSRFVV 63
Query: 67 EMLDSFESPQEFC-VVTEFAQGEL-FEILE-DDKCLPEEQVQSIAKQLVRALHYLHSNRI 123
+ ++E+ C V+T G+L F I + EE+ A ++ L LH RI
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI 123
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTA 183
++RD+KP+NIL+ +++ D G A + + R GT YMAPE+V+ + Y +
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI-RGRVGTVGYMAPEVVKNERYTFSP 182
Query: 184 DLWSLGVILYELFVGQPPF--YTNSVY--ALIRHIVKDPVKYPDEMSPNFKSFLKGLLNK 239
D W LG ++YE+ G+ PF V + R + +D +Y ++ S +S + LL K
Sbjct: 183 DWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTK 242
Query: 240 VPQNRL-----TWSALLEHPFVK 257
P RL + HPF +
Sbjct: 243 DPGFRLGCRGEGAEEVKAHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 79/238 (33%), Positives = 124/238 (52%), Gaps = 14/238 (5%)
Query: 30 QTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQG-- 87
+ V KF+M + E+ R E+ L H I++ D F+S + ++ E+ G
Sbjct: 94 EKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGD 151
Query: 88 ---ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLC 144
++ + L++ E +V + Q+V AL +HS +++HRD+K NI + ++KL
Sbjct: 152 LNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLG 211
Query: 145 DFGFARAMSANTV--VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPF 202
DFGF++ S + V S GTP Y+APEL + Y+ AD+WSLGVILYEL PF
Sbjct: 212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF 271
Query: 203 YTNSVYALIRHIV---KDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVK 257
S +++ ++ DP +P +S K+ L LL+K P R T LL F+K
Sbjct: 272 KGPSQREIMQQVLYGKYDP--FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-30
Identities = 86/297 (28%), Positives = 145/297 (48%), Gaps = 47/297 (15%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD-IHNLRQEIEILRKLKH 62
+++ ++++G G+FG+V ++K TG AMK + K EK+ + ++R E +IL +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 63 QNIIEMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
+++M SF+ + ++ EF G++ +L L EE Q + V A+ +H
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFG------------FARAMSANT------------- 156
IHRD+KP N+L+ A VKL DFG F R ++ N
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 157 ----------VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS 206
+ S GTP Y+APE+ + YN D WSLGVI+YE+ +G PPF + +
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 207 VYALIRHIV--KDPVKYPDEMSPNFKSFLKGLLNKV---PQNRLTWSALLE---HPF 255
R ++ K+ + +P E+ + K+ K L+ + +NR+ + + E HPF
Sbjct: 241 PQETYRKVMNWKETLVFPPEVPISEKA--KDLILRFCTDSENRIGSNGVEEIKSHPF 295
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-30
Identities = 83/284 (29%), Positives = 147/284 (51%), Gaps = 14/284 (4%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEK-DIHNLRQEIEILRK 59
M E+Y V++++G G+FG+V R K + + AMK + K ++ D +E +I+
Sbjct: 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLH 119
++++ +F+ + +V E+ G L + +PE+ + ++V AL +H
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIH 159
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV-LRSIKGTPLYMAPELVREQP 178
S +IHRD+KP N+L+ +KL DFG M +V + GTP Y++PE+++ Q
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 179 ----YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIV--KDPVKYPD--EMSPNFK 230
Y D WS+GV L+E+ VG PFY +S+ I+ K+ + +P+ E+S + K
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAK 279
Query: 231 SFLKGLLN--KVPQNRLTWSALLEHPFVKETSDELNAWELRATS 272
+ + L +V R + +HPF K +D+ N +R T+
Sbjct: 280 NLICAFLTDREVRLGRNGVEEIKQHPFFK--NDQWNWDNIRETA 321
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 83/281 (29%), Positives = 138/281 (49%), Gaps = 40/281 (14%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIE----ILRK 59
+ + +IE +G+G++GKV+K K G A+K + IH++ +EIE IL+
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL-------DPIHDIDEEIEAEYNILKA 70
Query: 60 LK-HQNIIEMLDSFESPQ-----------EFC---VVTEFAQGELFEILEDDKCLPEEQV 104
L H N+++ + E C VT+ +G L+ + + E +
Sbjct: 71 LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG----FLKRGERMEEPII 126
Query: 105 QSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG 164
I + + L +LH N+ IHRD+K NIL+ VKL DFG + +++ + + G
Sbjct: 127 AYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 186
Query: 165 TPLYMAPELVR-----EQPYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKDP 218
TP +MAPE++ + Y+ D+WSLG+ EL G PP + + AL + I ++P
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK-IPRNP 245
Query: 219 ---VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256
+ P+ S F F++ L K + R T S LL+H F+
Sbjct: 246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 86/293 (29%), Positives = 136/293 (46%), Gaps = 44/293 (15%)
Query: 4 ENYHVIELVGEGSFGKVYKGR-----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILR 58
+E +GEG+FGKVYKG + + +VA+K +K K RQE E++
Sbjct: 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIK-TLKENAEPKVQQEFRQEAELMS 63
Query: 59 KLKHQNIIEMLDSFESPQEFCVVTEF-AQGELFEIL------EDDKCLPE-EQVQS---- 106
L+H NI+ +L Q C++ E+ A G+L E L D E V+S
Sbjct: 64 DLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123
Query: 107 -----IAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM-SANTVVLR 160
IA Q+ + YL S+ +HRD+ +N L+G G VK+ DFG +R + SA+ ++
Sbjct: 124 SDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 161 SIKGTPL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFY---TNSVYALIR--H 213
S P+ +M PE + + +D+WS GV+L+E+F G P+Y V +IR
Sbjct: 184 SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ 243
Query: 214 IVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDELNAW 266
++ P P + + N++P R P K+ L +W
Sbjct: 244 LLPCPEDCP----ARVYALMIECWNEIPARR---------PRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-29
Identities = 81/288 (28%), Positives = 127/288 (44%), Gaps = 39/288 (13%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
Y I+ +G G++G V + T + VA+K I + D +EI++LR L H+N+
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66
Query: 66 IEMLDSFESPQ-----EFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
I + D P + +V E +L +I+ + L ++ Q QL+R L Y+HS
Sbjct: 67 IAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS 126
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVRE-QPY 179
++HRD+KP N+L+ A +K+CDFG AR S + T Y APEL+ Y
Sbjct: 127 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEY 186
Query: 180 NHTADLWSLGVILYELFVGQPPF----YTNSVYALI--------------------RHIV 215
D+WS+G I EL +P F Y + + + R+I
Sbjct: 187 TTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIR 246
Query: 216 KDPV--------KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPF 255
P +P +P L+ +L P R+T L HP+
Sbjct: 247 SLPYTPRQSFARLFPH-ANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 2e-29
Identities = 68/207 (32%), Positives = 111/207 (53%), Gaps = 3/207 (1%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
+E Y +E +GEG++ V+KGR K T VA+K I + +R E+ +L+ LKH
Sbjct: 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKH 63
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSN 121
NI+ + D + + +V E+ +L + ++D + V+ Q++R L Y H
Sbjct: 64 ANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE-LVREQPYN 180
+++HRD+KPQN+LI +KL DFG ARA S T + T Y P+ L+ Y+
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSV 207
D+W +G I +E+ G+P F ++V
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFPGSTV 210
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 89/299 (29%), Positives = 142/299 (47%), Gaps = 49/299 (16%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E Y ++ VG G++G V K TG+ VA+K + + +SE +E+ +L+ ++H+
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 64 NIIEMLDSFESP------QEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
N+I +LD F S Q+F +V + Q +L +I+ L E++VQ + Q++ L Y
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP--LSEDKVQYLVYQMLCGLKY 132
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT---VVLRSIKGTPLYMAPELV 174
+HS IIHRD+KP N+ + +K+ DFG AR A VV R Y APE++
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR------WYRAPEVI 186
Query: 175 RE-QPYNHTADLWSLGVILYELFVGQPPF----YTNSVYALI------------------ 211
YN T D+WS+G I+ E+ G+ F Y + + ++
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246
Query: 212 -RHIVKDPVKYPDE--------MSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261
+ +K KYP + SP L+ +L RLT + LEHP+ D
Sbjct: 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 83/306 (27%), Positives = 145/306 (47%), Gaps = 51/306 (16%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ Y ++ VG G++G V + TG VA+K + + +SE +E+ +L+ +KH+
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 64 NIIEMLDSFESPQ------EFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
N+I +LD F +F +V F +L ++++ +K L E+++Q + Q+++ L Y
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK-LSEDRIQFLVYQMLKGLKY 133
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT---VVLRSIKGTPLYMAPELV 174
+H+ IIHRD+KP N+ + +K+ DFG AR + VV R Y APE++
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR------WYRAPEVI 187
Query: 175 RE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEM-----SPN 228
Y T D+WS+G I+ E+ G+P F + + I+K E S +
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247
Query: 229 FKSFLKGL----------------------LNKV----PQNRLTWSALLEHPF---VKET 259
K+++K L L K+ ++R+T + L HP+ +
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307
Query: 260 SDELNA 265
DE A
Sbjct: 308 EDETEA 313
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 84/277 (30%), Positives = 143/277 (51%), Gaps = 38/277 (13%)
Query: 8 VIELVGEGSFGKVYKG------RRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL- 60
+ + +GEG+FG+V K T TVA+K ++K +EKD+ +L E+E+++ +
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNET-STVAVK-MLKDDATEKDLSDLVSEMEMMKMIG 73
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFA-QGELFEILE-----------DDKCLPEEQVQ--- 105
KH+NII +L VV E+A G L + L DD PEE +
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 106 --SIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK 163
S A Q+ R + +L S + IHRD+ +N+L+ V+K+ DFG AR + ++
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 164 G-TPL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSV---YALIR--HIV 215
G P+ +MAPE + ++ Y H +D+WS GV+L+E+F +G P+ V + L++ + +
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRM 253
Query: 216 KDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252
+ P E+ ++ ++VP R T+ L+E
Sbjct: 254 EKPQNCTQELY----HLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-29
Identities = 74/261 (28%), Positives = 127/261 (48%), Gaps = 39/261 (14%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD-IHNLRQEIEILRKLKH 62
E++ ++++G G+FG+V ++K TG AMK + K EK+ + ++R E +IL +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 63 QNIIEMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
+++M SF+ ++ EF G++ +L L EE+ Q + V A+ +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAM--SANTVVLRSIK---------------- 163
IHRD+KP N+L+ + VKL DFG + + T R++
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 164 -----------------GTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS 206
GTP Y+APE+ + YN D WSLGVI+YE+ +G PPF + +
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 207 VYALIRHIV--KDPVKYPDEM 225
+ ++ K+ + +P E+
Sbjct: 241 PQETYKKVMNWKETLIFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 82/303 (27%), Positives = 134/303 (44%), Gaps = 61/303 (20%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ Y +E +GEG++GKVYK R K TG+ VA+K E +EI +L+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGE-----LFEILEDD-------------KCLPEEQVQ 105
I L E E G+ +FE L+ D + LP + ++
Sbjct: 61 IYIVRLLDVEH-------VEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 106 SIAKQLVRALHYLHSNRIIHRDMKPQNILIG-AGSVVKLCDFGFARAMSANTVVLRSIKG 164
S QL++ + + H + ++HRD+KPQN+L+ ++K+ D G RA ++ ++S
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF---SIPVKSYTH 170
Query: 165 ---TPLYMAPE-LVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHI------ 214
T Y APE L+ Y+ D+WS+G I E+ QP F +S + HI
Sbjct: 171 EIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230
Query: 215 -----------VKDPVKYP-----------DEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252
++D ++P ++SP L+ +L P R++ A L
Sbjct: 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290
Query: 253 HPF 255
HP+
Sbjct: 291 HPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 7e-29
Identities = 86/302 (28%), Positives = 133/302 (44%), Gaps = 47/302 (15%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYT--GQTVAMKFIMK-HGKSEKDIHNLRQEIEILRKLK 61
Y +I+ +G+G++G V R T +TVA+K I K LR E+++LR +
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFR 59
Query: 62 -HQNIIEMLDS---FESP-QEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALH 116
H+NI + D F E + E + +L +I+ + L + QS Q++ L
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLK 119
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV----LRSIKGTPLYMAPE 172
Y+HS ++HRD+KP N+L+ A +K+CDFG AR S N + T Y APE
Sbjct: 120 YIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 173 -LVREQPYNHTADLWSLGVILYELFVGQPPFY---------------------------T 204
++ Q Y D+WS+G IL EL +P F +
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239
Query: 205 NSVYALIRHIVKDPVK-----YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259
IR + P K +P+ +P L+ LL P R++ LEHP++
Sbjct: 240 PKAQNYIRSLPNIPKKPFESIFPNA-NPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298
Query: 260 SD 261
D
Sbjct: 299 HD 300
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 21/210 (10%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIH--NLRQEIEILRKLK 61
E + + +G G FG+V++G K + VA+K + KS+ + + ++E++ L++L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVR-VAIKIL----KSDDLLKQQDFQKEVQALKRLR 60
Query: 62 HQNIIEMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQS------IAKQLVRA 114
H+++I + + ++TE +G L L PE QV +A Q+
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS----PEGQVLPVASLIDMACQVAEG 116
Query: 115 LHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-YMAPEL 173
+ YL IHRD+ +NIL+G V K+ DFG AR + V L S K P + APE
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEA 175
Query: 174 VREQPYNHTADLWSLGVILYELFV-GQPPF 202
++ +D+WS G++LYE+F GQ P+
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFTYGQVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 9e-29
Identities = 71/201 (35%), Positives = 106/201 (52%), Gaps = 5/201 (2%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDI-HNLRQEIEILRKLKHQ 63
+Y +E +GEGS+ VYKG + GQ VA+K I K+E+ + +E +L+ LKH
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVI--SMKTEEGVPFTAIREASLLKGLKHA 63
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGELFE-ILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+ + D + + V E+ +L + +++ L V+ QL+R L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE-LVREQPYNH 181
I+HRD+KPQN+LI +KL DFG ARA S + S T Y P+ L+ Y+
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183
Query: 182 TADLWSLGVILYELFVGQPPF 202
D+W G I E+ GQP F
Sbjct: 184 ALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-28
Identities = 104/377 (27%), Positives = 172/377 (45%), Gaps = 50/377 (13%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
Y VI+ +G G FG+V+ + K T + K I G E++ L E+ ++R+LKH+NI
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74
Query: 66 IEMLDSF--ESPQEFCVVTEFAQ-GELFEILEDDKC------LPEEQVQSIAKQLVRALH 116
+ +D F ++ Q+ ++ EF G+L ++ KC + E + I +QL+ AL
Sbjct: 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQ--KCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 117 YLHS-------NRIIHRDMKPQNILIGAG-----------------SVVKLCDFGFARAM 152
Y H+ R++HRD+KPQNI + G + K+ DFG ++ +
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 153 SANTVVLRSIKGTPLYMAPELV--REQPYNHTADLWSLGVILYELFVGQPPFY-TNSVYA 209
++ S GTP Y +PEL+ + Y+ +D+W+LG I+YEL G+ PF+ N+
Sbjct: 193 GIESMA-HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ 251
Query: 210 LIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDELNAWELR 269
LI + + P S +K LLN + R + L + +K + A
Sbjct: 252 LISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPPVGAAGGG 311
Query: 270 ATSVEARGCNATW---TAEGNAIQSSSGKSNSPAVSANNTSPSLHTDVELNSSNTSQ--S 324
A A G + E +Q ++ + A +AN + + +N N Q
Sbjct: 312 AGVAAAPGAVVARRNPSKEHPGLQLAAMEKAKHAEAANY---GISPNTLINQRNEEQHGR 368
Query: 325 NSSPCEAFPGFSSPNNV 341
SS C + S NNV
Sbjct: 369 RSSSCAS---RQSANNV 382
|
Length = 1021 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 76/271 (28%), Positives = 142/271 (52%), Gaps = 22/271 (8%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEK-DIHNLRQEIEILRKLKH 62
+++ +++++G G+FG+V + K TGQ AMK + K ++ + R+E ++L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 63 QNIIEMLDSFESPQEFCVVTEF-AQGELFEILE--DDKCLPEEQVQSIAKQLVRALHYLH 119
+ I + +F+ +V ++ G+L +L +D+ LPE+ + ++V A+ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVLAIDSVH 119
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK-GTPLYMAPELVREQP 178
+HRD+KP N+L+ ++L DFG + A+ V ++ GTP Y++PE+++
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 179 -----YNHTADLWSLGVILYELFVGQPPFYTNSV---YALIRHIVKDPVKYPDE---MSP 227
Y D WSLGV +YE+ G+ PFY S+ Y I + K+ ++P + +S
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN-HKEHFQFPPDVTDVSE 238
Query: 228 NFKSFLKGLLNKVPQNRLTWSAL---LEHPF 255
K ++ L+ P+ RL + L +HPF
Sbjct: 239 EAKDLIRRLICS-PETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-28
Identities = 84/308 (27%), Positives = 146/308 (47%), Gaps = 57/308 (18%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD-IHNLRQEIEILRKLKH 62
E++H ++++G+G+FG+V ++K TG+ AMK ++K +KD + +++ E ++L +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 63 QNIIEMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
++ + SF+ Q ++ EF G+L +L E+ + + V A+ +H
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFA-----------------------RAMSANTVV 158
IHRD+KP NILI G +KL DFG + R + N+V
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 159 LRSIK------------------------GTPLYMAPELVREQPYNHTADLWSLGVILYE 194
+ SI GTP Y+APE+ +Q Y D WSLG I++E
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
Query: 195 LFVGQPPFYTNSVYALIRHIV--KDPVKYPDE--MSPNFKSFLKGLLNKVPQNRLTWSAL 250
+G PPF + + + R I+ ++ + +PD+ +S + ++ L+ +NRL
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITN-AENRLGRGGA 299
Query: 251 LE---HPF 255
E HPF
Sbjct: 300 HEIKSHPF 307
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 80/271 (29%), Positives = 141/271 (52%), Gaps = 18/271 (6%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKY---TGQTVAMKFIMKHG--KSEKDIHNLRQEIEILRK 59
N+ +++++G G++GKV+ R+ TG+ AMK + K + K + + R E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 60 LKHQNIIEMLD-SFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
++ + L +F++ + ++ ++ G E+F L E++V+ + +++ AL +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARA-MSANTVVLRSIKGTPLYMAPELVRE 176
LH I++RD+K +NIL+ + V L DFG ++ +S S GT YMAPE++R
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180
Query: 177 QP-YNHTADLWSLGVILYELFVGQPPFY----TNSVYALIRHIVKDPVKYPDEMSPNFKS 231
+ + D WSLG++++EL G PF N+ + R I+K +P + P +
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240
Query: 232 FLKGLLNKVPQNRL-----TWSALLEHPFVK 257
L LL K P+ RL S + EHPF K
Sbjct: 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 24/205 (11%)
Query: 9 IELVGEGSFGKVYKGR----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
I+ +GEG FGKV R TG+ VA+K + H E+ + +EIEILR L H+N
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVK-SLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 65 IIEMLDSFESP--QEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVR-------A 114
I++ E P + ++ E+ G L L + Q K+L+
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSL------RDYLQRHRDQINLKRLLLFSSQICKG 121
Query: 115 LHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT--VVLRSIKGTPL-YMAP 171
+ YL S R IHRD+ +NIL+ + +VK+ DFG A+ + + ++ +P+ + AP
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 172 ELVREQPYNHTADLWSLGVILYELF 196
E +R ++ +D+WS GV LYELF
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 93/340 (27%), Positives = 156/340 (45%), Gaps = 35/340 (10%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIE--ILRK----LKHQ 63
+++G+GSFGKV K G+ A+K + +KD+ + ++E ++ K L +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKAL------KKDVVLIDDDVECTMVEKRVLALAWE 54
Query: 64 N--IIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
N + + +F++ + V EF G +L ++D + A ++V L +LHS
Sbjct: 55 NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS 114
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
II+RD+K N+++ +K+ DFG + + GTP Y+APE+++ Y
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYT 174
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
+ D WS GV+LYE+ +GQ PF+ + L I D YP ++ K L+ L +
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERD 234
Query: 241 PQNRLTWSALLE-HPFVKETSDELNAWELRATSVEARGCNATWTAEGNAIQSSSGKSNSP 299
P RL + HPF K + W T++E R + + K SP
Sbjct: 235 PTRRLGVVGNIRGHPFFKTIN-----W----TALEKRELDPPFKP----------KVKSP 275
Query: 300 AVSANNTSPSLHTDVELNSSNTSQSNSSPCEAFPGFSSPN 339
+ +N L L+ S+ + +S AF GFS N
Sbjct: 276 SDYSNFDREFLSEKPRLSYSDKNLIDSMDQSAFAGFSFIN 315
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-27
Identities = 83/274 (30%), Positives = 141/274 (51%), Gaps = 38/274 (13%)
Query: 12 VGEGSFGKVYKGR-------RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQ 63
+GEG FG+V + R TVA+K ++K ++KD+ +L E+E+++ + KH+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK-MLKDNATDKDLADLISEMELMKLIGKHK 78
Query: 64 NIIEMLDSFESPQEFCVVTEFA-QGELFEILE-----------DDKCLPEEQVQ-----S 106
NII +L V+ E+A +G L E L D +PEEQ+ S
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 107 IAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG-T 165
A Q+ R + YL S R IHRD+ +N+L+ +V+K+ DFG AR + ++ G
Sbjct: 139 CAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL 198
Query: 166 PL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPF---YTNSVYALIR--HIVKDP 218
P+ +MAPE + ++ Y H +D+WS G++++E+F +G P+ ++ L+R H + P
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKP 258
Query: 219 VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252
E+ ++ + VP R T+ L+E
Sbjct: 259 SNCTHELY----MLMRECWHAVPTQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 82/278 (29%), Positives = 136/278 (48%), Gaps = 18/278 (6%)
Query: 11 LVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKHQNIIEML 69
++G+G FG+V + + TG+ A K + K K K E +IL K+ + ++ +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 70 DSFESPQEFCVV-TEFAQGEL-FEILE-DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHR 126
++E+ C+V T G+L F I + E + A ++ L LH RI++R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYR 126
Query: 127 DMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLW 186
D+KP+NIL+ +++ D G A + + + GT YMAPE+V+ + Y + D W
Sbjct: 127 DLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFSPDWW 185
Query: 187 SLGVILYELFVGQPPFYTNS---VYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLNKVPQ 242
+LG +LYE+ GQ PF + +VK+ +Y ++ SP+ +S K LL K P+
Sbjct: 186 ALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPK 245
Query: 243 NRL-----TWSALLEHPFVKETSDELNAWELRATSVEA 275
RL + EHP K ++N L A +E
Sbjct: 246 ERLGCQGGGAREVKEHPLFK----QINFKRLEAGMLEP 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 85/304 (27%), Positives = 132/304 (43%), Gaps = 64/304 (21%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFI-MKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLD 70
+G GS G V+ + VA+K I + +S K H LR EI+I+R+L H NI+++ +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK--HALR-EIKIIRRLDHDNIVKVYE 69
Query: 71 -----------SFESPQEF---CVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALH 116
S E +V E+ + +L +LE L EE + QL+R L
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP-LSEEHARLFMYQLLRGLK 128
Query: 117 YLHSNRIIHRDMKPQNILIGAGS-VVKLCDFGFARAMSANTVVLRSIKG-------TPLY 168
Y+HS ++HRD+KP N+ I V+K+ DFG AR + + S KG T Y
Sbjct: 129 YIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY----SHKGYLSEGLVTKWY 184
Query: 169 MAPELVREQPYNHT--ADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK---------- 216
+P L+ P N+T D+W+ G I E+ G+P F ++ I++
Sbjct: 185 RSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243
Query: 217 ------DPVKYPDEMS----------PNFKS----FLKGLLNKVPQNRLTWSALLEHPFV 256
P ++ P FL+ +L P +RLT L HP++
Sbjct: 244 NELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303
Query: 257 KETS 260
S
Sbjct: 304 SCYS 307
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 68/201 (33%), Positives = 105/201 (52%), Gaps = 3/201 (1%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
++Y +E +GEGS+ VYKG+ K G+ VA+K I + +R E +L+ LKH
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKC-LPEEQVQSIAKQLVRALHYLHSNR 122
NI+ + D + + +V E+ +L + ++ L E V+ QL+R L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE-LVREQPYNH 181
I+HRD+KPQN+LI +KL DFG ARA S + + T Y P+ L+ Y+
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 182 TADLWSLGVILYELFVGQPPF 202
D+W +G I E+ G F
Sbjct: 184 CLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 77/261 (29%), Positives = 130/261 (49%), Gaps = 16/261 (6%)
Query: 11 LVGEGSFGKVYKGRRKYTGQTVAMKFI----MKHGKSEKDIHNLRQEIEILRKLKHQNII 66
++G G FG+VY R+ TG+ AMK + +K + E N R + ++ I+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 67 EMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIH 125
M +F +P + C + + G +L L E++++ A +++ L ++H+ +++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 126 RDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVRE-QPYNHTAD 184
RD+KP NIL+ V++ D G A S + GT YMAPE++++ Y+ +AD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGTAYDSSAD 178
Query: 185 LWSLGVILYELFVGQPPFY---TNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVP 241
+SLG +L++L G PF T + + R + V+ PD SP KS L+GLL +
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV 238
Query: 242 QNRLTW-----SALLEHPFVK 257
RL + EH F K
Sbjct: 239 SKRLGCLGRGAQEVKEHVFFK 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 78/264 (29%), Positives = 127/264 (48%), Gaps = 20/264 (7%)
Query: 11 LVGEGSFGKVYKGRRKYTGQTVAMKFI------MKHGKSEKDIHNLRQEIEILRKLKHQN 64
++G G FG+VY R+ TG+ AMK + MK G E N R + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGDCPF 58
Query: 65 IIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRI 123
I+ M +F +P + + + G +L L E +++ A +++ L ++H+ +
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFV 118
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE-LVREQPYNHT 182
++RD+KP NIL+ V++ D G A S + GT YMAPE L + Y+ +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGVAYDSS 176
Query: 183 ADLWSLGVILYELFVGQPPF---YTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNK 239
AD +SLG +L++L G PF T + + R + V+ PD SP +S L+GLL +
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236
Query: 240 VPQNRLTW-----SALLEHPFVKE 258
RL + EHPF +
Sbjct: 237 DVNRRLGCLGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 80/274 (29%), Positives = 141/274 (51%), Gaps = 38/274 (13%)
Query: 12 VGEGSFGKVYKGR-------RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQ 63
+GEG FG+V + TVA+K ++K +EKD+ +L E+E+++ + KH+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVK-MLKDDATEKDLSDLVSEMEMMKMIGKHK 81
Query: 64 NIIEMLDSFESPQEFCVVTEFA-QGELFEILE-----------DDKCLPEEQVQ-----S 106
NII +L + V+ E+A +G L E L D +P+EQ+ S
Sbjct: 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 107 IAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGT- 165
Q+ R + YL S + IHRD+ +N+L+ +V+K+ DFG AR ++ ++ G
Sbjct: 142 CTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL 201
Query: 166 PL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIR-----HIVKDP 218
P+ +MAPE + ++ Y H +D+WS GV+++E+F +G P+ V L + H + P
Sbjct: 202 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP 261
Query: 219 VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252
+E+ ++ + +P +R T+ L+E
Sbjct: 262 ANCTNELY----MMMRDCWHAIPSHRPTFKQLVE 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 9e-27
Identities = 83/271 (30%), Positives = 142/271 (52%), Gaps = 32/271 (11%)
Query: 12 VGEGSFGKVYKG------RRKYTGQT-VAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQ 63
+GEG FG+V + K T VA+K ++K +EKD+ +L E+E+++ + KH+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVK-MLKSDATEKDLSDLISEMEMMKMIGKHK 84
Query: 64 NIIEMLDSFESPQEFCVVTEFA-QGELFEILE-----------DDKCLPEEQVQ-----S 106
NII +L + V+ E+A +G L E L + +PEEQ+ S
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 107 IAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGT- 165
A Q+ R + YL S + IHRD+ +N+L+ +V+K+ DFG AR + ++ G
Sbjct: 145 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 204
Query: 166 PL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKD--PVKY 221
P+ +MAPE + ++ Y H +D+WS GV+L+E+F +G P+ V L + ++K+ +
Sbjct: 205 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-LLKEGHRMDK 263
Query: 222 PDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252
P + ++ + VP R T+ L+E
Sbjct: 264 PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 75/260 (28%), Positives = 126/260 (48%), Gaps = 24/260 (9%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQT---VAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
+ +G+GSFG V +G +G VA+K +K K + + +E I+ L H+N+I
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 67 EM----LDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSI---AKQLVRALHYL 118
+ L +VTE A G L + L D L + ++ A Q+ + YL
Sbjct: 60 RLYGVVLT-----HPLMMVTELAPLGSLLDRLRKD-ALGHFLISTLCDYAVQIANGMRYL 113
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI--KGTPL-YMAPELVR 175
S R IHRD+ +NIL+ + VK+ DFG RA+ N P + APE +R
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 176 EQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVK--DPVKYPDEMSPNFKSF 232
+ ++H +D+W GV L+E+F G+ P+ S +++ I K + ++ P+ + +
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNV 233
Query: 233 LKGLLNKVPQNRLTWSALLE 252
+ P +R T++AL E
Sbjct: 234 MLQCWAHNPADRPTFAALRE 253
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 2e-26
Identities = 84/271 (30%), Positives = 142/271 (52%), Gaps = 32/271 (11%)
Query: 12 VGEGSFGKVYKGR-------RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQ 63
+GEG FG+V + TVA+K ++K ++KD+ +L E+E+++ + KH+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVK-MLKDDATDKDLSDLVSEMEMMKMIGKHK 78
Query: 64 NIIEMLDSFESPQEFCVVTEFA-QGELFEILED----------DKC-LPEEQVQ-----S 106
NII +L + V+ E+A +G L E L D C LPEEQ+ S
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 107 IAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGT- 165
A Q+ R + YL S + IHRD+ +N+L+ +V+K+ DFG AR + ++ G
Sbjct: 139 CAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL 198
Query: 166 PL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKD--PVKY 221
P+ +MAPE + ++ Y H +D+WS GV+L+E+F +G P+ V L + ++K+ +
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDK 257
Query: 222 PDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252
P + ++ + VP R T+ L+E
Sbjct: 258 PANCTHELYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 2e-26
Identities = 64/214 (29%), Positives = 116/214 (54%), Gaps = 11/214 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEK-DIHNLRQEIEILRKLKH 62
+++ +I+++G G+FG+V + K+T + AMK + K ++ + R+E +L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 63 QNIIEMLDSFESPQEFCVVTEF-AQGELFEILE--DDKCLPEEQVQSIAKQLVRALHYLH 119
Q I + +F+ +V ++ G+L +L +D+ LPE+ + ++V A+H +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIH 119
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK-GTPLYMAPELVREQ- 177
+HRD+KP N+L+ ++L DFG M+ + V S+ GTP Y++PE+++
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 178 ----PYNHTADLWSLGVILYELFVGQPPFYTNSV 207
Y D WSLGV +YE+ G+ PFY S+
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 70/275 (25%), Positives = 121/275 (44%), Gaps = 29/275 (10%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQT-----VAMKFIMKHGKSEKDIHNLRQEIEILR 58
+ + +GEG+FGKV+ G + VA+K +K S + +E E+L
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVK-TLKETASNDARKDFEREAELLT 63
Query: 59 KLKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEIL------------EDDKC--LPEEQ 103
+H+NI++ +V E+ + G+L + L D L Q
Sbjct: 64 NFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123
Query: 104 VQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK 163
+ IA Q+ + YL S +HRD+ +N L+G VVK+ DFG +R + +
Sbjct: 124 LLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY--RVG 181
Query: 164 GTPL----YMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKDP 218
G + +M PE + + + +D+WS GV+L+E+F G+ P+Y S +I I +
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR 241
Query: 219 VKYPDEMSPNF-KSFLKGLLNKVPQNRLTWSALLE 252
+ P+ + G + PQ R+ + E
Sbjct: 242 LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 74/222 (33%), Positives = 115/222 (51%), Gaps = 15/222 (6%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLR--QEIEILRKLK 61
E Y + VG G++G V Q VA+K + + +S IH R +E+ +L+ +K
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL--IHARRTYRELRLLKHMK 72
Query: 62 HQNIIEMLDSF------ESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRAL 115
H+N+I +LD F E+ E +VT +L I++ K L +E VQ + QL+R L
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK-LSDEHVQFLIYQLLRGL 131
Query: 116 HYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVR 175
Y+HS IIHRD+KP N+ + +++ DFG AR + T Y APE++
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE---MTGYVATRWYRAPEIML 188
Query: 176 E-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK 216
YN T D+WS+G I+ EL G+ F N ++ I++
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIME 230
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 81/284 (28%), Positives = 134/284 (47%), Gaps = 36/284 (12%)
Query: 9 IELVGEGSFGKVYKGRRKYTG----QTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
+E +GE +FGK+YKG G Q VA+K +K + + +QE ++ +L H N
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIK-TLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 65 IIEMLDSFESPQEFCVVTEF-AQGELFEIL------EDDKCLPEEQ--VQS--------- 106
I+ +L Q C++ E+ QG+L E L D C +E V+S
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 107 IAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM-SANTVVLRSIKGT 165
IA Q+ + YL S+ +H+D+ +NILIG VK+ D G +R + SA+ ++
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 166 PL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKDP-VKYP 222
P+ +M PE + ++ +D+WS GV+L+E+F G P+Y S +I + K +
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCS 248
Query: 223 DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDELNAW 266
++ P S + + P R P K+ L +W
Sbjct: 249 EDCPPRMYSLMTECWQEGPSRR---------PRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 9 IELVGEGSFGKVYKG---RRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILR------K 59
EL G G+FG V KG + VA+K + K H + E LR +
Sbjct: 1 KEL-GHGNFGSVVKGVYLMKSGKEVEVAVKTL-------KQEHIAAGKKEFLREASVMAQ 52
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFA-QGELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
L H I+ ++ + +V E A G L + L+ + +P ++ +A Q+ + YL
Sbjct: 53 LDHPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYL 111
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGT--PL-YMAPELVR 175
S +HRD+ +N+L+ K+ DFG +RA+ A + R+ PL + APE +
Sbjct: 112 ESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 176 EQPYNHTADLWSLGVILYELF-VGQPPF 202
++ +D+WS GV L+E F G P+
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQT-VAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
E+ + +G G FG+V+ G + G T VA+K +K G + QE +I++KL+H
Sbjct: 6 ESLKLERKLGAGQFGEVWMG--TWNGTTKVAVK-TLKPGTMSPE--AFLQEAQIMKKLRH 60
Query: 63 QNIIEMLDSFESPQEFCVVTEF-AQGELFEILEDD--KCLPEEQVQSIAKQLVRALHYLH 119
++++ + +VTE+ ++G L + L+ K L Q+ +A Q+ + YL
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS-----IKGTPLYMAPELV 174
S IHRD+ +NIL+G V K+ DFG AR + + R IK T APE
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAA 176
Query: 175 REQPYNHTADLWSLGVILYELFV-GQPPF 202
+ +D+WS G++L E+ G+ P+
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-26
Identities = 71/215 (33%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK------HQNI 65
+G G+FG V+ G+ VA+K K NL + R+LK H N+
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALK------KMPNVFQNLVSCKRVFRELKMLCFFKHDNV 61
Query: 66 IEMLDSFESP-----QEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
+ LD + P +E VVTE Q +L +I+ + L + V+ Q++R L YLHS
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARA--------MSANTVVLRSIKGTPLYMAPE 172
I+HRD+KP N+L+ + V+K+CDFG AR M+ V T Y APE
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-------TQYYRAPE 174
Query: 173 -LVREQPYNHTADLWSLGVILYELFVGQPPFYTNS 206
L+ + Y D+WS+G I EL + F S
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-25
Identities = 76/260 (29%), Positives = 123/260 (47%), Gaps = 14/260 (5%)
Query: 11 LVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKHQNIIEML 69
++G+G FG+V + + TG+ A K + K K K E +IL K+ Q ++ +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 70 DSFESPQEFCVV-TEFAQGEL-FEILE-DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHR 126
++E+ C+V T G+L F I + EE+ A +++ L LH ++R
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYR 126
Query: 127 DMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLW 186
D+KP+NIL+ +++ D G A + + R GT YMAPE++ Q Y + D W
Sbjct: 127 DLKPENILLDDYGHIRISDLGLAVKIPEGESI-RGRVGTVGYMAPEVLNNQRYTLSPDYW 185
Query: 187 SLGVILYELFVGQPPFYTNSVYA----LIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQ 242
LG ++YE+ GQ PF + R +++ Y + S KS K LL K P+
Sbjct: 186 GLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPK 245
Query: 243 NRLTW-----SALLEHPFVK 257
RL + HPF +
Sbjct: 246 QRLGCQEEGAGEVKRHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 71/208 (34%), Positives = 109/208 (52%), Gaps = 15/208 (7%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLR--QEIEILRKLK 61
E Y + VG G++G V TG VA+K + + +S IH R +E+ +L+ +K
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMK 74
Query: 62 HQNIIEMLD------SFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRAL 115
H+N+I +LD S E + +VT +L I++ K L ++ VQ + Q++R L
Sbjct: 75 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGL 133
Query: 116 HYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVR 175
Y+HS IIHRD+KP N+ + +K+ DFG AR + T Y APE++
Sbjct: 134 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIML 190
Query: 176 E-QPYNHTADLWSLGVILYELFVGQPPF 202
YN T D+WS+G I+ EL G+ F
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 83/303 (27%), Positives = 139/303 (45%), Gaps = 51/303 (16%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHN-LRQEIEILRKLKH 62
+++ + +G G+ G V K + +G +A K I H + + I N + +E+++L +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLI--HLEIKPAIRNQIIRELKVLHECNS 58
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
I+ +F S E + E G L ++L+ +PE + I+ ++R L YL
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK 118
Query: 122 R-IIHRDMKPQNILIGAGSVVKLCDFGFARAM---SANTVVLRSIKGTPLYMAPELVREQ 177
I+HRD+KP NIL+ + +KLCDFG + + AN+ V GT YM+PE ++
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGT 173
Query: 178 PYNHTADLWSLGVILYELFVGQ----PPFYTN---------------------------- 205
Y +D+WSLG+ L E+ +G+ PP
Sbjct: 174 HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233
Query: 206 ----SVYALIRHIVKD-PVKYPDE-MSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259
+++ L+ +IV + P K P S F+ F+ L K P+ R L +HPF+K
Sbjct: 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293
Query: 260 SDE 262
E
Sbjct: 294 ELE 296
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 75/246 (30%), Positives = 126/246 (51%), Gaps = 16/246 (6%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQ-EIEILRKLKHQNIIEMLD 70
+G+G FG+V + K TG+ A K + K +K + E EIL K+ I+ +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 71 SFESPQEFCVVTEFAQG-----ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIH 125
+FES C+V G ++ + E + L E+V + Q+ + +LHS I++
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSMDIVY 118
Query: 126 RDMKPQNILIGAGSVVKLCDFGFARAM-SANTVVLRSIKGTPLYMAPELVREQPYNHTAD 184
RDMKP+N+L+ +L D G A + T+ R+ GT YMAPE+++E+PY++ D
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA--GTNGYMAPEILKEEPYSYPVD 176
Query: 185 LWSLGVILYELFVGQPPF--YTNSVYA--LIRHIVKDPVKYP-DEMSPNFKSFLKGLLNK 239
+++G +YE+ G+ PF + V L R ++D VK+ + K + L K
Sbjct: 177 WFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236
Query: 240 VPQNRL 245
P++RL
Sbjct: 237 KPEDRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 72/223 (32%), Positives = 115/223 (51%), Gaps = 45/223 (20%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQ------------EIEILRK 59
VG G++G VYK +RK GK EK+ + L+Q EI +LR+
Sbjct: 9 VGRGTYGHVYKAKRK-------------DGKDEKE-YALKQIEGTGISMSACREIALLRE 54
Query: 60 LKHQNIIEMLDSF--ESPQEFCVVTEFAQGELFEILEDDKC---------LPEEQVQSIA 108
LKH N+I + F S ++ ++ ++A+ +L+ I++ + LP V+S+
Sbjct: 55 LKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLL 114
Query: 109 KQLVRALHYLHSNRIIHRDMKPQNILI-GAG---SVVKLCDFGFARAMSANTVVLRSIKG 164
Q++ +HYLH+N ++HRD+KP NIL+ G G VK+ D GFAR ++ L +
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174
Query: 165 ---TPLYMAPELVR-EQPYNHTADLWSLGVILYELFVGQPPFY 203
T Y APEL+ + Y D+W++G I EL +P F+
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-25
Identities = 72/232 (31%), Positives = 111/232 (47%), Gaps = 15/232 (6%)
Query: 28 TGQTVAMKFI-MKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFC-VVTEFA 85
TG VA+K + + E R+E + +L H NI+ +LDS E+P V E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 86 QGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILI---GAGSVV 141
G L E+L D LP + + Q++ AL H+ I+HRD+KPQNI++ G
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 142 KLCDFGF------ARAMSANTVVLRS-IKGTPLYMAPELVREQPYNHTADLWSLGVILYE 194
K+ DFG R T+ + + GTP Y APE +R +P +DL++ G+I E
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
Query: 195 LFVGQPPFYTNSVYALI-RHIVKDPVKYPDEMSPN-FKSFLKGLLNKVPQNR 244
GQ SV ++ + + V P ++ + L+ LNK P+ R
Sbjct: 182 CLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 74/243 (30%), Positives = 121/243 (49%), Gaps = 9/243 (3%)
Query: 11 LVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKHQNIIEML 69
++G+G FG+V + + TG+ A K + K K K E IL K+ + ++ +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 70 DSFESPQEFCVV-TEFAQGEL-FEILE-DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHR 126
++E+ C+V T G+L F I + E++ A +L L L RI++R
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR 126
Query: 127 DMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLW 186
D+KP+NIL+ +++ D G A + V R GT YMAPE++ + Y + D W
Sbjct: 127 DLKPENILLDDRGHIRISDLGLAVQIPEGETV-RGRVGTVGYMAPEVINNEKYTFSPDWW 185
Query: 187 SLGVILYELFVGQPPF--YTNSVY--ALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQ 242
LG ++YE+ GQ PF V + R + +D +Y ++ S + KS + LL K P+
Sbjct: 186 GLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPK 245
Query: 243 NRL 245
RL
Sbjct: 246 ERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 5e-25
Identities = 71/253 (28%), Positives = 112/253 (44%), Gaps = 32/253 (12%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
Y VI+ + GS G+V+ + V +K K E +L+ + H +
Sbjct: 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTT--------LIEAMLLQNVNHPS 118
Query: 65 IIEMLDSFESPQEFCVVTEFAQGELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLHSNRI 123
+I M D+ S C+V +L+ L + + LP +Q I KQ++ L YLH+ RI
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRI 178
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTA 183
IHRD+K +NI I V + D G A+ L + GT APE++ YN A
Sbjct: 179 IHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL-GLAGTVETNAPEVLARDKYNSKA 237
Query: 184 DLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV--- 240
D+WS G++L+E+ A I +DP P+E + S L +++ +
Sbjct: 238 DIWSAGIVLFEML------------AYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285
Query: 241 -------PQNRLT 246
P +RL
Sbjct: 286 PEEFPRDPGSRLV 298
|
Length = 357 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 68/258 (26%), Positives = 115/258 (44%), Gaps = 41/258 (15%)
Query: 7 HVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
+ +G+G FG V G Y GQ VA+K + + E ++ L+H N++
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTA---AQAFLAEASVMTTLRHPNLV 63
Query: 67 EMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALH------YLH 119
++L +VTE+ A+G L + L V ++A+QL AL YL
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR----GRAVITLAQQLGFALDVCEGMEYLE 119
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR-SIKGTPLYMAPELVREQP 178
+HRD+ +N+L+ V K+ DFG A+ S + +K T APE +RE+
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKK 175
Query: 179 YNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKD-----PVKYPDE-------- 224
++ +D+WS G++L+E++ G+ P+ + ++ H+ K P P E
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDC 235
Query: 225 ------MSPNFKSFLKGL 236
P FK + L
Sbjct: 236 WELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 84/313 (26%), Positives = 148/313 (47%), Gaps = 61/313 (19%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHN-LRQEIEILRKLKH 62
+++ I +G G+ G V K + K +G +A K I H + + I N + +E+++L +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLI--HLEIKPAIRNQIIRELQVLHECNS 62
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYL-HS 120
I+ +F S E + E G L ++L++ K +PEE + ++ ++R L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAM---SANTVVLRSIKGTPLYMAPELVREQ 177
++I+HRD+KP NIL+ + +KLCDFG + + AN+ V GT YM+PE ++
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGT 177
Query: 178 PYNHTADLWSLGVILYELFVGQPPFY---------------------------------- 203
Y+ +D+WS+G+ L EL +G+ P
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG 237
Query: 204 ------------TNSVYALIRHIVKDPV-KYPDEM-SPNFKSFLKGLLNKVPQNRLTWSA 249
+++ L+ +IV +P K P+ + +P+F+ F+ L K P R
Sbjct: 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKM 297
Query: 250 LLEHPFVKETSDE 262
L+ H F+K + E
Sbjct: 298 LMNHTFIKRSEVE 310
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 73/271 (26%), Positives = 140/271 (51%), Gaps = 22/271 (8%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEK-DIHNLRQEIEILRKLKH 62
E++ +++++G G+FG+V + K + AMK + K ++ + R+E ++L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 63 QNIIEMLDSFESPQEFCVVTEF-AQGELFEILE--DDKCLPEEQVQSIAKQLVRALHYLH 119
Q I + +F+ +V ++ G+L +L +D+ LPE+ + ++V A+ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVH 119
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK-GTPLYMAPELVREQP 178
+HRD+KP NIL+ ++L DFG + + V S+ GTP Y++PE+++
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 179 -----YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIV--KDPVKYP---DEMSPN 228
Y D WSLGV +YE+ G+ PFY S+ I+ K+ ++P ++S +
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239
Query: 229 FKSFLKGLL----NKVPQNRLTWSALLEHPF 255
K ++ L+ +++ QN + +HPF
Sbjct: 240 AKDLIRRLICSREHRLGQNGI--EDFKQHPF 268
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-24
Identities = 71/223 (31%), Positives = 115/223 (51%), Gaps = 45/223 (20%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQ------------EIEILRK 59
VG G++G VYK +RK GK ++D + L+Q EI +LR+
Sbjct: 9 VGRGTYGHVYKAKRK-------------DGKDDRD-YALKQIEGTGISMSACREIALLRE 54
Query: 60 LKHQNIIEMLDSFES--PQEFCVVTEFAQGELFEILEDDKC---------LPEEQVQSIA 108
LKH N+I + F S ++ ++ ++A+ +L+ I++ + LP V+S+
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 114
Query: 109 KQLVRALHYLHSNRIIHRDMKPQNILI-GAG---SVVKLCDFGFARAMSANTVVLRSIKG 164
Q++ +HYLH+N ++HRD+KP NIL+ G G VK+ D GFAR ++ L +
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174
Query: 165 ---TPLYMAPELVR-EQPYNHTADLWSLGVILYELFVGQPPFY 203
T Y APEL+ + Y D+W++G I EL +P F+
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 78/297 (26%), Positives = 129/297 (43%), Gaps = 50/297 (16%)
Query: 11 LVGEGSFGK--VYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEM 68
L+G+ V+ + K T VA+K I S++D+ L+QEI R+L+H NI+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 69 LDSFESPQEFCVVTEF-AQGELFEILEDDKC--LPEEQVQSIAKQLVRALHYLHSNRIIH 125
+ SF E VV+ A G ++L+ LPE + I K ++ AL Y+HS IH
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIH 124
Query: 126 RDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLY-------MAPELVRE-- 176
R +K +IL+ V L ++ +M + R + P ++PE++++
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184
Query: 177 QPYNHTADLWSLGVILYELFVGQPPF--------YTNSVYALIRHIVKDPVKYPDEM--- 225
Q YN +D++S+G+ EL G PF V + ++ D YP
Sbjct: 185 QGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLL-DKSTYPLYEDSM 243
Query: 226 ------------------------SPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258
S +F F++ L + P++R + S LL H F K+
Sbjct: 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 68/253 (26%), Positives = 105/253 (41%), Gaps = 63/253 (24%)
Query: 8 VIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK----------HGKSEKDIHNLRQEIEIL 57
I+ +G G+FG+V R+ T AMK + K H K+E+DI L
Sbjct: 5 KIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDI---------L 55
Query: 58 RKLKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALH 116
+ ++ ++++ SF+ V ++ G ++ +L E+ + +L A+
Sbjct: 56 AEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIE 115
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFA--------------------------- 149
+H IHRD+KP NILI +KL DFG
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 150 ---------------RAMSANTVVL-RSIKGTPLYMAPELVREQPYNHTADLWSLGVILY 193
R + L S+ GTP Y+APE++ Y D WS+GVILY
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235
Query: 194 ELFVGQPPFYTNS 206
E+ VGQPPF ++
Sbjct: 236 EMLVGQPPFLADT 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 93/303 (30%), Positives = 140/303 (46%), Gaps = 54/303 (17%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
++Y + ++G GSFG VY+ T + VA+K +++ D +E+ I++ L H
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ------DPQYKNRELLIMKNLNHI 119
Query: 64 NIIEMLDSF--------ESPQEFCVVTEFAQGELFEILE----DDKCLPEEQVQSIAKQL 111
NII + D + E VV EF + + ++ ++ LP V+ + QL
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL 179
Query: 112 VRALHYLHSNRIIHRDMKPQNILIGAGS-VVKLCDFGFARAMSANTVVLRSIK--GTPLY 168
RAL Y+HS I HRD+KPQN+LI + +KLCDFG A+ + A RS+ + Y
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---RSVSYICSRFY 236
Query: 169 MAPELVR-EQPYNHTADLWSLGVILYELFVGQPPFY-TNSVYALIRHI------------ 214
APEL+ Y DLWSLG I+ E+ +G P F +SV L+R I
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296
Query: 215 VKDP----VKYPDEMSPNFK------------SFLKGLLNKVPQNRLTWSALLEHPFVKE 258
+P +K+PD + K +F+ L P RL L PF +
Sbjct: 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356
Query: 259 TSD 261
D
Sbjct: 357 LRD 359
|
Length = 440 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 6e-24
Identities = 64/198 (32%), Positives = 107/198 (54%), Gaps = 12/198 (6%)
Query: 9 IELVGEGSFGKV----YKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
I ++GEG FGKV Y TG+ VA+K +K +++ ++EI IL+ L H+N
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVK-TLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 65 IIEMLD--SFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
I++ S + + ++ E+ G L + L K L Q+ A+Q+ + YLHS
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFAQQICEGMAYLHSQ 126
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG--TPLY-MAPELVREQP 178
IHRD+ +N+L+ +VK+ DFG A+A+ R + +P++ A E ++E
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 179 YNHTADLWSLGVILYELF 196
+++ +D+WS GV LYEL
Sbjct: 187 FSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 57/190 (30%), Positives = 105/190 (55%), Gaps = 11/190 (5%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLD- 70
+G G +G+VY+G K TVA+K +K E + +E +++++KH N++++L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVK-TLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 71 -SFESPQEFCVVTEF-AQGELFEILE--DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHR 126
+ E P F ++TEF G L + L + + + + +A Q+ A+ YL IHR
Sbjct: 71 CTREPP--FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 128
Query: 127 DMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-YMAPELVREQPYNHTADL 185
D+ +N L+G +VK+ DFG +R M+ +T + P+ + APE + ++ +D+
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 188
Query: 186 WSLGVILYEL 195
W+ GV+L+E+
Sbjct: 189 WAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 11/201 (5%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQ-----TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
+GEG FG VY+G Y VA+K K+ S QE I+R+ H +
Sbjct: 12 RCIGEGQFGDVYQG--VYMSPENEKIAVAVK-TCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 65 IIEMLDSFESPQEFCVVTEFAQGELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHSNRI 123
I++++ + V+ GEL L+ +K L + + QL AL YL S R
Sbjct: 69 IVKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRF 128
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-YMAPELVREQPYNHT 182
+HRD+ +N+L+ + VKL DFG +R + + S P+ +MAPE + + +
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSA 188
Query: 183 ADLWSLGVILYELFV-GQPPF 202
+D+W GV ++E+ + G PF
Sbjct: 189 SDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 19/219 (8%)
Query: 53 EIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLV 112
E ILR + H +II++ +F + C++ + +L+ L + + + +I + ++
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVL 192
Query: 113 RALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFG---FARAMSANTVVLRSIKGTPLYM 169
RA+ YLH NRIIHRD+K +NI I V L DFG F ++AN GT
Sbjct: 193 RAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY--GWAGTIATN 250
Query: 170 APELVREQPYNHTADLWSLGVILYELFVGQPPFYTN-----------SVYALIRHIVKDP 218
APEL+ PY D+WS G++L+E+ + + +IR P
Sbjct: 251 APELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP 310
Query: 219 VKYPDEMSPNFKSFLKGLLNKV---PQNRLTWSALLEHP 254
++P + N GL K P +R W+ L E P
Sbjct: 311 NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELP 349
|
Length = 391 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 70/253 (27%), Positives = 122/253 (48%), Gaps = 25/253 (9%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEML 69
E++GEG FG V +G +YTGQ VA+K I K + +E ++ KL H+N++ +L
Sbjct: 12 EIIGEGEFGAVLQG--EYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLL 65
Query: 70 DSFESPQEFCVVTEF-AQGELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHR 126
+V E ++G L L + Q+ + + + YL S +++HR
Sbjct: 66 GVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHR 124
Query: 127 DMKPQNILIGAGSVVKLCDFGFARA--MSANTVVLRSIKGTPLYMAPELVREQPYNHTAD 184
D+ +NIL+ V K+ DFG AR M + L +K T APE ++ + ++ +D
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL-PVKWT----APEALKHKKFSSKSD 179
Query: 185 LWSLGVILYELF-VGQPPFYTNSVYALIRHIVK----DPVKYPDEMSPNFKSFLKGLLNK 239
+WS GV+L+E+F G+ P+ S+ + + K +P P+ + +
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP---PEGCPADVYVLMTSCWET 236
Query: 240 VPQNRLTWSALLE 252
P+ R ++ L E
Sbjct: 237 EPKKRPSFHKLRE 249
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 9e-23
Identities = 63/199 (31%), Positives = 111/199 (55%), Gaps = 13/199 (6%)
Query: 9 IELVGEGSFGKV----YKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
I+ +G+G+FG V Y + TG+ VA+K ++H +E + + +EIEIL+ L+H N
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVK-KLQHSTAEH-LRDFEREIEILKSLQHDN 66
Query: 65 IIEMLDSFESP--QEFCVVTEF-AQGELFEILEDDKC-LPEEQVQSIAKQLVRALHYLHS 120
I++ S + +V E+ G L + L+ + L ++ A Q+ + + YL S
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT--VVLRSIKGTPLY-MAPELVREQ 177
R +HRD+ +NIL+ + + VK+ DFG + + + +R +P++ APE + E
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 178 PYNHTADLWSLGVILYELF 196
++ +D+WS GV+LYELF
Sbjct: 187 KFSVASDVWSFGVVLYELF 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 14/232 (6%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
Y+++ + GS G+V+ + G K I+K K +EI+IL+ + H+ I
Sbjct: 94 YNILSSLTPGSEGEVFVCTKH--GDEQRKKVIVKAVTGGK---TPGREIDILKTISHRAI 148
Query: 66 IEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIH 125
I ++ ++ C+V + +LF ++ LP EQ +I ++L+ AL YLH IIH
Sbjct: 149 INLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIH 208
Query: 126 RDMKPQNILIGAGSVVKLCDFGFA--RAMSANTVVLRSIKGTPLYMAPELVREQPYNHTA 183
RD+K +NI + L DFG A +T GT +PEL+ PY
Sbjct: 209 RDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKT 268
Query: 184 DLWSLGVILYELFVGQPPFYTNSV-------YALIRHIVKDPVKYPDEMSPN 228
D+WS G++L+E+ V + V ++IR + P+++P S N
Sbjct: 269 DIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320
|
Length = 392 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 64/205 (31%), Positives = 111/205 (54%), Gaps = 12/205 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQT-VAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
E+ +I+ +G G FG+V+ G + G T VA+K +K G + + +E +I++KL+H
Sbjct: 6 ESLQLIKKLGNGQFGEVWMG--TWNGNTKVAVK-TLKPGTMSPE--SFLEEAQIMKKLRH 60
Query: 63 QNIIEMLDSFESPQEFCVVTEF-AQGELFEILEDD--KCLPEEQVQSIAKQLVRALHYLH 119
+++ L + S + +VTE+ ++G L + L+D + L + +A Q+ + Y+
Sbjct: 61 DKLVQ-LYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-YMAPELVREQP 178
IHRD++ NIL+G G V K+ DFG AR + N R P+ + APE
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 179 YNHTADLWSLGVILYELFV-GQPPF 202
+ +D+WS G++L EL G+ P+
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 2e-22
Identities = 64/199 (32%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 9 IELVGEGSFGKV----YKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
I +GEG FGKV Y TG+ VA+K +K I +L++EIEILR L H+N
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVK-SLKPESGGNHIADLKKEIEILRNLYHEN 67
Query: 65 IIEM--LDSFESPQEFCVVTEF-AQGELFEILEDDKC-LPEEQVQSIAKQLVRALHYLHS 120
I++ + + + ++ EF G L E L +K + +Q A Q+ + + YL S
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT---VVLRSIKGTPLYMAPELVREQ 177
+ +HRD+ +N+L+ + VK+ DFG +A+ + V + + APE + +
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 178 PYNHTADLWSLGVILYELF 196
+ +D+WS GV LYEL
Sbjct: 188 KFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-22
Identities = 75/302 (24%), Positives = 140/302 (46%), Gaps = 51/302 (16%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
++ Y ++ +G G+ G V G VA+K + + +++ +E+ +L+ + H
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 79
Query: 63 QNIIEMLDSF------ESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALH 116
+NII +L+ F E Q+ +V E L +++ + L E++ + Q++ +
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME--LDHERMSYLLYQMLCGIK 137
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVRE 176
+LHS IIHRD+KP NI++ + +K+ DFG AR N ++ + T Y APE++
Sbjct: 138 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV-TRYYRAPEVILG 196
Query: 177 QPYNHTADLWSLGVILYELFVGQPPF----------------------YTNSVYALIRHI 214
Y D+WS+G I+ EL G F + N + +R+
Sbjct: 197 MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256
Query: 215 VKDPVKYP----DEMSPNF------------KSFLKGLLNKV----PQNRLTWSALLEHP 254
V++ +YP +E+ P++ S + LL+K+ P R++ L HP
Sbjct: 257 VENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316
Query: 255 FV 256
++
Sbjct: 317 YI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 7e-22
Identities = 67/231 (29%), Positives = 117/231 (50%), Gaps = 17/231 (7%)
Query: 12 VGEGSFGKVYKGRRKYTGQT-VAMKFIMKHGKSEKDIHN---LRQEIEILRKL-KHQNII 66
+G G+FGKV + ++ MK +K K L E++I+ L H+NI+
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 67 EMLDSFESPQEFCVVTEFA-QGELFEIL--EDDKCLPEEQVQSIAKQLVRALHYLHSNRI 123
+L + V+TE+ G+L L + + L E + S + Q+ + + +L S
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC 162
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFAR-AMSANTVVLRSIKGTPL-YMAPELVREQPYNH 181
IHRD+ +N+L+ G +VK+CDFG AR M+ + V++ P+ +MAPE + Y
Sbjct: 163 IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTF 222
Query: 182 TADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKD------PVKYPDEM 225
+D+WS G++L+E+F +G P+ V + ++K+ P P E+
Sbjct: 223 ESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEI 273
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 13/202 (6%)
Query: 12 VGEGSFGKVYKGRRKYTGQT-VAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLD 70
+G G FG+V++G + T VA+K + KD E +I++KL+H +I++
Sbjct: 14 LGAGQFGEVWEGL--WNNTTPVAVKTLKPGTMDPKD---FLAEAQIMKKLRHPKLIQLYA 68
Query: 71 SFESPQEFCVVTEF-AQGELFEILEDDKC--LPEEQVQSIAKQLVRALHYLHSNRIIHRD 127
+ +VTE G L E L+ L Q+ +A Q+ + YL + IHRD
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRD 128
Query: 128 MKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-YMAPELVREQPYNHTADLW 186
+ +N+L+G ++ K+ DFG AR + + R P+ + APE ++ +D+W
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 187 SLGVILYELFV-GQPPF--YTN 205
S G++L E+ G+ P+ TN
Sbjct: 189 SFGILLTEIVTYGRMPYPGMTN 210
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 54/216 (25%), Positives = 108/216 (50%), Gaps = 16/216 (7%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNL----RQEIEILRK 59
N I +G G FG+V+ + K + ++ + NL R+E+++ RK
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEIL-----EDDKCLPE----EQVQSIAK 109
L H+N++ +L + ++ E+ G+L + L +D+K P +Q ++
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 110 QLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFAR-AMSANTVVLRSIKGTPLY 168
Q+ + +L + R +HRD+ +N L+ + VK+ ++ ++ LR+ +
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRW 184
Query: 169 MAPELVREQPYNHTADLWSLGVILYELFV-GQPPFY 203
+APE V+E ++ +D+WS GV+++E+F G+ PFY
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY 220
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-21
Identities = 64/226 (28%), Positives = 113/226 (50%), Gaps = 38/226 (16%)
Query: 12 VGEGSFGKVYK-------GRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
+GEG FGKV K GR YT TVA+K ++K S ++ +L E +L+++ H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYT--TVAVK-MLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 65 IIEMLDSFESPQEFCVVTEFAQ-GELFEIL------------------------EDDKCL 99
+I++ + ++ E+A+ G L L D++ L
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 100 PEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM-SANTVV 158
+ S A Q+ R + YL +++HRD+ +N+L+ G +K+ DFG +R + ++ V
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 159 LRSIKGTPL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPF 202
RS P+ +MA E + + Y +D+WS GV+L+E+ +G P+
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 61/196 (31%), Positives = 105/196 (53%), Gaps = 10/196 (5%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDS 71
+G+G FG+V+ G T + VA+K +K G + QE ++++KL+H+ +++ L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTR-VAIK-TLKPGTMSPEA--FLQEAQVMKKLRHEKLVQ-LYA 68
Query: 72 FESPQEFCVVTEF-AQGELFEIL--EDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDM 128
S + +VTE+ ++G L + L E K L Q+ +A Q+ + Y+ +HRD+
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 128
Query: 129 KPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-YMAPELVREQPYNHTADLWS 187
+ NIL+G V K+ DFG AR + N R P+ + APE + +D+WS
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 188 LGVILYELFV-GQPPF 202
G++L EL G+ P+
Sbjct: 189 FGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 55/203 (27%), Positives = 105/203 (51%), Gaps = 11/203 (5%)
Query: 9 IELVGEGSFGKVYKGRRKYTGQT----VAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
I+++G G+FG VYKG G+ VA+K +++ S K + E ++ + H +
Sbjct: 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIK-VLREETSPKANKEILDEAYVMASVDHPH 70
Query: 65 IIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHSNR 122
++ +L S Q ++T+ G L + + + K + + + + Q+ + + YL R
Sbjct: 71 VVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR 129
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG-TPL-YMAPELVREQPYN 180
++HRD+ +N+L+ VK+ DFG A+ + + + G P+ +MA E + + Y
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYT 189
Query: 181 HTADLWSLGVILYELFV-GQPPF 202
H +D+WS GV ++EL G P+
Sbjct: 190 HKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 5e-21
Identities = 69/215 (32%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 10 ELVGEGSFGKVYKGRRKYTG--QTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNII 66
+++GEG+FG+V K R K G A+K MK S+ D + E+E+L KL H NII
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 67 EMLDSFESPQEFCVVTEFA-QGELFE------ILEDD----------KCLPEEQVQSIAK 109
+L + E + E+A G L + +LE D L +Q+ A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 110 QLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-Y 168
+ R + YL + IHRD+ +NIL+G V K+ DFG +R V +++ P+ +
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE--VYVKKTMGRLPVRW 189
Query: 169 MAPELVREQPYNHTADLWSLGVILYELF-VGQPPF 202
MA E + Y +D+WS GV+L+E+ +G P+
Sbjct: 190 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 6e-21
Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 57/305 (18%)
Query: 9 IELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD-IHNLRQEIEILRKLKHQNIIE 67
I+ +G G+FG+V R+ T AMK + K ++ + +++ E +IL + ++ ++
Sbjct: 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVR 65
Query: 68 MLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHR 126
+ SF+ V ++ G++ +L PE+ + +L A+ +H IHR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125
Query: 127 DMKPQNILIGAGSVVKLCDFGFA------------------------------------- 149
D+KP NILI +KL DFG
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRC 185
Query: 150 ---------RAMSANTVVL-RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQ 199
RA + L S+ GTP Y+APE++ Y D WS+GVILYE+ VGQ
Sbjct: 186 GDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 245
Query: 200 PPFYTNSVYALIRHIVK--DPVKYPDE--MSPNFKSFLKGLLNKVPQNRLTWSALLE--- 252
PPF + ++ + P + +SP + L + P++RL + E
Sbjct: 246 PPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304
Query: 253 HPFVK 257
HPF K
Sbjct: 305 HPFFK 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 7e-21
Identities = 70/302 (23%), Positives = 137/302 (45%), Gaps = 51/302 (16%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
++ Y ++ +G G+ G V + VA+K + + +++ +E+ +++ + H
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 63 QNIIEMLDSF------ESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALH 116
+NII +L+ F E Q+ +V E L ++++ + L E++ + Q++ +
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIK 133
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVRE 176
+LHS IIHRD+KP NI++ + +K+ DFG AR + + ++ T Y APE++
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILG 192
Query: 177 QPYNHTADLWSLGVILYELF---------------------VGQP-PFYTNSVYALIRHI 214
Y D+WS+G I+ E+ +G P P + + +R+
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 215 VKDPVKY---------PDEMSP-----------NFKSFLKGLLNKVPQNRLTWSALLEHP 254
V++ KY PD + P + L +L P R++ L+HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312
Query: 255 FV 256
++
Sbjct: 313 YI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 7e-21
Identities = 82/311 (26%), Positives = 141/311 (45%), Gaps = 59/311 (18%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHN-LRQEIEILRKLKH 62
+++ I +G G+ G V+K K +G +A K I H + + I N + +E+++L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLI--HLEIKPAIRNQIIRELQVLHECNS 62
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYL-HS 120
I+ +F S E + E G L ++L+ +PE+ + ++ +++ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAM---SANTVVLRSIKGTPLYMAPELVREQ 177
++I+HRD+KP NIL+ + +KLCDFG + + AN+ V GT YM+PE ++
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGT 177
Query: 178 PYNHTADLWSLGVILYELFVG---------------------------------QPPFYT 204
Y+ +D+WS+G+ L E+ +G +PP
Sbjct: 178 HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP 237
Query: 205 NSVYA-----------LIRHIVKD-PVKYPD-EMSPNFKSFLKGLLNKVPQNRLTWSALL 251
S Y L+ +IV + P K P F+ F+ L K P R L+
Sbjct: 238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLM 297
Query: 252 EHPFVKETSDE 262
H F+K + E
Sbjct: 298 VHAFIKRSEAE 308
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 7e-21
Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 25/215 (11%)
Query: 10 ELVGEGSFGKVYKGRRKYTG--QTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNII 66
+++GEG+FG+V + K G A+K ++K SE D + E+E+L KL H NII
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIK-MLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 67 EMLDSFESPQEFCVVTEFAQ-GELFE------ILEDDKCLPEE----------QVQSIAK 109
+L + E+ + E+A G L + +LE D +E Q+ A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 110 QLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-Y 168
+ + YL + IHRD+ +N+L+G K+ DFG +R V +++ P+ +
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRG--EEVYVKKTMGRLPVRW 184
Query: 169 MAPELVREQPYNHTADLWSLGVILYELF-VGQPPF 202
MA E + Y +D+WS GV+L+E+ +G P+
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 9e-21
Identities = 56/208 (26%), Positives = 110/208 (52%), Gaps = 16/208 (7%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
+ ++ +++ +G+G FG V G Y G VA+K I K++ E ++ +L
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCI----KNDATAQAFLAEASVMTQL 56
Query: 61 KHQNIIEMLDSF-ESPQEFCVVTEF-AQGELFEILEDD--KCLPEEQVQSIAKQLVRALH 116
+H N++++L E +VTE+ A+G L + L L + + + + A+
Sbjct: 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-YMAPELVR 175
YL +N +HRD+ +N+L+ +V K+ DFG + S+ + P+ + APE +R
Sbjct: 117 YLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----TQDTGKLPVKWTAPEALR 172
Query: 176 EQPYNHTADLWSLGVILYELF-VGQPPF 202
E+ ++ +D+WS G++L+E++ G+ P+
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 66/246 (26%), Positives = 123/246 (50%), Gaps = 9/246 (3%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDS 71
+G G FG V+ G+ + + VA+K I + SE+D +E +++ KL H ++++
Sbjct: 12 LGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEED---FIEEAKVMMKLSHPKLVQLYGV 67
Query: 72 FESPQEFCVVTEFAQ-GELFEILEDDKC-LPEEQVQSIAKQLVRALHYLHSNRIIHRDMK 129
+ +VTEF + G L L + L ++ + S+ + + + YL N IHRD+
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA 127
Query: 130 PQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-YMAPELVREQPYNHTADLWSL 188
+N L+ + VVK+ DFG R + + S P+ + PE+ Y+ +D+WS
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSF 187
Query: 189 GVILYELFV-GQPPFYTNSVYALIRHIVKDPVKYPDEMSPNF-KSFLKGLLNKVPQNRLT 246
GV+++E+F G+ PF S Y ++ I + Y +++ + ++ P+ R T
Sbjct: 188 GVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPT 247
Query: 247 WSALLE 252
++ LL
Sbjct: 248 FAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 12/197 (6%)
Query: 12 VGEGSFGKVYKGRRKYTGQT-VAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLD 70
+G+G FG+V+ G + G T VA+K +K G + QE +I++KL+H ++ +
Sbjct: 14 LGQGCFGEVWMG--TWNGTTKVAIK-TLKPGTMMPEA--FLQEAQIMKKLRHDKLVPLY- 67
Query: 71 SFESPQEFCVVTEF-AQGELFEILE--DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRD 127
+ S + +VTEF +G L + L+ D K L Q+ +A Q+ + Y+ IHRD
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 128 MKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-YMAPELVREQPYNHTADLW 186
++ NIL+G V K+ DFG AR + N R P+ + APE + +D+W
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 187 SLGVILYELFV-GQPPF 202
S G++L EL G+ P+
Sbjct: 188 SFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 58/225 (25%), Positives = 113/225 (50%), Gaps = 11/225 (4%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQ---TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
+++G G FG+V++G K G+ VA+K +K G +EK + E I+ + H NII
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIK-TLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 67 EMLDSFESPQEFCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRII 124
+ + ++TE+ + G L + L D D Q+ + + + + YL +
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 125 HRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL---YMAPELVREQPYNH 181
HRD+ +NIL+ + K+ DFG +R + + + G + + APE + + +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189
Query: 182 TADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKDPVKYPDEM 225
+D+WS G++++E+ G+ P++ S + +++ I D + P M
Sbjct: 190 ASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-NDGFRLPAPM 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-20
Identities = 69/248 (27%), Positives = 106/248 (42%), Gaps = 59/248 (23%)
Query: 9 IELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQ------EIEILRKLKH 62
I+ +G G+FG+V + T AMK + K KD+ N Q E +IL + +
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRK-----KDVLNRNQVAHVKAERDILAEADN 60
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
+ ++++ SF+ V ++ G ++ +L + PE + +L A+ +H
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM 120
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFA-------------------------------- 149
IHRD+KP NILI +KL DFG
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 150 --------------RAMSANTVVL-RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYE 194
RA + L S+ GTP Y+APE++ + Y D WS+GVIL+E
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240
Query: 195 LFVGQPPF 202
+ VGQPPF
Sbjct: 241 MLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 68/208 (32%), Positives = 113/208 (54%), Gaps = 18/208 (8%)
Query: 9 IELVGEGSFGKVYKGRRKYTGQT-VAMKFIMKHGKSEKD-IHNLRQEIEILRKLKHQNII 66
++ +G G FG V+ G K+ G+ VA+K I + SE D I E +++ KL H N++
Sbjct: 9 LKELGSGQFGVVHLG--KWRGKIDVAIKMIREGAMSEDDFIE----EAKVMMKLSHPNLV 62
Query: 67 EMLDSFESPQEFCVVTEF-AQGELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLHSNRII 124
++ + +VTE+ A G L L E L E + + + A+ YL SN I
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 125 HRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGT--PL-YMAPELVREQPYNH 181
HRD+ +N L+G +VVK+ DFG AR + + S +GT P+ + PE+ ++
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT--SSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 182 TADLWSLGVILYELFV-GQPPF--YTNS 206
+D+WS GV+++E+F G+ P+ ++NS
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSNS 208
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 6/197 (3%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEML 69
EL+G+G+FG+V+KG K VA+K + E I L E IL++ H NI++++
Sbjct: 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFL-SEARILKQYDHPNIVKLI 58
Query: 70 DSFESPQEFCVVTEFAQG-ELFEILEDDKC-LPEEQVQSIAKQLVRALHYLHSNRIIHRD 127
Q +V E G + L K L +Q+ A + YL S IHRD
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRD 118
Query: 128 MKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-YMAPELVREQPYNHTADLW 186
+ +N L+G +V+K+ DFG +R +K P+ + APE + Y+ +D+W
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178
Query: 187 SLGVILYELF-VGQPPF 202
S G++L+E F +G P+
Sbjct: 179 SYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 6e-20
Identities = 62/219 (28%), Positives = 113/219 (51%), Gaps = 12/219 (5%)
Query: 10 ELVGEGSFGKVYKGRRKYTG---QTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
E++G G FG+V +GR K G VA+K +K G +EK + E I+ + H NII
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIK-TLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 67 EMLDSFESPQEFCVVTEFAQ-GELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLHSNRII 124
+ + ++TEF + G L L ++D Q+ + + + + YL +
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 125 HRDMKPQNILIGAGSVVKLCDFGFARAM---SANTVVLRSIKGT-PL-YMAPELVREQPY 179
HRD+ +NIL+ + V K+ DFG +R + +++ S+ G P+ + APE + + +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188
Query: 180 NHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKD 217
+D+WS G++++E+ G+ P++ S +I I +D
Sbjct: 189 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD 227
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 8e-20
Identities = 63/234 (26%), Positives = 112/234 (47%), Gaps = 32/234 (13%)
Query: 12 VGEGSFGKVYKGRR----KYTGQT-VAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
+G+G+FG+V++ R Y T VA+K ++K S + ++E ++ + H NI+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 67 EMLDSFESPQEFCVVTEF-AQGELFEILED---------------------DKCLPEEQV 104
++L + C++ E+ A G+L E L +
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 105 Q-SIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM-SANTVVLRSI 162
Q IAKQ+ + YL + +HRD+ +N L+G VVK+ DFG +R + SA+
Sbjct: 132 QLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN 191
Query: 163 KGTPL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHI 214
P+ +M PE + Y +D+W+ GV+L+E+F G P+Y + +I ++
Sbjct: 192 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV 245
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 8e-20
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQ---TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
+++G G FG+V +GR K G+ VA+K +K G S+K + E I+ + H NII
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIK-TLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 67 EMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALH-------YL 118
+ + ++TE+ G L DK L E + QLV L YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSL------DKFLRENDGKFTVGQLVGMLRGIASGMKYL 122
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM--SANTVVLRSIKGTPLYMAPELVRE 176
+HRD+ +NIL+ + V K+ DFG +R + S T + K + APE +
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 177 QPYNHTADLWSLGVILYE-LFVGQPPFY 203
+ + +D+WS G++++E + G+ P++
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYW 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 8e-20
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 31/214 (14%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMK-----FIM-KHGKSEKDIHNLRQEIEILRK 59
Y ++ +G G+ G V TGQ VA+K F H K +E+ +++
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRA------YRELVLMKL 71
Query: 60 LKHQNIIEMLDSF------ESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVR 113
+ H+NII +L+ F E Q+ +V E L ++++ D L E++ + Q++
Sbjct: 72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLC 129
Query: 114 ALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT-----VVLRSIKGTPLY 168
+ +LHS IIHRD+KP NI++ + +K+ DFG AR + VV R Y
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR------YY 183
Query: 169 MAPELVREQPYNHTADLWSLGVILYELFVGQPPF 202
APE++ Y D+WS+G I+ E+ G F
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-19
Identities = 57/242 (23%), Positives = 122/242 (50%), Gaps = 13/242 (5%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
++ Y ++ +G G+ G V + VA+K + + +++ +E+ +++ + H
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 63 QNIIEMLDSF------ESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALH 116
+NII +L+ F E Q+ +V E L ++++ + L E++ + Q++ +
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIK 140
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVRE 176
+LHS IIHRD+KP NI++ + +K+ DFG AR + + ++ T Y APE++
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILG 199
Query: 177 QPYNHTADLWSLGVILYELFVGQPPF----YTNSVYALIRHIVKDPVKYPDEMSPNFKSF 232
Y D+WS+G I+ E+ G F + + +I + ++ ++ P +++
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259
Query: 233 LK 234
++
Sbjct: 260 VE 261
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 2e-19
Identities = 68/215 (31%), Positives = 106/215 (49%), Gaps = 25/215 (11%)
Query: 10 ELVGEGSFGKVYKGRRKYTG--QTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ-NII 66
+++GEG+FG+V K R K G A+K MK S+ D + E+E+L KL H NII
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIK-RMKEYASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 67 EMLDSFESPQEFCVVTEFAQ-GELFE------ILEDDKCLPEE----------QVQSIAK 109
+L + E + E+A G L + +LE D Q+ A
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 110 QLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-Y 168
+ R + YL + IHRD+ +NIL+G V K+ DFG +R V +++ P+ +
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKTMGRLPVRW 177
Query: 169 MAPELVREQPYNHTADLWSLGVILYELF-VGQPPF 202
MA E + Y +D+WS GV+L+E+ +G P+
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLR----QEIEILRKLKHQNI 65
E +G+G+FG VYKG K VA+K +L+ QE EIL++ H NI
Sbjct: 1 EKIGKGNFGDVYKGVLK-GNTEVAVKTC-----RSTLPPDLKRKFLQEAEILKQYDHPNI 54
Query: 66 IEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKC-LPEEQVQSIAKQLVRALHYLHSNRI 123
++++ Q +V E G L L K L +++ ++ + YL S
Sbjct: 55 VKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC 114
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS-IKGTPL-YMAPELVREQPYNH 181
IHRD+ +N L+G +V+K+ DFG +R + +K P+ + APE + Y
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 182 TADLWSLGVILYELF-VGQPPF 202
+D+WS G++L+E F +G P+
Sbjct: 175 ESDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-19
Identities = 73/259 (28%), Positives = 124/259 (47%), Gaps = 29/259 (11%)
Query: 12 VGEGSFGKVYKGR-----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
+GEG+FGKV+ + VA+K + + +S + + ++E E+L L+HQ+I+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR--QDFQREAELLTVLQHQHIV 70
Query: 67 EMLDSFESPQEFCVVTEFAQ-GELFEILE----DDKCLPEEQVQS-----------IAKQ 110
+ +V E+ + G+L L D K L + + IA Q
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 111 LVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL--- 167
+ + YL S +HRD+ +N L+G G VVK+ DFG +R + + T R T L
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-TDYYRVGGRTMLPIR 189
Query: 168 YMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEM 225
+M PE + + + +D+WS GV+L+E+F G+ P+Y S I I + ++ P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTC 249
Query: 226 SPNFKSFLKGLLNKVPQNR 244
P + ++G + PQ R
Sbjct: 250 PPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 12/201 (5%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDS 71
+G G FG V+ G + VA+K I + SE+D +E +++ KL H ++++
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEED---FIEEAQVMMKLSHPKLVQLYGV 67
Query: 72 FESPQEFCVVTEFAQ-GELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMK 129
C+V EF + G L + L + +E + + + + YL S+ +IHRD+
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLA 127
Query: 130 PQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL---YMAPELVREQPYNHTADLW 186
+N L+G VVK+ DFG R + + S GT + +PE+ Y+ +D+W
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVLDDQYT--SSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 187 SLGVILYELFV-GQPPFYTNS 206
S GV+++E+F G+ P+ S
Sbjct: 186 SFGVLMWEVFSEGKTPYENRS 206
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 4e-19
Identities = 64/250 (25%), Positives = 121/250 (48%), Gaps = 19/250 (7%)
Query: 12 VGEGSFGKVYKGRRKYTGQ-TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLD 70
+G G FG V G K+ GQ VA+K I + SE + +E +++ KL H+ ++++
Sbjct: 12 LGTGQFGVVKYG--KWRGQYDVAIKMIKEGSMSEDE---FIEEAKVMMKLSHEKLVQLYG 66
Query: 71 SFESPQEFCVVTEF-AQGELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDM 128
+ +VTE+ + G L L E K Q+ + K + + YL S + IHRD+
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDL 126
Query: 129 KPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL---YMAPELVREQPYNHTADL 185
+N L+ VK+ DFG +R + + S G+ + PE++ ++ +D+
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDEYT--SSVGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 186 WSLGVILYELF-VGQPPF--YTNSVYALIRHIVKDPVKY-PDEMSPNFKSFLKGLLNKVP 241
W+ GV+++E++ +G+ P+ + NS + + + Y P S + + ++
Sbjct: 185 WAFGVLMWEVYSLGKMPYERFNNS--ETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKA 242
Query: 242 QNRLTWSALL 251
+ R T+ LL
Sbjct: 243 EERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 6e-19
Identities = 57/199 (28%), Positives = 113/199 (56%), Gaps = 10/199 (5%)
Query: 12 VGEGSFGKVYKG--RRKYTGQTVAMKFIMKHGKSEKDIHN-LRQEIEILRKLKHQNIIEM 68
+G G+FG V KG + K + +TVA+K I+K+ ++ + + L +E ++++L + I+ M
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 69 LDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRD 127
+ E+ + + +V E A+ G L + L+ +K + E+ + + Q+ + YL +HRD
Sbjct: 62 IGICEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 128 MKPQNILIGAGSVVKLCDFGFARAMSA--NTVVLRSIKGTPL-YMAPELVREQPYNHTAD 184
+ +N+L+ K+ DFG ++A+ A N ++ P+ + APE + ++ +D
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSD 180
Query: 185 LWSLGVILYELF-VGQPPF 202
+WS GV+++E F GQ P+
Sbjct: 181 VWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 4 ENYHVIELVGEGSFGKVYKG-----RRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILR 58
E +I +G+GSFG VY+G + VA+K + S ++ E +++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIK-TVNENASMRERIEFLNEASVMK 64
Query: 59 KLKHQNIIEMLDSFESPQEFCVVTEF-AQGELFEIL-----EDDKC-----LPEEQVQSI 107
+ +++ +L + Q VV E A+G+L L E + ++ +
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 108 AKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL 167
A ++ + YL + + +HRD+ +N ++ VK+ DFG R + T R L
Sbjct: 125 AAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY-ETDYYRKGGKGLL 183
Query: 168 ---YMAPELVREQPYNHTADLWSLGVILYEL--FVGQP 200
+MAPE +++ + +D+WS GV+L+E+ QP
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 4 ENYHVIELVGEGSFGKVYKGR-RKYTGQTVAMKFIMK---HGKSEKDIHNLRQEIEILRK 59
++ ++ +G G+FG+VY+G R G V ++ +K SE+D + E I+ K
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 60 LKHQNIIEMLD-SFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQ-------SIAKQL 111
HQNI+ ++ SFE F ++ A G+L L +++ PE A+ +
Sbjct: 66 FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 112 VRALHYLHSNRIIHRDMKPQNILI---GAGSVVKLCDFGFARAM------SANTVVLRSI 162
+ YL N IHRD+ +N L+ G G V K+ DFG AR + + I
Sbjct: 126 AKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 163 KGTPLYMAPELVREQPYNHTADLWSLGVILYELF-VGQPPF 202
K +M PE + + D+WS GV+L+E+F +G P+
Sbjct: 186 K----WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 2e-18
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 35 KFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQGELFEIL- 93
+ ++K G +H R +LR+L H ++ +LD C+V + +L+ L
Sbjct: 196 RVVVKAGWYASSVHEAR----LLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLG 251
Query: 94 EDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFG---FAR 150
+ L QV ++A+QL+ A+ Y+H IIHRD+K +N+L+ + L DFG FAR
Sbjct: 252 ARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311
Query: 151 AMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS---- 206
S +T I GT APE++ PY + D+WS G++++E V ++ S
Sbjct: 312 G-SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE 370
Query: 207 ---VYALIRHIVKDPVKYPDEMSPNFKSFL 233
A I I++ + DE + S L
Sbjct: 371 RRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400
|
Length = 461 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-18
Identities = 55/200 (27%), Positives = 101/200 (50%), Gaps = 8/200 (4%)
Query: 9 IELVGEGSFGKVYKGRRKYTGQTVAMKF---IMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
++++G G+FG VYKG G+TV + I+ K E I+ + H ++
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71
Query: 66 IEMLDSFESPQEFCVVTEFAQGELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHSNRII 124
+ +L SP V G L + + + K + + + + Q+ + + YL R++
Sbjct: 72 VRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV 131
Query: 125 HRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG-TPL-YMAPELVREQPYNHT 182
HRD+ +N+L+ + + VK+ DFG AR + + + G P+ +MA E + + + H
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191
Query: 183 ADLWSLGVILYEL--FVGQP 200
+D+WS GV ++EL F G+P
Sbjct: 192 SDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 23/238 (9%)
Query: 10 ELVGEGSFGKVYKG---RRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
+L+ EG+FG+++ G K + +K SE + L QE +L L HQNI+
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 67 EML--DSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSI--------AKQLVRALH 116
+L + F + G L L+ + Q++ A Q+ +
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM-SANTVVLRSIKGTPL-YMAPELV 174
YLH +IH+D+ +N +I VK+ D +R + + L + P+ +MA E +
Sbjct: 132 YLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL 191
Query: 175 REQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKD------PVKYPDEM 225
+ Y+ +D+WS GV+L+EL +GQ P+ + + +KD P+ PDE+
Sbjct: 192 VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-AYLKDGYRLAQPINCPDEL 248
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 66/226 (29%), Positives = 109/226 (48%), Gaps = 23/226 (10%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEML 69
E +G G+FG+V+ GR + VA+K + + L QE IL++ H NI+ ++
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFL-QEARILKQYSHPNIVRLI 59
Query: 70 DSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVR-------ALHYLHSNR 122
Q +V E QG F L E + K+L++ + YL S
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTF-----LRTEGPRLKVKELIQMVENAAAGMEYLESKH 114
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFAR----AMSANTVVLRSIKGTPL-YMAPELVREQ 177
IHRD+ +N L+ +V+K+ DFG +R + A+T ++ I P+ + APE +
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI---PVKWTAPEALNYG 171
Query: 178 PYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKDPVKYP 222
Y+ +D+WS G++L+E F +G P Y N R ++ V+ P
Sbjct: 172 RYSSESDVWSFGILLWEAFSLGAVP-YANLSNQQTREAIEQGVRLP 216
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 7e-18
Identities = 64/258 (24%), Positives = 110/258 (42%), Gaps = 38/258 (14%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHN--LRQEIEILRKL 60
++ Y +I L+G+G G+VY + VA+K I + + LR E +I L
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLR-EAKIAADL 59
Query: 61 KHQNIIEMLDSFESPQEFCVVT-EFAQGE-----LFEILEDDKCLPEEQVQSIAKQLVRA 114
H I+ + S S + T + +G L + + + E ++ +
Sbjct: 60 IHPGIVPVY-SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118
Query: 115 LH-------YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARA---------------- 151
H Y+HS ++HRD+KP NIL+G V + D+G A
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 152 --MSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYA 209
++ + I GTP YMAPE + P + + D+++LGVILY++ P+
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238
Query: 210 LIRHIVKDPVKYPDEMSP 227
+ +D + P E++P
Sbjct: 239 I---SYRDVILSPIEVAP 253
|
Length = 932 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 9e-18
Identities = 55/207 (26%), Positives = 105/207 (50%), Gaps = 15/207 (7%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQT-VAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
E+ +++ +G G FG+V+ G Y T VA+K +K G + +E +++ L+H
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGY--YNNSTKVAVK-TLKPGT--MSVQAFLEEANLMKTLQH 60
Query: 63 QNIIEMLDSFESPQEFCVVTEF-AQGELFEILEDDK----CLPEEQVQSIAKQLVRALHY 117
++ + + ++TE+ A+G L + L+ D+ LP ++ + Q+ + Y
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAY 118
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-YMAPELVRE 176
+ IHRD++ N+L+ + K+ DFG AR + N R P+ + APE +
Sbjct: 119 IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 178
Query: 177 QPYNHTADLWSLGVILYELFV-GQPPF 202
+ +D+WS G++LYE+ G+ P+
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 75/264 (28%), Positives = 125/264 (47%), Gaps = 43/264 (16%)
Query: 12 VGEGSFGKVYKGR-----RKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKHQNI 65
+GEG+FGKV+ + VA+K + + KD H +E E+L L+H++I
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH---REAELLTNLQHEHI 69
Query: 66 IEMLDSFESPQEFCVVTEFAQ-GELFEILE---DDKCL------PEEQVQS----IAKQL 111
++ +V E+ + G+L + L D L P E QS IA+Q+
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 112 VRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL---Y 168
+ YL S +HRD+ +N L+G +VK+ DFG +R + + T R T L +
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS-TDYYRVGGHTMLPIRW 188
Query: 169 MAPELVREQPYNHTADLWSLGVILYELFV-GQPPFY---TNSVYALIRH--IVKDPVKYP 222
M PE + + + +D+WSLGV+L+E+F G+ P+Y N V I +++ P P
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCP 248
Query: 223 DEM----------SPNFKSFLKGL 236
E+ P+ + +K +
Sbjct: 249 KEVYDLMLGCWQREPHMRLNIKEI 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 70/260 (26%), Positives = 120/260 (46%), Gaps = 28/260 (10%)
Query: 12 VGEGSFGKVYKGRRKYTGQT-----VAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
+GEG+FGKV+ T VA+K + + + + ++E E+L L+H++I+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--DFQREAELLTNLQHEHIV 70
Query: 67 EMLDSFESPQEFCVVTEF-----------AQGELFEILEDDKCLPEE------QVQSIAK 109
+ +V E+ A G IL D + + Q+ IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 110 QLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM-SANTVVLRSIKGTPL- 167
Q+ + YL S +HRD+ +N L+GA +VK+ DFG +R + S + + P+
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 190
Query: 168 YMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKDPVKYPDEMS 226
+M PE + + + +D+WS GVIL+E+F G+ P++ S +I I + V +
Sbjct: 191 WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVC 250
Query: 227 PN-FKSFLKGLLNKVPQNRL 245
P + G + PQ RL
Sbjct: 251 PKEVYDIMLGCWQREPQQRL 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-17
Identities = 51/150 (34%), Positives = 85/150 (56%), Gaps = 9/150 (6%)
Query: 110 QLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGT---P 166
Q+ R + +L S + IHRD+ +NIL+ +VVK+CDFG AR + + +R KG+ P
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR--KGSARLP 239
Query: 167 L-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKD--PVKYP 222
L +MAPE + ++ Y +D+WS GV+L+E+F +G P+ + +KD ++ P
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAP 299
Query: 223 DEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252
+ +P + P+ R T+SAL+E
Sbjct: 300 ENATPEIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 12/209 (5%)
Query: 12 VGEGSFGKVYKGRRKYTGQT-VAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLD 70
+G G FG+V+ Y T VA+K MK G + E +++ L+H +++ L
Sbjct: 14 LGAGQFGEVWMA--TYNKHTKVAVK-TMKPGSMS--VEAFLAEANVMKTLQHDKLVK-LH 67
Query: 71 SFESPQEFCVVTEFAQ-GELFEILEDDKC--LPEEQVQSIAKQLVRALHYLHSNRIIHRD 127
+ + + ++TEF G L + L+ D+ P ++ + Q+ + ++ IHRD
Sbjct: 68 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 127
Query: 128 MKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-YMAPELVREQPYNHTADLW 186
++ NIL+ A V K+ DFG AR + N R P+ + APE + + +D+W
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187
Query: 187 SLGVILYELFV-GQPPFYTNSVYALIRHI 214
S G++L E+ G+ P+ S +IR +
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSNPEVIRAL 216
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 2e-17
Identities = 58/213 (27%), Positives = 107/213 (50%), Gaps = 10/213 (4%)
Query: 11 LVGEGSFGKVYKGRRKYTGQ---TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIE 67
++G G FG+V GR K G+ VA+K +K G +EK + E I+ + H NII
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIK-TLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 68 MLDSFESPQEFCVVTEFAQ-GELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLHSNRIIH 125
+ + +VTE+ + G L L + D Q+ + + + + YL +H
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVH 129
Query: 126 RDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL---YMAPELVREQPYNHT 182
RD+ +NIL+ + V K+ DFG +R + + + +G + + APE + + +
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA 189
Query: 183 ADLWSLGVILYELF-VGQPPFYTNSVYALIRHI 214
+D+WS G++++E+ G+ P++ S +I+ I
Sbjct: 190 SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-17
Identities = 50/168 (29%), Positives = 89/168 (52%), Gaps = 6/168 (3%)
Query: 91 EILEDDK-CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFA 149
EILE+D+ L E + S + Q+ + + +L S IHRD+ +NIL+ G + K+CDFG A
Sbjct: 202 EILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA 261
Query: 150 RAMS--ANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNS 206
R + +N VV + + +MAPE + Y +D+WS G++L+E+F +G P+
Sbjct: 262 RDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321
Query: 207 VYALIRHIVKDPVKY--PDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252
V + ++K+ + P+ +K + P R T+ +++
Sbjct: 322 VDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 62/260 (23%), Positives = 120/260 (46%), Gaps = 24/260 (9%)
Query: 11 LVGEGSFGKVYKGRRKY-----TG-QTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
+G G+FG+VY+G +G VA+K ++ G ++++ +E ++ H N
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVK-TLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 65 IIEMLD-SFESPQEFCVVTEFAQGELFEILEDDKC-------LPEEQVQSIAKQLVRALH 116
I+++L + ++ ++ G+L L D + L +++ I + +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 117 YLHSNRIIHRDMKPQNILI-----GAGSVVKLCDFGFARAMSANTVVLRSIKGT-PL-YM 169
YL IHRD+ +N L+ A VVK+ DFG AR + + + +G P+ +M
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180
Query: 170 APELVREQPYNHTADLWSLGVILYE-LFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSP- 227
APE + + + +D+WS GV+++E L +GQ P+ + +++H+ E P
Sbjct: 181 APESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPD 240
Query: 228 NFKSFLKGLLNKVPQNRLTW 247
+ + P R T+
Sbjct: 241 KIYQLMTNCWAQDPSERPTF 260
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-17
Identities = 79/318 (24%), Positives = 139/318 (43%), Gaps = 79/318 (24%)
Query: 12 VGEGSFGKVYKG-----RRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ-NI 65
+G G+FGKV + + + +TVA+K ++K G + + L E++IL + H N+
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVK-MLKEGATASEYKALMTELKILIHIGHHLNV 73
Query: 66 IEMLDSFESPQ-------EFCVV---------------------TEFAQGELFEIL---- 93
+ +L + P E+C T + + E
Sbjct: 74 VNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL 133
Query: 94 ------------------------EDDKC-------LPEEQVQSIAKQLVRALHYLHSNR 122
ED++ L E + S + Q+ R + +L S +
Sbjct: 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK 193
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGT---PL-YMAPELVREQP 178
IHRD+ +NIL+ +VVK+CDFG AR + + +R KG PL +MAPE + ++
Sbjct: 194 CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR--KGDARLPLKWMAPESIFDKV 251
Query: 179 YNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKDPVKY--PDEMSPNFKSFLKG 235
Y +D+WS GV+L+E+F +G P+ + +K+ + P+ +P S +
Sbjct: 252 YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLD 311
Query: 236 LLNKVPQNRLTWSALLEH 253
+ P++R T+S L+E
Sbjct: 312 CWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 51/204 (25%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E +++ +G G FG+V+ G VA+K +K G + E ++++L+H
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGH-TKVAIK-SLKQGSMSPEA--FLAEANLMKQLQHP 61
Query: 64 NIIEMLDSFESPQEFCVVTEF-AQGELFEIL--EDDKCLPEEQVQSIAKQLVRALHYLHS 120
++ L + + + ++TE+ G L + L + L ++ +A Q+ + ++
Sbjct: 62 RLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER 120
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-YMAPELVREQPY 179
IHRD++ NIL+ K+ DFG AR + N R P+ + APE + +
Sbjct: 121 KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 180
Query: 180 NHTADLWSLGVILYELFV-GQPPF 202
+D+WS G++L E+ G+ P+
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-16
Identities = 50/151 (33%), Positives = 84/151 (55%), Gaps = 9/151 (5%)
Query: 110 QLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGT---P 166
Q+ + + +L S + IHRD+ +NIL+ +VVK+CDFG AR + + +R KG P
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR--KGDARLP 244
Query: 167 L-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKD--PVKYP 222
L +MAPE + ++ Y +D+WS GV+L+E+F +G P+ + +K+ ++ P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP 304
Query: 223 DEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253
D +P + + P R T+S L+EH
Sbjct: 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 9/201 (4%)
Query: 9 IELVGEGSFGKVYKGRRKYTGQT--VAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
+EL G G+FG V KG K + VA+K ++K+ + + +E EI+ +L + I+
Sbjct: 1 VEL-GSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIV 58
Query: 67 EMLDSFESPQEFCVVTEFAQGELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHSNRIIH 125
M+ E+ V+ + G L + L K + V + Q+ + YL +H
Sbjct: 59 RMIGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 126 RDMKPQNILIGAGSVVKLCDFGFARAMSA--NTVVLRSIKGTPL-YMAPELVREQPYNHT 182
RD+ +N+L+ K+ DFG ++A+ A + RS PL + APE + + ++
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178
Query: 183 ADLWSLGVILYELF-VGQPPF 202
+D+WS G+ ++E F GQ P+
Sbjct: 179 SDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-16
Identities = 75/288 (26%), Positives = 132/288 (45%), Gaps = 44/288 (15%)
Query: 9 IELVGEGSFGKVYKGRRKYTG-----QTVAMKFIMKHGKSEKDI-HNLRQEIEILRKLKH 62
+E +GE FGKVYKG T Q VA+K + K+E + + E + +L+H
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL--KDKAEGPLREEFKHEAMMRSRLQH 67
Query: 63 QNIIEMLDSFESPQEFCVVTEF-AQGELFEIL------------EDDKCL-----PEEQV 104
NI+ +L Q ++ + + +L E L +DDK + P + V
Sbjct: 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 105 QSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM-SANTVVLRSIK 163
I Q+ + +L S+ ++H+D+ +N+L+ VK+ D G R + +A+ L
Sbjct: 128 H-IVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 164 GTPL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPF--YTNS-VYALIRHIVKDP 218
P+ +M+PE + ++ +D+WS GV+L+E+F G P+ Y+N V +IR+ +
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN--RQV 244
Query: 219 VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDELNAW 266
+ PD+ + + N+ P R P K+ L W
Sbjct: 245 LPCPDDCPAWVYTLMLECWNEFPSRR---------PRFKDIHSRLRTW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 4e-16
Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 10 ELVGEGSFGKVY------------KGRRKYTGQTVAMKFIMKHGKSEKDIHN-LRQEIEI 56
E +GEG FG+V+ +G ++ GQ V + M K N +EI+I
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70
Query: 57 LRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GEL------------FEILEDDKCLPEEQ 103
+ +LK+ NII +L S C++TE+ + G+L F + +
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130
Query: 104 VQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM-SANTVVLRSI 162
+ +A Q+ + YL S +HRD+ +N L+G +K+ DFG +R + S + ++
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190
Query: 163 KGTPL-YMAPELVREQPYNHTADLWSLGVILYELFV 197
P+ +MA E + + +D+W+ GV L+E+F
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-15
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 3 VENYHVIELVGEGSFGKVYK-GRRKYTGQTVAMKFIMKHG----KSEKDIHN-------- 49
+ ++ VI+ + G+FGK++ R T + A + + K E+ I
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206
Query: 50 ---LRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDD----KCLPE- 101
L EI L +L H+NI+++ + S ++T+ +L+ + D+ K P
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 102 EQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR- 160
+Q ++I KQL+ A+ Y+H ++IHRD+K +NI + + L DFG A
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 161 SIKGTPLYMAPELVREQPYNHTADLWSLGVILYEL 195
GT +PE++ Y D+WS G+IL ++
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 51/160 (31%), Positives = 84/160 (52%), Gaps = 5/160 (3%)
Query: 94 EDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM- 152
ED L + + + Q+ + + +L S IHRD+ +N+L+ G V K+CDFG AR +
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIM 263
Query: 153 -SANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYAL 210
+N VV + + +MAPE + + Y +D+WS G++L+E+F +G+ P+ V +
Sbjct: 264 NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK 323
Query: 211 IRHIVKDPVKY--PDEMSPNFKSFLKGLLNKVPQNRLTWS 248
+VK + PD P S +K N P R T+S
Sbjct: 324 FYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFS 363
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-15
Identities = 41/122 (33%), Positives = 69/122 (56%), Gaps = 5/122 (4%)
Query: 86 QGELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKL 143
E+ +L DD + L + S Q+ R + +L S +HRD+ +N+L+ G +VK+
Sbjct: 219 DSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKI 278
Query: 144 CDFGFAR-AMSANTVVLRSIKGTPL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQP 200
CDFG AR M + V + P+ +MAPE + + Y +D+WS G++L+E+F +G
Sbjct: 279 CDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGT 338
Query: 201 PF 202
P+
Sbjct: 339 PY 340
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 19/224 (8%)
Query: 12 VGEGSFGKVYKGR--RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEML 69
+G G FGKV G YT V +K + ++ + L +E + R L+H N+++ L
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFL-EEAQPYRSLQHSNLLQCL 61
Query: 70 DSFESPQEFCVVTEFAQ-GELFEILED----DKCLPEEQV-QSIAKQLVRALHYLHSNRI 123
+ +V EF G+L L + P+ Q +A ++ L +LH N
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNF 121
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFAR-AMSANTVVLRSIKGTPL-YMAPELVREQPYN- 180
IH D+ +N L+ A VK+ D+G + + V PL ++APELV E N
Sbjct: 122 IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNL 181
Query: 181 ------HTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKD 217
+++WSLGV ++ELF +G P+ S ++ + V++
Sbjct: 182 LVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE 225
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 50/202 (24%), Positives = 95/202 (47%), Gaps = 9/202 (4%)
Query: 9 IELVGEGSFGKVYKGRRKYTGQT----VAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
++L+G G FG V+KG G + VA+K I + + + + + L H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-QDRSGRQTFQEITDHMLAMGSLDHAY 70
Query: 65 IIEMLDSFESPQEFCVVTEFAQGELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHSNRI 123
I+ +L V G L + + + L +++ + Q+ + ++YL +R+
Sbjct: 71 IVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSAN--TVVLRSIKGTPLYMAPELVREQPYNH 181
+HR++ +NIL+ + S+V++ DFG A + + K +MA E + Y H
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTH 190
Query: 182 TADLWSLGVILYELFV-GQPPF 202
+D+WS GV ++E+ G P+
Sbjct: 191 QSDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 5e-14
Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 43/227 (18%)
Query: 10 ELVGEGSFGKVYK----------------GRRKYTGQTVAMKFIMKHGKSEKDIHNLRQE 53
E +GEG FG+V+ RK VA+K I++ ++ ++ +E
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVK-ILRPDANKNARNDFLKE 69
Query: 54 IEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILE----DDK----------- 97
++IL +LK NII +L C++TE+ + G+L + L DDK
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 98 -CLPEEQVQS---IAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS 153
CLP S +A Q+ + YL S +HRD+ +N L+G +K+ DFG +R +
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 154 ANTVVLRSIKGTPL----YMAPELVREQPYNHTADLWSLGVILYELF 196
A I+G + +MA E + + +D+W+ GV L+E+
Sbjct: 190 AGDYY--RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-14
Identities = 39/134 (29%), Positives = 71/134 (52%), Gaps = 3/134 (2%)
Query: 72 FESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQ 131
+ESP + + + + ++ + L + + Q+ + +L S +HRD+ +
Sbjct: 209 YESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268
Query: 132 NILIGAGSVVKLCDFGFAR-AMSANTVVLRSIKGTPL-YMAPELVREQPYNHTADLWSLG 189
N+LI G +VK+CDFG AR M + + + PL +MAPE + Y +D+WS G
Sbjct: 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFG 328
Query: 190 VILYELF-VGQPPF 202
++L+E+F +G P+
Sbjct: 329 ILLWEIFTLGGTPY 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 6e-14
Identities = 52/202 (25%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 9 IELVGEGSFGKVYKGRRKYTGQT----VAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
I+++G G+FG VYKG G+ VA+K ++ S K + E ++ + + +
Sbjct: 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK-ELREATSPKANKEILDEAYVMASVDNPH 70
Query: 65 IIEMLDSFESPQEFCVVTEFAQGELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHSNRI 123
+ +L + + G L + + + K + + + + Q+ + ++YL R+
Sbjct: 71 VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRL 130
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG-TPL-YMAPELVREQPYNH 181
+HRD+ +N+L+ VK+ DFG A+ + A+ + G P+ +MA E + + Y H
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 182 TADLWSLGVILYELFV-GQPPF 202
+D+WS GV ++EL G P+
Sbjct: 191 QSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 7e-14
Identities = 47/150 (31%), Positives = 79/150 (52%), Gaps = 2/150 (1%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD-IHNLRQEIEILRKLK 61
+E + +++ + G+FGKVY GR+K + A+K + K K+ +H ++ E + L K
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62
Query: 62 HQNIIEMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
I+ + S +S +V E+ G++ +L EE ++ AL YLH
Sbjct: 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFAR 150
+ IIHRD+KP N+LI +KL DFG ++
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 54/226 (23%), Positives = 110/226 (48%), Gaps = 24/226 (10%)
Query: 12 VGEGSFGKVYKGRRKYTGQT-----VAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
+G+GSFG VY+G K + VA+K + + + I L E ++++ +++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNCHHVV 72
Query: 67 EMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQS------------IAKQLVR 113
+L Q V+ E +G+L L + PE + +A ++
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 114 ALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG-TPL-YMAP 171
+ YL++N+ +HRD+ +N ++ VK+ DFG R + + KG P+ +M+P
Sbjct: 131 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 172 ELVREQPYNHTADLWSLGVILYEL-FVGQPPFYTNSVYALIRHIVK 216
E +++ + +D+WS GV+L+E+ + + P+ S ++R +++
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 67/284 (23%), Positives = 132/284 (46%), Gaps = 29/284 (10%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRK--YTGQT---VAMKFIMKHGKSEKDIHNLRQEIEILR 58
E ++ +G+GSFG VY+G + G+ VA+K + + + I L E +++
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMK 64
Query: 59 KLKHQNIIEMLDSFESPQEFCVVTEF-AQGELFEIL-------EDDKCLP----EEQVQS 106
+++ +L Q VV E A G+L L E++ P +E +Q
Sbjct: 65 GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ- 123
Query: 107 IAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG-T 165
+A ++ + YL++ + +HRD+ +N ++ VK+ DFG R + + KG
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 166 PL-YMAPELVREQPYNHTADLWSLGVILYEL-FVGQPPFYTNSVYALIRHIVKDP-VKYP 222
P+ +MAPE +++ + ++D+WS GV+L+E+ + + P+ S +++ ++ + P
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 243
Query: 223 DEMSPNFKSFLKGLLNKVPQNRLTWSALLE------HPFVKETS 260
D ++ P+ R T+ ++ HP E S
Sbjct: 244 DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQT---VAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
++G+G FG VY G + A+K + + E+ L++ I I++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGI-IMKDFSHPNVL 59
Query: 67 E----MLDSFESPQEFCVVTEFAQGELFEILEDDKCLPE-EQVQSIAKQLVRALHYLHSN 121
L S SP V+ G+L + + P + + Q+ + + YL S
Sbjct: 60 SLLGICLPSEGSP--LVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK 117
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAM-SANTVVLRSIKGTPL---YMAPELVREQ 177
+ +HRD+ +N ++ VK+ DFG AR + + + G L +MA E ++ Q
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 178 PYNHTADLWSLGVILYELFV-GQPPF 202
+ +D+WS GV+L+EL G PP+
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 58/224 (25%), Positives = 107/224 (47%), Gaps = 19/224 (8%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFI--MKHGKSEKDIHNLRQEIEILRKLKHQNIIEML 69
+G G FGKV G + G + A + ++ + + QE++ R+L H N+++ L
Sbjct: 3 IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 70 DSFESPQEFCVVTEFAQ-GELFEILEDDKCL----PEEQV-QSIAKQLVRALHYLHSNRI 123
+ +V EF G+L L ++ + ++ V Q +A ++ L +LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADF 121
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARA-MSANTVVLRSIKGTPL-YMAPELVRE----- 176
IH D+ +N + A VK+ D+G A + + + PL ++APELV
Sbjct: 122 IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDL 181
Query: 177 QPYNHT--ADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKD 217
P + T +++WSLGV ++ELF P+ S +++ +V++
Sbjct: 182 LPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE 225
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 6e-13
Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 35/221 (15%)
Query: 8 VIELVGEGSFGKVY----------------KGRRKYTGQTVAMKFIMKHGKSEKDIHNLR 51
+E +GEG FG+V+ + VA+K + + S+ +
Sbjct: 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNAREDFL 67
Query: 52 QEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEIL-----------EDDKCL 99
+E++IL +L NI +L C++ E+ + G+L + L + K L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 100 PEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159
+ +A Q+ + YL S +HRD+ +N L+G +K+ DFG +R + ++
Sbjct: 128 SFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS--DY 185
Query: 160 RSIKG-TPL---YMAPELVREQPYNHTADLWSLGVILYELF 196
++G PL +MA E V + +D+W+ GV L+E+
Sbjct: 186 YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 59/268 (22%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 10 ELVGEGSFGKVYKGRRKY---TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
+++GEG FG V +G+ + VA+K + + +I E ++ H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 67 EML------DSFESPQEFCVVTEFAQ-GELFEIL------EDDKCLPEEQVQSIAKQLVR 113
+++ S + + V+ F + G+L L + LP + + +
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 114 ALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM-SANTVVLRSIKGTPL-YMAP 171
+ YL + IHRD+ +N ++ V + DFG ++ + S + I P+ ++A
Sbjct: 125 GMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 184
Query: 172 ELVREQPYNHTADLWSLGVILYELFV-GQPPF---YTNSVYALIRH--IVKDPVKYPDEM 225
E + ++ Y +D+W+ GV ++E+ GQ P+ + +Y +RH +K P DE+
Sbjct: 185 ESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDEL 244
Query: 226 SPNFKSFLKGLLNKVPQNRLTWSALLEH 253
+ P++R T++ L E
Sbjct: 245 Y----DLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 57/218 (26%), Positives = 104/218 (47%), Gaps = 33/218 (15%)
Query: 10 ELVGEGSFGKVY----KGRRKYTGQT------------VAMKFIMKHGKSEKDIHN-LRQ 52
E +GEG FG+V+ +G K+ + VA+K M + K+ N +
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVK--MLREDANKNARNDFLK 68
Query: 53 EIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEIL-----------EDDKCLP 100
EI+I+ +LK NII +L + C++TE+ + G+L + L D +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 101 EEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM-SANTVVL 159
+ +A Q+ + YL S +HRD+ +N L+G +K+ DFG +R + S + +
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 160 RSIKGTPL-YMAPELVREQPYNHTADLWSLGVILYELF 196
+ P+ +M+ E + + +D+W+ GV L+E+
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 51/202 (25%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 9 IELVGEGSFGKVYKGRRKYTGQT----VAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
++++G G+FG VYKG G+ VA+K +++ S K + E ++ +
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIK-VLRENTSPKANKEILDEAYVMAGVGSPY 70
Query: 65 IIEMLDSFESPQEFCVVTEFAQGELFEILEDDKC-LPEEQVQSIAKQLVRALHYLHSNRI 123
+ +L + V G L + + ++K + + + + Q+ + + YL R+
Sbjct: 71 VCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRL 130
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG-TPL-YMAPELVREQPYNH 181
+HRD+ +N+L+ + + VK+ DFG AR + + + G P+ +MA E + + + H
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTH 190
Query: 182 TADLWSLGVILYELFV-GQPPF 202
+D+WS GV ++EL G P+
Sbjct: 191 QSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 44/186 (23%), Positives = 75/186 (40%), Gaps = 26/186 (13%)
Query: 87 GELFEILE-DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCD 145
L +ILE + L EE++ ++ Q + AL LH K NIL+ ++KL
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKL-- 52
Query: 146 FGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTN 205
G + + P +MAPE+++ Q Y AD++SLG+ LYE + P Y
Sbjct: 53 DGSVAFKTPE-----QSRPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP-YNE 106
Query: 206 ------SVYALIRH-----IVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHP 254
+ L+ + +F+ F++ +++PQ R + L H
Sbjct: 107 ERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHC 166
Query: 255 FVKETS 260
Sbjct: 167 RALFAE 172
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-12
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 12/215 (5%)
Query: 20 VYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFC 79
VY R TG V ++ +E+ + L+ E+ + +H NI+ F +
Sbjct: 16 VYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLW 75
Query: 80 VVTEF-AQGELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIG 136
V++ F A G +L+ + + E + +I +R L+YLH N IHR++K +ILI
Sbjct: 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS 135
Query: 137 AGSVVKLCDFGFARAMSANTVVLRSIKGTPLY-------MAPELVRE--QPYNHTADLWS 187
+V L ++ N + + P + ++PEL+R+ YN +D++S
Sbjct: 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYS 195
Query: 188 LGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP 222
+G+ EL G+ PF ++ +K P P
Sbjct: 196 VGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP 230
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-11
Identities = 50/195 (25%), Positives = 91/195 (46%), Gaps = 18/195 (9%)
Query: 11 LVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLD 70
++ G G YKG+ G M+F++K I + EI + KL+H NI++++
Sbjct: 697 VISRGKKGASYKGKSIKNG----MQFVVKEINDVNSIPSS--EIADMGKLQHPNIVKLIG 750
Query: 71 SFESPQEFCVVTEFAQGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYLH---SNRIIHR 126
S + ++ E+ +G+ L E+L + L E+ + IA + +AL +LH S ++
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 127 DMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLW 186
++ P+ I+I L + +T S Y+APE + +D++
Sbjct: 808 NLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFIS----SAYVAPETRETKDITEKSDIY 862
Query: 187 SLGVILYELFVGQPP 201
G+IL EL G+ P
Sbjct: 863 GFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 61/226 (26%), Positives = 108/226 (47%), Gaps = 24/226 (10%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFI--MKHGKSEKDIHNLRQEIEILRKLKHQNIIEML 69
+G G FGKV YT VA + +K S K+ + Q+ + R L+H NI++ L
Sbjct: 3 IGNGWFGKVLLSE-IYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 70 DSFESPQEFCVVTEFAQ-GELFEIL--EDDKCLPEE--QVQSIAKQLVRALHYLHSNRII 124
+ +V E+ + G+L L E + +Q +A ++ + ++H + +
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL 121
Query: 125 HRDMKPQNILIGAGSVVKLCDF--GFARAMSANTVVLRSIKGTPL-YMAPELVRE----- 176
H D+ +N + + VK+ D+ G +R + + K PL ++APELV E
Sbjct: 122 HSDLALRNCFLTSDLTVKVGDYGIGPSR-YKEDYIETEDDKCVPLRWLAPELVGEFHGGL 180
Query: 177 --QPYNHTADLWSLGVILYELF--VGQPPFYTN-SVYALIRHIVKD 217
+++W+LGV L+ELF QP Y++ S ++ H++KD
Sbjct: 181 ITAEQTKPSNVWALGVTLWELFENAAQP--YSHLSDREVLNHVIKD 224
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 33/147 (22%), Positives = 67/147 (45%), Gaps = 11/147 (7%)
Query: 7 HVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
I+L+ G +VY + +++K S + + +E+ IL+ L + +
Sbjct: 1 SSIKLLKGGLTNRVYL----LGTKDE--DYVLKINPSREKGADREREVAILQLLARKGLP 54
Query: 67 --EMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRII 124
++L S ES ++ E+ +GE L++ +E + +L+ LH L +
Sbjct: 55 VPKVLASGESDGWSYLLMEWIEGE---TLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 125 HRDMKPQNILIGAGSVVKLCDFGFARA 151
H D+ P NIL+ G ++ + D+ +A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 64/250 (25%), Positives = 100/250 (40%), Gaps = 26/250 (10%)
Query: 15 GSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFES 74
G KV T QT FI+K + + R I I + + ++ + S
Sbjct: 4 GVIDKVLLVMDTRTQQT----FILKGLRKSSEYSRERLTI-IPHCVPN--MVCLHKYIVS 56
Query: 75 PQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNI 133
+V + A+G +L+ + +PEE V+ A ++V AL LH I+ RD+ P NI
Sbjct: 57 EDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116
Query: 134 LIGAGSVVKLCDFGFARAMSA---NTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGV 190
L+ ++L F + V +Y APE+ D WSLG
Sbjct: 117 LLDDRGHIQLTYFSRWSEVEDSCDGEAVEN------MYCAPEVGGISEETEACDWWSLGA 170
Query: 191 ILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTW--- 247
IL+EL G+ + + H + P+ +S +S L+ LL P RL
Sbjct: 171 ILFELLTGKTLVECHPS-GINTHTT---LNIPEWVSEEARSLLQQLLQFNPTERLGAGVA 226
Query: 248 --SALLEHPF 255
+ HPF
Sbjct: 227 GVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 51/211 (24%), Positives = 96/211 (45%), Gaps = 19/211 (9%)
Query: 11 LVGEGSFGKVYKGRRKY---TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIE 67
++G+G FG V + + K + Q VA+K + S DI +E +++ H N+I+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 68 MLD-SFES------PQEFCVVTEFAQGELFEIL------EDDKCLPEEQVQSIAKQLVRA 114
++ S S P ++ G+L L E+ LP + + +
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 115 LHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM-SANTVVLRSIKGTPL-YMAPE 172
+ YL S IHRD+ +N ++ V + DFG ++ + S + P+ ++A E
Sbjct: 126 MEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALE 185
Query: 173 LVREQPYNHTADLWSLGVILYELFV-GQPPF 202
+ + Y +D+W+ GV ++E+ GQ P+
Sbjct: 186 SLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 13 GEGSFGKVYKGRR------KYTGQTVAMKFIMKH-GKSEKDIHNLRQEIEILRKLKHQNI 65
G+G+F +YKG G + ++K G +D + ++ +L H+++
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHL 63
Query: 66 IEMLDSFESPQEFCVVTEFAQ-GELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHSNRI 123
+ L E +V E+ + G L L +K + +AKQL ALHYL ++
Sbjct: 64 V-KLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKL 122
Query: 124 IHRDMKPQNILI-------GAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-YMAPELVR 175
+H ++ +NIL+ G +KL D G TV+ R + + ++APE +R
Sbjct: 123 VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI-----TVLSREERVERIPWIAPECIR 177
Query: 176 EQPYNHT--ADLWSLGVILYELFVGQP-PFYTNS 206
+ T AD WS G L E+ P T S
Sbjct: 178 NGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 10 ELVGEGSFGKVYKGRRKYTG------QT-VAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
E +G+G+F K++KG R+ G +T V +K + K ++ + + + ++ +L H
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSE--SFFEAASMMSQLSH 58
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHS 120
++++ E +V E+ + G L L+ +K + +AKQL ALH+L
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED 118
Query: 121 NRIIHRDMKPQNILI--------GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE 172
+ H ++ +N+L+ G +KL D G + + ++L I ++ PE
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP----WVPPE 174
Query: 173 LVRE-QPYNHTADLWSLGVILYELFVG 198
+ Q + AD WS G L+E+F G
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-10
Identities = 52/226 (23%), Positives = 97/226 (42%), Gaps = 42/226 (18%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ + ++ L+GEG+FGKV + + + A+K + K +D + EI+ + K++
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDA---KIEIQFMEKVRQA 185
Query: 64 NIIEMLDSFESPQEF-------CVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALH 116
+ + + + F C+V L + + + I Q AL
Sbjct: 186 DPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALD 245
Query: 117 YLHSN-RIIHRDMKPQNILIGAGSV----------------VKLCDFG------FARAMS 153
Y H+ ++H D+KP+NIL+ V++CD G +R
Sbjct: 246 YFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRT-- 303
Query: 154 ANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQ 199
+I T Y +PE+V + ++ D+WS+G I+YEL+ G+
Sbjct: 304 -------AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 48/214 (22%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK----SEKDIHNLRQEIEILRKLKHQNIIE 67
+GEG FG V +G + +K +K K + ++ + E +++ H N++
Sbjct: 7 LGEGEFGSVMEG--QLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 68 ML---------DSFESPQEFCVVTEFAQ-GELFEIL------EDDKCLPEEQVQSIAKQL 111
++ + + SP V+ F + G+L L + + LP + + +
Sbjct: 65 LIGVCLQTVESEGYPSP---VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 112 VRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM-SANTVVLRSIKGTPL-YM 169
+ YL S IHRD+ +N ++ V + DFG ++ + + + I P+ ++
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 170 APELVREQPYNHTADLWSLGVILYELFV-GQPPF 202
A E + ++ Y +D+WS GV ++E+ GQ P+
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|237987 cd00020, ARM, Armadillo/beta-catenin-like repeats | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 30/121 (24%), Positives = 53/121 (43%), Gaps = 3/121 (2%)
Query: 1127 EYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCAD 1186
E + A L L L+ D NV+ +A AL N+ ++ ++ + + L+
Sbjct: 1 EAVIQAGGLPALVSLLSSSDENVQREAAWALSNLSAGNNDNIQAVVEAGGLPALVQLLKS 60
Query: 1187 PDKRTRKFACFSIGNAAYHNDVLYEELRRS--IPLLANILISDEEDKTKANAAGALSNLI 1244
D+ K A +++ N A + + + +P L N L+ + + NA GALSNL
Sbjct: 61 EDEEVVKAALWALRNLAAGPEDNKLIVLEAGGVPKLVN-LLDSSNEDIQKNATGALSNLA 119
Query: 1245 R 1245
Sbjct: 120 S 120
|
An approximately 40 amino acid long tandemly repeated sequence motif first identified in the Drosophila segment polarity gene armadillo; these repeats were also found in the mammalian armadillo homolog beta-catenin, the junctional plaque protein plakoglobin, the adenomatous polyposis coli (APC) tumor suppressor protein, and a number of other proteins. ARM has been implicated in mediating protein-protein interactions, but no common features among the target proteins recognized by the ARM repeats have been identified; related to the HEAT domain; three consecutive copies of the repeat are represented by this alignment model. Length = 120 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-09
Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 3/97 (3%)
Query: 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKY 221
I GTP Y+APEL+ +P+ D W+LGV L+E G PPF + + ++I+ + +
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPW 599
Query: 222 PD---EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPF 255
P+ ++S N ++ ++ LL P R L +HP
Sbjct: 600 PEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-08
Identities = 51/195 (26%), Positives = 92/195 (47%), Gaps = 20/195 (10%)
Query: 24 RRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83
R K TG+ V ++ I + + + L+ E+ + + H NI+ +F + E VVT
Sbjct: 20 RYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79
Query: 84 F-AQGELFEILEDDKC------LPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIG 136
F A G +++ C + E + I + +++AL Y+H +HR +K +ILI
Sbjct: 80 FMAYGSAKDLI----CTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS 135
Query: 137 AGSVVKLCDFGFARAMSANTVVLRSIKGTPLY-------MAPELVRE--QPYNHTADLWS 187
V L +M + LR + P Y ++PE++++ Q Y+ +D++S
Sbjct: 136 VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 195
Query: 188 LGVILYELFVGQPPF 202
+G+ EL G PF
Sbjct: 196 VGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 6e-08
Identities = 51/219 (23%), Positives = 98/219 (44%), Gaps = 9/219 (4%)
Query: 11 LVGEGSFGKVYKGRRKYTGQT---VAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIE 67
++G G FG++ +G K + VA+ ++ G S+K E L + H NI+
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIH-TLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 68 MLDSFESPQEFCVVTEF-AQGELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLHSNRIIH 125
+ +VTE+ + G L L + + L Q+ + L + YL +H
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVH 130
Query: 126 RDMKPQNILIGAGSVVKLCDFG-FARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTAD 184
+ + +L+ + V K+ F S S K L+ APE ++ ++ +D
Sbjct: 131 KGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASD 190
Query: 185 LWSLGVILYELFV-GQPPFYTNSVYALIRHIVKDPVKYP 222
+WS G++++E+ G+ P++ S +I+ V+D + P
Sbjct: 191 VWSFGIVMWEVMSYGERPYWDMSGQDVIK-AVEDGFRLP 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 10 ELVGEGSFGKVYKGRRKY--------TGQTVAMKFIMK-HGKSEKDIH-NLRQEIEILRK 59
E +G G+ ++Y G Y +K I+K S +DI + ++R+
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQG---ELFEILEDDKCLPEEQVQSIAKQLVRALH 116
+ H++I+ + E +V EF + +LF + D + + +AKQL AL
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK-VAKQLASALS 119
Query: 117 YLHSNRIIHRDMKPQNILIG-------AGSVVKLCDFGFARAMSANTVVLRS--IKGTPL 167
YL ++H ++ +NIL+ G +KL D G TV+ R ++ P
Sbjct: 120 YLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI-----TVLSRQECVERIP- 173
Query: 168 YMAPELVRE-QPYNHTADLWSLGVILYEL-FVGQPPF 202
++APE V + + + AD WS G L+E+ + G+ P
Sbjct: 174 WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|222285 pfam13646, HEAT_2, HEAT repeats | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 7e-07
Identities = 29/108 (26%), Positives = 45/108 (41%), Gaps = 21/108 (19%)
Query: 1135 LEFLKDFL-THEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRK 1193
LE L + L + DP VRA A ALG + + L++ DPD R+
Sbjct: 1 LEALLEALLSDPDPEVRAAAARALGELGD-----------PEALPALLELLKDPDPEVRR 49
Query: 1194 FACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALS 1241
A ++G ++P L +L D++ +A AA AL+
Sbjct: 50 AAAEALGKLG---------DPEALPALLELLQDDDDAVVRAAAASALA 88
|
This family includes multiple HEAT repeats. Length = 88 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-06
Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 50/176 (28%)
Query: 12 VGEGSFGKVYKG----RRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEI-----LRKLKH 62
+GEG+FG VYK ++ +K ++G +EI +R+
Sbjct: 140 LGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----------AVEIWMNERVRRACP 188
Query: 63 QNIIEMLDSFESP------QEFCVVTEFAQGE--LFE--------------ILEDDKCLP 100
+ + + F P E+ +V + +GE L + +L + LP
Sbjct: 189 NSCADFVYGFLEPVSSKKEDEYWLVWRY-EGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 101 ---EEQ---VQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS-VVKLCDFGFA 149
E + +Q+I +Q++ AL LHS I+HRD+KPQNI+ GS K+ D G A
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|237987 cd00020, ARM, Armadillo/beta-catenin-like repeats | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 21/102 (20%), Positives = 38/102 (37%)
Query: 1095 RVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKAC 1154
+ LL SS V + +S+L+ + + + A L L L ED V A
Sbjct: 11 ALVSLLSSSDENVQREAAWALSNLSAGNNDNIQAVVEAGGLPALVQLLKSEDEEVVKAAL 70
Query: 1155 SALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFAC 1196
AL N+ + + + L++ ++ +K A
Sbjct: 71 WALRNLAAGPEDNKLIVLEAGGVPKLVNLLDSSNEDIQKNAT 112
|
An approximately 40 amino acid long tandemly repeated sequence motif first identified in the Drosophila segment polarity gene armadillo; these repeats were also found in the mammalian armadillo homolog beta-catenin, the junctional plaque protein plakoglobin, the adenomatous polyposis coli (APC) tumor suppressor protein, and a number of other proteins. ARM has been implicated in mediating protein-protein interactions, but no common features among the target proteins recognized by the ARM repeats have been identified; related to the HEAT domain; three consecutive copies of the repeat are represented by this alignment model. Length = 120 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-05
Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 11/75 (14%)
Query: 99 LPEEQ-----VQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS 153
+P+++ ++ + +Q++ L LH I+HRD+KP+N+L+ VK+ DFG A M
Sbjct: 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360
Query: 154 ANTVVLRSIKGTPLY 168
I PLY
Sbjct: 361 T------GINFNPLY 369
|
Length = 507 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 50/227 (22%), Positives = 106/227 (46%), Gaps = 30/227 (13%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNL-RQEIEILRKLK 61
++ Y + L+ E +YKG + + V ++ K K K + ++ EI+ LR++
Sbjct: 20 IDKYTSV-LIKENDQNSIYKG--IFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID 76
Query: 62 HQNIIEM----LDSFESPQEFCVVTEFA-QGELFEILEDDKCLPEEQVQSIAKQLVRALH 116
NI+++ +D + ++ E+ +G L E+L+ +K L + +A + L+
Sbjct: 77 SNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLY 136
Query: 117 YLH-SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA------NTVVLRSIKGTPLYM 169
L+ ++++ + L+ +K+ G + +S+ N +V Y
Sbjct: 137 NLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV---------YF 187
Query: 170 APELVRE--QPYNHTADLWSLGVILYELFVGQPPFY---TNSVYALI 211
+ +++ + Y D++SLGV+L+E+F G+ PF T +Y LI
Sbjct: 188 SYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI 234
|
Length = 283 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-05
Identities = 19/59 (32%), Positives = 36/59 (61%)
Query: 91 EILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFA 149
EI + KC ++ +++I K ++ L Y+H + I H D+KP+NI++ + + D+G A
Sbjct: 115 EIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 7e-05
Identities = 45/138 (32%), Positives = 65/138 (47%), Gaps = 17/138 (12%)
Query: 77 EFCVVTEFAQ-GELFEILEDDKC-LPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNIL 134
E +V EF + G L L +K +P ++A+QL AL YL ++H ++ +NIL
Sbjct: 90 ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNIL 149
Query: 135 I-------GAGSVVKLCDFGFA-RAMSANTVVLRSIKGTPLYMAPELVREQPYNHTA-DL 185
+ G +KL D G + A+S V R P ++APE V TA D
Sbjct: 150 LARLGLAEGTSPFIKLSDPGVSFTALSREERVER----IP-WIAPECVPGGNSLSTAADK 204
Query: 186 WSLGVILYEL-FVGQPPF 202
WS G L E+ F G+ P
Sbjct: 205 WSFGTTLLEICFDGEVPL 222
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|237987 cd00020, ARM, Armadillo/beta-catenin-like repeats | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 29/121 (23%), Positives = 51/121 (42%), Gaps = 13/121 (10%)
Query: 1217 IPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALN 1276
+P L ++L S +E+ + AA ALSNL ++ + +V G + AL++L+
Sbjct: 9 LPALVSLLSSSDEN-VQREAAWALSNLSAGNNDNIQAVVEAGGLPALVQLLKSEDEEV-- 65
Query: 1277 PSRKDAVNESPLKIALFSLAKMCAHTPCRQFLQSSELFPVIARLRQSPESTIANYASVII 1336
K A+ AL +LA + + + P + L S I A+ +
Sbjct: 66 --VKAAL------WALRNLAAGPED--NKLIVLEAGGVPKLVNLLDSSNEDIQKNATGAL 115
Query: 1337 S 1337
S
Sbjct: 116 S 116
|
An approximately 40 amino acid long tandemly repeated sequence motif first identified in the Drosophila segment polarity gene armadillo; these repeats were also found in the mammalian armadillo homolog beta-catenin, the junctional plaque protein plakoglobin, the adenomatous polyposis coli (APC) tumor suppressor protein, and a number of other proteins. ARM has been implicated in mediating protein-protein interactions, but no common features among the target proteins recognized by the ARM repeats have been identified; related to the HEAT domain; three consecutive copies of the repeat are represented by this alignment model. Length = 120 |
| >gnl|CDD|227396 COG5064, SRP1, Karyopherin (importin) alpha [Intracellular trafficking and secretion] | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 0.001
Identities = 24/122 (19%), Positives = 51/122 (41%)
Query: 1093 PNRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAK 1152
P R+ LL + ++ L V ++ + I L+ + L+ N+R +
Sbjct: 287 PGRLVELLSHESAKIQTPALRSVGNIVTGSDDQTQVIINCGALKAFRSLLSSPKENIRKE 346
Query: 1153 ACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEE 1212
AC + N+ ++ ++ +I LI + + + +K AC++I NA +
Sbjct: 347 ACWTISNITAGNTEQIQAVIDANLIPPLIHLLSSAEYKIKKEACWAISNATSGGLNRPDI 406
Query: 1213 LR 1214
+R
Sbjct: 407 IR 408
|
Length = 526 |
| >gnl|CDD|224331 COG1413, COG1413, FOG: HEAT repeat [Energy production and conversion] | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 29/109 (26%), Positives = 42/109 (38%), Gaps = 20/109 (18%)
Query: 1135 LEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKF 1194
+ L L ED VR A ALG + + LL + +D D R R
Sbjct: 45 ADELLKLLEDEDLLVRLSAAVALGEL-----------GSEEAVPLLRELLSDEDPRVRDA 93
Query: 1195 ACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNL 1243
A ++G ++P L +L +DE + +A AA AL L
Sbjct: 94 AADALGEL---------GDPEAVPPLVELLENDENEGVRAAAARALGKL 133
|
Length = 335 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.002
Identities = 22/100 (22%), Positives = 46/100 (46%), Gaps = 18/100 (18%)
Query: 75 PQEFCVVTEFAQGELF-EILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNI 133
P +V E+ +G+ +++E+ + +++ R + LH I+H D+ NI
Sbjct: 69 PDNKTIVMEYIEGKPLKDVIEEGN-------DELLREIGRLVGKLHKAGIVHGDLTTSNI 121
Query: 134 LIGAGSVVKLCDFGFA--------RAMSANTVVLRSIKGT 165
++ + L DFG +A+ + V+ RS++ T
Sbjct: 122 IVRDDKLY-LIDFGLGKYSDEIEDKAVDLH-VLKRSLEST 159
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|205691 pfam13513, HEAT_EZ, HEAT-like repeat | Back alignment and domain information |
|---|
Score = 37.0 bits (86), Expect = 0.003
Identities = 13/55 (23%), Positives = 21/55 (38%), Gaps = 1/55 (1%)
Query: 1147 PNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGN 1201
VR A ALG + A ++ L+ D D R+ A +++G
Sbjct: 1 WEVREAAALALGALAGGGPE-LLRPAVPELLPALLPLLKDDDDEVREAAAWALGR 54
|
The HEAT repeat family is related to armadillo/beta-catenin-like repeats (see pfam00514). These EZ repeats are found in subunits of cyanobacterial phycocyanin lyase and other proteins and probably carry out a scaffolding role. Length = 55 |
| >gnl|CDD|182395 PRK10345, PRK10345, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 24/68 (35%), Positives = 33/68 (48%), Gaps = 14/68 (20%)
Query: 82 TEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNIL---IGAG 138
TEFA+ C EE V + + L + YL NRI+ ++KPQNIL I
Sbjct: 95 TEFAEQ----------CRYEEDVAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISES 144
Query: 139 SVVK-LCD 145
V+ +CD
Sbjct: 145 EVIPVVCD 152
|
Length = 210 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.004
Identities = 22/77 (28%), Positives = 41/77 (53%), Gaps = 6/77 (7%)
Query: 75 PQEFCVVTEFAQGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNI 133
P+ F +V E+ +GE L +++ + +++++ R + LHS IIH D+ N+
Sbjct: 71 PENFIIVMEYIEGEPLKDLINS----NGMEELELSREIGRLVGKLHSAGIIHGDLTTSNM 126
Query: 134 LIGAGSVVKLCDFGFAR 150
++ G + L DFG A
Sbjct: 127 ILSGGKIY-LIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.004
Identities = 19/77 (24%), Positives = 37/77 (48%), Gaps = 10/77 (12%)
Query: 75 PQEFCVVTEFAQGELF-EILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNI 133
P+E +V E+ G+ ++LE + E V+ + + + + LH I+H D+ N
Sbjct: 408 PEEKTIVMEYIGGKDLKDVLEGN----PELVRKVGEIVAK----LHKAGIVHGDLTTSNF 459
Query: 134 LIGAGSVVKLCDFGFAR 150
++ + L DFG +
Sbjct: 460 IVRDDRLY-LIDFGLGK 475
|
Length = 535 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.004
Identities = 30/123 (24%), Positives = 55/123 (44%), Gaps = 16/123 (13%)
Query: 51 RQEIEILRKLKHQNI-IEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAK 109
R+E IL K + + + ++ + P +V E+ +GEL K EE + +
Sbjct: 47 RREARILAKAREAGVPVPIVYDVD-PDNGLIVMEYIEGELL------KDALEEARPDLLR 99
Query: 110 QLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFAR------AMSANTVVL-RSI 162
++ R + LH I+H D+ NI++ G + DFG + + VL R++
Sbjct: 100 EVGRLVGKLHKAGIVHGDLTTSNIILSGGRIY-FIDFGLGEFSDEVEDKAVDLHVLERAL 158
Query: 163 KGT 165
+ T
Sbjct: 159 EST 161
|
Length = 204 |
| >gnl|CDD|177776 PLN00181, PLN00181, protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.004
Identities = 35/116 (30%), Positives = 52/116 (44%), Gaps = 12/116 (10%)
Query: 165 TPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS-VYALIRHIVKDP---VK 220
Y +PE N +D++ LGV+L+ELF S + +RH V P +
Sbjct: 178 MSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLN 237
Query: 221 YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDELNAWELRATSVEAR 276
+P E SF LL+ P R + S LL+ F+ E + L E R ++E R
Sbjct: 238 WPKE-----ASFCLWLLHPEPSCRPSMSELLQSEFINEPRENL---EEREAAMELR 285
|
Length = 793 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1342 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| PLN03200 | 2102 | cellulose synthase-interactive protein; Provisiona | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG0166 | 514 | consensus Karyopherin (importin) alpha [Intracellu | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| PLN03200 | 2102 | cellulose synthase-interactive protein; Provisiona | 99.68 | |
| KOG0166 | 514 | consensus Karyopherin (importin) alpha [Intracellu | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.48 | |
| PF10508 | 503 | Proteasom_PSMB: Proteasome non-ATPase 26S subunit; | 99.43 | |
| PF10508 | 503 | Proteasom_PSMB: Proteasome non-ATPase 26S subunit; | 99.38 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.33 | |
| cd00020 | 120 | ARM Armadillo/beta-catenin-like repeats. An approx | 99.31 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.31 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.25 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.22 | |
| COG5064 | 526 | SRP1 Karyopherin (importin) alpha [Intracellular t | 99.21 | |
| cd00020 | 120 | ARM Armadillo/beta-catenin-like repeats. An approx | 99.2 | |
| KOG4224 | 550 | consensus Armadillo repeat protein VAC8 required f | 99.18 | |
| PRK09687 | 280 | putative lyase; Provisional | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.05 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.97 | |
| KOG4224 | 550 | consensus Armadillo repeat protein VAC8 required f | 98.93 | |
| PRK09687 | 280 | putative lyase; Provisional | 98.93 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.92 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.92 | |
| COG5064 | 526 | SRP1 Karyopherin (importin) alpha [Intracellular t | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.82 | |
| PF05804 | 708 | KAP: Kinesin-associated protein (KAP) | 98.82 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.73 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.66 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.66 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.53 | |
| PF01602 | 526 | Adaptin_N: Adaptin N terminal region; InterPro: IP | 98.48 | |
| PRK13800 | 897 | putative oxidoreductase/HEAT repeat-containing pro | 98.45 | |
| PF04826 | 254 | Arm_2: Armadillo-like; InterPro: IPR006911 This en | 98.44 | |
| PRK13800 | 897 | putative oxidoreductase/HEAT repeat-containing pro | 98.39 | |
| PF05804 | 708 | KAP: Kinesin-associated protein (KAP) | 98.36 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.35 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.34 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.32 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.27 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.23 | |
| PF01602 | 526 | Adaptin_N: Adaptin N terminal region; InterPro: IP | 98.22 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.22 | |
| PF13646 | 88 | HEAT_2: HEAT repeats; PDB: 1OYZ_A 3FGA_A 2PF4_C 2I | 98.19 | |
| PF13513 | 55 | HEAT_EZ: HEAT-like repeat; PDB: 2Z5J_A 2OT8_B 2Z5O | 98.14 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.11 | |
| PF13646 | 88 | HEAT_2: HEAT repeats; PDB: 1OYZ_A 3FGA_A 2PF4_C 2I | 98.08 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.93 | |
| PF13513 | 55 | HEAT_EZ: HEAT-like repeat; PDB: 2Z5J_A 2OT8_B 2Z5O | 97.81 | |
| PF12348 | 228 | CLASP_N: CLASP N terminal; InterPro: IPR024395 Thi | 97.79 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.77 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.67 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.63 | |
| PF03224 | 312 | V-ATPase_H_N: V-ATPase subunit H; InterPro: IPR004 | 97.61 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.6 | |
| PF12717 | 178 | Cnd1: non-SMC mitotic condensation complex subunit | 97.58 | |
| TIGR02270 | 410 | conserved hypothetical protein. Members are found | 97.58 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.53 | |
| PTZ00429 | 746 | beta-adaptin; Provisional | 97.51 | |
| COG1413 | 335 | FOG: HEAT repeat [Energy production and conversion | 97.49 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.42 | |
| PF04826 | 254 | Arm_2: Armadillo-like; InterPro: IPR006911 This en | 97.42 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-50 Score=467.39 Aligned_cols=255 Identities=35% Similarity=0.615 Sum_probs=243.6
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~-~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
.+|+..+.||+|+|+.||++++..+|+.||+|++.+.. ......+.+.+||++++.++|||||+++++|++.+.+|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 46999999999999999999999999999999998753 33455688999999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
|+|+ |+|.+++++.++++|.+++.|++||+.||.|||+++|+|||||..|+|++++-++||+|||+|..+..+.....+
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T 177 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT 177 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence 9997 899999999999999999999999999999999999999999999999999999999999999999877667788
Q ss_pred ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCC
Q 000706 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVP 241 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDP 241 (1342)
.||||-|+|||++....++..+||||+||++|-|++|++||...+..+.+++|......+|..++.++++||++||+.||
T Consensus 178 lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P 257 (592)
T KOG0575|consen 178 LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNP 257 (592)
T ss_pred ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCcCccc
Q 000706 242 QNRLTWSALLEHPFVKE 258 (1342)
Q Consensus 242 eKRPSAeELLeHPFFre 258 (1342)
.+|||+++++.|+||..
T Consensus 258 ~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 258 SERPSLDEVLDHPFFKS 274 (592)
T ss_pred ccCCCHHHHhcCHhhhC
Confidence 99999999999999954
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=442.53 Aligned_cols=261 Identities=36% Similarity=0.677 Sum_probs=243.3
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE-KDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se-~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
+.++|++++.||+|+||+||.++.+.+++.||+|+++|....+ .+.+....|..+|.+++||+||+++..|++++.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 5789999999999999999999999999999999998775433 356789999999999999999999999999999999
Q ss_pred EEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceee
Q 000706 81 VTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~ 159 (1342)
|+||+. |+|+..|++.+.|+|..++.|+.+|+.||.|||++||+||||||||||++.+|+++|+|||+++..-......
T Consensus 103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t 182 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDAT 182 (357)
T ss_pred EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCcc
Confidence 999997 6999999999999999999999999999999999999999999999999999999999999999766666667
Q ss_pred ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-CCCCCHHHHHHHHHhcc
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKY-PDEMSPNFKSFLKGLLN 238 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~ef-P~eISpeLkDLIrKcLq 238 (1342)
.++|||+.|||||++.+.+|+..+|+||||+++|||++|.+||.+.+....+++|.+.+... |..++++.+++++++|+
T Consensus 183 ~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~ 262 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLK 262 (357)
T ss_pred ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhc
Confidence 78999999999999999999999999999999999999999999999999999999999544 45599999999999999
Q ss_pred cCCCCCC----CHHHHHcCcCcccchhh
Q 000706 239 KVPQNRL----TWSALLEHPFVKETSDE 262 (1342)
Q Consensus 239 kDPeKRP----SAeELLeHPFFre~~~e 262 (1342)
.||++|. ++.++.+||||.....+
T Consensus 263 rdp~~RLg~~~d~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 263 RDPRQRLGGPGDAEEIKRHPFFKGINWE 290 (357)
T ss_pred cCHHHhcCCCCChHHhhcCcccccCCHH
Confidence 9999996 69999999999987543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-50 Score=449.07 Aligned_cols=256 Identities=35% Similarity=0.616 Sum_probs=229.0
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCH-----HHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE-----KDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEF 78 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se-----~dierL~rEI~ILKrL~HPNIVKL~dvfeded~l 78 (1342)
+.|.+.+.||+|+||.|.+|..+.+|+.||||++.+..... .....+.+|+++|++++|||||+++++|++++..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 67999999999999999999999999999999997753221 1234578999999999999999999999999999
Q ss_pred EEEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCC---CcEEEeeccccccccC
Q 000706 79 CVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAG---SVVKLCDFGFARAMSA 154 (1342)
Q Consensus 79 yLVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsd---G~LKLiDFGLAr~l~s 154 (1342)
|+||||++ |+|++.+-.++.+.|..-+.+++|++.|+.|||++||+||||||+|||+..+ ..+||+|||+|+..+.
T Consensus 252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~ 331 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE 331 (475)
T ss_pred EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc
Confidence 99999997 7999999999999999999999999999999999999999999999999876 5899999999999874
Q ss_pred CceeeecccCCCCcCChhhhccCCC---CCCCcccchhhHHHHHHhCCCCCCCCcHHH-HHHHHhcCCCCC----CCCCC
Q 000706 155 NTVVLRSIKGTPLYMAPELVREQPY---NHTADLWSLGVILYELFVGQPPFYTNSVYA-LIRHIVKDPVKY----PDEMS 226 (1342)
Q Consensus 155 ss~~~~s~vGTp~YmAPEvL~g~~Y---T~KsDIWSLGVILYELLTGr~PF~g~s~~e-lirkIlr~~~ef----P~eIS 226 (1342)
. ...++.||||.|.|||++.+..+ ..++||||+||+||-+++|.+||.+..... ..++|.++.+.+ +..++
T Consensus 332 ~-sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Is 410 (475)
T KOG0615|consen 332 G-SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRIS 410 (475)
T ss_pred c-eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhh
Confidence 4 45678999999999999987653 347899999999999999999998866544 778888876544 45789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 227 PNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 227 peLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
.+..+||.+||..||++|||+.|+|+||||+...
T Consensus 411 eea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 411 EEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred HHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 9999999999999999999999999999999764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=454.02 Aligned_cols=257 Identities=67% Similarity=1.096 Sum_probs=251.9
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
|++|.+.+.||+|.||.||+|+.+.+.+.||+|.+.|.+..+++.+.+++|+++++.++||||+.++++|++..++|+|.
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 68999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 83 EFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 83 EY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
||+.|+|+++++.++.++|+.++.+..|++.||.|||+.+|.|||+||.|||++.+|.+|+||||+|+.+..+....+..
T Consensus 81 e~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsi 160 (808)
T KOG0597|consen 81 EYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSI 160 (808)
T ss_pred hhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999888999
Q ss_pred cCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCC
Q 000706 163 KGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQ 242 (1342)
Q Consensus 163 vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPe 242 (1342)
.|||.|||||++.+++|+..+|+||+|||+|||++|++||...+..++.+.|..++..+|...+..+.+|+.++|.+||.
T Consensus 161 kGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~ 240 (808)
T KOG0597|consen 161 KGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPA 240 (808)
T ss_pred cCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCcCcccc
Q 000706 243 NRLTWSALLEHPFVKET 259 (1342)
Q Consensus 243 KRPSAeELLeHPFFre~ 259 (1342)
+|.|+.+++.|||.+..
T Consensus 241 ~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 241 QRLTWTDLLGHPFWKGK 257 (808)
T ss_pred hcccHHHHhcChHHhhh
Confidence 99999999999998764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-49 Score=448.49 Aligned_cols=257 Identities=34% Similarity=0.580 Sum_probs=230.7
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEeCC-eEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-HQNIIEMLDSFESPQ-EFC 79 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~-HPNIVKL~dvfeded-~ly 79 (1342)
.+++|.++++||.|+||.||+|..+.+++.||||.+++.....+++.+++ |++.|++++ ||||+++++++.+.+ .+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLR-EvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLR-EVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHH-HHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 46899999999999999999999999999999999998877777666655 999999998 999999999998888 999
Q ss_pred EEEeccCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 80 VVTEFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 80 LVMEY~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
+|||||+.+|++++++ ++.|+|..++.|++||++||+|+|++|++|||+||||||+..+..+||+|||+|+...... .
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp-P 165 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP-P 165 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCC-C
Confidence 9999999999999986 5679999999999999999999999999999999999999988899999999999887654 4
Q ss_pred eecccCCCCcCChhhh-ccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC---C----------------
Q 000706 159 LRSIKGTPLYMAPELV-REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---P---------------- 218 (1342)
Q Consensus 159 ~~s~vGTp~YmAPEvL-~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~---~---------------- 218 (1342)
++.++.|.||+|||++ +...|+.++|||++|||++|+.+-++.|.|.++.+++.+|..- +
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn 245 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN 245 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence 5778899999999976 5567999999999999999999999999999998888887631 0
Q ss_pred CCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 219 VKYP-----------DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 219 ~efP-----------~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
+.+| +..++++.++|.+||.+||.+|||+.|+++||||+...
T Consensus 246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 1122 23678999999999999999999999999999998753
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=433.04 Aligned_cols=256 Identities=35% Similarity=0.644 Sum_probs=234.8
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-eEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ-EFCVV 81 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded-~lyLV 81 (1342)
.++.+.++.||+|..|+||+++|+.|++.+|+|++... ..+...+++.+|+++++.++|||||++|+.|..+. .++|+
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 45778889999999999999999999999999999433 45566788999999999999999999999999998 59999
Q ss_pred EeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCcEEEcCCCcEEEeeccccccccCCceee
Q 000706 82 TEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS-NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHs-rGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~ 159 (1342)
||||+ |+|.+.++..++++|.....++.++++||.|||+ ++|+||||||+||||+..|.+||||||.++.+... ..
T Consensus 157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a 234 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IA 234 (364)
T ss_pred hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hc
Confidence 99998 7899999888999999999999999999999995 99999999999999999999999999999887655 45
Q ss_pred ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCC-----cHHHHHHHHhc-CCCCCCCC-CCHHHHHH
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTN-----SVYALIRHIVK-DPVKYPDE-MSPNFKSF 232 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~-----s~~elirkIlr-~~~efP~e-ISpeLkDL 232 (1342)
.+++||..|||||.+.+..|+.++||||||+.++|+.+|+.||... ...+++..|.. .++.+|.. +|+++++|
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~F 314 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSF 314 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 7889999999999999999999999999999999999999999774 67888888888 56678886 99999999
Q ss_pred HHHhcccCCCCCCCHHHHHcCcCcccchh
Q 000706 233 LKGLLNKVPQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 233 IrKcLqkDPeKRPSAeELLeHPFFre~~~ 261 (1342)
|..||++||.+||++.|+++|||++....
T Consensus 315 V~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 315 VSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 99999999999999999999999986543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-48 Score=436.59 Aligned_cols=256 Identities=38% Similarity=0.690 Sum_probs=237.9
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC---HHHHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS---EKDIHNLRQEIEILRKLK-HQNIIEMLDSFESPQEF 78 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s---e~dierL~rEI~ILKrL~-HPNIVKL~dvfeded~l 78 (1342)
.++|++.+.||+|+||.||.|.+..+++.||+|++.+.... ....+.+.+|+.++++++ ||||+++++++..+..+
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 57999999999999999999999999999999987664211 234567789999999998 99999999999999999
Q ss_pred EEEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCC-CcEEEeeccccccccCCc
Q 000706 79 CVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAG-SVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 79 yLVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsd-G~LKLiDFGLAr~l~sss 156 (1342)
|+||||+. |+|++++.+.+++.|.+++.+|+|+++|++|||++||+||||||||||++.+ +++||+|||++.......
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~ 175 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGED 175 (370)
T ss_pred EEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCC
Confidence 99999997 6999999999999999999999999999999999999999999999999999 999999999998875444
Q ss_pred eeeecccCCCCcCChhhhccCC-CC-CCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCC-CHHHHHHH
Q 000706 157 VVLRSIKGTPLYMAPELVREQP-YN-HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEM-SPNFKSFL 233 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g~~-YT-~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eI-SpeLkDLI 233 (1342)
....+.+|||.|+|||++.+.. |+ .++||||+|++||.|++|+.||...+...+.++|.++.+.+|..+ ++++++|+
T Consensus 176 ~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~Li 255 (370)
T KOG0583|consen 176 GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARSLI 255 (370)
T ss_pred CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHHHH
Confidence 5667899999999999999987 86 789999999999999999999999999999999999999999999 99999999
Q ss_pred HHhcccCCCCCCCHHHHHcCcCccc
Q 000706 234 KGLLNKVPQNRLTWSALLEHPFVKE 258 (1342)
Q Consensus 234 rKcLqkDPeKRPSAeELLeHPFFre 258 (1342)
++||..||.+|+|+.++++||||+.
T Consensus 256 ~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 256 EKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHcCCCcccCCCHHHHhhChhhcc
Confidence 9999999999999999999999996
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=444.35 Aligned_cols=261 Identities=33% Similarity=0.603 Sum_probs=241.6
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFC 79 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~ly 79 (1342)
+..+|+.++.||+|+|++||+|+++.+++.||||++.|... .+...+-+..|-.+|.+| .||.|+++|-.|+|+..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 56899999999999999999999999999999999976532 233345677899999999 8999999999999999999
Q ss_pred EEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 80 VVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 80 LVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
+|+||++ |+|+++|.+.+.|+|..++.|+.||+.||+|||++||+||||||||||+++||++||+|||.|+.+++....
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 9999997 999999999999999999999999999999999999999999999999999999999999999987542211
Q ss_pred -------------eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCC
Q 000706 159 -------------LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEM 225 (1342)
Q Consensus 159 -------------~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eI 225 (1342)
..+++||..|.+||++.....++.+|||+||||+|+|+.|.+||.+.+++...++|..-.+.||+.+
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~f 310 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEGF 310 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCCC
Confidence 1458999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccchhh
Q 000706 226 SPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDE 262 (1342)
Q Consensus 226 SpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~~e 262 (1342)
++.+++||+++|..||.+|+|.+||.+||||.....+
T Consensus 311 p~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 311 PEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred CHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 9999999999999999999999999999999987544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=423.48 Aligned_cols=257 Identities=40% Similarity=0.728 Sum_probs=238.0
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
+++|.+.+.||+|+||+||+|+++.++..||||.+.+.....+..+.+..|+.+|+.++|||||+++++.++++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 67999999999999999999999999999999999988777788889999999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCC------CcEEEeeccccccccCC
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAG------SVVKLCDFGFARAMSAN 155 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsd------G~LKLiDFGLAr~l~ss 155 (1342)
|||+ |||.++|.+.+.++|..++.++.||+.||++||+++|+||||||+|||++.+ -.+||+|||+|+.+...
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 9998 8999999999999999999999999999999999999999999999999765 36999999999998855
Q ss_pred ceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCCCCCCHHHHHH
Q 000706 156 TVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV---KYPDEMSPNFKSF 232 (1342)
Q Consensus 156 s~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~---efP~eISpeLkDL 232 (1342)
. ...+.||+|.|||||++..+.|+.|+|+||+|+|+|+|++|++||...+..++...+.++.. .++...++...++
T Consensus 169 ~-~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~L 247 (429)
T KOG0595|consen 169 S-MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLREL 247 (429)
T ss_pred h-HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhh
Confidence 4 45678999999999999999999999999999999999999999999999998888877643 3445678888899
Q ss_pred HHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 233 LKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 233 IrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
+...|+.+|..|.+..+-+.|+++....
T Consensus 248 l~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 248 LISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhHHHhcCccccCchHHhhhhhhcccCc
Confidence 9999999999999999999999987654
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=408.49 Aligned_cols=255 Identities=33% Similarity=0.616 Sum_probs=233.7
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
.+++|++.+.||+|+||.||+|+++.+++.||+|.+.+... .....+.+.+|++++++++||||+++++.+.+++.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 46899999999999999999999999999999999976432 22345678899999999999999999999999999999
Q ss_pred EEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceee
Q 000706 81 VTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~ 159 (1342)
+|||++ |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--- 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--- 172 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc---
Confidence 999987 6899999988899999999999999999999999999999999999999999999999999998765433
Q ss_pred ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhccc
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqk 239 (1342)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+..+.+......+|..+++.+++||++||+.
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~ 252 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQT 252 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhc
Confidence 23569999999999999999999999999999999999999999988888888888888888889999999999999999
Q ss_pred CCCCCCC-----HHHHHcCcCcccc
Q 000706 240 VPQNRLT-----WSALLEHPFVKET 259 (1342)
Q Consensus 240 DPeKRPS-----AeELLeHPFFre~ 259 (1342)
||.+||+ ++++++||||++.
T Consensus 253 dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 253 DHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred CHHHcCCCCCCCHHHHhcCCccCCC
Confidence 9999997 8999999999874
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=413.82 Aligned_cols=257 Identities=33% Similarity=0.621 Sum_probs=242.4
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
++++|+.++.||.|+||.|.+++++.+|..||+|++.+... ..++.+...+|.++|+.+.||+++++++.+.+.+.+|+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 57899999999999999999999999999999999977643 34567889999999999999999999999999999999
Q ss_pred EEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceee
Q 000706 81 VTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~ 159 (1342)
||||++ |+|+.++++.++|+|..++.|+.||+.||+|||.++|++|||||||||+|.+|++||+|||+|+..... .
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r---T 198 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR---T 198 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---E
Confidence 999997 789999999999999999999999999999999999999999999999999999999999999987765 3
Q ss_pred ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhccc
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqk 239 (1342)
-+.||||.|+|||++..++|+.++|.|+||+++|||+.|.+||...+....+++|..+...+|..+++++++|++++|+.
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~v 278 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQV 278 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhh
Confidence 46789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCC-----CHHHHHcCcCcccchh
Q 000706 240 VPQNRL-----TWSALLEHPFVKETSD 261 (1342)
Q Consensus 240 DPeKRP-----SAeELLeHPFFre~~~ 261 (1342)
|-.+|. ...++..||||++...
T Consensus 279 D~t~R~gnlknG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 279 DLTKRFGNLKNGVEDIKNHPWFKGVDW 305 (355)
T ss_pred hhHhhhcCcCCCccccccCcccccccH
Confidence 999995 5789999999997643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=416.06 Aligned_cols=257 Identities=36% Similarity=0.595 Sum_probs=232.7
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
|+.|+.+..+|+|+||+||+|+++.||+.||||.+.....++...+-..+|+++|++++|||+|.++++|.....+++|+
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 68899999999999999999999999999999999887776766777899999999999999999999999999999999
Q ss_pred eccCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
|||+.++++.+++ ...++++.++.|++|++.|+.|+|+++++||||||||||++.+|.+||||||+|+.+..+...++.
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD 160 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD 160 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence 9999998888876 457999999999999999999999999999999999999999999999999999999877778889
Q ss_pred ccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC-------------------CCC
Q 000706 162 IKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP-------------------VKY 221 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~-------------------~ef 221 (1342)
++.|.||+|||.+.+ .+|+..+|||++||++.||++|.+.|.+.++.+++-.|.+.- ..+
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l 240 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL 240 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence 999999999998877 789999999999999999999999999998887776654311 011
Q ss_pred C------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 222 P------------DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 222 P------------~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
| +.++.-+.+|+++||..||.+|++.+|++.||||...
T Consensus 241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 1 2356678899999999999999999999999999544
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=402.20 Aligned_cols=251 Identities=33% Similarity=0.646 Sum_probs=228.1
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-C
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-G 87 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e-G 87 (1342)
+.||+|+||.||+|.++.+|+.||+|++++... .......+.+|++++++++||||+++++.+.+++.+|+||||++ |
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 479999999999999999999999999976432 23345677889999999999999999999999999999999997 6
Q ss_pred ChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCCC
Q 000706 88 ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL 167 (1342)
Q Consensus 88 SL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp~ 167 (1342)
+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence 89999988889999999999999999999999999999999999999999999999999999764433333455679999
Q ss_pred cCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCC--
Q 000706 168 YMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRL-- 245 (1342)
Q Consensus 168 YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRP-- 245 (1342)
|+|||++.+..|+.++||||+||++|||++|+.||...+.......+......+|..+++++.+||++||+.||++||
T Consensus 161 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 240 (323)
T cd05571 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG 240 (323)
T ss_pred ccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCC
Confidence 999999999999999999999999999999999999988888888888888889999999999999999999999999
Q ss_pred ---CHHHHHcCcCcccch
Q 000706 246 ---TWSALLEHPFVKETS 260 (1342)
Q Consensus 246 ---SAeELLeHPFFre~~ 260 (1342)
++.++++||||+...
T Consensus 241 ~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 241 GPEDAKEIMEHRFFASIN 258 (323)
T ss_pred CCCCHHHHHcCCCcCCCC
Confidence 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=397.04 Aligned_cols=254 Identities=30% Similarity=0.555 Sum_probs=232.3
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|++++++++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 589999999999999999999999999999999975432 2234567889999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
||++ |+|.+++.+.+.+++..++.++.|++.||+|||++|++||||||+|||++.+|.+||+|||+++...... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~---~~ 157 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT---WT 157 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc---cc
Confidence 9987 7899999988899999999999999999999999999999999999999999999999999998764432 23
Q ss_pred ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCC
Q 000706 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVP 241 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDP 241 (1342)
..||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+..+.+......+|..+++.++++|++||+.||
T Consensus 158 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp 237 (291)
T cd05612 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDR 237 (291)
T ss_pred ccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCH
Confidence 56999999999999999999999999999999999999999999888888888888888999999999999999999999
Q ss_pred CCCCC-----HHHHHcCcCcccch
Q 000706 242 QNRLT-----WSALLEHPFVKETS 260 (1342)
Q Consensus 242 eKRPS-----AeELLeHPFFre~~ 260 (1342)
.+||+ ++|+++||||+...
T Consensus 238 ~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 238 TRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred HHccCCccCCHHHHhcCccccCCC
Confidence 99995 99999999998643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=421.70 Aligned_cols=256 Identities=34% Similarity=0.510 Sum_probs=230.1
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP--QEFCV 80 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede--d~lyL 80 (1342)
.+.|+.+++||+|+||.||+|++..+|+.||+|.++.+...+.......+||.+|++++||||+++.+...+. ..+|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4678899999999999999999999999999999988776666667888999999999999999999999876 68999
Q ss_pred EEeccCCChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce-e
Q 000706 81 VTEFAQGELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV-V 158 (1342)
Q Consensus 81 VMEY~eGSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~-~ 158 (1342)
|+|||+.||..++... -.|++.+++.|+.||+.||+|||.+||+|||||..|||||.+|.+||+|||+|+.+..... .
T Consensus 196 VFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~ 275 (560)
T KOG0600|consen 196 VFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP 275 (560)
T ss_pred EEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcc
Confidence 9999999999998874 4799999999999999999999999999999999999999999999999999998876543 3
Q ss_pred eecccCCCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC----------CCC-----
Q 000706 159 LRSIKGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV----------KYP----- 222 (1342)
Q Consensus 159 ~~s~vGTp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~----------efP----- 222 (1342)
++..+-|.||+|||++.+. .|+.++|+||.||||.||+.|++.|.+.++.+++..|++-.. .+|
T Consensus 276 ~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~ 355 (560)
T KOG0600|consen 276 YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIF 355 (560)
T ss_pred cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccccc
Confidence 6778899999999988764 599999999999999999999999999999999998875211 111
Q ss_pred --------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCccc
Q 000706 223 --------------DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258 (1342)
Q Consensus 223 --------------~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre 258 (1342)
..+++...+|+.+||..||.+|.|+.++|+|+||..
T Consensus 356 kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 356 KPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred CCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 135778889999999999999999999999999944
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=437.19 Aligned_cols=258 Identities=31% Similarity=0.596 Sum_probs=242.0
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecC-CCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKH-GKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs-~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
++-|++++.||.|+.|.|.+|++..||+.+|||++.+. ...+.....+.+|+-+|+.+.|||++++|++|+++.++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 57799999999999999999999999999999999776 44455556789999999999999999999999999999999
Q ss_pred EeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 82 TEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
.||++ |+||+++.+.++++|.++.++++||+.|+.|||..+|+||||||||+|++..+++||+|||+|....+ .....
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-gklLe 169 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP-GKLLE 169 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC-Ccccc
Confidence 99997 89999999999999999999999999999999999999999999999999999999999999976544 45677
Q ss_pred cccCCCCcCChhhhccCCCC-CCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhccc
Q 000706 161 SIKGTPLYMAPELVREQPYN-HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g~~YT-~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqk 239 (1342)
+.||+|.|.+||++.+.+|+ .++||||+|+|||.|++|+.||++++...++.++.++.++.|..+++++++|+++||.+
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~V 249 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDV 249 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhcc
Confidence 88999999999999999985 78999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHcCcCcccchh
Q 000706 240 VPQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 240 DPeKRPSAeELLeHPFFre~~~ 261 (1342)
||.+|+|.+|+++|||+.....
T Consensus 250 Dp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 250 DPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred CccccccHHHHhhCchhhcCCC
Confidence 9999999999999999976543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=427.02 Aligned_cols=261 Identities=31% Similarity=0.594 Sum_probs=234.8
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFC 79 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-e~dierL~rEI~ILKrL~HPNIVKL~dvfeded~ly 79 (1342)
+++++|++++.||+|+||.||+|+-+.||+.||+|+++|.... ..+.+.++.|-++|...++|+||++|..|++.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 5789999999999999999999999999999999999887543 345678999999999999999999999999999999
Q ss_pred EEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCC---
Q 000706 80 VVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN--- 155 (1342)
Q Consensus 80 LVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ss--- 155 (1342)
+||||++ ||+..+|.+.+.++|+.++.|+.+.+.|++.+|+.|++||||||+|+|||.+|++||+|||++..+...
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 9999997 799999999999999999999999999999999999999999999999999999999999999643210
Q ss_pred -------------------cee-------------------------eecccCCCCcCChhhhccCCCCCCCcccchhhH
Q 000706 156 -------------------TVV-------------------------LRSIKGTPLYMAPELVREQPYNHTADLWSLGVI 191 (1342)
Q Consensus 156 -------------------s~~-------------------------~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVI 191 (1342)
... ....+|||-|+|||++.+..|+..+|+||||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 000 012469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCcHHHHHHHHhcCC--CCCCC--CCCHHHHHHHHHhcccCCCCCCC---HHHHHcCcCcccchhh
Q 000706 192 LYELFVGQPPFYTNSVYALIRHIVKDP--VKYPD--EMSPNFKSFLKGLLNKVPQNRLT---WSALLEHPFVKETSDE 262 (1342)
Q Consensus 192 LYELLTGr~PF~g~s~~elirkIlr~~--~efP~--eISpeLkDLIrKcLqkDPeKRPS---AeELLeHPFFre~~~e 262 (1342)
+|||+.|.+||.+++..+..++|.... ..+|. ..+++++|||.+||. ||++|.. ++||.+||||+....+
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence 999999999999999999999998764 55664 468999999999999 9999985 9999999999987543
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=391.90 Aligned_cols=248 Identities=34% Similarity=0.631 Sum_probs=226.2
Q ss_pred EcccCcEEEEEEEEccCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-CCh
Q 000706 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GEL 89 (1342)
Q Consensus 12 LGsGgFGtVYKArDk~TGe~VAVKvIkKs~-~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e-GSL 89 (1342)
||+|+||.||+|.+..+++.||+|.+++.. ........+.+|+.++++++||||+++++.+.+++..|+||||++ |+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999999999999999997642 233445678889999999999999999999999999999999997 789
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCCCcC
Q 000706 90 FEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYM 169 (1342)
Q Consensus 90 ~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp~Ym 169 (1342)
.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.............||+.|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~ 160 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence 99998888899999999999999999999999999999999999999999999999999986544333345567999999
Q ss_pred ChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCC---C
Q 000706 170 APELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRL---T 246 (1342)
Q Consensus 170 APEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRP---S 246 (1342)
|||++.+..++.++||||+||++|+|++|+.||.+.+..+..+.+...+..+|..++++++++|.+||+.||++|| +
T Consensus 161 aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~ 240 (312)
T cd05585 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNG 240 (312)
T ss_pred CHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCC
Confidence 9999999999999999999999999999999999988888888888888899999999999999999999999997 5
Q ss_pred HHHHHcCcCcccc
Q 000706 247 WSALLEHPFVKET 259 (1342)
Q Consensus 247 AeELLeHPFFre~ 259 (1342)
+.|+++||||.+.
T Consensus 241 ~~e~l~hp~~~~~ 253 (312)
T cd05585 241 AQEIKNHPFFSQL 253 (312)
T ss_pred HHHHHcCCCcCCC
Confidence 8999999999875
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=395.16 Aligned_cols=251 Identities=33% Similarity=0.646 Sum_probs=227.0
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-C
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-G 87 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e-G 87 (1342)
+.||+|+||.||++++..+|+.||+|.+++... .......+.+|+++++.++||||+++++.+.+++.+|+||||++ |
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 479999999999999999999999999976422 23345667789999999999999999999999999999999997 7
Q ss_pred ChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCCC
Q 000706 88 ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL 167 (1342)
Q Consensus 88 SL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp~ 167 (1342)
+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence 89999988889999999999999999999999999999999999999999999999999998764333333445679999
Q ss_pred cCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCC--
Q 000706 168 YMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRL-- 245 (1342)
Q Consensus 168 YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRP-- 245 (1342)
|+|||++.+..++.++|||||||++|+|++|+.||...+.......+......+|..++++++++|.+||+.||++|+
T Consensus 161 y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 240 (323)
T cd05595 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG 240 (323)
T ss_pred cCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCC
Confidence 999999999999999999999999999999999999988888888888888888999999999999999999999998
Q ss_pred ---CHHHHHcCcCcccch
Q 000706 246 ---TWSALLEHPFVKETS 260 (1342)
Q Consensus 246 ---SAeELLeHPFFre~~ 260 (1342)
++.++++||||.+..
T Consensus 241 ~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 241 GPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred CCCCHHHHHcCCCcCCCC
Confidence 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=388.40 Aligned_cols=254 Identities=31% Similarity=0.514 Sum_probs=217.8
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
.+++|++.+.||.|+||.||+|+++.+++.||+|.++..... .....+.+|++++++++||||+++++++.+++..|+|
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 478999999999999999999999999999999998654322 2234677899999999999999999999999999999
Q ss_pred EeccCCChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 82 TEFAQGELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 82 MEY~eGSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
|||++|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~ 161 (288)
T cd07871 82 FEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS 161 (288)
T ss_pred EeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence 999999999998764 4589999999999999999999999999999999999999999999999999976654443444
Q ss_pred cccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC---C----------------CC
Q 000706 161 SIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---P----------------VK 220 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~---~----------------~e 220 (1342)
...|++.|+|||++.+ ..++.++||||+|+++|+|++|++||.+.+..+....+... + ..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL 241 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence 5678999999998865 56899999999999999999999999887765555443221 0 00
Q ss_pred C-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 221 Y-----------PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 221 f-----------P~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
+ .+.+++++++||++||+.||.+|||++|+++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 1 12467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=431.34 Aligned_cols=261 Identities=29% Similarity=0.536 Sum_probs=242.0
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEF 78 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~l 78 (1342)
+++++|++++.||+|.||+|+++..+.+++.||||+++|... ..++.+..+.|.+++... +||.+++++..|++++++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 478999999999999999999999999999999999988753 345578899999999988 599999999999999999
Q ss_pred EEEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 79 CVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 79 yLVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
|+||||+.|..+-.+.+.+.|+|..++.|+..++.||.|||++||+|||||.+|||+|.+|++||+|||+++.--.....
T Consensus 445 ~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~ 524 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDR 524 (694)
T ss_pred EEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCc
Confidence 99999987433555666788999999999999999999999999999999999999999999999999999876655557
Q ss_pred eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcc
Q 000706 159 LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLN 238 (1342)
Q Consensus 159 ~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLq 238 (1342)
..++||||.|+|||++.++.|+.++|.|+|||++|||+.|..||.++++.+..+.|..+.+.+|..+|.+..++++++|+
T Consensus 525 TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll~ 604 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLR 604 (694)
T ss_pred cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHhc
Confidence 78899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCC-----HHHHHcCcCcccchh
Q 000706 239 KVPQNRLT-----WSALLEHPFVKETSD 261 (1342)
Q Consensus 239 kDPeKRPS-----AeELLeHPFFre~~~ 261 (1342)
+||++|.. ++++.+||||+++..
T Consensus 605 k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 605 KNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred cCcccccCCCCCCchhhhhCCccccCCH
Confidence 99999985 589999999999754
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=391.97 Aligned_cols=251 Identities=33% Similarity=0.628 Sum_probs=221.9
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC-HHHHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEIE-ILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-e~dierL~rEI~-ILKrL~HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
+.||+|+||+||+|.++.+|+.||+|++.+.... ......+..|.. +++.++||||+++++.+.+++..|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4799999999999999999999999999764321 222344455544 5678999999999999999999999999997
Q ss_pred CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCC
Q 000706 87 GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTP 166 (1342)
Q Consensus 87 GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp 166 (1342)
|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.............||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence 68999998888999999999999999999999999999999999999999999999999999876433333344567999
Q ss_pred CcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 000706 167 LYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLT 246 (1342)
Q Consensus 167 ~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRPS 246 (1342)
.|+|||++.+..++.++||||||+++|+|++|+.||...+..+..+.+.......++.+++++.++|++||+.||.+||+
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 240 (323)
T cd05575 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLG 240 (323)
T ss_pred hhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCC
Confidence 99999999999999999999999999999999999999888888888888888888889999999999999999999998
Q ss_pred H----HHHHcCcCcccch
Q 000706 247 W----SALLEHPFVKETS 260 (1342)
Q Consensus 247 A----eELLeHPFFre~~ 260 (1342)
+ .++++||||....
T Consensus 241 ~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 241 AKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred CCCCHHHHHcCCCcCCCC
Confidence 7 6999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=392.81 Aligned_cols=250 Identities=32% Similarity=0.642 Sum_probs=226.6
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-C
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-G 87 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e-G 87 (1342)
+.||+|+||.||++.+..+++.||+|++.+... .......+.+|+++++.++||||+++++.+.+++.+|+||||++ |
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999976532 23445678889999999999999999999999999999999997 6
Q ss_pred ChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCCC
Q 000706 88 ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL 167 (1342)
Q Consensus 88 SL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp~ 167 (1342)
+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||+.
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 160 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence 89999988888999999999999999999999999999999999999999999999999998764433333445679999
Q ss_pred cCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCC--
Q 000706 168 YMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRL-- 245 (1342)
Q Consensus 168 YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRP-- 245 (1342)
|+|||++.+..++.++|||||||++|+|++|+.||...+..+..+.+......+|..+++++.+||++||+.||++|+
T Consensus 161 y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 240 (328)
T cd05593 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGG 240 (328)
T ss_pred ccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCC
Confidence 999999999899999999999999999999999999888888888888888888999999999999999999999997
Q ss_pred ---CHHHHHcCcCcccc
Q 000706 246 ---TWSALLEHPFVKET 259 (1342)
Q Consensus 246 ---SAeELLeHPFFre~ 259 (1342)
++.|+++||||...
T Consensus 241 ~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 241 GPDDAKEIMRHSFFTGV 257 (328)
T ss_pred CCCCHHHHhcCCCcCCC
Confidence 89999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=382.78 Aligned_cols=253 Identities=36% Similarity=0.603 Sum_probs=216.5
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
++|++.+.||+|+||.||+++++.+++.||+|.+..........+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 58999999999999999999999999999999997664444445678889999999999999999999999999999999
Q ss_pred ccCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce-eeec
Q 000706 84 FAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV-VLRS 161 (1342)
Q Consensus 84 Y~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~-~~~s 161 (1342)
|+++++.+.+.+ ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence 999876666544 56799999999999999999999999999999999999999999999999999987653322 2234
Q ss_pred ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC-------------------CC--
Q 000706 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP-------------------VK-- 220 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~-------------------~e-- 220 (1342)
..|++.|+|||++.+..++.++|+||+||++|+|++|++||.+.+..+....+.... ..
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07848 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFP 240 (287)
T ss_pred cccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccC
Confidence 578999999999998889999999999999999999999998766544332221100 00
Q ss_pred -----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 221 -----------YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 221 -----------fP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
+...+++++.+|+.+||++||++|||++|+++||||
T Consensus 241 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 241 AVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 112367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=387.53 Aligned_cols=258 Identities=30% Similarity=0.509 Sum_probs=215.9
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
.++|++.+.||+|+||.||+|+++.+++.||+|++...... .......+|+++++.++||||+++++++.+++..|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 57899999999999999999999999999999998654322 22245678999999999999999999999999999999
Q ss_pred eccCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
||++++|.+++.+ .+.++++.++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 162 (303)
T cd07869 83 EYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN 162 (303)
T ss_pred ECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence 9999999998875 457999999999999999999999999999999999999999999999999999765444333445
Q ss_pred ccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCc-HHHHHHHHhc---CCC----------------C
Q 000706 162 IKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNS-VYALIRHIVK---DPV----------------K 220 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s-~~elirkIlr---~~~----------------e 220 (1342)
..||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.. ..+....+.. .+. .
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd07869 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242 (303)
T ss_pred CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence 678999999998865 458899999999999999999999998743 2233332211 000 0
Q ss_pred ----CC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccchh
Q 000706 221 ----YP---------DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 221 ----fP---------~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~~ 261 (1342)
.+ ...++++++|+.+||+.||++|||+.|+++||||++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 00 124568899999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=389.85 Aligned_cols=256 Identities=31% Similarity=0.547 Sum_probs=230.2
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCC-CcceEEEEEEeCCeEEEEE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQ-NIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HP-NIVKL~dvfeded~lyLVM 82 (1342)
+|++.+.||+|+||.||+|.+..+++.||+|++.+... .....+.+..|.+++..++|+ +|+++++++.+++.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 69999999999999999999999999999999976432 233456778899999999765 6889999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
||++ |+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++...........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence 9997 789999988888999999999999999999999999999999999999999999999999998754333333445
Q ss_pred ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCC
Q 000706 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVP 241 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDP 241 (1342)
..||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+....+......+|..+++++.+++++||+.||
T Consensus 161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P 240 (324)
T cd05587 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHP 240 (324)
T ss_pred ecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 67999999999999999999999999999999999999999999888888888888888899999999999999999999
Q ss_pred CCCCCH-----HHHHcCcCcccch
Q 000706 242 QNRLTW-----SALLEHPFVKETS 260 (1342)
Q Consensus 242 eKRPSA-----eELLeHPFFre~~ 260 (1342)
.+|++. +++++||||+...
T Consensus 241 ~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 241 AKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred HHcCCCCCCCHHHHhcCCCcCCCC
Confidence 999976 8999999998753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=390.03 Aligned_cols=251 Identities=32% Similarity=0.640 Sum_probs=226.3
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-C
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-G 87 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e-G 87 (1342)
+.||+|+||.||++.+..+++.||+|++++... .......+.+|+++++.++||||+++++.+.+++.+|+||||++ |
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 479999999999999999999999999976432 23345667889999999999999999999999999999999997 6
Q ss_pred ChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCC
Q 000706 88 ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS-NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTP 166 (1342)
Q Consensus 88 SL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHs-rGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp 166 (1342)
+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+++.............||+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 160 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence 899999888889999999999999999999997 7999999999999999999999999999876443333344567999
Q ss_pred CcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCC-
Q 000706 167 LYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRL- 245 (1342)
Q Consensus 167 ~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRP- 245 (1342)
.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+......+|..+++++.++|.+||+.||++|+
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 240 (325)
T cd05594 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLG 240 (325)
T ss_pred ccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCC
Confidence 9999999999999999999999999999999999999988888888888888888999999999999999999999997
Q ss_pred ----CHHHHHcCcCcccch
Q 000706 246 ----TWSALLEHPFVKETS 260 (1342)
Q Consensus 246 ----SAeELLeHPFFre~~ 260 (1342)
++.++++||||....
T Consensus 241 ~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 241 GGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred CCCCCHHHHhcCCCcCCCC
Confidence 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=389.22 Aligned_cols=255 Identities=33% Similarity=0.565 Sum_probs=214.7
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----CeEE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP-----QEFC 79 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede-----d~ly 79 (1342)
+|++.+.||+|+||.||+|.+..+++.||+|.+...........++.+|++++++++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 69999999999999999999999999999999875433344456788999999999999999999988543 3589
Q ss_pred EEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc---
Q 000706 80 VVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT--- 156 (1342)
Q Consensus 80 LVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss--- 156 (1342)
+||||++++|.+++.+...+++..++.++.|+++||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999997653221
Q ss_pred eeeecccCCCCcCChhhhcc--CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHh-------------------
Q 000706 157 VVLRSIKGTPLYMAPELVRE--QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIV------------------- 215 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g--~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIl------------------- 215 (1342)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+.
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 240 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 12234679999999999876 678999999999999999999999998765433221111
Q ss_pred --------cC-CCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 216 --------KD-PVKY---PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 216 --------r~-~~ef---P~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
.. +..+ .+.+++++.+++.+||+.||++|||++|+++||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 00 0111 12467889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=398.35 Aligned_cols=257 Identities=32% Similarity=0.575 Sum_probs=232.5
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCC-cEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTG-QTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEF 78 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TG-e~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~l 78 (1342)
+.+++|++.+.||+|+||.||+|.++.++ ..||+|.+.+... .....+.+.+|+++++.++||||+++++++.+++.+
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 35789999999999999999999876554 6899999865432 233456788999999999999999999999999999
Q ss_pred EEEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce
Q 000706 79 CVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 79 yLVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~ 157 (1342)
|+||||++ |+|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~- 185 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT- 185 (340)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc-
Confidence 99999996 7899999988899999999999999999999999999999999999999999999999999998765432
Q ss_pred eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhc
Q 000706 158 VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLL 237 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcL 237 (1342)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.....+.+......+|..++++++++|++||
T Consensus 186 --~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l 263 (340)
T PTZ00426 186 --YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLL 263 (340)
T ss_pred --ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHc
Confidence 345799999999999998899999999999999999999999999988888888888888889999999999999999
Q ss_pred ccCCCCCC-----CHHHHHcCcCcccch
Q 000706 238 NKVPQNRL-----TWSALLEHPFVKETS 260 (1342)
Q Consensus 238 qkDPeKRP-----SAeELLeHPFFre~~ 260 (1342)
+.||++|+ +++++++||||++..
T Consensus 264 ~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 264 SHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred ccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 99999995 899999999998754
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=397.32 Aligned_cols=256 Identities=30% Similarity=0.563 Sum_probs=221.7
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
++|++++.||+|+||.||++.+..+++.||+|++.+... .....+.+.+|++++++++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 589999999999999999999999999999999876432 2334567889999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce----
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV---- 157 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~---- 157 (1342)
||++ |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 9996 78999998888999999999999999999999999999999999999999999999999999964321000
Q ss_pred -------------------------------------------eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHH
Q 000706 158 -------------------------------------------VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYE 194 (1342)
Q Consensus 158 -------------------------------------------~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYE 194 (1342)
.....+||+.|+|||++.+..|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0012469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHhcC--CCCCCC--CCCHHHHHHHHHhcccCCCCC---CCHHHHHcCcCcccch
Q 000706 195 LFVGQPPFYTNSVYALIRHIVKD--PVKYPD--EMSPNFKSFLKGLLNKVPQNR---LTWSALLEHPFVKETS 260 (1342)
Q Consensus 195 LLTGr~PF~g~s~~elirkIlr~--~~efP~--eISpeLkDLIrKcLqkDPeKR---PSAeELLeHPFFre~~ 260 (1342)
|++|+.||...+..+....+... ...+|. .+++++++||.+||+ +|.+| +++.|+++||||+...
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 99999999988877777776642 334444 578999999999998 77765 5999999999998753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=393.06 Aligned_cols=256 Identities=37% Similarity=0.676 Sum_probs=227.5
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE-KDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se-~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
++|++.+.||+|+||.||+|++..+++.||+|++++..... .....+.+|++++..++||||+++++.+.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 58999999999999999999999999999999997653222 34567888999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc-----
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT----- 156 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss----- 156 (1342)
||++ |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 9996 6899999888889999999999999999999999999999999999999999999999999998765433
Q ss_pred ------------------------eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHH
Q 000706 157 ------------------------VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIR 212 (1342)
Q Consensus 157 ------------------------~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elir 212 (1342)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 240 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence 12334579999999999999999999999999999999999999999988777777
Q ss_pred HHhc--CCCCCCC--CCCHHHHHHHHHhcccCCCCCCC-HHHHHcCcCcccch
Q 000706 213 HIVK--DPVKYPD--EMSPNFKSFLKGLLNKVPQNRLT-WSALLEHPFVKETS 260 (1342)
Q Consensus 213 kIlr--~~~efP~--eISpeLkDLIrKcLqkDPeKRPS-AeELLeHPFFre~~ 260 (1342)
++.. ....+|. .+++++.+||.+||. ||.+||+ +.++++||||+...
T Consensus 241 ~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~ 292 (350)
T cd05573 241 KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID 292 (350)
T ss_pred HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence 7766 3444443 359999999999997 9999999 99999999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=386.76 Aligned_cols=255 Identities=30% Similarity=0.552 Sum_probs=221.6
Q ss_pred CEEEEEEEcccCcEEEEEEEEc---cCCcEEEEEEeecCCC--CHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRK---YTGQTVAMKFIMKHGK--SEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEF 78 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk---~TGe~VAVKvIkKs~~--se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~l 78 (1342)
+|++.+.||+|+||.||++++. .+++.||+|++.+... .....+.+.+|+++++++ +||||+++++++.+++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 6999999999999999998764 4789999999976422 223346688899999999 589999999999999999
Q ss_pred EEEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc-
Q 000706 79 CVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT- 156 (1342)
Q Consensus 79 yLVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss- 156 (1342)
|++|||++ |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 99999997 6899999888889999999999999999999999999999999999999999999999999998654322
Q ss_pred eeeecccCCCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCC----cHHHHHHHHhcCCCCCCCCCCHHHHH
Q 000706 157 VVLRSIKGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTN----SVYALIRHIVKDPVKYPDEMSPNFKS 231 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~----s~~elirkIlr~~~efP~eISpeLkD 231 (1342)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||... ........+......++..+++.+++
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 222346799999999998865 4789999999999999999999999642 34455556666777788889999999
Q ss_pred HHHHhcccCCCCCC-----CHHHHHcCcCcccc
Q 000706 232 FLKGLLNKVPQNRL-----TWSALLEHPFVKET 259 (1342)
Q Consensus 232 LIrKcLqkDPeKRP-----SAeELLeHPFFre~ 259 (1342)
++.+||+.||++|| +++++++||||++.
T Consensus 241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999999 88999999999875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=388.38 Aligned_cols=254 Identities=30% Similarity=0.579 Sum_probs=225.0
Q ss_pred EEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHH---HhcCCCCcceEEEEEEeCCeEEEE
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEIL---RKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~IL---KrL~HPNIVKL~dvfeded~lyLV 81 (1342)
|++.+.||+|+||.||+|.+..+++.||+|.+++... .....+.+.+|++++ +.++||||+++++++.+++..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 7899999999999999999999999999999976532 223345677777665 456799999999999999999999
Q ss_pred EeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 82 TEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
|||++ |+|..++.+ +.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence 99997 577777654 5799999999999999999999999999999999999999999999999999876443333344
Q ss_pred cccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccC
Q 000706 161 SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkD 240 (1342)
...|++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....+......+|..+++++.++|.+||+.|
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~d 239 (324)
T cd05589 160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRN 239 (324)
T ss_pred ccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 56799999999999999999999999999999999999999999988888888888888888999999999999999999
Q ss_pred CCCCC-----CHHHHHcCcCcccch
Q 000706 241 PQNRL-----TWSALLEHPFVKETS 260 (1342)
Q Consensus 241 PeKRP-----SAeELLeHPFFre~~ 260 (1342)
|.+|| ++.++++||||+...
T Consensus 240 P~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 240 PERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred HhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 99999 799999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=389.47 Aligned_cols=252 Identities=33% Similarity=0.560 Sum_probs=227.6
Q ss_pred EEEEcccCcEEEEEEEE---ccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEecc
Q 000706 9 IELVGEGSFGKVYKGRR---KYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFA 85 (1342)
Q Consensus 9 lK~LGsGgFGtVYKArD---k~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~ 85 (1342)
++.||+|+||.||++++ ..+|+.||+|++++............+|++++++++||||+++++++.+++.+|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36899999999999876 357899999999765443444556788999999999999999999999999999999999
Q ss_pred C-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccC
Q 000706 86 Q-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG 164 (1342)
Q Consensus 86 e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vG 164 (1342)
+ |+|.+++.+...+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.............|
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence 7 789999988888999999999999999999999999999999999999999999999999999876554334455679
Q ss_pred CCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 000706 165 TPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNR 244 (1342)
Q Consensus 165 Tp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKR 244 (1342)
|+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+......+|..+++++.+++++||+.||++|
T Consensus 161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R 240 (318)
T cd05582 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANR 240 (318)
T ss_pred ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHc
Confidence 99999999999888999999999999999999999999998888888888888888889999999999999999999999
Q ss_pred CC-----HHHHHcCcCcccch
Q 000706 245 LT-----WSALLEHPFVKETS 260 (1342)
Q Consensus 245 PS-----AeELLeHPFFre~~ 260 (1342)
|+ ++++++||||+...
T Consensus 241 ~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 241 LGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred CCCCCCCHHHHhCCCCcCCCC
Confidence 99 78899999998753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=410.20 Aligned_cols=244 Identities=35% Similarity=0.622 Sum_probs=225.9
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEE-EEE-eCCeEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLD-SFE-SPQEFCVV 81 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~d-vfe-ded~lyLV 81 (1342)
.+|+|+++||+|.||+||++.+..+|+.+|.|.++-...+.+.++.+..|+.+|++++|||||++++ .|. +..-++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4699999999999999999999999999999999877778888899999999999999999999998 454 44458999
Q ss_pred EeccC-CChHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhh--CC--ceecCCCCCcEEEcCCCcEEEeeccccccc
Q 000706 82 TEFAQ-GELFEILED----DKCLPEEQVQSIAKQLVRALHYLHS--NR--IIHRDMKPQNILIGAGSVVKLCDFGFARAM 152 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek----~g~LSEeeI~~I~~QLLsALaYLHs--rG--IVHRDLKPENILLdsdG~LKLiDFGLAr~l 152 (1342)
||||+ |||.+.|+. .+.++|..+|.++.|++.||+++|. .. |+||||||.|||++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99997 899998863 5689999999999999999999998 44 999999999999999999999999999999
Q ss_pred cCCceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CC-CCCCHHHH
Q 000706 153 SANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVK-YP-DEMSPNFK 230 (1342)
Q Consensus 153 ~sss~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~e-fP-~eISpeLk 230 (1342)
........+.+|||+||+||.+...+|++++||||+||++|||+.-++||.+.+..++.++|.++..+ .| +.+|.++.
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~ 258 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLR 258 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHH
Confidence 98887788899999999999999999999999999999999999999999999999999999998664 66 67899999
Q ss_pred HHHHHhcccCCCCCCCH
Q 000706 231 SFLKGLLNKVPQNRLTW 247 (1342)
Q Consensus 231 DLIrKcLqkDPeKRPSA 247 (1342)
.+|.-|+.+||+.||+.
T Consensus 259 ~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 259 ELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHccCCcccCCCc
Confidence 99999999999999983
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=388.67 Aligned_cols=251 Identities=33% Similarity=0.591 Sum_probs=225.4
Q ss_pred EEEEcccCcEEEEEEEEc---cCCcEEEEEEeecCCC--CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 9 IELVGEGSFGKVYKGRRK---YTGQTVAMKFIMKHGK--SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 9 lK~LGsGgFGtVYKArDk---~TGe~VAVKvIkKs~~--se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
++.||+|+||.||++++. .+++.||+|.+++... .......+.+|+++++.++||||+++++.+.+++.+|++||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999863 4788999999976422 22334567889999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 84 FAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
|++ |+|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++............
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 997 6899999988899999999999999999999999999999999999999999999999999987544333334456
Q ss_pred cCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCC
Q 000706 163 KGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQ 242 (1342)
Q Consensus 163 vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPe 242 (1342)
.||+.|+|||++.+..++.++||||||+++|||++|+.||...+.......+......+|..+++++.++|.+||+.||+
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 240 (323)
T cd05584 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPS 240 (323)
T ss_pred CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHh
Confidence 79999999999998889999999999999999999999999988888888888888888999999999999999999999
Q ss_pred CCC-----CHHHHHcCcCcccc
Q 000706 243 NRL-----TWSALLEHPFVKET 259 (1342)
Q Consensus 243 KRP-----SAeELLeHPFFre~ 259 (1342)
+|| +++++++||||+..
T Consensus 241 ~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 241 SRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HcCCCCCCCHHHHhcCCCcCCC
Confidence 999 89999999999875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=405.26 Aligned_cols=284 Identities=34% Similarity=0.591 Sum_probs=254.3
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
++|++.+.||+|.|+.||++.+..+|+.+|+|.+..........+.+.+|+++-+.++||||+++++.+.++...|+|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 67899999999999999999999999999999997666666677899999999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCC---CcEEEeeccccccccCCceee
Q 000706 84 FAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAG---SVVKLCDFGFARAMSANTVVL 159 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsd---G~LKLiDFGLAr~l~sss~~~ 159 (1342)
+++ |+|+.-|-++..++|..+-.+++||+++|.|+|.+||+|||+||+|+++.+. .-+||+|||++..++ +....
T Consensus 91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g~~~ 169 (355)
T KOG0033|consen 91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DGEAW 169 (355)
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-Ccccc
Confidence 998 5788888777789999999999999999999999999999999999999543 369999999999988 55567
Q ss_pred ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC----CCCCHHHHHHHHH
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP----DEMSPNFKSFLKG 235 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP----~eISpeLkDLIrK 235 (1342)
..++|||.|||||+++..+|+..+|||+.|+|||-|+.|++||++.+...++++|..+...++ +.++++.++||++
T Consensus 170 ~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lvrr 249 (355)
T KOG0033|consen 170 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRR 249 (355)
T ss_pred ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHH
Confidence 788999999999999999999999999999999999999999999999999999998865544 5789999999999
Q ss_pred hcccCCCCCCCHHHHHcCcCcccchhhhhHHHhhhhhhhcccCCCcccccCcc
Q 000706 236 LLNKVPQNRLTWSALLEHPFVKETSDELNAWELRATSVEARGCNATWTAEGNA 288 (1342)
Q Consensus 236 cLqkDPeKRPSAeELLeHPFFre~~~eLsa~eLr~~sve~r~~saswta~~na 288 (1342)
||+.||.+|+|+.|.|+|||+++...-....+........+..+++-...++.
T Consensus 250 ML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgav 302 (355)
T KOG0033|consen 250 MLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAI 302 (355)
T ss_pred HhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHH
Confidence 99999999999999999999998777666666776666666666555444443
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=385.05 Aligned_cols=251 Identities=34% Similarity=0.624 Sum_probs=221.0
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHH-HHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEI-EILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI-~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
+.||+|+||.||+|++..+++.||+|++.+... .......+..|. .+++.++||||+++++.+.+.+..|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999976432 122234445554 46788999999999999999999999999997
Q ss_pred CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCC
Q 000706 87 GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTP 166 (1342)
Q Consensus 87 GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp 166 (1342)
|+|.+.+.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++.............||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP 160 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence 68988888888899999999999999999999999999999999999999999999999999876433333344567999
Q ss_pred CcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 000706 167 LYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLT 246 (1342)
Q Consensus 167 ~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRPS 246 (1342)
.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...+..+|+..+.++.+++.+||+.||.+||+
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 240 (321)
T cd05603 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLG 240 (321)
T ss_pred ccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCC
Confidence 99999999998999999999999999999999999999888888888888888888899999999999999999999987
Q ss_pred H----HHHHcCcCcccch
Q 000706 247 W----SALLEHPFVKETS 260 (1342)
Q Consensus 247 A----eELLeHPFFre~~ 260 (1342)
. .++++|+||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 241 AKADFLEIKNHVFFSPIN 258 (321)
T ss_pred CCCCHHHHhCCCCcCCCC
Confidence 4 5999999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=385.55 Aligned_cols=251 Identities=29% Similarity=0.528 Sum_probs=222.5
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
+.||+|+||.||+|++..+++.||+|.+++... .....+....|..++... +||||+++++++.+++.+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999976432 222334556677777654 89999999999999999999999997
Q ss_pred CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCC
Q 000706 87 GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTP 166 (1342)
Q Consensus 87 GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp 166 (1342)
|+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.............||+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~ 160 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence 78999998888899999999999999999999999999999999999999999999999999986544334445567999
Q ss_pred CcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 000706 167 LYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLT 246 (1342)
Q Consensus 167 ~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRPS 246 (1342)
.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......+|..+++++.+++.+||+.||.+||+
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~ 240 (316)
T cd05592 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLG 240 (316)
T ss_pred cccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence 99999999998999999999999999999999999999888888888888888888889999999999999999999998
Q ss_pred H-HHHHcCcCcccch
Q 000706 247 W-SALLEHPFVKETS 260 (1342)
Q Consensus 247 A-eELLeHPFFre~~ 260 (1342)
+ .++++||||+...
T Consensus 241 ~~~~l~~h~~~~~~~ 255 (316)
T cd05592 241 VDGDIRQHPFFRGID 255 (316)
T ss_pred ChHHHHcCcccCCCC
Confidence 6 5899999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=386.87 Aligned_cols=251 Identities=29% Similarity=0.503 Sum_probs=222.8
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
+.||+|+||.||+|+++.+++.||+|.+++... ..........|..++... +||||+++++++.+++.+|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999999999999999976432 122345567788888764 89999999999999999999999997
Q ss_pred CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCC
Q 000706 87 GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTP 166 (1342)
Q Consensus 87 GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp 166 (1342)
|+|.+++.+.+++++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.............||+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence 68999998888899999999999999999999999999999999999999999999999999875433333345567999
Q ss_pred CcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 000706 167 LYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLT 246 (1342)
Q Consensus 167 ~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRPS 246 (1342)
.|+|||++.+..++.++||||+|+++|+|++|+.||.+.+..+..+.+......+|..++++++++|.+||+.||++||+
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~ 240 (316)
T cd05620 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLG 240 (316)
T ss_pred CccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence 99999999999999999999999999999999999999888888888877777888889999999999999999999999
Q ss_pred H-HHHHcCcCcccch
Q 000706 247 W-SALLEHPFVKETS 260 (1342)
Q Consensus 247 A-eELLeHPFFre~~ 260 (1342)
+ +++++||||+...
T Consensus 241 ~~~~~~~h~~f~~~~ 255 (316)
T cd05620 241 VVGNIRGHPFFKTIN 255 (316)
T ss_pred ChHHHHcCCCcCCCC
Confidence 7 5899999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=390.52 Aligned_cols=256 Identities=31% Similarity=0.586 Sum_probs=223.8
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
++|++.+.||+|+||+||+|++..+++.||+|++.+... .......+.+|+++++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 589999999999999999999999999999999976432 2234466888999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce----
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV---- 157 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~---- 157 (1342)
||++ |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.+.....
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 9997 78999998888899999999999999999999999999999999999999999999999999875432110
Q ss_pred ----------------------------------eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCC
Q 000706 158 ----------------------------------VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFY 203 (1342)
Q Consensus 158 ----------------------------------~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~ 203 (1342)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 0112469999999999999999999999999999999999999999
Q ss_pred CCcHHHHHHHHhcCC--CCCCC--CCCHHHHHHHHHhcccCCCCCCC---HHHHHcCcCcccch
Q 000706 204 TNSVYALIRHIVKDP--VKYPD--EMSPNFKSFLKGLLNKVPQNRLT---WSALLEHPFVKETS 260 (1342)
Q Consensus 204 g~s~~elirkIlr~~--~efP~--eISpeLkDLIrKcLqkDPeKRPS---AeELLeHPFFre~~ 260 (1342)
..+..+....+.... ..+|. .+++++++||.+||. +|.+|++ +.|+++||||+...
T Consensus 241 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 988877777766532 23333 468999999999997 9999998 99999999998753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=386.09 Aligned_cols=256 Identities=30% Similarity=0.536 Sum_probs=230.3
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyLVM 82 (1342)
+|++.+.||+|+||.||+|++..+++.||+|.+.+... .....+....|..++..+ +||+|+++++++.+++.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 69999999999999999999999999999999976532 223345567788888877 5889999999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
||++ |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~ 160 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT 160 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence 9997 789999988888999999999999999999999999999999999999999999999999999765443334455
Q ss_pred ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCC
Q 000706 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVP 241 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDP 241 (1342)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......+|..+++++.+++.+||+.||
T Consensus 161 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p 240 (323)
T cd05616 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 240 (323)
T ss_pred CCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCH
Confidence 67999999999999999999999999999999999999999999888888888888888999999999999999999999
Q ss_pred CCCCC-----HHHHHcCcCcccch
Q 000706 242 QNRLT-----WSALLEHPFVKETS 260 (1342)
Q Consensus 242 eKRPS-----AeELLeHPFFre~~ 260 (1342)
.+|++ ..++++||||+...
T Consensus 241 ~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 241 GKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred HhcCCCCCCCHHHHhcCCCcCCCC
Confidence 99997 48999999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=394.54 Aligned_cols=256 Identities=29% Similarity=0.527 Sum_probs=222.8
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
++|++.+.||+|+||+||+|.+..+++.||+|++++... .......+.+|+.++.+++||||+++++.++++..+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 589999999999999999999999999999999976432 2233467888999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce----
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV---- 157 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~---- 157 (1342)
||++ |+|.+++.+.+++++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 9997 68999999888999999999999999999999999999999999999999999999999999975432110
Q ss_pred -------------------------------eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCc
Q 000706 158 -------------------------------VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS 206 (1342)
Q Consensus 158 -------------------------------~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s 206 (1342)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 240 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence 0123579999999999999999999999999999999999999999988
Q ss_pred HHHHHHHHhcC--CCCCCC--CCCHHHHHHHHHhcccCCC---CCCCHHHHHcCcCcccch
Q 000706 207 VYALIRHIVKD--PVKYPD--EMSPNFKSFLKGLLNKVPQ---NRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 207 ~~elirkIlr~--~~efP~--eISpeLkDLIrKcLqkDPe---KRPSAeELLeHPFFre~~ 260 (1342)
..+..+++... ...+|+ .++++++++|.+|+. +|. .||+++|+++||||+...
T Consensus 241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence 88888777653 344454 468999999999875 444 458999999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=403.38 Aligned_cols=260 Identities=30% Similarity=0.472 Sum_probs=230.7
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEE--eCCeEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFE--SPQEFC 79 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfe--ded~ly 79 (1342)
.+++|+.+..|++|+||.||+|+|+.|++.||+|.++.....+..--.-.+||.++.+++|||||.+.++.. +-+.+|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 367899999999999999999999999999999999766433333334567999999999999999999885 446799
Q ss_pred EEEeccCCChHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 80 VVTEFAQGELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 80 LVMEY~eGSL~D~Lek~g-~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
+|||||+.||..++...+ +|.+.+++.++.|+++|++|||.++|+||||||+|+|++..|.+||+|||+|+.++.+...
T Consensus 154 ~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~ 233 (419)
T KOG0663|consen 154 IVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP 233 (419)
T ss_pred eeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence 999999999999998755 8999999999999999999999999999999999999999999999999999999999888
Q ss_pred eecccCCCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC-------------------
Q 000706 159 LRSIKGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP------------------- 218 (1342)
Q Consensus 159 ~~s~vGTp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~------------------- 218 (1342)
++..+.|.||+|||++.+. .|+.++|+||+|||+.||+++++.|.+.++.+++++|++.-
T Consensus 234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~ 313 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK 313 (419)
T ss_pred CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence 8889999999999988765 59999999999999999999999999999999999987510
Q ss_pred CCCCC-------------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccchh
Q 000706 219 VKYPD-------------EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 219 ~efP~-------------eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~~ 261 (1342)
..++. .++....+|++++|..||.+|.|+.|.|+|+||++...
T Consensus 314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 11111 14577889999999999999999999999999998543
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=386.06 Aligned_cols=250 Identities=32% Similarity=0.609 Sum_probs=220.0
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC-HHHHHHHHHHH-HHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEI-EILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-e~dierL~rEI-~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
+.||+|+||.||+|++..+++.||+|++.+.... ......+..|. .+++.++||||+++++.+.+++.+|+||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999999999999999999999764221 12223344444 45678899999999999999999999999997
Q ss_pred CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCC
Q 000706 87 GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTP 166 (1342)
Q Consensus 87 GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp 166 (1342)
|+|.+++.+.+.+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||+++.............||+
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 160 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP 160 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence 68999998888899999999999999999999999999999999999999999999999999976543333344567999
Q ss_pred CcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 000706 167 LYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLT 246 (1342)
Q Consensus 167 ~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRPS 246 (1342)
.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+..+.+...+..+++.++++++++|.+||+.||.+||+
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 240 (325)
T cd05602 161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLG 240 (325)
T ss_pred cccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCC
Confidence 99999999999999999999999999999999999999888888888888888888899999999999999999999998
Q ss_pred HH----HHHcCcCcccc
Q 000706 247 WS----ALLEHPFVKET 259 (1342)
Q Consensus 247 Ae----ELLeHPFFre~ 259 (1342)
+. ++++|+||...
T Consensus 241 ~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 241 AKDDFMEIKNHIFFSPI 257 (325)
T ss_pred CCCCHHHHhcCcccCCC
Confidence 65 89999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=384.26 Aligned_cols=251 Identities=34% Similarity=0.555 Sum_probs=226.2
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
+.||+|+||.||+|++..+++.||+|++++... .....+....|.+++..+ +||||+++++++++++.+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999976432 233445677889998876 89999999999999999999999997
Q ss_pred CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCC
Q 000706 87 GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTP 166 (1342)
Q Consensus 87 GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp 166 (1342)
|+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++..............||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence 68999998888999999999999999999999999999999999999999999999999999976544333444567999
Q ss_pred CcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCC-
Q 000706 167 LYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRL- 245 (1342)
Q Consensus 167 ~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRP- 245 (1342)
.|+|||++.+..++.++||||||+++|+|++|+.||...+..+..+.+......+|..+++++.+++.+||+.||++||
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~ 240 (321)
T cd05591 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLG 240 (321)
T ss_pred cccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCC
Confidence 9999999999999999999999999999999999999999999999998888888888999999999999999999999
Q ss_pred ------CHHHHHcCcCcccch
Q 000706 246 ------TWSALLEHPFVKETS 260 (1342)
Q Consensus 246 ------SAeELLeHPFFre~~ 260 (1342)
++.++++||||....
T Consensus 241 ~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 241 CVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred CCCCCCCHHHHhcCCccCCCC
Confidence 999999999997753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=378.28 Aligned_cols=256 Identities=28% Similarity=0.490 Sum_probs=221.6
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-e~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
.|++.+.||+|+||.||++.+..+++.||+|.+.+.... ......+.+|++++++++|+||+++++.+.+++..+++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 489999999999999999999999999999998765322 2223457789999999999999999999999999999999
Q ss_pred ccC-CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 84 FAQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 84 Y~e-GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
|++ |+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||+++++.+||+|||++....... ...
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TVR 159 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-eec
Confidence 997 688877754 3469999999999999999999999999999999999999999999999999998754332 234
Q ss_pred cccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcH----HHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 000706 161 SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSV----YALIRHIVKDPVKYPDEMSPNFKSFLKGL 236 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~----~elirkIlr~~~efP~eISpeLkDLIrKc 236 (1342)
...||+.|+|||++.+..|+.++|||||||++|+|++|+.||..... ......+......++..+++++.+|+++|
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 239 (285)
T cd05631 160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRML 239 (285)
T ss_pred CCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHH
Confidence 56799999999999999999999999999999999999999987543 22333444555677888999999999999
Q ss_pred cccCCCCCCC-----HHHHHcCcCcccchh
Q 000706 237 LNKVPQNRLT-----WSALLEHPFVKETSD 261 (1342)
Q Consensus 237 LqkDPeKRPS-----AeELLeHPFFre~~~ 261 (1342)
|+.||++||+ ++++++||||.+...
T Consensus 240 l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 240 LTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred hhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 9999999997 899999999988644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=385.20 Aligned_cols=250 Identities=36% Similarity=0.634 Sum_probs=220.7
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIE-ILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~-ILKrL~HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
+.||+|+||+||+|.++.+|+.||+|++.+... .......+..|.. +++.++||||+++++.+++++..|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999975422 2223344555554 5677899999999999999999999999997
Q ss_pred CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCC
Q 000706 87 GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTP 166 (1342)
Q Consensus 87 GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp 166 (1342)
|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.............||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP 160 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence 68999998888999999999999999999999999999999999999999999999999999876443333344567999
Q ss_pred CcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 000706 167 LYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLT 246 (1342)
Q Consensus 167 ~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRPS 246 (1342)
.|+|||++.+..++.++|||||||++|+|++|+.||...+..+..+.+......+++..+..+.+++++||+.||.+||+
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~ 240 (325)
T cd05604 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLG 240 (325)
T ss_pred hhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCC
Confidence 99999999999999999999999999999999999999888888888888877777889999999999999999999997
Q ss_pred H----HHHHcCcCcccc
Q 000706 247 W----SALLEHPFVKET 259 (1342)
Q Consensus 247 A----eELLeHPFFre~ 259 (1342)
+ .++++||||...
T Consensus 241 ~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 241 AKEDFLEIQEHPFFESL 257 (325)
T ss_pred CCCCHHHHhcCCCcCCC
Confidence 6 599999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=388.66 Aligned_cols=251 Identities=33% Similarity=0.568 Sum_probs=225.9
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
+.||+|+||.||+|.++.+++.||+|++.+... .....+....|..++..+ +||||+++++++.+.+.+|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999976421 223345677788888876 79999999999999999999999997
Q ss_pred CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCC
Q 000706 87 GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTP 166 (1342)
Q Consensus 87 GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp 166 (1342)
|+|.+++.+.+.+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.............||+
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP 160 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence 68999998888999999999999999999999999999999999999999999999999999876543333444567999
Q ss_pred CcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 000706 167 LYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLT 246 (1342)
Q Consensus 167 ~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRPS 246 (1342)
.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+......+|..++++++++|++||+.||++||+
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~ 240 (320)
T cd05590 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLG 240 (320)
T ss_pred cccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCC
Confidence 99999999999999999999999999999999999999998888899988888888899999999999999999999999
Q ss_pred H------HHHHcCcCcccch
Q 000706 247 W------SALLEHPFVKETS 260 (1342)
Q Consensus 247 A------eELLeHPFFre~~ 260 (1342)
+ +++++||||+...
T Consensus 241 ~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 241 SLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred CCCCCCHHHHHcCCCcCCCC
Confidence 8 9999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=375.81 Aligned_cols=252 Identities=32% Similarity=0.547 Sum_probs=211.9
Q ss_pred CCEEEEEEEcccCcEEEEEEEEcc-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc---CCCCcceEEEEEE-----e
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKY-TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL---KHQNIIEMLDSFE-----S 74 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~-TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL---~HPNIVKL~dvfe-----d 74 (1342)
++|++.+.||+|+||.||+|++.. +++.||+|.++.............+|+++++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 489999999999999999999854 467899999876543333334556677777766 6999999999885 3
Q ss_pred CCeEEEEEeccCCChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 000706 75 PQEFCVVTEFAQGELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM 152 (1342)
Q Consensus 75 ed~lyLVMEY~eGSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l 152 (1342)
...++++|||++|+|.+++.+ ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 456899999999999999875 346899999999999999999999999999999999999999999999999999876
Q ss_pred cCCceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC-----CC-------
Q 000706 153 SANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP-----VK------- 220 (1342)
Q Consensus 153 ~sss~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~-----~e------- 220 (1342)
... .......||+.|+|||++.+..++.++||||||+++|+|++|++||.+.+..+.+..+.... ..
T Consensus 161 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 161 SFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred cCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence 543 22344568999999999998899999999999999999999999999887766666554310 00
Q ss_pred ---------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 221 ---------------YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 221 ---------------fP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
..+.+++.+++++.+||+.||++|||+.|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 113467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=385.00 Aligned_cols=256 Identities=32% Similarity=0.554 Sum_probs=223.6
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
++|++.+.||+|+||.||++.++.+++.||+|.+++... .....+.+.+|+.+++.++||||+++++.+.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 589999999999999999999999999999999976533 2334567889999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee-e
Q 000706 83 EFAQ-GELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV-L 159 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~-~ 159 (1342)
||++ |+|.+++.+. +.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++......... .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 9996 7899998775 68999999999999999999999999999999999999999999999999999876544322 2
Q ss_pred ecccCCCCcCChhhhc------cCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC--CCCC--CCCCHHH
Q 000706 160 RSIKGTPLYMAPELVR------EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP--VKYP--DEMSPNF 229 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~------g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~--~efP--~eISpeL 229 (1342)
....||+.|+|||++. ...++.++||||||+++|+|++|+.||...+......++.... ..+| ..+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence 3357999999999986 4568899999999999999999999999887777777665432 2333 3578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 230 KSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 230 kDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
.+|+.+||+ ||.+||+++++++||||+...
T Consensus 241 ~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 241 LDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred HHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 999999998 999999999999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=391.40 Aligned_cols=259 Identities=32% Similarity=0.530 Sum_probs=232.2
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
.++|...+.||+|.||.||+|++..+|+.||||+++.....+.......+||+.|+.++||||+.++|.|...+.+.+|+
T Consensus 1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 46899999999999999999999999999999999876544444467888999999999999999999999999999999
Q ss_pred eccCCChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQGELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~eGSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
||++.+|...|++. ..++...++.|+.++++||+|||++.|+||||||.|+|++++|.+||+|||+++.+.+.......
T Consensus 81 Efm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 81 EFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH 160 (318)
T ss_pred EeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence 99999999999864 57999999999999999999999999999999999999999999999999999999887777777
Q ss_pred ccCCCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-----CCC-------------
Q 000706 162 IKGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV-----KYP------------- 222 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~-----efP------------- 222 (1342)
.+-|.||+|||.+.|. .|+..+||||.|||+.||+-|.+-|.+.++.+++..|++.-. .+|
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~ 240 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ 240 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhc
Confidence 7899999999988764 599999999999999999999999999999999988875210 111
Q ss_pred ----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccchh
Q 000706 223 ----------DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 223 ----------~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~~ 261 (1342)
...++++.||+.+||..||.+|+++.|+++|+||++...
T Consensus 241 ~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~ 289 (318)
T KOG0659|consen 241 FPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL 289 (318)
T ss_pred CCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence 123577899999999999999999999999999987543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=385.85 Aligned_cols=253 Identities=29% Similarity=0.544 Sum_probs=223.9
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
++|++.+.||+|+||.||+|++..+++.||+|++++... .......+.+|+++++.++||||+++++++++++..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 579999999999999999999999999999999976532 2234467888999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
||++ |+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~~ 157 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANS 157 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccCC
Confidence 9997 68999998888999999999999999999999999999999999999999999999999999976544 2345
Q ss_pred ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC--CCCC------CCCCHHHHHHH
Q 000706 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP--VKYP------DEMSPNFKSFL 233 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~--~efP------~eISpeLkDLI 233 (1342)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.... ...| ..+++++.++|
T Consensus 158 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li 237 (333)
T cd05600 158 VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI 237 (333)
T ss_pred cccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHH
Confidence 679999999999999999999999999999999999999999888777666554321 1111 24689999999
Q ss_pred HHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 234 KGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 234 rKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
.+||+.+|.+||++.++++||||.+.
T Consensus 238 ~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 238 TKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99999999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=389.08 Aligned_cols=256 Identities=28% Similarity=0.507 Sum_probs=219.7
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
.|++++.||+|+||+||+|++..+++.||+|++.+... .......+.+|++++++++||||+++++.+.+++.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 69999999999999999999999999999999976532 33445678999999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc------
Q 000706 84 FAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT------ 156 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss------ 156 (1342)
|++ |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 997 6899999888889999999999999999999999999999999999999999999999999975431100
Q ss_pred -----------------------------------------eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHH
Q 000706 157 -----------------------------------------VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYEL 195 (1342)
Q Consensus 157 -----------------------------------------~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYEL 195 (1342)
......+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el 241 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence 001235799999999999998999999999999999999
Q ss_pred HhCCCCCCCCcHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHhccc--CCCCCCCHHHHHcCcCcccch
Q 000706 196 FVGQPPFYTNSVYALIRHIVK--DPVKYPD--EMSPNFKSFLKGLLNK--VPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 196 LTGr~PF~g~s~~elirkIlr--~~~efP~--eISpeLkDLIrKcLqk--DPeKRPSAeELLeHPFFre~~ 260 (1342)
++|+.||...+..+....+.. ....+|. .+++++++||.+|+.. +|.+|+++.|+++||||++..
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred HhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 999999988776665555543 2333443 5799999999996654 555599999999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=390.13 Aligned_cols=256 Identities=28% Similarity=0.482 Sum_probs=220.3
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
.+|++++.||+|+||.||+|++..+++.||+|++.+... .......+.+|++++++++||||+++++.+++++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999999865422 1223466889999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCC------
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN------ 155 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ss------ 155 (1342)
||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 9997 789999998888999999999999999999999999999999999999999999999999997532100
Q ss_pred -------------------------------------ceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhC
Q 000706 156 -------------------------------------TVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVG 198 (1342)
Q Consensus 156 -------------------------------------s~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTG 198 (1342)
.......+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 0001135799999999999999999999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhcCC--CCC--CCCCCHHHHHHHHHhcccCCCCCC---CHHHHHcCcCcccch
Q 000706 199 QPPFYTNSVYALIRHIVKDP--VKY--PDEMSPNFKSFLKGLLNKVPQNRL---TWSALLEHPFVKETS 260 (1342)
Q Consensus 199 r~PF~g~s~~elirkIlr~~--~ef--P~eISpeLkDLIrKcLqkDPeKRP---SAeELLeHPFFre~~ 260 (1342)
+.||.+.+..+....+.... ..+ ...+++++.++|.+|+ .+|.+|+ ++.|+++||||+...
T Consensus 241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 99999887766665554322 222 3468999999999976 5999999 999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=382.65 Aligned_cols=251 Identities=31% Similarity=0.560 Sum_probs=219.5
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-e~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
+.||+|+||.||++.+..+++.||+|++++.... ......+.+|..+++.+ +||||+++++++.+++.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999865332 33456688899999998 79999999999999999999999997
Q ss_pred CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCC
Q 000706 87 GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTP 166 (1342)
Q Consensus 87 GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp 166 (1342)
|+|.+++.+.+++++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.............||+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence 68999998888999999999999999999999999999999999999999999999999999975333333344567999
Q ss_pred CcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCC---------cHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhc
Q 000706 167 LYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTN---------SVYALIRHIVKDPVKYPDEMSPNFKSFLKGLL 237 (1342)
Q Consensus 167 ~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~---------s~~elirkIlr~~~efP~eISpeLkDLIrKcL 237 (1342)
.|+|||++.+..++.++|+||||+++|+|++|+.||... ......+.+......+|..+++++.++|++||
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L 240 (329)
T cd05588 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFL 240 (329)
T ss_pred cccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 999999999999999999999999999999999999631 12234455666777888899999999999999
Q ss_pred ccCCCCCCC------HHHHHcCcCcccch
Q 000706 238 NKVPQNRLT------WSALLEHPFVKETS 260 (1342)
Q Consensus 238 qkDPeKRPS------AeELLeHPFFre~~ 260 (1342)
+.||.+|++ ++++++||||....
T Consensus 241 ~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 241 NKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred ccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 999999987 79999999997653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=390.53 Aligned_cols=255 Identities=29% Similarity=0.541 Sum_probs=220.7
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
.+|++++.||+|+||+||+|++..+++.||+|.+.+... .......+.+|++++++++||||+++++.+.+++.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 369999999999999999999999999999999976432 2334567889999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc-----
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT----- 156 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss----- 156 (1342)
||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 9997 6899999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred ------------------------------------------eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHH
Q 000706 157 ------------------------------------------VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYE 194 (1342)
Q Consensus 157 ------------------------------------------~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYE 194 (1342)
......+||+.|+|||++.+..|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 00123469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHhcC--CCCCC--CCCCHHHHHHHHHhcccCCCCCCC---HHHHHcCcCcccc
Q 000706 195 LFVGQPPFYTNSVYALIRHIVKD--PVKYP--DEMSPNFKSFLKGLLNKVPQNRLT---WSALLEHPFVKET 259 (1342)
Q Consensus 195 LLTGr~PF~g~s~~elirkIlr~--~~efP--~eISpeLkDLIrKcLqkDPeKRPS---AeELLeHPFFre~ 259 (1342)
|++|+.||.+.+..+....+... ...+| ..+++++.++|.+|+ .||.+|++ ++++++||||+..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 99999999988777666666542 23333 468999999999986 59999997 9999999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=383.76 Aligned_cols=249 Identities=35% Similarity=0.631 Sum_probs=217.8
Q ss_pred EcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc---CCCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKL---KHQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 12 LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL---~HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
||+|+||+||+|++..+++.||+|++.+... ..........|..++.+. +||||+++++.+++++.+|+||||++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6999999999999999999999999965422 222334455677777665 69999999999999999999999997
Q ss_pred CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCC
Q 000706 87 GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTP 166 (1342)
Q Consensus 87 GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp 166 (1342)
|+|.+++.+.+.+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||++..............||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence 68999998888999999999999999999999999999999999999999999999999999976544333445567999
Q ss_pred CcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCC-CCCHHHHHHHHHhcccCCCCC
Q 000706 167 LYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPD-EMSPNFKSFLKGLLNKVPQNR 244 (1342)
Q Consensus 167 ~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~-eISpeLkDLIrKcLqkDPeKR 244 (1342)
.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+..+.+......++. .+++++++||++||+.||++|
T Consensus 161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R 240 (330)
T cd05586 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240 (330)
T ss_pred cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence 99999998754 4899999999999999999999999998888888888877776665 478999999999999999999
Q ss_pred C----CHHHHHcCcCcccch
Q 000706 245 L----TWSALLEHPFVKETS 260 (1342)
Q Consensus 245 P----SAeELLeHPFFre~~ 260 (1342)
| ++.++++||||.+..
T Consensus 241 ~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 241 LGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CCCCCCHHHHhcCccccCCC
Confidence 8 799999999998754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=380.14 Aligned_cols=256 Identities=30% Similarity=0.551 Sum_probs=229.6
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLK-HQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~-HPNIVKL~dvfeded~lyLVM 82 (1342)
+|+..+.||+|+||.||+|.++.+++.||+|++.+... .....+.+..|.+++..+. |++|+++++++.+++.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 58899999999999999999999999999999976422 2233456778899998885 577889999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
||++ |+|.+++.+.+.+++.+++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+++...........
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~ 160 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence 9997 789999988888999999999999999999999999999999999999999999999999999765444334455
Q ss_pred ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCC
Q 000706 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVP 241 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDP 241 (1342)
..||+.|+|||++.+..++.++||||+|+++|+|++|+.||.+.+.....+.+......+|..+++++.+++.+||+.||
T Consensus 161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p 240 (323)
T cd05615 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHP 240 (323)
T ss_pred ccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCH
Confidence 67999999999999999999999999999999999999999999888888888888888899999999999999999999
Q ss_pred CCCCC-----HHHHHcCcCcccch
Q 000706 242 QNRLT-----WSALLEHPFVKETS 260 (1342)
Q Consensus 242 eKRPS-----AeELLeHPFFre~~ 260 (1342)
.+|++ .+++++||||+...
T Consensus 241 ~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 241 SKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred hhCCCCCCCCHHHHhcCcccCCCC
Confidence 99997 57999999998753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=381.02 Aligned_cols=251 Identities=33% Similarity=0.570 Sum_probs=225.5
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
+.||+|+||+||++.+..+++.||+|.+++... .......+.+|.++++.+ +||||+++++++++.+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999976532 223445677899999888 79999999999999999999999997
Q ss_pred CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCC
Q 000706 87 GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTP 166 (1342)
Q Consensus 87 GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp 166 (1342)
|+|.+++.+.+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++............+|++
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~ 160 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence 68999998888899999999999999999999999999999999999999999999999999875433333334567999
Q ss_pred CcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 000706 167 LYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLT 246 (1342)
Q Consensus 167 ~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRPS 246 (1342)
.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.......+......+|..+++++.++|.+||+.||.+||+
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s 240 (318)
T cd05570 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLG 240 (318)
T ss_pred cccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCC
Confidence 99999999999999999999999999999999999999888888888888888888899999999999999999999999
Q ss_pred H-----HHHHcCcCcccch
Q 000706 247 W-----SALLEHPFVKETS 260 (1342)
Q Consensus 247 A-----eELLeHPFFre~~ 260 (1342)
+ .++++||||+...
T Consensus 241 ~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 241 CLPTGEQDIKGHPFFREID 259 (318)
T ss_pred CCCCCHHHHhcCCCcCCCC
Confidence 9 9999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=400.41 Aligned_cols=254 Identities=38% Similarity=0.712 Sum_probs=233.3
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEIEILRKLK-HQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-e~dierL~rEI~ILKrL~-HPNIVKL~dvfeded~lyLV 81 (1342)
+.|++.+.||+|.||.||+++++.+|+.+|+|.+.+.... ......+.+|+++|+++. |||||++++.|++++.+|+|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 5799999999999999999999999999999999776442 234578999999999998 99999999999999999999
Q ss_pred EeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCC----CcEEEeeccccccccCCc
Q 000706 82 TEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAG----SVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsd----G~LKLiDFGLAr~l~sss 156 (1342)
||+++ |+|++.+.+. .++|..+..++.|++.+++|||+.|++||||||||+|+... +.+|++|||++..... .
T Consensus 115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-~ 192 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-G 192 (382)
T ss_pred EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-C
Confidence 99997 7999998776 49999999999999999999999999999999999999543 4799999999999887 5
Q ss_pred eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC----CCCCCHHHHHH
Q 000706 157 VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKY----PDEMSPNFKSF 232 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~ef----P~eISpeLkDL 232 (1342)
....+.+|||.|+|||++...+|+..+||||+|+++|.|++|.+||.+.+.......+..+.+.+ ++.++..+++|
T Consensus 193 ~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~ 272 (382)
T KOG0032|consen 193 ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDF 272 (382)
T ss_pred ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHH
Confidence 56788999999999999999999999999999999999999999999999988888998886654 45689999999
Q ss_pred HHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 233 LKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 233 IrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
|++||..||.+|+|+.++|+|||+++.
T Consensus 273 i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 273 IRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHhcccCcccCCCHHHHhcCccccCC
Confidence 999999999999999999999999875
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=376.48 Aligned_cols=257 Identities=28% Similarity=0.492 Sum_probs=218.4
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
.+++|++.+.||+|+||.||+|+++.+++.||+|.++..... .....+.+|++++++++||||+++++++.+++..|+|
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 468899999999999999999999999999999998754322 2234567899999999999999999999999999999
Q ss_pred EeccCCChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 82 TEFAQGELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 82 MEY~eGSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
|||++++|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..........
T Consensus 83 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (309)
T cd07872 83 FEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS 162 (309)
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence 999999999988764 4589999999999999999999999999999999999999999999999999976554443344
Q ss_pred cccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC---C----------------CC
Q 000706 161 SIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---P----------------VK 220 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~---~----------------~e 220 (1342)
...+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+... + ..
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN 242 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence 5568999999998865 45889999999999999999999999877654443333210 0 00
Q ss_pred -----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 221 -----------YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 221 -----------fP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
..+.+++++++||.+||+.||++|||+.|+++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 112468899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=396.61 Aligned_cols=255 Identities=36% Similarity=0.619 Sum_probs=219.2
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--eEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ--EFCVV 81 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded--~lyLV 81 (1342)
.+|...+.||+|+||.||++.+..+|+.+|||.+....... .+.+.+|+++|++++|||||++++...... .++++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 45888999999999999999999999999999987652221 577999999999999999999999754444 79999
Q ss_pred EeccC-CChHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcC-CCcEEEeeccccccccCC---
Q 000706 82 TEFAQ-GELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA-GSVVKLCDFGFARAMSAN--- 155 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek~g-~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLds-dG~LKLiDFGLAr~l~ss--- 155 (1342)
|||++ |+|.+++++.+ .++|..++.+.+|+++||+|||++||+||||||+|||++. +|.+||+|||+++.....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99997 79999999876 7999999999999999999999999999999999999999 799999999999877641
Q ss_pred ceeeecccCCCCcCChhhhccCC-CCCCCcccchhhHHHHHHhCCCCCCC-CcHHHHHHHHhcC--CCCCCCCCCHHHHH
Q 000706 156 TVVLRSIKGTPLYMAPELVREQP-YNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKD--PVKYPDEMSPNFKS 231 (1342)
Q Consensus 156 s~~~~s~vGTp~YmAPEvL~g~~-YT~KsDIWSLGVILYELLTGr~PF~g-~s~~elirkIlr~--~~efP~eISpeLkD 231 (1342)
........|||.|||||++.+.. ..+++|||||||++.||+||+.||.. ....+..-.+... .+.+|..+|+++++
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~ 254 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKD 254 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHH
Confidence 12234578999999999998632 33599999999999999999999987 3444444444433 35788899999999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 232 FLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 232 LIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
|+++|+..||++|||++++|+|||.+...
T Consensus 255 Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 255 FLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 99999999999999999999999987643
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=381.26 Aligned_cols=251 Identities=30% Similarity=0.567 Sum_probs=219.5
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
+.||+|+||.||+++++.+++.||+|.+++... .......+.+|+.++.++ +||||+++++++.+++.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999986532 234456688899988877 89999999999999999999999997
Q ss_pred CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCC
Q 000706 87 GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTP 166 (1342)
Q Consensus 87 GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp 166 (1342)
|+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.............||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence 68988888888999999999999999999999999999999999999999999999999999976433333344567999
Q ss_pred CcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCC---------CcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhc
Q 000706 167 LYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYT---------NSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLL 237 (1342)
Q Consensus 167 ~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g---------~s~~elirkIlr~~~efP~eISpeLkDLIrKcL 237 (1342)
.|+|||++.+..++.++||||||+++|+|++|+.||.. .......+.+......+|..+++++.+++.+||
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L 240 (329)
T cd05618 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFL 240 (329)
T ss_pred cccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHh
Confidence 99999999999999999999999999999999999952 112334455667777888999999999999999
Q ss_pred ccCCCCCCC------HHHHHcCcCcccch
Q 000706 238 NKVPQNRLT------WSALLEHPFVKETS 260 (1342)
Q Consensus 238 qkDPeKRPS------AeELLeHPFFre~~ 260 (1342)
+.||++||+ +.++++||||++..
T Consensus 241 ~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 241 NKDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred cCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 999999998 58999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=367.54 Aligned_cols=251 Identities=31% Similarity=0.545 Sum_probs=209.7
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc---CCCCcceEEEEEEe-----CC
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL---KHQNIIEMLDSFES-----PQ 76 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL---~HPNIVKL~dvfed-----ed 76 (1342)
+|++.+.||+|+||.||+|.++.+++.||+|.++.............+|+++++++ +||||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999999875433222223455677777665 79999999998864 34
Q ss_pred eEEEEEeccCCChHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccC
Q 000706 77 EFCVVTEFAQGELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA 154 (1342)
Q Consensus 77 ~lyLVMEY~eGSL~D~Lek~--g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~s 154 (1342)
.++++|||++++|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 68999999999999988763 3589999999999999999999999999999999999999999999999999987653
Q ss_pred CceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-----CC----------
Q 000706 155 NTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-----PV---------- 219 (1342)
Q Consensus 155 ss~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~-----~~---------- 219 (1342)
.. ......||+.|+|||++.+..++.++||||+||++|+|++|++||.+....+...++... ..
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07863 161 QM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239 (288)
T ss_pred cc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence 32 223456899999999999888999999999999999999999999887665554444320 00
Q ss_pred ------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 220 ------------KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 220 ------------efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
...+.++.++.+++.+||++||++|||+.|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0113467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=385.33 Aligned_cols=255 Identities=30% Similarity=0.569 Sum_probs=222.7
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
++|++.+.||+|+||.||++.++.+++.||+|++++... .......+.+|+.++.+++||||+++++.+.+++.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999975422 2334567888999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce----
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV---- 157 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~---- 157 (1342)
||++ |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 9997 68999998888999999999999999999999999999999999999999999999999999875432110
Q ss_pred -------------------------------eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCc
Q 000706 158 -------------------------------VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS 206 (1342)
Q Consensus 158 -------------------------------~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s 206 (1342)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 0123579999999999999999999999999999999999999999988
Q ss_pred HHHHHHHHhcC--CCCCCC--CCCHHHHHHHHHhcccCCCCCC---CHHHHHcCcCcccc
Q 000706 207 VYALIRHIVKD--PVKYPD--EMSPNFKSFLKGLLNKVPQNRL---TWSALLEHPFVKET 259 (1342)
Q Consensus 207 ~~elirkIlr~--~~efP~--eISpeLkDLIrKcLqkDPeKRP---SAeELLeHPFFre~ 259 (1342)
.......+... ...+|+ .++++++++|.+|+ .||.+|+ ++.|+++||||+..
T Consensus 241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred HHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 87777777643 334444 37899999999987 4999998 58999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=362.56 Aligned_cols=251 Identities=40% Similarity=0.724 Sum_probs=218.5
Q ss_pred EEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEecc
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFA 85 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~ 85 (1342)
|++++.||+|+||+||++++..+++.||+|.+..............+|+.++++++||||+++++++.++...+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999877554444445567999999999999999999999999999999999
Q ss_pred CC-ChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccC
Q 000706 86 QG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG 164 (1342)
Q Consensus 86 eG-SL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vG 164 (1342)
++ +|.+++.+.+.+++..++.++.|+++||.|||++|++||||||+||+++.++.++|+|||.+..............+
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 160 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVG 160 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 86 89999998888999999999999999999999999999999999999999999999999999765433444556779
Q ss_pred CCCcCChhhhc-cCCCCCCCcccchhhHHHHHHhCCCCCCCCc---HHHHHHHHhcCCC----CCCCCCCHHHHHHHHHh
Q 000706 165 TPLYMAPELVR-EQPYNHTADLWSLGVILYELFVGQPPFYTNS---VYALIRHIVKDPV----KYPDEMSPNFKSFLKGL 236 (1342)
Q Consensus 165 Tp~YmAPEvL~-g~~YT~KsDIWSLGVILYELLTGr~PF~g~s---~~elirkIlr~~~----efP~eISpeLkDLIrKc 236 (1342)
++.|+|||++. +..++.++|+||+|+++|+|++|..||.... ......+...... ......++++.++|.+|
T Consensus 161 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 240 (260)
T PF00069_consen 161 TPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKM 240 (260)
T ss_dssp SGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHH
Confidence 99999999998 7889999999999999999999999999873 3333333333211 11122348999999999
Q ss_pred cccCCCCCCCHHHHHcCcCc
Q 000706 237 LNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 237 LqkDPeKRPSAeELLeHPFF 256 (1342)
|+.||++||++.++++||||
T Consensus 241 l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 241 LSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp SSSSGGGSTTHHHHHTSGGG
T ss_pred ccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=376.89 Aligned_cols=256 Identities=29% Similarity=0.515 Sum_probs=220.3
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
.-++|++.+.||+|+||.||++.+..++..||+|.+.... .....+++.+|++++++++||||+++++++.+++.+++|
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999987542 334456789999999999999999999999999999999
Q ss_pred EeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC-CceecCCCCCcEEEcCCCcEEEeeccccccccCCceee
Q 000706 82 TEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN-RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsr-GIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~ 159 (1342)
|||++ |+|.+++.+.+.+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...... ..
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 159 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MA 159 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--cc
Confidence 99997 68999998888899999999999999999999986 6999999999999999999999999999765432 22
Q ss_pred ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHh------------------------
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIV------------------------ 215 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIl------------------------ 215 (1342)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP 239 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence 34579999999999999899999999999999999999999997655433322111
Q ss_pred ----------------------cC-CCCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 216 ----------------------KD-PVKY-PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 216 ----------------------r~-~~ef-P~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
.. .... ...+++++++||.+||++||++|||+.|+++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 00 1111 124678999999999999999999999999999998654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=379.74 Aligned_cols=251 Identities=30% Similarity=0.515 Sum_probs=222.2
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
+.||+|+||.||+|++..+++.||+|.+++... ..........|..+++.. +||||+++++++.+++.+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999976522 122335566788888764 99999999999999999999999997
Q ss_pred CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCC
Q 000706 87 GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTP 166 (1342)
Q Consensus 87 GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp 166 (1342)
|+|.+++.+...+++.++..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.............||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence 78999998888899999999999999999999999999999999999999999999999999875433333344567999
Q ss_pred CcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 000706 167 LYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLT 246 (1342)
Q Consensus 167 ~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRPS 246 (1342)
.|+|||++.+..++.++||||+||++|+|++|+.||...+..+..+.+......+|..++.+++++|.+||+.||++||+
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~ 240 (316)
T cd05619 161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLG 240 (316)
T ss_pred cccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcCC
Confidence 99999999998999999999999999999999999999888888887777777778889999999999999999999999
Q ss_pred HH-HHHcCcCcccch
Q 000706 247 WS-ALLEHPFVKETS 260 (1342)
Q Consensus 247 Ae-ELLeHPFFre~~ 260 (1342)
+. ++++||||++..
T Consensus 241 ~~~~l~~h~~~~~~~ 255 (316)
T cd05619 241 VKGDIRQHPFFREID 255 (316)
T ss_pred ChHHHHcCcccCCCC
Confidence 96 999999998854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=387.35 Aligned_cols=255 Identities=29% Similarity=0.494 Sum_probs=220.1
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-----eEE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ-----EFC 79 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded-----~ly 79 (1342)
+|++.+.||+|+||.||++.+..+++.||+|.+.+........+++.+|+++++.++||||+++++++.+++ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 589999999999999999999999999999998765444445677889999999999999999999998776 889
Q ss_pred EEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc-ee
Q 000706 80 VVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT-VV 158 (1342)
Q Consensus 80 LVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss-~~ 158 (1342)
+||||++++|.+.+...+.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~ 160 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH 160 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998654332 22
Q ss_pred eecccCCCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhc---------------------
Q 000706 159 LRSIKGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK--------------------- 216 (1342)
Q Consensus 159 ~~s~vGTp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr--------------------- 216 (1342)
.....+++.|+|||.+.+. .|+.++||||+||++|||++|+.||.+.+..+....+..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 240 (372)
T cd07853 161 MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHI 240 (372)
T ss_pred CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHH
Confidence 2345689999999998774 479999999999999999999999988766554443321
Q ss_pred --CCC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 217 --DPV---------KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 217 --~~~---------efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
.+. ......++++.+||.+||+.||++|||+.|+++||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 241 LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 111 1234568899999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=382.19 Aligned_cols=253 Identities=26% Similarity=0.469 Sum_probs=214.1
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ------ 76 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded------ 76 (1342)
+++|++.+.||+|+||.||++.+..+|+.||+|.+.+..........+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 57999999999999999999999999999999999766555555677889999999999999999999986543
Q ss_pred eEEEEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 77 EFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 77 ~lyLVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
.+|+||||++++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 100 ~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 177 (359)
T cd07876 100 DVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF 177 (359)
T ss_pred eeEEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCc
Confidence 5799999999999887753 48899999999999999999999999999999999999999999999999997654332
Q ss_pred eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhc--------------------
Q 000706 157 VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK-------------------- 216 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr-------------------- 216 (1342)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+..
T Consensus 178 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (359)
T cd07876 178 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256 (359)
T ss_pred -cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 22345789999999999999999999999999999999999999987654333222111
Q ss_pred --CCCCC--------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCccc
Q 000706 217 --DPVKY--------------------PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258 (1342)
Q Consensus 217 --~~~ef--------------------P~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre 258 (1342)
....+ ....++++++||.+||+.||++|||+.|+++||||..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 257 VENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 11110 1124578999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=375.17 Aligned_cols=256 Identities=27% Similarity=0.550 Sum_probs=218.6
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~-~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
++|++.+.||+|+||.||++++..+++.||+|++.+.. ......+.+.+|+.+++.++||||+++++.+++++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 58999999999999999999999999999999997532 22233456888999999999999999999999999999999
Q ss_pred eccC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee-e
Q 000706 83 EFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV-L 159 (1342)
Q Consensus 83 EY~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~-~ 159 (1342)
||++ |+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 9986 789999876 567999999999999999999999999999999999999999999999999998765543322 2
Q ss_pred ecccCCCCcCChhhhcc-----CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC--CCCC---CCCCHHH
Q 000706 160 RSIKGTPLYMAPELVRE-----QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP--VKYP---DEMSPNF 229 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g-----~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~--~efP---~eISpeL 229 (1342)
....||+.|+|||++.. ..++.++||||+||++|+|++|+.||...+..+....+.... ..++ ..+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence 23469999999999863 457889999999999999999999999888777777665432 2333 3478999
Q ss_pred HHHHHHhcccCCCC--CCCHHHHHcCcCcccc
Q 000706 230 KSFLKGLLNKVPQN--RLTWSALLEHPFVKET 259 (1342)
Q Consensus 230 kDLIrKcLqkDPeK--RPSAeELLeHPFFre~ 259 (1342)
+++|++||..++++ |+++.++++||||...
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 99999999765544 7899999999999875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=397.27 Aligned_cols=256 Identities=35% Similarity=0.671 Sum_probs=224.9
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC------------HHHHHHHHHHHHHHHhcCCCCcceEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS------------EKDIHNLRQEIEILRKLKHQNIIEMLD 70 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s------------e~dierL~rEI~ILKrL~HPNIVKL~d 70 (1342)
+.+|++.+.||+|.||.|.+|++..+++.||||++.|.... ....+++++||.+|+++.|||||++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 57899999999999999999999999999999999765321 122468999999999999999999999
Q ss_pred EEEeC--CeEEEEEeccC-CChHHHHhcCCC-CCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeec
Q 000706 71 SFESP--QEFCVVTEFAQ-GELFEILEDDKC-LPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDF 146 (1342)
Q Consensus 71 vfede--d~lyLVMEY~e-GSL~D~Lek~g~-LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDF 146 (1342)
+..++ +.+|||+|||. |.+.. .-..++ +++.+++.|+++++.||+|||.+||+||||||.|+|++++|++||+||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred eecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecc
Confidence 99765 57999999998 55544 334445 999999999999999999999999999999999999999999999999
Q ss_pred ccccccc-----CCceeeecccCCCCcCChhhhccC---CC-CCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC
Q 000706 147 GFARAMS-----ANTVVLRSIKGTPLYMAPELVREQ---PY-NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD 217 (1342)
Q Consensus 147 GLAr~l~-----sss~~~~s~vGTp~YmAPEvL~g~---~Y-T~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~ 217 (1342)
|.+.... .........+|||.|+|||...++ .| +.+.||||+|++||.|+.|+.||.++...++.++|...
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~ 334 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND 334 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC
Confidence 9998662 222334457899999999987662 23 57889999999999999999999999999999999999
Q ss_pred CCCCCCC--CCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 218 PVKYPDE--MSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 218 ~~efP~e--ISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
+..+|.. +.+.+++||.+||.+||++|.++.++..|||....
T Consensus 335 pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 335 PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 9999864 78999999999999999999999999999998654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=389.83 Aligned_cols=259 Identities=32% Similarity=0.534 Sum_probs=227.2
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
++.++|++.+.||.|.-++||+|+...+++.||||++..+.-.. +.+.+++|++.|+.++||||++++..|..+..+|+
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~-~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN-DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh-hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 36789999999999999999999999999999999997664433 37889999999999999999999999999999999
Q ss_pred EEeccC-CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce
Q 000706 81 VTEFAQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~ 157 (1342)
||.||. |++++.++. ...++|..+..+++++++||.|||++|.+|||||+.||||+++|.+||+|||.+..+.....
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 999997 899999876 34599999999999999999999999999999999999999999999999999876643322
Q ss_pred ----eeecccCCCCcCChhhhc--cCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC---------
Q 000706 158 ----VLRSIKGTPLYMAPELVR--EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP--------- 222 (1342)
Q Consensus 158 ----~~~s~vGTp~YmAPEvL~--g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP--------- 222 (1342)
.+.+++|||+|||||++. ...|+.|+||||||++..||.+|..||..-.....+..-.++.++.+
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~ 261 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDE 261 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHH
Confidence 225679999999999854 35699999999999999999999999998877776655555544322
Q ss_pred -CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 223 -DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 223 -~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
..++..++.+|..||.+||++|||++++++|+||+...
T Consensus 262 ~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 262 DKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred hhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 23677899999999999999999999999999998753
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=369.00 Aligned_cols=248 Identities=32% Similarity=0.566 Sum_probs=216.0
Q ss_pred EcccCcEEEEEEEEccCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-CCh
Q 000706 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GEL 89 (1342)
Q Consensus 12 LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-e~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e-GSL 89 (1342)
||+|+||+||++.++.+++.||+|.+.+.... ....+.+..|+++++.++||||+++++++.++...|+||||++ |+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999998764322 2234567789999999999999999999999999999999997 678
Q ss_pred HHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCC
Q 000706 90 FEILE----DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGT 165 (1342)
Q Consensus 90 ~D~Le----k~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGT 165 (1342)
.+++. ....+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..............||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 77763 34579999999999999999999999999999999999999999999999999998765544444456799
Q ss_pred CCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcH----HHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCC
Q 000706 166 PLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSV----YALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVP 241 (1342)
Q Consensus 166 p~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~----~elirkIlr~~~efP~eISpeLkDLIrKcLqkDP 241 (1342)
+.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ......+...+..++..+++++.+++.+||+.||
T Consensus 161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 240 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP 240 (280)
T ss_pred cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCH
Confidence 999999999999999999999999999999999999976432 3344455556667778899999999999999999
Q ss_pred CCCC-----CHHHHHcCcCcccc
Q 000706 242 QNRL-----TWSALLEHPFVKET 259 (1342)
Q Consensus 242 eKRP-----SAeELLeHPFFre~ 259 (1342)
++|| +++++++||||++.
T Consensus 241 ~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 241 EKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHhcCCCCCCHHHHhcChhhhcC
Confidence 9999 88999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=386.45 Aligned_cols=258 Identities=32% Similarity=0.574 Sum_probs=224.2
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFC 79 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~ly 79 (1342)
+..++|++.+.||+|+||.||++++..+++.||+|.+.+... .......+.+|+.+++.++||||+++++++.+++.+|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 356789999999999999999999999999999999975422 2223455778999999999999999999999999999
Q ss_pred EEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce-
Q 000706 80 VVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV- 157 (1342)
Q Consensus 80 LVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~- 157 (1342)
+||||++ |+|.+++.+ ..+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 9999997 688888765 4689999999999999999999999999999999999999999999999999987654322
Q ss_pred eeecccCCCCcCChhhhccC----CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC--CCCCC--CCCHHH
Q 000706 158 VLRSIKGTPLYMAPELVREQ----PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP--VKYPD--EMSPNF 229 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g~----~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~--~efP~--eISpeL 229 (1342)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+.... ..+|. .++.++
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 22346799999999988653 37899999999999999999999999988877777776543 44554 579999
Q ss_pred HHHHHHhcccCCCC--CCCHHHHHcCcCcccc
Q 000706 230 KSFLKGLLNKVPQN--RLTWSALLEHPFVKET 259 (1342)
Q Consensus 230 kDLIrKcLqkDPeK--RPSAeELLeHPFFre~ 259 (1342)
++||.+||+.+|.+ |++++|+++||||+..
T Consensus 279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 99999999999998 9999999999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=393.62 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=211.8
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
...+|++++.||+|+||.||+|.+..+++.||+|...+ ..+.+|++++++++||||++++++|..+...+++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 34689999999999999999999999999999996432 3467899999999999999999999999999999
Q ss_pred EeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCC-ceeee
Q 000706 82 TEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN-TVVLR 160 (1342)
Q Consensus 82 MEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ss-s~~~~ 160 (1342)
||++.++|++++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 162 ~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 162 LPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999999754322 22233
Q ss_pred cccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCc-------HHHHHHHHhc-----------------
Q 000706 161 SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS-------VYALIRHIVK----------------- 216 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s-------~~elirkIlr----------------- 216 (1342)
...||+.|+|||++.+..|+.++|||||||++|+|++|+.||.... ....+..+..
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 4679999999999999999999999999999999999998875421 1111111110
Q ss_pred ---------CCC----CCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 217 ---------DPV----KYP-----DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 217 ---------~~~----efP-----~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
... ..+ ..++.++.+||.+||+.||++|||+.|+++||||++..
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 000 001 12466899999999999999999999999999998753
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=361.80 Aligned_cols=252 Identities=33% Similarity=0.521 Sum_probs=214.8
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
+|++.+.||+|+||.||+|++..+++.|++|.++.....+.....+.+|+.++++++||||+++++++.+++.+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 69999999999999999999999999999999876544433446778899999999999999999999999999999999
Q ss_pred cCCChHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 85 AQGELFEILED---DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 85 ~eGSL~D~Lek---~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
++|+|.+++.. ...+++..++.++.|++.||+|||++|++||||||+||+++.+|.+||+|||++............
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (285)
T cd07861 81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH 160 (285)
T ss_pred CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccC
Confidence 99999988864 256999999999999999999999999999999999999999999999999999876544433344
Q ss_pred ccCCCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC----------------------
Q 000706 162 IKGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP---------------------- 218 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~---------------------- 218 (1342)
..+++.|+|||.+.+. .++.++|+||||+++|+|++|++||.+.+..+....+....
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
T cd07861 161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFP 240 (285)
T ss_pred CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhcc
Confidence 5678999999988654 57899999999999999999999998766543332221100
Q ss_pred -------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 219 -------VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 219 -------~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
......++++++++|++||+.||.+|||+.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 241 KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred ccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 01123478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=379.55 Aligned_cols=254 Identities=24% Similarity=0.433 Sum_probs=215.6
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP------Q 76 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede------d 76 (1342)
+++|++.+.||+|+||.||++.+..+++.||+|.+.+..........+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 5799999999999999999999999999999999977655555567788999999999999999999988643 3
Q ss_pred eEEEEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 77 EFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 77 ~lyLVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
..|++|||+++++.+.+.. .+++..++.++.|+++||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 96 ~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 173 (355)
T cd07874 96 DVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_pred eeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc
Confidence 5799999999999888764 48899999999999999999999999999999999999999999999999998754432
Q ss_pred eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhc--------------------
Q 000706 157 VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK-------------------- 216 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr-------------------- 216 (1342)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 174 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (355)
T cd07874 174 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252 (355)
T ss_pred -ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHH
Confidence 23445789999999999999999999999999999999999999987664433322211
Q ss_pred --CCC--------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 217 --DPV--------------------KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 217 --~~~--------------------efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
... ..+...+.++++||.+||+.||++|||+.|+++||||...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 000 0112245678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=372.79 Aligned_cols=257 Identities=26% Similarity=0.518 Sum_probs=220.9
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~-~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
++|++.+.||+|+||.||+++++.+++.||+|.+.+.. ........+.+|+.++..++|+||+++++.+++++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 68999999999999999999999999999999987532 22233456788999999999999999999999999999999
Q ss_pred eccC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce-ee
Q 000706 83 EFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV-VL 159 (1342)
Q Consensus 83 EY~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~-~~ 159 (1342)
||++ |+|.+++.+ .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 9986 789999976 56899999999999999999999999999999999999999999999999999987654332 22
Q ss_pred ecccCCCCcCChhhhcc-----CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC--CCCC---CCCCHHH
Q 000706 160 RSIKGTPLYMAPELVRE-----QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP--VKYP---DEMSPNF 229 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g-----~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~--~efP---~eISpeL 229 (1342)
....||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||...+..+....+.... .++| ..+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~ 240 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence 33579999999999875 468899999999999999999999999888777777776533 3333 3468999
Q ss_pred HHHHHHhcccCCCC--CCCHHHHHcCcCcccch
Q 000706 230 KSFLKGLLNKVPQN--RLTWSALLEHPFVKETS 260 (1342)
Q Consensus 230 kDLIrKcLqkDPeK--RPSAeELLeHPFFre~~ 260 (1342)
++++.+||..++++ |++++++++||||+...
T Consensus 241 ~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred HHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 99999999876655 56899999999998753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=385.12 Aligned_cols=257 Identities=29% Similarity=0.557 Sum_probs=222.0
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
..++|++.+.||+|+||.||++++..+++.||+|++.+... .......+.+|+.+++.++||||+++++.+.+++.+|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 45789999999999999999999999999999999975422 22334567889999999999999999999999999999
Q ss_pred EEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce-e
Q 000706 81 VTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV-V 158 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~-~ 158 (1342)
||||++ |+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 121 v~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~ 199 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199 (370)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence 999997 7899988654 689999999999999999999999999999999999999999999999999987654322 2
Q ss_pred eecccCCCCcCChhhhccCC----CCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC--CCCCC--CCCHHHH
Q 000706 159 LRSIKGTPLYMAPELVREQP----YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP--VKYPD--EMSPNFK 230 (1342)
Q Consensus 159 ~~s~vGTp~YmAPEvL~g~~----YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~--~efP~--eISpeLk 230 (1342)
.....||+.|+|||++.+.. ++.++|+||+||++|+|++|+.||...+.......+.... ..+|. .+++.++
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 279 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAK 279 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHH
Confidence 34567999999999987643 7889999999999999999999999988877777776532 44454 4699999
Q ss_pred HHHHHhcccCCCC--CCCHHHHHcCcCcccc
Q 000706 231 SFLKGLLNKVPQN--RLTWSALLEHPFVKET 259 (1342)
Q Consensus 231 DLIrKcLqkDPeK--RPSAeELLeHPFFre~ 259 (1342)
+++.+||+.+|.+ |+++.|+++||||+..
T Consensus 280 ~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 280 NLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 9999999866654 8999999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=355.05 Aligned_cols=253 Identities=30% Similarity=0.548 Sum_probs=222.1
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC---HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS---EKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s---e~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
++|++.+.||+|+||.||++.+..++++|++|.+...... ......+.+|++++++++||||+++++++++++..|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 6899999999999999999999999999999998754322 2234578889999999999999999999999999999
Q ss_pred EEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceee
Q 000706 81 VTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~ 159 (1342)
+|||++ ++|.+++.+.+.+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 999997 6899999888889999999999999999999999999999999999999999999999999997654322211
Q ss_pred ---ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC--CCCCCCCCCHHHHHHHH
Q 000706 160 ---RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD--PVKYPDEMSPNFKSFLK 234 (1342)
Q Consensus 160 ---~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~--~~efP~eISpeLkDLIr 234 (1342)
....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||...+.......+... ...++..+++++.++|+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 241 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLR 241 (263)
T ss_pred ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHH
Confidence 2356889999999999988999999999999999999999999876665555444433 44567788999999999
Q ss_pred HhcccCCCCCCCHHHHHcCcCc
Q 000706 235 GLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 235 KcLqkDPeKRPSAeELLeHPFF 256 (1342)
+||+.||++|||+.|+++||||
T Consensus 242 ~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 242 RTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=381.18 Aligned_cols=253 Identities=24% Similarity=0.440 Sum_probs=216.3
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP------Q 76 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede------d 76 (1342)
+++|++.+.||+|+||.||++.+..+++.||+|.+.+..........+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 5799999999999999999999999999999999976655555567788999999999999999999987543 3
Q ss_pred eEEEEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 77 EFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 77 ~lyLVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
.+|+||||++++|.+.+.. .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 103 ~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 180 (364)
T cd07875 103 DVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180 (364)
T ss_pred eEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC
Confidence 5799999999999988864 48899999999999999999999999999999999999999999999999998765432
Q ss_pred eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-------------------
Q 000706 157 VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD------------------- 217 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~------------------- 217 (1342)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...++...
T Consensus 181 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (364)
T cd07875 181 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259 (364)
T ss_pred -cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHH
Confidence 233457899999999999999999999999999999999999999887765555444321
Q ss_pred ---CCC--------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCccc
Q 000706 218 ---PVK--------------------YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258 (1342)
Q Consensus 218 ---~~e--------------------fP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre 258 (1342)
... .....+.++++||.+||+.||.+|||+.|+++||||..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 000 01113467899999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=375.65 Aligned_cols=252 Identities=31% Similarity=0.558 Sum_probs=221.0
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
+.||+|+||.||++.+..+++.||+|++++... .....+.+.+|+.++.++ +||||+++++++++.+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999976532 234456788899999888 69999999999999999999999997
Q ss_pred CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCC
Q 000706 87 GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTP 166 (1342)
Q Consensus 87 GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp 166 (1342)
|+|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++............+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence 68999998888899999999999999999999999999999999999999999999999999976433333345577999
Q ss_pred CcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCC-------CcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhccc
Q 000706 167 LYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYT-------NSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 167 ~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g-------~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqk 239 (1342)
.|+|||++.+..++.++||||||+++|+|++|+.||.. .........+...+..+|..+++.+.+++.+||+.
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~ 240 (327)
T cd05617 161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNK 240 (327)
T ss_pred ccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcc
Confidence 99999999999999999999999999999999999953 12334455566677788889999999999999999
Q ss_pred CCCCCCC------HHHHHcCcCcccchh
Q 000706 240 VPQNRLT------WSALLEHPFVKETSD 261 (1342)
Q Consensus 240 DPeKRPS------AeELLeHPFFre~~~ 261 (1342)
||++|++ ++++++||||+....
T Consensus 241 dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 241 DPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred CHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 9999997 579999999998643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=366.91 Aligned_cols=258 Identities=30% Similarity=0.530 Sum_probs=218.9
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
.+++|++.+.||.|+||.||+|.++.+++.||+|.++..... .....+.+|++++++++||||+++++++.+++..++|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 368999999999999999999999999999999998654322 2234567899999999999999999999999999999
Q ss_pred EeccCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 82 TEFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 82 MEY~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
|||++++|.+++.+ ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...........
T Consensus 83 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (301)
T cd07873 83 FEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS 162 (301)
T ss_pred EeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence 99999999998875 45789999999999999999999999999999999999999999999999999976554433334
Q ss_pred cccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC---C----------------CC
Q 000706 161 SIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---P----------------VK 220 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~---~----------------~e 220 (1342)
...+++.|+|||.+.+ ..++.++||||||+++|+|++|++||...+..+....+... + ..
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN 242 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccc
Confidence 4567899999998865 45788999999999999999999999887765544333210 0 01
Q ss_pred C-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 221 Y-----------PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 221 f-----------P~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
+ ...+++++++||.+||+.||.+|||+.|+++||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 1 134688999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=351.62 Aligned_cols=252 Identities=31% Similarity=0.621 Sum_probs=222.4
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeEEEEEe
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFES-PQEFCVVTE 83 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfed-ed~lyLVME 83 (1342)
+|++.+.||+|++|.||++.++.+++.|++|.+..........+.+.+|++++++++|||++++++.+.. +..+|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5999999999999999999999999999999997665555566778899999999999999999998864 456899999
Q ss_pred ccC-CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 84 FAQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 84 Y~e-GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
|++ ++|.+++.+ ...+++.+++.++.|++.+|.|||++|++||||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 997 689988875 34689999999999999999999999999999999999999999999999999987654444444
Q ss_pred cccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHhccc
Q 000706 161 SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV-KYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~-efP~eISpeLkDLIrKcLqk 239 (1342)
...|++.|+|||++.+..++.++|+||+|+++|+|++|+.||...+.......+..... ..+..+++++.+++.+||+.
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 240 (257)
T cd08223 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSK 240 (257)
T ss_pred cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhcc
Confidence 56789999999999998899999999999999999999999988776666555555433 45677899999999999999
Q ss_pred CCCCCCCHHHHHcCcCc
Q 000706 240 VPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 240 DPeKRPSAeELLeHPFF 256 (1342)
||++||++.++++||||
T Consensus 241 ~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 241 RPEKRPSVKSILRQPYI 257 (257)
T ss_pred CcccCCCHHHHhcCCCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=370.83 Aligned_cols=257 Identities=26% Similarity=0.534 Sum_probs=220.2
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
++|++.+.||+|+||.||+++++.+++.||+|.+.+... .......+.+|+.++..++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999865321 2223345788999999999999999999999999999999
Q ss_pred eccC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc-eee
Q 000706 83 EFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT-VVL 159 (1342)
Q Consensus 83 EY~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss-~~~ 159 (1342)
||++ |+|.+++.+ ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 9986 799999976 5679999999999999999999999999999999999999999999999999997654332 222
Q ss_pred ecccCCCCcCChhhhc-----cCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC--CCCC---CCCCHHH
Q 000706 160 RSIKGTPLYMAPELVR-----EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP--VKYP---DEMSPNF 229 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~-----g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~--~efP---~eISpeL 229 (1342)
....||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+.... ..+| ..+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~ 240 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence 3457999999999886 3468899999999999999999999999988888777776543 2333 3579999
Q ss_pred HHHHHHhcccCCCC--CCCHHHHHcCcCcccch
Q 000706 230 KSFLKGLLNKVPQN--RLTWSALLEHPFVKETS 260 (1342)
Q Consensus 230 kDLIrKcLqkDPeK--RPSAeELLeHPFFre~~ 260 (1342)
++|+++||..+|.+ |++++|+++||||....
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred HHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 99999999765554 68999999999998753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=407.03 Aligned_cols=253 Identities=35% Similarity=0.640 Sum_probs=230.3
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
..|+..++||+|+-|.||.|+...+++.||+|.+.......+ +-+.+|+.+|+..+|+|||++++.|...+.+|+|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK--ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch--hhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 468889999999999999999999999999999977654333 578999999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 84 FAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
|++ |+|.|.+.+. .++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+........+.
T Consensus 351 ym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~Tm 429 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTM 429 (550)
T ss_pred ecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccc
Confidence 998 6777776654 49999999999999999999999999999999999999999999999999999988777667789
Q ss_pred cCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC---CCCCCCCCCHHHHHHHHHhccc
Q 000706 163 KGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PVKYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 163 vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~---~~efP~eISpeLkDLIrKcLqk 239 (1342)
+|||+|||||+.....|++++||||||+++.||+.|++||..++....+..|... +...++.+|+++++|+.+||+.
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~ 509 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVV 509 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhc
Confidence 9999999999999999999999999999999999999999988777766666543 4566789999999999999999
Q ss_pred CCCCCCCHHHHHcCcCcccc
Q 000706 240 VPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 240 DPeKRPSAeELLeHPFFre~ 259 (1342)
||++|+++.|||+||||+-.
T Consensus 510 dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 510 DVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred chhcCCCHHHHhcChhhhhc
Confidence 99999999999999999654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=398.57 Aligned_cols=256 Identities=34% Similarity=0.622 Sum_probs=232.1
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
..|+..+.||+|.||.||+|.+..+++.||+|++.... .+.+++.+++|+.++.+++++||.++|+.|..+..+|++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 35888999999999999999999999999999997653 34567889999999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 84 FAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
|++ |++.+.++.++.++|.++..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..+........++
T Consensus 92 y~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tf 171 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTF 171 (467)
T ss_pred HhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccccc
Confidence 997 7899999888888999999999999999999999999999999999999999999999999999888777666889
Q ss_pred cCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHhcccCC
Q 000706 163 KGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK-DPVKYPDEMSPNFKSFLKGLLNKVP 241 (1342)
Q Consensus 163 vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr-~~~efP~eISpeLkDLIrKcLqkDP 241 (1342)
+|||.|||||+++...|+.++||||||++.|||++|.+||........+..|-+ .++.+...+++.+++||..||++||
T Consensus 172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P 251 (467)
T KOG0201|consen 172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNP 251 (467)
T ss_pred cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCc
Confidence 999999999999988999999999999999999999999987666444433433 3445566889999999999999999
Q ss_pred CCCCCHHHHHcCcCcccch
Q 000706 242 QNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 242 eKRPSAeELLeHPFFre~~ 260 (1342)
+.||++.++|+|+|++...
T Consensus 252 ~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 252 EFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred ccCcCHHHHhhhHHHHhcC
Confidence 9999999999999998754
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=364.22 Aligned_cols=252 Identities=29% Similarity=0.508 Sum_probs=214.0
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
+|++.+.||+|+||.||+|+++.+|+.|++|.++...........+.+|++++++++||||+++++++.+....|++|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 69999999999999999999999999999999976544333345677899999999999999999999999999999999
Q ss_pred cCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeeccc
Q 000706 85 AQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK 163 (1342)
Q Consensus 85 ~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~v 163 (1342)
++++|.+++.+ .+.+++..++.++.||++||.|||++|++||||||+||+++.++.+||+|||+++.............
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 160 (284)
T cd07839 81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEV 160 (284)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCc
Confidence 99999998865 56799999999999999999999999999999999999999999999999999987655444444556
Q ss_pred CCCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCC-CCcHHHHHHHHhcC--------------------CC--
Q 000706 164 GTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFY-TNSVYALIRHIVKD--------------------PV-- 219 (1342)
Q Consensus 164 GTp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~-g~s~~elirkIlr~--------------------~~-- 219 (1342)
+++.|+|||.+.+. .++.++||||||+++|+|++|..||. +.+..+..+.+.+. ..
T Consensus 161 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd07839 161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMY 240 (284)
T ss_pred cccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCC
Confidence 88999999988764 47899999999999999999988864 44444433333210 00
Q ss_pred -------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 220 -------KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 220 -------efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
...+.++++++++|.+||+.||.+|||++++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 241 PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0113467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=363.69 Aligned_cols=254 Identities=28% Similarity=0.503 Sum_probs=219.9
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-e~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
.|++.+.||+|+||.||++.+..+++.||+|.+.+.... ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 599999999999999999999999999999998754322 2223456789999999999999999999999999999999
Q ss_pred ccC-CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 84 FAQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 84 Y~e-GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
|++ |+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++....... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~ 159 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIR 159 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-ccc
Confidence 997 688887754 3469999999999999999999999999999999999999999999999999998764332 223
Q ss_pred cccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHH----HHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 000706 161 SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYA----LIRHIVKDPVKYPDEMSPNFKSFLKGL 236 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~e----lirkIlr~~~efP~eISpeLkDLIrKc 236 (1342)
...|++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.+... ....+......++..+++.+.+|+.+|
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05605 160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL 239 (285)
T ss_pred cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHH
Confidence 4578999999999998889999999999999999999999998765433 233344455667778999999999999
Q ss_pred cccCCCCCC-----CHHHHHcCcCcccc
Q 000706 237 LNKVPQNRL-----TWSALLEHPFVKET 259 (1342)
Q Consensus 237 LqkDPeKRP-----SAeELLeHPFFre~ 259 (1342)
|+.||++|| +++++++||||...
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 240 LTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred ccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 999999999 89999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=348.75 Aligned_cols=252 Identities=34% Similarity=0.557 Sum_probs=226.8
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
+|++.+.||+|+||.||++.+..+++.|++|.+............+.+|++++++++|||++++++.+.+++..|++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 58999999999999999999999999999999976655566677889999999999999999999999999999999999
Q ss_pred cC-CChHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 85 AQ-GELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 85 ~e-GSL~D~Lek~--g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
++ ++|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 96 6899988763 57999999999999999999999999999999999999999999999999999877655444445
Q ss_pred ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHhcccC
Q 000706 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP-VKYPDEMSPNFKSFLKGLLNKV 240 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~-~efP~eISpeLkDLIrKcLqkD 240 (1342)
..|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.....+.+.... ...+..+++++.+++.+||+.+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 240 (256)
T cd08529 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKD 240 (256)
T ss_pred cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCC
Confidence 678999999999999889999999999999999999999999888777777766653 3445578899999999999999
Q ss_pred CCCCCCHHHHHcCcCc
Q 000706 241 PQNRLTWSALLEHPFV 256 (1342)
Q Consensus 241 PeKRPSAeELLeHPFF 256 (1342)
|++||++.++++|||+
T Consensus 241 p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 241 YRQRPDTFQLLRNPSL 256 (256)
T ss_pred cccCcCHHHHhhCCCC
Confidence 9999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=389.02 Aligned_cols=255 Identities=32% Similarity=0.578 Sum_probs=224.9
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-----CCeEE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFES-----PQEFC 79 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfed-----ed~ly 79 (1342)
.|..++.||.|+||.|+.|.++.+|+.||+|++.+.-...-..++..+|++++++++|+||+.+++.+.. -+.+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 4556799999999999999999999999999998666666778899999999999999999999999865 35689
Q ss_pred EEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCC--ce
Q 000706 80 VVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN--TV 157 (1342)
Q Consensus 80 LVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ss--s~ 157 (1342)
+|+|+|+.+|.+.++.+..++++.+..+++|+++||+|+|+.|++||||||.|++++.+..+||+|||+|+..... ..
T Consensus 103 iV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~ 182 (359)
T KOG0660|consen 103 LVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDG 182 (359)
T ss_pred EehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCccc
Confidence 9999999999999999988999999999999999999999999999999999999999999999999999988642 23
Q ss_pred eeecccCCCCcCChhhh-ccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-------------------
Q 000706 158 VLRSIKGTPLYMAPELV-REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD------------------- 217 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL-~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~------------------- 217 (1342)
..+.++.|.||+|||++ ....|+.++||||+|||+.||++|++.|.|.+..++++.|..-
T Consensus 183 ~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~ 262 (359)
T KOG0660|consen 183 FMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARP 262 (359)
T ss_pred chhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHH
Confidence 34678899999999976 4567999999999999999999999999998876666655421
Q ss_pred ----CCCCC--------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 218 ----PVKYP--------DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 218 ----~~efP--------~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
.+..| ++.++.+.+|+.+||..||.+|+|++|+|+|||+...
T Consensus 263 yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 263 YIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 01111 3678999999999999999999999999999999764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=394.59 Aligned_cols=252 Identities=34% Similarity=0.662 Sum_probs=234.0
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~-~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
.+|++.+.||.|+||.|.+|++...|+.||||.|+++. +++.+.-++++||++|..++||||+++|++|++.+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 47999999999999999999999999999999998874 45667789999999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
||.. |+|+||+.+.+.++|.+++.+|+||.+|+.|+|.++++|||||.+|||+|.|+++||+|||++-.+.... ...+
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k-fLqT 211 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK-FLQT 211 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc-HHHH
Confidence 9986 8999999999999999999999999999999999999999999999999999999999999998876554 4578
Q ss_pred ccCCCCcCChhhhccCCCC-CCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccC
Q 000706 162 IKGTPLYMAPELVREQPYN-HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT-~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkD 240 (1342)
+||+|.|.+||++.+.+|. +.+|.||||++||-|+.|..||++.+...++++|.++.+.-|+ -+.++..||+.||.+|
T Consensus 212 FCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIRwmLmVN 290 (668)
T KOG0611|consen 212 FCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIRWMLMVN 290 (668)
T ss_pred hcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHHHHHhcC
Confidence 9999999999999999984 7899999999999999999999999999999999988765554 4567889999999999
Q ss_pred CCCCCCHHHHHcCcCcc
Q 000706 241 PQNRLTWSALLEHPFVK 257 (1342)
Q Consensus 241 PeKRPSAeELLeHPFFr 257 (1342)
|++|.|++++..|=|+.
T Consensus 291 P~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 291 PERRATIEDIASHWWVN 307 (668)
T ss_pred cccchhHHHHhhhheee
Confidence 99999999999998864
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=360.03 Aligned_cols=254 Identities=32% Similarity=0.639 Sum_probs=231.2
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
++|++.+.||+|+||.||++.+..+++.+|+|.+.+... .....+.+.+|++++++++||||+++++++.+++.+|++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 589999999999999999999999999999999876432 2234567889999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
||++ |+|.+++.+.+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~~ 157 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TYT 157 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CCC
Confidence 9994 899999988889999999999999999999999999999999999999999999999999999876544 234
Q ss_pred ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCC
Q 000706 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVP 241 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDP 241 (1342)
..|++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.....+.+......+|..+++.++++|.+||+.||
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 237 (290)
T cd05580 158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDL 237 (290)
T ss_pred CCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCH
Confidence 56899999999998888899999999999999999999999888877777778788888888899999999999999999
Q ss_pred CCCC-----CHHHHHcCcCcccch
Q 000706 242 QNRL-----TWSALLEHPFVKETS 260 (1342)
Q Consensus 242 eKRP-----SAeELLeHPFFre~~ 260 (1342)
.+|+ +++|+++||||+...
T Consensus 238 ~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 238 TKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred HHccCcccCCHHHHHcCcccccCC
Confidence 9999 899999999998754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=392.85 Aligned_cols=262 Identities=31% Similarity=0.540 Sum_probs=235.2
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFC 79 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-e~dierL~rEI~ILKrL~HPNIVKL~dvfeded~ly 79 (1342)
++++.|++++.||+|.-|+||+++.+.++..+|+|++.|.... .+...++..|-+||+.++||.++.+|..|+.++..|
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 4678899999999999999999999999999999999887543 344678889999999999999999999999999999
Q ss_pred EEEeccC-CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccC--
Q 000706 80 VVTEFAQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA-- 154 (1342)
Q Consensus 80 LVMEY~e-GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~s-- 154 (1342)
++||||+ |+|..+.++ ++.|+++.++.|+.+++.||+|||-.||++||||||||||.++|++.|.||.++.....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 9999997 788888765 56899999999999999999999999999999999999999999999999999853210
Q ss_pred -------------------------------C-c----------------------eeeecccCCCCcCChhhhccCCCC
Q 000706 155 -------------------------------N-T----------------------VVLRSIKGTPLYMAPELVREQPYN 180 (1342)
Q Consensus 155 -------------------------------s-s----------------------~~~~s~vGTp~YmAPEvL~g~~YT 180 (1342)
. . .....++||-.|.|||++++...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 011236799999999999999999
Q ss_pred CCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHhcccCCCCCCC----HHHHHcCc
Q 000706 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPD--EMSPNFKSFLKGLLNKVPQNRLT----WSALLEHP 254 (1342)
Q Consensus 181 ~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~--eISpeLkDLIrKcLqkDPeKRPS----AeELLeHP 254 (1342)
.++|+|+||+.+|||+.|..||.+.+..+...+|+..+..||+ .++..++|||+++|.+||++|.. +.||.+||
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHP 393 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCc
Confidence 9999999999999999999999999999999999999998885 46889999999999999999998 99999999
Q ss_pred Ccccchhh
Q 000706 255 FVKETSDE 262 (1342)
Q Consensus 255 FFre~~~e 262 (1342)
||+.....
T Consensus 394 FF~gVnWa 401 (459)
T KOG0610|consen 394 FFEGVNWA 401 (459)
T ss_pred cccCCChh
Confidence 99987543
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=376.71 Aligned_cols=253 Identities=32% Similarity=0.553 Sum_probs=212.8
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
.+++|+.++.||+|+||.||++++..+++.||+|++.... .......+.+|+++++.++|+||+++++++.+++.+|+|
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 3578999999999999999999999999999999986543 334456788999999999999999999999999999999
Q ss_pred EeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 82 TEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
|||++ |+|.+ ....++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 151 ~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 226 (353)
T PLN00034 151 LEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN 226 (353)
T ss_pred EecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccccc
Confidence 99998 45543 23467888999999999999999999999999999999999999999999999987654433344
Q ss_pred cccCCCCcCChhhhcc-----CCCCCCCcccchhhHHHHHHhCCCCCCCCcH---HHHHHHH-hcCCCCCCCCCCHHHHH
Q 000706 161 SIKGTPLYMAPELVRE-----QPYNHTADLWSLGVILYELFVGQPPFYTNSV---YALIRHI-VKDPVKYPDEMSPNFKS 231 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g-----~~YT~KsDIWSLGVILYELLTGr~PF~g~s~---~elirkI-lr~~~efP~eISpeLkD 231 (1342)
...||..|+|||.+.. ..++.++|||||||++|||++|+.||..... ......+ .......+..+++++++
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 306 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRH 306 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHH
Confidence 5679999999998743 2345689999999999999999999974332 2222222 23344566788999999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 232 FLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 232 LIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
||.+||+.||++|||+.|+++||||...
T Consensus 307 li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 307 FISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHccCChhhCcCHHHHhcCcccccC
Confidence 9999999999999999999999999863
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=353.73 Aligned_cols=253 Identities=33% Similarity=0.574 Sum_probs=213.4
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
++|++.+.||+|+||.||+|.++.+++.|++|.+.+........+.+.+|++++++++|||++++++++.++...+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 58999999999999999999999999999999987554333334567889999999999999999999999999999999
Q ss_pred ccCCChHH-HHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 84 FAQGELFE-ILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 Y~eGSL~D-~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
|+++.+.+ ++.....+++..++.++.|++.+|.|||++|++||||||+||+++.++.+||+|||++.............
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY 160 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCc
Confidence 99976555 44556679999999999999999999999999999999999999999999999999998776544333445
Q ss_pred cCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-------------------CCCC-
Q 000706 163 KGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-------------------PVKY- 221 (1342)
Q Consensus 163 vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~-------------------~~ef- 221 (1342)
.++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..+....+... ....
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07847 161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIP 240 (286)
T ss_pred ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCC
Confidence 68899999998876 55889999999999999999999999876654433322110 0000
Q ss_pred -----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 222 -----------PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 222 -----------P~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
.+.++..+.+|+.+||+.||++||++.|++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 241 EPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 12467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=391.89 Aligned_cols=251 Identities=25% Similarity=0.444 Sum_probs=206.5
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCC------CCcceEEEEEEeC-
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH------QNIIEMLDSFESP- 75 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~H------PNIVKL~dvfede- 75 (1342)
.++|++.+.||+|+||+||+|.+..+++.||||+++... ........|+++++.++| +++++++++|..+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 368999999999999999999999999999999986432 222345667777777654 4588999988754
Q ss_pred CeEEEEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCcEEEcCCC---------------
Q 000706 76 QEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS-NRIIHRDMKPQNILIGAGS--------------- 139 (1342)
Q Consensus 76 d~lyLVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHs-rGIVHRDLKPENILLdsdG--------------- 139 (1342)
.++|+|||+++++|.+++.+.+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 205 ~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 205 GHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred ceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 578999999999999999888899999999999999999999997 5999999999999998765
Q ss_pred -cEEEeeccccccccCCceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC
Q 000706 140 -VVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP 218 (1342)
Q Consensus 140 -~LKLiDFGLAr~l~sss~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~ 218 (1342)
.+||+|||.+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+....
T Consensus 285 ~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 361 (467)
T PTZ00284 285 CRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL 361 (467)
T ss_pred ceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence 499999998864332 2235679999999999999999999999999999999999999998876554433322110
Q ss_pred CCCC-----------------------------------------C-CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 219 VKYP-----------------------------------------D-EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 219 ~efP-----------------------------------------~-eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
..+| . ..++.+.+||.+||++||++|||++|+++||||
T Consensus 362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~ 441 (467)
T PTZ00284 362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV 441 (467)
T ss_pred CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccc
Confidence 0000 0 013567899999999999999999999999999
Q ss_pred ccc
Q 000706 257 KET 259 (1342)
Q Consensus 257 re~ 259 (1342)
+..
T Consensus 442 ~~~ 444 (467)
T PTZ00284 442 LKY 444 (467)
T ss_pred ccc
Confidence 864
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=374.29 Aligned_cols=253 Identities=31% Similarity=0.519 Sum_probs=213.4
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP------Q 76 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede------d 76 (1342)
.++|++++.||+|+||.||+|.+..+++.||+|.+.+........+.+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 4789999999999999999999999999999999876543334456678899999999999999999988543 4
Q ss_pred eEEEEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 77 EFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 77 ~lyLVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
..|++||+++++|.+++. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 94 ~~~~~~~~~~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 171 (343)
T cd07878 94 EVYLVTNLMGADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE- 171 (343)
T ss_pred cEEEEeecCCCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC-
Confidence 579999999999988765 456999999999999999999999999999999999999999999999999999876543
Q ss_pred eeeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC------------------
Q 000706 157 VVLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD------------------ 217 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~------------------ 217 (1342)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 172 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07878 172 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR 249 (343)
T ss_pred --cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHH
Confidence 234579999999999876 56899999999999999999999999876654444433211
Q ss_pred -----CCCCC--------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 218 -----PVKYP--------DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 218 -----~~efP--------~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
....+ ...++.+.+||.+||+.||.+|||+.|+++||||.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 00011 2356778999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=378.11 Aligned_cols=258 Identities=29% Similarity=0.550 Sum_probs=221.6
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFC 79 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~ly 79 (1342)
+..++|++.+.||+|+||.||+++++.+++.||+|++.+... .......+.+|+.+++.++||||+++++.+.+++..|
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 356899999999999999999999999999999999875322 2233456788999999999999999999999999999
Q ss_pred EEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce-
Q 000706 80 VVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV- 157 (1342)
Q Consensus 80 LVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~- 157 (1342)
+||||++ |+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus 120 lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence 9999997 688888765 4589999999999999999999999999999999999999999999999999987654322
Q ss_pred eeecccCCCCcCChhhhccCC----CCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC--CCCC--CCCCHHH
Q 000706 158 VLRSIKGTPLYMAPELVREQP----YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP--VKYP--DEMSPNF 229 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g~~----YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~--~efP--~eISpeL 229 (1342)
......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+.... ..+| ..+++++
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 278 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHH
Confidence 233567999999999987543 7899999999999999999999999988887777776542 3344 3689999
Q ss_pred HHHHHHhcccCCCC--CCCHHHHHcCcCcccc
Q 000706 230 KSFLKGLLNKVPQN--RLTWSALLEHPFVKET 259 (1342)
Q Consensus 230 kDLIrKcLqkDPeK--RPSAeELLeHPFFre~ 259 (1342)
+++|.+||+.++.+ |++++|+++||||++.
T Consensus 279 ~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 279 KNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 99999999854443 7899999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=391.65 Aligned_cols=249 Identities=33% Similarity=0.536 Sum_probs=209.2
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--------
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP-------- 75 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede-------- 75 (1342)
++|++++.||+|+||.||+|.+..+++.||+|.+.+.. ....+|+.+++.++||||++++++|...
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 57999999999999999999999999999999886442 2334699999999999999999887432
Q ss_pred CeEEEEEeccCCChHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC-cEEEeeccccc
Q 000706 76 QEFCVVTEFAQGELFEILE----DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS-VVKLCDFGFAR 150 (1342)
Q Consensus 76 d~lyLVMEY~eGSL~D~Le----k~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG-~LKLiDFGLAr 150 (1342)
..+++||||++|++.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 140 ~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 140 IFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred eEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 2478999999999888765 356799999999999999999999999999999999999999765 79999999998
Q ss_pred cccCCceeeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC------------
Q 000706 151 AMSANTVVLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD------------ 217 (1342)
Q Consensus 151 ~l~sss~~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~------------ 217 (1342)
.+..... .....||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+.++...
T Consensus 220 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 220 NLLAGQR-SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred hccCCCC-cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 7654332 234578999999998865 46899999999999999999999999987665554444321
Q ss_pred -----CC------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 218 -----PV------------KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 218 -----~~------------efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
.. .+|...++++.+||.+||++||.+|||+.|+++||||++.
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 00 1234567899999999999999999999999999999764
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=384.98 Aligned_cols=259 Identities=34% Similarity=0.570 Sum_probs=228.0
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEeCC------
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN-IIEMLDSFESPQ------ 76 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPN-IVKL~dvfeded------ 76 (1342)
+.|+.+++||+|+||+||+|+++.+|+.||+|+++-....+..-....+|+.+++.++|+| |+.+++++.+++
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4577788899999999999999999999999999766443333456788999999999999 999999998777
Q ss_pred eEEEEEeccCCChHHHHhcCC----CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 000706 77 EFCVVTEFAQGELFEILEDDK----CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM 152 (1342)
Q Consensus 77 ~lyLVMEY~eGSL~D~Lek~g----~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l 152 (1342)
.+++||||++-+|.+++...+ .++...++.+++||+.||+|||++||+||||||+||+|+++|.+||+|||+|+..
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 899999999999999998754 6888999999999999999999999999999999999999999999999999988
Q ss_pred cCCceeeecccCCCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC-------------
Q 000706 153 SANTVVLRSIKGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP------------- 218 (1342)
Q Consensus 153 ~sss~~~~s~vGTp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~------------- 218 (1342)
.-+...+...++|.||+|||++.+. .|+..+||||+|||++||+++++.|.+..+.++..+|++-.
T Consensus 171 ~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~ 250 (323)
T KOG0594|consen 171 SIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSS 250 (323)
T ss_pred cCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccc
Confidence 8676677888899999999998876 69999999999999999999999999999999988887410
Q ss_pred -----CCCC------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccchhh
Q 000706 219 -----VKYP------------DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDE 262 (1342)
Q Consensus 219 -----~efP------------~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~~e 262 (1342)
..++ +..+++..+++.+||+.+|.+|.|+..+++||||.+....
T Consensus 251 ~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 251 LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 0111 1223588899999999999999999999999999986543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=375.35 Aligned_cols=255 Identities=35% Similarity=0.624 Sum_probs=238.1
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHH-HHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEK-DIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~-dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
.+++|++++.||+|.||.||.|+.+.++-.+|+|++.|...... ...++++|+++...++||||+++|++|.++..+|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 47899999999999999999999999999999999977643222 24679999999999999999999999999999999
Q ss_pred EEeccC-CChHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce
Q 000706 81 VTEFAQ-GELFEILE--DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 81 VMEY~e-GSL~D~Le--k~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~ 157 (1342)
++||.. |+++..+. ..++++|...+.|+.|++.||.|+|.++++||||||+|+|++.+|.+||+|||.+.....+
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~-- 177 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN-- 177 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC--
Confidence 999986 99999998 6778999999999999999999999999999999999999999999999999999776533
Q ss_pred eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhc
Q 000706 158 VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLL 237 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcL 237 (1342)
...+.|||..|.+||...+..++..+|+|++|++.||++.|.+||......+.+++|.+....+|..++.+++|+|.+||
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ll 257 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRLL 257 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHHh
Confidence 34678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCHHHHHcCcCccc
Q 000706 238 NKVPQNRLTWSALLEHPFVKE 258 (1342)
Q Consensus 238 qkDPeKRPSAeELLeHPFFre 258 (1342)
.++|.+|.+..|+++|||+..
T Consensus 258 ~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 258 VKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ccCccccccHHHHhhhHHHHh
Confidence 999999999999999999864
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=370.40 Aligned_cols=256 Identities=28% Similarity=0.515 Sum_probs=218.6
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
.-++|++.+.||+|+||.||++.+..+++.+|+|.+.... .......+.+|++++++++||||+++++++.+++.+|+|
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 5689999999999999999999999999999999887643 334456788999999999999999999999999999999
Q ss_pred EeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC-CceecCCCCCcEEEcCCCcEEEeeccccccccCCceee
Q 000706 82 TEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN-RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsr-GIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~ 159 (1342)
|||++ |+|.+++.+.+.+++..++.++.|++.||.|||++ +++||||||+|||++.+|.+||+|||++...... ..
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~ 159 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MA 159 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--cc
Confidence 99997 68999999888899999999999999999999975 7999999999999999999999999999765432 22
Q ss_pred ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHH-------------------------
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHI------------------------- 214 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkI------------------------- 214 (1342)
....|++.|+|||++.+..++.++|+|||||++|+|++|+.||......+....+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS 239 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence 3456899999999999988999999999999999999999999765443222111
Q ss_pred -------------------hcC-CCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 215 -------------------VKD-PVKYP-DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 215 -------------------lr~-~~efP-~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
... +..++ ..+++++++||.+||++||++|||+.|+++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 111 11111 13578899999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=345.52 Aligned_cols=252 Identities=30% Similarity=0.600 Sum_probs=224.4
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
+|++.+.||+|+||.+|++.+..+++.|++|.+............+.+|++++++++||||+++++++++.+..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 69999999999999999999999999999999976544455557889999999999999999999999999999999999
Q ss_pred cC-CChHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 85 AQ-GELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 85 ~e-GSL~D~Lek~--g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
+. ++|.+++... ..+++..++.++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++............
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 97 6899988653 36899999999999999999999999999999999999999999999999999876554333334
Q ss_pred ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHhcccC
Q 000706 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP-VKYPDEMSPNFKSFLKGLLNKV 240 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~-~efP~eISpeLkDLIrKcLqkD 240 (1342)
..|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..+. ...+..++.++.++|.+||+.+
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 240 (256)
T cd08218 161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRN 240 (256)
T ss_pred ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCC
Confidence 568999999999998889999999999999999999999998887777776665543 3466778999999999999999
Q ss_pred CCCCCCHHHHHcCcCc
Q 000706 241 PQNRLTWSALLEHPFV 256 (1342)
Q Consensus 241 PeKRPSAeELLeHPFF 256 (1342)
|.+||++.++++||||
T Consensus 241 p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 241 PRDRPSVNSILEKNFI 256 (256)
T ss_pred hhhCcCHHHHhhCcCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=389.40 Aligned_cols=258 Identities=34% Similarity=0.622 Sum_probs=242.2
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-EEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQE-FCV 80 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~-lyL 80 (1342)
-+++|..++++|+|+||.++.++++.+++.|++|.+.-....+...+...+|+.+++++.|||||.+++.|++++. .+|
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 4789999999999999999999999999999999998887777777789999999999999999999999998888 999
Q ss_pred EEeccC-CChHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce
Q 000706 81 VTEFAQ-GELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~--g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~ 157 (1342)
||+|++ |++.+.|.+. ..|+|+.+..|+.|++.|+.|||+++|+|||||+.|||++.++.+||+|||+|+.++....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 999998 6899988653 5799999999999999999999999999999999999999999999999999999988776
Q ss_pred eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHh
Q 000706 158 VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP-VKYPDEMSPNFKSFLKGL 236 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~-~efP~eISpeLkDLIrKc 236 (1342)
...+.+|||.|+.||++.+.+|+.|+|||||||++|||++-+++|...+...++.+|.+.. .+.|..++.+++.+|+.|
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~ 241 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSM 241 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHH
Confidence 6678899999999999999999999999999999999999999999999999999999887 678889999999999999
Q ss_pred cccCCCCCCCHHHHHcCcCcccc
Q 000706 237 LNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 237 LqkDPeKRPSAeELLeHPFFre~ 259 (1342)
|..+|+.||++.++|.+|.+...
T Consensus 242 l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 242 LRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred hhcCCccCCCHHHHhhChhhhhH
Confidence 99999999999999999877643
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.12 Aligned_cols=252 Identities=36% Similarity=0.631 Sum_probs=224.5
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEE--eCCeEEEEE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFE--SPQEFCVVT 82 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfe--ded~lyLVM 82 (1342)
+|++.+.||.|+||.||++.+..+++.+++|.+..........+++.+|++++++++||||+++++.+. .+...|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 699999999999999999999999999999999876666667778999999999999999999999875 345689999
Q ss_pred eccC-CChHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhh-----hCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 000706 83 EFAQ-GELFEILED----DKCLPEEQVQSIAKQLVRALHYLH-----SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM 152 (1342)
Q Consensus 83 EY~e-GSL~D~Lek----~g~LSEeeI~~I~~QLLsALaYLH-----srGIVHRDLKPENILLdsdG~LKLiDFGLAr~l 152 (1342)
||++ ++|.+++.+ ..++++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9997 688888865 467999999999999999999999 899999999999999999999999999999887
Q ss_pred cCCceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCHHHHH
Q 000706 153 SANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV-KYPDEMSPNFKS 231 (1342)
Q Consensus 153 ~sss~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~-efP~eISpeLkD 231 (1342)
...........|++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.....+.+..... .++..++.++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNE 240 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 6555434556789999999999988899999999999999999999999998876666666665543 466788999999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 232 FLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 232 LIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
++.+||+.+|++||++.++++|||+
T Consensus 241 l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 241 VIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHccCCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=360.75 Aligned_cols=258 Identities=30% Similarity=0.481 Sum_probs=218.2
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP--QEFC 79 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede--d~ly 79 (1342)
.+++|++.+.||+|+||.||+|.+..+|+.||+|.++.............+|++++++++|+|++++++++.+. +.+|
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 47899999999999999999999999999999999875533332233456799999999999999999999755 5689
Q ss_pred EEEeccCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 80 VVTEFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 80 LVMEY~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
+||||++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 164 (309)
T cd07845 85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164 (309)
T ss_pred EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence 9999999999988875 467999999999999999999999999999999999999999999999999999877654333
Q ss_pred eecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-------------------C
Q 000706 159 LRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-------------------P 218 (1342)
Q Consensus 159 ~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~-------------------~ 218 (1342)
.....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|++||...+..+....+... .
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence 334456888999998865 55889999999999999999999999988776666554331 0
Q ss_pred CCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 219 VKYP-----------DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 219 ~efP-----------~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
...+ ...++++.++|.+||+.||++|||+.|+++||||++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 0111 1257889999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=381.99 Aligned_cols=249 Identities=32% Similarity=0.608 Sum_probs=220.0
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcE-EEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-eEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQT-VAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ-EFC 79 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~-VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded-~ly 79 (1342)
+.++..+.+.||+|+||+||++..+ |+. ||+|.+..........+.+.+|+.+|.+++|||||++++++.++. ...
T Consensus 39 ~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 39 DPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred ChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 4456677788999999999999765 666 999999877666665789999999999999999999999999888 799
Q ss_pred EEEeccC-CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC-ceecCCCCCcEEEcCCC-cEEEeeccccccccC
Q 000706 80 VVTEFAQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNR-IIHRDMKPQNILIGAGS-VVKLCDFGFARAMSA 154 (1342)
Q Consensus 80 LVMEY~e-GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrG-IVHRDLKPENILLdsdG-~LKLiDFGLAr~l~s 154 (1342)
+||||++ |+|.+++.+ .+.++...+..++.||++|+.|||+++ |+||||||+|||++.++ ++||+|||+++....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 9999997 899999977 678999999999999999999999999 99999999999999998 999999999987765
Q ss_pred CceeeecccCCCCcCChhhhc--cCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHh--cCCCCCCCCCCHHHH
Q 000706 155 NTVVLRSIKGTPLYMAPELVR--EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIV--KDPVKYPDEMSPNFK 230 (1342)
Q Consensus 155 ss~~~~s~vGTp~YmAPEvL~--g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIl--r~~~efP~eISpeLk 230 (1342)
.....+...||+.|||||+++ ...|+.++||||||+++|||+||+.||.+....+....+. ..++.+|...++.+.
T Consensus 197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~ 276 (362)
T KOG0192|consen 197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLS 276 (362)
T ss_pred ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 433334467999999999999 6689999999999999999999999999988766555554 335667788999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHc
Q 000706 231 SFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 231 DLIrKcLqkDPeKRPSAeELLe 252 (1342)
.++..||..||.+||++.+++.
T Consensus 277 ~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 277 SLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHhCCCCCCcCCCHHHHHH
Confidence 9999999999999999999865
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=353.81 Aligned_cols=252 Identities=33% Similarity=0.553 Sum_probs=215.0
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
+|++.+.||.|+||.||+|++..+++.|++|.+............+.+|++++++++||||+++++++.+++..|++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 59999999999999999999999999999999876544444446788899999999999999999999999999999999
Q ss_pred cCCChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 85 AQGELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 85 ~eGSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
++++|.+++.. ...+++..++.++.|++.||+|||++|++||||+|+||+++.++.+||+|||++.............
T Consensus 81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (284)
T cd07860 81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 160 (284)
T ss_pred cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccc
Confidence 99999998865 4568999999999999999999999999999999999999999999999999998765443333445
Q ss_pred cCCCCcCChhhhccCC-CCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC---CC-------------------
Q 000706 163 KGTPLYMAPELVREQP-YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PV------------------- 219 (1342)
Q Consensus 163 vGTp~YmAPEvL~g~~-YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~---~~------------------- 219 (1342)
.+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+..+...++... +.
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd07860 161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK 240 (284)
T ss_pred cccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhccc
Confidence 6789999999887644 688999999999999999999999877654443332211 00
Q ss_pred -------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 220 -------KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 220 -------efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
...+.++++++++|.+||+.||.+|||++++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 241 WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred ccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0113467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=342.31 Aligned_cols=252 Identities=31% Similarity=0.528 Sum_probs=226.3
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
+|++++.||.|+||.||.+++..+++.+++|.+...........++.+|++++++++|+||+++++++.+++..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 69999999999999999999999999999999877655566667888999999999999999999999999999999999
Q ss_pred cC-CChHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 85 AQ-GELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 85 ~e-GSL~D~Lek~--g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
++ |+|.+++.+. ..+++..+..++.|++.+|.|||+.|++||||||+||+++.++.+||+|||++............
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 97 6899998764 56899999999999999999999999999999999999999999999999999876554434445
Q ss_pred ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHhcccC
Q 000706 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV-KYPDEMSPNFKSFLKGLLNKV 240 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~-efP~eISpeLkDLIrKcLqkD 240 (1342)
..|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+..... ..+..++.++.+++.+||+.|
T Consensus 161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 240 (256)
T cd08221 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQD 240 (256)
T ss_pred cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccC
Confidence 6789999999999888899999999999999999999999998887777777665533 334567899999999999999
Q ss_pred CCCCCCHHHHHcCcCc
Q 000706 241 PQNRLTWSALLEHPFV 256 (1342)
Q Consensus 241 PeKRPSAeELLeHPFF 256 (1342)
|.+||++.++++|||+
T Consensus 241 p~~R~s~~~ll~~~~l 256 (256)
T cd08221 241 PEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCCCHHHHhhCcCC
Confidence 9999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=352.67 Aligned_cols=257 Identities=37% Similarity=0.646 Sum_probs=223.0
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
-++|++.+.||.|+||.||++.+..+++.+++|.+... .....+.+.+|++++++++||||+++++.+.++...|+||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 47899999999999999999999889999999998644 3445567888999999999999999999999999999999
Q ss_pred eccC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 83 EFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 83 EY~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
||++ |+|.+++.+ .+.+++..++.++.|++.+|.|||++|++||||||+||+++.++.+||+|||++...........
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence 9998 578888766 45799999999999999999999999999999999999999999999999999876554433344
Q ss_pred cccCCCCcCChhhhc-----cCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC---CCCCCCCCHHHHHH
Q 000706 161 SIKGTPLYMAPELVR-----EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP---VKYPDEMSPNFKSF 232 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~-----g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~---~efP~eISpeLkDL 232 (1342)
...|++.|++||.+. ...++.++|+||||+++|+|++|+.||...+.......+.... ...+..++.++.++
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDF 241 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHH
Confidence 556899999999874 3457789999999999999999999998877666665555542 23356788999999
Q ss_pred HHHhcccCCCCCCCHHHHHcCcCcccchh
Q 000706 233 LKGLLNKVPQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 233 IrKcLqkDPeKRPSAeELLeHPFFre~~~ 261 (1342)
|.+||+.||.+||++.++++||||.+..+
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (280)
T cd06611 242 LKSCLVKDPDDRPTAAELLKHPFVSDQSD 270 (280)
T ss_pred HHHHhccChhhCcCHHHHhcChhhcccch
Confidence 99999999999999999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=343.39 Aligned_cols=250 Identities=35% Similarity=0.601 Sum_probs=217.7
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
++|++.+.||.|+||.||+|.+..+++.+++|.+..... ...+.+.+|++++++++||||+++++.+.+++.+|++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 689999999999999999999999999999999975532 245788999999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 84 FAQ-GELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
|++ ++|.+++.+. .++++..++.++.|++.+|.|||++|++||||||+||+++.++.+||+|||++............
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 998 5788888765 78999999999999999999999999999999999999999999999999999876544333345
Q ss_pred ccCCCCcCChhhhccC---CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-----CCCCCCCHHHHHHH
Q 000706 162 IKGTPLYMAPELVREQ---PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV-----KYPDEMSPNFKSFL 233 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~---~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~-----efP~eISpeLkDLI 233 (1342)
..++..|++||.+.+. .++.++|+||||+++|+|++|+.||...+.......+..... ..+..++.++.+++
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFI 240 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHH
Confidence 6789999999998776 789999999999999999999999987765554444433311 22345678899999
Q ss_pred HHhcccCCCCCCCHHHHHcCcC
Q 000706 234 KGLLNKVPQNRLTWSALLEHPF 255 (1342)
Q Consensus 234 rKcLqkDPeKRPSAeELLeHPF 255 (1342)
++||..||.+|||+.+++.|+|
T Consensus 241 ~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 241 KKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHcCCChhhCCCHHHHhcCCC
Confidence 9999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.35 Aligned_cols=252 Identities=31% Similarity=0.579 Sum_probs=219.8
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCH-------HHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE-------KDIHNLRQEIEILRKLKHQNIIEMLDSFESPQE 77 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se-------~dierL~rEI~ILKrL~HPNIVKL~dvfeded~ 77 (1342)
+|.+.+.||.|+||.||+|.+..+++.|++|.+....... ...+.+.+|++++++++||||+++++++.+++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5889999999999999999999899999999886543221 223568889999999999999999999999999
Q ss_pred EEEEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 78 FCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 78 lyLVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
.+++|||++ ++|.+++.+.+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 999999997 5899999888889999999999999999999999999999999999999999999999999998765321
Q ss_pred e------eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHH
Q 000706 157 V------VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNF 229 (1342)
Q Consensus 157 ~------~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~-~~efP~eISpeL 229 (1342)
. ......|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+.......+... ....+..++.++
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEA 240 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHH
Confidence 1 112345889999999999888999999999999999999999999887665555554443 445667889999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 230 KSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 230 kDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
.++|++||+.||++||++.|+++||||
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 241 IDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=389.58 Aligned_cols=260 Identities=30% Similarity=0.531 Sum_probs=228.8
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-----
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ----- 76 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded----- 76 (1342)
..++|++.+.||+|+||+||+|.+..+++.||+|.+............+.+|+..+..++|+|++++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 357999999999999999999999999999999999877666777778899999999999999999998775332
Q ss_pred ---eEEEEEeccC-CChHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccc
Q 000706 77 ---EFCVVTEFAQ-GELFEILED----DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGF 148 (1342)
Q Consensus 77 ---~lyLVMEY~e-GSL~D~Lek----~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGL 148 (1342)
.+++||||++ |+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 3789999997 799998864 35799999999999999999999999999999999999999999999999999
Q ss_pred cccccCC--ceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC-CCCCCCC
Q 000706 149 ARAMSAN--TVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP-VKYPDEM 225 (1342)
Q Consensus 149 Ar~l~ss--s~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~-~efP~eI 225 (1342)
++.+... ........||+.|+|||++.+..|+.++||||||+++|||++|+.||.+.+..+....+.... ..+|+.+
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 269 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSI 269 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Confidence 9876432 122345679999999999999999999999999999999999999999988877777766543 3567889
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccchh
Q 000706 226 SPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 226 SpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~~ 261 (1342)
++++.+++.+||+.||.+||++.++++|||++....
T Consensus 270 ~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~ 305 (496)
T PTZ00283 270 SPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS 305 (496)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhh
Confidence 999999999999999999999999999999876443
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=350.82 Aligned_cols=251 Identities=33% Similarity=0.566 Sum_probs=214.7
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
.++|++.+.||+|+||.||+|.+..+++.|++|.++.... .....+.+|+.+++.++||||+++++.+.+++..|++|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 3688999999999999999999999999999999865532 33456788999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
||++ |+|.+++...+.+++.+++.++.|++.+|.|||++|++||||||+||+++.++.+||+|||++............
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06645 86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS 165 (267)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccccc
Confidence 9997 689999988889999999999999999999999999999999999999999999999999998766544333345
Q ss_pred ccCCCCcCChhhhc---cCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC---C--CCCCCHHHHHHH
Q 000706 162 IKGTPLYMAPELVR---EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVK---Y--PDEMSPNFKSFL 233 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~---g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~e---f--P~eISpeLkDLI 233 (1342)
..|++.|+|||.+. ...++.++|+||||+++|+|++|+.||.................. . ...++..+.++|
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFV 245 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHH
Confidence 67999999999874 456889999999999999999999999765543333332222211 1 124678999999
Q ss_pred HHhcccCCCCCCCHHHHHcCcC
Q 000706 234 KGLLNKVPQNRLTWSALLEHPF 255 (1342)
Q Consensus 234 rKcLqkDPeKRPSAeELLeHPF 255 (1342)
.+||+.||++||+++++++|||
T Consensus 246 ~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 246 KMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHccCCchhCcCHHHHhcCCC
Confidence 9999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=349.07 Aligned_cols=251 Identities=33% Similarity=0.541 Sum_probs=213.8
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
.++|++.+.||+|+||.||+|++..+++.|++|++..... .....+.+|+.++++++||||+++++.+..++.+|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 4689999999999999999999999999999999865432 23356788999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
||++ |+|.+++.+.+++++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++............
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS 165 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCc
Confidence 9998 689999888888999999999999999999999999999999999999999999999999999876543333344
Q ss_pred ccCCCCcCChhhhc---cCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-----CCCCCCHHHHHHH
Q 000706 162 IKGTPLYMAPELVR---EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVK-----YPDEMSPNFKSFL 233 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~---g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~e-----fP~eISpeLkDLI 233 (1342)
..|++.|+|||.+. ...++.++|+||+|+++|+|++|+.||......+....+...... .+..++..+.+||
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFV 245 (267)
T ss_pred cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHH
Confidence 56899999999874 445788999999999999999999999765543333222222111 1235688999999
Q ss_pred HHhcccCCCCCCCHHHHHcCcC
Q 000706 234 KGLLNKVPQNRLTWSALLEHPF 255 (1342)
Q Consensus 234 rKcLqkDPeKRPSAeELLeHPF 255 (1342)
++||+.||++||+++++++|+|
T Consensus 246 ~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 246 KISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHhhCChhhCcCHHHHhcCCC
Confidence 9999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=354.43 Aligned_cols=258 Identities=31% Similarity=0.514 Sum_probs=218.5
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
+++|++.+.||+|++|.||++.++.+++.|++|.+..........+.+.+|++++++++||||+++++++.+++.+|+||
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999998765444444467888999999999999999999999999999999
Q ss_pred eccCCChHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcC-CCcEEEeeccccccccCCceee
Q 000706 83 EFAQGELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA-GSVVKLCDFGFARAMSANTVVL 159 (1342)
Q Consensus 83 EY~eGSL~D~Lek~g--~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLds-dG~LKLiDFGLAr~l~sss~~~ 159 (1342)
||++++|.+.+.... .+++..++.++.||+.||+|||++|++||||||+||+++. ++.+||+|||++..........
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 999999999886543 3688999999999999999999999999999999999985 5579999999997665443333
Q ss_pred ecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC---CC----------------
Q 000706 160 RSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PV---------------- 219 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~---~~---------------- 219 (1342)
....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|++||...+..+...++... +.
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA 240 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence 44567899999998866 45789999999999999999999999887665555544321 00
Q ss_pred --C--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 220 --K--------YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 220 --e--------fP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
. ..+.+++++.++|.+||+.||++||++.++++||||++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 0 1235688999999999999999999999999999998753
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=359.36 Aligned_cols=244 Identities=32% Similarity=0.528 Sum_probs=196.1
Q ss_pred EEEEcccCcEEEEEEEEc--cCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEEEEec
Q 000706 9 IELVGEGSFGKVYKGRRK--YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFES--PQEFCVVTEF 84 (1342)
Q Consensus 9 lK~LGsGgFGtVYKArDk--~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfed--ed~lyLVMEY 84 (1342)
.++||+|+||.||+|+++ .+++.||+|.+...... ....+|++++++++||||+++++.+.+ +..+|++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999865 46789999998655332 346789999999999999999999854 5678999999
Q ss_pred cCCChHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEE----cCCCcEEEeecccccc
Q 000706 85 AQGELFEILED---------DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILI----GAGSVVKLCDFGFARA 151 (1342)
Q Consensus 85 ~eGSL~D~Lek---------~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILL----dsdG~LKLiDFGLAr~ 151 (1342)
++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 99999988753 1258999999999999999999999999999999999999 4567899999999987
Q ss_pred ccCCce---eeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcH---------HHHHHHHhcC-
Q 000706 152 MSANTV---VLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSV---------YALIRHIVKD- 217 (1342)
Q Consensus 152 l~sss~---~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~---------~elirkIlr~- 217 (1342)
...... ......||+.|+|||++.+ ..|+.++||||+||++|+|++|++||..... ......+...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 654321 2234678999999999876 4589999999999999999999999964321 1111111110
Q ss_pred --C-------------------------CC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 218 --P-------------------------VK----------YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 218 --~-------------------------~e----------fP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
+ .. .....+.++.+||++||+.||++|||++|+++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 00 001234678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=342.07 Aligned_cols=252 Identities=29% Similarity=0.538 Sum_probs=218.3
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
++|++.+.||.|+||+||+|....+++.+++|++....... ....+.+|+++++.++|+|++++++.+.+++..|++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 58999999999999999999998899999999987554433 56788999999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee-
Q 000706 84 FAQ-GELFEILEDD---KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV- 158 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~---g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~- 158 (1342)
|++ ++|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||++++++.+||+|||++..+......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 997 6788888763 46999999999999999999999999999999999999999999999999999776544322
Q ss_pred ---eecccCCCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC-CCCC-----CCCCHH
Q 000706 159 ---LRSIKGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP-VKYP-----DEMSPN 228 (1342)
Q Consensus 159 ---~~s~vGTp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~-~efP-----~eISpe 228 (1342)
.....|++.|++||.+... .++.++|+||||+++|+|++|+.||...+......+..... ..++ ..++++
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS 239 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHH
Confidence 2334689999999988776 78999999999999999999999998776655555544432 2222 256789
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 229 FKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 229 LkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
+.+++.+||+.||++||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 240 FRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=350.31 Aligned_cols=257 Identities=33% Similarity=0.586 Sum_probs=225.2
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
++|++.+.||.|+||.||+|.+..+++.|++|.+.... .......+.+|+++++.++|||++++++++.++...|+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 58999999999999999999999999999999987553 23344678899999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 84 FAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
|++ ++|.+++... ++++..++.++.|++.+|.|||++|++||||+|+||++++++.++|+|||+++............
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF 158 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccc
Confidence 997 6898888765 89999999999999999999999999999999999999999999999999998876554344456
Q ss_pred cCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-CCCCCCC-CCHHHHHHHHHhcccC
Q 000706 163 KGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-PVKYPDE-MSPNFKSFLKGLLNKV 240 (1342)
Q Consensus 163 vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~-~~efP~e-ISpeLkDLIrKcLqkD 240 (1342)
.|++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+... ....+.. +++++.+++.+||..|
T Consensus 159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~ 238 (274)
T cd06609 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKD 238 (274)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCC
Confidence 7899999999999888999999999999999999999999876655555444443 3334444 7899999999999999
Q ss_pred CCCCCCHHHHHcCcCcccchhh
Q 000706 241 PQNRLTWSALLEHPFVKETSDE 262 (1342)
Q Consensus 241 PeKRPSAeELLeHPFFre~~~e 262 (1342)
|++|||++++++||||++..+.
T Consensus 239 p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 239 PKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred hhhCcCHHHHhhChhhcCCCcc
Confidence 9999999999999999886554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=347.12 Aligned_cols=251 Identities=33% Similarity=0.550 Sum_probs=223.2
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
+|++.+.||.|+||.||++.+..+++.|++|.+.+... .....+.+.+|++++++++||||+++++.+++++..+++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 69999999999999999999999999999999976533 22456788999999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 84 FAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
|++ ++|.+++.+..++++..+..++.|++++|.|||++|++|+||||+||++++++.++|+|||++....... .....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 159 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTST 159 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-ccccc
Confidence 997 6899998877789999999999999999999999999999999999999999999999999998765443 22345
Q ss_pred cCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCc---HHHHHHHHhcCCCCCCCCCCHHHHHHHHHhccc
Q 000706 163 KGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS---VYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 163 vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s---~~elirkIlr~~~efP~eISpeLkDLIrKcLqk 239 (1342)
.|+..|++||.+.+..++.++|+||+|+++|+|++|+.||...+ ..............+|..+++++.++|.+||+.
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (258)
T cd05578 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLER 239 (258)
T ss_pred CCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccC
Confidence 68899999999998889999999999999999999999998766 344444444356677788999999999999999
Q ss_pred CCCCCCCH--HHHHcCcCc
Q 000706 240 VPQNRLTW--SALLEHPFV 256 (1342)
Q Consensus 240 DPeKRPSA--eELLeHPFF 256 (1342)
||.+||+. .|+++||||
T Consensus 240 ~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 240 DPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ChhHcCCccHHHHhcCCCC
Confidence 99999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=351.68 Aligned_cols=254 Identities=30% Similarity=0.493 Sum_probs=213.1
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCe-----
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-HQNIIEMLDSFESPQE----- 77 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~-HPNIVKL~dvfeded~----- 77 (1342)
++|++.+.||+|+||.||+|.+..+++.||+|.++...........+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 5899999999999999999999999999999998665333333456788999999994 6999999999987665
Q ss_pred EEEEEeccCCChHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcC-CCcEEEeecccccc
Q 000706 78 FCVVTEFAQGELFEILED-----DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA-GSVVKLCDFGFARA 151 (1342)
Q Consensus 78 lyLVMEY~eGSL~D~Lek-----~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLds-dG~LKLiDFGLAr~ 151 (1342)
.|++|||++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 899999999999998864 246899999999999999999999999999999999999998 88999999999986
Q ss_pred ccCCceeeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC---C--------
Q 000706 152 MSANTVVLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP---V-------- 219 (1342)
Q Consensus 152 l~sss~~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~---~-------- 219 (1342)
+...........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+......++.... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence 6543333334467899999998765 457899999999999999999999998876655544433210 0
Q ss_pred -----------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcc
Q 000706 220 -----------------KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVK 257 (1342)
Q Consensus 220 -----------------efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFr 257 (1342)
...+.+++++.+||.+||+.||.+||++.|++.||||+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00134788999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=375.46 Aligned_cols=250 Identities=27% Similarity=0.464 Sum_probs=210.5
Q ss_pred CCEEEEEEEcccCcEEEEEEEEc--cCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRK--YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk--~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
.+|++++.||+|+||.||++... .+++.|++|.+... ....+|++++++++||||+++++++......|++
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 46999999999999999999753 45678999987543 2345799999999999999999999999999999
Q ss_pred EeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce--ee
Q 000706 82 TEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV--VL 159 (1342)
Q Consensus 82 MEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~--~~ 159 (1342)
||++.++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 165 ~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~ 244 (392)
T PHA03207 165 MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244 (392)
T ss_pred ehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccc
Confidence 9999999999998788899999999999999999999999999999999999999999999999999976654322 22
Q ss_pred ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcH---HHHHHHHhc----CC--------------
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSV---YALIRHIVK----DP-------------- 218 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~---~elirkIlr----~~-------------- 218 (1342)
....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+... ...+..+.+ .+
T Consensus 245 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 324 (392)
T PHA03207 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKH 324 (392)
T ss_pred cccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHH
Confidence 346799999999999999999999999999999999999999976431 111221111 01
Q ss_pred -----------CCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 219 -----------VKYP-----DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 219 -----------~efP-----~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
...+ ..++.+++++|++||+.||++|||+.|++.||||+...
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 325 FKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred HHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 1111 13467889999999999999999999999999998643
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=348.12 Aligned_cols=253 Identities=34% Similarity=0.587 Sum_probs=216.8
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
+|++.+.||+|+||.||+|.+..+|+.|++|.+............+.+|+.++++++||||+++++++.++...|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 69999999999999999999999999999999977654445557788999999999999999999999999999999999
Q ss_pred cCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce-eeecc
Q 000706 85 AQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV-VLRSI 162 (1342)
Q Consensus 85 ~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~-~~~s~ 162 (1342)
++++|.+++.. .+++++..++.++.|++++|+|||++|++|+||||+||+++.++.++|+|||.+........ .....
T Consensus 81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 160 (286)
T cd07832 81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ 160 (286)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccc
Confidence 98899998864 56799999999999999999999999999999999999999999999999999987654331 23345
Q ss_pred cCCCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC-------------------C---
Q 000706 163 KGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP-------------------V--- 219 (1342)
Q Consensus 163 vGTp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~-------------------~--- 219 (1342)
.|+.+|+|||.+.+. .++.++||||+|+++|+|++|.+||.+.........+.... .
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07832 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFP 240 (286)
T ss_pred cCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCC
Confidence 689999999988654 46899999999999999999999998776555444333210 0
Q ss_pred --------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcc
Q 000706 220 --------KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVK 257 (1342)
Q Consensus 220 --------efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFr 257 (1342)
...++.+.++.++|.+||+.||++||+++++++||||.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 241 ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 01124578999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=346.96 Aligned_cols=255 Identities=30% Similarity=0.554 Sum_probs=211.8
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHH-HHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEI-LRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~I-LKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
++|++.+.||+|+||.||++.+..+|+.||+|.++........ .++..|+.. ++..+||||+++++++..++..|++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 5899999999999999999999999999999998765433333 344445554 66679999999999999999999999
Q ss_pred eccCCChHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhC-CceecCCCCCcEEEcCCCcEEEeeccccccccCCce
Q 000706 83 EFAQGELFEILED----DKCLPEEQVQSIAKQLVRALHYLHSN-RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 83 EY~eGSL~D~Lek----~g~LSEeeI~~I~~QLLsALaYLHsr-GIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~ 157 (1342)
||++|+|.+++.+ ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 80 EVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred hhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 9999998887753 34799999999999999999999998 99999999999999999999999999997654322
Q ss_pred eeecccCCCCcCChhhhcc----CCCCCCCcccchhhHHHHHHhCCCCCCCC-cHHHHHHHHhcC-CCCCC-CCCCHHHH
Q 000706 158 VLRSIKGTPLYMAPELVRE----QPYNHTADLWSLGVILYELFVGQPPFYTN-SVYALIRHIVKD-PVKYP-DEMSPNFK 230 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g----~~YT~KsDIWSLGVILYELLTGr~PF~g~-s~~elirkIlr~-~~efP-~eISpeLk 230 (1342)
......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||... ...+....+... ...++ ..+++++.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQ 238 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHH
Confidence 1223468899999998864 45788999999999999999999999753 223333333332 33343 35789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 231 SFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 231 DLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
++|.+||..||.+||++.++++||||+...
T Consensus 239 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 239 DFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=351.65 Aligned_cols=258 Identities=38% Similarity=0.622 Sum_probs=220.1
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
+.|++++.||.|+||.||++.+..+++.+++|.+... .....+.+.+|+++++.++||||+++++.+..++.+|+|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 5799999999999999999999999999999998654 34456778889999999999999999999999999999999
Q ss_pred ccCC-ChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 84 FAQG-ELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 84 Y~eG-SL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
|++| +|..++.+ ...+++..++.++.|++.+|.|||++|++||||||+||+++.++.+||+|||++............
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 169 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS 169 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccce
Confidence 9985 56666644 567999999999999999999999999999999999999999999999999998765443333344
Q ss_pred ccCCCCcCChhhhc-----cCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCCCCCCHHHHHHH
Q 000706 162 IKGTPLYMAPELVR-----EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV---KYPDEMSPNFKSFL 233 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~-----g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~---efP~eISpeLkDLI 233 (1342)
..+++.|+|||.+. ...++.++|+||||+++|+|++|+.||...+......++..... ..+..++.++.++|
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (292)
T cd06644 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFL 249 (292)
T ss_pred ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHH
Confidence 56899999999874 44578899999999999999999999987766555555544322 23456889999999
Q ss_pred HHhcccCCCCCCCHHHHHcCcCcccchhhh
Q 000706 234 KGLLNKVPQNRLTWSALLEHPFVKETSDEL 263 (1342)
Q Consensus 234 rKcLqkDPeKRPSAeELLeHPFFre~~~eL 263 (1342)
.+||+.||++||++.++++||||.......
T Consensus 250 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 250 KTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred HHHhcCCcccCcCHHHHhcCccccccccch
Confidence 999999999999999999999998765443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=355.35 Aligned_cols=256 Identities=32% Similarity=0.589 Sum_probs=224.8
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE-KDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se-~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
++|++.+.||+|+||.||+|.+..+++.|++|.+.+..... ...+.+.+|++++++++||||+++++.+.+++..|++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 58999999999999999999999999999999997764432 34567889999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce--
Q 000706 83 EFAQ-GELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV-- 157 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~--g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~-- 157 (1342)
||+. ++|.+++.+. ..+++..++.++.|++.+|+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 9987 5899988753 5799999999999999999999999999999999999999999999999999875532211
Q ss_pred ---------------------------eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHH
Q 000706 158 ---------------------------VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYAL 210 (1342)
Q Consensus 158 ---------------------------~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~el 210 (1342)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 11234688999999999988899999999999999999999999998887777
Q ss_pred HHHHhcCCCCCCCC--CCHHHHHHHHHhcccCCCCCCC----HHHHHcCcCcccc
Q 000706 211 IRHIVKDPVKYPDE--MSPNFKSFLKGLLNKVPQNRLT----WSALLEHPFVKET 259 (1342)
Q Consensus 211 irkIlr~~~efP~e--ISpeLkDLIrKcLqkDPeKRPS----AeELLeHPFFre~ 259 (1342)
...+......++.. ++++++++|.+||..||++||+ ++|+++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 77776665555544 6899999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=352.04 Aligned_cols=255 Identities=31% Similarity=0.513 Sum_probs=209.4
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-----
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ----- 76 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded----- 76 (1342)
.+++|++.+.||+|+||.||+|.+..+++.||+|.+..............+|++++++++||||+++++++.+.+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 367899999999999999999999999999999998655433333345678999999999999999999886543
Q ss_pred ---eEEEEEeccCCChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 000706 77 ---EFCVVTEFAQGELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM 152 (1342)
Q Consensus 77 ---~lyLVMEY~eGSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l 152 (1342)
..++||||++++|.+++.+. ..+++.+++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++...
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 45999999999999888754 47999999999999999999999999999999999999999999999999999766
Q ss_pred cCCce----eeecccCCCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC---------
Q 000706 153 SANTV----VLRSIKGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP--------- 218 (1342)
Q Consensus 153 ~sss~----~~~s~vGTp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~--------- 218 (1342)
..... ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+.......+..-.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 43221 12234578899999988664 47889999999999999999999998776544332222100
Q ss_pred ----------CCCCC-------------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 219 ----------VKYPD-------------EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 219 ----------~efP~-------------eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
..++. ..++.+.++|.+||+.||.+|||++|+++||||
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 00111 124678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=354.53 Aligned_cols=254 Identities=29% Similarity=0.507 Sum_probs=216.5
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE-KDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se-~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
.|++.+.||+|+||.||++.+..+++.||+|.+.+..... .....+.+|+.++++++|+|++++++.+.+++.+|++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 4889999999999999999999999999999987653322 223456789999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 84 FAQ-GELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~--g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
|++ |+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~ 159 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIK 159 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-ccc
Confidence 997 6888887543 369999999999999999999999999999999999999999999999999987654332 223
Q ss_pred cccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcH---HHHHHHHh-cCCCCCCCCCCHHHHHHHHHh
Q 000706 161 SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSV---YALIRHIV-KDPVKYPDEMSPNFKSFLKGL 236 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~---~elirkIl-r~~~efP~eISpeLkDLIrKc 236 (1342)
...|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||..... ........ .....++..+++++++|+++|
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05630 160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKML 239 (285)
T ss_pred CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHH
Confidence 45799999999999998999999999999999999999999986432 12222222 223356678899999999999
Q ss_pred cccCCCCCCC-----HHHHHcCcCcccc
Q 000706 237 LNKVPQNRLT-----WSALLEHPFVKET 259 (1342)
Q Consensus 237 LqkDPeKRPS-----AeELLeHPFFre~ 259 (1342)
|+.||++||| ++|+++||||++.
T Consensus 240 l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 240 LCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred hhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 9999999999 9999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=350.80 Aligned_cols=253 Identities=32% Similarity=0.555 Sum_probs=210.0
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
+++|++.+.||+|+||.||+|.++.+++.|++|.+....... ....+.+|++++++++||||+++++++.+++..|+||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 689999999999999999999999999999999986543221 1234567999999999999999999999999999999
Q ss_pred eccCCChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQGELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~eGSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
||++++|.+++.+. ..+++..++.++.|+++||.|||++|++||||||+||+++.++.+||+|||+++...........
T Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 83 EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence 99999999988753 57899999999999999999999999999999999999999999999999998765433322333
Q ss_pred ccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCc-HHHHHHHHhc---CC----------------C-
Q 000706 162 IKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNS-VYALIRHIVK---DP----------------V- 219 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s-~~elirkIlr---~~----------------~- 219 (1342)
..+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.. ..+....+.. .+ .
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence 457889999998865 458899999999999999999999997654 2222222211 00 0
Q ss_pred -C---------CCCCCC--HHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 220 -K---------YPDEMS--PNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 220 -e---------fP~eIS--peLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
. ....++ +++.+++.+||+.||++|||+.|+++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 001233 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=353.83 Aligned_cols=256 Identities=34% Similarity=0.521 Sum_probs=218.6
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC---HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS---EKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s---e~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
+|++.+.||+|+||.||+|.+..+++.|++|.++..... ......+.+|++++++++||||+++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 699999999999999999999999999999999765433 22345677899999999999999999999999999999
Q ss_pred EeccCCChHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 82 TEFAQGELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 82 MEY~eGSL~D~Lek~g-~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
|||++|+|.+++.+.. .+++..++.++.||++||.|||++|++||||||+||+++.++.+||+|||++...........
T Consensus 81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (298)
T cd07841 81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT 160 (298)
T ss_pred EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcccc
Confidence 9999889999998766 899999999999999999999999999999999999999999999999999987765443344
Q ss_pred cccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC---------------------
Q 000706 161 SIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP--------------------- 218 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~--------------------- 218 (1342)
...+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||.+.+..+...++....
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T cd07841 161 HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFK 240 (298)
T ss_pred ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccccc
Confidence 4567889999998854 457899999999999999999988888776555444443210
Q ss_pred --C-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 219 --V-----KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 219 --~-----efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
. ......+.++.++|.+||++||++|||+.|+++||||++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 241 PFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred ccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 0 01123467899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=363.17 Aligned_cols=250 Identities=29% Similarity=0.542 Sum_probs=206.2
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEE-----ccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRR-----KYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESP 75 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArD-----k~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfede 75 (1342)
.-++|++.+.||+|+||.||+|.+ ..+++.||+|.+++. ........+.+|+++++.+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 457999999999999999999975 345578999998654 3334456788999999999 899999999988654
Q ss_pred -CeEEEEEeccC-CChHHHHhcC---------------------------------------------------------
Q 000706 76 -QEFCVVTEFAQ-GELFEILEDD--------------------------------------------------------- 96 (1342)
Q Consensus 76 -d~lyLVMEY~e-GSL~D~Lek~--------------------------------------------------------- 96 (1342)
+.+|++|||++ |+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 46899999997 7899888642
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce--eeecccCCCCcC
Q 000706 97 -----KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV--VLRSIKGTPLYM 169 (1342)
Q Consensus 97 -----g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~--~~~s~vGTp~Ym 169 (1342)
.++++.++..++.|+++||+|||++||+||||||+|||++.++.+||+|||+++....... ......+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 2477889999999999999999999999999999999999999999999999986543221 112334667899
Q ss_pred ChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHH-HHHHHhcC-CCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 000706 170 APELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYA-LIRHIVKD-PVKYPDEMSPNFKSFLKGLLNKVPQNRLT 246 (1342)
Q Consensus 170 APEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~e-lirkIlr~-~~efP~eISpeLkDLIrKcLqkDPeKRPS 246 (1342)
|||++.+..|+.++||||||+++|||++ |..||.+....+ ....+..+ ....+...++++.+++.+||+.||.+|||
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs 323 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPT 323 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcC
Confidence 9999999999999999999999999997 999998754333 33333332 34456778999999999999999999999
Q ss_pred HHHHHc
Q 000706 247 WSALLE 252 (1342)
Q Consensus 247 AeELLe 252 (1342)
+.|+++
T Consensus 324 ~~el~~ 329 (338)
T cd05102 324 FSALVE 329 (338)
T ss_pred HHHHHH
Confidence 999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=356.40 Aligned_cols=253 Identities=29% Similarity=0.522 Sum_probs=216.5
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
++|++.+.||+|+||.||++.+..+++.+++|.+.... ......++.+|++++++++||||+++++.+.+++.+|++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 58999999999999999999999999999999986542 33445678889999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 84 FAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS-NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHs-rGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
|++ |+|.+++.+.+++++..+..++.|+++||.|||+ .|++||||||+||+++.++.+||+|||++...... ....
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS 157 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--cccc
Confidence 997 6899999888889999999999999999999997 59999999999999999999999999998765332 2234
Q ss_pred ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC------------------------
Q 000706 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD------------------------ 217 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~------------------------ 217 (1342)
..|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+...
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence 57899999999998888999999999999999999999999765433322221110
Q ss_pred -------------CCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 218 -------------PVKYP-DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 218 -------------~~efP-~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
++..| ..+++++++|+.+||..||++|||+.|+++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 11111 2367889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=338.89 Aligned_cols=251 Identities=33% Similarity=0.576 Sum_probs=222.4
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
+|++.+.||+|+||.||++.+..+++.+++|.+............+.+|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 69999999999999999999999999999999987665566677899999999999999999999999999999999999
Q ss_pred cC-CChHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC-cEEEeeccccccccCCceeee
Q 000706 85 AQ-GELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS-VVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 85 ~e-GSL~D~Lek~--g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG-~LKLiDFGLAr~l~sss~~~~ 160 (1342)
++ ++|.+++.+. ..+++..++.++.|++.+|+|||++|++||||||+||+++.++ .+||+|||.+........ ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~~ 159 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-AY 159 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-cc
Confidence 97 5899998763 4589999999999999999999999999999999999998654 689999999987654332 22
Q ss_pred cccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhccc
Q 000706 161 SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrKcLqk 239 (1342)
...|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+... ....+..+++++++++.+||+.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 239 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNL 239 (256)
T ss_pred ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccC
Confidence 356899999999999888999999999999999999999999887776666666554 3456677899999999999999
Q ss_pred CCCCCCCHHHHHcCcCc
Q 000706 240 VPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 240 DPeKRPSAeELLeHPFF 256 (1342)
||.+|||+.|+++||||
T Consensus 240 ~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 240 DPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ChhhCCCHHHHhhCCCC
Confidence 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=350.73 Aligned_cols=253 Identities=34% Similarity=0.575 Sum_probs=214.5
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
++|++.+.||+|+||.||+|.++.+++.||+|.+.+........+.+.+|+++++.++||||+++++++.+++..|++||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 58999999999999999999999899999999987654444445678889999999999999999999999999999999
Q ss_pred ccCCC-hHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 84 FAQGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 Y~eGS-L~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
|+++. +.++......+++..++.++.|++.+|.|||+.|++||||+|+||++++++.+||+|||++.............
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY 160 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcc
Confidence 99865 55555556679999999999999999999999999999999999999999999999999998765544444456
Q ss_pred cCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-------------------CCC--
Q 000706 163 KGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-------------------PVK-- 220 (1342)
Q Consensus 163 vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~-------------------~~e-- 220 (1342)
.++..|+|||.+.+ ..++.++||||||+++|+|++|++||...+..+....+... ...
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07846 161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP 240 (286)
T ss_pred cceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccc
Confidence 68999999998865 44788999999999999999999999876654433332210 000
Q ss_pred ----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 221 ----------YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 221 ----------fP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
..+.++..+.+++.+||+.||++||++.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 123567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=354.17 Aligned_cols=255 Identities=31% Similarity=0.511 Sum_probs=217.7
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP--QEFC 79 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede--d~ly 79 (1342)
++++|++.+.||.|+||.||+|.+..+++.+++|.++...........+.+|++++++++||||+++++++..+ +..|
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 46899999999999999999999999999999999976544433344667899999999999999999999877 8999
Q ss_pred EEEeccCCChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 80 VVTEFAQGELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 80 LVMEY~eGSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
++|||++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 83 lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 162 (293)
T cd07843 83 MVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162 (293)
T ss_pred EEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence 99999999999988764 46999999999999999999999999999999999999999999999999999877654333
Q ss_pred eecccCCCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC-------------------
Q 000706 159 LRSIKGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP------------------- 218 (1342)
Q Consensus 159 ~~s~vGTp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~------------------- 218 (1342)
.....+++.|+|||.+.+. .++.++|+||+|+++|+|++|.+||...+..+...++....
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 4445688999999988754 46899999999999999999999998776655544432210
Q ss_pred ------------CCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 219 ------------VKYPDE-MSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 219 ------------~efP~e-ISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
..++.. +++.++++|++||+.||++|||+.|+++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 112222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=382.46 Aligned_cols=255 Identities=32% Similarity=0.536 Sum_probs=223.8
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccC-CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYT-GQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~T-Ge~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
..|++.+.||+|+||.||+|.+..+ ++.|++|.+... .......+++|+++++.++||||+++++++.+++.+|+||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 3499999999999999999998877 788999977543 2344467788999999999999999999999999999999
Q ss_pred eccC-CChHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce
Q 000706 83 EFAQ-GELFEILED----DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 83 EY~e-GSL~D~Lek----~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~ 157 (1342)
||++ |+|.+++.+ ..++++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 9997 789887653 45799999999999999999999999999999999999999999999999999987654321
Q ss_pred --eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCHHHHHHHH
Q 000706 158 --VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV-KYPDEMSPNFKSFLK 234 (1342)
Q Consensus 158 --~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~-efP~eISpeLkDLIr 234 (1342)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..+.. ++|..++++++++|.
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 304 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLD 304 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHH
Confidence 23456799999999999999999999999999999999999999998888777777765543 466778999999999
Q ss_pred HhcccCCCCCCCHHHHHcCcCcccch
Q 000706 235 GLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 235 KcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
+||+.||++||++.+++.|||++...
T Consensus 305 ~~L~~dP~~Rps~~~~l~~~~~~~~~ 330 (478)
T PTZ00267 305 PLLSKNPALRPTTQQLLHTEFLKYVA 330 (478)
T ss_pred HHhccChhhCcCHHHHHhCHHHHHHH
Confidence 99999999999999999999987643
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=348.18 Aligned_cols=254 Identities=38% Similarity=0.625 Sum_probs=218.6
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
-|++.+.||.|+||.||++.+..++..+++|.+... .....+.+.+|+++++.++|||++++++.+..++..|+||||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 368899999999999999999999999999998543 344556788899999999999999999999999999999999
Q ss_pred cC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 85 AQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 85 ~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
++ |+|.+++.+ ..++++..++.++.|+++||.|||+.|++||||||+||+++.++.+||+|||++.............
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 163 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 163 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence 97 567776654 5679999999999999999999999999999999999999999999999999997654433333456
Q ss_pred cCCCCcCChhhhc-----cCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC---CCCCCCCCHHHHHHHH
Q 000706 163 KGTPLYMAPELVR-----EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP---VKYPDEMSPNFKSFLK 234 (1342)
Q Consensus 163 vGTp~YmAPEvL~-----g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~---~efP~eISpeLkDLIr 234 (1342)
.+++.|+|||.+. +..++.++|+||+|+++|+|++|++||...+..+....+.... ...+..++.+++++|.
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (282)
T cd06643 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK 243 (282)
T ss_pred cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHH
Confidence 7899999999873 4557889999999999999999999998877666655554432 2345568899999999
Q ss_pred HhcccCCCCCCCHHHHHcCcCcccch
Q 000706 235 GLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 235 KcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
+||+.||.+||++.++++||||+...
T Consensus 244 ~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 244 KCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHccCChhhCcCHHHHhcCCCEeccC
Confidence 99999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=350.70 Aligned_cols=255 Identities=28% Similarity=0.481 Sum_probs=219.6
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-e~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
.|+..+.||.|+||+||++.+..+++.||+|.+.+.... ......+.+|++++++++|+|++.+++.+.+++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 488999999999999999999999999999998665322 2233457789999999999999999999999999999999
Q ss_pred ccC-CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 84 FAQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 84 Y~e-GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
|++ |+|.+++.. ..++++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||++....... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIR 159 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-ccc
Confidence 997 678877754 3469999999999999999999999999999999999999999999999999997654332 223
Q ss_pred cccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHH----HHHHhcCCCCCCCCCCHHHHHHHHHh
Q 000706 161 SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYAL----IRHIVKDPVKYPDEMSPNFKSFLKGL 236 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~el----irkIlr~~~efP~eISpeLkDLIrKc 236 (1342)
...|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||........ ...+......++..+++++.+|+.+|
T Consensus 160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239 (285)
T ss_pred CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHH
Confidence 45799999999999988899999999999999999999999987654332 23334445566778899999999999
Q ss_pred cccCCCCCCC-----HHHHHcCcCcccch
Q 000706 237 LNKVPQNRLT-----WSALLEHPFVKETS 260 (1342)
Q Consensus 237 LqkDPeKRPS-----AeELLeHPFFre~~ 260 (1342)
|+.||++||+ +.++++|+||++..
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 240 LTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred ccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 9999999999 89999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=360.91 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=209.3
Q ss_pred EEEEEEccc--CcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 7 HVIELVGEG--SFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 7 rIlK~LGsG--gFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
+++++||+| +|++||++.++.+|+.||+|.++.........+.+.+|+++++.++||||+++++++.+++..|+||||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 357889999 789999999999999999999976655555567788999999999999999999999999999999999
Q ss_pred cC-CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce----
Q 000706 85 AQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV---- 157 (1342)
Q Consensus 85 ~e-GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~---- 157 (1342)
++ |+|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+++.||+..........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 97 789898865 34699999999999999999999999999999999999999999999999987544321111
Q ss_pred ---eeecccCCCCcCChhhhcc--CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-------------
Q 000706 158 ---VLRSIKGTPLYMAPELVRE--QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV------------- 219 (1342)
Q Consensus 158 ---~~~s~vGTp~YmAPEvL~g--~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~------------- 219 (1342)
......++..|+|||.+.+ ..|+.++|||||||++|+|++|+.||.................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 1122356788999999875 4689999999999999999999999976544332222211100
Q ss_pred ---------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccchh
Q 000706 220 ---------------------------------KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 220 ---------------------------------efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~~ 261 (1342)
++...+++++.+|+++||+.||++|||++|+++||||++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~ 315 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 315 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcch
Confidence 011235678999999999999999999999999999987543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=334.16 Aligned_cols=252 Identities=40% Similarity=0.719 Sum_probs=226.7
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
+|++.+.||+|+||.||++.+..+++.|++|.+............+.+|+++++.++|||++++++.+.+++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 69999999999999999999999999999999987665556667889999999999999999999999999999999999
Q ss_pred cC-CChHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceee
Q 000706 85 AQ-GELFEILED----DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159 (1342)
Q Consensus 85 ~e-GSL~D~Lek----~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~ 159 (1342)
++ ++|.+++.+ ..++++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 98 589988876 3789999999999999999999999999999999999999999999999999998776554344
Q ss_pred ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhcc
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLN 238 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrKcLq 238 (1342)
....|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+..+........ ....+..++.++.+++.+||.
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 240 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQ 240 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 4567899999999998888999999999999999999999999887766666665554 445566788999999999999
Q ss_pred cCCCCCCCHHHHHcCcCc
Q 000706 239 KVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 239 kDPeKRPSAeELLeHPFF 256 (1342)
.+|++|||+.++++||||
T Consensus 241 ~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 241 KDPEERPSIAQILQSPFI 258 (258)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=347.38 Aligned_cols=253 Identities=38% Similarity=0.645 Sum_probs=216.7
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
++|++.+.||+|+||.||+|.++.+++.|++|.++.........+.+.+|++++++++||||+++++++.+++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 58999999999999999999999999999999987654444445778999999999999999999999999999999999
Q ss_pred ccCCChHHH-HhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce-eeec
Q 000706 84 FAQGELFEI-LEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV-VLRS 161 (1342)
Q Consensus 84 Y~eGSL~D~-Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~-~~~s 161 (1342)
|+++++.+. ..+...+++..++.++.|++.||.|||++|++||||+|+||++++++.+||+|||++........ ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 999776655 44556799999999999999999999999999999999999999999999999999987665432 3344
Q ss_pred ccCCCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-------------------C---
Q 000706 162 IKGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-------------------P--- 218 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~-------------------~--- 218 (1342)
..++++|+|||.+.+. .++.++|+||||+++|+|++|++||.+.+..+....+... .
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence 6689999999999887 7899999999999999999999999876654433332110 0
Q ss_pred ----------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 219 ----------VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 219 ----------~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
..++..+++++.+||++||..||++||+++++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 01233458899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=387.60 Aligned_cols=256 Identities=28% Similarity=0.544 Sum_probs=239.3
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
=|.+.+.||+|-|+.|.+|++..+|+.||||++.|...+.-...++..|++.|+.++|||||++|++......+|+++|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 38888999999999999999999999999999999888777778899999999999999999999999999999999999
Q ss_pred cC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEE-cCCCcEEEeeccccccccCCceeeec
Q 000706 85 AQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILI-GAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 85 ~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILL-dsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
-+ |+|++||.+ ...+.|+.+++||.||+.|+.|+|+..+|||||||||+.+ .+-|-+||.|||++-.+.++. ..++
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-kL~T 177 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-KLTT 177 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc-hhhc
Confidence 76 799999865 5689999999999999999999999999999999999865 677899999999998877665 4577
Q ss_pred ccCCCCcCChhhhccCCCC-CCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccC
Q 000706 162 IKGTPLYMAPELVREQPYN-HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT-~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkD 240 (1342)
.||+..|-|||++.+..|+ +++||||||+|||-|++|++||...++.+.+..|....+..|..++.++++||..||..|
T Consensus 178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLvRd 257 (864)
T KOG4717|consen 178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLVRD 257 (864)
T ss_pred ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHhcC
Confidence 8999999999999999998 678999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHcCcCcccchh
Q 000706 241 PQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 241 PeKRPSAeELLeHPFFre~~~ 261 (1342)
|++|.+.++|..|+|++....
T Consensus 258 PkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 258 PKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred chhhccHHHHhccccccCCCC
Confidence 999999999999999987654
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=344.59 Aligned_cols=253 Identities=30% Similarity=0.550 Sum_probs=217.1
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC----HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS----EKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s----e~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
+|+..+.||+|+||.||++.+..+++.|++|.+...... ....+.+.+|++++++++||||+++++++.+++.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 589999999999999999999999999999998754321 2235678999999999999999999999999999999
Q ss_pred EEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC-cEEEeeccccccccCCce-
Q 000706 81 VTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS-VVKLCDFGFARAMSANTV- 157 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG-~LKLiDFGLAr~l~sss~- 157 (1342)
+|||++ ++|.+++.+.+++++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999997 68999998888899999999999999999999999999999999999998876 599999999977654321
Q ss_pred ---eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHH---HHHHHHh--cCCCCCCCCCCHHH
Q 000706 158 ---VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVY---ALIRHIV--KDPVKYPDEMSPNF 229 (1342)
Q Consensus 158 ---~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~---elirkIl--r~~~efP~eISpeL 229 (1342)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... .....+. ......++.+++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240 (268)
T ss_pred CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHH
Confidence 112346889999999998888999999999999999999999999754422 2222222 23445667789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCcCcc
Q 000706 230 KSFLKGLLNKVPQNRLTWSALLEHPFVK 257 (1342)
Q Consensus 230 kDLIrKcLqkDPeKRPSAeELLeHPFFr 257 (1342)
.+++.+||+.||.+||++.++++||||+
T Consensus 241 ~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 241 RDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=340.82 Aligned_cols=249 Identities=36% Similarity=0.645 Sum_probs=218.1
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
++|++.+.||.|+||.||++.+..+++.|++|.+.... ..+.+.+|++++++++||||+++++.+.++...|++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 68999999999999999999999889999999986442 25788999999999999999999999999999999999
Q ss_pred ccC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 84 FAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 84 Y~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
|++ ++|.+++.. ...+++..++.++.|+++||.|||+.|++||||+|+||+++.++.+||+|||++............
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 998 588888865 557899999999999999999999999999999999999999999999999999876654433344
Q ss_pred ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC---CCCCCCCCCHHHHHHHHHhcc
Q 000706 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PVKYPDEMSPNFKSFLKGLLN 238 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~---~~efP~eISpeLkDLIrKcLq 238 (1342)
..|+..|++||.+.+..++.++||||||+++|+|++|+.||...........+... ....+..++.++.+++.+||+
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLV 238 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHh
Confidence 56889999999999989999999999999999999999999876654444333322 223345678899999999999
Q ss_pred cCCCCCCCHHHHHcCcCc
Q 000706 239 KVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 239 kDPeKRPSAeELLeHPFF 256 (1342)
.||++|||+.|+++||||
T Consensus 239 ~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 239 KDPEERPSAIQLLQHPFI 256 (256)
T ss_pred cChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=344.62 Aligned_cols=250 Identities=34% Similarity=0.621 Sum_probs=211.8
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeC------C
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESP------Q 76 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfede------d 76 (1342)
+.|++.+.||+|+||.||+|.+..+++.||+|.+...... ...+..|+.+++++ +|||++++++++.+. .
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4689999999999999999999999999999998755332 24678899999998 799999999998653 4
Q ss_pred eEEEEEeccC-CChHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 000706 77 EFCVVTEFAQ-GELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS 153 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek~--g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ 153 (1342)
.+|++|||++ |+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 6899999997 6899988763 468999999999999999999999999999999999999999999999999998765
Q ss_pred CCceeeecccCCCCcCChhhhc-----cCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC--CCCCCCCC
Q 000706 154 ANTVVLRSIKGTPLYMAPELVR-----EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP--VKYPDEMS 226 (1342)
Q Consensus 154 sss~~~~s~vGTp~YmAPEvL~-----g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~--~efP~eIS 226 (1342)
..........|++.|+|||++. +..|+.++|+||+|+++|+|++|+.||...........+.... ...+..++
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 242 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcC
Confidence 4433344567999999999886 3458889999999999999999999997665544444333332 22234678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 227 PNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 227 peLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
.++.+|+.+||+.||.+|||+.|+++||||
T Consensus 243 ~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 243 KKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=342.39 Aligned_cols=251 Identities=31% Similarity=0.581 Sum_probs=216.3
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC----HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS----EKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s----e~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
+|++.+.||+|+||.||+|.+. +++.+|+|.+...... ......+.+|++++++++|+||+++++++.+++..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 6899999999999999999864 7889999998654321 2334668899999999999999999999999999999
Q ss_pred EEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCC----
Q 000706 81 VTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN---- 155 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ss---- 155 (1342)
+|||++ |+|.+++.+.+++++..++.++.|++.+|+|||+.|++|+||||+||++++++.+||+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 999997 689999988788999999999999999999999999999999999999999999999999998765321
Q ss_pred --ceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC---CCCCCCCCCHHHH
Q 000706 156 --TVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PVKYPDEMSPNFK 230 (1342)
Q Consensus 156 --s~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~---~~efP~eISpeLk 230 (1342)
........|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+... ....+..++.++.
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI 239 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHH
Confidence 11223456899999999999888999999999999999999999999876554443333322 2346677899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 231 SFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 231 DLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
++|++||+.||.+||++.|+++||||
T Consensus 240 ~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 240 DFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=353.71 Aligned_cols=254 Identities=33% Similarity=0.646 Sum_probs=221.4
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
++|++.+.||.|+||.||++.+..+++.|++|.+...... ..+.+.+|+.+++.++|||++++++++.+++.+|+|||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 5799999999999999999999999999999998654332 34678889999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 84 FAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
|++ |+|.+++.+ ..+++.++..++.|++.+|.|||++|++||||||+||+++.++.+||+|||++.............
T Consensus 97 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 175 (296)
T cd06655 97 YLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (296)
T ss_pred ecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCc
Confidence 997 577777754 468999999999999999999999999999999999999999999999999988765544333445
Q ss_pred cCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC---CCCCCCCCCHHHHHHHHHhccc
Q 000706 163 KGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PVKYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 163 vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~---~~efP~eISpeLkDLIrKcLqk 239 (1342)
.|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+... ....+..+++.++++|++||..
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 255 (296)
T cd06655 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEM 255 (296)
T ss_pred CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhc
Confidence 6899999999999888999999999999999999999999887765554444332 2334567899999999999999
Q ss_pred CCCCCCCHHHHHcCcCcccch
Q 000706 240 VPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 240 DPeKRPSAeELLeHPFFre~~ 260 (1342)
||++||++.++++||||+...
T Consensus 256 dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 256 DVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred ChhhCCCHHHHhhChHhhhcc
Confidence 999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=337.44 Aligned_cols=251 Identities=35% Similarity=0.605 Sum_probs=220.1
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCC---CCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG---KSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~---~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
+|+..+.||+|+||.||+|.+..+++.|++|.+.... ...+..+.+.+|+++++.++||||+++++++.++..+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5889999999999999999999899999999986543 2234557789999999999999999999999999999999
Q ss_pred EeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 82 TEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
|||++ ++|.+++.+.+.+++..++.++.|++.+|.|||+.|++||||+|+||+++.++.+||+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~ 159 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAK 159 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-ccc
Confidence 99997 5899999888889999999999999999999999999999999999999999999999999987764433 234
Q ss_pred cccCCCCcCChhhhccCC-CCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHhc
Q 000706 161 SIKGTPLYMAPELVREQP-YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK--DPVKYPDEMSPNFKSFLKGLL 237 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g~~-YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr--~~~efP~eISpeLkDLIrKcL 237 (1342)
...|++.|++||.+.... ++.++|+||||+++|+|++|+.||...........+.. ....++..+++++++++.+||
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 239 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL 239 (258)
T ss_pred ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence 556899999999987766 89999999999999999999999977665454444433 334566778999999999999
Q ss_pred ccCCCCCCCHHHHHcCcCc
Q 000706 238 NKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 238 qkDPeKRPSAeELLeHPFF 256 (1342)
+.||.+||++.++++|||+
T Consensus 240 ~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 240 QRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred hcCcccCcCHHHHhcCCCC
Confidence 9999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=350.22 Aligned_cols=247 Identities=30% Similarity=0.481 Sum_probs=208.2
Q ss_pred EcccCcEEEEEEEEccCCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-CCh
Q 000706 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE-KDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GEL 89 (1342)
Q Consensus 12 LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se-~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e-GSL 89 (1342)
||+|+||.||++.++.+|+.||+|.+.+..... ........|++++++++||||+++++.++++..+|++|||++ |+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999999999999999986543221 223445679999999999999999999999999999999997 688
Q ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCCC
Q 000706 90 FEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL 167 (1342)
Q Consensus 90 ~D~Lek~--g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp~ 167 (1342)
.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....... ......|++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~ 159 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNG 159 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCCC
Confidence 8877543 358999999999999999999999999999999999999999999999999998765433 2234568999
Q ss_pred cCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCc----HHHHHHHHhcCCCCCC-CCCCHHHHHHHHHhcccCCC
Q 000706 168 YMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS----VYALIRHIVKDPVKYP-DEMSPNFKSFLKGLLNKVPQ 242 (1342)
Q Consensus 168 YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s----~~elirkIlr~~~efP-~eISpeLkDLIrKcLqkDPe 242 (1342)
|+|||++.+..++.++|+||+||++|+|++|+.||.... ..+..+........++ ..+++++++++.+||+.||+
T Consensus 160 y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 239 (277)
T cd05607 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE 239 (277)
T ss_pred ccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHh
Confidence 999999998889999999999999999999999997643 2333344444333332 46899999999999999999
Q ss_pred CCCCH----HHHHcCcCcccc
Q 000706 243 NRLTW----SALLEHPFVKET 259 (1342)
Q Consensus 243 KRPSA----eELLeHPFFre~ 259 (1342)
+||++ +++++||||+..
T Consensus 240 ~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 240 DRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred hCCCCccchhhhhcChhhcCC
Confidence 99999 678899999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.55 Aligned_cols=252 Identities=38% Similarity=0.644 Sum_probs=226.1
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
+|++.+.||+|++|.||++.+..+++.|++|.+............+.+|++++++++|||++++++++.+++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 69999999999999999999999999999999987766556678899999999999999999999999999999999999
Q ss_pred cC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeeccc
Q 000706 85 AQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK 163 (1342)
Q Consensus 85 ~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~v 163 (1342)
++ ++|.+++.....+++..++.++.|++.+|.|||++|++||||||+||+++.++.+||+|||.+..............
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 160 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV 160 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccc
Confidence 97 58999998888899999999999999999999999999999999999999999999999999987765544344567
Q ss_pred CCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHh-cCCCCCCCCCCHHHHHHHHHhcccCCC
Q 000706 164 GTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIV-KDPVKYPDEMSPNFKSFLKGLLNKVPQ 242 (1342)
Q Consensus 164 GTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIl-r~~~efP~eISpeLkDLIrKcLqkDPe 242 (1342)
++..|++||.+.+..++.++|+|++|+++|+|++|+.||...+......... .....++..+++.+.+++.+||+.+|+
T Consensus 161 ~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 240 (254)
T cd06627 161 GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPN 240 (254)
T ss_pred cchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChh
Confidence 8999999999988888999999999999999999999998766544444433 344556778899999999999999999
Q ss_pred CCCCHHHHHcCcCc
Q 000706 243 NRLTWSALLEHPFV 256 (1342)
Q Consensus 243 KRPSAeELLeHPFF 256 (1342)
+|||+.+++.||||
T Consensus 241 ~R~~~~~~l~~~~~ 254 (254)
T cd06627 241 LRPTAKQLLKHPWI 254 (254)
T ss_pred hCcCHHHHhcCCCC
Confidence 99999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=338.64 Aligned_cols=248 Identities=33% Similarity=0.582 Sum_probs=219.2
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
+|++.+.||+|+||.||++.+..+++.|++|.++.... ....+.+.+|+.++++++|||++++++.+++++.+|++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 69999999999999999999999999999999865432 34456788899999999999999999999999999999999
Q ss_pred cC-CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 85 AQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 85 ~e-GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
++ |+|.+++.. ...++++.++.++.|++.||.|||++|++|+||||+||+++.++.++++|||.+............
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 97 689988864 346899999999999999999999999999999999999999999999999999876554433445
Q ss_pred ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHhcccC
Q 000706 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP-VKYPDEMSPNFKSFLKGLLNKV 240 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~-~efP~eISpeLkDLIrKcLqkD 240 (1342)
..|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+.... ...+..++..+.++|.+||+.|
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (255)
T cd08219 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRN 239 (255)
T ss_pred ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCC
Confidence 678999999999998889999999999999999999999999887766666665543 3456778999999999999999
Q ss_pred CCCCCCHHHHHcC
Q 000706 241 PQNRLTWSALLEH 253 (1342)
Q Consensus 241 PeKRPSAeELLeH 253 (1342)
|++||++.+++..
T Consensus 240 P~~Rp~~~~il~~ 252 (255)
T cd08219 240 PRSRPSATTILSR 252 (255)
T ss_pred cccCCCHHHHhhc
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=344.29 Aligned_cols=253 Identities=35% Similarity=0.645 Sum_probs=227.8
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLK-HQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~-HPNIVKL~dvfeded~lyLV 81 (1342)
++|++.+.||+|+||.||++.+..+++.|++|++.+... .......+.+|.+++++++ ||||+++++++.+++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 589999999999999999999999999999999876432 3344567888999999998 99999999999999999999
Q ss_pred Eecc-CCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc----
Q 000706 82 TEFA-QGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT---- 156 (1342)
Q Consensus 82 MEY~-eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss---- 156 (1342)
|||+ +++|.+++.+.+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 9999 47999999988899999999999999999999999999999999999999999999999999998665432
Q ss_pred ----------------eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC
Q 000706 157 ----------------VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVK 220 (1342)
Q Consensus 157 ----------------~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~e 220 (1342)
.......++..|++||...+..++.++|+||||+++|++++|+.||...+.....+.+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCC
Confidence 1223356789999999998888999999999999999999999999988877777777777778
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHcCcCc
Q 000706 221 YPDEMSPNFKSFLKGLLNKVPQNRLTW----SALLEHPFV 256 (1342)
Q Consensus 221 fP~eISpeLkDLIrKcLqkDPeKRPSA----eELLeHPFF 256 (1342)
++..+++.+.+++.+||+.||.+||++ +++++||||
T Consensus 241 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 888999999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=375.97 Aligned_cols=260 Identities=31% Similarity=0.617 Sum_probs=243.3
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
.+++|+.++.||+|.||.|-+++.+.+++.||+|+++|.-. ..++...-..|-++|+..+||.+..+...|+..+++++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 47899999999999999999999999999999999987633 33445667789999999999999999999999999999
Q ss_pred EEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceee
Q 000706 81 VTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~ 159 (1342)
||||+. |+|+-.+.+.+.|+|...+.|...|+.||.|||+++|++||||.+|.|+|.||++||+|||+++.--......
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~ 325 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTT 325 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccccee
Confidence 999986 7899999999999999999999999999999999999999999999999999999999999998776667778
Q ss_pred ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhccc
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqk 239 (1342)
.++||||.|+|||++....|+.++|.|.+|+++|||++|+.||...+...+..-|......||..++++++.|+.++|.+
T Consensus 326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~k 405 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLKK 405 (516)
T ss_pred ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhhc
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCC-----CHHHHHcCcCcccchh
Q 000706 240 VPQNRL-----TWSALLEHPFVKETSD 261 (1342)
Q Consensus 240 DPeKRP-----SAeELLeHPFFre~~~ 261 (1342)
||.+|. .+.|+.+|+||.....
T Consensus 406 dP~kRLGgGpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 406 DPKKRLGGGPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred ChHhhcCCCchhHHHHHhhhhhccCCH
Confidence 999997 4899999999998643
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=343.16 Aligned_cols=253 Identities=30% Similarity=0.561 Sum_probs=216.4
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC---CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK---SEKDIHNLRQEIEILRKLKHQNIIEMLDSFES--PQEF 78 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~---se~dierL~rEI~ILKrL~HPNIVKL~dvfed--ed~l 78 (1342)
.+|++.+.||+|+||.||++.+..+++.|++|.+..... .......+.+|++++++++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 379999999999999999999999999999999865432 22345678899999999999999999999875 4678
Q ss_pred EEEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc-
Q 000706 79 CVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT- 156 (1342)
Q Consensus 79 yLVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss- 156 (1342)
+++|||++ ++|.+++.+.+.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999997 6899999888889999999999999999999999999999999999999999999999999997654321
Q ss_pred --eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC--CCCCCCCCCHHHHHH
Q 000706 157 --VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD--PVKYPDEMSPNFKSF 232 (1342)
Q Consensus 157 --~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~--~~efP~eISpeLkDL 232 (1342)
.......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...........+... ...++..+++.++++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence 1122355889999999999888999999999999999999999999876655555444332 345566788999999
Q ss_pred HHHhcccCCCCCCCHHHHHcCcCcc
Q 000706 233 LKGLLNKVPQNRLTWSALLEHPFVK 257 (1342)
Q Consensus 233 IrKcLqkDPeKRPSAeELLeHPFFr 257 (1342)
+ +||..||++||+++|+++||||+
T Consensus 242 i-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 242 L-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred H-HHhcCChhhCcCHHHHhcCcccc
Confidence 9 57778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=339.62 Aligned_cols=251 Identities=35% Similarity=0.621 Sum_probs=213.2
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC-----
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQ----- 76 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded----- 76 (1342)
.++|++.+.||.|+||.||+|.++.+++.+++|.+..... ..+.+.+|+++++++ +||||+++++++.+..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4799999999999999999999998999999999865432 335788999999999 7999999999997644
Q ss_pred -eEEEEEeccC-CChHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 000706 77 -EFCVVTEFAQ-GELFEILED----DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFAR 150 (1342)
Q Consensus 77 -~lyLVMEY~e-GSL~D~Lek----~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr 150 (1342)
.+|++|||++ ++|.+++.. +..+++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||.+.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 4899999998 578887754 4579999999999999999999999999999999999999999999999999997
Q ss_pred cccCCceeeecccCCCCcCChhhhcc-----CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCC
Q 000706 151 AMSANTVVLRSIKGTPLYMAPELVRE-----QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV---KYP 222 (1342)
Q Consensus 151 ~l~sss~~~~s~vGTp~YmAPEvL~g-----~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~---efP 222 (1342)
.............|++.|+|||.+.. ..++.++||||||+++|+|++|+.||...........+..... ..+
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSP 241 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCch
Confidence 66544433445668999999998753 3477889999999999999999999987655555555544422 223
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 223 DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 223 ~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
..++++++++|.+||..||++|||+.|+++|||+
T Consensus 242 ~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 242 ENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 3478899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=371.52 Aligned_cols=256 Identities=34% Similarity=0.598 Sum_probs=232.2
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCC------CCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG------KSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESP 75 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~------~se~dierL~rEI~ILKrL-~HPNIVKL~dvfede 75 (1342)
...|.-.+.||+|..++|.++.++.+|+.+|+|++.... ....-.+.-..|+.+|+++ .||||+++.|+|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 457888899999999999999999999999999996432 1223345677899999998 799999999999999
Q ss_pred CeEEEEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccC
Q 000706 76 QEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA 154 (1342)
Q Consensus 76 d~lyLVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~s 154 (1342)
...++|+|.++ |+|+|++...-.++|++.+.+++|+++|++|||.++|+||||||+|||++++-++||+|||+++.+.+
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999997 99999999998999999999999999999999999999999999999999999999999999999887
Q ss_pred CceeeecccCCCCcCChhhhcc------CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC----CC
Q 000706 155 NTVVLRSIKGTPLYMAPELVRE------QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP----DE 224 (1342)
Q Consensus 155 ss~~~~s~vGTp~YmAPEvL~g------~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP----~e 224 (1342)
+. ..+..||||.|.|||.++. ..|+..+|+|++|+|+|-|+.|.+||+.....-+++.|..+.+.|. .+
T Consensus 176 Ge-kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWad 254 (411)
T KOG0599|consen 176 GE-KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWAD 254 (411)
T ss_pred ch-hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhh
Confidence 65 4577899999999998864 3578889999999999999999999999999999999999877663 57
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 225 MSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 225 ISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
++.+.++||.+||+.||.+|.|++|.|.||||.+.
T Consensus 255 is~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 255 ISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred ccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 89999999999999999999999999999999654
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=351.13 Aligned_cols=255 Identities=33% Similarity=0.618 Sum_probs=220.7
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
..+|++.+.||+|+||.||++.+..+++.|++|.+...... ..+.+.+|+.+++.++|||++++++.+.++...|+||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 36899999999999999999999999999999998765433 2367888999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
||++ |+|.+++.+ ..+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++............
T Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence 9997 688888764 46899999999999999999999999999999999999999999999999998876544333344
Q ss_pred ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC---CCCCCCCCCHHHHHHHHHhcc
Q 000706 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PVKYPDEMSPNFKSFLKGLLN 238 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~---~~efP~eISpeLkDLIrKcLq 238 (1342)
..|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+... ....+..+++.+.+++.+||.
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (296)
T cd06654 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255 (296)
T ss_pred ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCc
Confidence 57899999999999888999999999999999999999999877654433333322 223456788999999999999
Q ss_pred cCCCCCCCHHHHHcCcCcccch
Q 000706 239 KVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 239 kDPeKRPSAeELLeHPFFre~~ 260 (1342)
.||++||++.++++||||....
T Consensus 256 ~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 256 MDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred CCcccCcCHHHHhhChhhhccC
Confidence 9999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=385.33 Aligned_cols=249 Identities=37% Similarity=0.601 Sum_probs=218.6
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-C-----CCcceEEEEEEeCCeE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-H-----QNIIEMLDSFESPQEF 78 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~-H-----PNIVKL~dvfeded~l 78 (1342)
+|.+++.||+|+||.|-+|.+..|++.||||+++.. .....+...|+.+|+.++ | -|+|+++|+|...++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 789999999999999999999999999999999765 234567788999999996 4 3899999999999999
Q ss_pred EEEEeccCCChHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC--cEEEeeccccccccC
Q 000706 79 CVVTEFAQGELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS--VVKLCDFGFARAMSA 154 (1342)
Q Consensus 79 yLVMEY~eGSL~D~Lek~g--~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG--~LKLiDFGLAr~l~s 154 (1342)
|||+|.++-+|+++++.++ +++...++.++.||+.+|.+||+.||+|+||||||||+.+-+ .+|++|||.+.....
T Consensus 264 ciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 264 CIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred eeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 9999999999999998754 699999999999999999999999999999999999997644 799999999988665
Q ss_pred CceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-----------------
Q 000706 155 NTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD----------------- 217 (1342)
Q Consensus 155 ss~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~----------------- 217 (1342)
... ++.-+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+.++.+++..|.+-
T Consensus 344 ~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k 420 (586)
T KOG0667|consen 344 RVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK 420 (586)
T ss_pred cce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence 443 567899999999999999999999999999999999999999999999888877520
Q ss_pred ---C-CC-------------------------------CCC-----------CCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 000706 218 ---P-VK-------------------------------YPD-----------EMSPNFKSFLKGLLNKVPQNRLTWSALL 251 (1342)
Q Consensus 218 ---~-~e-------------------------------fP~-----------eISpeLkDLIrKcLqkDPeKRPSAeELL 251 (1342)
. .. .|. .-...+.+|+++||.+||.+|+|+.|++
T Consensus 421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal 500 (586)
T KOG0667|consen 421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQAL 500 (586)
T ss_pred ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHh
Confidence 0 00 110 1124578999999999999999999999
Q ss_pred cCcCcccc
Q 000706 252 EHPFVKET 259 (1342)
Q Consensus 252 eHPFFre~ 259 (1342)
+||||...
T Consensus 501 ~Hpfl~~~ 508 (586)
T KOG0667|consen 501 NHPFLTGT 508 (586)
T ss_pred cCcccccc
Confidence 99999864
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=337.94 Aligned_cols=255 Identities=35% Similarity=0.632 Sum_probs=226.1
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
++|++.+.||.|++|.||+|.+..+++.|++|.+...... .....+.+|++.+.+++|||++++++++..++..+++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 4799999999999999999999999999999998765432 445778999999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 84 FAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS-NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHs-rGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
|++ ++|.+++.+..++++..++.++.|+++++.|||+ .|++||||+|+||+++.++.++|+|||.+............
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 159 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT 159 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence 998 7899999888889999999999999999999999 99999999999999999999999999999877654444335
Q ss_pred ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCC---cHHHHHHHHhcC-CCCCCCC-CCHHHHHHHHHh
Q 000706 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTN---SVYALIRHIVKD-PVKYPDE-MSPNFKSFLKGL 236 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~---s~~elirkIlr~-~~efP~e-ISpeLkDLIrKc 236 (1342)
..++..|+|||.+.+..++.++|+||||+++|+|++|+.||... ...+..+.+... ....+.. ++..+.++|.+|
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 239 (264)
T cd06623 160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC 239 (264)
T ss_pred eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHH
Confidence 56889999999999888999999999999999999999999776 445555555543 3344555 889999999999
Q ss_pred cccCCCCCCCHHHHHcCcCcccc
Q 000706 237 LNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 237 LqkDPeKRPSAeELLeHPFFre~ 259 (1342)
|..+|++||++.|+++||||+..
T Consensus 240 l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 240 LQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ccCChhhCCCHHHHHhCHHHHhc
Confidence 99999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.32 Aligned_cols=252 Identities=35% Similarity=0.608 Sum_probs=218.6
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
+|++.+.||+|+||.||++.+..+++.|++|.++.........+.+.+|++++++++|+||+++++.+.+.+.+++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 69999999999999999999998999999999987655555678899999999999999999999999999999999999
Q ss_pred cC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceee----
Q 000706 85 AQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL---- 159 (1342)
Q Consensus 85 ~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~---- 159 (1342)
++ ++|.+++.+.+.+++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 160 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence 97 6899999888789999999999999999999999999999999999999999999999999998765433221
Q ss_pred ecccCCCCcCChhhhccCC---CCCCCcccchhhHHHHHHhCCCCCCCCc-HHHHHHHHhc-CCCCCCCC--CCHHHHHH
Q 000706 160 RSIKGTPLYMAPELVREQP---YNHTADLWSLGVILYELFVGQPPFYTNS-VYALIRHIVK-DPVKYPDE--MSPNFKSF 232 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g~~---YT~KsDIWSLGVILYELLTGr~PF~g~s-~~elirkIlr-~~~efP~e--ISpeLkDL 232 (1342)
....+++.|++||.+.+.. ++.++||||||+++|+|++|+.||.... .......+.. ....+|.. +++.+.++
T Consensus 161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (264)
T cd06626 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDF 240 (264)
T ss_pred cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHH
Confidence 2356889999999988766 8899999999999999999999997642 3333322322 23344544 48999999
Q ss_pred HHHhcccCCCCCCCHHHHHcCcCc
Q 000706 233 LKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 233 IrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
|.+||+.||++||++.|++.|||+
T Consensus 241 i~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 241 LDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=361.64 Aligned_cols=253 Identities=26% Similarity=0.484 Sum_probs=214.6
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP------Q 76 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede------d 76 (1342)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.+..........+.+|+.++++++||||++++++|... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 4689999999999999999999999999999999876544455556788899999999999999999988644 3
Q ss_pred eEEEEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 77 EFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 77 ~lyLVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
..|+||||++++|.+.+... +++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 95 DVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 172 (353)
T ss_pred cEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence 57999999999999988654 8999999999999999999999999999999999999999999999999998765433
Q ss_pred eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-------------------
Q 000706 157 VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD------------------- 217 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~------------------- 217 (1342)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+...
T Consensus 173 ~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (353)
T cd07850 173 M-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNY 251 (353)
T ss_pred C-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHH
Confidence 2 23456899999999999999999999999999999999999999876654433333210
Q ss_pred ---CCC--------------C-------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCccc
Q 000706 218 ---PVK--------------Y-------PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258 (1342)
Q Consensus 218 ---~~e--------------f-------P~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre 258 (1342)
... + +...+++++++|.+||+.||++|||+.|+++||||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 252 VENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 000 0 1124567899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=367.36 Aligned_cols=246 Identities=27% Similarity=0.445 Sum_probs=203.9
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
.+|++.+.||+|+||.||+|.+..+++.||+|...+. ....|+.++++++||||+++++++.+++..++|||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4799999999999999999999999999999975432 23458999999999999999999999999999999
Q ss_pred ccCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 84 FAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 Y~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
|+.|+|.+++.+ .+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus 138 ~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~ 216 (357)
T PHA03209 138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-AFLGL 216 (357)
T ss_pred ccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-ccccc
Confidence 999999998865 5679999999999999999999999999999999999999999999999999997543222 22345
Q ss_pred cCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCC-cH---------HHHHHHHhc----CCCCCC------
Q 000706 163 KGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTN-SV---------YALIRHIVK----DPVKYP------ 222 (1342)
Q Consensus 163 vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~-s~---------~elirkIlr----~~~efP------ 222 (1342)
.||+.|+|||++.+..|+.++|||||||++|||+++..|+... .. ...+..+.. .+..++
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 296 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296 (357)
T ss_pred cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence 6999999999999989999999999999999999865554321 10 011111111 111111
Q ss_pred ------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCccc
Q 000706 223 ------------------------DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258 (1342)
Q Consensus 223 ------------------------~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre 258 (1342)
..++.++.+||.+||+.||++|||+.|+++||||++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 134667788999999999999999999999999985
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=341.17 Aligned_cols=247 Identities=31% Similarity=0.579 Sum_probs=219.9
Q ss_pred EcccCcEEEEEEEEccCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-CCh
Q 000706 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GEL 89 (1342)
Q Consensus 12 LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-e~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e-GSL 89 (1342)
||.|+||.||++.+..+++.|++|.+.+.... ....+.+.+|++++++++||||+++++.+.++..+|++|||++ |+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999765432 3345679999999999999999999999999999999999987 789
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCCCcC
Q 000706 90 FEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYM 169 (1342)
Q Consensus 90 ~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp~Ym 169 (1342)
.+++.+...+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||++....... ......|++.|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~ 159 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYV 159 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCcc
Confidence 9999888889999999999999999999999999999999999999999999999999998765443 223356899999
Q ss_pred ChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCc--HHHHHHHHh--cCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 000706 170 APELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS--VYALIRHIV--KDPVKYPDEMSPNFKSFLKGLLNKVPQNRL 245 (1342)
Q Consensus 170 APEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s--~~elirkIl--r~~~efP~eISpeLkDLIrKcLqkDPeKRP 245 (1342)
+||.+.+..++.++|+||+|+++|+|++|..||.... ..+....+. .....+|...++++.++|.+||+.||++||
T Consensus 160 ~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 239 (262)
T cd05572 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERL 239 (262)
T ss_pred ChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCc
Confidence 9999988889999999999999999999999998766 666666666 445667777899999999999999999999
Q ss_pred C-----HHHHHcCcCcccc
Q 000706 246 T-----WSALLEHPFVKET 259 (1342)
Q Consensus 246 S-----AeELLeHPFFre~ 259 (1342)
+ +.|+++||||++.
T Consensus 240 ~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 240 GNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred CCcccCHHHHhcChhhhCC
Confidence 9 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=347.35 Aligned_cols=251 Identities=33% Similarity=0.529 Sum_probs=214.7
Q ss_pred EEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEecc
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFA 85 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~ 85 (1342)
|++.+.||.|++|.||+|.++.+|+.|++|++............+.+|++++++++|||++++++++.+++..|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 78899999999999999999999999999998765443334456788999999999999999999999999999999999
Q ss_pred CCChHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeeccc
Q 000706 86 QGELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK 163 (1342)
Q Consensus 86 eGSL~D~Lek~g--~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~v 163 (1342)
+++|.+++.... .+++..++.++.|++++|+|||++|++||||+|+||+++.++.+||+|||++..............
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 160 (283)
T cd07835 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEV 160 (283)
T ss_pred CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccc
Confidence 999999987755 799999999999999999999999999999999999999999999999999976654433334445
Q ss_pred CCCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC------------------------
Q 000706 164 GTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP------------------------ 218 (1342)
Q Consensus 164 GTp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~------------------------ 218 (1342)
+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+......++.+..
T Consensus 161 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd07835 161 VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKW 240 (283)
T ss_pred cccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccc
Confidence 78999999987654 57889999999999999999999998776544433332210
Q ss_pred -----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 219 -----VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 219 -----~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
....+.+++++.++|.+||+.||++|||++|+++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 241 ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01124567899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=343.14 Aligned_cols=248 Identities=32% Similarity=0.549 Sum_probs=208.5
Q ss_pred EEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEeC--CeEEEEE
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-HQNIIEMLDSFESP--QEFCVVT 82 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~-HPNIVKL~dvfede--d~lyLVM 82 (1342)
|++.+.||+|+||.||++.+..+++.||+|.+++....... ....+|+.+++++. |||++++++++.++ +.++++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 78999999999999999999999999999998765333332 23456888898884 99999999999887 8999999
Q ss_pred eccCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
||++|++++.+.+ .+.+++..++.++.|++.||+|||++|++||||||+||+++. +.+||+|||+++....... ...
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-~~~ 157 (282)
T cd07831 80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-YTE 157 (282)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-cCC
Confidence 9999999998876 457899999999999999999999999999999999999999 9999999999987654322 233
Q ss_pred ccCCCCcCChhhhc-cCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC------------------CCCCC
Q 000706 162 IKGTPLYMAPELVR-EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD------------------PVKYP 222 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~-g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~------------------~~efP 222 (1342)
..+++.|+|||.+. +..++.++|+||+|+++|+|++|+.||.+.+..+....+... ...++
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07831 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237 (282)
T ss_pred CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence 56899999999764 455789999999999999999999999887665544433210 11111
Q ss_pred -----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 223 -----------DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 223 -----------~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
..++.++.++|.+||++||++||+++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 2467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.85 Aligned_cols=253 Identities=30% Similarity=0.551 Sum_probs=216.7
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCC---CCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG---KSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP--QEF 78 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~---~se~dierL~rEI~ILKrL~HPNIVKL~dvfede--d~l 78 (1342)
.+|++.+.||+|+||.||++.+..+++.|++|.+.... ......+.+.+|++++++++||||+++++++.++ ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 68999999999999999999999999999999886432 2234456888999999999999999999998763 578
Q ss_pred EEEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc-
Q 000706 79 CVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT- 156 (1342)
Q Consensus 79 yLVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss- 156 (1342)
+++|||++ |+|.+++.+.+.+++..+..++.|++.+|+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 89999997 6899999887889999999999999999999999999999999999999999999999999997654221
Q ss_pred --eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC--CCCCCCCCCHHHHHH
Q 000706 157 --VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD--PVKYPDEMSPNFKSF 232 (1342)
Q Consensus 157 --~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~--~~efP~eISpeLkDL 232 (1342)
.......|+..|+|||++.+..++.++|+||||+++|+|++|+.||..........++... ....|..++..+.++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF 241 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence 1123356899999999998888999999999999999999999999876655555444433 234566778899999
Q ss_pred HHHhcccCCCCCCCHHHHHcCcCcc
Q 000706 233 LKGLLNKVPQNRLTWSALLEHPFVK 257 (1342)
Q Consensus 233 IrKcLqkDPeKRPSAeELLeHPFFr 257 (1342)
+++|+. +|++||+++|+++|||++
T Consensus 242 i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 242 LKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHhc-ChhhCCCHHHHhcCcccC
Confidence 999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=344.76 Aligned_cols=251 Identities=31% Similarity=0.543 Sum_probs=213.7
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
+|++.+.||.|++|.||+|++..+|+.|++|.++..... .....+.+|++++++++||||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 699999999999999999999999999999998765332 2235667899999999999999999999999999999999
Q ss_pred cCCChHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 85 AQGELFEILEDD---KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 85 ~eGSL~D~Lek~---g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
++|+|.+++... .+++++.+..++.|+++||.|||++|++||||||+||++++++.+||+|||++............
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (284)
T cd07836 80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN 159 (284)
T ss_pred CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence 999999988653 46899999999999999999999999999999999999999999999999999866544333344
Q ss_pred ccCCCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC---C---------------CC--
Q 000706 162 IKGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---P---------------VK-- 220 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~---~---------------~e-- 220 (1342)
..+++.|++||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+...++... + ..
T Consensus 160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07836 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP 239 (284)
T ss_pred ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccccc
Confidence 5678999999988654 4788999999999999999999999877655444433211 0 00
Q ss_pred ---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 221 ---------YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 221 ---------fP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
+.+..++++++++.+||+.||.+||++.|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 112457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=345.96 Aligned_cols=252 Identities=29% Similarity=0.530 Sum_probs=217.5
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCC-----cEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTG-----QTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP 75 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TG-----e~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede 75 (1342)
|.+++|++.+.||+|+||.||+|.+...+ +.|++|.++... .......+.+|++++++++||||+++++++.+.
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 46789999999999999999999876554 679999886543 334456788999999999999999999999999
Q ss_pred CeEEEEEeccC-CChHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCC
Q 000706 76 QEFCVVTEFAQ-GELFEILEDD----------------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAG 138 (1342)
Q Consensus 76 d~lyLVMEY~e-GSL~D~Lek~----------------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsd 138 (1342)
+..|++|||++ |+|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 99999999997 7899998754 458889999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCc--eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHh
Q 000706 139 SVVKLCDFGFARAMSANT--VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIV 215 (1342)
Q Consensus 139 G~LKLiDFGLAr~l~sss--~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIl 215 (1342)
+.+||+|||+++...... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+....+....+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999997653322 12233456888999999988889999999999999999998 999999888777777766
Q ss_pred cCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 216 KDP-VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 216 r~~-~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
... ...+..+++++.+++.+||+.||.+||++.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 543 34567889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=349.94 Aligned_cols=258 Identities=31% Similarity=0.576 Sum_probs=222.7
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-e~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
++|++.+.||+|+||.||++.+..+++.|++|.+.+.... ......+.+|+++++.++||||+++++.+.+++.+|++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4799999999999999999999999999999998765322 233567888999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc-----
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT----- 156 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss----- 156 (1342)
||++ |+|.++++..+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 9997 5899999888889999999999999999999999999999999999999999999999999986421100
Q ss_pred ----------eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC---C
Q 000706 157 ----------VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP---D 223 (1342)
Q Consensus 157 ----------~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP---~ 223 (1342)
.......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+....+......++ .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE 240 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccc
Confidence 011124578899999999888899999999999999999999999998877777776665543333 3
Q ss_pred CCCHHHHHHHHHhcccCCCCCCC---HHHHHcCcCcccchh
Q 000706 224 EMSPNFKSFLKGLLNKVPQNRLT---WSALLEHPFVKETSD 261 (1342)
Q Consensus 224 eISpeLkDLIrKcLqkDPeKRPS---AeELLeHPFFre~~~ 261 (1342)
.+++++.++|.+||+.||++||+ +.++++||||.....
T Consensus 241 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~ 281 (305)
T cd05609 241 ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW 281 (305)
T ss_pred cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence 57899999999999999999998 799999999977543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=329.64 Aligned_cols=252 Identities=37% Similarity=0.643 Sum_probs=223.8
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEEEEE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP--QEFCVVT 82 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede--d~lyLVM 82 (1342)
+|++.+.||+|++|.||+|.+..+++.+++|.+..........+.+.+|++++++++||||+++++.+.+. ..++++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 58999999999999999999999999999999977655456678899999999999999999999999988 8999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce--ee
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV--VL 159 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~--~~ 159 (1342)
||++ ++|.+++.+...+++..++.++.|++.+|+|||+.|++||||+|+||+++.++.+||+|||.+........ ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 9995 78999998877999999999999999999999999999999999999999999999999999987765543 13
Q ss_pred ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCc-HHHHHHHHh--cCCCCCCCCCCHHHHHHHHHh
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS-VYALIRHIV--KDPVKYPDEMSPNFKSFLKGL 236 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s-~~elirkIl--r~~~efP~eISpeLkDLIrKc 236 (1342)
....++..|++||.+.+..++.++|+||||+++|+|++|..||.... .......+. .....++...++.+.++|.+|
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 240 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKC 240 (260)
T ss_pred cCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHh
Confidence 44568999999999988889999999999999999999999998765 333333433 234556778899999999999
Q ss_pred cccCCCCCCCHHHHHcCcCc
Q 000706 237 LNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 237 LqkDPeKRPSAeELLeHPFF 256 (1342)
|+.||++||++.|+++||||
T Consensus 241 l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 241 LRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CcCChhhCCCHHHHhhCCCC
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.27 Aligned_cols=250 Identities=32% Similarity=0.538 Sum_probs=211.7
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+.. .......+.+|++++++++||||+++++.+..++..+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 57999999999999999999999999999999987553 23344678899999999999999999999999999999999
Q ss_pred ccCC-ChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 84 FAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 Y~eG-SL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
|++| +|..+ ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ....
T Consensus 80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (279)
T cd06619 80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTY 153 (279)
T ss_pred cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--ccCC
Confidence 9985 45433 357899999999999999999999999999999999999999999999999997654332 2345
Q ss_pred cCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcH-------HHHHHHHhcC-CCCC-CCCCCHHHHHHH
Q 000706 163 KGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSV-------YALIRHIVKD-PVKY-PDEMSPNFKSFL 233 (1342)
Q Consensus 163 vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~-------~elirkIlr~-~~ef-P~eISpeLkDLI 233 (1342)
.|++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ....+.+... +... ...++++++++|
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI 233 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHH
Confidence 799999999999988899999999999999999999999965321 1222222222 2222 345788999999
Q ss_pred HHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 234 KGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 234 rKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
.+||+.||++||+++|+++||||+...
T Consensus 234 ~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 234 TQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHhhCChhhCCCHHHHhcCccccccc
Confidence 999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=344.10 Aligned_cols=252 Identities=32% Similarity=0.554 Sum_probs=213.7
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeC-----C
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESP-----Q 76 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfede-----d 76 (1342)
.++|++.+.||+|+||.||++.+..+++.+++|.+..... ....+.+|+.+++++ +|||++++++++... +
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 4689999999999999999999999999999999865422 234677899999998 899999999998654 3
Q ss_pred eEEEEEeccC-CChHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 000706 77 EFCVVTEFAQ-GELFEILE----DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARA 151 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Le----k~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~ 151 (1342)
.+|+||||++ |+|.+++. ....+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 6899999997 68888775 346799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCceeeecccCCCCcCChhhhccC-----CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCCC
Q 000706 152 MSANTVVLRSIKGTPLYMAPELVREQ-----PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV---KYPD 223 (1342)
Q Consensus 152 l~sss~~~~s~vGTp~YmAPEvL~g~-----~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~---efP~ 223 (1342)
............|+..|+|||.+... .++.++||||||+++|+|++|+.||...........+.+... ..++
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE 257 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCccc
Confidence 65443333445689999999987643 368899999999999999999999988766555555544422 2345
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcc
Q 000706 224 EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVK 257 (1342)
Q Consensus 224 eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFr 257 (1342)
.++..++++|.+||+.||++||++.|+++||||+
T Consensus 258 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 258 KWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 6788999999999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=352.97 Aligned_cols=255 Identities=33% Similarity=0.624 Sum_probs=220.1
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
++|++.+.||+|+||.||++.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 6899999999999999999999999999999998754332 23567889999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 84 FAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
|++ ++|.+++.+ ..+++..+..++.|++.+|.|||+.|++||||||+|||++.++.+||+|||++.............
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 175 (297)
T cd06656 97 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (297)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcc
Confidence 997 678888765 468999999999999999999999999999999999999999999999999998765544333445
Q ss_pred cCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC---CCCCCCCCCHHHHHHHHHhccc
Q 000706 163 KGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PVKYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 163 vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~---~~efP~eISpeLkDLIrKcLqk 239 (1342)
.+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+... ....+..+++.+++++.+||+.
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 255 (297)
T cd06656 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEM 255 (297)
T ss_pred cCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccC
Confidence 7899999999999888999999999999999999999999876543333222221 2234567889999999999999
Q ss_pred CCCCCCCHHHHHcCcCcccchh
Q 000706 240 VPQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 240 DPeKRPSAeELLeHPFFre~~~ 261 (1342)
||++||++.++++||||+....
T Consensus 256 ~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 256 DVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred ChhhCcCHHHHhcCchhccccc
Confidence 9999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=336.53 Aligned_cols=252 Identities=32% Similarity=0.614 Sum_probs=220.8
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
+|++.+.||+|+||.||++.++.+++.+++|.+..........+.+.+|+++++.++||||+++++.+.+++..|+++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 69999999999999999999999999999999976544444556788999999999999999999999999999999999
Q ss_pred cC-CChHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC-cEEEeeccccccccCCceeee
Q 000706 85 AQ-GELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS-VVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 85 ~e-GSL~D~Lek~g--~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG-~LKLiDFGLAr~l~sss~~~~ 160 (1342)
++ ++|.+++.+.. .+++..++.++.|++.||.|||+.|++||||||+||++++++ .+||+|||.+...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 97 68999886543 589999999999999999999999999999999999999886 469999999987665443334
Q ss_pred cccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHhccc
Q 000706 161 SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV-KYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~-efP~eISpeLkDLIrKcLqk 239 (1342)
...|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+..... +.++..+.++.++|.+||..
T Consensus 161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 240 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKV 240 (257)
T ss_pred ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhcc
Confidence 45689999999999888899999999999999999999999988776666666555432 34556788999999999999
Q ss_pred CCCCCCCHHHHHcCcCc
Q 000706 240 VPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 240 DPeKRPSAeELLeHPFF 256 (1342)
+|++|||+.|+++||||
T Consensus 241 ~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 241 SPRDRPSITSILKRPFL 257 (257)
T ss_pred ChhhCcCHHHHhhCCCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=341.56 Aligned_cols=253 Identities=33% Similarity=0.608 Sum_probs=220.1
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
++|++.+.||+|+||.||++.++.+++.+++|.+.+... ......+.+|++++++++||||+++++.+..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 579999999999999999999999999999999876543 3445678889999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 84 FAQ-GELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHS-NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHs-rGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
|++ ++|.+++... ..+++..++.++.|++.+|+|||+ .|++||||||+||+++.++.+||+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-- 157 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-- 157 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--
Confidence 998 7899998765 789999999999999999999999 99999999999999999999999999998766433221
Q ss_pred cccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCC-----cHHHHHHHHhcC-CCCCCCC-CCHHHHHHH
Q 000706 161 SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTN-----SVYALIRHIVKD-PVKYPDE-MSPNFKSFL 233 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~-----s~~elirkIlr~-~~efP~e-ISpeLkDLI 233 (1342)
...++..|++||.+.+..++.++|+||||+++|+|++|+.||... ...+..+.+... ....+.. ++++++++|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFV 237 (265)
T ss_pred cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence 266899999999999889999999999999999999999999754 233444444433 3344444 889999999
Q ss_pred HHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 234 KGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 234 rKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
.+||..||++|||+.+++.||||+..
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 238 NLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHcCCCchhCcCHHHHhhCchhhcc
Confidence 99999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=350.54 Aligned_cols=244 Identities=32% Similarity=0.520 Sum_probs=194.9
Q ss_pred EEEEcccCcEEEEEEEEcc--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEE--eCCeEEEEEec
Q 000706 9 IELVGEGSFGKVYKGRRKY--TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFE--SPQEFCVVTEF 84 (1342)
Q Consensus 9 lK~LGsGgFGtVYKArDk~--TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfe--ded~lyLVMEY 84 (1342)
..+||+|+||.||+|+++. +++.||+|.+.+.... ..+.+|++++++++||||+++++++. .+...|++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 4689999999999998653 6688999998654322 35678999999999999999999884 45678999999
Q ss_pred cCCChHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEE----cCCCcEEEeecccccc
Q 000706 85 AQGELFEILED---------DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILI----GAGSVVKLCDFGFARA 151 (1342)
Q Consensus 85 ~eGSL~D~Lek---------~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILL----dsdG~LKLiDFGLAr~ 151 (1342)
++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 82 AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred eCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 99999988752 2258999999999999999999999999999999999999 5667999999999987
Q ss_pred ccCCce---eeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHH---------HHHHHHhcC-
Q 000706 152 MSANTV---VLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVY---------ALIRHIVKD- 217 (1342)
Q Consensus 152 l~sss~---~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~---------elirkIlr~- 217 (1342)
...... ......||+.|+|||.+.+ ..++.++||||||+++|||++|++||...... ....++...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 654322 2234568999999998876 45899999999999999999999999753211 111111100
Q ss_pred -------------CC------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 218 -------------PV------------------------KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 218 -------------~~------------------------efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
.. ......+..+.+++.+||+.||.+|||+.|+++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 0011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=345.24 Aligned_cols=254 Identities=31% Similarity=0.593 Sum_probs=216.1
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
++|++++.||+|+||.||++.+..+++.||+|.++.. ........+.+|++++++++||||+++++.+..++.+|++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 5899999999999999999999999999999998654 234445678899999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 84 FAQ-GELFEILEDD---KCLPEEQVQSIAKQLVRALHYLHS-NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~---g~LSEeeI~~I~~QLLsALaYLHs-rGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
|++ ++|.+++... ..+++..+..++.|++.+|.|||+ .|++||||||+||+++.++.+||+|||++..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 998 4787777653 379999999999999999999996 599999999999999999999999999997654332
Q ss_pred eecccCCCCcCChhhhccC------CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHH---HHHHhc-CCCCCCCCCCHH
Q 000706 159 LRSIKGTPLYMAPELVREQ------PYNHTADLWSLGVILYELFVGQPPFYTNSVYAL---IRHIVK-DPVKYPDEMSPN 228 (1342)
Q Consensus 159 ~~s~vGTp~YmAPEvL~g~------~YT~KsDIWSLGVILYELLTGr~PF~g~s~~el---irkIlr-~~~efP~eISpe 228 (1342)
.....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||........ ...+.. .+...+..++++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence 2334688899999988543 357899999999999999999999976543332 223333 345667779999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 229 FKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 229 LkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
+.++|.+||+.||++||++.++++||||....
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred HHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=355.78 Aligned_cols=255 Identities=33% Similarity=0.568 Sum_probs=222.2
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-----eEE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ-----EFC 79 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded-----~ly 79 (1342)
+|++.+.||+|+||.||+|++..+++.|++|.+.+........+.+.+|+.+++.++||||+++++++.+.+ .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 699999999999999999999989999999998765433445577889999999999999999999998775 789
Q ss_pred EEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc---
Q 000706 80 VVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT--- 156 (1342)
Q Consensus 80 LVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss--- 156 (1342)
++|||++++|.+++.+..++++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||.+.......
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998776543
Q ss_pred eeeecccCCCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC---------------
Q 000706 157 VVLRSIKGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVK--------------- 220 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~e--------------- 220 (1342)
.......+++.|+|||.+.+. .++.++|+||+|+++|+|++|++||.+.+..+..+.+......
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR 240 (330)
T ss_pred ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchh
Confidence 123445689999999999887 7899999999999999999999999887766655554431100
Q ss_pred ----------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 221 ----------------YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 221 ----------------fP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
..+.+++++.++|.+||++||.+||+++++++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 113467889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=344.56 Aligned_cols=253 Identities=31% Similarity=0.492 Sum_probs=209.0
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
.++|++.+.||+|+||.||+|.+..+++.|++|.+...... .....+.+|+++++.++|+||+++++++.+++..|++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 47899999999999999999999999999999998654322 22235678999999999999999999999999999999
Q ss_pred eccCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
||+++++.+++.+ .+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++...........
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 162 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS 162 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence 9999999887754 456889999999999999999999999999999999999999999999999999765443333344
Q ss_pred ccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcH-HHHHHHHhc---------------CC------
Q 000706 162 IKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSV-YALIRHIVK---------------DP------ 218 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~-~elirkIlr---------------~~------ 218 (1342)
..+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+. .+...++.. .+
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07870 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW 242 (291)
T ss_pred ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchh
Confidence 567999999998875 3578899999999999999999999976442 222222110 00
Q ss_pred --CCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 219 --VKYP---------DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 219 --~efP---------~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
...+ ...++++.+++.+||+.||.+|||+.|++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000 0125789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=342.57 Aligned_cols=250 Identities=32% Similarity=0.604 Sum_probs=210.8
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEE------eCC
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFE------SPQ 76 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfe------ded 76 (1342)
+.|++.+.||.|+||.||+|.+..+++.+++|.+.... .....+..|+.+++++ +|||++++++++. ..+
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 67999999999999999999999999999999986542 3345678899999998 7999999999984 356
Q ss_pred eEEEEEeccC-CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 000706 77 EFCVVTEFAQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS 153 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ 153 (1342)
.+|++|||++ |+|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 7899999997 589888865 3458899999999999999999999999999999999999999999999999987654
Q ss_pred CCceeeecccCCCCcCChhhhc-----cCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-C-CCCCCC
Q 000706 154 ANTVVLRSIKGTPLYMAPELVR-----EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV-K-YPDEMS 226 (1342)
Q Consensus 154 sss~~~~s~vGTp~YmAPEvL~-----g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~-e-fP~eIS 226 (1342)
..........|++.|+|||.+. ...++.++|+||||+++|+|++|+.||...........+..... . .+..++
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (282)
T cd06636 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWS 252 (282)
T ss_pred ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccC
Confidence 3333334567899999999875 35688899999999999999999999977655444433333321 1 234578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 227 PNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 227 peLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
+++.+||++||+.||.+|||+.|+++||||
T Consensus 253 ~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 253 KKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=341.43 Aligned_cols=251 Identities=29% Similarity=0.531 Sum_probs=210.3
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEE-----eCC
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFE-----SPQ 76 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfe-----ded 76 (1342)
.++|++.+.||+|+||.||++.+..+++.+++|.+..... ....+.+|+.+++.+ +||||+++++++. +++
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 93 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD 93 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence 4789999999999999999999999999999998754322 224677899999999 7999999999873 456
Q ss_pred eEEEEEeccC-CChHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 000706 77 EFCVVTEFAQ-GELFEILE----DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARA 151 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Le----k~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~ 151 (1342)
.++++|||++ |+|.+++. ....+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 173 (286)
T cd06638 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173 (286)
T ss_pred eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceee
Confidence 7899999997 67888764 345789999999999999999999999999999999999999999999999999987
Q ss_pred ccCCceeeecccCCCCcCChhhhcc-----CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC---CCCCC
Q 000706 152 MSANTVVLRSIKGTPLYMAPELVRE-----QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP---VKYPD 223 (1342)
Q Consensus 152 l~sss~~~~s~vGTp~YmAPEvL~g-----~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~---~efP~ 223 (1342)
............|++.|+|||.+.. ..++.++|+||+|+++|+|++|+.||...........+.... ...+.
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (286)
T cd06638 174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPE 253 (286)
T ss_pred cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCC
Confidence 6544333344569999999998753 457899999999999999999999998766544443333221 22344
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 224 EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 224 eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
.++.++.+++.+||+.||++|||+.|+++|+||
T Consensus 254 ~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 254 LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 567899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=335.03 Aligned_cols=248 Identities=33% Similarity=0.608 Sum_probs=219.4
Q ss_pred EcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-CCh
Q 000706 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GEL 89 (1342)
Q Consensus 12 LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e-GSL 89 (1342)
||.|+||.||++.+..+++.+++|.+.+... .....+.+.+|++++++++||||+++++.+.++...|++|||++ ++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999998999999999865533 22445678899999999999999999999999999999999997 689
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce--------eeec
Q 000706 90 FEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV--------VLRS 161 (1342)
Q Consensus 90 ~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~--------~~~s 161 (1342)
.+++.+.+.+++..++.++.|++++|.|||++|++||||+|+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 99998877899999999999999999999999999999999999999999999999999876543311 2334
Q ss_pred ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCC--CHHHHHHHHHhccc
Q 000706 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEM--SPNFKSFLKGLLNK 239 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eI--SpeLkDLIrKcLqk 239 (1342)
..+++.|++||......++.++|+||||+++|+|++|..||......+....+......++... ++.+.+++.+||+.
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 240 (265)
T cd05579 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVP 240 (265)
T ss_pred cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcC
Confidence 5688999999999888899999999999999999999999998888777777776666666554 89999999999999
Q ss_pred CCCCCCCH---HHHHcCcCcccc
Q 000706 240 VPQNRLTW---SALLEHPFVKET 259 (1342)
Q Consensus 240 DPeKRPSA---eELLeHPFFre~ 259 (1342)
+|.+|||+ .++++||||++.
T Consensus 241 ~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 241 DPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred CHhhcCCCccHHHHhcCccccCC
Confidence 99999999 999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=357.42 Aligned_cols=256 Identities=30% Similarity=0.530 Sum_probs=216.1
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----CeE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP-----QEF 78 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede-----d~l 78 (1342)
++|++.+.||+|+||+||++.+..+++.|++|.+++..........+.+|+.+++.++||||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 589999999999999999999999999999999876533334456677899999999999999999988644 358
Q ss_pred EEEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 79 CVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 79 yLVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
|++|||++++|.+++.+.+++++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 85 ~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 164 (337)
T cd07858 85 YIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF 164 (337)
T ss_pred EEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCccc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999999876544333
Q ss_pred eecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhc---C-----------------
Q 000706 159 LRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK---D----------------- 217 (1342)
Q Consensus 159 ~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr---~----------------- 217 (1342)
.....++..|+|||.+.. ..++.++|+||||+++|+|++|+.||.+.+.......+.. .
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (337)
T cd07858 165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRY 244 (337)
T ss_pred ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHH
Confidence 344568999999998765 4688999999999999999999999977653322221110 0
Q ss_pred --------C---CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 218 --------P---VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 218 --------~---~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
. ....+.+++++.++|++||+.||++|||++|+++||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 245 IRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 01124578999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=371.70 Aligned_cols=249 Identities=34% Similarity=0.603 Sum_probs=214.9
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----CeEE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP-----QEFC 79 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede-----d~ly 79 (1342)
.|+-.+.+|+|+||.||+|....+++.||||..-.+.. --.+|+++|+.++|||||++..+|... -...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 48889999999999999999999999999998855432 223699999999999999999888422 2456
Q ss_pred EEEeccCCChHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCC-CcEEEeeccccccccC
Q 000706 80 VVTEFAQGELFEILED----DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAG-SVVKLCDFGFARAMSA 154 (1342)
Q Consensus 80 LVMEY~eGSL~D~Lek----~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsd-G~LKLiDFGLAr~l~s 154 (1342)
+||||++.+|+++++. +..++.-.++-|.+||++||.|||+.||+||||||+|+|||.+ |.+||||||.|+.+..
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 8999999999999985 5789999999999999999999999999999999999999976 8999999999999877
Q ss_pred CceeeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC----------------
Q 000706 155 NTVVLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---------------- 217 (1342)
Q Consensus 155 ss~~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~---------------- 217 (1342)
+... .++..|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+++..+++..|.+-
T Consensus 179 ~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 179 GEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred CCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 6654 34456999999998765 56999999999999999999999999999888877776531
Q ss_pred -CCC------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 218 -PVK------------YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 218 -~~e------------fP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
... +....++++.+|+.++|..+|.+|.++.|++.||||.+..
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 011 2235789999999999999999999999999999998653
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=357.17 Aligned_cols=256 Identities=30% Similarity=0.516 Sum_probs=215.6
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEE----eCCeEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFE----SPQEFC 79 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfe----ded~ly 79 (1342)
++|++.+.||+|+||.||++.++.+++.|++|.+.+..........+.+|+.++++++||||+++++++. +...+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6899999999999999999999999999999998765443344567788999999999999999999875 345789
Q ss_pred EEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce--
Q 000706 80 VVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV-- 157 (1342)
Q Consensus 80 LVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~-- 157 (1342)
+||||++|+|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.+|.+||+|||++........
T Consensus 85 lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 164 (334)
T cd07855 85 VVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH 164 (334)
T ss_pred EEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCC
Confidence 999999999999998888899999999999999999999999999999999999999999999999999976543221
Q ss_pred --eeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhc------------------
Q 000706 158 --VLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK------------------ 216 (1342)
Q Consensus 158 --~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr------------------ 216 (1342)
......|+.+|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+..
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~ 244 (334)
T cd07855 165 KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRV 244 (334)
T ss_pred CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhH
Confidence 1224578999999998865 4589999999999999999999999977654332221111
Q ss_pred --------CCCCC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 217 --------DPVKY-----PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 217 --------~~~ef-----P~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
..... .+..++++.++|.+||+.||++||++.+++.||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 245 RKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred HHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 00111 13468899999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=339.78 Aligned_cols=251 Identities=20% Similarity=0.380 Sum_probs=213.5
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEc---cCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRK---YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQE 77 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk---~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~ 77 (1342)
++.++|++.+.||+|+||.||+|.++ ..+..||+|.++... .......+.+|+.++++++||||+++++++..++.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 45678999999999999999999764 456789999986542 33445678899999999999999999999999999
Q ss_pred EEEEEeccC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCC
Q 000706 78 FCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN 155 (1342)
Q Consensus 78 lyLVMEY~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ss 155 (1342)
.++||||++ |+|.+++.+ ...+++..++.++.|++.||+|||++|++||||||+||+++.++.+|++|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 999999997 578888876 457999999999999999999999999999999999999999999999999987654322
Q ss_pred cee-eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHH
Q 000706 156 TVV-LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSF 232 (1342)
Q Consensus 156 s~~-~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDL 232 (1342)
... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||...+..+..+.+... ..+.+..++..+.++
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQL 240 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 111 112335678999999999999999999999999999775 99999988877777766554 345567789999999
Q ss_pred HHHhcccCCCCCCCHHHHHc
Q 000706 233 LKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 233 IrKcLqkDPeKRPSAeELLe 252 (1342)
+.+||+.+|.+||+++++++
T Consensus 241 i~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 241 MLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHcCCCchhCCCHHHHHH
Confidence 99999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=335.19 Aligned_cols=251 Identities=32% Similarity=0.570 Sum_probs=213.9
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~-~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
+++|++.+.||+|+||.||+|+++.+++.||+|.++... ........+.+|++++++++||||+++++++.+.+..|++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 479999999999999999999999999999999886543 2344456788899999999999999999999999999999
Q ss_pred EeccC-CChHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 82 TEFAQ-GELFEILED----DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek----~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
|||++ |+|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 99998 688887742 3458999999999999999999999999999999999999999999999999998765544
Q ss_pred eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCc--HHHHHHHHhcCC-C-CCCCCCCHHHHHH
Q 000706 157 VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS--VYALIRHIVKDP-V-KYPDEMSPNFKSF 232 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s--~~elirkIlr~~-~-efP~eISpeLkDL 232 (1342)
.......|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||.... .......+.... . ..+..++..+.++
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLREL 240 (267)
T ss_pred HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence 33344568999999999988889999999999999999999999997543 334444443322 1 2234577899999
Q ss_pred HHHhcccCCCCCCCHHHHHcC
Q 000706 233 LKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 233 IrKcLqkDPeKRPSAeELLeH 253 (1342)
+.+||+.+|++||++.++++.
T Consensus 241 i~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 241 VSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHCCCCcccCcCHHHHHHH
Confidence 999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=342.45 Aligned_cols=257 Identities=33% Similarity=0.590 Sum_probs=223.2
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
..|+..+.||.|+||.||+|.+..+++.||+|.+.... .......+.+|++++++++||||+++++.+.++...|+|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 46889999999999999999999999999999987543 23445788899999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 84 FAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
|++ |+|.+++.. +++++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.............
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccc
Confidence 997 588888865 568999999999999999999999999999999999999999999999999997765544333445
Q ss_pred cCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhcccCC
Q 000706 163 KGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLNKVP 241 (1342)
Q Consensus 163 vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrKcLqkDP 241 (1342)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+... +...+..++..+.+++.+||+.||
T Consensus 162 ~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06640 162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDP 241 (277)
T ss_pred cCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCc
Confidence 6889999999998888999999999999999999999999877655554444333 344555678899999999999999
Q ss_pred CCCCCHHHHHcCcCcccchhh
Q 000706 242 QNRLTWSALLEHPFVKETSDE 262 (1342)
Q Consensus 242 eKRPSAeELLeHPFFre~~~e 262 (1342)
++||++.++++||||.....+
T Consensus 242 ~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 242 SFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred ccCcCHHHHHhChHhhhcchh
Confidence 999999999999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.52 Aligned_cols=251 Identities=36% Similarity=0.603 Sum_probs=217.6
Q ss_pred EEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEecc
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFA 85 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~ 85 (1342)
|++.+.||.|++|.||++.+..+++.+++|.+............+.+|++++++++||||+++++++.+++..+++|||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 78899999999999999999999999999998766544445567888999999999999999999999999999999999
Q ss_pred CCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccC
Q 000706 86 QGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG 164 (1342)
Q Consensus 86 eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vG 164 (1342)
++++.+.+.+ ...+++..++.++.|++.+|.|||++|++||||||+||+++.++.+||+|||.+..............+
T Consensus 81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 160 (283)
T cd05118 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV 160 (283)
T ss_pred CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccC
Confidence 9999998876 468999999999999999999999999999999999999999999999999999877655433344568
Q ss_pred CCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC---C----------------C-----
Q 000706 165 TPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---P----------------V----- 219 (1342)
Q Consensus 165 Tp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~---~----------------~----- 219 (1342)
+..|++||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+... + .
T Consensus 161 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05118 161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK 240 (283)
T ss_pred cccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccc
Confidence 8999999988776 7899999999999999999999999887765544443211 0 0
Q ss_pred ------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 220 ------KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 220 ------efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
...+.++.++.++|.+||+.||.+||++.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0112467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=323.36 Aligned_cols=248 Identities=40% Similarity=0.699 Sum_probs=216.4
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
+|++.+.||+|++|.||++.+..+++.+++|.+..... .....+.+|++++++++|||++++++.+..+...+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 58999999999999999999998999999999876543 3457888999999999999999999999999999999999
Q ss_pred cC-CChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 85 AQ-GELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 85 ~e-GSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
++ ++|.+++... +.+++..++.++.|++.+|.|||++|++||||+|+||+++.++.++|+|||.+........ ....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~ 157 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTM 157 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccce
Confidence 98 7888888765 6899999999999999999999999999999999999999999999999999987765432 3445
Q ss_pred cCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhc-CCCCCCC--CCCHHHHHHHHHhccc
Q 000706 163 KGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK-DPVKYPD--EMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 163 vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr-~~~efP~--eISpeLkDLIrKcLqk 239 (1342)
.++..|++||.+.+..++.++|+||||+++|+|++|+.||...+.......... .....+. .++.++.++|.+||+.
T Consensus 158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 237 (253)
T cd05122 158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK 237 (253)
T ss_pred ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccC
Confidence 689999999999888899999999999999999999999987754444333332 2222332 3489999999999999
Q ss_pred CCCCCCCHHHHHcCcC
Q 000706 240 VPQNRLTWSALLEHPF 255 (1342)
Q Consensus 240 DPeKRPSAeELLeHPF 255 (1342)
||++|||+.|+++|||
T Consensus 238 ~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 238 NPEKRPTAEQLLKHPF 253 (253)
T ss_pred ChhhCCCHHHHhcCCC
Confidence 9999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=343.90 Aligned_cols=254 Identities=34% Similarity=0.575 Sum_probs=210.1
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-------
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP------- 75 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede------- 75 (1342)
+++|++.+.||+|+||.||+|.++.+++.+++|.+..............+|++++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 6899999999999999999999999999999999865533332234567899999999999999999987443
Q ss_pred -CeEEEEEeccCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 000706 76 -QEFCVVTEFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS 153 (1342)
Q Consensus 76 -d~lyLVMEY~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ 153 (1342)
..+|++|||+++++.+.+.. ...+++..++.++.|+++||.|||++|++||||||+||++++++.+||+|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 35799999999999888765 4579999999999999999999999999999999999999999999999999997654
Q ss_pred CCce-----------eeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--
Q 000706 154 ANTV-----------VLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV-- 219 (1342)
Q Consensus 154 sss~-----------~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~-- 219 (1342)
.... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|++||.+.+.......+.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 3221 1123457889999998765 4588999999999999999999999988776555444332100
Q ss_pred ---------------------CCC-------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 220 ---------------------KYP-------DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 220 ---------------------efP-------~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
..+ ...++++.++|.+||+.||.+|||+.|++.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 000 1345678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=345.59 Aligned_cols=252 Identities=31% Similarity=0.561 Sum_probs=207.0
Q ss_pred CEEEEEEEcccCcEEEEEEEEcc--CCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKY--TGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP--QEFC 79 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~--TGe~VAVKvIkKs~-~se~dierL~rEI~ILKrL~HPNIVKL~dvfede--d~ly 79 (1342)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.+.. ......+.+.+|+.+++.++||||+++++++.+. +.+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 59999999999999999999988 89999999997643 1122235677899999999999999999999888 8899
Q ss_pred EEEeccCCChHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcC----CCcEEEeeccccc
Q 000706 80 VVTEFAQGELFEILED-----DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA----GSVVKLCDFGFAR 150 (1342)
Q Consensus 80 LVMEY~eGSL~D~Lek-----~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLds----dG~LKLiDFGLAr 150 (1342)
+||||+++++.+.+.. ...+++..++.++.|++.||.|||++|++||||||+||+++. ++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9999999998887743 236899999999999999999999999999999999999999 8999999999998
Q ss_pred cccCCce---eeecccCCCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHH---------HHHHHhc-
Q 000706 151 AMSANTV---VLRSIKGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYA---------LIRHIVK- 216 (1342)
Q Consensus 151 ~l~sss~---~~~s~vGTp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~e---------lirkIlr- 216 (1342)
....... ......+++.|+|||.+.+. .++.++||||||+++|+|++|++||.+..... ....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 7643322 22345688999999987664 58899999999999999999999997543221 1111100
Q ss_pred -------------------------CCCCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 217 -------------------------DPVKYP-----------DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 217 -------------------------~~~efP-----------~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
....++ ...+.++.+++.+||+.||++|||+.|+++||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 001111 1466789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=336.32 Aligned_cols=252 Identities=30% Similarity=0.537 Sum_probs=213.7
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC--------HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS--------EKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ 76 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s--------e~dierL~rEI~ILKrL~HPNIVKL~dvfeded 76 (1342)
+|.+.+.||.|+||.||+|.+..+++.+|+|.++..... ....+.+.+|+.++++++|||+++++++++..+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 699999999999999999999989999999988643111 112356788999999999999999999999999
Q ss_pred eEEEEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCC
Q 000706 77 EFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN 155 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ss 155 (1342)
.+++||||++ |+|.+++.+.+++++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 9999999986 789999988888999999999999999999999999999999999999999999999999999765432
Q ss_pred c--eeeecccCCCCcCChhhhccCC--CCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC--CCCCC----CCC
Q 000706 156 T--VVLRSIKGTPLYMAPELVREQP--YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD--PVKYP----DEM 225 (1342)
Q Consensus 156 s--~~~~s~vGTp~YmAPEvL~g~~--YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~--~~efP----~eI 225 (1342)
. .......|+..|++||.+.... ++.++|+||||+++|+|++|..||...+.......+... ...++ ..+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 1 1123346889999999887654 789999999999999999999999766655444443322 22222 356
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 226 SPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 226 SpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
+.++.++|.+||+.||.+||++.++++||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8999999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=341.27 Aligned_cols=247 Identities=32% Similarity=0.556 Sum_probs=213.2
Q ss_pred EcccCcEEEEEEEEccCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-CCh
Q 000706 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GEL 89 (1342)
Q Consensus 12 LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-e~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e-GSL 89 (1342)
||+|+||+||+|.+..+|+.|++|.+.+.... ......+.+|++++++++|||++++++.++..+..|+||||++ ++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999999999999998754322 2234456789999999999999999999999999999999998 689
Q ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCCC
Q 000706 90 FEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL 167 (1342)
Q Consensus 90 ~D~Lek~g--~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp~ 167 (1342)
.+++.+.+ .+++..++.++.|++.+|.|||++|++||||+|+||+++.++.+||+|||.+....... ......++..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~ 159 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-KIKGRAGTPG 159 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-ccccccCCCC
Confidence 98887655 79999999999999999999999999999999999999999999999999987654322 2234568889
Q ss_pred cCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcH----HHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCC
Q 000706 168 YMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSV----YALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQN 243 (1342)
Q Consensus 168 YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~----~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeK 243 (1342)
|++||.+.+..++.++|+||+|+++|+|++|+.||..... ......+...+..+++.+++++.++|.+||+.||.+
T Consensus 160 y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 239 (277)
T cd05577 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK 239 (277)
T ss_pred cCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhH
Confidence 9999999888899999999999999999999999976543 333344444566677788999999999999999999
Q ss_pred CC-----CHHHHHcCcCcccc
Q 000706 244 RL-----TWSALLEHPFVKET 259 (1342)
Q Consensus 244 RP-----SAeELLeHPFFre~ 259 (1342)
|| ++.++++||||.+.
T Consensus 240 R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 240 RLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred ccCCCcccHHHHHhChhhhcC
Confidence 99 89999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=346.15 Aligned_cols=244 Identities=20% Similarity=0.327 Sum_probs=210.1
Q ss_pred CCEEEE--EEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHH-HHHHHHHHHHHHHhcCCCCcceEEEEEEe----CC
Q 000706 4 ENYHVI--ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEK-DIHNLRQEIEILRKLKHQNIIEMLDSFES----PQ 76 (1342)
Q Consensus 4 drYrIl--K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~-dierL~rEI~ILKrL~HPNIVKL~dvfed----ed 76 (1342)
++++.. ..||+|+++.||+|.. +|+.||+|.+++...... ..+.+.+|++++++++||||+++++++.+ ..
T Consensus 18 ~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~ 95 (283)
T PHA02988 18 DDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95 (283)
T ss_pred HHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCC
Confidence 344444 6799999999999976 689999999976543332 24678899999999999999999999876 45
Q ss_pred eEEEEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC-CceecCCCCCcEEEcCCCcEEEeeccccccccC
Q 000706 77 EFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN-RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA 154 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsr-GIVHRDLKPENILLdsdG~LKLiDFGLAr~l~s 154 (1342)
..+++|||++ |+|.+++.+.+.+++.....++.|++.||.|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 96 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 96 RLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred ceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 7899999998 68999998888899999999999999999999984 999999999999999999999999999986543
Q ss_pred CceeeecccCCCCcCChhhhcc--CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC--CCCCCCCCCHHHH
Q 000706 155 NTVVLRSIKGTPLYMAPELVRE--QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD--PVKYPDEMSPNFK 230 (1342)
Q Consensus 155 ss~~~~s~vGTp~YmAPEvL~g--~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~--~~efP~eISpeLk 230 (1342)
.. ....|++.|+|||++.+ ..|+.++||||||+++|||++|+.||.+.+..+....+... +..+|...+++++
T Consensus 176 ~~---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 252 (283)
T PHA02988 176 PP---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIK 252 (283)
T ss_pred cc---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHH
Confidence 32 23458899999999876 67999999999999999999999999988877777776543 4455667899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHc
Q 000706 231 SFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 231 DLIrKcLqkDPeKRPSAeELLe 252 (1342)
+++.+||+.||++|||+.|+++
T Consensus 253 ~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 253 CIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHhcCCcccCcCHHHHHH
Confidence 9999999999999999999975
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=327.71 Aligned_cols=243 Identities=28% Similarity=0.535 Sum_probs=214.9
Q ss_pred EEEcccCcEEEEEEEEccC---CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC
Q 000706 10 ELVGEGSFGKVYKGRRKYT---GQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~T---Ge~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e 86 (1342)
+.||+|+||.||+|.+... +..|++|.+....... ..+.+.+|+++++.++|+|++++++++.++..++++|||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 4699999999999999866 8999999987664433 46788999999999999999999999999999999999995
Q ss_pred -CChHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 87 -GELFEILEDD---------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 87 -GSL~D~Lek~---------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
|+|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.+.......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 8999999875 789999999999999999999999999999999999999999999999999998776543
Q ss_pred --eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHH
Q 000706 157 --VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSF 232 (1342)
Q Consensus 157 --~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDL 232 (1342)
.......+++.|+|||.+....++.++||||+|+++|+|++ |..||...+..+..+.+... ....+..+++++.++
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYEL 239 (262)
T ss_pred ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHH
Confidence 22334567889999999988889999999999999999999 69999988877777776643 445677889999999
Q ss_pred HHHhcccCCCCCCCHHHHHcC
Q 000706 233 LKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 233 IrKcLqkDPeKRPSAeELLeH 253 (1342)
+.+||+.||++|||+.|++++
T Consensus 240 i~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 240 MLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHccCCcccCcCHHHHHHh
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=329.18 Aligned_cols=250 Identities=34% Similarity=0.615 Sum_probs=222.2
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
+|++.+.||+|+||.||++.+..+++.+++|.+............+.+|++++++++||||+++++++.++...|++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 69999999999999999999999999999999977655555567788899999999999999999999999999999999
Q ss_pred cC-CChHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceee
Q 000706 85 AQ-GELFEILED----DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159 (1342)
Q Consensus 85 ~e-GSL~D~Lek----~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~ 159 (1342)
++ ++|.+++.+ ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++...... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~ 158 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MA 158 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--Cc
Confidence 97 688888865 457899999999999999999999999999999999999999999999999999877654 23
Q ss_pred ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHhcc
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP-VKYPDEMSPNFKSFLKGLLN 238 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~-~efP~eISpeLkDLIrKcLq 238 (1342)
....+++.|++||.+.+..++.++|+||+|+++|+|++|+.||...+.......+.... ...+..++.++++++.+||+
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQ 238 (256)
T ss_pred ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcC
Confidence 34568999999999999889999999999999999999999999887766666555443 34556788999999999999
Q ss_pred cCCCCCCCHHHHHcCcCc
Q 000706 239 KVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 239 kDPeKRPSAeELLeHPFF 256 (1342)
.+|++||++.++++||++
T Consensus 239 ~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 239 VKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCcccCCCHHHHhcCCCC
Confidence 999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=334.50 Aligned_cols=252 Identities=31% Similarity=0.542 Sum_probs=211.9
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
.+.+.....||+|+||.||+|.+..++..|++|.+.... ....+.+.+|++++++++||||+++++++.+++..+++|
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 345556678999999999999999999999999886543 334567889999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcC-CCC--CHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcC-CCcEEEeeccccccccCCce
Q 000706 83 EFAQ-GELFEILEDD-KCL--PEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA-GSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~-g~L--SEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLds-dG~LKLiDFGLAr~l~sss~ 157 (1342)
||++ ++|.+++.+. .++ ++..+..++.|++.||+|||++|++||||||+||+++. ++.+||+|||.+........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 9997 6899988754 455 88999999999999999999999999999999999976 67999999999976654333
Q ss_pred eeecccCCCCcCChhhhccCC--CCCCCcccchhhHHHHHHhCCCCCCCCcHH--HHHH-HHhcCCCCCCCCCCHHHHHH
Q 000706 158 VLRSIKGTPLYMAPELVREQP--YNHTADLWSLGVILYELFVGQPPFYTNSVY--ALIR-HIVKDPVKYPDEMSPNFKSF 232 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g~~--YT~KsDIWSLGVILYELLTGr~PF~g~s~~--elir-kIlr~~~efP~eISpeLkDL 232 (1342)
......|++.|+|||.+.+.. ++.++|+||+|+++|+|++|+.||...... .... ........+|..++++++++
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence 334456899999999886543 788999999999999999999999754321 1111 12233455677889999999
Q ss_pred HHHhcccCCCCCCCHHHHHcCcCc
Q 000706 233 LKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 233 IrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
+.+||+.+|++|||+.|+++||||
T Consensus 245 i~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 245 ILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=342.31 Aligned_cols=257 Identities=31% Similarity=0.526 Sum_probs=214.1
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-HQNIIEMLDSFESPQEFC 79 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~-HPNIVKL~dvfeded~ly 79 (1342)
++.++|+..+.||+|+||.||++.+..+++.+|+|.+.+.... .....+.+|+.++.++. ||||+++++++.+++..+
T Consensus 1 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~ 79 (288)
T cd06616 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW 79 (288)
T ss_pred CcHHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence 4567899999999999999999999999999999998765433 44567888999999995 999999999999999999
Q ss_pred EEEeccCCChHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHhhhC-CceecCCCCCcEEEcCCCcEEEeecccccccc
Q 000706 80 VVTEFAQGELFEILE-----DDKCLPEEQVQSIAKQLVRALHYLHSN-RIIHRDMKPQNILIGAGSVVKLCDFGFARAMS 153 (1342)
Q Consensus 80 LVMEY~eGSL~D~Le-----k~g~LSEeeI~~I~~QLLsALaYLHsr-GIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ 153 (1342)
++|||+++++.++.. ....+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++....
T Consensus 80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 999999876655432 346799999999999999999999975 99999999999999999999999999997654
Q ss_pred CCceeeecccCCCCcCChhhhccC---CCCCCCcccchhhHHHHHHhCCCCCCCCc-HHHHHHHHhcC-CCCC----CCC
Q 000706 154 ANTVVLRSIKGTPLYMAPELVREQ---PYNHTADLWSLGVILYELFVGQPPFYTNS-VYALIRHIVKD-PVKY----PDE 224 (1342)
Q Consensus 154 sss~~~~s~vGTp~YmAPEvL~g~---~YT~KsDIWSLGVILYELLTGr~PF~g~s-~~elirkIlr~-~~ef----P~e 224 (1342)
.... .....|++.|+|||.+.+. .++.++||||+|+++|+|++|+.||.... ..+...++... +... +..
T Consensus 160 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 160 DSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred cCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 3322 2334589999999998766 68999999999999999999999997654 22333333322 2222 234
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 225 MSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 225 ISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
+++++.+|+.+||+.||++|||++++++||||+..
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 78999999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=342.13 Aligned_cols=256 Identities=30% Similarity=0.536 Sum_probs=219.2
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
++.++|++.+.||+|+||+||++.+..+++.||+|.+..... ....+.+.+|+++++.++||||+++++.+.+.+.+|+
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 356789999999999999999999999999999998865432 3445778899999999999999999999999999999
Q ss_pred EEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 81 VTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS-NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHs-rGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
||||++ |+|.+++.+.+++++..+..++.|++.+|.|||+ +|++||||||+||+++.++.++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 999997 6788888888889999999999999999999997 699999999999999999999999999986543221
Q ss_pred eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcH-----------HHHHHHHhcC-CCCCCC-CC
Q 000706 159 LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSV-----------YALIRHIVKD-PVKYPD-EM 225 (1342)
Q Consensus 159 ~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~-----------~elirkIlr~-~~efP~-eI 225 (1342)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .+..+.+... +..++. .+
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF 238 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhc
Confidence 2345689999999999888899999999999999999999999976443 1233333332 233333 37
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 226 SPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 226 SpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
+.++.+|+.+||+.||.+|||+.|+++|+||.+.
T Consensus 239 ~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 239 PEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 8899999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=332.24 Aligned_cols=248 Identities=26% Similarity=0.477 Sum_probs=214.0
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
++.++|++.+.||+|+||.||++..+ ++..+++|.+.+.... ...+.+|++++++++||||+++++++.+++..|+
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 1 INPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred CCHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence 56789999999999999999999875 4668999988654333 2467889999999999999999999999999999
Q ss_pred EEeccC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 81 VTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
+|||++ |+|.+++.+ .+.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||.++........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999997 789998865 456899999999999999999999999999999999999999999999999999765433222
Q ss_pred -eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcCC-CCCCCCCCHHHHHHHHH
Q 000706 159 -LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKDP-VKYPDEMSPNFKSFLKG 235 (1342)
Q Consensus 159 -~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~~-~efP~eISpeLkDLIrK 235 (1342)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+.... ...|...++++.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 122335567999999988889999999999999999999 999999888877777776653 34566678899999999
Q ss_pred hcccCCCCCCCHHHHHc
Q 000706 236 LLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 236 cLqkDPeKRPSAeELLe 252 (1342)
||+.||++||++.++++
T Consensus 237 c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 237 CWHEKPEGRPTFAELLR 253 (256)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=335.61 Aligned_cols=251 Identities=34% Similarity=0.551 Sum_probs=213.8
Q ss_pred EEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEEEEEe
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP--QEFCVVTE 83 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede--d~lyLVME 83 (1342)
|++.+.||+|+||.||+|.+..+++.+++|.+............+.+|++++++++|||++++++++.++ +..|++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 7899999999999999999999999999999987643333445678899999999999999999999888 89999999
Q ss_pred ccCCChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce-eeec
Q 000706 84 FAQGELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV-VLRS 161 (1342)
Q Consensus 84 Y~eGSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~-~~~s 161 (1342)
|++++|.+++.+. ..+++..++.++.|+++||+|||++|++|+||||+||++++++.+||+|||++........ ....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence 9999999988765 6899999999999999999999999999999999999999999999999999987654431 1233
Q ss_pred ccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-----C---------------
Q 000706 162 IKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV-----K--------------- 220 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~-----e--------------- 220 (1342)
..++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+..... .
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07840 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240 (287)
T ss_pred cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence 457889999997764 4578999999999999999999999988776555554432100 0
Q ss_pred -----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 221 -----------YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 221 -----------fP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
+....++++.+++++||+.||.+||++.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 001137889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=341.92 Aligned_cols=249 Identities=22% Similarity=0.390 Sum_probs=204.8
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEcc----------------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcc
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKY----------------TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~----------------TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIV 66 (1342)
-++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 3689999999999999999997542 34479999886542 344456788999999999999999
Q ss_pred eEEEEEEeCCeEEEEEeccC-CChHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHhhhCCceec
Q 000706 67 EMLDSFESPQEFCVVTEFAQ-GELFEILEDD-------------------KCLPEEQVQSIAKQLVRALHYLHSNRIIHR 126 (1342)
Q Consensus 67 KL~dvfeded~lyLVMEY~e-GSL~D~Lek~-------------------g~LSEeeI~~I~~QLLsALaYLHsrGIVHR 126 (1342)
++++++.+.+..+++|||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 99999999999999999997 6899988542 236778899999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEeeccccccccCCce--eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh--CCCCC
Q 000706 127 DMKPQNILIGAGSVVKLCDFGFARAMSANTV--VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV--GQPPF 202 (1342)
Q Consensus 127 DLKPENILLdsdG~LKLiDFGLAr~l~sss~--~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT--Gr~PF 202 (1342)
||||+|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|+|++ +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 9999999999999999999999986543322 1223446788999999988889999999999999999986 67788
Q ss_pred CCCcHHHHHHHHhc--------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 203 YTNSVYALIRHIVK--------DPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 203 ~g~s~~elirkIlr--------~~~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
...+..+....+.. .....++..++.+.+++.+||+.||++|||+.|+.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 243 GELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 77655544433211 112345567899999999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=334.82 Aligned_cols=250 Identities=34% Similarity=0.564 Sum_probs=212.2
Q ss_pred EEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc---CCCCcceEEEEEEeCCe-----
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL---KHQNIIEMLDSFESPQE----- 77 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL---~HPNIVKL~dvfeded~----- 77 (1342)
|++.+.||+|+||.||++.++.+++.||+|.++...........+.+|+.+++++ +|||++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999998899999999975544333344566788877766 59999999999988776
Q ss_pred EEEEEeccCCChHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCC
Q 000706 78 FCVVTEFAQGELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN 155 (1342)
Q Consensus 78 lyLVMEY~eGSL~D~Lek~g--~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ss 155 (1342)
++++|||++++|.+++.+.. .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||.+..+...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 99999999999999887643 5999999999999999999999999999999999999999999999999999876543
Q ss_pred ceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC-----CC----------
Q 000706 156 TVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP-----VK---------- 220 (1342)
Q Consensus 156 s~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~-----~e---------- 220 (1342)
.. .....+++.|+|||.+.+..++.++|+||||+++|+|++|++||.+.+..+...++...- ..
T Consensus 161 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07838 161 MA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS 239 (287)
T ss_pred cc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchh
Confidence 22 233457889999999998889999999999999999999999999887766666554310 00
Q ss_pred -C-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 221 -Y-----------PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 221 -f-----------P~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
+ .+.+++.+.++|.+||+.||.+||++.|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 240 SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 11346788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=337.24 Aligned_cols=254 Identities=32% Similarity=0.646 Sum_probs=218.3
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeEEEE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK---HQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~---HPNIVKL~dvfeded~lyLV 81 (1342)
.|++.+.||+|+||.||+|.+..+++.|++|.+.... .......+.+|++++++++ |||++++++++.++...|++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 5889999999999999999999999999999986543 2334567888999999996 99999999999999999999
Q ss_pred EeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 82 TEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
|||++ ++|.+++.. +.+++..++.++.|++.+|.|||+.|++||||+|+||+++.++.++|+|||++...........
T Consensus 81 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06917 81 MEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS 159 (277)
T ss_pred EecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccc
Confidence 99997 578888765 4799999999999999999999999999999999999999999999999999987765544444
Q ss_pred cccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-CCCCCC-CCCHHHHHHHHHhc
Q 000706 161 SIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-PVKYPD-EMSPNFKSFLKGLL 237 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~-~~efP~-eISpeLkDLIrKcL 237 (1342)
...|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+... +..++. .+++++.+++.+||
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 239 (277)
T cd06917 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACL 239 (277)
T ss_pred cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHc
Confidence 5678999999998865 45789999999999999999999999887665554443332 223333 37889999999999
Q ss_pred ccCCCCCCCHHHHHcCcCcccch
Q 000706 238 NKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 238 qkDPeKRPSAeELLeHPFFre~~ 260 (1342)
+.||++||++.|+++||||++..
T Consensus 240 ~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 240 DEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred CCCcccCcCHHHHhhChHhhccc
Confidence 99999999999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=337.15 Aligned_cols=250 Identities=27% Similarity=0.468 Sum_probs=215.0
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEc-----cCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRK-----YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ 76 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk-----~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded 76 (1342)
..++|++.+.||+|+||.||+|.+. .+++.||+|.++.... .+..+.+.+|++++++++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4678999999999999999999874 3467899999865433 334578899999999999999999999999999
Q ss_pred eEEEEEeccC-CChHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcE
Q 000706 77 EFCVVTEFAQ-GELFEILEDD--------------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVV 141 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek~--------------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~L 141 (1342)
..|++|||++ |+|.+++... ..+++..+..++.|++.+|.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999997 7899998653 347899999999999999999999999999999999999999999
Q ss_pred EEeeccccccccCCce--eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcCC
Q 000706 142 KLCDFGFARAMSANTV--VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKDP 218 (1342)
Q Consensus 142 KLiDFGLAr~l~sss~--~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~~ 218 (1342)
||+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR 241 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999976533221 1123346788999999999999999999999999999998 999998888777777776654
Q ss_pred C-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 219 V-KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 219 ~-efP~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
. ..+..++.++.+++++||+.||++||++.|+++
T Consensus 242 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 242 LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3 345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=337.29 Aligned_cols=254 Identities=33% Similarity=0.591 Sum_probs=221.0
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
-|++.+.||.|+||.||++.+..+++.||+|.+.... .......+.+|++++++++||||+++++.+.+++..|+||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 4788999999999999999999899999999886443 234456788999999999999999999999999999999999
Q ss_pred cC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeeccc
Q 000706 85 AQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK 163 (1342)
Q Consensus 85 ~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~v 163 (1342)
++ |+|.+++.. ..++++.+..++.|++.++.|||++|++|+||||+||+++.++.++|+|||++..............
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcccc
Confidence 97 578887764 4689999999999999999999999999999999999999999999999999977654433334456
Q ss_pred CCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhcccCCC
Q 000706 164 GTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLNKVPQ 242 (1342)
Q Consensus 164 GTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrKcLqkDPe 242 (1342)
++..|++||.+.+..++.++|+||||+++|+|++|..||...........+... ...++..++.++.+++.+||+.||.
T Consensus 163 ~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 242 (277)
T cd06641 163 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPS 242 (277)
T ss_pred CCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 899999999998888899999999999999999999999877665555555433 3345667889999999999999999
Q ss_pred CCCCHHHHHcCcCcccch
Q 000706 243 NRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 243 KRPSAeELLeHPFFre~~ 260 (1342)
+||++.++++||||.+..
T Consensus 243 ~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 243 FRPTAKELLKHKFIVRFA 260 (277)
T ss_pred hCcCHHHHHhCHHHhhhh
Confidence 999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=344.15 Aligned_cols=255 Identities=34% Similarity=0.594 Sum_probs=219.1
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
+.|++.+.||.|+||.||+|.+..+++.||+|.+..... ....+.+.+|++++++++||||+++++.+.+++.+|+|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 356778889999999999999998999999999865432 3345678899999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 84 FAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
|++ |+|.+++.. ..+++..++.++.|+++|+.|||++|++|+||+|+||+++.++.+||+|||++.............
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence 998 578887754 568999999999999999999999999999999999999999999999999998765443333445
Q ss_pred cCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhcccCC
Q 000706 163 KGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLNKVP 241 (1342)
Q Consensus 163 vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrKcLqkDP 241 (1342)
.|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+... +...+...+.++.++|.+||+.+|
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06642 162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDP 241 (277)
T ss_pred cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCc
Confidence 6889999999999888999999999999999999999999766554444444333 233445678899999999999999
Q ss_pred CCCCCHHHHHcCcCcccch
Q 000706 242 QNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 242 eKRPSAeELLeHPFFre~~ 260 (1342)
.+||++.++++||||....
T Consensus 242 ~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 242 RFRPTAKELLKHKFITRYT 260 (277)
T ss_pred ccCcCHHHHHHhHHHHHHh
Confidence 9999999999999997654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=328.61 Aligned_cols=250 Identities=36% Similarity=0.619 Sum_probs=214.0
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~-~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
+++|++.+.||+|+||.||+|.+..+|+.|++|.++... ......+.+.+|++++++++|+|++++++.+.+++..+++
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 478999999999999999999999999999999987533 2333467888999999999999999999999999999999
Q ss_pred EeccC-CChHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 82 TEFAQ-GELFEILED----DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek----~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
|||++ |+|.+++.+ ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 99997 689888854 3468999999999999999999999999999999999999999999999999998765544
Q ss_pred eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCc--HHHHHHHHhcCC-CCCCC-CCCHHHHHH
Q 000706 157 VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS--VYALIRHIVKDP-VKYPD-EMSPNFKSF 232 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s--~~elirkIlr~~-~efP~-eISpeLkDL 232 (1342)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.... ..+..+.+.... .+.+. .++.++.++
T Consensus 161 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDL 240 (267)
T ss_pred cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHH
Confidence 33344568999999999998889999999999999999999999996543 333444443332 23333 678899999
Q ss_pred HHHhcccCCCCCCCHHHHHc
Q 000706 233 LKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 233 IrKcLqkDPeKRPSAeELLe 252 (1342)
|.+||..+|++|||+.++++
T Consensus 241 i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 241 VSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=340.52 Aligned_cols=255 Identities=33% Similarity=0.529 Sum_probs=213.6
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-----
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ----- 76 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded----- 76 (1342)
.+++|++.+.||+|+||.||+|.++.+++.|++|.++...........+.+|++++++++|||++++++++.++.
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 367899999999999999999999999999999999765433333456778999999999999999999987655
Q ss_pred -----eEEEEEeccCCChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 000706 77 -----EFCVVTEFAQGELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFAR 150 (1342)
Q Consensus 77 -----~lyLVMEY~eGSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr 150 (1342)
.+|++|||+++++.+.+.+. ..+++..++.++.|++.||+|||+.|++||||||+||++++++.+||+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 89999999999998887754 479999999999999999999999999999999999999999999999999998
Q ss_pred cccCCce-eeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhc---CCC------
Q 000706 151 AMSANTV-VLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK---DPV------ 219 (1342)
Q Consensus 151 ~l~sss~-~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr---~~~------ 219 (1342)
....... ......+++.|++||.+.+ ..++.++||||||+++|+|++|++||...+..+....+.. .+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 244 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 7654331 2223346888999998865 3478999999999999999999999987766554444332 110
Q ss_pred ---------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 220 ---------------------KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 220 ---------------------efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
.....+++.+.+++.+||+.||.+||++.++++||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0112468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=373.13 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=207.2
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
..+|++.+.||+|+||.||+|.+..+++.||+|.... ....+|++++++++||||+++++++..++..+++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 3479999999999999999999999999999996321 23567999999999999999999999999999999
Q ss_pred eccCCChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce--ee
Q 000706 83 EFAQGELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV--VL 159 (1342)
Q Consensus 83 EY~eGSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~--~~ 159 (1342)
|++.|+|.+++.+. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 240 e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 240 PKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred EccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 99999999998764 5799999999999999999999999999999999999999999999999999986643321 12
Q ss_pred ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCc--------HHHHHHHHhcCC---CCCC------
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS--------VYALIRHIVKDP---VKYP------ 222 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s--------~~elirkIlr~~---~efP------ 222 (1342)
....||+.|+|||++.+..++.++|||||||++|||++|..|+.... ..+..+.+.... ..++
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 399 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR 399 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence 24579999999999999999999999999999999999887654321 122222222110 0010
Q ss_pred -------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCccc
Q 000706 223 -------------------------DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258 (1342)
Q Consensus 223 -------------------------~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre 258 (1342)
..+++++.+||.+||+.||++|||+.|+|+||||+.
T Consensus 400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 134568999999999999999999999999999974
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=381.01 Aligned_cols=247 Identities=31% Similarity=0.570 Sum_probs=219.2
Q ss_pred EEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-CCh
Q 000706 11 LVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GEL 89 (1342)
Q Consensus 11 ~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e-GSL 89 (1342)
.||+|+||+||.|+|..|..++|||.+... .....+-+++||.++++++|.|||++.+.+.+++.+-|.||-++ |+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 599999999999999999999999998543 34455779999999999999999999999999999999999997 688
Q ss_pred HHHHhc-CCCC--CHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEc-CCCcEEEeeccccccccCCceeeecccCC
Q 000706 90 FEILED-DKCL--PEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIG-AGSVVKLCDFGFARAMSANTVVLRSIKGT 165 (1342)
Q Consensus 90 ~D~Lek-~g~L--SEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLd-sdG~LKLiDFGLAr~l~sss~~~~s~vGT 165 (1342)
.++++. -+++ .|.++-.|.+||++||.|||++.|||||||-+|+||+ -.|-+||.|||.++.+..-.....++.||
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT 739 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT 739 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence 888864 5677 8999999999999999999999999999999999996 47899999999999988777778889999
Q ss_pred CCcCChhhhccCC--CCCCCcccchhhHHHHHHhCCCCCCCCc-HH-HHHH-HHhcCCCCCCCCCCHHHHHHHHHhcccC
Q 000706 166 PLYMAPELVREQP--YNHTADLWSLGVILYELFVGQPPFYTNS-VY-ALIR-HIVKDPVKYPDEMSPNFKSFLKGLLNKV 240 (1342)
Q Consensus 166 p~YmAPEvL~g~~--YT~KsDIWSLGVILYELLTGr~PF~g~s-~~-elir-kIlr~~~efP~eISpeLkDLIrKcLqkD 240 (1342)
..|||||++..++ |+.++|||||||++.||.||++||.... .. .+.+ -.++..++.|..++.+++.||.+|+.+|
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd 819 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPD 819 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCC
Confidence 9999999997654 8999999999999999999999997533 22 2222 2345677889999999999999999999
Q ss_pred CCCCCCHHHHHcCcCcccc
Q 000706 241 PQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 241 PeKRPSAeELLeHPFFre~ 259 (1342)
|.+||++.++|++||++..
T Consensus 820 ~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 820 PCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred cccCccHHHhccCcccccC
Confidence 9999999999999999865
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.27 Aligned_cols=253 Identities=34% Similarity=0.606 Sum_probs=219.6
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
+|+..+.||+|++|.||++.+..+++.+++|.+.... ....+.+.+|+.++++++|||++++++++..++..++++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 5666789999999999999999999999999885432 23345688999999999999999999999999999999999
Q ss_pred cC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeeccc
Q 000706 85 AQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK 163 (1342)
Q Consensus 85 ~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~v 163 (1342)
++ ++|.+++.+ +++++..+..++.|++.+|+|||++|++||||+|+||+++.++.++|+|||.+..............
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 176 (285)
T cd06648 98 LEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV 176 (285)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence 96 688888877 6799999999999999999999999999999999999999999999999998876544333334456
Q ss_pred CCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC---CCCCCHHHHHHHHHhcccC
Q 000706 164 GTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKY---PDEMSPNFKSFLKGLLNKV 240 (1342)
Q Consensus 164 GTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~ef---P~eISpeLkDLIrKcLqkD 240 (1342)
|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+.......+....... +..+++.+.+++.+||+.|
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 256 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRD 256 (285)
T ss_pred CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccC
Confidence 8999999999988889999999999999999999999998877766666665543222 3347889999999999999
Q ss_pred CCCCCCHHHHHcCcCcccch
Q 000706 241 PQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 241 PeKRPSAeELLeHPFFre~~ 260 (1342)
|++||++.++++||||+...
T Consensus 257 p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 257 PAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred hhhCcCHHHHccCcccccCC
Confidence 99999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=330.91 Aligned_cols=252 Identities=31% Similarity=0.571 Sum_probs=218.0
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCC---CCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG---KSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP--QEF 78 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~---~se~dierL~rEI~ILKrL~HPNIVKL~dvfede--d~l 78 (1342)
.+|++.+.||+|+||.||++++..+++.|++|.+.... ........+.+|++++++++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999885432 2234456788999999999999999999998764 568
Q ss_pred EEEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCC--
Q 000706 79 CVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN-- 155 (1342)
Q Consensus 79 yLVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ss-- 155 (1342)
+++|||++ ++|.+++.+.+.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999997 689999988788999999999999999999999999999999999999999999999999999865421
Q ss_pred -ceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC--CCCCCCCCCHHHHHH
Q 000706 156 -TVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD--PVKYPDEMSPNFKSF 232 (1342)
Q Consensus 156 -s~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~--~~efP~eISpeLkDL 232 (1342)
........|+..|+|||.+.+..++.++|+||||+++|+|++|+.||..........++... +..+|+.++++++++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 241 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF 241 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHH
Confidence 11123456899999999999888999999999999999999999999887666555555433 345788899999999
Q ss_pred HHHhcccCCCCCCCHHHHHcCcCc
Q 000706 233 LKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 233 IrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
+.+||+ +|.+||++.++++|||.
T Consensus 242 i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 242 LKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHhc-CcccCccHHHHhcCCCC
Confidence 999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.99 Aligned_cols=253 Identities=34% Similarity=0.578 Sum_probs=218.9
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~-~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
++|++.+.||+|+||.||++.+..+++.|++|.+.... ......+.+.+|+++++.++|||++++++++.+++..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 57999999999999999999999899999999986543 33444567889999999999999999999999999999999
Q ss_pred eccCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
||++|++.+.+.. .+++++..+..++.|++.+|.|||+.|++||||+|+||+++.++.+||+|||++...... ..
T Consensus 95 e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----~~ 170 (307)
T cd06607 95 EYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----NS 170 (307)
T ss_pred HhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----CC
Confidence 9999999888754 567999999999999999999999999999999999999999999999999998765433 23
Q ss_pred ccCCCCcCChhhhc---cCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-CCCC-CCCCCHHHHHHHHHh
Q 000706 162 IKGTPLYMAPELVR---EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-PVKY-PDEMSPNFKSFLKGL 236 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~---g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~-~~ef-P~eISpeLkDLIrKc 236 (1342)
..+++.|+|||.+. ...++.++||||||+++|+|++|+.||...+.......+... +... +..++.+++++|.+|
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 250 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSC 250 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHH
Confidence 46889999999874 456889999999999999999999999887766655554433 2222 345788999999999
Q ss_pred cccCCCCCCCHHHHHcCcCcccch
Q 000706 237 LNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 237 LqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
|+.||++||++.+++.||||....
T Consensus 251 l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 251 LQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred hcCChhhCcCHHHHhcChhhcccC
Confidence 999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.44 Aligned_cols=251 Identities=27% Similarity=0.477 Sum_probs=213.2
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEc----cCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRK----YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQE 77 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk----~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~ 77 (1342)
.+++|++.+.||+|+||.||+|... .+++.+++|.+.... .......+.+|++++++++||||+++++++..++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 5689999999999999999999853 456789999987543 33445678899999999999999999999999999
Q ss_pred EEEEEeccC-CChHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC
Q 000706 78 FCVVTEFAQ-GELFEILEDD-----------------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS 139 (1342)
Q Consensus 78 lyLVMEY~e-GSL~D~Lek~-----------------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG 139 (1342)
.|++|||++ |+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 999999997 7899988532 2478899999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCc--eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhc
Q 000706 140 VVKLCDFGFARAMSANT--VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVK 216 (1342)
Q Consensus 140 ~LKLiDFGLAr~l~sss--~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr 216 (1342)
.+||+|||+++...... .......++..|+|||.+.+..++.++|+||||+++|||++ |..||.+.+.......+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999998654332 12233446778999999988889999999999999999998 9999988776665555544
Q ss_pred C-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 217 D-PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 217 ~-~~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
. ....+..+++.+++++.+||+.||.+||++.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 242 RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 3 344567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=350.21 Aligned_cols=255 Identities=31% Similarity=0.591 Sum_probs=210.4
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----CeE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP-----QEF 78 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede-----d~l 78 (1342)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..... ......+.+|+.++++++||||+++++++... ...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 789999999999999999999999999999999864322 23345677899999999999999999887544 358
Q ss_pred EEEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce-
Q 000706 79 CVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV- 157 (1342)
Q Consensus 79 yLVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~- 157 (1342)
|++|||+++++.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 84 ~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 84 YIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162 (336)
T ss_pred EEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence 99999999999888754 5699999999999999999999999999999999999999999999999999976543221
Q ss_pred --eeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhc---C--------------
Q 000706 158 --VLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK---D-------------- 217 (1342)
Q Consensus 158 --~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr---~-------------- 217 (1342)
......|++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.+.......+.. .
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (336)
T cd07849 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRA 242 (336)
T ss_pred cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhh
Confidence 1223568999999998654 5689999999999999999999999987654332222110 0
Q ss_pred -------CC--C-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 218 -------PV--K-----YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 218 -------~~--e-----fP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
+. . ..+..++++.+++.+||+.||++|||+.|+++||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 243 RNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00 0 1134678899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=331.47 Aligned_cols=252 Identities=23% Similarity=0.455 Sum_probs=215.5
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccC---CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYT---GQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQE 77 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~T---Ge~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~ 77 (1342)
|.-++|++.+.||+|+||.||+|.++.+ ...|++|.++... .......+.+|+.++++++||||+++++++.+++.
T Consensus 1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred CChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 3567899999999999999999988644 4578999886543 33445678889999999999999999999999999
Q ss_pred EEEEEeccC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCC
Q 000706 78 FCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN 155 (1342)
Q Consensus 78 lyLVMEY~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ss 155 (1342)
.|++|||++ |+|.+++.+ .+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999997 689999865 457999999999999999999999999999999999999999999999999999887522
Q ss_pred ceee--ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHH
Q 000706 156 TVVL--RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKS 231 (1342)
Q Consensus 156 s~~~--~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkD 231 (1342)
.... ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+..+.+... ..+.+...++.+.+
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 2221 22335678999999998889999999999999999997 99999887777766666554 33556678999999
Q ss_pred HHHHhcccCCCCCCCHHHHHcC
Q 000706 232 FLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 232 LIrKcLqkDPeKRPSAeELLeH 253 (1342)
++.+||+.||++||++.|++++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=328.28 Aligned_cols=245 Identities=39% Similarity=0.705 Sum_probs=221.8
Q ss_pred EcccCcEEEEEEEEccCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEecc-CCCh
Q 000706 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFA-QGEL 89 (1342)
Q Consensus 12 LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-e~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~-eGSL 89 (1342)
||.|+||.||++.+..+++.+++|.+.+.... ......+.+|++++++++|||++++++.+++++..|++|||+ +++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999989999999998765332 234567889999999999999999999999999999999999 5889
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCCCcC
Q 000706 90 FEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYM 169 (1342)
Q Consensus 90 ~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp~Ym 169 (1342)
.+++.....+++..++.++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||.+..............++..|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence 99998888899999999999999999999999999999999999999999999999999987655433344566899999
Q ss_pred ChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH--
Q 000706 170 APELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTW-- 247 (1342)
Q Consensus 170 APEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRPSA-- 247 (1342)
+||...+..++.++|+||||+++|+|++|+.||...+.....+.+......++...+..+.+++.+||+.||++||++
T Consensus 161 ~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 999998888899999999999999999999999888877777777777778888889999999999999999999999
Q ss_pred -HHHHcCcCc
Q 000706 248 -SALLEHPFV 256 (1342)
Q Consensus 248 -eELLeHPFF 256 (1342)
+++++||||
T Consensus 241 ~~~l~~~~~f 250 (250)
T cd05123 241 AEEIKAHPFF 250 (250)
T ss_pred HHHHHhCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=336.27 Aligned_cols=251 Identities=35% Similarity=0.566 Sum_probs=216.2
Q ss_pred EEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEecc
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFA 85 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~ 85 (1342)
|++.+.||+|+||.||+|.+..+++.|++|.+..........+.+..|+.++++++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 78889999999999999999999999999999765433334466788999999999999999999999999999999999
Q ss_pred CCChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccC
Q 000706 86 QGELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG 164 (1342)
Q Consensus 86 eGSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vG 164 (1342)
+++|.+++.+. ..+++..++.++.|++.+|+|||++|++||||+|+||+++.++.+||+|||.++.............+
T Consensus 81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (282)
T cd07829 81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV 160 (282)
T ss_pred CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcccc
Confidence 99999999876 68999999999999999999999999999999999999999999999999999876654434444557
Q ss_pred CCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC------------------CC------
Q 000706 165 TPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD------------------PV------ 219 (1342)
Q Consensus 165 Tp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~------------------~~------ 219 (1342)
+..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+...++... ..
T Consensus 161 ~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd07829 161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFP 240 (282)
T ss_pred CcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccC
Confidence 8889999988766 7899999999999999999999999887655554443220 00
Q ss_pred -----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 220 -----KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 220 -----efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
...+.++..+.+++++||..||++||++.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 241 PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0012347789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=331.90 Aligned_cols=248 Identities=24% Similarity=0.487 Sum_probs=215.7
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
...+|++.+.||+|+||.||+|.++.+++.+++|.+.+.. .....+.+|++++++++||||+++++++..++.++++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 4567999999999999999999999999999999986442 2345688899999999999999999999999999999
Q ss_pred EeccC-CChHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 82 TEFAQ-GELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek~--g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
|||++ |+|.+++... ..+++..++.++.|++++|+|||++|++||||||+||++++++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 99986 7899988653 35899999999999999999999999999999999999999999999999999876544322
Q ss_pred e-ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHH
Q 000706 159 L-RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKG 235 (1342)
Q Consensus 159 ~-~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrK 235 (1342)
. ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+..+.+... ....+..+++++.+++.+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRA 240 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 1 12234567999999998899999999999999999998 99999887777766666553 456677889999999999
Q ss_pred hcccCCCCCCCHHHHHc
Q 000706 236 LLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 236 cLqkDPeKRPSAeELLe 252 (1342)
||+.||++||++.++++
T Consensus 241 cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 241 CWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HccCCcccCCCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.51 Aligned_cols=248 Identities=31% Similarity=0.515 Sum_probs=205.6
Q ss_pred EEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHH-HHHHHHHHHHHHH---hcCCCCcceEEEEEEeCCeEEEEEeccC
Q 000706 11 LVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEK-DIHNLRQEIEILR---KLKHQNIIEMLDSFESPQEFCVVTEFAQ 86 (1342)
Q Consensus 11 ~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~-dierL~rEI~ILK---rL~HPNIVKL~dvfeded~lyLVMEY~e 86 (1342)
.||+|+||.||++.+..+++.+|+|.+.+...... ......+|..+++ ..+|||++.+++.+.+++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999999976533222 1223334444333 3479999999999999999999999997
Q ss_pred -CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCC
Q 000706 87 -GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGT 165 (1342)
Q Consensus 87 -GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGT 165 (1342)
|+|.+++.+.+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....... .....|+
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~ 158 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGT 158 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccCcCCC
Confidence 6898999888889999999999999999999999999999999999999999999999999987654332 2334689
Q ss_pred CCcCChhhhc-cCCCCCCCcccchhhHHHHHHhCCCCCCCCc---HHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCC
Q 000706 166 PLYMAPELVR-EQPYNHTADLWSLGVILYELFVGQPPFYTNS---VYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVP 241 (1342)
Q Consensus 166 p~YmAPEvL~-g~~YT~KsDIWSLGVILYELLTGr~PF~g~s---~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDP 241 (1342)
+.|+|||.+. +..++.++|+||+|+++|+|++|+.||.... ..............+++.++++++++|.+||+.||
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 238 (279)
T cd05633 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV 238 (279)
T ss_pred cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCH
Confidence 9999999886 4568999999999999999999999997532 22222223344556778899999999999999999
Q ss_pred CCCC-----CHHHHHcCcCcccch
Q 000706 242 QNRL-----TWSALLEHPFVKETS 260 (1342)
Q Consensus 242 eKRP-----SAeELLeHPFFre~~ 260 (1342)
.+|| +++|+++||||+...
T Consensus 239 ~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 239 SKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred HHhcCCCCCCHHHHHhCccccCCC
Confidence 9999 699999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=346.41 Aligned_cols=253 Identities=35% Similarity=0.620 Sum_probs=216.1
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
+.|.....||+|+||.||++.+..+++.|++|.+.... ....+.+.+|+.+++.++|||++++++.+..++..|++||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 34556778999999999999999999999999986432 3345678899999999999999999999999999999999
Q ss_pred ccCC-ChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 84 FAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 Y~eG-SL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
|++| +|.+++.+ +.+++.+++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.............
T Consensus 100 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 178 (292)
T cd06658 100 FLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL 178 (292)
T ss_pred CCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence 9985 67776644 568999999999999999999999999999999999999999999999999987654433333445
Q ss_pred cCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC---CCCCCCCCCHHHHHHHHHhccc
Q 000706 163 KGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PVKYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 163 vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~---~~efP~eISpeLkDLIrKcLqk 239 (1342)
.|++.|+|||.+.+..++.++|+||+|+++|||++|+.||...+.......+... .......+++.+.+++.+||..
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 258 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVR 258 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccC
Confidence 6899999999998888999999999999999999999999887766555544332 2223345788999999999999
Q ss_pred CCCCCCCHHHHHcCcCcccc
Q 000706 240 VPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 240 DPeKRPSAeELLeHPFFre~ 259 (1342)
||.+|||++|+++||||+..
T Consensus 259 ~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 259 EPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred ChhHCcCHHHHhhChhhhcc
Confidence 99999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=401.24 Aligned_cols=260 Identities=30% Similarity=0.547 Sum_probs=233.3
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFC 79 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-e~dierL~rEI~ILKrL~HPNIVKL~dvfeded~ly 79 (1342)
|.-++|+|++.||+|+||.|..++++.+++.||+|++.|-... ..+...++.|-.+|-.-+.+.|++++..|+++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 4568999999999999999999999999999999999763221 223356888999999999999999999999999999
Q ss_pred EEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccC-Cce
Q 000706 80 VVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA-NTV 157 (1342)
Q Consensus 80 LVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~s-ss~ 157 (1342)
+||||++ |||..++.+..+++|+.++.|+..++.||.-+|+.|+|||||||+|||+|.+|++||+|||.+-.+.. +..
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 9999986 79999999988999999999999999999999999999999999999999999999999999988874 445
Q ss_pred eeecccCCCCcCChhhhcc-----CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC--CCCCC--CCCCHH
Q 000706 158 VLRSIKGTPLYMAPELVRE-----QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD--PVKYP--DEMSPN 228 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g-----~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~--~~efP--~eISpe 228 (1342)
.....+|||-|++||++.. +.|+..+|+||+|+++|||++|..||+.++..+.+.+|..- .+.|| ..+|++
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSee 311 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEE 311 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHH
Confidence 5567899999999999853 56899999999999999999999999999999999999864 67788 568999
Q ss_pred HHHHHHHhcccCCCCCCC---HHHHHcCcCcccchh
Q 000706 229 FKSFLKGLLNKVPQNRLT---WSALLEHPFVKETSD 261 (1342)
Q Consensus 229 LkDLIrKcLqkDPeKRPS---AeELLeHPFFre~~~ 261 (1342)
+++||+++++ +|..|.. ++++..||||.+...
T Consensus 312 akdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 312 AKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred HHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 9999999874 7888888 999999999998643
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=391.04 Aligned_cols=257 Identities=31% Similarity=0.585 Sum_probs=217.5
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFES--PQEFCV 80 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfed--ed~lyL 80 (1342)
+++|++++.||+|+||+||+|.+..+++.|++|.+............+..|+.++++++||||++++++|.+ ...+|+
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 679999999999999999999999999999999998766666667788999999999999999999998854 467999
Q ss_pred EEeccC-CChHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhC-------CceecCCCCCcEEEcC-----------
Q 000706 81 VTEFAQ-GELFEILED----DKCLPEEQVQSIAKQLVRALHYLHSN-------RIIHRDMKPQNILIGA----------- 137 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek----~g~LSEeeI~~I~~QLLsALaYLHsr-------GIVHRDLKPENILLds----------- 137 (1342)
||||++ |+|.++|.+ .+.+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 999997 789998865 35799999999999999999999984 4999999999999964
Q ss_pred ------CCcEEEeeccccccccCCceeeecccCCCCcCChhhhcc--CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHH
Q 000706 138 ------GSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVRE--QPYNHTADLWSLGVILYELFVGQPPFYTNSVYA 209 (1342)
Q Consensus 138 ------dG~LKLiDFGLAr~l~sss~~~~s~vGTp~YmAPEvL~g--~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~e 209 (1342)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+...
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ 250 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250 (1021)
T ss_pred ccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH
Confidence 2358999999998765432 2234579999999999854 458899999999999999999999998765444
Q ss_pred H-HHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 210 L-IRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 210 l-irkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
. ...+...+.......++++.+||..||+.+|.+||++.|+|.|||++...
T Consensus 251 qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 251 QLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 3 33333333222346789999999999999999999999999999998653
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=332.99 Aligned_cols=250 Identities=34% Similarity=0.597 Sum_probs=213.4
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
+++|++.+.||+|+||.||++.+..+++.+++|.+.+... .......+.+|+++++.++||||+++++++.+++..+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 5789999999999999999999999999999998865432 334456788999999999999999999999999999999
Q ss_pred EeccC-CChHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 82 TEFAQ-GELFEILED----DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek----~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
|||++ ++|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 99997 588888763 4568999999999999999999999999999999999999999999999999998765544
Q ss_pred eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcH--HHHHHHHhcCC-CC-CCCCCCHHHHHH
Q 000706 157 VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSV--YALIRHIVKDP-VK-YPDEMSPNFKSF 232 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~--~elirkIlr~~-~e-fP~eISpeLkDL 232 (1342)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+... ....+.+.... .+ .+..++++++++
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 240 (267)
T ss_pred cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHH
Confidence 334456789999999999888899999999999999999999999976432 33444443322 12 234578899999
Q ss_pred HHHhcccCCCCCCCHHHHHc
Q 000706 233 LKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 233 IrKcLqkDPeKRPSAeELLe 252 (1342)
+.+||..||++|||+.++++
T Consensus 241 i~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 241 VNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHhcCCCcccCCCHHHHHH
Confidence 99999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.51 Aligned_cols=246 Identities=29% Similarity=0.530 Sum_probs=209.1
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC-HHHHHHHHHHHHHH-HhcCCCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEIEIL-RKLKHQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-e~dierL~rEI~IL-KrL~HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
+.||.|+||.||+|.+..+++.||+|.+.+.... .........|..++ ...+|||++++++.+++++.+|++|||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 6799999999999999999999999998754322 22223344455444 44589999999999999999999999997
Q ss_pred CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCC
Q 000706 87 GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTP 166 (1342)
Q Consensus 87 GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp 166 (1342)
|+|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++..... .....|++
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~ 157 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGTP 157 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCCc
Confidence 68999998888899999999999999999999999999999999999999999999999999876433 23346889
Q ss_pred CcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC----CCCCCCHHHHHHHHHhcccCCC
Q 000706 167 LYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVK----YPDEMSPNFKSFLKGLLNKVPQ 242 (1342)
Q Consensus 167 ~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~e----fP~eISpeLkDLIrKcLqkDPe 242 (1342)
.|++||.+.+..++.++|+||+|+++|+|++|..||...+.......+...... .+..+++++.+++.+||+.||+
T Consensus 158 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 237 (260)
T cd05611 158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPA 237 (260)
T ss_pred CccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHH
Confidence 999999998888999999999999999999999999888777766666544333 2345789999999999999999
Q ss_pred CCC---CHHHHHcCcCcccc
Q 000706 243 NRL---TWSALLEHPFVKET 259 (1342)
Q Consensus 243 KRP---SAeELLeHPFFre~ 259 (1342)
+|| +++|++.||||++.
T Consensus 238 ~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 238 KRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred HccCCCcHHHHHcChHhhcC
Confidence 999 55899999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=345.34 Aligned_cols=254 Identities=36% Similarity=0.654 Sum_probs=218.5
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
+.|+....||+|+||.||++.+..+++.|++|.+..... ...+.+.+|+.+++.++|||++++++.+..++..|++||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 345566789999999999999999999999999865432 234568889999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 84 FAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
|++ ++|.+++. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.............
T Consensus 99 ~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 99 FLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred cCCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence 998 56776654 4568999999999999999999999999999999999999999999999999997665443333456
Q ss_pred cCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCCCCCCHHHHHHHHHhccc
Q 000706 163 KGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV---KYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 163 vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~---efP~eISpeLkDLIrKcLqk 239 (1342)
.|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..... ..+..+++++.+++++||+.
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~ 257 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR 257 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcC
Confidence 789999999999988899999999999999999999999988776666665544322 23346788999999999999
Q ss_pred CCCCCCCHHHHHcCcCcccch
Q 000706 240 VPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 240 DPeKRPSAeELLeHPFFre~~ 260 (1342)
||++||++.++++||||....
T Consensus 258 ~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 258 EPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred CcccCcCHHHHhhChhhccCC
Confidence 999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=337.14 Aligned_cols=248 Identities=29% Similarity=0.520 Sum_probs=208.2
Q ss_pred EEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHH-HHHHHHH---HHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC
Q 000706 11 LVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD-IHNLRQE---IEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ 86 (1342)
Q Consensus 11 ~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~d-ierL~rE---I~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e 86 (1342)
.||+|+||.||++.+..+++.||+|.+.+....... ......| .+.++..+||||+++++.+.+++.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999999999999999998765332111 1222333 344455689999999999999999999999997
Q ss_pred -CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCC
Q 000706 87 -GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGT 165 (1342)
Q Consensus 87 -GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGT 165 (1342)
|+|.+++.+.+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... .....|+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~ 158 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGT 158 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--CcCcCCC
Confidence 6888888888889999999999999999999999999999999999999999999999999987654322 2345699
Q ss_pred CCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCC---cHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCC
Q 000706 166 PLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTN---SVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVP 241 (1342)
Q Consensus 166 p~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~---s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDP 241 (1342)
..|+|||.+.+ ..++.++||||+|+++|+|++|+.||... ........+......+|..+++++.+++.+||..||
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p 238 (278)
T cd05606 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV 238 (278)
T ss_pred cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCH
Confidence 99999999874 46899999999999999999999999865 333444444445667777889999999999999999
Q ss_pred CCCC-----CHHHHHcCcCcccch
Q 000706 242 QNRL-----TWSALLEHPFVKETS 260 (1342)
Q Consensus 242 eKRP-----SAeELLeHPFFre~~ 260 (1342)
.+|| ++.++++||||++..
T Consensus 239 ~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 239 NRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HhccCCCCCCHHHHHhCccccCCC
Confidence 9999 999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=336.77 Aligned_cols=257 Identities=21% Similarity=0.408 Sum_probs=215.3
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEcc-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKY-----TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ 76 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~-----TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded 76 (1342)
+-++|++.+.||+|+||.||+|.++. .+..||+|.+..... ......+.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45799999999999999999997642 355799998865432 333456788999999999999999999999999
Q ss_pred eEEEEEeccC-CChHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEee
Q 000706 77 EFCVVTEFAQ-GELFEILEDD----------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCD 145 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek~----------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiD 145 (1342)
..|++|||++ |+|.+++.+. ...+...+..++.|++.||.|||++|++||||||+||+++.++.+||+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 9999999997 7999998652 2346678899999999999999999999999999999999999999999
Q ss_pred ccccccccCCcee--eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCC
Q 000706 146 FGFARAMSANTVV--LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKY 221 (1342)
Q Consensus 146 FGLAr~l~sss~~--~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~ef 221 (1342)
||+++........ .....++..|+|||.+.+..++.++|+||||+++|||++ |..||.+....+..+.+... ....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ 242 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9999765432211 112345678999999998889999999999999999998 79999887777766666544 3455
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHc------CcCcccc
Q 000706 222 PDEMSPNFKSFLKGLLNKVPQNRLTWSALLE------HPFVKET 259 (1342)
Q Consensus 222 P~eISpeLkDLIrKcLqkDPeKRPSAeELLe------HPFFre~ 259 (1342)
+...++.+++++.+||+.||++|||+.++++ ||||++.
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 243 PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 6677899999999999999999999999976 8888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=329.86 Aligned_cols=248 Identities=21% Similarity=0.389 Sum_probs=211.3
Q ss_pred EEEEEEEcccCcEEEEEEEEccC---CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-----
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYT---GQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQE----- 77 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~T---Ge~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~----- 77 (1342)
|++.+.||+|+||.||+|....+ ++.||+|.++...........+.+|++.++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67899999999999999987643 4789999998766666667789999999999999999999998865544
Q ss_pred -EEEEEeccC-CChHHHHhc------CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccc
Q 000706 78 -FCVVTEFAQ-GELFEILED------DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFA 149 (1342)
Q Consensus 78 -lyLVMEY~e-GSL~D~Lek------~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLA 149 (1342)
.+++|||++ |+|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 799999987 788888743 236899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcee--eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCC
Q 000706 150 RAMSANTVV--LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEM 225 (1342)
Q Consensus 150 r~l~sss~~--~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eI 225 (1342)
+........ .....++..|++||.+.+..++.++||||||+++|||++ |..||.+.+..+..+.+... ....+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDC 240 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCC
Confidence 866433221 112235678999999988889999999999999999999 99999887777776666554 44567788
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 226 SPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 226 SpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
++++.+++.+||+.||++||++.|++++
T Consensus 241 ~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 241 LDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=335.90 Aligned_cols=253 Identities=36% Similarity=0.644 Sum_probs=221.4
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
+.|++.+.||+|+||.||++.+..+++.|++|.+..... ..+.+.+|++++++++|+|++++++.+..++..|++||
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 568899999999999999999998999999999975533 44678889999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 84 FAQ-GELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~g-~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
|++ ++|.+++.+.+ .+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||++............
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 175 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS 175 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhcc
Confidence 998 78999998876 8999999999999999999999999999999999999999999999999998766544333334
Q ss_pred ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-CCC--CCCCCCHHHHHHHHHhcc
Q 000706 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-PVK--YPDEMSPNFKSFLKGLLN 238 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~-~~e--fP~eISpeLkDLIrKcLq 238 (1342)
..+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+... ... .+..++.+++++|.+||+
T Consensus 176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (286)
T cd06614 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV 255 (286)
T ss_pred ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhc
Confidence 56889999999999888999999999999999999999999887665555444332 222 223478999999999999
Q ss_pred cCCCCCCCHHHHHcCcCcccc
Q 000706 239 KVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 239 kDPeKRPSAeELLeHPFFre~ 259 (1342)
.+|.+||++.++++||||+..
T Consensus 256 ~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 256 KDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred cChhhCcCHHHHhhChHhhcc
Confidence 999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=379.44 Aligned_cols=256 Identities=36% Similarity=0.604 Sum_probs=225.5
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
-|+|+..||.|+||.||+|.++.++-..|-|+|.. ..+...+++.-||+||..++||+||++++.|..++.+||+.||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 46788999999999999999998888888898853 3456678899999999999999999999999999999999999
Q ss_pred cCCChHH-HHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 85 AQGELFE-ILE-DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 85 ~eGSL~D-~Le-k~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
|+|.--| .+. -+.++.|.++..+++|++.||.|||+++|+|||||..|||++-+|.++|+|||.+...........++
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsF 190 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSF 190 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccc
Confidence 9865444 433 36789999999999999999999999999999999999999999999999999987655544455678
Q ss_pred cCCCCcCChhhh-----ccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC---CCCCCCHHHHHHHH
Q 000706 163 KGTPLYMAPELV-----REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVK---YPDEMSPNFKSFLK 234 (1342)
Q Consensus 163 vGTp~YmAPEvL-----~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~e---fP~eISpeLkDLIr 234 (1342)
.|||+|||||+. +..+|++++||||||++|.||..+.+|...-+....+-+|.+..++ -|..++..+.||+.
T Consensus 191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk 270 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLK 270 (1187)
T ss_pred cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHH
Confidence 899999999965 5678999999999999999999999999998888888777765432 35678999999999
Q ss_pred HhcccCCCCCCCHHHHHcCcCcccchhh
Q 000706 235 GLLNKVPQNRLTWSALLEHPFVKETSDE 262 (1342)
Q Consensus 235 KcLqkDPeKRPSAeELLeHPFFre~~~e 262 (1342)
+||.+||..||++.++++||||.+....
T Consensus 271 ~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 271 RCLVKNPRNRPPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred HHHhcCCccCCCHHHHhhCcccccCCcc
Confidence 9999999999999999999999976554
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=347.87 Aligned_cols=256 Identities=29% Similarity=0.462 Sum_probs=214.7
Q ss_pred CCEEE-EEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHH------------HHHHHHHHHHHHhcCCCCcceEEE
Q 000706 4 ENYHV-IELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD------------IHNLRQEIEILRKLKHQNIIEMLD 70 (1342)
Q Consensus 4 drYrI-lK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~d------------ierL~rEI~ILKrL~HPNIVKL~d 70 (1342)
++|.. .+.||.|+||.||+|.+..+++.||+|.+.+....... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 46754 57799999999999999999999999998654322100 124678999999999999999999
Q ss_pred EEEeCCeEEEEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 000706 71 SFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFAR 150 (1342)
Q Consensus 71 vfeded~lyLVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr 150 (1342)
++..++..+++|||++|+|.+++.....+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||.+.
T Consensus 88 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 88 VYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred EEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcccee
Confidence 99999999999999999999999888889999999999999999999999999999999999999999999999999997
Q ss_pred cccC--------------CceeeecccCCCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHh
Q 000706 151 AMSA--------------NTVVLRSIKGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIV 215 (1342)
Q Consensus 151 ~l~s--------------ss~~~~s~vGTp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIl 215 (1342)
.... .........+++.|+|||.+.+. .++.++|+||||+++|+|++|++||.+.+..+....+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 6651 11122234578899999988764 46899999999999999999999999887666555443
Q ss_pred cC---CCC-------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 216 KD---PVK-------------------------YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 216 r~---~~e-------------------------fP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
.. +.. .....+.++.++|.+||+.||++||+++|++.||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 21 100 012357889999999999999999999999999999864
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.05 Aligned_cols=248 Identities=21% Similarity=0.439 Sum_probs=212.6
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
++.++|++.++||+|+||.||+|.+. +++.|++|.+.... ...+.+.+|+.++++++||||+++++.+.+.+..|+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 46789999999999999999999865 56789999876432 234678899999999999999999999999999999
Q ss_pred EEeccC-CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce
Q 000706 81 VTEFAQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~ 157 (1342)
+|||++ |+|.+++.+ ...+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 999986 789998865 45689999999999999999999999999999999999999999999999999987654322
Q ss_pred e-eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHH
Q 000706 158 V-LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLK 234 (1342)
Q Consensus 158 ~-~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIr 234 (1342)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+... +.+.+..++.++.+++.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMK 238 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 2 122345678999999988889999999999999999998 99999887776666665544 33444568899999999
Q ss_pred HhcccCCCCCCCHHHHHc
Q 000706 235 GLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 235 KcLqkDPeKRPSAeELLe 252 (1342)
+||+.||++||+++++.+
T Consensus 239 ~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 239 TCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=330.36 Aligned_cols=251 Identities=22% Similarity=0.413 Sum_probs=214.2
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYT-----GQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP 75 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~T-----Ge~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede 75 (1342)
+..++|++.+.||+|+||.||++.++.. ++.|++|.+.... .......+.+|+++++.++||||+++++++.++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 3568999999999999999999988643 4789999985443 233446788899999999999999999999999
Q ss_pred CeEEEEEeccC-CChHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEe
Q 000706 76 QEFCVVTEFAQ-GELFEILEDD----------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLC 144 (1342)
Q Consensus 76 d~lyLVMEY~e-GSL~D~Lek~----------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLi 144 (1342)
...|++|||++ |+|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 99999999996 7999988642 246788999999999999999999999999999999999999999999
Q ss_pred eccccccccCCce--eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCC
Q 000706 145 DFGFARAMSANTV--VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVK 220 (1342)
Q Consensus 145 DFGLAr~l~sss~--~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~e 220 (1342)
|||+++....... ......++..|+|||.+.+..++.++||||||+++|++++ |+.||...+..+..+.+... ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence 9999976543321 1223446788999999988889999999999999999998 99999887777766666544 345
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 221 YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 221 fP~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
.|...+.++.+++.+||+.+|++|||+.++++
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 242 LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 67778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=348.35 Aligned_cols=253 Identities=29% Similarity=0.521 Sum_probs=214.2
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ------ 76 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded------ 76 (1342)
.++|++.+.||+|+||.||++.+..+++.||+|.+.+..........+.+|++++++++||||+++++++..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 36899999999999999999999999999999998665444444567889999999999999999999987553
Q ss_pred eEEEEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 77 EFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 77 ~lyLVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
.+++||||++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 94 ~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 172 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM 172 (343)
T ss_pred eEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccCc
Confidence 4699999998888887764 579999999999999999999999999999999999999999999999999998654332
Q ss_pred eeeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC----------------
Q 000706 157 VVLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV---------------- 219 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~---------------- 219 (1342)
....+++.|++||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+.....
T Consensus 173 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07880 173 ---TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249 (343)
T ss_pred ---cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence 23467899999998876 4588999999999999999999999987665444443322110
Q ss_pred ---------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 220 ---------------KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 220 ---------------efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
...+.+++.+.++|.+||+.||++|||+.+++.||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 1123577889999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.77 Aligned_cols=256 Identities=34% Similarity=0.628 Sum_probs=219.8
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
.++|++.+.||+|+||.||++.+..+++.|++|.+..... ...+.+.+|+.+++.++|||++++++.+..++..|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 3689999999999999999999988999999999864432 23467888999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
||++ |+|.+++.+. .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++............
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred ecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence 9997 6888887654 5889999999999999999999999999999999999999999999999998766554444444
Q ss_pred ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-C--CCCCCCCCHHHHHHHHHhcc
Q 000706 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-P--VKYPDEMSPNFKSFLKGLLN 238 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~-~--~efP~eISpeLkDLIrKcLq 238 (1342)
..|++.|++||.+.+..++.++|+||||+++|++++|+.||...+.......+... . ...+..+++.++++|++||.
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 254 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 254 (293)
T ss_pred ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHcc
Confidence 56899999999998888999999999999999999999999877654443333222 1 22334578899999999999
Q ss_pred cCCCCCCCHHHHHcCcCcccchh
Q 000706 239 KVPQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 239 kDPeKRPSAeELLeHPFFre~~~ 261 (1342)
.+|++||++.+++.||||+....
T Consensus 255 ~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 255 MDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred CChhhCcCHHHHhcCHHHhcCcc
Confidence 99999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=335.59 Aligned_cols=250 Identities=27% Similarity=0.479 Sum_probs=213.9
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEE-----ccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRR-----KYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP 75 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArD-----k~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede 75 (1342)
|+-++|.+.+.||+|+||.||++.+ ..++..+++|.+... .......+.+|++++++++||||+++++++.+.
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3457899999999999999999975 234567899988644 234456789999999999999999999999999
Q ss_pred CeEEEEEeccC-CChHHHHhcCC-------------CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcE
Q 000706 76 QEFCVVTEFAQ-GELFEILEDDK-------------CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVV 141 (1342)
Q Consensus 76 d~lyLVMEY~e-GSL~D~Lek~g-------------~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~L 141 (1342)
+.+|++|||++ |+|.+++...+ .+++..++.++.|++.+|+|||++|++||||||+||++++++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999997 78999886433 48999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccCCce--eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcCC
Q 000706 142 KLCDFGFARAMSANTV--VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKDP 218 (1342)
Q Consensus 142 KLiDFGLAr~l~sss~--~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~~ 218 (1342)
||+|||+++....... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+..+.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999976543321 1122345778999999998889999999999999999998 999998887777777776654
Q ss_pred -CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 219 -VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 219 -~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
...+...++++.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3455678899999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=328.22 Aligned_cols=242 Identities=24% Similarity=0.431 Sum_probs=205.6
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-CC
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GE 88 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e-GS 88 (1342)
+.||+|+||.||+|+++.+++.||+|.+.+. ...+....+.+|++++++++||||+++++++.+++..|+||||++ ++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 4699999999999999999999999987644 334455678899999999999999999999999999999999986 68
Q ss_pred hHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceee--ecccCC
Q 000706 89 LFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL--RSIKGT 165 (1342)
Q Consensus 89 L~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~--~s~vGT 165 (1342)
|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......... ....++
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence 99998654 468999999999999999999999999999999999999999999999999987654322111 111234
Q ss_pred CCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhcccCCCC
Q 000706 166 PLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLNKVPQN 243 (1342)
Q Consensus 166 p~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrKcLqkDPeK 243 (1342)
..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+... +...+..++.++.+++.+||+.||++
T Consensus 160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 239 (252)
T cd05084 160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQ 239 (252)
T ss_pred eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhh
Confidence 56999999998889999999999999999997 99999876665555544433 44566778999999999999999999
Q ss_pred CCCHHHHHc
Q 000706 244 RLTWSALLE 252 (1342)
Q Consensus 244 RPSAeELLe 252 (1342)
|||+.++++
T Consensus 240 Rps~~~~~~ 248 (252)
T cd05084 240 RPSFSTVHQ 248 (252)
T ss_pred CcCHHHHHH
Confidence 999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=332.69 Aligned_cols=250 Identities=21% Similarity=0.400 Sum_probs=210.9
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEc-----cCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRK-----YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQE 77 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk-----~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~ 77 (1342)
-++|++.+.||+|+||.||+|.++ .+++.||+|.+.... .......+.+|+.+++.++||||+++++++.++..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 468999999999999999999764 245679999885432 23344668899999999999999999999999999
Q ss_pred EEEEEeccC-CChHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeec
Q 000706 78 FCVVTEFAQ-GELFEILEDD----------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDF 146 (1342)
Q Consensus 78 lyLVMEY~e-GSL~D~Lek~----------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDF 146 (1342)
.++||||++ |+|.+++.+. ..++...+..++.|++.||.|||+.|++||||||+||++++++.+||+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCC
Confidence 999999987 7899988652 23577889999999999999999999999999999999999999999999
Q ss_pred cccccccCCceee--ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcCC-CCCC
Q 000706 147 GFARAMSANTVVL--RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKDP-VKYP 222 (1342)
Q Consensus 147 GLAr~l~sss~~~--~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~~-~efP 222 (1342)
|+++......... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.....+.+.... ...+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKP 243 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 9987654332211 12345778999999998889999999999999999999 789998887777666655543 4566
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 223 DEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 223 ~eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
...++.+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 244 DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=377.29 Aligned_cols=259 Identities=31% Similarity=0.575 Sum_probs=244.1
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
.+..|.+.+.||+|.|+.|..+++..++..||+|.+++...+....+.+.+|+++|+.++|||||+++.+.+.+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 46789999999999999999999999999999999999988887778899999999999999999999999999999999
Q ss_pred EeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 82 TEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
|||+. |++++++.+.+++.+.+++.++.|+.++++|||+++|+|||||++|||++.+-++||+|||++..+... ....
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-~~lq 212 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-LMLQ 212 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc-cccc
Confidence 99975 899999999999999999999999999999999999999999999999999999999999999988844 4567
Q ss_pred cccCCCCcCChhhhccCCC-CCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhccc
Q 000706 161 SIKGTPLYMAPELVREQPY-NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g~~Y-T~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqk 239 (1342)
+.+|++.|.|||++.+..| ++.+|+||+|+++|-|++|..||++.+..+...+...+.+..|.-++.+++++|+++|..
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl 292 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVL 292 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHhhcc
Confidence 8899999999999999887 488999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHcCcCcccchh
Q 000706 240 VPQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 240 DPeKRPSAeELLeHPFFre~~~ 261 (1342)
+|.+|++.+++.+|.|......
T Consensus 293 ~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 293 NPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred CccccCCHHHhhhhcccchhhh
Confidence 9999999999999999865433
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=331.39 Aligned_cols=246 Identities=26% Similarity=0.509 Sum_probs=214.7
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
.+|++.+.||.|+||.||+|.+.. ++.+++|.+..... .....+.+|+++++.++||||+++++++.+.+..+++||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 579999999999999999999886 89999999865432 234578889999999999999999999999999999999
Q ss_pred ccC-CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 84 FAQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 84 Y~e-GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
|++ |+|.+++.+ ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.+...........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccccc
Confidence 997 699999875 34689999999999999999999999999999999999999999999999999987654433333
Q ss_pred cccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhcc
Q 000706 161 SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLN 238 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrKcLq 238 (1342)
...+++.|++||.+.+..++.++|+||||+++|+|++ |+.||...+..+..+.+... ..+.+...++.+.++|.+||+
T Consensus 163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 242 (261)
T cd05148 163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWA 242 (261)
T ss_pred CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcC
Confidence 4446778999999988889999999999999999998 89999887776666666543 345567889999999999999
Q ss_pred cCCCCCCCHHHHHc
Q 000706 239 KVPQNRLTWSALLE 252 (1342)
Q Consensus 239 kDPeKRPSAeELLe 252 (1342)
.||.+|||+.++++
T Consensus 243 ~~p~~Rpt~~~l~~ 256 (261)
T cd05148 243 AEPEDRPSFKALRE 256 (261)
T ss_pred CCchhCcCHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=335.73 Aligned_cols=244 Identities=27% Similarity=0.522 Sum_probs=206.0
Q ss_pred CCEEEEEEE--cccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEE
Q 000706 4 ENYHVIELV--GEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 4 drYrIlK~L--GsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyL 80 (1342)
++|++.+.+ |+|+||.||++.++.+++.+++|.+.+...... |+.....+ +|||++++++.+..++.+|+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 567777776 999999999999999999999999865432221 22222222 79999999999999999999
Q ss_pred EEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC-cEEEeeccccccccCCcee
Q 000706 81 VTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS-VVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG-~LKLiDFGLAr~l~sss~~ 158 (1342)
||||++ |+|.+++.+.++++++.++.++.|+++||.|||+.|++||||||+||+++.++ .++|+|||++.......
T Consensus 87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-- 164 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-- 164 (267)
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc--
Confidence 999996 79999998888999999999999999999999999999999999999999998 99999999997665332
Q ss_pred eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHH----HHHHHhcCCCCCCCCCCHHHHHHHH
Q 000706 159 LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYA----LIRHIVKDPVKYPDEMSPNFKSFLK 234 (1342)
Q Consensus 159 ~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~e----lirkIlr~~~efP~eISpeLkDLIr 234 (1342)
...|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||....... ............++..++.+.+||.
T Consensus 165 --~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 242 (267)
T PHA03390 165 --CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQ 242 (267)
T ss_pred --cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHH
Confidence 3458999999999999889999999999999999999999997654322 2222224444566679999999999
Q ss_pred HhcccCCCCCCC-HHHHHcCcCccc
Q 000706 235 GLLNKVPQNRLT-WSALLEHPFVKE 258 (1342)
Q Consensus 235 KcLqkDPeKRPS-AeELLeHPFFre 258 (1342)
+||+.||.+||+ ++|+++||||++
T Consensus 243 ~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 243 SMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHhccChhhCCchHHHHhcCCcccC
Confidence 999999999996 699999999963
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=328.98 Aligned_cols=241 Identities=24% Similarity=0.448 Sum_probs=207.8
Q ss_pred EEcccCcEEEEEEEE--ccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-C
Q 000706 11 LVGEGSFGKVYKGRR--KYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-G 87 (1342)
Q Consensus 11 ~LGsGgFGtVYKArD--k~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e-G 87 (1342)
+||+|+||.||+|.. ..+++.+|+|+++.........+.+.+|+.+++.++||||++++++++ .+..+++|||++ |
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 567889999998766555556678899999999999999999999875 456789999998 7
Q ss_pred ChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceee---ecccC
Q 000706 88 ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL---RSIKG 164 (1342)
Q Consensus 88 SL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~---~s~vG 164 (1342)
+|.+++.+.+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......... ....+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence 899999888889999999999999999999999999999999999999999999999999998765443221 12234
Q ss_pred CCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhcccCCC
Q 000706 165 TPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLNKVPQ 242 (1342)
Q Consensus 165 Tp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrKcLqkDPe 242 (1342)
++.|+|||.+.+..++.++|+||||+++|||++ |+.||...+..+....+... ..+.|...+++++++|.+||+.||+
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~ 240 (257)
T cd05116 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVD 240 (257)
T ss_pred CccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCch
Confidence 578999999988889999999999999999998 99999887777666666654 3456778999999999999999999
Q ss_pred CCCCHHHHHc
Q 000706 243 NRLTWSALLE 252 (1342)
Q Consensus 243 KRPSAeELLe 252 (1342)
+||++.++.+
T Consensus 241 ~Rp~~~~i~~ 250 (257)
T cd05116 241 ERPGFAVVEL 250 (257)
T ss_pred hCcCHHHHHH
Confidence 9999998854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=332.00 Aligned_cols=256 Identities=34% Similarity=0.532 Sum_probs=213.5
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFES--PQEFCVV 81 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfed--ed~lyLV 81 (1342)
++|+..+.||.|++|.||++.+..+++.+++|.+..... .....++.+|++++++++||||+++++++.+ .+.+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 589999999999999999999999999999999875533 2445678899999999999999999998854 4478999
Q ss_pred EeccC-CChHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 82 TEFAQ-GELFEILE----DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 82 MEY~e-GSL~D~Le----k~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
|||++ ++|.+++. +...+++..+..++.|++.+|.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 99997 57877654 24568999999999999999999999999999999999999999999999999987654322
Q ss_pred eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCC-----cHHHHHHHHhcC-CCCCC------CC
Q 000706 157 VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTN-----SVYALIRHIVKD-PVKYP------DE 224 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~-----s~~elirkIlr~-~~efP------~e 224 (1342)
. ....++..|++||.+.+..++.++|+||||+++|+|++|..||... ...+....+... ....+ ..
T Consensus 160 ~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd06621 160 A--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK 237 (287)
T ss_pred c--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence 1 2345788999999999889999999999999999999999999765 223334433331 11111 23
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccchhh
Q 000706 225 MSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDE 262 (1342)
Q Consensus 225 ISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~~e 262 (1342)
+++.+.+|+.+||..||.+|||+.|+++||||+.....
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred hHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 46789999999999999999999999999999776543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=333.84 Aligned_cols=256 Identities=32% Similarity=0.573 Sum_probs=219.1
Q ss_pred CEEEEEEEcccCcEEEEEEEEc---cCCcEEEEEEeecCCC--CHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRK---YTGQTVAMKFIMKHGK--SEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEF 78 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk---~TGe~VAVKvIkKs~~--se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~l 78 (1342)
+|++.+.||.|+||.||++.+. .+|+.||+|.+.+... .....+.+.+|+++++++ +||||+++++.++.+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999874 4789999999875422 122345678899999999 699999999999999999
Q ss_pred EEEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce
Q 000706 79 CVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 79 yLVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~ 157 (1342)
|+||||++ |+|.+++...+++++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999998 68999998888899999999999999999999999999999999999999999999999999977644321
Q ss_pred -eeecccCCCCcCChhhhccC--CCCCCCcccchhhHHHHHHhCCCCCCCC----cHHHHHHHHhcCCCCCCCCCCHHHH
Q 000706 158 -VLRSIKGTPLYMAPELVREQ--PYNHTADLWSLGVILYELFVGQPPFYTN----SVYALIRHIVKDPVKYPDEMSPNFK 230 (1342)
Q Consensus 158 -~~~s~vGTp~YmAPEvL~g~--~YT~KsDIWSLGVILYELLTGr~PF~g~----s~~elirkIlr~~~efP~eISpeLk 230 (1342)
......|+..|++||.+.+. .++.++|+||||+++|+|++|..||... ...+..+.+.....+++..+++.+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHH
Confidence 12245689999999988653 4788999999999999999999999643 2344455555566677888999999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHcCcCcccch
Q 000706 231 SFLKGLLNKVPQNRL-----TWSALLEHPFVKETS 260 (1342)
Q Consensus 231 DLIrKcLqkDPeKRP-----SAeELLeHPFFre~~ 260 (1342)
+++.+||+.||++|| +++++++||||+...
T Consensus 241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 999999999999997 899999999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=329.50 Aligned_cols=248 Identities=21% Similarity=0.383 Sum_probs=208.8
Q ss_pred EEEEEEEcccCcEEEEEEEEccCCc--EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC------Ce
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTGQ--TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP------QE 77 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~TGe--~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede------d~ 77 (1342)
|.+.+.||+|+||.||+|.+..+++ .+|+|.++.........+.+.+|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578899999999999999877765 689999876655566677889999999999999999999976422 35
Q ss_pred EEEEEeccC-CChHHHHhc------CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 000706 78 FCVVTEFAQ-GELFEILED------DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFAR 150 (1342)
Q Consensus 78 lyLVMEY~e-GSL~D~Lek------~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr 150 (1342)
.+++|||++ |+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 789999997 788887742 2358999999999999999999999999999999999999999999999999998
Q ss_pred cccCCcee--eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcCC-CCCCCCCC
Q 000706 151 AMSANTVV--LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKDP-VKYPDEMS 226 (1342)
Q Consensus 151 ~l~sss~~--~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~~-~efP~eIS 226 (1342)
........ .....+++.|++||.+.+..++.++||||||+++|+|++ |+.||.+....+..+.+.... ...+..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCL 240 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 76543221 122346778999999998889999999999999999999 899998877766666665543 35567788
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 227 PNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 227 peLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
..+.++|.+||+.||++|||+.+++++
T Consensus 241 ~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 241 DGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=328.89 Aligned_cols=249 Identities=22% Similarity=0.432 Sum_probs=212.3
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
++.++|++.+.||+|+||.||.+... .+..+|+|.+...... .+.+.+|++++++++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 1 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred CChHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence 45689999999999999999999765 3556999988654332 2467889999999999999999999999999999
Q ss_pred EEeccC-CChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 81 VTEFAQ-GELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
+|||++ |+|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.++........
T Consensus 77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999997 6899988763 47899999999999999999999999999999999999999999999999998765443321
Q ss_pred -eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcCC-CCCCCCCCHHHHHHHHH
Q 000706 159 -LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKDP-VKYPDEMSPNFKSFLKG 235 (1342)
Q Consensus 159 -~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~~-~efP~eISpeLkDLIrK 235 (1342)
.....++..|++||.+.+..++.++||||||+++|+|++ |+.||...+..+....+.... ...+...++.+.+++.+
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 112335677999999988889999999999999999998 999998877766666666543 33456678999999999
Q ss_pred hcccCCCCCCCHHHHHcC
Q 000706 236 LLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 236 cLqkDPeKRPSAeELLeH 253 (1342)
||+.||.+||++.+++++
T Consensus 237 cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 237 CWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HcCCCcccCCCHHHHHHh
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=355.95 Aligned_cols=249 Identities=29% Similarity=0.493 Sum_probs=206.9
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYT-----GQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQ 76 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~T-----Ge~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded 76 (1342)
.++|++.+.||+|+||.||+|++... ++.||+|.++.... ......+.+|+++++.+ +||||+++++.+.+.+
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 46799999999999999999986443 35799999975533 33456788999999999 8999999999999999
Q ss_pred eEEEEEeccC-CChHHHHhcC-----------------------------------------------------------
Q 000706 77 EFCVVTEFAQ-GELFEILEDD----------------------------------------------------------- 96 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek~----------------------------------------------------------- 96 (1342)
..|+||||++ |+|.+++.+.
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999997 7899887532
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee--eeccc
Q 000706 97 -----------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV--LRSIK 163 (1342)
Q Consensus 97 -----------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~--~~s~v 163 (1342)
.++++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++........ .....
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence 24788999999999999999999999999999999999999999999999999765433211 11233
Q ss_pred CCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHhcccC
Q 000706 164 GTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD--PVKYPDEMSPNFKSFLKGLLNKV 240 (1342)
Q Consensus 164 GTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~--~~efP~eISpeLkDLIrKcLqkD 240 (1342)
+++.|+|||++.+..++.++||||||+++|+|++ |+.||............... ....+...++++++++.+||+.|
T Consensus 276 ~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 355 (374)
T cd05106 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLE 355 (374)
T ss_pred CccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCC
Confidence 5667999999998899999999999999999997 99999875543333333332 33455667899999999999999
Q ss_pred CCCCCCHHHHHc
Q 000706 241 PQNRLTWSALLE 252 (1342)
Q Consensus 241 PeKRPSAeELLe 252 (1342)
|++|||+.++.+
T Consensus 356 p~~RPs~~~l~~ 367 (374)
T cd05106 356 PTERPTFSQISQ 367 (374)
T ss_pred hhhCcCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=332.08 Aligned_cols=251 Identities=30% Similarity=0.547 Sum_probs=213.4
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYT-----GQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESP 75 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~T-----Ge~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfede 75 (1342)
+-++|++.+.||+|+||.||++.+... ...+++|.+.... .......+.+|+++++++ +||||+++++++.++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 457899999999999999999987643 3789999887543 344556788999999999 899999999999999
Q ss_pred CeEEEEEeccC-CChHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCC
Q 000706 76 QEFCVVTEFAQ-GELFEILED----------------DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAG 138 (1342)
Q Consensus 76 d~lyLVMEY~e-GSL~D~Lek----------------~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsd 138 (1342)
+.+|++|||++ |+|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||+++.+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence 99999999986 789998853 3468999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCcee--eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHh
Q 000706 139 SVVKLCDFGFARAMSANTVV--LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIV 215 (1342)
Q Consensus 139 G~LKLiDFGLAr~l~sss~~--~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIl 215 (1342)
+.+||+|||+++.+...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+..+.+.
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 248 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 248 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 99999999999876543221 112234567999999988889999999999999999997 999998887766666655
Q ss_pred cCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 216 KDP-VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 216 r~~-~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
... ...+...+.++.+|+.+||..||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 249 EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 543 34566788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=329.10 Aligned_cols=249 Identities=25% Similarity=0.475 Sum_probs=212.7
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
|+..+|++.+.||+|+||.||++.++ +++.+++|.+.+..... ..+.+|++++++++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd05059 1 IDPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI 76 (256)
T ss_pred CChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence 46678999999999999999999876 56789999986543332 456779999999999999999999999999999
Q ss_pred EEeccC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 81 VTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
+|||++ ++|.+++.+ ...+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++........
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 77 VTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred EEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 999997 689999875 457899999999999999999999999999999999999999999999999999765432211
Q ss_pred e-ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHH
Q 000706 159 L-RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKG 235 (1342)
Q Consensus 159 ~-~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrK 235 (1342)
. ....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+... ....+...++++.+++.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 1 11223457999999998889999999999999999998 89999887777666666554 345667789999999999
Q ss_pred hcccCCCCCCCHHHHHcC
Q 000706 236 LLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 236 cLqkDPeKRPSAeELLeH 253 (1342)
||+.+|++|||+.|+++.
T Consensus 237 cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=343.78 Aligned_cols=255 Identities=30% Similarity=0.493 Sum_probs=211.4
Q ss_pred CEEEEEEEcccCcEEEEEEEEccC--CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe----CCe
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYT--GQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFES----PQE 77 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~T--Ge~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfed----ed~ 77 (1342)
+|++.+.||+|+||.||++.+..+ ++.||+|.+..........+.+.+|+++++++ +||||+++++.... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 699999999999999999999888 89999999865433333446678899999999 59999999987532 356
Q ss_pred EEEEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce
Q 000706 78 FCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 78 lyLVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~ 157 (1342)
+|++|||++++|.+++.....+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 160 (332)
T cd07857 81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG 160 (332)
T ss_pred EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccc
Confidence 89999999999999998888999999999999999999999999999999999999999999999999999986643221
Q ss_pred ----eeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC---------------
Q 000706 158 ----VLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD--------------- 217 (1342)
Q Consensus 158 ----~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~--------------- 217 (1342)
......|++.|+|||.+.+ ..++.++||||+|+++|+|++|++||...+.......+...
T Consensus 161 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (332)
T cd07857 161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSP 240 (332)
T ss_pred cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhh
Confidence 1233568999999998765 56899999999999999999999999876543333222110
Q ss_pred -------------CCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 218 -------------PVK---YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 218 -------------~~e---fP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
... ..+..+..+.+|+.+||+.||++|||+.|+++||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 241 KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 011 112457899999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=348.21 Aligned_cols=253 Identities=30% Similarity=0.518 Sum_probs=215.4
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-----
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQE----- 77 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~----- 77 (1342)
-++|++.+.||+|+||.||+|++..+++.|++|.+............+.+|+.+++.++|||++++++++..++.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 368999999999999999999999999999999986553334445677889999999999999999998866554
Q ss_pred -EEEEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 78 -FCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 78 -lyLVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
.|+|+||++++|.+++.. .++++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 94 ~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171 (343)
T ss_pred cEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence 899999999999998875 46999999999999999999999999999999999999999999999999999876443
Q ss_pred eeeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC----------------
Q 000706 157 VVLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV---------------- 219 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~---------------- 219 (1342)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+.....
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07851 172 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR 249 (343)
T ss_pred --ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHH
Confidence 234568899999998765 3678999999999999999999999987766555544432110
Q ss_pred ---------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 220 ---------------KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 220 ---------------efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
......++++.++|++||+.||++|||+.++++||||++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 0112358899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=338.90 Aligned_cols=251 Identities=27% Similarity=0.492 Sum_probs=210.9
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEE--EEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCe
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTV--AMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQE 77 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~V--AVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~ 77 (1342)
+.+++|++.+.||+|+||.||+|.++.++..+ ++|.++.. ........+.+|++++.++ +||||+++++++.+++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 45789999999999999999999998777654 66665432 2344456788899999999 89999999999999999
Q ss_pred EEEEEeccC-CChHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCc
Q 000706 78 FCVVTEFAQ-GELFEILEDD----------------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSV 140 (1342)
Q Consensus 78 lyLVMEY~e-GSL~D~Lek~----------------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~ 140 (1342)
+|++|||++ |+|.+++.+. ..+++..++.++.|++.||+|||++|++||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 999999997 7899988643 25789999999999999999999999999999999999999999
Q ss_pred EEEeeccccccccCCceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-C
Q 000706 141 VKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-P 218 (1342)
Q Consensus 141 LKLiDFGLAr~l~sss~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~ 218 (1342)
+||+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..+.+... .
T Consensus 163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05088 163 AKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 241 (303)
T ss_pred EEeCccccCcccchhhh-cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCc
Confidence 99999999864322111 111234667999999988889999999999999999998 99999887776666655443 2
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 219 VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 219 ~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
...+...++++.+++.+||+.||++||++.+++++
T Consensus 242 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34556688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=328.22 Aligned_cols=251 Identities=24% Similarity=0.458 Sum_probs=213.2
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCc---EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQ---TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQE 77 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe---~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~ 77 (1342)
++.++|++.+.||+|+||.||+|.+..+++ .+++|.++... .....+.+.+|+.++++++||||+++++++.+++.
T Consensus 1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred CCHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 467899999999999999999998865544 68999886543 34455788999999999999999999999999999
Q ss_pred EEEEEeccC-CChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCC
Q 000706 78 FCVVTEFAQ-GELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN 155 (1342)
Q Consensus 78 lyLVMEY~e-GSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ss 155 (1342)
.|++|||++ |+|.+++.+. +.+++.+++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 999999997 6899988754 56899999999999999999999999999999999999999999999999999876543
Q ss_pred ceee---ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHH
Q 000706 156 TVVL---RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFK 230 (1342)
Q Consensus 156 s~~~---~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLk 230 (1342)
.... ....++..|++||.+.+..++.++|+||||+++|++++ |+.||......+....+... +.+.+...++.+.
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 2211 11223567999999998889999999999999999886 99999887766666666554 2344456789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHc
Q 000706 231 SFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 231 DLIrKcLqkDPeKRPSAeELLe 252 (1342)
+++.+|++.+|.+||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=332.61 Aligned_cols=250 Identities=22% Similarity=0.387 Sum_probs=210.3
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCC----------------cEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCc
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTG----------------QTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TG----------------e~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNI 65 (1342)
..++|++.+.||+|+||.||+|.+..++ ..|++|.+.... .....+.+.+|++++++++||||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCE
Confidence 4579999999999999999999876544 457999886553 23456788899999999999999
Q ss_pred ceEEEEEEeCCeEEEEEeccC-CChHHHHhcCC-----------CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcE
Q 000706 66 IEMLDSFESPQEFCVVTEFAQ-GELFEILEDDK-----------CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNI 133 (1342)
Q Consensus 66 VKL~dvfeded~lyLVMEY~e-GSL~D~Lek~g-----------~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENI 133 (1342)
+++++++.+++..+++|||++ ++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999987 68999887655 789999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCce--eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh--CCCCCCCCcHHH
Q 000706 134 LIGAGSVVKLCDFGFARAMSANTV--VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV--GQPPFYTNSVYA 209 (1342)
Q Consensus 134 LLdsdG~LKLiDFGLAr~l~sss~--~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT--Gr~PF~g~s~~e 209 (1342)
+++.++.++|+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ +..||...+..+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999976543321 1223446778999999988889999999999999999998 788998766655
Q ss_pred HHHHHhcC--------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 210 LIRHIVKD--------PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 210 lirkIlr~--------~~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
..+.+... ....+...+.++.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 55544321 12334567889999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=346.17 Aligned_cols=256 Identities=33% Similarity=0.565 Sum_probs=213.9
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeC--CeEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESP--QEFC 79 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfede--d~ly 79 (1342)
.++|++.+.||+|+||.||+|.+..+++.+++|.+.+..........+.+|+.+++++ +||||+++++++... ..+|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 3689999999999999999999998999999998865433334445677899999999 999999999988643 4689
Q ss_pred EEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc---
Q 000706 80 VVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT--- 156 (1342)
Q Consensus 80 LVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss--- 156 (1342)
+||||++++|.+++.+. .+++..++.++.|++.||.|||++|++||||||+||+++.+|.+||+|||++.......
T Consensus 86 lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~ 164 (337)
T cd07852 86 LVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164 (337)
T ss_pred EEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccc
Confidence 99999999999998776 78999999999999999999999999999999999999999999999999998664332
Q ss_pred --eeeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC---------------
Q 000706 157 --VVLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP--------------- 218 (1342)
Q Consensus 157 --~~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~--------------- 218 (1342)
.......|++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+....+...++....
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (337)
T cd07852 165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPF 244 (337)
T ss_pred cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhh
Confidence 12234568999999998754 457899999999999999999999998765444333321110
Q ss_pred ----------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 219 ----------------VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 219 ----------------~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
....+.++.++.++|.+||+.||.+|||+.++++||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 245 AATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 01113468899999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=333.98 Aligned_cols=252 Identities=24% Similarity=0.422 Sum_probs=214.9
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEcc-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKY-----TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP 75 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~-----TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede 75 (1342)
+++.+|++.+.||+|+||.||+|.+.. .++.||+|.++... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 467889999999999999999998753 35789999987543 233456788999999999999999999999999
Q ss_pred CeEEEEEeccC-CChHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCC
Q 000706 76 QEFCVVTEFAQ-GELFEILED----------------DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAG 138 (1342)
Q Consensus 76 d~lyLVMEY~e-GSL~D~Lek----------------~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsd 138 (1342)
+..++++||++ ++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 99999999987 678888742 2358889999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCce--eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHh
Q 000706 139 SVVKLCDFGFARAMSANTV--VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIV 215 (1342)
Q Consensus 139 G~LKLiDFGLAr~l~sss~--~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIl 215 (1342)
+.+||+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+....+....+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999886543321 1223446788999999988889999999999999999998 889998887777777776
Q ss_pred cCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 216 KDP-VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 216 r~~-~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
... ...+...+.++.+++.+||+.||.+||++.+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 654 34567899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=339.04 Aligned_cols=251 Identities=22% Similarity=0.399 Sum_probs=209.9
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcE----EEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQT----VAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ 76 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~----VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded 76 (1342)
++..+|++.+.||+|+||.||+|.+..+++. ||+|.++.. ......+.+.+|+.+++.++||||+++++++..+
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 3567899999999999999999988666654 899988643 2334456788999999999999999999998765
Q ss_pred eEEEEEeccC-CChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccC
Q 000706 77 EFCVVTEFAQ-GELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA 154 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~s 154 (1342)
..++++||++ |+|.+++.+. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 5678999986 8999998764 4689999999999999999999999999999999999999999999999999987654
Q ss_pred Cceee--ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHH
Q 000706 155 NTVVL--RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFK 230 (1342)
Q Consensus 155 ss~~~--~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLk 230 (1342)
..... ....++..|++||.+.+..++.++||||||+++|||++ |+.||.+....+....+... ..+.+...+.++.
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 241 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 33222 22334667999999999999999999999999999997 99999887665544433332 3344567788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcC
Q 000706 231 SFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 231 DLIrKcLqkDPeKRPSAeELLeH 253 (1342)
+++.+||..||.+||++.+++.+
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=346.38 Aligned_cols=253 Identities=29% Similarity=0.489 Sum_probs=211.5
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP------Q 76 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede------d 76 (1342)
-++|++.+.||+|+||.||++.+..+++.||+|.+.+........+.+.+|++++++++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 4789999999999999999999999999999999876543334456788899999999999999999988643 3
Q ss_pred eEEEEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 77 EFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 77 ~lyLVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
..|+++|+++++|.+++.. ..+++..++.++.|+++||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~lv~~~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~- 173 (345)
T cd07877 96 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE- 173 (345)
T ss_pred cEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc-
Confidence 4789999998999887765 46999999999999999999999999999999999999999999999999998765432
Q ss_pred eeeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC-----------------
Q 000706 157 VVLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP----------------- 218 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~----------------- 218 (1342)
.....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+....
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (345)
T cd07877 174 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 251 (345)
T ss_pred --ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHH
Confidence 234568999999998866 568899999999999999999999998765444333221100
Q ss_pred ------CCC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 219 ------VKY--------PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 219 ------~ef--------P~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
... ....++++.++|.+||+.||.+||++.++++||||++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 252 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 000 11357889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=325.97 Aligned_cols=243 Identities=25% Similarity=0.524 Sum_probs=208.9
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEE-EeCCeEE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSF-ESPQEFC 79 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvf-eded~ly 79 (1342)
|++++|++.+.||+|+||.||++... ++.+++|.++... ..+.+.+|+.++++++|||++++++++ .+++..|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 56789999999999999999999654 8889999885432 235688899999999999999999975 4567899
Q ss_pred EEEeccC-CChHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 80 VVTEFAQ-GELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 80 LVMEY~e-GSL~D~Lek~g--~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
++|||++ |+|.+++.+.+ .+++..++.++.|++.+|+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999997 68999987643 48999999999999999999999999999999999999999999999999987654322
Q ss_pred eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHH
Q 000706 157 VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLK 234 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIr 234 (1342)
....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+... ....++..++.+.+++.
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMK 233 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 22335667999999998889999999999999999997 99999887776666666554 34456778999999999
Q ss_pred HhcccCCCCCCCHHHHHc
Q 000706 235 GLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 235 KcLqkDPeKRPSAeELLe 252 (1342)
+||+.||++|||+.++++
T Consensus 234 ~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 234 QCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHhcCChhhCcCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=328.83 Aligned_cols=250 Identities=22% Similarity=0.389 Sum_probs=210.4
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCc----EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQ----TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ 76 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe----~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded 76 (1342)
+..++|++.+.||+|+||+||+|++..+++ .||+|.++... .......+.+|+.+++.++||||+++++++...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS- 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence 356899999999999999999999877766 47999886543 344456788999999999999999999988754
Q ss_pred eEEEEEeccC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccC
Q 000706 77 EFCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA 154 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~s 154 (1342)
..+++|||++ |+|.+++.+ .+.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 5678999987 799999876 45799999999999999999999999999999999999999999999999999987654
Q ss_pred Cceee--ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHH
Q 000706 155 NTVVL--RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFK 230 (1342)
Q Consensus 155 ss~~~--~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLk 230 (1342)
..... ....+++.|++||.+.+..++.++||||||+++|||++ |..||...........+... ..+.+...++++.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHH
Confidence 33221 22335678999999998889999999999999999998 99999876665555544443 3445567889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHc
Q 000706 231 SFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 231 DLIrKcLqkDPeKRPSAeELLe 252 (1342)
+++.+||+.||++||++.++++
T Consensus 242 ~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 242 MIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.99 Aligned_cols=247 Identities=23% Similarity=0.447 Sum_probs=211.5
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
.-++|++.+.||+|+||.||+|.+. +++.|++|.++..... .+.+.+|++++++++||||+++++++...+..|++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 4578999999999999999999875 4578999998654332 35678899999999999999999999999999999
Q ss_pred EeccC-CChHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 82 TEFAQ-GELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek~g--~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
|||++ ++|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99994 78999987644 7999999999999999999999999999999999999999999999999999876533211
Q ss_pred -eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHH
Q 000706 159 -LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKG 235 (1342)
Q Consensus 159 -~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrK 235 (1342)
......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+.......+... ....+...+..+.+++.+
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLD 239 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 111223457999999998889999999999999999999 99999887776666666544 334566788999999999
Q ss_pred hcccCCCCCCCHHHHHc
Q 000706 236 LLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 236 cLqkDPeKRPSAeELLe 252 (1342)
||+.||++||++.++.+
T Consensus 240 ~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 240 CWKEDPDDRPTFETLQW 256 (261)
T ss_pred HhhcCcccCCCHHHHHH
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=324.66 Aligned_cols=244 Identities=26% Similarity=0.505 Sum_probs=213.4
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
++.++|++.+.||.|+||.||+|... |+.+++|.++.... ..+++.+|+.+++.++|+||+++++++.+.+..|+
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 46789999999999999999999764 88999999865532 45678899999999999999999999999999999
Q ss_pred EEeccC-CChHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce
Q 000706 81 VTEFAQ-GELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~g--~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~ 157 (1342)
+|||++ ++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 999998 69999987655 799999999999999999999999999999999999999999999999999987643221
Q ss_pred eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHH
Q 000706 158 VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKG 235 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrK 235 (1342)
...++..|+|||.+....++.++|+||||+++|+|++ |+.||...+..+....+... ....+...++++.++|.+
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKD 234 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHH
Confidence 2334567999999988889999999999999999997 99999888776666655544 345566789999999999
Q ss_pred hcccCCCCCCCHHHHHc
Q 000706 236 LLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 236 cLqkDPeKRPSAeELLe 252 (1342)
||+.+|++|||+.|+++
T Consensus 235 ~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 235 CWELDPAKRPTFKQLRE 251 (256)
T ss_pred HhccChhhCcCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=353.79 Aligned_cols=250 Identities=26% Similarity=0.476 Sum_probs=206.5
Q ss_pred CCCEEEEEEEcccCcEEEEEEEE-----ccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 000706 3 VENYHVIELVGEGSFGKVYKGRR-----KYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQ 76 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArD-----k~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded 76 (1342)
.++|++.+.||+|+||.||+|.+ ..++..||+|+++.... ....+.+.+|+++++.+ +||||+++++++.+.+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 35899999999999999999964 34567899999865432 33446788899999999 8999999999999999
Q ss_pred eEEEEEeccC-CChHHHHhcC-----------------------------------------------------------
Q 000706 77 EFCVVTEFAQ-GELFEILEDD----------------------------------------------------------- 96 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek~----------------------------------------------------------- 96 (1342)
..++||||++ |+|.+++.+.
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999997 7899888542
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee--
Q 000706 97 ----------------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV-- 158 (1342)
Q Consensus 97 ----------------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~-- 158 (1342)
..+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 14788899999999999999999999999999999999999999999999999866443221
Q ss_pred eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHH-HHHHhcC-CCCCCCCCCHHHHHHHHH
Q 000706 159 LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYAL-IRHIVKD-PVKYPDEMSPNFKSFLKG 235 (1342)
Q Consensus 159 ~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~el-irkIlr~-~~efP~eISpeLkDLIrK 235 (1342)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .+.+... ....|...+.++++++.+
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 352 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKS 352 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHH
Confidence 112335667999999999999999999999999999997 8999987554333 3333322 233455678899999999
Q ss_pred hcccCCCCCCCHHHHHcC
Q 000706 236 LLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 236 cLqkDPeKRPSAeELLeH 253 (1342)
||+.||++||++.|+++.
T Consensus 353 cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 353 CWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HccCChhHCcCHHHHHHH
Confidence 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=345.39 Aligned_cols=252 Identities=29% Similarity=0.509 Sum_probs=208.9
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--------
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP-------- 75 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede-------- 75 (1342)
.+|++.+.||.|+||.||+|.++.+++.|++|.+..... ...+.+.+|++++++++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 689999999999999999999999999999999865533 3446788899999999999999999876544
Q ss_pred ------CeEEEEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcC-CCcEEEeeccc
Q 000706 76 ------QEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA-GSVVKLCDFGF 148 (1342)
Q Consensus 76 ------d~lyLVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLds-dG~LKLiDFGL 148 (1342)
...|++|||++++|.+++.+ ..+++..++.++.|+++||.|||++|++||||||+||+++. ++.+||+|||.
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~ 161 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL 161 (342)
T ss_pred ccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence 35799999999999888764 46999999999999999999999999999999999999975 55789999999
Q ss_pred cccccCCce---eeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC------
Q 000706 149 ARAMSANTV---VLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP------ 218 (1342)
Q Consensus 149 Ar~l~sss~---~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~------ 218 (1342)
+........ ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+..+....+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07854 162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE 241 (342)
T ss_pred ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 976543211 1122357889999997654 568899999999999999999999998766544443332210
Q ss_pred -------------------C-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCccc
Q 000706 219 -------------------V-----KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258 (1342)
Q Consensus 219 -------------------~-----efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre 258 (1342)
. .+.+.++.++.+||.+||+.||++|||+.|+++||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 242 DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 0 012357789999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=333.24 Aligned_cols=259 Identities=31% Similarity=0.564 Sum_probs=214.4
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFC 79 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~ly 79 (1342)
+++++|++.+.||+|+||.||+|.+..+++.||+|.+++..... ....+.+|+.++.+. +||||+++++++.++...|
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 36789999999999999999999999889999999997654333 334555677766666 5999999999999999999
Q ss_pred EEEeccCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCcEEEcCCCcEEEeeccccccccCCce
Q 000706 80 VVTEFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHS-NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 80 LVMEY~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHs-rGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~ 157 (1342)
++|||+++.+.+.+.. .+++++..+..++.|++.+|+|||+ .|++||||+|+||+++.++.+||+|||++..+.....
T Consensus 91 ~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 91 ICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred EEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 9999999888877665 4679999999999999999999997 5999999999999999999999999999976543322
Q ss_pred eeecccCCCCcCChhhhccCC----CCCCCcccchhhHHHHHHhCCCCCCCCc-HHHHHHHHhcCC-CCCC--CCCCHHH
Q 000706 158 VLRSIKGTPLYMAPELVREQP----YNHTADLWSLGVILYELFVGQPPFYTNS-VYALIRHIVKDP-VKYP--DEMSPNF 229 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g~~----YT~KsDIWSLGVILYELLTGr~PF~g~s-~~elirkIlr~~-~efP--~eISpeL 229 (1342)
. ....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||.... ..+....+.... ...+ ..+++++
T Consensus 171 ~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (296)
T cd06618 171 K-TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDF 249 (296)
T ss_pred c-cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHH
Confidence 2 2345788999999887553 7899999999999999999999997633 334444444432 2222 3478899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCcCcccchh
Q 000706 230 KSFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 230 kDLIrKcLqkDPeKRPSAeELLeHPFFre~~~ 261 (1342)
.+|+.+||+.||++||+++++++||||+....
T Consensus 250 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 250 CSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred HHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 99999999999999999999999999986443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=329.89 Aligned_cols=251 Identities=24% Similarity=0.436 Sum_probs=212.2
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEcc-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKY-----TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ 76 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~-----TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded 76 (1342)
..++|++.+.||+|+||.||+|.+.. ++..|++|.+.... .......+.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 34789999999999999999999876 67889999875443 2333456888999999999999999999999999
Q ss_pred eEEEEEeccC-CChHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC---cEEEee
Q 000706 77 EFCVVTEFAQ-GELFEILEDDK-------CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS---VVKLCD 145 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek~g-------~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG---~LKLiD 145 (1342)
..+++|||++ |+|.+++.+.+ .+++..+..++.||+.||+|||++|++||||||+||+++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 9999999996 78999987543 589999999999999999999999999999999999998765 599999
Q ss_pred ccccccccCCcee--eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCC
Q 000706 146 FGFARAMSANTVV--LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKY 221 (1342)
Q Consensus 146 FGLAr~l~sss~~--~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~ef 221 (1342)
||+++........ ......+..|+|||++.+..++.++|||||||++|+|++ |+.||...+.....+.+... ...+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 242 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDP 242 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 9999876432211 112233567999999998889999999999999999997 99999987766666555443 4456
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 222 PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 222 P~eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
+..+++.+.+++.+||+.||++||++.++++|
T Consensus 243 ~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 243 PKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 77889999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=344.88 Aligned_cols=251 Identities=34% Similarity=0.564 Sum_probs=210.8
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC------Ce
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP------QE 77 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede------d~ 77 (1342)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.+....+.....+.+|+++++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 689999999999999999999999999999999876543333445678899999999999999999998654 35
Q ss_pred EEEEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce
Q 000706 78 FCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 78 lyLVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~ 157 (1342)
+|++|||+++++.++. ...++++.++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 95 ~~lv~e~~~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-- 170 (342)
T cd07879 95 FYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 170 (342)
T ss_pred EEEEecccccCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--
Confidence 6999999998887765 346899999999999999999999999999999999999999999999999999765432
Q ss_pred eeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-------------------
Q 000706 158 VLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD------------------- 217 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~------------------- 217 (1342)
.....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.......+...
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (342)
T cd07879 171 -MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKS 249 (342)
T ss_pred -CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHH
Confidence 233467899999998866 46889999999999999999999999887654444333220
Q ss_pred ----CCCC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 218 ----PVKY--------PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 218 ----~~ef--------P~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
.... .+..++++.+||.+||+.||++||++.+++.||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 250 YIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0001 12467889999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=336.05 Aligned_cols=252 Identities=34% Similarity=0.568 Sum_probs=216.8
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
.|...+.||+|+||.||+|++..+++.|++|.+..... .......+.+|+++++.++|||++++++++.+.+..|++||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 46677889999999999999999999999999875433 33445678889999999999999999999999999999999
Q ss_pred ccCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 84 FAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 Y~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
|+.|++.+.+.. ..++++.+++.++.|++.+|.|||++|++||||||+||+++.++.+||+|||++..... ....
T Consensus 102 ~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~~~ 177 (313)
T cd06633 102 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----ANSF 177 (313)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----CCCc
Confidence 999999888765 55799999999999999999999999999999999999999999999999999865332 2345
Q ss_pred cCCCCcCChhhhc---cCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHhc
Q 000706 163 KGTPLYMAPELVR---EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV--KYPDEMSPNFKSFLKGLL 237 (1342)
Q Consensus 163 vGTp~YmAPEvL~---g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~--efP~eISpeLkDLIrKcL 237 (1342)
.|+..|+|||.+. ...++.++|+||||+++|+|++|..||...+.......+..... .....++..+++|+.+||
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 257 (313)
T cd06633 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCL 257 (313)
T ss_pred cccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHc
Confidence 6899999999874 45688999999999999999999999988776665555544322 223457788999999999
Q ss_pred ccCCCCCCCHHHHHcCcCcccch
Q 000706 238 NKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 238 qkDPeKRPSAeELLeHPFFre~~ 260 (1342)
+.+|.+||++.++++||||+...
T Consensus 258 ~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 258 QKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred cCChhhCcCHHHHhcCcccCCCc
Confidence 99999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=322.33 Aligned_cols=248 Identities=26% Similarity=0.465 Sum_probs=213.4
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
++.++|++.+.||+|+||.||+|.+. +++.+++|.+...... .+.+.+|++++++++||||+++++++.++...++
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 35689999999999999999999876 5678999998754432 3568889999999999999999999999899999
Q ss_pred EEeccC-CChHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce
Q 000706 81 VTEFAQ-GELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~--g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~ 157 (1342)
+|||++ ++|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999997 6899998764 3689999999999999999999999999999999999999999999999999977653221
Q ss_pred e-eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHH
Q 000706 158 V-LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLK 234 (1342)
Q Consensus 158 ~-~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIr 234 (1342)
. .....++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||.+.+.....+.+... ....+...+.++.+++.
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLML 238 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 1 112234568999999998889999999999999999998 99999888777777777654 34456677899999999
Q ss_pred HhcccCCCCCCCHHHHHc
Q 000706 235 GLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 235 KcLqkDPeKRPSAeELLe 252 (1342)
+||+.||++||+++++.+
T Consensus 239 ~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 239 QCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHcccCcccCCCHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=343.12 Aligned_cols=252 Identities=26% Similarity=0.437 Sum_probs=206.2
Q ss_pred EEEccc--CcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 10 ELVGEG--SFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 10 K~LGsG--gFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
+.||+| +||+||++.+..+|+.||+|.+..........+.+.+|+.+++.++||||+++++++..++..|++|||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456776 99999999999999999999987665555666889999999999999999999999999999999999997
Q ss_pred CChHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee------
Q 000706 87 GELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV------ 158 (1342)
Q Consensus 87 GSL~D~Lek~--g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~------ 158 (1342)
|++.+++.+. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+|+.||+.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 6899888763 35899999999999999999999999999999999999999999999999865433211110
Q ss_pred -eecccCCCCcCChhhhccC--CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC---------------
Q 000706 159 -LRSIKGTPLYMAPELVREQ--PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVK--------------- 220 (1342)
Q Consensus 159 -~~s~vGTp~YmAPEvL~g~--~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~e--------------- 220 (1342)
.....++..|++||++.+. .++.++||||+|+++|+|++|+.||...............+..
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence 0112356779999998763 4789999999999999999999999876544433333221110
Q ss_pred --------------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccchh
Q 000706 221 --------------------------------YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 221 --------------------------------fP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~~ 261 (1342)
.+..+++.+.+|+++||+.||++|||+.|+++||||+...+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 11235678999999999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.02 Aligned_cols=241 Identities=25% Similarity=0.452 Sum_probs=205.6
Q ss_pred EEEcccCcEEEEEEEEccCC---cEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC
Q 000706 10 ELVGEGSFGKVYKGRRKYTG---QTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TG---e~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e 86 (1342)
++||+|+||.||+|....++ ..+++|.+...... ...+.+.+|++++++++|||+++++++++ .+.++++|||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 47999999999999876554 78999998765443 44567889999999999999999999876 456899999987
Q ss_pred -CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec---c
Q 000706 87 -GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS---I 162 (1342)
Q Consensus 87 -GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s---~ 162 (1342)
|+|.+++.+.+.+++..++.++.|++.+|+|||++|++||||||+||+++.++.+||+|||+++........... .
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05060 79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG 158 (257)
T ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCc
Confidence 789999988888999999999999999999999999999999999999999999999999999876544322211 1
Q ss_pred cCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhcccC
Q 000706 163 KGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLNKV 240 (1342)
Q Consensus 163 vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrKcLqkD 240 (1342)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+... +...+..+++.++++|.+||+.|
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 238 (257)
T cd05060 159 RWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYR 238 (257)
T ss_pred cccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCC
Confidence 23457999999998889999999999999999998 99999887766666665544 33566778999999999999999
Q ss_pred CCCCCCHHHHHc
Q 000706 241 PQNRLTWSALLE 252 (1342)
Q Consensus 241 PeKRPSAeELLe 252 (1342)
|++||++.++++
T Consensus 239 p~~Rp~~~~l~~ 250 (257)
T cd05060 239 PEDRPTFSELES 250 (257)
T ss_pred hhhCcCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=369.46 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=200.6
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCc-EEEEE--------------Eeec-CCCCHHHHHHHHHHHHHHHhcCCCCcc
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQ-TVAMK--------------FIMK-HGKSEKDIHNLRQEIEILRKLKHQNII 66 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe-~VAVK--------------vIkK-s~~se~dierL~rEI~ILKrL~HPNIV 66 (1342)
.++|++++.||+|+||+||+|..+.... ..+.| .+.+ ..........+.+|++++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987643322 22222 1111 112223345688999999999999999
Q ss_pred eEEEEEEeCCeEEEEEeccCCChHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcE
Q 000706 67 EMLDSFESPQEFCVVTEFAQGELFEILEDD-----KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVV 141 (1342)
Q Consensus 67 KL~dvfeded~lyLVMEY~eGSL~D~Lek~-----g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~L 141 (1342)
++++++++++..|++||+++++|++++... .......++.++.||+.||+|||++||+||||||+|||++.+|.+
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~v 306 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKI 306 (501)
T ss_pred cEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 999999999999999999999999987542 234567788999999999999999999999999999999999999
Q ss_pred EEeeccccccccCCce-eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCC-C--cHHHHHHHHhcC
Q 000706 142 KLCDFGFARAMSANTV-VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYT-N--SVYALIRHIVKD 217 (1342)
Q Consensus 142 KLiDFGLAr~l~sss~-~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g-~--s~~elirkIlr~ 217 (1342)
||+|||+++.+..... ......||+.|+|||++.+..|+.++|||||||++|||++|..++.. . .....+.++...
T Consensus 307 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~ 386 (501)
T PHA03210 307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDS 386 (501)
T ss_pred EEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHh
Confidence 9999999987654332 22346799999999999999999999999999999999998765432 1 222222221110
Q ss_pred ----CCCCC----------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 218 ----PVKYP----------------------------DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 218 ----~~efP----------------------------~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
..++| ..++.++.++|.+||+.||++|||+.|+++||||....
T Consensus 387 ~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 387 LSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred cccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 00111 13466788899999999999999999999999998754
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.09 Aligned_cols=251 Identities=25% Similarity=0.482 Sum_probs=213.8
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCc---EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQ---TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQE 77 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe---~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~ 77 (1342)
+++.+|++.+.||+|+||.||+|.++.+++ .|++|.+.+. ........+..|+.++++++||||+++++++.++..
T Consensus 1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred CChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 457889999999999999999999887665 5999988654 345556789999999999999999999999999999
Q ss_pred EEEEEeccC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCC
Q 000706 78 FCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN 155 (1342)
Q Consensus 78 lyLVMEY~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ss 155 (1342)
.+++|||++ |+|.+++.. .+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999997 588888875 457899999999999999999999999999999999999999999999999998765432
Q ss_pred cee--eec-c--cCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHH
Q 000706 156 TVV--LRS-I--KGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPN 228 (1342)
Q Consensus 156 s~~--~~s-~--vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpe 228 (1342)
... ... . ..+..|++||.+.+..++.++||||||+++|||++ |..||...+..+....+... +.+.+..+++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 211 111 1 12457999999998899999999999999999886 99999887777666666543 33455678899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHc
Q 000706 229 FKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 229 LkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
+.+++.+||..+|.+||++.+++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=323.25 Aligned_cols=246 Identities=22% Similarity=0.446 Sum_probs=209.5
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
.-++|++.+.||+|+||.||+|... +++.||+|.+.+.... ...+.+|+.++++++|||++++++++. .+..|++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 3478999999999999999999865 6788999998755433 246788999999999999999999874 4578999
Q ss_pred EeccC-CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce-
Q 000706 82 TEFAQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV- 157 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~- 157 (1342)
|||++ |+|.+++.+ ...+++.++..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 99996 789998865 34689999999999999999999999999999999999999999999999999977653322
Q ss_pred eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHH
Q 000706 158 VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKG 235 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrK 235 (1342)
......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..+....+... ..+.+...+.++.+++.+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRL 238 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 1223345678999999998889999999999999999998 99999887776666665443 334556788999999999
Q ss_pred hcccCCCCCCCHHHHHc
Q 000706 236 LLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 236 cLqkDPeKRPSAeELLe 252 (1342)
||+.||++||+++++++
T Consensus 239 ~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 239 CWKEKPEERPTFEYLRS 255 (260)
T ss_pred HccCChhhCCCHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=326.34 Aligned_cols=251 Identities=32% Similarity=0.587 Sum_probs=215.0
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCC---CCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG---KSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~---~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
+|++.+.||+|+||.||++.+..++..+++|.++... .......+...|+.++++++||||+++++++.+++..+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 6999999999999999999998887777777765422 2223345677899999999999999999999999999999
Q ss_pred EeccC-CChHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 82 TEFAQ-GELFEILED----DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek----~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
|||++ ++|.+++.+ ...+++..++.++.|++.||.|||++|++|+||||+||+++. +.+||+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 99997 578777753 457999999999999999999999999999999999999975 579999999998765544
Q ss_pred eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHH
Q 000706 157 VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKG 235 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrK 235 (1342)
.......|++.|++||.+.+..++.++|+||+|+++|+|++|..||...........+... ....+..+++++.++|.+
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQS 239 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHH
Confidence 4444566899999999998888999999999999999999999999877766666666544 344566788999999999
Q ss_pred hcccCCCCCCCHHHHHcCcCc
Q 000706 236 LLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 236 cLqkDPeKRPSAeELLeHPFF 256 (1342)
||+.||++||++.|+++||||
T Consensus 240 ~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 240 MLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=332.95 Aligned_cols=248 Identities=26% Similarity=0.490 Sum_probs=209.5
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCc--EEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQ--TVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe--~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyL 80 (1342)
++|++.+.||+|+||.||+|.++.++. .+++|.++.. ......+.+.+|++++.++ +||||+++++++.+.+.+|+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 789999999999999999999877765 4688877532 2334456788899999999 79999999999999999999
Q ss_pred EEeccC-CChHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEE
Q 000706 81 VTEFAQ-GELFEILEDD----------------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKL 143 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~----------------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKL 143 (1342)
+|||++ |+|.+++.+. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence 999987 7899998653 24889999999999999999999999999999999999999999999
Q ss_pred eeccccccccCCceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCC
Q 000706 144 CDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKY 221 (1342)
Q Consensus 144 iDFGLAr~l~sss~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~ef 221 (1342)
+|||++........ ......+..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+... ....
T Consensus 161 ~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (297)
T cd05089 161 ADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK 239 (297)
T ss_pred CCcCCCccccceec-cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 99999864322111 111223456999999998889999999999999999997 99999988877777766554 3345
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 222 PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 222 P~eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
+..+++++.+++.+||+.||.+||+++++++.
T Consensus 240 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 240 PRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 66789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.69 Aligned_cols=246 Identities=26% Similarity=0.495 Sum_probs=209.5
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
..++|++.+.||+|+||.||+|.+. ++..+++|.+....... +.+.+|+.++++++|||++++++++. .+..|++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 3578999999999999999999866 56779999987654332 46788999999999999999999885 4568999
Q ss_pred EeccC-CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 82 TEFAQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
|||++ |+|.+++.+ ...+++..++.++.|++.||.|||++|++||||||+||++++++.+||+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 99997 689998875 345899999999999999999999999999999999999999999999999999876543221
Q ss_pred -eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHH
Q 000706 159 -LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKG 235 (1342)
Q Consensus 159 -~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrK 235 (1342)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+..+..+.+... +.+.+...+..+.+++.+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQ 238 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 122335667999999988889999999999999999999 99999887777777766543 445667789999999999
Q ss_pred hcccCCCCCCCHHHHHc
Q 000706 236 LLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 236 cLqkDPeKRPSAeELLe 252 (1342)
||..||++|||+.++.+
T Consensus 239 ~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 239 CWKKDPEERPTFEYLQS 255 (260)
T ss_pred HcccCcccCcCHHHHHH
Confidence 99999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=327.63 Aligned_cols=249 Identities=34% Similarity=0.577 Sum_probs=209.4
Q ss_pred EEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEec
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-HQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~-HPNIVKL~dvfeded~lyLVMEY 84 (1342)
|++.+.||+|+||+||+|.+..+++.|++|.+.+...... .....+|+..+++++ |||++++++++.+++..|+||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 7899999999999999999998999999999865533222 234456899999998 99999999999999999999999
Q ss_pred cCCChHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 85 AQGELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 85 ~eGSL~D~Lek~g--~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
++|+|.+++.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~ 158 (283)
T cd07830 80 MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-YTDY 158 (283)
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-cCCC
Confidence 9999999987654 789999999999999999999999999999999999999999999999999987654322 2345
Q ss_pred cCCCCcCChhhhc-cCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC---CC-------------------
Q 000706 163 KGTPLYMAPELVR-EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PV------------------- 219 (1342)
Q Consensus 163 vGTp~YmAPEvL~-g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~---~~------------------- 219 (1342)
.++..|+|||.+. +..++.++|+||||+++|+|++|++||...+..+...++... +.
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence 6889999999875 445789999999999999999999999877655444333210 00
Q ss_pred --------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 220 --------KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 220 --------efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
...+..++++.++|++||+.||++|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0011236889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.56 Aligned_cols=250 Identities=30% Similarity=0.522 Sum_probs=211.3
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEcc-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKY-------TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFES 74 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~-------TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfed 74 (1342)
.++|.+.+.||+|+||.||++.+.. +...+|+|.++... .......+.+|+++++.+ +||||+++++++.+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3789999999999999999998643 23569999987542 344456788899999999 79999999999999
Q ss_pred CCeEEEEEeccC-CChHHHHhcCC----------------CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcC
Q 000706 75 PQEFCVVTEFAQ-GELFEILEDDK----------------CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA 137 (1342)
Q Consensus 75 ed~lyLVMEY~e-GSL~D~Lek~g----------------~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLds 137 (1342)
.+..|+||||++ |+|.+++.+.+ .+++.++..++.|++.||+|||++|++||||||+||+++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence 999999999997 79999987532 4788999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCceee--ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHH
Q 000706 138 GSVVKLCDFGFARAMSANTVVL--RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHI 214 (1342)
Q Consensus 138 dG~LKLiDFGLAr~l~sss~~~--~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkI 214 (1342)
++.+||+|||+++......... ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+..+.+
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~ 255 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 255 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 9999999999987654322111 11224568999999998889999999999999999998 89999887776666665
Q ss_pred hcCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 215 VKDP-VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 215 lr~~-~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
.... ...+...++++++++.+||..+|++||++.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 256 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 5543 45667789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=334.63 Aligned_cols=253 Identities=35% Similarity=0.573 Sum_probs=218.3
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
.|+..+.||+|+||.||++.+..+++.+++|.+..... ..+....+.+|++++++++|||++++++++.+++..|+|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 47889999999999999999999999999999875532 33445678899999999999999999999999999999999
Q ss_pred ccCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 84 FAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 Y~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
|++|++.+.+.. ..++++..+..++.|++.+|.|||++|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 106 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~ 181 (317)
T cd06635 106 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----NSF 181 (317)
T ss_pred CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----ccc
Confidence 999998887754 567999999999999999999999999999999999999999999999999998765432 234
Q ss_pred cCCCCcCChhhhc---cCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHhc
Q 000706 163 KGTPLYMAPELVR---EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV--KYPDEMSPNFKSFLKGLL 237 (1342)
Q Consensus 163 vGTp~YmAPEvL~---g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~--efP~eISpeLkDLIrKcL 237 (1342)
.|++.|+|||.+. ...++.++|+||||+++|+|++|+.||...+.......+..... ..+..+++.+++++.+||
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 261 (317)
T cd06635 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL 261 (317)
T ss_pred cCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHc
Confidence 6889999999873 45688999999999999999999999988776666665554432 223467889999999999
Q ss_pred ccCCCCCCCHHHHHcCcCcccchh
Q 000706 238 NKVPQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 238 qkDPeKRPSAeELLeHPFFre~~~ 261 (1342)
+.+|.+||++.++++|+|+.....
T Consensus 262 ~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 262 QKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred cCCcccCcCHHHHHhChhhhccCc
Confidence 999999999999999999866443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=328.61 Aligned_cols=256 Identities=31% Similarity=0.548 Sum_probs=217.0
Q ss_pred CEEEEEEEcccCcEEEEEEEEc---cCCcEEEEEEeecCCCC--HHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRK---YTGQTVAMKFIMKHGKS--EKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEF 78 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk---~TGe~VAVKvIkKs~~s--e~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~l 78 (1342)
+|++.+.||+|+||.||++.+. .+++.|++|.+++.... ....+.+.+|+++++++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999864 46789999998754221 22345678899999999 699999999999999999
Q ss_pred EEEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce
Q 000706 79 CVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 79 yLVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~ 157 (1342)
|+||||++ |+|.+++.+...+++..++.++.|++++|.|||+.|++||||||+||+++.++.++|+|||+++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999997 68999998878899999999999999999999999999999999999999999999999999876543322
Q ss_pred -eeecccCCCCcCChhhhccCC--CCCCCcccchhhHHHHHHhCCCCCCCCc----HHHHHHHHhcCCCCCCCCCCHHHH
Q 000706 158 -VLRSIKGTPLYMAPELVREQP--YNHTADLWSLGVILYELFVGQPPFYTNS----VYALIRHIVKDPVKYPDEMSPNFK 230 (1342)
Q Consensus 158 -~~~s~vGTp~YmAPEvL~g~~--YT~KsDIWSLGVILYELLTGr~PF~g~s----~~elirkIlr~~~efP~eISpeLk 230 (1342)
......|++.|++||.+.+.. ++.++|+||||+++|+|++|..||.... ..+..+.+.......+..+++++.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 240 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR 240 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHH
Confidence 122356899999999987654 7889999999999999999999996432 334445555566677778899999
Q ss_pred HHHHHhcccCCCCCCC---HHHHHcCcCcccch
Q 000706 231 SFLKGLLNKVPQNRLT---WSALLEHPFVKETS 260 (1342)
Q Consensus 231 DLIrKcLqkDPeKRPS---AeELLeHPFFre~~ 260 (1342)
+++.+||+.||++||| +.++++||||+...
T Consensus 241 ~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 241 DFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 9999999999999998 57889999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=322.56 Aligned_cols=251 Identities=22% Similarity=0.427 Sum_probs=212.8
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCc---EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQ---TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQE 77 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe---~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~ 77 (1342)
+..++|+..+.||+|+||.||+|.++.+++ .+++|.++... .....+.+..|++++++++|||++++++++.+.+.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 355789999999999999999999876655 78999886542 33445678899999999999999999999999999
Q ss_pred EEEEEeccC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCC
Q 000706 78 FCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN 155 (1342)
Q Consensus 78 lyLVMEY~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ss 155 (1342)
.|++|||++ |+|.+++.+ .+.+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 999999997 688888865 467999999999999999999999999999999999999999999999999999766432
Q ss_pred ceee---ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHH
Q 000706 156 TVVL---RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFK 230 (1342)
Q Consensus 156 s~~~---~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLk 230 (1342)
.... .....++.|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+... ..+.+...+.++.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 240 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 2111 11223457999999988889999999999999999997 99999887777777666543 3344556889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHc
Q 000706 231 SFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 231 DLIrKcLqkDPeKRPSAeELLe 252 (1342)
+++.+||+.||++||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=368.69 Aligned_cols=249 Identities=35% Similarity=0.602 Sum_probs=223.2
Q ss_pred EEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-e~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
|.-++.||.|+||-||.|++..+.+.||||.+.-.++. ...+.++.+|+++|+++.|||++.+.++|..+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55678899999999999999999999999999766543 34467899999999999999999999999999999999999
Q ss_pred cCCChHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeeccc
Q 000706 85 AQGELFEILE-DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK 163 (1342)
Q Consensus 85 ~eGSL~D~Le-k~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~v 163 (1342)
|-|+-.|.++ ..+++-|.++..|..+.+.||+|||+++.+|||||..|||+++.|.+||+|||.|....+. .+++
T Consensus 108 ClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----nsFv 183 (948)
T KOG0577|consen 108 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----NSFV 183 (948)
T ss_pred HhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch----hccc
Confidence 9998777775 3568999999999999999999999999999999999999999999999999999776543 5688
Q ss_pred CCCCcCChhhhc---cCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CC-CCCCCHHHHHHHHHhcc
Q 000706 164 GTPLYMAPELVR---EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV-KY-PDEMSPNFKSFLKGLLN 238 (1342)
Q Consensus 164 GTp~YmAPEvL~---g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~-ef-P~eISpeLkDLIrKcLq 238 (1342)
|||+|||||++. .+.|+-++||||||++..||...++|++..+....+-.|..+.. .+ ..+++..|.+||..||+
T Consensus 184 GTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLq 263 (948)
T KOG0577|consen 184 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQ 263 (948)
T ss_pred CCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHh
Confidence 999999999875 46799999999999999999999999999998888888877643 33 35789999999999999
Q ss_pred cCCCCCCCHHHHHcCcCccc
Q 000706 239 KVPQNRLTWSALLEHPFVKE 258 (1342)
Q Consensus 239 kDPeKRPSAeELLeHPFFre 258 (1342)
+-|..|||.+++++|+|+..
T Consensus 264 KipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 264 KIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred hCcccCCcHHHHhhcchhcc
Confidence 99999999999999999854
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=329.29 Aligned_cols=249 Identities=27% Similarity=0.460 Sum_probs=212.0
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEc-----cCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRK-----YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ 76 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk-----~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded 76 (1342)
..++|.+.+.||+|+||.||++.+. .++..+++|.+... .....+.+.+|++++++++||||+++++++.+.+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 4678999999999999999999753 34566888887543 2334467889999999999999999999999999
Q ss_pred eEEEEEeccC-CChHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC
Q 000706 77 EFCVVTEFAQ-GELFEILEDD----------------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS 139 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek~----------------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG 139 (1342)
..++||||++ |+|.+++... +.+++..++.++.||+.||+|||++|++||||||+||+++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999996 7899998653 2388999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCce--eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhc
Q 000706 140 VVKLCDFGFARAMSANTV--VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVK 216 (1342)
Q Consensus 140 ~LKLiDFGLAr~l~sss~--~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr 216 (1342)
.+||+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+..+.+..
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 240 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 240 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC
Confidence 999999999976544322 1223456788999999998889999999999999999998 9999988777777766655
Q ss_pred CCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 217 DPV-KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 217 ~~~-efP~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
... ..+...+.++.+++.+||+.||++||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 241 GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 433 345567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=324.66 Aligned_cols=246 Identities=26% Similarity=0.460 Sum_probs=208.2
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
..++|++.+.||+|+||.||+|.+..+ ..|++|.+++.... .+.+.+|++++++++||||+++++.+. ++..|++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 78 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence 457899999999999999999988654 56999998754332 246788999999999999999999875 4567999
Q ss_pred EeccC-CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 82 TEFAQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
|||++ |+|.+++.+ ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 99997 699999875 345899999999999999999999999999999999999999999999999999866543322
Q ss_pred e-ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHH
Q 000706 159 L-RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKG 235 (1342)
Q Consensus 159 ~-~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrK 235 (1342)
. ....++..|++||...+..++.++|+||||+++|+|++ |+.||......+....+... +...+..+++.+.+++.+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 238 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 238 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 1 22346678999999988889999999999999999999 89999887766666665543 334456789999999999
Q ss_pred hcccCCCCCCCHHHHHc
Q 000706 236 LLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 236 cLqkDPeKRPSAeELLe 252 (1342)
|++.||++||++.++++
T Consensus 239 ~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 239 CWRKEPEERPTFEYLQA 255 (262)
T ss_pred HccCCcccCCCHHHHHH
Confidence 99999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=316.62 Aligned_cols=246 Identities=31% Similarity=0.569 Sum_probs=212.2
Q ss_pred EEEEEEEcccCcEEEEEEEEccCC----cEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTG----QTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~TG----e~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
+++.+.||.|+||.||++.+...+ +.+|+|.+..... ....+.+..|+++++.++||||+++++++.+.+..|++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 467899999999999999998766 8899999865432 22557889999999999999999999999999999999
Q ss_pred EeccC-CChHHHHhcCCC--CCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 82 TEFAQ-GELFEILEDDKC--LPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek~g~--LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
|||++ ++|.+++..... +++..++.++.|++.+|+|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 99997 689999876544 999999999999999999999999999999999999999999999999999776543221
Q ss_pred ee-cccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHH
Q 000706 159 LR-SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKG 235 (1342)
Q Consensus 159 ~~-s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrK 235 (1342)
.. ...+++.|++||.+.+..++.++|+||+|+++|+|++ |+.||...+.....+.+... ....+..++.++.+++.+
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQ 239 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 11 2236789999999988889999999999999999998 89999887777777666554 334556689999999999
Q ss_pred hcccCCCCCCCHHHHHc
Q 000706 236 LLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 236 cLqkDPeKRPSAeELLe 252 (1342)
||+.||++|||+.|+++
T Consensus 240 ~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 240 CWAEDPEDRPTFSELVE 256 (258)
T ss_pred HCcCChhhCcCHHHHHh
Confidence 99999999999999975
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=327.98 Aligned_cols=250 Identities=28% Similarity=0.480 Sum_probs=212.5
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEc-----cCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRK-----YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP 75 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk-----~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede 75 (1342)
|+-++|++.++||+|+||.||++... .++..+++|.+.+. .......+.+|+++++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 45678999999999999999999643 35668899987543 344557899999999999999999999999999
Q ss_pred CeEEEEEeccC-CChHHHHhcCC---------------CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC
Q 000706 76 QEFCVVTEFAQ-GELFEILEDDK---------------CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS 139 (1342)
Q Consensus 76 d~lyLVMEY~e-GSL~D~Lek~g---------------~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG 139 (1342)
+..|++|||++ |+|.+++...+ .+++..++.++.|++.||+|||++|++||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999987 78999886542 488999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCcee--eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhc
Q 000706 140 VVKLCDFGFARAMSANTVV--LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVK 216 (1342)
Q Consensus 140 ~LKLiDFGLAr~l~sss~~--~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr 216 (1342)
.+||+|||++......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |.+||......+....+..
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 9999999999765433211 122335778999999998889999999999999999998 9999988776666666655
Q ss_pred C-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 217 D-PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 217 ~-~~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
. +...+..+++.+.+++.+||+.||++||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 4 34556778999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.09 Aligned_cols=249 Identities=35% Similarity=0.620 Sum_probs=212.8
Q ss_pred EEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-C
Q 000706 9 IELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-G 87 (1342)
Q Consensus 9 lK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e-G 87 (1342)
...||+|+||.||++.+..+++.+++|.+... .......+.+|+.+++.++|||++++++.+.+++..|++|||++ +
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 35799999999999999999999999987533 23345678899999999999999999999999999999999997 4
Q ss_pred ChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCCC
Q 000706 88 ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL 167 (1342)
Q Consensus 88 SL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp~ 167 (1342)
+|.+++. .+++++..++.++.|++.+|+|||++|++||||||+||+++.++.++|+|||++..............|++.
T Consensus 103 ~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 181 (292)
T cd06657 103 ALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY 181 (292)
T ss_pred cHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCcc
Confidence 6777654 456899999999999999999999999999999999999999999999999998766543333344568999
Q ss_pred cCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC---CCCCCCCCCHHHHHHHHHhcccCCCCC
Q 000706 168 YMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PVKYPDEMSPNFKSFLKGLLNKVPQNR 244 (1342)
Q Consensus 168 YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~---~~efP~eISpeLkDLIrKcLqkDPeKR 244 (1342)
|++||.+.+..++.++|+||+|+++|+|++|..||...........+... .......+++.+.+++.+||+.||.+|
T Consensus 182 y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R 261 (292)
T cd06657 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR 261 (292)
T ss_pred ccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccC
Confidence 99999998888999999999999999999999999887665554444332 222334578999999999999999999
Q ss_pred CCHHHHHcCcCcccch
Q 000706 245 LTWSALLEHPFVKETS 260 (1342)
Q Consensus 245 PSAeELLeHPFFre~~ 260 (1342)
|++.++++||||....
T Consensus 262 ~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 262 ATAAELLKHPFLAKAG 277 (292)
T ss_pred cCHHHHhcChHHhccC
Confidence 9999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=317.63 Aligned_cols=249 Identities=25% Similarity=0.482 Sum_probs=212.6
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
++..+|++.+.||+|+||.||++.+. +++.+++|.+.+..... ..+.+|++++++++|||++++++++.+....++
T Consensus 1 ~~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 1 IHPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL 76 (256)
T ss_pred CChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence 46789999999999999999999875 47789999886554332 457789999999999999999999999999999
Q ss_pred EEeccC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 81 VTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
+|||++ |+|.+++.. .+.++++.++.++.|++.+|.|||++|++||||||+||+++.++.+||+|||.+.........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 999997 678888875 456899999999999999999999999999999999999999999999999998765433211
Q ss_pred -eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHH
Q 000706 159 -LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKG 235 (1342)
Q Consensus 159 -~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrK 235 (1342)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...........+... ....+...+.++.+++.+
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 122335678999999988889999999999999999998 99999888777777766654 333455678999999999
Q ss_pred hcccCCCCCCCHHHHHcC
Q 000706 236 LLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 236 cLqkDPeKRPSAeELLeH 253 (1342)
||+.+|++|||+.+++++
T Consensus 237 ~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 237 CWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HcccChhhCCCHHHHHHh
Confidence 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.95 Aligned_cols=245 Identities=34% Similarity=0.588 Sum_probs=206.5
Q ss_pred EEEEEEcccCcEEEEEEEEc----cCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 7 HVIELVGEGSFGKVYKGRRK----YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 7 rIlK~LGsGgFGtVYKArDk----~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
++.+.||.|.||.||+|... ..+..|+||.++. .......+.+.+|++.+++++||||+++++++.+.+..++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence 57899999999999999887 4567899999954 344555788999999999999999999999999888899999
Q ss_pred eccC-CChHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc--e
Q 000706 83 EFAQ-GELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT--V 157 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~--g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss--~ 157 (1342)
||++ |+|.+++... ..+++..++.++.|+++||.|||+++++||||+++||++++++.+||+|||++....... .
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9997 7999999876 789999999999999999999999999999999999999999999999999998763221 2
Q ss_pred eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHH
Q 000706 158 VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKG 235 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrK 235 (1342)
......+...|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+... ....+..++..+.++|..
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQ 240 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHHH
Confidence 2233457788999999998889999999999999999999 78999888888777777554 334567789999999999
Q ss_pred hcccCCCCCCCHHHHHc
Q 000706 236 LLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 236 cLqkDPeKRPSAeELLe 252 (1342)
||..||++|||+.++++
T Consensus 241 C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 241 CWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HT-SSGGGS--HHHHHH
T ss_pred HcCCChhhCcCHHHHHh
Confidence 99999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=331.21 Aligned_cols=249 Identities=29% Similarity=0.533 Sum_probs=210.4
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEc-------cCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRK-------YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFES 74 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk-------~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfed 74 (1342)
-++|++.+.||+|+||.||++.+. .....+|+|.++... .......+.+|+++++++ +||||+++++++.+
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 368999999999999999999763 234568999886543 344456788899999999 69999999999999
Q ss_pred CCeEEEEEeccC-CChHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcC
Q 000706 75 PQEFCVVTEFAQ-GELFEILEDD----------------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA 137 (1342)
Q Consensus 75 ed~lyLVMEY~e-GSL~D~Lek~----------------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLds 137 (1342)
++.+|++|||++ |+|.+++.+. ..+++.++..++.|++.||.|||++|++||||||+||+++.
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE 169 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence 999999999997 7899998653 34888999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCceee--ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHH
Q 000706 138 GSVVKLCDFGFARAMSANTVVL--RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHI 214 (1342)
Q Consensus 138 dG~LKLiDFGLAr~l~sss~~~--~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkI 214 (1342)
++.+||+|||+++......... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~ 249 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL 249 (314)
T ss_pred CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999998664322111 11224567999999998889999999999999999999 89999888777766666
Q ss_pred hcCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 215 VKDP-VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 215 lr~~-~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
.... ...+...+.++++++.+||+.||++||++.|+++
T Consensus 250 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 250 REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 5543 3556778899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=320.42 Aligned_cols=246 Identities=26% Similarity=0.459 Sum_probs=207.6
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
..++|++.+.||+|+||.||++.+..+ ..+++|.+...... .+.+.+|++++++++|||++++++++. .+..|++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 347899999999999999999987644 46899987654322 356788999999999999999999885 4568999
Q ss_pred EeccC-CChHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 82 TEFAQ-GELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek~--g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
|||++ |+|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99997 6899998753 35899999999999999999999999999999999999999999999999999766443221
Q ss_pred -eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHH
Q 000706 159 -LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKG 235 (1342)
Q Consensus 159 -~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrK 235 (1342)
.....++..|+|||...+..++.++|+||||+++|+|++ |+.||.+....+....+... ....+...+..+++++++
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKL 238 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHH
Confidence 122345678999999988889999999999999999999 99999887776666666554 344567789999999999
Q ss_pred hcccCCCCCCCHHHHHc
Q 000706 236 LLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 236 cLqkDPeKRPSAeELLe 252 (1342)
||++||++||+++++++
T Consensus 239 ~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 239 CWKKDPDERPTFEYIQS 255 (260)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999865
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=332.41 Aligned_cols=253 Identities=33% Similarity=0.572 Sum_probs=216.1
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~-~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
+.|+..+.||+|+||.||+++++.+++.+++|.+.... .......++.+|+++++.++|||++++++++.++...|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 35778889999999999999999999999999986542 23344567888999999999999999999999999999999
Q ss_pred eccCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
||+.|++.+.+.. ..++++..+..++.|++.+|.|||++|++||||||+||+++.++.+||+|||++...... ..
T Consensus 95 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----~~ 170 (308)
T cd06634 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NX 170 (308)
T ss_pred EccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----cc
Confidence 9999998887753 557899999999999999999999999999999999999999999999999998765432 23
Q ss_pred ccCCCCcCChhhhc---cCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-C-CCCCCCHHHHHHHHHh
Q 000706 162 IKGTPLYMAPELVR---EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV-K-YPDEMSPNFKSFLKGL 236 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~---g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~-e-fP~eISpeLkDLIrKc 236 (1342)
..|++.|+|||.+. ...++.++||||||+++|+|++|..||...+..+....+..... . .+..++..++++|++|
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 250 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHH
Confidence 45889999999874 34578899999999999999999999987665555444444322 2 2346788999999999
Q ss_pred cccCCCCCCCHHHHHcCcCcccch
Q 000706 237 LNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 237 LqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
|+.+|++||++.++++|||+....
T Consensus 251 l~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 251 LQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred hhCCcccCCCHHHHhhCccccccC
Confidence 999999999999999999997753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=325.83 Aligned_cols=250 Identities=22% Similarity=0.394 Sum_probs=207.0
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcE----EEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQT----VAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ 76 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~----VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded 76 (1342)
++.++|++.+.||+|+||+||+|.+..+++. +++|.+... ........+..|+..+++++||||+++++++. ..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~ 81 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA 81 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence 4568999999999999999999998777764 666766432 22333467778888999999999999999875 45
Q ss_pred eEEEEEeccC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccC
Q 000706 77 EFCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA 154 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~s 154 (1342)
..+++|||++ |+|.+++.+ .+.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 5788999986 899999975 45799999999999999999999999999999999999999999999999999986643
Q ss_pred Cce--eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcCC-CCCCCCCCHHHH
Q 000706 155 NTV--VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKDP-VKYPDEMSPNFK 230 (1342)
Q Consensus 155 ss~--~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~~-~efP~eISpeLk 230 (1342)
... ......++..|++||.+.+..++.++||||||+++|||++ |+.||.+.......+.+.... ...+...+.++.
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVY 241 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHH
Confidence 322 2233456778999999988889999999999999999998 999998876655544444332 334455678999
Q ss_pred HHHHHhcccCCCCCCCHHHHHc
Q 000706 231 SFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 231 DLIrKcLqkDPeKRPSAeELLe 252 (1342)
+++.+|+..||.+|||+.|+++
T Consensus 242 ~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 242 MVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=325.84 Aligned_cols=250 Identities=25% Similarity=0.493 Sum_probs=211.9
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEc-----cCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRK-----YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ 76 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk-----~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded 76 (1342)
..++|++.+.||+|+||.||++.+. .+++.|++|.+.... .......+.+|+.++++++||||+++++++.+++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 4578999999999999999999874 367889999886543 3344567888999999999999999999999999
Q ss_pred eEEEEEeccC-CChHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcE
Q 000706 77 EFCVVTEFAQ-GELFEILEDDK----------------------CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNI 133 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek~g----------------------~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENI 133 (1342)
..|++|||++ |+|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 9999999997 68999986432 478889999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCce--eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHH
Q 000706 134 LIGAGSVVKLCDFGFARAMSANTV--VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYAL 210 (1342)
Q Consensus 134 LLdsdG~LKLiDFGLAr~l~sss~--~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~el 210 (1342)
+++.++.+||+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+....+.
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~ 241 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999876543221 1122335667999999998889999999999999999997 8899988777777
Q ss_pred HHHHhcCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 211 IRHIVKDPV-KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 211 irkIlr~~~-efP~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
...+..... ..+...+.++.+++.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 242 IYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 766665433 345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=331.05 Aligned_cols=251 Identities=28% Similarity=0.424 Sum_probs=201.8
Q ss_pred EEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 8 VIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 8 IlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
+.+.+|.| +.||.+++..+++.||+|++..........+.+.+|++++++++||||+++++++.+++..|++|||++
T Consensus 6 i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 6 IGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 44444444 555666667789999999998765556667889999999999999999999999999999999999998
Q ss_pred CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce-------
Q 000706 87 GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV------- 157 (1342)
Q Consensus 87 GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~------- 157 (1342)
|+|.+++.+ ...+++..++.++.|+++||+|||++||+||||||+||+++.+|.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 778888875 34689999999999999999999999999999999999999999999999999875532211
Q ss_pred eeecccCCCCcCChhhhcc--CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHH-HHHhcCC----------------
Q 000706 158 VLRSIKGTPLYMAPELVRE--QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALI-RHIVKDP---------------- 218 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g--~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~eli-rkIlr~~---------------- 218 (1342)
......++..|+|||.+.. ..|+.++|+||+|+++|+|++|+.||......... ..+....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 1223457888999999876 45889999999999999999999999865443322 2221110
Q ss_pred -----------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 219 -----------------VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 219 -----------------~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
...+..+++++.+|+.+||+.||++|||+.++++||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 001112346789999999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=364.43 Aligned_cols=248 Identities=37% Similarity=0.660 Sum_probs=224.3
Q ss_pred EEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccCCC
Q 000706 9 IELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQGE 88 (1342)
Q Consensus 9 lK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~eGS 88 (1342)
.+.||+|.||+||-|+++++|+.||||+|.|.+...+...++++|+.+|+++.||.||.+.-.|++++.+++|||-+.|+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 46899999999999999999999999999998888888899999999999999999999999999999999999999999
Q ss_pred hHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC---cEEEeeccccccccCCceeeeccc
Q 000706 89 LFEILE--DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS---VVKLCDFGFARAMSANTVVLRSIK 163 (1342)
Q Consensus 89 L~D~Le--k~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG---~LKLiDFGLAr~l~sss~~~~s~v 163 (1342)
.++.|. +.++++|...+.++.||+.||.|||.+||+|.||||||||+.+.. .+||||||+|+.++.... .++.+
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-RrsVV 727 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-RRSVV 727 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-hhhhc
Confidence 999875 467899999999999999999999999999999999999997654 799999999999887654 36788
Q ss_pred CCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC----CCCCCCCCHHHHHHHHHhccc
Q 000706 164 GTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP----VKYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 164 GTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~----~efP~eISpeLkDLIrKcLqk 239 (1342)
|||.|+|||+++++.|+..-|+||.|+|+|.-+.|..||...+ +..++|.... ...+.++++++.|||.++|+.
T Consensus 728 GTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqV 805 (888)
T KOG4236|consen 728 GTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQV 805 (888)
T ss_pred CCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999997543 2333444443 344467999999999999999
Q ss_pred CCCCCCCHHHHHcCcCcccc
Q 000706 240 VPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 240 DPeKRPSAeELLeHPFFre~ 259 (1342)
.-++|.|+++-+.|||+++.
T Consensus 806 km~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 806 KMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHhcchHhhccchhhhcc
Confidence 99999999999999999875
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=329.08 Aligned_cols=251 Identities=28% Similarity=0.526 Sum_probs=212.4
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEc-------cCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRK-------YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFE 73 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk-------~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfe 73 (1342)
..++|++.+.||+|+||.||+|++. .++..+++|.+... ........+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 4578999999999999999999752 23457999988644 2344557789999999999 8999999999999
Q ss_pred eCCeEEEEEeccC-CChHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEc
Q 000706 74 SPQEFCVVTEFAQ-GELFEILEDD----------------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIG 136 (1342)
Q Consensus 74 ded~lyLVMEY~e-GSL~D~Lek~----------------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLd 136 (1342)
.....|++|||++ |+|.+++.+. ..++...+..++.|++.||.|||++|++||||||+||+++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 9999999999997 6899998653 2477888999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCcee--eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHH
Q 000706 137 AGSVVKLCDFGFARAMSANTVV--LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRH 213 (1342)
Q Consensus 137 sdG~LKLiDFGLAr~l~sss~~--~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirk 213 (1342)
.++.+||+|||+++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+..+.
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 251 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 9999999999999876543221 122345678999999988889999999999999999998 8999988887777776
Q ss_pred HhcCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 214 IVKDP-VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 214 Ilr~~-~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
+.... ...+...+.++++++.+||..+|.+|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 252 LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 65443 34566788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=361.26 Aligned_cols=258 Identities=31% Similarity=0.532 Sum_probs=230.4
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE-KDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se-~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
..+.|+.-+.||+|+||.||.+.-+.||+.||+|.+.|.+... ....-..+|.+++++++.+.||.+-..|++++.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 4578899999999999999999999999999999986653222 223457789999999999999999999999999999
Q ss_pred EEeccC-CChHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce
Q 000706 81 VTEFAQ-GELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~g--~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~ 157 (1342)
||..|+ |||.-+|.+.+ .|+|..++.|+.+|+.||++||+++||+|||||+|||+|+.|+++|+|+|+|..+..+..
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP 342 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence 999997 78888887654 899999999999999999999999999999999999999999999999999998876553
Q ss_pred eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCc----HHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 000706 158 VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS----VYALIRHIVKDPVKYPDEMSPNFKSFL 233 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s----~~elirkIlr~~~efP~eISpeLkDLI 233 (1342)
....+||.+|||||++.+..|+...|.|+|||++|||+.|+.||.... ..+.-+.+...+.++++.+|++++++.
T Consensus 343 -~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc 421 (591)
T KOG0986|consen 343 -IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLC 421 (591)
T ss_pred -cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHH
Confidence 345689999999999999999999999999999999999999997543 345666778888999999999999999
Q ss_pred HHhcccCCCCCCC-----HHHHHcCcCcccch
Q 000706 234 KGLLNKVPQNRLT-----WSALLEHPFVKETS 260 (1342)
Q Consensus 234 rKcLqkDPeKRPS-----AeELLeHPFFre~~ 260 (1342)
+.+|++||.+|.. ++++.+||||+...
T Consensus 422 ~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln 453 (591)
T KOG0986|consen 422 EGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN 453 (591)
T ss_pred HHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence 9999999999985 67999999999853
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=322.05 Aligned_cols=251 Identities=24% Similarity=0.464 Sum_probs=213.0
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEcc-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKY-----TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ 76 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~-----TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded 76 (1342)
..++|++.+.||+|+||.||+|+.+. +.+.+++|.+.... .....+.+.+|++++++++||||+++++++.+.+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 45789999999999999999998753 35678999875432 2334567899999999999999999999999999
Q ss_pred eEEEEEeccC-CChHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeec
Q 000706 77 EFCVVTEFAQ-GELFEILEDDK---------CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDF 146 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek~g---------~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDF 146 (1342)
..|+||||++ |+|.+++.... .+++..+..++.|++.+|+|||++|++||||||+||+++.++.++++||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999997 79999997655 7999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCc-eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCC
Q 000706 147 GFARAMSANT-VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKDPV--KYP 222 (1342)
Q Consensus 147 GLAr~l~sss-~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~~~--efP 222 (1342)
|++....... .......++..|++||.+.+..++.++||||||+++|+|++ |..||...........+..... ..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence 9987543221 12233456778999999988888999999999999999998 8899987666666666654433 345
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 223 DEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 223 ~eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
..++..+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 6788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=342.13 Aligned_cols=249 Identities=28% Similarity=0.513 Sum_probs=205.0
Q ss_pred CCEEEEEEEcccCcEEEEEEEEc-----cCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe-CC
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRK-----YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFES-PQ 76 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk-----~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfed-ed 76 (1342)
++|++.+.||+|+||.||+|.+. .+++.||+|.++... .....+.+.+|+++++++ +||||+++++++.. +.
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 58999999999999999999743 345789999886443 334456788899999999 89999999998764 46
Q ss_pred eEEEEEeccC-CChHHHHhcC-----------------------------------------------------------
Q 000706 77 EFCVVTEFAQ-GELFEILEDD----------------------------------------------------------- 96 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek~----------------------------------------------------------- 96 (1342)
.++++|||++ |+|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 7899999997 6888887531
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce--eeecccCCCCcCChh
Q 000706 97 --KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV--VLRSIKGTPLYMAPE 172 (1342)
Q Consensus 97 --g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~--~~~s~vGTp~YmAPE 172 (1342)
.++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+..... ......++..|+|||
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 2678999999999999999999999999999999999999999999999999987643321 122344677899999
Q ss_pred hhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHH-HhcC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 000706 173 LVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRH-IVKD-PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSA 249 (1342)
Q Consensus 173 vL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirk-Ilr~-~~efP~eISpeLkDLIrKcLqkDPeKRPSAeE 249 (1342)
++.+..++.++|||||||++|+|++ |..||.+....+.... +... ....+...++++.+++.+||+.+|++||++.|
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~e 325 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSE 325 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999999999999999997 9999987543333322 2222 33445678899999999999999999999999
Q ss_pred HHcC
Q 000706 250 LLEH 253 (1342)
Q Consensus 250 LLeH 253 (1342)
+++|
T Consensus 326 ll~~ 329 (337)
T cd05054 326 LVEI 329 (337)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=316.26 Aligned_cols=241 Identities=27% Similarity=0.441 Sum_probs=206.2
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-CC
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GE 88 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e-GS 88 (1342)
++||+|+||.||++.+.. ++.|++|.+...... .....+.+|++++++++||||+++++++.+....|++|||++ ++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 469999999999999887 999999988765433 455678999999999999999999999999999999999996 67
Q ss_pred hHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee--cccCC
Q 000706 89 LFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR--SIKGT 165 (1342)
Q Consensus 89 L~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~--s~vGT 165 (1342)
|.+++.+ ...+++..+..++.|++.+|.|||++|++||||||+||+++.++.+||+|||++........... ...++
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence 9998865 45789999999999999999999999999999999999999999999999999976543222111 12235
Q ss_pred CCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhcccCCCC
Q 000706 166 PLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLNKVPQN 243 (1342)
Q Consensus 166 p~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrKcLqkDPeK 243 (1342)
..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+... ....+...+.++.+++.+||+.+|++
T Consensus 159 ~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 238 (251)
T cd05041 159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPEN 238 (251)
T ss_pred eccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhh
Confidence 67999999988889999999999999999999 89999887766655555443 34456778999999999999999999
Q ss_pred CCCHHHHHc
Q 000706 244 RLTWSALLE 252 (1342)
Q Consensus 244 RPSAeELLe 252 (1342)
|||+.|+++
T Consensus 239 Rp~~~ell~ 247 (251)
T cd05041 239 RPSFSEIYN 247 (251)
T ss_pred CcCHHHHHH
Confidence 999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=336.39 Aligned_cols=255 Identities=33% Similarity=0.536 Sum_probs=212.1
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFES-PQEFCVV 81 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfed-ed~lyLV 81 (1342)
-++|++.+.||.|+||.||++.+..+++.|++|.+.+........+.+.+|+++++.++||||+++++++.. ....|++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 368999999999999999999999999999999987654444445678889999999999999999999865 5678999
Q ss_pred EeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 82 TEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 82 MEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
|||++++|.+++.. .++++..+..++.|+++||.|||++|++||||||+||+++.++.+||+|||.+...... ...
T Consensus 89 ~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---~~~ 164 (328)
T cd07856 89 TELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---MTG 164 (328)
T ss_pred eehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC---cCC
Confidence 99999998887764 46899999999999999999999999999999999999999999999999999765432 233
Q ss_pred ccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHh---c---------------------
Q 000706 162 IKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIV---K--------------------- 216 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIl---r--------------------- 216 (1342)
..+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+. .
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (328)
T cd07856 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS 244 (328)
T ss_pred CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhh
Confidence 467889999998765 568999999999999999999999997655322111100 0
Q ss_pred --CCCCC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccchh
Q 000706 217 --DPVKY-----PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 217 --~~~ef-----P~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~~ 261 (1342)
..... .+.+++++.++|.+||+.+|++||++.+++.||||+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~ 296 (328)
T cd07856 245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296 (328)
T ss_pred ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence 00011 1346789999999999999999999999999999976433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=317.68 Aligned_cols=241 Identities=30% Similarity=0.524 Sum_probs=206.1
Q ss_pred EEEcccCcEEEEEEEEcc-CCc--EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC
Q 000706 10 ELVGEGSFGKVYKGRRKY-TGQ--TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~-TGe--~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e 86 (1342)
+.||+|++|.||+|.+.. .++ .+|+|.+...... ...+.+.+|++++++++||||+++++.+.+ ...+++|||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998865 333 5899998766443 556788999999999999999999999988 89999999996
Q ss_pred -CChHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee---ee
Q 000706 87 -GELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV---LR 160 (1342)
Q Consensus 87 -GSL~D~Lek~g--~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~---~~ 160 (1342)
|+|.+++.+.. .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++......... ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE 158 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence 79999997754 6899999999999999999999999999999999999999999999999999876543221 11
Q ss_pred cccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHhc
Q 000706 161 SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD--PVKYPDEMSPNFKSFLKGLL 237 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~--~~efP~eISpeLkDLIrKcL 237 (1342)
...++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+..+.+... ....+...+..+.+++.+||
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 238 (257)
T cd05040 159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCW 238 (257)
T ss_pred CCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHC
Confidence 2456788999999998899999999999999999998 99999877776666655532 33345677899999999999
Q ss_pred ccCCCCCCCHHHHHc
Q 000706 238 NKVPQNRLTWSALLE 252 (1342)
Q Consensus 238 qkDPeKRPSAeELLe 252 (1342)
+.+|++||++.++++
T Consensus 239 ~~~p~~Rps~~~~~~ 253 (257)
T cd05040 239 AHNPADRPTFAALRE 253 (257)
T ss_pred CCCcccCCCHHHHHH
Confidence 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=321.00 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=211.5
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEcc----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-CC
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKY----TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFES-PQ 76 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~----TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfed-ed 76 (1342)
+-++|++.+.||+|+||.||+|.+.. +++.+++|.+... ......+.+.+|+.++++++||||+++++++.+ +.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 56899999999999999999999875 3678899987643 345556778899999999999999999998765 57
Q ss_pred eEEEEEeccC-CChHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecc
Q 000706 77 EFCVVTEFAQ-GELFEILEDD--------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFG 147 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek~--------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFG 147 (1342)
..++++||++ |+|.+++... ..+++..++.++.|++.||+|||++|++||||||+||++++++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 7899999987 7899988653 458999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcee--eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCC
Q 000706 148 FARAMSANTVV--LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPD 223 (1342)
Q Consensus 148 LAr~l~sss~~--~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~ 223 (1342)
+++.+...... .....++..|+|||.+.+..++.++||||||+++|++++ |+.||...+..+....+... ....+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPI 242 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCC
Confidence 99866433221 122345677999999998889999999999999999998 99999887776666555543 233455
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 224 EMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 224 eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
.+++++.+++.+||+.||++|||+.++++
T Consensus 243 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 243 NCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 67899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.01 Aligned_cols=249 Identities=23% Similarity=0.414 Sum_probs=212.3
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCc----EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQ----TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQE 77 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe----~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~ 77 (1342)
..++|++.+.||+|+||.||+|.++.+|+ .+++|.+.+... ......+.+|+.++++++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 45789999999999999999999877665 589998765533 3445678899999999999999999999887 78
Q ss_pred EEEEEeccC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCC
Q 000706 78 FCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN 155 (1342)
Q Consensus 78 lyLVMEY~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ss 155 (1342)
.+++|||++ |+|.+++.+ ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||.++.....
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 899999987 789999876 456999999999999999999999999999999999999999999999999999876543
Q ss_pred ceeee--cccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHH
Q 000706 156 TVVLR--SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKS 231 (1342)
Q Consensus 156 s~~~~--s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkD 231 (1342)
..... ...++..|++||.+....++.++|+||||+++||+++ |+.||.+....+....+... ..+.+...+.++.+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYM 242 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 32221 1223567999999988889999999999999999998 99999988776666666544 34556677899999
Q ss_pred HHHHhcccCCCCCCCHHHHHc
Q 000706 232 FLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 232 LIrKcLqkDPeKRPSAeELLe 252 (1342)
++.+||..||++||++.++++
T Consensus 243 ~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 243 VLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=325.59 Aligned_cols=247 Identities=25% Similarity=0.465 Sum_probs=207.7
Q ss_pred CEEEEEEEcccCcEEEEEEEEcc-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKY-----TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFC 79 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~-----TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~ly 79 (1342)
+|++.+.||+|+||.||+|.+.. ..+.+++|.+.+.. ......++.+|+++++.++||||+++++.+..++..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 58999999999999999998753 23568888876543 3344577889999999999999999999999999999
Q ss_pred EEEeccC-CChHHHHhcC------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEE
Q 000706 80 VVTEFAQ-GELFEILEDD------------------------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNIL 134 (1342)
Q Consensus 80 LVMEY~e-GSL~D~Lek~------------------------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENIL 134 (1342)
++|||++ |+|.+++.+. .++++..++.++.|++.||.|||++|++||||||+||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 9999997 7898887542 35788999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeccccccccCCce--eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHH
Q 000706 135 IGAGSVVKLCDFGFARAMSANTV--VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALI 211 (1342)
Q Consensus 135 LdsdG~LKLiDFGLAr~l~sss~--~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~eli 211 (1342)
+++++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.......
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999976533221 1122345678999999988889999999999999999998 99999887766655
Q ss_pred HHHhcC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 212 RHIVKD-PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 212 rkIlr~-~~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
..+... ....+..++.++.+++.+||+.||++||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 240 NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 554433 33456678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.26 Aligned_cols=241 Identities=26% Similarity=0.452 Sum_probs=205.0
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-CC
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GE 88 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e-GS 88 (1342)
+.||+|+||.||++... +++.+|+|.+.... .......+.+|+++++.++||||+++++++.+.+..++||||++ |+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 46899999999999865 68899999886543 33444568889999999999999999999999999999999987 78
Q ss_pred hHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee-cccCCC
Q 000706 89 LFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR-SIKGTP 166 (1342)
Q Consensus 89 L~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~-s~vGTp 166 (1342)
|.+++.. ...+++..++.++.|++.+|.|+|++|++||||||+||+++.++.+||+|||++........... ...+++
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI 158 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence 9988865 44689999999999999999999999999999999999999999999999999976543322111 123456
Q ss_pred CcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhcccCCCCC
Q 000706 167 LYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLNKVPQNR 244 (1342)
Q Consensus 167 ~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrKcLqkDPeKR 244 (1342)
.|+|||.+.+..++.++||||||+++|++++ |..||...........+... ....+..++..+.+++.+||+.+|++|
T Consensus 159 ~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (250)
T cd05085 159 KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENR 238 (250)
T ss_pred cccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 7999999988889999999999999999998 99999887766666655544 345667789999999999999999999
Q ss_pred CCHHHHHc
Q 000706 245 LTWSALLE 252 (1342)
Q Consensus 245 PSAeELLe 252 (1342)
|++.|+++
T Consensus 239 p~~~~l~~ 246 (250)
T cd05085 239 PKFSELQK 246 (250)
T ss_pred CCHHHHHH
Confidence 99999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=329.39 Aligned_cols=249 Identities=27% Similarity=0.514 Sum_probs=209.0
Q ss_pred CCCEEEEEEEcccCcEEEEEEEE-----ccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 000706 3 VENYHVIELVGEGSFGKVYKGRR-----KYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQ 76 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArD-----k~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded 76 (1342)
.++|++.+.||+|+||.||++.+ ..++..+|+|.+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 46899999999999999999975 33456899998865432 34456788999999999 7999999999999999
Q ss_pred eEEEEEeccC-CChHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 000706 77 EFCVVTEFAQ-GELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS 153 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek~g--~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ 153 (1342)
..|++|||+. |+|.+++.... .+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++...
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 9999999987 78999987533 48999999999999999999999999999999999999999999999999998664
Q ss_pred CCce--eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC--CCCCCCCCCHH
Q 000706 154 ANTV--VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD--PVKYPDEMSPN 228 (1342)
Q Consensus 154 sss~--~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~--~~efP~eISpe 228 (1342)
.... ......+++.|+|||.+.+..++.++||||+|+++|+|++ |..||......+...+.... ....+...+++
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAE 272 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHH
Confidence 3321 1222346788999999998889999999999999999998 99999876654444333332 22345567899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHc
Q 000706 229 FKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 229 LkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
+.+++.+||+.+|++|||+.|+++
T Consensus 273 ~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 273 IYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=326.64 Aligned_cols=249 Identities=23% Similarity=0.387 Sum_probs=204.9
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCC--------------cEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTG--------------QTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEM 68 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TG--------------e~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL 68 (1342)
-++|++.+.||+|+||.||++.+..++ ..||+|.++.. ........+.+|++++++++|||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 358999999999999999999875432 35899998654 334455678999999999999999999
Q ss_pred EEEEEeCCeEEEEEeccC-CChHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEE
Q 000706 69 LDSFESPQEFCVVTEFAQ-GELFEILEDD------------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILI 135 (1342)
Q Consensus 69 ~dvfeded~lyLVMEY~e-GSL~D~Lek~------------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILL 135 (1342)
++++..++..|+||||++ ++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 999999999999999997 6898888542 136888999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCce--eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh--CCCCCCCCcHHHHH
Q 000706 136 GAGSVVKLCDFGFARAMSANTV--VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV--GQPPFYTNSVYALI 211 (1342)
Q Consensus 136 dsdG~LKLiDFGLAr~l~sss~--~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT--Gr~PF~g~s~~eli 211 (1342)
+.++.+||+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++ +..||...+..+..
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~ 242 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI 242 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH
Confidence 9999999999999976543221 1122345678999999988889999999999999999988 67888876655544
Q ss_pred HHHhc--------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 212 RHIVK--------DPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 212 rkIlr--------~~~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
..+.. .....++..++.+.+++++||..||++||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 243 ENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 43321 112334567899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=358.91 Aligned_cols=251 Identities=31% Similarity=0.607 Sum_probs=222.9
Q ss_pred EEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEecc
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFA 85 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~ 85 (1342)
|.++++||+|+||.||+|.++.+|..+|+|.+.- +.+.+.+.+|+.+|++++.|++|++|+.|.....+|||||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 6678899999999999999999999999998743 356688999999999999999999999999999999999999
Q ss_pred C-CChHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeeccc
Q 000706 86 Q-GELFEILE-DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK 163 (1342)
Q Consensus 86 e-GSL~D~Le-k~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~v 163 (1342)
+ |+..+.++ ++++++|.++..+++.-++||+|||...-+|||||..|||++.+|+.||+|||.+..+...-...++..
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVI 190 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVI 190 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccc
Confidence 8 99999886 578999999999999999999999999999999999999999999999999999988776655567788
Q ss_pred CCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC-CC--CCCCCCCHHHHHHHHHhcccC
Q 000706 164 GTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-PV--KYPDEMSPNFKSFLKGLLNKV 240 (1342)
Q Consensus 164 GTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~-~~--efP~eISpeLkDLIrKcLqkD 240 (1342)
|||.|||||++..-.|+.++||||||++..||..|++||..-.....+--|-.. ++ .-|+.+|.++.|||++||-++
T Consensus 191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~ 270 (502)
T KOG0574|consen 191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKK 270 (502)
T ss_pred cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCC
Confidence 999999999999999999999999999999999999999764433222222222 22 335678999999999999999
Q ss_pred CCCCCCHHHHHcCcCcccch
Q 000706 241 PQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 241 PeKRPSAeELLeHPFFre~~ 260 (1342)
|++|-|+.++++|||+++..
T Consensus 271 PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 271 PEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred HHHHHHHHHHhhhhhhcCCC
Confidence 99999999999999998864
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.28 Aligned_cols=240 Identities=25% Similarity=0.439 Sum_probs=202.0
Q ss_pred EEcccCcEEEEEEEEc--cCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-C
Q 000706 11 LVGEGSFGKVYKGRRK--YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-G 87 (1342)
Q Consensus 11 ~LGsGgFGtVYKArDk--~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e-G 87 (1342)
.||+|+||.||+|... .++..||+|.+... ......+.+.+|++++++++||||++++++++ .+..++||||++ |
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 4899999999999765 44567999988654 23444567889999999999999999999885 457899999997 6
Q ss_pred ChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec---cc
Q 000706 88 ELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS---IK 163 (1342)
Q Consensus 88 SL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s---~v 163 (1342)
+|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++............ ..
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence 89988874 557999999999999999999999999999999999999999999999999999866543322111 22
Q ss_pred CCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhcccCC
Q 000706 164 GTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLNKVP 241 (1342)
Q Consensus 164 GTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrKcLqkDP 241 (1342)
+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+... +...+...++++.+++.+||..||
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~ 239 (257)
T cd05115 160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKW 239 (257)
T ss_pred CCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCh
Confidence 3578999999988889999999999999999996 99999887776666665553 445667789999999999999999
Q ss_pred CCCCCHHHHHc
Q 000706 242 QNRLTWSALLE 252 (1342)
Q Consensus 242 eKRPSAeELLe 252 (1342)
++||++.++.+
T Consensus 240 ~~Rp~~~~i~~ 250 (257)
T cd05115 240 EDRPNFAKVEE 250 (257)
T ss_pred hhCcCHHHHHH
Confidence 99999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=367.19 Aligned_cols=246 Identities=28% Similarity=0.516 Sum_probs=209.8
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCCcceEEE-EEEe-----
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-HQNIIEMLD-SFES----- 74 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~-HPNIVKL~d-vfed----- 74 (1342)
|-.+++|.+.|.+|||+.||.|.+...|..||+|++.-. ++...+.+++|+++|++|. |+|||.++| ....
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 445789999999999999999999988899999988544 6677889999999999995 999999999 3321
Q ss_pred -CCeEEEEEeccC-CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC--ceecCCCCCcEEEcCCCcEEEeeccc
Q 000706 75 -PQEFCVVTEFAQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNR--IIHRDMKPQNILIGAGSVVKLCDFGF 148 (1342)
Q Consensus 75 -ed~lyLVMEY~e-GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrG--IVHRDLKPENILLdsdG~LKLiDFGL 148 (1342)
.-.++|.||||. |.|.|++.+ ..+|+|.++++|++|+++|+.+||... |+|||||-|||||+.+|++||||||.
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 235789999998 799999974 346999999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCceee---------ecccCCCCcCChhhh---ccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhc
Q 000706 149 ARAMSANTVVL---------RSIKGTPLYMAPELV---REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK 216 (1342)
Q Consensus 149 Ar~l~sss~~~---------~s~vGTp~YmAPEvL---~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr 216 (1342)
+.......... -....|+.|++||++ .+.+.++|+|||+|||+||.|+...+||.+.... .|..
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIln 268 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AILN 268 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEe
Confidence 97543222110 113479999999965 6788999999999999999999999999877432 4566
Q ss_pred CCCCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 217 DPVKYPD--EMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 217 ~~~efP~--eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
+.+.+|+ .++..+++||+.||+.||.+||++.|++.+
T Consensus 269 g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 269 GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 7777775 689999999999999999999999998764
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.11 Aligned_cols=246 Identities=22% Similarity=0.448 Sum_probs=208.9
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
..++|++.+.||+|+||.||++.+. .+..+++|.+.+. ....+.+.+|++++++++|+||+++++.+.+ ...|++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 4689999999999999999999865 5667999987643 2234678889999999999999999999987 788999
Q ss_pred EeccC-CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 82 TEFAQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
|||++ |+|.+++.+ ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||.+.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 99997 799999875 346788999999999999999999999999999999999999999999999999766433221
Q ss_pred -eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHH
Q 000706 159 -LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKG 235 (1342)
Q Consensus 159 -~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrK 235 (1342)
.....++..|+|||.+.+..++.++|+||||+++|++++ |+.||...+.......+... ..+.+...+.++.+++.+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 238 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR 238 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHH
Confidence 122345677999999998889999999999999999998 99999887776666665554 334556788999999999
Q ss_pred hcccCCCCCCCHHHHHc
Q 000706 236 LLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 236 cLqkDPeKRPSAeELLe 252 (1342)
||+.||++||++.++++
T Consensus 239 ~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 239 CWKNRPEERPTFEYIQS 255 (260)
T ss_pred HcccCcccCcCHHHHHH
Confidence 99999999999988864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.68 Aligned_cols=250 Identities=28% Similarity=0.441 Sum_probs=210.2
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccC---CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYT---GQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEF 78 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~T---Ge~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~l 78 (1342)
.-++|++.+.||+|+||.||+|.+... ...+++|...... .....+.+.+|++++++++||||+++++++.+ +..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 346899999999999999999987543 3468999875442 24455688999999999999999999998875 457
Q ss_pred EEEEeccC-CChHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 79 CVVTEFAQ-GELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 79 yLVMEY~e-GSL~D~Lek~g-~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
|++|||++ |+|.+++.+.. .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 89999997 78999997643 68999999999999999999999999999999999999999999999999997665432
Q ss_pred ee-eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHH
Q 000706 157 VV-LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFL 233 (1342)
Q Consensus 157 ~~-~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLI 233 (1342)
.. .....+++.|+|||.+....++.++||||||+++|+|++ |+.||...+..+....+... ....++..++++.+++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 241 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHH
Confidence 21 112234567999999988889999999999999999986 99999887776666665543 4456778899999999
Q ss_pred HHhcccCCCCCCCHHHHHcC
Q 000706 234 KGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 234 rKcLqkDPeKRPSAeELLeH 253 (1342)
.+|+..+|.+|||+.++++.
T Consensus 242 ~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 242 TKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.84 Aligned_cols=248 Identities=22% Similarity=0.398 Sum_probs=203.4
Q ss_pred CCEEEEEEEcccCcEEEEEEEEcc----------------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcce
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKY----------------TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIE 67 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~----------------TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVK 67 (1342)
++|++.+.||+|+||.||++.+.. ++..+|+|.+.... .......+.+|+++++.++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 589999999999999999986432 34468999886542 3344567889999999999999999
Q ss_pred EEEEEEeCCeEEEEEeccC-CChHHHHhcCC-----------CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEE
Q 000706 68 MLDSFESPQEFCVVTEFAQ-GELFEILEDDK-----------CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILI 135 (1342)
Q Consensus 68 L~dvfeded~lyLVMEY~e-GSL~D~Lek~g-----------~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILL 135 (1342)
+++++.+++..|++|||++ |+|.+++.+.. .+++..++.++.|++.||+|||++|++||||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 9999999999999999997 78999886532 36778999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCcee--eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh--CCCCCCCCcHHHHH
Q 000706 136 GAGSVVKLCDFGFARAMSANTVV--LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV--GQPPFYTNSVYALI 211 (1342)
Q Consensus 136 dsdG~LKLiDFGLAr~l~sss~~--~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT--Gr~PF~g~s~~eli 211 (1342)
+.++.+||+|||+++........ .....+++.|++||...+..++.++|+||||+++|||++ |..||...+..+..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 99999999999999765433211 112334678999999888889999999999999999998 78999776554444
Q ss_pred HHHhc--------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 212 RHIVK--------DPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 212 rkIlr--------~~~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
..... ...+.+...++.+.+|+.+||+.||++||++.++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 244 ENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 32211 112334567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.71 Aligned_cols=241 Identities=28% Similarity=0.514 Sum_probs=201.8
Q ss_pred EEEcccCcEEEEEEEEccCCcE--EEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEeccC
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQT--VAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCVVTEFAQ 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~--VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyLVMEY~e 86 (1342)
+.||+|+||.||+|.++.++.. +++|.++.. ......+.+.+|++++.++ +||||+++++++...+..|++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 3689999999999999887764 577877533 2334456788999999999 89999999999999999999999997
Q ss_pred -CChHHHHhcCC----------------CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccc
Q 000706 87 -GELFEILEDDK----------------CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFA 149 (1342)
Q Consensus 87 -GSL~D~Lek~g----------------~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLA 149 (1342)
|+|.+++.+.. .++++.++.++.|++.||+|||++|++||||||+||++++++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 79999986532 4789999999999999999999999999999999999999999999999998
Q ss_pred ccccCCceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCH
Q 000706 150 RAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSP 227 (1342)
Q Consensus 150 r~l~sss~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISp 227 (1342)
........ ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+..+.+... ..+.+...+.
T Consensus 160 ~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05047 160 RGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD 238 (270)
T ss_pred cccchhhh-ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCH
Confidence 64322111 111224567999999988889999999999999999997 99999887776666665543 3345567889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 228 NFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 228 eLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
++.+++.+|+..||.+|||+.++++
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 239 EVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHH
Confidence 9999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.42 Aligned_cols=242 Identities=27% Similarity=0.521 Sum_probs=206.2
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
+.+++|++.+.||+|+||.||++. .+++.|++|.++... ..+.+.+|+.++++++|||++++++++..+ ..++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred ccHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 467899999999999999999985 478899999885432 235688899999999999999999998765 4799
Q ss_pred EEeccC-CChHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce
Q 000706 81 VTEFAQ-GELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~g--~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~ 157 (1342)
+|||++ |+|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 999997 69999987543 58999999999999999999999999999999999999999999999999987643221
Q ss_pred eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHH
Q 000706 158 VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKG 235 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrK 235 (1342)
.....+..|+|||.+.+..++.+.|+||||+++|+|++ |+.||...+..+....+.+. ....++.+++++.+++.+
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 232 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTS 232 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHH
Confidence 22234677999999988889999999999999999997 99999887776666655544 234456788999999999
Q ss_pred hcccCCCCCCCHHHHHc
Q 000706 236 LLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 236 cLqkDPeKRPSAeELLe 252 (1342)
||+.+|++||++.++++
T Consensus 233 ~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 233 CWETEPKKRPSFHKLRE 249 (254)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=345.69 Aligned_cols=251 Identities=33% Similarity=0.596 Sum_probs=220.9
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEeccC-C
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCVVTEFAQ-G 87 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyLVMEY~e-G 87 (1342)
+.||+|+|+.|-.+....+|..||||++.|. ....+.++.+|++++.++ .|+||++++++|+++..+|+|||-+. |
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 5799999999999999999999999999876 345567899999999999 69999999999999999999999997 7
Q ss_pred ChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC---cEEEeeccccccccCC-------ce
Q 000706 88 ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS---VVKLCDFGFARAMSAN-------TV 157 (1342)
Q Consensus 88 SL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG---~LKLiDFGLAr~l~ss-------s~ 157 (1342)
.|+..|.+.+.|+|.++.+++.+|+.||.|||++||.||||||+|||..+-. -+|||||.+...+..+ +.
T Consensus 162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP 241 (463)
T KOG0607|consen 162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP 241 (463)
T ss_pred hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence 8999999999999999999999999999999999999999999999997654 5899999988644321 22
Q ss_pred eeecccCCCCcCChhhhc-----cCCCCCCCcccchhhHHHHHHhCCCCCCCCc---------------HHHHHHHHhcC
Q 000706 158 VLRSIKGTPLYMAPELVR-----EQPYNHTADLWSLGVILYELFVGQPPFYTNS---------------VYALIRHIVKD 217 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~-----g~~YT~KsDIWSLGVILYELLTGr~PF~g~s---------------~~elirkIlr~ 217 (1342)
...+.+|+..|||||+.. ...|+.+.|.||||+|+|-|++|++||.+.- ...+...|-.+
T Consensus 242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG 321 (463)
T KOG0607|consen 242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG 321 (463)
T ss_pred cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc
Confidence 345678999999999763 3459999999999999999999999996521 45677788889
Q ss_pred CCCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccchhh
Q 000706 218 PVKYPD----EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDE 262 (1342)
Q Consensus 218 ~~efP~----eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~~e 262 (1342)
.++||+ .+|.+.+++|+.+|..|+.+|.++.++++|||++....+
T Consensus 322 kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 322 KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 999986 589999999999999999999999999999999876543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=357.39 Aligned_cols=242 Identities=28% Similarity=0.503 Sum_probs=213.6
Q ss_pred EEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEecc
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFA 85 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~ 85 (1342)
+++++.||+|.||.||.|... ....||+|.++...... +.+.+|+++|++++|+|||++++++..++.+||||||+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 445678999999999999776 34489999997654433 45668999999999999999999999989999999999
Q ss_pred C-CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec-
Q 000706 86 Q-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS- 161 (1342)
Q Consensus 86 e-GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s- 161 (1342)
+ |+|.+++++ ++.+...+...++.||++|++||+++++|||||-..||||+++..+||+|||+|+....+......
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 7 999999987 567999999999999999999999999999999999999999999999999999965554433222
Q ss_pred ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhccc
Q 000706 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrKcLqk 239 (1342)
..-...|.|||.+....++.++||||||++||||+| |+.||.+.+..+.++.+.++ +.+-|+..|+++.+++..||..
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~ 443 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHE 443 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhC
Confidence 222345999999999999999999999999999998 99999999999999999887 5678889999999999999999
Q ss_pred CCCCCCCHHHHH
Q 000706 240 VPQNRLTWSALL 251 (1342)
Q Consensus 240 DPeKRPSAeELL 251 (1342)
+|++|||++.+.
T Consensus 444 ~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 444 DPEDRPTFETLR 455 (468)
T ss_pred CcccCCCHHHHH
Confidence 999999998664
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=345.28 Aligned_cols=248 Identities=34% Similarity=0.629 Sum_probs=216.6
Q ss_pred CCEEEE-EEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe----CCe
Q 000706 4 ENYHVI-ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFES----PQE 77 (1342)
Q Consensus 4 drYrIl-K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfed----ed~ 77 (1342)
++|++. +.||-|-.|.|-.+.++.||+++|+|++... ...++|++++-.. .|||||.++++|++ ...
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 566665 4699999999999999999999999987433 5678899887776 79999999999864 457
Q ss_pred EEEEEeccC-CChHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCC---CcEEEeecccccc
Q 000706 78 FCVVTEFAQ-GELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAG---SVVKLCDFGFARA 151 (1342)
Q Consensus 78 lyLVMEY~e-GSL~D~Lek~g--~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsd---G~LKLiDFGLAr~ 151 (1342)
+.+|||.++ |+|+..|++.+ .|+|+++..|++||..|+.|||+.+|.||||||||+|.... ..+||+|||+|+.
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 899999998 78999998765 59999999999999999999999999999999999999754 4799999999987
Q ss_pred ccCCceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCc----HHHHHHHHhcCCCCCCC----
Q 000706 152 MSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS----VYALIRHIVKDPVKYPD---- 223 (1342)
Q Consensus 152 l~sss~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s----~~elirkIlr~~~efP~---- 223 (1342)
...+. ...+.+-||+|.|||++....|+...|+||+|+++|-|++|.+||+... ...+.++|..+.+.||.
T Consensus 214 t~~~~-~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs 292 (400)
T KOG0604|consen 214 TQEPG-DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWS 292 (400)
T ss_pred cCCCc-cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHh
Confidence 65433 3456778999999999999999999999999999999999999998643 34566788888888874
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 224 EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 224 eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
.+|...+++|+++|..+|.+|.|++++++|||+...
T Consensus 293 ~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 293 CVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred HHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 478999999999999999999999999999999753
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=319.70 Aligned_cols=247 Identities=26% Similarity=0.450 Sum_probs=199.7
Q ss_pred CCE-EEEEEEcccCcEEEEEEE----EccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--CC
Q 000706 4 ENY-HVIELVGEGSFGKVYKGR----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFES--PQ 76 (1342)
Q Consensus 4 drY-rIlK~LGsGgFGtVYKAr----Dk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfed--ed 76 (1342)
++| ++.+.||+|+||+||++. ...+++.||+|.++... .......+.+|++++++++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 466 999999999999998764 34578899999986542 23344677889999999999999999998765 34
Q ss_pred eEEEEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCC
Q 000706 77 EFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN 155 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ss 155 (1342)
.+|++|||++ |+|.+++.+. .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 6899999997 6888888664 5999999999999999999999999999999999999999999999999999876543
Q ss_pred cee---eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHH--HHH------------HHHh-c-
Q 000706 156 TVV---LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVY--ALI------------RHIV-K- 216 (1342)
Q Consensus 156 s~~---~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~--eli------------rkIl-r- 216 (1342)
... .....++..|++||.+.+..++.++||||||+++|+|++|..||...... +.. .... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 221 11234566799999998888999999999999999999999998643211 100 0011 1
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 217 DPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 217 ~~~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
...+.+...+.++.+++.+||+.||++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 112335667899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=330.67 Aligned_cols=250 Identities=30% Similarity=0.519 Sum_probs=210.5
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEcc-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKY-------TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFES 74 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~-------TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfed 74 (1342)
-.+|++++.||+|+||.||+|++.. ++..|++|.++.. ......+.+.+|+++++++ +||||+++++++.+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3579999999999999999997642 2236899987643 3344557888999999999 89999999999999
Q ss_pred CCeEEEEEeccC-CChHHHHhcCC----------------CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcC
Q 000706 75 PQEFCVVTEFAQ-GELFEILEDDK----------------CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA 137 (1342)
Q Consensus 75 ed~lyLVMEY~e-GSL~D~Lek~g----------------~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLds 137 (1342)
++..|++|||++ |+|.+++.+.. .++..++..++.|++.||.|||++|++||||||+||+++.
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~ 169 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE 169 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence 999999999997 69999986532 3777889999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCcee--eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHH
Q 000706 138 GSVVKLCDFGFARAMSANTVV--LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHI 214 (1342)
Q Consensus 138 dG~LKLiDFGLAr~l~sss~~--~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkI 214 (1342)
++.+||+|||+++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+..+.+
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 249 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 249 (334)
T ss_pred CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 999999999999866443221 112234567999999999899999999999999999998 89999988877777666
Q ss_pred hcC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 215 VKD-PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 215 lr~-~~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
... ....+...+.++.+++.+||+.+|++||++.|++++
T Consensus 250 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 250 KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 554 335566788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=365.07 Aligned_cols=149 Identities=31% Similarity=0.545 Sum_probs=137.5
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
.+++|++.+.||+|+||.||+|.+..+++.||+|++++... .......+..|+.+++.++||||+++++.+.+.+.+|+
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 37899999999999999999999999999999999976432 33445678899999999999999999999999999999
Q ss_pred EEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 000706 81 VTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFAR 150 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr 150 (1342)
||||+. |+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999996 7899999888889999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=352.68 Aligned_cols=261 Identities=31% Similarity=0.542 Sum_probs=239.0
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFC 79 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-e~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~ly 79 (1342)
...+|..+..||.|+||.|-+|..+.+.+.||||+++++-.. .++.+--..|-++|..- +-|.+++++..|++.+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 456899999999999999999999999999999999876432 23345556688888776 5679999999999999999
Q ss_pred EEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee
Q 000706 80 VVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 80 LVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~ 158 (1342)
+||||+. |+|.-.|++-++|.|..+..|+..|+-||-|||++||++||||.+|||++.+|++||+|||+++.---+..+
T Consensus 427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~T 506 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVT 506 (683)
T ss_pred eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcc
Confidence 9999997 789999999999999999999999999999999999999999999999999999999999999876666677
Q ss_pred eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcc
Q 000706 159 LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLN 238 (1342)
Q Consensus 159 ~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLq 238 (1342)
.++++|||.|+|||++..++|+.++|.||+|++||||+.|++||+++++.++.+.|......+|..+|.++.++..+.|.
T Consensus 507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~lt 586 (683)
T KOG0696|consen 507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGLLT 586 (683)
T ss_pred eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHHhh
Confidence 88999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCC-----HHHHHcCcCcccchhh
Q 000706 239 KVPQNRLT-----WSALLEHPFVKETSDE 262 (1342)
Q Consensus 239 kDPeKRPS-----AeELLeHPFFre~~~e 262 (1342)
+.|.+|.. -+++..||||+....+
T Consensus 587 K~P~kRLGcg~~ge~di~~H~FFR~iDWe 615 (683)
T KOG0696|consen 587 KHPGKRLGCGPEGERDIREHPFFRRIDWE 615 (683)
T ss_pred cCCccccCCCCccccchhhCcchhhccHH
Confidence 99999975 4689999999987544
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=344.86 Aligned_cols=249 Identities=27% Similarity=0.490 Sum_probs=206.5
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEeCC
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYT-----GQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-HQNIIEMLDSFESPQ 76 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~T-----Ge~VAVKvIkKs~~se~dierL~rEI~ILKrL~-HPNIVKL~dvfeded 76 (1342)
-++|++++.||+|+||.||+|.+... +..||+|.+++.. .....+.+.+|++++++++ ||||+++++++.+.+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 46889999999999999999987432 3469999986543 3344567889999999996 999999999999999
Q ss_pred eEEEEEeccC-CChHHHHhcC-----------------------------------------------------------
Q 000706 77 EFCVVTEFAQ-GELFEILEDD----------------------------------------------------------- 96 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek~----------------------------------------------------------- 96 (1342)
..|+||||++ |+|.+++.+.
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999997 7898887542
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC
Q 000706 97 -------------------------------------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS 139 (1342)
Q Consensus 97 -------------------------------------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG 139 (1342)
..+++..+..++.|++.||.|||++|++||||||+|||++.++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC
Confidence 2477888999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCce--eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHH-HHHHHh
Q 000706 140 VVKLCDFGFARAMSANTV--VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYA-LIRHIV 215 (1342)
Q Consensus 140 ~LKLiDFGLAr~l~sss~--~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~e-lirkIl 215 (1342)
.+||+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ....+.
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~ 354 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK 354 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHh
Confidence 999999999986543221 1223456788999999998889999999999999999997 999998754333 233333
Q ss_pred cC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 216 KD-PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 216 r~-~~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
.. ....+..+++++.+++.+||+.||++||++.++.+
T Consensus 355 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 355 SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 32 34456678999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=318.81 Aligned_cols=249 Identities=29% Similarity=0.458 Sum_probs=203.7
Q ss_pred CCEEEEEEEcccCcEEEEEEEE----ccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--Ce
Q 000706 4 ENYHVIELVGEGSFGKVYKGRR----KYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP--QE 77 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArD----k~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede--d~ 77 (1342)
.-|++++.||+|+||.||++.. ..+++.|++|.++... .......+.+|++++++++|||++++++++.+. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 4589999999999999999974 4678899999986543 334456789999999999999999999998775 67
Q ss_pred EEEEEeccC-CChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCC
Q 000706 78 FCVVTEFAQ-GELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN 155 (1342)
Q Consensus 78 lyLVMEY~e-GSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ss 155 (1342)
.+++|||++ ++|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 899999996 7899988654 46899999999999999999999999999999999999999999999999999876543
Q ss_pred ce---eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCc---------------HHHHHHHHhc-
Q 000706 156 TV---VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS---------------VYALIRHIVK- 216 (1342)
Q Consensus 156 s~---~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s---------------~~elirkIlr- 216 (1342)
.. ......++..|+|||.+.+..++.++||||||+++|+|+++..|+.... .......+..
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 22 1223457778999999988889999999999999999999877653211 1111111111
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 217 DPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 217 ~~~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
...+.+..+++.+.+|+.+||+.||++||++.+++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1233456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=318.11 Aligned_cols=228 Identities=26% Similarity=0.350 Sum_probs=194.7
Q ss_pred cCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-CChHHHH
Q 000706 15 GSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEIL 93 (1342)
Q Consensus 15 GgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e-GSL~D~L 93 (1342)
|.||.||++.++.+++.||+|.+++.. ...+|...+....||||+++++++.+++..|++|||++ |+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999999999999999997652 12234455556679999999999999999999999997 6899999
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCCCcCChhh
Q 000706 94 EDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPEL 173 (1342)
Q Consensus 94 ek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp~YmAPEv 173 (1342)
.+..++++..+..++.|+++||.|||++|++||||||+||+++.++.++++|||.+....... ....++..|+|||.
T Consensus 77 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~aPE~ 153 (237)
T cd05576 77 SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYCAPEV 153 (237)
T ss_pred HHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccccCCcc
Confidence 887789999999999999999999999999999999999999999999999999886654432 23456788999999
Q ss_pred hccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----H
Q 000706 174 VREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTW-----S 248 (1342)
Q Consensus 174 L~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRPSA-----e 248 (1342)
+.+..++.++|+||+|+++|+|++|+.||........ .......|+.+++.++++|.+||+.||++||++ +
T Consensus 154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~ 229 (237)
T cd05576 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVE 229 (237)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchH
Confidence 9888899999999999999999999998865432110 112234667789999999999999999999985 9
Q ss_pred HHHcCcCc
Q 000706 249 ALLEHPFV 256 (1342)
Q Consensus 249 ELLeHPFF 256 (1342)
++++||||
T Consensus 230 ~~~~h~~~ 237 (237)
T cd05576 230 DIKSHPFF 237 (237)
T ss_pred HHHcCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=316.99 Aligned_cols=248 Identities=27% Similarity=0.479 Sum_probs=201.7
Q ss_pred CCCEEEEEEEcccCcEEEEEEE----EccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--CC
Q 000706 3 VENYHVIELVGEGSFGKVYKGR----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFES--PQ 76 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKAr----Dk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfed--ed 76 (1342)
=.+|++.+.||+|+||.||++. +..+++.|++|.+... .....+.+.+|++++++++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 3689999999999999999997 4567899999998644 34445678899999999999999999997643 45
Q ss_pred eEEEEEeccC-CChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccC
Q 000706 77 EFCVVTEFAQ-GELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA 154 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~s 154 (1342)
.+++||||++ |+|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++.++++||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 6899999996 7899998754 5689999999999999999999999999999999999999999999999999987654
Q ss_pred Ccee---eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHH---------------HHHHHhc
Q 000706 155 NTVV---LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYA---------------LIRHIVK 216 (1342)
Q Consensus 155 ss~~---~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~e---------------lirkIlr 216 (1342)
.... .....++..|+|||.+.+..++.++||||||+++|||++|..|+....... ....+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 3221 111223456999999998889999999999999999999887764332110 0111112
Q ss_pred C--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 217 D--PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 217 ~--~~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
. ..+.+..++.++.+++.+||..+|++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1 22345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.23 Aligned_cols=257 Identities=32% Similarity=0.547 Sum_probs=230.4
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
+.+|+-.++||+|+||+||+|+++.+++.||+|.++.+..++..-....+|+-+++.+.|.|||+++++...+..+-+|+
T Consensus 1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 45788899999999999999999999999999999877666665677889999999999999999999999999999999
Q ss_pred eccCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 83 EFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EY~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
|||+.+|..+... ++.++.+.++.++.|+++||.|+|++++.|||+||+|.+++.+|++|++|||+++.++-+...+..
T Consensus 81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysa 160 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160 (292)
T ss_pred HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence 9999999998865 678999999999999999999999999999999999999999999999999999999988888888
Q ss_pred ccCCCCcCChhhhccCC-CCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC-----C--------------
Q 000706 162 IKGTPLYMAPELVREQP-YNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKDPV-----K-------------- 220 (1342)
Q Consensus 162 ~vGTp~YmAPEvL~g~~-YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~~~-----e-------------- 220 (1342)
.+.|.||++|.++.+.. |+...|+||.|||+.|+.. |++.|.+.+..++.++|++-.. .
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp 240 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP 240 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence 88999999999987755 8999999999999999986 8999999999999998875210 0
Q ss_pred -CC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 221 -YP---------DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 221 -fP---------~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
+| +.+...-++++.++|..+|.+|.++++.++||||.+.
T Consensus 241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 11 1223456799999999999999999999999999764
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=319.70 Aligned_cols=237 Identities=23% Similarity=0.393 Sum_probs=196.2
Q ss_pred EEEcccCcEEEEEEEEccCCc-------EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQ-------TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe-------~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
+.||+|+||.||+|.+..+++ ++++|.+.... ....+.+.+|..+++.++|||++++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 468999999999998865444 38888775432 233467888999999999999999999999999999999
Q ss_pred eccC-CChHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCc--------EEEeeccccccc
Q 000706 83 EFAQ-GELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSV--------VKLCDFGFARAM 152 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g-~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~--------LKLiDFGLAr~l 152 (1342)
||++ |+|.+++.+.+ .+++..+..++.|++.||+|||++||+||||||+||+++.++. +|++|||++...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 9997 68999987644 5899999999999999999999999999999999999987764 699999998765
Q ss_pred cCCceeeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCC-CCCCCCcHHHHHHHHhcCCCCCCCCCCHHHH
Q 000706 153 SANTVVLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQ-PPFYTNSVYALIRHIVKDPVKYPDEMSPNFK 230 (1342)
Q Consensus 153 ~sss~~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr-~PF~g~s~~elirkIlr~~~efP~eISpeLk 230 (1342)
... ....+++.|+|||.+.+ ..++.++||||||+++|+|++|. .||...+.... .........+|...++++.
T Consensus 159 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd05078 159 LPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQLPAPKWTELA 233 (258)
T ss_pred CCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccCCCCCcHHHH
Confidence 432 23458889999999876 45799999999999999999984 66655444333 2334455667777889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcC
Q 000706 231 SFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 231 DLIrKcLqkDPeKRPSAeELLeH 253 (1342)
+++.+||+.||++|||++++++.
T Consensus 234 ~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 234 NLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=314.40 Aligned_cols=248 Identities=22% Similarity=0.398 Sum_probs=207.5
Q ss_pred EEEEEEEcccCcEEEEEEEEcc---CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 000706 6 YHVIELVGEGSFGKVYKGRRKY---TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ------ 76 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~---TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded------ 76 (1342)
|++.+.||+|+||.||+|.++. +++.+|+|.+..+.......+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6789999999999999998643 5789999999776666666778899999999999999999999886432
Q ss_pred eEEEEEeccC-CChHHHHhcC------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccc
Q 000706 77 EFCVVTEFAQ-GELFEILEDD------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFA 149 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek~------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLA 149 (1342)
..++++||+. |+|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3478899986 7888776421 25789999999999999999999999999999999999999999999999999
Q ss_pred ccccCCce--eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCC
Q 000706 150 RAMSANTV--VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEM 225 (1342)
Q Consensus 150 r~l~sss~--~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eI 225 (1342)
+....... ......+++.|++||.+.+..++.++||||||+++|+|++ |++||...+..+....+... ....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDC 240 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence 86643321 1122345678999999998889999999999999999999 89999887776666655543 33455678
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 226 SPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 226 SpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
++.+.+++.+||+.+|++||++.+++++
T Consensus 241 ~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 241 LEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=313.07 Aligned_cols=248 Identities=33% Similarity=0.612 Sum_probs=210.2
Q ss_pred CEEEEEEEcccCcEEEEEEEEcc-CCcEEEEEEeecCC--------CCHHHHHHHHHHHHHHHh-cCCCCcceEEEEEEe
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKY-TGQTVAMKFIMKHG--------KSEKDIHNLRQEIEILRK-LKHQNIIEMLDSFES 74 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~-TGe~VAVKvIkKs~--------~se~dierL~rEI~ILKr-L~HPNIVKL~dvfed 74 (1342)
+|++.+.||+|+||.||++.+.. +++.+++|.+.... .......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 58999999999999999999987 68899999885431 223345667788888875 799999999999999
Q ss_pred CCeEEEEEeccC-CChHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCcEEEcCCCcEEEeeccc
Q 000706 75 PQEFCVVTEFAQ-GELFEILE----DDKCLPEEQVQSIAKQLVRALHYLHS-NRIIHRDMKPQNILIGAGSVVKLCDFGF 148 (1342)
Q Consensus 75 ed~lyLVMEY~e-GSL~D~Le----k~g~LSEeeI~~I~~QLLsALaYLHs-rGIVHRDLKPENILLdsdG~LKLiDFGL 148 (1342)
++..+++|||++ ++|.+++. +...+++..++.++.|++.+|.|||+ .|++||||||+||+++.++.+||+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999997 57877763 34579999999999999999999996 7899999999999999999999999999
Q ss_pred cccccCCceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CC-CCCC
Q 000706 149 ARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVK-YP-DEMS 226 (1342)
Q Consensus 149 Ar~l~sss~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~e-fP-~eIS 226 (1342)
+....... ......|+..|++||.+.+..++.++|+||||+++|+|++|+.||...........+...... .+ ..++
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd08528 161 AKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239 (269)
T ss_pred eeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence 98765543 334566899999999999888999999999999999999999999887776666665554322 22 3578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 227 PNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 227 peLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
+++.++|.+||+.||++||++.|+..+
T Consensus 240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 240 EDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=311.32 Aligned_cols=243 Identities=23% Similarity=0.431 Sum_probs=199.4
Q ss_pred EEEcccCcEEEEEEEEcc---CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEE-eCCeEEEEEecc
Q 000706 10 ELVGEGSFGKVYKGRRKY---TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFE-SPQEFCVVTEFA 85 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~---TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfe-ded~lyLVMEY~ 85 (1342)
+.||+|+||.||+|.+.. ++..+|+|.+... ......+.+.+|+.+++.++||||+++++++. .++..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 468999999999998643 3457899987543 23344567888999999999999999999765 556789999998
Q ss_pred C-CChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce----ee
Q 000706 86 Q-GELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV----VL 159 (1342)
Q Consensus 86 e-GSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~----~~ 159 (1342)
. |+|.+++.+. ...++..+..++.|+++||.|||+.|++||||||+||+++.++.+||+|||+++....... ..
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 7 7999998763 4567888899999999999999999999999999999999999999999999976543211 11
Q ss_pred ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhc
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLL 237 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrKcL 237 (1342)
....+++.|+|||.+.+..++.++||||||+++|||++ |.+||...+..+....+... ....+...++.+.+++.+||
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 239 (262)
T cd05058 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCW 239 (262)
T ss_pred ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHc
Confidence 22346778999999988889999999999999999999 56778777766666666554 33445567899999999999
Q ss_pred ccCCCCCCCHHHHHcC
Q 000706 238 NKVPQNRLTWSALLEH 253 (1342)
Q Consensus 238 qkDPeKRPSAeELLeH 253 (1342)
..+|++||++.|+++.
T Consensus 240 ~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 240 HPKPEMRPTFSELVSR 255 (262)
T ss_pred CCChhhCCCHHHHHHH
Confidence 9999999999999763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=332.77 Aligned_cols=250 Identities=28% Similarity=0.526 Sum_probs=203.6
Q ss_pred CCCEEEEEEEcccCcEEEEEEEE-----ccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEe-C
Q 000706 3 VENYHVIELVGEGSFGKVYKGRR-----KYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFES-P 75 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArD-----k~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfed-e 75 (1342)
-++|++.+.||+|+||.||+|.+ ..+++.||+|.++... .......+.+|+.++.++ +||||+++++++.. +
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 46899999999999999999974 3567899999986543 334456788899999999 68999999998754 4
Q ss_pred CeEEEEEeccC-CChHHHHhcC----------------------------------------------------------
Q 000706 76 QEFCVVTEFAQ-GELFEILEDD---------------------------------------------------------- 96 (1342)
Q Consensus 76 d~lyLVMEY~e-GSL~D~Lek~---------------------------------------------------------- 96 (1342)
...+++|||++ |+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 56899999997 7898887542
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce--eeecccCC
Q 000706 97 ---------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV--VLRSIKGT 165 (1342)
Q Consensus 97 ---------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~--~~~s~vGT 165 (1342)
..++...+..++.|+++||+|||++||+||||||+||+++.++.+||+|||++........ ......++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 2367788899999999999999999999999999999999999999999999976533221 11223356
Q ss_pred CCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHH-HHHHHhcC-CCCCCCCCCHHHHHHHHHhcccCCC
Q 000706 166 PLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYA-LIRHIVKD-PVKYPDEMSPNFKSFLKGLLNKVPQ 242 (1342)
Q Consensus 166 p~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~e-lirkIlr~-~~efP~eISpeLkDLIrKcLqkDPe 242 (1342)
+.|+|||.+.+..++.++||||||+++|+|++ |..||....... ....+... ....|...++++.+++.+||+.||+
T Consensus 245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~ 324 (343)
T cd05103 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 324 (343)
T ss_pred cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 77999999988889999999999999999997 999997654322 22222222 3345566788999999999999999
Q ss_pred CCCCHHHHHcC
Q 000706 243 NRLTWSALLEH 253 (1342)
Q Consensus 243 KRPSAeELLeH 253 (1342)
+|||+.|+++|
T Consensus 325 ~Rps~~eil~~ 335 (343)
T cd05103 325 QRPTFSELVEH 335 (343)
T ss_pred hCcCHHHHHHH
Confidence 99999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=313.66 Aligned_cols=250 Identities=28% Similarity=0.497 Sum_probs=206.3
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEc----cCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--C
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRK----YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFES--P 75 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk----~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfed--e 75 (1342)
.-++|++.+.||+|+||.||++... .+++.+|+|.+...... ...+.+.+|+++++.++||||+++++++.. .
T Consensus 2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 3578999999999999999999864 34889999998765443 345788999999999999999999999877 5
Q ss_pred CeEEEEEeccC-CChHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 000706 76 QEFCVVTEFAQ-GELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS 153 (1342)
Q Consensus 76 d~lyLVMEY~e-GSL~D~Lek~g-~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ 153 (1342)
...+++|||++ |+|.+++.+.. .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||.+....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 68999999997 68999987644 69999999999999999999999999999999999999999999999999998765
Q ss_pred CCceee---ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHH--------------HHHHHhc
Q 000706 154 ANTVVL---RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYA--------------LIRHIVK 216 (1342)
Q Consensus 154 sss~~~---~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~e--------------lirkIlr 216 (1342)
...... ....++..|++||.+.+..++.++|+||||+++|+|++|..||....... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 332211 12335567999999988889999999999999999999999986542211 1112222
Q ss_pred C--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 217 D--PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 217 ~--~~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
. ....+...+.++.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2 23344567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=314.26 Aligned_cols=242 Identities=24% Similarity=0.467 Sum_probs=203.1
Q ss_pred EEEcccCcEEEEEEEEccCC------cEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 10 ELVGEGSFGKVYKGRRKYTG------QTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TG------e~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
+.||+|+||.||++.++... +.+++|.+.+.. .......+.+|+++++.++||||+++++++.+.+..+++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 36899999999999876443 689999886542 22345678889999999999999999999999999999999
Q ss_pred ccC-CChHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC-----cEEEeeccccc
Q 000706 84 FAQ-GELFEILED-------DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS-----VVKLCDFGFAR 150 (1342)
Q Consensus 84 Y~e-GSL~D~Lek-------~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG-----~LKLiDFGLAr 150 (1342)
|++ |+|.+++.+ ...+++..+..++.|++.||.|||++|++|+||||+||+++.++ .+||+|||+++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 987 789998864 23478899999999999999999999999999999999999887 89999999997
Q ss_pred cccCCce--eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCC
Q 000706 151 AMSANTV--VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMS 226 (1342)
Q Consensus 151 ~l~sss~--~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eIS 226 (1342)
....... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+... ....+..++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCP 239 (269)
T ss_pred ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccch
Confidence 6543221 1122345678999999998889999999999999999998 99999887766665555433 445667789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 227 PNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 227 peLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
+.+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 240 DKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999999999865
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=310.54 Aligned_cols=234 Identities=24% Similarity=0.408 Sum_probs=192.9
Q ss_pred EEEcccCcEEEEEEEEccCC----------cEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 000706 10 ELVGEGSFGKVYKGRRKYTG----------QTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFC 79 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TG----------e~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~ly 79 (1342)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+++++.++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999998766 34777776543221 4678889999999999999999999988 7789
Q ss_pred EEEeccC-CChHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC-------cEEEeeccccc
Q 000706 80 VVTEFAQ-GELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS-------VVKLCDFGFAR 150 (1342)
Q Consensus 80 LVMEY~e-GSL~D~Lek~g-~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG-------~LKLiDFGLAr 150 (1342)
++|||++ |+|.+++.+.+ .+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 9999997 78999987755 799999999999999999999999999999999999999888 79999999998
Q ss_pred cccCCceeeecccCCCCcCChhhhccC--CCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCCH
Q 000706 151 AMSANTVVLRSIKGTPLYMAPELVREQ--PYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKDPVKYPDEMSP 227 (1342)
Q Consensus 151 ~l~sss~~~~s~vGTp~YmAPEvL~g~--~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~~~efP~eISp 227 (1342)
.... .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||...+..+..... ......+.....
T Consensus 157 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~ 231 (259)
T cd05037 157 TVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY-QDQHRLPMPDCA 231 (259)
T ss_pred cccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-hcCCCCCCCCch
Confidence 6544 2234577889999998876 78999999999999999999 58888766433332222 222233333448
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 228 NFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 228 eLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
.+.+++.+||+.||.+|||+.++++
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 232 ELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 8999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=321.30 Aligned_cols=250 Identities=23% Similarity=0.404 Sum_probs=207.3
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCc----EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQ----TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQE 77 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe----~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~ 77 (1342)
.-++|++.+.||+|+||.||++.+..+++ .+++|.+..... ......+.+|+.+++.++||||+++++++..+ .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 45789999999999999999999877776 468887754432 33345688899999999999999999998754 4
Q ss_pred EEEEEeccC-CChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCC
Q 000706 78 FCVVTEFAQ-GELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN 155 (1342)
Q Consensus 78 lyLVMEY~e-GSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ss 155 (1342)
.++++||++ |+|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 678999987 7899998764 46899999999999999999999999999999999999999999999999999876543
Q ss_pred cee--eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHH
Q 000706 156 TVV--LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKS 231 (1342)
Q Consensus 156 s~~--~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkD 231 (1342)
... .....++..|++||.+.+..++.++||||||+++|||++ |..||.+....+..+.+... ....+...+..+.+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYM 242 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 322 222345778999999998889999999999999999997 99999876655444443332 23445567889999
Q ss_pred HHHHhcccCCCCCCCHHHHHcC
Q 000706 232 FLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 232 LIrKcLqkDPeKRPSAeELLeH 253 (1342)
++.+|+..||++||++.++++.
T Consensus 243 li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 243 VMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.43 Aligned_cols=249 Identities=18% Similarity=0.233 Sum_probs=194.8
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccC---CcEEEEEEeecCCCCHHH---------HHHHHHHHHHHHhcCCCCcceEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYT---GQTVAMKFIMKHGKSEKD---------IHNLRQEIEILRKLKHQNIIEMLD 70 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~T---Ge~VAVKvIkKs~~se~d---------ierL~rEI~ILKrL~HPNIVKL~d 70 (1342)
-++|++.+.||+|+||.||+|.+..+ ++.+++|........... ......+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999998777 667777764332211100 011222334455678999999998
Q ss_pred EEEeCC----eEEEEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeec
Q 000706 71 SFESPQ----EFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDF 146 (1342)
Q Consensus 71 vfeded----~lyLVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDF 146 (1342)
.+.... ..+++||++..++.+.+......++..++.++.|++.||.|||++|++||||||+|||++.++.+||+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 765443 4578899988888887776666789999999999999999999999999999999999999999999999
Q ss_pred cccccccCCce-------eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcH-H--------HH
Q 000706 147 GFARAMSANTV-------VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSV-Y--------AL 210 (1342)
Q Consensus 147 GLAr~l~sss~-------~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~-~--------el 210 (1342)
|+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... . +.
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~ 250 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDF 250 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHH
Confidence 99986643211 11234699999999999999999999999999999999999999976532 1 22
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 211 IRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 211 irkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
..++...... .+..++++.+++..|++.+|++||++.++++
T Consensus 251 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 251 IKRLHEGKIK-IKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHhhhhhhc-cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2333333322 3456889999999999999999999999875
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.52 Aligned_cols=241 Identities=24% Similarity=0.400 Sum_probs=193.2
Q ss_pred EEEcccCcEEEEEEEEc--cCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 10 ELVGEGSFGKVYKGRRK--YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk--~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
+.||+|+||.||+|... .....+++|.+.... .......+.+|+++++.++||||+++++.+.+....|++|||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 36899999999999643 244578888775432 33444667889999999999999999999999999999999997
Q ss_pred CChHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce--ee
Q 000706 87 GELFEILEDDK-----CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV--VL 159 (1342)
Q Consensus 87 GSL~D~Lek~g-----~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~--~~ 159 (1342)
|+|.+++.+.. ..++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 78999987532 356788899999999999999999999999999999999999999999999865433221 11
Q ss_pred ecccCCCCcCChhhhcc-------CCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CC-----CCCCCC
Q 000706 160 RSIKGTPLYMAPELVRE-------QPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PV-----KYPDEM 225 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g-------~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~-----efP~eI 225 (1342)
....+++.|+|||++.. ..++.++||||||+++|+|++ |..||......+....+... .. ..+..+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKY 239 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccC
Confidence 23346778999998743 456789999999999999999 88899877665555544332 22 233467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 226 SPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 226 SpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
++.+.+++..|+ .||++|||++++++
T Consensus 240 ~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 240 SDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 889999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=367.06 Aligned_cols=250 Identities=25% Similarity=0.397 Sum_probs=207.0
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
+++|++.+.||+|+||.||+|++..+++.||+|++.+... .....+++.+|++++++++||||+++++++.+++..|++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 5899999999999999999999999999999999975432 233456788999999999999999999999999999999
Q ss_pred EeccC-CChHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccc
Q 000706 82 TEFAQ-GELFEILED-----------DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFA 149 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek-----------~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLA 149 (1342)
|||++ |+|.+++.. ...++...++.++.|+++||+|||++||+||||||+||+++.+|.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 99997 688888753 123566778999999999999999999999999999999999999999999999
Q ss_pred ccccCCc------------------eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHH
Q 000706 150 RAMSANT------------------VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALI 211 (1342)
Q Consensus 150 r~l~sss------------------~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~eli 211 (1342)
+...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 8662110 0112356999999999999999999999999999999999999999875543332
Q ss_pred HH-HhcCCCCC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 212 RH-IVKDPVKY--PDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 212 rk-Ilr~~~ef--P~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
.. ....+... ...+++.+.+++.+||+.||++||+..+.+.
T Consensus 241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22 12222222 2468899999999999999999987655543
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=309.87 Aligned_cols=241 Identities=25% Similarity=0.376 Sum_probs=192.8
Q ss_pred EEEcccCcEEEEEEEEc--cCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 10 ELVGEGSFGKVYKGRRK--YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk--~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
+.||+|+||.||+|... .++..+++|.++.... ......+.+|+.++++++||||+++++.+.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 46899999999999754 4567799998865543 2334578889999999999999999999999999999999997
Q ss_pred CChHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee--e
Q 000706 87 GELFEILEDD-----KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV--L 159 (1342)
Q Consensus 87 GSL~D~Lek~-----g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~--~ 159 (1342)
|+|.+++... ...++..+..++.|++.||+|||++|++||||||+||+++.++++||+|||++......... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 7899988642 24667788899999999999999999999999999999999999999999999754433221 1
Q ss_pred ecccCCCCcCChhhhccC-------CCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHh-cCCCC-----CCCCC
Q 000706 160 RSIKGTPLYMAPELVREQ-------PYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIV-KDPVK-----YPDEM 225 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g~-------~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIl-r~~~e-----fP~eI 225 (1342)
....+++.|+|||++.+. .++.++|+||||+++|||++ |+.||......+...... ..... .....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL 239 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCC
Confidence 234578889999988642 35789999999999999996 999998765544433322 22222 22346
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 226 SPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 226 SpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
++.+.+++..|+ .+|++|||++|++.
T Consensus 240 ~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 240 SDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 788999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=350.43 Aligned_cols=256 Identities=30% Similarity=0.488 Sum_probs=218.4
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyL 80 (1342)
+-..|+++++||+||-+.||++... +.+.||+|.+.....+......+.+|+..|.++ .|.+|+++|||-..++.+|+
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 3467999999999999999999755 456788888877777788889999999999999 68999999999999999999
Q ss_pred EEeccCCChHHHHhcCCCCCH-HHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce--
Q 000706 81 VTEFAQGELFEILEDDKCLPE-EQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV-- 157 (1342)
Q Consensus 81 VMEY~eGSL~D~Lek~g~LSE-eeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~-- 157 (1342)
||||=+.||-.+|++.....+ -.++.|..|++.++.++|++||||-||||.|+|+-+ |.+||+|||+|..+..++.
T Consensus 438 vmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI 516 (677)
T KOG0596|consen 438 VMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSI 516 (677)
T ss_pred EeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCccccce
Confidence 999999999999988664433 588999999999999999999999999999999864 5999999999998876543
Q ss_pred eeecccCCCCcCChhhhccCC-----------CCCCCcccchhhHHHHHHhCCCCCCCC-cHHHHHHHHhcCC--CCCCC
Q 000706 158 VLRSIKGTPLYMAPELVREQP-----------YNHTADLWSLGVILYELFVGQPPFYTN-SVYALIRHIVKDP--VKYPD 223 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g~~-----------YT~KsDIWSLGVILYELLTGr~PF~g~-s~~elirkIlr~~--~efP~ 223 (1342)
...+.+||+-||+||.+.... .++++||||||||||+|+.|++||..- +....+..|.... .+||.
T Consensus 517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~ 596 (677)
T KOG0596|consen 517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPD 596 (677)
T ss_pred eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccC
Confidence 345678999999999885433 457899999999999999999999754 3555666666553 36666
Q ss_pred CCCHH-HHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 224 EMSPN-FKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 224 eISpe-LkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
.-+.+ +.++++.||..||++||++.++|+|||++..
T Consensus 597 ~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 597 IPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred CCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 55444 9999999999999999999999999999863
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=339.21 Aligned_cols=257 Identities=34% Similarity=0.546 Sum_probs=212.2
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCc----EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCe
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQ----TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFES-PQE 77 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe----~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfed-ed~ 77 (1342)
+..|++++.||+|+||.||+|..++++. .||+|.++........-...-+|+.+++.++|||++.+..+|.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4679999999999999999997655543 68999987653322333456789999999999999999999876 889
Q ss_pred EEEEEeccCCChHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCC----CcEEEeeccc
Q 000706 78 FCVVTEFAQGELFEILED-----DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAG----SVVKLCDFGF 148 (1342)
Q Consensus 78 lyLVMEY~eGSL~D~Lek-----~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsd----G~LKLiDFGL 148 (1342)
+|+++||.+.+|++.|+- .+.++...++.++.||+.|+.|||++-|+||||||.||||..+ |.+||+|||+
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 999999999999999863 3569999999999999999999999999999999999999888 8999999999
Q ss_pred cccccCCcee---eecccCCCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCc---------HHHHHHHHh
Q 000706 149 ARAMSANTVV---LRSIKGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNS---------VYALIRHIV 215 (1342)
Q Consensus 149 Ar~l~sss~~---~~s~vGTp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s---------~~elirkIl 215 (1342)
++.+...-.. ....+.|.||+|||.+.+. .||.++|+|+.|||+.||++-++.|.+.+ ..+++++|+
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 9988765433 3446789999999988765 59999999999999999999999887643 234555555
Q ss_pred cC---C--C------CCCC--------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCccc
Q 000706 216 KD---P--V------KYPD--------------------------EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258 (1342)
Q Consensus 216 r~---~--~------efP~--------------------------eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre 258 (1342)
.- + . .+|+ .-++...+|+.+||+.||.+|.|++++++|+||++
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~ 342 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE 342 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence 31 0 0 0111 12455778999999999999999999999999987
Q ss_pred c
Q 000706 259 T 259 (1342)
Q Consensus 259 ~ 259 (1342)
.
T Consensus 343 d 343 (438)
T KOG0666|consen 343 D 343 (438)
T ss_pred C
Confidence 5
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=338.47 Aligned_cols=251 Identities=25% Similarity=0.472 Sum_probs=208.3
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEc-----cCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEeC
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRK-----YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-HQNIIEMLDSFESP 75 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk-----~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~-HPNIVKL~dvfede 75 (1342)
..++|.+.+.||+|+||.||+|++. .+++.||+|+++.... ....+.+.+|++++.++. ||||+++++.+.++
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 3467899999999999999999853 4567899999976533 333456889999999997 99999999999999
Q ss_pred CeEEEEEeccC-CChHHHHhcCC---------------------------------------------------------
Q 000706 76 QEFCVVTEFAQ-GELFEILEDDK--------------------------------------------------------- 97 (1342)
Q Consensus 76 d~lyLVMEY~e-GSL~D~Lek~g--------------------------------------------------------- 97 (1342)
+..++||||++ |+|++++.+.+
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999997 79999885431
Q ss_pred -----------------------------------------CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEc
Q 000706 98 -----------------------------------------CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIG 136 (1342)
Q Consensus 98 -----------------------------------------~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLd 136 (1342)
.+++..++.++.|++.||.|||++|++||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 356778889999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCce--eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHH
Q 000706 137 AGSVVKLCDFGFARAMSANTV--VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRH 213 (1342)
Q Consensus 137 sdG~LKLiDFGLAr~l~sss~--~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirk 213 (1342)
+++.+||+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+....
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~ 353 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence 999999999999986533221 1223457888999999998889999999999999999998 8999987554444333
Q ss_pred -HhcC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 214 -IVKD-PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 214 -Ilr~-~~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
+..+ +...|..++.++.+++.+||..||.+||++.|+++.
T Consensus 354 ~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 354 AIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3332 345567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.97 Aligned_cols=237 Identities=22% Similarity=0.356 Sum_probs=192.1
Q ss_pred EEEcccCcEEEEEEEEcc------------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 000706 10 ELVGEGSFGKVYKGRRKY------------TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQE 77 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~------------TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~ 77 (1342)
+.||+|+||.||+|+... ....+++|.+.... ......+.+|+.+++.++||||+++++++.++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 468999999999997532 22358888875432 2334567889999999999999999999999999
Q ss_pred EEEEEeccC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCc-------EEEeeccc
Q 000706 78 FCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSV-------VKLCDFGF 148 (1342)
Q Consensus 78 lyLVMEY~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~-------LKLiDFGL 148 (1342)
.+++|||++ |+|..++.+ ...+++..++.++.|+++||+|||++|++||||||+|||++.++. +|++|||+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 999999998 567676654 457999999999999999999999999999999999999987664 89999999
Q ss_pred cccccCCceeeecccCCCCcCChhhhc-cCCCCCCCcccchhhHHHHHH-hCCCCCCCCcHHHHHHHHhcCCCCCCCCCC
Q 000706 149 ARAMSANTVVLRSIKGTPLYMAPELVR-EQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKDPVKYPDEMS 226 (1342)
Q Consensus 149 Ar~l~sss~~~~s~vGTp~YmAPEvL~-g~~YT~KsDIWSLGVILYELL-TGr~PF~g~s~~elirkIlr~~~efP~eIS 226 (1342)
+...... ....++..|+|||.+. +..++.++||||||+++|+|+ .|..||......+.. .............+
T Consensus 159 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (262)
T cd05077 159 PITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVTPSC 233 (262)
T ss_pred CccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCCCCh
Confidence 8765332 2345788999999886 466899999999999999998 588888766544332 23333333444456
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 227 PNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 227 peLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
+++.+++.+||+.||++||++.+++++
T Consensus 234 ~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 234 KELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=356.78 Aligned_cols=256 Identities=27% Similarity=0.500 Sum_probs=236.8
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecC-CCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKH-GKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs-~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
+.+++++..||-|+||.|=++........+|+|+++|. -...++.+.+..|-++|..++.|+||++|..|.++..+|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 56778889999999999999977655556899999765 35556678899999999999999999999999999999999
Q ss_pred Eecc-CCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 82 TEFA-QGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 82 MEY~-eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
||-| +|+++..+++++.|++..++.|+..+++|++|||++||++|||||||.+++.+|-+||.|||+|+.+..+..+ -
T Consensus 499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT-w 577 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT-W 577 (732)
T ss_pred HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCce-e
Confidence 9996 6899999999999999999999999999999999999999999999999999999999999999999887655 4
Q ss_pred cccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHhcc
Q 000706 161 SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD--PVKYPDEMSPNFKSFLKGLLN 238 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~--~~efP~eISpeLkDLIrKcLq 238 (1342)
++||||.|.|||++.++..+.++|+|+||+++|||++|++||.+.++...+..|.++ ...+|..++....+||+++..
T Consensus 578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr 657 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCR 657 (732)
T ss_pred eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHh
Confidence 689999999999999999999999999999999999999999999999999999986 567899999999999999999
Q ss_pred cCCCCCCC-----HHHHHcCcCcccc
Q 000706 239 KVPQNRLT-----WSALLEHPFVKET 259 (1342)
Q Consensus 239 kDPeKRPS-----AeELLeHPFFre~ 259 (1342)
.+|.+|.. +.|+.+|.||...
T Consensus 658 ~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 658 DNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred cCcHhhhccccCChHHHHhhhhhhcC
Confidence 99999986 8999999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=293.74 Aligned_cols=239 Identities=45% Similarity=0.776 Sum_probs=208.8
Q ss_pred CcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccCC-ChHHHHh
Q 000706 16 SFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILE 94 (1342)
Q Consensus 16 gFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~eG-SL~D~Le 94 (1342)
+||.||++.+..+++.+++|.+........ .+.+.+|++.+++++|+|++++++.+......+++|||+++ +|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999999998899999999876543322 57889999999999999999999999999999999999985 9999998
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCCCcCChhhh
Q 000706 95 DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELV 174 (1342)
Q Consensus 95 k~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp~YmAPEvL 174 (1342)
....+++..++.++.+++.++.|||+.|++|+||+|+||+++.++.++|+|||.+....... ......+++.|++||.+
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 80 KRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVL 158 (244)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHH
Confidence 77679999999999999999999999999999999999999999999999999998766543 23345688999999999
Q ss_pred ccCCCCCCCcccchhhHHHHHHhCCCCCCC-CcHHHHHHHHhcCCCCCCCC---CCHHHHHHHHHhcccCCCCCCCHHHH
Q 000706 175 REQPYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKDPVKYPDE---MSPNFKSFLKGLLNKVPQNRLTWSAL 250 (1342)
Q Consensus 175 ~g~~YT~KsDIWSLGVILYELLTGr~PF~g-~s~~elirkIlr~~~efP~e---ISpeLkDLIrKcLqkDPeKRPSAeEL 250 (1342)
.+..++.++|+|++|+++|+|++|..||.. .+.....+.+.......... ++.++.+++.+||..||++||++.++
T Consensus 159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 238 (244)
T smart00220 159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEA 238 (244)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence 888899999999999999999999999987 55555555555444443332 88999999999999999999999999
Q ss_pred HcCcCc
Q 000706 251 LEHPFV 256 (1342)
Q Consensus 251 LeHPFF 256 (1342)
++||||
T Consensus 239 ~~~~~~ 244 (244)
T smart00220 239 LQHPFF 244 (244)
T ss_pred hhCCCC
Confidence 999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.61 Aligned_cols=236 Identities=21% Similarity=0.339 Sum_probs=192.1
Q ss_pred EEcccCcEEEEEEEEccC------------------------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcc
Q 000706 11 LVGEGSFGKVYKGRRKYT------------------------GQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66 (1342)
Q Consensus 11 ~LGsGgFGtVYKArDk~T------------------------Ge~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIV 66 (1342)
.||+|+||.||+|....+ ...+++|.+.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 589999999999975322 2357888875432 22345678899999999999999
Q ss_pred eEEEEEEeCCeEEEEEeccC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC-----
Q 000706 67 EMLDSFESPQEFCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS----- 139 (1342)
Q Consensus 67 KL~dvfeded~lyLVMEY~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG----- 139 (1342)
++++++.++...|+||||++ |+|.+++.+ .+.+++..+..++.|++.||+|||++||+||||||+||+++.++
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 99999999999999999998 678777765 56799999999999999999999999999999999999997654
Q ss_pred --cEEEeeccccccccCCceeeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHH-hCCCCCCCCcHHHHHHHHh
Q 000706 140 --VVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIV 215 (1342)
Q Consensus 140 --~LKLiDFGLAr~l~sss~~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELL-TGr~PF~g~s~~elirkIl 215 (1342)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|+||||+++|||+ +|+.||......+... ..
T Consensus 160 ~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~ 234 (274)
T cd05076 160 SPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FY 234 (274)
T ss_pred cceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HH
Confidence 4899999988654322 22357888999998865 56899999999999999985 6999998765544332 33
Q ss_pred cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 216 KDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 216 r~~~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
......+...++++.++|.+||+.+|++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 235 EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 33445556677899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=382.40 Aligned_cols=257 Identities=32% Similarity=0.568 Sum_probs=227.3
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
+|+-...||.|.||.||.|.+..+|+..|+|.++-..........+.+|..+++.++|||+|++|++-.+.+..+|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 57778899999999999999999999999999976655555567889999999999999999999999999999999999
Q ss_pred cC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce----ee
Q 000706 85 AQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV----VL 159 (1342)
Q Consensus 85 ~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~----~~ 159 (1342)
|+ |+|.+.++.++-.+|...+.|..|++.|+.|||++|||||||||+||+++.+|.+|++|||.|..+..+.. ..
T Consensus 1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 97 89999999988899999999999999999999999999999999999999999999999999988765532 23
Q ss_pred ecccCCCCcCChhhhccC---CCCCCCcccchhhHHHHHHhCCCCCCC-CcHHHHHHHHhc-CCCCCCCCCCHHHHHHHH
Q 000706 160 RSIKGTPLYMAPELVREQ---PYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVK-DPVKYPDEMSPNFKSFLK 234 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g~---~YT~KsDIWSLGVILYELLTGr~PF~g-~s~~elirkIlr-~~~efP~eISpeLkDLIr 234 (1342)
....|||.|||||++.+. ....++|||||||++.||+||+.||.. ++....+-++.. ..+.+|+.++++-++||.
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle 1475 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLE 1475 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHH
Confidence 457899999999999764 356789999999999999999999975 344555555544 467889999999999999
Q ss_pred HhcccCCCCCCCHHHHHcCcCcccchh
Q 000706 235 GLLNKVPQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 235 KcLqkDPeKRPSAeELLeHPFFre~~~ 261 (1342)
.||..||++|.++.||++|.|-+...+
T Consensus 1476 ~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1476 HCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred HHHhcCchhhhHHHHHHHhhccccccc
Confidence 999999999999999999998776544
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=354.97 Aligned_cols=249 Identities=29% Similarity=0.515 Sum_probs=219.7
Q ss_pred EEEEEEcccCcEEEEEEEEccCCcEEEEEEeecC--CCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe--EEEEE
Q 000706 7 HVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKH--GKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQE--FCVVT 82 (1342)
Q Consensus 7 rIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs--~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~--lyLVM 82 (1342)
+....||+|+|-+||+|.|..+|-.||.-.++.. ...+...+++..|+.+|+.|+||||+++|++|.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4567899999999999999999999988665433 3455667899999999999999999999999986655 88999
Q ss_pred eccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC--CceecCCCCCcEEEcC-CCcEEEeeccccccccCCcee
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN--RIIHRDMKPQNILIGA-GSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsr--GIVHRDLKPENILLds-dG~LKLiDFGLAr~l~sss~~ 158 (1342)
|.+. |+|..|.++.++++.+.++.|++||++||.|||++ .|+|||||.+||||+. -|.+||+|+|+|........
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a- 201 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA- 201 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc-
Confidence 9986 99999999999999999999999999999999988 5999999999999976 47999999999998776543
Q ss_pred eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCC-CcHHHHHHHHhcCCC--CCCCCCCHHHHHHHHH
Q 000706 159 LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKDPV--KYPDEMSPNFKSFLKG 235 (1342)
Q Consensus 159 ~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g-~s~~elirkIlr~~~--efP~eISpeLkDLIrK 235 (1342)
....|||.|||||++. ..|+..+||||||+.+.||+|+..||.. .+..++++++..+.. .+..--.|++++||.+
T Consensus 202 -ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIek 279 (632)
T KOG0584|consen 202 -KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEK 279 (632)
T ss_pred -ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHH
Confidence 3478999999999988 6799999999999999999999999965 678888898887743 2334447999999999
Q ss_pred hcccCCCCCCCHHHHHcCcCcccc
Q 000706 236 LLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 236 cLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
||.. ...|||+.|||+||||...
T Consensus 280 Cl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 280 CLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HhcC-chhccCHHHHhhChhhccc
Confidence 9999 9999999999999999874
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.51 Aligned_cols=241 Identities=23% Similarity=0.353 Sum_probs=192.2
Q ss_pred EEEcccCcEEEEEEEEccC--CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 10 ELVGEGSFGKVYKGRRKYT--GQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~T--Ge~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
++||+|+||.||++..... ...+++|.+.... .....+.+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 3699999999999975432 2345667665432 23345678899999999999999999999999999999999998
Q ss_pred CChHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc--eeee
Q 000706 87 GELFEILEDD----KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT--VVLR 160 (1342)
Q Consensus 87 GSL~D~Lek~----g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss--~~~~ 160 (1342)
|+|.+++.+. ...++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++....... ....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 159 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence 6899998753 346777889999999999999999999999999999999999999999999986432211 1123
Q ss_pred cccCCCCcCChhhhcc-------CCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcCC------CCCCCCCC
Q 000706 161 SIKGTPLYMAPELVRE-------QPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKDP------VKYPDEMS 226 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g-------~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~~------~efP~eIS 226 (1342)
...+++.|+|||++.. ..++.++||||||+++|||++ |..||...+..+....+.... ...+..++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd05086 160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS 239 (268)
T ss_pred CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCc
Confidence 4568899999998743 245789999999999999996 577887777666665544331 22334578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 227 PNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 227 peLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
+.+.+++..|+ .+|++||+++++++
T Consensus 240 ~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 240 ERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 89999999999 68999999999965
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=348.38 Aligned_cols=235 Identities=34% Similarity=0.617 Sum_probs=208.7
Q ss_pred EEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC
Q 000706 7 HVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ 86 (1342)
Q Consensus 7 rIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e 86 (1342)
.-++.||.|+.|-||+|+. .++.||||+++. .-..+|+-|++++||||+++.+++.....++|+||||.
T Consensus 127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhhhccCcccceeeeec--cCceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 3467899999999999954 588999998742 22347888999999999999999999999999999997
Q ss_pred -CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCC
Q 000706 87 -GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGT 165 (1342)
Q Consensus 87 -GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGT 165 (1342)
|-|++.++...++.......|..+|+.|+.|||.+.|+|||||.-||||+.+..+||+|||.++..... .+.-.++||
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGT 274 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGT 274 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhh
Confidence 999999999999999999999999999999999999999999999999999999999999999887655 344568999
Q ss_pred CCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHhcccCCCC
Q 000706 166 PLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD--PVKYPDEMSPNFKSFLKGLLNKVPQN 243 (1342)
Q Consensus 166 p~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~--~~efP~eISpeLkDLIrKcLqkDPeK 243 (1342)
..|||||++++.+.+.|+||||||++||||+||..||..-+...++.-+-.+ ..+.|...+..++-||+.||+..|..
T Consensus 275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRN 354 (904)
T KOG4721|consen 275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRN 354 (904)
T ss_pred HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999999999999999876655444333333 34567889999999999999999999
Q ss_pred CCCHHHHHcC
Q 000706 244 RLTWSALLEH 253 (1342)
Q Consensus 244 RPSAeELLeH 253 (1342)
||++.+++.|
T Consensus 355 RPSFrqil~H 364 (904)
T KOG4721|consen 355 RPSFRQILLH 364 (904)
T ss_pred CccHHHHHHH
Confidence 9999999988
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=323.77 Aligned_cols=256 Identities=29% Similarity=0.556 Sum_probs=217.8
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyLV 81 (1342)
+++.+++..||.|+-|.||+++.+.+|...|||.+.+.+..++ .+++...++++... +.|+||+++++|..+..+++-
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee-~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE-NKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH-HHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 4556778899999999999999999999999999988866544 46777777776665 589999999999999999999
Q ss_pred EeccCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCcEEEcCCCcEEEeeccccccccCCceee
Q 000706 82 TEFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHS-NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159 (1342)
Q Consensus 82 MEY~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHs-rGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~ 159 (1342)
||.+..-...++++ .++++|..+-++...+++||.||.+ +||+|||+||+|||+|..|++||||||++..+-.....
T Consensus 170 MelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh- 248 (391)
T KOG0983|consen 170 MELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH- 248 (391)
T ss_pred HHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccc-
Confidence 99998655555544 4579999999999999999999976 59999999999999999999999999999877655433
Q ss_pred ecccCCCCcCChhhhcc---CCCCCCCcccchhhHHHHHHhCCCCCCC-CcHHHHHHHHhcCC-CCCCC--CCCHHHHHH
Q 000706 160 RSIKGTPLYMAPELVRE---QPYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKDP-VKYPD--EMSPNFKSF 232 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g---~~YT~KsDIWSLGVILYELLTGr~PF~g-~s~~elirkIlr~~-~efP~--eISpeLkDL 232 (1342)
+...|-+.|||||.+.. ..|+.++||||||++++||.||..||.+ ..+.+.+.++.... +.++. .+|+.+.+|
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~f 328 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSF 328 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHH
Confidence 34569999999998853 4599999999999999999999999987 45667777776653 33443 489999999
Q ss_pred HHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 233 LKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 233 IrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
+..||++|+.+||...++++|||++...
T Consensus 329 v~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 329 VKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHHhhcCcccCcchHHHhcCcceeecc
Confidence 9999999999999999999999997643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=366.79 Aligned_cols=251 Identities=30% Similarity=0.556 Sum_probs=205.6
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe---------
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFES--------- 74 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfed--------- 74 (1342)
.+|+.++.||+||||.||+++++-+|+.||||+|.-.. ......++.+|+..+.+++|||||++|..|.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 46788899999999999999999999999999997765 56667889999999999999999999722100
Q ss_pred --------------------------------------------------------------------------------
Q 000706 75 -------------------------------------------------------------------------------- 74 (1342)
Q Consensus 75 -------------------------------------------------------------------------------- 74 (1342)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------C--------CeEEEEEeccCCChHHHHhcCCCC--CHHHHHHHHHHHHHHHHHhhhCC
Q 000706 75 ----------------------P--------QEFCVVTEFAQGELFEILEDDKCL--PEEQVQSIAKQLVRALHYLHSNR 122 (1342)
Q Consensus 75 ----------------------e--------d~lyLVMEY~eGSL~D~Lek~g~L--SEeeI~~I~~QLLsALaYLHsrG 122 (1342)
+ ..+||-||||+.++++++.+.+.+ .....|++|+||++||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 136899999998777666554444 48899999999999999999999
Q ss_pred ceecCCCCCcEEEcCCCcEEEeecccccccc------------------CCceeeecccCCCCcCChhhhccCC---CCC
Q 000706 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMS------------------ANTVVLRSIKGTPLYMAPELVREQP---YNH 181 (1342)
Q Consensus 123 IVHRDLKPENILLdsdG~LKLiDFGLAr~l~------------------sss~~~~s~vGTp~YmAPEvL~g~~---YT~ 181 (1342)
|+||||||.|||+++++.|||+|||+|+... .+....++.+||..|+|||++.+.. |+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998721 1112345678999999999997655 999
Q ss_pred CCcccchhhHHHHHHhCCCCCCCC-cHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 182 TADLWSLGVILYELFVGQPPFYTN-SVYALIRHIVKDPVKYP----DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 182 KsDIWSLGVILYELLTGr~PF~g~-s~~elirkIlr~~~efP----~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
|+||||||+|+|||+. ||... +....+..+.++..+.+ ..--+.-..+|+.||+.||.+|||+.|+|++.||
T Consensus 798 KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ll 874 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELL 874 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCC
Confidence 9999999999999985 67654 33445555555544444 2234567789999999999999999999999999
Q ss_pred cc
Q 000706 257 KE 258 (1342)
Q Consensus 257 re 258 (1342)
..
T Consensus 875 pp 876 (1351)
T KOG1035|consen 875 PP 876 (1351)
T ss_pred Cc
Confidence 84
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=322.03 Aligned_cols=251 Identities=28% Similarity=0.441 Sum_probs=206.7
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-----C
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFES-----P 75 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfed-----e 75 (1342)
|+-++|++.+.||+|||+.||.+.+..+++.||+|++..+. .++.+..++|++..++++|||+++++++... .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 46789999999999999999999999999999999997764 4566889999999999999999999987633 3
Q ss_pred CeEEEEEeccC-CChHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCC--ceecCCCCCcEEEcCCCcEEEeeccc
Q 000706 76 QEFCVVTEFAQ-GELFEILED----DKCLPEEQVQSIAKQLVRALHYLHSNR--IIHRDMKPQNILIGAGSVVKLCDFGF 148 (1342)
Q Consensus 76 d~lyLVMEY~e-GSL~D~Lek----~g~LSEeeI~~I~~QLLsALaYLHsrG--IVHRDLKPENILLdsdG~LKLiDFGL 148 (1342)
...|++++|.. |+|.+.++. +..++|.++.+|+.++.+||++||+.. +.||||||.||++++++.++|.|||.
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence 45899999975 999998864 347999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCce---------eeecccCCCCcCChhhhc---cCCCCCCCcccchhhHHHHHHhCCCCCCCCcH--HHHHHHH
Q 000706 149 ARAMSANTV---------VLRSIKGTPLYMAPELVR---EQPYNHTADLWSLGVILYELFVGQPPFYTNSV--YALIRHI 214 (1342)
Q Consensus 149 Ar~l~sss~---------~~~s~vGTp~YmAPEvL~---g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~--~elirkI 214 (1342)
+....-... .......|..|+|||.+. +...+.++|||||||+||.|+.|..||...-. ....-.+
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv 255 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV 255 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee
Confidence 976532111 111234689999999875 44578999999999999999999999964211 0011112
Q ss_pred hcCCCCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 215 VKDPVKYPD--EMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 215 lr~~~efP~--eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
..+...+|. .+|..+.++|+.||+.||.+||++.+++.+
T Consensus 256 ~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 256 QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 233444443 489999999999999999999999999864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=328.67 Aligned_cols=262 Identities=29% Similarity=0.558 Sum_probs=235.6
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEF 78 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-e~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~l 78 (1342)
+++.+|++++.||+|+|+.|-.++.+.|.+.||+|+++|.-.+ .++++.++.|..+..+. +||.+|.++..|+++..+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 4688999999999999999999999999999999999887543 34567788898888887 799999999999999999
Q ss_pred EEEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce
Q 000706 79 CVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 79 yLVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~ 157 (1342)
++|.||++ |+|.-.+++.+.++|+.++.|-..|..||.|||++||++||||.+|+|++..|++||+|+|+++.--.+..
T Consensus 327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence 99999997 78888888888999999999999999999999999999999999999999999999999999987666666
Q ss_pred eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCC-------Cc-HHHHHHHHhcCCCCCCCCCCHHH
Q 000706 158 VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYT-------NS-VYALIRHIVKDPVKYPDEMSPNF 229 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g-------~s-~~elirkIlr~~~efP~eISpeL 229 (1342)
...+++|||.|+|||++++..|++.+|.|+||++++||+.|+.||+- .+ +.-+.+-|.......|..+|..+
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvka 486 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKA 486 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhh
Confidence 77889999999999999999999999999999999999999999952 22 33345556677888999999999
Q ss_pred HHHHHHhcccCCCCCCC------HHHHHcCcCcccchhh
Q 000706 230 KSFLKGLLNKVPQNRLT------WSALLEHPFVKETSDE 262 (1342)
Q Consensus 230 kDLIrKcLqkDPeKRPS------AeELLeHPFFre~~~e 262 (1342)
..++++.|++||.+|.. +.++..|+||+....+
T Consensus 487 s~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd 525 (593)
T KOG0695|consen 487 SHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD 525 (593)
T ss_pred HHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence 99999999999999964 7899999999976544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=349.10 Aligned_cols=242 Identities=32% Similarity=0.510 Sum_probs=211.7
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyLV 81 (1342)
.++|++...+|.|+|+.|..+.+..+++.+++|++.+.. .+..+|+.++... +||||+++++.+.++.+.|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 478999999999999999999999999999999997662 2344577666665 899999999999999999999
Q ss_pred EeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEE-cCCCcEEEeeccccccccCCceee
Q 000706 82 TEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILI-GAGSVVKLCDFGFARAMSANTVVL 159 (1342)
Q Consensus 82 MEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILL-dsdG~LKLiDFGLAr~l~sss~~~ 159 (1342)
||++. |.+.+.+...+.+. .++..|++||+.++.|||++|++||||||+|||+ ++.|+++|+|||.++..... .
T Consensus 395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~ 470 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---C 470 (612)
T ss_pred ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---h
Confidence 99997 56778777766555 8888999999999999999999999999999999 68999999999999887665 3
Q ss_pred ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHH-HHHHHHhcCCCCCCCCCCHHHHHHHHHhcc
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVY-ALIRHIVKDPVKYPDEMSPNFKSFLKGLLN 238 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~-elirkIlr~~~efP~eISpeLkDLIrKcLq 238 (1342)
.+.+-|..|.|||++...+|++++||||||++||+|++|+.||...... ++..++..++ +...+|.++++||++||+
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~--~s~~vS~~AKdLl~~LL~ 548 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK--FSECVSDEAKDLLQQLLQ 548 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc--cccccCHHHHHHHHHhcc
Confidence 3445688999999999999999999999999999999999999876544 5555554443 448899999999999999
Q ss_pred cCCCCCCCHHHHHcCcCc
Q 000706 239 KVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 239 kDPeKRPSAeELLeHPFF 256 (1342)
.||.+||++.+++.||||
T Consensus 549 ~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 549 VDPALRLGADEIGAHPWF 566 (612)
T ss_pred CChhhCcChhhhccCcch
Confidence 999999999999999999
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=342.16 Aligned_cols=260 Identities=28% Similarity=0.500 Sum_probs=219.9
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFC 79 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~-se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~ly 79 (1342)
|+-.-|..++.||-|+||+|.+++...|...||+|.++|... .......++.|-.||..-+++.||++|..|++++.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 344568999999999999999999988999999999977543 2334567888999999999999999999999999999
Q ss_pred EEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccc------
Q 000706 80 VVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM------ 152 (1342)
Q Consensus 80 LVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l------ 152 (1342)
+||||++ |++..+|.+.+-|+|+.++.|+.++.+|+++.|..|++||||||+|||||.+|++||+|||++.-+
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999997 799999999999999999999999999999999999999999999999999999999999999633
Q ss_pred ---cCCce---------------------------------eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHH
Q 000706 153 ---SANTV---------------------------------VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELF 196 (1342)
Q Consensus 153 ---~sss~---------------------------------~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELL 196 (1342)
..+.. .....+||+.|+|||++....|+..+|+||.|+|||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 11000 012246999999999999999999999999999999999
Q ss_pred hCCCCCCCCcHHHHHHHHhc--C--CCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHcCcCcccchh
Q 000706 197 VGQPPFYTNSVYALIRHIVK--D--PVKYPDEMSPNFKSFLKGLLNKVPQNRLT---WSALLEHPFVKETSD 261 (1342)
Q Consensus 197 TGr~PF~g~s~~elirkIlr--~--~~efP~eISpeLkDLIrKcLqkDPeKRPS---AeELLeHPFFre~~~ 261 (1342)
.|++||...+..+...++.. . .+.+..++++++.++|.++ ..++++|.. ++|+..||||+.+..
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred hCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHH-hcChhhhhcccchhhhhcCccccccch
Confidence 99999987665443333322 2 2334467999999999985 467888874 778999999998754
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=323.84 Aligned_cols=245 Identities=31% Similarity=0.468 Sum_probs=197.6
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-eEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ-EFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded-~lyLVM 82 (1342)
++|.-...||+|+||.||+|... +++.||||.+....... ..++.+|+.++.+++|||+|++++++.+.+ ..++|+
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY 151 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY 151 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence 56777889999999999999866 45899999876654332 345999999999999999999999999888 599999
Q ss_pred eccC-CChHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCC---ceecCCCCCcEEEcCCCcEEEeeccccccccC-C
Q 000706 83 EFAQ-GELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNR---IIHRDMKPQNILIGAGSVVKLCDFGFARAMSA-N 155 (1342)
Q Consensus 83 EY~e-GSL~D~Lek~g--~LSEeeI~~I~~QLLsALaYLHsrG---IVHRDLKPENILLdsdG~LKLiDFGLAr~l~s-s 155 (1342)
||++ |+|.+++.... ++++..+.+|+.++++||+|||+.. |+||||||+|||+|++.+.||+|||+|+.... .
T Consensus 152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~ 231 (361)
T KOG1187|consen 152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD 231 (361)
T ss_pred EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccc
Confidence 9997 99999997654 8999999999999999999999864 99999999999999999999999999976554 2
Q ss_pred ceeeecc-cCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCc------HHHHHHHHhcC-------CCCC
Q 000706 156 TVVLRSI-KGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS------VYALIRHIVKD-------PVKY 221 (1342)
Q Consensus 156 s~~~~s~-vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s------~~elirkIlr~-------~~ef 221 (1342)
... .+. .||..|++||....+..+.++||||||+++.|+++|+.|.+... ..+........ .+.+
T Consensus 232 ~~~-~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l 310 (361)
T KOG1187|consen 232 TSV-STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL 310 (361)
T ss_pred cce-eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence 222 222 79999999999988889999999999999999999998887432 12211111111 1111
Q ss_pred C-CCCC--H---HHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 222 P-DEMS--P---NFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 222 P-~eIS--p---eLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
. ..++ . .+..+...|++.+|++||++.|+.+
T Consensus 311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1 2333 2 2556778999999999999999743
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=329.60 Aligned_cols=255 Identities=31% Similarity=0.547 Sum_probs=212.9
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecC-----CCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEE-eCCe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKH-----GKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFE-SPQE 77 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs-----~~se~dierL~rEI~ILKrL~HPNIVKL~dvfe-ded~ 77 (1342)
++|-++..||+|+|+.||+|.|...++.||||+-... .+.+...+...+|.++++.++||.||++|++|. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 4677788999999999999999999999999976432 222334567888999999999999999999995 6778
Q ss_pred EEEEEeccCC-ChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC--CceecCCCCCcEEEc---CCCcEEEeecccccc
Q 000706 78 FCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN--RIIHRDMKPQNILIG---AGSVVKLCDFGFARA 151 (1342)
Q Consensus 78 lyLVMEY~eG-SL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsr--GIVHRDLKPENILLd---sdG~LKLiDFGLAr~ 151 (1342)
++-|+|||+| +|.-|++..+-++|.+++.|+.||+.||.||.+. .|+|-||||.|||+- .-|.+||+|||+++.
T Consensus 543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 9999999997 5777888899999999999999999999999976 699999999999994 357899999999998
Q ss_pred ccCCce-------eeecccCCCCcCChhhhcc----CCCCCCCcccchhhHHHHHHhCCCCCCCCcH-HHHHH--HHhcC
Q 000706 152 MSANTV-------VLRSIKGTPLYMAPELVRE----QPYNHTADLWSLGVILYELFVGQPPFYTNSV-YALIR--HIVKD 217 (1342)
Q Consensus 152 l~sss~-------~~~s~vGTp~YmAPEvL~g----~~YT~KsDIWSLGVILYELLTGr~PF~g~s~-~elir--kIlr~ 217 (1342)
++.... ......||.||++||.+.- ...+.++||||+|+|+|..+.|+.||..... .+++. .|.+.
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA 702 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA 702 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence 865432 2345789999999997642 3468899999999999999999999976543 22222 23332
Q ss_pred -CCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCccc
Q 000706 218 -PVKYP--DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258 (1342)
Q Consensus 218 -~~efP--~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre 258 (1342)
...|| +.+++++++||++||.+.-+.|..+.++..||||..
T Consensus 703 tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 703 TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 34555 568999999999999999999999999999999975
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=330.37 Aligned_cols=249 Identities=29% Similarity=0.491 Sum_probs=215.6
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCc---E-EEEEEeecC-CCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQ---T-VAMKFIMKH-GKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEF 78 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe---~-VAVKvIkKs-~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~l 78 (1342)
++-.+.++||+|+||.||+|..+..+. . ||+|..+.. .........+.+|.++|++++|||||++||+...+..+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344566999999999999998866433 3 899988753 35677788999999999999999999999999999999
Q ss_pred EEEEeccC-CChHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 79 CVVTEFAQ-GELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 79 yLVMEY~e-GSL~D~Lek~g-~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
++|||+|. |+|.+++++.+ .++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||+++.-....
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~ 316 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV 316 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence 99999997 79999999877 59999999999999999999999999999999999999999999999999987654111
Q ss_pred eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC--CCCCCCCCCHHHHHHH
Q 000706 157 VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD--PVKYPDEMSPNFKSFL 233 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~--~~efP~eISpeLkDLI 233 (1342)
.......-...|+|||.+...-|++++||||||+++||+++ |..||.+....+...+|... +...|...+.++..++
T Consensus 317 ~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~ 396 (474)
T KOG0194|consen 317 MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVM 396 (474)
T ss_pred eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHH
Confidence 11111234577999999999999999999999999999998 88999999999999998554 3456677888999999
Q ss_pred HHhcccCCCCCCCHHHHHc
Q 000706 234 KGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 234 rKcLqkDPeKRPSAeELLe 252 (1342)
.+|+..||++||++.++.+
T Consensus 397 ~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 397 KQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHhccCChhhccCHHHHHH
Confidence 9999999999999999865
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=320.46 Aligned_cols=257 Identities=30% Similarity=0.504 Sum_probs=212.2
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEE--------e
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFE--------S 74 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfe--------d 74 (1342)
+..|+-..+||+|.||.||+|+.+++|+.||+|++......+..-....+|++++..+.|+|++.+++.+. +
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 45677788999999999999999999999999876332222222244667999999999999999887653 3
Q ss_pred CCeEEEEEeccCCChHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 000706 75 PQEFCVVTEFAQGELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS 153 (1342)
Q Consensus 75 ed~lyLVMEY~eGSL~D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ 153 (1342)
...+|+||++|+.+|+..+.+. -+++..++..++.+++.||.|+|+..|+|||+||+|+|++.+|.+||+|||+++.+.
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 3458999999999999999875 589999999999999999999999999999999999999999999999999997764
Q ss_pred CCc----eeeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC----C----
Q 000706 154 ANT----VVLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV----K---- 220 (1342)
Q Consensus 154 sss----~~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~----e---- 220 (1342)
... ..++..+.|.||++||.+.+ ..|+++.|||..|||+.||+++.+-|.+.++..++..|..-.. +
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 322 22445677999999998765 5699999999999999999999999999888777766643110 0
Q ss_pred --------------CCC-------------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 221 --------------YPD-------------EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 221 --------------fP~-------------eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
.|+ .-.++..+|+.++|..||.+|+++.++++|.||...
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 111 013578899999999999999999999999999754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=331.65 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=177.5
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccC----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEE------
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYT----GQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDS------ 71 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~T----Ge~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dv------ 71 (1342)
..++|++.+.||+|+||.||+|.+..+ ++.||+|.+.+....+. ..+| .+.+..+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~----~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI----WMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH----HHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 468999999999999999999999988 99999998764332111 1111 1122222222222211
Q ss_pred EEeCCeEEEEEeccC-CChHHHHhcCCC--------------------CCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q 000706 72 FESPQEFCVVTEFAQ-GELFEILEDDKC--------------------LPEEQVQSIAKQLVRALHYLHSNRIIHRDMKP 130 (1342)
Q Consensus 72 feded~lyLVMEY~e-GSL~D~Lek~g~--------------------LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKP 130 (1342)
..++..+|+||||++ |+|.+++..... ..+..+..++.|++.||+|||++||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 245678999999997 689888864321 12345778999999999999999999999999
Q ss_pred CcEEEcC-CCcEEEeeccccccccCC-ceeeecccCCCCcCChhhhccC----------------------CCCCCCccc
Q 000706 131 QNILIGA-GSVVKLCDFGFARAMSAN-TVVLRSIKGTPLYMAPELVREQ----------------------PYNHTADLW 186 (1342)
Q Consensus 131 ENILLds-dG~LKLiDFGLAr~l~ss-s~~~~s~vGTp~YmAPEvL~g~----------------------~YT~KsDIW 186 (1342)
+|||++. ++.+||+|||+++.+... ........+++.|+|||++... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999986 579999999999865432 2223456799999999976432 244567999
Q ss_pred chhhHHHHHHhCCCCCCCCcHHHHHHHHhc-CCC-----------CC----------CCCCCHHHHHHHHHhcccCCCCC
Q 000706 187 SLGVILYELFVGQPPFYTNSVYALIRHIVK-DPV-----------KY----------PDEMSPNFKSFLKGLLNKVPQNR 244 (1342)
Q Consensus 187 SLGVILYELLTGr~PF~g~s~~elirkIlr-~~~-----------ef----------P~eISpeLkDLIrKcLqkDPeKR 244 (1342)
|+||++|||+++..|+... .....++.. ... .. .+.......+||.+||++||++|
T Consensus 364 SlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 9999999999977665432 111111111 000 01 11123345689999999999999
Q ss_pred CCHHHHHcCcCcccc
Q 000706 245 LTWSALLEHPFVKET 259 (1342)
Q Consensus 245 PSAeELLeHPFFre~ 259 (1342)
||+.|+++||||+..
T Consensus 442 ~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 442 ISAKAALAHPYFDRE 456 (566)
T ss_pred CCHHHHhCCcCcCCC
Confidence 999999999999864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=332.60 Aligned_cols=246 Identities=28% Similarity=0.536 Sum_probs=208.7
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
.++..+.+.||+|.||+||+|++- ..||||++.......+..+.+++|+.++++-+|.||+-+.+++..+.. .||+
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred HHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 356778999999999999999764 369999999888888889999999999999999999999999998888 9999
Q ss_pred eccCC-ChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccccccc--CCcee
Q 000706 83 EFAQG-ELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS--ANTVV 158 (1342)
Q Consensus 83 EY~eG-SL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~--sss~~ 158 (1342)
.+|+| +|+.++.. ...|...+.+.|++|+++|+.|||.++|+|||||..|||+.++++|||+|||++.... .....
T Consensus 467 qwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q 546 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQ 546 (678)
T ss_pred hhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccc
Confidence 99998 58888854 3468999999999999999999999999999999999999999999999999996533 12223
Q ss_pred eecccCCCCcCChhhhcc---CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-----CCCCCCCHHHH
Q 000706 159 LRSIKGTPLYMAPELVRE---QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV-----KYPDEMSPNFK 230 (1342)
Q Consensus 159 ~~s~vGTp~YmAPEvL~g---~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~-----efP~eISpeLk 230 (1342)
.....|...|||||+++. .+|++.+||||||+++|||++|..||......+.+-.+-++.. ....+.+.+++
T Consensus 547 ~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk 626 (678)
T KOG0193|consen 547 LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMK 626 (678)
T ss_pred cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHH
Confidence 334557888999998864 5699999999999999999999999996665555544444411 12235667999
Q ss_pred HHHHHhcccCCCCCCCHHHHHc
Q 000706 231 SFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 231 DLIrKcLqkDPeKRPSAeELLe 252 (1342)
+|+..||..++++||.+.+|+.
T Consensus 627 ~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 627 RLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHhcCcccCccHHHHHH
Confidence 9999999999999999999975
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=339.43 Aligned_cols=247 Identities=29% Similarity=0.531 Sum_probs=214.5
Q ss_pred CCEEEEEEEcccCcEEEEEEEEc-----cCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRK-----YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEF 78 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk-----~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~l 78 (1342)
.+-+..+.||+|+||+||+|+-. .+...||||.++.. ......+++++|++++..++|||||++++++.+++-.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 35677899999999999999653 23456999998655 3444678999999999999999999999999999999
Q ss_pred EEEEeccC-CChHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEE
Q 000706 79 CVVTEFAQ-GELFEILEDD--------------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKL 143 (1342)
Q Consensus 79 yLVMEY~e-GSL~D~Lek~--------------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKL 143 (1342)
|+|+|||. |||.++|+.. .+++..+...++.||+.|++||-++.+|||||-..|+||+++-.|||
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEe
Confidence 99999997 9999998632 23888999999999999999999999999999999999999999999
Q ss_pred eeccccccccCC-ceeee-cccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcCC-C
Q 000706 144 CDFGFARAMSAN-TVVLR-SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKDP-V 219 (1342)
Q Consensus 144 iDFGLAr~l~ss-s~~~~-s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~~-~ 219 (1342)
+|||+++..-.. ..... ...-..+|||||-+...+|+.++||||+||+|||+++ |+.||.+.+.++.++.|..+. .
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL 724 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLL 724 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcc
Confidence 999999864322 21111 2234677999999999999999999999999999997 999999999999999988775 4
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 000706 220 KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALL 251 (1342)
Q Consensus 220 efP~eISpeLkDLIrKcLqkDPeKRPSAeELL 251 (1342)
+-|+..|.++.+|+..||+.+|++||++.||-
T Consensus 725 ~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 725 SCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 66789999999999999999999999998884
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=319.81 Aligned_cols=251 Identities=29% Similarity=0.544 Sum_probs=210.8
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC--CC----CcceEEEEEEeCC
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK--HQ----NIIEMLDSFESPQ 76 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~--HP----NIVKL~dvfeded 76 (1342)
-.+|++++.+|+|+||.|-.+.+..++..+|+|+++.- ....+...-|+++++++. .| -++++.++|+..+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 36899999999999999999999999999999998543 344566777999999993 23 3788889999999
Q ss_pred eEEEEEeccCCChHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcC-----------------
Q 000706 77 EFCVVTEFAQGELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA----------------- 137 (1342)
Q Consensus 77 ~lyLVMEY~eGSL~D~Lek~g--~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLds----------------- 137 (1342)
+.+||+|.++-++++++.+++ +++-..++.+.+||+++++|||+.+++|-||||||||+.+
T Consensus 165 hiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 165 HICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred ceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceec
Confidence 999999999999999998865 6899999999999999999999999999999999999832
Q ss_pred ---CCcEEEeeccccccccCCceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHH---HH
Q 000706 138 ---GSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYA---LI 211 (1342)
Q Consensus 138 ---dG~LKLiDFGLAr~l~sss~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~e---li 211 (1342)
+..+|++|||.|+...... .+.+.|..|+|||++.+-+++.++||||+||||+|+.+|...|++.+..+ ++
T Consensus 245 ~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMM 321 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMM 321 (415)
T ss_pred cCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHH
Confidence 2358999999998755443 45678999999999999999999999999999999999999998766333 55
Q ss_pred HHHhcCC------------------CCCCCC-------------------------CCHHHHHHHHHhcccCCCCCCCHH
Q 000706 212 RHIVKDP------------------VKYPDE-------------------------MSPNFKSFLKGLLNKVPQNRLTWS 248 (1342)
Q Consensus 212 rkIlr~~------------------~efP~e-------------------------ISpeLkDLIrKcLqkDPeKRPSAe 248 (1342)
++|.... ..+++. -..++.||+++||..||.+|+|+.
T Consensus 322 erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~ 401 (415)
T KOG0671|consen 322 ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLR 401 (415)
T ss_pred HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHH
Confidence 5554311 111110 113588999999999999999999
Q ss_pred HHHcCcCcccc
Q 000706 249 ALLEHPFVKET 259 (1342)
Q Consensus 249 ELLeHPFFre~ 259 (1342)
|+|.||||...
T Consensus 402 EAL~HpFF~~~ 412 (415)
T KOG0671|consen 402 EALSHPFFARL 412 (415)
T ss_pred HHhcCHHhhcC
Confidence 99999999864
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=339.86 Aligned_cols=248 Identities=23% Similarity=0.496 Sum_probs=214.4
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCc-----EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQ-----TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEF 78 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe-----~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~l 78 (1342)
+.-+..+.||+|+||.||.|....... .||+|.+++.. +..+...+.+|..+|+.++|||||+++++.-+...+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 456788999999999999997754333 38999887653 455668899999999999999999999999999999
Q ss_pred EEEEeccC-CChHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 000706 79 CVVTEFAQ-GELFEILEDD-------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFAR 150 (1342)
Q Consensus 79 yLVMEY~e-GSL~D~Lek~-------g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr 150 (1342)
+|++|||+ |+|..+|++. ..++......++.|+++|++||+++++|||||-..|+|++....+||+|||+|+
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhH
Confidence 99999997 8999999875 358899999999999999999999999999999999999999999999999999
Q ss_pred cccCC-ceeeecc-cCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHH-HhcCCCCCCCCCC
Q 000706 151 AMSAN-TVVLRSI-KGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRH-IVKDPVKYPDEMS 226 (1342)
Q Consensus 151 ~l~ss-s~~~~s~-vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirk-Ilr~~~efP~eIS 226 (1342)
.+-.. ....... .-...|||||.+..+.++.++||||||+++||+++ |..||...+..+.... ...++.+.|...+
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP 930 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCP 930 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCC
Confidence 44322 2222222 22356999999999999999999999999999998 9999999888887774 4456788889999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 227 PNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 227 peLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
..+.+++..||+.+|++||++..+++
T Consensus 931 ~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 931 EKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred hHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999999999999999999999987
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=331.04 Aligned_cols=254 Identities=32% Similarity=0.594 Sum_probs=223.0
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEE-----eCCe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFE-----SPQE 77 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfe-----ded~ 77 (1342)
+-|++.+.||.|.+|.||+++++++++..|+|+....... .+.+..|.++++.. +|||++.+|++|. .++.
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 5689999999999999999999999999999998655332 24567788999887 7999999999984 4678
Q ss_pred EEEEEeccC-CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccC
Q 000706 78 FCVVTEFAQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA 154 (1342)
Q Consensus 78 lyLVMEY~e-GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~s 154 (1342)
+|+|||||+ |+.-|+++. +.++.|+.+..|++.++.|+.+||++.++|||+|-.|||++.+|.+||+|||.+..+..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 999999997 788887764 56899999999999999999999999999999999999999999999999999999888
Q ss_pred CceeeecccCCCCcCChhhhcc-----CCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC---CCCCCC
Q 000706 155 NTVVLRSIKGTPLYMAPELVRE-----QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVK---YPDEMS 226 (1342)
Q Consensus 155 ss~~~~s~vGTp~YmAPEvL~g-----~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~e---fP~eIS 226 (1342)
......+..|||.|||||++.. ..|+..+|+||||++..||..|.+|+...-....+-.|-+.|++ .|..++
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs 255 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWS 255 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHH
Confidence 7777788999999999998854 34788899999999999999999999877766666666555432 356789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 227 PNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 227 peLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
.++.+||..||.+|..+||+..++++|||+.+..
T Consensus 256 ~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 256 KKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred HHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 9999999999999999999999999999998654
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=329.07 Aligned_cols=240 Identities=38% Similarity=0.632 Sum_probs=196.9
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------eE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ------EF 78 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded------~l 78 (1342)
-|...+.||+|+||.||+++++.+|+.||||.+++... ....+..-+|+++|++++|||||+++++-++.. ..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcc-cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 46778899999999999999999999999999987642 334567788999999999999999999876544 56
Q ss_pred EEEEeccC-CChHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEE--cCCC--cEEEeeccccc
Q 000706 79 CVVTEFAQ-GELFEILED---DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILI--GAGS--VVKLCDFGFAR 150 (1342)
Q Consensus 79 yLVMEY~e-GSL~D~Lek---~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILL--dsdG--~LKLiDFGLAr 150 (1342)
.+|||||. |+|+..+++ ...++|.+++.++.++..||.|||++||+||||||+||++ ..+| ..||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 89999997 799999975 3579999999999999999999999999999999999998 3445 47999999999
Q ss_pred cccCCceeeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCCCCc----HHHHHHHHh-c--------
Q 000706 151 AMSANTVVLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNS----VYALIRHIV-K-------- 216 (1342)
Q Consensus 151 ~l~sss~~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~g~s----~~elirkIl-r-------- 216 (1342)
.++.+. ...+.+||+.|.+||++.. +.|+..+|.|||||++|+..||..||.... ..+....+. +
T Consensus 173 el~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 173 ELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred cCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 998776 6788999999999999984 789999999999999999999999995321 222222222 1
Q ss_pred ------CC------CCCCCCCCHH----HHHHHHHhcccCCCCCCC
Q 000706 217 ------DP------VKYPDEMSPN----FKSFLKGLLNKVPQNRLT 246 (1342)
Q Consensus 217 ------~~------~efP~eISpe----LkDLIrKcLqkDPeKRPS 246 (1342)
++ .++|...++. +...+..+|+.+|++|-.
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH 297 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence 12 2223334433 445678899999999984
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=309.00 Aligned_cols=250 Identities=27% Similarity=0.491 Sum_probs=216.1
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC------Ce
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP------QE 77 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfede------d~ 77 (1342)
.+|..++.+|.|+. .|..|.|.-++++|++|............++..+|..++..++|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 47999999999999 888899999999999999876655555567889999999999999999999999533 45
Q ss_pred EEEEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce
Q 000706 78 FCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 78 lyLVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~ 157 (1342)
.|+||||+.++|.+.+. ..++-+.+..+++|+++|++|||+.||+||||||+||++..++.+|+.|||+++..+.. .
T Consensus 96 ~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-~ 172 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-F 172 (369)
T ss_pred HHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc-c
Confidence 79999999999999887 44788999999999999999999999999999999999999999999999999887665 5
Q ss_pred eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC--------------------
Q 000706 158 VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-------------------- 217 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~-------------------- 217 (1342)
..+.++.|..|+|||++.+..|...+||||+||++.||++|+..|.+.+..++..++...
T Consensus 173 ~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv 252 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYV 252 (369)
T ss_pred ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHh
Confidence 667788999999999999988999999999999999999999999987766655544320
Q ss_pred --C-----CC----CCC-----------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcc
Q 000706 218 --P-----VK----YPD-----------EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVK 257 (1342)
Q Consensus 218 --~-----~e----fP~-----------eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFr 257 (1342)
. .. +|+ .-...+++++.+||..||++|.+++++|+|||++
T Consensus 253 ~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 253 ENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0 00 111 1124588999999999999999999999999997
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-33 Score=296.61 Aligned_cols=251 Identities=27% Similarity=0.508 Sum_probs=208.6
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEeC--CeE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-HQNIIEMLDSFESP--QEF 78 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~-HPNIVKL~dvfede--d~l 78 (1342)
+.++|++.+++|+|.|+.||.|.+..++++++||++++-. .+.+.+|+.+++.+. ||||+++++...++ ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 3689999999999999999999999999999999986542 367899999999995 99999999999765 467
Q ss_pred EEEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCC-CcEEEeeccccccccCCce
Q 000706 79 CVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAG-SVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 79 yLVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsd-G~LKLiDFGLAr~l~sss~ 157 (1342)
.+++||++.+-+..+.. .++...++.++.|++.||.|+|++||+|||+||.|+|++.. .+++|+|||+|.++.++.
T Consensus 111 aLiFE~v~n~Dfk~ly~--tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~- 187 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP--TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 187 (338)
T ss_pred hhHhhhhccccHHHHhh--hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc-
Confidence 89999998655554433 37888999999999999999999999999999999999865 479999999999988764
Q ss_pred eeecccCCCCcCChhhhcc-CCCCCCCcccchhhHHHHHHhCCCCCC-CCcHHHHHHHHhcC-----------------C
Q 000706 158 VLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFY-TNSVYALIRHIVKD-----------------P 218 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g-~~YT~KsDIWSLGVILYELLTGr~PF~-g~s~~elirkIlr~-----------------~ 218 (1342)
.++-.+.+.+|..||.+.. +.|+..-|+|||||++..|+..+-||+ +.+..+++-+|.+- +
T Consensus 188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld 267 (338)
T KOG0668|consen 188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD 267 (338)
T ss_pred eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence 4456678899999998754 569999999999999999999999985 44444444433210 0
Q ss_pred CC---------------C-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 219 VK---------------Y-----PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 219 ~e---------------f-----P~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
+. | ..-+++++.||+.++|..|-++|+|+.|.+.||||....
T Consensus 268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 00 0 012579999999999999999999999999999998653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=312.30 Aligned_cols=257 Identities=23% Similarity=0.317 Sum_probs=187.1
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEc----------------cCCcEEEEEEeecCCCCHH------------HHHHHHHH
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRK----------------YTGQTVAMKFIMKHGKSEK------------DIHNLRQE 53 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk----------------~TGe~VAVKvIkKs~~se~------------dierL~rE 53 (1342)
..++|++.++||+|+||+||+|... ..++.||||.+........ ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4579999999999999999999652 3456799999864321110 01123346
Q ss_pred HHHHHhcCCCCc-----ceEEEEEEe--------CCeEEEEEeccC-CChHHHHhcC-----------------------
Q 000706 54 IEILRKLKHQNI-----IEMLDSFES--------PQEFCVVTEFAQ-GELFEILEDD----------------------- 96 (1342)
Q Consensus 54 I~ILKrL~HPNI-----VKL~dvfed--------ed~lyLVMEY~e-GSL~D~Lek~----------------------- 96 (1342)
+.++.+++|.++ +++++++.. ++..|+||||++ |+|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766543 666666642 456899999997 7888877531
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCcee-eecccCCCCcCChhhh
Q 000706 97 -KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV-LRSIKGTPLYMAPELV 174 (1342)
Q Consensus 97 -g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~-~~s~vGTp~YmAPEvL 174 (1342)
..+++..++.++.|++.+|.|||++||+||||||+|||++.++.+||+|||++......... .....+|+.|+|||++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 12356778999999999999999999999999999999999999999999999765432211 1122358999999987
Q ss_pred ccCC--------------------CC--CCCcccchhhHHHHHHhCCC-CCCCCcH-----------HHHHHHHhcCCCC
Q 000706 175 REQP--------------------YN--HTADLWSLGVILYELFVGQP-PFYTNSV-----------YALIRHIVKDPVK 220 (1342)
Q Consensus 175 ~g~~--------------------YT--~KsDIWSLGVILYELLTGr~-PF~g~s~-----------~elirkIlr~~~e 220 (1342)
.... |+ .+.|+||+||++|+|++|.. ||..... ....+.+......
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 5322 22 24799999999999999876 7753211 1111122222333
Q ss_pred C--CCCCCHHHHHHHHHhcccCC---CCCCCHHHHHcCcCccc
Q 000706 221 Y--PDEMSPNFKSFLKGLLNKVP---QNRLTWSALLEHPFVKE 258 (1342)
Q Consensus 221 f--P~eISpeLkDLIrKcLqkDP---eKRPSAeELLeHPFFre 258 (1342)
+ .+..++..++|+.+||..+| .+|+|++|+|+||||..
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 3 35678999999999999876 68999999999999964
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=333.81 Aligned_cols=235 Identities=21% Similarity=0.333 Sum_probs=187.2
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
.|+..+.||+|+||.||+|++..+++.||+|.++..... ...|++.+++++||||+++++++.+++..|+||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 456678899999999999999999999999988644221 13468899999999999999999999999999999
Q ss_pred cC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 85 AQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLH---SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 85 ~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLH---srGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
++ |+|.+++++ +++..+..++.|+++||+||| +.+|+||||||+||+++.++..++. ||........ .
T Consensus 765 ~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~ 836 (968)
T PLN00113 765 IEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----T 836 (968)
T ss_pred CCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----C
Confidence 97 789999863 889999999999999999999 6799999999999999998887775 6655433221 2
Q ss_pred cccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCc-----HHHHHHHHhc---------CCC----CCC
Q 000706 161 SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS-----VYALIRHIVK---------DPV----KYP 222 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s-----~~elirkIlr---------~~~----efP 222 (1342)
...||+.|+|||++.+..|+.++||||||+++|||++|+.||+... ..+..+.... ... ..+
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence 3368999999999999999999999999999999999999985421 1111111111 000 011
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 223 DEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 223 ~eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
.....++.+++.+|++.||++|||+.|+++.
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 1112356789999999999999999999763
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-33 Score=303.08 Aligned_cols=255 Identities=29% Similarity=0.463 Sum_probs=213.1
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyLVM 82 (1342)
++.+-+..||.|+||+|++..++.+|+..|||.|+-.. .+.+.+++..|.+...+- +.||||++|+....++..||-|
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n-~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN-IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc-chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 34455678999999999999999999999999997553 355567788888766555 7899999999999999999999
Q ss_pred eccCCChHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 83 EFAQGELFEIL-----EDDKCLPEEQVQSIAKQLVRALHYLHS-NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 83 EY~eGSL~D~L-----ek~g~LSEeeI~~I~~QLLsALaYLHs-rGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
|.|+-++..+. .+...++|+.+-.+....+.||.||.+ ..|+|||+||+|||++..|.+||||||.+..+..+.
T Consensus 143 ELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 143 ELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred HHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 99997654432 245679999999999999999999975 489999999999999999999999999997765443
Q ss_pred eeeecccCCCCcCChhhhcc--CCCCCCCcccchhhHHHHHHhCCCCCCCC-cHHHHHHHHhcCCCC---CCC---CCCH
Q 000706 157 VVLRSIKGTPLYMAPELVRE--QPYNHTADLWSLGVILYELFVGQPPFYTN-SVYALIRHIVKDPVK---YPD---EMSP 227 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g--~~YT~KsDIWSLGVILYELLTGr~PF~g~-s~~elirkIlr~~~e---fP~---eISp 227 (1342)
. .+...|-..|||||.+.. ..|+-++|+||||++|||+.||+.|+.+. +..+++..+..+.++ ++. +++.
T Consensus 223 A-kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~ 301 (361)
T KOG1006|consen 223 A-KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF 301 (361)
T ss_pred H-hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence 2 234568999999998853 45999999999999999999999999875 456777777665443 222 4789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 228 NFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 228 eLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
.+..||.-||.+|-..||...+++++||++...
T Consensus 302 ~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 302 SMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred HHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 999999999999999999999999999998643
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=310.54 Aligned_cols=243 Identities=31% Similarity=0.524 Sum_probs=208.1
Q ss_pred EEEEEcccCcEEEEEEEEcc--CCc--EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 8 VIELVGEGSFGKVYKGRRKY--TGQ--TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 8 IlK~LGsGgFGtVYKArDk~--TGe--~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
..+.||.|.||.||+|.... .|+ .||||..+.+... ++.+.+..|..+|++++||||+++++++.+. ..|||||
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE 470 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME 470 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence 34679999999999997642 233 4788988765444 3467899999999999999999999999654 5799999
Q ss_pred ccC-CChHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 84 FAQ-GELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~g-~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
.++ |+|..+++.++ .++......|.+||..+|.|||+..+|||||-..||||.+...+||+|||+++.+..+.....+
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS 550 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS 550 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhcc
Confidence 998 99999998755 6999999999999999999999999999999999999999999999999999998776543332
Q ss_pred c-cCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhcc
Q 000706 162 I-KGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLN 238 (1342)
Q Consensus 162 ~-vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrKcLq 238 (1342)
. .-..-|||||-+.-..++.++|||-||+.+||++. |..||.+-...+.+.++.++ +.+.|+..|+.+..++.+||.
T Consensus 551 ~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWa 630 (974)
T KOG4257|consen 551 RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWA 630 (974)
T ss_pred ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhc
Confidence 1 12344999999998899999999999999999886 99999998777777666654 678899999999999999999
Q ss_pred cCCCCCCCHHHHHc
Q 000706 239 KVPQNRLTWSALLE 252 (1342)
Q Consensus 239 kDPeKRPSAeELLe 252 (1342)
+||.+||.+.++..
T Consensus 631 yeP~kRPrftei~~ 644 (974)
T KOG4257|consen 631 YEPSKRPRFTEIKA 644 (974)
T ss_pred cCcccCCcHHHHHH
Confidence 99999999988854
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=309.73 Aligned_cols=254 Identities=29% Similarity=0.501 Sum_probs=219.9
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccC-Cc--EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYT-GQ--TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEF 78 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~T-Ge--~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~l 78 (1342)
..++.++.++||+|.||.|++|.++.. |+ .||||.++...... ....+.+|+.+|.+++|||++++|++..+ ...
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 345566788999999999999988653 33 37999987654433 56889999999999999999999999988 778
Q ss_pred EEEEeccC-CChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCC
Q 000706 79 CVVTEFAQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN 155 (1342)
Q Consensus 79 yLVMEY~e-GSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ss 155 (1342)
.+|||+++ |+|.+.+.+ ...|.......|+.||+.|+.||..+++|||||-..|+++-....+||+|||+.+.++.+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 89999998 899999987 446888999999999999999999999999999999999999999999999999998876
Q ss_pred ceeeec---ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHH
Q 000706 156 TVVLRS---IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFK 230 (1342)
Q Consensus 156 s~~~~s---~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLk 230 (1342)
...+.. ..-...|+|||.++...++.++|+|++|+++|||++ |+.||.+-...+++++|-.+ +.+.|+..+.++.
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY 345 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY 345 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence 654421 233456999999999999999999999999999998 89999999999988888643 5677888999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCcCcc
Q 000706 231 SFLKGLLNKVPQNRLTWSALLEHPFVK 257 (1342)
Q Consensus 231 DLIrKcLqkDPeKRPSAeELLeHPFFr 257 (1342)
+++..||..+|++|||+..|.+.-+..
T Consensus 346 ~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 346 QIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHhccCCccccccHHHHHHhHHHH
Confidence 999999999999999999997654443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=249.42 Aligned_cols=211 Identities=44% Similarity=0.793 Sum_probs=188.5
Q ss_pred EcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEeccC-CChH
Q 000706 12 VGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GELF 90 (1342)
Q Consensus 12 LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~e-GSL~ 90 (1342)
||+|.+|.||++.+..+++.+++|.+....... ..+.+.+|++.++.++|++++++++++......+++|||++ ++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999998889999999987654322 34678999999999999999999999999999999999998 7899
Q ss_pred HHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcC-CCcEEEeeccccccccCCceeeecccCCCCc
Q 000706 91 EILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA-GSVVKLCDFGFARAMSANTVVLRSIKGTPLY 168 (1342)
Q Consensus 91 D~Lek~-g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLds-dG~LKLiDFGLAr~l~sss~~~~s~vGTp~Y 168 (1342)
+++... ..+++..++.++.+++++++|||++|++|+||+|.||+++. ++.++|+|||.+..............+...|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY 159 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence 988765 57999999999999999999999999999999999999999 8999999999998766543223345688899
Q ss_pred CChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 000706 169 MAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTW 247 (1342)
Q Consensus 169 mAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRPSA 247 (1342)
++||.+... .++.+.|+|++|+++|+| ..+.+++.+|++.||.+||++
T Consensus 160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R~~~ 208 (215)
T cd00180 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPSA 208 (215)
T ss_pred cChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccCcCH
Confidence 999998877 788999999999999999 678999999999999999999
Q ss_pred HHHHcCc
Q 000706 248 SALLEHP 254 (1342)
Q Consensus 248 eELLeHP 254 (1342)
.++++|+
T Consensus 209 ~~l~~~~ 215 (215)
T cd00180 209 KEILEHL 215 (215)
T ss_pred HHHhhCC
Confidence 9999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=308.03 Aligned_cols=250 Identities=32% Similarity=0.544 Sum_probs=213.2
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCC------CCcceEEEEEEeCCe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH------QNIIEMLDSFESPQE 77 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~H------PNIVKL~dvfeded~ 77 (1342)
.+|.+....|.|-|++|.+|.+..-|..||||+|.... -..+.=..|+++|++|+. -|+++++..|...++
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 57999999999999999999999999999999997553 223455679999999952 489999999999999
Q ss_pred EEEEEeccCCChHHHHhcCC---CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC-cEEEeecccccccc
Q 000706 78 FCVVTEFAQGELFEILEDDK---CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS-VVKLCDFGFARAMS 153 (1342)
Q Consensus 78 lyLVMEY~eGSL~D~Lek~g---~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG-~LKLiDFGLAr~l~ 153 (1342)
+|+|+|-+.-+|.+++++.+ .+....++.|..|++-||..|...||+|.||||+||||++.. .+||||||.|....
T Consensus 509 LClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ 588 (752)
T KOG0670|consen 509 LCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFAS 588 (752)
T ss_pred eEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccc
Confidence 99999999999999998754 588899999999999999999999999999999999998765 68999999998876
Q ss_pred CCceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCC----------
Q 000706 154 ANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPD---------- 223 (1342)
Q Consensus 154 sss~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~---------- 223 (1342)
.+.. +.+..+..|+|||++.|.+|+...|+||.||+||||.||+..|.+.+..++++-......+||.
T Consensus 589 enei--tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~d 666 (752)
T KOG0670|consen 589 ENEI--TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKD 666 (752)
T ss_pred cccc--cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhh
Confidence 6543 3455678899999999999999999999999999999999999998776666544322211110
Q ss_pred -------------------------------------------CCC-------HHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 224 -------------------------------------------EMS-------PNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 224 -------------------------------------------eIS-------peLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
.++ ..+++|+.+||..||++|.|+.|+|.|
T Consensus 667 qHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 667 QHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred hhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 011 358899999999999999999999999
Q ss_pred cCccc
Q 000706 254 PFVKE 258 (1342)
Q Consensus 254 PFFre 258 (1342)
|||.+
T Consensus 747 pFi~~ 751 (752)
T KOG0670|consen 747 PFITE 751 (752)
T ss_pred CcccC
Confidence 99974
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=315.14 Aligned_cols=251 Identities=24% Similarity=0.471 Sum_probs=224.3
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCc---EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQ---TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEF 78 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe---~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~l 78 (1342)
+...-+|.+.||.|.||.||+|+.+..|+ .||||.++ .+..++...++..|..||-+++||||+++.++.....-+
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK-~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLK-AGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeec-cCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 44567899999999999999999987775 48999884 567788888999999999999999999999999999999
Q ss_pred EEEEeccC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 79 CVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 79 yLVMEY~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
.|+.|||+ |.|..+|++ ++.|+..+..-+++.|+.|++||-++|+|||||-..||||+.+-.+|++|||+++.+..+.
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 99999997 999999975 5789999999999999999999999999999999999999999999999999999886654
Q ss_pred e-eeeccc--CCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHH
Q 000706 157 V-VLRSIK--GTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKS 231 (1342)
Q Consensus 157 ~-~~~s~v--GTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkD 231 (1342)
. .+++.- -..+|.|||.+...+++.++|+||+|+++||.+. |.-||+..+.++.++.|.++ +.+.|.+.|..+.+
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~q 865 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQ 865 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHH
Confidence 2 222222 2357999999999999999999999999999764 99999999999999999887 56677789999999
Q ss_pred HHHHhcccCCCCCCCHHHHHcC
Q 000706 232 FLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 232 LIrKcLqkDPeKRPSAeELLeH 253 (1342)
|+..||++|-.+||.+.||..+
T Consensus 866 LMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 866 LMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHhhcCCCHHHHHHH
Confidence 9999999999999999999764
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=301.44 Aligned_cols=245 Identities=25% Similarity=0.510 Sum_probs=215.1
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
+..+..+||-|.||.||.+.+++-.-.||||.++.+. ...+.+..|..+|+.+.|||+|++++++..+..+||++||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 4556788999999999999999988999999987553 4567899999999999999999999999999999999999
Q ss_pred cC-CChHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeec
Q 000706 85 AQ-GELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 85 ~e-GSL~D~Lek~g--~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s 161 (1342)
|. |+|++|+++.. .++.-....++.||.+|++||..++++||||-..|.||.++..+|++|||+++.+..++.+...
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence 85 99999998743 4677778899999999999999999999999999999999999999999999998876544332
Q ss_pred -ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHhcc
Q 000706 162 -IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLN 238 (1342)
Q Consensus 162 -~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrKcLq 238 (1342)
..-..-|.|||-+....++.++|||+||++|||+.| |-.||.+-+..+.+.-+.++ +.+-|+.+++...+|++.||+
T Consensus 425 GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~ 504 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWN 504 (1157)
T ss_pred CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhc
Confidence 122445999999999999999999999999999997 89999998887777766555 456788999999999999999
Q ss_pred cCCCCCCCHHHHHc
Q 000706 239 KVPQNRLTWSALLE 252 (1342)
Q Consensus 239 kDPeKRPSAeELLe 252 (1342)
++|..||++.|+-+
T Consensus 505 WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 505 WSPSDRPSFAEIHQ 518 (1157)
T ss_pred CCcccCccHHHHHH
Confidence 99999999998843
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=318.12 Aligned_cols=248 Identities=29% Similarity=0.465 Sum_probs=202.9
Q ss_pred EEEcccCcEE-EEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEeccCC
Q 000706 10 ELVGEGSFGK-VYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCVVTEFAQG 87 (1342)
Q Consensus 10 K~LGsGgFGt-VYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyLVMEY~eG 87 (1342)
+.+|.|.-|+ ||+|. ..|+.||||.+.. +.....++|++.|+.- +|||||++|..-.+....||..|.|..
T Consensus 515 eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGV--YEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred HHcccCCCCcEEEEEe--eCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 4678998885 89995 5689999998743 3346788999999988 699999999999999999999999999
Q ss_pred ChHHHHhcCCC----CCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcC---CC--cEEEeeccccccccCCcee
Q 000706 88 ELFEILEDDKC----LPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA---GS--VVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 88 SL~D~Lek~g~----LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLds---dG--~LKLiDFGLAr~l~sss~~ 158 (1342)
+|.++++..+. ......+..+.|+++||++||+.+|+||||||+||||+. ++ +++|+|||+++.+..+...
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 99999987421 111446889999999999999999999999999999976 34 6899999999998766543
Q ss_pred ---eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhC-CCCCCCCcHHHHHHHHhcCCCCC---CCCCCHHHHH
Q 000706 159 ---LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVG-QPPFYTNSVYALIRHIVKDPVKY---PDEMSPNFKS 231 (1342)
Q Consensus 159 ---~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTG-r~PF~g~s~~elirkIlr~~~ef---P~eISpeLkD 231 (1342)
..+..||.+|+|||++....-+.++||||+||++|+.++| .+||...-..+ .+|..+.... .+....++++
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~d~eA~d 745 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLPDCEAKD 745 (903)
T ss_pred hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCchHHHHH
Confidence 3356799999999999998888999999999999999986 99997653322 2444443322 2222228999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCcCcccchhhhhHH
Q 000706 232 FLKGLLNKVPQNRLTWSALLEHPFVKETSDELNAW 266 (1342)
Q Consensus 232 LIrKcLqkDPeKRPSAeELLeHPFFre~~~eLsa~ 266 (1342)
||.+|+++||..||++.++|.||||.+..+.+.-+
T Consensus 746 LI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl 780 (903)
T KOG1027|consen 746 LISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFL 780 (903)
T ss_pred HHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHH
Confidence 99999999999999999999999999877665543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=295.12 Aligned_cols=253 Identities=28% Similarity=0.533 Sum_probs=212.7
Q ss_pred EEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-----eEEEE
Q 000706 7 HVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ-----EFCVV 81 (1342)
Q Consensus 7 rIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded-----~lyLV 81 (1342)
+-.+.||.|+||.||.+.|..+|+++++|++......-...+++.+|++++..++|.|++...|..+-.. .+|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 4467899999999999999999999999988654444455678999999999999999999998876543 46889
Q ss_pred EeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc-eeee
Q 000706 82 TEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT-VVLR 160 (1342)
Q Consensus 82 MEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss-~~~~ 160 (1342)
+|.+..+|.+.|-....++.+.++.+++||++||+|||+.||.||||||.|.||++|..+||||||+++..+.+. ...+
T Consensus 136 TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMT 215 (449)
T KOG0664|consen 136 TELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMT 215 (449)
T ss_pred HHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhH
Confidence 999999999999999999999999999999999999999999999999999999999999999999999876543 3345
Q ss_pred cccCCCCcCChhhhccC-CCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHh-----------------------c
Q 000706 161 SIKGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIV-----------------------K 216 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g~-~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIl-----------------------r 216 (1342)
..+.|.+|+|||++.+. .|+.++||||.|||+.|++-.+..|...+..++++-|. +
T Consensus 216 qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR 295 (449)
T KOG0664|consen 216 HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLR 295 (449)
T ss_pred HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhc
Confidence 56789999999998775 49999999999999999999999998766555444332 2
Q ss_pred CCCCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccc
Q 000706 217 DPVKYP-----------DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 217 ~~~efP-----------~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
...+-| .+-..+..++..++|..||++|.+.++.+.|+|..+.
T Consensus 296 ~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 296 AGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred cCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 221111 1223567889999999999999999999999998654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=310.44 Aligned_cols=254 Identities=35% Similarity=0.596 Sum_probs=223.2
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
++|+.+..+|.|+||.||+++|+.+++..|+|+++... .++..-++.|+-+++.++||||+.+++.|-..+..|+.||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 68999999999999999999999999999999997653 3455778889999999999999999999999999999999
Q ss_pred ccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecc
Q 000706 84 FAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~ 162 (1342)
||+ |+|.+.-.-.++++|.++....+..+++|+|||++|-+|||||-.||++++.|.+|++|||.+..+...-.....+
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krksf 172 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSF 172 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcc
Confidence 998 5677766668899999999999999999999999999999999999999999999999999998887766666788
Q ss_pred cCCCCcCChhhh---ccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-----CCCCCCHHHHHHHH
Q 000706 163 KGTPLYMAPELV---REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVK-----YPDEMSPNFKSFLK 234 (1342)
Q Consensus 163 vGTp~YmAPEvL---~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~e-----fP~eISpeLkDLIr 234 (1342)
.|||+|||||+- +.+.|...+|||++|++..|+-.-++|.+..-......-..+..+. -+..+++.+-+|++
T Consensus 173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK 252 (829)
T KOG0576|consen 173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVK 252 (829)
T ss_pred cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHH
Confidence 999999999964 5677999999999999999999888887765555444444443322 23467899999999
Q ss_pred HhcccCCCCCCCHHHHHcCcCcccc
Q 000706 235 GLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 235 KcLqkDPeKRPSAeELLeHPFFre~ 259 (1342)
.+|.++|++||+++.+|.|||+...
T Consensus 253 ~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 253 GALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHhcCCCccCCChhhheeceeeccc
Confidence 9999999999999999999998765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=291.70 Aligned_cols=254 Identities=28% Similarity=0.475 Sum_probs=198.4
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-----CC---CcceEEEEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-----HQ---NIIEMLDSFE 73 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~-----HP---NIVKL~dvfe 73 (1342)
+-.+|.+.++||+|-|++||+|.|..+.+.||+|+.+-. +...+....||++|++++ |+ +||+++|.|.
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 347999999999999999999999999999999988532 334467788999999983 33 6999999996
Q ss_pred ----eCCeEEEEEeccCCChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhC-CceecCCCCCcEEEcCC--------
Q 000706 74 ----SPQEFCVVTEFAQGELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSN-RIIHRDMKPQNILIGAG-------- 138 (1342)
Q Consensus 74 ----ded~lyLVMEY~eGSL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsr-GIVHRDLKPENILLdsd-------- 138 (1342)
++.++++|+|+.+.+|+.+|++ .+.++...+++|++|++.||.|||++ ||+|-||||||||+..+
T Consensus 153 hsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred ecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhh
Confidence 5568999999999999999986 45799999999999999999999976 99999999999999310
Q ss_pred ---C----------------------------------------------------------------------------
Q 000706 139 ---S---------------------------------------------------------------------------- 139 (1342)
Q Consensus 139 ---G---------------------------------------------------------------------------- 139 (1342)
+
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence 0
Q ss_pred -------------------------------------------------------------------------------c
Q 000706 140 -------------------------------------------------------------------------------V 140 (1342)
Q Consensus 140 -------------------------------------------------------------------------------~ 140 (1342)
+
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 1
Q ss_pred EEEeeccccccccCCceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCc------HHHHHHHH
Q 000706 141 VKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS------VYALIRHI 214 (1342)
Q Consensus 141 LKLiDFGLAr~l~sss~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s------~~elirkI 214 (1342)
+||+|||.|..... .++.-..|..|++||++.+..|+..+||||++|++|||+||...|.-.+ +++-+..|
T Consensus 393 vKIaDlGNACW~~k---hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 393 VKIADLGNACWVHK---HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred EEEeeccchhhhhh---hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 34444444443221 1223347899999999999999999999999999999999999885321 11111111
Q ss_pred hc------------------------------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 215 VK------------------------------------------DPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 215 lr------------------------------------------~~~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
.. ..+.++.+-..++.+|+.-||+.+|+||||+.+.++
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 10 011122223457889999999999999999999999
Q ss_pred CcCcccchh
Q 000706 253 HPFVKETSD 261 (1342)
Q Consensus 253 HPFFre~~~ 261 (1342)
|||+.+...
T Consensus 550 hPwLn~~~~ 558 (590)
T KOG1290|consen 550 HPWLNPVAG 558 (590)
T ss_pred CccccCCCC
Confidence 999987643
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=300.77 Aligned_cols=200 Identities=33% Similarity=0.598 Sum_probs=180.2
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHH------HHHHHHHHHHHHhcC---CCCcceEEEEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD------IHNLRQEIEILRKLK---HQNIIEMLDSFE 73 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~d------ierL~rEI~ILKrL~---HPNIVKL~dvfe 73 (1342)
+.+|..++.+|.|+||.|+.|.++.+...|++|.|.|.+.-.+. .-.+..||++|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 56899999999999999999999999999999999887543322 123667999999997 999999999999
Q ss_pred eCCeEEEEEeccC-C-ChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 000706 74 SPQEFCVVTEFAQ-G-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARA 151 (1342)
Q Consensus 74 ded~lyLVMEY~e-G-SL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~ 151 (1342)
+++.+|++||-.+ | +|+++|+..+.++|.+++.|++|+..|+++||++||+|||||-||+.++.+|-+||+|||.+..
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 9999999999875 5 8999999999999999999999999999999999999999999999999999999999999987
Q ss_pred ccCCceeeecccCCCCcCChhhhccCCCC-CCCcccchhhHHHHHHhCCCCCCC
Q 000706 152 MSANTVVLRSIKGTPLYMAPELVREQPYN-HTADLWSLGVILYELFVGQPPFYT 204 (1342)
Q Consensus 152 l~sss~~~~s~vGTp~YmAPEvL~g~~YT-~KsDIWSLGVILYELLTGr~PF~g 204 (1342)
...+. +..++||..|.|||++.+.+|- ..-|||++|++||-++....||+.
T Consensus 720 ~ksgp--fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 TKSGP--FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hcCCC--cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 66554 4567899999999999999985 567999999999999999999863
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=247.48 Aligned_cols=214 Identities=42% Similarity=0.729 Sum_probs=186.0
Q ss_pred EEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEecc
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFA 85 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY~ 85 (1342)
|++.+.||.|++|.||++.+..+++.+++|.+...... ...+.+.+|++.+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 67899999999999999999988999999999765432 24578889999999999999999999999999999999999
Q ss_pred CC-ChHHHHhcCCC-CCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc-eeeecc
Q 000706 86 QG-ELFEILEDDKC-LPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT-VVLRSI 162 (1342)
Q Consensus 86 eG-SL~D~Lek~g~-LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss-~~~~s~ 162 (1342)
+| +|.+++..... +++..++.++.|++.++.|||++|++|+|++|+||+++.++.++|+|||.+....... ......
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 86 99999987666 8999999999999999999999999999999999999999999999999998765442 122345
Q ss_pred cCCCCcCChhhh-ccCCCCCCCcccchhhHHHHHHhCCCCCCC--CcHHHHHHHHhcCCCC
Q 000706 163 KGTPLYMAPELV-REQPYNHTADLWSLGVILYELFVGQPPFYT--NSVYALIRHIVKDPVK 220 (1342)
Q Consensus 163 vGTp~YmAPEvL-~g~~YT~KsDIWSLGVILYELLTGr~PF~g--~s~~elirkIlr~~~e 220 (1342)
.++..|++||.+ ....++.++|+|+||+++|+|++|+.||.. .+.....+.+..+...
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 220 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL 220 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence 688899999998 667788899999999999999999999977 4444666777666543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=297.66 Aligned_cols=247 Identities=30% Similarity=0.548 Sum_probs=210.0
Q ss_pred CEEEEEEEcccCcEEEEEEEEc---c----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 000706 5 NYHVIELVGEGSFGKVYKGRRK---Y----TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQ 76 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk---~----TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded 76 (1342)
+.++.+.||+|.||.||+|.-. . ....||||..+..... .+.+.+..|+++|+.+ .||||+.+.+.+.+++
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 3456779999999999999642 1 1456899998766554 6678899999999999 6999999999999999
Q ss_pred eEEEEEeccC-CChHHHHhcCC----------------CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC
Q 000706 77 EFCVVTEFAQ-GELFEILEDDK----------------CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS 139 (1342)
Q Consensus 77 ~lyLVMEY~e-GSL~D~Lek~g----------------~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG 139 (1342)
..++|+||+. |+|.+++++.+ .++......+..||+.|++||++.+++||||-..|||++.+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC
Confidence 9999999997 99999998755 388899999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCceee-ecccC--CCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCc-HHHHHHHH
Q 000706 140 VVKLCDFGFARAMSANTVVL-RSIKG--TPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNS-VYALIRHI 214 (1342)
Q Consensus 140 ~LKLiDFGLAr~l~sss~~~-~s~vG--Tp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s-~~elirkI 214 (1342)
.+||+|||+++......... ....| ...|||||.+....|+.++||||+|++|||+++ |..||.+-. ..+..+.+
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l 535 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFL 535 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHH
Confidence 99999999998654433222 22223 234999999999999999999999999999998 899998854 55666666
Q ss_pred hcC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 215 VKD-PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 215 lr~-~~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
..+ +.+.|...++++.++++.||+.+|++||++.++.+
T Consensus 536 ~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 536 KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 655 45778888999999999999999999999999865
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=291.81 Aligned_cols=246 Identities=24% Similarity=0.424 Sum_probs=205.7
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
.-.+.++||+|.||.|.+|.-. .+..||+|.++.... ......+.+|+++|.+++||||+++++++..++.++++|||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred heehhhhhcCcccceeEEEEec-CceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 4568899999999999999754 468999999876533 34457899999999999999999999999999999999999
Q ss_pred cC-CChHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCce--ee
Q 000706 85 AQ-GELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV--VL 159 (1342)
Q Consensus 85 ~e-GSL~D~Lek~g--~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~--~~ 159 (1342)
++ |+|.+++.++. .........++.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++.+-.+.. ..
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq 696 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ 696 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence 98 99999998763 234556677999999999999999999999999999999999999999999985543322 12
Q ss_pred ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHH--hCCCCCCCCcHHHHHHHHh---cC-----CCCCCCCCCHHH
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELF--VGQPPFYTNSVYALIRHIV---KD-----PVKYPDEMSPNF 229 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELL--TGr~PF~g~s~~elirkIl---r~-----~~efP~eISpeL 229 (1342)
...+-..+|||||.+..++++.++|+|+||+++||++ +...||.....++..++.. .. -...|.-.+.++
T Consensus 697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~l 776 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGL 776 (807)
T ss_pred cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHH
Confidence 2345567899999998889999999999999999976 5789998777666655432 22 123566788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHc
Q 000706 230 KSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 230 kDLIrKcLqkDPeKRPSAeELLe 252 (1342)
.+++..|++.|-++||+++++-.
T Consensus 777 yelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 777 YELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHHHHHhchhhhcCCCHHHHHH
Confidence 99999999999999999999854
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-29 Score=305.15 Aligned_cols=199 Identities=21% Similarity=0.261 Sum_probs=150.9
Q ss_pred hcCC-CCcceEEEEE-------EeCCeEEEEEeccCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q 000706 59 KLKH-QNIIEMLDSF-------ESPQEFCVVTEFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMK 129 (1342)
Q Consensus 59 rL~H-PNIVKL~dvf-------eded~lyLVMEY~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLK 129 (1342)
.++| +||++++++| .+.+.++.+|||++++|++++.+ ...+++.+++.+++||++||.|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 3445 5777777777 23456889999999999999976 4569999999999999999999999999999999
Q ss_pred CCcEEEcCC-------------------CcEEEeeccccccccCCc----------------eeeecccCCCCcCChhhh
Q 000706 130 PQNILIGAG-------------------SVVKLCDFGFARAMSANT----------------VVLRSIKGTPLYMAPELV 174 (1342)
Q Consensus 130 PENILLdsd-------------------G~LKLiDFGLAr~l~sss----------------~~~~s~vGTp~YmAPEvL 174 (1342)
|+||||+.. +.+|++|||+++...... .......||++|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 999999654 455666666665321100 001124689999999999
Q ss_pred ccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 175 REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP-VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 175 ~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~-~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
.+..|+.++|||||||++|||++|.+||..... ....+.... .+.+....+...+++.+||++||.+||++.|+++|
T Consensus 188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 188 NGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred ccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 999999999999999999999999998764321 111111111 11111224567899999999999999999999999
Q ss_pred cCcccc
Q 000706 254 PFVKET 259 (1342)
Q Consensus 254 PFFre~ 259 (1342)
|||.+.
T Consensus 266 ~~~~~~ 271 (793)
T PLN00181 266 EFINEP 271 (793)
T ss_pred hhhhhh
Confidence 999764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=278.47 Aligned_cols=255 Identities=29% Similarity=0.453 Sum_probs=200.1
Q ss_pred CCEEEEEEEcccCcEEEEEEEEcc---CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKY---TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFC 79 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~---TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~ly 79 (1342)
+.|+++++||+|.|++||++.+.. .++.||+|.+...... .++.+|+++|..+ .+.||+++.+.+..++...
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 468999999999999999999887 7889999998665433 5689999999999 6899999999999999999
Q ss_pred EEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcC-CCcEEEeeccccccccCCc--
Q 000706 80 VVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA-GSVVKLCDFGFARAMSANT-- 156 (1342)
Q Consensus 80 LVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLds-dG~LKLiDFGLAr~l~sss-- 156 (1342)
+||||++.+-+.-+... ++..+++.|++.++.||+++|.+||+||||||+|++.+. .++-.|.|||+|..++...
T Consensus 112 ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~ 189 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQT 189 (418)
T ss_pred EEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhh
Confidence 99999996544444433 668899999999999999999999999999999999975 4578999999997221000
Q ss_pred --------------------------------ee----------eecccCCCCcCChhhhccC-CCCCCCcccchhhHHH
Q 000706 157 --------------------------------VV----------LRSIKGTPLYMAPELVREQ-PYNHTADLWSLGVILY 193 (1342)
Q Consensus 157 --------------------------------~~----------~~s~vGTp~YmAPEvL~g~-~YT~KsDIWSLGVILY 193 (1342)
.. .-...||++|+|||++... ..+.++||||.|+|+.
T Consensus 190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L 269 (418)
T KOG1167|consen 190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL 269 (418)
T ss_pred hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence 00 0113599999999988654 4688999999999999
Q ss_pred HHHhCCCCCCCCc-HHHHHHHHh--------------cCC-------------------------------C------CC
Q 000706 194 ELFVGQPPFYTNS-VYALIRHIV--------------KDP-------------------------------V------KY 221 (1342)
Q Consensus 194 ELLTGr~PF~g~s-~~elirkIl--------------r~~-------------------------------~------ef 221 (1342)
.+++++.||.... +.+.+.++. .+. . ..
T Consensus 270 slls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~ 349 (418)
T KOG1167|consen 270 SLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIG 349 (418)
T ss_pred hhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccc
Confidence 9999999996432 111111110 000 0 00
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcccchhhhh
Q 000706 222 PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDELN 264 (1342)
Q Consensus 222 P~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~~eLs 264 (1342)
.+..+..+.+|+.+||..||.+|.|++++|+||||.+......
T Consensus 350 ~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~~~ 392 (418)
T KOG1167|consen 350 SDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRTER 392 (418)
T ss_pred cccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhhhh
Confidence 1123457899999999999999999999999999997654443
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=281.87 Aligned_cols=243 Identities=24% Similarity=0.420 Sum_probs=208.6
Q ss_pred EEEEEEcccCcEEEEEEEEccCCc----EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 7 HVIELVGEGSFGKVYKGRRKYTGQ----TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 7 rIlK~LGsGgFGtVYKArDk~TGe----~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
+..++||+|+||+||+|..-..|+ +||+|++....- .+....+.+|+-+|.+++|||+++++++..... +-||+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 456789999999999998866665 478888765433 333467888999999999999999999997766 88999
Q ss_pred eccC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeee
Q 000706 83 EFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 83 EY~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~ 160 (1342)
+|++ |.|.++++. +..+..+....|..||++|+.|||+++++||||-..||||.+-.++|+.|||+++........+.
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 9998 899999875 45799999999999999999999999999999999999999999999999999998887765554
Q ss_pred ccc--CCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHh
Q 000706 161 SIK--GTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGL 236 (1342)
Q Consensus 161 s~v--GTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~eISpeLkDLIrKc 236 (1342)
... -.+.|||=|.+....|+.++||||||+++||++| |..|+++....++-+.+..+ +.+-|+..+.++..++.+|
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkC 936 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKC 936 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHH
Confidence 432 3455888898999999999999999999999987 99999998877776665544 4566788899999999999
Q ss_pred cccCCCCCCCHHHHH
Q 000706 237 LNKVPQNRLTWSALL 251 (1342)
Q Consensus 237 LqkDPeKRPSAeELL 251 (1342)
|..|+..||+++++.
T Consensus 937 wmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 937 WMIDADSRPTFKELA 951 (1177)
T ss_pred hccCcccCccHHHHH
Confidence 999999999998875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-26 Score=226.90 Aligned_cols=250 Identities=38% Similarity=0.638 Sum_probs=208.5
Q ss_pred EEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHH-HHHHHHHHHHHHHhcCCC-CcceEEEEEEeCCeEEEEEe
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEK-DIHNLRQEIEILRKLKHQ-NIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~-dierL~rEI~ILKrL~HP-NIVKL~dvfeded~lyLVME 83 (1342)
|++.+.||.|+|+.||++.+. +.+++|.+.+...... ....+.+|+.++..+.|+ +++++++.+......++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999887 7899999977654443 467889999999999988 79999999988888999999
Q ss_pred ccC-CChHHHHhcCC---CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC-cEEEeeccccccccCCce-
Q 000706 84 FAQ-GELFEILEDDK---CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS-VVKLCDFGFARAMSANTV- 157 (1342)
Q Consensus 84 Y~e-GSL~D~Lek~g---~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG-~LKLiDFGLAr~l~sss~- 157 (1342)
|+. +++.+.+.... .+++.....++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.++.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 998 56776776664 799999999999999999999999999999999999999998 799999999986554332
Q ss_pred -----eeecccCCCCcCChhhhcc---CCCCCCCcccchhhHHHHHHhCCCCCCCCc----HHHHHHHHhcCCCC-CCCC
Q 000706 158 -----VLRSIKGTPLYMAPELVRE---QPYNHTADLWSLGVILYELFVGQPPFYTNS----VYALIRHIVKDPVK-YPDE 224 (1342)
Q Consensus 158 -----~~~s~vGTp~YmAPEvL~g---~~YT~KsDIWSLGVILYELLTGr~PF~g~s----~~elirkIlr~~~e-fP~e 224 (1342)
......|++.|++||.+.+ ..+....|+|++|++++++++|..||.... .......+...... ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 3456789999999999987 578899999999999999999999987765 34444544444433 2222
Q ss_pred CC--------HHHHHHHHHhcccCCCCCCCHHHHHcCcCccc
Q 000706 225 MS--------PNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258 (1342)
Q Consensus 225 IS--------peLkDLIrKcLqkDPeKRPSAeELLeHPFFre 258 (1342)
.. ..+.+++.+++..+|..|.+..+...++|...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 11 47899999999999999999999888865543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=255.31 Aligned_cols=213 Identities=28% Similarity=0.502 Sum_probs=181.4
Q ss_pred EEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEec
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
..-+..||+|++|.|-+.++.++|...|+|.++-.-. .....++.+|+++..+. ..|++|.+|+.+..+..+||.||.
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 3456789999999999999999999999999976543 44456777788877765 789999999999999999999999
Q ss_pred cCCChHHH----HhcCCCCCHHHHHHHHHHHHHHHHHhhhC-CceecCCCCCcEEEcCCCcEEEeeccccccccCCceee
Q 000706 85 AQGELFEI----LEDDKCLPEEQVQSIAKQLVRALHYLHSN-RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159 (1342)
Q Consensus 85 ~eGSL~D~----Lek~g~LSEeeI~~I~~QLLsALaYLHsr-GIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~ 159 (1342)
+.-+|..+ +++++.++|..+-+++..++.||.|||++ .++|||+||+|||++.+|++|+||||.+..+..+-. .
T Consensus 127 M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA-k 205 (282)
T KOG0984|consen 127 MDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA-K 205 (282)
T ss_pred hhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH-H
Confidence 99876654 55688999999999999999999999987 899999999999999999999999999987654432 2
Q ss_pred ecccCCCCcCChhhhc----cCCCCCCCcccchhhHHHHHHhCCCCCCC-CcHHHHHHHHhcCCCC
Q 000706 160 RSIKGTPLYMAPELVR----EQPYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKDPVK 220 (1342)
Q Consensus 160 ~s~vGTp~YmAPEvL~----g~~YT~KsDIWSLGVILYELLTGr~PF~g-~s~~elirkIlr~~~e 220 (1342)
+-..|-..|||||.+. ...|+-++||||||++++||.+++.||.. .++.++++++...+.+
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P 271 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP 271 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence 2245889999999764 34799999999999999999999999975 4678888888877543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=270.79 Aligned_cols=241 Identities=27% Similarity=0.498 Sum_probs=186.2
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHh--cCCCCcceEEEEEEeC----Ce
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRK--LKHQNIIEMLDSFESP----QE 77 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKr--L~HPNIVKL~dvfede----d~ 77 (1342)
.+.++.+.||+|.||.||+|..+ |+.||||++.-. +.....+|.++++. ++|+||+.+++.-..+ ..
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred heeEEEEEecCccccceeecccc--CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 35688999999999999999654 999999998432 22445667777776 4999999999765333 35
Q ss_pred EEEEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC--------CceecCCCCCcEEEcCCCcEEEeeccc
Q 000706 78 FCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN--------RIIHRDMKPQNILIGAGSVVKLCDFGF 148 (1342)
Q Consensus 78 lyLVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsr--------GIVHRDLKPENILLdsdG~LKLiDFGL 148 (1342)
+|+|.+|.+ |+|+|++.+ ..++.+...+++..+++||+|||.. .|.|||||..||||.++|...|+|+|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 799999998 999999988 5699999999999999999999953 499999999999999999999999999
Q ss_pred cccccCCce----eeecccCCCCcCChhhhccCC----CC--CCCcccchhhHHHHHHhC----------CCCCCC----
Q 000706 149 ARAMSANTV----VLRSIKGTPLYMAPELVREQP----YN--HTADLWSLGVILYELFVG----------QPPFYT---- 204 (1342)
Q Consensus 149 Ar~l~sss~----~~~s~vGTp~YmAPEvL~g~~----YT--~KsDIWSLGVILYELLTG----------r~PF~g---- 204 (1342)
|........ ..+..+||.+|||||++...- ++ ..+||||||.++||++.. ++||.+
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 987765432 345689999999999986532 11 358999999999999852 578854
Q ss_pred -CcHHHHHHHHhc--CCCCCCCCC--CH---HHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 205 -NSVYALIRHIVK--DPVKYPDEM--SP---NFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 205 -~s~~elirkIlr--~~~efP~eI--Sp---eLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
++.+++.+-+.. -++.+|..+ .+ .+-++++.||..||.-|.|+--+.+
T Consensus 443 DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 443 DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 233333333322 233444332 22 4567899999999999999766643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=274.16 Aligned_cols=241 Identities=26% Similarity=0.463 Sum_probs=188.8
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHh--cCCCCcceEEEEEEeCC---
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRK--LKHQNIIEMLDSFESPQ--- 76 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKr--L~HPNIVKL~dvfeded--- 76 (1342)
+++..++++.+|+|.||.||+|. .+++.||||++. ..+.+.+.+|-++.+. +.|+||+++++.-+-..
T Consensus 208 ~l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred cCCchhhHHHhhcCccceeehhh--ccCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 45667888999999999999994 457999999974 3455677778777775 58999999998765444
Q ss_pred -eEEEEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---------CceecCCCCCcEEEcCCCcEEEee
Q 000706 77 -EFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN---------RIIHRDMKPQNILIGAGSVVKLCD 145 (1342)
Q Consensus 77 -~lyLVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsr---------GIVHRDLKPENILLdsdG~LKLiD 145 (1342)
.+|+|+||.+ |+|.+|++.+ .++.....+++..+++||+|||+. .|+|||||.+||||..|++..|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 8999999987 9999999875 489999999999999999999963 599999999999999999999999
Q ss_pred ccccccccCCcee--eecccCCCCcCChhhhccCC-CC-----CCCcccchhhHHHHHHhCC------------CCCC--
Q 000706 146 FGFARAMSANTVV--LRSIKGTPLYMAPELVREQP-YN-----HTADLWSLGVILYELFVGQ------------PPFY-- 203 (1342)
Q Consensus 146 FGLAr~l~sss~~--~~s~vGTp~YmAPEvL~g~~-YT-----~KsDIWSLGVILYELLTGr------------~PF~-- 203 (1342)
||+|..+.+.... ....+||.+|||||++.+.- +. .+.||||+|.++|||++.- .||.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 9999888654322 23478999999999997642 22 3589999999999999742 2332
Q ss_pred ---CCcHHHHHHHHhc--CCCCCCCC-----CCHHHHHHHHHhcccCCCCCCCHHHH
Q 000706 204 ---TNSVYALIRHIVK--DPVKYPDE-----MSPNFKSFLKGLLNKVPQNRLTWSAL 250 (1342)
Q Consensus 204 ---g~s~~elirkIlr--~~~efP~e-----ISpeLkDLIrKcLqkDPeKRPSAeEL 250 (1342)
..+..++...+.+ .++.+|+. ...-+++.+..||..||+-|.|+.=+
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 1223333333332 34445432 23467899999999999999997544
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=230.20 Aligned_cols=158 Identities=28% Similarity=0.426 Sum_probs=130.8
Q ss_pred CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCC
Q 000706 87 GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGT 165 (1342)
Q Consensus 87 GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGT 165 (1342)
|+|.+++.+ ++++++.+++.++.|++.||.|||+++ ||+|||++.++.+|+ ||+++...... ..||
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~g~ 67 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SRVD 67 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-----CCCc
Confidence 789999986 456999999999999999999999999 999999999999999 99997765432 2589
Q ss_pred CCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcH-HHHHHHHhcCCCC-------CCCCCCH--HHHHHHHH
Q 000706 166 PLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSV-YALIRHIVKDPVK-------YPDEMSP--NFKSFLKG 235 (1342)
Q Consensus 166 p~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~-~elirkIlr~~~e-------fP~eISp--eLkDLIrK 235 (1342)
+.|+|||++.+..|+.++|||||||++|||++|+.||..... ......+...... .+..++. +++++|.+
T Consensus 68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 999999999999999999999999999999999999976543 2233333222111 1122333 69999999
Q ss_pred hcccCCCCCCCHHHHHcCcCcc
Q 000706 236 LLNKVPQNRLTWSALLEHPFVK 257 (1342)
Q Consensus 236 cLqkDPeKRPSAeELLeHPFFr 257 (1342)
||+.||.+||++.|+++|+|+.
T Consensus 148 cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 148 CASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=252.70 Aligned_cols=236 Identities=27% Similarity=0.478 Sum_probs=185.8
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEE-EEEeCCeEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLD-SFESPQEFCV 80 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~d-vfeded~lyL 80 (1342)
.|.|.|.+.||+|.||.+-+++++.++..+++|.+.+... ...++.+|..---.+ .|.||+.-|+ .|+..+.+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 3679999999999999999999999999999999876643 335677777544444 5889998776 4688889999
Q ss_pred EEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEc--CCCcEEEeeccccccccCCce
Q 000706 81 VTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIG--AGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLd--sdG~LKLiDFGLAr~l~sss~ 157 (1342)
+|||++ |+|..-+... .+.|...+.++.|+++|+.|||++++||||||.+||||- +..++||||||..+..+..-.
T Consensus 100 ~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred eeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 999998 9999988764 488999999999999999999999999999999999993 334899999999987654322
Q ss_pred eeecccCCCCcCChhhhcc---CC--CCCCCcccchhhHHHHHHhCCCCCCCCc----HHHHHHH-HhcCCCCCC---CC
Q 000706 158 VLRSIKGTPLYMAPELVRE---QP--YNHTADLWSLGVILYELFVGQPPFYTNS----VYALIRH-IVKDPVKYP---DE 224 (1342)
Q Consensus 158 ~~~s~vGTp~YmAPEvL~g---~~--YT~KsDIWSLGVILYELLTGr~PF~g~s----~~elirk-Ilr~~~efP---~e 224 (1342)
...-+..|.+||.... .. .++..|+|.||+++|.+++|..||+... .+-...+ ..+.....| ..
T Consensus 179 ---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~ 255 (378)
T KOG1345|consen 179 ---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNP 255 (378)
T ss_pred ---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcc
Confidence 2234567899996642 22 4678999999999999999999997532 1111112 112222333 35
Q ss_pred CCHHHHHHHHHhcccCCCCCC
Q 000706 225 MSPNFKSFLKGLLNKVPQNRL 245 (1342)
Q Consensus 225 ISpeLkDLIrKcLqkDPeKRP 245 (1342)
+++.+..+.++-|..+|++|-
T Consensus 256 fs~~a~r~Fkk~lt~~~~drc 276 (378)
T KOG1345|consen 256 FSEKALRLFKKSLTPRFKDRC 276 (378)
T ss_pred cCHHHHHHHHHhcCCcccccc
Confidence 788999999999999999993
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-26 Score=278.61 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=207.4
Q ss_pred EEEEEEcccCcEEEEEEEEccCCcEEEEEEeec---CCCCHH-HHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 7 HVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK---HGKSEK-DIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 7 rIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkK---s~~se~-dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
...+.+|.|++|.|+.+......+.++.|..+. ....+. ....+..|+-+-..+.|||++...+.+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456789999999999888877777777776542 222222 2233777888888999999988888777777766669
Q ss_pred eccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc----ee
Q 000706 83 EFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT----VV 158 (1342)
Q Consensus 83 EY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss----~~ 158 (1342)
|||+++|+..+...+.+...++-.++.|++.|++|+|+.|+.|||+||+|+++..+|.+||+|||.+.....+. ..
T Consensus 401 E~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~ 480 (601)
T KOG0590|consen 401 EYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHE 480 (601)
T ss_pred hcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhh
Confidence 99999999999998899999999999999999999999999999999999999999999999999997665332 33
Q ss_pred eecccCCCCcCChhhhccCCCCCC-CcccchhhHHHHHHhCCCCCCCCcHHHHH--H-------HHhcCCCCCCCCCCHH
Q 000706 159 LRSIKGTPLYMAPELVREQPYNHT-ADLWSLGVILYELFVGQPPFYTNSVYALI--R-------HIVKDPVKYPDEMSPN 228 (1342)
Q Consensus 159 ~~s~vGTp~YmAPEvL~g~~YT~K-sDIWSLGVILYELLTGr~PF~g~s~~eli--r-------kIlr~~~efP~eISpe 228 (1342)
....+|+..|+|||++.+..|++. +||||.|++++.|.+|+.||......+.. . ++..++......++.+
T Consensus 481 ~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~ 560 (601)
T KOG0590|consen 481 SSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRE 560 (601)
T ss_pred hcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhh
Confidence 456889999999999999999864 79999999999999999999764432221 1 1112222333467888
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 229 FKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 229 LkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
.+.+|.+||++||.+|.|++++++.+||++..
T Consensus 561 ~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 561 TRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 99999999999999999999999999999764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=233.25 Aligned_cols=247 Identities=26% Similarity=0.323 Sum_probs=197.1
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCC-cEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCC----CCcceEEEEE-EeCCeE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTG-QTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH----QNIIEMLDSF-ESPQEF 78 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TG-e~VAVKvIkKs~~se~dierL~rEI~ILKrL~H----PNIVKL~dvf-eded~l 78 (1342)
+|++.+.||+|+||.||.+.+..++ +.+|+|.......... ..+..|..++..+.. +++.++++.+ ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 8999999999999999999987764 6789998765432221 157778888888863 6999999999 588899
Q ss_pred EEEEeccCCChHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCC-----CcEEEeeccccc-
Q 000706 79 CVVTEFAQGELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAG-----SVVKLCDFGFAR- 150 (1342)
Q Consensus 79 yLVMEY~eGSL~D~Lek~--g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsd-----G~LKLiDFGLAr- 150 (1342)
|+||+.++.+|.++.... +.++..++..++.|++.+|+++|+.|++||||||+|+++... ..++|.|||+++
T Consensus 97 ~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 97 FIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 999999999999987543 689999999999999999999999999999999999999765 369999999998
Q ss_pred -ccc-CCc---ee----eecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcH---HHHHHHHhcCC
Q 000706 151 -AMS-ANT---VV----LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSV---YALIRHIVKDP 218 (1342)
Q Consensus 151 -~l~-sss---~~----~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~---~elirkIlr~~ 218 (1342)
.+- ... .. ...+.||..|.+++.+.+.+.+++.|+||++.++.++..|..||..... .....+.....
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~ 256 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL 256 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence 321 111 11 1235699999999999999999999999999999999999999976543 22222222221
Q ss_pred C-C-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 219 V-K-YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 219 ~-e-fP~eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
. . +....+.++.++...+-..+...+|....+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 257 LTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred ccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 1 1 334456788888888888899999998877653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.7e-25 Score=257.18 Aligned_cols=240 Identities=30% Similarity=0.492 Sum_probs=212.1
Q ss_pred EcccCcEEEEEEEE---ccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEeccC-
Q 000706 12 VGEGSFGKVYKGRR---KYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-HQNIIEMLDSFESPQEFCVVTEFAQ- 86 (1342)
Q Consensus 12 LGsGgFGtVYKArD---k~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~-HPNIVKL~dvfeded~lyLVMEY~e- 86 (1342)
+|.|.||.|++++- ...+..|++|+.++.............|..++..++ ||.+++++..++.+...|++++|..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 79999999997632 445778999998776444333335666888888886 9999999999999999999999987
Q ss_pred CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCC
Q 000706 87 GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTP 166 (1342)
Q Consensus 87 GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp 166 (1342)
|+|+..+.+...+.+.....+...++-+++++|+.|++|||+|++||+++.+|++++.|||+++..-..... |||.
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----cgt~ 157 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----CGTY 157 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----ccch
Confidence 699999999999999999999999999999999999999999999999999999999999999865443322 8999
Q ss_pred CcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 000706 167 LYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLT 246 (1342)
Q Consensus 167 ~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKRPS 246 (1342)
.|||||+++ .+..++|.||+|++.|+|++|..||.+ +..+.|.+....+|..++.++++++..++..+|.+|..
T Consensus 158 eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg 231 (612)
T KOG0603|consen 158 EYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLG 231 (612)
T ss_pred hhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhc
Confidence 999999999 578899999999999999999999988 77888999899999999999999999999999999974
Q ss_pred -----HHHHHcCcCcccchh
Q 000706 247 -----WSALLEHPFVKETSD 261 (1342)
Q Consensus 247 -----AeELLeHPFFre~~~ 261 (1342)
+.|+++|+||+....
T Consensus 232 ~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 232 AGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred cCcchhHHHhccchheeeeH
Confidence 689999999988654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=232.30 Aligned_cols=248 Identities=24% Similarity=0.373 Sum_probs=204.5
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCC-----cEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEE-EeCCe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTG-----QTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSF-ESPQE 77 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TG-----e~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvf-eded~ 77 (1342)
++++....+-+|+||.||+|..+..+ +.+-+|.++.+ ..+-+...+..|.-.+..+.|||+..+.++. ++.+.
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 46778888999999999999765332 33556666544 3344556778888899999999999999877 55667
Q ss_pred EEEEEeccC-CChHHHHhc-----C---CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccc
Q 000706 78 FCVVTEFAQ-GELFEILED-----D---KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGF 148 (1342)
Q Consensus 78 lyLVMEY~e-GSL~D~Lek-----~---g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGL 148 (1342)
.+..+.+.+ |+|..++.. . ..++..+...++.|+..|++|||++|++|.||-..|.++++.-.+||+|=.+
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaL 442 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSAL 442 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchh
Confidence 788889988 999999872 1 2467778889999999999999999999999999999999999999999999
Q ss_pred cccccCCceee--ecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcC-CCCCCCC
Q 000706 149 ARAMSANTVVL--RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDE 224 (1342)
Q Consensus 149 Ar~l~sss~~~--~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~-~~efP~e 224 (1342)
++.+-+..... ...-....||+||.+.+..|+.++|+||||+++|||+| |+.|+-.-+++++...+.++ +..-|-+
T Consensus 443 SRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~N 522 (563)
T KOG1024|consen 443 SRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFN 522 (563)
T ss_pred ccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCC
Confidence 98775543221 11223556999999999999999999999999999998 99999998988888777666 3455678
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 225 MSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 225 ISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
.|+++..++..||..+|++||+++|+..
T Consensus 523 CPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 523 CPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 9999999999999999999999999853
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=230.04 Aligned_cols=164 Identities=21% Similarity=0.295 Sum_probs=128.9
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEcc-CCcEEEEEEeecCC---CCHHHHHHHHHHHHHHHhcCCCCcce-EEEEEEeCCe
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKY-TGQTVAMKFIMKHG---KSEKDIHNLRQEIEILRKLKHQNIIE-MLDSFESPQE 77 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk~-TGe~VAVKvIkKs~---~se~dierL~rEI~ILKrL~HPNIVK-L~dvfeded~ 77 (1342)
.++|++.+.||+|+||+||+|+++. +++.+|||.+.... ........+.+|++++++++|+|++. +++. +.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence 4789999999999999999998876 67788999875331 12334567899999999999999984 5442 45
Q ss_pred EEEEEeccCCC-hHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC-CCCcEEEcCCCcEEEeeccccccccCC
Q 000706 78 FCVVTEFAQGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDM-KPQNILIGAGSVVKLCDFGFARAMSAN 155 (1342)
Q Consensus 78 lyLVMEY~eGS-L~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDL-KPENILLdsdG~LKLiDFGLAr~l~ss 155 (1342)
.|+||||++|. |. .+... . ...++.|++++|.|||++||+|||| ||+|||++.++.+||+|||+++.+...
T Consensus 93 ~~LVmE~~~G~~L~-~~~~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~ 165 (365)
T PRK09188 93 DGLVRGWTEGVPLH-LARPH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR 165 (365)
T ss_pred cEEEEEccCCCCHH-HhCcc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence 79999999864 54 33211 1 1468899999999999999999999 999999999999999999999876543
Q ss_pred cee--------eecccCCCCcCChhhhccC
Q 000706 156 TVV--------LRSIKGTPLYMAPELVREQ 177 (1342)
Q Consensus 156 s~~--------~~s~vGTp~YmAPEvL~g~ 177 (1342)
... .++..+++.|++||.+...
T Consensus 166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 166 GALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 211 1345688899999987543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-22 Score=220.42 Aligned_cols=242 Identities=24% Similarity=0.385 Sum_probs=202.7
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyLVM 82 (1342)
-.|+++++||+|.||+.+.|.+..++++||||.-.+... .-+++.|.+..+.+ ..++|..+|.+..+..+-.+||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 369999999999999999999999999999998755432 24688899999999 5689999999999999999999
Q ss_pred eccCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC-----cEEEeeccccccccCCc
Q 000706 83 EFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS-----VVKLCDFGFARAMSANT 156 (1342)
Q Consensus 83 EY~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG-----~LKLiDFGLAr~l~sss 156 (1342)
|..+-+|.|+..= ++.|+.+++..++.|++.-++|+|++.+++|||||+|+||..-+ .+.++|||+|+.+.++.
T Consensus 104 dLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 104 DLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred hhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 9999888777653 55799999999999999999999999999999999999997544 58999999999886542
Q ss_pred e-------eeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCC---CcHHHHHHHHhcCCCCCC----
Q 000706 157 V-------VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYT---NSVYALIRHIVKDPVKYP---- 222 (1342)
Q Consensus 157 ~-------~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g---~s~~elirkIlr~~~efP---- 222 (1342)
. ......||.+||+-..+.+.+.+.+.|+-|||-++++.+.|..||.+ .+..+.+++|-......|
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~L 263 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVL 263 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHH
Confidence 2 23456799999999999999999999999999999999999999987 445666677655433332
Q ss_pred -CCCCHHHHHHHHHhcccCCCCCCCHHH
Q 000706 223 -DEMSPNFKSFLKGLLNKVPQNRLTWSA 249 (1342)
Q Consensus 223 -~eISpeLkDLIrKcLqkDPeKRPSAeE 249 (1342)
..+|.++...++-.-+.+-.+-|..+-
T Consensus 264 c~g~P~efa~Yl~yvR~L~F~E~PDYdy 291 (449)
T KOG1165|consen 264 CEGFPEEFATYLRYVRRLDFFETPDYDY 291 (449)
T ss_pred HhcCHHHHHHHHHHHHhcCcccCCCHHH
Confidence 457778888887777777777776543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=211.44 Aligned_cols=244 Identities=22% Similarity=0.321 Sum_probs=202.3
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCC-CCcceEEEEEEeCCeEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH-QNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~H-PNIVKL~dvfeded~lyL 80 (1342)
-.+.|+++++||+|+||.+|.|....+|+.||+|+-...... .++..|.++.+.+++ ..|..+..++.+...-.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 357899999999999999999999999999999987544322 356779999999965 688888888999999999
Q ss_pred EEeccCCChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC---cEEEeeccccccccCCc
Q 000706 81 VTEFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS---VVKLCDFGFARAMSANT 156 (1342)
Q Consensus 81 VMEY~eGSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG---~LKLiDFGLAr~l~sss 156 (1342)
|||..+-+|.++..- .+.|+..++.-++.|++.-++|+|.++++||||||+|+|..-+. .+.|+|||+++.+.+..
T Consensus 89 VMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 89 VMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred eeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 999999888887753 45799999999999999999999999999999999999996443 69999999998775432
Q ss_pred -------eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCC---cHHHHHHHHhcCCCCCC----
Q 000706 157 -------VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTN---SVYALIRHIVKDPVKYP---- 222 (1342)
Q Consensus 157 -------~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~---s~~elirkIlr~~~efP---- 222 (1342)
...+...||.+|.+-..+.+...+.+.|+-|+|.++.++..|..||.+- +..+.+++|.+.....|
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~L 248 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVL 248 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHH
Confidence 2334567999999988888888889999999999999999999999874 34556666666555444
Q ss_pred -CCCCHHHHHHHHHhcccCCCCCCCHHH
Q 000706 223 -DEMSPNFKSFLKGLLNKVPQNRLTWSA 249 (1342)
Q Consensus 223 -~eISpeLkDLIrKcLqkDPeKRPSAeE 249 (1342)
..+|.++.-.+..|-..--++-|...-
T Consensus 249 C~G~P~EF~myl~Y~R~L~F~E~Pdy~y 276 (341)
T KOG1163|consen 249 CKGFPAEFAMYLNYCRGLGFEEKPDYMY 276 (341)
T ss_pred hCCCcHHHHHHHHHHhhcCCCCCCcHHH
Confidence 467889999999888777777777443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-22 Score=244.81 Aligned_cols=221 Identities=33% Similarity=0.604 Sum_probs=181.8
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
.+|+.+|.+..|+||.||..+|+.+.+++|+| +.+... -+++ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l------ilRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL------ILRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccch------hhhc---cccccCCccee-----------------
Confidence 57899999999999999999999999999995 433311 1111 34444555554
Q ss_pred ccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccC---------
Q 000706 84 FAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA--------- 154 (1342)
Q Consensus 84 Y~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~s--------- 154 (1342)
||=...++..++++.+. +.+++|+|+-||+|||+||+|.+|+.-|++|+.|||+++..--
T Consensus 136 ---gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg 204 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEG 204 (1205)
T ss_pred ---chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhc
Confidence 66666666666666554 7789999999999999999999999999999999999974311
Q ss_pred ------CceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCC---CC
Q 000706 155 ------NTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPD---EM 225 (1342)
Q Consensus 155 ------ss~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~---eI 225 (1342)
........+|||.|+|||++..+.|+..+|+|++|+|+||.+.|..||++++.++++..+..+...+|+ .+
T Consensus 205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~ 284 (1205)
T KOG0606|consen 205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEAL 284 (1205)
T ss_pred chHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCC
Confidence 111233468999999999999999999999999999999999999999999999999999988877775 47
Q ss_pred CHHHHHHHHHhcccCCCCCC---CHHHHHcCcCcccchhh
Q 000706 226 SPNFKSFLKGLLNKVPQNRL---TWSALLEHPFVKETSDE 262 (1342)
Q Consensus 226 SpeLkDLIrKcLqkDPeKRP---SAeELLeHPFFre~~~e 262 (1342)
++++++++.++|+.+|..|. .+-++.+|+||+.....
T Consensus 285 p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 285 PPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred CHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 88999999999999999995 57889999999876543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-21 Score=216.01 Aligned_cols=233 Identities=25% Similarity=0.385 Sum_probs=155.9
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcC----------CCCcceEEEEEE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEIEILRKLK----------HQNIIEMLDSFE 73 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-e~dierL~rEI~ILKrL~----------HPNIVKL~dvfe 73 (1342)
.+...+.||.|+++.||.++|..||+.+|+|+....... ....+++++|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 356788999999999999999999999999988655433 234667777765554432 223444444332
Q ss_pred ---------eC---C-----eEEEEEeccCCChHHHHh---cCC----CCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q 000706 74 ---------SP---Q-----EFCVVTEFAQGELFEILE---DDK----CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMK 129 (1342)
Q Consensus 74 ---------de---d-----~lyLVMEY~eGSL~D~Le---k~g----~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLK 129 (1342)
.. . ..+++|+-+.++|.+.+. ... .+.......+..|+++.+++||..|++|+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 11 1 236788888899887754 221 12233345667999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCceeeecccCCCCcCChhhhcc--------CCCCCCCcccchhhHHHHHHhCCCC
Q 000706 130 PQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVRE--------QPYNHTADLWSLGVILYELFVGQPP 201 (1342)
Q Consensus 130 PENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp~YmAPEvL~g--------~~YT~KsDIWSLGVILYELLTGr~P 201 (1342)
|+|+|++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|+||+++|.|+||+.|
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 99999999999999999988765543221 345678999997643 3478899999999999999999999
Q ss_pred CCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 000706 202 FYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNR 244 (1342)
Q Consensus 202 F~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeKR 244 (1342)
|............+ ..-.++|..++.||+++|+.||++|
T Consensus 250 f~~~~~~~~~~~~f----~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 250 FGLSSPEADPEWDF----SRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TCCCGGGSTSGGGG----TTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCccccccccc----hhcCCcCHHHHHHHHHHccCCcccC
Confidence 98654322221111 2223788999999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-22 Score=245.23 Aligned_cols=242 Identities=24% Similarity=0.369 Sum_probs=187.3
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCC--CCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG--KSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~--~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVM 82 (1342)
+|...+.||++.|=+|.+|++. +|. |++|++-++. ..-....+..+|++ ....++||++.+..+-+.+...|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 6889999999999999999876 344 8899986653 33344455555666 56679999999999988889999999
Q ss_pred eccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccc--c-CCceee
Q 000706 83 EFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM--S-ANTVVL 159 (1342)
Q Consensus 83 EY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l--~-sss~~~ 159 (1342)
+|+..+|+|.+..+..+.+-+-++|+.||+.||..+|+.||+|||||.|||||++-.-+.|+||..-+.. . ++...+
T Consensus 101 qyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf 180 (1431)
T KOG1240|consen 101 QYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF 180 (1431)
T ss_pred HHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence 9999999999999999999999999999999999999999999999999999999989999999876532 1 111122
Q ss_pred eccc----CCCCcCChhhhcc----------CC-CCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCCC-
Q 000706 160 RSIK----GTPLYMAPELVRE----------QP-YNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKDPVKYP- 222 (1342)
Q Consensus 160 ~s~v----GTp~YmAPEvL~g----------~~-YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~~~efP- 222 (1342)
..+. ..-.|+|||.+.. .+ .+++.||||+||+++|+++ |++||.-.....+. .+....+
T Consensus 181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr----~~~~~~~e 256 (1431)
T KOG1240|consen 181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYR----SGNADDPE 256 (1431)
T ss_pred eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHh----ccCccCHH
Confidence 2222 2334999997643 12 5678999999999999998 68888532221111 1100000
Q ss_pred ----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 000706 223 ----DEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 223 ----~eISpeLkDLIrKcLqkDPeKRPSAeELLeH 253 (1342)
.--+..++++|..|++.||.+|.++++.|+.
T Consensus 257 ~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 257 QLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1123478999999999999999999999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=9e-21 Score=197.32 Aligned_cols=141 Identities=18% Similarity=0.208 Sum_probs=111.1
Q ss_pred EEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHH------------------------HHHHHHHHHHHHhcCCCC
Q 000706 9 IELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD------------------------IHNLRQEIEILRKLKHQN 64 (1342)
Q Consensus 9 lK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~d------------------------ierL~rEI~ILKrL~HPN 64 (1342)
.+.||+|+||.||+|.+. +|+.||+|+++........ .....+|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 8999999999764321111 123345999999998887
Q ss_pred cceEEEEEEeCCeEEEEEeccCCC-hHHHHhcCCCCCHHHHHHHHHHHHHHHHHh-hhCCceecCCCCCcEEEcCCCcEE
Q 000706 65 IIEMLDSFESPQEFCVVTEFAQGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYL-HSNRIIHRDMKPQNILIGAGSVVK 142 (1342)
Q Consensus 65 IVKL~dvfeded~lyLVMEY~eGS-L~D~Lek~g~LSEeeI~~I~~QLLsALaYL-HsrGIVHRDLKPENILLdsdG~LK 142 (1342)
+.....+.... .++||||++|+ +.....+.++++++.+..++.|++.+|.|+ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 75444333222 38999999964 444444567899999999999999999999 799999999999999998 47899
Q ss_pred Eeecccccccc
Q 000706 143 LCDFGFARAMS 153 (1342)
Q Consensus 143 LiDFGLAr~l~ 153 (1342)
|+|||++...+
T Consensus 158 LiDFG~a~~~~ 168 (190)
T cd05147 158 IIDVSQSVEHD 168 (190)
T ss_pred EEEccccccCC
Confidence 99999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-20 Score=190.92 Aligned_cols=143 Identities=20% Similarity=0.207 Sum_probs=114.3
Q ss_pred EEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCH----------------------H--HHHHHHHHHHHHHhcCCC
Q 000706 8 VIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE----------------------K--DIHNLRQEIEILRKLKHQ 63 (1342)
Q Consensus 8 IlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se----------------------~--dierL~rEI~ILKrL~HP 63 (1342)
+.+.||+|+||.||+|.+. +|+.||+|++++..... . .......|.+.+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 89999999997652110 0 012346799999999999
Q ss_pred CcceEEEEEEeCCeEEEEEeccCCC-hHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCcEEEcCCCcE
Q 000706 64 NIIEMLDSFESPQEFCVVTEFAQGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYLHS-NRIIHRDMKPQNILIGAGSVV 141 (1342)
Q Consensus 64 NIVKL~dvfeded~lyLVMEY~eGS-L~D~Lek~g~LSEeeI~~I~~QLLsALaYLHs-rGIVHRDLKPENILLdsdG~L 141 (1342)
++.....+.... .|+||||++|. +........++++..+..++.|++.++.++|. +||+||||||+||+++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 886555444332 48999999874 44333344678899999999999999999999 9999999999999999 8899
Q ss_pred EEeeccccccccC
Q 000706 142 KLCDFGFARAMSA 154 (1342)
Q Consensus 142 KLiDFGLAr~l~s 154 (1342)
+|+|||++.....
T Consensus 157 ~liDFG~a~~~~~ 169 (190)
T cd05145 157 YIIDVSQAVELDH 169 (190)
T ss_pred EEEEcccceecCC
Confidence 9999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=196.38 Aligned_cols=170 Identities=14% Similarity=0.212 Sum_probs=131.3
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHH-HHHH------HHHHHHHHHhcCCCCcceEEEEEEeC-
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEK-DIHN------LRQEIEILRKLKHQNIIEMLDSFESP- 75 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~-dier------L~rEI~ILKrL~HPNIVKL~dvfede- 75 (1342)
++|++.+.+|.|+||.||++.+ ++..+|+|.++....... .... +.+|++.+.++.||+|..+.+++...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 5899999999999999999755 477899999975533222 2233 57899999999999999999987643
Q ss_pred -------CeEEEEEeccCC-ChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecc
Q 000706 76 -------QEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFG 147 (1342)
Q Consensus 76 -------d~lyLVMEY~eG-SL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFG 147 (1342)
...+++|||++| +|.++. .++++ ...++..++..+|+.|++|||+||+||+++.+| ++|+|||
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECC
Confidence 357999999997 566652 23332 456999999999999999999999999999998 9999999
Q ss_pred ccccccCCceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHH
Q 000706 148 FARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELF 196 (1342)
Q Consensus 148 LAr~l~sss~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELL 196 (1342)
........... ........|+.++|+|+||+++....
T Consensus 180 ~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 180 GKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 88654322111 11334445778999999999887553
|
|
| >PLN03200 cellulose synthase-interactive protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.4e-19 Score=229.45 Aligned_cols=248 Identities=19% Similarity=0.225 Sum_probs=210.6
Q ss_pred HHHHHHHhcCchhHHHhhcccccChhhhhhhccCCCchHHHHHHHHHHHHHhhch--hHH--HHHHhCCchHhHHHhhcC
Q 000706 1069 IAFLAKMIGQRSLAVQLVGKGLLDPNRVRRLLDSSTREVTLDVLMIVSDLARMDK--WFY--EYINGASMLEFLKDFLTH 1144 (1342)
Q Consensus 1069 i~~l~~~~~~~~~~~q~v~~~~~~~~~~~~~~~s~~~~~r~~f~~~va~lars~~--~~i--e~I~~aG~v~LL~~lLqd 1144 (1342)
.+.|..|+.++....-.+..|.+.| ++.+|++.+++.|.+=..++..++ ..+ .+. ..+...|++|.|..++++
T Consensus 79 aaaL~nLS~~e~nk~~Iv~~GaIpp--LV~LL~sGs~eaKe~AA~AL~sLS-~~~~~D~~~~~I~v~~GaVp~Lv~lL~~ 155 (2102)
T PLN03200 79 AAVLGVLCKEEDLRVKVLLGGCIPP--LLSLLKSGSAEAQKAAAEAIYAVS-SGGLSDHVGSKIFSTEGVVPSLWDQLQP 155 (2102)
T ss_pred HHHHHHHhcCHHHHHHHHHcCChHH--HHHHHHCCCHHHHHHHHHHHHHHH-cCcchhhhhhhhhhhcCChHHHHHHHhC
Confidence 3566677777777777778888888 888999999999999999999999 443 333 234569999999999999
Q ss_pred C---chhHHHHHHHHHHHHhcCCHHHHHhhhccCcHHHHhhhcCCCChhhhhhHHHHHHHhHhcCHHHHHHHHHh--HHH
Q 000706 1145 E---DPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS--IPL 1219 (1342)
Q Consensus 1145 ~---e~slqq~Aa~ALg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~Vae~--~p~ 1219 (1342)
+ +..+|+.|+.+|.+||.|.++.++.++++|++|.|+..|+++|+.++..||.+|.++++|.++..++|.+. +|.
T Consensus 156 gsk~d~~L~~~Av~AL~nLs~~~en~~~~IIeaGaVp~LV~LLsS~d~~lQ~eAa~aLa~Lass~ee~~~aVIeaGaVP~ 235 (2102)
T PLN03200 156 GNKQDKVVEGLLTGALRNLCGSTDGFWSATLEAGGVDILVKLLSSGNSDAQANAASLLARLMMAFESSISKVLDAGAVKQ 235 (2102)
T ss_pred CchhhHHHHHHHHHHHHHHhcCccchHHHHHHcCCHHHHHHHHcCCCHHHHHHHHHHHHHHHcCChHHHHHHHHCCCHHH
Confidence 7 67899999999999999999999999999999999999999999999999999999999999999999655 999
Q ss_pred HHHhhccC-CcHHHHHHHHHHHHHHHhCCHHHHHHHHhcCchHHHHHHhhccc-cc----cCCCCccccccCCchhhHHH
Q 000706 1220 LANILISD-EEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCS-VL----ALNPSRKDAVNESPLKIALF 1293 (1342)
Q Consensus 1220 lv~~cL~D-~D~~VR~nAA~aL~~IakHt~eLAq~VV~aGav~~LVd~~~qe~-~~----~~~~l~~~~~~~~~~ria~~ 1293 (1342)
++. +|++ .++.||++|||||++|++|+++..+.|+++||+|.||+++.... +. .-.+++ |.|+.
T Consensus 236 LV~-LL~sg~~~~VRE~AA~AL~nLAs~s~e~r~~Iv~aGgIp~LI~lL~sp~~e~~~~~~~~~Lq---------e~Avw 305 (2102)
T PLN03200 236 LLK-LLGQGNEVSVRAEAAGALEALSSQSKEAKQAIADAGGIPALINATVAPSKEFMQGEFAQALQ---------ENAMG 305 (2102)
T ss_pred HHH-HHccCCChHHHHHHHHHHHHHhcCCHHHHHHHHHCCCHHHHHHHHhCcchhhhccccchHHH---------HHHHH
Confidence 999 9975 67799999999999999999999999999999999998776322 10 002345 99999
Q ss_pred HHHhhhc-------------CCc-hhhhhhcC-CCchhhhhcccCCccccc
Q 000706 1294 SLAKMCA-------------HTP-CRQFLQSS-ELFPVIARLRQSPESTIA 1329 (1342)
Q Consensus 1294 ~L~~i~k-------------h~~-~aq~vvda-~~~~~ia~l~~~~d~~~k 1329 (1342)
+|++||. |++ ..+.++|+ ++++|+.+++++++.+++
T Consensus 306 ALsNIcgg~~~ll~~L~~ll~s~rd~~~~ada~gALayll~l~d~~~~~~~ 356 (2102)
T PLN03200 306 ALANICGGMSALILYLGELSESPRSPAPIADTLGALAYALMVFDSSAESTR 356 (2102)
T ss_pred HHHHHhCCchhhHHHHHHhhcccchHHHHHHHHhhHHHHHHhcCCchhhhh
Confidence 9999999 455 55666665 888888888887776665
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-19 Score=206.11 Aligned_cols=247 Identities=26% Similarity=0.434 Sum_probs=177.1
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCc-----------------------------------EEEEEEeecCCCCHH
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQ-----------------------------------TVAMKFIMKHGKSEK 45 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe-----------------------------------~VAVKvIkKs~~se~ 45 (1342)
|.+|+|+|++.||+|.-+.||.|+-..+|. +.|+|.+-.-.....
T Consensus 154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~ 233 (598)
T KOG4158|consen 154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG 233 (598)
T ss_pred cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence 458999999999999999999986554221 356666532211111
Q ss_pred H---HHHHHHHHH------H-----------HH----h-cCCCCcceEEEEEEe--------------------------
Q 000706 46 D---IHNLRQEIE------I-----------LR----K-LKHQNIIEMLDSFES-------------------------- 74 (1342)
Q Consensus 46 d---ierL~rEI~------I-----------LK----r-L~HPNIVKL~dvfed-------------------------- 74 (1342)
+ .+...+|.- . ++ + -.|||||++..+|.+
T Consensus 234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g 313 (598)
T KOG4158|consen 234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG 313 (598)
T ss_pred hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence 1 111222210 0 01 1 159999999876632
Q ss_pred -CCeEEEEEeccCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEE--cCCC--cEEEeecccc
Q 000706 75 -PQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILI--GAGS--VVKLCDFGFA 149 (1342)
Q Consensus 75 -ed~lyLVMEY~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILL--dsdG--~LKLiDFGLA 149 (1342)
+...|+||..++.+|.+++-.+ ..+....+-++.|+++|+.|||++||.|||+|.+|||+ ++|+ .+.++|||.+
T Consensus 314 ~~~tlylvMkrY~~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred CCceEEEehhcchhhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence 3357999999999999998654 36777888999999999999999999999999999998 4444 5899999987
Q ss_pred ccccCC------ceeeecccCCCCcCChhhhccCCC------CCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhc-
Q 000706 150 RAMSAN------TVVLRSIKGTPLYMAPELVREQPY------NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK- 216 (1342)
Q Consensus 150 r~l~ss------s~~~~s~vGTp~YmAPEvL~g~~Y------T~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr- 216 (1342)
-.-+.. ....-..-|....||||+....+- -.++|.|+.|.+.||++....||++..+..+-.+..+
T Consensus 393 LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe 472 (598)
T KOG4158|consen 393 LADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE 472 (598)
T ss_pred eeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh
Confidence 432221 111223457888999998865431 2578999999999999999999988544322222121
Q ss_pred -CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 000706 217 -DPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWS 248 (1342)
Q Consensus 217 -~~~efP~eISpeLkDLIrKcLqkDPeKRPSAe 248 (1342)
.-+.+|+.+++.++++|..+|+.||.||++..
T Consensus 473 ~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 473 SQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred hhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 23567788999999999999999999999843
|
|
| >KOG0166 consensus Karyopherin (importin) alpha [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=204.48 Aligned_cols=231 Identities=19% Similarity=0.244 Sum_probs=194.4
Q ss_pred hhhhhcc-CCCchHHHHHHHHHHHHHhhchhHHHHHHhCCchHhHHHhhcCCchhHHHHHHHHHHHHhcCCHHHHHhhhc
Q 000706 1095 RVRRLLD-SSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAK 1173 (1342)
Q Consensus 1095 ~~~~~~~-s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~v~LL~~lLqd~e~slqq~Aa~ALg~lakHS~eLAq~VVd 1173 (1342)
+.+.+|+ .+.|.++..=.-++-..|+-.+.+-....++|++|+|+.|++.|...|+.-|.-|||++|.||+.+...|++
T Consensus 113 ~lV~~l~~~~~~~lq~eAAWaLTnIAsgtse~T~~vv~agavp~fi~Ll~s~~~~v~eQavWALgNIagds~~~Rd~vl~ 192 (514)
T KOG0166|consen 113 RLVEFLSRDDNPTLQFEAAWALTNIASGTSEQTKVVVDAGAVPIFIQLLSSPSADVREQAVWALGNIAGDSPDCRDYVLS 192 (514)
T ss_pred HHHHHHccCCChhHHHHHHHHHHHHhcCchhhccccccCCchHHHHHHhcCCcHHHHHHHHHHHhccccCChHHHHHHHh
Confidence 4555555 555776443333333333222222333333999999999999999999999999999999999999999999
Q ss_pred cCcHHHHhhhcCCCCh-hhhhhHHHHHHHhHhcCHHHHHH--HHHhHHHHHHhhccCCcHHHHHHHHHHHHHHHhCCHHH
Q 000706 1174 NRIIGLLIDRCADPDK-RTRKFACFSIGNAAYHNDVLYEE--LRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKL 1250 (1342)
Q Consensus 1174 ~~iLp~Lv~~L~~~D~-~~Kr~ac~~L~~iAkHs~~LAe~--Vae~~p~lv~~cL~D~D~~VR~nAA~aL~~IakHt~eL 1250 (1342)
.++++.|+..|..+++ ...|++..+|+|+-+|..+.++. |.+++|.|+. ||...|+.|...|+|||+|++.|+.|.
T Consensus 193 ~g~l~pLl~~l~~~~~~~~lRn~tW~LsNlcrgk~P~P~~~~v~~iLp~L~~-ll~~~D~~Vl~Da~WAlsyLsdg~ne~ 271 (514)
T KOG0166|consen 193 CGALDPLLRLLNKSDKLSMLRNATWTLSNLCRGKNPSPPFDVVAPILPALLR-LLHSTDEEVLTDACWALSYLTDGSNEK 271 (514)
T ss_pred hcchHHHHHHhccccchHHHHHHHHHHHHHHcCCCCCCcHHHHHHHHHHHHH-HHhcCCHHHHHHHHHHHHHHhcCChHH
Confidence 9999999999999998 88999999999999999877764 4888999999 999999999999999999999999999
Q ss_pred HHHHHhcCchHHHHHHhhccccccCCCCccccccCCchhhHHHHHHhhhcCCc-hhhhhhcCCCchhhhhccc-CCcccc
Q 000706 1251 CEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTP-CRQFLQSSELFPVIARLRQ-SPESTI 1328 (1342)
Q Consensus 1251 Aq~VV~aGav~~LVd~~~qe~~~~~~~l~~~~~~~~~~ria~~~L~~i~kh~~-~aq~vvda~~~~~ia~l~~-~~d~~~ 1328 (1342)
-|.|+++|.+|.||++ ...++ .+.+ --|+.++|+|..++. ..|.|++++++|++..|+. ++..+|
T Consensus 272 iq~vi~~gvv~~LV~l-L~~~~---~~v~---------~PaLRaiGNIvtG~d~QTq~vi~~~~L~~l~~ll~~s~~~~i 338 (514)
T KOG0166|consen 272 IQMVIDAGVVPRLVDL-LGHSS---PKVV---------TPALRAIGNIVTGSDEQTQVVINSGALPVLSNLLSSSPKESI 338 (514)
T ss_pred HHHHHHccchHHHHHH-HcCCC---cccc---------cHHHhhccceeeccHHHHHHHHhcChHHHHHHHhccCcchhH
Confidence 9999999999999954 45555 4555 578999999999999 9999999999999999999 888889
Q ss_pred cceeeEEeecc
Q 000706 1329 ANYASVIISKV 1339 (1342)
Q Consensus 1329 k~~~~~~~~~~ 1339 (1342)
|..|--+||.+
T Consensus 339 kkEAcW~iSNI 349 (514)
T KOG0166|consen 339 KKEACWTISNI 349 (514)
T ss_pred HHHHHHHHHHh
Confidence 99776666653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=5e-18 Score=182.47 Aligned_cols=188 Identities=15% Similarity=0.139 Sum_probs=141.3
Q ss_pred EEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHH--HHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEE
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEK--DIHNLRQEIEILRKLK-HQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~--dierL~rEI~ILKrL~-HPNIVKL~dvfeded~lyLVM 82 (1342)
+.+...|++|+||+||.+.. .+.+++.+.+........ ....+.+|+++|++++ |+++++++++ +..|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 44678999999999998754 677888776654432111 1235789999999995 5889999886 4569999
Q ss_pred eccCCC-hHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC-CCCcEEEcCCCcEEEeeccccccccCCcee--
Q 000706 83 EFAQGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDM-KPQNILIGAGSVVKLCDFGFARAMSANTVV-- 158 (1342)
Q Consensus 83 EY~eGS-L~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDL-KPENILLdsdG~LKLiDFGLAr~l~sss~~-- 158 (1342)
||+.|. |.+.+.. . ...++.|+..+|.++|++||+|||| ||+|||++.+|.++|+|||++.........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 999875 5443211 1 2357899999999999999999999 799999999999999999999865543321
Q ss_pred -----------eecccCCCCcCChhhhccC-CCC-CCCcccchhhHHHHHHhCCCCCCCCc
Q 000706 159 -----------LRSIKGTPLYMAPELVREQ-PYN-HTADLWSLGVILYELFVGQPPFYTNS 206 (1342)
Q Consensus 159 -----------~~s~vGTp~YmAPEvL~g~-~YT-~KsDIWSLGVILYELLTGr~PF~g~s 206 (1342)
..-...++.|+.|+..+-- ..+ ...+.++.|.-+|.++|+..|++++.
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0012368889999865432 122 45688899999999999999987654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-17 Score=177.40 Aligned_cols=134 Identities=25% Similarity=0.363 Sum_probs=107.5
Q ss_pred EEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-----CCCCcceEEEEEEeCC---e-E
Q 000706 8 VIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-----KHQNIIEMLDSFESPQ---E-F 78 (1342)
Q Consensus 8 IlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-----~HPNIVKL~dvfeded---~-l 78 (1342)
-.+.||+|+|+.||. ++.++.. +||++..... ...+.+.+|+++++.+ +||||++++++++++. . +
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 457899999999995 6666666 6998865432 2346789999999999 5799999999998874 4 3
Q ss_pred EEEEeccC---CChHHHHhcCCCCCHHHHHHHHHHHHHHH-HHhhhCCceecCCCCCcEEEcCC----CcEEEeecccc
Q 000706 79 CVVTEFAQ---GELFEILEDDKCLPEEQVQSIAKQLVRAL-HYLHSNRIIHRDMKPQNILIGAG----SVVKLCDFGFA 149 (1342)
Q Consensus 79 yLVMEY~e---GSL~D~Lek~g~LSEeeI~~I~~QLLsAL-aYLHsrGIVHRDLKPENILLdsd----G~LKLiDFGLA 149 (1342)
.+||||.+ |+|.+++++. .+++. ..++.|++.++ +|||+++|+||||||+|||++.+ +.++|+||+.+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 47899954 6999999764 46666 36688888888 99999999999999999999743 37999995544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.7e-18 Score=212.10 Aligned_cols=193 Identities=25% Similarity=0.425 Sum_probs=162.3
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK---HQNIIEMLDSFESPQEF 78 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~---HPNIVKL~dvfeded~l 78 (1342)
+.+.|.|-+.||+|+||.||+|.+.. |+.||+|+-+.....+- .-=.+++.+|+ -+-|..+...+.-.+.-
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf-----YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEF-----YICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceee-----eehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 56789999999999999999999886 99999998765533222 11233444444 24566666777778888
Q ss_pred EEEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcC-------CCcEEEeeccccc
Q 000706 79 CVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA-------GSVVKLCDFGFAR 150 (1342)
Q Consensus 79 yLVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLds-------dG~LKLiDFGLAr 150 (1342)
++|+||.+ |+|.+++...+.+++..+..+..|++..+++||..||+||||||+|+|+.. +--++|+|||-+.
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 99999998 999999999999999999999999999999999999999999999999942 2259999999997
Q ss_pred ccc--CCceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCC
Q 000706 151 AMS--ANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQP 200 (1342)
Q Consensus 151 ~l~--sss~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~ 200 (1342)
.+. ++...+...++|-.+-.+|+..|.++++.+|.|.+..++|.|+.|+.
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 653 34456778899999999999999999999999999999999999874
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.9e-18 Score=180.67 Aligned_cols=144 Identities=17% Similarity=0.170 Sum_probs=114.0
Q ss_pred CEEEEEEEcccCcEEEEEEE-EccCCcEEEEEEeecCCCCH--------------------H--HHHHHHHHHHHHHhcC
Q 000706 5 NYHVIELVGEGSFGKVYKGR-RKYTGQTVAMKFIMKHGKSE--------------------K--DIHNLRQEIEILRKLK 61 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKAr-Dk~TGe~VAVKvIkKs~~se--------------------~--dierL~rEI~ILKrL~ 61 (1342)
-|++.+.||+|+||.||+|. +..+|+.||+|.++...... . ....+.+|++.++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47899999999999999998 67799999999987542110 0 1134678999999997
Q ss_pred CC--CcceEEEEEEeCCeEEEEEeccCCC-hHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC-ceecCCCCCcEEEcC
Q 000706 62 HQ--NIIEMLDSFESPQEFCVVTEFAQGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR-IIHRDMKPQNILIGA 137 (1342)
Q Consensus 62 HP--NIVKL~dvfeded~lyLVMEY~eGS-L~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrG-IVHRDLKPENILLds 137 (1342)
+. .+.++++. ...++||||++|. +.........+.+..+..++.|++.++++||++| ++||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 34455442 2348999999974 5555444556777788899999999999999999 99999999999999
Q ss_pred CCcEEEeecccccccc
Q 000706 138 GSVVKLCDFGFARAMS 153 (1342)
Q Consensus 138 dG~LKLiDFGLAr~l~ 153 (1342)
+++++|+|||.+...+
T Consensus 184 ~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCCEEEEEChhhhccC
Confidence 8899999999987544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.5e-19 Score=212.25 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=211.7
Q ss_pred CCEEEEEEEcccCcEEEEEEEEcc-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEE
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKY-TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-HQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~-TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~-HPNIVKL~dvfeded~lyLV 81 (1342)
..|++.+.||+|+|+.|-...... ....+++|.+..........++...|..+-+.+. |+|++++++...+.+..++.
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 468999999999999999887643 3445677877666555556677888999988887 99999999999999999999
Q ss_pred EeccC-CChHHHH-hcCC-CCCHHHHHHHHHHHHHHHHHhh-hCCceecCCCCCcEEEcCCC-cEEEeeccccccccC-C
Q 000706 82 TEFAQ-GELFEIL-EDDK-CLPEEQVQSIAKQLVRALHYLH-SNRIIHRDMKPQNILIGAGS-VVKLCDFGFARAMSA-N 155 (1342)
Q Consensus 82 MEY~e-GSL~D~L-ek~g-~LSEeeI~~I~~QLLsALaYLH-srGIVHRDLKPENILLdsdG-~LKLiDFGLAr~l~s-s 155 (1342)
+||.. |++++.+ .... ..+......++.|+..++.|+| ..++.|||+||+|.+++..+ .+|+.|||+|..+.. +
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 99976 6899988 5555 7888899999999999999999 99999999999999999999 999999999987765 2
Q ss_pred --ceeeecccC-CCCcCChhhhccCC-CCCCCcccchhhHHHHHHhCCCCCCCCcHHHHH-HHHh----cCCCCCCCCCC
Q 000706 156 --TVVLRSIKG-TPLYMAPELVREQP-YNHTADLWSLGVILYELFVGQPPFYTNSVYALI-RHIV----KDPVKYPDEMS 226 (1342)
Q Consensus 156 --s~~~~s~vG-Tp~YmAPEvL~g~~-YT~KsDIWSLGVILYELLTGr~PF~g~s~~eli-rkIl----r~~~efP~eIS 226 (1342)
.......+| ++.|.|||...+.. ..+..|+||.|+++.-+++|..||......... .... ......+..++
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSIS 259 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCC
Confidence 233455788 99999999988854 467899999999999999999999765432211 1111 11244556788
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCcCccc
Q 000706 227 PNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258 (1342)
Q Consensus 227 peLkDLIrKcLqkDPeKRPSAeELLeHPFFre 258 (1342)
....+++.+++..+|..|.+.+++..+||+..
T Consensus 260 ~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 260 DQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred hhhhhcccccccCCchhccccccccccccccc
Confidence 99999999999999999999999999999876
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.8e-18 Score=186.00 Aligned_cols=241 Identities=22% Similarity=0.442 Sum_probs=195.3
Q ss_pred CCCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 1 IgVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
+++.+..+..+|.+.-.|..|+++.+ |..++.|++.-...+....+++.+|.-.++-+.||||+.+++.+..+..+.+
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 35566677788889999999999665 6667788876555554445678889989999999999999999999999999
Q ss_pred EEeccC-CChHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCC--ceecCCCCCcEEEcCCCcEEEe--ecccccccc
Q 000706 81 VTEFAQ-GELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHSNR--IIHRDMKPQNILIGAGSVVKLC--DFGFARAMS 153 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~g--~LSEeeI~~I~~QLLsALaYLHsrG--IVHRDLKPENILLdsdG~LKLi--DFGLAr~l~ 153 (1342)
+..|++ |+|+..+.... .++..++.+++.++++|++|||+.. |.---|....+++|++-+.+|. |--++.
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--- 341 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--- 341 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee---
Confidence 999998 99999997643 4677899999999999999999874 4455688999999998866653 322221
Q ss_pred CCceeeecccCCCCcCChhhhccCCCC---CCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcC--CCCCCCCCCHH
Q 000706 154 ANTVVLRSIKGTPLYMAPELVREQPYN---HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD--PVKYPDEMSPN 228 (1342)
Q Consensus 154 sss~~~~s~vGTp~YmAPEvL~g~~YT---~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~--~~efP~eISpe 228 (1342)
......-.|.|++||.+..++-+ .++|+|||.+++||+.|...||..-+..+.-.+|.-. +..+|+.+++.
T Consensus 342 ----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~h 417 (448)
T KOG0195|consen 342 ----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRH 417 (448)
T ss_pred ----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHH
Confidence 11223357899999999877644 5689999999999999999999988877776666543 66789999999
Q ss_pred HHHHHHHhcccCCCCCCCHHHH
Q 000706 229 FKSFLKGLLNKVPQNRLTWSAL 250 (1342)
Q Consensus 229 LkDLIrKcLqkDPeKRPSAeEL 250 (1342)
...|+.-|++.||.+||.+..+
T Consensus 418 m~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 418 MNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred HHHHHHHHhcCCCCcCCCccee
Confidence 9999999999999999987665
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.6e-16 Score=163.27 Aligned_cols=135 Identities=23% Similarity=0.441 Sum_probs=112.8
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHH------HHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEK------DIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~------dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
+.||+|++|.||+|.+ +|..+++|.......... ...++.+|++++..+.|+++.....++.+.+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6799999999999976 678899998654322111 12457789999999999999888877777888999999
Q ss_pred ccCC-ChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 000706 84 FAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARA 151 (1342)
Q Consensus 84 Y~eG-SL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~ 151 (1342)
|++| +|.+.+..... ....++.+++.+|.++|+.|++|||++|+|||++ ++.++++|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9985 78887765432 7889999999999999999999999999999999 78999999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=162.72 Aligned_cols=131 Identities=21% Similarity=0.393 Sum_probs=105.9
Q ss_pred EEcccCcEEEEEEEEccCCcEEEEEEeecCCCC--H----HHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 11 LVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS--E----KDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 11 ~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s--e----~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
.||+|+||.||++. .++..+++|........ + ....++.+|++++..+.|+++.....++.+++..+++|||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 37999999999997 46788999986543221 1 1235678899999999988766665556667778999999
Q ss_pred cCC-ChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 000706 85 AQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARA 151 (1342)
Q Consensus 85 ~eG-SL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~ 151 (1342)
++| +|.+.+..... .++.|++.+|.+||+.|++|||++|+||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 974 67777654321 7899999999999999999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PLN03200 cellulose synthase-interactive protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=8.9e-16 Score=200.73 Aligned_cols=271 Identities=17% Similarity=0.201 Sum_probs=225.3
Q ss_pred CCcchhhhhccccccc-ccCchHHHHHHHhcCchhHHHhhcccccChhhhhhhccCCCchHHHHHHHHHHHHHhhchhHH
Q 000706 1048 GVPGIILRCLEHMELK-NLGRPIAFLAKMIGQRSLAVQLVGKGLLDPNRVRRLLDSSTREVTLDVLMIVSDLARMDKWFY 1126 (1342)
Q Consensus 1048 ~~~~~~~~~~~~~~~~-~~~~pi~~l~~~~~~~~~~~q~v~~~~~~~~~~~~~~~s~~~~~r~~f~~~va~lars~~~~i 1126 (1342)
.+-..+.+.|.|=.-. ..++=+--|+.+.+.+.+..-|...+ .++.++.||.+...+++.+-+..+..++.....+.
T Consensus 362 ~v~~~LV~Llr~k~p~~vqe~V~eALasl~gN~~l~~~L~~~d--aik~LV~LL~~~~~evQ~~Av~aL~~L~~~~~e~~ 439 (2102)
T PLN03200 362 VIEQILVKLLKPRDTKLVQERIIEALASLYGNAYLSRKLNHAE--AKKVLVGLITMATADVQEELIRALSSLCCGKGGLW 439 (2102)
T ss_pred ccHHHHHHHhCCCCCchhHHHHHHHHHHhcCChHHHHHHHhcc--chhhhhhhhccCCHHHHHHHHHHHHHHhCCCHHHH
Confidence 3334455666664211 11222334555556665554444433 36779999999999999999999999997778899
Q ss_pred HHHHhCCchHhHHHhhcCCchhHHHHHHHHHHHHhcCCHHHHHhhhccCcHHHHhhhcCCCChhhhhhHHHHHHHhHhcC
Q 000706 1127 EYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHN 1206 (1342)
Q Consensus 1127 e~I~~aG~v~LL~~lLqd~e~slqq~Aa~ALg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs 1206 (1342)
..|.+.|.+|.|+.+|.++.+.+|+.|+.+|++|++.+++-.+.|+++|++|.|+.+|.++|.++|++||.+|+|++.|+
T Consensus 440 ~aIi~~ggIp~LV~LL~s~s~~iQ~~A~~~L~nLa~~ndenr~aIieaGaIP~LV~LL~s~~~~iqeeAawAL~NLa~~~ 519 (2102)
T PLN03200 440 EALGGREGVQLLISLLGLSSEQQQEYAVALLAILTDEVDESKWAITAAGGIPPLVQLLETGSQKAKEDSATVLWNLCCHS 519 (2102)
T ss_pred HHHHHcCcHHHHHHHHcCCCHHHHHHHHHHHHHHHcCCHHHHHHHHHCCCHHHHHHHHcCCCHHHHHHHHHHHHHHhCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHH--HhHHHHHHhhccCCcHHHHHHHHHHHHHHHhCCHH-----------------------------------
Q 000706 1207 DVLYEELR--RSIPLLANILISDEEDKTKANAAGALSNLIRNSSK----------------------------------- 1249 (1342)
Q Consensus 1207 ~~LAe~Va--e~~p~lv~~cL~D~D~~VR~nAA~aL~~IakHt~e----------------------------------- 1249 (1342)
.+-...|. ..+|+|+. +|++.|+.+|++|||+|.+++++...
T Consensus 520 ~qir~iV~~aGAIppLV~-LL~sgd~~~q~~Aa~AL~nLi~~~d~~~I~~Lv~LLlsdd~~~~~~aL~vLgnIlsl~~~~ 598 (2102)
T PLN03200 520 EDIRACVESAGAVPALLW-LLKNGGPKGQEIAAKTLTKLVRTADAATISQLTALLLGDLPESKVHVLDVLGHVLSVASLE 598 (2102)
T ss_pred HHHHHHHHHCCCHHHHHH-HHhCCCHHHHHHHHHHHHHHHhccchhHHHHHHHHhcCCChhHHHHHHHHHHHHHhhcchh
Confidence 88888784 45999999 99999999999999999999865421
Q ss_pred --HHHHHHhcCchHHHHHHhhccccccCCCCccccccCCchhhHHHHHHhhhcCCc-hhhhhhcCCCchhhhhcccCCcc
Q 000706 1250 --LCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTP-CRQFLQSSELFPVIARLRQSPES 1326 (1342)
Q Consensus 1250 --LAq~VV~aGav~~LVd~~~qe~~~~~~~l~~~~~~~~~~ria~~~L~~i~kh~~-~aq~vvda~~~~~ia~l~~~~d~ 1326 (1342)
.-+.+.+.||++.|+++....++ ..| +-|..+|++||...+ ..|.++++|+||-+-.++++.+.
T Consensus 599 d~~~~g~~~~ggL~~Lv~LL~sgs~----~ik---------k~Aa~iLsnL~a~~~d~~~avv~agaIpPLV~LLss~~~ 665 (2102)
T PLN03200 599 DLVREGSAANDALRTLIQLLSSSKE----ETQ---------EKAASVLADIFSSRQDLCESLATDEIINPCIKLLTNNTE 665 (2102)
T ss_pred HHHHHhhhccccHHHHHHHHcCCCH----HHH---------HHHHHHHHHHhcCChHHHHHHHHcCCHHHHHHHHhcCCh
Confidence 01112257999999988887766 777 778899999999999 88999999999999999999999
Q ss_pred cccceeeE
Q 000706 1327 TIANYASV 1334 (1342)
Q Consensus 1327 ~~k~~~~~ 1334 (1342)
.+++++..
T Consensus 666 ~v~keAA~ 673 (2102)
T PLN03200 666 AVATQSAR 673 (2102)
T ss_pred HHHHHHHH
Confidence 88887654
|
|
| >KOG0166 consensus Karyopherin (importin) alpha [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1e-16 Score=188.49 Aligned_cols=276 Identities=19% Similarity=0.233 Sum_probs=232.9
Q ss_pred cCCcchhhhhcccc--cccccCchHHHHHHHhcCchhHHHhhcccccChhhhhhhccCCCchHHHHHHHHHHHHHhhchh
Q 000706 1047 VGVPGIILRCLEHM--ELKNLGRPIAFLAKMIGQRSLAVQLVGKGLLDPNRVRRLLDSSTREVTLDVLMIVSDLARMDKW 1124 (1342)
Q Consensus 1047 ~~~~~~~~~~~~~~--~~~~~~~pi~~l~~~~~~~~~~~q~v~~~~~~~~~~~~~~~s~~~~~r~~f~~~va~lars~~~ 1124 (1342)
-|+=.....|+.+= |--++| .-=-||.+|+..+--.+.|-+--++|- ...++.|....|+-+-+..+...|.-.+.
T Consensus 108 ~G~v~~lV~~l~~~~~~~lq~e-AAWaLTnIAsgtse~T~~vv~agavp~-fi~Ll~s~~~~v~eQavWALgNIagds~~ 185 (514)
T KOG0166|consen 108 SGVVPRLVEFLSRDDNPTLQFE-AAWALTNIASGTSEQTKVVVDAGAVPI-FIQLLSSPSADVREQAVWALGNIAGDSPD 185 (514)
T ss_pred cCcHHHHHHHHccCCChhHHHH-HHHHHHHHhcCchhhccccccCCchHH-HHHHhcCCcHHHHHHHHHHHhccccCChH
Confidence 35545555666532 222333 233478899777777777744445555 67788899999999988888888866666
Q ss_pred HHHHHHhCCchHhHHHhhcCCch-hHHHHHHHHHHHHhcCCHHHHHhhhccCcHHHHhhhcCCCChhhhhhHHHHHHHhH
Q 000706 1125 FYEYINGASMLEFLKDFLTHEDP-NVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAA 1203 (1342)
Q Consensus 1125 ~ie~I~~aG~v~LL~~lLqd~e~-slqq~Aa~ALg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iA 1203 (1342)
-=.+..+.|+|+.|..+++.+.+ ++.|.++-+|++||+|..--+...+-..+||-|..+|.+.|+.+..-||.+|+.++
T Consensus 186 ~Rd~vl~~g~l~pLl~~l~~~~~~~~lRn~tW~LsNlcrgk~P~P~~~~v~~iLp~L~~ll~~~D~~Vl~Da~WAlsyLs 265 (514)
T KOG0166|consen 186 CRDYVLSCGALDPLLRLLNKSDKLSMLRNATWTLSNLCRGKNPSPPFDVVAPILPALLRLLHSTDEEVLTDACWALSYLT 265 (514)
T ss_pred HHHHHHhhcchHHHHHHhccccchHHHHHHHHHHHHHHcCCCCCCcHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHHh
Confidence 66777889999999999999998 99999999999999999655555555679999999999999999999999999999
Q ss_pred hcCHHHHHHHHHh--HHHHHHhhccCCcHHHHHHHHHHHHHHHhCCHHHHHHHHhcCchHHHHHHhhccccccCCCCccc
Q 000706 1204 YHNDVLYEELRRS--IPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKD 1281 (1342)
Q Consensus 1204 kHs~~LAe~Vae~--~p~lv~~cL~D~D~~VR~nAA~aL~~IakHt~eLAq~VV~aGav~~LVd~~~qe~~~~~~~l~~~ 1281 (1342)
.|+.|..++|.+. .|.|+. ||.-+++.|+-.|--++|||+-+|.+..|.|+++|++|.|-.+...+|+ ...|
T Consensus 266 dg~ne~iq~vi~~gvv~~LV~-lL~~~~~~v~~PaLRaiGNIvtG~d~QTq~vi~~~~L~~l~~ll~~s~~---~~ik-- 339 (514)
T KOG0166|consen 266 DGSNEKIQMVIDAGVVPRLVD-LLGHSSPKVVTPALRAIGNIVTGSDEQTQVVINSGALPVLSNLLSSSPK---ESIK-- 339 (514)
T ss_pred cCChHHHHHHHHccchHHHHH-HHcCCCcccccHHHhhccceeeccHHHHHHHHhcChHHHHHHHhccCcc---hhHH--
Confidence 9999999999655 999999 9999999999999999999999999999999999999999978887888 6788
Q ss_pred cccCCchhhHHHHHHhhhcCCc-hhhhhhcCCCchhhhhcccCCcccccceeeEEee
Q 000706 1282 AVNESPLKIALFSLAKMCAHTP-CRQFLQSSELFPVIARLRQSPESTIANYASVIIS 1337 (1342)
Q Consensus 1282 ~~~~~~~ria~~~L~~i~kh~~-~aq~vvda~~~~~ia~l~~~~d~~~k~~~~~~~~ 1337 (1342)
+=|.-.+++|+.+++ =.|+|+|+|.+|.|..++++-|.++|+-|.-.|+
T Consensus 340 -------kEAcW~iSNItAG~~~qiqaVida~l~p~Li~~l~~~ef~~rKEAawaIs 389 (514)
T KOG0166|consen 340 -------KEACWTISNITAGNQEQIQAVIDANLIPVLINLLQTAEFDIRKEAAWAIS 389 (514)
T ss_pred -------HHHHHHHHHhhcCCHHHHHHHHHcccHHHHHHHHhccchHHHHHHHHHHH
Confidence 445689999999999 9999999999999999999999999988765554
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.6e-16 Score=161.36 Aligned_cols=138 Identities=21% Similarity=0.292 Sum_probs=107.6
Q ss_pred EEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHH--------------------HHHHHHHHHHHHHhcCCC--
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEK--------------------DIHNLRQEIEILRKLKHQ-- 63 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~--------------------dierL~rEI~ILKrL~HP-- 63 (1342)
|.+.+.||+|+||.||++... +|+.||||+++....... .......|+.++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888999999999999999875 799999998765421100 112366789999999877
Q ss_pred CcceEEEEEEeCCeEEEEEeccCC-ChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEE
Q 000706 64 NIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVK 142 (1342)
Q Consensus 64 NIVKL~dvfeded~lyLVMEY~eG-SL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LK 142 (1342)
++++.++ ....+++|||++| +|.+... ......++.+++.++.++|++|++||||||+||+++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 4444444 2445899999986 4544322 134567889999999999999999999999999999999999
Q ss_pred EeeccccccccC
Q 000706 143 LCDFGFARAMSA 154 (1342)
Q Consensus 143 LiDFGLAr~l~s 154 (1342)
|+|||.+.....
T Consensus 166 liDfg~~~~~~~ 177 (198)
T cd05144 166 IIDWPQMVSTDH 177 (198)
T ss_pred EEECCccccCCC
Confidence 999999966554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2e-17 Score=193.11 Aligned_cols=174 Identities=27% Similarity=0.451 Sum_probs=135.8
Q ss_pred CeEEEEEeccC-CChHHHHhcCC---CCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 000706 76 QEFCVVTEFAQ-GELFEILEDDK---CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARA 151 (1342)
Q Consensus 76 d~lyLVMEY~e-GSL~D~Lek~g---~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~ 151 (1342)
.+.||.|++|. ++|.++|..+. ..+......++.|+..+++| +|.+|||+||.||+...++.+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 36799999997 88999997543 35667888999999999999 9999999999999999999999999999987
Q ss_pred ccCCc------eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCC--CC
Q 000706 152 MSANT------VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKDPVK--YP 222 (1342)
Q Consensus 152 l~sss------~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLT-Gr~PF~g~s~~elirkIlr~~~e--fP 222 (1342)
..... ...+...||++||+||++.+..|+.++|||+||++|||++. -..+|... .....+..+.++ +.
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~g~ip~~~~ 482 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRDGIIPPEFL 482 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---HhhhhhhcCCCChHHh
Confidence 75443 12345679999999999999999999999999999999997 33333221 122222222222 22
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 223 DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 223 ~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
.++ |+-.+|+.+||...|.+||++.+.-.|+|.
T Consensus 483 ~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 483 QDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 333 344589999999999999988777777764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1e-15 Score=154.47 Aligned_cols=138 Identities=23% Similarity=0.290 Sum_probs=101.0
Q ss_pred EEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHH----------------------HHHHHHHHHhcCCC--C
Q 000706 9 IELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHN----------------------LRQEIEILRKLKHQ--N 64 (1342)
Q Consensus 9 lK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dier----------------------L~rEI~ILKrL~HP--N 64 (1342)
.+.||+|+||.||+|.+. +++.||+|+++........... ...|.+.+.++.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999887 8999999998764322111111 14566677776544 3
Q ss_pred cceEEEEEEeCCeEEEEEeccCC-ChH-HHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCcEEEcCCCcE
Q 000706 65 IIEMLDSFESPQEFCVVTEFAQG-ELF-EILEDDKCLPEEQVQSIAKQLVRALHYLHS-NRIIHRDMKPQNILIGAGSVV 141 (1342)
Q Consensus 65 IVKL~dvfeded~lyLVMEY~eG-SL~-D~Lek~g~LSEeeI~~I~~QLLsALaYLHs-rGIVHRDLKPENILLdsdG~L 141 (1342)
+.++++.. ..+++|||++| ++. ..+.... . ...++.++.+++.++.++|. +|++||||||+||+++ ++.+
T Consensus 81 ~~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDLN----RHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEecC----CCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 45555432 35899999986 221 1122111 1 16788999999999999999 9999999999999999 8899
Q ss_pred EEeeccccccccC
Q 000706 142 KLCDFGFARAMSA 154 (1342)
Q Consensus 142 KLiDFGLAr~l~s 154 (1342)
+++|||.+.....
T Consensus 154 ~liDfg~a~~~~~ 166 (187)
T cd05119 154 YIIDVPQAVEIDH 166 (187)
T ss_pred EEEECcccccccC
Confidence 9999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.9e-15 Score=179.13 Aligned_cols=136 Identities=21% Similarity=0.342 Sum_probs=109.1
Q ss_pred CEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCC-CC-----HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KS-----EKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEF 78 (1342)
Q Consensus 5 rYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~-~s-----e~dierL~rEI~ILKrL~HPNIVKL~dvfeded~l 78 (1342)
.|...+.||+|+||+||++... ++.+++|...... .. ....+++.+|+++++.++|++++.++.+..++...
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3456789999999999999764 3444455432221 11 11235688999999999999999888877777788
Q ss_pred EEEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 000706 79 CVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARA 151 (1342)
Q Consensus 79 yLVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~ 151 (1342)
++||||++ ++|.+++. ....++.|++.+|.|||+.|++||||||+||++ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999997 57887765 356789999999999999999999999999999 677999999999865
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.4e-15 Score=137.85 Aligned_cols=132 Identities=28% Similarity=0.386 Sum_probs=111.0
Q ss_pred EEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCC--CCcceEEEEEEeCCeEEEEEecc
Q 000706 8 VIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH--QNIIEMLDSFESPQEFCVVTEFA 85 (1342)
Q Consensus 8 IlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~H--PNIVKL~dvfeded~lyLVMEY~ 85 (1342)
+.+.||+|.++.||++... ++.+++|....... ...+.+|+.+++.++| +++++++.+++..+..|++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 4688999999999999875 37899998865432 3568889999999976 58999999998888999999999
Q ss_pred CCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CceecCCCCCcEEEcCCCcEEEeecccccc
Q 000706 86 QGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN---RIIHRDMKPQNILIGAGSVVKLCDFGFARA 151 (1342)
Q Consensus 86 eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsr---GIVHRDLKPENILLdsdG~LKLiDFGLAr~ 151 (1342)
+|.....+ +......++.++.++++++|.. +++|||++|+||+++.++.+++.|||.+..
T Consensus 76 ~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 86533221 5567778899999999999985 799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.9e-15 Score=175.44 Aligned_cols=196 Identities=26% Similarity=0.481 Sum_probs=156.4
Q ss_pred HHhcCCCCcceEEEEEEeCCeEEEEEeccC-CChHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCc-eecCCCCCcE
Q 000706 57 LRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRI-IHRDMKPQNI 133 (1342)
Q Consensus 57 LKrL~HPNIVKL~dvfeded~lyLVMEY~e-GSL~D~Lek-~g~LSEeeI~~I~~QLLsALaYLHsrGI-VHRDLKPENI 133 (1342)
|+.+.|.|+.++++...++...++|.+||. |+|+|.+.. .-.++......++++++.||+|+|...| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 356899999999999999999999999997 999999987 5578888999999999999999999866 9999999999
Q ss_pred EEcCCCcEEEeeccccccccCC--ceeeecccCCCCcCChhhhccCC-------CCCCCcccchhhHHHHHHhCCCCCCC
Q 000706 134 LIGAGSVVKLCDFGFARAMSAN--TVVLRSIKGTPLYMAPELVREQP-------YNHTADLWSLGVILYELFVGQPPFYT 204 (1342)
Q Consensus 134 LLdsdG~LKLiDFGLAr~l~ss--s~~~~s~vGTp~YmAPEvL~g~~-------YT~KsDIWSLGVILYELLTGr~PF~g 204 (1342)
+++....+||.|||+....... ........-..-|.|||.++... .+.+.|+||+|+++||+++.+.||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 9999999999999998776421 11111122345589999987642 35679999999999999999999975
Q ss_pred C----cHHHHHHHHhc-CCCCCC------CCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 000706 205 N----SVYALIRHIVK-DPVKYP------DEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 205 ~----s~~elirkIlr-~~~efP------~eISpeLkDLIrKcLqkDPeKRPSAeELLe 252 (1342)
. +..+.+..+.+ ....+. ...++++..+++.|+..+|.+||+++++..
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 2 22345555544 222121 145567999999999999999999988743
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.5e-15 Score=177.65 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=206.2
Q ss_pred CEEEEEEEcc--cCcEEEEEEEE--ccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEE
Q 000706 5 NYHVIELVGE--GSFGKVYKGRR--KYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFC 79 (1342)
Q Consensus 5 rYrIlK~LGs--GgFGtVYKArD--k~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~ly 79 (1342)
.|.+.+.+|. |.+|.||.+.. ..++..+|+|.-+..........+-.+|+...+.+ .|+|.++.+..++..+..|
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4677888999 99999999988 88899999998544443333334555677777777 5899999999999999999
Q ss_pred EEEeccCCChHHHHhcCC-CCCHHHHHHHHHHHHH----HHHHhhhCCceecCCCCCcEEEcCC-CcEEEeecccccccc
Q 000706 80 VVTEFAQGELFEILEDDK-CLPEEQVQSIAKQLVR----ALHYLHSNRIIHRDMKPQNILIGAG-SVVKLCDFGFARAMS 153 (1342)
Q Consensus 80 LVMEY~eGSL~D~Lek~g-~LSEeeI~~I~~QLLs----ALaYLHsrGIVHRDLKPENILLdsd-G~LKLiDFGLAr~l~ 153 (1342)
+-+|+++.+|.++..... .+++..++.++.+... ||.++|..+++|-|+||.||+...+ ...+++|||+...++
T Consensus 195 iqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~ 274 (524)
T KOG0601|consen 195 IQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKIS 274 (524)
T ss_pred eeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEcc
Confidence 999999999999887644 4899999999999999 9999999999999999999999999 789999999999887
Q ss_pred CCceeeec-----ccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCC--cHHHHHHHHhcCCCCCCCCCC
Q 000706 154 ANTVVLRS-----IKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTN--SVYALIRHIVKDPVKYPDEMS 226 (1342)
Q Consensus 154 sss~~~~s-----~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~--s~~elirkIlr~~~efP~eIS 226 (1342)
........ ..|...|++||..++- ++...|+|++|.++.+-.++..++... +.....+... .+.++-...+
T Consensus 275 ~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~e~~~~~s 352 (524)
T KOG0601|consen 275 DGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPLEFCEGGS 352 (524)
T ss_pred CCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-CchhhhcCcc
Confidence 66533222 2688899999987764 889999999999999999887776543 3333333322 3334445567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCcCccc
Q 000706 227 PNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258 (1342)
Q Consensus 227 peLkDLIrKcLqkDPeKRPSAeELLeHPFFre 258 (1342)
.++...+..|+..+|..|++.+.+..|+++.+
T Consensus 353 ~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 353 SSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 77888999999999999999999999999874
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.4e-14 Score=152.62 Aligned_cols=135 Identities=19% Similarity=0.267 Sum_probs=104.3
Q ss_pred EEEc-ccCcEEEEEEEEccCCcEEEEEEeecCCC-----------CHHHHHHHHHHHHHHHhcCCCCc--ceEEEEEEeC
Q 000706 10 ELVG-EGSFGKVYKGRRKYTGQTVAMKFIMKHGK-----------SEKDIHNLRQEIEILRKLKHQNI--IEMLDSFESP 75 (1342)
Q Consensus 10 K~LG-sGgFGtVYKArDk~TGe~VAVKvIkKs~~-----------se~dierL~rEI~ILKrL~HPNI--VKL~dvfede 75 (1342)
..|| .|+.|+||.+... ++.+++|.+.+... ......++.+|++++.+++|+++ ++++++...+
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 7888888888654 78899998865321 11223568889999999998875 6777764332
Q ss_pred C-e---EEEEEeccCC--ChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccc
Q 000706 76 Q-E---FCVVTEFAQG--ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFA 149 (1342)
Q Consensus 76 d-~---lyLVMEY~eG--SL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLA 149 (1342)
. . .++||||++| +|.+++.+ .++++.. +.|++.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 2 3599999985 67777755 4566553 578999999999999999999999999999999999999988
Q ss_pred cc
Q 000706 150 RA 151 (1342)
Q Consensus 150 r~ 151 (1342)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 65
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.6e-14 Score=176.57 Aligned_cols=261 Identities=26% Similarity=0.428 Sum_probs=211.8
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHH-HHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEK-DIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~-dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyL 80 (1342)
..+++.+.+-+-+|.++.++.+....+|...+.|...+...-.. +.+..+.+-+++-...+|.++.....+......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 35788899999999999999998887887777776543322111 23344445555444556777766666667778899
Q ss_pred EEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCC----
Q 000706 81 VTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN---- 155 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~ss---- 155 (1342)
+|+|.+ |+|...+...+..+++-++.++..+..+++|||...+.|||++|.|++...+|+.++.|||.....+--
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 999997 689999988888999999999999999999999999999999999999999999999999844322100
Q ss_pred ---------------------------ceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHH
Q 000706 156 ---------------------------TVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVY 208 (1342)
Q Consensus 156 ---------------------------s~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~ 208 (1342)
........||+.|.+||.+.+......+|+|+.|+.++|.++|.+||......
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 00112346999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCC---CCCCHHHHHHHHHhcccCCCCCCCHH---HHHcCcCcccchhh
Q 000706 209 ALIRHIVKDPVKYP---DEMSPNFKSFLKGLLNKVPQNRLTWS---ALLEHPFVKETSDE 262 (1342)
Q Consensus 209 elirkIlr~~~efP---~eISpeLkDLIrKcLqkDPeKRPSAe---ELLeHPFFre~~~e 262 (1342)
...+.+......+| ...+++.++++...+..+|.+|..+. +...||||+....+
T Consensus 1042 ~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1042 QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcc
Confidence 99988888766555 46899999999999999999999877 99999999986543
|
|
| >PF10508 Proteasom_PSMB: Proteasome non-ATPase 26S subunit; InterPro: IPR019538 The 26S proteasome is an enzymatic complex that degrades ubiquitinated proteins in eukaryotic cells | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.8e-12 Score=152.46 Aligned_cols=188 Identities=24% Similarity=0.292 Sum_probs=167.0
Q ss_pred hhHHHHHHhCCchHhHHHhhcCCchhHHHHHHHHHHHHhcCCHHHHHhhhccCcHHHHhhhcCCCChhhhhhHHHHHHHh
Q 000706 1123 KWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNA 1202 (1342)
Q Consensus 1123 ~~~ie~I~~aG~v~LL~~lLqd~e~slqq~Aa~ALg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~i 1202 (1342)
......+ ..+..++|...|.+|++.||+.++.+|+++++|+++.++.++++++++.++.+|.++|..+.+.|+-+|..+
T Consensus 68 ~~~~~~l-~~~~~~~L~~gL~h~~~~Vr~l~l~~l~~~~~~~~~~~~~~~~~~l~~~i~~~L~~~d~~Va~~A~~~L~~l 146 (503)
T PF10508_consen 68 ALSPDSL-LPQYQPFLQRGLTHPSPKVRRLALKQLGRIARHSEGAAQLLVDNELLPLIIQCLRDPDLSVAKAAIKALKKL 146 (503)
T ss_pred ccCHHHH-HHHHHHHHHHHhcCCCHHHHHHHHHHHHHHhcCCHHHHHHhcCccHHHHHHHHHcCCcHHHHHHHHHHHHHH
Confidence 3344443 567889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCHHHHHHH-HHhHHHHHHhhccCCcHHHHHHHHHHHHHHHhCCHHHHHHHHhcCchHHHHHHhhccccccCCCCccc
Q 000706 1203 AYHNDVLYEEL-RRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKD 1281 (1342)
Q Consensus 1203 AkHs~~LAe~V-ae~~p~lv~~cL~D~D~~VR~nAA~aL~~IakHt~eLAq~VV~aGav~~LVd~~~qe~~~~~~~l~~~ 1281 (1342)
++|...+.+.+ .+..+.|.. ++...++.+|-.+-.++.+|++|++++++.+++.|.++.|++...+ .| .-+|
T Consensus 147 ~~~~~~~~~l~~~~~~~~L~~-l~~~~~~~vR~Rv~el~v~i~~~S~~~~~~~~~sgll~~ll~eL~~-dD---iLvq-- 219 (503)
T PF10508_consen 147 ASHPEGLEQLFDSNLLSKLKS-LMSQSSDIVRCRVYELLVEIASHSPEAAEAVVNSGLLDLLLKELDS-DD---ILVQ-- 219 (503)
T ss_pred hCCchhHHHHhCcchHHHHHH-HHhccCHHHHHHHHHHHHHHHhcCHHHHHHHHhccHHHHHHHHhcC-cc---HHHH--
Confidence 99999998766 444788888 8888899999999999999999999999999999999999965555 66 3455
Q ss_pred cccCCchhhHHHHHHhhhcCCchhhhhhcCCCchhhhhcccCCc
Q 000706 1282 AVNESPLKIALFSLAKMCAHTPCRQFLQSSELFPVIARLRQSPE 1325 (1342)
Q Consensus 1282 ~~~~~~~ria~~~L~~i~kh~~~aq~vvda~~~~~ia~l~~~~d 1325 (1342)
.-++..|++||+++.-++++.+.|.++.|..++.+.+
T Consensus 220 -------lnalell~~La~~~~g~~yL~~~gi~~~L~~~l~~~~ 256 (503)
T PF10508_consen 220 -------LNALELLSELAETPHGLQYLEQQGIFDKLSNLLQDSE 256 (503)
T ss_pred -------HHHHHHHHHHHcChhHHHHHHhCCHHHHHHHHHhccc
Confidence 6788899999994449999999999999999998654
|
26S proteasome non-ATPase regulatory subunit 5 is one of a number of chaperones that are involved in the assembly of the proteasome. The chaperones dissociate before 26S proteasome formation is complete [].; GO: 0044183 protein binding involved in protein folding |
| >PF10508 Proteasom_PSMB: Proteasome non-ATPase 26S subunit; InterPro: IPR019538 The 26S proteasome is an enzymatic complex that degrades ubiquitinated proteins in eukaryotic cells | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.5e-11 Score=146.16 Aligned_cols=257 Identities=16% Similarity=0.187 Sum_probs=196.9
Q ss_pred hhhhcccccccccCchHHHHHHHhc--Cchh-HHHhhcccccChhhhhhhccCCCchHHHHHHHHHHHHHhhchhHHHHH
Q 000706 1053 ILRCLEHMELKNLGRPIAFLAKMIG--QRSL-AVQLVGKGLLDPNRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYI 1129 (1342)
Q Consensus 1053 ~~~~~~~~~~~~~~~pi~~l~~~~~--~~~~-~~q~v~~~~~~~~~~~~~~~s~~~~~r~~f~~~va~lars~~~~ie~I 1129 (1342)
++.|+.--...+++.=...|.|+.. ++.. ..|+ +..+...|.+..|.||..-++.|..+++.....++.+
T Consensus 43 lf~~L~~~~~e~v~~~~~iL~~~l~~~~~~~l~~~~-------~~~L~~gL~h~~~~Vr~l~l~~l~~~~~~~~~~~~~~ 115 (503)
T PF10508_consen 43 LFDCLNTSNREQVELICDILKRLLSALSPDSLLPQY-------QPFLQRGLTHPSPKVRRLALKQLGRIARHSEGAAQLL 115 (503)
T ss_pred HHHHHhhcChHHHHHHHHHHHHHHhccCHHHHHHHH-------HHHHHHHhcCCCHHHHHHHHHHHHHHhcCCHHHHHHh
Confidence 5555554444455555555555552 2222 1111 1234455667889999999999999997776678888
Q ss_pred HhCCchHhHHHhhcCCchhHHHHHHHHHHHHhcCCHHHHHhhhccCcHHHHhhhcCCCChhhhhhHHHHHHHhHhcCHHH
Q 000706 1130 NGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVL 1209 (1342)
Q Consensus 1130 ~~aG~v~LL~~lLqd~e~slqq~Aa~ALg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~L 1209 (1342)
.+.++++++..||.|++..+.+.|+.+|.+|++|.+++. .+++++.++.|...+...|..+|..+.-++.++++||+++
T Consensus 116 ~~~~l~~~i~~~L~~~d~~Va~~A~~~L~~l~~~~~~~~-~l~~~~~~~~L~~l~~~~~~~vR~Rv~el~v~i~~~S~~~ 194 (503)
T PF10508_consen 116 VDNELLPLIIQCLRDPDLSVAKAAIKALKKLASHPEGLE-QLFDSNLLSKLKSLMSQSSDIVRCRVYELLVEIASHSPEA 194 (503)
T ss_pred cCccHHHHHHHHHcCCcHHHHHHHHHHHHHHhCCchhHH-HHhCcchHHHHHHHHhccCHHHHHHHHHHHHHHHhcCHHH
Confidence 889999999999999999999999999999999999886 5889999999999999989999999999999999999999
Q ss_pred HHHHHH--hHHHHHHhhccCCcHHHHHHHHHHHHHHHhCCHHHHHHHHhcCchHHHHHHhhccccccCCC-CccccccCC
Q 000706 1210 YEELRR--SIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNP-SRKDAVNES 1286 (1342)
Q Consensus 1210 Ae~Vae--~~p~lv~~cL~D~D~~VR~nAA~aL~~IakHt~eLAq~VV~aGav~~LVd~~~qe~~~~~~~-l~~~~~~~~ 1286 (1342)
++.+.+ +|+.++. +|++.|.-||.||...|.++|+ +++-++-+++.|.++.|++++.+..+ .| +. +.
T Consensus 195 ~~~~~~sgll~~ll~-eL~~dDiLvqlnalell~~La~-~~~g~~yL~~~gi~~~L~~~l~~~~~---dp~~~--~~--- 264 (503)
T PF10508_consen 195 AEAVVNSGLLDLLLK-ELDSDDILVQLNALELLSELAE-TPHGLQYLEQQGIFDKLSNLLQDSEE---DPRLS--SL--- 264 (503)
T ss_pred HHHHHhccHHHHHHH-HhcCccHHHHHHHHHHHHHHHc-ChhHHHHHHhCCHHHHHHHHHhcccc---CCccc--ch---
Confidence 999977 6999999 9999999999999999999999 77889999999999999998887777 56 33 11
Q ss_pred chhhHHHHHHhhhcCCc--hhhhhhcCCCchhhhhcccCCccccc
Q 000706 1287 PLKIALFSLAKMCAHTP--CRQFLQSSELFPVIARLRQSPESTIA 1329 (1342)
Q Consensus 1287 ~~ria~~~L~~i~kh~~--~aq~vvda~~~~~ia~l~~~~d~~~k 1329 (1342)
-+=-.+...++|+.+.| +-+.. ...+..+-..+++.|...+
T Consensus 265 ~l~g~~~f~g~la~~~~~~v~~~~--p~~~~~l~~~~~s~d~~~~ 307 (503)
T PF10508_consen 265 LLPGRMKFFGNLARVSPQEVLELY--PAFLERLFSMLESQDPTIR 307 (503)
T ss_pred hhhhHHHHHHHHHhcChHHHHHHH--HHHHHHHHHHhCCCChhHH
Confidence 00111256788988665 22111 1122233455566666554
|
26S proteasome non-ATPase regulatory subunit 5 is one of a number of chaperones that are involved in the assembly of the proteasome. The chaperones dissociate before 26S proteasome formation is complete [].; GO: 0044183 protein binding involved in protein folding |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=1e-12 Score=157.33 Aligned_cols=144 Identities=19% Similarity=0.290 Sum_probs=98.7
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC----------------------------H----HHHHH--
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS----------------------------E----KDIHN-- 49 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s----------------------------e----~dier-- 49 (1342)
.+|+. +.||+|++|.||+|+.+.+|+.||||++++.... . +..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 7899999999999999878999999999754110 0 11122
Q ss_pred ----HHHHHHHHHhcC----CCCcceEEEEEE-eCCeEEEEEeccCC-ChHHH--HhcCC----CCCHHHHHHHHHHHHH
Q 000706 50 ----LRQEIEILRKLK----HQNIIEMLDSFE-SPQEFCVVTEFAQG-ELFEI--LEDDK----CLPEEQVQSIAKQLVR 113 (1342)
Q Consensus 50 ----L~rEI~ILKrL~----HPNIVKL~dvfe-ded~lyLVMEY~eG-SL~D~--Lek~g----~LSEeeI~~I~~QLLs 113 (1342)
+.+|...+.++. +.+.+.+-++|. -....++||||++| .+.+. +.+.+ .+.+..+..++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 334444444442 333344334442 24567899999986 56553 33333 355555666666665
Q ss_pred HHHHhhhCCceecCCCCCcEEEcCCC----cEEEeeccccccccCC
Q 000706 114 ALHYLHSNRIIHRDMKPQNILIGAGS----VVKLCDFGFARAMSAN 155 (1342)
Q Consensus 114 ALaYLHsrGIVHRDLKPENILLdsdG----~LKLiDFGLAr~l~ss 155 (1342)
..|++|+|+||.||+++.+| .++++|||++..++..
T Consensus 278 ------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 278 ------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 58999999999999999988 9999999999877543
|
|
| >cd00020 ARM Armadillo/beta-catenin-like repeats | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.1e-11 Score=113.38 Aligned_cols=115 Identities=25% Similarity=0.272 Sum_probs=108.8
Q ss_pred HHhCCchHhHHHhhcCCchhHHHHHHHHHHHHhcCCHHHHHhhhccCcHHHHhhhcCCCChhhhhhHHHHHHHhHhcCHH
Q 000706 1129 INGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDV 1208 (1342)
Q Consensus 1129 I~~aG~v~LL~~lLqd~e~slqq~Aa~ALg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~ 1208 (1342)
+.+.|+++.|..++.++.+.+|..|+.+|++|+.++++..+.+++.+++|.|+..|.++|..+++.++.+|++++.+.++
T Consensus 3 ~~~~~~i~~l~~~l~~~~~~~~~~a~~~l~~l~~~~~~~~~~~~~~~~i~~l~~~l~~~~~~v~~~a~~~L~~l~~~~~~ 82 (120)
T cd00020 3 VIQAGGLPALVSLLSSSDENVQREAAWALSNLSAGNNDNIQAVVEAGGLPALVQLLKSEDEEVVKAALWALRNLAAGPED 82 (120)
T ss_pred HHHcCChHHHHHHHHcCCHHHHHHHHHHHHHHhcCCHHHHHHHHHCCChHHHHHHHhCCCHHHHHHHHHHHHHHccCcHH
Confidence 56789999999999999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred HHHHHHH--hHHHHHHhhccCCcHHHHHHHHHHHHHHH
Q 000706 1209 LYEELRR--SIPLLANILISDEEDKTKANAAGALSNLI 1244 (1342)
Q Consensus 1209 LAe~Vae--~~p~lv~~cL~D~D~~VR~nAA~aL~~Ia 1244 (1342)
-.+.+.+ .+|.++. +|+++|..+|+.|+++|++++
T Consensus 83 ~~~~~~~~g~l~~l~~-~l~~~~~~~~~~a~~~l~~l~ 119 (120)
T cd00020 83 NKLIVLEAGGVPKLVN-LLDSSNEDIQKNATGALSNLA 119 (120)
T ss_pred HHHHHHHCCChHHHHH-HHhcCCHHHHHHHHHHHHHhh
Confidence 7777755 4999999 999999999999999999985
|
An approximately 40 amino acid long tandemly repeated sequence motif first identified in the Drosophila segment polarity gene armadillo; these repeats were also found in the mammalian armadillo homolog beta-catenin, the junctional plaque protein plakoglobin, the adenomatous polyposis coli (APC) tumor suppressor protein, and a number of other proteins. ARM has been implicated in mediating protein-protein interactions, but no common features among the target proteins recognized by the ARM repeats have been identified; related to the HEAT domain; three consecutive copies of the repeat are represented by this alignment model. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.2e-11 Score=146.51 Aligned_cols=232 Identities=21% Similarity=0.287 Sum_probs=156.9
Q ss_pred EEEEEEEcccCcEEEE-EEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEec
Q 000706 6 YHVIELVGEGSFGKVY-KGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEF 84 (1342)
Q Consensus 6 YrIlK~LGsGgFGtVY-KArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVMEY 84 (1342)
|++ +...-+..+ +| .|..+.++.++.|..++.... .......+-++-++.++||||+++++.++.++..|+|+|.
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTEr 90 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTER 90 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeec
Confidence 444 333334444 44 466778899999998876543 4456677888999999999999999999999999999999
Q ss_pred cCCChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh-hCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeeccc
Q 000706 85 AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLH-SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK 163 (1342)
Q Consensus 85 ~eGSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLH-srGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~v 163 (1342)
+.- |..++++ +....+..-++||+.||.||| +.+++|++|.-..|+|+..|+.||++|.++..............
T Consensus 91 V~P-l~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~ 166 (690)
T KOG1243|consen 91 VRP-LETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLY 166 (690)
T ss_pred ccc-HHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccch
Confidence 751 2223332 236778888999999999998 56899999999999999999999999998865543332112222
Q ss_pred CCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhcccCCCC
Q 000706 164 GTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQN 243 (1342)
Q Consensus 164 GTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqkDPeK 243 (1342)
--..|..|+.+.... -..|.|.||+++++++.|..+ .... ...+..++.....+-.+-+-..+.+
T Consensus 167 ~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~~--~~~~-----------~~~~~~ipk~~~~~~~k~~~~~~~~ 231 (690)
T KOG1243|consen 167 LIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSLL--TKTD-----------LSNTGKIPKALIELYCKKLGATELK 231 (690)
T ss_pred hhhcccChhhcCccc--cchhhhhHHHHHHHHhCcccC--cchh-----------hhccCccchhHHHHHHHHhcccccc
Confidence 233366676544322 457999999999999998322 2111 1112233333334444444555555
Q ss_pred CCCHH----H-HHcCcCcccch
Q 000706 244 RLTWS----A-LLEHPFVKETS 260 (1342)
Q Consensus 244 RPSAe----E-LLeHPFFre~~ 260 (1342)
||... + .+-|.||++..
T Consensus 232 r~n~~~~~~~~~~~~gff~n~f 253 (690)
T KOG1243|consen 232 RPNKLRFILECRLLGGFFRNDF 253 (690)
T ss_pred ccchhhHHHHHHhccccccchH
Confidence 55422 2 23478887653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.29 E-value=9.6e-12 Score=145.62 Aligned_cols=141 Identities=23% Similarity=0.311 Sum_probs=96.0
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCH--HH------------------------------------HHHHH
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE--KD------------------------------------IHNLR 51 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se--~d------------------------------------ierL~ 51 (1342)
+.||.|++|.||+|+.+ +|+.||||+.++..... .+ .-++.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999865 79999999985431000 00 01244
Q ss_pred HHHHHHHhcC-----CCCcceEEEEEEeCCeEEEEEeccCC-ChHHHHhcC-CCCCHHHHHHHHHHHHH-HHHHhhhCCc
Q 000706 52 QEIEILRKLK-----HQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDD-KCLPEEQVQSIAKQLVR-ALHYLHSNRI 123 (1342)
Q Consensus 52 rEI~ILKrL~-----HPNIVKL~dvfeded~lyLVMEY~eG-SL~D~Lek~-g~LSEeeI~~I~~QLLs-ALaYLHsrGI 123 (1342)
+|.+.+.++. ++++.-..-+.+.....++||||++| +|.+..... ...+ ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 5666666652 34332222222334457999999986 566654321 1222 2345556655 4788999999
Q ss_pred eecCCCCCcEEEcCCCcEEEeeccccccccC
Q 000706 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSA 154 (1342)
Q Consensus 124 VHRDLKPENILLdsdG~LKLiDFGLAr~l~s 154 (1342)
+|+|+||.||+++.+|+++++|||++..++.
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999987754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.3e-12 Score=150.72 Aligned_cols=249 Identities=20% Similarity=0.229 Sum_probs=188.4
Q ss_pred CCCEEEEEEEcccCcEEEEEEEEc-cCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEE
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRK-YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 3 VdrYrIlK~LGsGgFGtVYKArDk-~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~dvfeded~lyL 80 (1342)
..+|..+..||.|.|+.||...-+ .++..|++|...+..........-..|+.+...+ .|.+++..+..|...+..|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 457899999999999999987655 6788999998877655444434445577777666 68999999988888888889
Q ss_pred EEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCC-CcEEEeeccccccccCCcee
Q 000706 81 VTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAG-SVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 81 VMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsd-G~LKLiDFGLAr~l~sss~~ 158 (1342)
-.||++ +++...+.-...+++...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||....+.-...
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~- 422 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG- 422 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceecc-
Confidence 999997 4544444334458889999999999999999999999999999999999886 7889999999865322111
Q ss_pred eecccCCCCcC--ChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 000706 159 LRSIKGTPLYM--APELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGL 236 (1342)
Q Consensus 159 ~~s~vGTp~Ym--APEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~~efP~eISpeLkDLIrKc 236 (1342)
...+.-+++ +|+......+..+.|+++||..+++..++.+.-+... ....+..+..+..+....++..+...+
T Consensus 423 --~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~~~p~~~~~~~~~q~~~kv~ 497 (524)
T KOG0601|consen 423 --VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSGDTPNLPGLKLQLQVLLKVM 497 (524)
T ss_pred --cccccccccccchhhccccccccccccccccccccccccCcccCcccc---cceeeecccccCCCchHHhhhhhhhhh
Confidence 112333344 5666667778899999999999999998865432222 122334444444444457888899999
Q ss_pred cccCCCCCCCHHHHHcCcCcc
Q 000706 237 LNKVPQNRLTWSALLEHPFVK 257 (1342)
Q Consensus 237 LqkDPeKRPSAeELLeHPFFr 257 (1342)
+..|+..|+.+.++..|+-|.
T Consensus 498 ~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 498 INPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred cCCccccchhhhhhcccchhh
Confidence 999999999999999887553
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.3e-11 Score=120.49 Aligned_cols=127 Identities=20% Similarity=0.239 Sum_probs=94.3
Q ss_pred EEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeEEEEEeccCC
Q 000706 9 IELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI-IEMLDSFESPQEFCVVTEFAQG 87 (1342)
Q Consensus 9 lK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNI-VKL~dvfeded~lyLVMEY~eG 87 (1342)
++.|+.|.++.||++... ++.|++|....... ......+|+.+++.+.+.++ .+++.+.. ...++||||++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence 477899999999999754 78899998754421 11245679999998865444 45555443 335799999997
Q ss_pred C-hHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCc-----eecCCCCCcEEEcCCCcEEEeecccccc
Q 000706 88 E-LFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRI-----IHRDMKPQNILIGAGSVVKLCDFGFARA 151 (1342)
Q Consensus 88 S-L~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGI-----VHRDLKPENILLdsdG~LKLiDFGLAr~ 151 (1342)
. +.+. ......+..+++++|+.||+.++ +|||++|.||+++ ++.++++|||.+..
T Consensus 76 ~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred Cccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 4 3322 11123457899999999999985 9999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1e-12 Score=147.80 Aligned_cols=236 Identities=20% Similarity=0.264 Sum_probs=157.5
Q ss_pred EEEEEEccCCcEEEEEEeecCC-CCHH-HHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----CeEEEEEeccC-CChHH
Q 000706 20 VYKGRRKYTGQTVAMKFIMKHG-KSEK-DIHNLRQEIEILRKLKHQNIIEMLDSFESP-----QEFCVVTEFAQ-GELFE 91 (1342)
Q Consensus 20 VYKArDk~TGe~VAVKvIkKs~-~se~-dierL~rEI~ILKrL~HPNIVKL~dvfede-----d~lyLVMEY~e-GSL~D 91 (1342)
||.+.++..|..|+...+.... ++.. ..+..+.-..-+-++.|.|+|+++.++.+. ....++.||+. |++..
T Consensus 82 v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~ 161 (458)
T KOG1266|consen 82 VYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQ 161 (458)
T ss_pred HHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHH
Confidence 5555556566555544442211 0111 111122223344556799999999988544 45789999997 89888
Q ss_pred HHhc----CCCCCHHHHHHHHHHHHHHHHHhhhC--CceecCCCCCcEEEcCCCcEEEeeccccccccCCc-----eeee
Q 000706 92 ILED----DKCLPEEQVQSIAKQLVRALHYLHSN--RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT-----VVLR 160 (1342)
Q Consensus 92 ~Lek----~g~LSEeeI~~I~~QLLsALaYLHsr--GIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss-----~~~~ 160 (1342)
++++ .+.+.....++|+.||+.||.|||+. -|+|+++..+.|++..+|-+|+.--.- ....... ....
T Consensus 162 fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~ 240 (458)
T KOG1266|consen 162 FLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKS 240 (458)
T ss_pred HHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhh
Confidence 8865 34688899999999999999999986 599999999999999999888753211 1111110 1111
Q ss_pred cccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCC-CCCcHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhccc
Q 000706 161 SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPF-YTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 161 s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF-~g~s~~elirkIlr~~~efP~eISpeLkDLIrKcLqk 239 (1342)
...+-++|.+||.-.....+.++|||+||+...+|..+..-- ...+....-..+...-..... +--++++.+|++.
T Consensus 241 ~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~len---~lqr~~i~kcl~~ 317 (458)
T KOG1266|consen 241 VNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLEN---GLQRGSITKCLEG 317 (458)
T ss_pred ccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeeccC---ccccCcCcccccC
Confidence 234678899999766666788999999999999999876542 222222111222221111111 2234689999999
Q ss_pred CCCCCCCHHHHHcCcCcccc
Q 000706 240 VPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 240 DPeKRPSAeELLeHPFFre~ 259 (1342)
.|..||++.+++.||.+-+.
T Consensus 318 eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 318 EPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred CCCCCcchhhhhcCceeeec
Confidence 99999999999999976554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.8e-11 Score=126.15 Aligned_cols=140 Identities=14% Similarity=0.150 Sum_probs=103.3
Q ss_pred EEEEcccCcEEEEEEEEcc------CCcEEEEEEeecCCC-----------C---------HHHHHH----HHHHHHHHH
Q 000706 9 IELVGEGSFGKVYKGRRKY------TGQTVAMKFIMKHGK-----------S---------EKDIHN----LRQEIEILR 58 (1342)
Q Consensus 9 lK~LGsGgFGtVYKArDk~------TGe~VAVKvIkKs~~-----------s---------e~dier----L~rEI~ILK 58 (1342)
...||.|.-+.||.|.... .+..+|+|+.+-... + ...... ..+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999997653 357899998843100 0 011122 348999999
Q ss_pred hcCC--CCcceEEEEEEeCCeEEEEEeccCCC-hHHHHhcCCCCCHHHHHHHHHHHHHHHHHh-hhCCceecCCCCCcEE
Q 000706 59 KLKH--QNIIEMLDSFESPQEFCVVTEFAQGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYL-HSNRIIHRDMKPQNIL 134 (1342)
Q Consensus 59 rL~H--PNIVKL~dvfeded~lyLVMEY~eGS-L~D~Lek~g~LSEeeI~~I~~QLLsALaYL-HsrGIVHRDLKPENIL 134 (1342)
++.. -++.+++++ ..-++||||++|+ +.....+...+++++...+..|++.+|.+| |+.|++||||++.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9953 467777765 4568999999864 322222333466677788899999999999 8999999999999999
Q ss_pred EcCCCcEEEeecccccccc
Q 000706 135 IGAGSVVKLCDFGFARAMS 153 (1342)
Q Consensus 135 LdsdG~LKLiDFGLAr~l~ 153 (1342)
++ ++.++|+|||.+...+
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 97 4689999999886654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG5064 SRP1 Karyopherin (importin) alpha [Intracellular trafficking and secretion] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.6e-10 Score=130.18 Aligned_cols=231 Identities=19% Similarity=0.263 Sum_probs=195.4
Q ss_pred HhhcccccChhhhhhhccCCCchHHHHHHHHHHHHHhhchhHHHHHHh-----------CCchHhHHHhhcCCchhHHHH
Q 000706 1084 QLVGKGLLDPNRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYING-----------ASMLEFLKDFLTHEDPNVRAK 1152 (1342)
Q Consensus 1084 q~v~~~~~~~~~~~~~~~s~~~~~r~~f~~~va~lars~~~~ie~I~~-----------aG~v~LL~~lLqd~e~slqq~ 1152 (1342)
|-|=+--.+|| .+.|+++.+|.+ .+| | ++|++-.|++ +|++|+++.+|.+++-.|+.-
T Consensus 108 q~VIdaGvVpR-fvefm~~~q~~m-lqf-----E----AaWalTNiaSGtt~QTkvVvd~~AVPlfiqlL~s~~~~V~eQ 176 (526)
T COG5064 108 QPVIDAGVVPR-FVEFMDEIQRDM-LQF-----E----AAWALTNIASGTTQQTKVVVDAGAVPLFIQLLSSTEDDVREQ 176 (526)
T ss_pred hhHHhccccHH-HHHHHHhcchhH-HHH-----H----HHHHHhhhccCcccceEEEEeCCchHHHHHHHcCchHHHHHH
Confidence 44433334554 567887777654 233 3 4599999988 999999999999999999999
Q ss_pred HHHHHHHHhcCCHHHHHhhhccCcHHHHhhhcCCCCh--hhhhhHHHHHHHhHhc--CHHHHHHHHHhHHHHHHhhccCC
Q 000706 1153 ACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDK--RTRKFACFSIGNAAYH--NDVLYEELRRSIPLLANILISDE 1228 (1342)
Q Consensus 1153 Aa~ALg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~--~~Kr~ac~~L~~iAkH--s~~LAe~Vae~~p~lv~~cL~D~ 1228 (1342)
|.-|||+||--|+....-|...|++-.|...|.++-. ..-|++-..|+|+-+- -++=-+.+..++|-|.. ++.-.
T Consensus 177 avWALGNiAGDS~~~RD~vL~~galeplL~ll~ss~~~ismlRn~TWtLSNlcRGknP~P~w~~isqalpiL~K-Liys~ 255 (526)
T COG5064 177 AVWALGNIAGDSEGCRDYVLQCGALEPLLGLLLSSAIHISMLRNATWTLSNLCRGKNPPPDWSNISQALPILAK-LIYSR 255 (526)
T ss_pred HHHHhccccCCchhHHHHHHhcCchHHHHHHHHhccchHHHHHHhHHHHHHhhCCCCCCCchHHHHHHHHHHHH-HHhhc
Confidence 9999999999999999999999999999988887766 6678999999999764 33444556777888888 88899
Q ss_pred cHHHHHHHHHHHHHHHhCCHHHHHHHHhcCchHHHHHHhhccccccCCCCccccccCCchhhHHHHHHhhhcCCc-hhhh
Q 000706 1229 EDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTP-CRQF 1307 (1342)
Q Consensus 1229 D~~VR~nAA~aL~~IakHt~eLAq~VV~aGav~~LVd~~~qe~~~~~~~l~~~~~~~~~~ria~~~L~~i~kh~~-~aq~ 1307 (1342)
|+.|---|.|||.|++-...|--|.|.+.|.++.|||+...+.. ... .-|+.+.|+|---+. -.|.
T Consensus 256 D~evlvDA~WAiSYlsDg~~E~i~avld~g~~~RLvElLs~~sa----~iq---------tPalR~vGNIVTG~D~QTqv 322 (526)
T COG5064 256 DPEVLVDACWAISYLSDGPNEKIQAVLDVGIPGRLVELLSHESA----KIQ---------TPALRSVGNIVTGSDDQTQV 322 (526)
T ss_pred CHHHHHHHHHHHHHhccCcHHHHHHHHhcCCcHHHHHHhcCccc----ccc---------CHHHHhhcCeeecCccceeh
Confidence 99999999999999999999999999999999999998877544 223 447889999999998 8999
Q ss_pred hhcCCCchhhhhcccCCcccccceeeEEeecc
Q 000706 1308 LQSSELFPVIARLRQSPESTIANYASVIISKV 1339 (1342)
Q Consensus 1308 vvda~~~~~ia~l~~~~d~~~k~~~~~~~~~~ 1339 (1342)
+++.|+++.+-+|++||.-.||+.+--.||..
T Consensus 323 iI~~G~L~a~~~lLs~~ke~irKEaCWTiSNI 354 (526)
T COG5064 323 IINCGALKAFRSLLSSPKENIRKEACWTISNI 354 (526)
T ss_pred heecccHHHHHHHhcChhhhhhhhhheeeccc
Confidence 99999999999999999999999887777753
|
|
| >cd00020 ARM Armadillo/beta-catenin-like repeats | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.3e-10 Score=108.11 Aligned_cols=116 Identities=17% Similarity=0.233 Sum_probs=105.0
Q ss_pred hhhccCcHHHHhhhcCCCChhhhhhHHHHHHHhHhcCHHHHHHHH--HhHHHHHHhhccCCcHHHHHHHHHHHHHHHhCC
Q 000706 1170 SLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELR--RSIPLLANILISDEEDKTKANAAGALSNLIRNS 1247 (1342)
Q Consensus 1170 ~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~Va--e~~p~lv~~cL~D~D~~VR~nAA~aL~~IakHt 1247 (1342)
.+++.|+++.|+..|.+.|.++|+.++.+|+++++++++..+.+. +.+|.++. +|.|.|+.|+++|+|+|++|+.+.
T Consensus 2 ~~~~~~~i~~l~~~l~~~~~~~~~~a~~~l~~l~~~~~~~~~~~~~~~~i~~l~~-~l~~~~~~v~~~a~~~L~~l~~~~ 80 (120)
T cd00020 2 AVIQAGGLPALVSLLSSSDENVQREAAWALSNLSAGNNDNIQAVVEAGGLPALVQ-LLKSEDEEVVKAALWALRNLAAGP 80 (120)
T ss_pred hHHHcCChHHHHHHHHcCCHHHHHHHHHHHHHHhcCCHHHHHHHHHCCChHHHHH-HHhCCCHHHHHHHHHHHHHHccCc
Confidence 367889999999999999999999999999999999999998885 45999999 999999999999999999999999
Q ss_pred HHHHHHHHhcCchHHHHHHhhccccccCCCCccccccCCchhhHHHHHHhhh
Q 000706 1248 SKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMC 1299 (1342)
Q Consensus 1248 ~eLAq~VV~aGav~~LVd~~~qe~~~~~~~l~~~~~~~~~~ria~~~L~~i~ 1299 (1342)
++-.+.+++.|+++.|++++... + ...+ +.++.+|..||
T Consensus 81 ~~~~~~~~~~g~l~~l~~~l~~~-~---~~~~---------~~a~~~l~~l~ 119 (120)
T cd00020 81 EDNKLIVLEAGGVPKLVNLLDSS-N---EDIQ---------KNATGALSNLA 119 (120)
T ss_pred HHHHHHHHHCCChHHHHHHHhcC-C---HHHH---------HHHHHHHHHhh
Confidence 99999999999999999766544 4 3566 88889998887
|
An approximately 40 amino acid long tandemly repeated sequence motif first identified in the Drosophila segment polarity gene armadillo; these repeats were also found in the mammalian armadillo homolog beta-catenin, the junctional plaque protein plakoglobin, the adenomatous polyposis coli (APC) tumor suppressor protein, and a number of other proteins. ARM has been implicated in mediating protein-protein interactions, but no common features among the target proteins recognized by the ARM repeats have been identified; related to the HEAT domain; three consecutive copies of the repeat are represented by this alignment model. |
| >KOG4224 consensus Armadillo repeat protein VAC8 required for vacuole fusion, inheritance and cytosol-to-vacuole protein targeting [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.18 E-value=9.3e-11 Score=132.94 Aligned_cols=209 Identities=22% Similarity=0.272 Sum_probs=182.8
Q ss_pred CCCchHHHHHHHHHHHHHhhchhHHHHHHhCCchHhHHHhhcCCchhHHHHHHHHHHHHhcCCHHHHHhhhccCcHHHHh
Q 000706 1102 SSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLI 1181 (1342)
Q Consensus 1102 s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~v~LL~~lLqd~e~slqq~Aa~ALg~lakHS~eLAq~VVd~~iLp~Lv 1181 (1342)
++.-+++...|--+-.|| ....|=--|++.|++.+|.-+-.-++--+|+.+..||.+| -||.|-.+.+|.+|.+|.|+
T Consensus 137 td~vevqcnaVgCitnLa-T~d~nk~kiA~sGaL~pltrLakskdirvqrnatgaLlnm-Ths~EnRr~LV~aG~lpvLV 214 (550)
T KOG4224|consen 137 TDGVEVQCNAVGCITNLA-TFDSNKVKIARSGALEPLTRLAKSKDIRVQRNATGALLNM-THSRENRRVLVHAGGLPVLV 214 (550)
T ss_pred CCCcEEEeeehhhhhhhh-ccccchhhhhhccchhhhHhhcccchhhHHHHHHHHHHHh-hhhhhhhhhhhccCCchhhh
Confidence 555677777777777888 6677778889999999999999999999999999999998 59999999999999999999
Q ss_pred hhcCCCChhhhhhHHHHHHHhH---hcCHHHHHHHHHhHHHHHHhhccCCcHHHHHHHHHHHHHHHhCCHHHHHHHHhcC
Q 000706 1182 DRCADPDKRTRKFACFSIGNAA---YHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKG 1258 (1342)
Q Consensus 1182 ~~L~~~D~~~Kr~ac~~L~~iA---kHs~~LAe~Vae~~p~lv~~cL~D~D~~VR~nAA~aL~~IakHt~eLAq~VV~aG 1258 (1342)
..++..|..++-.+|-+|++|| .|--.|||.=-..+|+||+ +.+|.+++||=.|+.|||++|..|+ ---.||++|
T Consensus 215 sll~s~d~dvqyycttaisnIaVd~~~Rk~Laqaep~lv~~Lv~-Lmd~~s~kvkcqA~lALrnlasdt~-Yq~eiv~ag 292 (550)
T KOG4224|consen 215 SLLKSGDLDVQYYCTTAISNIAVDRRARKILAQAEPKLVPALVD-LMDDGSDKVKCQAGLALRNLASDTE-YQREIVEAG 292 (550)
T ss_pred hhhccCChhHHHHHHHHhhhhhhhHHHHHHHHhcccchHHHHHH-HHhCCChHHHHHHHHHHhhhcccch-hhhHHHhcC
Confidence 9999999999999999999998 4555666655557999999 9999999999999999999998775 456799999
Q ss_pred chHHHHHHhhccccccCCCCccccccCCchhhHHHHHHhhhcCCchhhhhhcCCCchhhhhcccCCccc
Q 000706 1259 AMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQFLQSSELFPVIARLRQSPEST 1327 (1342)
Q Consensus 1259 av~~LVd~~~qe~~~~~~~l~~~~~~~~~~ria~~~L~~i~kh~~~aq~vvda~~~~~ia~l~~~~d~~ 1327 (1342)
++|.||+++ |+|- .|+. -.+++-+-+|+-|+-=+--++|+|-+--+-+|+.-.|..
T Consensus 293 ~lP~lv~Ll-qs~~---~pli---------lasVaCIrnisihplNe~lI~dagfl~pLVrlL~~~dnE 348 (550)
T KOG4224|consen 293 SLPLLVELL-QSPM---GPLI---------LASVACIRNISIHPLNEVLIADAGFLRPLVRLLRAGDNE 348 (550)
T ss_pred CchHHHHHH-hCcc---hhHH---------HHHHHHHhhcccccCcccceecccchhHHHHHHhcCCch
Confidence 999999887 8888 7888 778888999999988777889999988888888865554
|
|
| >PRK09687 putative lyase; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=5.3e-10 Score=124.59 Aligned_cols=190 Identities=19% Similarity=0.280 Sum_probs=135.7
Q ss_pred hhhhhhccCCCchHHHHHHHHHHHHHhhchhHHHHHHhCCchHhHHHh-hcCCchhHHHHHHHHHHHHhcCC----HHHH
Q 000706 1094 NRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDF-LTHEDPNVRAKACSALGNMCRHS----SYFY 1168 (1342)
Q Consensus 1094 ~~~~~~~~s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~v~LL~~l-Lqd~e~slqq~Aa~ALg~lakHS----~eLA 1168 (1342)
..+..++.+..|.+|..=+..+.++-+.... ...++++|+.+ +.|+++.||+.|+.+||+++... +++.
T Consensus 57 ~~l~~ll~~~d~~vR~~A~~aLg~lg~~~~~------~~~a~~~L~~l~~~D~d~~VR~~A~~aLG~~~~~~~~~~~~a~ 130 (280)
T PRK09687 57 RLAIELCSSKNPIERDIGADILSQLGMAKRC------QDNVFNILNNLALEDKSACVRASAINATGHRCKKNPLYSPKIV 130 (280)
T ss_pred HHHHHHHhCCCHHHHHHHHHHHHhcCCCccc------hHHHHHHHHHHHhcCCCHHHHHHHHHHHhcccccccccchHHH
Confidence 3455666677788876655555555421100 23478888866 88999999999999999986432 1111
Q ss_pred H----------------------hhhccCcHHHHhhhcCCCChhhhhhHHHHHHHhHhcCHHHHHHHHHhHHHHHHhhcc
Q 000706 1169 S----------------------SLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILIS 1226 (1342)
Q Consensus 1169 q----------------------~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~Vae~~p~lv~~cL~ 1226 (1342)
+ .+-+..+++.|+..|.|+|..+|+.|+++||++..+++ +++|.|+. .|+
T Consensus 131 ~~l~~~~~D~~~~VR~~a~~aLg~~~~~~ai~~L~~~L~d~~~~VR~~A~~aLg~~~~~~~-------~~~~~L~~-~L~ 202 (280)
T PRK09687 131 EQSQITAFDKSTNVRFAVAFALSVINDEAAIPLLINLLKDPNGDVRNWAAFALNSNKYDNP-------DIREAFVA-MLQ 202 (280)
T ss_pred HHHHHHhhCCCHHHHHHHHHHHhccCCHHHHHHHHHHhcCCCHHHHHHHHHHHhcCCCCCH-------HHHHHHHH-Hhc
Confidence 1 11244578888888888888888888888888866655 45666888 888
Q ss_pred CCcHHHHHHHHHHHHHHHhCCHHHHHHHHhcCchHHHHHHhhccccccCCCCccccccCCchhhHHHHHHhhhcCCchhh
Q 000706 1227 DEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQ 1306 (1342)
Q Consensus 1227 D~D~~VR~nAA~aL~~IakHt~eLAq~VV~aGav~~LVd~~~qe~~~~~~~l~~~~~~~~~~ria~~~L~~i~kh~~~aq 1306 (1342)
|.|+.||++|+++|+++ .++ -++|.|+++..+ ++ ++ +-++.+||+|-
T Consensus 203 D~~~~VR~~A~~aLg~~--~~~---------~av~~Li~~L~~-~~-----~~---------~~a~~ALg~ig------- 249 (280)
T PRK09687 203 DKNEEIRIEAIIGLALR--KDK---------RVLSVLIKELKK-GT-----VG---------DLIIEAAGELG------- 249 (280)
T ss_pred CCChHHHHHHHHHHHcc--CCh---------hHHHHHHHHHcC-Cc-----hH---------HHHHHHHHhcC-------
Confidence 99999999999999886 333 578888865443 33 34 56788899886
Q ss_pred hhhcCCCchhhhhccc-CCcccccceee
Q 000706 1307 FLQSSELFPVIARLRQ-SPESTIANYAS 1333 (1342)
Q Consensus 1307 ~vvda~~~~~ia~l~~-~~d~~~k~~~~ 1333 (1342)
+..++|.|.++++ ++|..+++.+-
T Consensus 250 ---~~~a~p~L~~l~~~~~d~~v~~~a~ 274 (280)
T PRK09687 250 ---DKTLLPVLDTLLYKFDDNEIITKAI 274 (280)
T ss_pred ---CHhHHHHHHHHHhhCCChhHHHHHH
Confidence 3478999999997 99999988653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.2e-09 Score=111.85 Aligned_cols=139 Identities=23% Similarity=0.288 Sum_probs=103.3
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCC--CCcceEEEEEEeC---CeEEEEEec
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH--QNIIEMLDSFESP---QEFCVVTEF 84 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~H--PNIVKL~dvfede---d~lyLVMEY 84 (1342)
+.|+.|.++.||++... +|+.|++|........ .....+..|.++++.+.+ .++.+++.+.... +..+++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 67899999999999764 3688999987544321 123567889999999965 3467777777654 367899999
Q ss_pred cCCC-hHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-------------------------------------------
Q 000706 85 AQGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYLHS------------------------------------------- 120 (1342)
Q Consensus 85 ~eGS-L~D~Lek~g~LSEeeI~~I~~QLLsALaYLHs------------------------------------------- 120 (1342)
++|. +.+.+.. ..++++....++.++++.|.+||+
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9874 4433221 346677777777777777777773
Q ss_pred -------------CCceecCCCCCcEEEcC--CCcEEEeecccccc
Q 000706 121 -------------NRIIHRDMKPQNILIGA--GSVVKLCDFGFARA 151 (1342)
Q Consensus 121 -------------rGIVHRDLKPENILLds--dG~LKLiDFGLAr~ 151 (1342)
..++|+|++|.||+++. ++.+.++||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23689999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.7e-09 Score=112.06 Aligned_cols=132 Identities=23% Similarity=0.375 Sum_probs=100.2
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHH------HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEe
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD------IHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~d------ierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLVME 83 (1342)
..+++|+-+.+|.+.. -|.++++|.=.++...... ..+..+|.+++.++.--.|...+-+..+++.-.|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 3578999999999844 4656777754333221111 3457789999999876666666666677888889999
Q ss_pred ccCCChHH-HHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 000706 84 FAQGELFE-ILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARA 151 (1342)
Q Consensus 84 Y~eGSL~D-~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~ 151 (1342)
|++|.+.. .+... ...+++.+-.-+.-||..||+|+||+++||++..++ +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99997554 66654 245677777788889999999999999999998875 99999999864
|
|
| >KOG4224 consensus Armadillo repeat protein VAC8 required for vacuole fusion, inheritance and cytosol-to-vacuole protein targeting [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.7e-08 Score=114.98 Aligned_cols=320 Identities=21% Similarity=0.259 Sum_probs=227.6
Q ss_pred HHHHHHHHHhhccceeeeccCCCCCccccccccc-eeeeccCCCCcccccchhhHHHHHHhhhhHHHHHhhcCCcchhhh
Q 000706 977 RDIINAVIDLLAFPFVAVQNAPGLPSATASVNSG-FILNMGSAGGKVCMEDRDMAKAIEEDMGKYIKILMEVGVPGIILR 1055 (1342)
Q Consensus 977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1342)
||-+.-|.-+++-|--.+|-+.| +-+| |-+|||--|=-|-|-.-|.. |-+-|+.- |-|.-+-..
T Consensus 84 res~epvl~llqs~d~~Iq~aa~-------~alGnlAVn~enk~liv~l~Gl~~L--i~qmmtd~------vevqcnaVg 148 (550)
T KOG4224|consen 84 RESNEPVLALLQSCDKCIQCAAG-------EALGNLAVNMENKGLIVSLLGLDLL--ILQMMTDG------VEVQCNAVG 148 (550)
T ss_pred hhhhhHHHHHHhCcchhhhhhhh-------hhhccceeccCCceEEEeccChHHH--HHHhcCCC------cEEEeeehh
Confidence 56667777788888877887654 4455 77788777666665544431 22222210 111222333
Q ss_pred hccccccc-ccCch------HHHHHHHhcCchhHHHhhcccccCh-----------------hhhhhhccCCCchHHHHH
Q 000706 1056 CLEHMELK-NLGRP------IAFLAKMIGQRSLAVQLVGKGLLDP-----------------NRVRRLLDSSTREVTLDV 1111 (1342)
Q Consensus 1056 ~~~~~~~~-~~~~p------i~~l~~~~~~~~~~~q~v~~~~~~~-----------------~~~~~~~~s~~~~~r~~f 1111 (1342)
|...|--- ....- .--|+||+...+..+|--.+|.+.- .-.+++++|..+.++---
T Consensus 149 CitnLaT~d~nk~kiA~sGaL~pltrLakskdirvqrnatgaLlnmThs~EnRr~LV~aG~lpvLVsll~s~d~dvqyyc 228 (550)
T KOG4224|consen 149 CITNLATFDSNKVKIARSGALEPLTRLAKSKDIRVQRNATGALLNMTHSRENRRVLVHAGGLPVLVSLLKSGDLDVQYYC 228 (550)
T ss_pred hhhhhhccccchhhhhhccchhhhHhhcccchhhHHHHHHHHHHHhhhhhhhhhhhhccCCchhhhhhhccCChhHHHHH
Confidence 44333211 11111 1246777766666666555554432 346788889999998888
Q ss_pred HHHHHHHHhhchhHHHHHHhCC--chHhHHHhhcCCchhHHHHHHHHHHHHhcCCHHHHHhhhccCcHHHHhhhcCCCCh
Q 000706 1112 LMIVSDLARMDKWFYEYINGAS--MLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDK 1189 (1342)
Q Consensus 1112 ~~~va~lars~~~~ie~I~~aG--~v~LL~~lLqd~e~slqq~Aa~ALg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~ 1189 (1342)
.-.++-.| ....|=..++++| ++|-|+.+.-|+.+-+|=-|++||++||..+++.. .||++|.||+++.+| |++
T Consensus 229 ttaisnIa-Vd~~~Rk~Laqaep~lv~~Lv~Lmd~~s~kvkcqA~lALrnlasdt~Yq~-eiv~ag~lP~lv~Ll--qs~ 304 (550)
T KOG4224|consen 229 TTAISNIA-VDRRARKILAQAEPKLVPALVDLMDDGSDKVKCQAGLALRNLASDTEYQR-EIVEAGSLPLLVELL--QSP 304 (550)
T ss_pred HHHhhhhh-hhHHHHHHHHhcccchHHHHHHHHhCCChHHHHHHHHHHhhhcccchhhh-HHHhcCCchHHHHHH--hCc
Confidence 88888888 7778888899999 99999999999999999999999999999888765 478999999999999 555
Q ss_pred hhhh--hHHHHHHHhHhcCHHHHHHH-HHh--HHHHHHhhccCCcHH-HHHHHHHHHHHHHhCCHHHHHHHHhcCchHHH
Q 000706 1190 RTRK--FACFSIGNAAYHNDVLYEEL-RRS--IPLLANILISDEEDK-TKANAAGALSNLIRNSSKLCEDIVSKGAMQAL 1263 (1342)
Q Consensus 1190 ~~Kr--~ac~~L~~iAkHs~~LAe~V-ae~--~p~lv~~cL~D~D~~-VR~nAA~aL~~IakHt~eLAq~VV~aGav~~L 1263 (1342)
+.+- ..-||+|||+-|-. -|.+ +|. +-+||. +|.-.|.. .+=.|-..|+++|.-++.=-..+..+||+|.|
T Consensus 305 ~~plilasVaCIrnisihpl--Ne~lI~dagfl~pLVr-lL~~~dnEeiqchAvstLrnLAasse~n~~~i~esgAi~kl 381 (550)
T KOG4224|consen 305 MGPLILASVACIRNISIHPL--NEVLIADAGFLRPLVR-LLRAGDNEEIQCHAVSTLRNLAASSEHNVSVIRESGAIPKL 381 (550)
T ss_pred chhHHHHHHHHHhhcccccC--cccceecccchhHHHH-HHhcCCchhhhhhHHHHHHHHhhhhhhhhHHHhhcCchHHH
Confidence 5555 55689999999953 3333 444 888999 88877766 88899999999999888888899999999999
Q ss_pred HHHhhccccccCCCCccccccCCchhhHHHHHHhhhcCCchhhhhhcCCCchhhhhcccCCcccccce
Q 000706 1264 IKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQFLQSSELFPVIARLRQSPESTIANY 1331 (1342)
Q Consensus 1264 Vd~~~qe~~~~~~~l~~~~~~~~~~ria~~~L~~i~kh~~~aq~vvda~~~~~ia~l~~~~d~~~k~~ 1331 (1342)
+|++.+.|. ..+. +|+. .++-++-...-...+.|+|-+|.+.|+..+....++-+
T Consensus 382 ~eL~lD~pv----svqs--------eisa-c~a~Lal~d~~k~~lld~gi~~iLIp~t~s~s~Ev~gN 436 (550)
T KOG4224|consen 382 IELLLDGPV----SVQS--------EISA-CIAQLALNDNDKEALLDSGIIPILIPWTGSESEEVRGN 436 (550)
T ss_pred HHHHhcCCh----hHHH--------HHHH-HHHHHHhccccHHHHhhcCCcceeecccCccchhhccc
Confidence 999999998 5541 3332 23333333334567899999999999998776665543
|
|
| >PRK09687 putative lyase; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.9e-09 Score=120.28 Aligned_cols=133 Identities=15% Similarity=0.195 Sum_probs=92.2
Q ss_pred ccChhhhhhhccCCCchHHHHHHHHHHHHHhhchhHHHHHHhCCchHhHHHhhcCCchhHHHHHHHHHHHHhcCCHHHHH
Q 000706 1090 LLDPNRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYS 1169 (1342)
Q Consensus 1090 ~~~~~~~~~~~~s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~v~LL~~lLqd~e~slqq~Aa~ALg~lakHS~eLAq 1169 (1342)
-.+++....+|.+..+.+|...+.. +..+-...+++++..+++|+++.+|+.|+.+||.|-.....
T Consensus 22 ~~~~~~L~~~L~d~d~~vR~~A~~a-----------L~~~~~~~~~~~l~~ll~~~d~~vR~~A~~aLg~lg~~~~~--- 87 (280)
T PRK09687 22 KLNDDELFRLLDDHNSLKRISSIRV-----------LQLRGGQDVFRLAIELCSSKNPIERDIGADILSQLGMAKRC--- 87 (280)
T ss_pred hccHHHHHHHHhCCCHHHHHHHHHH-----------HHhcCcchHHHHHHHHHhCCCHHHHHHHHHHHHhcCCCccc---
Confidence 4566777788888888888765444 33444577899999999999999999999999998653321
Q ss_pred hhhccCcHHHHhhh-cCCCChhhhhhHHHHHHHhHhcCHHHHHHHHHhHHHHHHhhccCCcHHHHHHHHHHHHHH
Q 000706 1170 SLAKNRIIGLLIDR-CADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNL 1243 (1342)
Q Consensus 1170 ~VVd~~iLp~Lv~~-L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~Vae~~p~lv~~cL~D~D~~VR~nAA~aL~~I 1243 (1342)
...++|.|... +.|+|..+|++|+.+||++......- ..+.++.+.. ++.|.|+.||..|+++|+++
T Consensus 88 ---~~~a~~~L~~l~~~D~d~~VR~~A~~aLG~~~~~~~~~---~~~a~~~l~~-~~~D~~~~VR~~a~~aLg~~ 155 (280)
T PRK09687 88 ---QDNVFNILNNLALEDKSACVRASAINATGHRCKKNPLY---SPKIVEQSQI-TAFDKSTNVRFAVAFALSVI 155 (280)
T ss_pred ---hHHHHHHHHHHHhcCCCHHHHHHHHHHHhccccccccc---chHHHHHHHH-HhhCCCHHHHHHHHHHHhcc
Confidence 34578888877 78999999999999999985433210 1112223333 44555555555555555544
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.2e-08 Score=109.22 Aligned_cols=142 Identities=23% Similarity=0.335 Sum_probs=109.5
Q ss_pred EEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCH------HHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 000706 8 VIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE------KDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 8 IlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se------~dierL~rEI~ILKrL~HPNIVKL~dvfeded~lyLV 81 (1342)
.+..+-+|+-+.|+++. ..|+.+.||.=....... -...+..+|++.+.++.--.|.-..-+|.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 67889999999999995 458998888643222111 1245677899999998766776666677777778899
Q ss_pred EeccCC--ChHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC---cEEEeecccccc
Q 000706 82 TEFAQG--ELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS---VVKLCDFGFARA 151 (1342)
Q Consensus 82 MEY~eG--SL~D~Lek~--g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG---~LKLiDFGLAr~ 151 (1342)
|||++| ++.+++... ....++....++.+|-+.+.-||..+++||||..+||++..+| .+.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999998 788887652 2233333378899999999999999999999999999997766 458999999843
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.92 E-value=9.3e-09 Score=121.72 Aligned_cols=209 Identities=19% Similarity=0.281 Sum_probs=158.1
Q ss_pred EEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCCcceEEEEEE----eCCeEEEEEeccC--CChHH
Q 000706 18 GKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFE----SPQEFCVVTEFAQ--GELFE 91 (1342)
Q Consensus 18 GtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPNIVKL~dvfe----ded~lyLVMEY~e--GSL~D 91 (1342)
.+.|++....+|..|++|+++-.+. ........-+++++++.|+|+|++.++|. .+..+++|++|.+ ++|++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 5789999999999999999843221 11122334578899999999999999886 4456899999988 57888
Q ss_pred HHhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCc
Q 000706 92 ILED---------------DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 92 ~Lek---------------~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss 156 (1342)
+--. +...+|+.+|.|+.||..||.++|+.|+.-+-|.|.+|+++.+-+++|...|....+..+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 6522 2347899999999999999999999999999999999999999999999888876655433
Q ss_pred eeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhCCCC-CCCCcHHHH-HHHHhcCCCCCCCCCCHHHHHHHH
Q 000706 157 VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPP-FYTNSVYAL-IRHIVKDPVKYPDEMSPNFKSFLK 234 (1342)
Q Consensus 157 ~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~P-F~g~s~~el-irkIlr~~~efP~eISpeLkDLIr 234 (1342)
. |.+.. ..+-|.=.||.+++.|.||..- +......+. .+. ....++.+++++|.
T Consensus 448 ~--------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~-------I~~~yS~D~rn~v~ 503 (655)
T KOG3741|consen 448 T--------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR-------ITTTYSTDLRNVVE 503 (655)
T ss_pred C--------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH-------hhhhhhHHHHHHHH
Confidence 0 11111 2356788899999999999654 222222222 222 23467889999999
Q ss_pred HhcccCCCCCCCHHHHHcC
Q 000706 235 GLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 235 KcLqkDPeKRPSAeELLeH 253 (1342)
.+...++++ -++.+++.|
T Consensus 504 yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 504 YLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHhcCccc-ccHHHHHHH
Confidence 999999987 678888766
|
|
| >COG5064 SRP1 Karyopherin (importin) alpha [Intracellular trafficking and secretion] | Back alignment and domain information |
|---|
Probab=98.86 E-value=5.8e-09 Score=117.98 Aligned_cols=226 Identities=23% Similarity=0.253 Sum_probs=184.4
Q ss_pred hccCCCchHHHHHHHHHHHHHhhchhHHHHHHhCCchHhHHHhhcCCchhHHHHHHHHHHHHhcCCHHHHHhhhccCcHH
Q 000706 1099 LLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIG 1178 (1342)
Q Consensus 1099 ~~~s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~v~LL~~lLqd~e~slqq~Aa~ALg~lakHS~eLAq~VVd~~iLp 1178 (1342)
|+-|-.||+-+|-.=.++=+..-.-..+.++...|..+=|+.+|.+|...||.-|..+.|+|---++.=-|.+++.|+|+
T Consensus 251 Liys~D~evlvDA~WAiSYlsDg~~E~i~avld~g~~~RLvElLs~~sa~iqtPalR~vGNIVTG~D~QTqviI~~G~L~ 330 (526)
T COG5064 251 LIYSRDPEVLVDACWAISYLSDGPNEKIQAVLDVGIPGRLVELLSHESAKIQTPALRSVGNIVTGSDDQTQVIINCGALK 330 (526)
T ss_pred HHhhcCHHHHHHHHHHHHHhccCcHHHHHHHHhcCCcHHHHHHhcCccccccCHHHHhhcCeeecCccceehheecccHH
Confidence 33455566666655555555433344556666799999999999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCChhhhhhHHHHHHHhHhcCHHHHHHHHHh--HHHHHHhhccCCcHHHHHHHHHHHHHHHhCC---HHHHHH
Q 000706 1179 LLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS--IPLLANILISDEEDKTKANAAGALSNLIRNS---SKLCED 1253 (1342)
Q Consensus 1179 ~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~Vae~--~p~lv~~cL~D~D~~VR~nAA~aL~~IakHt---~eLAq~ 1253 (1342)
.+-.+|+++-..+||-||.+|+||.--+.+-+++|-|. +|+|+. +|.-.|-++||-|.|||.|...|- |+.-..
T Consensus 331 a~~~lLs~~ke~irKEaCWTiSNITAGnteqiqavid~nliPpLi~-lls~ae~k~kKEACWAisNatsgg~~~PD~iry 409 (526)
T COG5064 331 AFRSLLSSPKENIRKEACWTISNITAGNTEQIQAVIDANLIPPLIH-LLSSAEYKIKKEACWAISNATSGGLNRPDIIRY 409 (526)
T ss_pred HHHHHhcChhhhhhhhhheeecccccCCHHHHHHHHhcccchHHHH-HHHHHHHHHHHHHHHHHHhhhccccCCchHHHH
Confidence 99999999999999999999999999999999999554 999999 999999999999999999998774 788899
Q ss_pred HHhcCchHHHHHHhhccccccCCCCccccccCCchhhHHHHHHhhhcCC----------c--hhhhhhcCCCchhhhhcc
Q 000706 1254 IVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHT----------P--CRQFLQSSELFPVIARLR 1321 (1342)
Q Consensus 1254 VV~aGav~~LVd~~~qe~~~~~~~l~~~~~~~~~~ria~~~L~~i~kh~----------~--~aq~vvda~~~~~ia~l~ 1321 (1342)
+|+-|.+-.|++|..-.+. ... -.++-++-+|-|-. + -|.+|-+||.+-.|--+-
T Consensus 410 Lv~qG~IkpLc~~L~~~dN----kii---------ev~LD~~eniLk~Ge~d~~~~~~nin~ya~~vE~Aggmd~I~~~Q 476 (526)
T COG5064 410 LVSQGFIKPLCDLLDVVDN----KII---------EVALDAIENILKVGEQDRLRYGKNINIYAVYVEKAGGMDAIHGLQ 476 (526)
T ss_pred HHHccchhHHHHHHhccCc----cch---------hhhHHHHHHHHhhhhHHHHhccCCccHHHHHHHhcccHHHHHHhh
Confidence 9999999999988765443 223 45566665554421 2 677888899999999998
Q ss_pred cCCcccccceeeEEeec
Q 000706 1322 QSPESTIANYASVIISK 1338 (1342)
Q Consensus 1322 ~~~d~~~k~~~~~~~~~ 1338 (1342)
++.+.++-..|--||.|
T Consensus 477 ~s~n~~iy~KAYsIIe~ 493 (526)
T COG5064 477 DSVNRTIYDKAYSIIEK 493 (526)
T ss_pred hccccHHHHHHHHHHHH
Confidence 88777776555555543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=6.7e-08 Score=107.48 Aligned_cols=132 Identities=16% Similarity=0.162 Sum_probs=95.7
Q ss_pred cEEEEEEEEccCCcEEEEEEeecCCCCH--H-------HHHHHHHHHHHHHhcCCCCc--ceEEEEEEe-----CCeEEE
Q 000706 17 FGKVYKGRRKYTGQTVAMKFIMKHGKSE--K-------DIHNLRQEIEILRKLKHQNI--IEMLDSFES-----PQEFCV 80 (1342)
Q Consensus 17 FGtVYKArDk~TGe~VAVKvIkKs~~se--~-------dierL~rEI~ILKrL~HPNI--VKL~dvfed-----ed~lyL 80 (1342)
...|++. ...|+.|.+|........+ + ......+|.+.+.++..-+| +++..+++. ...-++
T Consensus 35 ~rrvvr~--~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 35 GRRTLRF--ELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred CceEEEE--EECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 3346665 3467889999774433111 0 01136789998888844333 344555543 235689
Q ss_pred EEeccCC--ChHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcC-------CCcEEEeecccc
Q 000706 81 VTEFAQG--ELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA-------GSVVKLCDFGFA 149 (1342)
Q Consensus 81 VMEY~eG--SL~D~Lek--~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLds-------dG~LKLiDFGLA 149 (1342)
|||+++| +|.+++.+ ..+.++.....++.++...+..||+.||+|||+++.|||++. ++.+.++||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 9999997 58888754 345677888899999999999999999999999999999975 458999999987
Q ss_pred c
Q 000706 150 R 150 (1342)
Q Consensus 150 r 150 (1342)
.
T Consensus 193 ~ 193 (268)
T PRK15123 193 Q 193 (268)
T ss_pred c
Confidence 5
|
|
| >PF05804 KAP: Kinesin-associated protein (KAP) | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.4e-07 Score=116.66 Aligned_cols=231 Identities=18% Similarity=0.261 Sum_probs=186.2
Q ss_pred HHHHHHHhcCchhHHHhhcccccChhhhhhhccCCCchHHHHHHHHHHHHHhhchhHHHHHHhCCchHhHHHhhcCCchh
Q 000706 1069 IAFLAKMIGQRSLAVQLVGKGLLDPNRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPN 1148 (1342)
Q Consensus 1069 i~~l~~~~~~~~~~~q~v~~~~~~~~~~~~~~~s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~v~LL~~lLqd~e~s 1148 (1342)
+.+|..||.|+..-.=.+++|.+.+ ++++|++...++.+..+..+-.|+ -...|=..|.+.|+++-|..+++.+...
T Consensus 270 ~~lLlNLAed~~ve~kM~~~~iV~~--Lv~~Ldr~n~ellil~v~fLkkLS-i~~ENK~~m~~~giV~kL~kLl~s~~~~ 346 (708)
T PF05804_consen 270 FYLLLNLAEDPRVELKMVNKGIVSL--LVKCLDRENEELLILAVTFLKKLS-IFKENKDEMAESGIVEKLLKLLPSENED 346 (708)
T ss_pred HHHHHHHhcChHHHHHHHhcCCHHH--HHHHHcCCCHHHHHHHHHHHHHHc-CCHHHHHHHHHcCCHHHHHHHhcCCCHH
Confidence 4468889999988888899998877 788999999999998888888999 8889999999999999999999999999
Q ss_pred HHHHHHHHHHHHhcCCHHHHHhhhccCcHHHHhhhcCCCChhhhhhHHHHHHHhHhcCHHHHHHH--HHhHHHHHHhhcc
Q 000706 1149 VRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEEL--RRSIPLLANILIS 1226 (1342)
Q Consensus 1149 lqq~Aa~ALg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~V--ae~~p~lv~~cL~ 1226 (1342)
+++.|..+|.+|+-+ +++...+|+.|++|.|+.+|.++ ..+..+...|.+++. .++-=... -+.+|.+++.++.
T Consensus 347 l~~~aLrlL~NLSfd-~~~R~~mV~~GlIPkLv~LL~d~--~~~~val~iLy~LS~-dd~~r~~f~~TdcIp~L~~~Ll~ 422 (708)
T PF05804_consen 347 LVNVALRLLFNLSFD-PELRSQMVSLGLIPKLVELLKDP--NFREVALKILYNLSM-DDEARSMFAYTDCIPQLMQMLLE 422 (708)
T ss_pred HHHHHHHHHHHhCcC-HHHHHHHHHCCCcHHHHHHhCCC--chHHHHHHHHHHhcc-CHhhHHHHhhcchHHHHHHHHHh
Confidence 999999999999855 66799999999999999999865 455667788888876 33322233 3559999995666
Q ss_pred CCcHHHHHHHHHHHHHHHhCCHHHHHHHHhcCchHHHHHHhhccccccCCCCccccccCCchhhHHHHHHhhhcCCc-hh
Q 000706 1227 DEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTP-CR 1305 (1342)
Q Consensus 1227 D~D~~VR~nAA~aL~~IakHt~eLAq~VV~aGav~~LVd~~~qe~~~~~~~l~~~~~~~~~~ria~~~L~~i~kh~~-~a 1305 (1342)
-+++.|...+..++.|++.+ +.-||.+++.|+++.|++.+....+ + .-+.-+=+|+.|++ .-
T Consensus 423 ~~~~~v~~eliaL~iNLa~~-~rnaqlm~~g~gL~~L~~ra~~~~D----~------------lLlKlIRNiS~h~~~~k 485 (708)
T PF05804_consen 423 NSEEEVQLELIALLINLALN-KRNAQLMCEGNGLQSLMKRALKTRD----P------------LLLKLIRNISQHDGPLK 485 (708)
T ss_pred CCCccccHHHHHHHHHHhcC-HHHHHHHHhcCcHHHHHHHHHhccc----H------------HHHHHHHHHHhcCchHH
Confidence 67899998888889998755 5778999999999999988876655 2 23457789999996 43
Q ss_pred hhhhcCCCchhhhhcccCCc
Q 000706 1306 QFLQSSELFPVIARLRQSPE 1325 (1342)
Q Consensus 1306 q~vvda~~~~~ia~l~~~~d 1325 (1342)
...+| .|.-|+.++++.|
T Consensus 486 ~~f~~--~i~~L~~~v~~~~ 503 (708)
T PF05804_consen 486 ELFVD--FIGDLAKIVSSGD 503 (708)
T ss_pred HHHHH--HHHHHHHHhhcCC
Confidence 33333 5555566666544
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=6.9e-08 Score=102.57 Aligned_cols=128 Identities=25% Similarity=0.322 Sum_probs=85.4
Q ss_pred EEEEEEEccCCcEEEEEEeecCC------------------------CCHHHHHHHHHHHHHHHhcCCC--CcceEEEEE
Q 000706 19 KVYKGRRKYTGQTVAMKFIMKHG------------------------KSEKDIHNLRQEIEILRKLKHQ--NIIEMLDSF 72 (1342)
Q Consensus 19 tVYKArDk~TGe~VAVKvIkKs~------------------------~se~dierL~rEI~ILKrL~HP--NIVKL~dvf 72 (1342)
.||.|... +|+.+|+|+.+... ..........+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999864 68899999885320 0011134578899999999765 567777553
Q ss_pred EeCCeEEEEEeccC--CChHHHHhcCCCCCHHHHHHHHHHHHHHHHH-hhhCCceecCCCCCcEEEcCCCcEEEeecccc
Q 000706 73 ESPQEFCVVTEFAQ--GELFEILEDDKCLPEEQVQSIAKQLVRALHY-LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFA 149 (1342)
Q Consensus 73 eded~lyLVMEY~e--GSL~D~Lek~g~LSEeeI~~I~~QLLsALaY-LHsrGIVHRDLKPENILLdsdG~LKLiDFGLA 149 (1342)
.-++||||++ |.....+.+.. ++.+....++.+++..+.. +|+.|++||||.+.||+++++ .+.++|||.+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~-~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa 153 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD-LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA 153 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG-GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred ----CCEEEEEecCCCccchhhHHhcc-ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence 2369999998 75444444322 2245566788888886555 579999999999999999988 9999999988
Q ss_pred cccc
Q 000706 150 RAMS 153 (1342)
Q Consensus 150 r~l~ 153 (1342)
....
T Consensus 154 v~~~ 157 (188)
T PF01163_consen 154 VDSS 157 (188)
T ss_dssp EETT
T ss_pred eecC
Confidence 6544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=7e-09 Score=125.82 Aligned_cols=150 Identities=23% Similarity=0.428 Sum_probs=115.2
Q ss_pred HHHHHHHHhhhC-CceecCCCCCcEEEcCCCcEEEeeccccccccCCceee-e--------cccCCCCcCChhhhccCCC
Q 000706 110 QLVRALHYLHSN-RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL-R--------SIKGTPLYMAPELVREQPY 179 (1342)
Q Consensus 110 QLLsALaYLHsr-GIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~-~--------s~vGTp~YmAPEvL~g~~Y 179 (1342)
+...|+.|+|+. ++||+.|.|++|.++.+|.+||+.|+++.....+.... . -..-...|.|||.+.....
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 344899999986 89999999999999999999999999987655422211 0 0124556999999998888
Q ss_pred CCCCcccchhhHHHHHH-hCCCCCCCCcHHHHHH--HHh--cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q 000706 180 NHTADLWSLGVILYELF-VGQPPFYTNSVYALIR--HIV--KDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHP 254 (1342)
Q Consensus 180 T~KsDIWSLGVILYELL-TGr~PF~g~s~~elir--kIl--r~~~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHP 254 (1342)
+.++|+||+|+++|.+. .|+.-+.......... ... .....++..+++++++=+.+++..|+..||++.+++..|
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIP 266 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhccc
Confidence 99999999999999999 4555554432211111 111 123345678999999999999999999999999999999
Q ss_pred Ccccc
Q 000706 255 FVKET 259 (1342)
Q Consensus 255 FFre~ 259 (1342)
||.+.
T Consensus 267 ff~D~ 271 (700)
T KOG2137|consen 267 FFSDP 271 (700)
T ss_pred ccCCc
Confidence 99875
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=3.6e-07 Score=106.63 Aligned_cols=233 Identities=16% Similarity=0.204 Sum_probs=153.5
Q ss_pred EEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCCcceEEE------EEEe-CCeEE
Q 000706 8 VIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLD------SFES-PQEFC 79 (1342)
Q Consensus 8 IlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL-~HPNIVKL~d------vfed-ed~ly 79 (1342)
..+.||+|+-+.+|..-.- + ..+-|++.+...... .+ ....|... .||-+-.-+. +.-+ ...+.
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~--aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQ--AQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCccccCCccceeeecchh--h-chhheeecCCCchHH--HH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 3567999999999975322 2 234587765533221 11 12223333 5663322011 1112 23378
Q ss_pred EEEeccCCC--hHHHHh------cCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 000706 80 VVTEFAQGE--LFEILE------DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARA 151 (1342)
Q Consensus 80 LVMEY~eGS--L~D~Le------k~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~ 151 (1342)
+.|..+.|- ...+.. ......+....+..+.|+.+.+.||+.|.+-||+.++|+||++++.+.|.|-..- .
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf-q 165 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF-Q 165 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce-e
Confidence 899998763 333221 1234778899999999999999999999999999999999999999999986543 2
Q ss_pred ccCCceeeecccCCCCcCChhhhc-----cCCCCCCCcccchhhHHHHHHhC-CCCCCCCc-------HHH--HHHHHh-
Q 000706 152 MSANTVVLRSIKGTPLYMAPELVR-----EQPYNHTADLWSLGVILYELFVG-QPPFYTNS-------VYA--LIRHIV- 215 (1342)
Q Consensus 152 l~sss~~~~s~vGTp~YmAPEvL~-----g~~YT~KsDIWSLGVILYELLTG-r~PF~g~s-------~~e--lirkIl- 215 (1342)
+..+...+...+|.+.|.+||.-+ +..-+...|-|.||+++|+++.| ++||.+-. ..+ +..-.+
T Consensus 166 i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 166 INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 334455566778999999999644 44566789999999999999986 99997521 111 111000
Q ss_pred ------cC----CCCCC-CCCCHHHHHHHHHhccc--CCCCCCCHHH
Q 000706 216 ------KD----PVKYP-DEMSPNFKSFLKGLLNK--VPQNRLTWSA 249 (1342)
Q Consensus 216 ------r~----~~efP-~eISpeLkDLIrKcLqk--DPeKRPSAeE 249 (1342)
.+ +..+| .-++++++.+..+|+.. ++.-|||++.
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 11 11111 23678999999999875 4678999654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.7e-07 Score=97.89 Aligned_cols=125 Identities=22% Similarity=0.276 Sum_probs=93.2
Q ss_pred cCCcEEEEEEeecCCCCH-----HHHHHHHHHHHHHHhcCCC--CcceEEEEEEeC----CeEEEEEeccCC--ChHHHH
Q 000706 27 YTGQTVAMKFIMKHGKSE-----KDIHNLRQEIEILRKLKHQ--NIIEMLDSFESP----QEFCVVTEFAQG--ELFEIL 93 (1342)
Q Consensus 27 ~TGe~VAVKvIkKs~~se-----~dierL~rEI~ILKrL~HP--NIVKL~dvfede----d~lyLVMEY~eG--SL~D~L 93 (1342)
..++.|-+|......... -...+..+|.+.+.++..- ..++++.+.+.. ...++++|+++| +|.+++
T Consensus 30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~ 109 (206)
T PF06293_consen 30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLL 109 (206)
T ss_pred ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHH
Confidence 345666666543221110 1234677888888888543 345666666543 245899999986 688888
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC---cEEEeecccccc
Q 000706 94 EDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS---VVKLCDFGFARA 151 (1342)
Q Consensus 94 ek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG---~LKLiDFGLAr~ 151 (1342)
......+......++.++...+.-||+.||+|+|+++.|||++.++ .+.++||+.++.
T Consensus 110 ~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 110 QQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 8755577888899999999999999999999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.2e-07 Score=102.95 Aligned_cols=135 Identities=22% Similarity=0.297 Sum_probs=102.1
Q ss_pred EEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCC------------------CC--HHHHHHHHHHHHHHHhcCCC--C
Q 000706 7 HVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG------------------KS--EKDIHNLRQEIEILRKLKHQ--N 64 (1342)
Q Consensus 7 rIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~------------------~s--e~dierL~rEI~ILKrL~HP--N 64 (1342)
.++.+||.|.-+.||.|.+. .|.++|+|+-+-.. .. .-.+....+|.++|.++... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 46789999999999999876 78999999753210 01 11234577899999999654 6
Q ss_pred cceEEEEEEeCCeEEEEEeccCCC-hHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEE
Q 000706 65 IIEMLDSFESPQEFCVVTEFAQGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKL 143 (1342)
Q Consensus 65 IVKL~dvfeded~lyLVMEY~eGS-L~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKL 143 (1342)
+.+.+++ +.-.+||||++|. |.+. +++.+....++..|++-+.-+-..|++|+|+.+-||++++||.+.+
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 7777663 4567999999984 3332 2245556677777887777777999999999999999999999999
Q ss_pred eecccccc
Q 000706 144 CDFGFARA 151 (1342)
Q Consensus 144 iDFGLAr~ 151 (1342)
+||--+..
T Consensus 244 IDwPQ~v~ 251 (304)
T COG0478 244 IDWPQAVP 251 (304)
T ss_pred EeCccccc
Confidence 99965543
|
|
| >PF01602 Adaptin_N: Adaptin N terminal region; InterPro: IPR002553 Proteins synthesized on the ribosome and processed in the endoplasmic reticulum are transported from the Golgi apparatus to the trans-Golgi network (TGN), and from there via small carrier vesicles to their final destination compartment | Back alignment and domain information |
|---|
Probab=98.48 E-value=6.7e-07 Score=104.85 Aligned_cols=140 Identities=23% Similarity=0.250 Sum_probs=119.1
Q ss_pred hhhhhccCCCchHHHHHHHHHHHHHhhchhHHHHHHhCCchHhHHHhhcCCchhHHHHHHHHHHHHhcCCHHHHHhhhcc
Q 000706 1095 RVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKN 1174 (1342)
Q Consensus 1095 ~~~~~~~s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~v~LL~~lLqd~e~slqq~Aa~ALg~lakHS~eLAq~VVd~ 1174 (1342)
.+.++.+|..++++.-.-..+..++...+. +-.+ ++.-|+.=+++|++.+|..|..+|++++ ++|+++.+
T Consensus 46 ~vi~l~~s~~~~~Krl~yl~l~~~~~~~~~-~~~l----~~n~l~kdl~~~n~~~~~lAL~~l~~i~--~~~~~~~l--- 115 (526)
T PF01602_consen 46 EVIKLISSKDLELKRLGYLYLSLYLHEDPE-LLIL----IINSLQKDLNSPNPYIRGLALRTLSNIR--TPEMAEPL--- 115 (526)
T ss_dssp HHHCTCSSSSHHHHHHHHHHHHHHTTTSHH-HHHH----HHHHHHHHHCSSSHHHHHHHHHHHHHH---SHHHHHHH---
T ss_pred HHHHHhCCCCHHHHHHHHHHHHHHhhcchh-HHHH----HHHHHHHhhcCCCHHHHHHHHhhhhhhc--ccchhhHH---
Confidence 567788888888888887788888855555 2222 5666777899999999999999999999 99999876
Q ss_pred CcHHHHhhhcCCCChhhhhhHHHHHHHhHhcCHHHHHHHHHhHHHHHHhhccCCcHHHHHHHHHHHHHHHhCCHHH
Q 000706 1175 RIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKL 1250 (1342)
Q Consensus 1175 ~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~Vae~~p~lv~~cL~D~D~~VR~nAA~aL~~IakHt~eL 1250 (1342)
+|.+..+|.|+++++||.|+.|+..+.+..+++.+.- .+|.+.. +|+|.|+.|+.+|..++.+| |++++.
T Consensus 116 --~~~v~~ll~~~~~~VRk~A~~~l~~i~~~~p~~~~~~--~~~~l~~-lL~d~~~~V~~~a~~~l~~i-~~~~~~ 185 (526)
T PF01602_consen 116 --IPDVIKLLSDPSPYVRKKAALALLKIYRKDPDLVEDE--LIPKLKQ-LLSDKDPSVVSAALSLLSEI-KCNDDS 185 (526)
T ss_dssp --HHHHHHHHHSSSHHHHHHHHHHHHHHHHHCHCCHHGG--HHHHHHH-HTTHSSHHHHHHHHHHHHHH-HCTHHH
T ss_pred --HHHHHHHhcCCchHHHHHHHHHHHHHhccCHHHHHHH--HHHHHhh-hccCCcchhHHHHHHHHHHH-ccCcch
Confidence 7899999999999999999999999999999876542 5888888 99999999999999999999 888876
|
This traffic is bidirectional, to ensure that proteins required to form vesicles are recycled. Vesicles have specific coat proteins (such as clathrin or coatomer) that are important for cargo selection and direction of transfer []. Clathrin coats contain both clathrin and adaptor complexes that link clathrin to receptors in coated vesicles. Clathrin-associated protein complexes are believed to interact with the cytoplasmic tails of membrane proteins, leading to their selection and concentration. The two major types of clathrin adaptor complexes are the heterotetrameric adaptor protein (AP) complexes, and the monomeric GGA (Golgi-localising, Gamma-adaptin ear domain homology, ARF-binding proteins) adaptors []. All AP complexes are heterotetramers composed of two large subunits (adaptins), a medium subunit (mu) and a small subunit (sigma). Each subunit has a specific function. Adaptin subunits recognise and bind to clathrin through their hinge region (clathrin box), and recruit accessory proteins that modulate AP function through their C-terminal appendage domains. By contrast, GGAs are monomers composed of four domains, which have functions similar to AP subunits: an N-terminal VHS (Vps27p/Hrs/Stam) domain, a GAT (GGA and Tom1) domain, a hinge region, and a C-terminal GAE (gamma-adaptin ear) domain. The GAE domain is similar to the AP gamma-adaptin ear domain, being responsible for the recruitment of accessory proteins that regulate clathrin-mediated endocytosis []. While clathrin mediates endocytic protein transport from ER to Golgi, coatomers (COPI, COPII) primarily mediate intra-Golgi transport, as well as the reverse Golgi to ER transport of dilysine-tagged proteins []. Coatomers reversibly associate with Golgi (non-clathrin-coated) vesicles to mediate protein transport and for budding from Golgi membranes []. Coatomer complexes are hetero-oligomers composed of at least an alpha, beta, beta', gamma, delta, epsilon and zeta subunits. This entry represents the N-terminal domain of various adaptins from different AP clathrin adaptor complexes (including AP1, AP2, AP3 and AP4), and from the beta and gamma subunits of various coatomer (COP) adaptors. This domain has a 2-layer alpha/alpha fold that forms a right-handed superhelix, and is a member of the ARM repeat superfamily []. The N-terminal region of the various AP adaptor proteins share strong sequence identity; by contrast, the C-terminal domains of different adaptins share similar structural folds, but have little sequence identity []. It has been proposed that the N-terminal domain interacts with another uniform component of the coated vesicles. More information about these proteins can be found at Protein of the Month: Clathrin [].; GO: 0006886 intracellular protein transport, 0016192 vesicle-mediated transport, 0030117 membrane coat; PDB: 1W63_C 2JKR_A 2JKT_A 2XA7_A 2VGL_B 3TJZ_E. |
| >PRK13800 putative oxidoreductase/HEAT repeat-containing protein; Provisional | Back alignment and domain information |
|---|
Probab=98.45 E-value=8.4e-07 Score=112.76 Aligned_cols=177 Identities=15% Similarity=0.171 Sum_probs=132.6
Q ss_pred ChhhhhhhccCCCchHHHHHHHHHHHHHhhchhHHHHHHhCCchHhHHHhhcCCchhHHHHHHHHHHHHhcCCHHHHHhh
Q 000706 1092 DPNRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSL 1171 (1342)
Q Consensus 1092 ~~~~~~~~~~s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~v~LL~~lLqd~e~slqq~Aa~ALg~lakHS~eLAq~V 1171 (1342)
++..+...|.+..|.||..-++.+.++- ..+.|..++.|+++.||+.++.+||.+.+..
T Consensus 715 ~~~~l~~~L~D~d~~VR~~Av~aL~~~~--------------~~~~l~~~l~D~~~~VR~~aa~aL~~~~~~~------- 773 (897)
T PRK13800 715 DAALFAAALGDPDHRVRIEAVRALVSVD--------------DVESVAGAATDENREVRIAVAKGLATLGAGG------- 773 (897)
T ss_pred CHHHHHHHhcCCCHHHHHHHHHHHhccc--------------CcHHHHHHhcCCCHHHHHHHHHHHHHhcccc-------
Confidence 4566667778888888877777666542 2345677899999999999999999887642
Q ss_pred hccCcHHHHhhhcCCCChhhhhhHHHHHHHhHhcCHHHHHHHHHhHHHHHHhhccCCcHHHHHHHHHHHHHHHhCCHHHH
Q 000706 1172 AKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLC 1251 (1342)
Q Consensus 1172 Vd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~Vae~~p~lv~~cL~D~D~~VR~nAA~aL~~IakHt~eLA 1251 (1342)
...++.|...++|+|+.+|..|..+|+++-.. .+.++.++. .|+|.|+.||++||.+|+.+.
T Consensus 774 --~~~~~~L~~ll~D~d~~VR~aA~~aLg~~g~~--------~~~~~~l~~-aL~d~d~~VR~~Aa~aL~~l~------- 835 (897)
T PRK13800 774 --APAGDAVRALTGDPDPLVRAAALAALAELGCP--------PDDVAAATA-ALRASAWQVRQGAARALAGAA------- 835 (897)
T ss_pred --chhHHHHHHHhcCCCHHHHHHHHHHHHhcCCc--------chhHHHHHH-HhcCCChHHHHHHHHHHHhcc-------
Confidence 22378888999999999999999999887432 111244777 899999999999999998773
Q ss_pred HHHHhcCchHHHHHHhhccccccCCCCccccccCCchhhHHHHHHhhhcCCchhhhhhcCCCchhhhhcccCCcccccce
Q 000706 1252 EDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQFLQSSELFPVIARLRQSPESTIANY 1331 (1342)
Q Consensus 1252 q~VV~aGav~~LVd~~~qe~~~~~~~l~~~~~~~~~~ria~~~L~~i~kh~~~aq~vvda~~~~~ia~l~~~~d~~~k~~ 1331 (1342)
+..+++.|++.. ++|+ ...| +.|+.+|+++ +. +..+.+.|.++++++|+.+++.
T Consensus 836 ----~~~a~~~L~~~L-~D~~---~~VR---------~~A~~aL~~~-~~--------~~~a~~~L~~al~D~d~~Vr~~ 889 (897)
T PRK13800 836 ----ADVAVPALVEAL-TDPH---LDVR---------KAAVLALTRW-PG--------DPAARDALTTALTDSDADVRAY 889 (897)
T ss_pred ----ccchHHHHHHHh-cCCC---HHHH---------HHHHHHHhcc-CC--------CHHHHHHHHHHHhCCCHHHHHH
Confidence 234558888555 4555 4788 8889999997 22 3345778889999999999887
Q ss_pred ee
Q 000706 1332 AS 1333 (1342)
Q Consensus 1332 ~~ 1333 (1342)
|.
T Consensus 890 A~ 891 (897)
T PRK13800 890 AR 891 (897)
T ss_pred HH
Confidence 64
|
|
| >PF04826 Arm_2: Armadillo-like; InterPro: IPR006911 This entry consists of mammalian proteins of unknown function | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.6e-06 Score=93.55 Aligned_cols=224 Identities=17% Similarity=0.215 Sum_probs=170.0
Q ss_pred ccChhhhhhhcc----CCCchHHHHHHHHHHHHHhhchhHHHHHHhCCchHhHHHhhcCCchhHHHHHHHHHHHHhcCCH
Q 000706 1090 LLDPNRVRRLLD----SSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSS 1165 (1342)
Q Consensus 1090 ~~~~~~~~~~~~----s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~v~LL~~lLqd~e~slqq~Aa~ALg~lakHS~ 1165 (1342)
.++|.+..+|+. +..|..+-.-+-+....| +.+.|-+.|.+.|.++++..+|.+|.|.+|..|..||.+|+-..+
T Consensus 8 ~l~~~~l~~Ll~lL~~t~dp~i~e~al~al~n~a-af~~nq~~Ir~~Ggi~lI~~lL~~p~~~vr~~AL~aL~Nls~~~e 86 (254)
T PF04826_consen 8 ILEAQELQKLLCLLESTEDPFIQEKALIALGNSA-AFPFNQDIIRDLGGISLIGSLLNDPNPSVREKALNALNNLSVNDE 86 (254)
T ss_pred CcCHHHHHHHHHHHhcCCChHHHHHHHHHHHhhc-cChhHHHHHHHcCCHHHHHHHcCCCChHHHHHHHHHHHhcCCChh
Confidence 355655555544 667999999899999988 999999999999999999999999999999999999999988766
Q ss_pred HHHHhhhccCcHHHHhhhcCC--CChhhhhhHHHHHHHhHhcCHHHHHHHHHhHHHHHHhhccCCcHHHHHHHHHHHHHH
Q 000706 1166 YFYSSLAKNRIIGLLIDRCAD--PDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNL 1243 (1342)
Q Consensus 1166 eLAq~VVd~~iLp~Lv~~L~~--~D~~~Kr~ac~~L~~iAkHs~~LAe~Vae~~p~lv~~cL~D~D~~VR~nAA~aL~~I 1243 (1342)
..-+ +. ..++++...+.. -|..++.++--.|++++ ...+-=+.++..+|.++. +|..-+..+|..+-.+|-++
T Consensus 87 n~~~-Ik--~~i~~Vc~~~~s~~lns~~Q~agLrlL~nLt-v~~~~~~~l~~~i~~ll~-LL~~G~~~~k~~vLk~L~nL 161 (254)
T PF04826_consen 87 NQEQ-IK--MYIPQVCEETVSSPLNSEVQLAGLRLLTNLT-VTNDYHHMLANYIPDLLS-LLSSGSEKTKVQVLKVLVNL 161 (254)
T ss_pred hHHH-HH--HHHHHHHHHHhcCCCCCHHHHHHHHHHHccC-CCcchhhhHHhhHHHHHH-HHHcCChHHHHHHHHHHHHh
Confidence 6543 32 357777776553 37788888888899885 334444556888999999 99999999999999999999
Q ss_pred HhCCHHHHHHHHhcCchHHHHHHhhccccccCCCCccccccCCchhhHHHHHHhhhcCCc-hhhh--------------h
Q 000706 1244 IRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTP-CRQF--------------L 1308 (1342)
Q Consensus 1244 akHt~eLAq~VV~aGav~~LVd~~~qe~~~~~~~l~~~~~~~~~~ria~~~L~~i~kh~~-~aq~--------------v 1308 (1342)
+. +|.+++.+++++++..++ ...+..+- .. -+..++.-..+|.+|=- =.+. .
T Consensus 162 S~-np~~~~~Ll~~q~~~~~~-~Lf~~~~~--~~---------~l~~~l~~~~ni~~~~~~~~~~~~~~~~~~~~L~~~~ 228 (254)
T PF04826_consen 162 SE-NPDMTRELLSAQVLSSFL-SLFNSSES--KE---------NLLRVLTFFENINENIKKEAYVFVQDDFSEDSLFSLF 228 (254)
T ss_pred cc-CHHHHHHHHhccchhHHH-HHHccCCc--cH---------HHHHHHHHHHHHHHhhCcccceeccccCCchhHHHHH
Confidence 86 578899999999999999 44444430 11 12566777777766643 1111 1
Q ss_pred hcCC-CchhhhhcccCCccccccee
Q 000706 1309 QSSE-LFPVIARLRQSPESTIANYA 1332 (1342)
Q Consensus 1309 vda~-~~~~ia~l~~~~d~~~k~~~ 1332 (1342)
-|.+ ...-+..|..|||+.+|.||
T Consensus 229 ~e~~~~~~~l~~l~~h~d~ev~~~v 253 (254)
T PF04826_consen 229 GESSQLAKKLQALANHPDPEVKEQV 253 (254)
T ss_pred ccHHHHHHHHHHHHcCCCHHHhhhc
Confidence 1222 22345567889999999886
|
|
| >PRK13800 putative oxidoreductase/HEAT repeat-containing protein; Provisional | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.1e-06 Score=111.70 Aligned_cols=191 Identities=16% Similarity=0.118 Sum_probs=102.5
Q ss_pred ChhhhhhhccCCCchHHHHHHHHHHHHHhhchhHHHHHHhCCchHhHHHhhcCCchhHHHHHHHHHHHHhcCC---HHHH
Q 000706 1092 DPNRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHS---SYFY 1168 (1342)
Q Consensus 1092 ~~~~~~~~~~s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~v~LL~~lLqd~e~slqq~Aa~ALg~lakHS---~eLA 1168 (1342)
+...+...|.+..|.||..=++.+.+.. ..++++.|..+|.|+++.||..|+.+|++|.... +.|.
T Consensus 622 ~~~~L~~~L~D~d~~VR~~Av~~L~~~~-----------~~~~~~~L~~aL~D~d~~VR~~Aa~aL~~l~~~~~~~~~L~ 690 (897)
T PRK13800 622 SVAELAPYLADPDPGVRRTAVAVLTETT-----------PPGFGPALVAALGDGAAAVRRAAAEGLRELVEVLPPAPALR 690 (897)
T ss_pred hHHHHHHHhcCCCHHHHHHHHHHHhhhc-----------chhHHHHHHHHHcCCCHHHHHHHHHHHHHHHhccCchHHHH
Confidence 3344555556666666655555544433 2445566666666666666666666666553211 0000
Q ss_pred Hh-----------hh------ccCcHHHHhhhcCCCChhhhhhHHHHHHHhHhcCHHHHHHHHHhHHHHHHhhccCCcHH
Q 000706 1169 SS-----------LA------KNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDK 1231 (1342)
Q Consensus 1169 q~-----------VV------d~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~Vae~~p~lv~~cL~D~D~~ 1231 (1342)
+. ++ ..+-...|+..|.|+|+.+|+.|..+|+.+-. .+.|.. +|+|+|+.
T Consensus 691 ~~L~~~d~~VR~~A~~aL~~~~~~~~~~l~~~L~D~d~~VR~~Av~aL~~~~~------------~~~l~~-~l~D~~~~ 757 (897)
T PRK13800 691 DHLGSPDPVVRAAALDVLRALRAGDAALFAAALGDPDHRVRIEAVRALVSVDD------------VESVAG-AATDENRE 757 (897)
T ss_pred HHhcCCCHHHHHHHHHHHHhhccCCHHHHHHHhcCCCHHHHHHHHHHHhcccC------------cHHHHH-HhcCCCHH
Confidence 00 00 00112334455566666666666666555411 234555 67777777
Q ss_pred HHHHHHHHHHHHHhCCHHHHHHHHhcCchHHHHHHhhccccccCCCCccccccCCchhhHHHHHHhhhcCCchhhhhhcC
Q 000706 1232 TKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQFLQSS 1311 (1342)
Q Consensus 1232 VR~nAA~aL~~IakHt~eLAq~VV~aGav~~LVd~~~qe~~~~~~~l~~~~~~~~~~ria~~~L~~i~kh~~~aq~vvda 1311 (1342)
||..||.+|+.+... +.++++.|..+ .++++ -..| ..|+.+|+++....+
T Consensus 758 VR~~aa~aL~~~~~~---------~~~~~~~L~~l-l~D~d---~~VR---------~aA~~aLg~~g~~~~-------- 807 (897)
T PRK13800 758 VRIAVAKGLATLGAG---------GAPAGDAVRAL-TGDPD---PLVR---------AAALAALAELGCPPD-------- 807 (897)
T ss_pred HHHHHHHHHHHhccc---------cchhHHHHHHH-hcCCC---HHHH---------HHHHHHHHhcCCcch--------
Confidence 777777777776432 12336777733 44555 3445 667788888743211
Q ss_pred CCchhhhhcccCCcccccceeeEEee
Q 000706 1312 ELFPVIARLRQSPESTIANYASVIIS 1337 (1342)
Q Consensus 1312 ~~~~~ia~l~~~~d~~~k~~~~~~~~ 1337 (1342)
.++.+...++++|..+++.|--.+.
T Consensus 808 -~~~~l~~aL~d~d~~VR~~Aa~aL~ 832 (897)
T PRK13800 808 -DVAAATAALRASAWQVRQGAARALA 832 (897)
T ss_pred -hHHHHHHHhcCCChHHHHHHHHHHH
Confidence 2245677788888888876543333
|
|
| >PF05804 KAP: Kinesin-associated protein (KAP) | Back alignment and domain information |
|---|
Probab=98.36 E-value=9.9e-06 Score=100.77 Aligned_cols=215 Identities=13% Similarity=0.154 Sum_probs=178.2
Q ss_pred hhhhhhccCCCchHHHHHHHHHHHHHhhchhHHHHHHhCCchHhHHHhhcCCchhHHHHHHHHHHHHhcCCHHHHHhhhc
Q 000706 1094 NRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAK 1173 (1342)
Q Consensus 1094 ~~~~~~~~s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~v~LL~~lLqd~e~slqq~Aa~ALg~lakHS~eLAq~VVd 1173 (1342)
++...++......+|+.| ..+..+| ..+++-..+.+.|++++|+.+|+....-+.-.+...|-+|+=+.+. -..+.+
T Consensus 253 kk~~~l~~kQeqLlrv~~-~lLlNLA-ed~~ve~kM~~~~iV~~Lv~~Ldr~n~ellil~v~fLkkLSi~~EN-K~~m~~ 329 (708)
T PF05804_consen 253 KKLQTLIRKQEQLLRVAF-YLLLNLA-EDPRVELKMVNKGIVSLLVKCLDRENEELLILAVTFLKKLSIFKEN-KDEMAE 329 (708)
T ss_pred HHHHHHHHHHHHHHHHHH-HHHHHHh-cChHHHHHHHhcCCHHHHHHHHcCCCHHHHHHHHHHHHHHcCCHHH-HHHHHH
Confidence 666777778888899888 5588999 8899999999999999999999999999999999999999988775 677789
Q ss_pred cCcHHHHhhhcCCCChhhhhhHHHHHHHhHhcCHHHHHHH-HHhHHHHHHhhccCCcHHHHHHHHHHHHHHHhCCHHHHH
Q 000706 1174 NRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEEL-RRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCE 1252 (1342)
Q Consensus 1174 ~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~V-ae~~p~lv~~cL~D~D~~VR~nAA~aL~~IakHt~eLAq 1252 (1342)
.+++|-|+..+..++..+.+.+.-.|.|++.+..--.+.| ...+|+|+. +|+|. ..+..|-..|.+++. +++-=.
T Consensus 330 ~giV~kL~kLl~s~~~~l~~~aLrlL~NLSfd~~~R~~mV~~GlIPkLv~-LL~d~--~~~~val~iLy~LS~-dd~~r~ 405 (708)
T PF05804_consen 330 SGIVEKLLKLLPSENEDLVNVALRLLFNLSFDPELRSQMVSLGLIPKLVE-LLKDP--NFREVALKILYNLSM-DDEARS 405 (708)
T ss_pred cCCHHHHHHHhcCCCHHHHHHHHHHHHHhCcCHHHHHHHHHCCCcHHHHH-HhCCC--chHHHHHHHHHHhcc-CHhhHH
Confidence 9999999999999999999999999999999988877777 556999999 99865 456666666666665 556556
Q ss_pred HHHhcCchHHHHHHhhccccccCCCCccccccCCchhhHHHHHHhhhcCCchhhhhhcCCCchhhhhc-ccCCccc
Q 000706 1253 DIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQFLQSSELFPVIARL-RQSPEST 1327 (1342)
Q Consensus 1253 ~VV~aGav~~LVd~~~qe~~~~~~~l~~~~~~~~~~ria~~~L~~i~kh~~~aq~vvda~~~~~ia~l-~~~~d~~ 1327 (1342)
.+...+++|.|++++...|+ .... .-++..+-++|.+...||.+++.+.++.+-.. +...|+-
T Consensus 406 ~f~~TdcIp~L~~~Ll~~~~---~~v~---------~eliaL~iNLa~~~rnaqlm~~g~gL~~L~~ra~~~~D~l 469 (708)
T PF05804_consen 406 MFAYTDCIPQLMQMLLENSE---EEVQ---------LELIALLINLALNKRNAQLMCEGNGLQSLMKRALKTRDPL 469 (708)
T ss_pred HHhhcchHHHHHHHHHhCCC---cccc---------HHHHHHHHHHhcCHHHHHHHHhcCcHHHHHHHHHhcccHH
Confidence 77888999999999988888 4444 34567778889888899999999888876543 3355544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.35 E-value=3.7e-06 Score=91.02 Aligned_cols=137 Identities=17% Similarity=0.245 Sum_probs=86.6
Q ss_pred CCCCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCC--CcceEEEEEEeCCeEE
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ--NIIEMLDSFESPQEFC 79 (1342)
Q Consensus 2 gVdrYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HP--NIVKL~dvfeded~ly 79 (1342)
+++++ ..||.|..+.||+. .+..+++|...... ....+.+|.++++.+..- .+.+++++.++.+..+
T Consensus 2 ~~~~~---~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~g 70 (226)
T TIGR02172 2 DLSDW---TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLG 70 (226)
T ss_pred ChhHh---eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeee
Confidence 44455 67899999999984 25568889875432 123568899999998643 3578888888888899
Q ss_pred EEEeccCCC--hHHHH------------------h--cC---CCCCHHH-HHHHHHH----------HHH-HHHHhh---
Q 000706 80 VVTEFAQGE--LFEIL------------------E--DD---KCLPEEQ-VQSIAKQ----------LVR-ALHYLH--- 119 (1342)
Q Consensus 80 LVMEY~eGS--L~D~L------------------e--k~---g~LSEee-I~~I~~Q----------LLs-ALaYLH--- 119 (1342)
++||+++|. +.+.+ . .. ...+... ...+-.+ +.. ...+|.
T Consensus 71 lv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~ 150 (226)
T TIGR02172 71 LIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVP 150 (226)
T ss_pred eeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCC
Confidence 999999984 11111 0 00 0111111 0011000 111 112222
Q ss_pred -hCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 000706 120 -SNRIIHRDMKPQNILIGAGSVVKLCDFGFAR 150 (1342)
Q Consensus 120 -srGIVHRDLKPENILLdsdG~LKLiDFGLAr 150 (1342)
...++|+|++|.||++++++ +.++||+.+.
T Consensus 151 ~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 151 DTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 12478999999999999988 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.34 E-value=4e-06 Score=91.40 Aligned_cols=136 Identities=16% Similarity=0.156 Sum_probs=101.0
Q ss_pred cccCcEEEEEEEEccCCcEEEEEEeecCCCC----HHHHHHHHHHHHHHHhcCCC--CcceEEEEEE---eC--CeEEEE
Q 000706 13 GEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS----EKDIHNLRQEIEILRKLKHQ--NIIEMLDSFE---SP--QEFCVV 81 (1342)
Q Consensus 13 GsGgFGtVYKArDk~TGe~VAVKvIkKs~~s----e~dierL~rEI~ILKrL~HP--NIVKL~dvfe---de--d~lyLV 81 (1342)
|+||.+.|++... .|+.|-+|.-..+... ......+.+|+..++++..- .+.++. ++. .+ ..-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 5699999998743 4557888876422110 11345788999999998532 244554 332 12 235899
Q ss_pred EeccCC--ChHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCc--EEEeecccccc
Q 000706 82 TEFAQG--ELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSV--VKLCDFGFARA 151 (1342)
Q Consensus 82 MEY~eG--SL~D~Lek~--g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~--LKLiDFGLAr~ 151 (1342)
+|-++| +|.+++.+. .+.++.....+..++...+.-||+.|+.|+|+-+.||+++.+|. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 999885 788888663 35688888899999999999999999999999999999987776 99999986653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.1e-05 Score=82.57 Aligned_cols=137 Identities=23% Similarity=0.303 Sum_probs=80.8
Q ss_pred EEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCC--CcceEEEEE---EeCCeEEEEEe
Q 000706 9 IELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ--NIIEMLDSF---ESPQEFCVVTE 83 (1342)
Q Consensus 9 lK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HP--NIVKL~dvf---eded~lyLVME 83 (1342)
++.|+.|..+.||+..... +.+++|..... .....+.+|..+++.+... .+.+++... ......+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 5789999999999997663 58999986433 3456788899999888433 355666643 33446799999
Q ss_pred ccCCC-hHH----------------HHh---cC----CCCCHHH------HHHH---------------HHHHHH-HHHH
Q 000706 84 FAQGE-LFE----------------ILE---DD----KCLPEEQ------VQSI---------------AKQLVR-ALHY 117 (1342)
Q Consensus 84 Y~eGS-L~D----------------~Le---k~----g~LSEee------I~~I---------------~~QLLs-ALaY 117 (1342)
+++|. +.+ .+. +. .++.... .... ...+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 99975 333 010 11 1111000 0000 011122 2333
Q ss_pred hh-------hCCceecCCCCCcEEEc-CCCcEEEeecccccc
Q 000706 118 LH-------SNRIIHRDMKPQNILIG-AGSVVKLCDFGFARA 151 (1342)
Q Consensus 118 LH-------srGIVHRDLKPENILLd-sdG~LKLiDFGLAr~ 151 (1342)
++ ...++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 33 24599999999999999 667778999987743
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.2e-07 Score=112.38 Aligned_cols=234 Identities=23% Similarity=0.282 Sum_probs=167.0
Q ss_pred EEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEeCCeEEEEEeccCCC-
Q 000706 11 LVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN-IIEMLDSFESPQEFCVVTEFAQGE- 88 (1342)
Q Consensus 11 ~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HPN-IVKL~dvfeded~lyLVMEY~eGS- 88 (1342)
.+++|+++.+||.++..+.... .+++... ...+-++++|.+++||| .+..++-++.++..++.|+++.+.
T Consensus 249 ~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 4578999999999877665555 6766433 34566899999999999 777778888889999999999743
Q ss_pred -hHHHH-hcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCC
Q 000706 89 -LFEIL-EDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTP 166 (1342)
Q Consensus 89 -L~D~L-ek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp 166 (1342)
....+ ...-.+.+.+.....+.-.++++|+|+.-=+||| ||+..+ +..|..||+....+.... ..++..+++
T Consensus 321 s~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~~~~ 394 (829)
T KOG0576|consen 321 SSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAIGTP 394 (829)
T ss_pred cccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-ccccCCCCC
Confidence 22211 1112344555566677778899999998878998 776665 689999999988776553 446677999
Q ss_pred CcCChhhhccCCCCCCCcccchhhHHHHHHhCCCCCCCCcHHHHHHHHhcCC--CCCCC--CCCH-HHHHHHHHhcccCC
Q 000706 167 LYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP--VKYPD--EMSP-NFKSFLKGLLNKVP 241 (1342)
Q Consensus 167 ~YmAPEvL~g~~YT~KsDIWSLGVILYELLTGr~PF~g~s~~elirkIlr~~--~efP~--eISp-eLkDLIrKcLqkDP 241 (1342)
.+++||+.....++...|.|++|.--.+|.-|.+|-..... ....+-.++ +.+.. ..++ .-.++...|+..-|
T Consensus 395 ~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P 472 (829)
T KOG0576|consen 395 EPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLP 472 (829)
T ss_pred CCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCCCccccchhhhcCcccccCCcccccCCCC
Confidence 99999999999999999999999888888888777543110 000000000 00000 0111 12247789999999
Q ss_pred CCCCCHHHHHcCcCcccch
Q 000706 242 QNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 242 eKRPSAeELLeHPFFre~~ 260 (1342)
..|+....++.|.+|..+.
T Consensus 473 ~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 473 PTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred CCCcchhhHHHHHHhccCc
Confidence 9999999999999887653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=5.7e-06 Score=99.91 Aligned_cols=142 Identities=19% Similarity=0.296 Sum_probs=93.7
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCC---------------------------CH-H----------HHHHHH
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK---------------------------SE-K----------DIHNLR 51 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~---------------------------se-~----------dierL~ 51 (1342)
+.|+.++-|.||+|+.. +|+.||||+.++.-. .. . ..-++.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56888999999999876 599999999854210 00 0 011245
Q ss_pred HHHHHHHhc-----CCCCcceEEEEEEeCCeEEEEEeccCCC-hHHH--HhcCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 000706 52 QEIEILRKL-----KHQNIIEMLDSFESPQEFCVVTEFAQGE-LFEI--LEDDKCLPEEQVQSIAKQLVRALHYLHSNRI 123 (1342)
Q Consensus 52 rEI~ILKrL-----~HPNIVKL~dvfeded~lyLVMEY~eGS-L~D~--Lek~g~LSEeeI~~I~~QLLsALaYLHsrGI 123 (1342)
+|...+.++ +.|++.-..=+++-.....++|||++|. +.+. +++ ..++.+.+...+.+.. +..+=..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 566666655 2455443344445566778999999984 4444 344 3455333332222211 233334899
Q ss_pred eecCCCCCcEEEcCCCcEEEeeccccccccCC
Q 000706 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSAN 155 (1342)
Q Consensus 124 VHRDLKPENILLdsdG~LKLiDFGLAr~l~ss 155 (1342)
+|.|.+|.||+++.+|++.+.|||+...+++.
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 99999999999999999999999999877654
|
|
| >PF01602 Adaptin_N: Adaptin N terminal region; InterPro: IPR002553 Proteins synthesized on the ribosome and processed in the endoplasmic reticulum are transported from the Golgi apparatus to the trans-Golgi network (TGN), and from there via small carrier vesicles to their final destination compartment | Back alignment and domain information |
|---|
Probab=98.22 E-value=4e-06 Score=98.38 Aligned_cols=214 Identities=22% Similarity=0.209 Sum_probs=159.0
Q ss_pred cChhhhhhhccCCCchHHHHHHHHHHHHHhhchhHHHHHHhCCchHhHHHhhcCCchhHHHHHHHHHHHHhcCCHHHHHh
Q 000706 1091 LDPNRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSS 1170 (1342)
Q Consensus 1091 ~~~~~~~~~~~s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~v~LL~~lLqd~e~slqq~Aa~ALg~lakHS~eLAq~ 1170 (1342)
+..+++..=+.+..|.+|.-=+++++.++ .+.-++. +++.+..++.|+.|.||++|+.++.++.+..|++.+.
T Consensus 79 l~~n~l~kdl~~~n~~~~~lAL~~l~~i~--~~~~~~~-----l~~~v~~ll~~~~~~VRk~A~~~l~~i~~~~p~~~~~ 151 (526)
T PF01602_consen 79 LIINSLQKDLNSPNPYIRGLALRTLSNIR--TPEMAEP-----LIPDVIKLLSDPSPYVRKKAALALLKIYRKDPDLVED 151 (526)
T ss_dssp HHHHHHHHHHCSSSHHHHHHHHHHHHHH---SHHHHHH-----HHHHHHHHHHSSSHHHHHHHHHHHHHHHHHCHCCHHG
T ss_pred HHHHHHHHhhcCCCHHHHHHHHhhhhhhc--ccchhhH-----HHHHHHHHhcCCchHHHHHHHHHHHHHhccCHHHHHH
Confidence 45567777788999999999999998887 3333333 4788999999999999999999999999999986543
Q ss_pred hhccCcHHHHhhhcCCCChhhhhhHHHHHHHhHhcCHHHHH-HHHHhHHHHHHhhccCCcHHHHHHHHHHHHHHHhCCHH
Q 000706 1171 LAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYE-ELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSK 1249 (1342)
Q Consensus 1171 VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe-~Vae~~p~lv~~cL~D~D~~VR~nAA~aL~~IakHt~e 1249 (1342)
. .++.|..+|.|+|+-++.+|+.++..+ +++++.+. .+...++.|.+ ++.+++|-++.++...++.+++.+++
T Consensus 152 ---~-~~~~l~~lL~d~~~~V~~~a~~~l~~i-~~~~~~~~~~~~~~~~~L~~-~l~~~~~~~q~~il~~l~~~~~~~~~ 225 (526)
T PF01602_consen 152 ---E-LIPKLKQLLSDKDPSVVSAALSLLSEI-KCNDDSYKSLIPKLIRILCQ-LLSDPDPWLQIKILRLLRRYAPMEPE 225 (526)
T ss_dssp ---G-HHHHHHHHTTHSSHHHHHHHHHHHHHH-HCTHHHHTTHHHHHHHHHHH-HHTCCSHHHHHHHHHHHTTSTSSSHH
T ss_pred ---H-HHHHHhhhccCCcchhHHHHHHHHHHH-ccCcchhhhhHHHHHHHhhh-cccccchHHHHHHHHHHHhcccCChh
Confidence 3 689999999999999999999999999 99999865 34555777777 77999999999999999999999998
Q ss_pred HHH--HHHh-------------------------------cCchHHHHHHhhccccccCCCCccccccCCchhhHHHHHH
Q 000706 1250 LCE--DIVS-------------------------------KGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLA 1296 (1342)
Q Consensus 1250 LAq--~VV~-------------------------------aGav~~LVd~~~qe~~~~~~~l~~~~~~~~~~ria~~~L~ 1296 (1342)
..+ .+++ ..+++.|+.+.. +++ .++| -+++.+|.
T Consensus 226 ~~~~~~~i~~l~~~l~s~~~~V~~e~~~~i~~l~~~~~~~~~~~~~L~~lL~-s~~---~nvr---------~~~L~~L~ 292 (526)
T PF01602_consen 226 DADKNRIIEPLLNLLQSSSPSVVYEAIRLIIKLSPSPELLQKAINPLIKLLS-SSD---PNVR---------YIALDSLS 292 (526)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSSSHHHHHHHHHHHHHHHT-SSS---HHHH---------HHHHHHHH
T ss_pred hhhHHHHHHHHHHHhhccccHHHHHHHHHHHHhhcchHHHHhhHHHHHHHhh-ccc---chhe---------hhHHHHHH
Confidence 882 2221 233444443433 333 2355 67777788
Q ss_pred hhhcCCchhhhhhcCCCchhhhhcccCCcccccceeeE
Q 000706 1297 KMCAHTPCRQFLQSSELFPVIARLRQSPESTIANYASV 1334 (1342)
Q Consensus 1297 ~i~kh~~~aq~vvda~~~~~ia~l~~~~d~~~k~~~~~ 1334 (1342)
.|+++.| +.+. .....+-.+..++|..+|+.+--
T Consensus 293 ~l~~~~~--~~v~--~~~~~~~~l~~~~d~~Ir~~~l~ 326 (526)
T PF01602_consen 293 QLAQSNP--PAVF--NQSLILFFLLYDDDPSIRKKALD 326 (526)
T ss_dssp HHCCHCH--HHHG--THHHHHHHHHCSSSHHHHHHHHH
T ss_pred Hhhcccc--hhhh--hhhhhhheecCCCChhHHHHHHH
Confidence 8887772 1222 33334445555777778776533
|
This traffic is bidirectional, to ensure that proteins required to form vesicles are recycled. Vesicles have specific coat proteins (such as clathrin or coatomer) that are important for cargo selection and direction of transfer []. Clathrin coats contain both clathrin and adaptor complexes that link clathrin to receptors in coated vesicles. Clathrin-associated protein complexes are believed to interact with the cytoplasmic tails of membrane proteins, leading to their selection and concentration. The two major types of clathrin adaptor complexes are the heterotetrameric adaptor protein (AP) complexes, and the monomeric GGA (Golgi-localising, Gamma-adaptin ear domain homology, ARF-binding proteins) adaptors []. All AP complexes are heterotetramers composed of two large subunits (adaptins), a medium subunit (mu) and a small subunit (sigma). Each subunit has a specific function. Adaptin subunits recognise and bind to clathrin through their hinge region (clathrin box), and recruit accessory proteins that modulate AP function through their C-terminal appendage domains. By contrast, GGAs are monomers composed of four domains, which have functions similar to AP subunits: an N-terminal VHS (Vps27p/Hrs/Stam) domain, a GAT (GGA and Tom1) domain, a hinge region, and a C-terminal GAE (gamma-adaptin ear) domain. The GAE domain is similar to the AP gamma-adaptin ear domain, being responsible for the recruitment of accessory proteins that regulate clathrin-mediated endocytosis []. While clathrin mediates endocytic protein transport from ER to Golgi, coatomers (COPI, COPII) primarily mediate intra-Golgi transport, as well as the reverse Golgi to ER transport of dilysine-tagged proteins []. Coatomers reversibly associate with Golgi (non-clathrin-coated) vesicles to mediate protein transport and for budding from Golgi membranes []. Coatomer complexes are hetero-oligomers composed of at least an alpha, beta, beta', gamma, delta, epsilon and zeta subunits. This entry represents the N-terminal domain of various adaptins from different AP clathrin adaptor complexes (including AP1, AP2, AP3 and AP4), and from the beta and gamma subunits of various coatomer (COP) adaptors. This domain has a 2-layer alpha/alpha fold that forms a right-handed superhelix, and is a member of the ARM repeat superfamily []. The N-terminal region of the various AP adaptor proteins share strong sequence identity; by contrast, the C-terminal domains of different adaptins share similar structural folds, but have little sequence identity []. It has been proposed that the N-terminal domain interacts with another uniform component of the coated vesicles. More information about these proteins can be found at Protein of the Month: Clathrin [].; GO: 0006886 intracellular protein transport, 0016192 vesicle-mediated transport, 0030117 membrane coat; PDB: 1W63_C 2JKR_A 2JKT_A 2XA7_A 2VGL_B 3TJZ_E. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.22 E-value=9.1e-06 Score=89.32 Aligned_cols=137 Identities=19% Similarity=0.313 Sum_probs=87.2
Q ss_pred CCEEEEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCCHH-HHHH------HHHHHHHHHhcCCCC---cceEEE---
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEK-DIHN------LRQEIEILRKLKHQN---IIEMLD--- 70 (1342)
Q Consensus 4 drYrIlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~se~-dier------L~rEI~ILKrL~HPN---IVKL~d--- 70 (1342)
.+|++.+.+-......|.+- ..+|+.+++|..+......+ .... ..+++..+.++...+ ...++-
T Consensus 31 ~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 47888888888887777765 45689999998654322111 1111 223344444443222 222222
Q ss_pred --EEEeCCeEEEEEeccCCC-hHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCCcEEEeecc
Q 000706 71 --SFESPQEFCVVTEFAQGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFG 147 (1342)
Q Consensus 71 --vfeded~lyLVMEY~eGS-L~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG~LKLiDFG 147 (1342)
.+.-....+++|||++|. |.+... +++ .+...+.+.+.-+|+.|++|+|.+|.|++++.+ .++++||+
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~ 179 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQ 179 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECc
Confidence 222334567999999984 444321 233 244567788999999999999999999999965 59999998
Q ss_pred cccc
Q 000706 148 FARA 151 (1342)
Q Consensus 148 LAr~ 151 (1342)
..+.
T Consensus 180 ~k~~ 183 (229)
T PF06176_consen 180 GKRM 183 (229)
T ss_pred cccc
Confidence 6643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF13646 HEAT_2: HEAT repeats; PDB: 1OYZ_A 3FGA_A 2PF4_C 2IAE_A 3B2A_A | Back alignment and domain information |
|---|
Probab=98.19 E-value=4.9e-06 Score=75.43 Aligned_cols=86 Identities=33% Similarity=0.481 Sum_probs=71.7
Q ss_pred hHhHHHhh-cCCchhHHHHHHHHHHHHhcCCHHHHHhhhccCcHHHHhhhcCCCChhhhhhHHHHHHHhHhcCHHHHHHH
Q 000706 1135 LEFLKDFL-THEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEEL 1213 (1342)
Q Consensus 1135 v~LL~~lL-qd~e~slqq~Aa~ALg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~V 1213 (1342)
||.|...| .|+++.+|+.|+.+||++. ++ .++|.|...++|+|+.+|++|+.+|+++. =
T Consensus 1 i~~L~~~l~~~~~~~vr~~a~~~L~~~~--~~---------~~~~~L~~~l~d~~~~vr~~a~~aL~~i~---------~ 60 (88)
T PF13646_consen 1 IPALLQLLQNDPDPQVRAEAARALGELG--DP---------EAIPALIELLKDEDPMVRRAAARALGRIG---------D 60 (88)
T ss_dssp HHHHHHHHHTSSSHHHHHHHHHHHHCCT--HH---------HHHHHHHHHHTSSSHHHHHHHHHHHHCCH---------H
T ss_pred CHHHHHHHhcCCCHHHHHHHHHHHHHcC--CH---------hHHHHHHHHHcCCCHHHHHHHHHHHHHhC---------C
Confidence 46677766 9999999999999999663 23 55999999999999999999999999984 1
Q ss_pred HHhHHHHHHhhccC-CcHHHHHHHHHHHH
Q 000706 1214 RRSIPLLANILISD-EEDKTKANAAGALS 1241 (1342)
Q Consensus 1214 ae~~p~lv~~cL~D-~D~~VR~nAA~aL~ 1241 (1342)
.+.+|.|.. +++| .+..||+.|+.+|+
T Consensus 61 ~~~~~~L~~-~l~~~~~~~vr~~a~~aL~ 88 (88)
T PF13646_consen 61 PEAIPALIK-LLQDDDDEVVREAAAEALG 88 (88)
T ss_dssp HHTHHHHHH-HHTC-SSHHHHHHHHHHHH
T ss_pred HHHHHHHHH-HHcCCCcHHHHHHHHhhcC
Confidence 446888888 6655 67888999999986
|
|
| >PF13513 HEAT_EZ: HEAT-like repeat; PDB: 2Z5J_A 2OT8_B 2Z5O_A 2H4M_A 2QMR_A 1QBK_B 2Z5M_A 2Z5K_A 2Z5N_A 1GCJ_B | Back alignment and domain information |
|---|
Probab=98.14 E-value=4.2e-06 Score=71.36 Aligned_cols=54 Identities=33% Similarity=0.466 Sum_probs=49.9
Q ss_pred hhhhhhHHHHHHHhHhcCHHHHHHH-HHhHHHHHHhhccCCcHHHHHHHHHHHHHH
Q 000706 1189 KRTRKFACFSIGNAAYHNDVLYEEL-RRSIPLLANILISDEEDKTKANAAGALSNL 1243 (1342)
Q Consensus 1189 ~~~Kr~ac~~L~~iAkHs~~LAe~V-ae~~p~lv~~cL~D~D~~VR~nAA~aL~~I 1243 (1342)
+.+|++||.+|++++.+.++..+.. .+++|.|+. +|+|.++.||++|++||++|
T Consensus 1 p~vR~~A~~aLg~l~~~~~~~~~~~~~~~~~~L~~-~L~d~~~~VR~~A~~aLg~l 55 (55)
T PF13513_consen 1 PRVRRAAAWALGRLAEGCPELLQPYLPELLPALIP-LLQDDDDSVRAAAAWALGNL 55 (55)
T ss_dssp HHHHHHHHHHHHCTTTTTHHHHHHHHHHHHHHHHH-HTTSSSHHHHHHHHHHHHCH
T ss_pred CHHHHHHHHHHhhHhcccHHHHHHHHHHHHHHHHH-HHcCCCHHHHHHHHHHHhcC
Confidence 3689999999999999999998887 667999999 99999999999999999986
|
... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.9e-05 Score=86.67 Aligned_cols=138 Identities=20% Similarity=0.240 Sum_probs=99.5
Q ss_pred EEEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC--------------------HHH--HHHHHHHHHHHHhcC--CCC
Q 000706 9 IELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS--------------------EKD--IHNLRQEIEILRKLK--HQN 64 (1342)
Q Consensus 9 lK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s--------------------e~d--ierL~rEI~ILKrL~--HPN 64 (1342)
...|..|.-+.||+|.. .++..+|+|+++..... ... .....+|+.-|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 44788899999999975 46889999998543111 111 123566888888884 445
Q ss_pred cceEEEEEEeCCeEEEEEeccCCC--hHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCcEEEcCCCcE
Q 000706 65 IIEMLDSFESPQEFCVVTEFAQGE--LFEILEDDKCLPEEQVQSIAKQLVRALHYLHS-NRIIHRDMKPQNILIGAGSVV 141 (1342)
Q Consensus 65 IVKL~dvfeded~lyLVMEY~eGS--L~D~Lek~g~LSEeeI~~I~~QLLsALaYLHs-rGIVHRDLKPENILLdsdG~L 141 (1342)
+.+.+.+. .-.+||||++.. -.-.|++ -++.++++..+..++++.+.-|-. .|+||+||+.-|||+. ++.+
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 56666655 346999999844 1112222 234444788889999999999876 8999999999999999 8899
Q ss_pred EEeecccccccc
Q 000706 142 KLCDFGFARAMS 153 (1342)
Q Consensus 142 KLiDFGLAr~l~ 153 (1342)
.++|||-+....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999886654
|
|
| >PF13646 HEAT_2: HEAT repeats; PDB: 1OYZ_A 3FGA_A 2PF4_C 2IAE_A 3B2A_A | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.7e-06 Score=76.20 Aligned_cols=87 Identities=33% Similarity=0.413 Sum_probs=71.4
Q ss_pred HHHHhhhc-CCCChhhhhhHHHHHHHhHhcCHHHHHHHHHhHHHHHHhhccCCcHHHHHHHHHHHHHHHhCCHHHHHHHH
Q 000706 1177 IGLLIDRC-ADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIV 1255 (1342)
Q Consensus 1177 Lp~Lv~~L-~~~D~~~Kr~ac~~L~~iAkHs~~LAe~Vae~~p~lv~~cL~D~D~~VR~nAA~aL~~IakHt~eLAq~VV 1255 (1342)
||.|+..| .++|+++|..++.+|+++. .+ +.+|.|+. +|+|+|+.||.+|+++|++|.
T Consensus 1 i~~L~~~l~~~~~~~vr~~a~~~L~~~~---~~------~~~~~L~~-~l~d~~~~vr~~a~~aL~~i~----------- 59 (88)
T PF13646_consen 1 IPALLQLLQNDPDPQVRAEAARALGELG---DP------EAIPALIE-LLKDEDPMVRRAAARALGRIG----------- 59 (88)
T ss_dssp HHHHHHHHHTSSSHHHHHHHHHHHHCCT---HH------HHHHHHHH-HHTSSSHHHHHHHHHHHHCCH-----------
T ss_pred CHHHHHHHhcCCCHHHHHHHHHHHHHcC---CH------hHHHHHHH-HHcCCCHHHHHHHHHHHHHhC-----------
Confidence 67889988 9999999999999999552 11 66899999 999999999999999999983
Q ss_pred hcCchHHHHHHhhccccccCCCCccccccCCchhhHHHHHH
Q 000706 1256 SKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLA 1296 (1342)
Q Consensus 1256 ~aGav~~LVd~~~qe~~~~~~~l~~~~~~~~~~ria~~~L~ 1296 (1342)
+..+++.|++.+.++++ ...| +.|+.+||
T Consensus 60 ~~~~~~~L~~~l~~~~~---~~vr---------~~a~~aL~ 88 (88)
T PF13646_consen 60 DPEAIPALIKLLQDDDD---EVVR---------EAAAEALG 88 (88)
T ss_dssp HHHTHHHHHHHHTC-SS---HHHH---------HHHHHHHH
T ss_pred CHHHHHHHHHHHcCCCc---HHHH---------HHHHhhcC
Confidence 34488999988877777 4557 77777775
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.00 E-value=6e-05 Score=80.66 Aligned_cols=72 Identities=25% Similarity=0.227 Sum_probs=51.4
Q ss_pred EEEcccCc-EEEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEeccCC
Q 000706 10 ELVGEGSF-GKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-HQNIIEMLDSFESPQEFCVVTEFAQG 87 (1342)
Q Consensus 10 K~LGsGgF-GtVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~-HPNIVKL~dvfeded~lyLVMEY~eG 87 (1342)
+.|-.|.. +.||+.... ++.+.+|...... ...+.+|+++++.+. +--+.+++++...++..++|||+++|
T Consensus 4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 34555666 789998643 4678889764332 235677999988883 34466888888777788999999988
Q ss_pred C
Q 000706 88 E 88 (1342)
Q Consensus 88 S 88 (1342)
.
T Consensus 77 ~ 77 (244)
T cd05150 77 V 77 (244)
T ss_pred c
Confidence 4
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.93 E-value=3.8e-05 Score=98.33 Aligned_cols=204 Identities=25% Similarity=0.338 Sum_probs=147.4
Q ss_pred HHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE----EEEeccC-CChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh
Q 000706 46 DIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFC----VVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120 (1342)
Q Consensus 46 dierL~rEI~ILKrL~HPNIVKL~dvfeded~ly----LVMEY~e-GSL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHs 120 (1342)
.+.....|...+....|+|++.++.+..+....- +..|++. -++...++.-+.++.+..+.+..++++||.|+|+
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 3455666788888889999999999886554443 3445665 4788888888899999999999999999999999
Q ss_pred CCceecCCCCC---cEEEcCCCcEEEe--eccccccccCCceeeecccCCCCcCChhhhccCCCCCC--CcccchhhHHH
Q 000706 121 NRIIHRDMKPQ---NILIGAGSVVKLC--DFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHT--ADLWSLGVILY 193 (1342)
Q Consensus 121 rGIVHRDLKPE---NILLdsdG~LKLi--DFGLAr~l~sss~~~~s~vGTp~YmAPEvL~g~~YT~K--sDIWSLGVILY 193 (1342)
....|.-+... +--++..+...+. ||+..+.+........ ..-+..+.+||......++.+ .|+|.+|....
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~-~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS-DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccchh-hcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 96655555444 4444556667777 9998887765543322 234666888888777666655 69999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCC-HHHHHHHHHhcccCCCCCCCHHHHHcCcCcccch
Q 000706 194 ELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMS-PNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 194 ELLTGr~PF~g~s~~elirkIlr~~~efP~eIS-peLkDLIrKcLqkDPeKRPSAeELLeHPFFre~~ 260 (1342)
.+..|..+-.... .+..+-+..+ ....+...+|+..++++|+++.+++.|+|.+...
T Consensus 384 ~~~~~~~i~~~~~----------~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 384 QLSQGEDISEKSA----------VPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred hhhhcCccccccc----------chhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 9988765422111 0111111111 2677889999999999999999999999987543
|
|
| >PF13513 HEAT_EZ: HEAT-like repeat; PDB: 2Z5J_A 2OT8_B 2Z5O_A 2H4M_A 2QMR_A 1QBK_B 2Z5M_A 2Z5K_A 2Z5N_A 1GCJ_B | Back alignment and domain information |
|---|
Probab=97.81 E-value=2.2e-05 Score=66.99 Aligned_cols=55 Identities=27% Similarity=0.381 Sum_probs=51.2
Q ss_pred hhHHHHHHHHHHHHhcCCHHHHHhhhccCcHHHHhhhcCCCChhhhhhHHHHHHHh
Q 000706 1147 PNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNA 1202 (1342)
Q Consensus 1147 ~slqq~Aa~ALg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~i 1202 (1342)
|.+|+.|+.+||+|+.+.++..+. .-.+++|.|..+|.|++..+|.+||++|++|
T Consensus 1 p~vR~~A~~aLg~l~~~~~~~~~~-~~~~~~~~L~~~L~d~~~~VR~~A~~aLg~l 55 (55)
T PF13513_consen 1 PRVRRAAAWALGRLAEGCPELLQP-YLPELLPALIPLLQDDDDSVRAAAAWALGNL 55 (55)
T ss_dssp HHHHHHHHHHHHCTTTTTHHHHHH-HHHHHHHHHHHHTTSSSHHHHHHHHHHHHCH
T ss_pred CHHHHHHHHHHhhHhcccHHHHHH-HHHHHHHHHHHHHcCCCHHHHHHHHHHHhcC
Confidence 679999999999999999999988 5567999999999999999999999999986
|
... |
| >PF12348 CLASP_N: CLASP N terminal; InterPro: IPR024395 This domain is found in the N-terminal region of CLIP-associated proteins (CLASPs), which are widely conserved microtubule plus-end-tracking proteins that regulate the stability of dynamic microtubules [, ] | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00014 Score=77.36 Aligned_cols=140 Identities=22% Similarity=0.221 Sum_probs=98.3
Q ss_pred HHHHHHHHHHHhhchhHHHHHHhCCchHhHHHhhcCCchhHHHHHHHHHHHHhcCCHHHHHhhhccCc-HHHHhhhcCCC
Q 000706 1109 LDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRI-IGLLIDRCADP 1187 (1342)
Q Consensus 1109 ~~f~~~va~lars~~~~ie~I~~aG~v~LL~~lLqd~e~slqq~Aa~ALg~lakHS~eLAq~VVd~~i-Lp~Lv~~L~~~ 1187 (1342)
..-.+.+.++++.-...++.. -...+|.|...+.|+-..+++.|..+|-.|++|.+- ...+ ++.+..++.|+
T Consensus 71 ~~A~~~l~~l~~~l~~~~~~~-~~~~l~~Ll~~~~~~~~~i~~~a~~~L~~i~~~~~~------~~~~~~~~l~~~~~~K 143 (228)
T PF12348_consen 71 KTACQLLSDLARQLGSHFEPY-ADILLPPLLKKLGDSKKFIREAANNALDAIIESCSY------SPKILLEILSQGLKSK 143 (228)
T ss_dssp HHHHHHHHHHHHHHGGGGHHH-HHHHHHHHHHGGG---HHHHHHHHHHHHHHHTTS-H--------HHHHHHHHHHTT-S
T ss_pred HHHHHHHHHHHHHHhHhHHHH-HHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHCCc------HHHHHHHHHHHHHhCC
Confidence 344556666665444445444 245789999999999999999999999999998771 2233 78899999999
Q ss_pred ChhhhhhHHHHHHHhHhcCH----HHH--HHHHHhHHHHHHhhccCCcHHHHHHHHHHHHHHHhCCHHHHHHHHh
Q 000706 1188 DKRTRKFACFSIGNAAYHND----VLY--EELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVS 1256 (1342)
Q Consensus 1188 D~~~Kr~ac~~L~~iAkHs~----~LA--e~Vae~~p~lv~~cL~D~D~~VR~nAA~aL~~IakHt~eLAq~VV~ 1256 (1342)
++.+|..++-+|..+....+ .+- ..+..+.|.+.. ||.|.|+.||++|-.++..+.+|-++-|+.+.+
T Consensus 144 n~~vR~~~~~~l~~~l~~~~~~~~~l~~~~~~~~l~~~l~~-~l~D~~~~VR~~Ar~~~~~l~~~~~~~a~~~~~ 217 (228)
T PF12348_consen 144 NPQVREECAEWLAIILEKWGSDSSVLQKSAFLKQLVKALVK-LLSDADPEVREAARECLWALYSHFPERAESILS 217 (228)
T ss_dssp -HHHHHHHHHHHHHHHTT-----GGG--HHHHHHHHHHHHH-HHTSS-HHHHHHHHHHHHHHHHHH-HHH-----
T ss_pred CHHHHHHHHHHHHHHHHHccchHhhhcccchHHHHHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHCCHhhccchh
Confidence 99999999999998866555 222 223566888888 999999999999999999999999999988773
|
The domain is also found in other proteins involved in microtubule binding, including STU1, MOR1 and spindle pole body component Alp14.; PDB: 2QK2_A. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00027 Score=89.68 Aligned_cols=80 Identities=14% Similarity=0.213 Sum_probs=56.8
Q ss_pred EEEEEcccCcEEEEEEEEccCC--cEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCCc--ceEEEEEEeC---CeEE
Q 000706 8 VIELVGEGSFGKVYKGRRKYTG--QTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-HQNI--IEMLDSFESP---QEFC 79 (1342)
Q Consensus 8 IlK~LGsGgFGtVYKArDk~TG--e~VAVKvIkKs~~se~dierL~rEI~ILKrL~-HPNI--VKL~dvfede---d~ly 79 (1342)
-++.++.|.++.+|+......+ ..+++|+....... .....+.+|+++++.+. |+++ .+++.++.+. +..|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 3678899999999998765332 46888875432211 12246788999999995 6665 7777777654 4679
Q ss_pred EEEeccCCC
Q 000706 80 VVTEFAQGE 88 (1342)
Q Consensus 80 LVMEY~eGS 88 (1342)
+||||++|.
T Consensus 121 lVME~v~G~ 129 (822)
T PLN02876 121 YIMEYLEGR 129 (822)
T ss_pred EEEEecCCc
Confidence 999999985
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00025 Score=86.29 Aligned_cols=140 Identities=17% Similarity=0.279 Sum_probs=87.6
Q ss_pred EEEcccCcEEEEEEEEccCCcEEEEEEeecCCCC-----------------------------HHHHHH------HHHHH
Q 000706 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-----------------------------EKDIHN------LRQEI 54 (1342)
Q Consensus 10 K~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~s-----------------------------e~dier------L~rEI 54 (1342)
+.||.-+.|.||+|+.+. |+.||||+-++.-.. ++-.+. +.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 568889999999999774 999999987543111 000111 23344
Q ss_pred HHHHhc----CCCC------cceEEEEEEeCCeEEEEEeccCC---ChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 000706 55 EILRKL----KHQN------IIEMLDSFESPQEFCVVTEFAQG---ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121 (1342)
Q Consensus 55 ~ILKrL----~HPN------IVKL~dvfeded~lyLVMEY~eG---SL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsr 121 (1342)
+-.+++ .|-+ |.++|. .-.....++|||++| +-.+.|.+.+ ++...+...+.+.. ++-+=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~--~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAY--LEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHH--HHHHHhc
Confidence 333333 3434 333332 224567899999997 2335566654 55544333222221 1223357
Q ss_pred CceecCCCCCcEEEcC----CCcEEEeeccccccccCC
Q 000706 122 RIIHRDMKPQNILIGA----GSVVKLCDFGFARAMSAN 155 (1342)
Q Consensus 122 GIVHRDLKPENILLds----dG~LKLiDFGLAr~l~ss 155 (1342)
|++|.|-+|.||+++. ++.+.+.|||+.......
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 8999999999999984 568999999998776543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.63 E-value=3.9e-06 Score=108.45 Aligned_cols=205 Identities=17% Similarity=0.082 Sum_probs=139.8
Q ss_pred HHHHHHHHhcCCCCcceEEEEEE--eCCeEEEEEeccC-CChHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhC--
Q 000706 51 RQEIEILRKLKHQNIIEMLDSFE--SPQEFCVVTEFAQ-GELFEILEDD----KCLPEEQVQSIAKQLVRALHYLHSN-- 121 (1342)
Q Consensus 51 ~rEI~ILKrL~HPNIVKL~dvfe--ded~lyLVMEY~e-GSL~D~Lek~----g~LSEeeI~~I~~QLLsALaYLHsr-- 121 (1342)
..|.+-.+...|+++...+.-.. ++...|.+++|+. |.+++.|.++ .+..+..+.....+......-+|..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 33444455567888877665543 3456799999987 8899988653 3455555555555547777777754
Q ss_pred ---CceecCCCCCcEEEcCCCcEEEeeccccccccCCceeeecccCCCCcCChhhhccCCCCCCCcccchhhHHHHHHhC
Q 000706 122 ---RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVG 198 (1342)
Q Consensus 122 ---GIVHRDLKPENILLdsdG~LKLiDFGLAr~l~sss~~~~s~vGTp~YmAPEvL~g~~YT~KsDIWSLGVILYELLTG 198 (1342)
--+|+++|+-|.++..+-++|++++|+.+...+.........+++.|+.|++.....++.+.|+|..|+-+|+...|
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 26899999999999999999999999999666665566677899999999999988899999999999999999998
Q ss_pred CCCCCCCcHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 000706 199 QPPFYTNSVYALIRHIVKDP--VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 199 r~PF~g~s~~elirkIlr~~--~efP~eISpeLkDLIrKcLqkDPeKRPSAeELLeHPFF 256 (1342)
..+|........ +.+..+. .+.+.-.|.+.......+|-+.-..||.-...+..+.|
T Consensus 1437 n~~fi~flq~~L-kgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1437 NAYFIFFLQPAL-KGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred cHHHHHHHHHHH-cCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence 888743222211 1111111 12222333444444445555555666666555555444
|
|
| >PF03224 V-ATPase_H_N: V-ATPase subunit H; InterPro: IPR004908 ATPases (or ATP synthases) are membrane-bound enzyme complexes/ion transporters that combine ATP synthesis and/or hydrolysis with the transport of protons across a membrane | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00065 Score=76.91 Aligned_cols=220 Identities=15% Similarity=0.165 Sum_probs=149.3
Q ss_pred cccccChhhhhhhccC--CCchHHHHHHHHHHHHHhhchhHHHHHHh-----C-CchHhHHHhhcCCchhHHHHHHHHHH
Q 000706 1087 GKGLLDPNRVRRLLDS--STREVTLDVLMIVSDLARMDKWFYEYING-----A-SMLEFLKDFLTHEDPNVRAKACSALG 1158 (1342)
Q Consensus 1087 ~~~~~~~~~~~~~~~s--~~~~~r~~f~~~va~lars~~~~ie~I~~-----a-G~v~LL~~lLqd~e~slqq~Aa~ALg 1158 (1342)
..|-.--+.+..+|.. ..+.+..-.+..++|+.+..+...+.+.. . ..+..|..++..+|..++..|+..|+
T Consensus 51 ~~~~~~~~~~l~lL~~~~~~~d~v~yvL~li~dll~~~~~~~~~~~~~~~~~~~~~~~~fl~ll~~~D~~i~~~a~~iLt 130 (312)
T PF03224_consen 51 EDGDQYASLFLNLLNKLSSNDDTVQYVLTLIDDLLSDDPSRVELFLELAKQDDSDPYSPFLKLLDRNDSFIQLKAAFILT 130 (312)
T ss_dssp -----------HHHHHH---HHHHHHHHHHHHHHHH-SSSSHHHHHHHHH-TTH--HHHHHHH-S-SSHHHHHHHHHHHH
T ss_pred hchhhHHHHHHHHHHHccCcHHHHHHHHHHHHHHHhcCHHHHHHHHHhcccccchhHHHHHHHhcCCCHHHHHHHHHHHH
Confidence 4444445556677764 45555666677889999888877777766 1 14444445999999999999999999
Q ss_pred HHhcCCHHHHHhhhccCcHHHHhhhcCC----CChhhhhhHHHHHHHhHhcCHHHHHHH--HHhHHHHHHhhc-------
Q 000706 1159 NMCRHSSYFYSSLAKNRIIGLLIDRCAD----PDKRTRKFACFSIGNAAYHNDVLYEEL--RRSIPLLANILI------- 1225 (1342)
Q Consensus 1159 ~lakHS~eLAq~VVd~~iLp~Lv~~L~~----~D~~~Kr~ac~~L~~iAkHs~~LAe~V--ae~~p~lv~~cL------- 1225 (1342)
.|+.+.+.-....+ .++++.+...|++ +|..+...+..+|+++.++ .+..+.+ .+.++.++. .|
T Consensus 131 ~Ll~~~~~~~~~~~-~~~l~~ll~~L~~~l~~~~~~~~~~av~~L~~LL~~-~~~R~~f~~~~~v~~l~~-iL~~~~~~~ 207 (312)
T PF03224_consen 131 SLLSQGPKRSEKLV-KEALPKLLQWLSSQLSSSDSELQYIAVQCLQNLLRS-KEYRQVFWKSNGVSPLFD-ILRKQATNS 207 (312)
T ss_dssp HHHTSTTT--HHHH-HHHHHHHHHHHH-TT-HHHH---HHHHHHHHHHHTS-HHHHHHHHTHHHHHHHHH-HHH------
T ss_pred HHHHcCCccccchH-HHHHHHHHHHHHHhhcCCCcchHHHHHHHHHHHhCc-chhHHHHHhcCcHHHHHH-HHHhhcccC
Confidence 99999988877755 5667777776665 6777889999999999954 5566666 555888888 77
Q ss_pred cCCcHHHHHHHHHHHHHHHhCCHHHHHHHHhcCchHHHHHHhhccccccCCCCccccccCCchhhHHHHHHhhhcCCc--
Q 000706 1226 SDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTP-- 1303 (1342)
Q Consensus 1226 ~D~D~~VR~nAA~aL~~IakHt~eLAq~VV~aGav~~LVd~~~qe~~~~~~~l~~~~~~~~~~ria~~~L~~i~kh~~-- 1303 (1342)
.-.+..+-=.+.-|+--+ .-+++.++.+++.+.++.|++.+...+- |--.|+++.+|-++..-++
T Consensus 208 ~~~~~Ql~Y~~ll~lWlL-SF~~~~~~~~~~~~~i~~L~~i~~~~~K------------EKvvRv~la~l~Nl~~~~~~~ 274 (312)
T PF03224_consen 208 NSSGIQLQYQALLCLWLL-SFEPEIAEELNKKYLIPLLADILKDSIK------------EKVVRVSLAILRNLLSKAPKS 274 (312)
T ss_dssp ---HHHHHHHHHHHHHHH-TTSHHHHHHHHTTSHHHHHHHHHHH--S------------HHHHHHHHHHHHHTTSSSSTT
T ss_pred CCCchhHHHHHHHHHHHH-hcCHHHHHHHhccchHHHHHHHHHhccc------------chHHHHHHHHHHHHHhccHHH
Confidence 233555666666666555 4678999999999999999977765543 2235999999999999999
Q ss_pred hhhhhhcCCCchhhhhccc
Q 000706 1304 CRQFLQSSELFPVIARLRQ 1322 (1342)
Q Consensus 1304 ~aq~vvda~~~~~ia~l~~ 1322 (1342)
++..+++.+..|++.-|-.
T Consensus 275 ~~~~mv~~~~l~~l~~L~~ 293 (312)
T PF03224_consen 275 NIELMVLCGLLKTLQNLSE 293 (312)
T ss_dssp HHHHHHHH-HHHHHHHHHS
T ss_pred HHHHHHHccHHHHHHHHhc
Confidence 9999999999999987765
|
ATPases can harness the energy from a proton gradient, using the flux of ions across the membrane via the ATPase proton channel to drive the synthesis of ATP. Some ATPases work in reverse, using the energy from the hydrolysis of ATP to create a proton gradient. There are different types of ATPases, which can differ in function (ATP synthesis and/or hydrolysis), structure (e.g., F-, V- and A-ATPases, which contain rotary motors) and in the type of ions they transport [, ]. The different types include: F-ATPases (F1F0-ATPases), which are found in mitochondria, chloroplasts and bacterial plasma membranes where they are the prime producers of ATP, using the proton gradient generated by oxidative phosphorylation (mitochondria) or photosynthesis (chloroplasts). V-ATPases (V1V0-ATPases), which are primarily found in eukaryotic vacuoles and catalyse ATP hydrolysis to transport solutes and lower pH in organelles. A-ATPases (A1A0-ATPases), which are found in Archaea and function like F-ATPases (though with respect to their structure and some inhibitor responses, A-ATPases are more closely related to the V-ATPases). P-ATPases (E1E2-ATPases), which are found in bacteria and in eukaryotic plasma membranes and organelles, and function to transport a variety of different ions across membranes. E-ATPases, which are cell-surface enzymes that hydrolyse a range of NTPs, including extracellular ATP. V-ATPases (also known as V1V0-ATPase or vacuolar ATPase) (3.6.3.14 from EC) are found in the eukaryotic endomembrane system, and in the plasma membrane of prokaryotes and certain specialised eukaryotic cells. V-ATPases hydrolyse ATP to drive a proton pump, and are involved in a variety of vital intra- and inter-cellular processes such as receptor mediated endocytosis, protein trafficking, active transport of metabolites, homeostasis and neurotransmitter release []. V-ATPases are composed of two linked complexes: the V1 complex (subunits A-H) contains the catalytic core that hydrolyses ATP, while the V0 complex (subunits a, c, c', c'', d) forms the membrane-spanning pore. V-ATPases may have an additional role in membrane fusion through binding to t-SNARE proteins []. This entry represents subunit H (also known as Vma13p) found in the V1 complex of V-ATPases. This subunit has a regulatory function, being responsible for activating ATPase activity and coupling ATPase activity to proton flow []. The yeast enzyme contains five motifs similar to the HEAT or Armadillo repeats seen in the importins, and can be divided into two distinct domains: a large N-terminal domain consisting of stacked alpha helices, and a smaller C-terminal alpha-helical domain with a similar superhelical topology to an armadillo repeat []. More information about this protein can be found at Protein of the Month: ATP Synthases [].; GO: 0046961 proton-transporting ATPase activity, rotational mechanism, 0015991 ATP hydrolysis coupled proton transport, 0000221 vacuolar proton-transporting V-type ATPase, V1 domain; PDB: 1HO8_A. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00089 Score=72.39 Aligned_cols=129 Identities=21% Similarity=0.377 Sum_probs=92.1
Q ss_pred EEEEcccCcEEEEEEEEccCCcEEEEEEeecCC--------------CCHHHHHHHHHHHHHHHhcC------CCCcceE
Q 000706 9 IELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG--------------KSEKDIHNLRQEIEILRKLK------HQNIIEM 68 (1342)
Q Consensus 9 lK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~--------------~se~dierL~rEI~ILKrL~------HPNIVKL 68 (1342)
...||+|+.=.||.- . .+....||+.+... ......++..+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357899999999963 3 34456789886654 11122355666777666665 7899999
Q ss_pred EEEEEeCCeEEEEEeccC---C----ChHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCcEEEcCCC--
Q 000706 69 LDSFESPQEFCVVTEFAQ---G----ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS-- 139 (1342)
Q Consensus 69 ~dvfeded~lyLVMEY~e---G----SL~D~Lek~g~LSEeeI~~I~~QLLsALaYLHsrGIVHRDLKPENILLdsdG-- 139 (1342)
+++.+++....+|+|.+. | +|.+++.+. .+++ .... .+-+-..||-+++|+.+|++|+||++..++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 999999999999999963 4 577887554 4666 4333 334455688899999999999999996432
Q ss_pred --cEEEee
Q 000706 140 --VVKLCD 145 (1342)
Q Consensus 140 --~LKLiD 145 (1342)
.+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12717 Cnd1: non-SMC mitotic condensation complex subunit 1 | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00034 Score=73.41 Aligned_cols=94 Identities=22% Similarity=0.358 Sum_probs=80.8
Q ss_pred chhHHHHHHHHHHHHhcCCHHHHHhhhccCcHHHHhhhcCCCChhhhhhHHHHHHHhHhcCHHHHHHH---HHhHHHHHH
Q 000706 1146 DPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEEL---RRSIPLLAN 1222 (1342)
Q Consensus 1146 e~slqq~Aa~ALg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~V---ae~~p~lv~ 1222 (1342)
+|.||..+..+||+||.--|.+.+. .+|.+..+|.|+|+.+||+|..+|.++... +.+ ...|..++.
T Consensus 1 ~~~vR~n~i~~l~DL~~r~~~~ve~-----~~~~l~~~L~D~~~~VR~~al~~Ls~Li~~-----d~ik~k~~l~~~~l~ 70 (178)
T PF12717_consen 1 DPSVRNNAIIALGDLCIRYPNLVEP-----YLPNLYKCLRDEDPLVRKTALLVLSHLILE-----DMIKVKGQLFSRILK 70 (178)
T ss_pred CHHHHHHHHHHHHHHHHhCcHHHHh-----HHHHHHHHHCCCCHHHHHHHHHHHHHHHHc-----CceeehhhhhHHHHH
Confidence 4789999999999999887777754 489999999999999999999999998743 333 333699999
Q ss_pred hhccCCcHHHHHHHHHHHHHHHhC-CHHH
Q 000706 1223 ILISDEEDKTKANAAGALSNLIRN-SSKL 1250 (1342)
Q Consensus 1223 ~cL~D~D~~VR~nAA~aL~~IakH-t~eL 1250 (1342)
||.|+|+.||+.|..++.++.+. +++.
T Consensus 71 -~l~D~~~~Ir~~A~~~~~e~~~~~~~~~ 98 (178)
T PF12717_consen 71 -LLVDENPEIRSLARSFFSELLKKRNPNI 98 (178)
T ss_pred -HHcCCCHHHHHHHHHHHHHHHHhccchH
Confidence 99999999999999999999998 5553
|
|
| >TIGR02270 conserved hypothetical protein | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00049 Score=81.53 Aligned_cols=172 Identities=18% Similarity=0.136 Sum_probs=124.7
Q ss_pred hHHHHHHhhhhHHHHHhhcCCcchhhhhccccc-ccccCchHHHHHHHhcCchhHHHhhcccccChhhhhhhccCCCchH
Q 000706 1029 MAKAIEEDMGKYIKILMEVGVPGIILRCLEHME-LKNLGRPIAFLAKMIGQRSLAVQLVGKGLLDPNRVRRLLDSSTREV 1107 (1342)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~pi~~l~~~~~~~~~~~q~v~~~~~~~~~~~~~~~s~~~~~ 1107 (1342)
....+|+-+--.|.-|.-.| |..+--|...|. -.+-|. .+.+-++-. -.++-..-..+...|++..+.|
T Consensus 33 ~la~ldeRL~AhLdgL~~~G-~~a~~~L~~aL~~d~~~ev--~~~aa~al~-------~~~~~~~~~~L~~~L~d~~~~v 102 (410)
T TIGR02270 33 DLAELEERLLAHVDGLVLAG-KAATELLVSALAEADEPGR--VACAALALL-------AQEDALDLRSVLAVLQAGPEGL 102 (410)
T ss_pred HHHhHHHHHHHHHHHHHHhh-HhHHHHHHHHHhhCCChhH--HHHHHHHHh-------ccCChHHHHHHHHHhcCCCHHH
Confidence 34678889999999998888 888888888884 333332 112222200 0011111344555566666666
Q ss_pred HHHHHHHHHHHHhhchhHHHHHHhCCchHhHHHhhcCCchhHHHHHHHHHHHHhcCCHHHHHhhhccCcHHHHhhhcCCC
Q 000706 1108 TLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADP 1187 (1342)
Q Consensus 1108 r~~f~~~va~lars~~~~ie~I~~aG~v~LL~~lLqd~e~slqq~Aa~ALg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~ 1187 (1342)
|.. .+.+++-|...++.+.|..+|.+++|.+|+.+..+||. ...+..+.|.+.|+|.
T Consensus 103 r~a-----------aa~ALg~i~~~~a~~~L~~~L~~~~p~vR~aal~al~~------------r~~~~~~~L~~~L~d~ 159 (410)
T TIGR02270 103 CAG-----------IQAALGWLGGRQAEPWLEPLLAASEPPGRAIGLAALGA------------HRHDPGPALEAALTHE 159 (410)
T ss_pred HHH-----------HHHHHhcCCchHHHHHHHHHhcCCChHHHHHHHHHHHh------------hccChHHHHHHHhcCC
Confidence 643 34556667778899999999999999999999999988 2334567899999999
Q ss_pred ChhhhhhHHHHHHHhHhcCHHHHHHHHHhHHHHHHhhccCCcHHHHHHHHHHHHHH
Q 000706 1188 DKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNL 1243 (1342)
Q Consensus 1188 D~~~Kr~ac~~L~~iAkHs~~LAe~Vae~~p~lv~~cL~D~D~~VR~nAA~aL~~I 1243 (1342)
|+++|+.|.-+||.+-. .+..|.|.. .+.|.|+.||+.|+++++.+
T Consensus 160 d~~Vra~A~raLG~l~~---------~~a~~~L~~-al~d~~~~VR~aA~~al~~l 205 (410)
T TIGR02270 160 DALVRAAALRALGELPR---------RLSESTLRL-YLRDSDPEVRFAALEAGLLA 205 (410)
T ss_pred CHHHHHHHHHHHHhhcc---------ccchHHHHH-HHcCCCHHHHHHHHHHHHHc
Confidence 99999999999998653 244666777 89999999999999999888
|
Members are found in Myxococcus xanthus (six members), Geobacter sulfurreducens, and Pseudomonas aeruginosa; a short protein homologous to the N-terminal region is found in Mesorhizobium loti. All sequence are from Proteobacteria. The function is unknown. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0013 Score=77.97 Aligned_cols=78 Identities=17% Similarity=0.185 Sum_probs=55.1
Q ss_pred EEEEEcccCcEEEEEEEEccCCcEEEEEEeecCCC----C-HHHHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeEE
Q 000706 8 VIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK----S-EKDIHNLRQEIEILRKLK---HQNIIEMLDSFESPQEFC 79 (1342)
Q Consensus 8 IlK~LGsGgFGtVYKArDk~TGe~VAVKvIkKs~~----s-e~dierL~rEI~ILKrL~---HPNIVKL~dvfeded~ly 79 (1342)
-.+.||.|.+..||++.+...++.++||.-..... . ....++...|.+.|+.+. ..++++++.+ +++..+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 35789999999999998864446899998542211 0 123456777888888863 3467777776 446678
Q ss_pred EEEeccCC
Q 000706 80 VVTEFAQG 87 (1342)
Q Consensus 80 LVMEY~eG 87 (1342)
+||||+++
T Consensus 108 lVME~L~~ 115 (401)
T PRK09550 108 TVMEDLSD 115 (401)
T ss_pred EEEecCCC
Confidence 99999874
|
|
| >PTZ00429 beta-adaptin; Provisional | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0011 Score=83.59 Aligned_cols=140 Identities=23% Similarity=0.193 Sum_probs=111.2
Q ss_pred hhhhhccCCCchHHHHHHHHHHHHHhhchh-HHHHHHhCCchHhHHHhhcCCchhHHHHHHHHHHHHhcCCHHHHHhhhc
Q 000706 1095 RVRRLLDSSTREVTLDVLMIVSDLARMDKW-FYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAK 1173 (1342)
Q Consensus 1095 ~~~~~~~s~~~~~r~~f~~~va~lars~~~-~ie~I~~aG~v~LL~~lLqd~e~slqq~Aa~ALg~lakHS~eLAq~VVd 1173 (1342)
.|.++.+|...++|.=.-..+..+|+..|. .+- ++.-|+-=++||.|.+|..|...|+.|- .+++.+.+
T Consensus 72 dVvk~~~S~d~elKKLvYLYL~~ya~~~pelalL------aINtl~KDl~d~Np~IRaLALRtLs~Ir--~~~i~e~l-- 141 (746)
T PTZ00429 72 DVVKLAPSTDLELKKLVYLYVLSTARLQPEKALL------AVNTFLQDTTNSSPVVRALAVRTMMCIR--VSSVLEYT-- 141 (746)
T ss_pred HHHHHhCCCCHHHHHHHHHHHHHHcccChHHHHH------HHHHHHHHcCCCCHHHHHHHHHHHHcCC--cHHHHHHH--
Confidence 345567777788888777778888855554 222 3556777889999999999999999875 46676654
Q ss_pred cCcHHHHhhhcCCCChhhhhhHHHHHHHhHhcCHHHHHHHHHhHHHHHHhhccCCcHHHHHHHHHHHHHHHhCCHH
Q 000706 1174 NRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSK 1249 (1342)
Q Consensus 1174 ~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~Vae~~p~lv~~cL~D~D~~VR~nAA~aL~~IakHt~e 1249 (1342)
++.+..+|.|+|+++||.|+.|+..+-++++++.+ ..+.+|.|.. +|.|.|+.|..||..+|.+|..+.++
T Consensus 142 ---~~~lkk~L~D~~pYVRKtAalai~Kly~~~pelv~-~~~~~~~L~~-LL~D~dp~Vv~nAl~aL~eI~~~~~~ 212 (746)
T PTZ00429 142 ---LEPLRRAVADPDPYVRKTAAMGLGKLFHDDMQLFY-QQDFKKDLVE-LLNDNNPVVASNAAAIVCEVNDYGSE 212 (746)
T ss_pred ---HHHHHHHhcCCCHHHHHHHHHHHHHHHhhCccccc-ccchHHHHHH-HhcCCCccHHHHHHHHHHHHHHhCch
Confidence 45688899999999999999999999998887632 1345788888 99999999999999999999877653
|
|
| >COG1413 FOG: HEAT repeat [Energy production and conversion] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00077 Score=75.83 Aligned_cols=179 Identities=24% Similarity=0.353 Sum_probs=128.8
Q ss_pred cChhhhhhhccCCCchHHHHHHHHHHHHHhhchhHHHHHHhCCchHhHHHhhcCCchhHHHHHHHHHHHHhcCCHHHHHh
Q 000706 1091 LDPNRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSS 1170 (1342)
Q Consensus 1091 ~~~~~~~~~~~s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~v~LL~~lLqd~e~slqq~Aa~ALg~lakHS~eLAq~ 1170 (1342)
.....+..++.+..+.+|..-... ++-+...-++|.|+.++.|+++.+|..|+.+||++-
T Consensus 43 ~~~~~~~~~l~~~~~~vr~~aa~~-----------l~~~~~~~av~~l~~~l~d~~~~vr~~a~~aLg~~~--------- 102 (335)
T COG1413 43 EAADELLKLLEDEDLLVRLSAAVA-----------LGELGSEEAVPLLRELLSDEDPRVRDAAADALGELG--------- 102 (335)
T ss_pred hhHHHHHHHHcCCCHHHHHHHHHH-----------HhhhchHHHHHHHHHHhcCCCHHHHHHHHHHHHccC---------
Confidence 556677777878777777654433 455556778999999999999999999999998763
Q ss_pred hhccCcHHHHhhhcC-CCChhhhhhHHHHHHHhHhcC------------H----------H-------HHHHHH-----H
Q 000706 1171 LAKNRIIGLLIDRCA-DPDKRTRKFACFSIGNAAYHN------------D----------V-------LYEELR-----R 1215 (1342)
Q Consensus 1171 VVd~~iLp~Lv~~L~-~~D~~~Kr~ac~~L~~iAkHs------------~----------~-------LAe~Va-----e 1215 (1342)
+...+|.|+..|. |.|.++|+.+.++|+.+--.. . . .++++. +
T Consensus 103 --~~~a~~~li~~l~~d~~~~vR~~aa~aL~~~~~~~a~~~l~~~l~~~~~~~a~~~~~~~~~~~r~~a~~~l~~~~~~~ 180 (335)
T COG1413 103 --DPEAVPPLVELLENDENEGVRAAAARALGKLGDERALDPLLEALQDEDSGSAAAALDAALLDVRAAAAEALGELGDPE 180 (335)
T ss_pred --ChhHHHHHHHHHHcCCcHhHHHHHHHHHHhcCchhhhHHHHHHhccchhhhhhhhccchHHHHHHHHHHHHHHcCChh
Confidence 3458899999999 799999999999998775433 1 1 112222 2
Q ss_pred hHHHHHHhhccCCcHHHHHHHHHHHHHHHhCCHHHHHHHHhcCchHHHHHHhhccccccCCCCccccccCCchhhHHHHH
Q 000706 1216 SIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSL 1295 (1342)
Q Consensus 1216 ~~p~lv~~cL~D~D~~VR~nAA~aL~~IakHt~eLAq~VV~aGav~~LVd~~~qe~~~~~~~l~~~~~~~~~~ria~~~L 1295 (1342)
.++.+.. .|+|.+..||..|+.+|+.+..|+ ..++..++ ...+.++ ...| +.++.+|
T Consensus 181 ~~~~l~~-~l~~~~~~vr~~Aa~aL~~~~~~~---------~~~~~~l~-~~~~~~~---~~vr---------~~~~~~l 237 (335)
T COG1413 181 AIPLLIE-LLEDEDADVRRAAASALGQLGSEN---------VEAADLLV-KALSDES---LEVR---------KAALLAL 237 (335)
T ss_pred hhHHHHH-HHhCchHHHHHHHHHHHHHhhcch---------hhHHHHHH-HHhcCCC---HHHH---------HHHHHHh
Confidence 2788888 999999999999999999998888 33334444 5555555 5666 6677777
Q ss_pred HhhhcCCc---hhhhhhcCCCc
Q 000706 1296 AKMCAHTP---CRQFLQSSELF 1314 (1342)
Q Consensus 1296 ~~i~kh~~---~aq~vvda~~~ 1314 (1342)
+++--... +++.+.+....
T Consensus 238 ~~~~~~~~~~~l~~~l~~~~~~ 259 (335)
T COG1413 238 GEIGDEEAVDALAKALEDEDVI 259 (335)
T ss_pred cccCcchhHHHHHHHHhccchH
Confidence 76643332 55555554443
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00068 Score=72.86 Aligned_cols=70 Identities=20% Similarity=0.217 Sum_probs=45.0
Q ss_pred EEEEcccCcE-EEEEEEEccCCcEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCC---CcceEEEEEEeC---CeEEEE
Q 000706 9 IELVGEGSFG-KVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ---NIIEMLDSFESP---QEFCVV 81 (1342)
Q Consensus 9 lK~LGsGgFG-tVYKArDk~TGe~VAVKvIkKs~~se~dierL~rEI~ILKrL~HP---NIVKL~dvfede---d~lyLV 81 (1342)
++.++.|+.. .||+. +..+++|..+.. .....+.+|.+++..+... -+.++++..+.. ...|++
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 3567777776 59976 235778865432 1234788899999888532 345555544332 245889
Q ss_pred EeccCC
Q 000706 82 TEFAQG 87 (1342)
Q Consensus 82 MEY~eG 87 (1342)
||+++|
T Consensus 73 ~~~i~G 78 (235)
T cd05155 73 YRWLEG 78 (235)
T ss_pred EEeecC
Confidence 999987
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF04826 Arm_2: Armadillo-like; InterPro: IPR006911 This entry consists of mammalian proteins of unknown function | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0017 Score=72.71 Aligned_cols=178 Identities=20% Similarity=0.240 Sum_probs=139.9
Q ss_pred HhCCchHhHHHhhc-CCchhHHHHHHHHHHHHhcCCHHHHHhhhccCcHHHHhhhcCCCChhhhhhHHHHHHHhHhcCHH
Q 000706 1130 NGASMLEFLKDFLT-HEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDV 1208 (1342)
Q Consensus 1130 ~~aG~v~LL~~lLq-d~e~slqq~Aa~ALg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~ 1208 (1342)
.+++-+.-|.-+|+ ..+|.+|+.|..+||+.|-|+ .--..+.+.|.++.+...|.++|+.+|..|..+|.|+|-....
T Consensus 9 l~~~~l~~Ll~lL~~t~dp~i~e~al~al~n~aaf~-~nq~~Ir~~Ggi~lI~~lL~~p~~~vr~~AL~aL~Nls~~~en 87 (254)
T PF04826_consen 9 LEAQELQKLLCLLESTEDPFIQEKALIALGNSAAFP-FNQDIIRDLGGISLIGSLLNDPNPSVREKALNALNNLSVNDEN 87 (254)
T ss_pred cCHHHHHHHHHHHhcCCChHHHHHHHHHHHhhccCh-hHHHHHHHcCCHHHHHHHcCCCChHHHHHHHHHHHhcCCChhh
Confidence 34555666777777 468999999999999998877 4444566779999999999999999999999999999987554
Q ss_pred HHHHHHHhHHHHHHhhccCC-cHHHHHHHHHHHHHHHhCCHHHHHHHHhcCchHHHHHHhhccccccCCCCccccccCCc
Q 000706 1209 LYEELRRSIPLLANILISDE-EDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESP 1287 (1342)
Q Consensus 1209 LAe~Vae~~p~lv~~cL~D~-D~~VR~nAA~aL~~IakHt~eLAq~VV~aGav~~LVd~~~qe~~~~~~~l~~~~~~~~~ 1287 (1342)
.- .+...++.+......++ |..+..++-.+|+++. -+.+- +.++ +..++-|+.+.....+ ..|
T Consensus 88 ~~-~Ik~~i~~Vc~~~~s~~lns~~Q~agLrlL~nLt-v~~~~-~~~l-~~~i~~ll~LL~~G~~----~~k-------- 151 (254)
T PF04826_consen 88 QE-QIKMYIPQVCEETVSSPLNSEVQLAGLRLLTNLT-VTNDY-HHML-ANYIPDLLSLLSSGSE----KTK-------- 151 (254)
T ss_pred HH-HHHHHHHHHHHHHhcCCCCCHHHHHHHHHHHccC-CCcch-hhhH-HhhHHHHHHHHHcCCh----HHH--------
Confidence 43 45666888887445543 7788899999999995 33333 3444 3478889988777666 566
Q ss_pred hhhHHHHHHhhhcCCchhhhhhcCCCchhhhhcccCCc
Q 000706 1288 LKIALFSLAKMCAHTPCRQFLQSSELFPVIARLRQSPE 1325 (1342)
Q Consensus 1288 ~ria~~~L~~i~kh~~~aq~vvda~~~~~ia~l~~~~d 1325 (1342)
-=++..|..+++-+..++.++.+++.+-+-.|.+..+
T Consensus 152 -~~vLk~L~nLS~np~~~~~Ll~~q~~~~~~~Lf~~~~ 188 (254)
T PF04826_consen 152 -VQVLKVLVNLSENPDMTRELLSAQVLSSFLSLFNSSE 188 (254)
T ss_pred -HHHHHHHHHhccCHHHHHHHHhccchhHHHHHHccCC
Confidence 5688899999998889999999999988888888654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1342 | ||||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-43 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-43 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-42 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-42 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-42 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-42 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-42 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-41 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-41 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-40 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-40 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-40 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-40 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-40 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-39 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-39 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-39 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-39 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-39 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-39 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-39 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-39 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-38 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-38 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-38 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-38 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-38 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-38 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-38 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-38 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-38 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-38 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-38 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-37 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-37 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-37 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-37 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-37 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-37 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-37 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-37 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-37 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-37 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-37 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-36 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-36 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-36 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-36 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-36 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-36 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-36 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-36 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-36 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-36 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-36 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-36 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-36 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-36 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-36 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-36 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-36 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-36 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-36 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-36 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-36 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-36 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-36 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-36 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-36 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-36 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-36 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-36 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-36 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-36 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-36 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-36 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-36 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-36 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-36 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-36 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-36 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-36 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-36 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-36 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-36 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-36 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-36 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-36 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-36 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-36 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-36 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-36 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-36 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-36 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-36 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-36 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-36 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-36 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-36 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-36 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-36 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-35 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-35 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-35 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-35 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-35 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-35 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-35 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-35 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-35 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-35 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-35 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-35 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-35 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-35 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-35 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-35 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-35 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-34 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-34 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-34 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-34 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-34 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-34 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-34 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-34 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-34 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-34 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-33 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-33 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-33 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-33 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-33 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-33 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-33 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-33 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-33 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-33 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-33 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-33 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-33 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-33 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-33 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-33 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-33 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-33 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-33 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-33 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-33 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-33 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-33 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-33 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-33 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-32 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-32 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-32 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-32 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-32 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-32 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-32 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-32 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-32 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-32 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-32 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-32 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-32 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-32 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-32 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-32 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-32 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-32 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-32 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-32 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-32 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-32 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-32 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-32 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-32 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-32 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-32 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-32 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-32 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-32 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-32 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-32 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-32 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-32 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-32 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-32 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-32 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-32 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-32 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-32 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-32 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-32 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-32 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-32 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-32 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-32 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-32 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-32 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-32 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-32 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-32 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-32 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-32 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-32 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-32 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-32 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-32 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-32 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-32 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-32 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-32 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-32 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-32 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-31 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-31 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-31 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-31 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-31 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-31 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-31 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-31 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-31 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-31 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-31 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-31 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-31 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-31 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-31 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-31 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-31 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-31 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-31 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-31 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-31 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-31 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-31 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-31 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-31 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-31 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-31 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-31 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-31 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-31 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-31 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-31 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-31 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-31 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-31 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-31 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-31 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-31 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-31 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-30 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-30 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-30 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-30 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-30 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-30 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-30 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-30 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-30 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-30 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-30 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-30 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-30 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-30 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-30 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-30 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-30 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-30 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-30 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-30 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-30 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-30 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-29 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-29 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-29 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-29 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-29 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-29 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-29 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-29 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-29 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-29 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-29 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-29 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-29 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-29 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-29 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-29 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-29 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-29 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-29 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-29 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-29 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-29 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-29 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-29 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-29 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-29 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-29 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-29 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-29 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-29 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-29 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-29 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-29 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-29 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-29 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-29 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-29 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-29 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-29 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-29 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-29 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-29 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-29 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-29 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-29 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-29 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-29 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-29 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-28 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-28 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-28 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-28 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-28 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-28 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-28 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-28 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-28 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-28 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-28 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-28 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-28 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-28 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-28 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-28 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-28 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-28 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-28 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-27 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-27 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-27 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-27 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-27 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-27 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-27 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-27 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-27 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-27 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-27 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-27 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-27 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-27 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-27 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-27 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-27 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-27 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-27 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-27 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-27 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-27 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-26 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-26 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-26 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-26 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-26 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-26 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-26 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-26 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-26 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-26 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-26 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-26 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-26 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-26 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-26 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-26 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-26 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-26 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-26 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-25 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-25 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-25 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-25 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-25 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-25 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-25 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-25 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-25 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-25 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-25 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-25 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-25 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-25 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-25 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-25 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-25 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-25 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-25 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-25 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-25 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-24 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-24 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-24 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-24 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-24 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-24 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-24 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-24 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-24 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-24 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-24 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-24 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-24 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-24 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-24 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-24 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-24 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-24 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-24 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-24 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-24 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-24 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-24 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-24 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-24 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-24 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-24 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-24 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-24 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-24 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-24 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-24 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-24 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-24 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-24 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-24 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-24 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-24 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-24 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-24 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-24 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-24 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-24 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-24 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-24 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-24 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-24 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-24 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-24 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-23 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-23 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-23 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-23 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-23 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-23 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-23 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-23 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-23 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-23 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-23 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-23 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-23 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-23 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-23 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-23 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-23 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-23 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-23 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-23 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-23 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-23 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-23 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-23 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-23 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-23 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-23 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-23 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-23 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-23 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-23 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-23 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-23 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-23 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-23 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-23 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-23 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-23 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-23 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-23 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-23 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-23 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-23 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-23 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-23 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-23 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-23 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-23 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-23 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-23 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-23 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-23 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-23 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-23 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-23 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-23 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-23 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-23 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-23 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-23 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-23 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-23 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-23 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-23 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-23 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-23 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-23 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-23 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-23 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-23 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-23 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-23 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-23 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-23 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-23 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-23 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-23 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-23 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-23 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-23 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-23 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-23 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-23 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-23 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-23 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-23 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-23 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-23 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-23 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-23 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-23 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-23 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-23 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-23 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-23 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-23 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-23 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-23 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-23 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-23 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-23 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-23 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-23 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-23 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-23 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-23 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-23 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-22 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-22 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-22 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-22 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-22 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-22 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-22 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-22 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-22 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-22 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-22 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-22 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-22 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-22 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-22 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-22 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-22 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-22 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-22 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-22 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-22 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-22 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-22 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-22 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-22 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-22 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-22 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-22 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-22 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-21 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-21 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-21 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-21 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-21 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-21 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-21 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-21 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-21 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-21 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-21 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-21 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-21 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-21 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-21 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-21 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-21 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-21 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-21 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-21 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-21 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-21 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-21 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-21 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-21 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-21 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-21 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-21 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-21 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-21 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-21 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-21 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-21 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-21 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-21 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-21 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-21 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-21 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-20 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-20 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-20 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-20 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-20 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-20 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-20 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-20 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-20 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-20 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-20 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-20 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-20 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-20 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-19 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-19 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-19 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-19 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-19 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-19 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-19 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-19 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-19 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-19 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-19 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-19 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-19 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-19 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-19 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-18 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-18 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-18 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-18 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-18 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-18 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-18 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-18 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-18 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-18 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-18 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-18 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-18 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-18 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-18 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-18 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-18 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-18 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-18 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-18 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-18 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-18 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-17 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-17 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-17 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-17 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-17 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-17 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-17 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-17 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-17 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-17 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-17 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-17 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-17 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-17 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-17 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-17 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-17 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-17 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-17 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-17 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-17 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-17 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-17 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-17 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-17 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-17 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-17 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-17 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-16 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-16 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-16 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-16 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-16 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-16 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-16 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-16 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-16 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-16 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-16 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-16 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-16 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-16 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-15 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-15 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-15 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-15 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-15 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-14 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-14 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-14 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-14 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-13 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-12 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-12 |
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 362 bits (931), Expect = e-115
Identities = 89/326 (27%), Positives = 165/326 (50%), Gaps = 5/326 (1%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E Y ++ +GEGSFGK + G+ +K I S K+ R+E+ +L +KH
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 64 NIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDK--CLPEEQVQSIAKQLVRALHYLHS 120
NI++ +SFE +V ++ + G+LF+ + K E+Q+ Q+ AL ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
+I+HRD+K QNI + V+L DFG AR +++ + R+ GTP Y++PE+ +PYN
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYN 203
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVK-YPDEMSPNFKSFLKGLLNK 239
+ +D+W+LG +LYEL + F S+ L+ I+ S + +S + L +
Sbjct: 204 NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKR 263
Query: 240 VPQNRLTWSALLEHPFVKETSDELNAWELRATSVEARGCNATWTAEGNAIQSSSGKSNSP 299
P++R + +++LE F+ + ++ + +L A + + + A + +SG+++
Sbjct: 264 NPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSIS 323
Query: 300 AVSAN-NTSPSLHTDVELNSSNTSQS 324
+ A T P+ + L
Sbjct: 324 VMPAQKITKPAAKYGIPLAYKKYGDK 349
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 341 bits (878), Expect = e-108
Identities = 82/287 (28%), Positives = 138/287 (48%), Gaps = 20/287 (6%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
Y +++ +G G KV++ + Q A+K++ + + + R EI L KL+
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86
Query: 64 N--IIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
+ II + D + Q +V E +L L+ K + + +S K ++ A+H +H +
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT--VVLRSIKGTPLYMAPELVREQP- 178
I+H D+KP N LI G ++KL DFG A M +T VV S GT YM PE +++
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 179 ----------YNHTADLWSLGVILYELFVGQPPFY--TNSVYALIRHIVKD-PVKYPDEM 225
+ +D+WSLG ILY + G+ PF N + L I + +++PD
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 265
Query: 226 SPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDELNAWELRATS 272
+ + LK L + P+ R++ LL HP+V+ + +N T
Sbjct: 266 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 312
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 341 bits (876), Expect = e-107
Identities = 81/279 (29%), Positives = 137/279 (49%), Gaps = 20/279 (7%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
Y +++ +G G KV++ + Q A+K++ + + + R EI L KL+
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 64 N--IIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
+ II + D + Q +V E +L L+ K + + +S K ++ A+H +H +
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT--VVLRSIKGTPLYMAPELVREQP- 178
I+H D+KP N LI G ++KL DFG A M +T VV S GT YM PE +++
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 179 ----------YNHTADLWSLGVILYELFVGQPPFY--TNSVYALIRHIVKD-PVKYPDEM 225
+ +D+WSLG ILY + G+ PF N + L I + +++PD
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 246
Query: 226 SPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDELN 264
+ + LK L + P+ R++ LL HP+V+ + +N
Sbjct: 247 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 285
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-105
Identities = 85/268 (31%), Positives = 135/268 (50%), Gaps = 13/268 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E+Y V+ +G GS+G+ K RRK G+ + K + +E + L E+ +LR+LKH
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 64 NIIEMLDSF--ESPQEFCVVTEFAQ-GELFEIL----EDDKCLPEEQVQSIAKQLVRALH 116
NI+ D + +V E+ + G+L ++ ++ + L EE V + QL AL
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 117 YLHS-----NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAP 171
H + ++HRD+KP N+ + VKL DFG AR ++ +T ++ GTP YM+P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 172 ELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV-KYPDEMSPNFK 230
E + YN +D+WSLG +LYEL PPF S L I + + P S
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELN 245
Query: 231 SFLKGLLNKVPQNRLTWSALLEHPFVKE 258
+ +LN +R + +LE+P + E
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 337 bits (865), Expect = e-105
Identities = 80/279 (28%), Positives = 136/279 (48%), Gaps = 20/279 (7%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
Y +++ +G G KV++ + Q A+K++ + + + R EI L KL+
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 64 N--IIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
+ II + D + Q +V E +L L+ K + + +S K ++ A+H +H +
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT--VVLRSIKGTPLYMAPELVREQPY 179
I+H D+KP N LI G ++KL DFG A M +T VV S G YM PE +++
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 180 NHT-----------ADLWSLGVILYELFVGQPPF--YTNSVYALIRHIVKD-PVKYPDEM 225
+ +D+WSLG ILY + G+ PF N + L I + +++PD
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 293
Query: 226 SPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDELN 264
+ + LK L + P+ R++ LL HP+V+ + +N
Sbjct: 294 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 332
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 322 bits (827), Expect = e-100
Identities = 72/257 (28%), Positives = 120/257 (46%), Gaps = 5/257 (1%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KH 62
+++ + +G GS+G+V+K R K G+ A+K M + KD E+ K+ +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSN 121
+ + ++E + TE L + E LPE QV + + AL +LHS
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNH 181
++H D+KP NI +G KL DFG + +G P YMAPEL++ Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQEGDPRYMAPELLQG-SYGT 234
Query: 182 TADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVP 241
AD++SLG+ + E+ + + +R P ++ +S +S L +L P
Sbjct: 235 AADVFSLGLTILEVACNMELPHGGEGWQQLRQG-YLPPEFTAGLSSELRSVLVMMLEPDP 293
Query: 242 QNRLTWSALLEHPFVKE 258
+ R T ALL P +++
Sbjct: 294 KLRATAEALLALPVLRQ 310
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 321 bits (826), Expect = e-100
Identities = 86/267 (32%), Positives = 137/267 (51%), Gaps = 14/267 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFI-MKHGKSEKDIHNLRQEIEILRKLKH 62
N+ + + +G G F +VY+ G VA+K + + K + +EI++L++L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQ-GELFEIL----EDDKCLPEEQVQSIAKQLVRALHY 117
N+I+ SF E +V E A G+L ++ + + +PE V QL AL +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQ 177
+HS R++HRD+KP N+ I A VVKL D G R S+ T S+ GTP YM+PE + E
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 211
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYTN--SVYALIRHIVKDPVKYP----DEMSPNFKS 231
YN +D+WSLG +LYE+ Q PFY + ++Y+L + I + YP D S +
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSEELRQ 269
Query: 232 FLKGLLNKVPQNRLTWSALLEHPFVKE 258
+ +N P+ R + + +
Sbjct: 270 LVNMCINPDPEKRPDVTYVYDVAKRMH 296
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = 2e-96
Identities = 77/281 (27%), Positives = 130/281 (46%), Gaps = 32/281 (11%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
++ IEL+G G FG+V+K + + G+T +K + + + +E++ L KL H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV------KYNNEKAEREVKALAKLDHV 64
Query: 64 NIIEMLDSFESPQEF----------------CVVTEFA-QGELFEILEDDK--CLPEEQV 104
NI+ ++ + EF +G L + +E + L +
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 105 QSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG 164
+ +Q+ + + Y+HS ++I+RD+KP NI + VK+ DFG ++ N KG
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK-NDGKRTRSKG 183
Query: 165 TPLYMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKDPVKYPD 223
T YM+PE + Q Y DL++LG+IL EL V F T+ + +R D
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG-----IISD 238
Query: 224 EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDELN 264
K+ L+ LL+K P++R S +L V + S E N
Sbjct: 239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 7e-85
Identities = 81/262 (30%), Positives = 140/262 (53%), Gaps = 4/262 (1%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLK 61
+E++ + +G+G FG VY R K + +A+K + K + H LR+E+EI L+
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 62 HQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
H NI+ + F ++ E+A G ++ L+ E++ + +L AL Y HS
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
R+IHRD+KP+N+L+G+ +K+ DFG++ + A + + GT Y+ PE++ + ++
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
DLWSLGV+ YE VG+PPF N+ + I + +PD ++ + + LL
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 245
Query: 241 PQNRLTWSALLEHPFVKETSDE 262
P R +LEHP++ S +
Sbjct: 246 PSQRPMLREVLEHPWITANSSK 267
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 3e-84
Identities = 69/298 (23%), Positives = 124/298 (41%), Gaps = 49/298 (16%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ + +++G+G+ V++GR K TG A+K + + +E E+L+KL H+
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHK 67
Query: 64 NIIEMLDSFESP--QEFCVVTEFAQ-GELFEILEDDK---CLPEEQVQSIAKQLVRALHY 117
NI+++ E + ++ EF G L+ +LE+ LPE + + + +V +++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 118 LHSNRIIHRDMKPQNILIGAG----SVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPEL 173
L N I+HR++KP NI+ G SV KL DFG AR + + S+ GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDM 186
Query: 174 VR--------EQPYNHTADLWSLGVILYELFVGQPPFYTNS------------------- 206
++ Y T DLWS+GV Y G PF
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 207 VYALIRHIVKDPVKYPDEMSPN----------FKSFLKGLLNKVPQNRLTWSALLEHP 254
+ ++ P+ + +M + L +L + +
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 8e-84
Identities = 89/258 (34%), Positives = 145/258 (56%), Gaps = 4/258 (1%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEILRKLK 61
++++ + +G+G FG VY R K +A+K + K + E H LR+EIEI L+
Sbjct: 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 62 HQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
H NI+ M + F + ++ EFA GEL++ L+ E++ + ++L ALHY H
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
++IHRD+KP+N+L+G +K+ DFG++ + A ++ R++ GT Y+ PE++ + ++
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMCGTLDYLPPEMIEGKTHD 190
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
DLW GV+ YE VG PPF + S R IV +K+P +S K + LL
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYH 250
Query: 241 PQNRLTWSALLEHPFVKE 258
P RL ++EHP+VK
Sbjct: 251 PPQRLPLKGVMEHPWVKA 268
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 6e-83
Identities = 65/285 (22%), Positives = 117/285 (41%), Gaps = 34/285 (11%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
++ I+ +G G FG V++ + K A+K ++ E + +E++ L KL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIK-RIRLPNRELAREKVMREVKALAKLEHP 63
Query: 64 NIIEMLDSFESPQEF------------CVVTEFAQGE-LFEILEDDKCL---PEEQVQSI 107
I+ +++ + + + E L + + + I
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 108 AKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT----------- 156
Q+ A+ +LHS ++HRD+KP NI VVK+ DFG AM +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 157 -VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIV 215
GT LYM+PE + Y+H D++SLG+IL+EL PF T V
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV 240
Query: 216 KDPV--KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258
++ + P ++ +L+ P R ++E+ ++
Sbjct: 241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 1e-81
Identities = 77/258 (29%), Positives = 123/258 (47%), Gaps = 2/258 (0%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLK 61
Y +G+G F K ++ T + A K + K + EI I R L
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73
Query: 62 HQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
HQ+++ FE VV E + L E+ + K L E + + +Q+V YLH
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
NR+IHRD+K N+ + VK+ DFG A + + + + GTP Y+APE++ ++ ++
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
D+WS+G I+Y L VG+PPF T+ + I K+ P ++P S ++ +L
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 253
Query: 241 PQNRLTWSALLEHPFVKE 258
P R T + LL F
Sbjct: 254 PTARPTINELLNDEFFTS 271
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 270 bits (691), Expect = 2e-81
Identities = 84/328 (25%), Positives = 138/328 (42%), Gaps = 44/328 (13%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
+G V ++ EG F VY+ + +G+ A+K ++ + E+ + QE+ ++KL
Sbjct: 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKL 82
Query: 61 K-HQNIIEMLDSFESPQ--------EFCVVTEFAQGELFEIL---EDDKCLPEEQVQSIA 108
H NI++ + + EF ++TE +G+L E L E L + V I
Sbjct: 83 SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF 142
Query: 109 KQLVRALHYLHSNR--IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK--- 163
Q RA+ ++H + IIHRD+K +N+L+ +KLCDFG A +S S +
Sbjct: 143 YQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202
Query: 164 ---------GTPLYMAPELV---REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALI 211
TP+Y PE++ P D+W+LG ILY L Q PF + ++
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262
Query: 212 RHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDELNAWELRAT 271
P D F S ++ +L P+ RL+ + ++ E+ A
Sbjct: 263 NGKYSIP--PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL-----------QEIAAA 309
Query: 272 SVEARGCNATWTAEGNAIQSSSGKSNSP 299
T E N S+ S P
Sbjct: 310 RNVNPKSPITELLEQNGGYGSATLSRGP 337
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 2e-81
Identities = 66/277 (23%), Positives = 110/277 (39%), Gaps = 26/277 (9%)
Query: 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK 61
++Y I+ +GEG F V + G A+K I+ H ++D ++E ++ R
Sbjct: 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFN 84
Query: 62 HQNIIEMLDSF----ESPQEFCVVTEFAQ-GELFEILE----DDKCLPEEQVQSIAKQLV 112
H NI+ ++ + E ++ F + G L+ +E L E+Q+ + +
Sbjct: 85 HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 113 RALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK--------- 163
R L +H+ HRD+KP NIL+G L D G + R
Sbjct: 145 RGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 164 GTPLYMAPELVREQPY---NHTADLWSLGVILYELFVGQPPF-YTNSVYALIRHIVKDPV 219
T Y APEL Q + + D+WSLG +LY + G+ P+ + V++ +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264
Query: 220 KYP--DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHP 254
P S L ++ P R LL
Sbjct: 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 269 bits (691), Expect = 2e-81
Identities = 77/258 (29%), Positives = 123/258 (47%), Gaps = 2/258 (0%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLK 61
Y +G+G F K ++ T + A K + K + EI I R L
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99
Query: 62 HQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
HQ+++ FE VV E + L E+ + K L E + + +Q+V YLH
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
NR+IHRD+K N+ + VK+ DFG A + + + + GTP Y+APE++ ++ ++
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
D+WS+G I+Y L VG+PPF T+ + I K+ P ++P S ++ +L
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 279
Query: 241 PQNRLTWSALLEHPFVKE 258
P R T + LL F
Sbjct: 280 PTARPTINELLNDEFFTS 297
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 4e-81
Identities = 65/288 (22%), Positives = 129/288 (44%), Gaps = 39/288 (13%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
++ I ++G+G+FG+V K R + A+K I +E+ + + E+ +L L HQ
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQ 62
Query: 64 NIIEMLDSF-------------ESPQEFCVVTEFAQ-GELFEILEDDKC-LPEEQVQSIA 108
++ ++ + + E+ + G L++++ + ++ +
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 109 KQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV---------- 158
+Q++ AL Y+HS IIHRD+KP NI I VK+ DFG A+ + + +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 159 ----LRSIKGTPLYMAPELVREQP-YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRH 213
L S GT +Y+A E++ YN D++SLG+I +E+ P +++
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKK 240
Query: 214 IVKDPVKYPDEM----SPNFKSFLKGLLNKVPQNRLTWSALLEHPFVK 257
+ +++P + K ++ L++ P R LL ++
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 4e-81
Identities = 68/297 (22%), Positives = 122/297 (41%), Gaps = 49/297 (16%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ + +++G+G+ V++GR K TG A+K + + +E E+L+KL H+
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHK 67
Query: 64 NIIEMLDSFESP--QEFCVVTEFAQ-GELFEILEDDK---CLPEEQVQSIAKQLVRALHY 117
NI+++ E + ++ EF G L+ +LE+ LPE + + + +V +++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 118 LHSNRIIHRDMKPQNILIGAG----SVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPEL 173
L N I+HR++KP NI+ G SV KL DFG AR + + S+ GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDM 186
Query: 174 VR--------EQPYNHTADLWSLGVILYELFVGQPPFYTNS------------------- 206
++ Y T DLWS+GV Y G PF
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 207 VYALIRHIVKDPVKY----------PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253
+ ++ P+ + + L +L + +
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 6e-81
Identities = 81/259 (31%), Positives = 139/259 (53%), Gaps = 3/259 (1%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLK 61
+E++ V L+G+GSF VY+ +TG VA+K I K + ++ E++I +LK
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 62 HQNIIEMLDSFESPQEFCVVTEFA-QGELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLH 119
H +I+E+ + FE +V E GE+ L K E + + Q++ + YLH
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
S+ I+HRD+ N+L+ +K+ DFG A + ++ GTP Y++PE+ +
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH 189
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNK 239
+D+WSLG + Y L +G+PPF T++V + +V + P +S K + LL +
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRR 249
Query: 240 VPQNRLTWSALLEHPFVKE 258
P +RL+ S++L+HPF+
Sbjct: 250 NPADRLSLSSVLDHPFMSR 268
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 5e-79
Identities = 88/267 (32%), Positives = 143/267 (53%), Gaps = 10/267 (3%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E Y+++ ++G+GSFG+V K + + T Q A+K I K KD + +E+E+L+KL H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 64 NIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+++ + E F +V E G ELF+ + K E I KQ+ + Y+H +
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 123 IIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
I+HRD+KP+NIL+ +K+ DFG + ++ GT Y+APE V Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYIAPE-VLRGTY 199
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE----MSPNFKSFLKG 235
+ D+WS GVILY L G PPFY + Y +++ + + +S + K ++
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 236 LLNKVPQNRLTWSALLEHPFVKETSDE 262
+L P R+T + LEHP++++ S E
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSE 286
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 1e-78
Identities = 98/528 (18%), Positives = 193/528 (36%), Gaps = 57/528 (10%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
+ + E +G G FG V + + TG+ VA+K + S K+ EI+I++KL H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNH 71
Query: 63 QNIIEMLDSFESPQEF------CVVTEFAQ-GELFEIL---EDDKCLPEEQVQSIAKQLV 112
N++ + + Q+ + E+ + G+L + L E+ L E ++++ +
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 113 RALHYLHSNRIIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYM 169
AL YLH NRIIHRD+KP+NI++ + K+ D G+A+ + + GT Y+
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTEFVGTLQYL 190
Query: 170 APELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK------------- 216
APEL+ ++ Y T D WS G + +E G PF N V+
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250
Query: 217 -----------DPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDELNA 265
P ++ + +L+ +L + R T + L+
Sbjct: 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310
Query: 266 WELRATSVEARGCNATWTAEGNAIQSSSGKSNSPAVSANNTSPSLHTDVELNSSNTSQSN 325
L ++ + + E +Q+ +T L +S + ++
Sbjct: 311 KLLSVMNMVSGRVHTYPVTENENLQNLKSW------LQQDTGIPEEEQELLQASGLALNS 364
Query: 326 SSPCEAFPGFSSPNNVKPSGSQALNRLENNSRTVKGALSI---------CQDNEALALIL 376
+ P + + + + + +N + +S+ + L
Sbjct: 365 AQPLTQYVIDCTVIDGRQGEGDLIFLFDNRKTVYEPQISLPAHPESVSIVLQDPKRPLTY 424
Query: 377 LPLKK-WSQGSQNTCRDQDVLN-SNQSLRILSNLVAASAIQSNGLLDEIISELLDFSSVV 434
L++ W Q Q ++ Q R + + + + + SE + +
Sbjct: 425 THLRRVWGQIWQTIRALKEDCARLLQGQRTSMVNLLRYNTELSKKKNSMTSECEQLKAKL 484
Query: 435 VSLKASELNDLLAKSFLIIKMLIDNSGSCIASSYFTNWVAVVEIFSKV 482
++S + L K ++ I + A V + +V
Sbjct: 485 DFFRSS-IQIDLEKYSEQMEFGITSEKLLSAWREMEQAVELCGREREV 531
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 1e-78
Identities = 89/263 (33%), Positives = 139/263 (52%), Gaps = 9/263 (3%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+NY V E +G+G+F V + K TG A K I S +D L +E I RKL+H
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 64 NIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+ + DS + +V + GELFE + + E +Q++ ++ Y HSN
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 123 IIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
I+HR++KP+N+L+ G+ VKL DFG A ++ + GTP Y++PE++++ PY
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-AWHGFAGTPGYLSPEVLKKDPY 184
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP----DEMSPNFKSFLKG 235
+ D+W+ GVILY L VG PPF+ + L I YP D ++P KS +
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244
Query: 236 LLNKVPQNRLTWSALLEHPFVKE 258
+L P+ R+T L+ P++
Sbjct: 245 MLTVNPKKRITADQALKVPWICN 267
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 1e-78
Identities = 88/320 (27%), Positives = 152/320 (47%), Gaps = 19/320 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E Y + E +G G FG V++ + +T KF+ G D +++EI IL +H+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHR 61
Query: 64 NIIEMLDSFESPQEFCVVTEFAQG-ELFE-ILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
NI+ + +SFES +E ++ EF G ++FE I L E ++ S Q+ AL +LHS+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 122 RIIHRDMKPQNILIGA--GSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
I H D++P+NI+ S +K+ +FG AR + R + P Y APE+ +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYYAPEVHQHDVV 180
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEM----SPNFKSFLKG 235
+ D+WSLG ++Y L G PF + +I +I+ + +E S F+
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240
Query: 236 LLNKVPQNRLTWSALLEHPFVKETSDELNAWELRATSVEARGCNATWTAEGNAI------ 289
LL K ++R+T S L+HP++K+ + ++ ++ T R + + N +
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQKIERVST-KVIRTLKHRRYYHTLIKKDLNMVVSAARI 299
Query: 290 QSSSGKSNSPAVSANNTSPS 309
+ VS +
Sbjct: 300 SCGGAIRSQKGVSVAKVKVA 319
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 5e-78
Identities = 92/272 (33%), Positives = 145/272 (53%), Gaps = 14/272 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFI----MKHGKSEKDIHNLRQEIEILRK 59
++Y + E +G G F V K R+K TG+ A KFI + + + +E+ ILR+
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
++H NII + D FE+ + ++ E GELF+ L + + L E++ KQ++ +HYL
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 119 HSNRIIHRDMKPQNILI----GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELV 174
HS RI H D+KP+NI++ +KL DFG A + A ++I GTP ++APE+V
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAPEIV 183
Query: 175 REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE----MSPNFK 230
+P AD+WS+GVI Y L G PF + + +I + +E S K
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK 243
Query: 231 SFLKGLLNKVPQNRLTWSALLEHPFVKETSDE 262
F++ LL K P+ R+T + LEH ++K
Sbjct: 244 DFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 8e-78
Identities = 84/269 (31%), Positives = 142/269 (52%), Gaps = 11/269 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ Y ++E +G G+FG V++ K TG+ KFI D + ++ EI I+ +L H
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHP 108
Query: 64 NIIEMLDSFESPQEFCVVTEFAQG-ELFE-ILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
+I + D+FE E ++ EF G ELF+ I +D + E +V + +Q L ++H +
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 122 RIIHRDMKPQNILIGA--GSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
I+H D+KP+NI+ S VK+ DFG A ++ + + ++ T + APE+V +P
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-VKVTTATAEFAAPEIVDREPV 227
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEM----SPNFKSFLKG 235
D+W++GV+ Y L G PF ++++ + ++ ++ SP K F+K
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 287
Query: 236 LLNKVPQNRLTWSALLEHPFVKETSDELN 264
LL K P+ RLT LEHP++K L
Sbjct: 288 LLQKEPRKRLTVHDALEHPWLKGDHSNLT 316
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 2e-77
Identities = 82/271 (30%), Positives = 133/271 (49%), Gaps = 13/271 (4%)
Query: 4 ENYHVI-ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
Y + + +G G F V + K TGQ A KF+ K + + + EI +L K
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 63 Q-NIIEMLDSFESPQEFCVVTEFAQ-GELFE--ILEDDKCLPEEQVQSIAKQLVRALHYL 118
+I + + +E+ E ++ E+A GE+F + E + + E V + KQ++ ++YL
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 119 HSNRIIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVR 175
H N I+H D+KPQNIL+ +K+ DFG +R + LR I GTP Y+APE++
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYLAPEILN 206
Query: 176 EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE----MSPNFKS 231
P D+W++G+I Y L PF +I + V Y +E +S
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATD 266
Query: 232 FLKGLLNKVPQNRLTWSALLEHPFVKETSDE 262
F++ LL K P+ R T L H ++++ E
Sbjct: 267 FIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 4e-77
Identities = 83/271 (30%), Positives = 146/271 (53%), Gaps = 11/271 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKH 62
+ Y ++G+GSFG+V + K TGQ A+K I K K + D +L +E+++L++L H
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
NI+++ + FE F +V E G ELF+ + K E I +Q++ + Y+H N
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 122 RIIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQP 178
+I+HRD+KP+N+L+ + +++ DFG + + ++ GT Y+APE V
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKMKDKIGTAYYIAPE-VLHGT 203
Query: 179 YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE----MSPNFKSFLK 234
Y+ D+WS GVILY L G PPF + Y +++ + K + +S + K ++
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 263
Query: 235 GLLNKVPQNRLTWSALLEHPFVKETSDELNA 265
+L VP R++ L+H +++ + E +
Sbjct: 264 KMLTYVPSMRISARDALDHEWIQTYTKEQIS 294
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 4e-77
Identities = 88/286 (30%), Positives = 140/286 (48%), Gaps = 14/286 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEK----DIHNLRQEIEILRK 59
+ Y + E +G G F V K R K TG A KFI K + +E+ ILR+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
+ H N+I + D +E+ + ++ E GELF+ L + L EE+ S KQ++ ++YL
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 119 HSNRIIHRDMKPQNILI----GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELV 174
H+ +I H D+KP+NI++ +KL DFG A + ++I GTP ++APE+V
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEIV 190
Query: 175 REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE----MSPNFK 230
+P AD+WS+GVI Y L G PF ++ + +I + +E S K
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK 250
Query: 231 SFLKGLLNKVPQNRLTWSALLEHPFVKETSDELNAWELRATSVEAR 276
F++ LL K + RLT L HP++ ++ +
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLEN 296
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 4e-77
Identities = 84/269 (31%), Positives = 133/269 (49%), Gaps = 8/269 (2%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E Y + E +G+G+F V + + GQ A I S +D L +E I R LKH
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 64 NIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+ + DS ++ + G ELFE + + E +Q++ A+ + H
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 123 IIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
++HR++KP+N+L+ G+ VKL DFG A + GTP Y++PE++R+ PY
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP----DEMSPNFKSFLKG 235
DLW+ GVILY L VG PPF+ + L + I +P D ++P K +
Sbjct: 191 GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINK 250
Query: 236 LLNKVPQNRLTWSALLEHPFVKETSDELN 264
+L P R+T + L+HP++ S +
Sbjct: 251 MLTINPSKRITAAEALKHPWISHRSTVAS 279
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 5e-77
Identities = 90/267 (33%), Positives = 145/267 (54%), Gaps = 10/267 (3%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E Y+++ ++G+GSFG+V K + + T Q A+K I K KD + +E+E+L+KL H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 64 NIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+++ + E F +V E GELF+ + K E I KQ+ + Y+H +
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 123 IIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
I+HRD+KP+NIL+ +K+ DFG + NT ++ GT Y+APE V Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPE-VLRGTY 199
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP----DEMSPNFKSFLKG 235
+ D+WS GVILY L G PPFY + Y +++ + + +S + K ++
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 236 LLNKVPQNRLTWSALLEHPFVKETSDE 262
+L P R+T + LEHP++++ S E
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSE 286
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 263 bits (673), Expect = 6e-77
Identities = 84/267 (31%), Positives = 139/267 (52%), Gaps = 10/267 (3%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E Y ++ +G G++G+V R K T A+K I K S L +E+ +L+ L H
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 64 NIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+++ D FE + + +V E +G ELF+ + E I KQ++ + YLH +
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 123 IIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
I+HRD+KP+N+L+ +++K+ DFG + N ++ GT Y+APE V + Y
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERLGTAYYIAPE-VLRKKY 214
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE----MSPNFKSFLKG 235
+ D+WS+GVIL+ L G PPF + ++R + K + +S K +K
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274
Query: 236 LLNKVPQNRLTWSALLEHPFVKETSDE 262
+L Q R++ LEHP++KE +
Sbjct: 275 MLQFDSQRRISAQQALEHPWIKEMCSK 301
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 7e-77
Identities = 82/266 (30%), Positives = 133/266 (50%), Gaps = 14/266 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ + +G G+FG V+ + +G +K I K +S+ + + EIE+L+ L H
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD-RSQVPMEQIEAEIEVLKSLDHP 80
Query: 64 NIIEMLDSFESPQEFCVVTEFAQ-GELFE-ILE---DDKCLPEEQVQSIAKQLVRALHYL 118
NII++ + FE +V E + GEL E I+ K L E V + KQ++ AL Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 119 HSNRIIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVR 175
HS ++H+D+KP+NIL S +K+ DFG A ++ + GT LYMAPE V
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-HSTNAAGTALYMAPE-VF 198
Query: 176 EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK---DPVKYPDEMSPNFKSF 232
++ D+WS GV++Y L G PF S+ + + + ++P
Sbjct: 199 KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDL 258
Query: 233 LKGLLNKVPQNRLTWSALLEHPFVKE 258
LK +L K P+ R + + +L H + K+
Sbjct: 259 LKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 2e-76
Identities = 86/268 (32%), Positives = 143/268 (53%), Gaps = 14/268 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFI----MKHGKSEKDIHNLRQEIEILRK 59
+ Y E +G G F V K R K TG A KFI K + ++ +E+ IL++
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
++H N+I + + +E+ + ++ E G ELF+ L + + L EE+ KQ++ ++YL
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 119 HSNRIIHRDMKPQNILI----GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELV 174
HS +I H D+KP+NI++ +K+ DFG A + ++I GTP ++APE+V
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIV 189
Query: 175 REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE----MSPNFK 230
+P AD+WS+GVI Y L G PF ++ + ++ ++ DE S K
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 231 SFLKGLLNKVPQNRLTWSALLEHPFVKE 258
F++ LL K P+ R+T L+HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIKP 277
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 2e-76
Identities = 89/286 (31%), Positives = 139/286 (48%), Gaps = 14/286 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEK----DIHNLRQEIEILRK 59
+ Y + E +G G F V K R K TG A KFI K + +E+ ILR+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
+ H NII + D +E+ + ++ E GELF+ L + L EE+ S KQ++ ++YL
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 119 HSNRIIHRDMKPQNILI----GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELV 174
H+ +I H D+KP+NI++ +KL DFG A + ++I GTP ++APE+V
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEIV 190
Query: 175 REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE----MSPNFK 230
+P AD+WS+GVI Y L G PF ++ + +I + +E S K
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK 250
Query: 231 SFLKGLLNKVPQNRLTWSALLEHPFVKETSDELNAWELRATSVEAR 276
F++ LL K + RLT L HP++ + +
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLEN 296
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 3e-76
Identities = 89/263 (33%), Positives = 140/263 (53%), Gaps = 9/263 (3%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+NY V E +G+G+F V + K TG A K I S +D L +E I RKL+H
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 64 NIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+ + DS + +V + GELFE + + E +Q++ ++ Y HSN
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 123 IIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
I+HR++KP+N+L+ G+ VKL DFG A ++ ++ GTP Y++PE++++ PY
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP----DEMSPNFKSFLKG 235
+ D+W+ GVILY L VG PPF+ + L I YP D ++P KS +
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267
Query: 236 LLNKVPQNRLTWSALLEHPFVKE 258
+L P+ R+T L+ P++
Sbjct: 268 MLTVNPKKRITADQALKVPWICN 290
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 1e-75
Identities = 86/263 (32%), Positives = 135/263 (51%), Gaps = 12/263 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ Y + +G GS+G+V +K T A K I K +D+ +QEIEI++ L H
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMKSLDHP 66
Query: 64 NIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NII + ++FE + +V E GELFE + + E I K ++ A+ Y H
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 123 IIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
+ HRD+KP+N L S +KL DFG A ++R+ GTP Y++P+ V E Y
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-MMRTKVGTPYYVSPQ-VLEGLY 184
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE----MSPNFKSFLKG 235
D WS GV++Y L G PPF + ++ I + +P++ +SP +S ++
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244
Query: 236 LLNKVPQNRLTWSALLEHPFVKE 258
LL K P+ R+T LEH + ++
Sbjct: 245 LLTKSPKQRITSLQALEHEWFEK 267
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 1e-75
Identities = 84/263 (31%), Positives = 145/263 (55%), Gaps = 12/263 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ + +E++G G+F +V+ +++ TG+ A+K I K +L EI +L+K+KH+
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK--SPAFRDSSLENEIAVLKKIKHE 66
Query: 64 NIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+ + D +ES + +V + GELF+ + + E+ + +Q++ A+ YLH N
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 123 IIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
I+HRD+KP+N+L S + + DFG ++ ++ + GTP Y+APE++ ++PY
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYVAPEVLAQKPY 184
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP----DEMSPNFKSFLKG 235
+ D WS+GVI Y L G PPFY + L I + ++ D++S + K F+
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICH 244
Query: 236 LLNKVPQNRLTWSALLEHPFVKE 258
LL K P R T L HP++
Sbjct: 245 LLEKDPNERYTCEKALSHPWIDG 267
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 1e-75
Identities = 83/257 (32%), Positives = 133/257 (51%), Gaps = 11/257 (4%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEML 69
E++G G FG+V+K TG +A K I + KD ++ EI ++ +L H N+I++
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLDHANLIQLY 152
Query: 70 DSFESPQEFCVVTEFAQG-ELFE-ILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRD 127
D+FES + +V E+ G ELF+ I+++ L E KQ+ + ++H I+H D
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLD 212
Query: 128 MKPQNILIG--AGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADL 185
+KP+NIL +K+ DFG AR L+ GTP ++APE+V + D+
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKVNFGTPEFLAPEVVNYDFVSFPTDM 271
Query: 186 WSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEM----SPNFKSFLKGLLNKVP 241
WS+GVI Y L G PF ++ + +I+ DE S K F+ LL K
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331
Query: 242 QNRLTWSALLEHPFVKE 258
R++ S L+HP++ +
Sbjct: 332 SWRISASEALKHPWLSD 348
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 252 bits (647), Expect = 3e-75
Identities = 99/328 (30%), Positives = 147/328 (44%), Gaps = 21/328 (6%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK---HGKSEKDIHNLRQEIEILRKL 60
+ Y + E++G+G F V + + TGQ A+K + +L++E I L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQG-ELFE-ILE---DDKCLPEEQVQSIAKQLVRAL 115
KH +I+E+L+++ S +V EF G +L I++ E +Q++ AL
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 116 HYLHSNRIIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE 172
Y H N IIHRD+KP +L+ + VKL FG A + + +V GTP +MAPE
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE 203
Query: 173 LVREQPYNHTADLWSLGVILYELFVGQPPFY-TNSVYALIRHIVKDPVKYP----DEMSP 227
+V+ +PY D+W GVIL+ L G PFY T L I+K K +S
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKYKMNPRQWSHISE 261
Query: 228 NFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDELNAWELRATSVEARGCNA--TWTAE 285
+ K ++ +L P R+T L HP++KE L T + R NA
Sbjct: 262 SAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGA 321
Query: 286 GNAIQSSSGKSNSPAVSANNTSPSLHTD 313
A SS K NS P D
Sbjct: 322 VLAAVSSH-KFNSFYGDPPEELPDFSED 348
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 3e-75
Identities = 79/317 (24%), Positives = 135/317 (42%), Gaps = 56/317 (17%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK---HGKSEKDIHNLRQEIEILRKL 60
+ YH+ +G+GS+G V T A+K + K + KD+ ++ E+ +++KL
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQ-GELFE---------------------------- 91
H NI + + +E Q C+V E G L +
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 92 ------------ILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA-- 137
D E+ + +I +Q+ ALHYLH+ I HRD+KP+N L
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 138 GSVVKLCDFGFARAMSANT----VVLRSIKGTPLYMAPELVR--EQPYNHTADLWSLGVI 191
+KL DFG ++ + + GTP ++APE++ + Y D WS GV+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 192 LYELFVGQPPFYTNSVYALIRHIVKDPVKYP----DEMSPNFKSFLKGLLNKVPQNRLTW 247
L+ L +G PF + I ++ + + + +SP + L LLN+ R
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325
Query: 248 SALLEHPFVKETSDELN 264
L+HP++ + SD++
Sbjct: 326 MRALQHPWISQFSDKIY 342
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 5e-75
Identities = 89/281 (31%), Positives = 140/281 (49%), Gaps = 21/281 (7%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-----------HGKSEKDIHNLRQ 52
E+Y + +G G++G+V + K A+K I K + EK +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 53 EIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQL 111
EI +L+ L H NII++ D FE + F +VTEF +G ELFE + + E +I KQ+
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 112 VRALHYLHSNRIIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLY 168
+ + YLH + I+HRD+KP+NIL+ + +K+ DFG + S LR GT Y
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS-KDYKLRDRLGTAYY 214
Query: 169 MAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE---- 224
+APE V ++ YN D+WS GVI+Y L G PPF + +I+ + K +
Sbjct: 215 IAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKN 273
Query: 225 MSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDELNA 265
+S K +K +L R T L ++K+ ++ +N
Sbjct: 274 ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINK 314
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 5e-75
Identities = 60/283 (21%), Positives = 115/283 (40%), Gaps = 32/283 (11%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KH 62
+H +E +G G FG V+K ++ G A+K K D N +E+ L +H
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQG-----ELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
+++ ++ + E+ G + E E +++ + Q+ R L Y
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 118 LHSNRIIHRDMKPQNILI-------------------GAGSVVKLCDFGFARAMSANTVV 158
+HS ++H D+KP NI I + K+ D G +S+ V
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 190
Query: 159 LRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD 217
+G ++A E+++E + AD+++L + + +P + IR
Sbjct: 191 ----EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLP 246
Query: 218 PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260
+ P +S F LK +++ P+ R + AL++H + S
Sbjct: 247 RI--PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 7e-75
Identities = 77/273 (28%), Positives = 138/273 (50%), Gaps = 11/273 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
++Y + E +G G+FG V++ + TG A KF+M E D +R+EI+ + L+H
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 214
Query: 64 NIIEMLDSFESPQEFCVVTEFAQG-ELFE-ILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
++ + D+FE E ++ EF G ELFE + ++ + E++ +Q+ + L ++H N
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 122 RIIHRDMKPQNILIG--AGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
+H D+KP+NI+ + +KL DFG + ++ GT + APE+ +P
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-VKVTTGTAEFAAPEVAEGKPV 333
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE----MSPNFKSFLKG 235
+ D+WS+GV+ Y L G PF + +R++ D +S + K F++
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 393
Query: 236 LLNKVPQNRLTWSALLEHPFVKETSDELNAWEL 268
LL P R+T LEHP++ + ++
Sbjct: 394 LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 426
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 1e-74
Identities = 78/268 (29%), Positives = 137/268 (51%), Gaps = 10/268 (3%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEILRK 59
E++ +++GEGSF V R T + A+K + K H E + + +E +++ +
Sbjct: 27 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
L H +++ +F+ ++ +A+ GEL + + E + ++V AL YL
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR--SIKGTPLYMAPELVRE 176
H IIHRD+KP+NIL+ +++ DFG A+ +S + R S GT Y++PEL+ E
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206
Query: 177 QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGL 236
+ ++DLW+LG I+Y+L G PPF + Y + + I+K +P++ P + ++ L
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 266
Query: 237 LNKVPQNRLT------WSALLEHPFVKE 258
L RL + L HPF +
Sbjct: 267 LVLDATKRLGCEEMEGYGPLKAHPFFES 294
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 5e-73
Identities = 86/262 (32%), Positives = 139/262 (53%), Gaps = 13/262 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFI-MKHGKSEKDIHNLRQEIEILRKLKH 62
+ + + +G GSFG VY R + VA+K + +S + ++ +E+ L+KL+H
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSN 121
N I+ + +V E+ G ++LE K L E ++ ++ ++ L YLHS+
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMS-ANTVVLRSIKGTPLYMAPELV---REQ 177
+IHRD+K NIL+ +VKL DFG A M+ AN+ V GTP +MAPE++ E
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEG 228
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD--PVKYPDEMSPNFKSFLKG 235
Y+ D+WSLG+ EL +PP + + + + HI ++ P S F++F+
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 288
Query: 236 LLNKVPQNRLTWSALLEHPFVK 257
L K+PQ+R T LL+H FV
Sbjct: 289 CLQKIPQDRPTSEVLLKHRFVL 310
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 6e-73
Identities = 87/269 (32%), Positives = 145/269 (53%), Gaps = 14/269 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E + +E +G+GSFG+V+KG T + VA+K I+ ++E +I +++QEI +L +
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 64 NIIEMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
+ + S+ + ++ E+ G ++LE L E Q+ +I +++++ L YLHS +
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK 139
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSA-----NTVVLRSIKGTPLYMAPELVREQ 177
IHRD+K N+L+ VKL DFG A ++ NT V GTP +MAPE++++
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPEVIKQS 194
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK-DPVKYPDEMSPNFKSFLKGL 236
Y+ AD+WSLG+ EL G+PP ++ I K +P S K F++
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 254
Query: 237 LNKVPQNRLTWSALLEHPFVKETSDELNA 265
LNK P R T LL+H F+ + + +
Sbjct: 255 LNKEPSFRPTAKELLKHKFILRNAKKTSY 283
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 8e-73
Identities = 85/272 (31%), Positives = 134/272 (49%), Gaps = 21/272 (7%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-HQN 64
+ +GEGSF K K + Q A+K I K + N ++EI L+ + H N
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPN 67
Query: 65 IIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRI 123
I+++ + F +V E G ELFE ++ K E + I ++LV A+ ++H +
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGV 127
Query: 124 IHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
+HRD+KP+N+L +K+ DFGFAR + L++ T Y APEL+ + Y+
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYD 187
Query: 181 HTADLWSLGVILYELFVGQPPFY-------TNSVYALIRHIVKDPVKYPDE----MSPNF 229
+ DLWSLGVILY + GQ PF S +++ I K + E +S
Sbjct: 188 ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEA 247
Query: 230 KSFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261
K ++GLL P RL S L + ++++ S
Sbjct: 248 KDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 1e-72
Identities = 87/274 (31%), Positives = 138/274 (50%), Gaps = 20/274 (7%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-------HGKSEKDIHNLRQEIEI 56
ENY E++G G V + K T + A+K I + ++ +E++I
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 57 LRKLK-HQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRA 114
LRK+ H NII++ D++E+ F +V + + GELF+ L + L E++ + I + L+
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 115 LHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELV 174
+ LH I+HRD+KP+NIL+ +KL DFGF+ + LR + GTP Y+APE++
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEII 195
Query: 175 R------EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP----DE 224
Y D+WS GVI+Y L G PPF+ ++R I+ ++ D+
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 255
Query: 225 MSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258
S K + L PQ R T L HPF ++
Sbjct: 256 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 2e-72
Identities = 93/273 (34%), Positives = 154/273 (56%), Gaps = 22/273 (8%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E + ++ +G+G+FGKVYK + K TG A K I KSE+++ + EIEIL H
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIET--KSEEELEDYIVEIEILATCDHP 76
Query: 64 NIIEMLDSFESPQEFCVVTEF-AQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSN 121
I+++L ++ + ++ EF G + I+ + D+ L E Q+Q + +Q++ AL++LHS
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA-----NTVVLRSIKGTPLYMAPELV-- 174
RIIHRD+K N+L+ ++L DFG + ++ + GTP +MAPE+V
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMC 191
Query: 175 ---REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP---VKYPDEMSPN 228
++ PY++ AD+WSLG+ L E+ +PP + + ++ I K + P + S
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE 251
Query: 229 FKSFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261
F+ FLK L+K P+ R + + LLEHPFV +
Sbjct: 252 FRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 2e-72
Identities = 63/281 (22%), Positives = 121/281 (43%), Gaps = 23/281 (8%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
+G ++ +++G G+ G + R + + VA+K I+ + +E+++LR+
Sbjct: 21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILP-----ECFSFADREVQLLRES 74
Query: 61 -KHQNIIEMLDSFESPQEFCVVTEFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYL 118
+H N+I + + Q + E L E +E D + ++ +Q L +L
Sbjct: 75 DEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 119 HSNRIIHRDMKPQNILI-----GAGSVVKLCDFGFARAMSAN---TVVLRSIKGTPLYMA 170
HS I+HRD+KP NILI + DFG + ++ + GT ++A
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 171 PELVRE---QPYNHTADLWSLGVILYELFV-GQPPFYTNS---VYALIRHIVKDPVKYPD 223
PE++ E + +T D++S G + Y + G PF + L+ D +
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEK 254
Query: 224 EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDELN 264
+ ++ ++ PQ R + +L+HPF +L
Sbjct: 255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQ 295
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 5e-72
Identities = 86/283 (30%), Positives = 146/283 (51%), Gaps = 20/283 (7%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK------HGKSEKDIHNLRQEIEIL 57
+ Y + + +G G+ G+V + T + VA++ I K + N+ EIEIL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 58 RKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALH 116
+KL H II++ + F++ + +V E + GELF+ + +K L E + Q++ A+
Sbjct: 195 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 117 YLHSNRIIHRDMKPQNILIGA---GSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPEL 173
YLH N IIHRD+KP+N+L+ + ++K+ DFG ++ + + ++R++ GTP Y+APE+
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEV 312
Query: 174 VRE---QPYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKDPVKYP----DEM 225
+ YN D WSLGVIL+ G PPF + +L I + E+
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 372
Query: 226 SPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDELNAWEL 268
S +K LL P+ R T L HP++++ + +L
Sbjct: 373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 415
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 5e-72
Identities = 87/266 (32%), Positives = 142/266 (53%), Gaps = 14/266 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ + V +G G+ VY+ ++K T + A+K + K D +R EI +L +L H
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK----TVDKKIVRTEIGVLLRLSHP 108
Query: 64 NIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NII++ + FE+P E +V E GELF+ + + E KQ++ A+ YLH N
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 123 IIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
I+HRD+KP+N+L + +K+ DFG ++ + V+++++ GTP Y APE++R Y
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAY 227
Query: 180 NHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKDPVKYP----DEMSPNFKSFLK 234
D+WS+G+I Y L G PFY + R I+ + DE+S N K ++
Sbjct: 228 GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVR 287
Query: 235 GLLNKVPQNRLTWSALLEHPFVKETS 260
L+ P+ RLT L+HP+V +
Sbjct: 288 KLIVLDPKKRLTTFQALQHPWVTGKA 313
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 6e-72
Identities = 72/262 (27%), Positives = 128/262 (48%), Gaps = 14/262 (5%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEML 69
+G GSF VYKG T VA + ++ + ++E E+L+ L+H NI+
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 70 DSF----ESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR-- 122
DS+ + + +VTE G L L+ K + + ++S +Q+++ L +LH+
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 123 IIHRDMKPQNILI-GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNH 181
IIHRD+K NI I G VK+ D G A A+ +++ GTP +MAPE+ E+ Y+
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAPEMYEEK-YDE 208
Query: 182 TADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKD--PVKYPDEMSPNFKSFLKGLLN 238
+ D+++ G+ + E+ + P+ + + R + P + P K ++G +
Sbjct: 209 SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268
Query: 239 KVPQNRLTWSALLEHPFVKETS 260
+ R + LL H F +E +
Sbjct: 269 QNKDERYSIKDLLNHAFFQEET 290
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 7e-72
Identities = 70/286 (24%), Positives = 117/286 (40%), Gaps = 19/286 (6%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHN-LRQEIEILRKLK 61
V VG GSFG+V++ + K TG A+K + + +E+ L
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV--------RLEVFRVEELVACAGLS 108
Query: 62 HQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
I+ + + + E + G L ++++ CLPE++ Q + L YLH+
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 121 NRIIHRDMKPQNILIGA-GSVVKLCDFGFARAMSAN-----TVVLRSIKGTPLYMAPELV 174
RI+H D+K N+L+ + GS LCDFG A + + + I GT +MAPE+V
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 175 REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP---VKYPDEMSPNFKS 231
+P + D+WS ++ + G P+ L I +P + P +P
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQ 288
Query: 232 FLKGLLNKVPQNRLTWSALLEHPFVKETSDELNAWELRATSVEARG 277
++ L K P +R + L + E RG
Sbjct: 289 AIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRG 334
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 8e-72
Identities = 94/265 (35%), Positives = 150/265 (56%), Gaps = 21/265 (7%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E + V+E +GEGS+G VYK K TGQ VA+K + E D+ + +EI I+++
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV----PVESDLQEIIKEISIMQQCDSP 84
Query: 64 NIIEMLDSFESPQEFCVVTEF-AQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSN 121
++++ S+ + +V E+ G + +I+ +K L E+++ +I + ++ L YLH
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA-----NTVVLRSIKGTPLYMAPELVRE 176
R IHRD+K NIL+ KL DFG A ++ NTV+ GTP +MAPE+++E
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPFWMAPEVIQE 199
Query: 177 QPYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKDP---VKYPDEMSPNFKSF 232
YN AD+WSLG+ E+ G+PP+ + + A+ I +P + P+ S NF F
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPTNPPPTFRKPELWSDNFTDF 258
Query: 233 LKGLLNKVPQNRLTWSALLEHPFVK 257
+K L K P+ R T + LL+HPFV+
Sbjct: 259 VKQCLVKSPEQRATATQLLQHPFVR 283
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 1e-71
Identities = 69/307 (22%), Positives = 127/307 (41%), Gaps = 51/307 (16%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKH---------------GKSEKDI 47
+ +Y +I + +G F K+ + + A+K K +
Sbjct: 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 48 HNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCL------- 99
+ + E++I+ +K++ + + E ++ E+ + + + E L
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 100 -PEEQVQSIAKQLVRALHYLHSNR-IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157
P + ++ I K ++ + Y+H+ + I HRD+KP NIL+ VKL DFG + M
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK- 206
Query: 158 VLRSIKGTPLYMAPELVREQP--YNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHI 214
++ +GT +M PE + D+WSLG+ LY +F PF S+ L +I
Sbjct: 207 -IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265
Query: 215 VKDPVKYP-------------------DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPF 255
++YP + +S FLK L K P R+T L+H +
Sbjct: 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325
Query: 256 VKETSDE 262
+ +T+ E
Sbjct: 326 LADTNIE 332
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 1e-71
Identities = 87/263 (33%), Positives = 149/263 (56%), Gaps = 17/263 (6%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ Y E +G+G+ G VY TGQ VA++ + + +K++ + EI ++R+ K+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNP 77
Query: 64 NIIEMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+ LDS+ E VV E+ A G L +++ + C+ E Q+ ++ ++ ++AL +LHSN+
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSA-----NTVVLRSIKGTPLYMAPELVREQ 177
+IHRD+K NIL+G VKL DFGF ++ +T+V GTP +MAPE+V +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAPEVVTRK 191
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP---VKYPDEMSPNFKSFLK 234
Y D+WSLG++ E+ G+PP+ + + I + ++ P+++S F+ FL
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251
Query: 235 GLLNKVPQNRLTWSALLEHPFVK 257
L + R + LL+H F+K
Sbjct: 252 RCLEMDVEKRGSAKELLQHQFLK 274
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 2e-71
Identities = 89/267 (33%), Positives = 149/267 (55%), Gaps = 17/267 (6%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+GEGS G V R K++G+ VA+K + + ++ L E+ I+R +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHF 102
Query: 64 NIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
N++EM S+ +E V+ EF Q G L +I+ L EEQ+ ++ + +++AL YLH+
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG 161
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSA-----NTVVLRSIKGTPLYMAPELVREQ 177
+IHRD+K +IL+ VKL DFGF +S ++V GTP +MAPE++
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRS 216
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP---VKYPDEMSPNFKSFLK 234
Y D+WSLG+++ E+ G+PP++++S ++ + P +K ++SP + FL+
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE 276
Query: 235 GLLNKVPQNRLTWSALLEHPFVKETSD 261
+L + PQ R T LL+HPF+ +T
Sbjct: 277 RMLVRDPQERATAQELLDHPFLLQTGL 303
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 2e-71
Identities = 42/306 (13%), Positives = 88/306 (28%), Gaps = 48/306 (15%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKHQ 63
++E + G V+ R + A+K S ++ L + +L +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 64 NIIEMLDSF--------------------------ESPQEFCVVTEFAQGELFEILE--- 94
+ E D + + ++ A +L +
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 95 ----DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFAR 150
+ + QL+R L S ++H P N+ I + L D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 151 AMSANTVVLRSIKGTPLYMAPELV--REQPYNHTADLWSLGVILYELFVGQPPFY--TNS 206
+ + Y E + + H + W LG+ +Y ++ PF T
Sbjct: 243 KVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299
Query: 207 VYALIRHIVKDPVKYPD-------EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259
+ + + K+ + LN + RL +E P +
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359
Query: 260 SDELNA 265
+E+++
Sbjct: 360 QNEISS 365
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 3e-71
Identities = 82/258 (31%), Positives = 143/258 (55%), Gaps = 3/258 (1%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
+ NY +++ +G+G+F KV R TG+ VA+K I K + + L +E+ I++ L H
Sbjct: 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH 73
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
NI+++ + E+ + ++ E+A GE+F+ L + E++ +S +Q+V A+ Y H
Sbjct: 74 PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN- 180
RI+HRD+K +N+L+ A +K+ DFGF+ + L + G P Y APEL + + Y+
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFCGAPPYAAPELFQGKKYDG 192
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
D+WSLGVILY L G PF ++ L +++ + P MS + ++ LK L
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLN 252
Query: 241 PQNRLTWSALLEHPFVKE 258
P R T +++ ++
Sbjct: 253 PIKRGTLEQIMKDRWINA 270
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 4e-71
Identities = 86/275 (31%), Positives = 144/275 (52%), Gaps = 20/275 (7%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK------HGKSEKDIHNLRQEIEIL 57
+ Y + + +G G+ G+V + T + VA+K I K + N+ EIEIL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 58 RKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALH 116
+KL H II++ + F++ ++ +V E + GELF+ + +K L E + Q++ A+
Sbjct: 70 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 117 YLHSNRIIHRDMKPQNILIGA---GSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPEL 173
YLH N IIHRD+KP+N+L+ + ++K+ DFG ++ + + ++R++ GTP Y+APE+
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEV 187
Query: 174 VRE---QPYNHTADLWSLGVILYELFVGQPPFYTNSV-YALIRHIVKDPVKYP----DEM 225
+ YN D WSLGVIL+ G PPF + +L I + E+
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 247
Query: 226 SPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260
S +K LL P+ R T L HP++++
Sbjct: 248 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 5e-71
Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 19/271 (7%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KH 62
+ Y V E +G GS+ + K T A+K I +K + +EIEIL + +H
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRYGQH 75
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
NII + D ++ + VVTE + GEL + + K E + ++ + + + YLH+
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 122 RIIHRDMKPQNILI----GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQ 177
++HRD+KP NIL G +++CDFGFA+ + A +L + T ++APE++ Q
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ 195
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYTN---SVYALIRHIVKDPVKYP----DEMSPNFK 230
Y+ D+WSLGV+LY + G PF + ++ I + +S K
Sbjct: 196 GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAK 255
Query: 231 SFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261
+ +L+ P RLT + +L HP++
Sbjct: 256 DLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 1e-70
Identities = 87/272 (31%), Positives = 144/272 (52%), Gaps = 19/272 (6%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKH------GKSEKDIHNLRQEIEIL 57
+ Y +++G G V + + TG A+K + + E+ R+E IL
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 58 RKLK-HQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRAL 115
R++ H +II ++DS+ES +V + + GELF+ L + L E++ +SI + L+ A+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213
Query: 116 HYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVR 175
+LH+N I+HRD+KP+NIL+ ++L DFGF+ + LR + GTP Y+APE+++
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-KLRELCGTPGYLAPEILK 272
Query: 176 ------EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP----DEM 225
Y DLW+ GVIL+ L G PPF+ ++R I++ ++ D+
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR 332
Query: 226 SPNFKSFLKGLLNKVPQNRLTWSALLEHPFVK 257
S K + LL P+ RLT L+HPF +
Sbjct: 333 SSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 1e-70
Identities = 85/268 (31%), Positives = 129/268 (48%), Gaps = 16/268 (5%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK------HGKSEKDIHNLRQEIEI 56
+ Y + +G G+FG V+ K + V +KFI K + + + EI I
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 57 LRKLKHQNIIEMLDSFESPQEFCVVTEFAQ--GELFEILEDDKCLPEEQVQSIAKQLVRA 114
L +++H NII++LD FE+ F +V E +LF ++ L E I +QLV A
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142
Query: 115 LHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELV 174
+ YL IIHRD+K +NI+I +KL DFG A + + + GT Y APE++
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFCGTIEYCAPEVL 201
Query: 175 REQPYN-HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFL 233
PY ++WSLGV LY L + PF + V+ + P +S S +
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSKELMSLV 255
Query: 234 KGLLNKVPQNRLTWSALLEHPFVKETSD 261
GLL VP+ R T L+ P+V + +
Sbjct: 256 SGLLQPVPERRTTLEKLVTDPWVTQPVN 283
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 2e-70
Identities = 91/349 (26%), Positives = 159/349 (45%), Gaps = 16/349 (4%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRK 59
+ +++ ++ +G+GSFGKV ++ T + AMK++ K ++ N+ +E++I++
Sbjct: 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
L+H ++ + SF+ ++ +V + G+L L+ + EE V+ +LV AL YL
Sbjct: 72 LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYL 131
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQP 178
+ RIIHRDMKP NIL+ V + DF A + T + ++ GT YMAPE+ +
Sbjct: 132 QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-QITTMAGTKPYMAPEMFSSRK 190
Query: 179 ---YNHTADLWSLGVILYELFVGQPPFY---TNSVYALIRHIVKDPVKYPDEMSPNFKSF 232
Y+ D WSLGV YEL G+ P++ + S ++ V YP S S
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSL 250
Query: 233 LKGLLNKVPQNRL-TWSALLEHPFVKETS-DELNAWELRAT---SVEARGCNATWTAEGN 287
LK LL P R S + P++ + + D + L + C+ T+ E
Sbjct: 251 LKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCDPTFELEEM 310
Query: 288 AIQSSSGKSNSPAVSANNTSPSLHTDVELNSSNTSQSNSSPCEAFPGFS 336
++S + + + + S + F F+
Sbjct: 311 ILESKP--LHKKKKRLAKKEKDMRKCDSSQTCLLQEHLDSVQKEFIIFN 357
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 3e-70
Identities = 77/247 (31%), Positives = 126/247 (51%), Gaps = 5/247 (2%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEILRK 59
++ + I+ +G GSFG+V + K +G AMK + K K I + E IL+
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
+ ++++ SF+ +V E+ G E+F L E + A Q+V YL
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQP 178
HS +I+RD+KP+N+LI +++ DFGFA+ + T ++ GTP +APE++ +
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEIILSKG 214
Query: 179 YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLN 238
YN D W+LGV++YE+ G PPF+ + + IV V++P S + K L+ LL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ 274
Query: 239 KVPQNRL 245
R
Sbjct: 275 VDLTKRF 281
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 3e-70
Identities = 82/265 (30%), Positives = 142/265 (53%), Gaps = 10/265 (3%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRK 59
++++ ++ +G GSFG+V+ R ++ G+ AMK + K K + + E +L
Sbjct: 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
+ H II M +F+ Q+ ++ ++ +G ELF +L + P + A ++ AL YL
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQP 178
HS II+RD+KP+NIL+ +K+ DFGFA+ + T ++ GTP Y+APE+V +P
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTKP 179
Query: 179 YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLN 238
YN + D WS G+++YE+ G PFY ++ I+ +++P + + K L L+
Sbjct: 180 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 239
Query: 239 KVPQNRL-----TWSALLEHPFVKE 258
+ RL + HP+ KE
Sbjct: 240 RDLSQRLGNLQNGTEDVKNHPWFKE 264
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 1e-69
Identities = 78/287 (27%), Positives = 139/287 (48%), Gaps = 33/287 (11%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKH---------------------- 40
+ Y + + +G+GS+G V + AMK + K
Sbjct: 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 41 --GKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQE--FCVVTEFAQ-GELFEILED 95
+ I + QEI IL+KL H N++++++ + P E +V E G + E+
Sbjct: 72 GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL 131
Query: 96 DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN 155
L E+Q + + L++ + YLH +IIHRD+KP N+L+G +K+ DFG + +
Sbjct: 132 KP-LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 156 TVVLRSIKGTPLYMAPELVRE--QPYN-HTADLWSLGVILYELFVGQPPFYTNSVYALIR 212
+L + GTP +MAPE + E + ++ D+W++GV LY GQ PF + L
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS 250
Query: 213 HIVKDPVKYPD--EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVK 257
I +++PD +++ + K + +L+K P++R+ + HP+V
Sbjct: 251 KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 5e-69
Identities = 55/335 (16%), Positives = 105/335 (31%), Gaps = 47/335 (14%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLK------- 61
++G+ + + TG++ + + I +++E+ LR L+
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 62 ---HQNIIEMLDSFESPQ-----------------EFCVVTEFAQGELFEILE------- 94
H I D + PQ + Q L E
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 95 DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA 154
K L + Q++R L LH ++H ++P +I++ V L F A
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263
Query: 155 NTVVLR-SIKGTPLYMAPELVREQP-----YNHTADLWSLGVILYELFVGQPPFYTNSVY 208
+ V P A ++ D W+LG+ +Y ++ P ++
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323
Query: 209 ALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDELNAWEL 268
I + + ++ L+G L ++RL +E P ++ EL+A L
Sbjct: 324 GGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAA-L 378
Query: 269 RATSVEARGCNATWTAEGNAIQSSSGKSNSPAVSA 303
+ Q + AV+A
Sbjct: 379 PLYQTDGEPTREGGAPPSGTSQPDEA-GAAEAVTA 412
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 6e-69
Identities = 82/258 (31%), Positives = 142/258 (55%), Gaps = 3/258 (1%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLK 61
+ Y + E +GEGSFGKV T Q VA+KFI + K + +EI L+ L+
Sbjct: 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR 67
Query: 62 HQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
H +II++ D +P + +V E+A GELF+ + + K + E++ + +Q++ A+ Y H +
Sbjct: 68 HPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN- 180
+I+HRD+KP+N+L+ VK+ DFG + M+ L++ G+P Y APE++ + Y
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPEVINGKLYAG 186
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
D+WS G++LY + VG+ PF + L + + PD +SP +S ++ ++
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVAD 246
Query: 241 PQNRLTWSALLEHPFVKE 258
P R+T + P+
Sbjct: 247 PMQRITIQEIRRDPWFNV 264
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 1e-68
Identities = 77/280 (27%), Positives = 133/280 (47%), Gaps = 18/280 (6%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK----HGKSEKDIHNLRQEIEILRKL 60
Y V L+G G FG VY G R VA+K + K + + E+ +L+K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 61 KHQ--NIIEMLDSFESPQEFCVVTEFAQ--GELFEILEDDKCLPEEQVQSIAKQLVRALH 116
+I +LD FE P F ++ E + +LF+ + + L EE +S Q++ A+
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 163
Query: 117 YLHSNRIIHRDMKPQNILIGAGSV-VKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVR 175
+ H+ ++HRD+K +NILI +KL DFG + V GT +Y PE +R
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIR 221
Query: 176 EQPYN-HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLK 234
Y+ +A +WSLG++LY++ G PF + I++ V + +S + ++
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHLIR 275
Query: 235 GLLNKVPQNRLTWSALLEHPFVKETSDELNAWELRATSVE 274
L P +R T+ + HP++++ E+ S+
Sbjct: 276 WCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLS 315
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 1e-68
Identities = 80/259 (30%), Positives = 140/259 (54%), Gaps = 4/259 (1%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLK 61
+ +Y + + +G G+FGKV G + TG VA+K + + +S + +++EI+ L+ +
Sbjct: 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 62 HQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
H +II++ +P +F +V E+ GELF+ + + E + + + +Q++ A+ Y H
Sbjct: 70 HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
+ ++HRD+KP+N+L+ A K+ DFG + MS LR+ G+P Y APE++ + Y
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSCGSPNYAAPEVISGRLYA 188
Query: 181 -HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNK 239
D+WS GVILY L G PF V L + I P+ ++ + + L +L
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQV 248
Query: 240 VPQNRLTWSALLEHPFVKE 258
P R T + EH + K+
Sbjct: 249 DPLKRATIKDIREHEWFKQ 267
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 4e-68
Identities = 53/282 (18%), Positives = 104/282 (36%), Gaps = 32/282 (11%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKY-----TGQTVAMKFIMKHGKSEKDIHNLRQEIE 55
+G + +V L+GEG+F +VY+ + Q +K + + + Q +E
Sbjct: 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLME 119
Query: 56 ILRKLKHQNIIEMLDSFESPQEFCVVTEFA-QGELFEILE-----DDKCLPEEQVQSIAK 109
L+ ++ + +V E G L + +K +P+ V S A
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 110 QLVRALHYLHSNRIIHRDMKPQNILIGAGSV-----------VKLCDFGFARAMSA--NT 156
+++ + +H IIH D+KP N ++G G + + L D G + M
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 157 VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYA-LIRHIV 215
+ + T + E++ +P+N+ D + + +Y + G N +
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299
Query: 216 KDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVK 257
+ + P + F +LN + L LL K
Sbjct: 300 R---RLPH--LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 4e-68
Identities = 48/307 (15%), Positives = 98/307 (31%), Gaps = 54/307 (17%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLK-- 61
++G+ + + TG++ + + I +++E+ LR L+
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 62 -----------------------HQNIIEMLDSFESPQ--EFCVVTEFAQGELFEILED- 95
+ +I + + Q L E
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 96 ------DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFA 149
K L + Q++R L LH ++H ++P +I++ V L F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 150 RAMSANTVVLRSIKGTPLYMAPELV-----------REQPYNHTADLWSLGVILYELFVG 198
A V + + PEL R + D W+LG+++Y ++
Sbjct: 254 VRDGARVVSS----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 199 QPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258
P ++ I + + ++ L+G L ++RL +E P ++
Sbjct: 310 DLPITKDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365
Query: 259 TSDELNA 265
EL+A
Sbjct: 366 LRTELSA 372
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 4e-68
Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 12/267 (4%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKH--GKSEKDIHNLRQEIEILRKL 60
+ Y + +L+GEGS+GKV + T A+K + K + N+++EI++LR+L
Sbjct: 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 61 KHQNIIEMLD--SFESPQEFCVVTEFAQG---ELFEILEDDKCLPEEQVQSIAKQLVRAL 115
+H+N+I+++D E Q+ +V E+ E+ + + + + P Q QL+ L
Sbjct: 64 RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQLIDGL 122
Query: 116 HYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV--VLRSIKGTPLYMAPEL 173
YLHS I+H+D+KP N+L+ G +K+ G A A+ R+ +G+P + PE+
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 174 VR-EQPYN-HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKS 231
++ D+WS GV LY + G PF +++Y L +I K P + P
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSD 242
Query: 232 FLKGLLNKVPQNRLTWSALLEHPFVKE 258
LKG+L P R + + +H + ++
Sbjct: 243 LLKGMLEYEPAKRFSIRQIRQHSWFRK 269
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 4e-68
Identities = 67/262 (25%), Positives = 128/262 (48%), Gaps = 8/262 (3%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
VE++ +++ +GEG++G+V + T + VA+K + ++ N+++EI I + L H
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNH 64
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
+N+++ + E+ GELF+ +E D +PE Q QL+ + YLH
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV--VLRSIKGTPLYMAPELVREQPY 179
I HRD+KP+N+L+ +K+ DFG A N +L + GT Y+APEL++ + +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 180 N-HTADLWSLGVILYELFVGQPPFY-TNSVYALIRHIVKDPVKYPD--EMSPNFKSFLKG 235
+ D+WS G++L + G+ P+ + + ++ + L
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244
Query: 236 LLNKVPQNRLTWSALLEHPFVK 257
+L + P R+T + + +
Sbjct: 245 ILVENPSARITIPDIKKDRWYN 266
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 6e-68
Identities = 82/262 (31%), Positives = 131/262 (50%), Gaps = 12/262 (4%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEML 69
++G+G++G VY GR +A+K I + + + L +EI + + LKH+NI++ L
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPE--RDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 70 DSFESPQEFCVVTEF-AQGELFEILEDDK---CLPEEQVQSIAKQLVRALHYLHSNRIIH 125
SF + E G L +L E+ + KQ++ L YLH N+I+H
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 145
Query: 126 RDMKPQNILIGAGS-VVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQP--YNHT 182
RD+K N+LI S V+K+ DFG ++ ++ + GT YMAPE++ + P Y
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 205
Query: 183 ADLWSLGVILYELFVGQPPFYT-NSVYALIRHIV--KDPVKYPDEMSPNFKSFLKGLLNK 239
AD+WSLG + E+ G+PPFY A + + K + P+ MS K+F+
Sbjct: 206 ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEP 265
Query: 240 VPQNRLTWSALLEHPFVKETSD 261
P R + LL F+K +S
Sbjct: 266 DPDKRACANDLLVDEFLKVSSK 287
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 7e-68
Identities = 73/273 (26%), Positives = 128/273 (46%), Gaps = 20/273 (7%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK----HGKSEKDIHNLRQEIEILR 58
Y + L+G+G FG V+ G R VA+K I + D E+ +L
Sbjct: 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89
Query: 59 KL----KHQNIIEMLDSFESPQEFCVVTEFAQ--GELFEILEDDKCLPEEQVQSIAKQLV 112
K+ H +I +LD FE+ + F +V E +LF+ + + L E + Q+V
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149
Query: 113 RALHYLHSNRIIHRDMKPQNILIGAGS-VVKLCDFGFARAMSANTVVLRSIKGTPLYMAP 171
A+ + HS ++HRD+K +NILI KL DFG + GT +Y P
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRVYSPP 207
Query: 172 ELVREQPYN-HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFK 230
E + Y+ A +WSLG++LY++ G PF + I++ + +P +SP+
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAELHFPAHVSPDCC 261
Query: 231 SFLKGLLNKVPQNRLTWSALLEHPFVKETSDEL 263
+ ++ L P +R + +L P+++ ++++
Sbjct: 262 ALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV 294
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 9e-68
Identities = 80/266 (30%), Positives = 137/266 (51%), Gaps = 11/266 (4%)
Query: 1 MGVENYHVIELVGEGSFGKVY---KGRRKYTGQTVAMKFIMKHG--KSEKDIHNLRQEIE 55
+ E + ++ ++G+G +GKV+ K TG+ AMK + K ++ KD + + E
Sbjct: 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN 73
Query: 56 ILRKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRA 114
IL ++KH I++++ +F++ + ++ E+ GELF LE + E+ ++ A
Sbjct: 74 ILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA 133
Query: 115 LHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELV 174
L +LH II+RD+KP+NI++ VKL DFG + + V + GT YMAPE++
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEIL 193
Query: 175 REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLK 234
+N D WSLG ++Y++ G PPF + I I+K + P ++ + LK
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 253
Query: 235 GLLNKVPQNRL-----TWSALLEHPF 255
LL + +RL + HPF
Sbjct: 254 KLLKRNAASRLGAGPGDAGEVQAHPF 279
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 1e-67
Identities = 70/283 (24%), Positives = 132/283 (46%), Gaps = 26/283 (9%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
++Y + E++G G+ V + VA+K + K + + L +EI+ + + H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIK-RINLEKCQTSMDELLKEIQAMSQCHHP 73
Query: 64 NIIEMLDSFESPQEFCVVTEF-AQGELFEIL--------EDDKCLPEEQVQSIAKQLVRA 114
NI+ SF E +V + + G + +I+ L E + +I ++++
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 115 LHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK-----GTPLYM 169
L YLH N IHRD+K NIL+G V++ DFG + ++ + R+ GTP +M
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 170 APELV-REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP---------- 218
APE++ + + Y+ AD+WS G+ EL G P++ ++ +++
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQD 253
Query: 219 VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261
+ + +F+ + L K P+ R T + LL H F ++ +
Sbjct: 254 KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 1e-67
Identities = 90/282 (31%), Positives = 150/282 (53%), Gaps = 32/282 (11%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KH 62
+ ++ELVG G++G+VYKGR TGQ A+K + G E++I +QEI +L+K H
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEI---KQEINMLKKYSHH 80
Query: 63 QNIIEMLDSF------ESPQEFCVVTEF-AQGELFEILE--DDKCLPEEQVQSIAKQLVR 113
+NI +F + +V EF G + ++++ L EE + I ++++R
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140
Query: 114 ALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA-----NTVVLRSIKGTPLY 168
L +LH +++IHRD+K QN+L+ + VKL DFG + + NT + GTP +
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYW 195
Query: 169 MAPELVR-----EQPYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKD--PVK 220
MAPE++ + Y+ +DLWSLG+ E+ G PP + + AL I ++ P
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRL 254
Query: 221 YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDE 262
+ S F+SF++ L K R L++HPF+++ +E
Sbjct: 255 KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNE 296
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 2e-67
Identities = 82/262 (31%), Positives = 146/262 (55%), Gaps = 7/262 (2%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEILRK 59
+ + ++ ++L+G+G+FGKV R K TG+ AMK + K ++ ++ + E +L+
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
+H + + +F++ C V E+A G ELF L ++ EE+ + ++V AL YL
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQP 178
HS +++RD+K +N+++ +K+ DFG + ++ +++ GTP Y+APE++ +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 179 YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLN 238
Y D W LGV++YE+ G+ PFY L I+ + +++P +SP KS L GLL
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 239 KVPQNRL-----TWSALLEHPF 255
K P+ RL ++EH F
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRF 263
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 3e-67
Identities = 79/276 (28%), Positives = 132/276 (47%), Gaps = 19/276 (6%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KH 62
E+ + +G G++G V K K +GQ +A+K ++ EK+ L +++++ +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVK-RIRSTVDEKEQKQLLMDLDVVMRSSDC 80
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEILED-----DKCLPEEQVQSIAKQLVRALHY 117
I++ + + + E + + D +PEE + I V+AL++
Sbjct: 81 PYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 118 LHSNR-IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE---- 172
L N IIHRD+KP NIL+ +KLCDFG + + +++ G YMAPE
Sbjct: 141 LKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDP 199
Query: 173 LVREQPYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKDP-----VKYPDEMS 226
Q Y+ +D+WSLG+ LYEL G+ P+ NSV+ + +VK E S
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFS 259
Query: 227 PNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDE 262
P+F +F+ L K R + LL+HPF+ +
Sbjct: 260 PSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER 295
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 5e-67
Identities = 87/278 (31%), Positives = 146/278 (52%), Gaps = 29/278 (10%)
Query: 4 ENYHVI-ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-K 61
++Y + +++G G GKV + + TGQ A+K + D RQE++ +
Sbjct: 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-------YDSPKARQEVDHHWQASG 80
Query: 62 HQNIIEMLDSFESPQE----FCVVTEFAQ-GELFE-ILE-DDKCLPEEQVQSIAKQLVRA 114
+I+ +LD +E+ ++ E + GELF I E D+ E + I + + A
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 115 LHYLHSNRIIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAP 171
+ +LHS+ I HRD+KP+N+L +V+KL DFGFA+ + N L++ TP Y+AP
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN--ALQTPCYTPYYVAP 198
Query: 172 ELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS----VYALIRHIVKDPVKYP----D 223
E++ + Y+ + D+WSLGVI+Y L G PPFY+N+ + R I +P
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS 258
Query: 224 EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261
E+S + K ++ LL P RLT + + HP++ ++
Sbjct: 259 EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV 296
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 7e-67
Identities = 67/262 (25%), Positives = 128/262 (48%), Gaps = 8/262 (3%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
VE++ +++ +GEG++G+V + T + VA+K + ++ N+++EI I + L H
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNH 64
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
+N+++ + E+ GELF+ +E D +PE Q QL+ + YLH
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV--VLRSIKGTPLYMAPELVREQPY 179
I HRD+KP+N+L+ +K+ DFG A N +L + GT Y+APEL++ + +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 180 N-HTADLWSLGVILYELFVGQPPFY-TNSVYALIRHIVKDPVKYPD--EMSPNFKSFLKG 235
+ D+WS G++L + G+ P+ + + ++ + L
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244
Query: 236 LLNKVPQNRLTWSALLEHPFVK 257
+L + P R+T + + +
Sbjct: 245 ILVENPSARITIPDIKKDRWYN 266
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 7e-67
Identities = 71/276 (25%), Positives = 135/276 (48%), Gaps = 23/276 (8%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEI-LRKLKH 62
++ I +G G++G V K R +GQ +A+K ++ + ++ L +++I +R +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVK-RIRATVNSQEQKRLLMDLDISMRTVDC 65
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEIL----EDDKCLPEEQVQSIAKQLVRALHYL 118
+ + + + E L + + + +PE+ + IA +V+AL +L
Sbjct: 66 PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 119 HSN-RIIHRDMKPQNILIGAGSVVKLCDFGFA----RAMSANTVVLRSIKGTPLYMAPE- 172
HS +IHRD+KP N+LI A VK+CDFG + ++ + G YMAPE
Sbjct: 126 HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-----GCKPYMAPER 180
Query: 173 ---LVREQPYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKD--PVKYPDEMS 226
+ ++ Y+ +D+WSLG+ + EL + + P+ + + + ++ +V++ P D+ S
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS 240
Query: 227 PNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDE 262
F F L K + R T+ L++HPF +
Sbjct: 241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESK 276
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 8e-67
Identities = 81/264 (30%), Positives = 135/264 (51%), Gaps = 9/264 (3%)
Query: 1 MGVENYHVIELVGEGSFGKVY---KGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEIL 57
+ +++++G+GSFGKV+ K Q AMK + K +D + E +IL
Sbjct: 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 80
Query: 58 RKLKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALH 116
++ H I+++ +F++ + ++ +F + G+LF L + EE V+ +L AL
Sbjct: 81 VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVRE 176
+LHS II+RD+KP+NIL+ +KL DFG ++ + S GT YMAPE+V
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 177 QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGL 236
+ + +AD WS GV+++E+ G PF + I+K + P +SP +S L+ L
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRML 260
Query: 237 LNKVPQNRL-----TWSALLEHPF 255
+ P NRL + H F
Sbjct: 261 FKRNPANRLGAGPDGVEEIKRHSF 284
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 1e-66
Identities = 78/284 (27%), Positives = 128/284 (45%), Gaps = 38/284 (13%)
Query: 10 ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-HQNIIEM 68
+++GEG+ +V T Q A+K I K + + +E+E+L + + H+N++E+
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 69 LDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRD 127
++ FE F +V E + G + + + E + + + + AL +LH+ I HRD
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 128 MKPQNILI---GAGSVVKLCDFGFARAMSAN-------TVVLRSIKGTPLYMAPELVR-- 175
+KP+NIL S VK+CDF + N T L + G+ YMAPE+V
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 176 ---EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEM------- 225
Y+ DLWSLGVILY L G PPF + + +
Sbjct: 197 SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG 256
Query: 226 ------------SPNFKSFLKGLLNKVPQNRLTWSALLEHPFVK 257
S K + LL + + RL+ + +L+HP+V+
Sbjct: 257 KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-66
Identities = 76/259 (29%), Positives = 127/259 (49%), Gaps = 4/259 (1%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEIL-R 58
+ +E++ + +++G+GSFGKV+ K T Q A+K + K + D+ E +L
Sbjct: 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 59 KLKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
+H + M +F++ + V E+ G+L ++ + A +++ L +
Sbjct: 74 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 133
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQ 177
LHS I++RD+K NIL+ +K+ DFG + + GTP Y+APE++ Q
Sbjct: 134 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 193
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLL 237
YNH+ D WS GV+LYE+ +GQ PF+ L I D YP + K L L
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 253
Query: 238 NKVPQNRL-TWSALLEHPF 255
+ P+ RL + +HP
Sbjct: 254 VREPEKRLGVRGDIRQHPL 272
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 2e-66
Identities = 85/279 (30%), Positives = 147/279 (52%), Gaps = 28/279 (10%)
Query: 3 VENYHVI-ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL- 60
+++Y V +++G G GKV + K T + A+K + +D R+E+E+ +
Sbjct: 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRAS 112
Query: 61 KHQNIIEMLDSFE----SPQEFCVVTEFAQG-ELFE-ILE-DDKCLPEEQVQSIAKQLVR 113
+ +I+ ++D +E + +V E G ELF I + D+ E + I K +
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 114 ALHYLHSNRIIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMA 170
A+ YLHS I HRD+KP+N+L +++KL DFGFA+ +++ L + TP Y+A
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVA 231
Query: 171 PELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYA----LIRHIVKDPVKYP---- 222
PE++ + Y+ + D+WSLGVI+Y L G PPFY+N A + I ++P
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291
Query: 223 DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261
E+S K ++ LL P R+T + + HP++ +++
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 3e-66
Identities = 81/262 (30%), Positives = 143/262 (54%), Gaps = 7/262 (2%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEIL-R 58
++H ++++G+GSFGKV R K A+K + K +K+ ++ E +L +
Sbjct: 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 59 KLKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
+KH ++ + SF++ + V ++ G ELF L+ ++C E + + A ++ AL Y
Sbjct: 95 NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGY 154
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQ 177
LHS I++RD+KP+NIL+ + + L DFG + + + GTP Y+APE++ +Q
Sbjct: 155 LHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ 214
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLL 237
PY+ T D W LG +LYE+ G PPFY+ + + +I+ P++ ++ + + L+GLL
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLL 274
Query: 238 NKVPQNRL----TWSALLEHPF 255
K RL + + H F
Sbjct: 275 QKDRTKRLGAKDDFMEIKSHVF 296
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 7e-66
Identities = 80/278 (28%), Positives = 148/278 (53%), Gaps = 9/278 (3%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEILRK 59
+ + + ++L+G+G+FGKV + K TG+ AMK + K ++ ++ + E +L+
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
+H + + SF++ C V E+A G ELF L ++ E++ + ++V AL YL
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 264
Query: 119 HSNR-IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQ 177
HS + +++RD+K +N+++ +K+ DFG + + +++ GTP Y+APE++ +
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 324
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLL 237
Y D W LGV++YE+ G+ PFY L I+ + +++P + P KS L GLL
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 384
Query: 238 NKVPQNRLTWSA-----LLEHPFVKETS-DELNAWELR 269
K P+ RL + +++H F + +L
Sbjct: 385 KKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLS 422
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 8e-66
Identities = 85/264 (32%), Positives = 131/264 (49%), Gaps = 9/264 (3%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEILRK 59
+G++N+ I ++G+GSFGKV R K TG A+K + K + D+ E IL
Sbjct: 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 60 -LKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
H + ++ F++P V EF G +L ++ + E + + A +++ AL +
Sbjct: 80 ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQ 177
LH II+RD+K N+L+ KL DFG + N V + GTP Y+APE+++E
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLL 237
Y D W++GV+LYE+ G PF + L I+ D V YP + + LK +
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFM 259
Query: 238 NKVPQNRL------TWSALLEHPF 255
K P RL A+L HPF
Sbjct: 260 TKNPTMRLGSLTQGGEHAILRHPF 283
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 2e-65
Identities = 70/271 (25%), Positives = 132/271 (48%), Gaps = 14/271 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KH 62
+ + +G G+ G+V+K R + TG +A+K M+ ++++ + +++++ K
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK-QMRRSGNKEENKRILMDLDVVLKSHDC 83
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGELFEI-LEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
I++ +F + + + E ++ +PE + + +V+AL+YL
Sbjct: 84 PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 122 R-IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE-----LVR 175
+IHRD+KP NIL+ +KLCDFG + + + G YMAPE
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 176 EQPYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVKDP---VKYPDEMSPNFKS 231
+ Y+ AD+WSLG+ L EL GQ P+ + + ++ ++++ + S +F+S
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQS 262
Query: 232 FLKGLLNKVPQNRLTWSALLEHPFVKETSDE 262
F+K L K + R ++ LLEH F+K
Sbjct: 263 FVKDCLTKDHRKRPKYNKLLEHSFIKRYETL 293
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 2e-65
Identities = 67/297 (22%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-HQN 64
+++G GS G V + + G+ VA+K ++ EI++L + H N
Sbjct: 17 VVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLI-----DFCDIALMEIKLLTESDDHPN 70
Query: 65 IIEMLDSFESPQEFCVVTEFAQGELFEIL-------EDDKCLPEEQVQSIAKQLVRALHY 117
+I S + + + E L +++ E+ K E S+ +Q+ + +
Sbjct: 71 VIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 118 LHSNRIIHRDMKPQNILI-------------GAGSVVKLCDFGFARAM----SANTVVLR 160
LHS +IIHRD+KPQNIL+ + + DFG + + S+ L
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 161 SIKGTPLYMAPELVRE-------QPYNHTADLWSLGVILYE-LFVGQPPFY-TNSVYALI 211
+ GT + APEL+ E + + D++S+G + Y L G+ PF S + I
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 212 RHIVKD----PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDELN 264
+ + + + +++ P R T +L HP S +L
Sbjct: 251 IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLE 307
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 4e-65
Identities = 82/273 (30%), Positives = 135/273 (49%), Gaps = 15/273 (5%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEILRK 59
MG + + ++G G FG+V+ + K TG+ A K + K K K E +IL K
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQ-GELF----EILEDDKCLPEEQVQSIAKQLVRA 114
+ + I+ + +FE+ + C+V G++ + ED+ E + Q+V
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 115 LHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELV 174
L +LH II+RD+KP+N+L+ V++ D G A + A + GTP +MAPEL+
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 175 REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYA----LIRHIVKDPVKYPDEMSPNFK 230
+ Y+ + D ++LGV LYE+ + PF L + +++ V YPD+ SP K
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421
Query: 231 SFLKGLLNKVPQNRL-----TWSALLEHPFVKE 258
F + LL K P+ RL + L HP ++
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 4e-65
Identities = 77/308 (25%), Positives = 135/308 (43%), Gaps = 55/308 (17%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+++ I +G G+ G V+K K +G +A K I K + + +E+++L +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSP 91
Query: 64 NIIEMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
I+ +F S E + E G L ++L+ +PE+ + ++ +++ L YL
Sbjct: 92 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 123 -IIHRDMKPQNILIGAGSVVKLCDFGFARAMS---ANTVVLRSIKGTPLYMAPELVREQP 178
I+HRD+KP NIL+ + +KLCDFG + + AN+ V GT YM+PE ++
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGTH 206
Query: 179 YNHTADLWSLGVILYELFVGQPPFYTN--------------------------------- 205
Y+ +D+WS+G+ L E+ VG+ P
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266
Query: 206 ---------SVYALIRHIVKD--PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHP 254
+++ L+ +IV + P S F+ F+ L K P R L+ H
Sbjct: 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326
Query: 255 FVKETSDE 262
F+K + E
Sbjct: 327 FIKRSDAE 334
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 6e-65
Identities = 77/263 (29%), Positives = 128/263 (48%), Gaps = 8/263 (3%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEIL-R 58
M + +++ + ++G+GSFGKV RK T + A+K + K + D+ E +L
Sbjct: 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 59 KLKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
K + ++ F++ V E+ G +L ++ E A ++ L +
Sbjct: 77 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 136
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQ 177
L S II+RD+K N+++ + +K+ DFG + + V ++ GTP Y+APE++ Q
Sbjct: 137 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 196
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLL 237
PY + D W+ GV+LYE+ GQ PF L + I++ V YP MS + KGL+
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM 256
Query: 238 NKVPQNRL-----TWSALLEHPF 255
K P RL + EH F
Sbjct: 257 TKHPGKRLGCGPEGERDIKEHAF 279
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 9e-65
Identities = 83/259 (32%), Positives = 143/259 (55%), Gaps = 4/259 (1%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLK 61
+ +Y + + +G G+FGKV G+ + TG VA+K + + +S + +R+EI+ L+ +
Sbjct: 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 62 HQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
H +II++ +P + +V E+ GELF+ + + L E++ + + +Q++ + Y H
Sbjct: 75 HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR 134
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
+ ++HRD+KP+N+L+ A K+ DFG + MS LR+ G+P Y APE++ + Y
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSCGSPNYAAPEVISGRLYA 193
Query: 181 -HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNK 239
D+WS GVILY L G PF + V L + I P ++P+ S LK +L
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQV 253
Query: 240 VPQNRLTWSALLEHPFVKE 258
P R T + EH + K+
Sbjct: 254 DPMKRATIKDIREHEWFKQ 272
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 2e-64
Identities = 77/273 (28%), Positives = 141/273 (51%), Gaps = 18/273 (6%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEILRK 59
+G++++ ++ ++G GS+ KV R K T + AMK + K ++DI ++ E + +
Sbjct: 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 60 -LKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
H ++ + F++ V E+ G+L ++ + LPEE + + ++ AL+Y
Sbjct: 66 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQ 177
LH II+RD+K N+L+ + +KL D+G + + GTP Y+APE++R +
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 185
Query: 178 PYNHTADLWSLGVILYELFVGQPPF---------YTNSVYALIRHIVKDPVKYPDEMSPN 228
Y + D W+LGV+++E+ G+ PF N+ L + I++ ++ P +S
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 245
Query: 229 FKSFLKGLLNKVPQNRL------TWSALLEHPF 255
S LK LNK P+ RL ++ + HPF
Sbjct: 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 7e-64
Identities = 71/248 (28%), Positives = 137/248 (55%), Gaps = 14/248 (5%)
Query: 7 HVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
++ E +G GSFG V++ ++ G VA+K +M+ + ++ +E+ I+++L+H NI+
Sbjct: 40 NIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 67 EMLDSFESPQEFCVVTEFA-QGELFEIL---EDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
+ + P +VTE+ +G L+ +L + L E + S+A + + ++YLH+
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 123 --IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
I+HR++K N+L+ VK+CDFG +R ++ + +S GTP +MAPE++R++P N
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD----PVKYPDEMSPNFKSFLKGL 236
+D++S GVIL+EL Q P+ + ++ + + P ++P + ++G
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI--PRNLNPQVAAIIEGC 275
Query: 237 LNKVPQNR 244
P R
Sbjct: 276 WTNEPWKR 283
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 1e-63
Identities = 74/268 (27%), Positives = 125/268 (46%), Gaps = 14/268 (5%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEILRK 59
+ + ++G+G FG+V + + TG+ A K + K K K E +IL K
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEIL--EDDKCLPEEQVQSIAKQLVRALH 116
+ + ++ + ++E+ C+V G+L + PE + A ++ L
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVRE 176
LH RI++RD+KP+NIL+ +++ D G A + + + GT YMAPE+V+
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI-KGRVGTVGYMAPEVVKN 359
Query: 177 QPYNHTADLWSLGVILYELFVGQPPFYTNSVYA----LIRHIVKDPVKYPDEMSPNFKSF 232
+ Y + D W+LG +LYE+ GQ PF + R + + P +Y + SP +S
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSL 419
Query: 233 LKGLLNKVPQNRL-----TWSALLEHPF 255
LL K P RL + + EHP
Sbjct: 420 CSQLLCKDPAERLGCRGGSAREVKEHPL 447
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 2e-63
Identities = 76/273 (27%), Positives = 141/273 (51%), Gaps = 18/273 (6%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEILRK 59
+G++++ ++ ++G GS+ KV R K T + AM+ + K ++DI ++ E + +
Sbjct: 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 60 -LKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
H ++ + F++ V E+ G+L ++ + LPEE + + ++ AL+Y
Sbjct: 109 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQ 177
LH II+RD+K N+L+ + +KL D+G + + GTP Y+APE++R +
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 228
Query: 178 PYNHTADLWSLGVILYELFVGQPPF---------YTNSVYALIRHIVKDPVKYPDEMSPN 228
Y + D W+LGV+++E+ G+ PF N+ L + I++ ++ P +S
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 288
Query: 229 FKSFLKGLLNKVPQNRL------TWSALLEHPF 255
S LK LNK P+ RL ++ + HPF
Sbjct: 289 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 3e-63
Identities = 76/265 (28%), Positives = 132/265 (49%), Gaps = 14/265 (5%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
+ Y ++ +G G+FG R K T + VA+K+I + N+++EI R L+H
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYI---ERGAAIDENVQREIINHRSLRH 75
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
NI+ + +P ++ E+A GEL+E + + E++ + +QL+ + Y HS
Sbjct: 76 PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM 135
Query: 122 RIIHRDMKPQNILIGAGSV--VKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
+I HRD+K +N L+ +K+CDFG++++ ++ +S GTP Y+APE++ Q Y
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRQEY 194
Query: 180 N-HTADLWSLGVILYELFVGQPPFYTNSVYALIR----HIVKDPVKYPDE--MSPNFKSF 232
+ AD+WS GV LY + VG PF R I+ PD+ +SP
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254
Query: 233 LKGLLNKVPQNRLTWSALLEHPFVK 257
+ + P R++ + H +
Sbjct: 255 ISRIFVADPATRISIPEIKTHSWFL 279
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 2e-62
Identities = 82/285 (28%), Positives = 141/285 (49%), Gaps = 17/285 (5%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEILRK 59
M E+Y V++++G G+FG+V R K T + AMK + K D +E +I+
Sbjct: 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
++++ +F+ + +V E+ G +L ++ + +PE+ + ++V AL +
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAI 184
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL-RSIKGTPLYMAPELVREQ 177
HS IHRD+KP N+L+ +KL DFG M+ +V + GTP Y++PE+++ Q
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244
Query: 178 P----YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIV--KDPVKYPD--EMSPNF 229
Y D WS+GV LYE+ VG PFY +S+ I+ K+ + +PD ++S
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304
Query: 230 KSFLKGLLNKVPQNRLTWSALLE---HPFVKETS-DELNAWELRA 270
K+ + L + RL + + E H F K + A
Sbjct: 305 KNLICAFLTD-REVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVA 348
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 3e-62
Identities = 92/293 (31%), Positives = 137/293 (46%), Gaps = 47/293 (16%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMK-FIMKHGKSEKDIHNLRQEIEILRKLK 61
+E Y I +GEGS+G V+K R + TGQ VA+K F+ LR EI +L++LK
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLK 60
Query: 62 HQNIIEMLDSFESPQEFCVVTEFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHS 120
H N++ +L+ F + +V E+ + L+ + +PE V+SI Q ++A+++ H
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA------NTVVLRSIKGTPLYMAPE-L 173
+ IHRD+KP+NILI SV+KLCDFGFAR ++ + V T Y +PE L
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA------TRWYRSPELL 174
Query: 174 VREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK-----------DPVKYP 222
V + Y D+W++G + EL G P + S + I K
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234
Query: 223 D--------------------EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPF 255
+S LKG L+ P RLT LL HP+
Sbjct: 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 4e-62
Identities = 74/274 (27%), Positives = 130/274 (47%), Gaps = 20/274 (7%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEILRK 59
+ +++ +++++G G+F +V + K TGQ AMK + K ++ R+E ++L
Sbjct: 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILE-DDKCLPEEQVQSIAKQLVRALHY 117
+ I ++ +F+ +V E+ G +L +L + +P E + ++V A+
Sbjct: 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN-TVVLRSIKGTPLYMAPELVRE 176
+H +HRD+KP NIL+ ++L DFG + A+ TV GTP Y++PE+++
Sbjct: 178 VHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 177 Q-------PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVK-----YPDE 224
Y D W+LGV YE+F GQ PFY +S IV +
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG 297
Query: 225 MSPNFKSFLKGLLNKVPQNRLTWSALLE---HPF 255
+ + F++ LL P+ RL + HPF
Sbjct: 298 VPEEARDFIQRLLCP-PETRLGRGGAGDFRTHPF 330
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 6e-62
Identities = 88/274 (32%), Positives = 141/274 (51%), Gaps = 19/274 (6%)
Query: 1 MGVENYHVIELVGEGSFGKVY---KGRRKYTGQTVAMKFIMKHG--KSEKDIHNLRQEIE 55
+G+EN+ +++++G G++GKV+ K TG+ AMK + K + K + R E +
Sbjct: 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 110
Query: 56 ILRKLKHQN-IIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVR 113
+L ++ ++ + +F++ + ++ ++ GELF L + E +VQ ++V
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 170
Query: 114 ALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFA-RAMSANTVVLRSIKGTPLYMAPE 172
AL +LH II+RD+K +NIL+ + V L DFG + ++ T GT YMAP+
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
Query: 173 LVREQPYNHT--ADLWSLGVILYELFVGQPPFYT----NSVYALIRHIVKDPVKYPDEMS 226
+VR H D WSLGV++YEL G PF NS + R I+K YP EMS
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 290
Query: 227 PNFKSFLKGLLNKVPQNRL-----TWSALLEHPF 255
K ++ LL K P+ RL + EH F
Sbjct: 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 1e-61
Identities = 74/272 (27%), Positives = 135/272 (49%), Gaps = 18/272 (6%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEILRK 59
+ E++ +++++G G+FG+V + K + AMK + K + R+E ++L
Sbjct: 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN 130
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILE-DDKCLPEEQVQSIAKQLVRALHY 117
+ I + +F+ +V ++ G +L +L + LPEE + ++V A+
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFA-RAMSANTVVLRSIKGTPLYMAPELVRE 176
+H +HRD+KP NIL+ ++L DFG + M TV GTP Y++PE+++
Sbjct: 191 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 177 QP-----YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIV--KDPVKYP---DEMS 226
Y D WSLGV +YE+ G+ PFY S+ I+ K+ ++P ++S
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS 310
Query: 227 PNFKSFLKGLLNKVPQNRLTWSALLE---HPF 255
N K ++ L+ ++RL + + + HPF
Sbjct: 311 ENAKDLIRRLICS-REHRLGQNGIEDFKKHPF 341
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-61
Identities = 77/263 (29%), Positives = 128/263 (48%), Gaps = 8/263 (3%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEIL-R 58
M + +++ + ++G+GSFGKV RK T + A+K + K + D+ E +L
Sbjct: 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 59 KLKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
K + ++ F++ V E+ G +L ++ E A ++ L +
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQ 177
L S II+RD+K N+++ + +K+ DFG + + V ++ GTP Y+APE++ Q
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 517
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLL 237
PY + D W+ GV+LYE+ GQ PF L + I++ V YP MS + KGL+
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM 577
Query: 238 NKVPQNRL-----TWSALLEHPF 255
K P RL + EH F
Sbjct: 578 TKHPGKRLGCGPEGERDIKEHAF 600
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 2e-61
Identities = 91/293 (31%), Positives = 144/293 (49%), Gaps = 47/293 (16%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMK-FIMKHGKSEKDIHNLRQEIEILRKLK 61
+E Y + LVGEGS+G V K R K TG+ VA+K F+ +R EI++L++L+
Sbjct: 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLR 82
Query: 62 HQNIIEMLDSFESPQEFCVVTEFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHS 120
H+N++ +L+ + + + +V EF + + LE L + VQ Q++ + + HS
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA------NTVVLRSIKGTPLYMAPE-L 173
+ IIHRD+KP+NIL+ VVKLCDFGFAR ++A + V T Y APE L
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA------TRWYRAPELL 196
Query: 174 VREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK----------------- 216
V + Y D+W++G ++ E+F+G+P F +S + HI+
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256
Query: 217 --DPVKYPD------------EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPF 255
V+ P+ ++S K L+ P R + LL H F
Sbjct: 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-60
Identities = 75/272 (27%), Positives = 131/272 (48%), Gaps = 16/272 (5%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEILRK 59
+ + ++ V ++G G FG+VY R+ TG+ AMK + K K ++ E +L
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 60 LKHQN---IIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRAL 115
+ + I+ M +F +P + + + G+L L E ++ A +++ L
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 116 HYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELV- 174
++H+ +++RD+KP NIL+ V++ D G A S + GT YMAPE++
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQ 363
Query: 175 REQPYNHTADLWSLGVILYELFVGQPPFY---TNSVYALIRHIVKDPVKYPDEMSPNFKS 231
+ Y+ +AD +SLG +L++L G PF T + + R + V+ PD SP +S
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 423
Query: 232 FLKGLLNKVPQNRL-----TWSALLEHPFVKE 258
L+GLL + RL + E PF +
Sbjct: 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 5e-60
Identities = 72/254 (28%), Positives = 125/254 (49%), Gaps = 26/254 (10%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ V E+VG G+FG V K K+ + VA+K I +SE + E+ L ++ H
Sbjct: 8 KEIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQI----ESESERKAFIVELRQLSRVNHP 61
Query: 64 NIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDK---CLPEEQVQSIAKQLVRALHYLH 119
NI+++ + +P C+V E+A+ G L+ +L + S Q + + YLH
Sbjct: 62 NIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 120 S---NRIIHRDMKPQNILIGA-GSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVR 175
S +IHRD+KP N+L+ A G+V+K+CDFG A + + + KG+ +MAPE+
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT---NNKGSAAWMAPEVFE 176
Query: 176 EQPYNHTADLWSLGVILYELFVGQPPF--YTNSVYALIRHIVKD---PVKYPDEMSPNFK 230
Y+ D++S G+IL+E+ + PF + ++ + P+ + +
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL--IKNLPKPIE 234
Query: 231 SFLKGLLNKVPQNR 244
S + +K P R
Sbjct: 235 SLMTRCWSKDPSQR 248
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-59
Identities = 66/314 (21%), Positives = 120/314 (38%), Gaps = 60/314 (19%)
Query: 4 ENYHVIELVGEG--SFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK 61
Y ++ ++G+G V R K TG+ V ++ I S + + L+ E+ + +
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 62 HQNIIEMLDSFESPQEFCVVTEF-AQGELFEILED--DKCLPEEQVQSIAKQLVRALHYL 118
H NI+ +F + E VVT F A G +++ + E + I + +++AL Y+
Sbjct: 85 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI 144
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK-------GTPLYMAP 171
H +HR +K +ILI V L +M ++ R + +++P
Sbjct: 145 HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 172 ELVRE--QPYNHTADLWSLGVILYELFVGQPPFY-------------------------- 203
E++++ Q Y+ +D++S+G+ EL G PF
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264
Query: 204 --------------------TNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVPQN 243
+ + Y SP+F F++ L + P
Sbjct: 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDA 324
Query: 244 RLTWSALLEHPFVK 257
R + S LL H F K
Sbjct: 325 RPSASTLLNHSFFK 338
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 2e-59
Identities = 79/279 (28%), Positives = 133/279 (47%), Gaps = 49/279 (17%)
Query: 3 VENYHVI-ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL- 60
+++Y V +++G G GKV + K T + A+K + +D R+E+E+ +
Sbjct: 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRAS 68
Query: 61 KHQNIIEMLDSFE----SPQEFCVVTEFAQ-GELFE-ILE-DDKCLPEEQVQSIAKQLVR 113
+ +I+ ++D +E + +V E GELF I + D+ E + I K +
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 114 ALHYLHSNRIIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMA 170
A+ YLHS I HRD+KP+N+L +++KL DFGF A
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------A 167
Query: 171 PELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYA----LIRHIVKDPVKYP---- 222
E + Y+ + D+WSLGVI+Y L G PPFY+N A + I ++P
Sbjct: 168 KE-TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226
Query: 223 DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261
E+S K ++ LL P R+T + + HP++ +++
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 4e-58
Identities = 67/265 (25%), Positives = 126/265 (47%), Gaps = 22/265 (8%)
Query: 7 HVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
+ EL+G+G FG+VY G ++ G VA++ I +E + ++E+ R+ +H+N++
Sbjct: 36 EIGELIGKGRFGQVYHG--RWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 67 EMLDSFESPQEFCVVTEFAQ-GELFEILEDDKC-LPEEQVQSIAKQLVRALHYLHSNRII 124
+ + SP ++T + L+ ++ D K L + + IA+++V+ + YLH+ I+
Sbjct: 93 LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGIL 152
Query: 125 HRDMKPQNILIGAGSVVKLCDFGFARAM-----SANTVVLRSIKGTPLYMAPELVR---- 175
H+D+K +N+ G V + DFG LR G ++APE++R
Sbjct: 153 HKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 176 -----EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD--PVKYPDEMSPN 228
+ P++ +D+++LG I YEL + PF T A+I + P M
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKE 271
Query: 229 FKSFLKGLLNKVPQNRLTWSALLEH 253
L + R T++ L++
Sbjct: 272 ISDILLFCWAFEQEERPTFTKLMDM 296
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 5e-58
Identities = 81/265 (30%), Positives = 131/265 (49%), Gaps = 25/265 (9%)
Query: 7 HVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE--KDIHNLRQEIEILRKLKHQN 64
+ E++G G FGKVY+ + G VA+K + + I N+RQE ++ LKH N
Sbjct: 10 TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 65 IIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR- 122
II + C+V EFA+ G L +L + +P + + + A Q+ R ++YLH
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAI 126
Query: 123 --IIHRDMKPQNILIG--------AGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE 172
IIHRD+K NILI + ++K+ DFG AR T S G +MAPE
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGAYAWMAPE 184
Query: 173 LVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD----PVKYPDEMSPN 228
++R ++ +D+WS GV+L+EL G+ PF A+ + + P+ P
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI--PSTCPEP 242
Query: 229 FKSFLKGLLNKVPQNRLTWSALLEH 253
F ++ N P +R +++ +L+
Sbjct: 243 FAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-56
Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 18/213 (8%)
Query: 7 HVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
E++G+G FG+ K + TG+ + MK +++ E+ +E++++R L+H N++
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVL 70
Query: 67 EMLDSFESPQEFCVVTEF-AQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRII 124
+ + + +TE+ G L I++ D P Q S AK + + YLHS II
Sbjct: 71 KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNII 130
Query: 125 HRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR--------------SIKGTPLYMA 170
HRD+ N L+ V + DFG AR M ++ G P +MA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 171 PELVREQPYNHTADLWSLGVILYELFVGQPPFY 203
PE++ + Y+ D++S G++L E+
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP 223
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 3e-56
Identities = 49/252 (19%), Positives = 110/252 (43%), Gaps = 23/252 (9%)
Query: 7 HVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
+ + + E G+++KG ++ G + +K + S + + +E LR H N++
Sbjct: 13 NFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 67 EMLDSFESP--QEFCVVTEFAQ-GELFEILEDDKC--LPEEQVQSIAKQLVRALHYLHS- 120
+L + +SP ++T + G L+ +L + + + Q A + R + +LH+
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 121 -NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
I + ++++I ++ + + + P ++APE ++++P
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM-----YAPAWVAPEALQKKPE 185
Query: 180 NHT---ADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD----PVKYPDEMSPNFKSF 232
+ AD+WS V+L+EL + PF S + + + + P +SP+
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI--PPGISPHVSKL 243
Query: 233 LKGLLNKVPQNR 244
+K +N+ P R
Sbjct: 244 MKICMNEDPAKR 255
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 6e-56
Identities = 78/260 (30%), Positives = 131/260 (50%), Gaps = 17/260 (6%)
Query: 7 HVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
V + +G GSFG VYKG K+ G VA+K + + + + + E+ +LRK +H NI+
Sbjct: 27 TVGQRIGSGSFGTVYKG--KWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 67 EMLDSFESPQEFCVVTEF-AQGELFEILEDDKC-LPEEQVQSIAKQLVRALHYLHSNRII 124
+ +PQ +VT++ L+ L + +++ IA+Q R + YLH+ II
Sbjct: 84 LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSII 142
Query: 125 HRDMKPQNILIGAGSVVKLCDFGFARAMS--ANTVVLRSIKGTPLYMAPELVREQ---PY 179
HRD+K NI + + VK+ DFG A S + + + G+ L+MAPE++R Q PY
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 180 NHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVK-----DPVKYPDEMSPNFKSFL 233
+ +D+++ G++LYEL GQ P+ N+ +I + + D K K +
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLM 262
Query: 234 KGLLNKVPQNRLTWSALLEH 253
L K R ++ +L
Sbjct: 263 AECLKKKRDERPSFPRILAE 282
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 2e-55
Identities = 87/296 (29%), Positives = 140/296 (47%), Gaps = 47/296 (15%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFI-MKHGKSEKD---IHNLRQEIEILR 58
+ Y ++ +GEG F VYK R K T Q VA+K I + H KD LR EI++L+
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQ 67
Query: 59 KLKHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKC-LPEEQVQSIAKQLVRALHY 117
+L H NII +LD+F +V +F + +L I++D+ L +++ ++ L Y
Sbjct: 68 ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA------NTVVLRSIKGTPLYMAP 171
LH + I+HRD+KP N+L+ V+KL DFG A++ + + VV T Y AP
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV------TRWYRAP 181
Query: 172 E-LVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK-----DPVKYPDEM 225
E L + Y D+W++G IL EL + P +S + I + ++PD
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241
Query: 226 S-PNFKSF----------------------LKGLLNKVPQNRLTWSALLEHPFVKE 258
S P++ +F ++GL P R+T + L+ +
Sbjct: 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-55
Identities = 84/297 (28%), Positives = 140/297 (47%), Gaps = 50/297 (16%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD---IHNLRQEIEILRK 59
++ Y +E +GEG++G V+K + + T + VA+K + + + LR EI +L++
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV--RLDDDDEGVPSSALR-EICLLKE 57
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKC-LPEEQVQSIAKQLVRALHYL 118
LKH+NI+ + D S ++ +V EF +L + + L E V+S QL++ L +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA------NTVVLRSIKGTPLYMAPE 172
HS ++HRD+KPQN+LI +KL +FG ARA VV T Y P+
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV------TLWYRPPD 171
Query: 173 -LVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVK-----DPVKYPDEM 225
L + Y+ + D+WS G I EL G+P F N V ++ I + ++P
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231
Query: 226 S-PNFKSF-----------------------LKGLLNKVPQNRLTWSALLEHPFVKE 258
P++K + L+ LL P R++ L+HP+ +
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 3e-55
Identities = 58/259 (22%), Positives = 110/259 (42%), Gaps = 29/259 (11%)
Query: 8 VIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD-----IHNLRQEIEILRKLKH 62
+ +G+G FG V+KGR VA+K ++ + ++E+ I+ L H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHS 120
NI+++ +V EF G+L+ L D + + + + Y+ +
Sbjct: 83 PNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 121 NR--IIHRDMKPQNILIGAGS-----VVKLCDFGFARAMSANTVVLRSIKGTPLYMAPEL 173
I+HRD++ NI + + K+ DFG ++ + + G +MAPE
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV---SGLLGNFQWMAPET 197
Query: 174 --VREQPYNHTADLWSLGVILYELFVGQPPF--YTNSVYALIRHIVKD----PVKYPDEM 225
E+ Y AD +S +ILY + G+ PF Y+ I I ++ + P++
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI--PEDC 255
Query: 226 SPNFKSFLKGLLNKVPQNR 244
P ++ ++ + P+ R
Sbjct: 256 PPRLRNVIELCWSGDPKKR 274
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 5e-55
Identities = 85/297 (28%), Positives = 144/297 (48%), Gaps = 51/297 (17%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD---IHNLRQEIEILRK 59
+E Y +E VGEG++G VYK + G+ VA+K I +E + +R EI +L++
Sbjct: 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI--RLDAEDEGIPSTAIR-EISLLKE 75
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKC-LPEEQVQSIAKQLVRALHYL 118
L H NI+ ++D S + +V EF + +L ++L+++K L + Q++ QL+R + +
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA------NTVVLRSIKGTPLYMAPE 172
H +RI+HRD+KPQN+LI + +KL DFG ARA + VV T Y AP+
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV------TLWYRAPD 189
Query: 173 -LVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK--------------- 216
L+ + Y+ + D+WS+G I E+ G+P F + + I
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249
Query: 217 ----DPVKYPDEMSPNFKSFLKG-------LLNKV----PQNRLTWSALLEHPFVKE 258
+ + S + G LL+ + P R++ + HP+ K+
Sbjct: 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 6e-55
Identities = 77/298 (25%), Positives = 140/298 (46%), Gaps = 54/298 (18%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD---IHNLRQEIEILRK 59
++ Y I +GEG++G+VYK T +TVA+K I + E++ +R E+ +L++
Sbjct: 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI--RLEHEEEGVPGTAIR-EVSLLKE 89
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLH 119
L+H+NIIE+ ++ E+A+ +L + ++ + + ++S QL+ +++ H
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 120 SNRIIHRDMKPQNILIGAGS-----VVKLCDFGFARAMSA------NTVVLRSIKGTPLY 168
S R +HRD+KPQN+L+ V+K+ DFG ARA + ++ T Y
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII------TLWY 203
Query: 169 MAPE-LVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK-----DPVKYP 222
PE L+ + Y+ + D+WS+ I E+ + P F +S + I + D +P
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263
Query: 223 DEMS-PNFKSF------------------------LKGLLNKVPQNRLTWSALLEHPF 255
+ P++K L +L P R++ LEHP+
Sbjct: 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-54
Identities = 86/296 (29%), Positives = 137/296 (46%), Gaps = 50/296 (16%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD---IHNLRQEIEILRK 59
+E YH +E +GEG++G VYK + G+T A+K I + E + +R EI IL++
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI--RLEKEDEGIPSTTIR-EISILKE 56
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKC-LPEEQVQSIAKQLVRALHYL 118
LKH NI+++ D + + +V E +L ++L+ + L +S QL+ + Y
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA------NTVVLRSIKGTPLYMAPE 172
H R++HRD+KPQN+LI +K+ DFG ARA + +V T Y AP+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV------TLWYRAPD 170
Query: 173 -LVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK-----DPVKYPDEMS 226
L+ + Y+ T D+WS+G I E+ G P F S + I + + +P+
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 227 -PNFKSF-----------------------LKGLLNKVPQNRLTWSALLEHPFVKE 258
P + L +L P R+T LEH + KE
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-53
Identities = 83/302 (27%), Positives = 132/302 (43%), Gaps = 53/302 (17%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFI----MKHGKSEKDIHNLRQEIEILR 58
Y + +G G++G VYK R ++G VA+K + G I +R E+ +LR
Sbjct: 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLR 66
Query: 59 KLK---HQNIIEMLD-----SFESPQEFCVVTEFAQGELFEILED--DKCLPEEQVQSIA 108
+L+ H N++ ++D + + +V E +L L+ LP E ++ +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 109 KQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA-----NTVVLRSIK 163
+Q +R L +LH+N I+HRD+KP+NIL+ +G VKL DFG AR S VV
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV----- 181
Query: 164 GTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK------- 216
T Y APE++ + Y D+WS+G I E+F +P F NS + I
Sbjct: 182 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240
Query: 217 ----DPVKYPDEMSPNFK----------------SFLKGLLNKVPQNRLTWSALLEHPFV 256
V P P L +L P R++ L+H ++
Sbjct: 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300
Query: 257 KE 258
+
Sbjct: 301 HK 302
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-53
Identities = 85/295 (28%), Positives = 135/295 (45%), Gaps = 53/295 (17%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD----IHNLRQEIEILR 58
+E Y ++ +GEG++ VYKG+ K T VA+K I + E + +R E+ +L+
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIR-EVSLLK 55
Query: 59 KLKHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKC-LPEEQVQSIAKQLVRALHY 117
LKH NI+ + D + + +V E+ +L + L+D + V+ QL+R L Y
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA------NTVVLRSIKGTPLYMAP 171
H +++HRD+KPQN+LI +KL DFG ARA S N VV T Y P
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV------TLWYRPP 169
Query: 172 E-LVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK-------------- 216
+ L+ Y+ D+W +G I YE+ G+P F ++V + I +
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 229
Query: 217 -----DPVKYPDEMSPNFKSFLKG-------LLNKV----PQNRLTWSALLEHPF 255
YP + S LL K+ +NR++ ++HPF
Sbjct: 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-52
Identities = 84/307 (27%), Positives = 135/307 (43%), Gaps = 62/307 (20%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD----IHNLRQEIEILR 58
+ +E +G G++ VYKG K TG VA+K + K + + +R EI +++
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIR-EISLMK 58
Query: 59 KLKHQNIIEMLDSFESPQEFCVVTEFAQGELFEILED------DKCLPEEQVQSIAKQLV 112
+LKH+NI+ + D + + +V EF +L + ++ + L V+ QL+
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 113 RALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA------NTVVLRSIKGTP 166
+ L + H N+I+HRD+KPQN+LI +KL DFG ARA + VV T
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV------TL 172
Query: 167 LYMAPE-LVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK-----DPVK 220
Y AP+ L+ + Y+ + D+WS G IL E+ G+P F + ++ I +
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232
Query: 221 YPDEMS-PNFKSF----------------------------LKGLLNKVPQNRLTWSALL 251
+P P + L GLL P RL+ L
Sbjct: 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292
Query: 252 EHPFVKE 258
HP+ E
Sbjct: 293 HHPWFAE 299
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 3e-52
Identities = 82/302 (27%), Positives = 140/302 (46%), Gaps = 55/302 (18%)
Query: 3 VENYHVIELVGEGSFGKVYKGR-RKYTGQTVAMKFIMKHGKSEKD---IHNLRQEIEILR 58
+ Y + +GEG++GKV+K R K G+ VA+K + ++ ++ + +R E+ +LR
Sbjct: 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIR-EVAVLR 66
Query: 59 KLK---HQNIIEMLD-----SFESPQEFCVVTEFAQGELFEILED--DKCLPEEQVQSIA 108
L+ H N++ + D + + +V E +L L+ + +P E ++ +
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 109 KQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA-----NTVVLRSIK 163
QL+R L +LHS+R++HRD+KPQNIL+ + +KL DFG AR S + VV
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV----- 181
Query: 164 GTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK------- 216
T Y APE++ + Y DLWS+G I E+F +P F +S + I+
Sbjct: 182 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 217 ----DPVKYPDEMSPNFK----------------SFLKGLLNKVPQNRLTWSALLEHPFV 256
V P + + L L P R++ + L HP+
Sbjct: 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300
Query: 257 KE 258
++
Sbjct: 301 QD 302
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 6e-52
Identities = 54/271 (19%), Positives = 101/271 (37%), Gaps = 25/271 (9%)
Query: 7 HVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
++ K + + + + S + +I + +N +
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 67 EMLDSFESPQEFCVVTEFAQGE-LFEILEDDKCL---PEEQVQSIAKQLVRALHYLHSNR 122
L + + + E L + + L I Q+ A+ +LHS
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK------------GTPLYMA 170
++HRD+KP NI VVK+ DFG AM + + GT LYM+
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 171 PELVREQPYNHTADLWSLGVILYELFVGQPPFYTNS----VYALIRHIVKDPVKYPDEMS 226
PE + Y+H D++SLG+IL+EL F T + +R++ + +
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFPLL--FTQKY 299
Query: 227 PNFKSFLKGLLNKVPQNRLTWSALLEHPFVK 257
P ++ +L+ P R + ++E+ +
Sbjct: 300 PQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 4e-13
Identities = 17/83 (20%), Positives = 37/83 (44%), Gaps = 1/83 (1%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
++ I+ +G G FG V++ + K A+K ++ E + +E++ L KL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIK-RIRLPNRELAREKVMREVKALAKLEHP 64
Query: 64 NIIEMLDSFESPQEFCVVTEFAQ 86
I+ +++ E +
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDE 87
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 9e-52
Identities = 80/306 (26%), Positives = 139/306 (45%), Gaps = 54/306 (17%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD---IHNLRQEIEILRK 59
V Y + +G+G+FG+V+K R + TGQ VA+K ++ +EK+ I LR EI+IL+
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME--NEKEGFPITALR-EIKILQL 72
Query: 60 LKHQNIIEMLDSFESPQEFCV--------VTEFAQGELFEILED-DKCLPEEQVQSIAKQ 110
LKH+N++ +++ + V +F + +L +L + +++ + +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 111 LVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL--- 167
L+ L+Y+H N+I+HRDMK N+LI V+KL DFG ARA S + + T
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS-QPNRYTNRVVT 191
Query: 168 --YMAPE-LVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHI---------- 214
Y PE L+ E+ Y DLW G I+ E++ P N+ + I
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251
Query: 215 -------------VKDPVKYPDEMSPNFKSFLKG-----LLNKV----PQNRLTWSALLE 252
++ ++ K++++ L++K+ P R+ L
Sbjct: 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311
Query: 253 HPFVKE 258
H F
Sbjct: 312 HDFFWS 317
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 5e-51
Identities = 86/301 (28%), Positives = 133/301 (44%), Gaps = 58/301 (19%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+Y +++G GSFG VY+ + +G+ VA+K +++ + + R E++I+RKL H
Sbjct: 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NR-ELQIMRKLDHC 107
Query: 64 NIIEMLDSFESPQE------FCVVTEFAQGELFEILED----DKCLPEEQVQSIAKQLVR 113
NI+ + F S E +V ++ ++ + + LP V+ QL R
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 114 ALHYLHSNRIIHRDMKPQNILIGAGS-VVKLCDFGFARAMS---ANT--VVLRSIKGTPL 167
+L Y+HS I HRD+KPQN+L+ + V+KLCDFG A+ + N + R
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR------Y 221
Query: 168 YMAPELV-REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK---------- 216
Y APEL+ Y + D+WS G +L EL +GQP F +S + I+K
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281
Query: 217 -------DPVKYPD------------EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVK 257
K+P P + LL P RLT H F
Sbjct: 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341
Query: 258 E 258
E
Sbjct: 342 E 342
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-49
Identities = 82/302 (27%), Positives = 136/302 (45%), Gaps = 61/302 (20%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
Y +++G GSFG V++ + + + VA+K +++ + + R E++I+R +KH
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFK-----NR-ELQIMRIVKHP 92
Query: 64 NIIEMLDSFESPQEFC------VVTEFAQGELFEILED----DKCLPEEQVQSIAKQLVR 113
N++++ F S + +V E+ ++ + +P ++ QL+R
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 114 ALHYLHSNRIIHRDMKPQNILIGAGS-VVKLCDFGFARAMS---ANT--VVLRSIKGTPL 167
+L Y+HS I HRD+KPQN+L+ S V+KL DFG A+ + N + R
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR------Y 206
Query: 168 YMAPELV-REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK-----DPVKY 221
Y APEL+ Y D+WS G ++ EL GQP F S + I+K +
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266
Query: 222 PDEMSPNF--------------KSFLKG-------LLNKV----PQNRLTWSALLEHPFV 256
M+PN+ K F L++++ P RLT L HPF
Sbjct: 267 K-TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325
Query: 257 KE 258
E
Sbjct: 326 DE 327
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 6e-48
Identities = 75/260 (28%), Positives = 118/260 (45%), Gaps = 27/260 (10%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHN-LRQEIEILRKLKHQ- 63
Y V++++G+GSFG+V K Q VA+K + ++EK H +EI IL L+ Q
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV----RNEKRFHRQAAEEIRILEHLRKQD 154
Query: 64 -----NIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKC--LPEEQVQSIAKQLVRALH 116
N+I ML++F C+ E L+E+++ +K V+ A +++ L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 117 YLHSNRIIHRDMKPQNILI--GAGSVVKLCDFG---FARAMSANTVVLRSIKGTPLYMAP 171
LH NRIIH D+KP+NIL+ S +K+ DFG + + R Y AP
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF------YRAP 268
Query: 172 ELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEM---SPN 228
E++ Y D+WSLG IL EL G P + +++ ++ S
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR 328
Query: 229 FKSFLKGLLNKVPQNRLTWS 248
K+F+ T S
Sbjct: 329 AKNFVSSKGYPRYCTVTTLS 348
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-47
Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 33/229 (14%)
Query: 7 HVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEI--LRKLKHQN 64
++E VG+G +G+V++G + G+ VA+K S +D + +E E+ L+H+N
Sbjct: 11 TLLECVGKGRYGEVWRG--SWQGENVAVKIF-----SSRDEKSWFRETELYNTVMLRHEN 63
Query: 65 IIEML----DSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLH 119
I+ + S S + ++T + + G L++ L+ L I + L +LH
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLH 122
Query: 120 SNR--------IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR----SIKGTPL 167
I HRD+K +NIL+ + D G A S +T L GT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 168 YMAPELVREQP------YNHTADLWSLGVILYELFVGQPPFYTNSVYAL 210
YMAPE++ E D+W+ G++L+E+ Y
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-47
Identities = 69/248 (27%), Positives = 123/248 (49%), Gaps = 10/248 (4%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK--HGKSEKDIHNLRQEIEILRKLKHQ 63
Y +++ +G G VY VA+K + + E+ + +E+ +L HQ
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+ M+D E + +V E+ +G L E +E L + + Q++ + + H R
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL-RSIKGTPLYMAPELVREQPYNH 181
I+HRD+KPQNILI + +K+ DFG A+A+S ++ + GT Y +PE + + +
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 182 TADLWSLGVILYELFVGQPPFYTNSVYAL-IRHIVKDPVKYPDEMSPNFKSFLKGL---- 236
D++S+G++LYE+ VG+PPF + ++ I+HI ++ + L +
Sbjct: 192 CTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRA 251
Query: 237 LNKVPQNR 244
K NR
Sbjct: 252 TEKDKANR 259
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 7e-47
Identities = 72/228 (31%), Positives = 113/228 (49%), Gaps = 38/228 (16%)
Query: 3 VENYHVIEL-VGEGSFGKVYKGRRKY--TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRK 59
+ + VG G++G VYK +RK + A+K I G S + R EI +LR+
Sbjct: 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACR-EIALLRE 74
Query: 60 LKHQNIIEMLDSFESPQEFCV--VTEFAQGELFEILEDDKC---------LPEEQVQSIA 108
LKH N+I + F S + V + ++A+ +L+ I++ + LP V+S+
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 109 KQLVRALHYLHSNRIIHRDMKPQNILIGAGS----VVKLCDFGFARAMSA---------N 155
Q++ +HYLH+N ++HRD+KP NIL+ VK+ D GFAR ++
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 156 TVVLRSIKGTPLYMAPE-LVREQPYNHTADLWSLGVILYELFVGQPPF 202
VV T Y APE L+ + Y D+W++G I EL +P F
Sbjct: 195 VVV------TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-46
Identities = 67/334 (20%), Positives = 127/334 (38%), Gaps = 92/334 (27%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHN-LRQEIEILRKLKHQ- 63
+ VI +G+G+FG+V + + A+K + ++ K + E +IL+K+++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV----RNIKKYTRSAKIEADILKKIQNDD 92
Query: 64 ----NIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKC--LPEEQVQSIAKQLVRALHY 117
NI++ F C++ E L+EI+ + E ++ ++++AL+Y
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 118 LHSNRIIHRDMKPQNILI-------------------------GAGSVVKLCDFG---FA 149
L + H D+KP+NIL+ + +KL DFG F
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK 212
Query: 150 RAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYA 209
+ + R Y APE++ ++ ++D+WS G +L EL+ G F T+
Sbjct: 213 SDYHGSIINTRQ------YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHME 266
Query: 210 LIRHIVK--------------------------DPVKYPDEMS----------------- 226
+ + + +P+ S
Sbjct: 267 HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326
Query: 227 ---PNFKSFLKGLLNKVPQNRLTWSALLEHPFVK 257
F FL +L P R + + LL+H F++
Sbjct: 327 IKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-46
Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 8/246 (3%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD--IHNLRQEIEILRKLKHQ 63
Y + LVG G G VY+ + VA+K +M S +++E +L+
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
+++ + D E + V G L +L L + +I +Q+ AL H+
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV-LRSIKGTPLYMAPELVREQPYNH 181
HRD+KP+NIL+ A L DFG A A + + L + GT YMAPE E +
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATY 214
Query: 182 TADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV---KYPDEMSPNFKSFLKGLLN 238
AD+++L +LYE G PP+ + + + HI + + F + + +
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMA 274
Query: 239 KVPQNR 244
K P++R
Sbjct: 275 KNPEDR 280
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-46
Identities = 72/354 (20%), Positives = 134/354 (37%), Gaps = 82/354 (23%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNL-RQEIEILRKLK--- 61
Y ++ +G G F V+ + VAMK + + +K EI++L+++
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDAD 76
Query: 62 --------HQNIIEMLDSFE----SPQEFCVVTEFAQGELFEILE--DDKCLPEEQVQSI 107
+I+++LD F + +V E L +++ + + +P V+ I
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136
Query: 108 AKQLVRALHYLHSN-RIIHRDMKPQNILI------GAGSVVKLCDFGFARAMSANTVVLR 160
+KQL+ L Y+H IIH D+KP+N+L+ +K+ D G A +
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHYTN 194
Query: 161 SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVY---------ALI 211
SI+ T Y +PE++ P+ AD+WS +++EL G F + + A I
Sbjct: 195 SIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 212 ---------------------------------------RHIVKDPVKYPDEMSPNFKSF 232
++ + K+ + + F
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313
Query: 233 LKGLLNKVPQNRLTWSALLEHPFVKETSDELNAWELRATSVEARGCNA-TWTAE 285
L +L P+ R L+ HP++K+T + + G + W E
Sbjct: 314 LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEE-IRVPDRELYGSGSDIPGWFEE 366
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-45
Identities = 79/314 (25%), Positives = 130/314 (41%), Gaps = 65/314 (20%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLR--QEIEILRKL 60
++ + V + G+G+FG V G+ K TG +VA+K +++ + R Q ++ L L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFR----NRELQIMQDLAVL 76
Query: 61 KHQNIIEMLDSFESPQE-------FCVVTEFAQGELFEIL----EDDKCLPEEQVQSIAK 109
H NI+++ F + E VV E+ L P ++
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 110 QLVRALHYLH--SNRIIHRDMKPQNILI-GAGSVVKLCDFGFARAMS---ANT--VVLRS 161
QL+R++ LH S + HRD+KP N+L+ A +KLCDFG A+ +S N + R
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR- 195
Query: 162 IKGTPLYMAPELV-REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK---- 216
Y APEL+ Q Y D+WS+G I E+ +G+P F ++ + IV+
Sbjct: 196 -----YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250
Query: 217 -------------DPVKYPDEMSPNFKSFLKG-----------LLNKV----PQNRLTWS 248
V + + + LL+ + P+ R+
Sbjct: 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY 310
Query: 249 ALLEHPFVKETSDE 262
L HP+ E D
Sbjct: 311 EALCHPYFDELHDP 324
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-45
Identities = 69/328 (21%), Positives = 127/328 (38%), Gaps = 86/328 (26%)
Query: 6 YHVIELVGEGSFGKVYKGR-RKYTGQTVAMKFIMKHGKSEKDIHN-LRQEIEILRKLKHQ 63
Y +++ +GEG+FGKV + K G+ VA+K + K+ R EI++L L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV----KNVDRYCEAARSEIQVLEHLNTT 71
Query: 64 ------NIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKC--LPEEQVQSIAKQLVRAL 115
++ML+ FE C+V E ++ ++++ + ++ +A Q+ +++
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 116 HYLHSNRIIHRDMKPQNILI-------------------GAGSVVKLCDFG---FARAMS 153
++LHSN++ H D+KP+NIL +K+ DFG +
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH 191
Query: 154 ANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRH 213
+ V R Y APE++ ++ D+WS+G IL E ++G F T+ +
Sbjct: 192 STLVSTRH------YRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245
Query: 214 IV--------------------------------------------KDPVKYPDEMSPNF 229
+ K+ + D
Sbjct: 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL 305
Query: 230 KSFLKGLLNKVPQNRLTWSALLEHPFVK 257
++ +L P R+T L+HPF
Sbjct: 306 FDLIQKMLEYDPAKRITLREALKHPFFD 333
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-45
Identities = 53/225 (23%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 9 IELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEM 68
++ +G+G +G+V+ G K+ G+ VA+K ++ EI ++H+NI+
Sbjct: 42 VKQIGKGRYGEVWMG--KWRGEKVAVKVFFTTEEASW---FRETEIYQTVLMRHENILGF 96
Query: 69 L----DSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR- 122
+ S + ++T++ + G L++ L+ L + + +A V L +LH+
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 123 -------IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT----VVLRSIKGTPLYMAP 171
I HRD+K +NIL+ + D G A ++T + + GT YM P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 172 EL------VREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYAL 210
E+ AD++S G+IL+E+ Y L
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-45
Identities = 73/338 (21%), Positives = 120/338 (35%), Gaps = 86/338 (25%)
Query: 6 YHVIELVGEGSFGKVYKGR-RKYTGQTVAMKFIMKHGKSEKDIHN-LRQEIEILRKLKHQ 63
Y ++ +GEG+FGKV + VA+K I ++ R EI +L+K+K +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKII----RNVGKYREAARLEINVLKKIKEK 76
Query: 64 ------NIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKC--LPEEQVQSIAKQLVRAL 115
+ M D F C+ E FE L+++ P V+ +A QL AL
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136
Query: 116 HYLHSNRIIHRDMKPQNILI-------------------GAGSVVKLCDFG---FARAMS 153
+LH N++ H D+KP+NIL + +++ DFG F
Sbjct: 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH 196
Query: 154 ANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRH 213
V R Y PE++ E + D+WS+G IL+E + G F T+ +
Sbjct: 197 TTIVATRH------YRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250
Query: 214 IV--------------------------------------------KDPVKYPDEMSPNF 229
+ K +
Sbjct: 251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQL 310
Query: 230 KSFLKGLLNKVPQNRLTWSALLEHPFVKETSDELNAWE 267
++ +L P R+T + L HPF + E ++
Sbjct: 311 FDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFH 348
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-45
Identities = 73/333 (21%), Positives = 125/333 (37%), Gaps = 90/333 (27%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ Y + + +G GSFG V + +G+ A+K +++ + + R E++I++ L H
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-----NR-ELDIMKVLDHV 60
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGEL------------------------------FEIL 93
NII+++D F + + + E +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 94 EDD------------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS-V 140
D + +P + QL RA+ ++HS I HRD+KPQN+L+ +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 141 VKLCDFGFARAMS---ANT--VVLRSIKGTPLYMAPELV-REQPYNHTADLWSLGVILYE 194
+KLCDFG A+ + + + R Y APEL+ Y + DLWS+G + E
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAYICSR------FYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 195 LFVGQPPF-------------------------YTNSVYALIR--HIVKDP--VKYPDEM 225
L +G+P F N Y +R + P+
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGT 294
Query: 226 SPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258
L+ +L P R+ + HPF
Sbjct: 295 PSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 5e-45
Identities = 73/308 (23%), Positives = 125/308 (40%), Gaps = 63/308 (20%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-H 62
++Y ++ +G G + +V++ + V +K + K K R EI+IL L+
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL----KPVKKKKIKR-EIKILENLRGG 90
Query: 63 QNIIEMLDSFESPQEFC---VVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLH 119
NII + D + P V + ++ + L + ++ ++++AL Y H
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCH 147
Query: 120 SNRIIHRDMKPQNILI-GAGSVVKLCDFGFARAMSANT-----VVLRSIKGTPLYMAPE- 172
S I+HRD+KP N++I ++L D+G A V R + PE
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY------FKGPEL 201
Query: 173 LVREQPYNHTADLWSLGVILYEL-FVGQPPFYTNSVYALIRHIVK---------DPVKYP 222
LV Q Y+++ D+WSLG +L + F +P F+ + Y + I K KY
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261
Query: 223 DEMSPNFKSFLKG------------------------LLNKV----PQNRLTWSALLEHP 254
E+ P F L L+K+ Q+RLT +EHP
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321
Query: 255 FVKETSDE 262
+ +
Sbjct: 322 YFYTVVKD 329
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-45
Identities = 67/258 (25%), Positives = 115/258 (44%), Gaps = 29/258 (11%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHN-LRQEIEILRKLKHQ- 63
Y + L+G+GSFG+V K + + VA+K I K++K N + E+ +L +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII----KNKKAFLNQAQIEVRLLELMNKHD 111
Query: 64 -----NIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKC--LPEEQVQSIAKQLVRALH 116
I+ + F C+V E L+++L + + + A+Q+ AL
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 117 YLHSNR--IIHRDMKPQNILI--GAGSVVKLCDFG---FARAMSANTVVLRSIKGTPLYM 169
+L + IIH D+KP+NIL+ S +K+ DFG + R Y
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------YR 225
Query: 170 APELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEM---S 226
+PE++ PY+ D+WSLG IL E+ G+P F + + IV+ P + +
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA 285
Query: 227 PNFKSFLKGLLNKVPQNR 244
P + F + L + +
Sbjct: 286 PKARKFFEKLPDGTWNLK 303
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-44
Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 7 HVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
+ E +G+G FG+V++G K+ G+ VA+K E+ EI L+H+NI+
Sbjct: 45 VLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENIL 99
Query: 67 EML----DSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
+ + + +V+++ + G LF+ L + E + +A L +LH
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHME 158
Query: 122 R--------IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT----VVLRSIKGTPLYM 169
I HRD+K +NIL+ + D G A + T + GT YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 170 APELVRE------QPYNHTADLWSLGVILYELFVGQPPFYTNSVYAL 210
APE++ + AD++++G++ +E+ + Y L
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 71/253 (28%), Positives = 126/253 (49%), Gaps = 15/253 (5%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK--HGKSEKDIHNLRQEIEILRKLKHQ 63
Y + E++G G +V+ R + VA+K +++ + R+E + L H
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 64 NIIEMLDSFESPQEFCV----VTEFAQGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
I+ + D+ E+ V E+ G L +I+ + + ++ + +AL++
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL---RSIKGTPLYMAPELVR 175
H N IIHRD+KP NI+I A + VK+ DFG ARA++ + + ++ GT Y++PE R
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 176 EQPYNHTADLWSLGVILYELFVGQPPFYTNS----VYALIRHIVKDPVKYPDEMSPNFKS 231
+ +D++SLG +LYE+ G+PPF +S Y +R P + +S + +
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDA 252
Query: 232 FLKGLLNKVPQNR 244
+ L K P+NR
Sbjct: 253 VVLKALAKNPENR 265
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-44
Identities = 88/314 (28%), Positives = 140/314 (44%), Gaps = 61/314 (19%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLR--QEIEILRKLK 61
++ + L+GEG++G V K TG+ VA+K K +K + LR +EI+IL+ K
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFALRTLREIKILKHFK 67
Query: 62 HQNIIEMLDSFESP-----QEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALH 116
H+NII + + E ++ E Q +L ++ L ++ +Q Q +RA+
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-LSDDHIQYFIYQTLRAVK 126
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYM------- 169
LH + +IHRD+KP N+LI + +K+CDFG AR + + G M
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 170 ---APE-LVREQPYNHTADLWSLGVILYELFVGQPPFYTNSV---YALIRHIVKDPVKYP 222
APE ++ Y+ D+WS G IL ELF+ +P F LI I+ P
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH--S 244
Query: 223 DEM-----SPNFKSFLKG----------------------LLNKV----PQNRLTWSALL 251
D SP + ++K LL ++ P R+T L
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304
Query: 252 EHPFVKE---TSDE 262
EHP+++ +DE
Sbjct: 305 EHPYLQTYHDPNDE 318
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 6e-44
Identities = 81/303 (26%), Positives = 134/303 (44%), Gaps = 55/303 (18%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLR--QEIEILRKLK 61
+ Y VG G++G V K +G+ VA+K + + + +I R +E+ +L+ ++
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--PFQSEIFAKRAYRELLLLKHMQ 81
Query: 62 HQNIIEMLDSFESP------QEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRAL 115
H+N+I +LD F +F +V F Q +L +I+ EE++Q + Q+++ L
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQMLKGL 139
Query: 116 HYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT---VVLRSIKGTPLYMAPE 172
Y+HS ++HRD+KP N+ + +K+ DFG AR A VV R Y APE
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR------WYRAPE 193
Query: 173 -LVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE------M 225
++ YN T D+WS+G I+ E+ G+ F + I+ P
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL-KVTGVPGTEFVQKLN 252
Query: 226 SPNFKSFLKG----------------------LLNKV----PQNRLTWSALLEHPFVKET 259
KS+++ LL K+ RLT + L HPF +
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312
Query: 260 SDE 262
D
Sbjct: 313 RDP 315
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 8e-44
Identities = 52/221 (23%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
++E+ G FG V+K + + VA+K K E+ L +KH+
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQN---EYEVYSLPGMKHE 78
Query: 64 NIIEML----DSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
NI++ + + ++T F + G L + L+ + + ++ IA+ + R L YL
Sbjct: 79 NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYL 137
Query: 119 HSN----------RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA--NTVVLRSIKGTP 166
H + I HRD+K +N+L+ + DFG A A + GT
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 167 LYMAPELVR-----EQPYNHTADLWSLGVILYELFVGQPPF 202
YMAPE++ ++ D++++G++L+EL
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 9e-44
Identities = 75/313 (23%), Positives = 127/313 (40%), Gaps = 62/313 (19%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-------EKDIHNLR--QEI 54
Y V + GS+G V G G VA+K + R +EI
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 55 EILRKLKHQNIIEMLDSFESP-----QEFCVVTEFAQGELFEILEDDKC-LPEEQVQSIA 108
+L H NI+ + D F + +VTE + +L +++ D + + + +Q
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 109 KQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT-----VVLRSIK 163
++ LH LH ++HRD+ P NIL+ + + +CDF AR +A+ V R
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR--- 197
Query: 164 GTPLYMAPELV-REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP 222
Y APELV + + + D+WS G ++ E+F + F ++ Y + IV + V P
Sbjct: 198 ---WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV-EVVGTP 253
Query: 223 DE------MSPNFKSFLKG-----------------------LLNKV----PQNRLTWSA 249
SP+ + +L+ L+ K+ PQ R++
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313
Query: 250 LLEHPFVKETSDE 262
L HP+ + D
Sbjct: 314 ALRHPYFESLFDP 326
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-43
Identities = 55/246 (22%), Positives = 104/246 (42%), Gaps = 22/246 (8%)
Query: 6 YHVIELVGEGSFGKVYKGR-RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
Y V + G G +Y R G+ V +K + H + E + L ++ H +
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAMAMAERQFLAEVVHPS 140
Query: 65 IIEMLDSFESPQEFCV-----VTEFAQGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
I+++ + E V E+ G+ L LP + + +++ AL YL
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--LPVAEAIAYLLEILPALSYL 198
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQP 178
HS +++ D+KP+NI++ +KL D G +++ + GTP + APE+VR P
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYLY----GTPGFQAPEIVRTGP 253
Query: 179 YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLN 238
D++++G L L + P V + +D + ++ L+ ++
Sbjct: 254 -TVATDIYTVGRTLAALTLDLPTRNGRYV----DGLPEDDP--VLKTYDSYGRLLRRAID 306
Query: 239 KVPQNR 244
P+ R
Sbjct: 307 PDPRQR 312
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 3e-43
Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 40/225 (17%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEI--LRKLK 61
+N ++EL+G G +G VYKG + VA+K S + N E I + ++
Sbjct: 13 DNLKLLELIGRGRYGAVYKG--SLDERPVAVKVF-----SFANRQNFINEKNIYRVPLME 65
Query: 62 HQNII-----EMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRAL 115
H NI + + + E+ +V E+ G L + L +A + R L
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGL 124
Query: 116 HYLHS---------NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR------ 160
YLH+ I HRD+ +N+L+ + DFG + ++ N +V
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 161 --SIKGTPLYMAPELVRE-------QPYNHTADLWSLGVILYELF 196
S GT YMAPE++ + D+++LG+I +E+F
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 4e-43
Identities = 79/302 (26%), Positives = 139/302 (46%), Gaps = 52/302 (17%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD-IHNLRQEIEILRKLKH 62
Y ++ VG G++G V TG VA+K + + +SE R E+ +L+ ++H
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRH 83
Query: 63 QNIIEMLD------SFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALH 116
+N+I +LD + + +F +V F +L ++++ +K L E+++Q + Q+++ L
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLKGLR 142
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT---VVLRSIKGTPLYMAPE- 172
Y+H+ IIHRD+KP N+ + +K+ DFG AR + VV R Y APE
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR------WYRAPEV 196
Query: 173 LVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE------MS 226
++ Y T D+WS+G I+ E+ G+ F + ++ I+ P S
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM-KVTGTPPAEFVQRLQS 255
Query: 227 PNFKSFLKG----------------------LLNKV----PQNRLTWSALLEHPFVKETS 260
K+++KG LL K+ + R+T L HP+ +
Sbjct: 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315
Query: 261 DE 262
D
Sbjct: 316 DT 317
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 9e-43
Identities = 80/356 (22%), Positives = 130/356 (36%), Gaps = 99/356 (27%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLR--QEIEILRKLK 61
+ Y + L+G GS+G V + K + VA+K I++ E I R +EI IL +L
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR--VFEDLIDCKRILREIAILNRLN 110
Query: 62 HQNIIEMLD-----SFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALH 116
H +++++LD E E VV E A + ++ L E ++++ L+ +
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL--------- 167
Y+HS I+HRD+KP N L+ VK+CDFG AR + + +P
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 168 ------------------YMAPE-LVREQPYNHTADLWSLGVILYE-------------- 194
Y APE ++ ++ Y D+WS+G I E
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290
Query: 195 ---LFVGQPPFYTNSVYALIRHIVKDPVKYPDEM-------------------SPNFKSF 232
LF G F + D++ + K +
Sbjct: 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRY 350
Query: 233 LKG----------------------LLNKV----PQNRLTWSALLEHPFVKETSDE 262
++ LL ++ P R+T + L HPF KE
Sbjct: 351 IRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-42
Identities = 60/257 (23%), Positives = 118/257 (45%), Gaps = 27/257 (10%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD-IHNLRQEIEILRKLKH 62
+ Y ++ +G G+ G V + VA+K + + +++ R E+ +++ + H
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 83
Query: 63 QNIIEMLD------SFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALH 116
+NII +L+ S E Q+ +V E L ++++ + L E++ + Q++ +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIK 141
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT-----VVLRSIKGTPLYMAP 171
+LHS IIHRD+KP NI++ + +K+ DFG AR + VV R Y AP
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY------YRAP 195
Query: 172 ELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE-----MS 226
E++ Y D+WS+G I+ E+ G F ++ + + P +
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI-EQLGTPCPEFMKKLQ 254
Query: 227 PNFKSFLKGLLNKVPQN 243
P +++++ +
Sbjct: 255 PTVRTYVENRPKYAGYS 271
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 2e-42
Identities = 74/302 (24%), Positives = 135/302 (44%), Gaps = 48/302 (15%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLR--QEIEILRKLK 61
Y + +GEG++G V VA+K K E + R +EI+IL + +
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFR 83
Query: 62 HQNIIEMLDSFESP-----QEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALH 116
H+NII + D +P ++ +V + + +L+++L+ L + + Q++R L
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLK 142
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG---TPLYMAPE- 172
Y+HS ++HRD+KP N+L+ +K+CDFG AR + + T Y APE
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 173 LVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE------MS 226
++ + Y + D+WS+G IL E+ +P F + HI+ + P + ++
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL-GILGSPSQEDLNCIIN 261
Query: 227 PNFKSFLKG----------------------LLNKV----PQNRLTWSALLEHPFVKETS 260
+++L LL+K+ P R+ L HP++++
Sbjct: 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 261 DE 262
D
Sbjct: 322 DP 323
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-42
Identities = 82/302 (27%), Positives = 133/302 (44%), Gaps = 52/302 (17%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD-IHNLRQEIEILRKLKH 62
E Y + VG G++G V TG VA+K + + +S R E+ +L+ +KH
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 87
Query: 63 QNIIEMLD------SFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALH 116
+N+I +LD S E + +VT +L I++ K L ++ VQ + Q++R L
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLK 146
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT---VVLRSIKGTPLYMAPE- 172
Y+HS IIHRD+KP N+ + +K+ DFG AR + V R Y APE
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR------WYRAPEI 200
Query: 173 LVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE------MS 226
++ YN T D+WS+G I+ EL G+ F ++ I+ V P S
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL-RLVGTPGAELLKKISS 259
Query: 227 PNFKSFLKG----------------------LLNKV----PQNRLTWSALLEHPFVKETS 260
+ +++++ LL K+ R+T + L H + +
Sbjct: 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319
Query: 261 DE 262
D
Sbjct: 320 DP 321
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 81/310 (26%), Positives = 129/310 (41%), Gaps = 56/310 (18%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIM-KHGKSEKDIHNLRQEIEILRKLKH 62
Y ++ +G G G V+ + VA+K I+ +S K H LR EI+I+R+L H
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK--HALR-EIKIIRRLDH 67
Query: 63 QNIIEMLD--------------SFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIA 108
NI+++ + S +V E+ + +L +LE L EE +
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-LLEEHARLFM 126
Query: 109 KQLVRALHYLHSNRIIHRDMKPQNILIGAGS-VVKLCDFGFARAMSANTVVLRSIKG--- 164
QL+R L Y+HS ++HRD+KP N+ I V+K+ DFG AR M + +
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 165 TPLYMAPE-LVREQPYNHTADLWSLGVILYELFVGQPPF--------------------- 202
T Y +P L+ Y D+W+ G I E+ G+ F
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246
Query: 203 -----YTNSVYALIRHIVKDP-----VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252
+ + IR+ + +P P +S FL+ +L P +RLT L
Sbjct: 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAEEALS 305
Query: 253 HPFVKETSDE 262
HP++ S
Sbjct: 306 HPYMSIYSFP 315
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-42
Identities = 69/313 (22%), Positives = 130/313 (41%), Gaps = 63/313 (20%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD-IHNLRQEIEILRKLKH 62
+ Y ++ +G G+ G V + VA+K + + +++ R E+ +++ + H
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 120
Query: 63 QNIIEMLD------SFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALH 116
+NII +L+ + E Q+ +V E L ++++ + L E++ + Q++ +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIK 178
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT-----VVLRSIKGTPLYMAP 171
+LHS IIHRD+KP NI++ + +K+ DFG AR + VV R Y AP
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY------YRAP 232
Query: 172 ELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIV---------------- 215
E++ Y D+WS+G I+ E+ + F ++
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292
Query: 216 -----------KDPV----KYPDEMSPNFKSFLKG-------LLNKV----PQNRLTWSA 249
+ +PD + P K LL+K+ P R++
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352
Query: 250 LLEHPFVKETSDE 262
L+HP++ D
Sbjct: 353 ALQHPYINVWYDP 365
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-40
Identities = 83/347 (23%), Positives = 132/347 (38%), Gaps = 89/347 (25%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD-IHNLRQEIEILRKLKH 62
+NY + L+G GS+G VY K T + VA+K + + + D LR EI IL +LK
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKS 84
Query: 63 QNIIEMLDSF--ESPQEFC---VVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
II + D + +F +V E A +L ++ + L EE +++I L+ ++
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL---------- 167
+H + IIHRD+KP N L+ VK+CDFG AR +++
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 168 ------------YMAPE-LVREQPYNHTADLWSLGVILYE-----------------LFV 197
Y APE ++ ++ Y + D+WS G I E LF
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264
Query: 198 GQPPFYTNSVYALIRHIVKDPVK----------YPDE------MSPNFKSFLKG------ 235
G F + + K P E P ++K
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324
Query: 236 ----------------LLNKV----PQNRLTWSALLEHPFVKETSDE 262
LL + P R+T L+HP++K+ +
Sbjct: 325 INLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK 371
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-39
Identities = 67/226 (29%), Positives = 112/226 (49%), Gaps = 30/226 (13%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLR--QEIEILRKLK 61
Y +++ +G+G++G V+K + TG+ VA+K I + R +EI IL +L
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD--AFQNSTDAQRTFREIMILTELS 66
Query: 62 -HQNIIEMLDSFESP--QEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
H+NI+ +L+ + ++ +V ++ + +L ++ + L Q + QL++ + YL
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANI-LEPVHKQYVVYQLIKVIKYL 125
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL----------- 167
HS ++HRDMKP NIL+ A VK+ DFG +R+ V +I +
Sbjct: 126 HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 168 ----------YMAPE-LVREQPYNHTADLWSLGVILYELFVGQPPF 202
Y APE L+ Y D+WSLG IL E+ G+P F
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 9 IELVGEGSFGKVYKGR----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
I +GEG FGKV TG+ VA+K +K + +QEI+ILR L H++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK-ALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 65 IIEML----DSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLH 119
II+ D+ + +V E+ G L + L + Q+ A+Q+ + YLH
Sbjct: 95 IIKYKGCCEDAGAAS--LQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLH 151
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL---YMAPELVRE 176
+ IHRD+ +N+L+ +VK+ DFG A+A+ R + + APE ++E
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 177 QPYNHTADLWSLGVILYELF 196
+ + +D+WS GV LYEL
Sbjct: 212 YKFYYASDVWSFGVTLYELL 231
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 7 HVIELVGEGSFGKVYKGR----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
I +GEG FGKV R TG+ VA+K +K I +L++EIEILR L H
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK-SLKPESGGNHIADLKKEIEILRNLYH 82
Query: 63 QNIIEMLD--SFESPQEFCVVTEFAQ-GELFEILEDDK-CLPEEQVQSIAKQLVRALHYL 118
+NI++ + + ++ EF G L E L +K + +Q A Q+ + + YL
Sbjct: 83 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL 142
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL---YMAPELVR 175
S + +HRD+ +N+L+ + VK+ DFG +A+ + + APE +
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202
Query: 176 EQPYNHTADLWSLGVILYELF 196
+ + +D+WS GV L+EL
Sbjct: 203 QSKFYIASDVWSFGVTLHELL 223
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-38
Identities = 57/201 (28%), Positives = 106/201 (52%), Gaps = 17/201 (8%)
Query: 9 IELVGEGSFGKVYKGR----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
++ +G+G+FG V R + TG+ VA+K ++H +E+ + + +EIEIL+ L+H N
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK-KLQHS-TEEHLRDFEREIEILKSLQHDN 103
Query: 65 IIEML----DSFESPQEFCVVTEFA-QGELFEILEDDK-CLPEEQVQSIAKQLVRALHYL 118
I++ + ++ E+ G L + L+ K + ++ Q+ + + YL
Sbjct: 104 IVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL---YMAPELVR 175
+ R IHRD+ +NIL+ + VK+ DFG + + + + + + APE +
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 176 EQPYNHTADLWSLGVILYELF 196
E ++ +D+WS GV+LYELF
Sbjct: 222 ESKFSVASDVWSFGVVLYELF 242
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 5e-38
Identities = 57/201 (28%), Positives = 106/201 (52%), Gaps = 17/201 (8%)
Query: 9 IELVGEGSFGKVYKGR----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
++ +G+G+FG V R + TG+ VA+K ++H +E+ + + +EIEIL+ L+H N
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK-KLQHS-TEEHLRDFEREIEILKSLQHDN 72
Query: 65 IIEML----DSFESPQEFCVVTEFA-QGELFEILEDDK-CLPEEQVQSIAKQLVRALHYL 118
I++ + ++ E+ G L + L+ K + ++ Q+ + + YL
Sbjct: 73 IVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL---YMAPELVR 175
+ R IHRD+ +NIL+ + VK+ DFG + + + + + + APE +
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 176 EQPYNHTADLWSLGVILYELF 196
E ++ +D+WS GV+LYELF
Sbjct: 191 ESKFSVASDVWSFGVVLYELF 211
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-36
Identities = 55/214 (25%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 9 IELVGEGSFGKVYKGR----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
I +G+G+FG V R TG VA+K ++H ++ + ++EI+IL+ L
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQ-RDFQREIQILKALHSDF 85
Query: 65 IIEML----DSFESPQEFCVVTEFA-QGELFEILEDDKC-LPEEQVQSIAKQLVRALHYL 118
I++ +V E+ G L + L+ + L ++ + Q+ + + YL
Sbjct: 86 IVKYRGVSYGPGRQS--LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 143
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL---YMAPELVR 175
S R +HRD+ +NIL+ + + VK+ DFG A+ + + + + APE +
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 176 EQPYNHTADLWSLGVILYELF-VGQPPFYTNSVY 208
+ ++ +D+WS GV+LYELF ++ +
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF 237
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 46/234 (19%), Positives = 97/234 (41%), Gaps = 27/234 (11%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQ---TVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
+ + + ++G+G FG V + + K VA+K + + DI +E +++
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 61 KHQNIIEML------DSFESPQEFCVVTEFAQ-GELFEIL------EDDKCLPEEQVQSI 107
H ++ +++ + V+ F + G+L L E+ LP + +
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 108 AKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM------SANTVVLRS 161
+ + YL S IHRD+ +N ++ V + DFG +R +
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 162 IKGTPLYMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHI 214
+K ++A E + + Y +D+W+ GV ++E+ GQ P+ + ++
Sbjct: 203 VK----WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-35
Identities = 59/220 (26%), Positives = 114/220 (51%), Gaps = 12/220 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ + +G G +G+VY+G K TVA+K +K E + +E +++++KH
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK-TLKEDTMEVE--EFLKEAAVMKEIKHP 276
Query: 64 NIIEMLD--SFESPQEFCVVTEFAQ-GELFEIL--EDDKCLPEEQVQSIAKQLVRALHYL 118
N++++L + E P F ++TEF G L + L + + + + +A Q+ A+ YL
Sbjct: 277 NLVQLLGVCTREPP--FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-YMAPELVREQ 177
IHR++ +N L+G +VK+ DFG +R M+ +T + P+ + APE +
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 178 PYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVK 216
++ +D+W+ GV+L+E+ G P+ + + + K
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 54/218 (24%), Positives = 110/218 (50%), Gaps = 18/218 (8%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ +++ +G+G FG V G Y G VA+K +K+ + + E ++ +L+H
Sbjct: 21 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVK-CIKNDATAQA---FLAEASVMTQLRHS 74
Query: 64 NIIEMLD--SFESPQEFCVVTEFAQ-GELFEIL--EDDKCLPEEQVQSIAKQLVRALHYL 118
N++++L E +VTE+ G L + L L + + + + A+ YL
Sbjct: 75 NLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR-SIKGTPLYMAPELVREQ 177
N +HRD+ +N+L+ +V K+ DFG + S+ + +K + APE +RE+
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREK 189
Query: 178 PYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHI 214
++ +D+WS G++L+E++ G+ P+ + ++ +
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-35
Identities = 54/221 (24%), Positives = 100/221 (45%), Gaps = 12/221 (5%)
Query: 7 HVIELVGEGSFGKVYKGRRKYTG---QTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
H E++G G FG VY G A+K + ++ E I++ H
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK-SLNRITDIGEVSQFLTEGIIMKDFSHP 86
Query: 64 NIIEMLD-SFESPQEFCVVTEFAQ-GELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLHS 120
N++ +L S VV + + G+L + + + + Q+ + + YL S
Sbjct: 87 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAM-SANTVVLRSIKGTPL---YMAPELVRE 176
+ +HRD+ +N ++ VK+ DFG AR M + + G L +MA E ++
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 177 QPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVK 216
Q + +D+WS GV+L+EL G PP+ + + + ++++
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-35
Identities = 78/362 (21%), Positives = 128/362 (35%), Gaps = 118/362 (32%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK---- 61
YHVI +G G F V+ + VAMK ++K + + EI +L+ ++
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTE--TALDEIRLLKSVRNSDP 95
Query: 62 ----HQNIIEMLDSFE--SPQE--FCVVTEFAQGELFEILE--DDKCLPEEQVQSIAKQL 111
+ ++++LD F+ C+V E L + + + + LP V+ I +Q+
Sbjct: 96 NDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQV 155
Query: 112 VRALHYLHS-NRIIHRDMKPQNILIGAGSV------------------------------ 140
++ L YLH+ RIIH D+KP+NIL+
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 141 -------------------VKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNH 181
VK+ D G A + + T Y + E++ YN
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGSGYNT 272
Query: 182 TADLWSLGVILYELFVGQPPFYTNSVY---------ALI--------------------- 211
AD+WS + +EL G F +S ALI
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332
Query: 212 -------RHIVKDP-----------VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253
+HI K ++ E + F FL +L +P+ R T + L H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392
Query: 254 PF 255
P+
Sbjct: 393 PW 394
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-34
Identities = 55/218 (25%), Positives = 107/218 (49%), Gaps = 16/218 (7%)
Query: 9 IELVGEGSFGKVYKGRRKYTGQ----TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
I+++G G+FG VYKG G+ VA+K ++ S K + E ++ + + +
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK-ELREATSPKANKEILDEAYVMASVDNPH 78
Query: 65 IIEMLD-SFESPQEFCVVTEFA-QGELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLHSN 121
+ +L S ++T+ G L + + E + + + + Q+ + ++YL
Sbjct: 79 VCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG-TPL-YMAPELVREQPY 179
R++HRD+ +N+L+ VK+ DFG A+ + A + G P+ +MA E + + Y
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 180 NHTADLWSLGVILYELF-VGQPPF--YTNS-VYALIRH 213
H +D+WS GV ++EL G P+ S + +++
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 60/220 (27%), Positives = 114/220 (51%), Gaps = 12/220 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ + +G G +G+VY+G K TVA+K +K E + +E +++++KH
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK-TLKEDTMEVE--EFLKEAAVMKEIKHP 69
Query: 64 NIIEMLD--SFESPQEFCVVTEFAQ-GELFEIL--EDDKCLPEEQVQSIAKQLVRALHYL 118
N++++L + E P F ++TEF G L + L + + + + +A Q+ A+ YL
Sbjct: 70 NLVQLLGVCTREPP--FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-YMAPELVREQ 177
IHRD+ +N L+G +VK+ DFG +R M+ +T + P+ + APE +
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 178 PYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVK 216
++ +D+W+ GV+L+E+ G P+ + + + K
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 14/220 (6%)
Query: 7 HVIELVGEGSFGKVYKGRRKYTGQ---TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
H ++G+G FG VY G Q A+K + + + +E ++R L H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK-SLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 64 NIIEMLD--SFESPQEFCVVTEFAQ-GELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLH 119
N++ ++ V+ + G+L + + + + + S Q+ R + YL
Sbjct: 83 NVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM-SANTVVLRSIKGTPL---YMAPELVR 175
+ +HRD+ +N ++ VK+ DFG AR + ++ + L + A E ++
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 176 EQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHI 214
+ +D+WS GV+L+EL G PP+ + L +
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL 241
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-34
Identities = 53/219 (24%), Positives = 98/219 (44%), Gaps = 12/219 (5%)
Query: 7 HVIELVGEGSFGKVYKGRRKYTG---QTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
H E++G G FG VY G A+K + ++ E I++ H
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK-SLNRITDIGEVSQFLTEGIIMKDFSHP 150
Query: 64 NIIEMLD-SFESPQEFCVVTEFAQ-GELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLHS 120
N++ +L S VV + + G+L + + + + Q+ + + +L S
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAM-SANTVVLRSIKGTPL---YMAPELVRE 176
+ +HRD+ +N ++ VK+ DFG AR M + + G L +MA E ++
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 177 QPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHI 214
Q + +D+WS GV+L+EL G PP+ + + + ++
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-34
Identities = 47/233 (20%), Positives = 99/233 (42%), Gaps = 26/233 (11%)
Query: 4 ENYHVIELVGEGSFGKVYKGR---RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
+ +++GEG FG V +G T VA+K + S+++I E ++
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 61 KHQNIIEML-----DSFESPQEFCVVTEFAQ-GELFEIL------EDDKCLPEEQVQSIA 108
H N+I +L S + + V+ F + G+L L K +P + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 109 KQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM------SANTVVLRSI 162
+ + YL + +HRD+ +N ++ V + DFG ++ + + +
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 163 KGTPLYMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHI 214
K ++A E + ++ Y +D+W+ GV ++E+ G P+ + + ++
Sbjct: 214 K----WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-34
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 10/206 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E+ + E +G G+FG+V+ GR + VA+K + QE IL++ H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVK-SCRETLPPDLKAKFLQEARILKQYSHP 172
Query: 64 NIIEMLD--SFESPQEFCVVTEFAQ-GELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLH 119
NI+ ++ + + P +V E Q G+ L + L + + + + YL
Sbjct: 173 NIVRLIGVCTQKQP--IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGT-PL-YMAPELVREQ 177
S IHRD+ +N L+ +V+K+ DFG +R + P+ + APE +
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 178 PYNHTADLWSLGVILYELF-VGQPPF 202
Y+ +D+WS G++L+E F +G P+
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPY 316
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-34
Identities = 55/216 (25%), Positives = 110/216 (50%), Gaps = 18/216 (8%)
Query: 8 VIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIE 67
+++ +G+G FG V G Y G VA+K +K+ + + E ++ +L+H N+++
Sbjct: 197 LLQTIGKGEFGDVMLG--DYRGNKVAVK-CIKNDATAQA---FLAEASVMTQLRHSNLVQ 250
Query: 68 MLD--SFESPQEFCVVTEFAQ-GELFEIL--EDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
+L E +VTE+ G L + L L + + + + A+ YL N
Sbjct: 251 LLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR-SIKGTPLYMAPELVREQPYNH 181
+HRD+ +N+L+ +V K+ DFG + S+ + +K + APE +RE+ ++
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREKKFST 365
Query: 182 TADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVK 216
+D+WS G++L+E++ G+ P+ + ++ + K
Sbjct: 366 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-33
Identities = 62/219 (28%), Positives = 111/219 (50%), Gaps = 12/219 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E+ + +G+G FG+V+ G T + VA+K +K G + QE ++++KL+H+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIK-TLKPGTMSPE--AFLQEAQVMKKLRHE 239
Query: 64 NIIEMLD-SFESPQEFCVVTEF-AQGELFEIL--EDDKCLPEEQVQSIAKQLVRALHYLH 119
++++ E P +VTE+ ++G L + L E K L Q+ +A Q+ + Y+
Sbjct: 240 KLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-YMAPELVREQP 178
+HRD++ NIL+G V K+ DFG AR + N R P+ + APE
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 179 YNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVK 216
+ +D+WS G++L EL G+ P+ ++ + +
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 55/224 (24%), Positives = 106/224 (47%), Gaps = 22/224 (9%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQT-VAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
++ +G G FG V+ G + + VA+K ++ G ++ + +E E++ KL H
Sbjct: 8 SELTFVQEIGSGQFGLVHLG--YWLNKDKVAIK-TIREGAMSEE--DFIEEAEVMMKLSH 62
Query: 63 QNIIEMLD--SFESPQEFCVVTEF-AQGELFEIL-EDDKCLPEEQVQSIAKQLVRALHYL 118
++++ ++P C+VTEF G L + L E + + + + YL
Sbjct: 63 PKLVQLYGVCLEQAP--ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS-----IKGTPLYMAPEL 173
+IHRD+ +N L+G V+K+ DFG R + + + +K + +PE+
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK----WASPEV 176
Query: 174 VREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVK 216
Y+ +D+WS GV+++E+F G+ P+ S ++ I
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 220
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 15/213 (7%)
Query: 13 GEGSFGKVYKGRRKYTGQT--VAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLD 70
G G+FG V +G + + VA+K ++K G + D + +E +I+ +L + I+ ++
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIK-VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 71 -SFESPQEFCVVTEFAQ-GELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRD 127
+V E A G L + L + +P V + Q+ + YL +HRD
Sbjct: 78 VCQAEA--LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135
Query: 128 MKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGT--PL-YMAPELVREQPYNHTAD 184
+ +N+L+ K+ DFG ++A+ A+ + PL + APE + + ++ +D
Sbjct: 136 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSD 195
Query: 185 LWSLGVILYELF-VGQPPF--YTNS-VYALIRH 213
+WS GV ++E GQ P+ V A I
Sbjct: 196 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 55/219 (25%), Positives = 107/219 (48%), Gaps = 14/219 (6%)
Query: 7 HVIELVGEGSFGKVYKGRRKYTGQ---TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
H+ +++G G G+V GR + GQ VA+K +K G +E+ + E I+ + H
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK-ALKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 64 NIIEMLD--SFESPQEFCVVTEFAQ-GELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLH 119
NII + + +VTE+ + G L L D Q+ + + + + YL
Sbjct: 111 NIIRLEGVVTRGRL--AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL---YMAPELVRE 176
+HRD+ +N+L+ + V K+ DFG +R + + + G + + APE +
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 177 QPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHI 214
+ ++ +D+WS GV+++E+ G+ P++ + +I +
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 56/213 (26%), Positives = 113/213 (53%), Gaps = 15/213 (7%)
Query: 13 GEGSFGKVYKG--RRKYTGQTVAMKFIMKHGKSEKDIHN-LRQEIEILRKLKHQNIIEML 69
G G+FG V KG + K +TVA+K I+K+ ++ + + L E ++++L + I+ M+
Sbjct: 26 GSGNFGTVKKGYYQMKKVVKTVAVK-ILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 70 D-SFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRD 127
+ +V E A+ G L + L+ ++ + ++ + + Q+ + YL + +HRD
Sbjct: 85 GICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 142
Query: 128 MKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGT--PL-YMAPELVREQPYNHTAD 184
+ +N+L+ K+ DFG ++A+ A+ ++ P+ + APE + ++ +D
Sbjct: 143 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSD 202
Query: 185 LWSLGVILYELF-VGQPPF--YTNS-VYALIRH 213
+WS GV+++E F GQ P+ S V A++
Sbjct: 203 VWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 5e-33
Identities = 62/219 (28%), Positives = 111/219 (50%), Gaps = 12/219 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E+ + +G+G FG+V+ G T + VA+K +K G + QE ++++KL+H+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIK-TLKPGTMSPE--AFLQEAQVMKKLRHE 322
Query: 64 NIIEMLD-SFESPQEFCVVTEF-AQGELFEIL--EDDKCLPEEQVQSIAKQLVRALHYLH 119
++++ E P +VTE+ ++G L + L E K L Q+ +A Q+ + Y+
Sbjct: 323 KLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-YMAPELVREQP 178
+HRD++ NIL+G V K+ DFG AR + N R P+ + APE
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440
Query: 179 YNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVK 216
+ +D+WS G++L EL G+ P+ ++ + +
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-33
Identities = 52/232 (22%), Positives = 106/232 (45%), Gaps = 24/232 (10%)
Query: 4 ENYHVIELVGEGSFGKVYKGR-----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILR 58
E + +G+GSFG VY+G + VA+K + S ++ E +++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK-TVNEAASMRERIEFLNEASVMK 83
Query: 59 KLKHQNIIEMLD--SFESPQEFCVVTEFAQ-GELFEIL----------EDDKCLPEEQVQ 105
+ +++ +L S P V+ E G+L L ++
Sbjct: 84 EFNCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 106 SIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGT 165
+A ++ + YL++N+ +HRD+ +N ++ VK+ DFG R + + KG
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 166 -PL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHI 214
P+ +M+PE +++ + +D+WS GV+L+E+ + + P+ S ++R +
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 22/222 (9%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQT-VAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
E +++ +G G FG V G K+ GQ VA+K ++K G +D QE + + KL H
Sbjct: 8 EEITLLKELGSGQFGVVKLG--KWKGQYDVAVK-MIKEGSMSED--EFFQEAQTMMKLSH 62
Query: 63 QNIIEMLD--SFESPQEFCVVTEF-AQGELFEIL-EDDKCLPEEQVQSIAKQLVRALHYL 118
+++ S E P +VTE+ + G L L K L Q+ + + + +L
Sbjct: 63 PKLVKFYGVCSKEYP--IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS-----IKGTPLYMAPEL 173
S++ IHRD+ +N L+ VK+ DFG R + + V +K + APE+
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK----WSAPEV 176
Query: 174 VREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHI 214
Y+ +D+W+ G++++E+F +G+ P+ + ++ +
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-33
Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 13/204 (6%)
Query: 9 IELVGEGSFGKVYKGRRKYTGQ----TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
I+++G G+FG VYKG G+ VA+K ++ S K + E ++ + + +
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK-ELREATSPKANKEILDEAYVMASVDNPH 78
Query: 65 IIEMLD-SFESPQEFCVVTEFA-QGELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLHSN 121
+ +L S ++T+ G L + + E + + + + Q+ + ++YL
Sbjct: 79 VCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG-TPL-YMAPELVREQPY 179
R++HRD+ +N+L+ VK+ DFG A+ + A + G P+ +MA E + + Y
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 180 NHTADLWSLGVILYELF-VGQPPF 202
H +D+WS GV ++EL G P+
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPY 220
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-33
Identities = 50/206 (24%), Positives = 102/206 (49%), Gaps = 13/206 (6%)
Query: 7 HVIELVGEGSFGKVYKGRRKYTGQ----TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
++++G G FG V+KG G+ V +K +++ + + + + L H
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIK-VIEDKSGRQSFQAVTDHMLAIGSLDH 74
Query: 63 QNIIEMLD-SFESPQEFCVVTEFA-QGELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLH 119
+I+ +L S +VT++ G L + + + L + + + Q+ + ++YL
Sbjct: 75 AHIVRLLGLCPGSS--LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 132
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKG-TPL-YMAPELVREQ 177
+ ++HR++ +N+L+ + S V++ DFG A + + L + TP+ +MA E +
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 178 PYNHTADLWSLGVILYELF-VGQPPF 202
Y H +D+WS GV ++EL G P+
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEPY 218
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 69/256 (26%), Positives = 117/256 (45%), Gaps = 35/256 (13%)
Query: 4 ENYHVIELVGEGSFGKVYKGR-----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILR 58
+ +G G+FGKV + + TVA+K ++K + L E+++L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK-MLKPSAHLTEREALMSELKVLS 81
Query: 59 KL-KHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEIL------------------EDDKC 98
L H NI+ +L + V+TE+ G+L L +D+
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 99 LPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158
L E + S + Q+ + + +L S IHRD+ +NIL+ G + K+CDFG AR + ++
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 159 LRSIKGT-PL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIV 215
+ P+ +MAPE + Y +D+WS G+ L+ELF +G P+ V + ++
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 216 KD------PVKYPDEM 225
K+ P P EM
Sbjct: 262 KEGFRMLSPEHAPAEM 277
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 68/255 (26%), Positives = 120/255 (47%), Gaps = 34/255 (13%)
Query: 4 ENYHVIELVGEGSFGKVYKGR-----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILR 58
+ + + +G G+FG+V + + T +TVA+K ++K G + + L E++IL
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRALMSELKILI 85
Query: 59 KL-KHQNIIEMLD-SFESPQEFCVVTEFAQ-GELFEIL----------------EDDKCL 99
+ H N++ +L + V+ EF + G L L L
Sbjct: 86 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 100 PEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159
E + + Q+ + + +L S + IHRD+ +NIL+ +VVK+CDFG AR + + +
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205
Query: 160 RSIKGT-PL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVK 216
R PL +MAPE + ++ Y +D+WS GV+L+E+F +G P+ + +K
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265
Query: 217 D------PVKYPDEM 225
+ P EM
Sbjct: 266 EGTRMRAPDYTTPEM 280
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 55/224 (24%), Positives = 113/224 (50%), Gaps = 22/224 (9%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQT-VAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
++ ++ +G G FG V G K+ GQ VA+K ++K G +D +E +++ L H
Sbjct: 24 KDLTFLKELGTGQFGVVKYG--KWRGQYDVAIK-MIKEGSMSED--EFIEEAKVMMNLSH 78
Query: 63 QNIIEMLD--SFESPQEFCVVTEF-AQGELFEIL-EDDKCLPEEQVQSIAKQLVRALHYL 118
+ ++++ + + P ++TE+ A G L L E +Q+ + K + A+ YL
Sbjct: 79 EKLVQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS-----IKGTPLYMAPEL 173
S + +HRD+ +N L+ VVK+ DFG +R + + ++ + PE+
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPEV 192
Query: 174 VREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVK 216
+ ++ +D+W+ GV+++E++ +G+ P+ + HI +
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 60/244 (24%), Positives = 115/244 (47%), Gaps = 34/244 (13%)
Query: 4 ENYHVIELVGEGSFGKVYKGR-----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILR 58
+N + + +GEG FGKV K + TVA+K ++K S ++ +L E +L+
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK-MLKENASPSELRDLLSEFNVLK 81
Query: 59 KLKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEIL------------------------ 93
++ H ++I++ + ++ E+A+ G L L
Sbjct: 82 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 94 EDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS 153
D++ L + S A Q+ + + YL +++HRD+ +NIL+ G +K+ DFG +R +
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 154 ANTVVLRSIKGT-PL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYAL 210
++ +G P+ +MA E + + Y +D+WS GV+L+E+ +G P+ L
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261
Query: 211 IRHI 214
+
Sbjct: 262 FNLL 265
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-32
Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 11/219 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQ---TVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
E + +GEG FG V++G VA+K K+ S+ QE +R+
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK-TCKNCTSDSVREKFLQEALTMRQF 448
Query: 61 KHQNIIEMLD-SFESPQEFCVVTEFA-QGELFEIL-EDDKCLPEEQVQSIAKQLVRALHY 117
H +I++++ E+P ++ E GEL L L + A QL AL Y
Sbjct: 449 DHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL-YMAPELVRE 176
L S R +HRD+ +N+L+ + VKL DFG +R M +T S P+ +MAPE +
Sbjct: 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 177 QPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHI 214
+ + +D+W GV ++E+ G PF +I I
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-32
Identities = 58/211 (27%), Positives = 104/211 (49%), Gaps = 14/211 (6%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQ---TVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
N + ++VG G FG+V GR K + +VA+K +K G +EK + E I+ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK-TLKVGYTEKQRRDFLGEASIMGQF 103
Query: 61 KHQNIIEMLD--SFESPQEFCVVTEF-AQGELFEIL-EDDKCLPEEQVQSIAKQLVRALH 116
H NII + + P +VTE+ G L L + D Q+ + + + +
Sbjct: 104 DHPNIIRLEGVVTKSKP--VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 117 YLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL---YMAPEL 173
YL +HRD+ +NILI + V K+ DFG R + + + +G + + +PE
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 174 VREQPYNHTADLWSLGVILYELF-VGQPPFY 203
+ + + +D+WS G++L+E+ G+ P++
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 69/239 (28%), Positives = 125/239 (52%), Gaps = 29/239 (12%)
Query: 4 ENYHVIELVGEGSFGKVYKGR-------RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEI 56
+ + + +GEG+FG+V + TVA+K ++K +EKD+ +L E+E+
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK-MLKDDATEKDLSDLVSEMEM 93
Query: 57 LRKL-KHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEIL----------------EDDKC 98
++ + KH+NII +L + V+ E+A G L E L ++
Sbjct: 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 99 LPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158
+ + + S QL R + YL S + IHRD+ +N+L+ +V+K+ DFG AR ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 159 LRSIKGT-PL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHI 214
++ G P+ +MAPE + ++ Y H +D+WS GV+++E+F +G P+ V L + +
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-32
Identities = 69/239 (28%), Positives = 124/239 (51%), Gaps = 29/239 (12%)
Query: 4 ENYHVIELVGEGSFGKVYKGR-------RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEI 56
+ + + +GEG FG+V + TVA+K ++K +EKD+ +L E+E+
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK-MLKDDATEKDLSDLVSEMEM 139
Query: 57 LRKL-KHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEIL----------------EDDKC 98
++ + KH+NII +L + V+ E+A G L E L ++
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 99 LPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158
+ + + S QL R + YL S + IHRD+ +N+L+ +V+K+ DFG AR ++
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259
Query: 159 LRSIKGT-PL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHI 214
++ G P+ +MAPE + ++ Y H +D+WS GV+++E+F +G P+ V L + +
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 67/225 (29%), Positives = 104/225 (46%), Gaps = 22/225 (9%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQ---TVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
E + +GEG FG V++G VA+K K+ S+ QE +R+
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCTSDSVREKFLQEALTMRQF 73
Query: 61 KHQNIIEMLD-SFESPQEFCVVTEF-AQGELFEIL-EDDKCLPEEQVQSIAKQLVRALHY 117
H +I++++ E+P ++ E GEL L L + A QL AL Y
Sbjct: 74 DHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 131
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS-----IKGTPLYMAPE 172
L S R +HRD+ +N+L+ + VKL DFG +R M +T S IK +MAPE
Sbjct: 132 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPE 187
Query: 173 LVREQPYNHTADLWSLGVILYELF-VGQPPF--YTNS-VYALIRH 213
+ + + +D+W GV ++E+ G PF N+ V I +
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 232
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-32
Identities = 57/212 (26%), Positives = 104/212 (49%), Gaps = 15/212 (7%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTG----QTVAMKFIMKHGKSEKDIHNLRQEIEILRK 59
+++G G FG+VYKG K + VA+K +K G +EK + E I+ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK-TLKAGYTEKQRVDFLGEAGIMGQ 102
Query: 60 LKHQNIIEMLD--SFESPQEFCVVTEF-AQGELFEIL-EDDKCLPEEQVQSIAKQLVRAL 115
H NII + S P ++TE+ G L + L E D Q+ + + + +
Sbjct: 103 FSHHNIIRLEGVISKYKP--MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 116 HYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL---YMAPE 172
YL + +HRD+ +NIL+ + V K+ DFG +R + + + G + + APE
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 173 LVREQPYNHTADLWSLGVILYELF-VGQPPFY 203
+ + + +D+WS G++++E+ G+ P++
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPYW 252
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 59/224 (26%), Positives = 107/224 (47%), Gaps = 22/224 (9%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQT-VAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
E ++E +G G FG+V+ G Y G T VA+K +K G D E ++++L+H
Sbjct: 13 ETLKLVERLGAGQFGEVWMG--YYNGHTKVAVK-SLKQGSMSPD--AFLAEANLMKQLQH 67
Query: 63 QNIIEMLD-SFESPQEFCVVTEF-AQGELFEIL--EDDKCLPEEQVQSIAKQLVRALHYL 118
Q ++ + + P ++TE+ G L + L L ++ +A Q+ + ++
Sbjct: 68 QRLVRLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS-----IKGTPLYMAPEL 173
IHRD++ NIL+ K+ DFG AR + N R IK + APE
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK----WTAPEA 181
Query: 174 VREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVK 216
+ + +D+WS G++L E+ G+ P+ + +I+++ +
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 68/233 (29%), Positives = 109/233 (46%), Gaps = 25/233 (10%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTG--QTVAMKFIMKHGKSEKDIHNLRQEIEILRKL- 60
+ +++GEG+FG+V K R K G A+K MK S+ D + E+E+L KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK-RMKEYASKDDHRDFAGELEVLCKLG 83
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEIL----------------EDDKCLPEEQ 103
H NII +L + E + E+A G L + L L +Q
Sbjct: 84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 104 VQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK 163
+ A + R + YL + IHRD+ +NIL+G V K+ DFG +R V +++
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMG 201
Query: 164 GTPL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHI 214
P+ +MA E + Y +D+WS GV+L+E+ +G P+ + L +
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 65/261 (24%), Positives = 120/261 (45%), Gaps = 40/261 (15%)
Query: 4 ENYHVIELVGEGSFGKVYKGR-----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILR 58
EN +++G G+FGKV + VA+K ++K + L E++++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK-MLKEKADSSEREALMSELKMMT 103
Query: 59 KL-KHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEIL----------------------- 93
+L H+NI+ +L + ++ E+ G+L L
Sbjct: 104 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 94 EDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS 153
ED L E + A Q+ + + +L +HRD+ +N+L+ G VVK+CDFG AR +
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 154 ANTVVLRSIKGT-PL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYAL 210
+++ + P+ +MAPE + E Y +D+WS G++L+E+F +G P+ V A
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 283
Query: 211 IRHIVKD------PVKYPDEM 225
++++ P +E+
Sbjct: 284 FYKLIQNGFKMDQPFYATEEI 304
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 62/238 (26%), Positives = 112/238 (47%), Gaps = 29/238 (12%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQ-----TVAMKFIMKHGKSEKDIHNLRQEIEILR 58
N + +G G+FGKV + G+ VA+K ++K + L E++I+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK-MLKSTAHADEKEALMSELKIMS 104
Query: 59 KL-KHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEIL--------------EDDKCLPEE 102
L +H+NI+ +L + V+TE+ G+L L +
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164
Query: 103 QVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162
+ + Q+ + + +L S IHRD+ +N+L+ G V K+ DFG AR + ++ +
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 163 KGT-PL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFY---TNS-VYALIRH 213
P+ +MAPE + + Y +D+WS G++L+E+F +G P+ NS Y L++
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-31
Identities = 70/239 (29%), Positives = 124/239 (51%), Gaps = 29/239 (12%)
Query: 4 ENYHVIELVGEGSFGKVYKGR-------RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEI 56
+ + + +GEG+FG+V + VA+K ++K +EKD+ +L E+E+
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK-MLKSDATEKDLSDLISEMEM 127
Query: 57 LRKL-KHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEIL----------------EDDKC 98
++ + KH+NII +L + V+ E+A G L E L ++
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 99 LPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158
L + + S A Q+ R + YL S + IHRD+ +N+L+ +V+K+ DFG AR +
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 159 LRSIKGT-PL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHI 214
++ G P+ +MAPE + ++ Y H +D+WS GV+L+E+F +G P+ V L + +
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 24/234 (10%)
Query: 4 ENYHVIELVGEGSFGKVYKGR-----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILR 58
+N +I +G G+FG+VY+G+ + VA+K + SE+D + E I+
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDELDFLMEALIIS 88
Query: 59 KLKHQNIIEML--DSFESPQEFCVVTEF-AQGELFEIL-------EDDKCLPEEQVQSIA 108
K HQNI+ + P ++ E A G+L L L + +A
Sbjct: 89 KFNHQNIVRCIGVSLQSLP--RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 109 KQLVRALHYLHSNRIIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGT 165
+ + YL N IHRD+ +N L+ G G V K+ DFG AR + + +
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 166 -PL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVK 216
P+ +M PE E + D WS GV+L+E+F +G P+ + S ++ +
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 57/239 (23%), Positives = 102/239 (42%), Gaps = 32/239 (13%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTG-----QTVAMKFIMKHGKSEKDIHNLRQEIEILR 58
+E +GE FGKVYKG Q VA+K +K R E +
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK-TLKDKAEGPLREEFRHEAMLRA 67
Query: 59 KLKHQNIIEMLD--SFESPQEFCVVTEF-AQGELFEIL----------------EDDKCL 99
+L+H N++ +L + + P ++ + + G+L E L L
Sbjct: 68 RLQHPNVVCLLGVVTKDQP--LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 100 PEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159
+ Q+ + YL S+ ++H+D+ +N+L+ VK+ D G R +
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV-YAADYY 184
Query: 160 RSIKGTPL---YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHI 214
+ + + L +MAPE + ++ +D+WS GV+L+E+F G P+ S ++ I
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 243
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-31
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 13 GEGSFGKVYKGRRKYTGQT--VAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLD 70
G G+FG V +G + + VA+K ++K G + D + +E +I+ +L + I+ ++
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIK-VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 71 SFESPQEFCVVTEFAQ-GELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDM 128
++ +V E A G L + L + +P V + Q+ + YL +HR++
Sbjct: 404 VCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNL 462
Query: 129 KPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL---YMAPELVREQPYNHTADL 185
+N+L+ K+ DFG ++A+ A+ + + APE + + ++ +D+
Sbjct: 463 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 522
Query: 186 WSLGVILYELF-VGQPPF--YTNS-VYALIRH 213
WS GV ++E GQ P+ V A I
Sbjct: 523 WSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-31
Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 8 VIELVGEGSFGKVYKGRRKYTGQT-VAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNII 66
+ + +G G FG+V+ Y T VA+K MK G + E +++ L+H ++
Sbjct: 192 LEKKLGAGQFGEVWMA--TYNKHTKVAVK-TMKPGSMSVE--AFLAEANVMKTLQHDKLV 246
Query: 67 EMLD-SFESPQEFCVVTEFAQ-GELFEIL--EDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
++ + P ++TEF G L + L ++ P ++ + Q+ + ++
Sbjct: 247 KLHAVVTKEP--IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS-----IKGTPLYMAPELVREQ 177
IHRD++ NIL+ A V K+ DFG AR + N R IK + APE +
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK----WTAPEAINFG 360
Query: 178 PYNHTADLWSLGVILYELF-VGQPPF 202
+ +D+WS G++L E+ G+ P+
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIPY 386
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-31
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 9 IELVGEGSFGKVYKGR-RKYTGQT--VAMKFIMKHGK--SEKDIHNLRQEIEILRKLKHQ 63
+E +G+GSFG V +G +G+T VA+K +K + + + +E+ + L H+
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVK-CLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 64 NIIEMLD-SFESPQEFCVVTEFA-QGELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLHS 120
N+I + P +VTE A G L + L + + A Q+ + YL S
Sbjct: 82 NLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL---YMAPELVREQ 177
R IHRD+ +N+L+ +VK+ DFG RA+ N + + + APE ++ +
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 178 PYNHTADLWSLGVILYELF-VGQPPF 202
++H +D W GV L+E+F GQ P+
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEPW 225
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-30
Identities = 63/238 (26%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 4 ENYHVIELVGEGSFGKVYKGR-----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILR 58
+N +I +G G+FG+VY+G+ + VA+K + SE+D + E I+
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDELDFLMEALIIS 129
Query: 59 KLKHQNIIEML--DSFESPQEFCVVTEFAQ-GELFEIL-------EDDKCLPEEQVQSIA 108
K HQNI+ + P ++ E G+L L L + +A
Sbjct: 130 KFNHQNIVRCIGVSLQSLP--RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 109 KQLVRALHYLHSNRIIHRDMKPQNILI---GAGSVVKLCDFGFARAM------SANTVVL 159
+ + YL N IHRD+ +N L+ G G V K+ DFG AR + +
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVK 216
+K +M PE E + D WS GV+L+E+F +G P+ + S ++ +
Sbjct: 248 LPVK----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 33/249 (13%), Positives = 69/249 (27%), Gaps = 40/249 (16%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFI-MKHGKSEKDIHNLRQEIEILRKLKHQN 64
Y ++ G + ++ + VA+ F+ + + + L ++
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 65 IIEMLDSFESPQEFCVVTEFAQGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRI 123
+ +LD + VV E+ +G L E+ + + L A H +
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGV 150
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTA 183
P + + V L M N
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA--------------------TMPDA-------NPQD 183
Query: 184 DLWSLGVILYELFVGQPPF----YTNSVYALIRHIVKDPVKYPDEMSPN----FKSFLKG 235
D+ +G LY L V + P + + R P++ P ++ + +
Sbjct: 184 DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIE-PADIDRDIPFQISAVAAR 242
Query: 236 LLNKVPQNR 244
+ R
Sbjct: 243 SVQGDGGIR 251
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 53/232 (22%), Positives = 95/232 (40%), Gaps = 28/232 (12%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQT-------VAMKFIMKHGKSEKDIHNLRQEIEI 56
E+ E +G+G+F K++KG R+ G V +K ++ + + +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLK-VLDKA-HRNYSESFFEAASM 65
Query: 57 LRKLKHQNIIEMLDSFESPQEFCVVTEF-AQGELFEIL-EDDKCLPEEQVQSIAKQLVRA 114
+ KL H++++ E +V EF G L L ++ C+ +AKQL A
Sbjct: 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA 125
Query: 115 LHYLHSNRIIHRDMKPQNILI--------GAGSVVKLCDFGFARAMSANTVVLRSIKGTP 166
+H+L N +IH ++ +NIL+ G +KL D G + + ++ I
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP--- 182
Query: 167 LYMAPE-LVREQPYNHTADLWSLGVILYELF-VGQPPFY--TNS-VYALIRH 213
++ PE + + N D WS G L+E+ G P +
Sbjct: 183 -WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQT---VAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
E+ + ++GEG FG+VY+G VA+K K + + E I++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVK-TCKKDCTLDNKEKFMSEAVIMKNL 70
Query: 61 KHQNIIEMLD-SFESPQEFCVVTEFAQ-GELFEIL-EDDKCLPEEQVQSIAKQLVRALHY 117
H +I++++ E P ++ E GEL L + L + + Q+ +A+ Y
Sbjct: 71 DHPHIVKLIGIIEEEP--TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS-----IKGTPLYMAPE 172
L S +HRD+ +NIL+ + VKL DFG +R + S IK +M+PE
Sbjct: 129 LESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK----WMSPE 184
Query: 173 LVREQPYNHTADLWSLGVILYELF-VGQPPFY 203
+ + + +D+W V ++E+ G+ PF+
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 216
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 58/247 (23%), Positives = 111/247 (44%), Gaps = 40/247 (16%)
Query: 4 ENYHVIELVGEGSFGKVYKGR-----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILR 58
N + +GEG+FG+V++ R VA+K ++K S + ++E ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQREAALMA 105
Query: 59 KLKHQNIIEMLD--SFESPQEFCVVTEFAQ-GELFEIL---------------------- 93
+ + NI+++L + P C++ E+ G+L E L
Sbjct: 106 EFDNPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 94 --EDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARA 151
L + IA+Q+ + YL + +HRD+ +N L+G VVK+ DFG +R
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 152 MSANTVVLRSIKGTPL---YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSV 207
+ + ++ + +M PE + Y +D+W+ GV+L+E+F G P+Y +
Sbjct: 224 I-YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282
Query: 208 YALIRHI 214
+I ++
Sbjct: 283 EEVIYYV 289
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 64/239 (26%), Positives = 110/239 (46%), Gaps = 33/239 (13%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTG-----QTVAMKFIMKHGKSEKDIHNLRQEIEILR 58
+ + +GEG+FGKV+ VA+K +K + + ++E E+L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK-ALKDP-TLAARKDFQREAELLT 72
Query: 59 KLKHQNIIEMLD--SFESPQEFCVVTEF-AQGELFEIL----------------EDDKCL 99
L+H++I++ P +V E+ G+L + L + L
Sbjct: 73 NLQHEHIVKFYGVCGDGDP--LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 100 PEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159
Q+ IA Q+ + YL S +HRD+ +N L+GA +VK+ DFG +R + +
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY- 189
Query: 160 RSIKGTPL---YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHI 214
R T L +M PE + + + +D+WS GVIL+E+F G+ P++ S +I I
Sbjct: 190 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 248
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-30
Identities = 64/237 (27%), Positives = 110/237 (46%), Gaps = 30/237 (12%)
Query: 4 ENYHVIELVGEGSFGKVYKGR-----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILR 58
+ + +GEG+FGKV+ + VA+K +K SE + ++E E+L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVK-ALKEA-SESARQDFQREAELLT 98
Query: 59 KLKHQNIIEMLD--SFESPQEFCVVTEFAQ-GELFEIL---------------EDDKCLP 100
L+HQ+I+ + P +V E+ + G+L L L
Sbjct: 99 MLQHQHIVRFFGVCTEGRP--LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 101 EEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160
Q+ ++A Q+ + YL +HRD+ +N L+G G VVK+ DFG +R + +
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 216
Query: 161 SIKGT-PL-YMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHI 214
+ P+ +M PE + + + +D+WS GV+L+E+F G+ P+Y S I I
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-28
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 11 LVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLD 70
L+G G FGKVYKG + G VA+K + +S + I EIE L +H +++ ++
Sbjct: 46 LIGHGVFGKVYKGVLR-DGAKVALK--RRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 71 SFESPQEFCVVTEF-AQGE----LFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIH 125
+ E ++ ++ G L+ + EQ I R LHYLH+ IIH
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIH 162
Query: 126 RDMKPQNILIGAGSVVKLCDFGFARAMSAN------TVVLRSIKGTPLYMAPELVREQPY 179
RD+K NIL+ V K+ DFG ++ + TVV KGT Y+ PE +
Sbjct: 163 RDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV----KGTLGYIDPEYFIKGRL 218
Query: 180 NHTADLWSLGVILYELFVGQPP 201
+D++S GV+L+E+ +
Sbjct: 219 TEKSDVYSFGVVLFEVLCARSA 240
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 66/204 (32%), Positives = 99/204 (48%), Gaps = 13/204 (6%)
Query: 11 LVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQ---EIEILRKLKHQNIIE 67
+GEG FG VYKG TVA+K + +Q EI+++ K +H+N++E
Sbjct: 38 KMGEGGFGVVYKGYVN--NTTVAVK-KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 68 MLDSFESPQEFCVVTEF-AQGELFEIL---EDDKCLPEEQVQSIAKQLVRALHYLHSNRI 123
+L + C+V + G L + L + L IA+ +++LH N
Sbjct: 95 LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 154
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSA--NTVVLRSIKGTPLYMAPELVREQPYNH 181
IHRD+K NIL+ K+ DFG ARA TV+ I GT YMAPE +R +
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPK 214
Query: 182 TADLWSLGVILYELFVGQPPFYTN 205
+D++S GV+L E+ G P +
Sbjct: 215 -SDIYSFGVVLLEIITGLPAVDEH 237
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
Y + +G GSFG +Y G G+ VA+K ++ K++ L E +I + ++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK--LECVKTKH--PQLHIESKIYKMMQGG 64
Query: 64 NIIEMLDSFESPQEF-CVVTEFAQGELFEILED--DKC---LPEEQVQSIAKQLVRALHY 117
I + + ++ +V E L LED + C + V +A Q++ + Y
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMEL----LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 118 LHSNRIIHRDMKPQNILIGAG---SVVKLCDFGFARA-MSANTVVL------RSIKGTPL 167
+HS IHRD+KP N L+G G ++V + DFG A+ A T +++ GT
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 168 YM--APELVREQPYNHTADLWSLGVILYELFVGQPP 201
Y L EQ DL SLG +L +G P
Sbjct: 181 YASINTHLGIEQSRR--DDLESLGYVLMYFNLGSLP 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 2e-23
Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ + +G GSFG++Y G T + VA+K + L E +I R L+
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLE----NVKTKHPQLLYESKIYRILQGG 62
Query: 64 NIIEMLDSFESPQEF-CVVTEFAQGELFEILED--DKC---LPEEQVQSIAKQLVRALHY 117
I + F ++ +V + L LED + C L + V +A Q++ + +
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDL----LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
Query: 118 LHSNRIIHRDMKPQNILIGAG---SVVKLCDFGFARA-MSANTVVL------RSIKGTPL 167
+HS +HRD+KP N L+G G + V + DFG A+ +T +++ GT
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 168 YM--APELVREQPYNHTADLWSLGVILYELFVGQPP 201
Y L EQ + DL SLG +L G P
Sbjct: 179 YASVNTHLGIEQ--SRRDDLESLGYVLMYFLRGSLP 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
N+ V + +G G+FG++ G+ YT + VA+K + L E ++L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL----EPMKSRAPQLHLEYRFYKQLGSGD 65
Query: 65 IIEMLDSFESPQEF-CVVTEFAQG----ELFEILEDDKCLPEEQVQSIAKQLVRALHYLH 119
I + F ++ +V E G +LF++ D+ + V IA QL+ + Y+H
Sbjct: 66 GIPQVYYFGPCGKYNAMVLEL-LGPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVH 122
Query: 120 SNRIIHRDMKPQNILIGAG-----SVVKLCDFGFARA-MSANTVVL------RSIKGTPL 167
S +I+RD+KP+N LIG V+ + DF A+ + T +S+ GT
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182
Query: 168 YM--APELVREQPYNHTADLWSLGVILYELFVGQPP 201
YM L +EQ DL +LG + G P
Sbjct: 183 YMSINTHLGKEQSRR--DDLEALGHMFMYFLRGSLP 216
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 41/232 (17%), Positives = 81/232 (34%), Gaps = 45/232 (19%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHN-LRQEIEILRKLKHQ 63
+ + + +G G FG +Y + A + K E + L E++ +++ +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVV----KVEYQENGPLFSELKFYQRVAKK 93
Query: 64 NIIEMLDSFESPQEFCV-------VTEFAQGE------------LFEILEDDKCLPEEQV 104
+ I+ + + +TEF L +I + + V
Sbjct: 94 DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTV 153
Query: 105 QSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAG--SVVKLCDFGFA-RAMSANTVV--- 158
+ +++ L Y+H N +H D+K N+L+G V L D+G + R
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213
Query: 159 ---LRSIKGTPLYMA------PELVREQPYNHTADLWSLGVILYELFVGQPP 201
+ GT + + L R +D+ LG + G+ P
Sbjct: 214 ENPRKGHNGTIEFTSLDAHKGVALSRR------SDVEILGYCMLRWLCGKLP 259
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 28/217 (12%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+Y V +GEGSFG +++G Q VA+K + +S+ LR E + L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDA--PQLRDEYRTYKLLAGC 65
Query: 64 NIIEMLDSFESPQEF-CVVTEFAQG----ELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
I + F +V + G +L ++ + + V AKQ++ + +
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDL-LGPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSI 122
Query: 119 HSNRIIHRDMKPQNILIGAG-----SVVKLCDFGFARA-MSANTVVL------RSIKGTP 166
H +++RD+KP N LIG +++ + DFG + T +++ GT
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 167 LYM--APELVREQPYNHTADLWSLGVILYELFVGQPP 201
YM L REQ + DL +LG + G P
Sbjct: 183 RYMSINTHLGREQ--SRRDDLEALGHVFMYFLRGSLP 217
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 7e-22
Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+N+ ++G G FGKVYKGR G VA+K +K +++ + E+E++ H+
Sbjct: 30 DNFSNKNILGRGGFGKVYKGRLA-DGTLVAVK-RLKEERTQGGELQFQTEVEMISMAVHR 87
Query: 64 NIIEMLDSFESPQEFCV-------VTEFAQ-----GELFEILEDDKCLPEEQVQSIAKQL 111
N++ + FC+ V + L E E L + Q IA
Sbjct: 88 NLLRLRG-------FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 140
Query: 112 VRALHYLH--SN-RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA-NTVVLRSIKGTPL 167
R L YLH + +IIHRD+K NIL+ + DFG A+ M +T V +++GT
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 200
Query: 168 YMAPELVREQPYNHTADLWSLGVILYELFVGQPPF 202
++APE + + D++ GV+L EL GQ F
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 5e-20
Identities = 40/234 (17%), Positives = 78/234 (33%), Gaps = 46/234 (19%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMK--FIMKHGKSEKDIHNLRQEIEILRKLKH 62
+ V +G+G FG +Y + ++V ++K S+ L E++ ++
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMN-SSESVGSDAPCVVKVEPSDNG--PLFTELKFYQRAAK 92
Query: 63 QNIIEMLDSFES------PQEFCVVTEFAQGELFEI---------LED--DKC---LPEE 102
I+ P+ + G+ + L+ + +
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRK 152
Query: 103 QVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAG--SVVKLCDFGFA-RAMSANTVV- 158
V ++ +++ L Y+H + +H D+K N+L+ V L D+G A R
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 159 -----LRSIKGTPLYMA------PELVREQPYNHTADLWSLGVILYELFVGQPP 201
R GT + + R DL LG + + G P
Sbjct: 213 YAADPKRCHDGTIEFTSIDAHNGVAPSRR------GDLEILGYCMIQWLTGHLP 260
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 6e-20
Identities = 49/230 (21%), Positives = 87/230 (37%), Gaps = 17/230 (7%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
++E G+ + +R + GK + + + Q+
Sbjct: 103 MVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSS 162
Query: 66 IEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIH 125
E E L E + + Q+ + + +L S + IH
Sbjct: 163 ASSGFVEEKSLSDVEEEEA------PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 216
Query: 126 RDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPL---YMAPELVREQPYNHT 182
RD+ +NIL+ +VVK+CDFG AR + + L +MAPE + ++ Y
Sbjct: 217 RDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQ 275
Query: 183 ADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKD------PVKYPDEM 225
+D+WS GV+L+E+F +G P+ + +K+ P EM
Sbjct: 276 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEM 325
|
| >4db6_A Armadillo repeat protein; solenoid repeat, armadillo repeat motif, de novo protein; 1.80A {Synthetic construct} PDB: 4db9_A 4dba_A Length = 210 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-20
Identities = 34/215 (15%), Positives = 85/215 (39%), Gaps = 15/215 (6%)
Query: 1127 EYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCAD 1186
+ + S L + L D A L + + ++ + L+ +
Sbjct: 6 HHHHHGSELPQMVQQLNSPDQQELQSALRKLSQIASGGNEQIQAVIDAGALPALVQLLSS 65
Query: 1187 PDKRTRKFACFSIGNAAYHNDVLYEELRRS--IPLLANILISDEEDKTKANAAGALSNLI 1244
P+++ + A +++ N A + + + + +P L L+S ++ A ALSN+
Sbjct: 66 PNEQILQEALWALSNIASGGNEQIQAVIDAGALPALVQ-LLSSPNEQILQEALWALSNIA 124
Query: 1245 RNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPC 1304
++ + ++ GA+ AL++L++ + ++A+ AL ++A
Sbjct: 125 SGGNEQIQAVIDAGALPALVQLLSSPNEQI----LQEALW------ALSNIASGGNE--Q 172
Query: 1305 RQFLQSSELFPVIARLRQSPESTIANYASVIISKV 1339
+Q ++ + + +L+ I A + K+
Sbjct: 173 KQAVKEAGALEKLEQLQSHENEKIQKEAQEALEKL 207
|
| >4db6_A Armadillo repeat protein; solenoid repeat, armadillo repeat motif, de novo protein; 1.80A {Synthetic construct} PDB: 4db9_A 4dba_A Length = 210 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 28/151 (18%), Positives = 64/151 (42%), Gaps = 3/151 (1%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSAL 1157
+LL S ++ + L +S++A + + A L L L+ + + +A AL
Sbjct: 61 QLLSSPNEQILQEALWALSNIASGGNEQIQAVIDAGALPALVQLLSSPNEQILQEALWAL 120
Query: 1158 GNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS- 1216
N+ + ++ + L+ + P+++ + A +++ N A + + ++ +
Sbjct: 121 SNIASGGNEQIQAVIDAGALPALVQLLSSPNEQILQEALWALSNIASGGNEQKQAVKEAG 180
Query: 1217 -IPLLANILISDEEDKTKANAAGALSNLIRN 1246
+ L L S E +K + A AL L +
Sbjct: 181 ALEKLEQ-LQSHENEKIQKEAQEALEKLQSH 210
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-19
Identities = 40/234 (17%), Positives = 76/234 (32%), Gaps = 44/234 (18%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTG--------QTVAMKFIMKHGKSEKDIHNLR---- 51
+ + + G +Y+ T Q ++K K G+ + + +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 52 ----QEIEILRKLKHQNIIEMLDSFESPQEFCV-VTEFAQG----ELFEILEDDKCLPEE 102
+ + L I + ++ V G + + L E
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS-LGRSLQSALD-VSPKHVLSER 159
Query: 103 QVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAG--SVVKLCDFGFARA-MSANTVV- 158
V +A +L+ AL +LH N +H ++ +NI + S V L +GFA + V
Sbjct: 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA 219
Query: 159 -----LRSIKGTPLYMA------PELVREQPYNHTADLWSLGVILYELFVGQPP 201
+G +++ R +DL SLG + + G P
Sbjct: 220 YVEGSRSPHEGDLEFISMDLHKGCGPSRR------SDLQSLGYCMLKWLYGFLP 267
|
| >4db8_A Armadillo-repeat protein; solenoid repeat, de novo protein; 2.50A {Synthetic construct} Length = 252 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 41/244 (16%), Positives = 99/244 (40%), Gaps = 17/244 (6%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSAL 1157
+ L+S + L S + + + A L L L+ + + +A AL
Sbjct: 19 QQLNSDDMQEQLSATRKFSQILSDGNEQIQAVIDAGALPALVQLLSSPNEQILQEALWAL 78
Query: 1158 GNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS- 1216
N+ + ++ + L+ + P+++ + A +++ N A + + + +
Sbjct: 79 SNIASGGNEQIQAVIDAGALPALVQLLSSPNEQILQEALWALSNIASGGNEQIQAVIDAG 138
Query: 1217 -IPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLAL 1275
+P L +L S ++ A ALSN+ ++ + ++ GA+ AL++L++ +
Sbjct: 139 ALPALVQLL-SSPNEQILQEALWALSNIASGGNEQIQAVIDAGALPALVQLLSSPN---- 193
Query: 1276 NPSRKDAVNESPLKIALFSLAKMCAHTP-CRQFLQSSELFPVIARLRQSPESTIANYASV 1334
E L+ AL++L+ + + +Q ++ + + +L+ I A
Sbjct: 194 ---------EQILQEALWALSNIASGGNEQKQAVKEAGALEKLEQLQSHENEKIQKEAQE 244
Query: 1335 IISK 1338
+ K
Sbjct: 245 ALEK 248
|
| >4db8_A Armadillo-repeat protein; solenoid repeat, de novo protein; 2.50A {Synthetic construct} Length = 252 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 36/213 (16%), Positives = 85/213 (39%), Gaps = 15/213 (7%)
Query: 1127 EYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCAD 1186
+ + S L + L +D + A + + ++ + L+ +
Sbjct: 6 HHHHHGSELPQMTQQLNSDDMQEQLSATRKFSQILSDGNEQIQAVIDAGALPALVQLLSS 65
Query: 1187 PDKRTRKFACFSIGNAAYHNDVLYEELRRS--IPLLANILISDEEDKTKANAAGALSNLI 1244
P+++ + A +++ N A + + + + +P L +L S ++ A ALSN+
Sbjct: 66 PNEQILQEALWALSNIASGGNEQIQAVIDAGALPALVQLL-SSPNEQILQEALWALSNIA 124
Query: 1245 RNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPC 1304
++ + ++ GA+ AL++L++ + ++A+ AL ++A
Sbjct: 125 SGGNEQIQAVIDAGALPALVQLLSSPNE----QILQEALW------ALSNIAS--GGNEQ 172
Query: 1305 RQFLQSSELFPVIARLRQSPESTIANYASVIIS 1337
Q + + P + +L SP I A +S
Sbjct: 173 IQAVIDAGALPALVQLLSSPNEQILQEALWALS 205
|
| >4db8_A Armadillo-repeat protein; solenoid repeat, de novo protein; 2.50A {Synthetic construct} Length = 252 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 28/148 (18%), Positives = 63/148 (42%), Gaps = 3/148 (2%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSAL 1157
+LL S ++ + L +S++A + + A L L L+ + + +A AL
Sbjct: 103 QLLSSPNEQILQEALWALSNIASGGNEQIQAVIDAGALPALVQLLSSPNEQILQEALWAL 162
Query: 1158 GNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS- 1216
N+ + ++ + L+ + P+++ + A +++ N A + + ++ +
Sbjct: 163 SNIASGGNEQIQAVIDAGALPALVQLLSSPNEQILQEALWALSNIASGGNEQKQAVKEAG 222
Query: 1217 -IPLLANILISDEEDKTKANAAGALSNL 1243
+ L L S E +K + A AL L
Sbjct: 223 ALEKLEQ-LQSHENEKIQKEAQEALEKL 249
|
| >4db8_A Armadillo-repeat protein; solenoid repeat, de novo protein; 2.50A {Synthetic construct} Length = 252 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 4e-05
Identities = 18/108 (16%), Positives = 44/108 (40%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSAL 1157
+LL S ++ + L +S++A + + A L L L+ + + +A AL
Sbjct: 145 QLLSSPNEQILQEALWALSNIASGGNEQIQAVIDAGALPALVQLLSSPNEQILQEALWAL 204
Query: 1158 GNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYH 1205
N+ + ++ + + L + +++ +K A ++ H
Sbjct: 205 SNIASGGNEQKQAVKEAGALEKLEQLQSHENEKIQKEAQEALEKLQSH 252
|
| >4db8_A Armadillo-repeat protein; solenoid repeat, de novo protein; 2.50A {Synthetic construct} Length = 252 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 24/125 (19%), Positives = 54/125 (43%), Gaps = 3/125 (2%)
Query: 1040 YIKILMEVGVPGIILRCLEHMELKNLGRPIAFLAKM-IGQRSLAVQLVGKGLLDPNRVRR 1098
I+ +++ G +++ L + L + L+ + G ++ G L + +
Sbjct: 130 QIQAVIDAGALPALVQLLSSPNEQILQEALWALSNIASGGNEQIQAVIDAGALPA--LVQ 187
Query: 1099 LLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALG 1158
LL S ++ + L +S++A + + A LE L+ +HE+ ++ +A AL
Sbjct: 188 LLSSPNEQILQEALWALSNIASGGNEQKQAVKEAGALEKLEQLQSHENEKIQKEAQEALE 247
Query: 1159 NMCRH 1163
+ H
Sbjct: 248 KLQSH 252
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 88.0 bits (217), Expect = 1e-18
Identities = 56/325 (17%), Positives = 99/325 (30%), Gaps = 79/325 (24%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFI------MKHGKSEKDIHNLRQEIEIL 57
E E +GEG FG+V++ VA+K I + +G +K + EI I
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 58 RKL---------KHQNIIEMLDSF-------------------ESPQEFCVVTEFAQGEL 89
++L + + I + F +L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 90 FEILE-----------DDKCLPEEQVQSIAKQLVRALHYLHSN-RIIHRDMKPQNILIGA 137
F +LE K +SI QL +L ++ R HRD+ N+L+
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 138 --------------------GSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQ 177
G V + D+ +R VV + M +L
Sbjct: 198 TSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVF-----CDVSMDEDLFTGD 252
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYTNS--VYALIRHIVKDPVKYPDEMSPNFKSF--- 232
++ D++ L G+ Y+N ++ L ++K +P K
Sbjct: 253 -GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRK 311
Query: 233 LKGLLNKVPQNRLTWSALLEHPFVK 257
++ + L +H K
Sbjct: 312 IQEFHRTMLNFSSATDLLCQHSLFK 336
|
| >2jdq_A Importin alpha-1 subunit; transport, PB2 subunit, nuclear protein, protein transport, armadillo repeats; 2.2A {Homo sapiens} PDB: 3tj3_A Length = 450 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 4e-18
Identities = 40/246 (16%), Positives = 94/246 (38%), Gaps = 18/246 (7%)
Query: 1096 VRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACS 1155
V L + + +++++A + + A + + L+ E +V+ +A
Sbjct: 70 VEFLKRKENCTLQFESAWVLTNIASGNSLQTRIVIQAGAVPIFIELLSSEFEDVQEQAVW 129
Query: 1156 ALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRT-RKFACFSIGNAAYHND--VLYEE 1212
ALGN+ S+ + I+ L+ + ++ T + A +++ N + +
Sbjct: 130 ALGNIAGDSTMCRDYVLDCNILPPLLQLFSKQNRLTMTRNAVWALSNLCRGKSPPPEFAK 189
Query: 1213 LRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSV 1272
+ + +L+ L+ + A+A ALS L + + ++ G + L++L+
Sbjct: 190 VSPCLNVLSW-LLFVSDTDVLADACWALSYLSDGPNDKIQAVIDAGVCRRLVELLMHNDY 248
Query: 1273 LALNPSRKDAVNESPLKIALFSLAKMCAHTP-CRQFLQSSELFPVIARLRQSPESTIANY 1331
++P AL ++ + Q + + + L SP+ +I
Sbjct: 249 KVVSP-------------ALRAVGNIVTGDDIQTQVILNCSALQSLLHLLSSPKESIKKE 295
Query: 1332 ASVIIS 1337
A IS
Sbjct: 296 ACWTIS 301
|
| >2jdq_A Importin alpha-1 subunit; transport, PB2 subunit, nuclear protein, protein transport, armadillo repeats; 2.2A {Homo sapiens} PDB: 3tj3_A Length = 450 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 3e-13
Identities = 41/236 (17%), Positives = 86/236 (36%), Gaps = 7/236 (2%)
Query: 1040 YIKILMEVGVPGIILRCLEHMELKNLGRPIAFLAKMIGQRSLAVQLV-GKGLLDPNRVRR 1098
+I+++ G I + L + + L + G ++ V +L P + +
Sbjct: 99 QTRIVIQAGAVPIFIELLSSEFEDVQEQAVWALGNIAGDSTMCRDYVLDCNILPP--LLQ 156
Query: 1099 LLDSSTREVTLDVLMIV-SDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSAL 1157
L R + S+L R E+ + L L L D +V A AC AL
Sbjct: 157 LFSKQNRLTMTRNAVWALSNLCRGKSPPPEFAKVSPCLNVLSWLLFVSDTDVLADACWAL 216
Query: 1158 GNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS- 1216
+ + ++ + L++ D + A ++GN +D+ + +
Sbjct: 217 SYLSDGPNDKIQAVIDAGVCRRLVELLMHNDYKVVSPALRAVGNIVTGDDIQTQVILNCS 276
Query: 1217 -IPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCS 1271
+ L + L+S ++ K A +SN+ + + ++ ALI ++
Sbjct: 277 ALQSLLH-LLSSPKESIKKEACWTISNITAGNRAQIQTVIDANIFPALISILQTAE 331
|
| >2jdq_A Importin alpha-1 subunit; transport, PB2 subunit, nuclear protein, protein transport, armadillo repeats; 2.2A {Homo sapiens} PDB: 3tj3_A Length = 450 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 37/183 (20%), Positives = 66/183 (36%), Gaps = 15/183 (8%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSAL 1157
LL + +V L V ++ D + I S L+ L L+ +++ +AC +
Sbjct: 241 ELLMHNDYKVVSPALRAVGNIVTGDDIQTQVILNCSALQSLLHLLSSPKESIKKEACWTI 300
Query: 1158 GNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHND---VLYEELR 1214
N+ + ++ I LI + RTRK A ++I NA + Y
Sbjct: 301 SNITAGNRAQIQTVIDANIFPALISILQTAEFRTRKEAAWAITNATSGGSAEQIKYLVEL 360
Query: 1215 RSIPLLANILISDEEDKTKANAAGALSNLIRNSSK-----------LCEDIVSKGAMQAL 1263
I L ++L + + K A L N++R + C I + +
Sbjct: 361 GCIKPLCDLL-TVMDSKIVQVALNGLENILRLGEQEAKRNGTGINPYCALIEEAYGLDKI 419
Query: 1264 IKL 1266
L
Sbjct: 420 EFL 422
|
| >2jdq_A Importin alpha-1 subunit; transport, PB2 subunit, nuclear protein, protein transport, armadillo repeats; 2.2A {Homo sapiens} PDB: 3tj3_A Length = 450 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 32/206 (15%), Positives = 67/206 (32%), Gaps = 35/206 (16%)
Query: 1171 LAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYH--NDVLYEELRRS--IPLLANILIS 1226
I +I+ + A N + E + + L
Sbjct: 16 APGGVITSDMIEMIFSKSPEQQLSATQKFRKLLSKEPNPPIDEVISTPGVVARFVEFLKR 75
Query: 1227 DEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKL-------VADCSVLAL---- 1275
E + +A L+N+ +S ++ GA+ I+L V + +V AL
Sbjct: 76 KENCTLQFESAWVLTNIASGNSLQTRIVIQAGAVPIFIELLSSEFEDVQEQAVWALGNIA 135
Query: 1276 --NPSRKDAV-----------------NESPLKIALFSLAKMCAHT-PCRQFLQSSELFP 1315
+ +D V + + A+++L+ +C P +F + S
Sbjct: 136 GDSTMCRDYVLDCNILPPLLQLFSKQNRLTMTRNAVWALSNLCRGKSPPPEFAKVSPCLN 195
Query: 1316 VIARLRQSPESTIANYASVIISKVGD 1341
V++ L ++ + A +S + D
Sbjct: 196 VLSWLLFVSDTDVLADACWALSYLSD 221
|
| >3oqs_A Importin subunit alpha-2; importin alpha, karyopherin alpha, nuclear localisation SIGN recognition, chloride intracellular channel 4, CLIC4 NLS; 2.00A {Mus musculus} PDB: 3rz9_A 3rzx_A 1q1s_C 1q1t_C 3tpo_A 3knd_A 1ejy_I 1iq1_C 1ejl_I 1pjn_B 1pjm_B 3q5u_A 3fey_C 3fex_C 1ial_A 1y2a_C 3btr_C 3l3q_A* 3ve6_A 2c1m_A ... Length = 510 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 1e-17
Identities = 44/250 (17%), Positives = 94/250 (37%), Gaps = 22/250 (8%)
Query: 1096 VRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACS 1155
V L + + + ++++A + + + L ++ +A
Sbjct: 106 VSFLGKTDCSPIQFESAWALTNIASGTSEQTKAVVDGGAIPAFISLLASPHAHISEQAVW 165
Query: 1156 ALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKF-----ACFSIGNAAYHND--V 1208
ALGN+ S F + K+ I L+ A PD T +++ N + +
Sbjct: 166 ALGNIAGDGSAFRDLVIKHGAIDPLLALLAVPDLSTLACGYLRNLTWTLSNLCRNKNPAP 225
Query: 1209 LYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVA 1268
+ + + +P L L+ + + A++ A+S L ++ E +V KG + L+KL+
Sbjct: 226 PLDAVEQILPTLVR-LLHHNDPEVLADSCWAISYLTDGPNERIEMVVKKGVVPQLVKLLG 284
Query: 1269 DCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTP-CRQFLQSSELFPVIARLRQSPEST 1327
+ + P AL ++ + T Q + + V L +P++
Sbjct: 285 ATELPIVTP-------------ALRAIGNIVTGTDEQTQKVIDAGALAVFPSLLTNPKTN 331
Query: 1328 IANYASVIIS 1337
I A+ +S
Sbjct: 332 IQKEATWTMS 341
|
| >3oqs_A Importin subunit alpha-2; importin alpha, karyopherin alpha, nuclear localisation SIGN recognition, chloride intracellular channel 4, CLIC4 NLS; 2.00A {Mus musculus} PDB: 3rz9_A 3rzx_A 1q1s_C 1q1t_C 3tpo_A 3knd_A 1ejy_I 1iq1_C 1ejl_I 1pjn_B 1pjm_B 3q5u_A 3fey_C 3fex_C 1ial_A 1y2a_C 3btr_C 3l3q_A* 3ve6_A 2c1m_A ... Length = 510 | Back alignment and structure |
|---|
Score = 78.5 bits (193), Expect = 5e-15
Identities = 37/251 (14%), Positives = 87/251 (34%), Gaps = 24/251 (9%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSAL 1157
RLL + EV D +S L E + ++ L L + + A A+
Sbjct: 239 RLLHHNDPEVLADSCWAISYLTDGPNERIEMVVKKGVVPQLVKLLGATELPIVTPALRAI 298
Query: 1158 GNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS- 1216
GN+ + + + + +P +K A +++ N +++
Sbjct: 299 GNIVTGTDEQTQKVIDAGALAVFPSLLTNPKTNIQKEATWTMSNITAGRQDQIQQVVNHG 358
Query: 1217 -IPLLANILISDEEDKTKANAAGALSNLIRNSS-KLCEDIVSKGAMQALIKLVADCSVLA 1274
+P L +L + T+ AA A++N + + +V G ++ L+ L+
Sbjct: 359 LVPFLVGVLSKADFK-TQKEAAWAITNYTSGGTVEQIVYLVHCGIIEPLMNLL------- 410
Query: 1275 LNPSRKDAVNESPLKIALFSLAKMCAHT-------PCRQFLQSSELFPVIARLRQSPEST 1327
A + +++ L +++ + ++ I L++ +
Sbjct: 411 ------SAKDTKIIQVILDAISNIFQAAEKLGETEKLSIMIEECGGLDKIEALQRHENES 464
Query: 1328 IANYASVIISK 1338
+ + +I K
Sbjct: 465 VYKASLNLIEK 475
|
| >3oqs_A Importin subunit alpha-2; importin alpha, karyopherin alpha, nuclear localisation SIGN recognition, chloride intracellular channel 4, CLIC4 NLS; 2.00A {Mus musculus} PDB: 3rz9_A 3rzx_A 1q1s_C 1q1t_C 3tpo_A 3knd_A 1ejy_I 1iq1_C 1ejl_I 1pjn_B 1pjm_B 3q5u_A 3fey_C 3fex_C 1ial_A 1y2a_C 3btr_C 3l3q_A* 3ve6_A 2c1m_A ... Length = 510 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 3e-14
Identities = 42/249 (16%), Positives = 86/249 (34%), Gaps = 22/249 (8%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLARMDKW-FYEYINGASMLEFLKDFLTHED-PNVRAKACS 1155
+ ++S+ E L L +K + I A ++ FL D ++ ++
Sbjct: 64 KGINSNNLESQLQATQAARKLLSREKQPPIDNIIRAGLIPKFVSFLGKTDCSPIQFESAW 123
Query: 1156 ALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRR 1215
AL N+ +S ++ I I A P + A +++GN A + + +
Sbjct: 124 ALTNIASGTSEQTKAVVDGGAIPAFISLLASPHAHISEQAVWALGNIAGDGSAFRDLVIK 183
Query: 1216 S--IPLLANILISDEEDKTK----ANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVAD 1269
I L +L + N LSNL RN + + + L++L+
Sbjct: 184 HGAIDPLLALLAVPDLSTLACGYLRNLTWTLSNLCRNKNPAPPLDAVEQILPTLVRLLHH 243
Query: 1270 CSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCR-QFLQSSELFPVIARLRQSPESTI 1328
+ L + ++++ + R + + + P + +L + E I
Sbjct: 244 N-------------DPEVLADSCWAISYLTDGPNERIEMVVKKGVVPQLVKLLGATELPI 290
Query: 1329 ANYASVIIS 1337
A I
Sbjct: 291 VTPALRAIG 299
|
| >2z6h_A Catenin beta-1, beta-catenin; C-terminal domain, activator, alternative splicing, cell adhesion, cytoplasm, cytoskeleton, disease mutation, nucleus; 2.20A {Homo sapiens} Length = 644 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 1e-15
Identities = 33/247 (13%), Positives = 79/247 (31%), Gaps = 17/247 (6%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTH-EDPNVRAKACSA 1156
+LL+ + V ++V L++ + + + M+ + + + D
Sbjct: 21 KLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGT 80
Query: 1157 LGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS 1216
L N+ H ++ K+ I L+ P +A ++ N H + +R +
Sbjct: 81 LHNLSHHREG-LLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLA 139
Query: 1217 --IPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLA 1274
+ + +L + K A L L + + I++ G QAL+ ++ +
Sbjct: 140 GGLQKMVALL-NKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEK 198
Query: 1275 LNPSRKDAVNESPLKIALFSLAKMCAHTPCRQFLQSSELFPVIARLRQSPESTIANYASV 1334
L L L + + + + + + P +
Sbjct: 199 L------------LWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLW 246
Query: 1335 IISKVGD 1341
+ + D
Sbjct: 247 TLRNLSD 253
|
| >2z6h_A Catenin beta-1, beta-catenin; C-terminal domain, activator, alternative splicing, cell adhesion, cytoplasm, cytoskeleton, disease mutation, nucleus; 2.20A {Homo sapiens} Length = 644 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 1e-09
Identities = 39/236 (16%), Positives = 85/236 (36%), Gaps = 19/236 (8%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFL-THEDPNVRAKACSA 1156
LL+ + + + LA ++ I + + L + + T+ +
Sbjct: 147 ALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRV 206
Query: 1157 LGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS 1216
L + SS ++ + + L DP +R + +++ N + E +
Sbjct: 207 LKVLSVCSSN-KPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQ-EGMEGL 264
Query: 1217 IPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALN 1276
+ L L+ ++ AAG LSNL N+ K + G ++AL++ V L
Sbjct: 265 LGTLVQ-LLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTV-------LR 316
Query: 1277 PSRKDAVNESPLKIALFSLAKMCAHTPC----RQFLQSSELFPVIARLRQSPESTI 1328
++ + E A+ +L + + + ++ PV+ +L P
Sbjct: 317 AGDREDITEP----AICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWP 368
|
| >2z6h_A Catenin beta-1, beta-catenin; C-terminal domain, activator, alternative splicing, cell adhesion, cytoplasm, cytoskeleton, disease mutation, nucleus; 2.20A {Homo sapiens} Length = 644 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 6e-07
Identities = 34/199 (17%), Positives = 62/199 (31%), Gaps = 29/199 (14%)
Query: 1096 VRRLLDSSTRE-VTLDVLMIVSDLA---RMDKWFYEYINGASMLEFLKDFLTHEDPNVRA 1151
VR +L + RE +T + + L + + + L + L
Sbjct: 311 VRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLI 370
Query: 1152 KACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYE 1211
KA L ++ L + I L+ + T++ + V E
Sbjct: 371 KATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRME 430
Query: 1212 ELRRS-----------------------IPLLANILISDEEDKTKANAAGALSNLIRNSS 1248
E+ IPL +L + + AAG L L ++
Sbjct: 431 EIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLL-YSPIENIQRVAAGVLCELAQD-K 488
Query: 1249 KLCEDIVSKGAMQALIKLV 1267
+ E I ++GA L +L+
Sbjct: 489 EAAEAIEAEGATAPLTELL 507
|
| >2z6h_A Catenin beta-1, beta-catenin; C-terminal domain, activator, alternative splicing, cell adhesion, cytoplasm, cytoskeleton, disease mutation, nucleus; 2.20A {Homo sapiens} Length = 644 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 9e-04
Identities = 18/125 (14%), Positives = 36/125 (28%), Gaps = 8/125 (6%)
Query: 1145 EDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAY 1204
+ AL + R + I L + P + ++ A + A
Sbjct: 428 RMEEIVEGCTGALHILARDVHN-RIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQ 486
Query: 1205 HNDVLYEELRRS--IPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQA 1262
+ E + L +L S E AA L + + +D + +++
Sbjct: 487 DKE-AAEAIEAEGATAPLTELLHSRNE-GVATYAAAVLFRMSEDKP---QDYKKRLSVEL 541
Query: 1263 LIKLV 1267
L
Sbjct: 542 TSSLF 546
|
| >1jdh_A Beta-catenin; beta-catenin, protein-protein complex, transcription; 1.90A {Homo sapiens} SCOP: a.118.1.1 PDB: 1qz7_A 1g3j_A 1th1_A* 1i7w_A* 1i7x_A 1jpp_A 1m1e_A 1v18_A* 3oux_A 3ouw_A 1jpw_A 3tx7_A* 2gl7_A 1t08_A 1luj_A 2bct_A 3bct_A* 3ifq_A* 3sla_A 3sl9_A Length = 529 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 1e-15
Identities = 33/247 (13%), Positives = 79/247 (31%), Gaps = 17/247 (6%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTH-EDPNVRAKACSA 1156
+LL+ + V ++V L++ + + + M+ + + + D
Sbjct: 24 KLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGT 83
Query: 1157 LGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS 1216
L N+ H ++ K+ I L+ P +A ++ N H + +R +
Sbjct: 84 LHNLSHHREG-LLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLA 142
Query: 1217 --IPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLA 1274
+ + +L + K A L L + + I++ G QAL+ ++ +
Sbjct: 143 GGLQKMVALL-NKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEK 201
Query: 1275 LNPSRKDAVNESPLKIALFSLAKMCAHTPCRQFLQSSELFPVIARLRQSPESTIANYASV 1334
L L L + + + + + + P +
Sbjct: 202 L------------LWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLW 249
Query: 1335 IISKVGD 1341
+ + D
Sbjct: 250 TLRNLSD 256
|
| >1jdh_A Beta-catenin; beta-catenin, protein-protein complex, transcription; 1.90A {Homo sapiens} SCOP: a.118.1.1 PDB: 1qz7_A 1g3j_A 1th1_A* 1i7w_A* 1i7x_A 1jpp_A 1m1e_A 1v18_A* 3oux_A 3ouw_A 1jpw_A 3tx7_A* 2gl7_A 1t08_A 1luj_A 2bct_A 3bct_A* 3ifq_A* 3sla_A 3sl9_A Length = 529 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 3e-12
Identities = 41/244 (16%), Positives = 81/244 (33%), Gaps = 19/244 (7%)
Query: 1096 VRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACS 1155
VR + +++ E + +L+ + I + + L L +V A +
Sbjct: 65 VRTMQNTNDVETARCTAGTLHNLSHHRE-GLLAIFKSGGIPALVKMLGSPVDSVLFYAIT 123
Query: 1156 ALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRR 1215
L N+ H ++ + ++ + + + AY N +
Sbjct: 124 TLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILA 183
Query: 1216 S--IPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVL 1273
S L NI+ + +K + L L SS IV G MQAL + D S
Sbjct: 184 SGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSS-NKPAIVEAGGMQALGLHLTDPS-- 240
Query: 1274 ALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQFLQSSELFPVIARLRQSPESTIANYAS 1333
+ ++ L++L + + L + +L S + + A+
Sbjct: 241 -----------QRLVQNCLWTLRNLSDAA--TKQEGMEGLLGTLVQLLGSDDINVVTCAA 287
Query: 1334 VIIS 1337
I+S
Sbjct: 288 GILS 291
|
| >1jdh_A Beta-catenin; beta-catenin, protein-protein complex, transcription; 1.90A {Homo sapiens} SCOP: a.118.1.1 PDB: 1qz7_A 1g3j_A 1th1_A* 1i7w_A* 1i7x_A 1jpp_A 1m1e_A 1v18_A* 3oux_A 3ouw_A 1jpw_A 3tx7_A* 2gl7_A 1t08_A 1luj_A 2bct_A 3bct_A* 3ifq_A* 3sla_A 3sl9_A Length = 529 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-10
Identities = 41/236 (17%), Positives = 86/236 (36%), Gaps = 19/236 (8%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFL-THEDPNVRAKACSA 1156
LL+ + + + LA ++ I + + L + + T+ +
Sbjct: 150 ALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRV 209
Query: 1157 LGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS 1216
L + SS ++ + + L DP +R + +++ N + E +
Sbjct: 210 LKVLSVCSSN-KPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATK-QEGMEGL 267
Query: 1217 IPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALN 1276
+ L +L SD+ AAG LSNL N+ K + G ++AL++ V L
Sbjct: 268 LGTLVQLLGSDDI-NVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTV-------LR 319
Query: 1277 PSRKDAVNESPLKIALFSLAKMCAHTPC----RQFLQSSELFPVIARLRQSPESTI 1328
++ + E A+ +L + + + ++ PV+ +L P
Sbjct: 320 AGDREDITEP----AICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWP 371
|
| >1jdh_A Beta-catenin; beta-catenin, protein-protein complex, transcription; 1.90A {Homo sapiens} SCOP: a.118.1.1 PDB: 1qz7_A 1g3j_A 1th1_A* 1i7w_A* 1i7x_A 1jpp_A 1m1e_A 1v18_A* 3oux_A 3ouw_A 1jpw_A 3tx7_A* 2gl7_A 1t08_A 1luj_A 2bct_A 3bct_A* 3ifq_A* 3sla_A 3sl9_A Length = 529 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 4e-07
Identities = 29/156 (18%), Positives = 48/156 (30%), Gaps = 25/156 (16%)
Query: 1135 LEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKF 1194
L + L KA L ++ L + I L+ + T++
Sbjct: 357 LPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRR 416
Query: 1195 ACFSIGNAAYHNDVLYEELRRS-----------------------IPLLANILISDEEDK 1231
+ V EE+ IPL +L S E
Sbjct: 417 TSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIE-N 475
Query: 1232 TKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLV 1267
+ AAG L L ++ + E I ++GA L +L+
Sbjct: 476 IQRVAAGVLCELAQD-KEAAEAIEAEGATAPLTELL 510
|
| >1wa5_B Importin alpha subunit; nuclear transport/complex, nuclear transport, exportin, RAN GTPase, protein transport; HET: GTP; 2.0A {Saccharomyces cerevisiae} SCOP: a.118.1.1 PDB: 1un0_A 2c1t_A 1bk5_A 1ee5_A 1bk6_A 1ee4_A Length = 530 | Back alignment and structure |
|---|
Score = 80.1 bits (197), Expect = 2e-15
Identities = 45/303 (14%), Positives = 113/303 (37%), Gaps = 17/303 (5%)
Query: 1041 IKILMEVGVPGIILRCLEHMELKNLGRPIAFLAKMIGQ-RSLAVQLVGKGLLDPNRVRRL 1099
K++++ + ++ L ++ + I L + G ++ ++P + L
Sbjct: 166 TKVVVDADAVPLFIQLLYTGSVEVKEQAIWALGNVAGDSTDYRDYVLQCNAMEP--ILGL 223
Query: 1100 LDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGN 1159
+S+ + +S+L R K ++ + L L + D AC A+
Sbjct: 224 FNSNKPSLIRTATWTLSNLCRGKKPQPDWSVVSQALPTLAKLIYSMDTETLVDACWAISY 283
Query: 1160 MCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS--I 1217
+ ++ RI L++ + + A ++GN ND+ + + + +
Sbjct: 284 LSDGPQEAIQAVIDVRIPKRLVELLSHESTLVQTPALRAVGNIVTGNDLQTQVVINAGVL 343
Query: 1218 PLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNP 1277
P L L+S ++ K A +SN+ +++ + ++ + L+KL+
Sbjct: 344 PALRL-LLSSPKENIKKEACWTISNITAGNTEQIQAVIDANLIPPLVKLLEVAE----YK 398
Query: 1278 SRKDAVNESPLKIALFSLAKMCAHTP-CRQFLQSSELFPVIARLRQSPESTIANYASVII 1336
++K+A A+ + + P ++L S + L + ++ I +
Sbjct: 399 TKKEAC------WAISNASSGGLQRPDIIRYLVSQGCIKPLCDLLEIADNRIIEVTLDAL 452
Query: 1337 SKV 1339
+
Sbjct: 453 ENI 455
|
| >1wa5_B Importin alpha subunit; nuclear transport/complex, nuclear transport, exportin, RAN GTPase, protein transport; HET: GTP; 2.0A {Saccharomyces cerevisiae} SCOP: a.118.1.1 PDB: 1un0_A 2c1t_A 1bk5_A 1ee5_A 1bk6_A 1ee4_A Length = 530 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 3e-15
Identities = 47/258 (18%), Positives = 94/258 (36%), Gaps = 31/258 (12%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSAL 1157
+L+ S E +D +S L+ + + + + + L + L+HE V+ A A+
Sbjct: 264 KLIYSMDTETLVDACWAISYLSDGPQEAIQAVIDVRIPKRLVELLSHESTLVQTPALRAV 323
Query: 1158 GNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS- 1216
GN+ + + ++ L + P + +K AC++I N N + + +
Sbjct: 324 GNIVTGNDLQTQVVINAGVLPALRLLLSSPKENIKKEACWTISNITAGNTEQIQAVIDAN 383
Query: 1217 -IPLLANILISDEEDKTKANAAGALSNLIR---NSSKLCEDIVSKGAMQALIKLVADCSV 1272
IP L +L E TK A A+SN + +VS+G ++ L L+
Sbjct: 384 LIPPLVKLLEVAEYK-TKKEACWAISNASSGGLQRPDIIRYLVSQGCIKPLCDLL----- 437
Query: 1273 LALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQFLQSSELFPV------------IARL 1320
+ + +++ L +L + + + + I
Sbjct: 438 --------EIADNRIIEVTLDALENILKMGEADKEARGLNINENADFIEKAGGMEKIFNC 489
Query: 1321 RQSPESTIANYASVIISK 1338
+Q+ I A II
Sbjct: 490 QQNENDKIYEKAYKIIET 507
|
| >1wa5_B Importin alpha subunit; nuclear transport/complex, nuclear transport, exportin, RAN GTPase, protein transport; HET: GTP; 2.0A {Saccharomyces cerevisiae} SCOP: a.118.1.1 PDB: 1un0_A 2c1t_A 1bk5_A 1ee5_A 1bk6_A 1ee4_A Length = 530 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 5e-15
Identities = 40/245 (16%), Positives = 93/245 (37%), Gaps = 17/245 (6%)
Query: 1096 VRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACS 1155
V + ++ + L+ ++++A + + A + L V+ +A
Sbjct: 136 VEFMRENQPEMLQLEAAWALTNIASGTSAQTKVVVDADAVPLFIQLLYTGSVEVKEQAIW 195
Query: 1156 ALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHND--VLYEEL 1213
ALGN+ S+ + + + + ++ + A +++ N + +
Sbjct: 196 ALGNVAGDSTDYRDYVLQCNAMEPILGLFNSNKPSLIRTATWTLSNLCRGKKPQPDWSVV 255
Query: 1214 RRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVL 1273
+++P LA LI + +T +A A+S L + + ++ + L++L++ S L
Sbjct: 256 SQALPTLAK-LIYSMDTETLVDACWAISYLSDGPQEAIQAVIDVRIPKRLVELLSHESTL 314
Query: 1274 ALNPSRKDAVNESPLKIALFSLAKMCAHTP-CRQFLQSSELFPVIARLRQSPESTIANYA 1332
P AL ++ + Q + ++ + P + L SP+ I A
Sbjct: 315 VQTP-------------ALRAVGNIVTGNDLQTQVVINAGVLPALRLLLSSPKENIKKEA 361
Query: 1333 SVIIS 1337
IS
Sbjct: 362 CWTIS 366
|
| >1wa5_B Importin alpha subunit; nuclear transport/complex, nuclear transport, exportin, RAN GTPase, protein transport; HET: GTP; 2.0A {Saccharomyces cerevisiae} SCOP: a.118.1.1 PDB: 1un0_A 2c1t_A 1bk5_A 1ee5_A 1bk6_A 1ee4_A Length = 530 | Back alignment and structure |
|---|
Score = 68.1 bits (166), Expect = 1e-11
Identities = 33/188 (17%), Positives = 73/188 (38%), Gaps = 17/188 (9%)
Query: 1095 RVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKAC 1154
R+ LL + V L V ++ + + + A +L L+ L+ N++ +AC
Sbjct: 303 RLVELLSHESTLVQTPALRAVGNIVTGNDLQTQVVINAGVLPALRLLLSSPKENIKKEAC 362
Query: 1155 SALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELR 1214
+ N+ ++ ++ +I L+ + +T+K AC++I NA+ + +R
Sbjct: 363 WTISNITAGNTEQIQAVIDANLIPPLVKLLEVAEYKTKKEACWAISNASSGGLQRPDIIR 422
Query: 1215 R-----SIPLLANILISDEEDKTKANAAGALSNLIRNSSKL-----------CEDIVSKG 1258
I L ++L +++ AL N+++ + I G
Sbjct: 423 YLVSQGCIKPLCDLL-EIADNRIIEVTLDALENILKMGEADKEARGLNINENADFIEKAG 481
Query: 1259 AMQALIKL 1266
M+ +
Sbjct: 482 GMEKIFNC 489
|
| >1wa5_B Importin alpha subunit; nuclear transport/complex, nuclear transport, exportin, RAN GTPase, protein transport; HET: GTP; 2.0A {Saccharomyces cerevisiae} SCOP: a.118.1.1 PDB: 1un0_A 2c1t_A 1bk5_A 1ee5_A 1bk6_A 1ee4_A Length = 530 | Back alignment and structure |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 33/203 (16%), Positives = 76/203 (37%), Gaps = 33/203 (16%)
Query: 1172 AKNRIIGLLIDRCADPDKRTRKFACFSIGN-AAYHNDVLYEELRRS--IPLLANILISDE 1228
+ + + + D + + A + + + + ++ +P L + ++
Sbjct: 84 QLQQELPQMTQQLNSDDMQEQLSATVKFRQILSREHRPPIDVVIQAGVVPRLVEFMRENQ 143
Query: 1229 EDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKL-------VADCSVLAL------ 1275
+ + AA AL+N+ +S + +V A+ I+L V + ++ AL
Sbjct: 144 PEMLQLEAAWALTNIASGTSAQTKVVVDADAVPLFIQLLYTGSVEVKEQAIWALGNVAGD 203
Query: 1276 NPSRKDAV----------------NESPLKIALFSLAKMCAH-TPCRQFLQSSELFPVIA 1318
+ +D V S ++ A ++L+ +C P + S+ P +A
Sbjct: 204 STDYRDYVLQCNAMEPILGLFNSNKPSLIRTATWTLSNLCRGKKPQPDWSVVSQALPTLA 263
Query: 1319 RLRQSPESTIANYASVIISKVGD 1341
+L S ++ A IS + D
Sbjct: 264 KLIYSMDTETLVDACWAISYLSD 286
|
| >1xqr_A HSPBP1 protein; armadillo repeat, superhelical twist, chaperone; 2.10A {Homo sapiens} SCOP: a.118.1.21 PDB: 1xqs_A* Length = 296 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 29/198 (14%), Positives = 63/198 (31%), Gaps = 6/198 (3%)
Query: 1072 LAKMIGQRSLAVQLVGKGLLDPNRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYING 1131
LA + A + V R L++ + ++ ++ E + G
Sbjct: 64 LADLCENMDNAADFCQLSGMHL-LVGRYLEAGAAGLRWRAAQLIGTCSQNVAAIQEQVLG 122
Query: 1132 ASMLEFLKDFLTHE-DPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKR 1190
L L L + VR KA A+ + R + +L+ ++
Sbjct: 123 LGALRKLLRLLDRDACDTVRVKALFAISCLVREQEAGLLQFLRLDGFSVLMRAMQQQVQK 182
Query: 1191 TRKFACFSIGNAAYHNDVLYEELRRS--IPLLANILISDEEDKTKANAAGALSNLIRNSS 1248
+ + F + N + L + L L+ E + GAL +L+ +
Sbjct: 183 LKVKSAFLLQNLLVGHPEHKGTLCSMGMVQQLVA-LVRTEHSPFHEHVLGALCSLVTDFP 241
Query: 1249 KLCEDIVSKG-AMQALIK 1265
+ + ++ L++
Sbjct: 242 QGVRECREPELGLEELLR 259
|
| >1xqr_A HSPBP1 protein; armadillo repeat, superhelical twist, chaperone; 2.10A {Homo sapiens} SCOP: a.118.1.21 PDB: 1xqs_A* Length = 296 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 31/199 (15%), Positives = 62/199 (31%), Gaps = 18/199 (9%)
Query: 1134 MLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCAD-PDKRTR 1192
M + D R A L ++C + + + + LL+ R + R
Sbjct: 41 MPPTAGEAEQAADQQEREGALELLADLC-ENMDNAADFCQLSGMHLLVGRYLEAGAAGLR 99
Query: 1193 KFACFSIGNAAYHNDVLYEELRRS--IPLLANILISDEEDKTKANAAGALSNLIRNSSKL 1250
A IG + + + E++ + L +L D D + A A+S L+R
Sbjct: 100 WRAAQLIGTCSQNVAAIQEQVLGLGALRKLLRLLDRDACDTVRVKALFAISCLVREQEAG 159
Query: 1251 CEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTP-CRQFLQ 1309
+ L++ + + + F L + P + L
Sbjct: 160 LLQFLRLDGFSVLMRAMQQQ-------------VQKLKVKSAFLLQNLLVGHPEHKGTLC 206
Query: 1310 SSELFPVIARLRQSPESTI 1328
S + + L ++ S
Sbjct: 207 SMGMVQQLVALVRTEHSPF 225
|
| >1xqr_A HSPBP1 protein; armadillo repeat, superhelical twist, chaperone; 2.10A {Homo sapiens} SCOP: a.118.1.21 PDB: 1xqs_A* Length = 296 | Back alignment and structure |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 26/200 (13%), Positives = 55/200 (27%), Gaps = 10/200 (5%)
Query: 1025 EDRDMAKAIEEDMGKYIKILMEVGVPGIILRCLEHMELKNLGRPIAFLAKMIGQRSLAVQ 1084
E+ D A + + G+ ++ R LE R + + +
Sbjct: 69 ENMDNAADFCQ-LS---------GMHLLVGRYLEAGAAGLRWRAAQLIGTCSQNVAAIQE 118
Query: 1085 LVGKGLLDPNRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTH 1144
V +R L + V + L +S L R + L +
Sbjct: 119 QVLGLGALRKLLRLLDRDACDTVRVKALFAISCLVREQEAGLLQFLRLDGFSVLMRAMQQ 178
Query: 1145 EDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAY 1204
+ ++ K+ L N+ +L ++ L+ + ++ +
Sbjct: 179 QVQKLKVKSAFLLQNLLVGHPEHKGTLCSMGMVQQLVALVRTEHSPFHEHVLGALCSLVT 238
Query: 1205 HNDVLYEELRRSIPLLANIL 1224
E R L +L
Sbjct: 239 DFPQGVRECREPELGLEELL 258
|
| >2z6g_A B-catenin; FULL-length, beta-catenin, cell adhesion; 3.40A {Danio rerio} Length = 780 | Back alignment and structure |
|---|
Score = 78.5 bits (193), Expect = 8e-15
Identities = 33/247 (13%), Positives = 79/247 (31%), Gaps = 17/247 (6%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTH-EDPNVRAKACSA 1156
+LL+ + V ++V L++ + + + M+ + + + D
Sbjct: 157 KLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTSGT 216
Query: 1157 LGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS 1216
L N+ H ++ K+ I L++ P A ++ N H + +R +
Sbjct: 217 LHNLSHHREG-LLAIFKSGGIPALVNMLGSPVDSVLFHAITTLHNLLLHQEGAKMAVRLA 275
Query: 1217 --IPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLA 1274
+ + L++ K A L L + + I++ G QAL+ ++ +
Sbjct: 276 GGLQKMVA-LLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEK 334
Query: 1275 LNPSRKDAVNESPLKIALFSLAKMCAHTPCRQFLQSSELFPVIARLRQSPESTIANYASV 1334
L L L + + + + + + P +
Sbjct: 335 L------------LWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLW 382
Query: 1335 IISKVGD 1341
+ + D
Sbjct: 383 TLRNLSD 389
|
| >2z6g_A B-catenin; FULL-length, beta-catenin, cell adhesion; 3.40A {Danio rerio} Length = 780 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 4e-13
Identities = 36/247 (14%), Positives = 73/247 (29%), Gaps = 23/247 (9%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSAL 1157
++ + T E L V + + I A ++ L LT + L
Sbjct: 325 NIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTL 384
Query: 1158 GNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS- 1216
N+ ++ ++G L+ D A + N +N + +
Sbjct: 385 RNLSDAAT---KQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVG 441
Query: 1217 --IPLLANILISDEEDKTKANAAGALSNLIR---NSSKLCEDIVSKGAMQALIKLVADCS 1271
L+ +L + + + A AL +L ++ + + ++KL+ S
Sbjct: 442 GIEALVRTVLRAGDREDITEPAICALRHLTSRHQDAEMAQNAVRLHYGLPVVVKLLHPPS 501
Query: 1272 VLALNPSRKDAVNESPLKIALFSLAKMCAHTP-CRQFLQSSELFPVIARLRQSPESTIAN 1330
PL A L + A P L+ P + +L
Sbjct: 502 -------------HWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQR 548
Query: 1331 YASVIIS 1337
S+ +
Sbjct: 549 RTSMGGT 555
|
| >2z6g_A B-catenin; FULL-length, beta-catenin, cell adhesion; 3.40A {Danio rerio} Length = 780 | Back alignment and structure |
|---|
Score = 65.8 bits (160), Expect = 7e-11
Identities = 20/177 (11%), Positives = 50/177 (28%), Gaps = 6/177 (3%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSAL 1157
+L S V + + +L + + A L+ + L + A L
Sbjct: 241 NMLGSPVDSVLFHAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCL 300
Query: 1158 GNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS- 1216
+ + + + L++ + + + +
Sbjct: 301 QILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAG 360
Query: 1217 -IPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSV 1272
+ L ++D + N L NL S + +G + L++L+ +
Sbjct: 361 GMQALGL-HLTDPSQRLVQNCLWTLRNL---SDAATKQEGMEGLLGTLVQLLGSDDI 413
|
| >2z6g_A B-catenin; FULL-length, beta-catenin, cell adhesion; 3.40A {Danio rerio} Length = 780 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 1e-06
Identities = 33/199 (16%), Positives = 62/199 (31%), Gaps = 29/199 (14%)
Query: 1096 VRRLLDSSTR----EVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRA 1151
VR +L + R E + L ++ + + + L + L
Sbjct: 447 VRTVLRAGDREDITEPAICALRHLTSRHQDAEMAQNAVRLHYGLPVVVKLLHPPSHWPLI 506
Query: 1152 KACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYE 1211
KA L ++ L + I L+ + T++ + V E
Sbjct: 507 KATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRME 566
Query: 1212 ELRRS-----------------------IPLLANILISDEEDKTKANAAGALSNLIRNSS 1248
E+ + IPL +L + + AAG L L ++
Sbjct: 567 EIVEACTGALHILARDIHNRIVIRGLNTIPLFVQLL-YSPIENIQRVAAGVLCELAQD-K 624
Query: 1249 KLCEDIVSKGAMQALIKLV 1267
+ E I ++GA L +L+
Sbjct: 625 EAAEAIEAEGATAPLTELL 643
|
| >3now_A UNC-45 protein, SD10334P; armadillo repeat, HSP90, myosin, tetra-tricopeptide repeat, binding protein required for myosin function; 2.99A {Drosophila melanogaster} Length = 810 | Back alignment and structure |
|---|
Score = 70.6 bits (172), Expect = 2e-12
Identities = 27/174 (15%), Positives = 61/174 (35%), Gaps = 2/174 (1%)
Query: 1096 VRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACS 1155
+ L T + LM +++LA M++ + I + ++ +L + + A
Sbjct: 586 LNLLQQDCTALENFESLMALTNLASMNESVRQRIIKEQGVSKIEYYLMEDHLYLTRAAAQ 645
Query: 1156 ALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEEL-- 1213
L N+ N + L C D D+ T ++ + E++
Sbjct: 646 CLCNLVMSEDVIKMFEGNNDRVKFLALLCEDEDEETATACAGALAIITSVSVKCCEKILA 705
Query: 1214 RRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLV 1267
S + + LI++ + + N+I ++ + + M+ L L
Sbjct: 706 IASWLDILHTLIANPSPAVQHRGIVIILNMINAGEEIAKKLFETDIMELLSGLG 759
|
| >3now_A UNC-45 protein, SD10334P; armadillo repeat, HSP90, myosin, tetra-tricopeptide repeat, binding protein required for myosin function; 2.99A {Drosophila melanogaster} Length = 810 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 3e-11
Identities = 46/296 (15%), Positives = 106/296 (35%), Gaps = 23/296 (7%)
Query: 1041 IKILMEVGVPGIILRCLEHMELKNLGRPIAFLAKMIGQRSLAVQLVGKGLLDPNRVRRLL 1100
I +L G+ + + + L + G + L ++V +G + + R+
Sbjct: 488 ITVLANEGITTALCALAKTESHNSQELIARVLNAVCGLKELRGKVVQEGGVKA--LLRMA 545
Query: 1101 DSSTREVTLDVLMIVSDLARMD--KWFYEYINGASMLEFLKDFLTHE-DPNVRAKACSAL 1157
T + ++ + + + ++ L + L + ++ AL
Sbjct: 546 LEGTEKGKRHATQALARIGITINPEVSFSGQRSLDVIRPLLNLLQQDCTALENFESLMAL 605
Query: 1158 GNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVL--YEELRR 1215
N+ + + K + + + + + A + N DV+ +E
Sbjct: 606 TNLASMNESVRQRIIKEQGVSKIEYYLMEDHLYLTRAAAQCLCNLVMSEDVIKMFEGNND 665
Query: 1216 SIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVS-KGAMQALIKLVADCSVLA 1274
+ LA +L DE+++T AGAL+ + S K CE I++ + L L+A+
Sbjct: 666 RVKFLA-LLCEDEDEETATACAGALAIITSVSVKCCEKILAIASWLDILHTLIANP---- 720
Query: 1275 LNPSRKDAVNESPLKIALFSLAKMCAHTP-CRQFLQSSELFPVIARLRQSPESTIA 1329
+ + + + M + L +++ +++ L Q P+ T A
Sbjct: 721 ---------SPAVQHRGIVIILNMINAGEEIAKKLFETDIMELLSGLGQLPDDTRA 767
|
| >3now_A UNC-45 protein, SD10334P; armadillo repeat, HSP90, myosin, tetra-tricopeptide repeat, binding protein required for myosin function; 2.99A {Drosophila melanogaster} Length = 810 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 1e-09
Identities = 28/246 (11%), Positives = 72/246 (29%), Gaps = 36/246 (14%)
Query: 1127 EYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCAD 1186
+ + L E N + L +C + + + L+ +
Sbjct: 489 TVLANEGITTALCALAKTESHNSQELIARVLNAVCGLKEL-RGKVVQEGGVKALLRMALE 547
Query: 1187 PDKRTRKFACFSIGNAAYHND----VLYEELRRSIPLLANILISDEEDKTKANAAGALSN 1242
++ ++ A ++ + + I L N+L D + AL+N
Sbjct: 548 GTEKGKRHATQALARIGITINPEVSFSGQRSLDVIRPLLNLLQQDCTALENFESLMALTN 607
Query: 1243 LIRNSSKLCEDIVSKGAMQALIKLVAD-------------CSVLALNPSRKDAVNESPL- 1288
L + + + I+ + + + + + C+++ K +
Sbjct: 608 LASMNESVRQRIIKEQGVSKIEYYLMEDHLYLTRAAAQCLCNLVMSEDVIKMFEGNNDRV 667
Query: 1289 ---------------KIALFSLAKMCAHTP--CRQFLQSSELFPVIARLRQSPESTIANY 1331
+LA + + + C + L + ++ L +P + +
Sbjct: 668 KFLALLCEDEDEETATACAGALAIITSVSVKCCEKILAIASWLDILHTLIANPSPAVQHR 727
Query: 1332 ASVIIS 1337
VII
Sbjct: 728 GIVIIL 733
|
| >3now_A UNC-45 protein, SD10334P; armadillo repeat, HSP90, myosin, tetra-tricopeptide repeat, binding protein required for myosin function; 2.99A {Drosophila melanogaster} Length = 810 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 5e-07
Identities = 22/157 (14%), Positives = 50/157 (31%), Gaps = 5/157 (3%)
Query: 1092 DPNRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRA 1151
+++ L +T + +L + + ++FL ED
Sbjct: 624 GVSKIEYYLMEDHLYLTRAAAQCLCNLVMSEDVIKMFEGNNDRVKFLALLCEDEDEETAT 683
Query: 1152 KACSALGNMCRHSSYFYSSL-AKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLY 1210
AL + S + A + +L A+P + I N + +
Sbjct: 684 ACAGALAIITSVSVKCCEKILAIASWLDILHTLIANPSPAVQHRGIVIILNMINAGEEIA 743
Query: 1211 EELRRS--IPLLANILISDEE--DKTKANAAGALSNL 1243
++L + + LL+ + ++ K + A L+
Sbjct: 744 KKLFETDIMELLSGLGQLPDDTRAKAREVATQCLAAA 780
|
| >3nmw_A APC variant protein; ARMADIILO repeats domain, cell adhesion-cell cycle complex; 1.60A {Homo sapiens} PDB: 3nmx_A 3t7u_A 3au3_A 3qhe_A Length = 354 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 34/211 (16%), Positives = 75/211 (35%), Gaps = 12/211 (5%)
Query: 1133 SMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNR-IIGLLIDRCADPDKRT 1191
E H +R A AL N+ ++L + + L+ + +
Sbjct: 84 VDCEMYGLTNDHYSITLRRYAGMALTNLTFGDVANKATLCSMKGCMRALVAQLKSESEDL 143
Query: 1192 RKFACFSIGNAAYHNDVLYEELRRS---IPLLANILISDEEDKTKANAAGALSNLIRNSS 1248
++ + N ++ DV ++ R + L + +++ T + AL NL + +
Sbjct: 144 QQVIASVLRNLSWRADVNSKKTLREVGSVKALMECALEVKKESTLKSVLSALWNLSAHCT 203
Query: 1249 KLCEDIVS-KGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTP-CRQ 1306
+ DI + GA+ L+ + S + L +++ + A RQ
Sbjct: 204 ENKADICAVDGALAFLVGTLTYRSQTNTLAIIESGGG------ILRNVSSLIATNEDHRQ 257
Query: 1307 FLQSSELFPVIARLRQSPESTIANYASVIIS 1337
L+ + + + +S TI + A +
Sbjct: 258 ILRENNCLQTLLQHLKSHSLTIVSNACGTLW 288
|
| >3nmw_A APC variant protein; ARMADIILO repeats domain, cell adhesion-cell cycle complex; 1.60A {Homo sapiens} PDB: 3nmx_A 3t7u_A 3au3_A 3qhe_A Length = 354 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 24/186 (12%), Positives = 61/186 (32%), Gaps = 26/186 (13%)
Query: 1129 INGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLID------ 1182
++ K+ + + A L + + ++ + + + +
Sbjct: 28 EAHEPGMDQDKNPMPAPVEHQICPAVCVLMKLSFDEEH-RHAMNELGGLQAIAELLQVDC 86
Query: 1183 -----RCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS---IPLLANILISDEEDKTKA 1234
R++A ++ N + + L + L L S+ ED +
Sbjct: 87 EMYGLTNDHYSITLRRYAGMALTNLTFGDVANKATLCSMKGCMRALVAQLKSESED-LQQ 145
Query: 1235 NAAGALSNLIRNSSKLCED-IVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALF 1293
A L NL + + + G+++AL++ + + K ++ AL+
Sbjct: 146 VIASVLRNLSWRADVNSKKTLREVGSVKALMECALEVKKEST---LKSVLS------ALW 196
Query: 1294 SLAKMC 1299
+L+ C
Sbjct: 197 NLSAHC 202
|
| >3nmw_A APC variant protein; ARMADIILO repeats domain, cell adhesion-cell cycle complex; 1.60A {Homo sapiens} PDB: 3nmx_A 3t7u_A 3au3_A 3qhe_A Length = 354 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 32/218 (14%), Positives = 72/218 (33%), Gaps = 31/218 (14%)
Query: 1135 LEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFY-SSLAKNRIIGLLIDRCADP-DKRTR 1192
+ L L E +++ S L N+ + +L + + L++ + + T
Sbjct: 129 MRALVAQLKSESEDLQQVIASVLRNLSWRADVNSKKTLREVGSVKALMECALEVKKESTL 188
Query: 1193 KFACFSIGNAAYHNDVLYEELRRS---IPLLANILISDEEDKT---KANAAGALSNLIRN 1246
K ++ N + H ++ + L L + T + G L N+
Sbjct: 189 KSVLSALWNLSAHCTENKADICAVDGALAFLVGTLTYRSQTNTLAIIESGGGILRNV--- 245
Query: 1247 SSKLCED------IVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCA 1300
SS + + + +Q L++ + S + + A +L + A
Sbjct: 246 SSLIATNEDHRQILRENNCLQTLLQHLKSHS-------------LTIVSNACGTLWNLSA 292
Query: 1301 HTP-CRQFLQSSELFPVIARLRQSPESTIANYASVIIS 1337
P ++ L ++ L S IA ++ +
Sbjct: 293 RNPKDQEALWDMGAVSMLKNLIHSKHKMIAMGSAAALR 330
|
| >3nmw_A APC variant protein; ARMADIILO repeats domain, cell adhesion-cell cycle complex; 1.60A {Homo sapiens} PDB: 3nmx_A 3t7u_A 3au3_A 3qhe_A Length = 354 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 35/221 (15%), Positives = 76/221 (34%), Gaps = 26/221 (11%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLA-RMDKWFYEYINGASMLEFLKDFLTH-EDPNVRAKACS 1155
L S + ++ + ++ +L+ R D + + ++ L + + + S
Sbjct: 134 AQLKSESEDLQQVIASVLRNLSWRADVNSKKTLREVGSVKALMECALEVKKESTLKSVLS 193
Query: 1156 ALGNMCRHSSYFYSSLAKN-----RIIGLLIDRCADPDKRTRKFACFSIGNAAYH--NDV 1208
AL N+ H + + + ++G L R + + N + +
Sbjct: 194 ALWNLSAHCTENKADICAVDGALAFLVGTLTYRSQTNTLAIIESGGGILRNVSSLIATNE 253
Query: 1209 LYEELRRS---IPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIK 1265
+ ++ R + L L S +NA G L NL + K E + GA+ L
Sbjct: 254 DHRQILRENNCLQTLLQHLKSHSL-TIVSNACGTLWNLSARNPKDQEALWDMGAVSMLKN 312
Query: 1266 LVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQ 1306
L+ S+ + + +L + A+ P +
Sbjct: 313 LIH---------SKHKMIAMG----SAAALRNLMANRPAKY 340
|
| >3nmz_A APC variant protein; protein-protein complex, armadillo repeats, cell adhesion-CE complex; 3.01A {Homo sapiens} Length = 458 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 8e-12
Identities = 34/211 (16%), Positives = 75/211 (35%), Gaps = 12/211 (5%)
Query: 1133 SMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNR-IIGLLIDRCADPDKRT 1191
E H +R A AL N+ ++L + + L+ + +
Sbjct: 200 VDCEMYGLTNDHYSITLRRYAGMALTNLTFGDVANKATLCSMKGCMRALVAQLKSESEDL 259
Query: 1192 RKFACFSIGNAAYHNDVLYEELRRS---IPLLANILISDEEDKTKANAAGALSNLIRNSS 1248
++ + N ++ DV ++ R + L + +++ T + AL NL + +
Sbjct: 260 QQVIASVLRNLSWRADVNSKKTLREVGSVKALMECALEVKKESTLKSVLSALWNLSAHCT 319
Query: 1249 KLCEDIVS-KGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTP-CRQ 1306
+ DI + GA+ L+ + S + L +++ + A RQ
Sbjct: 320 ENKADICAVDGALAFLVGTLTYRSQTNTLAIIESGGG------ILRNVSSLIATNEDHRQ 373
Query: 1307 FLQSSELFPVIARLRQSPESTIANYASVIIS 1337
L+ + + + +S TI + A +
Sbjct: 374 ILRENNCLQTLLQHLKSHSLTIVSNACGTLW 404
|
| >3nmz_A APC variant protein; protein-protein complex, armadillo repeats, cell adhesion-CE complex; 3.01A {Homo sapiens} Length = 458 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 6e-09
Identities = 24/186 (12%), Positives = 61/186 (32%), Gaps = 26/186 (13%)
Query: 1129 INGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLID------ 1182
++ K+ + + A L + + ++ + + + +
Sbjct: 144 EAHEPGMDQDKNPMPAPVEHQICPAVCVLMKLSFDEEH-RHAMNELGGLQAIAELLQVDC 202
Query: 1183 -----RCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS---IPLLANILISDEEDKTKA 1234
R++A ++ N + + L + L L S+ ED +
Sbjct: 203 EMYGLTNDHYSITLRRYAGMALTNLTFGDVANKATLCSMKGCMRALVAQLKSESED-LQQ 261
Query: 1235 NAAGALSNLIRNSSKLCED-IVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALF 1293
A L NL + + + G+++AL++ + + K ++ AL+
Sbjct: 262 VIASVLRNLSWRADVNSKKTLREVGSVKALMECALEVKKEST---LKSVLS------ALW 312
Query: 1294 SLAKMC 1299
+L+ C
Sbjct: 313 NLSAHC 318
|
| >3nmz_A APC variant protein; protein-protein complex, armadillo repeats, cell adhesion-CE complex; 3.01A {Homo sapiens} Length = 458 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 32/219 (14%), Positives = 72/219 (32%), Gaps = 31/219 (14%)
Query: 1134 MLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFY-SSLAKNRIIGLLIDRCADP-DKRT 1191
+ L L E +++ S L N+ + +L + + L++ + + T
Sbjct: 244 CMRALVAQLKSESEDLQQVIASVLRNLSWRADVNSKKTLREVGSVKALMECALEVKKEST 303
Query: 1192 RKFACFSIGNAAYHNDVLYEELRRS---IPLLANILISDEEDKT---KANAAGALSNLIR 1245
K ++ N + H ++ + L L + T + G L N+
Sbjct: 304 LKSVLSALWNLSAHCTENKADICAVDGALAFLVGTLTYRSQTNTLAIIESGGGILRNV-- 361
Query: 1246 NSSKLCED------IVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMC 1299
SS + + + +Q L++ + S + + A +L +
Sbjct: 362 -SSLIATNEDHRQILRENNCLQTLLQHLKSHS-------------LTIVSNACGTLWNLS 407
Query: 1300 AHTP-CRQFLQSSELFPVIARLRQSPESTIANYASVIIS 1337
A P ++ L ++ L S IA ++ +
Sbjct: 408 ARNPKDQEALWDMGAVSMLKNLIHSKHKMIAMGSAAALR 446
|
| >3nmz_A APC variant protein; protein-protein complex, armadillo repeats, cell adhesion-CE complex; 3.01A {Homo sapiens} Length = 458 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 35/221 (15%), Positives = 76/221 (34%), Gaps = 26/221 (11%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLA-RMDKWFYEYINGASMLEFLKDFLTH-EDPNVRAKACS 1155
L S + ++ + ++ +L+ R D + + ++ L + + + S
Sbjct: 250 AQLKSESEDLQQVIASVLRNLSWRADVNSKKTLREVGSVKALMECALEVKKESTLKSVLS 309
Query: 1156 ALGNMCRHSSYFYSSLAK-----NRIIGLLIDRCADPDKRTRKFACFSIGNAAYH--NDV 1208
AL N+ H + + + ++G L R + + N + +
Sbjct: 310 ALWNLSAHCTENKADICAVDGALAFLVGTLTYRSQTNTLAIIESGGGILRNVSSLIATNE 369
Query: 1209 LYEELRRS---IPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIK 1265
+ ++ R + L L S +NA G L NL + K E + GA+ L
Sbjct: 370 DHRQILRENNCLQTLLQHLKSHSL-TIVSNACGTLWNLSARNPKDQEALWDMGAVSMLKN 428
Query: 1266 LVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQ 1306
L+ S+ + + +L + A+ P +
Sbjct: 429 LIH---------SKHKMIAMG----SAAALRNLMANRPAKY 456
|
| >3nmz_A APC variant protein; protein-protein complex, armadillo repeats, cell adhesion-CE complex; 3.01A {Homo sapiens} Length = 458 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 31/222 (13%), Positives = 64/222 (28%), Gaps = 49/222 (22%)
Query: 1142 LTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLL--------------------- 1180
+ RA+A +AL N+ + R++ LL
Sbjct: 91 NSRGSKEARARASAALHNIIHSQPDDKRGRREIRVLHLLEQIRAYCETCWEWQEAHEPGM 150
Query: 1181 ---IDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS--IPLLANILISDEED----- 1230
+ P + A + ++ + + + +A +L D E
Sbjct: 151 DQDKNPMPAPVEHQICPAVCVLMKLSFDEEHR-HAMNELGGLQAIAELLQVDCEMYGLTN 209
Query: 1231 -----KTKANAAGALSNLIRNSSKLCEDIVS-KGAMQALIKLVADCSVLALNPSRKDAVN 1284
+ A AL+NL + S KG M+AL+ + S ++ +
Sbjct: 210 DHYSITLRRYAGMALTNLTFGDVANKATLCSMKGCMRALVAQLKSESEDL----QQVIAS 265
Query: 1285 ESPLKIALFSLAKMCAHTPCRQFLQSSELFPVIARLRQSPES 1326
L +L+ A ++ L+ + +
Sbjct: 266 ------VLRNLSWR-ADVNSKKTLREVGSVKALMECALEVKK 300
|
| >1xm9_A Plakophilin 1; armadillo repeat, cell adhesion; 2.80A {Homo sapiens} SCOP: a.118.1.24 Length = 457 | Back alignment and structure |
|---|
Score = 64.1 bits (155), Expect = 1e-10
Identities = 31/194 (15%), Positives = 68/194 (35%), Gaps = 8/194 (4%)
Query: 1135 LEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKF 1194
+ +L+ +D +A + + C + + I L+D P++ ++
Sbjct: 4 IPKAVQYLSSQDEKYQAIGAYYIQHTCFQDESAKQQVYQLGGICKLVDLLRSPNQNVQQA 63
Query: 1195 ACFSIGNAAYHNDVLYEELRRS--IPLLANILISDEEDKTKANAAGALSNLIRNSSKLCE 1252
A ++ N + + E RR I ++L + + G L NL L E
Sbjct: 64 AAGALRNLVFRSTTNKLETRRQNGIREAVSLLRRTGNAEIQKQLTGLLWNLSSTDE-LKE 122
Query: 1253 DIVSKGAMQALIKLV---ADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQFLQ 1309
++++ A+ L V + ++ V+ A L + + RQ ++
Sbjct: 123 ELIA-DALPVLADRVIIPFSGWCDGNSNMSREVVDPEVFFNATGCLRNLSSADAGRQTMR 181
Query: 1310 SSE-LFPVIARLRQ 1322
+ L + Q
Sbjct: 182 NYSGLIDSLMAYVQ 195
|
| >1xm9_A Plakophilin 1; armadillo repeat, cell adhesion; 2.80A {Homo sapiens} SCOP: a.118.1.24 Length = 457 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 6e-07
Identities = 31/190 (16%), Positives = 64/190 (33%), Gaps = 16/190 (8%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSAL 1157
+ L S + + D+ + + + L D L + NV+ A AL
Sbjct: 9 QYLSSQDEKYQAIGAYYIQHTCFQDESAKQQVYQLGGICKLVDLLRSPNQNVQQAAAGAL 68
Query: 1158 GNMCRHSSYFYSSLAKNRIIGLLIDR-CADPDKRTRKFACFSIGNAAYHNDVLYEELRRS 1216
N+ S+ + I + + +K + N + +++ E + +
Sbjct: 69 RNLVFRSTTNKLETRRQNGIREAVSLLRRTGNAEIQKQLTGLLWNLSSTDELKEELIADA 128
Query: 1217 IPLLANILIS---------------DEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQ 1261
+P+LA+ +I + + NA G L NL + G +
Sbjct: 129 LPVLADRVIIPFSGWCDGNSNMSREVVDPEVFFNATGCLRNLSSADAGRQTMRNYSGLID 188
Query: 1262 ALIKLVADCS 1271
+L+ V +C
Sbjct: 189 SLMAYVQNCV 198
|
| >1xm9_A Plakophilin 1; armadillo repeat, cell adhesion; 2.80A {Homo sapiens} SCOP: a.118.1.24 Length = 457 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 1e-06
Identities = 25/207 (12%), Positives = 58/207 (28%), Gaps = 25/207 (12%)
Query: 1112 LMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSS- 1170
L + W Y + L + + AL N+ S
Sbjct: 266 LPEEETNPKGSGWLYHSDAIRTYLNLMGK---SKKDATLEACAGALQNLTASKGLMSSGM 322
Query: 1171 ----LAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILIS 1226
K + + + + + + N + H + + P + +L S
Sbjct: 323 SQLIGLKEKGLPQIARLLQSGNSDVVRSGASLLSNMSRHPLLHRVMGNQVFPEVTRLLTS 382
Query: 1227 -----DEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKD 1281
+ ++A + NL+ + +L + S + +I L +
Sbjct: 383 HTGNTSNSEDILSSACYTVRNLMASQPQLAKQYFSSSMLNNIINLC------------RS 430
Query: 1282 AVNESPLKIALFSLAKMCAHTPCRQFL 1308
+ + + A L+ M + + L
Sbjct: 431 SASPKAAEAARLLLSDMWSSKELQGVL 457
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 2e-10
Identities = 81/513 (15%), Positives = 149/513 (29%), Gaps = 155/513 (30%)
Query: 343 PSGSQALNRL-----ENNSRTVKGAL-SICQDNEALALILLPLKKWSQGSQ------NTC 390
RL V+ + + + N ++ P+K +
Sbjct: 58 KDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN--YKFLMSPIKTEQRQPSMMTRMYIEQ 115
Query: 391 RDQDVLNSNQSLRILSNLVAASAIQSNGLLDEIISELLDFSSVVV-SLKASELNDLLAKS 449
RD+ + N NQ N+ L + + EL +V++ + S K+
Sbjct: 116 RDR-LYNDNQVFAKY-NVSRLQPYLK---LRQALLELRPAKNVLIDGVLGS------GKT 164
Query: 450 FLIIKMLIDNSGSCIASSYFTN---WVAVVEIFSKVVSCNEDASGRVLYEATACITVML- 505
++ + + + C W+ + +CN + + ML
Sbjct: 165 WVALDVCLSYKVQCK----MDFKIFWL-------NLKNCNSPET----------VLEMLQ 203
Query: 506 ---SRVAQNLKASSSAPGPDANSTPRVNETLKRILDHA--KTSGLV-DHLCCCLATSGSN 559
++ N + S + L+R+L + LV ++
Sbjct: 204 KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ--------- 254
Query: 560 LNSGSSNMLRAACETCKAIF-----SLVDVL----EIHFSMENAYLFPLNAFWSHSLLR- 609
++ A +CK + + D L H S+++ + L SLL
Sbjct: 255 ----NAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDH-HSMTLTPDEVKSLLLK 309
Query: 610 -LDIRDHERGSLVGPESARIID----ALTRAFLRSKAVQLAINHCLHQRAEATLSAVIQL 664
LD R + L P + ++ +R ++ H + L+ +I+
Sbjct: 310 YLDCRPQD---L--PREVLTTNPRRLSIIAESIRDGLAT--WDNWKHVNCDK-LTTIIES 361
Query: 665 LSRCCLRSGIIPSIL------CG-FPSSLPVTTVV-------SGGEDGTAVLEIFSILSL 710
L + P+ FP S + T++ D V+ SL
Sbjct: 362 ----SLNV-LEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL 416
Query: 711 CASSNKDSQVGETSNVKGKLSNPCALALHSCLFLAIVAQCLKSTLRNSALFMLTTTPKKQ 770
K+S + + S LK L N +
Sbjct: 417 VEKQPKESTIS----------------IPSIYLE------LKVKLEN----------EYA 444
Query: 771 LSRLKILAHY-----FSSDDRIKT----YFQLH 794
L R I+ HY F SDD I YF H
Sbjct: 445 LHR-SIVDHYNIPKTFDSDDLIPPYLDQYFYSH 476
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 1e-08
Identities = 104/690 (15%), Positives = 187/690 (27%), Gaps = 238/690 (34%)
Query: 674 IIPSILCGFPSSLPVTTVVSGGEDGTAVLEIFSILSLCASSNKDSQVGETSNVKGKLSNP 733
I+ F + V +D SILS D + V G
Sbjct: 21 ILSVFEDAFVDNFDCKDV----QDMPK-----SILS---KEEIDHIIMSKDAVSG----- 63
Query: 734 CALALHSCLFL---AIVAQCLKSTLRNSALFMLTTTPKKQLSRLKILAHYFSSDD----- 785
L L L +V + ++ LR + F+++ +Q + Y D
Sbjct: 64 -TLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND 122
Query: 786 ----------RIKTYFQLHSASAMLAFASILSLE----SGATVESSIYEIAVPLIPPTAT 831
R++ Y +L A L A + ++ SG T +
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTW----------V---ALD 169
Query: 832 LCDLLKITSGNADQMGPISQSNSFSYWHGLKDGCVGLLESRLKCGGPLAVQQMIASNIPM 891
+C K+ ++ +W L C N P
Sbjct: 170 VCLSYKVQCKMDFKI----------FW--LNLK---------NC------------NSPE 196
Query: 892 LLIDLLANTHSSQQIGSTRDQMMLSPAGVVSTISSIYHCLSGGVLMFRQVLLKNEYMK-- 949
++++L QI + + I SI L R++L Y
Sbjct: 197 TVLEMLQKLLY--QIDPNWTSRSDHSSNIKLRIHSIQAEL-------RRLLKSKPYENCL 247
Query: 950 LICNLLSDV-HLKLVKGWGGPGGGKDGI----RD--IINAVIDLLAFPFVAVQNAPG--- 999
L+ L +V + K + K I R + + + ++
Sbjct: 248 LV---LLNVQNAKAWNAFNL--SCK--ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 1000 -----------------LPSATASVNSGFILNMGSAGGKVCMEDRDMAKAIE-------E 1035
LP + N L++ + RD + +
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNP-RRLSIIAE------SIRDGLATWDNWKHVNCD 353
Query: 1036 DMGKYIKILMEVGVPGIILRCLEHMEL--KNLGRPIAFLA----KMIGQ--RSLAVQLVG 1087
+ I+ + V P + + + + + P L+ +I + +L
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
Query: 1088 KGLL--DPNRVR-RLLDSSTREVTLDVLMIVSDLARM----------------------- 1121
L+ P + + L++ + + + +
Sbjct: 414 YSLVEKQPKESTISIPS-----IYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPY 468
Query: 1122 -DKWFYEYI--------NGASMLEFLKDFLTHEDPN-VRAKACSALGNMCRHSSYFYSSL 1171
D++FY +I + M F FL D + K RH S +
Sbjct: 469 LDQYFYSHIGHHLKNIEHPERMTLFRMVFL---DFRFLEQK--------IRHDS--TAWN 515
Query: 1172 AKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDK 1231
A I+ L K + + C ND YE L +I + L EE
Sbjct: 516 ASGSILNTLQQL-----KFYKPYIC--------DNDPKYERLVNAI---LDFLPKIEE-- 557
Query: 1232 TKANAAGALSNLIRNSSKLCEDIVSKGAMQ 1261
NLI SK D++ M
Sbjct: 558 ----------NLIC--SK-YTDLLRIALMA 574
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 2e-06
Identities = 88/584 (15%), Positives = 168/584 (28%), Gaps = 171/584 (29%)
Query: 34 MKFIMKHGKSE-KDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQGEL--- 89
K I+ K E I + + +L + S QE +V +F + L
Sbjct: 42 PKSILS--KEEIDHIIMSKDAVSGTLRL--------FWTLLSKQE-EMVQKFVEEVLRIN 90
Query: 90 FEILED-------DKCLPEEQ-----------VQSIAKQLVRALHYLHSNRIIHRDMKP- 130
++ L + Q AK V L R +++P
Sbjct: 91 YKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPA 150
Query: 131 QNILI----GAG------SVVK----LCDFGF-------ARAMSANTVV-----LRSIKG 164
+N+LI G+G V C F S TV+ L
Sbjct: 151 KNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQID 210
Query: 165 TPLYMAPE------------------LVREQPYNHT----ADLWSLGVILYELFVGQ--- 199
+ L++ +PY + ++ + F
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW--NAFNLSCKI 268
Query: 200 -----PPFYTNSVYALIR-HIVKDPVK---YPDEMSPNFKSFLKGLLNKVPQNRLTWSAL 250
T+ + A HI D PDE+ +L +P+ L
Sbjct: 269 LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR-----EVL 323
Query: 251 LEHPFV-----KETSDELNAWE-LRATSVEARGCNATWTAEGNAIQSSSGKSNSPAVSAN 304
+P + D L W+ + + + I+S S N
Sbjct: 324 TTNPRRLSIIAESIRDGLATWDNWKHVNCDKL---------TTIIES----------SLN 364
Query: 305 NTSPSLHTDVELNSSNTSQSNSSPCEAFPGFSSPNNVK-PSGSQALNRL--ENNSRTVKG 361
P+ + + F P + P + L+ + + V
Sbjct: 365 VLEPAEY-----------RKMFDRLSVF-----PPSAHIP--TILLSLIWFDVIKSDVMV 406
Query: 362 ALSICQDNEALALILLPLKKWSQGSQNTCRD--QDVLNSNQSLRIL-SNLVAASAIQSNG 418
++ +L ++K + S + ++ ++ L ++V I
Sbjct: 407 VVNKLH-KYSL------VEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTF 459
Query: 419 LLDEIISELLD---FSSVVVSLKA---SELNDLLAKSFL----IIKMLIDNSGSCIASSY 468
D++I LD +S + LK E L FL + + + +S + AS
Sbjct: 460 DSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGS 519
Query: 469 FTNWVAVVEIFSKVVSCNEDASGRVLYEATACITVMLSRVAQNL 512
N + ++ + + N+ R++ I L ++ +NL
Sbjct: 520 ILNTLQQLKFYKPYICDNDPKYERLVNA----ILDFLPKIEENL 559
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 5e-06
Identities = 48/398 (12%), Positives = 114/398 (28%), Gaps = 118/398 (29%)
Query: 1033 IEEDMG----KYIKILMEVGVPGIILRCLEHMELKNLGRPI---AFLAKMIGQRSLAVQL 1085
++ + G +Y IL V + + +++++ + I + +I +
Sbjct: 7 MDFETGEHQYQYKDIL-SVFEDAFV-DNFDCKDVQDMPKSILSKEEIDHIIMSKD----- 59
Query: 1086 VGKGLLDPNRVRRLLDSSTREVTLDVLMIVSDLARMD-KWFYEYI----NGASMLE---- 1136
+ RL + + V V ++ R++ K+ I SM+
Sbjct: 60 ------AVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYI 113
Query: 1137 ------------FLKDFLTHEDP--NVR--------------------------AKACSA 1156
F K ++ P +R C +
Sbjct: 114 EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLS 173
Query: 1157 LGNMCRHSSY-FYSSLAKNRIIGLLIDR----C--ADPDKRTRKFACFSIGNAAYHNDVL 1209
C+ F+ +L +++ DP+ +R N +
Sbjct: 174 YKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR---SDHSSNIKLRIHSI 230
Query: 1210 YEELRRSIP-------LLANIL--ISDEE----------------DKTKANAAGALSNLI 1244
ELRR + LL +L + + + K + A +
Sbjct: 231 QAELRRLLKSKPYENCLL--VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSA-ATTT 287
Query: 1245 RNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPC 1304
S ++ +++L+ DC L ++ + +P ++++ A+
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQDL---PREVLTTNPRRLSII--AESIRDGLA 342
Query: 1305 R----QFLQSSELFPVIAR-LRQ-SPESTIANYASVII 1336
+ + +L +I L P + + +
Sbjct: 343 TWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV 380
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 3e-05
Identities = 38/280 (13%), Positives = 83/280 (29%), Gaps = 90/280 (32%)
Query: 41 GKSEKDIHNLRQEIEILRKLKHQNIIEM-LDSFESPQEF------CVVTEFAQG-----E 88
+S +D + + K IIE L+ E P E+ V F
Sbjct: 334 AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE-PAEYRKMFDRLSV--FPPSAHIPTI 390
Query: 89 LFEILEDDKCLPEEQVQSIAKQLVRA----------LHYLHSNRIIHRDMKPQ------- 131
L ++ D + + V + +L + + S I+ ++K +
Sbjct: 391 LLSLIWFD--VIKSDVMVVVNKLHKYSLVEKQPKESTISIPS---IYLELKVKLENEYAL 445
Query: 132 -NILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNH--------- 181
++ + + ++ ++ + Y Y+H
Sbjct: 446 HRSIVDH--------YNIPKTFDSDDLIPPYLDQ---YF---------YSHIGHHLKNIE 485
Query: 182 TADLWSLGVILYEL---FVGQ-------PPFYTNSVYALI-------RHIVKDPVKYPDE 224
+ +L +++ L F+ Q + S+ + +I + KY +
Sbjct: 486 HPERMTLFRMVF-LDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKY-ER 543
Query: 225 MSPNFKSFLKGL---LNKVPQNRLTWSALL-EHPFVKETS 260
+ FL + L L AL+ E + E +
Sbjct: 544 LVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEA 583
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 6e-05
Identities = 50/442 (11%), Positives = 120/442 (27%), Gaps = 144/442 (32%)
Query: 56 ILRKLKHQNIIEMLDSFESPQEFC---VVTEFAQGELFEILEDDKCLPEEQVQSIAKQLV 112
+L +++ + C + T K + L
Sbjct: 249 VLLNVQNAKAWNAFN-LS-----CKILLTTR------------FK--------QVTDFLS 282
Query: 113 RALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS--IKGTPLYMA 170
+ H + ++ + V L + + L + P ++
Sbjct: 283 -------AATTTHISLDHHSMTLTPDEVKSL----LLKYLDCRPQDLPREVLTTNPRRLS 331
Query: 171 --PELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKY--PDEMS 226
E +R+ W + + + I++ + P E
Sbjct: 332 IIAESIRDGL-----ATWD--------------NWKHVNCDKLTTIIESSLNVLEPAEYR 372
Query: 227 PNFKS---FLKGLLNKVPQNRLT--WSALLEHPFVKETSDELNAWELRATS-VEARGCNA 280
F F +P L+ W +++ + +N +L S VE + +
Sbjct: 373 KMFDRLSVFPPSA--HIPTILLSLIWFDVIK----SDVMVVVN--KLHKYSLVEKQPKES 424
Query: 281 TWTAEGNAIQSSSGKSNSPAVSANNTSPSLHTDVELNSSNTSQSNSSPCEAFPGFSSPNN 340
T + I PS++ ++++ N + S + +
Sbjct: 425 TIS-----I------------------PSIYLELKVKLENEYALHRSIVDHY-------- 453
Query: 341 VKPSGSQALNRLENNSRTVKGA-----------LSICQDNEALAL---ILLPL----KKW 382
+++ L + E + L + L +K
Sbjct: 454 ------NIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKI 507
Query: 383 SQGSQNTCRDQDVLNSNQSLRILSNLVAASAIQSNGLLDEIISELLDFSSVVVSLKASEL 442
S +LN+ Q L+ + ++ + +++ +LDF L E
Sbjct: 508 RHDSTAWNASGSILNTLQQLKFYKPYI----CDNDPKYERLVNAILDF------LPKIEE 557
Query: 443 NDLLAKSFLIIKMLIDNSGSCI 464
N + +K ++++ + I
Sbjct: 558 NLICSKYTDLLRIALMAEDEAI 579
|
| >3tt9_A Plakophilin-2; cell adhesion; 1.55A {Homo sapiens} Length = 233 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 26/142 (18%), Positives = 56/142 (39%), Gaps = 6/142 (4%)
Query: 1130 NGASMLEFLKDFLT--HEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADP 1187
+ LE L H P+ + A + + + C S + + R I L+
Sbjct: 5 DMEMTLERAVSMLEADHMLPSRISAAATFIQHECFQKSEARKRVNQLRGILKLLQLLKVQ 64
Query: 1188 DKRTRKFACFSIGNAAYHNDVLYEELRRS--IPLLANILISDEEDKTKANAAGALSNLIR 1245
++ ++ C ++ N + ++ E+ +P L +L + +TK G L NL
Sbjct: 65 NEDVQRAVCGALRNLVFEDNDNKLEVAELNGVPRLLQVLKQTRDLETKKQITGLLWNLSS 124
Query: 1246 NSSKLCEDIVSKGAMQALIKLV 1267
N ++++ A+ L + +
Sbjct: 125 NDKL--KNLMITEALLTLTENI 144
|
| >3tt9_A Plakophilin-2; cell adhesion; 1.55A {Homo sapiens} Length = 233 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 25/196 (12%), Positives = 61/196 (31%), Gaps = 19/196 (9%)
Query: 1095 RVRRLLDSSTREVTL--DVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAK 1152
R +L++ + + + +N + L L ++ +V+
Sbjct: 12 RAVSMLEADHMLPSRISAAATFIQHECFQKSEARKRVNQLRGILKLLQLLKVQNEDVQRA 71
Query: 1153 ACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCAD-PDKRTRKFACFSIGNAAYHNDVLYE 1211
C AL N+ + +A+ + L+ D T+K + N + ++ +
Sbjct: 72 VCGALRNLVFEDNDNKLEVAELNGVPRLLQVLKQTRDLETKKQITGLLWNLSSNDKLKNL 131
Query: 1212 ELRRSIPLLANILI---------------SDEEDKTKANAAGALSNLIRNSSKLCEDIVS 1256
+ ++ L +I + N G L N+ + + +
Sbjct: 132 MITEALLTLTENIIIPFSGWPEGDYPKANGLLDFDIFYNVTGCLRNMSSAGADGRKAMRR 191
Query: 1257 -KGAMQALIKLVADCS 1271
G + +L+ V
Sbjct: 192 CDGLIDSLVHYVRGTI 207
|
| >1te4_A Conserved protein MTH187; methanobacterium thermoautotrophicum, structural proteomics, heat-like repeat; NMR {Methanothermobacterthermautotrophicus} SCOP: a.118.1.16 Length = 131 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 8e-08
Identities = 26/135 (19%), Positives = 44/135 (32%), Gaps = 33/135 (24%)
Query: 1135 LEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKF 1194
L + E+ VR +AL M + L++ ++ D R R
Sbjct: 14 LVPRGSHMADENKWVRRDVSTALSRM------------GDEAFEPLLESLSNEDWRIRGA 61
Query: 1195 ACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDI 1254
A + IGN R++ L +L D+ ++ AA +L I
Sbjct: 62 AAWIIGNFQD---------ERAVEPLIKLL-EDDSGFVRSGAARSLEQ-----------I 100
Query: 1255 VSKGAMQALIKLVAD 1269
+ A+ KL
Sbjct: 101 GGERVRAAMEKLAET 115
|
| >1te4_A Conserved protein MTH187; methanobacterium thermoautotrophicum, structural proteomics, heat-like repeat; NMR {Methanothermobacterthermautotrophicus} SCOP: a.118.1.16 Length = 131 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 19/106 (17%), Positives = 29/106 (27%), Gaps = 21/106 (19%)
Query: 1135 LEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKF 1194
E L + L++ED +R A +GN R + LI D R
Sbjct: 44 FEPLLESLSNEDWRIRGAAAWIIGNFQDE-----------RAVEPLIKLLEDDSGFVRSG 92
Query: 1195 ACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGAL 1240
A S+ R + + + A L
Sbjct: 93 AARSLEQIGG---------ERVRAAMEKLA-ETGTGFARKVAVNYL 128
|
| >3l6x_A Catenin delta-1; catenin, armadillo, ARM, JMD, CE adhesion, complex, cell-CELL adhesion, ARVCF, delta-catenin DP120, JAC-1, cell membrane, membrane; 2.40A {Homo sapiens} PDB: 3l6y_A Length = 584 | Back alignment and structure |
|---|
Score = 54.2 bits (129), Expect = 2e-07
Identities = 23/170 (13%), Positives = 61/170 (35%), Gaps = 12/170 (7%)
Query: 1114 IVSDLARMDKWFYEYINGASMLEFLKDFLTH-EDPNVRAKACSALGNMC----RHSSYFY 1168
+ ++ YE + ++ L + P + + A+ N+C + Y
Sbjct: 289 VANNTGTSPARGYELLFQPEVVRIYISLLKESKTPAILEASAGAIQNLCAGRWTYGRYIR 348
Query: 1169 SSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILIS-- 1226
S+L + + + + D + +R K A ++ N A + +IP L L
Sbjct: 349 SALRQEKALSAIADLLTNEHERVVKAASGALRNLAVDARNKELIGKHAIPNLVKNLPGGQ 408
Query: 1227 -----DEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCS 1271
+ + T + ++ +I + + + + ++ L+ + +
Sbjct: 409 QNSSWNFSEDTVISILNTINEVIAENLEAAKKLRETQGIEKLVLINKSGN 458
|
| >1b3u_A Protein (protein phosphatase PP2A); scaffold protein, phosphorylation, heat repeat; 2.30A {Homo sapiens} SCOP: a.118.1.2 PDB: 2ie4_A* 2ie3_A* 2npp_A* 3k7v_A* 3k7w_A* 3fga_A* 2pf4_A 2iae_A 2nym_A* 2nyl_A* 3dw8_A* 2pkg_A 3c5w_A Length = 588 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 7e-07
Identities = 35/251 (13%), Positives = 80/251 (31%), Gaps = 14/251 (5%)
Query: 1022 VCMEDRDMAKAIEEDMGKYIKILMEVGVPGIILRCLEHMELKNLGRPIAFLAKMIGQRSL 1081
+E+ + E + + + ++ + + +
Sbjct: 96 ATVEETVVRDKAVESLRAISHEHSPSDLEAHFVPLVKRLAGGDWFTSRTSACGLFSVCYP 155
Query: 1082 AVQLVGKGLLDPNRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDF 1141
V K L R L T V + + A++ + + + + ++ +
Sbjct: 156 RVSSAVKAELRQ-YFRNLCSDDTPMVRRAAASKLGEFAKVLE--LDNVK-SEIIPMFSNL 211
Query: 1142 LTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGN 1201
+ E +VR A A N+ + + ++ L D R R
Sbjct: 212 ASDEQDSVRLLAVEACVNIAQLLP---QEDLEALVMPTLRQAAEDKSWRVRYMVADKFTE 268
Query: 1202 AAY--HNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLC-EDIVSKG 1258
++ +L +P N L+ D E + +A A+ + N S C E+++
Sbjct: 269 LQKAVGPEITKTDL---VPAFQN-LMKDCEAEVRAAASHKVKEFCENLSADCRENVIMSQ 324
Query: 1259 AMQALIKLVAD 1269
+ + +LV+D
Sbjct: 325 ILPCIKELVSD 335
|
| >1b3u_A Protein (protein phosphatase PP2A); scaffold protein, phosphorylation, heat repeat; 2.30A {Homo sapiens} SCOP: a.118.1.2 PDB: 2ie4_A* 2ie3_A* 2npp_A* 3k7v_A* 3k7w_A* 3fga_A* 2pf4_A 2iae_A 2nym_A* 2nyl_A* 3dw8_A* 2pkg_A 3c5w_A Length = 588 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 8e-05
Identities = 17/110 (15%), Positives = 38/110 (34%), Gaps = 12/110 (10%)
Query: 1094 NRVRRLLDSST---REVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVR 1150
+V + R TL + ++S++ D +++ L + NVR
Sbjct: 483 PKVLAMSGDPNYLHRMTTLFCINVLSEVCGQDI-TTKHM-----LPTVLRMAGDPVANVR 536
Query: 1151 AKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIG 1200
+L + +S ++ + +L D D + FA ++
Sbjct: 537 FNVAKSLQKIG---PILDNSTLQSEVKPILEKLTQDQDVDVKYFAQEALT 583
|
| >1oyz_A Hypothetical protein YIBA; structural genomics, PSI, protein structure initiative, northeast structural genomics consortium, NESG; 2.10A {Escherichia coli} SCOP: a.118.1.16 Length = 280 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 21/142 (14%), Positives = 41/142 (28%), Gaps = 22/142 (15%)
Query: 1129 INGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDR-CADP 1187
G + +F + ++ R LG + ++ + +L + D
Sbjct: 50 RGGQDAVRLAIEFCSDKNYIRRDIGAFILGQI------KICKKCEDNVFNILNNMALNDK 103
Query: 1188 DKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNS 1247
R A S N + ++ + D+ + A A+S
Sbjct: 104 SACVRATAIESTAQRCKKNPIYSPKI---VEQSQITA-FDKSTNVRRATAFAISV----- 154
Query: 1248 SKLCEDIVSKGAMQALIKLVAD 1269
I K + LI L+ D
Sbjct: 155 ------INDKATIPLLINLLKD 170
|
| >1oyz_A Hypothetical protein YIBA; structural genomics, PSI, protein structure initiative, northeast structural genomics consortium, NESG; 2.10A {Escherichia coli} SCOP: a.118.1.16 Length = 280 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 20/133 (15%), Positives = 42/133 (31%), Gaps = 29/133 (21%)
Query: 1129 INGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPD 1188
IN + + L + L + +VR A A+ +S I ++ D +
Sbjct: 155 INDKATIPLLINLLKDPNGDVRNWAAFAININKYDNS---------DIRDCFVEMLQDKN 205
Query: 1189 KRTRKFACFSIGN------------AAYHNDVLYE--------ELRRSIPLLANILISDE 1228
+ R A + N V + + +P+L +L +
Sbjct: 206 EEVRIEAIIGLSYRKDKRVLSVLCDELKKNTVYDDIIEAAGELGDKTLLPVLDTMLYKFD 265
Query: 1229 EDKTKANAAGALS 1241
+++ +A L
Sbjct: 266 DNEIITSAIDKLK 278
|
| >3ltj_A Alpharep-4; protein engineering, heat-like repeat, protein binding; 1.80A {Synthetic} Length = 201 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 33/142 (23%), Positives = 46/142 (32%), Gaps = 32/142 (22%)
Query: 1128 YINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADP 1187
I +E L L ED VR A ALG + + + LI D
Sbjct: 71 QIGDERAVEPLIKALKDEDGWVRQSAAVALGQIGDERA-----------VEPLIKALKDE 119
Query: 1188 DKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNS 1247
D R A F++G R++ L L DE+ + +AA AL
Sbjct: 120 DWFVRIAAAFALGEIGD---------ERAVEPLIKAL-KDEDGWVRQSAADALGE----- 164
Query: 1248 SKLCEDIVSKGAMQALIKLVAD 1269
I + A+ KL
Sbjct: 165 ------IGGERVRAAMEKLAET 180
|
| >3ltj_A Alpharep-4; protein engineering, heat-like repeat, protein binding; 1.80A {Synthetic} Length = 201 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 23/115 (20%), Positives = 32/115 (27%), Gaps = 21/115 (18%)
Query: 1129 INGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPD 1188
I +E L L ED VR A ALG + R + LI D D
Sbjct: 103 IGDERAVEPLIKALKDEDWFVRIAAAFALGE-----------IGDERAVEPLIKALKDED 151
Query: 1189 KRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNL 1243
R+ A ++G R + + + A L
Sbjct: 152 GWVRQSAADALGEIGG---------ERVRAAMEKLA-ETGTGFARKVAVNYLETH 196
|
| >3ltj_A Alpharep-4; protein engineering, heat-like repeat, protein binding; 1.80A {Synthetic} Length = 201 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 40/217 (18%), Positives = 70/217 (32%), Gaps = 44/217 (20%)
Query: 1135 LEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKF 1194
+E L + VR A ALG + R + LI D D R+
Sbjct: 16 VEMYIKNLQDDSYYVRRAAAYALGKI-----------GDERAVEPLIKALKDEDAWVRRA 64
Query: 1195 ACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSS-----K 1249
A ++G R++ L L DE+ + +AA AL + + K
Sbjct: 65 AADALGQI---------GDERAVEPLIKAL-KDEDGWVRQSAAVALGQIGDERAVEPLIK 114
Query: 1250 LCED---IVSKGAMQALIKLVADCSVLALNPSRKDAVNESPL--KIALFSLAKMCAHTPC 1304
+D V A AL ++ + +V L + KD E + A +L +
Sbjct: 115 ALKDEDWFVRIAAAFALGEIGDERAVEPLIKALKD---EDGWVRQSAADALGE------- 164
Query: 1305 RQFLQSSELFPVIARLRQSPESTIANYASVIISKVGD 1341
+ + + +L ++ A +
Sbjct: 165 ---IGGERVRAAMEKLAETGTGFARKVAVNYLETHKS 198
|
| >3ltm_A Alpha-REP4; protein engineering, heat-like repeat, protein binding; HET: 1PE 12P; 2.15A {Synthetic} Length = 211 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 34/142 (23%), Positives = 46/142 (32%), Gaps = 32/142 (22%)
Query: 1128 YINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADP 1187
I +E L L ED VR A ALG + R + LI D
Sbjct: 76 QIGDERAVEPLIKALKDEDGWVRQSAAVALGQ-----------IGDERAVEPLIKALKDE 124
Query: 1188 DKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNS 1247
D R A F++G R++ L L DE+ + +AA AL
Sbjct: 125 DWFVRIAAAFALGEIGD---------ERAVEPLIKAL-KDEDGWVRQSAADALGE----- 169
Query: 1248 SKLCEDIVSKGAMQALIKLVAD 1269
I + A+ KL
Sbjct: 170 ------IGGERVRAAMEKLAET 185
|
| >3ltm_A Alpha-REP4; protein engineering, heat-like repeat, protein binding; HET: 1PE 12P; 2.15A {Synthetic} Length = 211 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 23/115 (20%), Positives = 32/115 (27%), Gaps = 21/115 (18%)
Query: 1129 INGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPD 1188
I +E L L ED VR A ALG + R + LI D D
Sbjct: 108 IGDERAVEPLIKALKDEDWFVRIAAAFALGE-----------IGDERAVEPLIKALKDED 156
Query: 1189 KRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNL 1243
R+ A ++G R + + + A L
Sbjct: 157 GWVRQSAADALGEIGG---------ERVRAAMEKLA-ETGTGFARKVAVNYLETH 201
|
| >3ltm_A Alpha-REP4; protein engineering, heat-like repeat, protein binding; HET: 1PE 12P; 2.15A {Synthetic} Length = 211 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 31/143 (21%), Positives = 47/143 (32%), Gaps = 32/143 (22%)
Query: 1127 EYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCAD 1186
+E L + VR A ALG + R + LI D
Sbjct: 13 PLRADPEKVEMYIKNLQDDSYYVRRAAAYALGKI-----------GDERAVEPLIKALKD 61
Query: 1187 PDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRN 1246
D R+ A ++G R++ L L DE+ + +AA AL
Sbjct: 62 EDAWVRRAAADALGQIGD---------ERAVEPLIKAL-KDEDGWVRQSAAVALGQ---- 107
Query: 1247 SSKLCEDIVSKGAMQALIKLVAD 1269
I + A++ LIK + D
Sbjct: 108 -------IGDERAVEPLIKALKD 123
|
| >2bpt_A Importin beta-1 subunit; nuclear transport, nucleocytoplasmic transport, nuclear trafficking, importin- beta, complex; 1.99A {Saccharomyces cerevisiae} SCOP: a.118.1.1 PDB: 2bku_B 3ea5_B* 3nd2_A Length = 861 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 4e-05
Identities = 19/137 (13%), Positives = 52/137 (37%), Gaps = 5/137 (3%)
Query: 1134 MLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRK 1193
+LEF++ +T ++ R A A G++ + ++ + +++ D + ++
Sbjct: 370 VLEFVEQNITADNWRNREAAVMAFGSIMDGPDKVQRTYYVHQALPSILNLMNDQSLQVKE 429
Query: 1194 FACFSIGNAAYHNDVLYEELRRS-IPLLANILISDEED--KTKANAAGALSNLIRNSSKL 1250
+ IG + V + +P + + +D K N + + NL+ ++
Sbjct: 430 TTAWCIGR--IADSVAESIDPQQHLPGVVQACLIGLQDHPKVATNCSWTIINLVEQLAEA 487
Query: 1251 CEDIVSKGAMQALIKLV 1267
+ + L+
Sbjct: 488 TPSPIYNFYPALVDGLI 504
|
| >2bpt_A Importin beta-1 subunit; nuclear transport, nucleocytoplasmic transport, nuclear trafficking, importin- beta, complex; 1.99A {Saccharomyces cerevisiae} SCOP: a.118.1.1 PDB: 2bku_B 3ea5_B* 3nd2_A Length = 861 | Back alignment and structure |
|---|
Score = 44.4 bits (104), Expect = 2e-04
Identities = 25/204 (12%), Positives = 65/204 (31%), Gaps = 13/204 (6%)
Query: 1133 SMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLID---RCADPDK 1189
L + + + + V+ +G R + S+ + + ++
Sbjct: 411 QALPSILNLMNDQSLQVKETTAWCIG---RIADSVAESIDPQQHLPGVVQACLIGLQDHP 467
Query: 1190 RTRKFACFSIGNAA--YHNDVLYEELRRSIPLLANIL----ISDEEDKTKANAAGALSNL 1243
+ ++I N L+ ++ D E +A+A AL+ +
Sbjct: 468 KVATNCSWTIINLVEQLAEATPSPIYNFYPALVDGLIGAANRIDNEFNARASAFSALTTM 527
Query: 1244 IRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTP 1303
+ ++ + + + + KL SV + +DA + L+ + ++
Sbjct: 528 VEYATDTVAETSASISTFVMDKLGQTMSVDENQLTLEDAQSLQELQSNILTVLAAVIRKS 587
Query: 1304 CRQFLQ-SSELFPVIARLRQSPES 1326
+ L + RL + +S
Sbjct: 588 PSSVEPVADMLMGLFFRLLEKKDS 611
|
| >2db0_A 253AA long hypothetical protein; heat repeats, helical structure, structural genomics; 2.20A {Pyrococcus horikoshii} Length = 253 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 28/148 (18%), Positives = 55/148 (37%), Gaps = 8/148 (5%)
Query: 1110 DVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYS 1169
D+ +++ ++K S+L+ L + L + V A S + + + Y
Sbjct: 9 DIREALANGEHLEKILIMAKYDESVLKKLIELLDDDLWTVVKNAISIIMVIAKTREDLYE 68
Query: 1170 SLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEE 1229
+ K ++ LL + + G A E ++ IP+L +
Sbjct: 69 PMLK-KLFSLLKK---SEAIPLTQEIAKAFGQMAKEKP---ELVKSMIPVLFANY-RIGD 120
Query: 1230 DKTKANAAGALSNLIRNSSKLCEDIVSK 1257
+KTK N + AL + + + L IV
Sbjct: 121 EKTKINVSYALEEIAKANPMLMASIVRD 148
|
| >4fdd_A Transportin-1; heat repeats, karyopherin, nuclear import, protein transport importin, transportin, transport protein; 2.30A {Homo sapiens} PDB: 2ot8_A 2h4m_A 2z5k_A 2z5j_A 2qmr_A 2z5m_A 2z5n_A 2z5o_A 1qbk_B* Length = 852 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 4e-05
Identities = 20/125 (16%), Positives = 39/125 (31%), Gaps = 6/125 (4%)
Query: 1133 SMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTR 1192
++ L L+ + VR+ C L ++ L+ R D +KR +
Sbjct: 400 ELIPHLIQCLSDKKALVRSITCWTLSRYAHWVVSQPPDTYLKPLMTELLKRILDSNKRVQ 459
Query: 1193 KFACFSIGNAAYHNDVLYEELRRSIPLLANIL---ISDEEDKTKANAAGALSNLIRNSSK 1249
+ AC + + EL + + + L S + K A+ L +
Sbjct: 460 EAACSAFATLE---EEACTELVPYLAYILDTLVFAFSKYQHKNLLILYDAIGTLADSVGH 516
Query: 1250 LCEDI 1254
Sbjct: 517 HLNKP 521
|
| >1qgr_A Protein (importin beta subunit); transport receptor, nuclear import, heat motif, NLS-binding; 2.30A {Homo sapiens} SCOP: a.118.1.1 PDB: 1qgk_A 2p8q_A 2q5d_A 3lww_A 1ukl_A 2qna_A Length = 876 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 1e-04
Identities = 34/196 (17%), Positives = 68/196 (34%), Gaps = 9/196 (4%)
Query: 1134 MLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRK 1193
+L F+K+ + + D R A A G + + + LI+ DP R
Sbjct: 367 VLPFIKEHIKNPDWRYRDAAVMAFGCILEGPEPSQLKPLVIQAMPTLIELMKDPSVVVRD 426
Query: 1194 FACFSIGNAAYHNDVLYEELRRSIPLLANILIS-DEEDKTKANAAGALSNLIRNS--SKL 1250
A +++G PLL ++ E + +N A S+L + +
Sbjct: 427 TAAWTVGRICELLPEAAINDVYLAPLLQCLIEGLSAEPRVASNVCWAFSSLAEAAYEAAD 486
Query: 1251 CEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLK----IALFSLAKMCAHTPCRQ 1306
D + A L L + + +++ L+ +L + K A
Sbjct: 487 VADDQEEPATYCLSSSFELIVQKLLETTDRPDGHQNNLRSSAYESLMEIVKNSAKDCYPA 546
Query: 1307 FLQSSELFPVIARLRQ 1322
+++ ++ RL+Q
Sbjct: 547 VQKTTL--VIMERLQQ 560
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1342 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-87 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-84 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-84 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-83 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-82 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-82 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-80 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-80 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-80 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-79 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-78 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-78 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-78 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-76 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-76 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-76 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-75 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-72 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-71 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-71 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-71 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-69 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-69 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-69 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-68 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-68 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-68 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-68 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-66 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-66 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-66 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-65 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-65 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-65 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-64 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-63 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-63 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-62 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-62 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-62 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-61 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-60 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-58 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-58 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-58 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-47 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-47 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-28 | |
| d1xm9a1 | 457 | a.118.1.24 (A:244-700) Plakophilin 1 {Human (Homo | 2e-11 | |
| d1xm9a1 | 457 | a.118.1.24 (A:244-700) Plakophilin 1 {Human (Homo | 1e-08 | |
| d1xm9a1 | 457 | a.118.1.24 (A:244-700) Plakophilin 1 {Human (Homo | 4e-06 | |
| d1xm9a1 | 457 | a.118.1.24 (A:244-700) Plakophilin 1 {Human (Homo | 2e-05 | |
| d1jdha_ | 529 | a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) | 7e-09 | |
| d1jdha_ | 529 | a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) | 8e-06 | |
| d1jdha_ | 529 | a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) | 2e-05 | |
| d1jdha_ | 529 | a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) | 1e-04 | |
| d1jdha_ | 529 | a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) | 0.002 | |
| d1wa5b_ | 503 | a.118.1.1 (B:) Karyopherin alpha {Baker's yeast (S | 5e-08 | |
| d1wa5b_ | 503 | a.118.1.1 (B:) Karyopherin alpha {Baker's yeast (S | 3e-06 | |
| d1q1sc_ | 434 | a.118.1.1 (C:) Importin alpha {Mouse (Mus musculus | 1e-06 | |
| d1xqra1 | 264 | a.118.1.21 (A:87-350) Hsp70-binding protein 1 (Hsp | 2e-06 | |
| d1u6gc_ | 1207 | a.118.1.2 (C:) Cullin-associated NEDD8-dissociated | 8e-06 | |
| d1u6gc_ | 1207 | a.118.1.2 (C:) Cullin-associated NEDD8-dissociated | 2e-04 | |
| d1u6gc_ | 1207 | a.118.1.2 (C:) Cullin-associated NEDD8-dissociated | 0.001 | |
| d1b3ua_ | 588 | a.118.1.2 (A:) Constant regulatory domain of prote | 1e-05 | |
| d1ibrb_ | 458 | a.118.1.1 (B:) Importin beta {Human (Homo sapiens) | 1e-04 | |
| d1qbkb_ | 888 | a.118.1.1 (B:) Karyopherin beta2 {Human (Homo sapi | 2e-04 | |
| d2vglb_ | 579 | a.118.1.10 (B:) Adaptin beta subunit N-terminal fr | 0.001 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 283 bits (725), Expect = 1e-87
Identities = 80/260 (30%), Positives = 139/260 (53%), Gaps = 4/260 (1%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEILRKLK 61
+E++ + +G+G FG VY R K + +A+K + K + H LR+E+EI L+
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 62 HQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
H NI+ + F ++ E+A G ++ L+ E++ + +L AL Y HS
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
R+IHRD+KP+N+L+G+ +K+ DFG++ ++ ++ GT Y+ PE++ + ++
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--RTTLCGTLDYLPPEMIEGRMHD 182
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
DLWSLGV+ YE VG+PPF N+ + I + +PD ++ + + LL
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 242
Query: 241 PQNRLTWSALLEHPFVKETS 260
P R +LEHP++ S
Sbjct: 243 PSQRPMLREVLEHPWITANS 262
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 274 bits (702), Expect = 4e-84
Identities = 99/269 (36%), Positives = 151/269 (56%), Gaps = 12/269 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ + +I +G+G+FGKVYK + K T A K I KSE+++ + EI+IL H
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHP 69
Query: 64 NIIEMLDSFESPQEFCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSN 121
NI+++LD+F ++ EF G + ++ + ++ L E Q+Q + KQ + AL+YLH N
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELV-----RE 176
+IIHRD+K NIL +KL DFG + + S GTP +MAPE+V ++
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 177 QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK---DPVKYPDEMSPNFKSFL 233
+PY++ AD+WSLG+ L E+ +PP + + ++ I K + P S NFK FL
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249
Query: 234 KGLLNKVPQNRLTWSALLEHPFVKETSDE 262
K L K R T S LL+HPFV S++
Sbjct: 250 KKCLEKNVDARWTTSQLLQHPFVTVDSNK 278
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 274 bits (701), Expect = 5e-84
Identities = 77/265 (29%), Positives = 134/265 (50%), Gaps = 10/265 (3%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK-HGKSEKDIHNLRQEIEILRKLKH 62
E++ +++GEGSF V R T + A+K + K H E + + +E +++ +L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
+++ +F+ ++ +A+ GEL + + E + ++V AL YLH
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN--TVVLRSIKGTPLYMAPELVREQPY 179
IIHRD+KP+NIL+ +++ DFG A+ +S S GT Y++PEL+ E+
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNK 239
++DLW+LG I+Y+L G PPF + Y + + I+K +P++ P + ++ LL
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 247
Query: 240 VPQNRLTW------SALLEHPFVKE 258
RL L HPF +
Sbjct: 248 DATKRLGCEEMEGYGPLKAHPFFES 272
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 272 bits (697), Expect = 2e-83
Identities = 87/275 (31%), Positives = 150/275 (54%), Gaps = 5/275 (1%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ Y E +G+G+ G VY TGQ VA++ + + +K++ + EI ++R+ K+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNP 77
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRI 123
NI+ LDS+ E VV E+ G + + C+ E Q+ ++ ++ ++AL +LHSN++
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTA 183
IHRD+K NIL+G VKL DFGF ++ ++ GTP +MAPE+V + Y
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 184 DLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PVKYPDEMSPNFKSFLKGLLNKV 240
D+WSLG++ E+ G+PP+ + + I + ++ P+++S F+ FL L+
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257
Query: 241 PQNRLTWSALLEHPFVKETSDELNAWELRATSVEA 275
+ R + LL+H F+K + L A + EA
Sbjct: 258 VEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEA 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 271 bits (694), Expect = 3e-82
Identities = 78/266 (29%), Positives = 135/266 (50%), Gaps = 11/266 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
++Y + E +G G+FG V++ + TG A KF+M E D +R+EI+ + L+H
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 83
Query: 64 NIIEMLDSFESPQEFCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSN 121
++ + D+FE E ++ EF GELFE + D + E++ +Q+ + L ++H N
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 122 RIIHRDMKPQNILIGA--GSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
+H D+KP+NI+ + +KL DFG + ++ GT + APE+ +P
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-VKVTTGTAEFAAPEVAEGKPV 202
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE----MSPNFKSFLKG 235
+ D+WS+GV+ Y L G PF + +R++ D +S + K F++
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 262
Query: 236 LLNKVPQNRLTWSALLEHPFVKETSD 261
LL P R+T LEHP++ +
Sbjct: 263 LLLADPNTRMTIHQALEHPWLTPGNA 288
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 267 bits (683), Expect = 9e-82
Identities = 84/266 (31%), Positives = 132/266 (49%), Gaps = 13/266 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E+Y V+ +G GS+G+ K RRK G+ + K + +E + L E+ +LR+LKH
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 64 NIIEMLDSF--ESPQEFCVVTEFAQ-GELFEILEDD----KCLPEEQVQSIAKQLVRALH 116
NI+ D + +V E+ + G+L ++ + L EE V + QL AL
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 117 YLH-----SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAP 171
H + ++HRD+KP N+ + VKL DFG AR ++ +T ++ GTP YM+P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 172 ELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK-DPVKYPDEMSPNFK 230
E + YN +D+WSLG +LYEL PPF S L I + + P S
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELN 243
Query: 231 SFLKGLLNKVPQNRLTWSALLEHPFV 256
+ +LN +R + +LE+P +
Sbjct: 244 EIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 267 bits (683), Expect = 1e-80
Identities = 85/270 (31%), Positives = 144/270 (53%), Gaps = 11/270 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ Y ++E +G G+FG V++ K TG+ KFI D + ++ EI I+ +L H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHP 86
Query: 64 NIIEMLDSFESPQEFCVVTEFAQ-GELFE-ILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
+I + D+FE E ++ EF GELF+ I +D + E +V + +Q L ++H +
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 122 RIIHRDMKPQNILI--GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
I+H D+KP+NI+ S VK+ DFG A ++ + +V + T + APE+V +P
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVDREPV 205
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE----MSPNFKSFLKG 235
D+W++GV+ Y L G PF ++++ + ++ ++ +SP K F+K
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 265
Query: 236 LLNKVPQNRLTWSALLEHPFVKETSDELNA 265
LL K P+ RLT LEHP++K L +
Sbjct: 266 LLQKEPRKRLTVHDALEHPWLKGDHSNLTS 295
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 265 bits (678), Expect = 2e-80
Identities = 84/262 (32%), Positives = 133/262 (50%), Gaps = 11/262 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKH 62
+ + + +G GSFG VY R + VA+K + GK S + ++ +E+ L+KL+H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
N I+ + +V E+ G + K L E ++ ++ ++ L YLHS+
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVR---EQP 178
+IHRD+K NIL+ +VKL DFG A M+ S GTP +MAPE++ E
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----SFVGTPYWMAPEVILAMDEGQ 190
Query: 179 YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK--DPVKYPDEMSPNFKSFLKGL 236
Y+ D+WSLG+ EL +PP + + + + HI + P S F++F+
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250
Query: 237 LNKVPQNRLTWSALLEHPFVKE 258
L K+PQ+R T LL+H FV
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVLR 272
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 264 bits (675), Expect = 4e-80
Identities = 91/339 (26%), Positives = 151/339 (44%), Gaps = 25/339 (7%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEIL-RKL 60
+E++ + +++G+GSFGKV+ K T Q A+K + K + D+ E +L
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLH 119
+H + M +F++ + V E+ G+L ++ + A +++ L +LH
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
S I++RD+K NIL+ +K+ DFG + + GTP Y+APE++ Q Y
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNK 239
NH+ D WS GV+LYE+ +GQ PF+ L I D YP + K L L +
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240
Query: 240 VPQNRLT-WSALLEHPFVKETS-DELNAWELRATSVEARGCNATWTAEGNAIQSSSGKSN 297
P+ RL + +HP +E + +EL E+ K
Sbjct: 241 EPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRP--------------------KVK 280
Query: 298 SPAVSANNTSPSLHTDVELNSSNTSQSNSSPCEAFPGFS 336
SP +N L+ L+ ++ + NS F FS
Sbjct: 281 SPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNFS 319
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 261 bits (668), Expect = 1e-79
Identities = 71/263 (26%), Positives = 132/263 (50%), Gaps = 8/263 (3%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
VE++ +++ +GEG++G+V + T + VA+K I+ ++ N+++EI I + L H
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNH 62
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
+N+++ + E+ G ELF+ +E D +PE Q QL+ + YLH
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN--TVVLRSIKGTPLYMAPELVREQPY 179
I HRD+KP+N+L+ +K+ DFG A N +L + GT Y+APEL++ + +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 180 NHTA-DLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKY---PDEMSPNFKSFLKG 235
+ D+WS G++L + G+ P+ S K+ Y ++ + L
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 236 LLNKVPQNRLTWSALLEHPFVKE 258
+L + P R+T + + + +
Sbjct: 243 ILVENPSARITIPDIKKDRWYNK 265
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 259 bits (664), Expect = 2e-78
Identities = 87/308 (28%), Positives = 156/308 (50%), Gaps = 13/308 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E Y + E +G G FG V++ + +T KF+ G + + ++EI IL +H+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV---KKEISILNIARHR 61
Query: 64 NIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKC-LPEEQVQSIAKQLVRALHYLHSN 121
NI+ + +SFES +E ++ EF G ++FE + L E ++ S Q+ AL +LHS+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 122 RIIHRDMKPQNILIGA--GSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
I H D++P+NI+ S +K+ +FG AR + R + P Y APE+ +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYYAPEVHQHDVV 180
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE----MSPNFKSFLKG 235
+ D+WSLG ++Y L G PF + +I +I+ + +E +S F+
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240
Query: 236 LLNKVPQNRLTWSALLEHPFVKETSDELNAWELRATSVEARGCNATWTAEGNAIQSSSGK 295
LL K ++R+T S L+HP++K+ + ++ ++ T R + + N + S++
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQKIERVS-TKVIRTLKHRRYYHTLIKKDLNMVVSAARI 299
Query: 296 SNSPAVSA 303
S A+ +
Sbjct: 300 SCGGAIRS 307
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 259 bits (662), Expect = 3e-78
Identities = 73/305 (23%), Positives = 135/305 (44%), Gaps = 49/305 (16%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+++ I +G G+ G V+K K +G +A K ++ + + +E+++L +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARK-LIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 64 NIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS-N 121
I+ +F S E + E G L ++L+ +PE+ + ++ +++ L YL +
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNH 181
+I+HRD+KP NIL+ + +KLCDFG + + + + S GT YM+PE ++ Y+
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV 182
Query: 182 TADLWSLGVILYELFVGQPPFYTNS----------------------------------- 206
+D+WS+G+ L E+ VG+ P
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242
Query: 207 -------VYALIRHIVKD--PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVK 257
++ L+ +IV + P S F+ F+ L K P R L+ H F+K
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302
Query: 258 ETSDE 262
+ E
Sbjct: 303 RSDAE 307
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 258 bits (660), Expect = 4e-78
Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 10/262 (3%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ Y +++G G+F +V K T + VA+K + E ++ EI +L K+KH
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIK-CIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 64 NIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+ + D +ES ++ + GELF+ + + E + Q++ A+ YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 123 IIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
I+HRD+KP+N+L S + + DFG ++ +V L + GTP Y+APE++ ++PY
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV-LSTACGTPGYVAPEVLAQKPY 186
Query: 180 NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP----DEMSPNFKSFLKG 235
+ D WS+GVI Y L G PPFY + L I+K ++ D++S + K F++
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246
Query: 236 LLNKVPQNRLTWSALLEHPFVK 257
L+ K P+ R T L+HP++
Sbjct: 247 LMEKDPEKRFTCEQALQHPWIA 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 251 bits (643), Expect = 3e-76
Identities = 88/274 (32%), Positives = 138/274 (50%), Gaps = 20/274 (7%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-------EKDIHNLRQEIEI 56
ENY E++G G V + K T + A+K I G ++ +E++I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 57 LRKLK-HQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRA 114
LRK+ H NII++ D++E+ F +V + + GELF+ L + L E++ + I + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 115 LHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELV 174
+ LH I+HRD+KP+NIL+ +KL DFGF+ + LR + GTP Y+APE++
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEII 181
Query: 175 R------EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP----DE 224
Y D+WS GVI+Y L G PPF+ ++R I+ ++ D+
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241
Query: 225 MSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258
S K + L PQ R T L HPF ++
Sbjct: 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 253 bits (647), Expect = 3e-76
Identities = 81/262 (30%), Positives = 140/262 (53%), Gaps = 10/262 (3%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKH 62
+++ ++ +G GSFG+V+ R ++ G+ AMK + K K + + E +L + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 63 QNIIEMLDSFESPQEFCVVTEFAQGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
II M +F+ Q+ ++ ++ +G LF +L + P + A ++ AL YLHS
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNH 181
II+RD+KP+NIL+ +K+ DFGFA+ + T ++ GTP Y+APE+V +PYN
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTKPYNK 180
Query: 182 TADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVP 241
+ D WS G+++YE+ G PFY ++ I+ +++P + + K L L+ +
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDL 240
Query: 242 QNRL-----TWSALLEHPFVKE 258
RL + HP+ KE
Sbjct: 241 SQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (639), Expect = 9e-76
Identities = 74/263 (28%), Positives = 125/263 (47%), Gaps = 14/263 (5%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
+G GSF VYKG T VA + ++ + ++E E+L+ L+H NI
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 66 IEMLDSFESPQE----FCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
+ DS+ES + +VTE G L L+ K + + ++S +Q+++ L +LH+
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 121 N--RIIHRDMKPQNILI-GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQ 177
IIHRD+K NI I G VK+ D G A A+ +++ GTP +MAPE+ +
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYE-E 187
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PVKYPDEMSPNFKSFLK 234
Y+ + D+++ G+ + E+ + P+ A I V P + P K ++
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 247
Query: 235 GLLNKVPQNRLTWSALLEHPFVK 257
G + + R + LL H F +
Sbjct: 248 GCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (640), Expect = 5e-75
Identities = 88/341 (25%), Positives = 159/341 (46%), Gaps = 19/341 (5%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLK 61
+ ++ ++L+G+G+FGKV R K TG+ AMK + K ++ ++ + E +L+ +
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 62 HQNIIEMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS 120
H + + +F++ C V E+ GELF L ++ EE+ + ++V AL YLHS
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYN 180
+++RD+K +N+++ +K+ DFG + ++ +++ GTP Y+APE++ + Y
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 181 HTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKV 240
D W LGV++YE+ G+ PFY L I+ + +++P +SP KS L GLL K
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 241 PQNRLTWSA-----LLEHPFVKETSDELNAWELRATSVEARGCNATWTAEGNAIQSSSGK 295
P+ RL ++EH F + W+ V + + + + S
Sbjct: 244 PKQRLGGGPSDAKEVMEHRFFLSIN-----WQ----DVVQKKLLPPFKPQ---VTSEVDT 291
Query: 296 SNSPAVSANNTSPSLHTDVELNSSNTSQSNSSPCEAFPGFS 336
+ D + E F F
Sbjct: 292 RYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFD 332
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 4e-72
Identities = 86/268 (32%), Positives = 143/268 (53%), Gaps = 14/268 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFI----MKHGKSEKDIHNLRQEIEILRK 59
+ Y E +G G F V K R K TG A KFI K + ++ +E+ IL++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
++H N+I + + +E+ + ++ E G ELF+ L + + L EE+ KQ++ ++YL
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 119 HSNRIIHRDMKPQNILI----GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELV 174
HS +I H D+KP+NI++ +K+ DFG A + ++I GTP ++APE+V
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIV 188
Query: 175 REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE----MSPNFK 230
+P AD+WS+GVI Y L G PF ++ + ++ ++ DE S K
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 231 SFLKGLLNKVPQNRLTWSALLEHPFVKE 258
F++ LL K P+ R+T L+HP++K
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 4e-71
Identities = 73/263 (27%), Positives = 125/263 (47%), Gaps = 17/263 (6%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
V + +G GSFG VYKG+ VA+K + + + + + E+ +LRK +H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 64 NIIEMLDSFESPQEFCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSN 121
NI+ + + + + +VT++ + L+ L + ++ IA+Q + + YLH+
Sbjct: 65 NILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMS--ANTVVLRSIKGTPLYMAPELVREQ-- 177
IIHRD+K NI + VK+ DFG A S + + + G+ L+MAPE++R Q
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 178 -PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK------DPVKYPDEMSPNFK 230
PY+ +D+++ G++LYEL GQ P+ + I +V D K K
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243
Query: 231 SFLKGLLNKVPQNRLTWSALLEH 253
+ L K R + +L
Sbjct: 244 RLMAECLKKKRDERPLFPQILAS 266
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (610), Expect = 5e-71
Identities = 83/279 (29%), Positives = 147/279 (52%), Gaps = 28/279 (10%)
Query: 3 VENYHVI-ELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL- 60
+++Y V +++G G GKV + K T + A+K + +D R+E+E+ +
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRAS 62
Query: 61 KHQNIIEMLDSFESPQE----FCVVTEFAQ-GELFEILED--DKCLPEEQVQSIAKQLVR 113
+ +I+ ++D +E+ +V E GELF ++D D+ E + I K +
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 114 ALHYLHSNRIIHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMA 170
A+ YLHS I HRD+KP+N+L +++KL DFGFA+ +++ + + TP Y+A
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-TTPCYTPYYVA 181
Query: 171 PELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHI--------VKDPVKYP 222
PE++ + Y+ + D+WSLGVI+Y L G PPFY+N A+ + + P
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 223 DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261
E+S K ++ LL P R+T + + HP++ +++
Sbjct: 242 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 239 bits (611), Expect = 9e-71
Identities = 76/272 (27%), Positives = 130/272 (47%), Gaps = 16/272 (5%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFI----MKHGKSEKDIHNLRQEIEI 56
+ + ++ V ++G G FG+VY R+ TG+ AMK + +K + E N R + +
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 57 LRKLKHQNIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRAL 115
+ I+ M +F +P + + + G +L L E ++ A +++ L
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120
Query: 116 HYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE-LV 174
++H+ +++RD+KP NIL+ V++ D G A S + GT YMAPE L
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPEVLQ 178
Query: 175 REQPYNHTADLWSLGVILYELFVGQPPFY---TNSVYALIRHIVKDPVKYPDEMSPNFKS 231
+ Y+ +AD +SLG +L++L G PF T + + R + V+ PD SP +S
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 232 FLKGLLNKVPQNRLTWSA-----LLEHPFVKE 258
L+GLL + RL + E PF +
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 235 bits (601), Expect = 1e-69
Identities = 80/263 (30%), Positives = 131/263 (49%), Gaps = 10/263 (3%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG-KSEKDIHNLRQEIEILRKLKH 62
+ + I+ +G GSFG+V + K +G AMK + K K I + E IL+ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 63 QNIIEMLDSFESPQEFCVVTEF-AQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
++++ SF+ +V E+ A GE+F L E + A Q+V YLHS
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNH 181
+I+RD+KP+N+LI +++ DFGFA+ + T ++ GTP +APE++ + YN
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEIILSKGYNK 217
Query: 182 TADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNKVP 241
D W+LGV++YE+ G PPF+ + + IV V++P S + K L+ LL
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 242 QNRL-----TWSALLEHPFVKET 259
R + + H + T
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATT 300
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 1e-69
Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 18/263 (6%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE----KDIHNLRQEIEILRKLK 61
Y V L+G G FG VY G R VA+K + K S+ + + E+ +L+K+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 62 --HQNIIEMLDSFESPQEFCVVTEFAQG--ELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
+I +LD FE P F ++ E + +LF+ + + L EE +S Q++ A+ +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 118 LHSNRIIHRDMKPQNILIGA-GSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVRE 176
H+ ++HRD+K +NILI +KL DFG + GT +Y PE +R
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRY 183
Query: 177 QPY-NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKG 235
Y +A +WSLG++LY++ G PF + I++ V + +S + ++
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIRW 237
Query: 236 LLNKVPQNRLTWSALLEHPFVKE 258
L P +R T+ + HP++++
Sbjct: 238 CLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 3e-69
Identities = 87/292 (29%), Positives = 141/292 (48%), Gaps = 32/292 (10%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
EN+ +E +GEG++G VYK R K TG+ VA+K I ++E +EI +L++L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGELFEILE--DDKCLPEEQVQSIAKQLVRALHYLHSN 121
NI+++LD + + +V EF +L + ++ +P ++S QL++ L + HS+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNH 181
R++HRD+KPQN+LI +KL DFG ARA T Y APE++ Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 182 TA-DLWSLGVILYELFVGQPPFYTNSVYALIRHIVK------------------------ 216
TA D+WSLG I E+ + F +S + I +
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 217 -----DPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDEL 263
D K + + +S L +L+ P R++ A L HPF ++ + +
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 230 bits (587), Expect = 1e-68
Identities = 82/286 (28%), Positives = 128/286 (44%), Gaps = 32/286 (11%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E YH +E +GEG++G VYK + G+T A+K I + E +EI IL++LKH
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGELFEILE-DDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+++ D + + +V E +L ++L+ + L +S QL+ + Y H R
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE-LVREQPYNH 181
++HRD+KPQN+LI +K+ DFG ARA T Y AP+ L+ + Y+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 182 TADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK------------------------- 216
T D+WS+G I E+ G P F S + I +
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 217 ----DPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258
+ + + L +L P R+T LEH + KE
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 2e-68
Identities = 75/284 (26%), Positives = 123/284 (43%), Gaps = 33/284 (11%)
Query: 8 VIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD---IHNLRQEIEILRKLKHQN 64
++ +GEG F VYK R K T Q VA+K I +SE +EI++L++L H N
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 65 IIEMLDSFESPQEFCVVTEFAQGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRI 123
II +LD+F +V +F + + I ++ L +++ ++ L YLH + I
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 124 IHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE-LVREQPYNHT 182
+HRD+KP N+L+ V+KL DFG A++ + T Y APE L + Y
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181
Query: 183 ADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE------------------ 224
D+W++G IL EL + P +S + I + +E
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241
Query: 225 ----------MSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258
+ ++GL P R+T + L+ +
Sbjct: 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 228 bits (582), Expect = 4e-68
Identities = 72/267 (26%), Positives = 132/267 (49%), Gaps = 13/267 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKH-GKSEKDIHNLRQEIEILRKLKH 62
+ Y + E++G G +V+ R + VA+K + + R+E + L H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 63 QNIIEMLDSFESP----QEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
I+ + D+ E+ +V E+ G L +I+ + + ++ + +AL++
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN---TVVLRSIKGTPLYMAPELV 174
H N IIHRD+KP NI+I A + VK+ DFG ARA++ + ++ GT Y++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 175 REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD----PVKYPDEMSPNFK 230
R + +D++SLG +LYE+ G+PPF +S ++ V++ P + +S +
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246
Query: 231 SFLKGLLNKVPQNRLTWSALLEHPFVK 257
+ + L K P+NR +A + V+
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 5e-68
Identities = 63/256 (24%), Positives = 121/256 (47%), Gaps = 15/256 (5%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ +++ +G+G FG V G Y G VA+K I K++ E ++ +L+H
Sbjct: 7 KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHS 60
Query: 64 NIIEMLDSF-ESPQEFCVVTEFAQ-GELFEILEDDKC--LPEEQVQSIAKQLVRALHYLH 119
N++++L E +VTE+ G L + L L + + + + A+ YL
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPY 179
N +HRD+ +N+L+ +V K+ DFG + S+ + K + APE +RE+ +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKF 177
Query: 180 NHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLL 237
+ +D+WS G++L+E++ G+ P+ + ++ + K + PD P +K
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 237
Query: 238 NKVPQNRLTWSALLEH 253
+ R ++ L E
Sbjct: 238 HLDAAMRPSFLQLREQ 253
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 2e-66
Identities = 71/299 (23%), Positives = 123/299 (41%), Gaps = 42/299 (14%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
Y + +GEG++G V VA+K + + + +EI+IL + +H+
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-KISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 64 NIIEMLDSFESP-----QEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
NII + D +P ++ +VT +L+++L+ L + + Q++R L Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYI 125
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT---VVLRSIKGTPLYMAPE-LV 174
HS ++HRD+KP N+L+ +K+CDFG AR + L T Y APE ++
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 175 REQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDE---------- 224
+ Y + D+WS+G IL E+ +P F + HI+ E
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 225 ---------------------MSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDE 262
L +L P R+ L HP++++ D
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (570), Expect = 2e-66
Identities = 78/287 (27%), Positives = 131/287 (45%), Gaps = 32/287 (11%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ Y +E +GEG++G V+K + + T + VA+K + E + +EI +L++LKH+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 64 NIIEMLDSFESPQEFCVVTEFA-QGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR 122
NI+ + D S ++ +V EF Q + L E V+S QL++ L + HS
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 123 IIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPE-LVREQPYNH 181
++HRD+KPQN+LI +KL +FG ARA + T Y P+ L + Y+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 182 TADLWSLGVILYELFVG-QPPFYTNSVYALIRHIVK------------------------ 216
+ D+WS G I EL +P F N V ++ I +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 217 -----DPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258
V +++ + L+ LL P R++ L+HP+ +
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 7e-66
Identities = 57/260 (21%), Positives = 115/260 (44%), Gaps = 11/260 (4%)
Query: 13 GEGSFGKVYKG--RRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLD 70
G G+FG V KG + K +TVA+K + L E ++++L + I+ M+
Sbjct: 16 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 75
Query: 71 SFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKP 130
E+ V+ G L + L+ ++ + ++ + + Q+ + YL + +HRD+
Sbjct: 76 ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAA 135
Query: 131 QNILIGAGSVVKLCDFGFARAMSAN---TVVLRSIKGTPLYMAPELVREQPYNHTADLWS 187
+N+L+ K+ DFG ++A+ A+ K + APE + ++ +D+WS
Sbjct: 136 RNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWS 195
Query: 188 LGVILYELF-VGQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLNKVPQNRL 245
GV+++E F GQ P+ + + K + P + +NR
Sbjct: 196 FGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRP 255
Query: 246 TWSAL---LEHPFVKETSDE 262
++A+ L + + + +E
Sbjct: 256 GFAAVELRLRNYY-YDVVNE 274
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 1e-65
Identities = 76/297 (25%), Positives = 136/297 (45%), Gaps = 42/297 (14%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
Y ++ VG G++G V TG VA+K + + +SE +E+ +L+ ++H+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 64 NIIEMLDSFESPQ------EFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
N+I +LD F + +F +V F +L ++++ +K L E+++Q + Q+++ L Y
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRY 136
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVRE- 176
+H+ IIHRD+KP N+ + +K+ DFG AR + + T Y APE++
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWYRAPEVILNW 193
Query: 177 QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEM----------- 225
Y T D+WS+G I+ E+ G+ F + ++ I+K P E
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253
Query: 226 --------------------SPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDE 262
SP + L+ +L + R+T L HP+ + D
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (565), Expect = 3e-65
Identities = 75/302 (24%), Positives = 124/302 (41%), Gaps = 46/302 (15%)
Query: 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
V Y + +G+G+FG+V+K R + TGQ VA+K ++ + E +EI+IL+ LKH
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68
Query: 63 QNIIEMLDSFESPQE--------FCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVR 113
+N++ +++ + +V +F + + +++ + + L+
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 114 ALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT----VVLRSIKGTPLYM 169
L+Y+H N+I+HRDMK N+LI V+KL DFG ARA S + T Y
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 170 APELVR-EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEM--- 225
PEL+ E+ Y DLW G I+ E++ P N+ + I + E+
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 226 -----------------------------SPNFKSFLKGLLNKVPQNRLTWSALLEHPFV 256
P + LL P R+ L H F
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
Query: 257 KE 258
Sbjct: 309 WS 310
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 5e-65
Identities = 93/290 (32%), Positives = 152/290 (52%), Gaps = 20/290 (6%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRR---KYTGQTVAMKFIMKH--GKSEKDIHNLRQEIE 55
+G+EN+ +++++G G++GKV+ R+ TG+ AMK + K + K + R E +
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 56 ILRKLKHQ-NIIEMLDSFESPQEFCVVTEFAQG-ELFEILEDDKCLPEEQVQSIAKQLVR 113
+L ++ ++ + +F++ + ++ ++ G ELF L + E +VQ ++V
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140
Query: 114 ALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA-NTVVLRSIKGTPLYMAPE 172
AL +LH II+RD+K +NIL+ + V L DFG ++ A T GT YMAP+
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 173 LVREQPYNHT--ADLWSLGVILYELFVGQPPFYT----NSVYALIRHIVKDPVKYPDEMS 226
+VR H D WSLGV++YEL G PF NS + R I+K YP EMS
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 227 PNFKSFLKGLLNKVPQNRLTWSA-----LLEHPFVKETS-DELNAWELRA 270
K ++ LL K P+ RL + EH F ++ + D+L A ++ A
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPA 310
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 8e-65
Identities = 81/294 (27%), Positives = 136/294 (46%), Gaps = 39/294 (13%)
Query: 3 VENYHVIELVGEGSFGKVYKGR-RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK 61
+ Y + +GEG++GKV+K R K G+ VA+K + E + +E+ +LR L+
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 62 ---HQNIIEMLDSFESPQE-----FCVVTEFAQGELFEILE--DDKCLPEEQVQSIAKQL 111
H N++ + D + +V E +L L+ + +P E ++ + QL
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 112 VRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAP 171
+R L +LHS+R++HRD+KPQNIL+ + +KL DFG AR S + S+ T Y AP
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYRAP 184
Query: 172 ELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK--------------- 216
E++ + Y DLWS+G I E+F +P F +S + I+
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 217 ------------DPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258
K+ ++ K L L P R++ + L HP+ ++
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 6e-64
Identities = 57/255 (22%), Positives = 119/255 (46%), Gaps = 9/255 (3%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
++ ++ +G G FG V G+ + VA+K I + SE + +E +++ L H+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEF---IEEAKVMMNLSHE 59
Query: 64 NIIEMLDSFESPQEFCVVTEF-AQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSN 121
++++ + ++TE+ A G L L + +Q+ + K + A+ YL S
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAM-SANTVVLRSIKGTPLYMAPELVREQPYN 180
+ +HRD+ +N L+ VVK+ DFG +R + K + PE++ ++
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 181 HTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLN 238
+D+W+ GV+++E++ +G+ P+ + HI + + P S + + +
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWH 239
Query: 239 KVPQNRLTWSALLEH 253
+ R T+ LL +
Sbjct: 240 EKADERPTFKILLSN 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 8e-64
Identities = 70/285 (24%), Positives = 127/285 (44%), Gaps = 36/285 (12%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQT-----VAMKFIMKHGKSEKDIHNLRQEIEILR 58
EN +++G G+FGKV +T VA+K ++K + L E++++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK-MLKEKADSSEREALMSELKMMT 95
Query: 59 KL-KHQNIIEMLDSFESPQEFCVVTEFA-QGELFEIL----------------------- 93
+L H+NI+ +L + ++ E+ G+L L
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 94 EDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS 153
ED L E + A Q+ + + +L +HRD+ +N+L+ G VVK+CDFG AR +
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 154 A--NTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYAL 210
+ N VV + + +MAPE + E Y +D+WS G++L+E+F +G P+ V A
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 211 IRHIVKDPVK--YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253
++++ K P + ++ + R ++ L
Sbjct: 276 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 2e-63
Identities = 78/298 (26%), Positives = 126/298 (42%), Gaps = 46/298 (15%)
Query: 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN 64
+Y +++G GSFG VY+ + +G+ VA+K +++ + + +E++I+RKL H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NRELQIMRKLDHCN 74
Query: 65 IIEMLDSFESPQE------FCVVTEFAQGELFEILED----DKCLPEEQVQSIAKQLVRA 114
I+ + F S E +V ++ ++ + + LP V+ QL R+
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 115 LHYLHSNRIIHRDMKPQNILIGA-GSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPEL 173
L Y+HS I HRD+KPQN+L+ +V+KLCDFG A+ + + I +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 194
Query: 174 VREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK----------------- 216
Y + D+WS G +L EL +GQP F +S + I+K
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 217 ------------DPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDE 262
+ P + LL P RLT H F E D
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 2e-63
Identities = 59/260 (22%), Positives = 113/260 (43%), Gaps = 12/260 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E ++E +G G FG+V+ G VA+K + + S E ++++L+HQ
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAF---LAEANLMKQLQHQ 68
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGELFEIL--EDDKCLPEEQVQSIAKQLVRALHYLHSN 121
++ + + + G L + L L ++ +A Q+ + ++
Sbjct: 69 RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR-SIKGTPLYMAPELVREQPYN 180
IHRD++ NIL+ K+ DFG AR + N R K + APE + +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 181 HTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLN 238
+D+WS G++L E+ G+ P+ + +I+++ + + PD ++
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWK 248
Query: 239 KVPQNRLTWSAL---LEHPF 255
+ P++R T+ L LE F
Sbjct: 249 ERPEDRPTFDYLRSVLEDFF 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 3e-63
Identities = 58/270 (21%), Positives = 122/270 (45%), Gaps = 15/270 (5%)
Query: 4 ENYHVIELV-GEGSFGKVYKGRRKYT--GQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
+N + ++ G G+FG V +G + VA+K ++K G + D + +E +I+ +L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIK-VLKQGTEKADTEEMMREAQIMHQL 66
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDK-CLPEEQVQSIAKQLVRALHYL 118
+ I+ ++ ++ + +V E A G L + L + +P V + Q+ + YL
Sbjct: 67 DNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN---TVVLRSIKGTPLYMAPELVR 175
+HRD+ +N+L+ K+ DFG ++A+ A+ + K + APE +
Sbjct: 126 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185
Query: 176 EQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVK-DPVKYPDEMSPNFKSFL 233
+ ++ +D+WS GV ++E GQ P+ ++ I + ++ P E P + +
Sbjct: 186 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALM 245
Query: 234 KGLLNKVPQNRLTWSAL---LEHPFVKETS 260
++R + + + + S
Sbjct: 246 SDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 4e-63
Identities = 54/258 (20%), Positives = 109/258 (42%), Gaps = 8/258 (3%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMK---HGKSEKDIHNLRQEIEILRKL 60
+ I+++G G+FG VYKG G+ V + +K S K + E ++ +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDK-CLPEEQVQSIAKQLVRALHYLH 119
+ ++ +L + + G L + + + K + + + + Q+ + ++YL
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN--TVVLRSIKGTPLYMAPELVREQ 177
R++HRD+ +N+L+ VK+ DFG A+ + A K +MA E + +
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 178 PYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKDP-VKYPDEMSPNFKSFLKG 235
Y H +D+WS GV ++EL G P+ + + K + P + + +
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 248
Query: 236 LLNKVPQNRLTWSALLEH 253
+R + L+
Sbjct: 249 CWMIDADSRPKFRELIIE 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 6e-63
Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 9/255 (3%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
++ +G G FG V+ G VA+K I + SE+D +E E++ KL H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEED---FIEEAEVMMKLSHP 60
Query: 64 NIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKCL-PEEQVQSIAKQLVRALHYLHSN 121
++++ C+V EF + G L + L + L E + + + + YL
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAM-SANTVVLRSIKGTPLYMAPELVREQPYN 180
+IHRD+ +N L+G V+K+ DFG R + K + +PE+ Y+
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 181 HTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLN 238
+D+WS GV+++E+F G+ P+ S ++ I + P S + +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWK 240
Query: 239 KVPQNRLTWSALLEH 253
+ P++R +S LL
Sbjct: 241 ERPEDRPAFSRLLRQ 255
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 1e-62
Identities = 69/257 (26%), Positives = 112/257 (43%), Gaps = 8/257 (3%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQT---VAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
E + +GEG FG V++G VA+K K+ S+ QE +R+
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCTSDSVREKFLQEALTMRQF 65
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKC-LPEEQVQSIAKQLVRALHYLH 119
H +I++++ + ++ GEL L+ K L + A QL AL YL
Sbjct: 66 DHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS-IKGTPLYMAPELVREQP 178
S R +HRD+ +N+L+ + VKL DFG +R M +T S K +MAPE + +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 179 YNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVK-DPVKYPDEMSPNFKSFLKGL 236
+ +D+W GV ++E+ + G PF +I I + + P P S +
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKC 245
Query: 237 LNKVPQNRLTWSALLEH 253
P R ++ L
Sbjct: 246 WAYDPSRRPRFTELKAQ 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 212 bits (540), Expect = 4e-62
Identities = 55/262 (20%), Positives = 112/262 (42%), Gaps = 13/262 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQT---VAMKFIMKHGKSEKDIHNLRQEIEILRKL 60
+ +++G G FG+V G K G+ VA+K +K G +EK + E I+ +
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIK-TLKSGYTEKQRRDFLSEASIMGQF 84
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKC--LPEEQVQSIAKQLVRALHYL 118
H N+I + ++TEF + + Q+ + + + + YL
Sbjct: 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN-----TVVLRSIKGTPLYMAPEL 173
+HRD+ +NIL+ + V K+ DFG +R + + K + APE
Sbjct: 145 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204
Query: 174 VREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKDP-VKYPDEMSPNFKS 231
++ + + +D+WS G++++E+ G+ P++ + +I I +D + P +
Sbjct: 205 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 264
Query: 232 FLKGLLNKVPQNRLTWSALLEH 253
+ K +R + ++
Sbjct: 265 LMLDCWQKDRNHRPKFGQIVNT 286
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 4e-62
Identities = 73/295 (24%), Positives = 121/295 (41%), Gaps = 40/295 (13%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E Y + VG G++G V TG VA+K + + +S +E+ +L+ +KH+
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 64 NIIEMLDSFESPQEFC-----VVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
N+I +LD F + + G + + L ++ VQ + Q++R L Y+
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 119 HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELV-REQ 177
HS IIHRD+KP N+ + +K+ DFG AR T Y APE++
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 194
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEM------------ 225
YN T D+WS+G I+ EL G+ F ++ I++ E+
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 226 -------------------SPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261
+P L+ +L R+T + L H + + D
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 9e-62
Identities = 64/263 (24%), Positives = 117/263 (44%), Gaps = 11/263 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
E+ + +G+G FG+V+ G T + VA+K + S + QE ++++KL+H+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAF---LQEAQVMKKLRHE 72
Query: 64 NIIEMLDSFESPQEFCVVTEFAQGELFEI--LEDDKCLPEEQVQSIAKQLVRALHYLHSN 121
++++ + V ++G L + E K L Q+ +A Q+ + Y+
Sbjct: 73 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR-SIKGTPLYMAPELVREQPYN 180
+HRD++ NIL+G V K+ DFG AR + N R K + APE +
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192
Query: 181 HTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLLN 238
+D+WS G++L EL G+ P+ ++ + + + P E + +
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR 252
Query: 239 KVPQNRLTWSALLE--HPFVKET 259
K P+ R T+ L + T
Sbjct: 253 KEPEERPTFEYLQAFLEDYFTST 275
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 1e-61
Identities = 66/264 (25%), Positives = 124/264 (46%), Gaps = 11/264 (4%)
Query: 1 MGVENYHVIELVGEGSFGKVYKGRRKYT---GQTVAMKFIMKHG-KSEKDIHNLRQEIEI 56
+G ++ ++E +G+GSFG V +G +VA+K + + + + +E+
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 57 LRKLKHQNIIEMLDSFESPQEFCVVTEFAQGELFEIL-EDDKCLPEEQVQSIAKQLVRAL 115
+ L H+N+I + +P V G L + L + + A Q+ +
Sbjct: 65 MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 116 HYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN---TVVLRSIKGTPLYMAPE 172
YL S R IHRD+ +N+L+ +VK+ DFG RA+ N V+ K + APE
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 173 LVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKDPVKY--PDEMSPNF 229
++ + ++H +D W GV L+E+F GQ P+ + ++ I K+ + P++ +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244
Query: 230 KSFLKGLLNKVPQNRLTWSALLEH 253
+ + P++R T+ AL +
Sbjct: 245 YNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (532), Expect = 4e-61
Identities = 62/265 (23%), Positives = 129/265 (48%), Gaps = 11/265 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ + +G G +G+VY+G K TVA+K + + ++ +E +++++KH
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHP 73
Query: 64 NIIEMLDSFESPQEFCVVTEFA-QGELFEILED--DKCLPEEQVQSIAKQLVRALHYLHS 120
N++++L F ++TEF G L + L + + + + +A Q+ A+ YL
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 121 NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS-IKGTPLYMAPELVREQPY 179
IHRD+ +N L+G +VK+ DFG +R M+ +T + K + APE + +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 180 NHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKGLL 237
+ +D+W+ GV+L+E+ G P+ + + + KD ++ P+ ++
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 253
Query: 238 NKVPQNRLTWSALLE--HPFVKETS 260
P +R +++ + + +E+S
Sbjct: 254 QWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (527), Expect = 2e-60
Identities = 57/288 (19%), Positives = 104/288 (36%), Gaps = 29/288 (10%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI 65
Y + +G GSFG +Y G G+ VA+K + L E +I + ++
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE----CVKTKHPQLHIESKIYKMMQGGVG 64
Query: 66 IEML-DSFESPQEFCVVTEFAQGEL-FEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRI 123
I + +V E L + + V +A Q++ + Y+HS
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124
Query: 124 IHRDMKPQNILI---GAGSVVKLCDFGFARAMSANTV-------VLRSIKGTPLYMAPEL 173
IHRD+KP N L+ G++V + DFG A+ +++ GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 174 VREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK--------DPVKYPDEM 225
+ DL SLG +L +G P+ + +
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 226 SPNFKSFLKGLLNKVPQNRLTWSAL---LEHPFVKE--TSDELNAWEL 268
F ++L + ++ +S L + F ++ + D + W +
Sbjct: 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 292
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 3e-60
Identities = 70/272 (25%), Positives = 118/272 (43%), Gaps = 24/272 (8%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTG--QTVAMKFIMKHGKSEKDIHNLRQEIEILRKL- 60
+ +++GEG+FG+V K R K G A+K MK S+ D + E+E+L KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK-RMKEYASKDDHRDFAGELEVLCKLG 68
Query: 61 KHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKC----------------LPEEQ 103
H NII +L + E + E+A G L + L + L +Q
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 104 VQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIK 163
+ A + R + YL + IHRD+ +NIL+G V K+ DFG +R +
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGR 187
Query: 164 GTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKY 221
+MA E + Y +D+WS GV+L+E+ G P+ + L + + ++
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247
Query: 222 PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253
P ++ + P R +++ +L
Sbjct: 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (525), Expect = 4e-60
Identities = 60/283 (21%), Positives = 124/283 (43%), Gaps = 35/283 (12%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRK-----YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILR 58
N + +GEG+FG+V++ R VA+K ++K S + ++E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQREAALMA 71
Query: 59 KLKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILED---------------------- 95
+ + NI+++L + C++ E+ G+L E L
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 96 --DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM- 152
L + IA+Q+ + YL + +HRD+ +N L+G VVK+ DFG +R +
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 153 -SANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQ-PPFYTNSVYAL 210
+ + +M PE + Y +D+W+ GV+L+E+F P+Y + +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 211 IRHIVK-DPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252
I ++ + + P+ + ++ +K+P +R ++ ++
Sbjct: 252 IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-59
Identities = 63/307 (20%), Positives = 124/307 (40%), Gaps = 51/307 (16%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ Y ++ +G G+ G V + VA+K + + +++ +E+ +++ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 64 NIIEMLDSF------ESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHY 117
NII +L+ F E Q+ +V E L ++++ L E++ + Q++ + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKH 134
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQ 177
LHS IIHRD+KP NI++ + +K+ DFG AR + ++ T Y APE++
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGM 193
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEM------------ 225
Y D+WS+G I+ E+ + F +++ E
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 226 ------------------------------SPNFKSFLKGLLNKVPQNRLTWSALLEHPF 255
+ + L +L P R++ L+HP+
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 313
Query: 256 VKETSDE 262
+ D
Sbjct: 314 INVWYDP 320
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 4e-59
Identities = 72/279 (25%), Positives = 127/279 (45%), Gaps = 31/279 (11%)
Query: 4 ENYHVIELVGEGSFGKVYKGR-----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILR 58
+ +G G+FGKV + + TVA+K ++K + L E+++L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK-MLKPSAHLTEREALMSELKVLS 81
Query: 59 KLK-HQNIIEMLDSFESPQEFCVVTEFAQ-GELFEIL------------------EDDKC 98
L H NI+ +L + V+TE+ G+L L +D+
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 99 LPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM--SANT 156
L E + S + Q+ + + +L S IHRD+ +NIL+ G + K+CDFG AR + +N
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 157 VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIV 215
VV + + +MAPE + Y +D+WS G+ L+ELF +G P+ V + ++
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 216 KDPVK--YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252
K+ + P+ +K + P R T+ +++
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-58
Identities = 57/260 (21%), Positives = 116/260 (44%), Gaps = 12/260 (4%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQ----TVAMKFIMKHGKSEKDIHNLRQEIEILRK 59
+++G G FG+VYKG K + VA+K +K G +EK + E I+ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK-TLKAGYTEKQRVDFLGEAGIMGQ 65
Query: 60 LKHQNIIEMLDSFESPQEFCVVTEFAQGELFEIL--EDDKCLPEEQVQSIAKQLVRALHY 117
H NII + + ++TE+ + + E D Q+ + + + + Y
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 118 LHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN---TVVLRSIKGTPLYMAPELV 174
L + +HRD+ +NIL+ + V K+ DFG +R + + T K + APE +
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 175 REQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSF 232
+ + +D+WS G++++E+ G+ P++ S + +++ I + P +
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245
Query: 233 LKGLLNKVPQNRLTWSALLE 252
+ + R ++ ++
Sbjct: 246 MMQCWQQERARRPKFADIVS 265
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 200 bits (509), Expect = 4e-58
Identities = 57/292 (19%), Positives = 102/292 (34%), Gaps = 31/292 (10%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+Y V +GEGSFG +++G Q VA+KF D LR E + L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE----PRRSDAPQLRDEYRTYKLLAGC 60
Query: 64 NIIEML-DSFESPQEFCVVTEFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSN 121
I + + +V + L ++L+ + + V AKQ++ + +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 122 RIIHRDMKPQNILIGA-----GSVVKLCDFGFARAMS-------ANTVVLRSIKGTPLYM 169
+++RD+KP N LIG +++ + DFG + +++ GT YM
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 170 APELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK--------DPVKY 221
+ + + DL +LG + G P+ + + +
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 222 PDEMSPNFKSFLKGLLNKVPQNRLTWS---ALLEHPFVKE--TSDELNAWEL 268
F ++ N + L + T DE W L
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 5e-58
Identities = 75/279 (26%), Positives = 137/279 (49%), Gaps = 30/279 (10%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYT-------GQTVAMKFIMKHGKSEKDIHNLRQEIEI 56
+ + + +GEG+FG+V VA+K ++K +EKD+ +L E+E+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK-MLKSDATEKDLSDLISEMEM 71
Query: 57 LRKL-KHQNIIEMLDSFESPQEFCVVTEFA-QGELFEILEDDKC---------------- 98
++ + KH+NII +L + V+ E+A +G L E L+ +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 99 LPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158
L + + S A Q+ R + YL S + IHRD+ +N+L+ +V+K+ DFG AR +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 159 LRS--IKGTPLYMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIV 215
++ + +MAPE + ++ Y H +D+WS GV+L+E+F +G P+ V L + +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 216 KD-PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253
+ + P + ++ + VP R T+ L+E
Sbjct: 252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 201 bits (511), Expect = 6e-58
Identities = 65/299 (21%), Positives = 123/299 (41%), Gaps = 53/299 (17%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-H 62
++Y ++ +G G + +V++ + V +K + +++EI+IL L+
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGG 89
Query: 63 QNIIEMLDSFESPQE--FCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLH 119
NII + D + P +V E + ++ + L + ++ ++++AL Y H
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146
Query: 120 SNRIIHRDMKPQNILIGA-GSVVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVRE-Q 177
S I+HRD+KP N++I ++L D+G A + + + PEL+ + Q
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVDYQ 205
Query: 178 PYNHTADLWSLGVILYELFVGQPPFYT-NSVYALIRHIVK-------------------- 216
Y+++ D+WSLG +L + + PF+ + Y + I K
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265
Query: 217 -----------------DPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258
+ +SP FL LL Q+RLT +EHP+
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-57
Identities = 56/283 (19%), Positives = 119/283 (42%), Gaps = 27/283 (9%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRK-----YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILR 58
E + +G+GSFG VY+G K VA+K + S ++ E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK-TVNEAASMRERIEFLNEASVMK 78
Query: 59 KLKHQNIIEMLDSFESPQEFCVVTEFAQ-GELFEILEDDKC----------LPEEQVQSI 107
+ +++ +L Q V+ E G+L L + ++ +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 108 AKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN--TVVLRSIKGT 165
A ++ + YL++N+ +HRD+ +N ++ VK+ DFG R +
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 166 PLYMAPELVREQPYNHTADLWSLGVILYELF-VGQPPFYTNSVYALIRHIVKDPV-KYPD 223
+M+PE +++ + +D+WS GV+L+E+ + + P+ S ++R +++ + PD
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 258
Query: 224 EMSPNFKSFLKGLLNKVPQNRLTWSALLE------HPFVKETS 260
++ P+ R ++ ++ P +E S
Sbjct: 259 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 3e-55
Identities = 57/260 (21%), Positives = 110/260 (42%), Gaps = 13/260 (5%)
Query: 6 YHVIELVGEGSFGKVYKGR---RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH 62
H E++G G FG VY G A+K + ++ E I++ H
Sbjct: 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK-SLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 63 QNIIEMLD-SFESPQEFCVVTEFAQ-GELFEILEDDKCLPEE-QVQSIAKQLVRALHYLH 119
N++ +L S VV + + G+L + ++ P + Q+ + + +L
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 120 SNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN----TVVLRSIKGTPLYMAPELVR 175
S + +HRD+ +N ++ VK+ DFG AR M K +MA E ++
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 176 EQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFL 233
Q + +D+WS GV+L+EL G PP+ + + + ++++ + P+ +
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVM 267
Query: 234 KGLLNKVPQNRLTWSALLEH 253
+ + R ++S L+
Sbjct: 268 LKCWHPKAEMRPSFSELVSR 287
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 8e-55
Identities = 71/279 (25%), Positives = 128/279 (45%), Gaps = 30/279 (10%)
Query: 4 ENYHVIELVGEGSFGKVYKGR-----RKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILR 58
+ + + +G G+FG+V + + T +TVA+K ++K G + + L E++IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRALMSELKILI 71
Query: 59 KLKHQNIIEMLD--SFESPQEFCVVTEFAQ-GELFEILEDDK----------------CL 99
+ H + L + V+ EF + G L L + L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 100 PEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159
E + + Q+ + + +L S + IHRD+ +NIL+ +VVK+CDFG AR + + +
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 160 R--SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVG-QPPFYTNSVYALIRHIVK 216
R + +MAPE + ++ Y +D+WS GV+L+E+F P+ + +K
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 217 DPVKY--PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253
+ + PD +P + + P R T+S L+EH
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 2e-47
Identities = 59/294 (20%), Positives = 111/294 (37%), Gaps = 51/294 (17%)
Query: 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQ 63
+ E +G+G FG+V++G K+ G+ VA+K + EI L+H+
Sbjct: 3 RTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFR---EAEIYQTVMLRHE 57
Query: 64 NIIEMLDSFESPQ----EFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYL 118
NI+ + + + +V+++ + G LF+ L + E + +A L +L
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHL 116
Query: 119 HS--------NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT----VVLRSIKGTP 166
H I HRD+K +NIL+ + D G A + T + GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 167 LYMAPELVREQ------PYNHTADLWSLGVILYELFVGQPPFYTNSVY------------ 208
YMAPE++ + AD++++G++ +E+ + Y
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 209 --ALIRHIVKDPVKYPD--------EMSPNFKSFLKGLLNKVPQNRLTWSALLE 252
+R +V + P+ E ++ RLT + +
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 171 bits (433), Expect = 3e-47
Identities = 62/326 (19%), Positives = 115/326 (35%), Gaps = 72/326 (22%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN- 64
Y ++ +G G F V+ + VAMK + + EI++L+++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADN 71
Query: 65 ----------IIEMLDSFESPQEFCVVTEFAQGE------LFEILEDDKCLPEEQVQSIA 108
I+++LD F V + + +P V+ I+
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 109 KQLVRALHYLHSNR-IIHRDMKPQNILIGA-GSVVKLCDFGFARAMSANTVV--LRSIKG 164
KQL+ L Y+H IIH D+KP+N+L+ S L A +A +
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 165 TPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYAL-------------- 210
T Y +PE++ P+ AD+WS +++EL G F + ++
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 211 ----------------------------------IRHIVKDPVKYPDEMSPNFKSFLKGL 236
+ ++ + K+ + + FL +
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311
Query: 237 LNKVPQNRLTWSALLEHPFVKETSDE 262
L P+ R L+ HP++K+T
Sbjct: 312 LQLDPRKRADAGGLVNHPWLKDTLGM 337
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 110 bits (275), Expect = 4e-28
Identities = 28/208 (13%), Positives = 65/208 (31%), Gaps = 37/208 (17%)
Query: 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQE------------ 53
+ +L+GEG V+ + +KF S K + R
Sbjct: 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 54 ----IEILRKLKHQNIIEMLDSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAK 109
L+KL+ + ++ V+ E + + + E +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAK------ELYRVRVENPDEVLD 110
Query: 110 QLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS---ANTVVLRSIKGTP 166
++ + + I+H D+ N+L+ + + DF + + ++ R ++
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNII 169
Query: 167 LYMAPELVREQPYNHTADLWSLGVILYE 194
Y + Y D+ S + +
Sbjct: 170 TYF------SRTYRTEKDINSAIDRILQ 191
|
| >d1xm9a1 a.118.1.24 (A:244-700) Plakophilin 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 457 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Plakophilin 1 helical region domain: Plakophilin 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.6 bits (158), Expect = 2e-11
Identities = 27/172 (15%), Positives = 58/172 (33%), Gaps = 5/172 (2%)
Query: 1141 FLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIG 1200
+L+ +D +A + + C + + I L+D P++ ++ A ++
Sbjct: 10 YLSSQDEKYQAIGAYYIQHTCFQDESAKQQVYQLGGICKLVDLLRSPNQNVQQAAAGALR 69
Query: 1201 NAAYHNDVLYEELRRS--IPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKG 1258
N + + E RR I ++L + + G L NL E++++
Sbjct: 70 NLVFRSTTNKLETRRQNGIREAVSLLRRTGNAEIQKQLTGLLWNLSSTDEL-KEELIADA 128
Query: 1259 AMQALIKLVADCSVLALNPSRKDAVNESP--LKIALFSLAKMCAHTPCRQFL 1308
+++ S S P A L + + RQ +
Sbjct: 129 LPVLADRVIIPFSGWCDGNSNMSREVVDPEVFFNATGCLRNLSSADAGRQTM 180
|
| >d1xm9a1 a.118.1.24 (A:244-700) Plakophilin 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 457 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Plakophilin 1 helical region domain: Plakophilin 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.8 bits (135), Expect = 1e-08
Identities = 39/385 (10%), Positives = 92/385 (23%), Gaps = 20/385 (5%)
Query: 932 SGGVLMFRQVLLKNEYMKLICNLLSDVHLKLVKGWGGPGGGKDGIRDIINAVID-LLAFP 990
G+ +L + ++ L + D + + + VI +
Sbjct: 85 QNGIREAVSLLRRTGNAEIQKQLTGLLWNLSSTDELKEELIADALPVLADRVIIPFSGWC 144
Query: 991 FVAVQNAPGLPSATASVNSGFILNMGSAGGKVCMEDRDMAKAIEEDMGKYIKILMEVGVP 1050
+ + N+ L S+ R+ + I+ M +
Sbjct: 145 DGNSNMSREVVDPEVFFNATGCLRNLSSADAGRQTMRNYSGLIDSLMAYVQNCVAASRCD 204
Query: 1051 GIILRCLEHMELKNLGRPIAFLAKMIGQRSLAVQLVGKGLLDPNRVRRLLDSSTREVTLD 1110
+ + R A + Q + D
Sbjct: 205 DKSVENCMCVLHNLSYRLDAEVPTRYRQLEYNARNAYTEKSSTGCFSNKSDKMMNNNYDC 264
Query: 1111 VLMIVSDLARMDKWFYEYINGASMLEFLK--DFLTHEDPNVRAKACSALGNMCRHSSYFY 1168
L + W Y + L + + A S
Sbjct: 265 PLPEEETNPKGSGWLYHSDAIRTYLNLMGKSKKDATLEACAGALQNLTASKGLMSSGMSQ 324
Query: 1169 SSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDE 1228
K + + + + + + N + H + + P + +L S
Sbjct: 325 LIGLKEKGLPQIARLLQSGNSDVVRSGASLLSNMSRHPLLHRVMGNQVFPEVTRLLTSHT 384
Query: 1229 EDK-----TKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAV 1283
+ ++A + NL+ + +L + S + +I L +
Sbjct: 385 GNTSNSEDILSSACYTVRNLMASQPQLAKQYFSSSMLNNIINLCRSSA------------ 432
Query: 1284 NESPLKIALFSLAKMCAHTPCRQFL 1308
+ + A L+ M + + L
Sbjct: 433 SPKAAEAARLLLSDMWSSKELQGVL 457
|
| >d1xm9a1 a.118.1.24 (A:244-700) Plakophilin 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 457 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Plakophilin 1 helical region domain: Plakophilin 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.7 bits (114), Expect = 4e-06
Identities = 25/164 (15%), Positives = 61/164 (37%), Gaps = 16/164 (9%)
Query: 1180 LIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS--IPLLANILISDEEDKTKANAA 1237
+ + D++ + + I + + ++ +++ + I L + L+ + AA
Sbjct: 7 AVQYLSSQDEKYQAIGAYYIQHTCFQDESAKQQVYQLGGICKLVD-LLRSPNQNVQQAAA 65
Query: 1238 GALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAK 1297
GAL NL+ S+ + + ++ + L+ + ++ L L
Sbjct: 66 GALRNLVFRSTTNKLETRRQNGIREAVSLLRRT-------------GNAEIQKQLTGLLW 112
Query: 1298 MCAHTPCRQFLQSSELFPVIARLRQSPESTIANYASVIISKVGD 1341
+ T + ++ PV+A P S + S + +V D
Sbjct: 113 NLSSTDELKEELIADALPVLADRVIIPFSGWCDGNSNMSREVVD 156
|
| >d1xm9a1 a.118.1.24 (A:244-700) Plakophilin 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 457 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Plakophilin 1 helical region domain: Plakophilin 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.4 bits (108), Expect = 2e-05
Identities = 26/189 (13%), Positives = 51/189 (26%), Gaps = 16/189 (8%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSAL 1157
+ L S + + D+ + + + L D L + NV+ A AL
Sbjct: 9 QYLSSQDEKYQAIGAYYIQHTCFQDESAKQQVYQLGGICKLVDLLRSPNQNVQQAAAGAL 68
Query: 1158 GNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDV--------- 1208
N+ S+ + I + + + D
Sbjct: 69 RNLVFRSTTNKLETRRQNGIREAVSLLRRTGNAEIQKQLTGLLWNLSSTDELKEELIADA 128
Query: 1209 -------LYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQ 1261
+ +N+ + + NA G L NL + G +
Sbjct: 129 LPVLADRVIIPFSGWCDGNSNMSREVVDPEVFFNATGCLRNLSSADAGRQTMRNYSGLID 188
Query: 1262 ALIKLVADC 1270
+L+ V +C
Sbjct: 189 SLMAYVQNC 197
|
| >d1jdha_ a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) [TaxId: 9606]} Length = 529 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: beta-Catenin species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.6 bits (137), Expect = 7e-09
Identities = 24/139 (17%), Positives = 54/139 (38%), Gaps = 3/139 (2%)
Query: 1135 LEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADP-DKRTRK 1193
+ L L ED V KA + + + + ++ + +++ ++ + D T +
Sbjct: 19 IPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETAR 78
Query: 1194 FACFSIGNAAYHNDVLYEELRRS-IPLLANILISDEEDKTKANAAGALSNLIRNSSKLCE 1252
++ N ++H + L + IP L +L D A L NL+ +
Sbjct: 79 CTAGTLHNLSHHREGLLAIFKSGGIPALVKML-GSPVDSVLFYAITTLHNLLLHQEGAKM 137
Query: 1253 DIVSKGAMQALIKLVADCS 1271
+ G +Q ++ L+ +
Sbjct: 138 AVRLAGGLQKMVALLNKTN 156
|
| >d1jdha_ a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) [TaxId: 9606]} Length = 529 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: beta-Catenin species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.6 bits (111), Expect = 8e-06
Identities = 18/118 (15%), Positives = 42/118 (35%), Gaps = 2/118 (1%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTH-EDPNVRAKACSA 1156
+LL+ + V ++V L++ + + + M+ + + + D
Sbjct: 24 KLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGT 83
Query: 1157 LGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELR 1214
L N+ H ++ K+ I L+ P +A ++ N H + +R
Sbjct: 84 LHNLSHHREG-LLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVR 140
|
| >d1jdha_ a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) [TaxId: 9606]} Length = 529 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: beta-Catenin species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.4 bits (108), Expect = 2e-05
Identities = 23/134 (17%), Positives = 50/134 (37%), Gaps = 15/134 (11%)
Query: 1204 YHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQAL 1263
Y +D E R+IP L L++DE+ AA + L + + + S + A+
Sbjct: 8 YQDD--AELATRAIPELTK-LLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAI 64
Query: 1264 IKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQFLQSSELFPVIARLRQS 1323
++ + + + + + +L + H + S P + ++ S
Sbjct: 65 VRTMQNTN------------DVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGS 112
Query: 1324 PESTIANYASVIIS 1337
P ++ YA +
Sbjct: 113 PVDSVLFYAITTLH 126
|
| >d1jdha_ a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) [TaxId: 9606]} Length = 529 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: beta-Catenin species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (101), Expect = 1e-04
Identities = 31/187 (16%), Positives = 57/187 (30%), Gaps = 25/187 (13%)
Query: 1106 EVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSS 1165
E + L ++ + + + L + L KA L
Sbjct: 328 EPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCP 387
Query: 1166 YFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS--------- 1216
++ L + I L+ + T++ + V EE+
Sbjct: 388 ANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILA 447
Query: 1217 --------------IPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQA 1262
IPL +L S E+ + AAG L L ++ + E I ++GA
Sbjct: 448 RDVHNRIVIRGLNTIPLFVQLLYSPIEN-IQRVAAGVLCELAQD-KEAAEAIEAEGATAP 505
Query: 1263 LIKLVAD 1269
L +L+
Sbjct: 506 LTELLHS 512
|
| >d1jdha_ a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) [TaxId: 9606]} Length = 529 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: beta-Catenin species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 0.002
Identities = 14/101 (13%), Positives = 27/101 (26%), Gaps = 5/101 (4%)
Query: 1145 EDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAY 1204
+ AL + R + I L + P + ++ A + A
Sbjct: 431 RMEEIVEGCTGALHILARDVHNR-IVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQ 489
Query: 1205 HNDVLYEELRRS--IPLLANILISDEEDKTKANAAGALSNL 1243
+ E + L L+ + AA L +
Sbjct: 490 DKEAA-EAIEAEGATAPLTE-LLHSRNEGVATYAAAVLFRM 528
|
| >d1wa5b_ a.118.1.1 (B:) Karyopherin alpha {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 503 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Karyopherin alpha species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 54.7 bits (130), Expect = 5e-08
Identities = 31/176 (17%), Positives = 68/176 (38%), Gaps = 3/176 (1%)
Query: 1094 NRVRRLLDSSTREVTLD-VLMIVSDLARMDKWFYEYINGASMLEFLKDF-LTHEDPNVRA 1151
++ + L+S + L + L+R + + + A ++ L +F ++ ++
Sbjct: 79 PQMTQQLNSDDMQEQLSATVKFRQILSREHRPPIDVVIQAGVVPRLVEFMRENQPEMLQL 138
Query: 1152 KACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYE 1211
+A AL N+ +S + + L I ++ A +++GN A + +
Sbjct: 139 EAAWALTNIASGTSAQTKVVVDADAVPLFIQLLYTGSVEVKEQAIWALGNVAGDSTDYRD 198
Query: 1212 ELRRSIPLLANI-LISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKL 1266
+ + + + L + + A LSNL R + V A+ L KL
Sbjct: 199 YVLQCNAMEPILGLFNSNKPSLIRTATWTLSNLCRGKKPQPDWSVVSQALPTLAKL 254
|
| >d1wa5b_ a.118.1.1 (B:) Karyopherin alpha {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 503 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Karyopherin alpha species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 48.9 bits (115), Expect = 3e-06
Identities = 46/257 (17%), Positives = 95/257 (36%), Gaps = 29/257 (11%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSAL 1157
+L+ S E +D +S L+ + + + + + L + L+HE V+ A A+
Sbjct: 253 KLIYSMDTETLVDACWAISYLSDGPQEAIQAVIDVRIPKRLVELLSHESTLVQTPALRAV 312
Query: 1158 GNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS- 1216
GN+ + + ++ L + P + +K AC++I N N + + +
Sbjct: 313 GNIVTGNDLQTQVVINAGVLPALRLLLSSPKENIKKEACWTISNITAGNTEQIQAVIDAN 372
Query: 1217 IPLLANILISDEEDKTKANAAGALSNLIRNSSK---LCEDIVSKGAMQALIKLVADCSVL 1273
+ L+ E KTK A A+SN + + +VS+G ++ L L+
Sbjct: 373 LIPPLVKLLEVAEYKTKKEACWAISNASSGGLQRPDIIRYLVSQGCIKPLCDLL------ 426
Query: 1274 ALNPSRKDAVNESPLKIALFSLAKMCAH------------TPCRQFLQSSELFPVIARLR 1321
+ + +++ L +L + F++ + I +
Sbjct: 427 -------EIADNRIIEVTLDALENILKMGEADKEARGLNINENADFIEKAGGMEKIFNCQ 479
Query: 1322 QSPESTIANYASVIISK 1338
Q+ I A II
Sbjct: 480 QNENDKIYEKAYKIIET 496
|
| >d1q1sc_ a.118.1.1 (C:) Importin alpha {Mouse (Mus musculus) [TaxId: 10090]} Length = 434 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Importin alpha species: Mouse (Mus musculus) [TaxId: 10090]
Score = 50.2 bits (118), Expect = 1e-06
Identities = 35/182 (19%), Positives = 66/182 (36%), Gaps = 8/182 (4%)
Query: 1098 RLLDSSTREVTLDVLMIVSDLARMDKWF-YEYINGASMLEFLKDFLTHED-PNVRAKACS 1155
+ ++S+ E L L +K + I A ++ FL D ++ ++
Sbjct: 20 KGINSNNLESQLQATQAARKLLSREKQPPIDNIIRAGLIPKFVSFLGKTDCSPIQFESAW 79
Query: 1156 ALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRR 1215
AL N+ +S ++ I I A P + A +++GN A + + +
Sbjct: 80 ALTNIASGTSEQTKAVVDGGAIPAFISLLASPHAHISEQAVWALGNIAGDGSAFRDLVIK 139
Query: 1216 S------IPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVAD 1269
+ LLA +S N LSNL RN + + + L++L+
Sbjct: 140 HGAIDPLLALLAVPDLSTLACGYLRNLTWTLSNLCRNKNPAPPLDAVEQILPTLVRLLHH 199
Query: 1270 CS 1271
Sbjct: 200 ND 201
|
| >d1xqra1 a.118.1.21 (A:87-350) Hsp70-binding protein 1 (HspBP1) {Human (Homo sapiens) [TaxId: 9606]} Length = 264 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: HspBP1 domain domain: Hsp70-binding protein 1 (HspBP1) species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.1 bits (113), Expect = 2e-06
Identities = 28/180 (15%), Positives = 61/180 (33%), Gaps = 2/180 (1%)
Query: 1092 DPNRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRA 1151
P ++ ++ L +++DL ++ + M + +L +R
Sbjct: 18 MPPTAGEAEQAADQQEREGALELLADLCENMDNAADFCQLSGMHLLVGRYLEAGAAGLRW 77
Query: 1152 KACSALGNMCRHSSYFYSSLAKNRIIGLLIDR-CADPDKRTRKFACFSIGNAAYHNDVLY 1210
+A +G ++ + + + L+ D R A F+I +
Sbjct: 78 RAAQLIGTCSQNVAAIQEQVLGLGALRKLLRLLDRDACDTVRVKALFAISCLVREQEAGL 137
Query: 1211 EELRRSIPL-LANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVAD 1269
+ R + + + K K +A L NL+ + + S G +Q L+ LV
Sbjct: 138 LQFLRLDGFSVLMRAMQQQVQKLKVKSAFLLQNLLVGHPEHKGTLCSMGMVQQLVALVRT 197
|
| >d1u6gc_ a.118.1.2 (C:) Cullin-associated NEDD8-dissociated protein 1 (Tip120) {Human (Homo sapiens) [TaxId: 9606]} Length = 1207 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: HEAT repeat domain: Cullin-associated NEDD8-dissociated protein 1 (Tip120) species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 8e-06
Identities = 41/251 (16%), Positives = 77/251 (30%), Gaps = 13/251 (5%)
Query: 1034 EEDMGKYIKILME-VGVPGIILRCLEHMELKNLGRPIAFLAKMIGQRSLAVQLVGKGLLD 1092
E + + L + LR + + LK + I L +LA + K +
Sbjct: 78 EYQVETIVDTLCTNMLSDKEQLRDISSIGLKTV---IGELPPASSGSALAANVCKK--IT 132
Query: 1093 PNRVRRLLDSSTREVTLDVLMIVSDLA-RMDKWFYEYINGASMLEFLKDFLTHEDPNVRA 1151
+ V L+ L I++D+ R + S+L L LT VR
Sbjct: 133 GRLTSAIAKQEDVSVQLEALDIMADMLSRQGGLLVNFHP--SILTCLLPQLTSPRLAVRK 190
Query: 1152 KACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYE 1211
+ ALG++ ++ L + T + I +
Sbjct: 191 RTIIALGHLVMSCGNIVFVDLIEHLLSELSK---NDSMSTTRTYIQCIAAISRQAGHRIG 247
Query: 1212 ELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCS 1271
E I L + ++D+ + A + +R K VS + +K +
Sbjct: 248 EYLEKIIPLVVKFCNVDDDELREYCIQAFESFVRRCPKEVYPHVST-IINICLKYLTYDP 306
Query: 1272 VLALNPSRKDA 1282
+ +D
Sbjct: 307 NYNYDDEDEDE 317
|
| >d1u6gc_ a.118.1.2 (C:) Cullin-associated NEDD8-dissociated protein 1 (Tip120) {Human (Homo sapiens) [TaxId: 9606]} Length = 1207 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: HEAT repeat domain: Cullin-associated NEDD8-dissociated protein 1 (Tip120) species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 2e-04
Identities = 29/234 (12%), Positives = 68/234 (29%), Gaps = 45/234 (19%)
Query: 1072 LAKMIGQRSLAVQLVGKGLLDPNRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYING 1131
+AK + + A G ++ ST + L L+ + ++ +
Sbjct: 796 IAKCVAALTRACPKEGPAVVGQFIQDVKNSRSTDSIRLLALLSLGEVGHHIDLSGQ---- 851
Query: 1132 ASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKN----------------- 1174
+ + + + V++ A ALG++ + Y
Sbjct: 852 LELKSVILEAFSSPSEEVKSAASYALGSISVGNLPEYLPFVLQEITSQPKRQYLLLHSLK 911
Query: 1175 ----------------RIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIP 1218
I LL+ C ++ TR +G + +P
Sbjct: 912 EIISSASVVGLKPYVENIWALLLKHCECAEEGTRNVVAECLGKLTLIDPETL------LP 965
Query: 1219 LLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSV 1272
L L +++ A+ I + + + ++ K + +K + D +
Sbjct: 966 RLKGYL-ISGSSYARSSVVTAVKFTISDHPQPIDPLL-KNCIGDFLKTLEDPDL 1017
|
| >d1u6gc_ a.118.1.2 (C:) Cullin-associated NEDD8-dissociated protein 1 (Tip120) {Human (Homo sapiens) [TaxId: 9606]} Length = 1207 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: HEAT repeat domain: Cullin-associated NEDD8-dissociated protein 1 (Tip120) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (95), Expect = 0.001
Identities = 26/209 (12%), Positives = 67/209 (32%), Gaps = 10/209 (4%)
Query: 1131 GASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKR 1190
+ + L + +T D + R A + L + S ++ +++ +++ D +
Sbjct: 1 ASYHISNLLEKMTSSDKDFRFMATNDLMTELQKDSIKLDDDSERKVVKMILKLLEDKNGE 60
Query: 1191 TRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKL 1250
+ A +G ++ + L ++SD+E + + ++ L +I L
Sbjct: 61 VQNLAVKCLGPLVSKVKE--YQVETIVDTLCTNMLSDKE-QLRDISSIGLKTVIGE---L 114
Query: 1251 CEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQFLQS 1310
+ K + A+ +V AL +A M +
Sbjct: 115 PPASSGSALAANVCKKITGRLTSAIAKQEDVSVQLE----ALDIMADMLSRQGGLLVNFH 170
Query: 1311 SELFPVIARLRQSPESTIANYASVIISKV 1339
+ + SP + + + +
Sbjct: 171 PSILTCLLPQLTSPRLAVRKRTIIALGHL 199
|
| >d1b3ua_ a.118.1.2 (A:) Constant regulatory domain of protein phosphatase 2a, pr65alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 588 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: HEAT repeat domain: Constant regulatory domain of protein phosphatase 2a, pr65alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.5 bits (111), Expect = 1e-05
Identities = 16/100 (16%), Positives = 36/100 (36%), Gaps = 9/100 (9%)
Query: 1101 DSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNM 1160
+ R TL + ++S++ D +++ L + NVR +L +
Sbjct: 493 NYLHRMTTLFCINVLSEVCGQDI-TTKHM-----LPTVLRMAGDPVANVRFNVAKSLQKI 546
Query: 1161 CRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIG 1200
+S ++ + +L D D + FA ++
Sbjct: 547 G---PILDNSTLQSEVKPILEKLTQDQDVDVKYFAQEALT 583
|
| >d1ibrb_ a.118.1.1 (B:) Importin beta {Human (Homo sapiens) [TaxId: 9606]} Length = 458 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Importin beta species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 1e-04
Identities = 15/72 (20%), Positives = 27/72 (37%)
Query: 1134 MLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRK 1193
+L F+K+ + + D R A A G + + + LI+ DP R
Sbjct: 366 VLPFIKEHIKNPDWRYRDAAVMAFGCILEGPEPSQLKPLVIQAMPTLIELMKDPSVVVRD 425
Query: 1194 FACFSIGNAAYH 1205
A +++G
Sbjct: 426 TAAWTVGRICEL 437
|
| >d1qbkb_ a.118.1.1 (B:) Karyopherin beta2 {Human (Homo sapiens) [TaxId: 9606]} Length = 888 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Karyopherin beta2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.1 bits (100), Expect = 2e-04
Identities = 39/230 (16%), Positives = 76/230 (33%), Gaps = 22/230 (9%)
Query: 1096 VRRLLDSSTREVTLDVLMIVSDLAR-MDKWFYEYINGASMLEFLKDFLTHEDPNVRAKAC 1154
+ + + EV ++ DL + + I + L L E +V A
Sbjct: 670 MYQCMQDKMPEVRQSSFALLGDLTKACFQHVKPCIA--DFMPILGTNLNPEFISVCNNAT 727
Query: 1155 SALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPD--KRTRKFACFSIGNAAYHN-DVLYE 1211
A+G + ++ L++ P+ K + +IG Y +
Sbjct: 728 WAIGEISIQMGIEMQPYIPM-VLHQLVEIINRPNTPKTLLENTAITIGRLGYVCPQEVAP 786
Query: 1212 ELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCS 1271
L++ I L + +++ K +A + +I + G +Q I C
Sbjct: 787 MLQQFIRPWCTSLRNIRDNEEKDSAFRGICTMISVN--------PSGVIQDFIFF---CD 835
Query: 1272 VLALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQFLQSSELFPVIARLR 1321
+A + KD + + KI L R+F FP+ + R
Sbjct: 836 AVASWINPKDDLRDMFCKI-LHGFKNQVGDENWRRFSDQ---FPLPLKER 881
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1342 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1q1sc_ | 434 | Importin alpha {Mouse (Mus musculus) [TaxId: 10090 | 99.85 | |
| d1wa5b_ | 503 | Karyopherin alpha {Baker's yeast (Saccharomyces ce | 99.83 | |
| d1wa5b_ | 503 | Karyopherin alpha {Baker's yeast (Saccharomyces ce | 99.82 | |
| d1jdha_ | 529 | beta-Catenin {Human (Homo sapiens) [TaxId: 9606]} | 99.81 | |
| d1q1sc_ | 434 | Importin alpha {Mouse (Mus musculus) [TaxId: 10090 | 99.79 | |
| d1xqra1 | 264 | Hsp70-binding protein 1 (HspBP1) {Human (Homo sapi | 99.77 | |
| d1jdha_ | 529 | beta-Catenin {Human (Homo sapiens) [TaxId: 9606]} | 99.73 | |
| d1xqra1 | 264 | Hsp70-binding protein 1 (HspBP1) {Human (Homo sapi | 99.69 | |
| d1xm9a1 | 457 | Plakophilin 1 {Human (Homo sapiens) [TaxId: 9606]} | 99.54 | |
| d1xm9a1 | 457 | Plakophilin 1 {Human (Homo sapiens) [TaxId: 9606]} | 99.51 | |
| d1b3ua_ | 588 | Constant regulatory domain of protein phosphatase | 99.07 | |
| d2vglb_ | 579 | Adaptin beta subunit N-terminal fragment {Human (H | 99.04 | |
| d1b3ua_ | 588 | Constant regulatory domain of protein phosphatase | 98.81 | |
| d2vglb_ | 579 | Adaptin beta subunit N-terminal fragment {Human (H | 98.72 | |
| d1oyza_ | 276 | Hypothetical protein YibA {Escherichia coli [TaxId | 98.67 | |
| d1qbkb_ | 888 | Karyopherin beta2 {Human (Homo sapiens) [TaxId: 96 | 98.62 | |
| d1oyza_ | 276 | Hypothetical protein YibA {Escherichia coli [TaxId | 98.6 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.52 | |
| d1u6gc_ | 1207 | Cullin-associated NEDD8-dissociated protein 1 (Tip | 98.37 | |
| d1qbkb_ | 888 | Karyopherin beta2 {Human (Homo sapiens) [TaxId: 96 | 98.35 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.28 | |
| d2vgla_ | 584 | Adaptin alpha C subunit N-terminal fragment {Mouse | 98.24 | |
| d2vgla_ | 584 | Adaptin alpha C subunit N-terminal fragment {Mouse | 98.24 | |
| d1u6gc_ | 1207 | Cullin-associated NEDD8-dissociated protein 1 (Tip | 98.22 | |
| d1ibrb_ | 458 | Importin beta {Human (Homo sapiens) [TaxId: 9606]} | 98.12 | |
| d1te4a_ | 111 | MTH187 {Archaeon Methanobacterium thermoautotrophi | 98.12 | |
| d1te4a_ | 111 | MTH187 {Archaeon Methanobacterium thermoautotrophi | 98.1 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.04 | |
| d1ibrb_ | 458 | Importin beta {Human (Homo sapiens) [TaxId: 9606]} | 98.0 | |
| d2bpta1 | 861 | Importin beta {Baker's yeast (Saccharomyces cerevi | 97.72 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.49 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.35 | |
| d1lrva_ | 233 | Leucine-rich repeat variant {Azotobacter vinelandi | 97.27 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.25 | |
| d2bpta1 | 861 | Importin beta {Baker's yeast (Saccharomyces cerevi | 97.25 | |
| d1lrva_ | 233 | Leucine-rich repeat variant {Azotobacter vinelandi | 97.23 | |
| d1qgra_ | 876 | Importin beta {Human (Homo sapiens) [TaxId: 9606]} | 96.54 | |
| d1qgra_ | 876 | Importin beta {Human (Homo sapiens) [TaxId: 9606]} | 96.29 | |
| d1wa5c_ | 959 | Exportin Cse1p {Baker's yeast (Saccharomyces cerev | 96.01 | |
| d2b6ca1 | 213 | Hypothetical protein EF3068 {Enterococcus faecalis | 94.37 | |
| d1t06a_ | 235 | Hypothetical protein BC3264 {Bacillus cereus (stra | 93.94 | |
| d1lsha1 | 336 | Lipovitellin-phosvitin complex, superhelical domai | 93.79 | |
| d1upka_ | 330 | Mo25 protein {Human (Homo sapiens) [TaxId: 9606]} | 88.85 | |
| d1ho8a_ | 477 | Regulatory subunit H of the V-type ATPase {Baker's | 85.6 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=430.26 Aligned_cols=260 Identities=32% Similarity=0.638 Sum_probs=241.6
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 988788999997325937999999956995999999615799-9789999999999999359998115888887089599
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFC 79 (1342)
Q Consensus 1 mdIDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~-seseikrL~rEIkILkkLsHPNIVKLidvfeded~iy 79 (1342)
+.+++|++++.||+|+||.||+|+++.+++.||+|++.+... .....+.+.+|+.++++++||||+++++++++++.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCC
T ss_conf 84474289889831768499999998999899999981565449799999999999998679998877876403564211
Q ss_pred EEEECCC-CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCEE
Q ss_conf 9994369-884889860999999999999999999999866099250388998379758970899533632124577401
Q 000706 80 VVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 80 IVMEYve-GSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~~ 158 (1342)
+||||++ |+|++++.+.+.++|..++.|+.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+........
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred CCEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCCCCC
T ss_conf 10003579860555532567759999999999965211343159622464777847658998888205652003567862
Q ss_pred EECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf 20235888768812120389987775320466799988389999998399999998429999999999889999998110
Q 000706 159 LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLN 238 (1342)
Q Consensus 159 ~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~plelP~eISpeLkdLIkkMLs 238 (1342)
....+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+..+..+.+......+|..+|+++++||.+||+
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~ 241 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred CCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
T ss_conf 05510088996666504898883331022306788998789999996999999998528998986689999999986663
Q ss_pred CCCCCCCC-----HHHHHCCCCCCCCH
Q ss_conf 19999999-----98997295763431
Q 000706 239 KVPQNRLT-----WSALLEHPFVKETS 260 (1342)
Q Consensus 239 kDPeKRPT-----aeELLkHPfFke~~ 260 (1342)
+||.+|++ ++|+++||||++..
T Consensus 242 ~dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 242 KDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp SSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred CCCHHHCCCCCCCHHHHHCCCCCCCCC
T ss_conf 893442256523499997291503699
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=426.59 Aligned_cols=256 Identities=31% Similarity=0.612 Sum_probs=235.9
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCH-HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 8878899999732593799999995699599999961579997-899999999999993599981158888870895999
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE-KDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 2 dIDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~se-seikrL~rEIkILkkLsHPNIVKLidvfeded~iyI 80 (1342)
.+++|++++.||+|+||.||+|+++.+++.||+|++.+..... ...+.+.+|++++++++||||+++++++.+++.+|+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
T ss_conf 15376998898517785899999989994999999816885676899999999999985688888859999998999899
Q ss_pred EEECCC-CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCEEE
Q ss_conf 994369-8848898609999999999999999999998660992503889983797589708995336321245774012
Q 000706 81 VTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159 (1342)
Q Consensus 81 VMEYve-GSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~~~ 159 (1342)
||||++ |+|.+++.+.+++++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~--~ 161 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--R 161 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--C
T ss_pred EEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECCCCCEEECCCCEEEECCCCC--C
T ss_conf 98504798589887504899999999999999999999998894652202344146689987115556335448885--2
Q ss_pred ECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 02358887688121203899877753204667999883899999983999999984299999999998899999981101
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 160 ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~plelP~eISpeLkdLIkkMLsk 239 (1342)
....||+.|+|||++.+.+|+.++||||+||++|+|++|+.||.+.+..+....+.+....+|+.+++++++||.+||+.
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 241 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 35578876349999758998931440467599999832999988899999999997189999866899999999997647
Q ss_pred CCCCCCCHHHHHCCCCCCCC
Q ss_conf 99999999899729576343
Q 000706 240 VPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 240 DPeKRPTaeELLkHPfFke~ 259 (1342)
||++|||++|+++||||.+.
T Consensus 242 dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 242 NPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp SGGGSCCHHHHHTCHHHHHH
T ss_pred CHHHCCCHHHHHCCCCCCCC
T ss_conf 97689099999719070783
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=421.06 Aligned_cols=253 Identities=33% Similarity=0.626 Sum_probs=228.2
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf 78899999732593799999995699599999961579997899999999999993599981158888870895999994
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 DrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~iyIVME 83 (1342)
++|++.+.||+|+||.||+|+++.+++.||+|.+.+..... .+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHH--HHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 05388789812858299999998999899999984301727--9999999999986799988058577988999899997
Q ss_pred CCC-CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCEEEECC
Q ss_conf 369-8848898609999999999999999999998660992503889983797589708995336321245774012023
Q 000706 84 FAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 Yve-GSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~~~ssi 162 (1342)
|++ |+|.+++.+ +++++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+++.+..........
T Consensus 98 y~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 176 (293)
T d1yhwa1 98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (293)
T ss_dssp CCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred ECCCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCCCCCC
T ss_conf 0379808988641-599999999999999999999998797226776888688789968642515641321366644444
Q ss_pred CCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC---CCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 5888768812120389987775320466799988389999998399999998429---9999999998899999981101
Q 000706 163 KGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PVKYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 163 vGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~---plelP~eISpeLkdLIkkMLsk 239 (1342)
+||+.|+|||++.+.+|+.++||||+||++|+|++|+.||.+.+..+....+... ....+..+++++++||.+||+.
T Consensus 177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 256 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256 (293)
T ss_dssp CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCS
T ss_pred CCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 44777368266447998801203137299999804889989979999999998579998888553799999999998669
Q ss_pred CCCCCCCHHHHHCCCCCCCC
Q ss_conf 99999999899729576343
Q 000706 240 VPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 240 DPeKRPTaeELLkHPfFke~ 259 (1342)
||++|||+.|+++||||+..
T Consensus 257 dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 257 DVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp STTTSCCHHHHTTCGGGGGC
T ss_pred CHHHCCCHHHHHCCHHHCCC
T ss_conf 96689099999649965778
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=415.51 Aligned_cols=257 Identities=31% Similarity=0.562 Sum_probs=236.4
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 88788999997325937999999956995999999615799-97899999999999993599981158888870895999
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 2 dIDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~-seseikrL~rEIkILkkLsHPNIVKLidvfeded~iyI 80 (1342)
.+++|++++.||+|+||.||+|+++.+++.||+|++.+... .....+.+.+|+++++.++||||+++++++.+....|+
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCC
T ss_conf 72370898896117680899999989998999999826774588999999999999997487727403444432222232
Q ss_pred EEECCC-CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCEEE
Q ss_conf 994369-8848898609999999999999999999998660992503889983797589708995336321245774012
Q 000706 81 VTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159 (1342)
Q Consensus 81 VMEYve-GSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~~~ 159 (1342)
||||+. |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~--- 195 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--- 195 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB---
T ss_pred CCCCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCCCCCEEEEECEEEEECCCCC---
T ss_conf 22233466226667515898999999999999998999985998617679999360778978861010333225666---
Q ss_pred ECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 02358887688121203899877753204667999883899999983999999984299999999998899999981101
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 160 ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~plelP~eISpeLkdLIkkMLsk 239 (1342)
....||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+.......+......+|..+++++.+||.+||+.
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 275 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCS
T ss_pred CCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
T ss_conf 43367635678899717998853311450078999975889989959999999986179889766899999999998340
Q ss_pred CCCCCC-----CHHHHHCCCCCCCCHH
Q ss_conf 999999-----9989972957634314
Q 000706 240 VPQNRL-----TWSALLEHPFVKETSD 261 (1342)
Q Consensus 240 DPeKRP-----TaeELLkHPfFke~~e 261 (1342)
||.+|+ |++++++||||+....
T Consensus 276 dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 276 DLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred CHHHCCCCCCCCHHHHHCCCCCCCCCH
T ss_conf 998606553454999971905158998
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=414.66 Aligned_cols=254 Identities=30% Similarity=0.568 Sum_probs=230.2
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 87889999973259379999999569959999996157999789999999999999359998115888887089599999
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 IDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~iyIVM 82 (1342)
+++|++++.||+|+||.||+|+++.+++.||+|++.+.. ..+.+.+.+|++++++++||||+++++++++++.+|+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 657589889840768199999988999899999984524--316999999999998679979992999999899999999
Q ss_pred ECCC-CCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECC--CCCEEEEECCCCCCCCCCCEE
Q ss_conf 4369-884889860-999999999999999999999866099250388998379758--970899533632124577401
Q 000706 83 EFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA--GSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 83 EYve-GSLlDlLek-~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIds--dG~IKLiDFGLAk~l~sss~~ 158 (1342)
||++ |+|++++.+ .+++++..++.++.||+.||.|||++|++||||||+|||++. ++.+||+|||+++.......
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~- 181 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS- 181 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC-
T ss_pred ECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCCCC-
T ss_conf 8579988999997623789999999999999999999975697600015467364168898699954521044256543-
Q ss_pred EECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCC----CCCCHHHHHHHH
Q ss_conf 2023588876881212038998777532046679998838999999839999999842999999----999988999999
Q 000706 159 LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP----DEMSPNFKSFLK 234 (1342)
Q Consensus 159 ~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~plelP----~eISpeLkdLIk 234 (1342)
.....||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+..+..+.+......++ ..+++++++||.
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 261 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHH
T ss_pred CCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHH
T ss_conf 20006862421889975899872676554659999998598998997999999999847889894223589999999999
Q ss_pred HHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 8110199999999899729576343
Q 000706 235 GLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 235 kMLskDPeKRPTaeELLkHPfFke~ 259 (1342)
+||+.||++|||+.|+++||||++.
T Consensus 262 ~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 262 KLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp HHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred HHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 9756896679089998629132889
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=422.56 Aligned_cols=259 Identities=29% Similarity=0.563 Sum_probs=235.8
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 88788999997325937999999956995999999615799-97899999999999993599981158888870895999
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 2 dIDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~-seseikrL~rEIkILkkLsHPNIVKLidvfeded~iyI 80 (1342)
..++|++++.||+|+||.||+|+++.+++.||+|++.+... .....+.+.+|++++++++||||+++++++++++.+|+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
T ss_conf 99877898898508790999999989997999999865775577789999999999987688886179999998998899
Q ss_pred EEECCC-CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC--E
Q ss_conf 994369-8848898609999999999999999999998660992503889983797589708995336321245774--0
Q 000706 81 VTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT--V 157 (1342)
Q Consensus 81 VMEYve-GSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss--~ 157 (1342)
||||++ |+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCCCCC
T ss_conf 99704898777765315999999999999999999976216508847677412366888538860321024225677643
Q ss_pred EEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf 12023588876881212038998777532046679998838999999839999999842999999999988999999811
Q 000706 158 VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLL 237 (1342)
Q Consensus 158 ~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~plelP~eISpeLkdLIkkML 237 (1342)
.....+||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+..+...++......+|..+++++++||.+||
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 245 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 245 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTS
T ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHC
T ss_conf 33555677552584400268989666230456999998038899899599999999971899998547999999999985
Q ss_pred CCCCCCCCCHHH------HHCCCCCCCCH
Q ss_conf 019999999989------97295763431
Q 000706 238 NKVPQNRLTWSA------LLEHPFVKETS 260 (1342)
Q Consensus 238 skDPeKRPTaeE------LLkHPfFke~~ 260 (1342)
+.||++|||++| +++||||++..
T Consensus 246 ~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 246 VLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp CSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred CCCHHHCCCHHHHCCCHHHHCCCCCCCCC
T ss_conf 57976891978973778987697647899
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=415.32 Aligned_cols=257 Identities=32% Similarity=0.606 Sum_probs=236.9
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 887889999973259379999999569959999996157999-7899999999999993599981158888870895999
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS-EKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 2 dIDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~s-eseikrL~rEIkILkkLsHPNIVKLidvfeded~iyI 80 (1342)
.+++|++++.||+|+||.||+|+++.+++.||+|++.+.... ....+.+.+|+.++++++||||+++++++++++.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred CHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEE
T ss_conf 65470888897207680899999989997999999845775488999999999999986369675330356852880056
Q ss_pred EEECCC-CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCEEE
Q ss_conf 994369-8848898609999999999999999999998660992503889983797589708995336321245774012
Q 000706 81 VTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159 (1342)
Q Consensus 81 VMEYve-GSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~~~ 159 (1342)
||||++ |++.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++..... .
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---~ 158 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---T 158 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---B
T ss_pred EEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECCCCCEEEECCCCCEEECCC---C
T ss_conf 7650378632234322221110079999999987655412476770556810503868998898317521671245---6
Q ss_pred ECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 02358887688121203899877753204667999883899999983999999984299999999998899999981101
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 160 ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~plelP~eISpeLkdLIkkMLsk 239 (1342)
...+||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+..+...++......+|..+++++++++.+||++
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 238 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITR 238 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
T ss_conf 43457634359999838999804304653336899975989999969999999997089889977899999999999544
Q ss_pred CCCCCC-----CHHHHHCCCCCCCCHH
Q ss_conf 999999-----9989972957634314
Q 000706 240 VPQNRL-----TWSALLEHPFVKETSD 261 (1342)
Q Consensus 240 DPeKRP-----TaeELLkHPfFke~~e 261 (1342)
||.+|+ |++++++||||++...
T Consensus 239 dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 239 DLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred CHHHCCCCCHHHHHHHHCCCCCCCCCH
T ss_conf 997666431021999981935146798
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=416.00 Aligned_cols=255 Identities=32% Similarity=0.588 Sum_probs=230.4
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 87889999973259379999999569959999996157999789999999999999359998115888887089599999
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 IDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~iyIVM 82 (1342)
.++|++++.||+|+||.||+|+++.+++.||+|++.+.. ..+.+.+.+|+.++++++||||+++++++++++.+|+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 403599899931778299999998999799999988726--467999999999998679979891999999899999999
Q ss_pred ECCC-CCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEC--CCCCEEEEECCCCCCCCCCCEE
Q ss_conf 4369-8848898609-9999999999999999999986609925038899837975--8970899533632124577401
Q 000706 83 EFAQ-GELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIG--AGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 83 EYve-GSLlDlLek~-k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILId--sdG~IKLiDFGLAk~l~sss~~ 158 (1342)
||++ |+|++.+.+. .++++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~- 184 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 184 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred ECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCCCC-
T ss_conf 8289980888898638998999999999999999999997792651314455311346788489952563034378872-
Q ss_pred EECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCC----CCCCHHHHHHHH
Q ss_conf 2023588876881212038998777532046679998838999999839999999842999999----999988999999
Q 000706 159 LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP----DEMSPNFKSFLK 234 (1342)
Q Consensus 159 ~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~plelP----~eISpeLkdLIk 234 (1342)
.....||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+..+....+......++ ..+++++++||.
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 264 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred EEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHH
T ss_conf 01004764534899974799897633389899999999688998997999999999847889893002479999999999
Q ss_pred HHCCCCCCCCCCHHHHHCCCCCCCCH
Q ss_conf 81101999999998997295763431
Q 000706 235 GLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 235 kMLskDPeKRPTaeELLkHPfFke~~ 260 (1342)
+||++||.+|||+.|+++||||+...
T Consensus 265 ~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 265 NLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp TTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 97569966891899996097348882
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=418.48 Aligned_cols=257 Identities=26% Similarity=0.467 Sum_probs=223.5
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 88788999997325937999999956995999999615799978999999999999935999811588888708959999
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 2 dIDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~iyIV 81 (1342)
.+++|++++.||+|+||.||+|+++.+++.||+|++.+.... ...+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC-HHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEE
T ss_conf 874608998972174809999999999979999998456641-2799999999999857998884696540467436798
Q ss_pred EECCC-CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC--EE
Q ss_conf 94369-8848898609999999999999999999998660992503889983797589708995336321245774--01
Q 000706 82 TEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT--VV 158 (1342)
Q Consensus 82 MEYve-GSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss--~~ 158 (1342)
|||++ |+|++++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCCCC
T ss_conf 86458980899975379999999999999999999999975983575468997887899879832314224046886531
Q ss_pred EECCCCCCCCCCHHHHCCCCC-CCCCCCCCHHHHHHHHHHCCCCCCCCCHH-HHHHHHHCCCC--CCCCCCCHHHHHHHH
Q ss_conf 202358887688121203899-87775320466799988389999998399-99999842999--999999988999999
Q 000706 159 LRSIKGTPLYMAPELVREQPY-NHTADLWSLGVILYELFVGQPPFYTNSVY-ALIRHIVKDPV--KYPDEMSPNFKSFLK 234 (1342)
Q Consensus 159 ~ssivGTp~YlAPEIL~g~~Y-T~kSDIWSLGVILYELLTGklPF~gss~~-elikkIvk~pl--elP~eISpeLkdLIk 234 (1342)
....+||+.|+|||++.+.++ +.++||||+|+++|+|++|+.||...... .....+..... ..+..+++++.+|+.
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 241 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred CCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH
T ss_conf 11325574742872861899999710161737999999829978888985999999986388878864469999999999
Q ss_pred HHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 8110199999999899729576343
Q 000706 235 GLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 235 kMLskDPeKRPTaeELLkHPfFke~ 259 (1342)
+||+.||++|||++|+++||||++.
T Consensus 242 ~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 242 KILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 9767996689099999619845859
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=415.02 Aligned_cols=254 Identities=33% Similarity=0.623 Sum_probs=230.2
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf 78899999732593799999995699599999961579997899999999999993599981158888870895999994
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 DrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~iyIVME 83 (1342)
++|++.+.||+|+||.||+|+++.+++.||+|++.+..... ....+.+|+.++++++||||+++++++++++.+|+|||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHH-HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 66699889940658399999999999899999981577312-89999999999986799899919899998998889885
Q ss_pred CCC-CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEC---CCCCEEEEECCCCCCCCCCCEEE
Q ss_conf 369-88488986099999999999999999999986609925038899837975---89708995336321245774012
Q 000706 84 FAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIG---AGSVVKLCDFGFARAMSANTVVL 159 (1342)
Q Consensus 84 Yve-GSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILId---sdG~IKLiDFGLAk~l~sss~~~ 159 (1342)
|++ |+|.+++.+.+++++..++.++.|++.||.|||++||+||||||+||++. .++.+||+|||+++...... ..
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-~~ 166 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-VL 166 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred CCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCCCC-EE
T ss_conf 26898488865303678878999999999999875241305568704630011046888249983154358725897-04
Q ss_pred ECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCC----CCCCCHHHHHHHHH
Q ss_conf 02358887688121203899877753204667999883899999983999999984299999----99999889999998
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKY----PDEMSPNFKSFLKG 235 (1342)
Q Consensus 160 ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~plel----P~eISpeLkdLIkk 235 (1342)
...+||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+..+....+......+ ++.+|+++++||.+
T Consensus 167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 246 (307)
T d1a06a_ 167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246 (307)
T ss_dssp ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred EEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHH
T ss_conf 40032842259188737999807873451599999985979999989999999986168777876666789999999999
Q ss_pred HCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 110199999999899729576343
Q 000706 236 LLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 236 MLskDPeKRPTaeELLkHPfFke~ 259 (1342)
||+.||.+|||+.|+++||||+..
T Consensus 247 ~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 247 LMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 760897579189998629844799
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=415.60 Aligned_cols=254 Identities=33% Similarity=0.573 Sum_probs=233.2
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CCEEEE
Q ss_conf 878899999732593799999995699599999961579997899999999999993599981158888870--895999
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFES--PQEFCV 80 (1342)
Q Consensus 3 IDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfed--ed~iyI 80 (1342)
.|+|++.+.||+|+||.||+|+++.+++.||+|.+.+....+...+.+.+|++++++++||||+++++++.+ ++.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 33379967983088919999999999979999998746579799999999999999778999824899999178998999
Q ss_pred EEECCC-CCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 994369-884889860----999999999999999999999866099-----2503889983797589708995336321
Q 000706 81 VTEFAQ-GELFEILED----DKCLPEEQVQSIAKQLVRALHYLHSNR-----IIHRDMKPQNILIGAGSVVKLCDFGFAR 150 (1342)
Q Consensus 81 VMEYve-GSLlDlLek----~k~LSEeeIikIl~QILkALaYLHskG-----IVHRDIKPENILIdsdG~IKLiDFGLAk 150 (1342)
||||++ |+|.+++.+ .+.+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf 99568999389999851545789999999999999999999999716778878858676542574788857980010003
Q ss_pred CCCCCCEEEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC-CCCCCCCHHH
Q ss_conf 245774012023588876881212038998777532046679998838999999839999999842999-9999999889
Q 000706 151 AMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV-KYPDEMSPNF 229 (1342)
Q Consensus 151 ~l~sss~~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~pl-elP~eISpeL 229 (1342)
............+||+.|+|||++.+..|+.++||||+|+++|+|++|+.||.+.+..+....+..... ..|..+|+++
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l 242 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 242 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred ECCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
T ss_conf 22457775566778823279999839999938988752789999801889989989999999997189988974359999
Q ss_pred HHHHHHHCCCCCCCCCCHHHHHCCCCC
Q ss_conf 999998110199999999899729576
Q 000706 230 KSFLKGLLNKVPQNRLTWSALLEHPFV 256 (1342)
Q Consensus 230 kdLIkkMLskDPeKRPTaeELLkHPfF 256 (1342)
++|+.+||+.||++|||+.|+++|||+
T Consensus 243 ~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 243 NEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHCCCCHHHCCCHHHHHHCCCC
T ss_conf 999999767995579189999729819
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=413.52 Aligned_cols=258 Identities=30% Similarity=0.529 Sum_probs=235.1
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHH-HCCCCCCCEEEEEEEECCEEEE
Q ss_conf 8788999997325937999999956995999999615799-9789999999999999-3599981158888870895999
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILR-KLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 3 IDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~-seseikrL~rEIkILk-kLsHPNIVKLidvfeded~iyI 80 (1342)
+|+|++++.||+|+||+||+|+++.+++.||+|++.+... .....+.+..|..++. .++||||+++++++++++..|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEE
T ss_conf 99718865894087828999999999989999998055533848999999999999984799968789889704983167
Q ss_pred EEECCC-CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCEEE
Q ss_conf 994369-8848898609999999999999999999998660992503889983797589708995336321245774012
Q 000706 81 VTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVL 159 (1342)
Q Consensus 81 VMEYve-GSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~~~ 159 (1342)
||||++ |+|.+++...+.+++..++.++.|++.||.|||++|++||||||+|||++.++++||+|||+++.........
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EEEECCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEECCCCCHHHHCCCCCCCC
T ss_conf 77503798089986404789999999999999999999986893403476540444489963015553023235665334
Q ss_pred ECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 02358887688121203899877753204667999883899999983999999984299999999998899999981101
Q 000706 160 RSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFLKGLLNK 239 (1342)
Q Consensus 160 ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~plelP~eISpeLkdLIkkMLsk 239 (1342)
....||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+..+....+....+.+|..+|+++++||.+||+.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~ 240 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240 (320)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCS
T ss_pred CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 54578777689999827998832320112278989873889999989999999997189989756799999999996544
Q ss_pred CCCCCCCHH-HHHCCCCCCCCH
Q ss_conf 999999998-997295763431
Q 000706 240 VPQNRLTWS-ALLEHPFVKETS 260 (1342)
Q Consensus 240 DPeKRPTae-ELLkHPfFke~~ 260 (1342)
||.+||++. ++++||||++..
T Consensus 241 dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 241 EPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp SGGGSBTTBSCGGGSGGGTTCC
T ss_pred CCCCCCCHHHHHHHCCHHCCCC
T ss_conf 8987838899998090131589
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=409.50 Aligned_cols=259 Identities=29% Similarity=0.499 Sum_probs=227.0
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCC----CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 988788999997325937999999956995999999615799----9789999999999999359998115888887089
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK----SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ 76 (1342)
Q Consensus 1 mdIDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~----seseikrL~rEIkILkkLsHPNIVKLidvfeded 76 (1342)
|.+++|++.+.||+|+||.||+|+++.+++.||+|++.+... ..........|+++++.++||||+++++++++++
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
T ss_conf 97776851018842889099999999999799999984587542667999999999999985089985889999999899
Q ss_pred EEEEEEECCC-CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 5999994369-884889860999999999999999999999866099250388998379758970899533632124577
Q 000706 77 EFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN 155 (1342)
Q Consensus 77 ~iyIVMEYve-GSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~ss 155 (1342)
.+|+||||++ |+|.+++.+.+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECCCCCEEEEEECEEEECCCC
T ss_conf 88999991489838999873255327899999999999999999779622044422167858896798220102333788
Q ss_pred CEEEECCCCCCCCCCHHHHC-CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC---HHHHHHHHHCCCCCCCCCCCHHHHH
Q ss_conf 40120235888768812120-3899877753204667999883899999983---9999999842999999999988999
Q 000706 156 TVVLRSIKGTPLYMAPELVR-EQPYNHTADLWSLGVILYELFVGQPPFYTNS---VYALIRHIVKDPVKYPDEMSPNFKS 231 (1342)
Q Consensus 156 s~~~ssivGTp~YlAPEIL~-g~~YT~kSDIWSLGVILYELLTGklPF~gss---~~elikkIvk~plelP~eISpeLkd 231 (1342)
. ....+||+.|+|||++. +..|+.++||||+||++|+|++|+.||.+.+ .....+.+...+..+|..+++++++
T Consensus 161 ~--~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (364)
T d1omwa3 161 K--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238 (364)
T ss_dssp C--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHH
T ss_pred C--CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHH
T ss_conf 6--43311345542168760389998441046778999999859998888998999999986046888788778999999
Q ss_pred HHHHHCCCCCCCCCC-----HHHHHCCCCCCCCHH
Q ss_conf 999811019999999-----989972957634314
Q 000706 232 FLKGLLNKVPQNRLT-----WSALLEHPFVKETSD 261 (1342)
Q Consensus 232 LIkkMLskDPeKRPT-----aeELLkHPfFke~~e 261 (1342)
||.+||+.||++||| ++|+++||||++...
T Consensus 239 li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp HHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred HHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCCCH
T ss_conf 99998566988808874357999974910237898
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=414.41 Aligned_cols=256 Identities=38% Similarity=0.617 Sum_probs=227.0
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf 78899999732593799999995699599999961579997899999999999993599981158888870895999994
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 4 DrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~iyIVME 83 (1342)
|.|++++.||+|+||.||+|+++.+++.||+|++.+.. ....+.+.+|++++++++||||+++++++.+++.+|+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
T ss_conf 37598479930778199999999999399999987289--9999999999999986799998849889800995899996
Q ss_pred CCC-CCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCEEEEC
Q ss_conf 369-884889860-999999999999999999999866099250388998379758970899533632124577401202
Q 000706 84 FAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 84 Yve-GSLlDlLek-~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~~~ss 161 (1342)
|++ |+|.+++.+ .+++++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred CCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECCCCCEEEEECHHHHCCCCCCCCCCC
T ss_conf 27998188999862899999999999999999999999889887140700314878999899716123035778641001
Q ss_pred CCCCCCCCCHHHHC-----CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCHHHHHHH
Q ss_conf 35888768812120-----38998777532046679998838999999839999999842999---99999998899999
Q 000706 162 IKGTPLYMAPELVR-----EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV---KYPDEMSPNFKSFL 233 (1342)
Q Consensus 162 ivGTp~YlAPEIL~-----g~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~pl---elP~eISpeLkdLI 233 (1342)
..||+.|+|||++. +..|+.++||||+||++|+|++|+.||.+.+..+...++..... ..+..+++++++||
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li 249 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
T ss_conf 02562647999983202578888806657878999999820889999989999999997079987776566999999999
Q ss_pred HHHCCCCCCCCCCHHHHHCCCCCCCCHH
Q ss_conf 9811019999999989972957634314
Q 000706 234 KGLLNKVPQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 234 kkMLskDPeKRPTaeELLkHPfFke~~e 261 (1342)
.+||+.||++|||+.|+++||||+....
T Consensus 250 ~~~L~~dp~~R~t~~ell~hp~~~~~~~ 277 (288)
T d2jfla1 250 KKCLEKNVDARWTTSQLLQHPFVTVDSN 277 (288)
T ss_dssp HHHSCSSTTTSCCHHHHTTSGGGCCCCC
T ss_pred HHHCCCCHHHCCCHHHHHCCCCCCCCCC
T ss_conf 9976699668919999962923188989
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=415.05 Aligned_cols=256 Identities=30% Similarity=0.531 Sum_probs=221.2
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 87889999973259379999999569959999996157999789999999999999359998115888887089599999
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 IDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~iyIVM 82 (1342)
-|+|++++.||+|+||.||+|+++.+++.||+|++++... ....+++.+|+.++++++|||||++++++.+++.+|+||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 5688897897127780999999989996999999875409-789999999999998679999994999999899999999
Q ss_pred ECCC-CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCEEEE
Q ss_conf 4369-8848898609999999999999999999998660-9925038899837975897089953363212457740120
Q 000706 83 EFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS-NRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 83 EYve-GSLlDlLek~k~LSEeeIikIl~QILkALaYLHs-kGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~~~s 160 (1342)
||++ |+|.+++.+.+.+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--~~ 161 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--AN 161 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--C-
T ss_pred ECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEEEECCCCCCCCCCC--CC
T ss_conf 7679986899874249999999999999999999999985999714457799468789989995487762567886--21
Q ss_pred CCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHH-------------------------------
Q ss_conf 2358887688121203899877753204667999883899999983999-------------------------------
Q 000706 161 SIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYA------------------------------- 209 (1342)
Q Consensus 161 sivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gss~~e------------------------------- 209 (1342)
+.+||++|+|||++.+.+|+.++||||+||++|||++|+.||.+.+..+
T Consensus 162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241 (322)
T ss_dssp --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred CCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 11377141194687589989488899899999999988899899887899999988751775457742123332211112
Q ss_pred -----------HHHHHHCC-CCCCC-CCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCHH
Q ss_conf -----------99998429-99999-999988999999811019999999989972957634314
Q 000706 210 -----------LIRHIVKD-PVKYP-DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 210 -----------likkIvk~-plelP-~eISpeLkdLIkkMLskDPeKRPTaeELLkHPfFke~~e 261 (1342)
....+... ++..+ ..+++++.+|+.+||+.||++|||++|+++||||++...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp ----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCCCC
T ss_conf 22354134778876650268766764448999999999986899467908999960986476982
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=405.72 Aligned_cols=255 Identities=33% Similarity=0.599 Sum_probs=231.5
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCH----HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 78899999732593799999995699599999961579997----89999999999999359998115888887089599
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE----KDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFC 79 (1342)
Q Consensus 4 DrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~se----seikrL~rEIkILkkLsHPNIVKLidvfeded~iy 79 (1342)
++|++++.||+|+||.||+|+++.+++.||+|++.+..... ...+.+.+|++++++++||||+++++++++++.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 67798279811789599999999999899999987566321340689999999999998679989993889999799899
Q ss_pred EEEECCC-CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCC----CEEEEECCCCCCCCC
Q ss_conf 9994369-88488986099999999999999999999986609925038899837975897----089953363212457
Q 000706 80 VVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS----VVKLCDFGFARAMSA 154 (1342)
Q Consensus 80 IVMEYve-GSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG----~IKLiDFGLAk~l~s 154 (1342)
+||||++ |+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+++.++ .+|++|||++.....
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEECCCCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHHHHHCCC
T ss_conf 99986778643100103564215578999999999987666254221133301279825898666469643344210577
Q ss_pred CCEEEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCC----CCCCHHHH
Q ss_conf 74012023588876881212038998777532046679998838999999839999999842999999----99998899
Q 000706 155 NTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP----DEMSPNFK 230 (1342)
Q Consensus 155 ss~~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~plelP----~eISpeLk 230 (1342)
... .....|++.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+..+....+......++ ..+|++++
T Consensus 170 ~~~-~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 248 (293)
T d1jksa_ 170 GNE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248 (293)
T ss_dssp SCB-CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred CCC-CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCHHCCCCCHHHH
T ss_conf 763-1224777743099998189999766522140999999708899889999999999981688887010478899999
Q ss_pred HHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 99998110199999999899729576343
Q 000706 231 SFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 231 dLIkkMLskDPeKRPTaeELLkHPfFke~ 259 (1342)
+||.+||+.||.+|||++|+++||||+..
T Consensus 249 ~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 249 DFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred HHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 99999863896689199999619041888
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=405.91 Aligned_cols=252 Identities=32% Similarity=0.543 Sum_probs=224.3
Q ss_pred CEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCH-HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf 8899999732593799999995699599999961579997-899999999999993599981158888870895999994
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE-KDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 5 rYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~se-seikrL~rEIkILkkLsHPNIVKLidvfeded~iyIVME 83 (1342)
.|++++.||+|+||.||+|++..+++.||+|.+.+..... ...+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 56762797018880999999989993999999844443588999999999999997789998238999998998899998
Q ss_pred CCCC-CHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCEEEECC
Q ss_conf 3698-848898609999999999999999999998660992503889983797589708995336321245774012023
Q 000706 84 FAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 YveG-SLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~~~ssi 162 (1342)
|++| ++..++...+++++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~----~~~ 171 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSF 171 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----CCC
T ss_pred ECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCCCCEEEEECCCCCCCCCC----CCC
T ss_conf 0699945789973799999999999999999999998689766678842179879997898443653346778----731
Q ss_pred CCCCCCCCHHHHCC---CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCHHHHHHHHHHC
Q ss_conf 58887688121203---8998777532046679998838999999839999999842999--999999988999999811
Q 000706 163 KGTPLYMAPELVRE---QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPV--KYPDEMSPNFKSFLKGLL 237 (1342)
Q Consensus 163 vGTp~YlAPEIL~g---~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~pl--elP~eISpeLkdLIkkML 237 (1342)
.||+.|+|||++.+ ..|+.++||||+||++|+|++|+.||.+.+..+....+..... ..+..+|+++++||.+||
T Consensus 172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 251 (309)
T d1u5ra_ 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251 (309)
T ss_dssp CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHT
T ss_pred CCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHC
T ss_conf 34766368899834678886721454558999999987889999979999999998289998887888999999999977
Q ss_pred CCCCCCCCCHHHHHCCCCCCCCH
Q ss_conf 01999999998997295763431
Q 000706 238 NKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 238 skDPeKRPTaeELLkHPfFke~~ 260 (1342)
+.||.+|||++|+++||||....
T Consensus 252 ~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 252 QKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp CSSGGGSCCHHHHTTCHHHHSCC
T ss_pred CCCHHHCCCHHHHHHCHHHCCCC
T ss_conf 37965791899997199753789
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=407.89 Aligned_cols=255 Identities=31% Similarity=0.548 Sum_probs=231.0
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 87889999973259379999999569959999996157999789999999999999359998115888887089599999
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 IDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~iyIVM 82 (1342)
+|+|++++.||+|+||.||+|+++.+++.||+|.+++.. .+...+.+|+++|++++||||+++++++++++.+|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC---CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 010588789831778399999998999699999975786---65999999999998579979890989998899889999
Q ss_pred ECCC-CCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCC--CEEEEECCCCCCCCCCCEE
Q ss_conf 4369-88488986099-999999999999999999986609925038899837975897--0899533632124577401
Q 000706 83 EFAQ-GELFEILEDDK-CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS--VVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 83 EYve-GSLlDlLek~k-~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG--~IKLiDFGLAk~l~sss~~ 158 (1342)
||++ |+|++++.+.+ .+++.+++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~- 159 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred ECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCCCC-
T ss_conf 5389980889987538999999999999999999999987699751355444344378851899764411100346775-
Q ss_pred EECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCC----CCCCHHHHHHHH
Q ss_conf 2023588876881212038998777532046679998838999999839999999842999999----999988999999
Q 000706 159 LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP----DEMSPNFKSFLK 234 (1342)
Q Consensus 159 ~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~plelP----~eISpeLkdLIk 234 (1342)
.....+++.|+|||...+..|+.++||||+||++|+|++|+.||.+.+..+....+......++ ..+++++++||.
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 239 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred CCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHCCCCCHHHHHHHH
T ss_conf 32122332223402104877784011302799999998289999998999999999838999880223678999999999
Q ss_pred HHCCCCCCCCCCHHHHHCCCCCCCCHH
Q ss_conf 811019999999989972957634314
Q 000706 235 GLLNKVPQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 235 kMLskDPeKRPTaeELLkHPfFke~~e 261 (1342)
+||+.||.+|||+.|+++||||++..+
T Consensus 240 ~~L~~dp~~R~s~~eil~hp~~~~~~~ 266 (321)
T d1tkia_ 240 RLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 986699668909999963996566753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=402.18 Aligned_cols=249 Identities=29% Similarity=0.500 Sum_probs=220.7
Q ss_pred EEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE----CCEEEEE
Q ss_conf 899999732593799999995699599999961579997899999999999993599981158888870----8959999
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFES----PQEFCVV 81 (1342)
Q Consensus 6 YkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfed----ed~iyIV 81 (1342)
|++.++||+|+||.||+|+++.+++.||+|.+..........+.+.+|++++++++||||+++++++++ +..+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf 88516970082849999999999959999998512279899999999999998579998506999984033458889999
Q ss_pred EECCC-CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CEECCCCCCCEEEC-CCCCEEEEECCCCCCCCCCCE
Q ss_conf 94369-884889860999999999999999999999866099--25038899837975-897089953363212457740
Q 000706 82 TEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNR--IIHRDMKPQNILIG-AGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 82 MEYve-GSLlDlLek~k~LSEeeIikIl~QILkALaYLHskG--IVHRDIKPENILId-sdG~IKLiDFGLAk~l~sss~ 157 (1342)
|||++ |+|.+++.+.+.+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||+++......
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~- 169 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF- 169 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS-
T ss_pred EECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCCCEEEEECCCCEECCCCC-
T ss_conf 9578989489997513554699999999999999999997899799687674351166799988980057654236876-
Q ss_pred EEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC-CHHHHHHHHHCCC--CCCCCCCCHHHHHHHH
Q ss_conf 120235888768812120389987775320466799988389999998-3999999984299--9999999988999999
Q 000706 158 VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTN-SVYALIRHIVKDP--VKYPDEMSPNFKSFLK 234 (1342)
Q Consensus 158 ~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gs-s~~elikkIvk~p--lelP~eISpeLkdLIk 234 (1342)
....+||+.|+|||++.+ +|+.++||||+||++|+|++|+.||.+. +.....+.+..+. ..++...++++++||.
T Consensus 170 -~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~ 247 (270)
T d1t4ha_ 170 -AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 247 (270)
T ss_dssp -BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred -CCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH
T ss_conf -677553813008988478-999867110079999999878899987655999999997389986567557899999999
Q ss_pred HHCCCCCCCCCCHHHHHCCCCCC
Q ss_conf 81101999999998997295763
Q 000706 235 GLLNKVPQNRLTWSALLEHPFVK 257 (1342)
Q Consensus 235 kMLskDPeKRPTaeELLkHPfFk 257 (1342)
+||++||++|||++|+++||||+
T Consensus 248 ~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 248 GCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHCCCCHHHCCCHHHHHCCCCCC
T ss_conf 97637975892999996775409
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=401.89 Aligned_cols=260 Identities=32% Similarity=0.556 Sum_probs=226.6
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 87889999973259379999999569959999996157999789999999999999359998115888887089599999
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 IDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~iyIVM 82 (1342)
+|+|++++.||+|+||.||+|++..+++.||+|++......+...+++.+|++++++++||||+++++++++++.+|+||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf 99977651772376809999999999979999998022257589999999999998679983887445332243203788
Q ss_pred ECCCCCHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCEEEE
Q ss_conf 4369884889860--99999999999999999999986609925038899837975897089953363212457740120
Q 000706 83 EFAQGELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLR 160 (1342)
Q Consensus 83 EYveGSLlDlLek--~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~~~s 160 (1342)
||++|++++++.. .+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||.++..........
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~ 160 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 160 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred EECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECCCCCCEECCCCCCEECCCCCCCCE
T ss_conf 62377445554420256888899999999999999986528899213571140113467621035786134368864100
Q ss_pred CCCCCCCCCCHHHHCCCC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC---CC---------------CC
Q ss_conf 235888768812120389-987775320466799988389999998399999998429---99---------------99
Q 000706 161 SIKGTPLYMAPELVREQP-YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PV---------------KY 221 (1342)
Q Consensus 161 sivGTp~YlAPEIL~g~~-YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~---pl---------------el 221 (1342)
...||+.|+|||++.... ++.++||||+|+++|+|++|+.||.+.+..+....+... +. .+
T Consensus 161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240 (298)
T ss_dssp CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTS
T ss_pred EECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCCCCCCCC
T ss_conf 10365215411221366577742210333313427966879989889999999999832898333144422242124345
Q ss_pred -----------CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCHHH
Q ss_conf -----------99999889999998110199999999899729576343145
Q 000706 222 -----------PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSDE 262 (1342)
Q Consensus 222 -----------P~eISpeLkdLIkkMLskDPeKRPTaeELLkHPfFke~~ee 262 (1342)
...+++++++|+.+||+.||++|||+.|+++||||++..+.
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCC
T ss_conf 4322220444166789999999999763995579189999678701469999
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=394.84 Aligned_cols=255 Identities=35% Similarity=0.615 Sum_probs=229.2
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCH-------HHHHHHHHHHHHHHHCC-CCCCCEEEEEEEE
Q ss_conf 878899999732593799999995699599999961579997-------89999999999999359-9981158888870
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE-------KDIHNLRQEIEILRKLK-HQNIIEMLDSFES 74 (1342)
Q Consensus 3 IDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~se-------seikrL~rEIkILkkLs-HPNIVKLidvfed 74 (1342)
.++|++.+.||+|+||+||+|++..+++.||+|++.+..... ...+.+.+|+.++++++ ||||+++++++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEECCC-CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 895999994369-8848898609999999999999999999998660992503889983797589708995336321245
Q 000706 75 PQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS 153 (1342)
Q Consensus 75 ed~iyIVMEYve-GSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~ 153 (1342)
++.+|+||||++ |+|.+++...+++++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCHHEEECC
T ss_conf 76059999768986689999865999999999999999999999987599432346254898689983871240316726
Q ss_pred CCCEEEECCCCCCCCCCHHHHCC------CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCC----C
Q ss_conf 77401202358887688121203------8998777532046679998838999999839999999842999999----9
Q 000706 154 ANTVVLRSIKGTPLYMAPELVRE------QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYP----D 223 (1342)
Q Consensus 154 sss~~~ssivGTp~YlAPEIL~g------~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~plelP----~ 223 (1342)
... ......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+.+..+..+.+......++ .
T Consensus 162 ~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (277)
T d1phka_ 162 PGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240 (277)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred CCC-CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf 887-2134524678889888605344567889923318565602310322888988999999999998189888985434
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 99988999999811019999999989972957634
Q 000706 224 EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258 (1342)
Q Consensus 224 eISpeLkdLIkkMLskDPeKRPTaeELLkHPfFke 258 (1342)
.+|+++++|+.+||+.||++|||++|+++||||++
T Consensus 241 ~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHH
T ss_conf 68999999999976589668919999973978797
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=394.77 Aligned_cols=253 Identities=30% Similarity=0.517 Sum_probs=219.0
Q ss_pred EEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHH---HHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf 9999973259379999999569959999996157999789---9999999999993599981158888870895999994
Q 000706 7 HVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKD---IHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVTE 83 (1342)
Q Consensus 7 kILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~sese---ikrL~rEIkILkkLsHPNIVKLidvfeded~iyIVME 83 (1342)
+.++.||+|+||+||+|+++.+++.||+|++++....... .+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CCCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHH
T ss_conf 95638512728299999999999699999984202124567999999999999986799998689854225874022045
Q ss_pred CCCCCHHHHH-HCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCEEEECC
Q ss_conf 3698848898-609999999999999999999998660992503889983797589708995336321245774012023
Q 000706 84 FAQGELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRSI 162 (1342)
Q Consensus 84 YveGSLlDlL-ek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~~~ssi 162 (1342)
|++|++...+ ...+.+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||.++............
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~ 160 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 160 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred HHCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 53450776554126677899999999999999988631635503577625885377841146576100057875543302
Q ss_pred CCCCCCCCHHHHCC-CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC---CC-----------------CC
Q ss_conf 58887688121203-89987775320466799988389999998399999998429---99-----------------99
Q 000706 163 KGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD---PV-----------------KY 221 (1342)
Q Consensus 163 vGTp~YlAPEIL~g-~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~---pl-----------------el 221 (1342)
+||+.|+|||++.+ ..|+.++||||+||++|+|++|.+||.+.+..+....+.+. +. .+
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ua2a_ 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240 (299)
T ss_dssp CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred ECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCHHHHHCCC
T ss_conf 04733363999726778880564363042899998596999999999999999985189972545210002134430347
Q ss_pred --------CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf --------99999889999998110199999999899729576343
Q 000706 222 --------PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 222 --------P~eISpeLkdLIkkMLskDPeKRPTaeELLkHPfFke~ 259 (1342)
....++++.+|+.+||+.||++|||++|+|+||||++.
T Consensus 241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 8988678565689999999999763894569089999679965789
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=395.07 Aligned_cols=249 Identities=33% Similarity=0.649 Sum_probs=214.2
Q ss_pred CCCEEEEE-EECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEE----CC
Q ss_conf 87889999-97325937999999956995999999615799978999999999999935-99981158888870----89
Q 000706 3 VENYHVIE-LVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFES----PQ 76 (1342)
Q Consensus 3 IDrYkILK-~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkL-sHPNIVKLidvfed----ed 76 (1342)
+++|++.+ .||+|+||.||+|+++.+++.||+|++.+. ..+.+|+.++.++ +||||++++++|++ +.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-------HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCC
T ss_conf 148798107965454869999998899989999998974-------7799999999986699997829899950346897
Q ss_pred EEEEEEECCC-CCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECC---CCCEEEEECCCCC
Q ss_conf 5999994369-8848898609--99999999999999999999866099250388998379758---9708995336321
Q 000706 77 EFCVVTEFAQ-GELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA---GSVVKLCDFGFAR 150 (1342)
Q Consensus 77 ~iyIVMEYve-GSLlDlLek~--k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIds---dG~IKLiDFGLAk 150 (1342)
.+|+||||++ |+|++++.+. .++++..++.|+.|++.||.|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEE
T ss_conf 89999977899849999986278775799999999999999999997698644410022011355556631135455123
Q ss_pred CCCCCCEEEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHH----HHHHHCCCCCCCC---
Q ss_conf 245774012023588876881212038998777532046679998838999999839999----9998429999999---
Q 000706 151 AMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYAL----IRHIVKDPVKYPD--- 223 (1342)
Q Consensus 151 ~l~sss~~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gss~~el----ikkIvk~plelP~--- 223 (1342)
...... .....+||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+.... ...+......+|.
T Consensus 163 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 241 (335)
T d2ozaa1 163 ETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241 (335)
T ss_dssp ECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHH
T ss_pred ECCCCC-CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC
T ss_conf 336888-6432267756379277748988888888764516778865889988988778899999998538888898543
Q ss_pred -CCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf -999889999998110199999999899729576343
Q 000706 224 -EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 224 -eISpeLkdLIkkMLskDPeKRPTaeELLkHPfFke~ 259 (1342)
.+|+++++||.+||+.||.+|||+.|+++||||++.
T Consensus 242 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 242 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp HHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHCC
T ss_conf 4699999999999756996579099999709876178
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=386.30 Aligned_cols=255 Identities=32% Similarity=0.501 Sum_probs=223.3
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 87889999973259379999999569959999996157999789999999999999359998115888887089599999
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 IDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~iyIVM 82 (1342)
+|+|++++.||+|+||.||+|+++ +++.||+|++......+...+++.+|+.++++++||||+++++.+.+++..+++|
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEE
T ss_conf 999634318722778189999968-9999999998123268589999999999998679986876601204677315899
Q ss_pred ECCCCCHHHHH-HCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCEEEEC
Q ss_conf 43698848898-60999999999999999999999866099250388998379758970899533632124577401202
Q 000706 83 EFAQGELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EYveGSLlDlL-ek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~~~ss 161 (1342)
|++.|.+...+ ...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+|++|||.+............
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EEEHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECCCCCEEECCCCCCEECCCCCCCCCE
T ss_conf 74004567899860477514456899999999999860574882678775056868997873236643011467654101
Q ss_pred CCCCCCCCCHHHHCCC-CCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC----------------------
Q ss_conf 3588876881212038-99877753204667999883899999983999999984299----------------------
Q 000706 162 IKGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP---------------------- 218 (1342)
Q Consensus 162 ivGTp~YlAPEIL~g~-~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~p---------------------- 218 (1342)
..|++.|+|||.+.+. .++.++||||+|+++|+|++|+.||.+.+..+...++....
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHHCCCCCC
T ss_conf 02431101378871788888410021117589999779799898898999999998638997110421233322143333
Q ss_pred -------CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf -------9999999988999999811019999999989972957634
Q 000706 219 -------VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKE 258 (1342)
Q Consensus 219 -------lelP~eISpeLkdLIkkMLskDPeKRPTaeELLkHPfFke 258 (1342)
..+....++.+.+|+++||+.||++|||+.|+++||||++
T Consensus 240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred CCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 35676466651258999999999986689668909999856922074
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=385.05 Aligned_cols=257 Identities=32% Similarity=0.537 Sum_probs=215.2
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCC-CCEEEEEEEECCCCCHHHHHHHHHHHHHHHHC---CCCCCCEEEEEEEE----
Q ss_conf 87889999973259379999999569-95999999615799978999999999999935---99981158888870----
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYT-GQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL---KHQNIIEMLDSFES---- 74 (1342)
Q Consensus 3 IDrYkILK~LGsGaFGtVYKArdk~T-Gk~VAIKvIkKs~~seseikrL~rEIkILkkL---sHPNIVKLidvfed---- 74 (1342)
-++|++++.||+|+||.||+|++..+ ++.||+|++.+..........+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred -CCEEEEEEECCCCCHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf -89599999436988488986--099999999999999999999986609925038899837975897089953363212
Q 000706 75 -PQEFCVVTEFAQGELFEILE--DDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARA 151 (1342)
Q Consensus 75 -ed~iyIVMEYveGSLlDlLe--k~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~ 151 (1342)
....+++|||++|++..+.. ....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||.++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred CCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECCCCCEEECCHHHHHH
T ss_conf 67469999974058714444430378999899999999999999999758898357986278985899754210001011
Q ss_pred CCCCCEEEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC--------------
Q ss_conf 457740120235888768812120389987775320466799988389999998399999998429--------------
Q 000706 152 MSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD-------------- 217 (1342)
Q Consensus 152 l~sss~~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~-------------- 217 (1342)
..... ......||+.|+|||++.+.+|+.++||||+||++|+|++|++||.+.+..+....+...
T Consensus 166 ~~~~~-~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 244 (305)
T d1blxa_ 166 YSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244 (305)
T ss_dssp CCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred HCCCC-CCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHCCCCCCC
T ss_conf 00234-57776548511483100179888111000328999999878799899898999999998407996110532111
Q ss_pred -------------CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCH
Q ss_conf -------------9999999998899999981101999999998997295763431
Q 000706 218 -------------PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 218 -------------plelP~eISpeLkdLIkkMLskDPeKRPTaeELLkHPfFke~~ 260 (1342)
...++..+++.+++|+.+||+.||++|||+.|+++||||++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCH
T ss_conf 10333022345645440445899999999998748966791899996696340752
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=389.89 Aligned_cols=249 Identities=31% Similarity=0.581 Sum_probs=219.3
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCH----HHHHHHHHHHHHHHHCC--CCCCCEEEEEEEECCE
Q ss_conf 78899999732593799999995699599999961579997----89999999999999359--9981158888870895
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSE----KDIHNLRQEIEILRKLK--HQNIIEMLDSFESPQE 77 (1342)
Q Consensus 4 DrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~se----seikrL~rEIkILkkLs--HPNIVKLidvfeded~ 77 (1342)
++|++++.||+|+||.||+|++..+++.||+|.+.+..... ....++.+|+.++++++ ||||+++++++++++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
T ss_conf 83799679840878399999999999799999985688443345567999999999999743589881279999830996
Q ss_pred EEEEEECCC--CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCC-CCEEEEECCCCCCCCC
Q ss_conf 999994369--8848898609999999999999999999998660992503889983797589-7089953363212457
Q 000706 78 FCVVTEFAQ--GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAG-SVVKLCDFGFARAMSA 154 (1342)
Q Consensus 78 iyIVMEYve--GSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsd-G~IKLiDFGLAk~l~s 154 (1342)
.|+||||+. +++++++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEECCCCCCEECCC
T ss_conf 89999833686228999861589999999999999999999998779755667611147744788489775465353244
Q ss_pred CCEEEECCCCCCCCCCHHHHCCCCC-CCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 7401202358887688121203899-877753204667999883899999983999999984299999999998899999
Q 000706 155 NTVVLRSIKGTPLYMAPELVREQPY-NHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPDEMSPNFKSFL 233 (1342)
Q Consensus 155 ss~~~ssivGTp~YlAPEIL~g~~Y-T~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~plelP~eISpeLkdLI 233 (1342)
. ......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+ .+.+....++..+|+++++||
T Consensus 164 ~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~~~li 235 (273)
T d1xwsa_ 164 T--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLI 235 (273)
T ss_dssp S--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHHHHH
T ss_pred C--CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH------HHHHCCCCCCCCCCHHHHHHH
T ss_conf 4--55665658774799998489978865332554034536756889988736------776154477877999999999
Q ss_pred HHHCCCCCCCCCCHHHHHCCCCCCCCH
Q ss_conf 981101999999998997295763431
Q 000706 234 KGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 234 kkMLskDPeKRPTaeELLkHPfFke~~ 260 (1342)
.+||+.||++|||++|+++||||++..
T Consensus 236 ~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 236 RWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 997608975893999985398667887
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=381.91 Aligned_cols=253 Identities=28% Similarity=0.511 Sum_probs=220.8
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC------E
Q ss_conf 7889999973259379999999569959999996157999789999999999999359998115888887089------5
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ------E 77 (1342)
Q Consensus 4 DrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded------~ 77 (1342)
++|++++.||+|+||.||+|.++.+++.||+|++.+........+.+.+|+++|++++||||+++++++...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCCE
T ss_conf 71899889801778199999999999899999985222596999999999999986689875479998635765555415
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCE
Q ss_conf 99999436988488986099999999999999999999986609925038899837975897089953363212457740
Q 000706 78 FCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 78 iyIVMEYveGSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~ 157 (1342)
+|+||||++++|.+.+.. +++++..++.++.|++.||.|||++||+||||||+|||++.++.+|++|||.++.....
T Consensus 98 ~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-- 174 (346)
T d1cm8a_ 98 FYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-- 174 (346)
T ss_dssp CEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--
T ss_pred EEEEEECCCCCHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCCCCCCCCCCCCCCEECCCCC--
T ss_conf 999984055218999874-02269999999999999999987378764566851111210012211343102206876--
Q ss_pred EEECCCCCCCCCCHHHHCCC-CCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC------------------
Q ss_conf 12023588876881212038-99877753204667999883899999983999999984299------------------
Q 000706 158 VLRSIKGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDP------------------ 218 (1342)
Q Consensus 158 ~~ssivGTp~YlAPEIL~g~-~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~p------------------ 218 (1342)
.....||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+....+....
T Consensus 175 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (346)
T d1cm8a_ 175 -MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253 (346)
T ss_dssp -CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred -CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHHHHCCHHHHH
T ss_conf -3102455333588998178789965010300389999997869988897689999998503788488886530003443
Q ss_pred -------------CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCH
Q ss_conf -------------999999998899999981101999999998997295763431
Q 000706 219 -------------VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 219 -------------lelP~eISpeLkdLIkkMLskDPeKRPTaeELLkHPfFke~~ 260 (1342)
.......++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 3115786665566775568999999999997729955792999996396237587
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=379.80 Aligned_cols=258 Identities=29% Similarity=0.462 Sum_probs=218.0
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE-------
Q ss_conf 8878899999732593799999995699599999961579997899999999999993599981158888870-------
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFES------- 74 (1342)
Q Consensus 2 dIDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfed------- 74 (1342)
++++|++++.||+|+||+||+|+++.+++.||||++.+.........++.+|++++++++|||++++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCC
T ss_conf 62798899997227482999999989997999999842224637899999999999983599966067654024654444
Q ss_pred -CCEEEEEEECCCCCHHHHH-HCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf -8959999943698848898-60999999999999999999999866099250388998379758970899533632124
Q 000706 75 -PQEFCVVTEFAQGELFEIL-EDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAM 152 (1342)
Q Consensus 75 -ed~iyIVMEYveGSLlDlL-ek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l 152 (1342)
++..|++|||+++.+.... .....+++..++.++.|++.||.|||++||+||||||+|||++.++.+|++|||+++..
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCEEEEEEECCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECCCCCEEEEECCEEEEC
T ss_conf 57638999853578741012220344330899999999999998852299885676722203668996876313500223
Q ss_pred CCCC----EEEECCCCCCCCCCHHHHCCC-CCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCC----
Q ss_conf 5774----012023588876881212038-9987775320466799988389999998399999998429999999----
Q 000706 153 SANT----VVLRSIKGTPLYMAPELVREQ-PYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVKYPD---- 223 (1342)
Q Consensus 153 ~sss----~~~ssivGTp~YlAPEIL~g~-~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~plelP~---- 223 (1342)
.... ......+||+.|+|||++.+. .|+.++||||+||++|+|++|+.||.+.+..+....+.+....++.
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred CCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCC
T ss_conf 55444321135660249787428997079998917870067864661744879989989999999999841899825534
Q ss_pred ----------------------------CCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf ----------------------------999889999998110199999999899729576343
Q 000706 224 ----------------------------EMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 224 ----------------------------eISpeLkdLIkkMLskDPeKRPTaeELLkHPfFke~ 259 (1342)
..++++.+|+.+||+.||++|||++|+++||||++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred CCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 4320344433201334455503340444599899999999873896589099999749501569
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=376.32 Aligned_cols=252 Identities=23% Similarity=0.454 Sum_probs=221.6
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCC---EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCE
Q ss_conf 988788999997325937999999956995---99999961579997899999999999993599981158888870895
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQ---TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQE 77 (1342)
Q Consensus 1 mdIDrYkILK~LGsGaFGtVYKArdk~TGk---~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~ 77 (1342)
++.++|++.+.||+|+||.||+|+++.+++ .+|+|.+... ......+.+.+|+++|++++|||||++++++.+++.
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 0800427856980278829999999579978899999997844-598999999999999985799888618999962887
Q ss_pred EEEEEECCC-CCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 999994369-884889860-999999999999999999999866099250388998379758970899533632124577
Q 000706 78 FCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN 155 (1342)
Q Consensus 78 iyIVMEYve-GSLlDlLek-~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~ss 155 (1342)
.|+||||++ |+|.+++.. .+.+++.++..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCCEECCCC
T ss_conf 79999722798530021045679999999999999999889885279835761504489889991998884431575677
Q ss_pred CEE-----EECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCC-CCCCCCCCCHH
Q ss_conf 401-----202358887688121203899877753204667999883-89999998399999998429-99999999988
Q 000706 156 TVV-----LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPN 228 (1342)
Q Consensus 156 s~~-----~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLT-GklPF~gss~~elikkIvk~-plelP~eISpe 228 (1342)
... .....||+.|+|||.+.+..|+.++||||||+++|||++ |+.||.+.+..+....+..+ ..+.|..++++
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 261 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSA 261 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHH
T ss_conf 77653650256668830038788836997861214453578999986799999999999999999737889997422699
Q ss_pred HHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 9999998110199999999899729
Q 000706 229 FKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 229 LkdLIkkMLskDPeKRPTaeELLkH 253 (1342)
+.+|+.+||+.||++|||+.|++++
T Consensus 262 l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 262 LHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9999999758797689299999999
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.19 Aligned_cols=248 Identities=33% Similarity=0.532 Sum_probs=211.4
Q ss_pred CEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE------CCEE
Q ss_conf 8899999732593799999995699599999961579997899999999999993599981158888870------8959
Q 000706 5 NYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFES------PQEF 78 (1342)
Q Consensus 5 rYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfed------ed~i 78 (1342)
+|+.++.||+|+||+||+|+++.+++.||+|++.+.... ..+|++++++++||||+++++++.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH------HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEE
T ss_conf 767516982176839999999999979999998816068------99999999866898987387899744765773189
Q ss_pred EEEEECCCCCHHHHH----HCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCC-CEEEEECCCCCCCC
Q ss_conf 999943698848898----6099999999999999999999986609925038899837975897-08995336321245
Q 000706 79 CVVTEFAQGELFEIL----EDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS-VVKLCDFGFARAMS 153 (1342)
Q Consensus 79 yIVMEYveGSLlDlL----ek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG-~IKLiDFGLAk~l~ 153 (1342)
|+||||+++++.+.+ .....+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCCCCEEEECCCCHHHCC
T ss_conf 99984168860788886310368999999999999999999999866876457886037873589711673366054404
Q ss_pred CCCEEEECCCCCCCCCCHHHHCC-CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC---------------
Q ss_conf 77401202358887688121203-89987775320466799988389999998399999998429---------------
Q 000706 154 ANTVVLRSIKGTPLYMAPELVRE-QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKD--------------- 217 (1342)
Q Consensus 154 sss~~~ssivGTp~YlAPEIL~g-~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~--------------- 217 (1342)
... ......|++.|+|||.+.+ ..|+.++||||+||++|||++|+.||...+..+.+..+.+.
T Consensus 175 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 175 RGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp TTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred CCC-CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHHHCCC
T ss_conf 776-5320025555568277640468882100024652778550287998987999999999997489817765430621
Q ss_pred --CCC------------CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf --999------------999999889999998110199999999899729576343
Q 000706 218 --PVK------------YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 218 --ple------------lP~eISpeLkdLIkkMLskDPeKRPTaeELLkHPfFke~ 259 (1342)
... .....++++.+|+.+||+.||++|||+.|+++||||++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 01103554456744443156899999999999765895579299999669845246
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=379.56 Aligned_cols=251 Identities=25% Similarity=0.469 Sum_probs=216.4
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCC-----EEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEEC
Q ss_conf 88788999997325937999999956995-----999999615799978999999999999935-999811588888708
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQ-----TVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESP 75 (1342)
Q Consensus 2 dIDrYkILK~LGsGaFGtVYKArdk~TGk-----~VAIKvIkKs~~seseikrL~rEIkILkkL-sHPNIVKLidvfede 75 (1342)
+-++|++++.||+|+||.||+|++..+++ .||+|.+.+.. .......+.+|+.++.++ +|||||++++++.++
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 789939701983078819999998578855420499999966335-8789999999999999715899686877888629
Q ss_pred CEEEEEEECCC-CCHHHHHHCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCC
Q ss_conf 95999994369-8848898609-----------------------99999999999999999999866099250388998
Q 000706 76 QEFCVVTEFAQ-GELFEILEDD-----------------------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQ 131 (1342)
Q Consensus 76 d~iyIVMEYve-GSLlDlLek~-----------------------k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPE 131 (1342)
+.+|+||||++ |+|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHH
T ss_conf 95899997279995999998625777510221000012220012577899999999999999999997399050527032
Q ss_pred CEEECCCCCEEEEECCCCCCCCCCCE--EEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCHH
Q ss_conf 37975897089953363212457740--1202358887688121203899877753204667999883-89999998399
Q 000706 132 NILIGAGSVVKLCDFGFARAMSANTV--VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVY 208 (1342)
Q Consensus 132 NILIdsdG~IKLiDFGLAk~l~sss~--~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLT-GklPF~gss~~ 208 (1342)
|||++.++.+||+|||+|+....... ......||+.|+|||++.+..|+.++|||||||++|||++ |+.||.+.+..
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred CCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCHH
T ss_conf 14434598289851422220457786156234357876578388727999963303000399999983899999998989
Q ss_pred HHHHHHHCC--CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 999998429--999999999889999998110199999999899729
Q 000706 209 ALIRHIVKD--PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 209 elikkIvk~--plelP~eISpeLkdLIkkMLskDPeKRPTaeELLkH 253 (1342)
+...++... +++.|..+++++++||.+||+.||++|||++|+++|
T Consensus 274 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 99999985699899887678999999999758896689399999999
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.93 Aligned_cols=257 Identities=29% Similarity=0.483 Sum_probs=224.3
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 87889999973259379999999569959999996157999789999999999999359998115888887089599999
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 3 IDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~iyIVM 82 (1342)
+++|++++.||+|+||+||+|++..+++.||+|+++..........++.+|+.+++.++||||+++++++.++...+++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf 99978626971286819999999999969999998032178689999999999998567578882135444443115886
Q ss_pred ECCCC-CHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCEEEEC
Q ss_conf 43698-84889860999999999999999999999866099250388998379758970899533632124577401202
Q 000706 83 EFAQG-ELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVVLRS 161 (1342)
Q Consensus 83 EYveG-SLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~~~ss 161 (1342)
|++.| ++..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++...........
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~ 160 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred EECCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCCCCCEE
T ss_conf 30233222112123565403678999999999987743399860014676121133782665204601104688751001
Q ss_pred CCCCCCCCCHHHHCCCC-CCCCCCCCCHHHHHHHHHHCCCCCC-CCCHHHHHHHHHC---C-------------------
Q ss_conf 35888768812120389-9877753204667999883899999-9839999999842---9-------------------
Q 000706 162 IKGTPLYMAPELVREQP-YNHTADLWSLGVILYELFVGQPPFY-TNSVYALIRHIVK---D------------------- 217 (1342)
Q Consensus 162 ivGTp~YlAPEIL~g~~-YT~kSDIWSLGVILYELLTGklPF~-gss~~elikkIvk---~------------------- 217 (1342)
..+++.|+|||++.+.. ++.++||||+||++|+|++|+.||. +.+..+....+.. .
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred ECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCCCCCCCC
T ss_conf 03443101466750698888044402654188998518999988999999999998611899735513443222113344
Q ss_pred -------CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf -------999999999889999998110199999999899729576343
Q 000706 218 -------PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 218 -------plelP~eISpeLkdLIkkMLskDPeKRPTaeELLkHPfFke~ 259 (1342)
....+..+++.+.+|+++||+.||++|||++|+|+||||++.
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred CCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 4544310433065689999999999864996689099999649534079
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.47 Aligned_cols=255 Identities=24% Similarity=0.443 Sum_probs=222.1
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE------ECC
Q ss_conf 87889999973259379999999569959999996157999789999999999999359998115888887------089
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFE------SPQ 76 (1342)
Q Consensus 3 IDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfe------ded 76 (1342)
+++|++++.||+|+||+||+|+++.+++.||||++.+.........++.+|+.++++++||||+++++++. +..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf 37759988962175859999999999989999998823369799999999999998648987648998970256434576
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 59999943698848898609999999999999999999998660992503889983797589708995336321245774
Q 000706 77 EFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 77 ~iyIVMEYveGSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss 156 (1342)
.+|+||||+.|++++.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+|++|||+++......
T Consensus 96 ~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~ 173 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_dssp EEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EEEEEEECCCHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEEEECHHHHHCCCCCC
T ss_conf 269998414467787650--389999999999999999988652211245677632113654431320102321146665
Q ss_pred EEEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHC--------------------
Q ss_conf 012023588876881212038998777532046679998838999999839999999842--------------------
Q 000706 157 VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK-------------------- 216 (1342)
Q Consensus 157 ~~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk-------------------- 216 (1342)
.....++|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 174 -~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 252 (355)
T d2b1pa1 174 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252 (355)
T ss_dssp --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHH
T ss_pred -CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHHHHHH
T ss_conf -5332214655558133147777877433356625789865989988897788999999720589879998765667777
Q ss_pred --CCCCCC--------------------CCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCH
Q ss_conf --999999--------------------99998899999981101999999998997295763431
Q 000706 217 --DPVKYP--------------------DEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 217 --~plelP--------------------~eISpeLkdLIkkMLskDPeKRPTaeELLkHPfFke~~ 260 (1342)
...... ...++++.+|+++||..||++|||++|+|+||||++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred HHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCC
T ss_conf 641754356664212643335432101333799999999998769945790899996694208788
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=375.62 Aligned_cols=249 Identities=24% Similarity=0.463 Sum_probs=218.1
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 98878899999732593799999995699599999961579997899999999999993599981158888870895999
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 1 mdIDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~iyI 80 (1342)
++.++|++.+.||+|+||.||+|+++.+++.||+|++++.... .+++.+|++++++++||||+++++++.+++..|+
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCH---HHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEE
T ss_conf 4579939865982088808999999999969999997776103---9999999999986799988267752745785478
Q ss_pred EEECCC-CCHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCE
Q ss_conf 994369-884889860--99999999999999999999986609925038899837975897089953363212457740
Q 000706 81 VTEFAQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 81 VMEYve-GSLlDlLek--~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~ 157 (1342)
+|||++ |+|.+++.+ ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred EEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCCC
T ss_conf 76314676067775303554157999999999999978889878930576045768998999289832445465378872
Q ss_pred -EEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCC-CCCHHHHHHHHHCC-CCCCCCCCCHHHHHHHH
Q ss_conf -1202358887688121203899877753204667999883899999-98399999998429-99999999988999999
Q 000706 158 -VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFY-TNSVYALIRHIVKD-PVKYPDEMSPNFKSFLK 234 (1342)
Q Consensus 158 -~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~-gss~~elikkIvk~-plelP~eISpeLkdLIk 234 (1342)
......|++.|+|||++.+..|+.++||||+|+++|||++|..||. +.+.....+.+..+ .+++|..+++++.+|+.
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 250 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 250 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred EEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
T ss_conf 21035566546669278727999810430217899999986799887742599999998558888887433099999999
Q ss_pred HHCCCCCCCCCCHHHHHC
Q ss_conf 811019999999989972
Q 000706 235 GLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 235 kMLskDPeKRPTaeELLk 252 (1342)
+||+.||++|||+.++++
T Consensus 251 ~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 251 ACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHCCCCHHHCCCHHHHHH
T ss_conf 975779768939999999
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.19 Aligned_cols=255 Identities=28% Similarity=0.531 Sum_probs=215.8
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC-----EE
Q ss_conf 7889999973259379999999569959999996157999789999999999999359998115888887089-----59
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ-----EF 78 (1342)
Q Consensus 4 DrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded-----~i 78 (1342)
++|++++.||+|+||+||+|.++.+++.||||++.+.. .....+++.+|+.+|++++||||+++++++..+. .+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC-CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 98599789940648099999999999499999980310-95899999999999997689898858889950564554149
Q ss_pred EEEEECCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCE-
Q ss_conf 9999436988488986099999999999999999999986609925038899837975897089953363212457740-
Q 000706 79 CVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV- 157 (1342)
Q Consensus 79 yIVMEYveGSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~- 157 (1342)
|++|++.+|+|++++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~ 165 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EEEEEECCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCCCC
T ss_conf 999962598656644058-9999999999999999999999789867778764378879997787545705650477764
Q ss_pred --EEECCCCCCCCCCHHHHC-CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHC------------------
Q ss_conf --120235888768812120-38998777532046679998838999999839999999842------------------
Q 000706 158 --VLRSIKGTPLYMAPELVR-EQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVK------------------ 216 (1342)
Q Consensus 158 --~~ssivGTp~YlAPEIL~-g~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk------------------ 216 (1342)
.....+|++.|+|||++. +..|+.++||||+|+++|+|++|+.||.+.+..+.......
T Consensus 166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T d1pmea_ 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245 (345)
T ss_dssp CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred CEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHHHH
T ss_conf 10101102652000387860478887410100467013377669799788888999998765206997566423433222
Q ss_pred ------CCC-------CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCH
Q ss_conf ------999-------99999998899999981101999999998997295763431
Q 000706 217 ------DPV-------KYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETS 260 (1342)
Q Consensus 217 ------~pl-------elP~eISpeLkdLIkkMLskDPeKRPTaeELLkHPfFke~~ 260 (1342)
.+. .....+++++.+|+.+||+.||.+|||+.|+++||||++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 202446775577877783789999999999997648956790899986198655588
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=374.78 Aligned_cols=252 Identities=28% Similarity=0.454 Sum_probs=220.7
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC----EE
Q ss_conf 788999997325937999999956995999999615799-9789999999999999359998115888887089----59
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGK-SEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ----EF 78 (1342)
Q Consensus 4 DrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~-seseikrL~rEIkILkkLsHPNIVKLidvfeded----~i 78 (1342)
++|++.+.||+|+||.||+|++..+++.||+|++.+... .....+++.+|+++++.++||||+++++++..++ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCEE
T ss_conf 20698689960899299999999999899999985566469899999999999998569998873114354326887669
Q ss_pred EEEEECCC-CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC-
Q ss_conf 99994369-8848898609999999999999999999998660992503889983797589708995336321245774-
Q 000706 79 CVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT- 156 (1342)
Q Consensus 79 yIVMEYve-GSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss- 156 (1342)
|+||||++ |+|.+++...+++++.+++.++.|++.||.|||++||+||||||+|||++.++..+++|||.+.......
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~ 166 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred EEEEECCCCCEEHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHCCCCC
T ss_conf 99997788987101120358999999999999999999999857952763467556657543201003444322123544
Q ss_pred --EEEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCC----CCCCCCHHHH
Q ss_conf --0120235888768812120389987775320466799988389999998399999998429999----9999998899
Q 000706 157 --VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVK----YPDEMSPNFK 230 (1342)
Q Consensus 157 --~~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~ple----lP~eISpeLk 230 (1342)
......+||+.|+|||++.+..|+.++||||+|+++|+|++|+.||.+.+..+...++...... .++.+|+++.
T Consensus 167 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~ 246 (277)
T d1o6ya_ 167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246 (277)
T ss_dssp ------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHH
T ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCHHCCCCCHHHH
T ss_conf 33334642576243699998399999663202652899999769799899699999999984699997100347899999
Q ss_pred HHHHHHCCCCCCCCC-CHHHHHCCCCC
Q ss_conf 999981101999999-99899729576
Q 000706 231 SFLKGLLNKVPQNRL-TWSALLEHPFV 256 (1342)
Q Consensus 231 dLIkkMLskDPeKRP-TaeELLkHPfF 256 (1342)
+||.+||++||.+|| |++++ .|+|+
T Consensus 247 ~li~~~L~~dp~~R~~sa~~l-~~~l~ 272 (277)
T d1o6ya_ 247 AVVLKALAKNPENRYQTAAEM-RADLV 272 (277)
T ss_dssp HHHHHHTCSSGGGSCSSHHHH-HHHHH
T ss_pred HHHHHHCCCCHHHCHHHHHHH-HHHHH
T ss_conf 999998667976777399999-99999
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.44 Aligned_cols=252 Identities=22% Similarity=0.401 Sum_probs=218.2
Q ss_pred CCEEEE-EEECCCCCEEEEEEEEC--CCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 788999-99732593799999995--699599999961579997899999999999993599981158888870895999
Q 000706 4 ENYHVI-ELVGEGSFGKVYKGRRK--YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 4 DrYkIL-K~LGsGaFGtVYKArdk--~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~iyI 80 (1342)
+.+.+. ++||+|+||.||+|..+ .+++.||+|+++.........+.+.+|++++++++||||++++++++++ ..|+
T Consensus 6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~l 84 (277)
T d1xbba_ 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWML 84 (277)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEECCCCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC-CEEE
T ss_conf 537001878345878299999981697385999999880108989999999999999867998985277775059-7799
Q ss_pred EEECCC-CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCEE-
Q ss_conf 994369-884889860999999999999999999999866099250388998379758970899533632124577401-
Q 000706 81 VTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV- 158 (1342)
Q Consensus 81 VMEYve-GSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~~- 158 (1342)
||||++ |+|.+++.+..++++..+..++.|++.||.|||+++|+||||||+|||++.++.+|++|||+++........
T Consensus 85 vmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred EEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCC
T ss_conf 99747889689997522578999999999999999766874795567776113102356751234134533134323443
Q ss_pred --EECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCC-CCCCCCCCCHHHHHHHH
Q ss_conf --202358887688121203899877753204667999883-89999998399999998429-99999999988999999
Q 000706 159 --LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLK 234 (1342)
Q Consensus 159 --~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLT-GklPF~gss~~elikkIvk~-plelP~eISpeLkdLIk 234 (1342)
.....||+.|+|||++.+..|+.++||||||+++|||++ |+.||.+.+..+....+..+ +++.|..+|+++.+|+.
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~ 244 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 244 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred CCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
T ss_conf 22445677842039166537999843443034031328965899999998999999999828999998656799999999
Q ss_pred HHCCCCCCCCCCHHHHH---CCCCC
Q ss_conf 81101999999998997---29576
Q 000706 235 GLLNKVPQNRLTWSALL---EHPFV 256 (1342)
Q Consensus 235 kMLskDPeKRPTaeELL---kHPfF 256 (1342)
+||+.||.+|||+.+++ +|+|+
T Consensus 245 ~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 245 LCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHCCCCHHHCCCHHHHHHHHHCHHH
T ss_conf 9758897689098999998528875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.52 Aligned_cols=249 Identities=25% Similarity=0.463 Sum_probs=220.4
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 98878899999732593799999995699599999961579997899999999999993599981158888870895999
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 1 mdIDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~iyI 80 (1342)
||-++|++++.||+|+||.||+|++. +++.||+|.+.+..... +.+.+|++++++++||||+++++++.+++..|+
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred CCHHHCEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCH---HHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEE
T ss_conf 89699588889820888299999988-99999999987886768---999999999996689975653524315993379
Q ss_pred EEECCC-CCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCE-
Q ss_conf 994369-8848898609-9999999999999999999986609925038899837975897089953363212457740-
Q 000706 81 VTEFAQ-GELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV- 157 (1342)
Q Consensus 81 VMEYve-GSLlDlLek~-k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~- 157 (1342)
||||++ |+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCE
T ss_conf 99836999189975201347889999999999999877653164310443153266668877686553210023688733
Q ss_pred EEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCC-CCCCCCCCCHHHHHHHHH
Q ss_conf 1202358887688121203899877753204667999883-89999998399999998429-999999999889999998
Q 000706 158 VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKG 235 (1342)
Q Consensus 158 ~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLT-GklPF~gss~~elikkIvk~-plelP~eISpeLkdLIkk 235 (1342)
......||+.|+|||++.+..|+.++||||||+++|||++ |++||...+..+..+.+..+ +...|...++++.+++.+
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred EECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
T ss_conf 50430017666785786079998403321059999999878988877899999999998068889954367999999999
Q ss_pred HCCCCCCCCCCHHHHHCC
Q ss_conf 110199999999899729
Q 000706 236 LLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 236 MLskDPeKRPTaeELLkH 253 (1342)
||+.||++|||++|+++|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HCCCCHHHCCCHHHHHHH
T ss_conf 765797689199999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.90 Aligned_cols=261 Identities=33% Similarity=0.564 Sum_probs=225.5
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEE---CCCCCEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEE
Q ss_conf 9887889999973259379999999---56995999999615799--97899999999999993599-981158888870
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRR---KYTGQTVAMKFIMKHGK--SEKDIHNLRQEIEILRKLKH-QNIIEMLDSFES 74 (1342)
Q Consensus 1 mdIDrYkILK~LGsGaFGtVYKArd---k~TGk~VAIKvIkKs~~--seseikrL~rEIkILkkLsH-PNIVKLidvfed 74 (1342)
+++++|++++.||+|+||.||+|++ +.+++.||+|.+.+... .....+.+.+|++++++++| |||+++++++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred CCHHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
T ss_conf 45102599989832878399999987658879489999983677210168999999999999864679839996200024
Q ss_pred CCEEEEEEECCC-CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 895999994369-8848898609999999999999999999998660992503889983797589708995336321245
Q 000706 75 PQEFCVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMS 153 (1342)
Q Consensus 75 ed~iyIVMEYve-GSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~ 153 (1342)
+...+++|||+. |+|++++...+.+++..++.++.|++.||.|+|++|++||||||+||+++.++.+||+|||+++...
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECCCCCEEEEECCCHHHHC
T ss_conf 87300123123411799998730454378888889999999988514998965477320124699988874132022203
Q ss_pred CCC-EEEECCCCCCCCCCHHHHCCC--CCCCCCCCCCHHHHHHHHHHCCCCCCCCC----HHHHHHHHHCCCCCCCCCCC
Q ss_conf 774-012023588876881212038--99877753204667999883899999983----99999998429999999999
Q 000706 154 ANT-VVLRSIKGTPLYMAPELVREQ--PYNHTADLWSLGVILYELFVGQPPFYTNS----VYALIRHIVKDPVKYPDEMS 226 (1342)
Q Consensus 154 sss-~~~ssivGTp~YlAPEIL~g~--~YT~kSDIWSLGVILYELLTGklPF~gss----~~elikkIvk~plelP~eIS 226 (1342)
... .......|++.|++||.+.+. .++.++||||+||++|+|++|+.||.+.+ .....+........+|..++
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred CCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 44443221222333331068760577688713251777799999976899988887777999999833568998865479
Q ss_pred HHHHHHHHHHCCCCCCCCC-----CHHHHHCCCCCCCCHH
Q ss_conf 8899999981101999999-----9989972957634314
Q 000706 227 PNFKSFLKGLLNKVPQNRL-----TWSALLEHPFVKETSD 261 (1342)
Q Consensus 227 peLkdLIkkMLskDPeKRP-----TaeELLkHPfFke~~e 261 (1342)
+++.+|+.+||++||.+|| |++|+++||||++...
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred HHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCCCH
T ss_conf 9999999997445898819997450999974972348998
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.40 Aligned_cols=253 Identities=22% Similarity=0.421 Sum_probs=217.9
Q ss_pred CCCCEEEEEE-ECCCCCEEEEEEEECC--CCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
Q ss_conf 8878899999-7325937999999956--995999999615799978999999999999935999811588888708959
Q 000706 2 GVENYHVIEL-VGEGSFGKVYKGRRKY--TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEF 78 (1342)
Q Consensus 2 dIDrYkILK~-LGsGaFGtVYKArdk~--TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~i 78 (1342)
.-++|.+.+. ||+|+||.||+|.++. ++..||||.+++. ......+.+.+|++++++++|||||++++++++ +.+
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred CCCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEE
T ss_conf 444718878487306080999999960897689999998820-397899999999999986799888068656036-807
Q ss_pred EEEEECCC-CCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 99994369-884889860-9999999999999999999998660992503889983797589708995336321245774
Q 000706 79 CVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 79 yIVMEYve-GSLlDlLek-~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss 156 (1342)
|+||||++ |+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEECCCHHHHCCCCCC
T ss_conf 99998078996899752125699999999999999998789986881057676466045468854203313421155434
Q ss_pred EE---EECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCC-CCCCCCCCCHHHHH
Q ss_conf 01---202358887688121203899877753204667999883-89999998399999998429-99999999988999
Q 000706 157 VV---LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKS 231 (1342)
Q Consensus 157 ~~---~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLT-GklPF~gss~~elikkIvk~-plelP~eISpeLkd 231 (1342)
.. .....||+.|+|||++.+..|+.++||||||+++|||++ |+.||.+.+..+....+..+ +++.|+.+++++.+
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 243 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
T ss_conf 32113562113743358688727999954123220178999993899999997999999999818999999767899999
Q ss_pred HHHHHCCCCCCCCCCHHHHH---CCCCC
Q ss_conf 99981101999999998997---29576
Q 000706 232 FLKGLLNKVPQNRLTWSALL---EHPFV 256 (1342)
Q Consensus 232 LIkkMLskDPeKRPTaeELL---kHPfF 256 (1342)
|+.+||+.||++|||+.+++ +|+|+
T Consensus 244 li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 244 LMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 9999757797689099999999999999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.08 Aligned_cols=252 Identities=29% Similarity=0.483 Sum_probs=216.9
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC------CE
Q ss_conf 788999997325937999999956995999999615799978999999999999935999811588888708------95
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP------QE 77 (1342)
Q Consensus 4 DrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfede------d~ 77 (1342)
++|++++.||+|+||+||+|+++.+++.||+|++.+........+++.+|++++++++|||++++++++... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCE
T ss_conf 87188889831788399999999999799999988200286899999999999986689874259999963464566864
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCE
Q ss_conf 99999436988488986099999999999999999999986609925038899837975897089953363212457740
Q 000706 78 FCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 78 iyIVMEYveGSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~ 157 (1342)
.++++++.+|+|.+++.. +++++..++.++.|++.||.|||++||+||||||+|||++.++.+|++|||.+......
T Consensus 98 ~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-- 174 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 174 (348)
T ss_dssp CEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG--
T ss_pred EEEEEEECCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCC--
T ss_conf 999996258862320022-45309999999999999999997388765166776334554322001321000125754--
Q ss_pred EEECCCCCCCCCCHHHHCCCC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCC----------------
Q ss_conf 120235888768812120389-987775320466799988389999998399999998429999----------------
Q 000706 158 VLRSIKGTPLYMAPELVREQP-YNHTADLWSLGVILYELFVGQPPFYTNSVYALIRHIVKDPVK---------------- 220 (1342)
Q Consensus 158 ~~ssivGTp~YlAPEIL~g~~-YT~kSDIWSLGVILYELLTGklPF~gss~~elikkIvk~ple---------------- 220 (1342)
.....|++.|+|||+..+.. ++.++||||+|+++|+|++|+.||.+.+.......+......
T Consensus 175 -~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (348)
T d2gfsa1 175 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253 (348)
T ss_dssp -GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHH
T ss_pred -CCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHCCCHHHHH
T ss_conf -4443454355583553377567855124320589999976889978898899999999730799757732001024454
Q ss_pred -------C--------CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf -------9--------99999889999998110199999999899729576343
Q 000706 221 -------Y--------PDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKET 259 (1342)
Q Consensus 221 -------l--------P~eISpeLkdLIkkMLskDPeKRPTaeELLkHPfFke~ 259 (1342)
. ....++++++||++||+.||.+|||+.|+|+||||++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 443035578755566267899999999999775883459389998559954879
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=365.31 Aligned_cols=251 Identities=25% Similarity=0.464 Sum_probs=207.7
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEE--CCEE
Q ss_conf 88788999997325937999999956995999999615799978999999999999935-99981158888870--8959
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFES--PQEF 78 (1342)
Q Consensus 2 dIDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkL-sHPNIVKLidvfed--ed~i 78 (1342)
+.++|++++.||+|+||+||+|+++.+++.||+|++++.. .+++.+|+++|+.+ +||||+++++++.. ...+
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCE
T ss_conf 9867189789831748199999988999799999988899-----99999999999851579987679999981687712
Q ss_pred EEEEECCC-CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCC-CEEEEECCCCCCCCCCC
Q ss_conf 99994369-88488986099999999999999999999986609925038899837975897-08995336321245774
Q 000706 79 CVVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGS-VVKLCDFGFARAMSANT 156 (1342)
Q Consensus 79 yIVMEYve-GSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG-~IKLiDFGLAk~l~sss 156 (1342)
++||||++ |+|.+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 108 ~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 108 ALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred EEEEEECCCCCHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCEECCCCC
T ss_conf 688863179858997---46899999999999999999887643344345644123774899836641565426646887
Q ss_pred EEEECCCCCCCCCCHHHHCCCC-CCCCCCCCCHHHHHHHHHHCCCCCCCCC-HHHHHHHHHC-------------C----
Q ss_conf 0120235888768812120389-9877753204667999883899999983-9999999842-------------9----
Q 000706 157 VVLRSIKGTPLYMAPELVREQP-YNHTADLWSLGVILYELFVGQPPFYTNS-VYALIRHIVK-------------D---- 217 (1342)
Q Consensus 157 ~~~ssivGTp~YlAPEIL~g~~-YT~kSDIWSLGVILYELLTGklPF~gss-~~elikkIvk-------------~---- 217 (1342)
......+|+.|+|||.+.+.. |+.++||||+|+++|+|++|+.||.... ..+....+.. .
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 185 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCCCCC
T ss_conf -4443224864247610268888884523233545558760488999887601899999999878841555554225444
Q ss_pred --------------------CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCHH
Q ss_conf --------------------99999999988999999811019999999989972957634314
Q 000706 218 --------------------PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEHPFVKETSD 261 (1342)
Q Consensus 218 --------------------plelP~eISpeLkdLIkkMLskDPeKRPTaeELLkHPfFke~~e 261 (1342)
.......+++++.+||++||+.||++|||++|+|+||||++..+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred CCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCC
T ss_conf 7430000033343311211552112448999999999986699568908999964935588797
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.01 Aligned_cols=252 Identities=23% Similarity=0.440 Sum_probs=217.1
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 98878899999732593799999995699599999961579997899999999999993599981158888870895999
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 1 mdIDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~iyI 80 (1342)
+.-++|++.+.||+|+||.||+|+++ ++..||||.+.+.... .+.+.+|+.++++++||||+++++++.+ +..|+
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CCHHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEE
T ss_conf 38899388679810798289999999-9999999998647688---8999999999986799988578731045-97699
Q ss_pred EEECCC-CCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCE
Q ss_conf 994369-8848898609--9999999999999999999986609925038899837975897089953363212457740
Q 000706 81 VTEFAQ-GELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 81 VMEYve-GSLlDlLek~--k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~ 157 (1342)
||||++ |+|.+++... .++++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCC
T ss_conf 99957898288887514789887889999999999999999748954675642251562024404234101477358864
Q ss_pred E-EECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHC-CCCCCCCCHHHHHHHHHCC-CCCCCCCCCHHHHHHHH
Q ss_conf 1-2023588876881212038998777532046679998838-9999998399999998429-99999999988999999
Q 000706 158 V-LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVG-QPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLK 234 (1342)
Q Consensus 158 ~-~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTG-klPF~gss~~elikkIvk~-plelP~eISpeLkdLIk 234 (1342)
. .....|++.|+|||++.+..|+.++||||||+++|||++| .+||...+..+....+..+ +...|..+++++.+|+.
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 244 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
T ss_conf 42035677444458289837999824564525799999996898888888999999999706888896557199999999
Q ss_pred HHCCCCCCCCCCHHHHHC--CCCCC
Q ss_conf 811019999999989972--95763
Q 000706 235 GLLNKVPQNRLTWSALLE--HPFVK 257 (1342)
Q Consensus 235 kMLskDPeKRPTaeELLk--HPfFk 257 (1342)
+||+.||++|||+.++++ |+||.
T Consensus 245 ~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 245 LCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 9758897689399999998611321
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.26 Aligned_cols=249 Identities=22% Similarity=0.453 Sum_probs=223.6
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 98878899999732593799999995699599999961579997899999999999993599981158888870895999
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 1 mdIDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~iyI 80 (1342)
||-++|++++.||+|+||.||+|+++ ++..||+|.+++..... +.+.+|+.++.+++||||+++++++.+++.+++
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCH---HHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEE
T ss_conf 99699799689820788399999988-99899999987475778---999999999996689860158899850781699
Q ss_pred EEECCC-CCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCEE
Q ss_conf 994369-884889860-999999999999999999999866099250388998379758970899533632124577401
Q 000706 81 VTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV 158 (1342)
Q Consensus 81 VMEYve-GSLlDlLek-~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~~ 158 (1342)
||||++ |+|.+++.. ...+++..++.++.|+++||.|||++||+||||||+||+++.++.+||+|||+++........
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EEECCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCE
T ss_conf 99704899388864102467768999999999999999875468434665413588769984798861442023578722
Q ss_pred -EECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCC-CCCCCCCCCHHHHHHHHH
Q ss_conf -202358887688121203899877753204667999883-89999998399999998429-999999999889999998
Q 000706 159 -LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLKG 235 (1342)
Q Consensus 159 -~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLT-GklPF~gss~~elikkIvk~-plelP~eISpeLkdLIkk 235 (1342)
.....||+.|+|||++.+..|+.++||||||+++|||++ |+.||.+.+..+....+..+ +...|...++++.+|+.+
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred EECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
T ss_conf 52465788775780786379988521033643246739755999988999999999998079789965465999999999
Q ss_pred HCCCCCCCCCCHHHHHCC
Q ss_conf 110199999999899729
Q 000706 236 LLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 236 MLskDPeKRPTaeELLkH 253 (1342)
||+.||++|||++++++|
T Consensus 237 cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HCCCCHHHCCCHHHHHHH
T ss_conf 766897689399999987
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.34 Aligned_cols=249 Identities=28% Similarity=0.509 Sum_probs=212.3
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 98878899999732593799999995699599999961579997899999999999993599981158888870895999
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 1 mdIDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~iyI 80 (1342)
++-++|++.+.||+|+||.||+|+.+ ..||||+++.........+.+.+|+.++++++||||++++++.. ++.+++
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l 80 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI 80 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred CCCCCEEEEEEEEECCCCEEEEEEEC---CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf 15451899889830788589999999---98999999734699899999999999998479987864567971-558999
Q ss_pred EEECCC-CCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC--
Q ss_conf 994369-884889860-9999999999999999999998660992503889983797589708995336321245774--
Q 000706 81 VTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT-- 156 (1342)
Q Consensus 81 VMEYve-GSLlDlLek-~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss-- 156 (1342)
||||++ |+|.+++.. ..++++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECCCCCEEECCCCCEEECCCCCCC
T ss_conf 99658998889998523578999999999999999988875099951614789979818997887500221333556776
Q ss_pred EEEECCCCCCCCCCHHHHCC---CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHH-HHHHCCC-----CCCCCCCCH
Q ss_conf 01202358887688121203---89987775320466799988389999998399999-9984299-----999999998
Q 000706 157 VVLRSIKGTPLYMAPELVRE---QPYNHTADLWSLGVILYELFVGQPPFYTNSVYALI-RHIVKDP-----VKYPDEMSP 227 (1342)
Q Consensus 157 ~~~ssivGTp~YlAPEIL~g---~~YT~kSDIWSLGVILYELLTGklPF~gss~~eli-kkIvk~p-----lelP~eISp 227 (1342)
.......||+.|+|||++.+ .+|+.++||||||+++|||++|+.||.+.+..... ..+.... ...+..+++
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 240 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCH
T ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCHHCCCCCHH
T ss_conf 31256655743179999950568999953151635999999997889989989699999999658889860003655549
Q ss_pred HHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 89999998110199999999899729
Q 000706 228 NFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 228 eLkdLIkkMLskDPeKRPTaeELLkH 253 (1342)
++.+|+.+||+.||.+|||+.+++++
T Consensus 241 ~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 241 AMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 99999999758897689299999999
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.57 Aligned_cols=251 Identities=22% Similarity=0.418 Sum_probs=216.1
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 98878899999732593799999995699----59999996157999789999999999999359998115888887089
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTG----QTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ 76 (1342)
Q Consensus 1 mdIDrYkILK~LGsGaFGtVYKArdk~TG----k~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded 76 (1342)
|+.+.|++.+.||+|+||.||+|..+.++ ..||||.+... ........+.+|++++++++|||||++++++.+++
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
T ss_conf 78899686159811779099999996899878799999998844-59689999999999998568987832367783388
Q ss_pred EEEEEEECCC-CCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 5999994369-884889860-99999999999999999999986609925038899837975897089953363212457
Q 000706 77 EFCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA 154 (1342)
Q Consensus 77 ~iyIVMEYve-GSLlDlLek-~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~s 154 (1342)
..+++|||+. |++.+.+.. .+.+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CEEEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCEEEECCCCHHHCCCC
T ss_conf 03899972135740222102345420899999999999854121212342576564427888998499845510300357
Q ss_pred CCE---EEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHC-CCCCCCCCHHHHHHHHHCC-CCCCCCCCCHHH
Q ss_conf 740---12023588876881212038998777532046679998838-9999998399999998429-999999999889
Q 000706 155 NTV---VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVG-QPPFYTNSVYALIRHIVKD-PVKYPDEMSPNF 229 (1342)
Q Consensus 155 ss~---~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTG-klPF~gss~~elikkIvk~-plelP~eISpeL 229 (1342)
... ......||+.|+|||++.+..|+.++||||||+++|||+++ .+||...+..+..+.+..+ .++.|..+++++
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 242 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 242 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred CCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCHHHHHHH
T ss_conf 87652674267777343488887049999735563448989999967988655689999999986357899850457999
Q ss_pred HHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 99999811019999999989972
Q 000706 230 KSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 230 kdLIkkMLskDPeKRPTaeELLk 252 (1342)
.+++.+||+.||++|||+.|+++
T Consensus 243 ~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 243 YQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 99999977679768939999999
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.47 Aligned_cols=250 Identities=22% Similarity=0.385 Sum_probs=213.7
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCC----EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
Q ss_conf 8788999997325937999999956995----999999615799978999999999999935999811588888708959
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQ----TVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEF 78 (1342)
Q Consensus 3 IDrYkILK~LGsGaFGtVYKArdk~TGk----~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~i 78 (1342)
-++|++++.||+|+||.||+|.+..+++ +||+|.+.+. ......+.+.+|+.++++++|||||++++++.+++.
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~- 85 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV- 85 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSE-
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCE-
T ss_conf 899978319820899299999995899889899999996513-497999999999999986799888158999961983-
Q ss_pred EEEEECC-CCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 9999436-9884889860-9999999999999999999998660992503889983797589708995336321245774
Q 000706 79 CVVTEFA-QGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 79 yIVMEYv-eGSLlDlLek-~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss 156 (1342)
+++||++ .|+|.+.+.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECCCCCEEEECCCCCEECCCCC
T ss_conf 69998426874010111334579999999999999999999987695047621203116799875860255222335444
Q ss_pred EE--EECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCC-CCCCCCCCCHHHHHH
Q ss_conf 01--202358887688121203899877753204667999883-89999998399999998429-999999999889999
Q 000706 157 VV--LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSF 232 (1342)
Q Consensus 157 ~~--~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLT-GklPF~gss~~elikkIvk~-plelP~eISpeLkdL 232 (1342)
.. .....||+.|+|||++.+..|+.++||||||+++|||++ |.+||.+.+..+....+..+ .++.|+.+++++.+|
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~l 245 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 245 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHH
T ss_pred CCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
T ss_conf 53223651058644670887469998356544079999999977999999999899999997599899985568999999
Q ss_pred HHHHCCCCCCCCCCHHHHHCCC
Q ss_conf 9981101999999998997295
Q 000706 233 LKGLLNKVPQNRLTWSALLEHP 254 (1342)
Q Consensus 233 IkkMLskDPeKRPTaeELLkHP 254 (1342)
+.+||+.||.+|||+.|+++|.
T Consensus 246 i~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 246 MVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHCCCCHHHCCCHHHHHHHH
T ss_conf 9984789934691999999999
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.84 Aligned_cols=253 Identities=25% Similarity=0.450 Sum_probs=217.2
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 98878899999732593799999995699599999961579997899999999999993599981158888870895999
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEFCV 80 (1342)
Q Consensus 1 mdIDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~iyI 80 (1342)
++.++|++.+.||+|+||.||+|+++.+ +.||+|++....... +.+.+|+.++++++|||||++++++.+ +..|+
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~l 88 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 88 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEECCC-CEEEEEEECCCCCCH---HHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEE
T ss_conf 4779979846993079809999999999-999999988044888---999999999986666788689999823-97599
Q ss_pred EEECCC-CCHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCE
Q ss_conf 994369-884889860--99999999999999999999986609925038899837975897089953363212457740
Q 000706 81 VTEFAQ-GELFEILED--DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTV 157 (1342)
Q Consensus 81 VMEYve-GSLlDlLek--~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~ 157 (1342)
||||++ |+|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++.......
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCC
T ss_conf 99944799435420000355305999999999999999987541143353123079998999299844255542568873
Q ss_pred E-EECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHC-CCCCCCCCHHHHHHHHHCC-CCCCCCCCCHHHHHHHH
Q ss_conf 1-2023588876881212038998777532046679998838-9999998399999998429-99999999988999999
Q 000706 158 V-LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVG-QPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLK 234 (1342)
Q Consensus 158 ~-~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTG-klPF~gss~~elikkIvk~-plelP~eISpeLkdLIk 234 (1342)
. .....|++.|+|||.+.+..++.++||||||+++|||++| ++||......+....+... ..+.+..+++++++++.
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 248 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 248 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
T ss_conf 35245455665458089837998917741323589999986899999888899999999826899998323799999999
Q ss_pred HHCCCCCCCCCCHHHHHC--CCCCCC
Q ss_conf 811019999999989972--957634
Q 000706 235 GLLNKVPQNRLTWSALLE--HPFVKE 258 (1342)
Q Consensus 235 kMLskDPeKRPTaeELLk--HPfFke 258 (1342)
+||+.||++||+++++++ ++||..
T Consensus 249 ~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 249 QCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 97566975891999999987666238
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.71 Aligned_cols=251 Identities=27% Similarity=0.425 Sum_probs=218.4
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCC---CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCE
Q ss_conf 98878899999732593799999995699---599999961579997899999999999993599981158888870895
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTG---QTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQE 77 (1342)
Q Consensus 1 mdIDrYkILK~LGsGaFGtVYKArdk~TG---k~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~ 77 (1342)
++-++|++++.||+|+||.||+|++..++ ..||+|.+... ......+.+.+|+.++++++||||+++++++. ++.
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred CCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCE
T ss_conf 6889969877993078829999999369964499999993656-68799999999999998689999856988995-374
Q ss_pred EEEEEECCC-CCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 999994369-884889860-999999999999999999999866099250388998379758970899533632124577
Q 000706 78 FCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSAN 155 (1342)
Q Consensus 78 iyIVMEYve-GSLlDlLek-~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~ss 155 (1342)
.|+||||++ |++.+++.. .+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECCCCCEEECCCHHHEECCCC
T ss_conf 79999840698077654224789999999999999987752302267441410265532067896787650342133677
Q ss_pred CE-EEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCC-CCCCCCCCCHHHHHH
Q ss_conf 40-1202358887688121203899877753204667999883-89999998399999998429-999999999889999
Q 000706 156 TV-VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSF 232 (1342)
Q Consensus 156 s~-~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLT-GklPF~gss~~elikkIvk~-plelP~eISpeLkdL 232 (1342)
.. ......||+.|+|||++.+..|+.++||||||+++|||++ |.+||.+.+..+....+..+ ..+.|+.+|+++.+|
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 241 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 241 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred CCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
T ss_conf 62330540058310326675169988745244424789999826999988899999999998189998987779999999
Q ss_pred HHHHCCCCCCCCCCHHHHHCC
Q ss_conf 998110199999999899729
Q 000706 233 LKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 233 IkkMLskDPeKRPTaeELLkH 253 (1342)
|.+||+.||.+|||+.|+++|
T Consensus 242 i~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 242 MTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHCCCCHHHCCCHHHHHHH
T ss_conf 999768797689299999999
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.18 Aligned_cols=251 Identities=27% Similarity=0.478 Sum_probs=220.8
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCE--EEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEECCE
Q ss_conf 9887889999973259379999999569959--99999615799978999999999999935-99981158888870895
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQT--VAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESPQE 77 (1342)
Q Consensus 1 mdIDrYkILK~LGsGaFGtVYKArdk~TGk~--VAIKvIkKs~~seseikrL~rEIkILkkL-sHPNIVKLidvfeded~ 77 (1342)
++.++|++.+.||+|+||.||+|+++.++.. ||+|.+.+.. .....+.+.+|++++.++ +||||+++++++.+++.
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred CCHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCE
T ss_conf 6879968877982078828999999899969999999978233-857999999999999862289988367888841873
Q ss_pred EEEEEECCC-CCHHHHHHCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCC
Q ss_conf 999994369-8848898609----------------99999999999999999999866099250388998379758970
Q 000706 78 FCVVTEFAQ-GELFEILEDD----------------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSV 140 (1342)
Q Consensus 78 iyIVMEYve-GSLlDlLek~----------------k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~ 140 (1342)
.|+||||++ |+|.+++.+. ..+++..+..++.|++.||.|+|+++++||||||+|||++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCC
T ss_conf 69999802898699998640355555123101234578999999999999999987663089545550520489868876
Q ss_pred EEEEECCCCCCCCCCCEEEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCC-C
Q ss_conf 89953363212457740120235888768812120389987775320466799988389-999998399999998429-9
Q 000706 141 VKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQ-PPFYTNSVYALIRHIVKD-P 218 (1342)
Q Consensus 141 IKLiDFGLAk~l~sss~~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGk-lPF~gss~~elikkIvk~-p 218 (1342)
+||+|||+++...... ......||+.|+|||.+.+..|+.++||||||+++|||++|. +||.+.+..+..+.+..+ .
T Consensus 166 ~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~ 244 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244 (309)
T ss_dssp EEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred EEECCCCCCCCCCCCC-CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 3874344322444223-455301377555538752699996221531388999998368999999999999999982688
Q ss_pred CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 99999999889999998110199999999899729
Q 000706 219 VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 219 lelP~eISpeLkdLIkkMLskDPeKRPTaeELLkH 253 (1342)
++.|..+++++.+||.+||+.||++|||+.++++|
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 88876678999999999767896689499999999
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=355.09 Aligned_cols=248 Identities=24% Similarity=0.467 Sum_probs=218.5
Q ss_pred CCEEEEEEECCCCCEEEEEEEEC-----CCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
Q ss_conf 78899999732593799999995-----6995999999615799978999999999999935999811588888708959
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRK-----YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQEF 78 (1342)
Q Consensus 4 DrYkILK~LGsGaFGtVYKArdk-----~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded~i 78 (1342)
++|++.+.||+|+||.||+|+.+ .+++.||||++.+. ......+++.+|+.++++++||||+++++++.+.+..
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHH-CCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCCCE
T ss_conf 893886798207883999999888765778829999998821-0857999999999999966899765524666059803
Q ss_pred EEEEECCC-CCHHHHHHCC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCE
Q ss_conf 99994369-8848898609------------------------9999999999999999999986609925038899837
Q 000706 79 CVVTEFAQ-GELFEILEDD------------------------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNI 133 (1342)
Q Consensus 79 yIVMEYve-GSLlDlLek~------------------------k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENI 133 (1342)
+++|||++ |+|.+++... ..+++..+..++.|++.||+|||+++++||||||+||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI 171 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 171 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCE
T ss_conf 89998158992999998527554210000111001210346788989999999999999985541357868548840116
Q ss_pred EECCCCCEEEEECCCCCCCCCCC--EEEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCC-CCCCCCCHHHH
Q ss_conf 97589708995336321245774--0120235888768812120389987775320466799988389-99999839999
Q 000706 134 LIGAGSVVKLCDFGFARAMSANT--VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQ-PPFYTNSVYAL 210 (1342)
Q Consensus 134 LIdsdG~IKLiDFGLAk~l~sss--~~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGk-lPF~gss~~el 210 (1342)
|++.++.+||+|||+++...... .......|++.|+|||.+.+..|+.++||||||+++|||++|. +||.+.+..+.
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~ 251 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred EECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCCCHHHH
T ss_conf 89899928983314421136776411157777676767989972688980563025236299998068999999899999
Q ss_pred HHHHHCCC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 99984299-9999999988999999811019999999989972
Q 000706 211 IRHIVKDP-VKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 211 ikkIvk~p-lelP~eISpeLkdLIkkMLskDPeKRPTaeELLk 252 (1342)
...+..+. +..|..+++++.+|+.+||+.||.+|||+.|+++
T Consensus 252 ~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 252 IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9999739978887325299999999974889657939999999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.11 Aligned_cols=251 Identities=29% Similarity=0.531 Sum_probs=220.2
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCC-------CEEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEE
Q ss_conf 98878899999732593799999995699-------5999999615799978999999999999935-999811588888
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTG-------QTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSF 72 (1342)
Q Consensus 1 mdIDrYkILK~LGsGaFGtVYKArdk~TG-------k~VAIKvIkKs~~seseikrL~rEIkILkkL-sHPNIVKLidvf 72 (1342)
++.++|++++.||+|+||.||+|++..++ ..||+|.+++.. .......+.+|...+.++ +||||+++++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCEEEECCCCC
T ss_conf 258996970098516782899999857875556675499999988112-8688999999999999813999697346522
Q ss_pred EECCEEEEEEECCC-CCHHHHHHCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEE
Q ss_conf 70895999994369-8848898609----------------999999999999999999998660992503889983797
Q 000706 73 ESPQEFCVVTEFAQ-GELFEILEDD----------------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILI 135 (1342)
Q Consensus 73 eded~iyIVMEYve-GSLlDlLek~----------------k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILI 135 (1342)
.+++.+|+||||++ |+|.+++... ..+++..++.++.|++.||+|||+++++||||||+|||+
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCEEE
T ss_conf 01886899997369990999998606776432223345743467999999999999999987663797863022102245
Q ss_pred CCCCCEEEEECCCCCCCCCCCE--EEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCHHHHHH
Q ss_conf 5897089953363212457740--1202358887688121203899877753204667999883-899999983999999
Q 000706 136 GAGSVVKLCDFGFARAMSANTV--VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIR 212 (1342)
Q Consensus 136 dsdG~IKLiDFGLAk~l~sss~--~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLT-GklPF~gss~~elik 212 (1342)
+.++.+||+|||+++....... ......|++.|+|||.+.+..|+.++||||||+++|||++ |.+||.+.+..+..+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHH
T ss_conf 47897676221110113555554314667888466326675179888255547758888874017989899999999999
Q ss_pred HHHCC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 98429-99999999988999999811019999999989972
Q 000706 213 HIVKD-PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 213 kIvk~-plelP~eISpeLkdLIkkMLskDPeKRPTaeELLk 252 (1342)
.+..+ .+..|..+++++.+||.+||+.||++|||+.|+++
T Consensus 249 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 99728888987435299999999976679767939999999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.37 Aligned_cols=251 Identities=27% Similarity=0.506 Sum_probs=217.2
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCC-C--CEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 9887889999973259379999999569-9--59999996157999-789999999999999359998115888887089
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYT-G--QTVAMKFIMKHGKS-EKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ 76 (1342)
Q Consensus 1 mdIDrYkILK~LGsGaFGtVYKArdk~T-G--k~VAIKvIkKs~~s-eseikrL~rEIkILkkLsHPNIVKLidvfeded 76 (1342)
|+-++|++.+.||+|+||.||+|+...+ + ..||+|.+.+.... ....+.+.+|+.++++++||||+++++++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ECHHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-C
T ss_conf 864891997898038883999999988999079999999983555798999999999999986899998789877740-1
Q ss_pred EEEEEEECCC-CCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 5999994369-884889860-99999999999999999999986609925038899837975897089953363212457
Q 000706 77 EFCVVTEFAQ-GELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSA 154 (1342)
Q Consensus 77 ~iyIVMEYve-GSLlDlLek-~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~s 154 (1342)
..++||||++ |++.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred CHHEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCCCCCEEECCCHHHHHCCC
T ss_conf 00114654238612544421268999999999999999999875217875205668881565565433256115553035
Q ss_pred CCE---EEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCC--CCCCCCCCHH
Q ss_conf 740---1202358887688121203899877753204667999883-899999983999999984299--9999999988
Q 000706 155 NTV---VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKDP--VKYPDEMSPN 228 (1342)
Q Consensus 155 ss~---~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLT-GklPF~gss~~elikkIvk~p--lelP~eISpe 228 (1342)
... ......|+..|+|||++.+..++.++||||||+++|||++ |+.||.+.+..+....+.+.. ++.+..+|++
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred CCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHH
T ss_conf 88752654763257310799998379999421566148999999968999999969999999998479999985445399
Q ss_pred HHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 999999811019999999989972
Q 000706 229 FKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 229 LkdLIkkMLskDPeKRPTaeELLk 252 (1342)
+.+++.+||..||++|||+.++++
T Consensus 244 l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 244 IYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 999999976889667929999999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.88 Aligned_cols=251 Identities=28% Similarity=0.505 Sum_probs=209.2
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECC-----CCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEEC
Q ss_conf 88788999997325937999999956-----995999999615799978999999999999935-999811588888708
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKY-----TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFESP 75 (1342)
Q Consensus 2 dIDrYkILK~LGsGaFGtVYKArdk~-----TGk~VAIKvIkKs~~seseikrL~rEIkILkkL-sHPNIVKLidvfede 75 (1342)
.-++|++++.||+|+||.||+|.+.. +++.||+|.+++.. .....+.+.+|...+.++ +|+||+.+++++.++
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCC
T ss_conf 679979844984167839999998677755578399999986001-7178999999999988614998499741154047
Q ss_pred -CEEEEEEECCC-CCHHHHHHCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECC
Q ss_conf -95999994369-8848898609----------------99999999999999999999866099250388998379758
Q 000706 76 -QEFCVVTEFAQ-GELFEILEDD----------------KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA 137 (1342)
Q Consensus 76 -d~iyIVMEYve-GSLlDlLek~----------------k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIds 137 (1342)
..++++|||++ |+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC
T ss_conf 97579999845899299999853666665322202332146899999999999999999887379717867731065779
Q ss_pred CCCEEEEECCCCCCCCCCCE--EEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHC-CCCCCCCCHHH-HHHH
Q ss_conf 97089953363212457740--12023588876881212038998777532046679998838-99999983999-9999
Q 000706 138 GSVVKLCDFGFARAMSANTV--VLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVG-QPPFYTNSVYA-LIRH 213 (1342)
Q Consensus 138 dG~IKLiDFGLAk~l~sss~--~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTG-klPF~gss~~e-likk 213 (1342)
++.+||+|||+|+....... ......||+.|+|||++.+..|+.++||||+|+++|||+++ .+||.+....+ ....
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf 98289845752001135665222475166721020368646889966322136789999986889999899989999999
Q ss_pred HHCC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 8429-999999999889999998110199999999899729
Q 000706 214 IVKD-PVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 214 Ivk~-plelP~eISpeLkdLIkkMLskDPeKRPTaeELLkH 253 (1342)
+..+ .+..|+.+++++.+++.+||+.||++|||+.|+++|
T Consensus 250 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 96389888886578999999999767796679199999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.68 Aligned_cols=244 Identities=25% Similarity=0.518 Sum_probs=216.3
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE-ECCEEE
Q ss_conf 9887889999973259379999999569959999996157999789999999999999359998115888887-089599
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFE-SPQEFC 79 (1342)
Q Consensus 1 mdIDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfe-ded~iy 79 (1342)
+++++|++.+.||+|+||.||+|+.+ ++.||+|.++++. ..+.+.+|++++++++||||+++++++. +++.+|
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CCHHHEEEEEEEECCCCEEEEEEEEC--CEEEEEEEECCHH----HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEE
T ss_conf 57899488579820798089999999--9099999988577----79999999999986789898549878872389289
Q ss_pred EEEECCC-CCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 9994369-8848898609--999999999999999999998660992503889983797589708995336321245774
Q 000706 80 VVTEFAQ-GELFEILEDD--KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 80 IVMEYve-GSLlDlLek~--k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss 156 (1342)
+||||++ |+|.+++.+. ..+++..+..++.|++.||.|||+++++||||||+|||++.++.+|++|||+++......
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECCCCCEEECCCCCCEECCCCC
T ss_conf 99963699989999874578888999999999999852321133765536665676014689977632456003447877
Q ss_pred EEEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCC-CCCCCCCCCHHHHHHHH
Q ss_conf 01202358887688121203899877753204667999883-89999998399999998429-99999999988999999
Q 000706 157 VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIRHIVKD-PVKYPDEMSPNFKSFLK 234 (1342)
Q Consensus 157 ~~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLT-GklPF~gss~~elikkIvk~-plelP~eISpeLkdLIk 234 (1342)
....+++.|+|||.+.+..++.++||||||+++|||++ |++||...+..+....+..+ .++++..+++++.+|+.
T Consensus 158 ---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 234 (262)
T d1byga_ 158 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred ---CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
T ss_conf ---65566646778178727988858877757999999997899999999999999999808999997657999999999
Q ss_pred HHCCCCCCCCCCHHHHHCC
Q ss_conf 8110199999999899729
Q 000706 235 GLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 235 kMLskDPeKRPTaeELLkH 253 (1342)
+||..||.+|||+.+++++
T Consensus 235 ~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 235 NCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHCCCCHHHCCCHHHHHHH
T ss_conf 9756697689399999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.84 Aligned_cols=252 Identities=21% Similarity=0.384 Sum_probs=219.9
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECC-----CCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC
Q ss_conf 988788999997325937999999956-----995999999615799978999999999999935999811588888708
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRKY-----TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESP 75 (1342)
Q Consensus 1 mdIDrYkILK~LGsGaFGtVYKArdk~-----TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfede 75 (1342)
++-++|++++.||+|+||.||+|.+.. ++..||||++++. ........+.+|+.++++++||||+++++++..+
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred ECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
T ss_conf 268991883598207881899999878644778968999998701-2868999999999999976999884125478428
Q ss_pred CEEEEEEECCC-CCHHHHHHC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEE
Q ss_conf 95999994369-884889860----------9999999999999999999998660992503889983797589708995
Q 000706 76 QEFCVVTEFAQ-GELFEILED----------DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLC 144 (1342)
Q Consensus 76 d~iyIVMEYve-GSLlDlLek----------~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLi 144 (1342)
+..++||||++ |+|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++++||+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCCEEECCCCEEEEE
T ss_conf 81067776048998899987503321134446887999999999999999998764796543286775403599649994
Q ss_pred ECCCCCCCCCCCEE--EECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHC-CCCCCCCCHHHHHHHHHCC-CCC
Q ss_conf 33632124577401--2023588876881212038998777532046679998838-9999998399999998429-999
Q 000706 145 DFGFARAMSANTVV--LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVG-QPPFYTNSVYALIRHIVKD-PVK 220 (1342)
Q Consensus 145 DFGLAk~l~sss~~--~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTG-klPF~gss~~elikkIvk~-ple 220 (1342)
|||+++........ .....|++.|+|||.+.+..++.++||||||+++|||++| ++||.+.+..+....+..+ ...
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~ 255 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred ECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf 24542023577630313402316323788887369988333444378999999968999999989999999998088888
Q ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 999999889999998110199999999899729
Q 000706 221 YPDEMSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 221 lP~eISpeLkdLIkkMLskDPeKRPTaeELLkH 253 (1342)
.|..+++.+.+++.+||+.||++|||+.+++++
T Consensus 256 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 863353999999999757796589399999999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.46 Aligned_cols=251 Identities=27% Similarity=0.490 Sum_probs=214.3
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEEC-----CCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEE
Q ss_conf 98878899999732593799999995-----6995999999615799978999999999999935-99981158888870
Q 000706 1 MGVENYHVIELVGEGSFGKVYKGRRK-----YTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKL-KHQNIIEMLDSFES 74 (1342)
Q Consensus 1 mdIDrYkILK~LGsGaFGtVYKArdk-----~TGk~VAIKvIkKs~~seseikrL~rEIkILkkL-sHPNIVKLidvfed 74 (1342)
++-++|++++.||+|+||.||+|+.. .+++.||+|.+++.. .......+.+|+.+++.+ +||||+++++++.+
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE
T ss_conf 7789969854982068829999998066447788699999987424-877999999999998762699988789989831
Q ss_pred CCEEEEEEECCC-CCHHHHHHCCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEE
Q ss_conf 895999994369-88488986099------------------99999999999999999998660992503889983797
Q 000706 75 PQEFCVVTEFAQ-GELFEILEDDK------------------CLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILI 135 (1342)
Q Consensus 75 ed~iyIVMEYve-GSLlDlLek~k------------------~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILI 135 (1342)
++..|++|||++ |+|.+++.+.. .+++..+..++.|++.||+|||++|++||||||+||++
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCC
T ss_conf 99789999737998799999853566544444533222334588999999999999999998875792666241021000
Q ss_pred CCCCCEEEEECCCCCCCCCCC--EEEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCHHHHHH
Q ss_conf 589708995336321245774--01202358887688121203899877753204667999883-899999983999999
Q 000706 136 GAGSVVKLCDFGFARAMSANT--VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFV-GQPPFYTNSVYALIR 212 (1342)
Q Consensus 136 dsdG~IKLiDFGLAk~l~sss--~~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLT-GklPF~gss~~elik 212 (1342)
+.++.+|++|||.++...... .......||+.|+|||.+.+..++.++||||||+++|||++ |.+||...+..+.+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred CCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf 02575210234010233678861586201359687677886179999740010258999999858998877899899999
Q ss_pred HHHC--CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 9842--999999999988999999811019999999989972
Q 000706 213 HIVK--DPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 213 kIvk--~plelP~eISpeLkdLIkkMLskDPeKRPTaeELLk 252 (1342)
++.. .++..+...++++.+||.+||+.||++|||+.++++
T Consensus 259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 998668988985436599999999975779657929999999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.65 Aligned_cols=246 Identities=22% Similarity=0.402 Sum_probs=207.9
Q ss_pred EEEEEECCCCCEEEEEEEECCCC---CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE-CCEEEEEE
Q ss_conf 99999732593799999995699---599999961579997899999999999993599981158888870-89599999
Q 000706 7 HVIELVGEGSFGKVYKGRRKYTG---QTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFES-PQEFCVVT 82 (1342)
Q Consensus 7 kILK~LGsGaFGtVYKArdk~TG---k~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfed-ed~iyIVM 82 (1342)
++.+.||+|+||+||+|++..++ ..||||.+++. ......+++.+|++++++++||||+++++++.+ ++..++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred CCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 2666981368809999999779987999999998843-697899999999999986789998678678980699438999
Q ss_pred ECCC-CCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCEE--
Q ss_conf 4369-8848898609-99999999999999999999866099250388998379758970899533632124577401--
Q 000706 83 EFAQ-GELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFARAMSANTVV-- 158 (1342)
Q Consensus 83 EYve-GSLlDlLek~-k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLAk~l~sss~~-- 158 (1342)
||++ |+|.+++... ..+++..+..++.|++.||.|+|+.+|+||||||+|||+++++.+||+|||+++........
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCCCC
T ss_conf 87406741442101345404899999999988765200336762577668757677999889910652322556655531
Q ss_pred --EECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC-CHHHHHHHHHCC-CCCCCCCCCHHHHHHHH
Q ss_conf --20235888768812120389987775320466799988389999998-399999998429-99999999988999999
Q 000706 159 --LRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTN-SVYALIRHIVKD-PVKYPDEMSPNFKSFLK 234 (1342)
Q Consensus 159 --~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gs-s~~elikkIvk~-plelP~eISpeLkdLIk 234 (1342)
.....||+.|+|||.+.+..++.++||||||+++|||++|..||... +..+....+..+ .+..|..+++++.+|+.
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~ 268 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 268 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred EECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
T ss_conf 00256555645567688743799974574661999999997899998889999999999808988996447599999999
Q ss_pred HHCCCCCCCCCCHHHHHCC
Q ss_conf 8110199999999899729
Q 000706 235 GLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 235 kMLskDPeKRPTaeELLkH 253 (1342)
+||+.||++||++.|+++|
T Consensus 269 ~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 269 KCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHCCCCHHHCCCHHHHHHH
T ss_conf 9768897689399999999
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=333.46 Aligned_cols=250 Identities=23% Similarity=0.329 Sum_probs=205.5
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCC-CCEEEEEEEECCEEEEEE
Q ss_conf 7889999973259379999999569959999996157999789999999999999359998-115888887089599999
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN-IIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 DrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPN-IVKLidvfeded~iyIVM 82 (1342)
++|++.+.||+|+||.||+|++..+++.||+|++...... ..+..|+++++.++|++ |+.+.+++.+.+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC----HHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEE
T ss_conf 8899968985078809999999889989999997210058----889999999997038996017999995198778999
Q ss_pred ECCCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECC---CCCEEEEECCCCCCCCCCC--
Q ss_conf 4369884889860-999999999999999999999866099250388998379758---9708995336321245774--
Q 000706 83 EFAQGELFEILED-DKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA---GSVVKLCDFGFARAMSANT-- 156 (1342)
Q Consensus 83 EYveGSLlDlLek-~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIds---dG~IKLiDFGLAk~l~sss-- 156 (1342)
||++|++.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+|||++. +..+|++|||+++.+....
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 83 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred EECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCCCCC
T ss_conf 87387133324430688768999999999999999999799442667876606433577761565046751342554455
Q ss_pred -----EEEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHH---HH-----CCCCCCCC
Q ss_conf -----012023588876881212038998777532046679998838999999839999999---84-----29999999
Q 000706 157 -----VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVYALIRH---IV-----KDPVKYPD 223 (1342)
Q Consensus 157 -----~~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gss~~elikk---Iv-----k~plelP~ 223 (1342)
.......||+.|+|||++.+.+|+.++||||||+++|||++|+.||........... .. ......+.
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTT
T ss_pred CCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCHHHHCC
T ss_conf 41000135776787353299999189989832188617789999849876655305779999998523567898357534
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCHHHH---HCCCCCC
Q ss_conf 999889999998110199999999899---7295763
Q 000706 224 EMSPNFKSFLKGLLNKVPQNRLTWSAL---LEHPFVK 257 (1342)
Q Consensus 224 eISpeLkdLIkkMLskDPeKRPTaeEL---LkHPfFk 257 (1342)
.+|+++.+++.+||+.||.+||++.++ ++|+|.+
T Consensus 243 ~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 7889999999998439955791999999999999997
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=327.23 Aligned_cols=245 Identities=21% Similarity=0.309 Sum_probs=206.8
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEECCEEEEEE
Q ss_conf 78899999732593799999995699599999961579997899999999999993599-98115888887089599999
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH-QNIIEMLDSFESPQEFCVVT 82 (1342)
Q Consensus 4 DrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsH-PNIVKLidvfeded~iyIVM 82 (1342)
++|++++.||+|+||.||+|++..+++.||+|++.+.... ..+.+|++.++.+.| +|++.+++++.++...|+||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEE
T ss_conf 8069979984178829999999889979999997502582----999999999999648999877999960188117999
Q ss_pred ECCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECC-----CCCEEEEECCCCCCCCCCC
Q ss_conf 43698848898609-99999999999999999999866099250388998379758-----9708995336321245774
Q 000706 83 EFAQGELFEILEDD-KCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGA-----GSVVKLCDFGFARAMSANT 156 (1342)
Q Consensus 83 EYveGSLlDlLek~-k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIds-----dG~IKLiDFGLAk~l~sss 156 (1342)
||++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++.+....
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 81 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred EECCCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEECCCCC
T ss_conf 96488879999752031106899999999999999999779662667713152347543447956872366057714676
Q ss_pred -------EEEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC---CHHHHHHHHHCC-----CCCC
Q ss_conf -------0120235888768812120389987775320466799988389999998---399999998429-----9999
Q 000706 157 -------VVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTN---SVYALIRHIVKD-----PVKY 221 (1342)
Q Consensus 157 -------~~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gs---s~~elikkIvk~-----plel 221 (1342)
.......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.+. .......++... ....
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred CCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHH
T ss_conf 65411102467627751026798964888886999898319999998698767885302199999999705679995896
Q ss_pred CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 9999988999999811019999999989972
Q 000706 222 PDEMSPNFKSFLKGLLNKVPQNRLTWSALLE 252 (1342)
Q Consensus 222 P~eISpeLkdLIkkMLskDPeKRPTaeELLk 252 (1342)
+..+|+++.+++..|+..+|++||+++.+.+
T Consensus 241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf 5799899999999984399300859999999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=326.85 Aligned_cols=250 Identities=27% Similarity=0.496 Sum_probs=198.7
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-----------CCCCCEEEEEE
Q ss_conf 7889999973259379999999569959999996157999789999999999999359-----------99811588888
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-----------HQNIIEMLDSF 72 (1342)
Q Consensus 4 DrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLs-----------HPNIVKLidvf 72 (1342)
++|++++.||+|+||+||+|+++.+++.||||++++. ....+...+|+++++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC---CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEE
T ss_conf 8579989975077818999999999979999998343---1336899999999998401455555422767647899876
Q ss_pred EE--CCEEEEEEECCC--CCHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEECCCCCCCEEECCCC------
Q ss_conf 70--895999994369--8848898--609999999999999999999998660-9925038899837975897------
Q 000706 73 ES--PQEFCVVTEFAQ--GELFEIL--EDDKCLPEEQVQSIAKQLVRALHYLHS-NRIIHRDMKPQNILIGAGS------ 139 (1342)
Q Consensus 73 ed--ed~iyIVMEYve--GSLlDlL--ek~k~LSEeeIikIl~QILkALaYLHs-kGIVHRDIKPENILIdsdG------ 139 (1342)
.. ....+.+|++.. +...... .....+++..++.++.|++.||.|||+ .||+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred EECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCCCCCC
T ss_conf 31256520234320003542000001223467868999999999999988876405864656770570563057656443
Q ss_pred CEEEEECCCCCCCCCCCEEEECCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHH------HHHHH
Q ss_conf 089953363212457740120235888768812120389987775320466799988389999998399------99999
Q 000706 140 VVKLCDFGFARAMSANTVVLRSIKGTPLYMAPELVREQPYNHTADLWSLGVILYELFVGQPPFYTNSVY------ALIRH 213 (1342)
Q Consensus 140 ~IKLiDFGLAk~l~sss~~~ssivGTp~YlAPEIL~g~~YT~kSDIWSLGVILYELLTGklPF~gss~~------elikk 213 (1342)
.++++|||.+...... ....+|++.|+|||++.+..|+.++|+||+|+++++|++|+.||...... +....
T Consensus 170 ~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred EEEEEECCCCCCCCCC---CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHH
T ss_conf 0567531442123445---4223665210571321466777643201237899999878899898755432102689999
Q ss_pred ---HHC---------------------------------------CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf ---842---------------------------------------99999999998899999981101999999998997
Q 000706 214 ---IVK---------------------------------------DPVKYPDEMSPNFKSFLKGLLNKVPQNRLTWSALL 251 (1342)
Q Consensus 214 ---Ivk---------------------------------------~plelP~eISpeLkdLIkkMLskDPeKRPTaeELL 251 (1342)
+.. ....++...++++.+|+.+||..||.+|||++|+|
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 99983799878862453220001320122024323577644421000156743589999999998779945790899996
Q ss_pred CCCCCCCC
Q ss_conf 29576343
Q 000706 252 EHPFVKET 259 (1342)
Q Consensus 252 kHPfFke~ 259 (1342)
+||||++.
T Consensus 327 ~Hp~f~~~ 334 (362)
T d1q8ya_ 327 NHPWLKDT 334 (362)
T ss_dssp TCGGGTTC
T ss_pred CCCCCCCC
T ss_conf 69340789
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=320.08 Aligned_cols=244 Identities=23% Similarity=0.355 Sum_probs=192.1
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC----EEE
Q ss_conf 7889999973259379999999569959999996157999789999999999999359998115888887089----599
Q 000706 4 ENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNIIEMLDSFESPQ----EFC 79 (1342)
Q Consensus 4 DrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNIVKLidvfeded----~iy 79 (1342)
.+|.+.+.||+|+||.||+|+. +++.||+|.+.... ........|+..+.+++||||+++++++.+++ .+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE--CCEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEE
T ss_conf 6899988982078819999999--99899999987200---467999999999962799868326889983798604899
Q ss_pred EEEECCC-CCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 9994369-8848898609999999999999999999998660--------992503889983797589708995336321
Q 000706 80 VVTEFAQ-GELFEILEDDKCLPEEQVQSIAKQLVRALHYLHS--------NRIIHRDMKPQNILIGAGSVVKLCDFGFAR 150 (1342)
Q Consensus 80 IVMEYve-GSLlDlLek~k~LSEeeIikIl~QILkALaYLHs--------kGIVHRDIKPENILIdsdG~IKLiDFGLAk 150 (1342)
+||||++ |+|.+++++. .+++..++.++.|++.||.|+|. +||+||||||+|||++.++.+||+|||+++
T Consensus 78 lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEECCCCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCC
T ss_conf 999646698989998658-9998999999999999999988766520468986615317313578688776887638662
Q ss_pred CCCCCCE----EEECCCCCCCCCCHHHHCCCC------CCCCCCCCCHHHHHHHHHHCCCCCCCC---------------
Q ss_conf 2457740----120235888768812120389------987775320466799988389999998---------------
Q 000706 151 AMSANTV----VLRSIKGTPLYMAPELVREQP------YNHTADLWSLGVILYELFVGQPPFYTN--------------- 205 (1342)
Q Consensus 151 ~l~sss~----~~ssivGTp~YlAPEIL~g~~------YT~kSDIWSLGVILYELLTGklPF~gs--------------- 205 (1342)
....... ......||+.|+|||++.+.. ++.++||||||+++|||++|..||...
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred CCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCC
T ss_conf 34677762001355250354767822105654546777675012201599999996289988766311241012255643
Q ss_pred CHHHHHHHHHCCC--CCCCCC-----CCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 3999999984299--999999-----99889999998110199999999899729
Q 000706 206 SVYALIRHIVKDP--VKYPDE-----MSPNFKSFLKGLLNKVPQNRLTWSALLEH 253 (1342)
Q Consensus 206 s~~elikkIvk~p--lelP~e-----ISpeLkdLIkkMLskDPeKRPTaeELLkH 253 (1342)
......+...... +.++.. ....+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 0999999875024688877655776899999999999760698589599999999
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1.3e-22 Score=167.70 Aligned_cols=166 Identities=16% Similarity=0.164 Sum_probs=122.6
Q ss_pred EEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCC----------------HHHHHHHHHHHHHHHHCCCCCCCEEE
Q ss_conf 89999973259379999999569959999996157999----------------78999999999999935999811588
Q 000706 6 YHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKS----------------EKDIHNLRQEIEILRKLKHQNIIEML 69 (1342)
Q Consensus 6 YkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~s----------------eseikrL~rEIkILkkLsHPNIVKLi 69 (1342)
|.+++.||+|+||.||+|.+. +++.||+|+++..... .........|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred CHHCCEEEECCCEEEEEEECC-CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
T ss_conf 022778024856599999979-9999999998604434666556563000888999999778999999981699914499
Q ss_pred EEEEECCEEEEEEECCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 88870895999994369884889860999999999999999999999866099250388998379758970899533632
Q 000706 70 DSFESPQEFCVVTEFAQGELFEILEDDKCLPEEQVQSIAKQLVRALHYLHSNRIIHRDMKPQNILIGAGSVVKLCDFGFA 149 (1342)
Q Consensus 70 dvfeded~iyIVMEYveGSLlDlLek~k~LSEeeIikIl~QILkALaYLHskGIVHRDIKPENILIdsdG~IKLiDFGLA 149 (1342)
+... .+++|||+++..... +++..+..++.|++.++.|||++|++||||||+|||++.+ .++|+|||.+
T Consensus 81 ~~~~----~~lvme~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a 149 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQS 149 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTC
T ss_pred EECC----CEEEEEEECCCCCCC------HHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEECC-CEEEEECCCC
T ss_conf 8628----889999504565420------0157899999999999999826888983689036114289-8999877884
Q ss_pred CCCCCCCEEEECCCCCCCCCC------HHHHCCCCCCCCCCCCCHHHHH
Q ss_conf 124577401202358887688------1212038998777532046679
Q 000706 150 RAMSANTVVLRSIKGTPLYMA------PELVREQPYNHTADLWSLGVIL 192 (1342)
Q Consensus 150 k~l~sss~~~ssivGTp~YlA------PEIL~g~~YT~kSDIWSLGVIL 192 (1342)
.....+... .|.. .+. ....|..++|+||+.--+
T Consensus 150 ~~~~~~~~~--------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 150 VEVGEEGWR--------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EETTSTTHH--------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCCCCCCCH--------HHHHHHHHHHHHH-HCCCCCCCCCHHHHHHHH
T ss_conf 308998709--------9998779999999-757899844689999987
|
| >d1q1sc_ a.118.1.1 (C:) Importin alpha {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Importin alpha species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.85 E-value=4.8e-19 Score=143.57 Aligned_cols=230 Identities=17% Similarity=0.205 Sum_probs=201.4
Q ss_pred HHHHHCCCCCCHHHHHHHHHHHHHHHHCHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHCC
Q ss_conf 14351038872478999999999983166589999828963867874049926699999999987721879999965316
Q 000706 1095 RVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKN 1174 (1342)
Q Consensus 1095 ~~~~~~~s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~i~LL~~lLqd~e~siqq~Aa~aLg~lakHS~eLAq~VVd~ 1174 (1342)
....++.+..++++.+-+..++.++.........+...|+++.|+.++.++++.+++.++.+|++++.++++....+++.
T Consensus 192 ~l~~ll~~~~~~~~~~a~~~l~~l~~~~~~~~~~~~~~~~~~~Lv~ll~~~~~~~~~~al~~l~~l~~~~~~~~~~~~~~ 271 (434)
T d1q1sc_ 192 TLVRLLHHNDPEVLADSCWAISYLTDGPNERIEMVVKKGVVPQLVKLLGATELPIVTPALRAIGNIVTGTDEQTQKVIDA 271 (434)
T ss_dssp HHHHHTTCSCHHHHHHHHHHHHHHTSSCHHHHHHHHTTTCHHHHHHHHTCSCHHHHHHHHHHHHHHTTSCHHHHHHHHHT
T ss_pred HHHHHHHCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHCCCCHHCCCCCCCCHHHHHHCHHHHHHHHHHHHHHHHHHHHHC
T ss_conf 99999852442012567766402201234567777631542010000234306554021221356776666778999852
Q ss_pred CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHHHHHHH--HHHHHHHHHCCCCCHHHHHHHHHHHHHHHHC-CHHHH
Q ss_conf 93789862017998234535889999867169888999997--6799999610278578999899999999728-99899
Q 000706 1175 RIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRR--SIPLLANILISDEEDKTKANAAGALSNLIRN-SSKLC 1251 (1342)
Q Consensus 1175 ~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~Vae--~~p~lv~~cL~D~D~~VR~nAA~al~~IakH-t~eLA 1251 (1342)
++++.|+..+.+.|..+|+.++.+|++++.++.+..+.+.+ ++|.++. ++.+.++.+|++|+|+|++++.+ +++..
T Consensus 272 ~~~~~l~~ll~~~~~~v~~~a~~~L~~l~~~~~~~~~~i~~~~~i~~li~-~l~~~~~~v~~~a~~~l~nl~~~~~~~~~ 350 (434)
T d1q1sc_ 272 GALAVFPSLLTNPKTNIQKEATWTMSNITAGRQDQIQQVVNHGLVPFLVG-VLSKADFKTQKEAAWAITNYTSGGTVEQI 350 (434)
T ss_dssp TGGGGHHHHTTCSSHHHHHHHHHHHHHHTTSCHHHHHHHHHTTCHHHHHH-HHHSSCHHHHHHHHHHHHHHHHHSCHHHH
T ss_pred CCCCHHHHHHCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHH-HHHCCCHHHHHHHHHHHHHHHHCCCHHHH
T ss_conf 56405777613641466688887886520045045777766546899998-77515868899999999999834999999
Q ss_pred HHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC------CCC-HHHHHHCCCCCHHHHHCCCCC
Q ss_conf 9999069669999985506533478884322347812658998886421------780-124413289710454101688
Q 000706 1252 EDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCA------HTP-CRQFLQSSELFPVIARLRQSP 1324 (1342)
Q Consensus 1252 q~VV~aGav~~LVd~~~q~~~~~~~~l~~~~~~~~~~ria~~~L~~i~k------h~~-~aq~vvda~~~~~ia~l~~~~ 1324 (1342)
+.+++.|+++.|+++. ++++ ...+ ..++.+|..|.+ +.+ ..+-+.+.+.+..|-.|..|+
T Consensus 351 ~~l~~~~~i~~L~~ll-~~~d---~~~~---------~~~l~~l~~ll~~~~~~~~~~~~~~~~~~~~~~~~i~~L~~~~ 417 (434)
T d1q1sc_ 351 VYLVHCGIIEPLMNLL-SAKD---TKII---------QVILDAISNIFQAAEKLGETEKLSIMIEECGGLDKIEALQRHE 417 (434)
T ss_dssp HHHHHTTCHHHHHHHT-TSSC---HHHH---------HHHHHHHHHHHHHHHTTTCHHHHHHHHHHTTSHHHHHHHHTCS
T ss_pred HHHHHCCCHHHHHHHH-CCCC---HHHH---------HHHHHHHHHHHHHHHHCCCCHHHHHHHHHCCCHHHHHHHHCCC
T ss_conf 9999897699999986-5999---8999---------9999999999998875477489999999868799999988699
Q ss_pred CCCCCCEEEEEEEC
Q ss_conf 40100213688631
Q 000706 1325 ESTIANYASVIISK 1338 (1342)
Q Consensus 1325 d~~~k~~~~~~~~~ 1338 (1342)
+..+...+.-||.|
T Consensus 418 n~~i~~~a~~il~~ 431 (434)
T d1q1sc_ 418 NESVYKASLNLIEK 431 (434)
T ss_dssp SHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHH
T ss_conf 89999999999999
|
| >d1wa5b_ a.118.1.1 (B:) Karyopherin alpha {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Karyopherin alpha species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.83 E-value=9.6e-19 Score=141.50 Aligned_cols=282 Identities=19% Similarity=0.195 Sum_probs=217.7
Q ss_pred HHHHHHCCCCCHHHHHCCCCCCCCCCCHHHHHHHHHCCCHHHHHHH-CCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHH
Q ss_conf 7898650985043462012221124850899998820802588862-045347111435103887247899999999998
Q 000706 1041 IKILMEVGVPGIILRCLEHMELKNLGRPIAFLAKMIGQRSLAVQLV-GKGLLDPNRVRRLLDSSTREVTLDVLMIVSDLA 1119 (1342)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pi~~l~~~~~~~~~~~q~v-~~~~~~~~~~~~~~~s~~~~~r~~f~~~va~la 1119 (1342)
-..+++.|+...+++++.+-......--+.+|..+..+......+. -.+. ......++.+..++++.+....++.++
T Consensus 197 r~~l~~~~~~~~L~~ll~~~~~~~~~~~~~~l~nl~~~~~~~~~~~~~~~~--l~~l~~~l~~~d~~~~~~~~~~l~~l~ 274 (503)
T d1wa5b_ 197 RDYVLQCNAMEPILGLFNSNKPSLIRTATWTLSNLCRGKKPQPDWSVVSQA--LPTLAKLIYSMDTETLVDACWAISYLS 274 (503)
T ss_dssp HHHHHHTTCHHHHHHGGGSCCHHHHHHHHHHHHHHHCCSSSCCCHHHHGGG--HHHHHHHTTCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCCCCHHHCCCCCHHHHHHHHHHHHHHHCCCCCCHHHHHHHHH--HHHHHHHHCCCCHHHHHHHHHHHHHHC
T ss_conf 998874135563012045688899999999999984687420479999999--999998723563899999999987532
Q ss_pred HHCHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHCCCCCHHHHHHHHHHH
Q ss_conf 31665899998289638678740499266999999999877218799999653169378986201799823453588999
Q 000706 1120 RMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSI 1199 (1342)
Q Consensus 1120 rs~~~~ie~I~~aG~i~LL~~lLqd~e~siqq~Aa~aLg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L 1199 (1342)
...+..+..+.+.|+++.|..++.++.+.++..++.+||+|+.++++....+++.++++.|..++.++|..+++.+|++|
T Consensus 275 ~~~~~~~~~~~~~~~~~~l~~ll~~~~~~v~~~al~~l~nl~~~~~~~~~~~~~~~~l~~l~~ll~~~~~~i~~~~~~~l 354 (503)
T d1wa5b_ 275 DGPQEAIQAVIDVRIPKRLVELLSHESTLVQTPALRAVGNIVTGNDLQTQVVINAGVLPALRLLLSSPKENIKKEACWTI 354 (503)
T ss_dssp SSCHHHHHHHHHTTCHHHHHHGGGCSCHHHHHHHHHHHHHHTTSCHHHHHHHHHTTHHHHHHHHTTCSCHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHHH
T ss_conf 27711110011223311101102578636445677777778778888787631234099999996399788899998778
Q ss_pred HHHHHCCHHHHHHHHHH--HHHHHHHHCCCCCHHHHHHHHHHHHHHHHC---CHHHHHHHHHCCCHHHHHHHHHCCCCCC
Q ss_conf 98671698889999976--799999610278578999899999999728---9989999990696699999855065334
Q 000706 1200 GNAAYHNDVLYEELRRS--IPLLANILISDEEDKTKANAAGALSNLIRN---SSKLCEDIVSKGAMQALIKLVADCSVLA 1274 (1342)
Q Consensus 1200 ~~iAkHs~~LAe~Vae~--~p~lv~~cL~D~D~~VR~nAA~al~~IakH---t~eLAq~VV~aGav~~LVd~~~q~~~~~ 1274 (1342)
++++.++.+..+.+.+. +|.++. .|...++.||++|+|+|.+++.+ .++..+.+++.|+++.|+++.. .++
T Consensus 355 ~nl~~~~~~~~~~i~~~~~l~~li~-~l~~~~~~v~~~a~~~l~nl~~~~~~~~~~~~~l~~~~~l~~l~~~L~-~~d-- 430 (503)
T d1wa5b_ 355 SNITAGNTEQIQAVIDANLIPPLVK-LLEVAEYKTKKEACWAISNASSGGLQRPDIIRYLVSQGCIKPLCDLLE-IAD-- 430 (503)
T ss_dssp HHHTTSCHHHHHHHHHTTCHHHHHH-HHHHSCHHHHHHHHHHHHHHHHHTTTCTHHHHHHHHTTCHHHHHHHTT-TCC--
T ss_pred HHHHHCCHHHHHHHHHCCCCCHHHH-HCCCCCHHHHHHHHHHHHHHHHCCCCCHHHHHHHHHCCCHHHHHHHHC-CCC--
T ss_conf 8886146988899997146523677-602687368999999999997365354899999998976999999865-998--
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHCC------------CCHHHHHHCCCCCHHHHHCCCCCCCCCCCEEEEEEEC
Q ss_conf 788843223478126589988864217------------8012441328971045410168840100213688631
Q 000706 1275 LNPSRKDAVNESPLKIALFSLAKMCAH------------TPCRQFLQSSELFPVIARLRQSPESTIANYASVIISK 1338 (1342)
Q Consensus 1275 ~~~l~~~~~~~~~~ria~~~L~~i~kh------------~~~aq~vvda~~~~~ia~l~~~~d~~~k~~~~~~~~~ 1338 (1342)
.... ..++.+|..|-+. .+.++.+.+.|++..|-.|..|++..+...|.-|+.+
T Consensus 431 -~~~~---------~~~L~~l~~ll~~~~~~~~~~~~~~~~~~~~iee~g~~~~i~~Lq~~~~~~i~~~A~~il~~ 496 (503)
T d1wa5b_ 431 -NRII---------EVTLDALENILKMGEADKEARGLNINENADFIEKAGGMEKIFNCQQNENDKIYEKAYKIIET 496 (503)
T ss_dssp -HHHH---------HHHHHHHHHHHHHHHHHHHHHTCSSCHHHHHHHHTTHHHHHHGGGGCSCHHHHHHHHHHHHH
T ss_pred -HHHH---------HHHHHHHHHHHHHHHHHHHHHCCCCHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHHHHHHH
T ss_conf -8999---------99999999999988877565302301899999988779999998769989999999999998
|
| >d1wa5b_ a.118.1.1 (B:) Karyopherin alpha {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Karyopherin alpha species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.82 E-value=1.2e-18 Score=140.85 Aligned_cols=272 Identities=15% Similarity=0.202 Sum_probs=219.0
Q ss_pred HHHCCCCCHHHHHCCCCCCCCCCCHHHHHHHHHCC-CHHHHHHHCCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHC
Q ss_conf 86509850434620122211248508999988208-02588862045347111435103887247899999999998316
Q 000706 1044 LMEVGVPGIILRCLEHMELKNLGRPIAFLAKMIGQ-RSLAVQLVGKGLLDPNRVRRLLDSSTREVTLDVLMIVSDLARMD 1122 (1342)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~pi~~l~~~~~~-~~~~~q~v~~~~~~~~~~~~~~~s~~~~~r~~f~~~va~lars~ 1122 (1342)
+.+.|.--++...+..-.....+.-+.+|..++++ +.....++..|.. .....++++..+.++...+..++.+++..
T Consensus 158 ~~~~g~i~~l~~lL~s~~~~i~~~a~~~L~nia~~~~~~r~~l~~~~~~--~~L~~ll~~~~~~~~~~~~~~l~nl~~~~ 235 (503)
T d1wa5b_ 158 VVDADAVPLFIQLLYTGSVEVKEQAIWALGNVAGDSTDYRDYVLQCNAM--EPILGLFNSNKPSLIRTATWTLSNLCRGK 235 (503)
T ss_dssp HHHTTCHHHHHHHHHHCCHHHHHHHHHHHHHHHTTCHHHHHHHHHTTCH--HHHHHGGGSCCHHHHHHHHHHHHHHHCCS
T ss_pred HHHCCCHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCC--CCCHHHCCCCCHHHHHHHHHHHHHHHCCC
T ss_conf 9967874789998559971589999999999854118999988741355--63012045688899999999999984687
Q ss_pred HHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHCCCCCHHHHHHHHHHHHHH
Q ss_conf 65899998289638678740499266999999999877218799999653169378986201799823453588999986
Q 000706 1123 KWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNA 1202 (1342)
Q Consensus 1123 ~~~ie~I~~aG~i~LL~~lLqd~e~siqq~Aa~aLg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~i 1202 (1342)
..........++++.|..++.++++.++..++.+|++++.++++..+.+++.++++.|+..+.+.|..++..++.+|+++
T Consensus 236 ~~~~~~~~~~~~l~~l~~~l~~~d~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~l~~ll~~~~~~v~~~al~~l~nl 315 (503)
T d1wa5b_ 236 KPQPDWSVVSQALPTLAKLIYSMDTETLVDACWAISYLSDGPQEAIQAVIDVRIPKRLVELLSHESTLVQTPALRAVGNI 315 (503)
T ss_dssp SSCCCHHHHGGGHHHHHHHTTCCCHHHHHHHHHHHHHHHSSCHHHHHHHHHTTCHHHHHHGGGCSCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHH
T ss_conf 42047999999999999872356389999999998753227711110011223311101102578636445677777778
Q ss_pred HHCCHHHHHHHH--HHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 716988899999--767999996102785789998999999997289989999990696699999855065334788843
Q 000706 1203 AYHNDVLYEELR--RSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRK 1280 (1342)
Q Consensus 1203 AkHs~~LAe~Va--e~~p~lv~~cL~D~D~~VR~nAA~al~~IakHt~eLAq~VV~aGav~~LVd~~~q~~~~~~~~l~~ 1280 (1342)
+.++.+..+.+. .++|.+.. +|+..++.+|+.++|+|++++.++++..+.+++.|+++.++++...... ..+
T Consensus 316 ~~~~~~~~~~~~~~~~l~~l~~-ll~~~~~~i~~~~~~~l~nl~~~~~~~~~~i~~~~~l~~li~~l~~~~~----~v~- 389 (503)
T d1wa5b_ 316 VTGNDLQTQVVINAGVLPALRL-LLSSPKENIKKEACWTISNITAGNTEQIQAVIDANLIPPLVKLLEVAEY----KTK- 389 (503)
T ss_dssp TTSCHHHHHHHHHTTHHHHHHH-HTTCSCHHHHHHHHHHHHHHTTSCHHHHHHHHHTTCHHHHHHHHHHSCH----HHH-
T ss_pred HHHHHHHHHHHHCCCHHHHHHH-HHCCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHCCCCCHHHHHCCCCCH----HHH-
T ss_conf 7788887876312340999999-9639978889999877888861469888999971465236776026873----689-
Q ss_pred CCCCCCCHHHHHHHHHHHHCCC---C-HHHHHHCCCCCHHHHHCCCCCCCCCCCE
Q ss_conf 2234781265899888642178---0-1244132897104541016884010021
Q 000706 1281 DAVNESPLKIALFSLAKMCAHT---P-CRQFLQSSELFPVIARLRQSPESTIANY 1331 (1342)
Q Consensus 1281 ~~~~~~~~ria~~~L~~i~kh~---~-~aq~vvda~~~~~ia~l~~~~d~~~k~~ 1331 (1342)
+.++.+|++++.+. + ..+.+++.++++.+..+++..|.++...
T Consensus 390 --------~~a~~~l~nl~~~~~~~~~~~~~l~~~~~l~~l~~~L~~~d~~~~~~ 436 (503)
T d1wa5b_ 390 --------KEACWAISNASSGGLQRPDIIRYLVSQGCIKPLCDLLEIADNRIIEV 436 (503)
T ss_dssp --------HHHHHHHHHHHHHTTTCTHHHHHHHHTTCHHHHHHHTTTCCHHHHHH
T ss_pred --------HHHHHHHHHHHHCCCCCHHHHHHHHHCCCHHHHHHHHCCCCHHHHHH
T ss_conf --------99999999997365354899999998976999999865998899999
|
| >d1jdha_ a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: beta-Catenin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=1.6e-18 Score=140.06 Aligned_cols=225 Identities=16% Similarity=0.127 Sum_probs=105.0
Q ss_pred HHHHCCCCCCHHHHHHHHHHHHHHHHCHHHHHHHHHCCCHHHHHHHHC--CCCHHHHHHHHHHHHHHHCC---CHHHHHH
Q ss_conf 435103887247899999999998316658999982896386787404--99266999999999877218---7999996
Q 000706 1096 VRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLT--HEDPNVRAKACSALGNMCRH---SSYFYSS 1170 (1342)
Q Consensus 1096 ~~~~~~s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~i~LL~~lLq--d~e~siqq~Aa~aLg~lakH---S~eLAq~ 1170 (1342)
.+.+++++.++++..-..+++.++-....+...+.+.|.++.|...+. .+.+.++..++.+|++++.. .+.....
T Consensus 271 Lv~ll~~~~~~~~~~a~~~L~~l~~~~~~~~~~i~~~~~i~~Li~~l~~~~~~~~~~~~a~~aL~~l~~~~~~~~~~~~~ 350 (529)
T d1jdha_ 271 LVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNA 350 (529)
T ss_dssp HHHHTTCSCHHHHHHHHHHHHHHTTTCHHHHHHHHHTTHHHHHHHHHHHHTTCHHHHHHHHHHHHHHTSSSTTHHHHHHH
T ss_pred HHHHCCCCCHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHCCCCHHHCCHHHHHH
T ss_conf 45412454288999999988750122037888888750078999999840011137889998850022000000035666
Q ss_pred HHCCCCHHHHHHHCCCCCH-HHHHHHHHHHHHHHHCCHHHHHHH-HHHHHHHHHHHCCCCCH------------------
Q ss_conf 5316937898620179982-345358899998671698889999-97679999961027857------------------
Q 000706 1171 LAKNRIIGLLIDRCADPDK-RTRKFACFSIGNAAYHNDVLYEEL-RRSIPLLANILISDEED------------------ 1230 (1342)
Q Consensus 1171 VVd~~iLp~Lv~~L~~~D~-~~Kr~ac~~L~~iAkHs~~LAe~V-ae~~p~lv~~cL~D~D~------------------ 1230 (1342)
+...+.++.|+..+.+++. ..++.++.+|++++.+........ ...+|.++. +|.+.+.
T Consensus 351 i~~~~~l~~L~~ll~~~~~~~~~~~~~~~l~~l~~~~~~~~~l~~~g~i~~L~~-lL~~~~~~~~~~~~~~~~~~~~~~~ 429 (529)
T d1jdha_ 351 VRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQ-LLVRAHQDTQRRTSMGGTQQQFVEG 429 (529)
T ss_dssp HHHTTCHHHHHHTTSTTCCHHHHHHHHHHHHHHTTSGGGHHHHHHTTHHHHHHH-HHHHHHHHHC-----------CBTT
T ss_pred HHHCCCCHHHHHHHHCCCHHHHHHHHHHHHHHCCHHHHHHHHHHHCCCHHHHHH-HHHCCCHHHHHHHHHHHHHHHHHCC
T ss_conf 776456124789871531278999999987500003566666653265799999-9866788999999860346776412
Q ss_pred ----HHHHHHHHHHHHHHHCCHHHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHH
Q ss_conf ----8999899999999728998999999069669999985506533478884322347812658998886421780124
Q 000706 1231 ----KTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQ 1306 (1342)
Q Consensus 1231 ----~VR~nAA~al~~IakHt~eLAq~VV~aGav~~LVd~~~q~~~~~~~~l~~~~~~~~~~ria~~~L~~i~kh~~~aq 1306 (1342)
.+.+.+..++..++++.. -.+.+...|+++.|+++..+..+ ..+ +.++.+|.+++.+...++
T Consensus 430 ~~~~~~~~~~~~al~~la~~~~-~r~~~~~~~~i~~Lv~lL~~~~~----~v~---------~~a~~aL~~L~~~~~~~~ 495 (529)
T d1jdha_ 430 VRMEEIVEGCTGALHILARDVH-NRIVIRGLNTIPLFVQLLYSPIE----NIQ---------RVAAGVLCELAQDKEAAE 495 (529)
T ss_dssp BCHHHHHHHHHHHHHHHTTSHH-HHHHHHHTTCHHHHHHGGGCSCH----HHH---------HHHHHHHHHHTTSHHHHH
T ss_pred CCHHHHHHHHHHHHHHHCCCHH-HHHHHHHCCCHHHHHHHHCCCCH----HHH---------HHHHHHHHHHHCCHHHHH
T ss_conf 1319999999999999844988-89999978889999998679998----999---------999999999865946699
Q ss_pred HHHCCCCCHHHHHCCCCCCCCCCCEEEEE
Q ss_conf 41328971045410168840100213688
Q 000706 1307 FLQSSELFPVIARLRQSPESTIANYASVI 1335 (1342)
Q Consensus 1307 ~vvda~~~~~ia~l~~~~d~~~k~~~~~~ 1335 (1342)
.+.++|+++.|..|+.+.+..+++++...
T Consensus 496 ~i~~~g~~~~L~~Ll~s~n~~v~~~a~~a 524 (529)
T d1jdha_ 496 AIEAEGATAPLTELLHSRNEGVATYAAAV 524 (529)
T ss_dssp HHHHTTCHHHHHHGGGCSSHHHHHHHHHH
T ss_pred HHHHCCCHHHHHHHHCCCCHHHHHHHHHH
T ss_conf 99988889999998579999999999999
|
| >d1q1sc_ a.118.1.1 (C:) Importin alpha {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Importin alpha species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.79 E-value=7.9e-18 Score=135.32 Aligned_cols=207 Identities=15% Similarity=0.204 Sum_probs=141.9
Q ss_pred HHHHHHHHHHCHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHCCCCCHHH
Q ss_conf 99999998316658999982896386787404992669999999998772187999996531693789862017998234
Q 000706 1112 LMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRT 1191 (1342)
Q Consensus 1112 ~~~va~lars~~~~ie~I~~aG~i~LL~~lLqd~e~siqq~Aa~aLg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~ 1191 (1342)
...++.+++............++++.|..++.++++.++..++.+|++++.++++....+.+.++++.|+.++.+.|..+
T Consensus 167 ~~~l~~~~~~~~~~~~~~~~~~~l~~l~~ll~~~~~~~~~~a~~~l~~l~~~~~~~~~~~~~~~~~~~Lv~ll~~~~~~~ 246 (434)
T d1q1sc_ 167 TWTLSNLCRNKNPAPPLDAVEQILPTLVRLLHHNDPEVLADSCWAISYLTDGPNERIEMVVKKGVVPQLVKLLGATELPI 246 (434)
T ss_dssp HHHHHHHTCCCTTCCCHHHHHHHHHHHHHHTTCSCHHHHHHHHHHHHHHTSSCHHHHHHHHTTTCHHHHHHHHTCSCHHH
T ss_pred HHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHHCCCCHHHHHHHHHHHHCCCCHHCCCCCCCCHHHH
T ss_conf 99998886426422114436569999999985244201256776640220123456777763154201000023430655
Q ss_pred HHHHHHHHHHHHHCCHHHHHHHHH--HHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHCCCHHHHHHHHHC
Q ss_conf 535889999867169888999997--679999961027857899989999999972899899999906966999998550
Q 000706 1192 RKFACFSIGNAAYHNDVLYEELRR--SIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVAD 1269 (1342)
Q Consensus 1192 Kr~ac~~L~~iAkHs~~LAe~Vae--~~p~lv~~cL~D~D~~VR~nAA~al~~IakHt~eLAq~VV~aGav~~LVd~~~q 1269 (1342)
+..++.+|++++.++.+..+.+.+ +++.++. +|++.++.||+.|++++++++.++++..+.+.+.|+++.++++. .
T Consensus 247 ~~~al~~l~~l~~~~~~~~~~~~~~~~~~~l~~-ll~~~~~~v~~~a~~~L~~l~~~~~~~~~~i~~~~~i~~li~~l-~ 324 (434)
T d1q1sc_ 247 VTPALRAIGNIVTGTDEQTQKVIDAGALAVFPS-LLTNPKTNIQKEATWTMSNITAGRQDQIQQVVNHGLVPFLVGVL-S 324 (434)
T ss_dssp HHHHHHHHHHHTTSCHHHHHHHHHTTGGGGHHH-HTTCSSHHHHHHHHHHHHHHTTSCHHHHHHHHHTTCHHHHHHHH-H
T ss_pred HHCHHHHHHHHHHHHHHHHHHHHHCCCCCHHHH-HHCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHH-H
T ss_conf 402122135677666677899985256405777-61364146668888788652004504577776654689999877-5
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC--HHHHHHCCCCCHHHHHCCCCCCCCCCCEE
Q ss_conf 6533478884322347812658998886421780--12441328971045410168840100213
Q 000706 1270 CSVLALNPSRKDAVNESPLKIALFSLAKMCAHTP--CRQFLQSSELFPVIARLRQSPESTIANYA 1332 (1342)
Q Consensus 1270 ~~~~~~~~l~~~~~~~~~~ria~~~L~~i~kh~~--~aq~vvda~~~~~ia~l~~~~d~~~k~~~ 1332 (1342)
.++ ...+ +.++.+|++++.|.. ..+.++++++++.|..+++..|.++...+
T Consensus 325 ~~~---~~v~---------~~a~~~l~nl~~~~~~~~~~~l~~~~~i~~L~~ll~~~d~~~~~~~ 377 (434)
T d1q1sc_ 325 KAD---FKTQ---------KEAAWAITNYTSGGTVEQIVYLVHCGIIEPLMNLLSAKDTKIIQVI 377 (434)
T ss_dssp SSC---HHHH---------HHHHHHHHHHHHHSCHHHHHHHHHTTCHHHHHHHTTSSCHHHHHHH
T ss_pred CCC---HHHH---------HHHHHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHH
T ss_conf 158---6889---------9999999999834999999999989769999998659998999999
|
| >d1xqra1 a.118.1.21 (A:87-350) Hsp70-binding protein 1 (HspBP1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: HspBP1 domain domain: Hsp70-binding protein 1 (HspBP1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=4.2e-17 Score=130.40 Aligned_cols=202 Identities=17% Similarity=0.166 Sum_probs=172.5
Q ss_pred HHHHCCCCCCHHHHHHHHHHHHHHHHCHHHHHHHHHCCCHHHHH-HHHCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHCC
Q ss_conf 43510388724789999999999831665899998289638678-74049926699999999987721879999965316
Q 000706 1096 VRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLK-DFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKN 1174 (1342)
Q Consensus 1096 ~~~~~~s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~i~LL~-~lLqd~e~siqq~Aa~aLg~lakHS~eLAq~VVd~ 1174 (1342)
+.....+.+.+.|..-+..+++++ ....+-..+.+.|.++.|. .++.++++.+|+.|+.+||+++.|++..-+.+++.
T Consensus 22 ~~~~~~~~~~~~~~~Al~~L~~L~-~~~d~a~~l~~~gg~~~ll~~ll~s~~~~vr~~A~~~L~~l~~~~~~~~~~~~~~ 100 (264)
T d1xqra1 22 AGEAEQAADQQEREGALELLADLC-ENMDNAADFCQLSGMHLLVGRYLEAGAAGLRWRAAQLIGTCSQNVAAIQEQVLGL 100 (264)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHH-TSHHHHHHHHHTTHHHHHHHTTTTCSSHHHHHHHHHHHHHHHTTCHHHHHHHHHT
T ss_pred HHHHHCCCCHHHHHHHHHHHHHHH-CCHHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_conf 777650799999999999999997-6978899999869999999998379999999999999999998888888999972
Q ss_pred CCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHCCHHHHHHHHHH--HHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHH
Q ss_conf 93789862017-9982345358899998671698889999976--79999961027857899989999999972899899
Q 000706 1175 RIIGLLIDRCA-DPDKRTRKFACFSIGNAAYHNDVLYEELRRS--IPLLANILISDEEDKTKANAAGALSNLIRNSSKLC 1251 (1342)
Q Consensus 1175 ~iLp~Lv~~L~-~~D~~~Kr~ac~~L~~iAkHs~~LAe~Vae~--~p~lv~~cL~D~D~~VR~nAA~al~~IakHt~eLA 1251 (1342)
+++|.|+..|. +.|...++.++++|+++++|+.+-.+.+.+. ++.++. +|++.|+.++++++++|++++.++++..
T Consensus 101 ~~i~~Lv~lL~~~~~~~v~~~a~~aL~~l~~~~~~~~~~~~~~~gi~~L~~-lL~~~~~~~~~~a~~~L~~l~~~~~~~~ 179 (264)
T d1xqra1 101 GALRKLLRLLDRDACDTVRVKALFAISCLVREQEAGLLQFLRLDGFSVLMR-AMQQQVQKLKVKSAFLLQNLLVGHPEHK 179 (264)
T ss_dssp THHHHHHHHHHHCSCHHHHHHHHHHHHHHHTTCHHHHHHHHHTTHHHHHHH-HHHSSCHHHHHHHHHHHHHHHHHCGGGH
T ss_pred CCHHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHH-HHHCCCHHHHHHHHHHHHHHHHCCHHHH
T ss_conf 763799999604998999999999999874244026789987201268899-8805865788999999999874457788
Q ss_pred HHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC-HHHHHHCCC
Q ss_conf 9999069669999985506533478884322347812658998886421780-124413289
Q 000706 1252 EDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTP-CRQFLQSSE 1312 (1342)
Q Consensus 1252 q~VV~aGav~~LVd~~~q~~~~~~~~l~~~~~~~~~~ria~~~L~~i~kh~~-~aq~vvda~ 1312 (1342)
+.++++|++|.|+++.. +++ ...+ +.++.+|+.++..+| ..+.....+
T Consensus 180 ~~~~~~~~v~~L~~lL~-~~~---~~~~---------~~a~~aL~~L~~~~~~~~~~~~~~~ 228 (264)
T d1xqra1 180 GTLCSMGMVQQLVALVR-TEH---SPFH---------EHVLGALCSLVTDFPQGVRECREPE 228 (264)
T ss_dssp HHHHHTTHHHHHHHHHT-SCC---STHH---------HHHHHHHHHHHTTCHHHHHHHHCGG
T ss_pred HHHHHHHHHHHHHHHHC-CCC---HHHH---------HHHHHHHHHHHHCCHHHHHHHHHHH
T ss_conf 88887646899999973-999---8999---------9999999999864889999998744
|
| >d1jdha_ a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: beta-Catenin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=1.5e-16 Score=126.71 Aligned_cols=254 Identities=15% Similarity=0.142 Sum_probs=124.4
Q ss_pred HHHHHHHHCCCHHHHHHHCCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCHHHHHHHHHCCCHHHHHHHHCCCCHH
Q ss_conf 89999882080258886204534711143510388724789999999999831665899998289638678740499266
Q 000706 1069 IAFLAKMIGQRSLAVQLVGKGLLDPNRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPN 1148 (1342)
Q Consensus 1069 i~~l~~~~~~~~~~~q~v~~~~~~~~~~~~~~~s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~i~LL~~lLqd~e~s 1148 (1342)
...+..+..++....+++..|. ......++.+..+.++..-+...+.++..... .+...|+++.|..++.++++.
T Consensus 207 ~~~l~~ls~~~~~~~~~~~~g~--~~~L~~ll~~~~~~~~~~a~~~l~~ls~~~~~---~~~~~~~i~~Lv~ll~~~~~~ 281 (529)
T d1jdha_ 207 SRVLKVLSVCSSNKPAIVEAGG--MQALGLHLTDPSQRLVQNCLWTLRNLSDAATK---QEGMEGLLGTLVQLLGSDDIN 281 (529)
T ss_dssp HHHHHHHTTSTTHHHHHHHTTH--HHHHHTTTTSSCHHHHHHHHHHHHHHHTTCTT---CSCCHHHHHHHHHHTTCSCHH
T ss_pred HHHHHHHHCCCCCCCHHHHHHH--HHHHHHHHCCCCHHHHHHHHHHHHHCCCCCCC---HHHHHHCCHHHHHHCCCCCHH
T ss_conf 9987511013323304565433--34699986254015553015677750432110---256640101445412454288
Q ss_pred HHHHHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHCCHH---HHHHHH--HHHHHHH
Q ss_conf 9999999998772187999996531693789862017--99823453588999986716988---899999--7679999
Q 000706 1149 VRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCA--DPDKRTRKFACFSIGNAAYHNDV---LYEELR--RSIPLLA 1221 (1342)
Q Consensus 1149 iqq~Aa~aLg~lakHS~eLAq~VVd~~iLp~Lv~~L~--~~D~~~Kr~ac~~L~~iAkHs~~---LAe~Va--e~~p~lv 1221 (1342)
++..|+.+|++++.++++..+.+++.+.++.|+..+. ..+..++..++.+|++++.-..+ ..+.+. ..++.++
T Consensus 282 ~~~~a~~~L~~l~~~~~~~~~~i~~~~~i~~Li~~l~~~~~~~~~~~~a~~aL~~l~~~~~~~~~~~~~i~~~~~l~~L~ 361 (529)
T d1jdha_ 282 VVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVV 361 (529)
T ss_dssp HHHHHHHHHHHHTTTCHHHHHHHHHTTHHHHHHHHHHHHTTCHHHHHHHHHHHHHHTSSSTTHHHHHHHHHHTTCHHHHH
T ss_pred HHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHCCCCHHHCCHHHHHHHHHCCCCHHHH
T ss_conf 99999998875012203788888875007899999984001113788999885002200000003566677645612478
Q ss_pred HHHCCCCC-HHHHHHHHHHHHHHHHCCHHHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCC------------CCCCCCH
Q ss_conf 96102785-7899989999999972899899999906966999998550653347888432------------2347812
Q 000706 1222 NILISDEE-DKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKD------------AVNESPL 1288 (1342)
Q Consensus 1222 ~~cL~D~D-~~VR~nAA~al~~IakHt~eLAq~VV~aGav~~LVd~~~q~~~~~~~~l~~~------------~~~~~~~ 1288 (1342)
. +|++++ ..+.+++.+++++++.+. +....+.++|+++.|+++.....+ -..++. ...+...
T Consensus 362 ~-ll~~~~~~~~~~~~~~~l~~l~~~~-~~~~~l~~~g~i~~L~~lL~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (529)
T d1jdha_ 362 K-LLHPPSHWPLIKATVGLIRNLALCP-ANHAPLREQGAIPRLVQLLVRAHQ---DTQRRTSMGGTQQQFVEGVRMEEIV 436 (529)
T ss_dssp H-TTSTTCCHHHHHHHHHHHHHHTTSG-GGHHHHHHTTHHHHHHHHHHHHHH---HHC-----------CBTTBCHHHHH
T ss_pred H-HHHCCCHHHHHHHHHHHHHHCCHHH-HHHHHHHHCCCHHHHHHHHHCCCH---HHHHHHHHHHHHHHHHCCCCHHHHH
T ss_conf 9-8715312789999999875000035-666666532657999999866788---9999998603467764121319999
Q ss_pred HHHHHHHHHHHCCCCHHHHHHCCCCCHHHHHCCCCCCCCCCCEE
Q ss_conf 65899888642178012441328971045410168840100213
Q 000706 1289 KIALFSLAKMCAHTPCRQFLQSSELFPVIARLRQSPESTIANYA 1332 (1342)
Q Consensus 1289 ria~~~L~~i~kh~~~aq~vvda~~~~~ia~l~~~~d~~~k~~~ 1332 (1342)
+....+|..++++....+.+.+.++++.+..++.+++..+++.+
T Consensus 437 ~~~~~al~~la~~~~~r~~~~~~~~i~~Lv~lL~~~~~~v~~~a 480 (529)
T d1jdha_ 437 EGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVA 480 (529)
T ss_dssp HHHHHHHHHHTTSHHHHHHHHHTTCHHHHHHGGGCSCHHHHHHH
T ss_pred HHHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHH
T ss_conf 99999999984498889999978889999998679998999999
|
| >d1xqra1 a.118.1.21 (A:87-350) Hsp70-binding protein 1 (HspBP1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: HspBP1 domain domain: Hsp70-binding protein 1 (HspBP1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=2.3e-16 Score=125.39 Aligned_cols=188 Identities=15% Similarity=0.132 Sum_probs=166.1
Q ss_pred HHHHHHHHCCCHHHHHHHCCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCHHHHHHHHHCCCHHHHHHHHC-CCCH
Q ss_conf 899998820802588862045347111435103887247899999999998316658999982896386787404-9926
Q 000706 1069 IAFLAKMIGQRSLAVQLVGKGLLDPNRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLT-HEDP 1147 (1342)
Q Consensus 1069 i~~l~~~~~~~~~~~q~v~~~~~~~~~~~~~~~s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~i~LL~~lLq-d~e~ 1147 (1342)
..-|..++.+.-.++.|+.-|.. +--+..+++|..+++|..-...++.+++..+..-..+.+.|+++.|+.++. ++++
T Consensus 38 l~~L~~L~~~~d~a~~l~~~gg~-~~ll~~ll~s~~~~vr~~A~~~L~~l~~~~~~~~~~~~~~~~i~~Lv~lL~~~~~~ 116 (264)
T d1xqra1 38 LELLADLCENMDNAADFCQLSGM-HLLVGRYLEAGAAGLRWRAAQLIGTCSQNVAAIQEQVLGLGALRKLLRLLDRDACD 116 (264)
T ss_dssp HHHHHHHHTSHHHHHHHHHTTHH-HHHHHTTTTCSSHHHHHHHHHHHHHHHTTCHHHHHHHHHTTHHHHHHHHHHHCSCH
T ss_pred HHHHHHHHCCHHHHHHHHHCCCH-HHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHCCCCH
T ss_conf 99999997697889999986999-99999983799999999999999999988888889999727637999996049989
Q ss_pred HHHHHHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHH--HHHHHHHHC
Q ss_conf 699999999987721879999965316937898620179982345358899998671698889999976--799999610
Q 000706 1148 NVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRS--IPLLANILI 1225 (1342)
Q Consensus 1148 siqq~Aa~aLg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~Vae~--~p~lv~~cL 1225 (1342)
.+++.++.||+.+++++++....++..++++.|+..+.+.|..+++.+|.+|++++.++++..+.+.+. +|.|+. .|
T Consensus 117 ~v~~~a~~aL~~l~~~~~~~~~~~~~~~gi~~L~~lL~~~~~~~~~~a~~~L~~l~~~~~~~~~~~~~~~~v~~L~~-lL 195 (264)
T d1xqra1 117 TVRVKALFAISCLVREQEAGLLQFLRLDGFSVLMRAMQQQVQKLKVKSAFLLQNLLVGHPEHKGTLCSMGMVQQLVA-LV 195 (264)
T ss_dssp HHHHHHHHHHHHHHTTCHHHHHHHHHTTHHHHHHHHHHSSCHHHHHHHHHHHHHHHHHCGGGHHHHHHTTHHHHHHH-HH
T ss_pred HHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH-HH
T ss_conf 99999999999874244026789987201268899880586578899999999987445778888887646899999-97
Q ss_pred CCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHCC
Q ss_conf 278578999899999999728998999999069
Q 000706 1226 SDEEDKTKANAAGALSNLIRNSSKLCEDIVSKG 1258 (1342)
Q Consensus 1226 ~D~D~~VR~nAA~al~~IakHt~eLAq~VV~aG 1258 (1342)
++.|+.+|+.|+++|++++..+++-.+.+...+
T Consensus 196 ~~~~~~~~~~a~~aL~~L~~~~~~~~~~~~~~~ 228 (264)
T d1xqra1 196 RTEHSPFHEHVLGALCSLVTDFPQGVRECREPE 228 (264)
T ss_dssp TSCCSTHHHHHHHHHHHHHTTCHHHHHHHHCGG
T ss_pred CCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_conf 399989999999999999864889999998744
|
| >d1xm9a1 a.118.1.24 (A:244-700) Plakophilin 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Plakophilin 1 helical region domain: Plakophilin 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=4.3e-14 Score=109.99 Aligned_cols=171 Identities=11% Similarity=0.130 Sum_probs=132.0
Q ss_pred HCHHHHHHHHHCCCHHHHHHHHC-CCCHHHHHHHHHHHHHHHCCCHH-----HHHHHHCCCCHHHHHHHCCCCCHHHHHH
Q ss_conf 16658999982896386787404-99266999999999877218799-----9996531693789862017998234535
Q 000706 1121 MDKWFYEYINGASMLEFLKDFLT-HEDPNVRAKACSALGNMCRHSSY-----FYSSLAKNRIIGLLIDRCADPDKRTRKF 1194 (1342)
Q Consensus 1121 s~~~~ie~I~~aG~i~LL~~lLq-d~e~siqq~Aa~aLg~lakHS~e-----LAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ 1194 (1342)
........+...++++.|..++. ...+.++..++.++..++.+... ....+..++++|.|+..+.+.+..+++.
T Consensus 271 ~~~~~~~~~~~~~~i~~l~~l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~l~~L~~~l~~~~~~v~~~ 350 (457)
T d1xm9a1 271 TNPKGSGWLYHSDAIRTYLNLMGKSKKDATLEACAGALQNLTASKGLMSSGMSQLIGLKEKGLPQIARLLQSGNSDVVRS 350 (457)
T ss_dssp SSCCGGGGGGSHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHTTCSSSHHHHHHHHHHTTSCCHHHHHHHTTCSCHHHHHH
T ss_pred HHHHHHHHHHHHCHHHHHHHHHHCCCCHHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHCCCHHHHHHHHCCCCHHHHHH
T ss_conf 31677789986047999999873366357889999998888614400048899999998397688975403750899999
Q ss_pred HHHHHHHHHHCCHHHHHHH-HHHHHHHHHHHCCC------CCHHHHHHHHHHHHHHHHCCHHHHHHHHHCCCHHHHHHHH
Q ss_conf 8899998671698889999-97679999961027------8578999899999999728998999999069669999985
Q 000706 1195 ACFSIGNAAYHNDVLYEEL-RRSIPLLANILISD------EEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLV 1267 (1342)
Q Consensus 1195 ac~~L~~iAkHs~~LAe~V-ae~~p~lv~~cL~D------~D~~VR~nAA~al~~IakHt~eLAq~VV~aGav~~LVd~~ 1267 (1342)
+|.+|++++.+... .+.+ ...+|.++. .|.+ .++.|+++|+++|++++.++++..+.++++||++.|++++
T Consensus 351 a~~~l~~La~~~~~-~~~i~~~~i~~li~-~L~~~~~~~~~~~~v~~~a~~~L~~l~~~~~~~~~~l~~~g~i~~L~~l~ 428 (457)
T d1xm9a1 351 GASLLSNMSRHPLL-HRVMGNQVFPEVTR-LLTSHTGNTSNSEDILSSACYTVRNLMASQPQLAKQYFSSSMLNNIINLC 428 (457)
T ss_dssp HHHHHHHHHTSGGG-HHHHHHHTHHHHHH-TTTSCCSCSTTHHHHHHHHHHHHHHHHTTCTHHHHHHCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHCHHH-HHHHHHHHHHHHHH-HHHCCCCCCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHH
T ss_conf 99999998607667-99999965999999-98553667678599999999999998617999999999888899999998
Q ss_pred HCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHH
Q ss_conf 50653347888432234781265899888642178012
Q 000706 1268 ADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCR 1305 (1342)
Q Consensus 1268 ~q~~~~~~~~l~~~~~~~~~~ria~~~L~~i~kh~~~a 1305 (1342)
..... ...+ +.|...|++++.|.+++
T Consensus 429 ~~~~~---~~~~---------~aA~~~L~~L~~~~~~~ 454 (457)
T d1xm9a1 429 RSSAS---PKAA---------EAARLLLSDMWSSKELQ 454 (457)
T ss_dssp HCTTC---HHHH---------HHHHHHHHTTSSSTTCS
T ss_pred HCCCC---HHHH---------HHHHHHHHHHHCCHHHH
T ss_conf 68998---9999---------99999999997498647
|
| >d1xm9a1 a.118.1.24 (A:244-700) Plakophilin 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Plakophilin 1 helical region domain: Plakophilin 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=1.2e-12 Score=100.29 Aligned_cols=148 Identities=15% Similarity=0.130 Sum_probs=114.3
Q ss_pred HHCCCCCCHHHHHHHHHHHHHHHHCHHH-----HHHHHHCCCHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCHHHHHHHH
Q ss_conf 5103887247899999999998316658-----99998289638678740499266999999999877218799999653
Q 000706 1098 RLLDSSTREVTLDVLMIVSDLARMDKWF-----YEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLA 1172 (1342)
Q Consensus 1098 ~~~~s~~~~~r~~f~~~va~lars~~~~-----ie~I~~aG~i~LL~~lLqd~e~siqq~Aa~aLg~lakHS~eLAq~VV 1172 (1342)
.+.+++.+++.......+..++...... -..+.+.|+++.|..++.++++.++..++.+|++++.+.+ ..+.+.
T Consensus 291 l~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~l~~L~~~l~~~~~~v~~~a~~~l~~La~~~~-~~~~i~ 369 (457)
T d1xm9a1 291 LMGKSKKDATLEACAGALQNLTASKGLMSSGMSQLIGLKEKGLPQIARLLQSGNSDVVRSGASLLSNMSRHPL-LHRVMG 369 (457)
T ss_dssp HHHHCCCHHHHHHHHHHHHHHTTCSSSHHHHHHHHHHTTSCCHHHHHHHTTCSCHHHHHHHHHHHHHHHTSGG-GHHHHH
T ss_pred HHHCCCCHHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHHHHHHHHHHCHH-HHHHHH
T ss_conf 8733663578899999988886144000488999999983976889754037508999999999999860766-799999
Q ss_pred CCCCHHHHHHHCCCC------CHHHHHHHHHHHHHHHHCCHHHHHHH--HHHHHHHHHHHCCC-CCHHHHHHHHHHHHHH
Q ss_conf 169378986201799------82345358899998671698889999--97679999961027-8578999899999999
Q 000706 1173 KNRIIGLLIDRCADP------DKRTRKFACFSIGNAAYHNDVLYEEL--RRSIPLLANILISD-EEDKTKANAAGALSNL 1243 (1342)
Q Consensus 1173 d~~iLp~Lv~~L~~~------D~~~Kr~ac~~L~~iAkHs~~LAe~V--ae~~p~lv~~cL~D-~D~~VR~nAA~al~~I 1243 (1342)
.++++.|+..|... +..++..+|.+|++++.++++..+.+ ...++.|+. .+++ .++.|+++|+.+|+++
T Consensus 370 -~~~i~~li~~L~~~~~~~~~~~~v~~~a~~~L~~l~~~~~~~~~~l~~~g~i~~L~~-l~~~~~~~~~~~aA~~~L~~L 447 (457)
T d1xm9a1 370 -NQVFPEVTRLLTSHTGNTSNSEDILSSACYTVRNLMASQPQLAKQYFSSSMLNNIIN-LCRSSASPKAAEAARLLLSDM 447 (457)
T ss_dssp -HHTHHHHHHTTTSCCSCSTTHHHHHHHHHHHHHHHHTTCTHHHHHHCCHHHHHHHHH-HHHCTTCHHHHHHHHHHHHTT
T ss_pred -HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHHCCCHHHHHH-HHHCCCCHHHHHHHHHHHHHH
T ss_conf -965999999985536676785999999999999986179999999998888999999-986899899999999999999
Q ss_pred HHCCH
Q ss_conf 72899
Q 000706 1244 IRNSS 1248 (1342)
Q Consensus 1244 akHt~ 1248 (1342)
++|.+
T Consensus 448 ~~~~~ 452 (457)
T d1xm9a1 448 WSSKE 452 (457)
T ss_dssp SSSTT
T ss_pred HCCHH
T ss_conf 74986
|
| >d1b3ua_ a.118.1.2 (A:) Constant regulatory domain of protein phosphatase 2a, pr65alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: HEAT repeat domain: Constant regulatory domain of protein phosphatase 2a, pr65alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.07 E-value=1.1e-09 Score=80.21 Aligned_cols=177 Identities=15% Similarity=0.128 Sum_probs=125.8
Q ss_pred HHHHCCCCCCHHHHHHHHHHHHHHHH-CHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHHHHHHHHHCC-CHHHHHHHHC
Q ss_conf 43510388724789999999999831-665899998289638678740499266999999999877218-7999996531
Q 000706 1096 VRRLLDSSTREVTLDVLMIVSDLARM-DKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRH-SSYFYSSLAK 1173 (1342)
Q Consensus 1096 ~~~~~~s~~~~~r~~f~~~va~lars-~~~~ie~I~~aG~i~LL~~lLqd~e~siqq~Aa~aLg~lakH-S~eLAq~VVd 1173 (1342)
+..++.+..+.+|...++.+..++.. .... ......+++..++.|+...+|+.|+.+||.|+++ +++.+.
T Consensus 407 l~~~~~d~~~~~r~~~~~~l~~l~~~~~~~~----~~~~l~~~l~~~l~D~~~~VR~~A~~~L~~l~~~~~~~~~~---- 478 (588)
T d1b3ua_ 407 IVELAEDAKWRVRLAIIEYMPLLAGQLGVEF----FDEKLNSLCMAWLVDHVYAIREAATSNLKKLVEKFGKEWAH---- 478 (588)
T ss_dssp HHHHHTCSSHHHHHHHHHHHHHHHHHHCGGG----CCHHHHHHHHHGGGCSSHHHHHHHHHHHHHHHHHHCHHHHH----
T ss_pred HHHHHHCCCHHHHHHHHHHHHHHHHHCCHHH----HHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHCCHHHH----
T ss_conf 9999843358899999999999997718476----77888888776356874168999999999999983938789----
Q ss_pred CCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHHHH
Q ss_conf 69378986201799823453588999986716988899999767999996102785789998999999997289989999
Q 000706 1174 NRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCED 1253 (1342)
Q Consensus 1174 ~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~Vae~~p~lv~~cL~D~D~~VR~nAA~al~~IakHt~eLAq~ 1253 (1342)
..++|.+...+.+++...|..++++++.+++.-+.- ....+++|.++. +++|++|.||.++|+++++|.+.-.+ .
T Consensus 479 ~~i~~~l~~~~~~~~~~~R~~~~~~l~~l~~~~~~~-~~~~~ilp~ll~-~~~D~v~nVR~~a~~~l~~i~~~~~~---~ 553 (588)
T d1b3ua_ 479 ATIIPKVLAMSGDPNYLHRMTTLFCINVLSEVCGQD-ITTKHMLPTVLR-MAGDPVANVRFNVAKSLQKIGPILDN---S 553 (588)
T ss_dssp HHTHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHH-HHHHHTHHHHHH-GGGCSCHHHHHHHHHHHHHHGGGSCH---H
T ss_pred HHHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHCCHH-HHHHHHHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHCCC---H
T ss_conf 999999999865998789999999999999986968-789999999998-85999879999999999999987080---7
Q ss_pred HHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 990696699999855065334788843223478126589988864
Q 000706 1254 IVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKM 1298 (1342)
Q Consensus 1254 VV~aGav~~LVd~~~q~~~~~~~~l~~~~~~~~~~ria~~~L~~i 1298 (1342)
.+.....|.|. -..++++ .--| ..|.-+|.-+
T Consensus 554 ~~~~~i~~~l~-~L~~D~d---~dVr---------~~A~~al~~l 585 (588)
T d1b3ua_ 554 TLQSEVKPILE-KLTQDQD---VDVK---------YFAQEALTVL 585 (588)
T ss_dssp HHHHHHHHHHH-HHTTCSS---HHHH---------HHHHHHHHHT
T ss_pred HHHHHHHHHHH-HHCCCCC---HHHH---------HHHHHHHHHH
T ss_conf 57999999999-9757998---7799---------9999999987
|
| >d1b3ua_ a.118.1.2 (A:) Constant regulatory domain of protein phosphatase 2a, pr65alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: HEAT repeat domain: Constant regulatory domain of protein phosphatase 2a, pr65alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.81 E-value=1.4e-07 Score=65.93 Aligned_cols=176 Identities=15% Similarity=0.120 Sum_probs=80.1
Q ss_pred CHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHHHHH
Q ss_conf 63867874049926699999999987721879999965316937898620179982345358899998671698889999
Q 000706 1134 MLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEEL 1213 (1342)
Q Consensus 1134 ~i~LL~~lLqd~e~siqq~Aa~aLg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~V 1213 (1342)
.++.+...+.++.+.+|..++.+++.++++ +-.......+.+.+..++.+++..+|..|+.+|+.++++.++ ....
T Consensus 403 ll~~l~~~~~d~~~~~r~~~~~~l~~l~~~---~~~~~~~~~l~~~l~~~l~D~~~~VR~~A~~~L~~l~~~~~~-~~~~ 478 (588)
T d1b3ua_ 403 LLPAIVELAEDAKWRVRLAIIEYMPLLAGQ---LGVEFFDEKLNSLCMAWLVDHVYAIREAATSNLKKLVEKFGK-EWAH 478 (588)
T ss_dssp HHHHHHHHHTCSSHHHHHHHHHHHHHHHHH---HCGGGCCHHHHHHHHHGGGCSSHHHHHHHHHHHHHHHHHHCH-HHHH
T ss_pred HHHHHHHHHHCCCHHHHHHHHHHHHHHHHH---CCHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHCC-HHHH
T ss_conf 789999998433588999999999999977---184767788888877635687416899999999999998393-8789
Q ss_pred HHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHH
Q ss_conf 97679999961027857899989999999972899899999906966999998550653347888432234781265899
Q 000706 1214 RRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALF 1293 (1342)
Q Consensus 1214 ae~~p~lv~~cL~D~D~~VR~nAA~al~~IakHt~eLAq~VV~aGav~~LVd~~~q~~~~~~~~l~~~~~~~~~~ria~~ 1293 (1342)
..++|.+.. .++|.+..+|..+..+++.+++.- ..........|.|.++ ..+|+ -+-| ..++.
T Consensus 479 ~~i~~~l~~-~~~~~~~~~R~~~~~~l~~l~~~~---~~~~~~~~ilp~ll~~-~~D~v---~nVR---------~~a~~ 541 (588)
T d1b3ua_ 479 ATIIPKVLA-MSGDPNYLHRMTTLFCINVLSEVC---GQDITTKHMLPTVLRM-AGDPV---ANVR---------FNVAK 541 (588)
T ss_dssp HHTHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHH---HHHHHHHHTHHHHHHG-GGCSC---HHHH---------HHHHH
T ss_pred HHHHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHC---CHHHHHHHHHHHHHHH-CCCCC---HHHH---------HHHHH
T ss_conf 999999999-865998789999999999999986---9687899999999988-59998---7999---------99999
Q ss_pred HHHHHHCCCCHHHHHHCCCCCHHHHHCCCCCCCCCCCEE
Q ss_conf 888642178012441328971045410168840100213
Q 000706 1294 SLAKMCAHTPCRQFLQSSELFPVIARLRQSPESTIANYA 1332 (1342)
Q Consensus 1294 ~L~~i~kh~~~aq~vvda~~~~~ia~l~~~~d~~~k~~~ 1332 (1342)
+|+.|+++-+- ........|.+-+|..++|..+|.+|
T Consensus 542 ~l~~i~~~~~~--~~~~~~i~~~l~~L~~D~d~dVr~~A 578 (588)
T d1b3ua_ 542 SLQKIGPILDN--STLQSEVKPILEKLTQDQDVDVKYFA 578 (588)
T ss_dssp HHHHHGGGSCH--HHHHHHHHHHHHHHTTCSSHHHHHHH
T ss_pred HHHHHHHHCCC--HHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_conf 99999987080--75799999999997579987799999
|
| >d1oyza_ a.118.1.16 (A:) Hypothetical protein YibA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: PBS lyase HEAT-like repeat domain: Hypothetical protein YibA species: Escherichia coli [TaxId: 562]
Probab=98.67 E-value=6.4e-08 Score=68.24 Aligned_cols=176 Identities=17% Similarity=0.231 Sum_probs=110.4
Q ss_pred HHHCCCCCCHHHHHHHHHHHHHHHHCHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHCCCC
Q ss_conf 35103887247899999999998316658999982896386787404992669999999998772187999996531693
Q 000706 1097 RRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRI 1176 (1342)
Q Consensus 1097 ~~~~~s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~i~LL~~lLqd~e~siqq~Aa~aLg~lakHS~eLAq~VVd~~i 1176 (1342)
..+++...+.+|..-+..+..++...+... ...++.|...+.|+.+.+++.++.++|.+. +...
T Consensus 93 ~~~l~d~~~~vr~~a~~aL~~~~~~~~~~~-----~~~~~~l~~~~~d~~~~vr~~a~~~l~~~~-----------~~~~ 156 (276)
T d1oyza_ 93 NMALNDKSACVRATAIESTAQRCKKNPIYS-----PKIVEQSQITAFDKSTNVRRATAFAISVIN-----------DKAT 156 (276)
T ss_dssp HHHHHCSCHHHHHHHHHHHHHHHHHCGGGH-----HHHHHHHHHHTTCSCHHHHHHHHHHHHTC--------------CC
T ss_pred HHHHCCCCHHHHHHHHHHHHHHCCCCCHHH-----HHHHHHHHHHHCCCCHHHHHHHHHHHHHCC-----------HHHH
T ss_conf 998669976689999999998702462101-----899999999864720489999999874102-----------3889
Q ss_pred HHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHHHHHHH
Q ss_conf 78986201799823453588999986716988899999767999996102785789998999999997289989999990
Q 000706 1177 IGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVS 1256 (1342)
Q Consensus 1177 Lp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~Vae~~p~lv~~cL~D~D~~VR~nAA~al~~IakHt~eLAq~VV~ 1256 (1342)
++.+..++.+++...+..+..+++.+........ +.++. .+.+.+..+|..++++++.+. +
T Consensus 157 ~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~-~~~~~~~~~~~~~~~al~~~~-----------~ 217 (276)
T d1oyza_ 157 IPLLINLLKDPNGDVRNWAAFAININKYDNSDIR-------DCFVE-MLQDKNEEVRIEAIIGLSYRK-----------D 217 (276)
T ss_dssp HHHHHHHHTCSSHHHHHHHHHHHHHHTCCCHHHH-------HHHHH-HTTCSCHHHHHHHHHHHHHTT-----------C
T ss_pred HHHHHHHCCCCCCHHHHHHHHHHHHHHCCCCCCC-------HHHHH-HHHHHHHHHHHHHCCCCCHHH-----------H
T ss_conf 9998874046640111357778776510211133-------16666-411000012333200100000-----------0
Q ss_pred CCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHCCCCCHHHHHCCCC-CCCCCCCEE
Q ss_conf 6966999998550653347888432234781265899888642178012441328971045410168-840100213
Q 000706 1257 KGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTPCRQFLQSSELFPVIARLRQS-PESTIANYA 1332 (1342)
Q Consensus 1257 aGav~~LVd~~~q~~~~~~~~l~~~~~~~~~~ria~~~L~~i~kh~~~aq~vvda~~~~~ia~l~~~-~d~~~k~~~ 1332 (1342)
..+++.|++... ++ ..| .-++.+|++|. |.+++|.|-.++.. .|..++++|
T Consensus 218 ~~~~~~L~~~l~-d~-----~vr---------~~a~~aL~~ig----------~~~~~~~L~~~l~~~~d~~vr~~A 269 (276)
T d1oyza_ 218 KRVLSVLCDELK-KN-----TVY---------DDIIEAAGELG----------DKTLLPVLDTMLYKFDDNEIITSA 269 (276)
T ss_dssp GGGHHHHHHHHT-SS-----SCC---------HHHHHHHHHHC----------CGGGHHHHHHHHTTSSCCHHHHHH
T ss_pred HHHHHHHHHHHC-CH-----HHH---------HHHHHHHHHCC----------CHHHHHHHHHHHCCCCCHHHHHHH
T ss_conf 004999999957-95-----999---------99999998759----------987999999998049999999999
|
| >d1qbkb_ a.118.1.1 (B:) Karyopherin beta2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Karyopherin beta2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.62 E-value=2e-07 Score=64.91 Aligned_cols=182 Identities=13% Similarity=0.171 Sum_probs=119.3
Q ss_pred HHHHHHHHHHHHHH-HCHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHCC
Q ss_conf 78999999999983-16658999982896386787404992669999999998772187999996531693789862017
Q 000706 1107 VTLDVLMIVSDLAR-MDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCA 1185 (1342)
Q Consensus 1107 ~r~~f~~~va~lar-s~~~~ie~I~~aG~i~LL~~lLqd~e~siqq~Aa~aLg~lakHS~eLAq~VVd~~iLp~Lv~~L~ 1185 (1342)
+....+..++.++. .......++.....++++..+++++.+.+|+.|..++|++++|.++.-+..++ .+++.|...|.
T Consensus 638 ~~~~~l~~l~~l~~~l~~~~~~~~~~~~l~~~l~~~l~~~~~~vr~~a~~llgdl~~~~~~~~~~~l~-~~~~~l~~~L~ 716 (888)
T d1qbkb_ 638 FMIVALDLLSGLAEGLGGNIEQLVARSNILTLMYQCMQDKMPEVRQSSFALLGDLTKACFQHVKPCIA-DFMPILGTNLN 716 (888)
T ss_dssp HHHHHHHHHHHHHHHHTTTTHHHHHTSCHHHHHHHHHTCSSHHHHHHHHHHHHHHHHHCGGGTGGGHH-HHHHHHHHTCC
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHC
T ss_conf 99999999888998730566666658569999999967997689999999988778751687787799-99999998738
Q ss_pred CCCHHHHHHHHHHHHHHHHCCHH-HHHHHHHHHHHHHHHHCCCC--CHHHHHHHHHHHHHHHHCCHHHHHHHHHCCCHHH
Q ss_conf 99823453588999986716988-89999976799999610278--5789998999999997289989999990696699
Q 000706 1186 DPDKRTRKFACFSIGNAAYHNDV-LYEELRRSIPLLANILISDE--EDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQA 1262 (1342)
Q Consensus 1186 ~~D~~~Kr~ac~~L~~iAkHs~~-LAe~Vae~~p~lv~~cL~D~--D~~VR~nAA~al~~IakHt~eLAq~VV~aGav~~ 1262 (1342)
+.+.-++.+||+++|.+|.+.++ +.+-+..+++.++. .|+++ ...|++|+|.|||-++...++.-.--..- -++.
T Consensus 717 ~~~~~v~~~a~~~ig~ia~~~~~~~~py~~~il~~L~~-il~~~~~~~~v~~n~~~~lgrl~~~~p~~~~~~l~~-~~~~ 794 (888)
T d1qbkb_ 717 PEFISVCNNATWAIGEISIQMGIEMQPYIPMVLHQLVE-IINRPNTPKTLLENTAITIGRLGYVCPQEVAPMLQQ-FIRP 794 (888)
T ss_dssp GGGHHHHHHHHHHHHHHHHHTGGGGGGGSHHHHHHHHH-HHTCTTCCHHHHHHHHHHHHHHHHHCHHHHGGGGGG-THHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCHHHHHHHHHHHHHHHHHCHHHHHHHHHH-HHHH
T ss_conf 67789999999999999998779865059999999999-876998637899999999999998797988864999-9999
Q ss_pred HHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 99985506533478884322347812658998886421780
Q 000706 1263 LIKLVADCSVLALNPSRKDAVNESPLKIALFSLAKMCAHTP 1303 (1342)
Q Consensus 1263 LVd~~~q~~~~~~~~l~~~~~~~~~~ria~~~L~~i~kh~~ 1303 (1342)
++.-...-.+ +.-| ..|...+.++-...|
T Consensus 795 ~~~~l~~~~d---~~ek---------~~~~~g~~~~i~~~p 823 (888)
T d1qbkb_ 795 WCTSLRNIRD---NEEK---------DSAFRGICTMISVNP 823 (888)
T ss_dssp HHHHHTTSCC---SHHH---------HHHHHHHHHHHHHCG
T ss_pred HHHHHCCCCC---CHHH---------HHHHHHHHHHHHHCC
T ss_conf 9997263798---1899---------999999999999784
|
| >d1oyza_ a.118.1.16 (A:) Hypothetical protein YibA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: PBS lyase HEAT-like repeat domain: Hypothetical protein YibA species: Escherichia coli [TaxId: 562]
Probab=98.60 E-value=3.7e-07 Score=63.08 Aligned_cols=135 Identities=15% Similarity=0.077 Sum_probs=95.8
Q ss_pred CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCHHHHH
Q ss_conf 34711143510388724789999999999831665899998289638678740499266999999999877218799999
Q 000706 1090 LLDPNRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYS 1169 (1342)
Q Consensus 1090 ~~~~~~~~~~~~s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~i~LL~~lLqd~e~siqq~Aa~aLg~lakHS~eLAq 1169 (1342)
-++-.....+|++..|.+|..-+....... ...+++.|..++.|+++.+|+.|+.+||.+........
T Consensus 18 ~~~~~~L~~~L~d~~~~vR~~A~~~L~~~~-----------~~~~~~~l~~~l~d~~~~vr~~a~~aL~~l~~~~~~~~- 85 (276)
T d1oyza_ 18 KLNDDELFRLLDDHNSLKRISSARVLQLRG-----------GQDAVRLAIEFCSDKNYIRRDIGAFILGQIKICKKCED- 85 (276)
T ss_dssp TSCHHHHHHHTTCSSHHHHHHHHHHHHHHC-----------CHHHHHHHHHHHTCSSHHHHHHHHHHHHHSCCCTTTHH-
T ss_pred CCCHHHHHHHHCCCCHHHHHHHHHHHHHHC-----------CHHHHHHHHHHHCCCCHHHHHHHHHHHHHHCCCCCCCC-
T ss_conf 279999998846999999999999998618-----------87399999999809998999999999987202212120-
Q ss_pred HHHCCCCH-HHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 65316937-89862017998234535889999867169888999997679999961027857899989999999972
Q 000706 1170 SLAKNRII-GLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIR 1245 (1342)
Q Consensus 1170 ~VVd~~iL-p~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~Vae~~p~lv~~cL~D~D~~VR~nAA~al~~Iak 1245 (1342)
.++ ..+...+.++|..+|++++.+|+++..+.....+. .++.+.. .+.|.++.||..++.+++.+..
T Consensus 86 -----~~~~~l~~~~l~d~~~~vr~~a~~aL~~~~~~~~~~~~~---~~~~l~~-~~~d~~~~vr~~a~~~l~~~~~ 153 (276)
T d1oyza_ 86 -----NVFNILNNMALNDKSACVRATAIESTAQRCKKNPIYSPK---IVEQSQI-TAFDKSTNVRRATAFAISVIND 153 (276)
T ss_dssp -----HHHHHHHHHHHHCSCHHHHHHHHHHHHHHHHHCGGGHHH---HHHHHHH-HTTCSCHHHHHHHHHHHHTC--
T ss_pred -----CHHHHHHHHHHCCCCHHHHHHHHHHHHHHCCCCCHHHHH---HHHHHHH-HHCCCCHHHHHHHHHHHHHCCH
T ss_conf -----229999999866997668999999999870246210189---9999999-8647204899999998741023
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.52 E-value=6.3e-07 Score=61.49 Aligned_cols=140 Identities=20% Similarity=0.217 Sum_probs=90.4
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEECCEEEEE
Q ss_conf 87889999973259379999999569959999996157999789999999999999359-99811588888708959999
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-HQNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 3 IDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLs-HPNIVKLidvfeded~iyIV 81 (1342)
++.|++.+..+.++.+.||+.. .++..+.+|......... ...+..|...+..+. +--+.+++.+.++++..|+|
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHCEEEEECCCCCCCCCEEEEE--ECCCEEEEEECCCCCCCC--HHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEE
T ss_conf 1352799767899877189999--089869999848876532--556999999999876069987289997508964999
Q ss_pred EECCCCC-HHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q ss_conf 9436988-48898609999999999999999999998660----------------------------------------
Q 000706 82 TEFAQGE-LFEILEDDKCLPEEQVQSIAKQLVRALHYLHS---------------------------------------- 120 (1342)
Q Consensus 82 MEYveGS-LlDlLek~k~LSEeeIikIl~QILkALaYLHs---------------------------------------- 120 (1342)
|++.+|. +.+..... .. ...+..++.+.+..||+
T Consensus 89 ~~~l~G~~~~~~~~~~--~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE--QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHTTTC--SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEECCCCCCCCCCCCC--CC---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 9860433435433440--26---999999899999998556842143576446565557789987765555430332320
Q ss_pred -------------------CCCEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf -------------------9925038899837975897089953363212
Q 000706 121 -------------------NRIIHRDMKPQNILIGAGSVVKLCDFGFARA 151 (1342)
Q Consensus 121 -------------------kGIVHRDIKPENILIdsdG~IKLiDFGLAk~ 151 (1342)
..++|+|+.|.||+++.++..-++||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 05799999999844986781789860047642364996599960231441
|
| >d1u6gc_ a.118.1.2 (C:) Cullin-associated NEDD8-dissociated protein 1 (Tip120) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: HEAT repeat domain: Cullin-associated NEDD8-dissociated protein 1 (Tip120) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.37 E-value=6.6e-07 Score=61.36 Aligned_cols=129 Identities=11% Similarity=0.110 Sum_probs=105.9
Q ss_pred CHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHHHH-
Q ss_conf 6386787404992669999999998772187999996531693789862017998234535889999867169888999-
Q 000706 1134 MLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEE- 1212 (1342)
Q Consensus 1134 ~i~LL~~lLqd~e~siqq~Aa~aLg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~- 1212 (1342)
.++.|...+.+++..+|..++-+||+|+...+ ...+|.|...+.++|...|..+..+++.+..+..+-.+.
T Consensus 929 i~~~L~~~~~~~~~~vr~~~a~~lg~L~~~~~--------~~~lp~L~~~l~~~~~~~r~~ai~~l~~~~~~~~~~~~~~ 1000 (1207)
T d1u6gc_ 929 IWALLLKHCECAEEGTRNVVAECLGKLTLIDP--------ETLLPRLKGYLISGSSYARSSVVTAVKFTISDHPQPIDPL 1000 (1207)
T ss_dssp HHHHHTTCCCCSSTTHHHHHHHHHHHHHHSSG--------GGTHHHHTTTSSSSCHHHHHHHHHHTGGGCCSSCCTHHHH
T ss_pred HHHHHHHHHCCCCHHHHHHHHHHHHHHHHCCH--------HHHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHCCHHHHHH
T ss_conf 99999988179718799999999998870278--------9999999998579999999999999999998665546789
Q ss_pred HHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHCCCHHHHHHHHHCCCC
Q ss_conf 997679999961027857899989999999972899899999906966999998550653
Q 000706 1213 LRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSV 1272 (1342)
Q Consensus 1213 Vae~~p~lv~~cL~D~D~~VR~nAA~al~~IakHt~eLAq~VV~aGav~~LVd~~~q~~~ 1272 (1342)
+.+.+|.++. +|+|+|+.||++|-+++..++++.++|-....+. -+|.|++.....+|
T Consensus 1001 l~~li~~ll~-~l~d~~~~vR~~al~~l~~~~~~~p~li~~~l~~-llp~l~~~t~~~~e 1058 (1207)
T d1u6gc_ 1001 LKNCIGDFLK-TLEDPDLNVRRVALVTFNSAAHNKPSLIRDLLDT-VLPHLYNETKVRKE 1058 (1207)
T ss_dssp HHHHSTTTHH-HHSSSSTHHHHHHHHHHHHHHHHCGGGTGGGHHH-HHHHHHHTTSCCGG
T ss_pred HHHHHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHCHHHHHHHHHH-HHHHHHHHHCCCHH
T ss_conf 9999999999-8679998999999999999998486989999999-99999998512564
|
| >d1qbkb_ a.118.1.1 (B:) Karyopherin beta2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Karyopherin beta2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.35 E-value=8.5e-07 Score=60.63 Aligned_cols=148 Identities=15% Similarity=0.176 Sum_probs=111.4
Q ss_pred HHCCCCCCHHHHHHHHHHHHHHHHCHHHH-HHHHHCCCHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHCCCC
Q ss_conf 51038872478999999999983166589-99982896386787404992669999999998772187999996531693
Q 000706 1098 RLLDSSTREVTLDVLMIVSDLARMDKWFY-EYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRI 1176 (1342)
Q Consensus 1098 ~~~~s~~~~~r~~f~~~va~lars~~~~i-e~I~~aG~i~LL~~lLqd~e~siqq~Aa~aLg~lakHS~eLAq~VVd~~i 1176 (1342)
..+.+..+++|..-...+.++++.....+ .++. ..++.|...+.++.++++..|+.++|+||.+..+--+..+ ..+
T Consensus 672 ~~l~~~~~~vr~~a~~llgdl~~~~~~~~~~~l~--~~~~~l~~~L~~~~~~v~~~a~~~ig~ia~~~~~~~~py~-~~i 748 (888)
T d1qbkb_ 672 QCMQDKMPEVRQSSFALLGDLTKACFQHVKPCIA--DFMPILGTNLNPEFISVCNNATWAIGEISIQMGIEMQPYI-PMV 748 (888)
T ss_dssp HHHTCSSHHHHHHHHHHHHHHHHHCGGGTGGGHH--HHHHHHHHTCCGGGHHHHHHHHHHHHHHHHHTGGGGGGGS-HHH
T ss_pred HHHCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH--HHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHHHHHHH-HHH
T ss_conf 9967997689999999988778751687787799--9999999873867789999999999999998779865059-999
Q ss_pred HHHHHHHCCCCCH--HHHHHHHHHHHHHHHCCHHH-HHHHHHHHHHHHHHHCCC-CCHHHHHHHHHHHHHHHHCCHH
Q ss_conf 7898620179982--34535889999867169888-999997679999961027-8578999899999999728998
Q 000706 1177 IGLLIDRCADPDK--RTRKFACFSIGNAAYHNDVL-YEELRRSIPLLANILISD-EEDKTKANAAGALSNLIRNSSK 1249 (1342)
Q Consensus 1177 Lp~Lv~~L~~~D~--~~Kr~ac~~L~~iAkHs~~L-Ae~Vae~~p~lv~~cL~D-~D~~VR~nAA~al~~IakHt~e 1249 (1342)
++.|+..|.+++. .++.++|-|||-++...++. ++-+...++..+. -|.+ .|..-|+.|-..++.+++.++.
T Consensus 749 l~~L~~il~~~~~~~~v~~n~~~~lgrl~~~~p~~~~~~l~~~~~~~~~-~l~~~~d~~ek~~~~~g~~~~i~~~p~ 824 (888)
T d1qbkb_ 749 LHQLVEIINRPNTPKTLLENTAITIGRLGYVCPQEVAPMLQQFIRPWCT-SLRNIRDNEEKDSAFRGICTMISVNPS 824 (888)
T ss_dssp HHHHHHHHTCTTCCHHHHHHHHHHHHHHHHHCHHHHGGGGGGTHHHHHH-HHTTSCCSHHHHHHHHHHHHHHHHCGG
T ss_pred HHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHCHHHHHHHHHHHHHHHHH-HHCCCCCCHHHHHHHHHHHHHHHHCCH
T ss_conf 9999998769986378999999999999987979888649999999999-726379818999999999999997849
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.28 E-value=5.4e-06 Score=55.21 Aligned_cols=140 Identities=19% Similarity=0.169 Sum_probs=82.3
Q ss_pred EEEEECCCCCEEEEEEEECCCCCEEEEEEEECCC----C-CHHHHHHHHHHHHHHHHC-CC--CCCCEEEEEEEECCEEE
Q ss_conf 9999732593799999995699599999961579----9-978999999999999935-99--98115888887089599
Q 000706 8 VIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHG----K-SEKDIHNLRQEIEILRKL-KH--QNIIEMLDSFESPQEFC 79 (1342)
Q Consensus 8 ILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~----~-seseikrL~rEIkILkkL-sH--PNIVKLidvfeded~iy 79 (1342)
-.+.||.|....||++.+..+++.+++|.-.... . ......+...|...++.+ .+ ..+++++.+ +++..+
T Consensus 30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~ 107 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 107 (392)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCE
T ss_conf 699807985276899995799848999617713034677788877899999999998650579885528998--598877
Q ss_pred EEEECCCCC--HHHHHHCCCCCCHHHHHHHHHHHH---------------------------------------------
Q ss_conf 999436988--488986099999999999999999---------------------------------------------
Q 000706 80 VVTEFAQGE--LFEILEDDKCLPEEQVQSIAKQLV--------------------------------------------- 112 (1342)
Q Consensus 80 IVMEYveGS--LlDlLek~k~LSEeeIikIl~QIL--------------------------------------------- 112 (1342)
++||+.++. +...+......+ .....+...+.
T Consensus 108 lvmE~L~~~~~~~~~l~~~~~~~-~~a~~lg~~La~~h~~~~~~~~~~~~~~~~~~~~~n~~l~~~~e~~~~~~py~~~~ 186 (392)
T d2pula1 108 TVMEDLSHLKIARKGLIEGENYP-HLSQHIGEFLGKTLFYSSDYALEPKVKKQLVKQFTNPELCDITERLVFTDPFFDHD 186 (392)
T ss_dssp EEECCCTTSEEHHHHHHHTCCCT-THHHHHHHHHHHHHHHTSTTTSCHHHHHHHHHHTCCHHHHHHHHHHTTTGGGTTCT
T ss_pred EEEECCCCCCCCHHHHCCCCHHH-HHHHHHHHHHHHHHHHHCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHCCHHHHHHH
T ss_conf 98713577653022201542128-99999999999999873503344211101233446578887777640104788988
Q ss_pred ----------------------HHHHHH------HHCCCEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf ----------------------999986------609925038899837975897089953363212
Q 000706 113 ----------------------RALHYL------HSNRIIHRDMKPQNILIGAGSVVKLCDFGFARA 151 (1342)
Q Consensus 113 ----------------------kALaYL------HskGIVHRDIKPENILIdsdG~IKLiDFGLAk~ 151 (1342)
.....+ ....++|||+.|.|||++.+ .++++||..+..
T Consensus 187 ~~~~~~~~~~~~~~l~~d~~l~~~~~~l~~~~~~~~~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 187 TNDFEEELRPFVEKLWNNDSVKIEAAKLKKSFLTSAETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp TCCCCGGGHHHHHHHHTCHHHHHHHHHHHHHHHHBCCEEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred HHHCCHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCEECCCCCCCCEEECCC-CEEEECHHHCCC
T ss_conf 741065455778765520789999999874323688600335776784667599-308952265222
|
| >d1u6gc_ a.118.1.2 (C:) Cullin-associated NEDD8-dissociated protein 1 (Tip120) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: HEAT repeat domain: Cullin-associated NEDD8-dissociated protein 1 (Tip120) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.22 E-value=1.8e-05 Score=51.61 Aligned_cols=111 Identities=23% Similarity=0.267 Sum_probs=73.1
Q ss_pred CCCHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHH-
Q ss_conf 8963867874049926699999999987721879999965316937898620179982345358899998671698889-
Q 000706 1132 ASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLY- 1210 (1342)
Q Consensus 1132 aG~i~LL~~lLqd~e~siqq~Aa~aLg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LA- 1210 (1342)
...+|.|..++.++.+.+|+.++.+++.+..++++-....+.. .++.+...|+++|..+||.|..+|.+++++.++|-
T Consensus 961 ~~~lp~L~~~l~~~~~~~r~~ai~~l~~~~~~~~~~~~~~l~~-li~~ll~~l~d~~~~vR~~al~~l~~~~~~~p~li~ 1039 (1207)
T d1u6gc_ 961 ETLLPRLKGYLISGSSYARSSVVTAVKFTISDHPQPIDPLLKN-CIGDFLKTLEDPDLNVRRVALVTFNSAAHNKPSLIR 1039 (1207)
T ss_dssp GGTHHHHTTTSSSSCHHHHHHHHHHTGGGCCSSCCTHHHHHHH-HSTTTHHHHSSSSTHHHHHHHHHHHHHHHHCGGGTG
T ss_pred HHHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHCCHHHHHHHHH-HHHHHHHHHCCCCHHHHHHHHHHHHHHHHHCHHHHH
T ss_conf 9999999998579999999999999999998665546789999-999999986799989999999999999984869899
Q ss_pred HHHHHHHHHHHHHHCCCC------------------CHHHHHHHHHHHHHHH
Q ss_conf 999976799999610278------------------5789998999999997
Q 000706 1211 EELRRSIPLLANILISDE------------------EDKTKANAAGALSNLI 1244 (1342)
Q Consensus 1211 e~Vae~~p~lv~~cL~D~------------------D~~VR~nAA~al~~Ia 1244 (1342)
+.+..++|.++. ..+.. ---+||+|.-|+-.+.
T Consensus 1040 ~~l~~llp~l~~-~t~~~~e~ir~v~~gp~kh~~d~gl~~rk~a~e~~~~~l 1090 (1207)
T d1u6gc_ 1040 DLLDTVLPHLYN-ETKVRKELIREVEMGPFKHTVDDGLDIRKAAFECMYTLL 1090 (1207)
T ss_dssp GGHHHHHHHHHH-TTSCCGGGEEEEEETTEEEEEETHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH-HHCCCHHHEEEEECCCCEEECCCCHHHHHHHHHHHHHHH
T ss_conf 999999999999-851256430345058951105885899999999999999
|
| >d1ibrb_ a.118.1.1 (B:) Importin beta {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Importin beta species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.12 E-value=8.4e-06 Score=53.89 Aligned_cols=116 Identities=16% Similarity=0.183 Sum_probs=85.3
Q ss_pred CCCCHHHHHHHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHCC--HHHHHHHHHHHHHH
Q ss_conf 4992669999999998772187999996531693789862017998234535889999867169--88899999767999
Q 000706 1143 THEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHN--DVLYEELRRSIPLL 1220 (1342)
Q Consensus 1143 qd~e~siqq~Aa~aLg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs--~~LAe~Vae~~p~l 1220 (1342)
.|.+.+++..|+.+++.+++-.++ .+. ..+++.+...+.++|.+.|..++++|++++.+. ..+.+.+.+++|.+
T Consensus 337 ~~~~~~~~~~a~~~l~~l~~~~~~---~~~-~~l~~~i~~~l~s~~~~~r~aal~~l~~i~~~~~~~~~~~~l~~i~~~l 412 (458)
T d1ibrb_ 337 DDDDWNPCKAAGVCLMLLATCCED---DIV-PHVLPFIKEHIKNPDWRYRDAAVMAFGCILEGPEPSQLKPLVIQAMPTL 412 (458)
T ss_dssp CTTCCSHHHHHHHHHHHHHHHTTT---THH-HHHHHHHHHHTTCSSHHHHHHHHHHHHHTSSSSCTTTTCTTTTTHHHHH
T ss_pred CCCCCCHHHHHHHHHHHHHHHCCH---HHH-HHHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_conf 112233999999999999875517---556-6789999998569998999999999999997547767898899999999
Q ss_pred HHHHCCCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHCCCHHHHHHH
Q ss_conf 9961027857899989999999972899899999906966999998
Q 000706 1221 ANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKL 1266 (1342)
Q Consensus 1221 v~~cL~D~D~~VR~nAA~al~~IakHt~eLAq~VV~aGav~~LVd~ 1266 (1342)
+. +|+|+++.||.+|+|||+.++.+-++ ...+.--++.|++.
T Consensus 413 ~~-~l~d~~~~VR~~a~~~l~~i~~~~~~---~~~~~~~l~~ll~~ 454 (458)
T d1ibrb_ 413 IE-LMKDPSVVVRDTAAWTVGRICELLPE---AAINDVYLAPLLQC 454 (458)
T ss_dssp HH-GGGCSCHHHHHHHHHHHHHHHHHGGG---GCCSTTTHHHHHHH
T ss_pred HH-HHCCCCHHHHHHHHHHHHHHHHHHHC---CCCHHHHHHHHHHH
T ss_conf 98-84899899999999999999997201---00135689999999
|
| >d1te4a_ a.118.1.16 (A:) MTH187 {Archaeon Methanobacterium thermoautotrophicum [TaxId: 145262]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: PBS lyase HEAT-like repeat domain: MTH187 species: Archaeon Methanobacterium thermoautotrophicum [TaxId: 145262]
Probab=98.12 E-value=3.9e-06 Score=56.12 Aligned_cols=86 Identities=23% Similarity=0.199 Sum_probs=38.9
Q ss_pred CHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHHHHH
Q ss_conf 63867874049926699999999987721879999965316937898620179982345358899998671698889999
Q 000706 1134 MLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEEL 1213 (1342)
Q Consensus 1134 ~i~LL~~lLqd~e~siqq~Aa~aLg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~V 1213 (1342)
+++.|+.++.|+++.+|+.|+.+||++.. .++++.|...|.|+|..+|+.|+.+|+.+..
T Consensus 23 ~~~~L~~~l~d~~~~vR~~a~~~L~~~~~-----------~~~~~~L~~~l~d~~~~VR~~a~~aL~~i~~--------- 82 (111)
T d1te4a_ 23 AFEPLLESLSNEDWRIRGAAAWIIGNFQD-----------ERAVEPLIKLLEDDSGFVRSGAARSLEQIGG--------- 82 (111)
T ss_dssp THHHHHHGGGCSCHHHHHHHHHHHGGGCS-----------HHHHHHHHHHHHHCCTHHHHHHHHHHHHHCS---------
T ss_pred HHHHHHHHHCCCCHHHHHHHHHHHHHCCH-----------HHHHHHHHHHHCCCHHHHHHHHHHHHHHHCC---------
T ss_conf 99999999749987899999999876101-----------2327998733023033799999999998676---------
Q ss_pred HHHHHHHHHHHCCCCCHHHHHHHHHHH
Q ss_conf 976799999610278578999899999
Q 000706 1214 RRSIPLLANILISDEEDKTKANAAGAL 1240 (1342)
Q Consensus 1214 ae~~p~lv~~cL~D~D~~VR~nAA~al 1240 (1342)
.+..|.|.. +|+|+|+.||++|+.+|
T Consensus 83 ~~~~~~L~~-ll~d~~~~vr~~A~~aL 108 (111)
T d1te4a_ 83 ERVRAAMEK-LAETGTGFARKVAVNYL 108 (111)
T ss_dssp HHHHHHHHH-HTTSCCTHHHHHHHHHG
T ss_pred CCHHHHHHH-HHCCCCHHHHHHHHHHH
T ss_conf 114999999-88299899999999998
|
| >d1te4a_ a.118.1.16 (A:) MTH187 {Archaeon Methanobacterium thermoautotrophicum [TaxId: 145262]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: PBS lyase HEAT-like repeat domain: MTH187 species: Archaeon Methanobacterium thermoautotrophicum [TaxId: 145262]
Probab=98.10 E-value=4.1e-07 Score=62.75 Aligned_cols=109 Identities=26% Similarity=0.350 Sum_probs=84.3
Q ss_pred HCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
Q ss_conf 04992669999999998772187999996531693789862017998234535889999867169888999997679999
Q 000706 1142 LTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLA 1221 (1342)
Q Consensus 1142 Lqd~e~siqq~Aa~aLg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~Vae~~p~lv 1221 (1342)
|.|+.+.||+.|+.+||++.. ..++.|+..|.|+|..+|+.|+.+|+.+.. .+.+|.+.
T Consensus 1 L~D~~~~VR~~A~~aL~~~~~------------~~~~~L~~~l~d~~~~vR~~a~~~L~~~~~---------~~~~~~L~ 59 (111)
T d1te4a_ 1 MADENKWVRRDVSTALSRMGD------------EAFEPLLESLSNEDWRIRGAAAWIIGNFQD---------ERAVEPLI 59 (111)
T ss_dssp CCSSCCCSSSSCCSSTTSCSS------------TTHHHHHHGGGCSCHHHHHHHHHHHGGGCS---------HHHHHHHH
T ss_pred CCCCCHHHHHHHHHHHHHHCH------------HHHHHHHHHHCCCCHHHHHHHHHHHHHCCH---------HHHHHHHH
T ss_conf 989599999999999987387------------899999999749987899999999876101---------23279987
Q ss_pred HHHCCCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 961027857899989999999972899899999906966999998550653347888432234781265899888
Q 000706 1222 NILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAMQALIKLVADCSVLALNPSRKDAVNESPLKIALFSLA 1296 (1342)
Q Consensus 1222 ~~cL~D~D~~VR~nAA~al~~IakHt~eLAq~VV~aGav~~LVd~~~q~~~~~~~~l~~~~~~~~~~ria~~~L~ 1296 (1342)
. +|+|.|+.||.+|+++|+.| +++ ++++.|.++. ++++ -..| +.|+.+|.
T Consensus 60 ~-~l~d~~~~VR~~a~~aL~~i--~~~---------~~~~~L~~ll-~d~~---~~vr---------~~A~~aL~ 109 (111)
T d1te4a_ 60 K-LLEDDSGFVRSGAARSLEQI--GGE---------RVRAAMEKLA-ETGT---GFAR---------KVAVNYLE 109 (111)
T ss_dssp H-HHHHCCTHHHHHHHHHHHHH--CSH---------HHHHHHHHHT-TSCC---THHH---------HHHHHHGG
T ss_pred H-HHCCCHHHHHHHHHHHHHHH--CCC---------CHHHHHHHHH-CCCC---HHHH---------HHHHHHHH
T ss_conf 3-30230337999999999986--761---------1499999988-2998---9999---------99999987
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.04 E-value=2.2e-05 Score=51.12 Aligned_cols=132 Identities=17% Similarity=0.158 Sum_probs=80.4
Q ss_pred CEEEEEEECCCC-CEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCC--CCCCEEEEEEEECCEEEEE
Q ss_conf 889999973259-3799999995699599999961579997899999999999993599--9811588888708959999
Q 000706 5 NYHVIELVGEGS-FGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKH--QNIIEMLDSFESPQEFCVV 81 (1342)
Q Consensus 5 rYkILK~LGsGa-FGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsH--PNIVKLidvfeded~iyIV 81 (1342)
.++. +.+..|. .+.||+.... .+..+.+|....... ..+..|...++.+.. -.+.+++....+++..+++
T Consensus 12 g~~~-~~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 12 GYDW-AQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp TCEE-EECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCCE-EECCCCCCCCEEEEEEEC-CCCEEEEEECCCCCH-----HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEE
T ss_conf 9835-876786547758999938-987899995896677-----689999999999986599988613222456615999
Q ss_pred EECCCCC-HHHHHHCCCCCCHHHHHHHHHHHHHH----------------------------------------------
Q ss_conf 9436988-48898609999999999999999999----------------------------------------------
Q 000706 82 TEFAQGE-LFEILEDDKCLPEEQVQSIAKQLVRA---------------------------------------------- 114 (1342)
Q Consensus 82 MEYveGS-LlDlLek~k~LSEeeIikIl~QILkA---------------------------------------------- 114 (1342)
|++++|. +.+. ...... ...++...
T Consensus 85 ~~~i~G~~~~~~-----~~~~~~---~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (255)
T d1nd4a_ 85 LGEVPGQDLLSS-----HLAPAE---KVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 156 (255)
T ss_dssp EECCSSEETTTS-----CCCHHH---HHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EEEEECCCCCCC-----CCCHHH---HHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHH
T ss_conf 874413554322-----126899---999999999987368854488755412468899999987541101134011213
Q ss_pred -----HHHHHH-------CCCEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf -----998660-------9925038899837975897089953363212
Q 000706 115 -----LHYLHS-------NRIIHRDMKPQNILIGAGSVVKLCDFGFARA 151 (1342)
Q Consensus 115 -----LaYLHs-------kGIVHRDIKPENILIdsdG~IKLiDFGLAk~ 151 (1342)
+..+.+ ..++|+|+.|.|||++.++..-++||+.+..
T Consensus 157 ~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 157 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 7999999998718765795678678887635773796589998533265
|
| >d1ibrb_ a.118.1.1 (B:) Importin beta {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Importin beta species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.00 E-value=7.7e-06 Score=54.15 Aligned_cols=88 Identities=18% Similarity=0.148 Sum_probs=51.5
Q ss_pred CHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHHHHH
Q ss_conf 63867874049926699999999987721879999965316937898620179982345358899998671698889999
Q 000706 1134 MLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEEL 1213 (1342)
Q Consensus 1134 ~i~LL~~lLqd~e~siqq~Aa~aLg~lakHS~eLAq~VVd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~V 1213 (1342)
.++.+...+.++++.+|..|+.+||.++.....-.-.-.-..++|.|+.++.|++..+|..||.||++++.+-++-.. .
T Consensus 366 l~~~i~~~l~s~~~~~r~aal~~l~~i~~~~~~~~~~~~l~~i~~~l~~~l~d~~~~VR~~a~~~l~~i~~~~~~~~~-~ 444 (458)
T d1ibrb_ 366 VLPFIKEHIKNPDWRYRDAAVMAFGCILEGPEPSQLKPLVIQAMPTLIELMKDPSVVVRDTAAWTVGRICELLPEAAI-N 444 (458)
T ss_dssp HHHHHHHHTTCSSHHHHHHHHHHHHHTSSSSCTTTTCTTTTTHHHHHHHGGGCSCHHHHHHHHHHHHHHHHHGGGGCC-S
T ss_pred HHHHHHHHHCCCCHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHCCCC-H
T ss_conf 899999985699989999999999999975477678988999999999884899899999999999999997201001-3
Q ss_pred HHHHHHHHH
Q ss_conf 976799999
Q 000706 1214 RRSIPLLAN 1222 (1342)
Q Consensus 1214 ae~~p~lv~ 1222 (1342)
.+.+|+++.
T Consensus 445 ~~~l~~ll~ 453 (458)
T d1ibrb_ 445 DVYLAPLLQ 453 (458)
T ss_dssp TTTHHHHHH
T ss_pred HHHHHHHHH
T ss_conf 568999999
|
| >d2bpta1 a.118.1.1 (A:1-861) Importin beta {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Importin beta species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.72 E-value=0.0002 Score=44.61 Aligned_cols=187 Identities=15% Similarity=0.195 Sum_probs=121.2
Q ss_pred HCCCCCCHHHHHHHHHHHHHHHH-CHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHCCCCH
Q ss_conf 10388724789999999999831-66589999828963867874049926699999999987721879999965316937
Q 000706 1099 LLDSSTREVTLDVLMIVSDLARM-DKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRII 1177 (1342)
Q Consensus 1099 ~~~s~~~~~r~~f~~~va~lars-~~~~ie~I~~aG~i~LL~~lLqd~e~siqq~Aa~aLg~lakHS~eLAq~VVd~~iL 1177 (1342)
+..++...+|.+.+..++.++.. +.....|+. .++|.|..++++.++.+++.|+.++|+|++..++.-...++ +++
T Consensus 606 l~~~~~~~v~~~~l~~l~~l~~~~~~~~~~~l~--~i~p~l~~~l~~~~~~v~~~a~~~l~~i~~~~~~~~~~~~~-~i~ 682 (861)
T d2bpta1 606 LEKKDSAFIEDDVFYAISALAASLGKGFEKYLE--TFSPYLLKALNQVDSPVSITAVGFIADISNSLEEDFRRYSD-AMM 682 (861)
T ss_dssp HHSTTGGGTHHHHHHHHHHHHHHHGGGGHHHHH--HHHHHHHHHHHCTTSHHHHHHHHHHHHHHHHTGGGGHHHHH-HHH
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH--HHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH-HHH
T ss_conf 015883658878999998888774578999999--97059998737998899999999999999975787271199-999
Q ss_pred HHHHHHCCCC--CHHHHHHHHHHHHHHHHCCH-HHHHHHHHHHHHHHHHHCCCC-----------CHHHHHHHHHHHHHH
Q ss_conf 8986201799--82345358899998671698-889999976799999610278-----------578999899999999
Q 000706 1178 GLLIDRCADP--DKRTRKFACFSIGNAAYHND-VLYEELRRSIPLLANILISDE-----------EDKTKANAAGALSNL 1243 (1342)
Q Consensus 1178 p~Lv~~L~~~--D~~~Kr~ac~~L~~iAkHs~-~LAe~Vae~~p~lv~~cL~D~-----------D~~VR~nAA~al~~I 1243 (1342)
+.|...++++ +..+|..++.||+.++..-+ .+.+-+..++|-+.. .+... -..||+++.+++..|
T Consensus 683 ~~L~~~l~~~~~~~~~k~~~~~~l~~i~~~~~~~~~~~l~~~~~~l~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~i 761 (861)
T d2bpta1 683 NVLAQMISNPNARRELKPAVLSVFGDIASNIGADFIPYLNDIMALCVA-AQNTKPENGTLEALDYQIKVLEAVLDAYVGI 761 (861)
T ss_dssp HHHHHHHHCTTCCTTHHHHHHHHHHHHHHHHGGGGHHHHHHHHHHHHH-HHTCCCSSSSHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_conf 999998578888899999999999999999879889999999999999-8576777541899999999999999999999
Q ss_pred HH---CCHHHHHHHHHCCCHHHHHHH---HHCCCCCCC-CCCCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 72---899899999906966999998---550653347-8884322347812658998886421780
Q 000706 1244 IR---NSSKLCEDIVSKGAMQALIKL---VADCSVLAL-NPSRKDAVNESPLKIALFSLAKMCAHTP 1303 (1342)
Q Consensus 1244 ak---Ht~eLAq~VV~aGav~~LVd~---~~q~~~~~~-~~l~~~~~~~~~~ria~~~L~~i~kh~~ 1303 (1342)
.. .+++.-+-. ++.++++ +.+++.... ...+ +.++..++++|..-+
T Consensus 762 ~~~~~~~~~~~~p~-----~~~i~~~i~~~~~~~~~~~~~~~~---------~~~~~~i~~l~~~~~ 814 (861)
T d2bpta1 762 VAGLHDKPEALFPY-----VGTIFQFIAQVAEDPQLYSEDATS---------RAAVGLIGDIAAMFP 814 (861)
T ss_dssp HHHTTTCHHHHGGG-----HHHHHHHHHHHHHCHHHHTSHHHH---------HHHHHHHHHHHHHCT
T ss_pred HHHHCCCHHHHHHH-----HHHHHHHHHHHHHCCCCCCCHHHH---------HHHHHHHHHHHHHCC
T ss_conf 99845777789988-----999999999997077658779999---------999999999998774
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.49 E-value=0.00067 Score=41.03 Aligned_cols=131 Identities=17% Similarity=0.225 Sum_probs=75.1
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCC--CEEE-----EEEEECCEEEEEEECCCC
Q ss_conf 593799999995699599999961579997899999999999993599981--1588-----888708959999943698
Q 000706 15 GSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQNI--IEML-----DSFESPQEFCVVTEFAQG 87 (1342)
Q Consensus 15 GaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPNI--VKLi-----dvfeded~iyIVMEYveG 87 (1342)
+.-..||++... +|+.|++|+.+....+. +.+..|...+..+....+ +... ..++..+..+.++++.+|
T Consensus 33 s~EN~vy~v~~~-dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQDE-DRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECCT-TCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred CCCCEEEEEECC-CCCEEEEEEECCCCCCH---HHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCC
T ss_conf 612026999838-99979999847877889---99999999999998559987875206898056653479999865277
Q ss_pred CHH-----HHHH-------------CC------CC-------------------CCHH---HHHHHHHHHHHHHHHHH--
Q ss_conf 848-----8986-------------09------99-------------------9999---99999999999999866--
Q 000706 88 ELF-----EILE-------------DD------KC-------------------LPEE---QVQSIAKQLVRALHYLH-- 119 (1342)
Q Consensus 88 SLl-----DlLe-------------k~------k~-------------------LSEe---eIikIl~QILkALaYLH-- 119 (1342)
... +.+. .. .. ++.. .....+.++...+.-.-
T Consensus 109 ~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 188 (325)
T d1zyla1 109 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 188 (325)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 68899999999998999999886303578655677897887665689998747699889899999999999999984545
Q ss_pred --HCCCEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf --09925038899837975897089953363212
Q 000706 120 --SNRIIHRDMKPQNILIGAGSVVKLCDFGFARA 151 (1342)
Q Consensus 120 --skGIVHRDIKPENILIdsdG~IKLiDFGLAk~ 151 (1342)
..+++|+|+.+.|||++++ ..++||+-+..
T Consensus 189 ~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 189 DFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CCCCEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 687120247888042878389--35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.35 E-value=0.0024 Score=37.26 Aligned_cols=77 Identities=14% Similarity=0.198 Sum_probs=49.8
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECC-------CCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEE
Q ss_conf 8788999997325937999999956-------9959999996157999789999999999999359-9981158888870
Q 000706 3 VENYHVIELVGEGSFGKVYKGRRKY-------TGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLK-HQNIIEMLDSFES 74 (1342)
Q Consensus 3 IDrYkILK~LGsGaFGtVYKArdk~-------TGk~VAIKvIkKs~~seseikrL~rEIkILkkLs-HPNIVKLidvfed 74 (1342)
.++.++ +.|+.|-...+|++.... ..+.+.+++.-. .... ....+|..+++.+. +.-..++++++.+
T Consensus 42 ~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 42 LEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETE---SHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred CCCEEE-EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC-CCHH---HHHHHHHHHHHHHHHCCCCCEEEEECCC
T ss_conf 301699-9917853343489996887754457898179996599-6116---5899999999999757999808998189
Q ss_pred CCEEEEEEECCCCC
Q ss_conf 89599999436988
Q 000706 75 PQEFCVVTEFAQGE 88 (1342)
Q Consensus 75 ed~iyIVMEYveGS 88 (1342)
++||||++|.
T Consensus 117 ----g~I~efi~g~ 126 (395)
T d1nw1a_ 117 ----GRLEEYIPSR 126 (395)
T ss_dssp ----EEEECCCCEE
T ss_pred ----CEEEEEECCC
T ss_conf ----5699973455
|
| >d1lrva_ a.118.1.5 (A:) Leucine-rich repeat variant {Azotobacter vinelandii [TaxId: 354]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Leucine-rich repeat variant domain: Leucine-rich repeat variant species: Azotobacter vinelandii [TaxId: 354]
Probab=97.27 E-value=0.0022 Score=37.49 Aligned_cols=161 Identities=20% Similarity=0.239 Sum_probs=77.0
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCHHHHHCCCCC-----CCCCCCHHHHHHHHHCCCHHHHHHHCCCCC
Q ss_conf 889732334536699999845558789865098504346201222-----112485089999882080258886204534
Q 000706 1017 SAGGKVCMEDRDMAKAIEEDMGKYIKILMEVGVPGIILRCLEHME-----LKNLGRPIAFLAKMIGQRSLAVQLVGKGLL 1091 (1342)
Q Consensus 1017 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~pi~~l~~~~~~~~~~~q~v~~~~~ 1091 (1342)
.-.|+.||-|+-+ +-|+- +.+. -|...-..+.|=. .---.-|+..|.+|..|+...|.-..-..+
T Consensus 21 c~~~~~~~~~~~~-~~~dr----f~~~-----~p~l~~~~l~~p~~e~Ra~Aa~~a~~~~L~~Ll~D~d~~VR~~AA~~L 90 (233)
T d1lrva_ 21 CTPGDACVAVESG-RQIDR----FFRN-----NPHLAVQYLADPFWERRAIAVRYSPVEALTPLIRDSDEVVRRAVAYRL 90 (233)
T ss_dssp SBTTTBCSSSSCH-HHHHH----HHHH-----CGGGGGGGTTCSSHHHHHHHHTTSCGGGGGGGTTCSSHHHHHHHHTTS
T ss_pred CCCHHHHHHHHHH-HHHHH----HHHC-----CHHHHHHHHCCCCHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHHHHC
T ss_conf 7713889999999-99989----9850-----989999885499699999987019999999882698989999999974
Q ss_pred CHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCHHHHHHH
Q ss_conf 71114351038872478999999999983166589999828963867874049926699999999987721879999965
Q 000706 1092 DPNRVRRLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSL 1171 (1342)
Q Consensus 1092 ~~~~~~~~~~s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~i~LL~~lLqd~e~siqq~Aa~aLg~lakHS~eLAq~V 1171 (1342)
.+.....++....++||....... ..+.|..++.|+++.|++.++..+
T Consensus 91 p~~~L~~L~~D~d~~VR~~aa~~l------------------~~~~L~~Ll~D~d~~VR~~aa~~~-------------- 138 (233)
T d1lrva_ 91 PREQLSALMFDEDREVRITVADRL------------------PLEQLEQMAADRDYLVRAYVVQRI-------------- 138 (233)
T ss_dssp CSGGGGGTTTCSCHHHHHHHHHHS------------------CTGGGGGGTTCSSHHHHHHHHHHS--------------
T ss_pred CHHHHHHHHCCCCHHHHHHHHHCC------------------CHHHHHHHHCCCCHHHHHHHHHCC--------------
T ss_conf 899999984499746899887426------------------889999985599878999998611--------------
Q ss_pred HCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHH
Q ss_conf 316937898620179982345358899998671698889999976799999610278578999899999
Q 000706 1172 AKNRIIGLLIDRCADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGAL 1240 (1342)
Q Consensus 1172 Vd~~iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~LAe~Vae~~p~lv~~cL~D~D~~VR~nAA~al 1240 (1342)
..+.|..++.++|..+|+.++..++ .+.+.. +++|.|+.||+++|..+
T Consensus 139 ----~~~~L~~L~~D~d~~VR~~aA~~~~----------------~~~L~~-l~~D~d~~VR~~aa~~L 186 (233)
T d1lrva_ 139 ----PPGRLFRFMRDEDRQVRKLVAKRLP----------------EESLGL-MTQDPEPEVRRIVASRL 186 (233)
T ss_dssp ----CGGGGGGTTTCSCHHHHHHHHHHSC----------------GGGGGG-STTCSSHHHHHHHHHHC
T ss_pred ----CHHHHHHHHCCCCHHHHHHHHHHCC----------------HHHHHH-HCCCCCHHHHHHHHHHC
T ss_conf ----0668998834897899999998459----------------999998-70599889999999845
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.25 E-value=0.0014 Score=38.94 Aligned_cols=143 Identities=15% Similarity=0.158 Sum_probs=79.2
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCC--CCEEE------EEEE
Q ss_conf 887889999973259379999999569959999996157999789999999999999359998--11588------8887
Q 000706 2 GVENYHVIELVGEGSFGKVYKGRRKYTGQTVAMKFIMKHGKSEKDIHNLRQEIEILRKLKHQN--IIEML------DSFE 73 (1342)
Q Consensus 2 dIDrYkILK~LGsGaFGtVYKArdk~TGk~VAIKvIkKs~~seseikrL~rEIkILkkLsHPN--IVKLi------dvfe 73 (1342)
++++..-.+.|..|--.+.|+.... +..|++|+..+.. +. ..+..|++++..+...+ +.... .+..
T Consensus 16 ~lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~-~~---~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~ 89 (316)
T d2ppqa1 16 DVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV-EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE 89 (316)
T ss_dssp CCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred CCCCCEEEECCCCCCCCCEEEEEEC--CCCEEEEECCCCC-CH---HHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEE
T ss_conf 9998568523788852673899978--9728999807899-98---8999999998754302555455641048976213
Q ss_pred ECCEEEEEEECCCCCHH-----HH---H-------H---CCC------CC------------------CHHHHHHHHHHH
Q ss_conf 08959999943698848-----89---8-------6---099------99------------------999999999999
Q 000706 74 SPQEFCVVTEFAQGELF-----EI---L-------E---DDK------CL------------------PEEQVQSIAKQL 111 (1342)
Q Consensus 74 ded~iyIVMEYveGSLl-----Dl---L-------e---k~k------~L------------------SEeeIikIl~QI 111 (1342)
-......++.+..|.-. .. + . ... .. ........+...
T Consensus 90 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 169 (316)
T d2ppqa1 90 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE 169 (316)
T ss_dssp ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred EECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHH
T ss_conf 41255024531146553332046788888998764544432024531011101200245677776531141279999999
Q ss_pred HHHHHHHH----HCCCEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 99999866----0992503889983797589708995336321
Q 000706 112 VRALHYLH----SNRIIHRDMKPQNILIGAGSVVKLCDFGFAR 150 (1342)
Q Consensus 112 LkALaYLH----skGIVHRDIKPENILIdsdG~IKLiDFGLAk 150 (1342)
...+.... ..|++|+|+.++||+++.+...-++||+.+.
T Consensus 170 ~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 170 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 8764204855454503337863656402045412674222123
|
| >d2bpta1 a.118.1.1 (A:1-861) Importin beta {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Importin beta species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.25 E-value=0.00047 Score=42.07 Aligned_cols=140 Identities=14% Similarity=0.242 Sum_probs=60.3
Q ss_pred CCCCCHHHHHHHHHHHHHHHHCHHHHHHHHHCCCHHHHHHHHCCCC--HHHHHHHHHHHHHHHCCCH-HHHHHHHCCCCH
Q ss_conf 3887247899999999998316658999982896386787404992--6699999999987721879-999965316937
Q 000706 1101 DSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHED--PNVRAKACSALGNMCRHSS-YFYSSLAKNRII 1177 (1342)
Q Consensus 1101 ~s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~i~LL~~lLqd~e--~siqq~Aa~aLg~lakHS~-eLAq~VVd~~iL 1177 (1342)
....+.+|..-+..++++++.....+.... ...++.|..+++++. +.+|..+..+||+|+..-. ++..-+ +.++
T Consensus 649 ~~~~~~v~~~a~~~l~~i~~~~~~~~~~~~-~~i~~~L~~~l~~~~~~~~~k~~~~~~l~~i~~~~~~~~~~~l--~~~~ 725 (861)
T d2bpta1 649 NQVDSPVSITAVGFIADISNSLEEDFRRYS-DAMMNVLAQMISNPNARRELKPAVLSVFGDIASNIGADFIPYL--NDIM 725 (861)
T ss_dssp HCTTSHHHHHHHHHHHHHHHHTGGGGHHHH-HHHHHHHHHHHHCTTCCTTHHHHHHHHHHHHHHHHGGGGHHHH--HHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHH--HHHH
T ss_conf 799889999999999999997578727119-9999999998578888899999999999999999879889999--9999
Q ss_pred HHHHHHCCCCC-----------HHHHHHHHHHHHHHHH---CCH-HHHHHHHHHHHHHHHHHCCC----CCHHHHHHHHH
Q ss_conf 89862017998-----------2345358899998671---698-88999997679999961027----85789998999
Q 000706 1178 GLLIDRCADPD-----------KRTRKFACFSIGNAAY---HND-VLYEELRRSIPLLANILISD----EEDKTKANAAG 1238 (1342)
Q Consensus 1178 p~Lv~~L~~~D-----------~~~Kr~ac~~L~~iAk---Hs~-~LAe~Vae~~p~lv~~cL~D----~D~~VR~nAA~ 1238 (1342)
+.+...+..+. ..+|..++.++..+.+ .++ .+.+.+..+++.+.. .++| .++.++++++.
T Consensus 726 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~i~~~~~~~~~~~~p~~~~i~~~i~~-~~~~~~~~~~~~~~~~~~~ 804 (861)
T d2bpta1 726 ALCVAAQNTKPENGTLEALDYQIKVLEAVLDAYVGIVAGLHDKPEALFPYVGTIFQFIAQ-VAEDPQLYSEDATSRAAVG 804 (861)
T ss_dssp HHHHHHHTCCCSSSSHHHHHHHHHHHHHHHHHHHHHHHHTTTCHHHHGGGHHHHHHHHHH-HHHCHHHHTSHHHHHHHHH
T ss_pred HHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHH-HHHCCCCCCCHHHHHHHHH
T ss_conf 999998576777541899999999999999999999998457777899889999999999-9707765877999999999
Q ss_pred HHHHHH
Q ss_conf 999997
Q 000706 1239 ALSNLI 1244 (1342)
Q Consensus 1239 al~~Ia 1244 (1342)
+||.++
T Consensus 805 ~i~~l~ 810 (861)
T d2bpta1 805 LIGDIA 810 (861)
T ss_dssp HHHHHH
T ss_pred HHHHHH
T ss_conf 999999
|
| >d1lrva_ a.118.1.5 (A:) Leucine-rich repeat variant {Azotobacter vinelandii [TaxId: 354]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Leucine-rich repeat variant domain: Leucine-rich repeat variant species: Azotobacter vinelandii [TaxId: 354]
Probab=97.23 E-value=9.7e-05 Score=46.70 Aligned_cols=24 Identities=25% Similarity=0.297 Sum_probs=12.3
Q ss_pred HHHHHHHHCCCCHHHHHHHHHHHH
Q ss_conf 386787404992669999999998
Q 000706 1135 LEFLKDFLTHEDPNVRAKACSALG 1158 (1342)
Q Consensus 1135 i~LL~~lLqd~e~siqq~Aa~aLg 1158 (1342)
+.+|..++.|+++.||+.++..||
T Consensus 68 ~~~L~~Ll~D~d~~VR~~AA~~Lp 91 (233)
T d1lrva_ 68 VEALTPLIRDSDEVVRRAVAYRLP 91 (233)
T ss_dssp GGGGGGGTTCSSHHHHHHHHTTSC
T ss_pred HHHHHHHHCCCCHHHHHHHHHHCC
T ss_conf 999998826989899999999748
|
| >d1qgra_ a.118.1.1 (A:) Importin beta {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Importin beta species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.54 E-value=0.02 Score=31.01 Aligned_cols=101 Identities=21% Similarity=0.268 Sum_probs=46.2
Q ss_pred CCHHHHHHHHHHHHHHHHCHH-HHHHHHHCCCHHHHHHHHCCCC-HHHHHHHHHHHHHHHCCCHHHHHHHHCCCCHHHHH
Q ss_conf 724789999999999831665-8999982896386787404992-66999999999877218799999653169378986
Q 000706 1104 TREVTLDVLMIVSDLARMDKW-FYEYINGASMLEFLKDFLTHED-PNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLI 1181 (1342)
Q Consensus 1104 ~~~~r~~f~~~va~lars~~~-~ie~I~~aG~i~LL~~lLqd~e-~siqq~Aa~aLg~lakHS~eLAq~VVd~~iLp~Lv 1181 (1342)
...++.+.+..++.+++.-.. ...++ ..+++.|...+++.+ +.+++.++..+|++++..++.-... -..+++.+.
T Consensus 621 ~~~~~~~~l~~l~~l~~~~~~~~~~~l--~~ii~~l~~~l~~~~~~~v~~~a~~~l~~l~~~~~~~~~~~-~~~i~~~l~ 697 (876)
T d1qgra_ 621 SGGVQEDALMAVSTLVEVLGGEFLKYM--EAFKPFLGIGLKNYAEYQVCLAAVGLVGDLCRALQSNIIPF-CDEVMQLLL 697 (876)
T ss_dssp CCHHHHHHHHHHHHHHHHHGGGGGGGH--HHHHHHHHHHHHHCTTHHHHHHHHHHHHHHHHHHGGGGHHH-HHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHHHCCHHHHHHH--HHHHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHH
T ss_conf 863589999999999987221067779--98999999998188858999999999999998727765426-999999999
Q ss_pred HHCCCC--CHHHHHHHHHHHHHHHHCCH
Q ss_conf 201799--82345358899998671698
Q 000706 1182 DRCADP--DKRTRKFACFSIGNAAYHND 1207 (1342)
Q Consensus 1182 ~~L~~~--D~~~Kr~ac~~L~~iAkHs~ 1207 (1342)
..|.+. +..+|.+++.+++.++...+
T Consensus 698 ~~l~~~~~~~~~k~~~~~~i~~i~~~~~ 725 (876)
T d1qgra_ 698 ENLGNENVHRSVKPQILSVFGDIALAIG 725 (876)
T ss_dssp HHHTCTTSCGGGHHHHHHHHHHHHHHHG
T ss_pred HHHCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf 9818766889999999999999999970
|
| >d1qgra_ a.118.1.1 (A:) Importin beta {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Importin beta species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.29 E-value=0.028 Score=30.04 Aligned_cols=173 Identities=14% Similarity=0.143 Sum_probs=83.4
Q ss_pred HHCCCCCCHHHHHHHHHHHHHHHHCHHHHHHHHHCCCHHHHHHHHCCCC--HHHHHHHHHHHHHHHCCCHHHHHHHHCCC
Q ss_conf 5103887247899999999998316658999982896386787404992--66999999999877218799999653169
Q 000706 1098 RLLDSSTREVTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHED--PNVRAKACSALGNMCRHSSYFYSSLAKNR 1175 (1342)
Q Consensus 1098 ~~~~s~~~~~r~~f~~~va~lars~~~~ie~I~~aG~i~LL~~lLqd~e--~siqq~Aa~aLg~lakHS~eLAq~VVd~~ 1175 (1342)
.+-+.+.+++|...+..+.+++|.....+.-. -...++.|...++++. +.+|..+..++|+|+....+-.+..+ ..
T Consensus 657 ~l~~~~~~~v~~~a~~~l~~l~~~~~~~~~~~-~~~i~~~l~~~l~~~~~~~~~k~~~~~~i~~i~~~~~~~~~~yl-~~ 734 (876)
T d1qgra_ 657 GLKNYAEYQVCLAAVGLVGDLCRALQSNIIPF-CDEVMQLLLENLGNENVHRSVKPQILSVFGDIALAIGGEFKKYL-EV 734 (876)
T ss_dssp HHHHCTTHHHHHHHHHHHHHHHHHHGGGGHHH-HHHHHHHHHHHHTCTTSCGGGHHHHHHHHHHHHHHHGGGGGGGH-HH
T ss_pred HHHCCCCHHHHHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHH-HH
T ss_conf 98188858999999999999998727765426-99999999998187668899999999999999999708658789-99
Q ss_pred CHHHHHHHCC---CCCHH--------HHHHHHHHHHHHH---HCC----HHHHHHHHHHHHHHHH---HH--CCCCCHHH
Q ss_conf 3789862017---99823--------4535889999867---169----8889999976799999---61--02785789
Q 000706 1176 IIGLLIDRCA---DPDKR--------TRKFACFSIGNAA---YHN----DVLYEELRRSIPLLAN---IL--ISDEEDKT 1232 (1342)
Q Consensus 1176 iLp~Lv~~L~---~~D~~--------~Kr~ac~~L~~iA---kHs----~~LAe~Vae~~p~lv~---~c--L~D~D~~V 1232 (1342)
+++.|..... +++.. ++..+.-+...+- |-+ ......+.+.++.++. .+ -.+.+..+
T Consensus 735 ~l~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~~~~~~~~~~~ 814 (876)
T d1qgra_ 735 VLNTLQQASQAQVDKSDYDMVDYLNELRESCLEAYTGIVQGLKGDQENVHPDVMLVQPRVEFILSFIDHIAGDEDHTDGV 814 (876)
T ss_dssp HHHHHHHHHTCCCCTTCHHHHHHHHHHHHHHHHHHHHHHHHHHCSSSSCCGGGGGSGGGHHHHHHHHHHHHTCSCCCHHH
T ss_pred HHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCHHH
T ss_conf 99999999862467651568999999999999999999998422321112449999999989999999986488778999
Q ss_pred HHHHHHHHHHHHHC-CHHHHHHHHHCCCHHHHHHHHHCCCC
Q ss_conf 99899999999728-99899999906966999998550653
Q 000706 1233 KANAAGALSNLIRN-SSKLCEDIVSKGAMQALIKLVADCSV 1272 (1342)
Q Consensus 1233 R~nAA~al~~IakH-t~eLAq~VV~aGav~~LVd~~~q~~~ 1272 (1342)
+.+|..+|+.+++. ..+..+.+.+..-+..|++-...+++
T Consensus 815 ~~~~~~~i~~l~~~~g~~~~~~~~~~~~v~~ll~~~~~s~~ 855 (876)
T d1qgra_ 815 VACAAGLIGDLCTAFGKDVLKLVEARPMIHELLTEGRRSKT 855 (876)
T ss_dssp HHHHHHHHHHHHHHHCTHHHHHHHTSHHHHHHHHHHHHCSC
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHCCC
T ss_conf 99999999999999777899988468089999999871998
|
| >d1wa5c_ a.118.1.1 (C:) Exportin Cse1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Exportin Cse1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=96.01 E-value=0.026 Score=30.30 Aligned_cols=80 Identities=13% Similarity=0.086 Sum_probs=45.7
Q ss_pred CCCCHHHHHHHHHHHHHHHC-CCHHHHHHHHCC---CCHHHHHH-----HCC-CCCHHHHHHHHHHHHHHHHCCHHHHHH
Q ss_conf 49926699999999987721-879999965316---93789862-----017-998234535889999867169888999
Q 000706 1143 THEDPNVRAKACSALGNMCR-HSSYFYSSLAKN---RIIGLLID-----RCA-DPDKRTRKFACFSIGNAAYHNDVLYEE 1212 (1342)
Q Consensus 1143 qd~e~siqq~Aa~aLg~lak-HS~eLAq~VVd~---~iLp~Lv~-----~L~-~~D~~~Kr~ac~~L~~iAkHs~~LAe~ 1212 (1342)
....+.+.+..+..++.+|- +.+...-.++++ +...++.. ... -.+.+-||-.|.++..+-.++..+.+.
T Consensus 772 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~l~l~~ll~~~~~~~~~ 851 (959)
T d1wa5c_ 772 NSKTERYVKKLTVFFGLISNKLGSDFLIHFIDEVQDGLFQQIWGNFIITTLPTIGNLLDRKIALIGVLNMVINGQFFQSK 851 (959)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHCHHHHHHHHHTTSTTHHHHHHHHTHHHHGGGCCSHHHHHHHHHHHHHHHHSCHHHHHH
T ss_pred HCCCHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCHHHHHH
T ss_conf 04608999999999999998719999999999843215899999999731410399999999999999986588614257
Q ss_pred HHHHHHHHHH
Q ss_conf 9976799999
Q 000706 1213 LRRSIPLLAN 1222 (1342)
Q Consensus 1213 Vae~~p~lv~ 1222 (1342)
+...+..++.
T Consensus 852 ~~~~~~~~~~ 861 (959)
T d1wa5c_ 852 YPTLISSTMN 861 (959)
T ss_dssp CGGGHHHHHH
T ss_pred HHHHHHHHHH
T ss_conf 9999999999
|
| >d2b6ca1 a.118.1.17 (A:3-215) Hypothetical protein EF3068 {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: BC3264-like domain: Hypothetical protein EF3068 species: Enterococcus faecalis [TaxId: 1351]
Probab=94.37 E-value=0.055 Score=28.07 Aligned_cols=189 Identities=10% Similarity=-0.011 Sum_probs=104.8
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCHHHHHHHHHCCCHHHHHHHC-CCCCCHHHHHHHCCCCCCH
Q ss_conf 669999984555878986509850434620122211248508999988208025888620-4534711143510388724
Q 000706 1028 DMAKAIEEDMGKYIKILMEVGVPGIILRCLEHMELKNLGRPIAFLAKMIGQRSLAVQLVG-KGLLDPNRVRRLLDSSTRE 1106 (1342)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pi~~l~~~~~~~~~~~q~v~-~~~~~~~~~~~~~~s~~~~ 1106 (1342)
|..|| ..|-+|.|--++ -+|.+..-+.+++-+-. -++-. +--.....+..+.++..+|
T Consensus 7 ~pe~A--~~m~~Ymk~~~~-----------------flGV~~P~~r~laK~~~--k~~~~~~~~~~~~l~~~L~~~~~~E 65 (213)
T d2b6ca1 7 NPETA--AKMSAYMKHQFV-----------------FAGIPAPERQALSKQLL--KESHTWPKEKLCQEIEAYYQKTERE 65 (213)
T ss_dssp CHHHH--HHHHHHTTTSSC-----------------CCCCCHHHHHHHTHHHH--HHHTTSCHHHHHHHHHHHHTSSSHH
T ss_pred CHHHH--HHHHHHCCCCCE-----------------EECCCHHHHHHHHHHHH--HHCCCCCHHHHHHHHHHHHCCCHHH
T ss_conf 99999--999987477884-----------------54887699999999999--8667898778999999998386479
Q ss_pred HHHHHHHHHHHHHHHCHHHHHHHHHCCCHHHHHHHHCCCC--HHHHHHHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHC
Q ss_conf 7899999999998316658999982896386787404992--66999999999877218799999653169378986201
Q 000706 1107 VTLDVLMIVSDLARMDKWFYEYINGASMLEFLKDFLTHED--PNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLLIDRC 1184 (1342)
Q Consensus 1107 ~r~~f~~~va~lars~~~~ie~I~~aG~i~LL~~lLqd~e--~siqq~Aa~aLg~lakHS~eLAq~VVd~~iLp~Lv~~L 1184 (1342)
.|.--+..+....+ . ..- ..++.+.-++.+.. -.+-..+-...|.+..|.+++ .+.+..-.
T Consensus 66 ~r~~a~~ll~~~~~-~-~~~------~~l~~~~~~~~~~~~Wd~vD~~~~~i~~~~~~~~~~~---------~~~l~~w~ 128 (213)
T d2b6ca1 66 YQYVAIDLALQNVQ-R-FSL------EEVVAFKAYVPQKAWWDSVDAWRKFFGSWVALHLTEL---------PTIFALFY 128 (213)
T ss_dssp HHHHHHHHHHHTGG-G-CCH------HHHHHGGGGTTTTCSHHHHHHHHHHHHHHHHHSGGGH---------HHHHHHHT
T ss_pred HHHHHHHHHHHHHH-C-CCH------HHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHH---------HHHHHHHH
T ss_conf 99999999999886-0-689------9999999998037409888899999999999826668---------99999998
Q ss_pred CCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHCCCH
Q ss_conf 7998234535889999867169888999997679999961027857899989999999972899899999906966
Q 000706 1185 ADPDKRTRKFACFSIGNAAYHNDVLYEELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCEDIVSKGAM 1260 (1342)
Q Consensus 1185 ~~~D~~~Kr~ac~~L~~iAkHs~~LAe~Vae~~p~lv~~cL~D~D~~VR~nAA~al~~IakHt~eLAq~VV~aGav 1260 (1342)
.+.|...||.++-++-.--+... ....|+.+.. ++.|.+..|+++.+|+|++++|++|+....-++...+
T Consensus 129 ~s~~~w~rR~aiv~~l~~~~~~~-----~~~~~~~~~~-~~~d~e~~i~kAigW~Lre~~k~~p~~v~~fl~~~~L 198 (213)
T d2b6ca1 129 GAENFWNRRVALNLQLMLKEKTN-----QDLLKKAIIY-DRTTEEFFIQKAIGWSLRQYSKTNPQWVEELMKELVL 198 (213)
T ss_dssp TCSSHHHHHHHHHTTTTCGGGCC-----HHHHHHHHHH-TTTCCCHHHHHHHHHHHHHHTTTCHHHHHHHHHHSCC
T ss_pred HCCCHHHHHHHHHHHHHHHHCCC-----HHHHHHHHHH-HCCCHHHHHHHHHHHHHHHHHHHCHHHHHHHHHHCCC
T ss_conf 29979999999998899987556-----7799999998-4799099999999999999987798999999986899
|
| >d1t06a_ a.118.1.17 (A:) Hypothetical protein BC3264 {Bacillus cereus (strain ATCC 14579 / DSM 31) [TaxId: 226900]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: BC3264-like domain: Hypothetical protein BC3264 species: Bacillus cereus (strain ATCC 14579 / DSM 31) [TaxId: 226900]
Probab=93.94 E-value=0.12 Score=25.80 Aligned_cols=81 Identities=12% Similarity=0.049 Sum_probs=62.2
Q ss_pred CHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHH--HHH-HHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCHHHHH
Q ss_conf 378986201799823453588999986716988--899-99976799999610278578999899999999728998999
Q 000706 1176 IIGLLIDRCADPDKRTRKFACFSIGNAAYHNDV--LYE-ELRRSIPLLANILISDEEDKTKANAAGALSNLIRNSSKLCE 1252 (1342)
Q Consensus 1176 iLp~Lv~~L~~~D~~~Kr~ac~~L~~iAkHs~~--LAe-~Vae~~p~lv~~cL~D~D~~VR~nAA~al~~IakHt~eLAq 1252 (1342)
....+-....+.|.+.||++-..+...+.|..+ +-+ .+.+.++.+.. .+.|..+.||++.+|+|++|.+++++|-+
T Consensus 109 ~~~~~~~W~~S~~~w~rRag~~~~~~~~~~~~~~~~~~~~~~~~L~~~~~-~i~d~~~~v~kAv~W~Lr~ig~~~~~l~~ 187 (235)
T d1t06a_ 109 AQDVADKWIASGDELKMSAGWSCYCWLLGNRKDNAFSESKISDMLEMVKD-TIHHSPERTKSAMNNFLNTVAISYVPLHE 187 (235)
T ss_dssp HHHHHHHHHHSCCHHHHHHHHHHHHHHHHHSCGGGSCHHHHHHHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHCGGGHH
T ss_pred HHHHHHHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHH-HCCCCHHHHHHHHHHHHHHHHCCCHHHHH
T ss_conf 89999998649848999999999999998476678877899999999998-55585699999999999998530767789
Q ss_pred HHHHC
Q ss_conf 99906
Q 000706 1253 DIVSK 1257 (1342)
Q Consensus 1253 ~VV~a 1257 (1342)
..+..
T Consensus 188 ~al~~ 192 (235)
T d1t06a_ 188 KAVEI 192 (235)
T ss_dssp HHHHH
T ss_pred HHHHH
T ss_conf 99999
|
| >d1lsha1 a.118.4.1 (A:285-620) Lipovitellin-phosvitin complex, superhelical domain {Lamprey (Ichthyomyzon unicuspis) [TaxId: 30308]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Lipovitellin-phosvitin complex, superhelical domain family: Lipovitellin-phosvitin complex, superhelical domain domain: Lipovitellin-phosvitin complex, superhelical domain species: Lamprey (Ichthyomyzon unicuspis) [TaxId: 30308]
Probab=93.79 E-value=0.15 Score=25.05 Aligned_cols=23 Identities=22% Similarity=0.346 Sum_probs=9.7
Q ss_pred HHHHHHHHHHHHHHHHCCHHHHH
Q ss_conf 78999899999999728998999
Q 000706 1230 DKTKANAAGALSNLIRNSSKLCE 1252 (1342)
Q Consensus 1230 ~~VR~nAA~al~~IakHt~eLAq 1252 (1342)
+.+|..|.+|++.++++.+...+
T Consensus 224 ~~vR~aAi~Alr~~~~~~p~~v~ 246 (336)
T d1lsha1 224 TRVQAEAIMALRNIAKRDPRKVQ 246 (336)
T ss_dssp HHHHHHHHHTTTTGGGTCHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCHHHH
T ss_conf 78999999999876550869999
|
| >d1upka_ a.118.1.15 (A:) Mo25 protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Mo25 protein domain: Mo25 protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.85 E-value=0.5 Score=21.57 Aligned_cols=135 Identities=16% Similarity=0.100 Sum_probs=47.4
Q ss_pred HHHHHHHHHHHHHHH----HCHHHHHHHHH-CCCHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHCCCCHHHH
Q ss_conf 478999999999983----16658999982-8963867874049926699999999987721879999965316937898
Q 000706 1106 EVTLDVLMIVSDLAR----MDKWFYEYING-ASMLEFLKDFLTHEDPNVRAKACSALGNMCRHSSYFYSSLAKNRIIGLL 1180 (1342)
Q Consensus 1106 ~~r~~f~~~va~lar----s~~~~ie~I~~-aG~i~LL~~lLqd~e~siqq~Aa~aLg~lakHS~eLAq~VVd~~iLp~L 1180 (1342)
|-|-|++++++.+-| ++...++||.+ ..++..|...--+++.++ .++.+=|-|-.-+.+|.-|....-.-..
T Consensus 84 E~RKD~~~if~~llR~~~~~~~p~v~Yl~~~~eil~~L~~gye~~eiAl---~~G~mLREcik~e~lak~iL~s~~f~~f 160 (330)
T d1upka_ 84 EGKKDVAQIFNNILRRQIGTRTPTVEYICTQQNILFMLLKGYESPEIAL---NCGIMLRECIRHEPLAKIILWSEQFYDF 160 (330)
T ss_dssp HHHHHHHHHHHHHHTCCBTTBCHHHHHHHTCTHHHHHHHHGGGSTTTHH---HHHHHHHHHHTSHHHHHHHHHSGGGGHH
T ss_pred CHHHHHHHHHHHHHHCCCCCCCCCHHHHHCCHHHHHHHHHHCCCCCHHH---HHHHHHHHHHHHHHHHHHHHCCHHHHHH
T ss_conf 1132299999999616789998608998839789999986328860323---5659999999339999999733889999
Q ss_pred HHHCCCCCHHHHHHHHHHHHHH-HHCCHHHHHHHH---H-HHHHHHHHHCCCCCHHHHHHHHHHHHHHH
Q ss_conf 6201799823453588999986-716988899999---7-67999996102785789998999999997
Q 000706 1181 IDRCADPDKRTRKFACFSIGNA-AYHNDVLYEELR---R-SIPLLANILISDEEDKTKANAAGALSNLI 1244 (1342)
Q Consensus 1181 v~~L~~~D~~~Kr~ac~~L~~i-AkHs~~LAe~Va---e-~~p~lv~~cL~D~D~~VR~nAA~al~~Ia 1244 (1342)
..-+..++--+---|-.+++.+ .+|..--||-+. + .|...-. +|....=.+|+-+--.||+|.
T Consensus 161 F~yv~~~~FdiasDAf~TfkelLt~hk~~~aefl~~Nyd~Ff~~~~~-LL~s~NYVtrRqSlKLLgelL 228 (330)
T d1upka_ 161 FRYVEMSTFDIASDAFATFKDLLTRHKLLSAEFLEQHYDRFFSEYEK-LLHSENYVTKRQSLKLLGELL 228 (330)
T ss_dssp HHHTTCSSHHHHHHHHHHHHHHHHSSHHHHHHHHHHTHHHHHHHHHH-HTTCSSHHHHHHHHHHHHHHH
T ss_pred HHHHCCCCHHHHHHHHHHHHHHHHHCHHHHHHHHHHHHHHHHHHHHH-HHCCCCHHHHHHHHHHHHHHH
T ss_conf 99973871588898999999999708899999999849999999999-964884277998899999998
|
| >d1ho8a_ a.118.1.9 (A:) Regulatory subunit H of the V-type ATPase {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Regulatory subunit H of the V-type ATPase domain: Regulatory subunit H of the V-type ATPase species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=85.60 E-value=0.58 Score=21.16 Aligned_cols=59 Identities=15% Similarity=0.119 Sum_probs=25.7
Q ss_pred CHHHHHHHHHHHHHHHHCCHHHHHHHHHH--HHHHHHHHCCCCCHHHHHHHHHHHHHHHHCC
Q ss_conf 82345358899998671698889999976--7999996102785789998999999997289
Q 000706 1188 DKRTRKFACFSIGNAAYHNDVLYEELRRS--IPLLANILISDEEDKTKANAAGALSNLIRNS 1247 (1342)
Q Consensus 1188 D~~~Kr~ac~~L~~iAkHs~~LAe~Vae~--~p~lv~~cL~D~D~~VR~nAA~al~~IakHt 1247 (1342)
|+.+---||+=||...+|-+.=-..+.+- =..++. ++.+.|+.||++|--|+..+..||
T Consensus 415 D~~~lAVAc~DiGefvr~~P~gr~il~~lg~K~~vM~-Lm~h~d~~Vr~eAL~avQklm~~n 475 (477)
T d1ho8a_ 415 EKIIIQVALNDITHVVELLPESIDVLDKTGGKADIME-LLNHSDSRVKYEALKATQAIIGYT 475 (477)
T ss_dssp HHHHHHHHHHHHHHHHHHCTTHHHHHHHHSHHHHHHH-HTSCSSHHHHHHHHHHHHHHHHHS
T ss_pred CCCEEEHHHHHHHHHHHHCCCHHHHHHHCCCHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHC
T ss_conf 8233313350077999978533679988283999998-864999799999999999999850
|